Compound_Id	Well_Id	Is_Ref	Conc_uM	Rel_Cell_Count	Induction	Cluster_AKT_PI3K_MTOR	Cluster_Aurora	Cluster_BET	Cluster_DNA_Synth	Cluster_HDAC	Cluster_HSP90	Cluster_LCH	Cluster_Na_K-ATPase	Cluster_Protein_Synth	Cluster_Pyrimidine_Synth	Cluster_Tubulin	Cluster_Uncoupler	Cluster_High	Cluster_Sim	Trivial_Name	Known_Act	Chiral	Smiles
247214	247214:04:02_10.00	True	10.0	91	43.4	0.0	0.0	79.6	0.0	74.6	13.9	93.0	28.1	53.5	0.0	72.6	56.3	LCH	93.0	Chlorpromazine hydrochloride	non selective compound: intended target=DRD2, number of targets=174. Dopamine receptor antagonist, anti-emetic, antipsychotic, Dopamine antagonist. Chlorpromazine hydrochloride is used as a substitute for benzidine, o-dianisidine and o-tolidine in the determination of microquantities of hemoglobin and peroxidase.; Wang et al., Evidence-based and quantitative prioritization of tool compounds in phenotypic drug discovery Cell Chem. Biol. 23, 862-874 (2016).	False	CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21
282109	282109:02:03_10.00	True	10.0	98	17.1	0.0	0.0	76.8	0.0	74.4	9.0	87.8	39.9	49.2	0.0	72.5	50.9	LCH	87.8	Dibucaine hydrochloride, Cinchocaine ;hydrochloride	potent, long-acting local anesthetic.	False	CCCCOc1cc(C(=O)NCCN(CC)CC)c2ccccc2n1
406837	406837:01:06_10.00	True	10.0	90	6.2	0.0	20.7	0.0	44.5	0.0	0.0	0.0	0.0	0.0	42.7	0.0	0.0	DNA_Synth	44.5	Molidustat, BAY 85-3934	it is a potent hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor with IC50 of 480 nM, 280 nM, and 450 nM for PHD1, PHD2, and PHD, respectively. In vitro, Molidustat induces the transcription of hypoxia-sensitive genes in HeLa, A549, and Hep3B cells.	False	O=c1c(-n2ccnn2)c[nH]n1-c1cc(N2CCOCC2)ncn1
392894	392894:01:08_10.00	True	10.0	51	22.6	12.8	75.8	0.0	54.5	0.0	31.4	0.0	0.0	0.0	48.2	0.0	0.0	Aurora	75.8	BX-795 hydrochloride	BX-795 was initially characterized as a potent inhbitor of 3-phosphoinositide-dependent kinase-1. Additional studies with BX-795 have shown that the molecule is also a potent dual inhibitor of IKKe and TBK1 which are known to regulate the expression of interferons via the phosphorylation of interferon regulatory factor 3 (IRF3).	False	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1
393275	393275:01:04_09.50	True	9.5	103	5.2	6.1	0.0	0.0	0.0	0.0	0.0	0.0	27.6	0.0	10.9	0.0	0.0	Na_K-ATPase	27.6	Darglitazone	it is a highly potent and selective PPAR-? (peroxisome proliferator-activated receptor-?) agonist. It is a thiazolidinedione approximately 200x more potent than ciglitazone and restores euglycemia and reduced circulating TG and VLDL in the ob/ob mice. It also offers a significant neuroprotection and promotes recovery after a hypoxic-ischemic insult in the diabetic ob/ob mouse.	False	Cc1oc(-c2ccccc2)nc1CCC(=O)c1ccc(CC2SC(=O)NC2=O)cc1
392453	392453:01:07_01.00	True	1.0	91	79.3	0.0	0.0	77.1	0.0	71.7	0.0	86.0	32.8	47.7	0.0	71.5	53.1	LCH	86.0	Bafilomycin A1, Baf-A1	macrolide antibiotic, specific vacuolar-type H-ATPase inhibitor, prevents lysosomal Ca2+ uptake, inhibits endosomal, lysosomal and vacuolar acidification, autophagic degradation by rising pH and thus inactivating the lysosomal acid hydrolases.	True	CO/C1=C\C(C)=C\[C@@H](C)[C@@H](O)[C@H](C)C/C(C)=C/C=C\[C@H](OC)[C@@H]([C@@H](C)[C@@H](O)C(C)[C@@]2(O)C[C@@H](O)[C@H](C)[C@@H](C(C)C)O2)OC1=O
393773	393773:01:07_10.00	True	10.0	102	6.4	54.2	0.0	22.5	0.0	21.6	5.9	33.4	14.4	4.6	0.0	2.8	44.5	AKT_PI3K_MTOR	54.2	Pilaralisib	Pilaralisib (XL147; SAR245408) is a potent and highly selective class I PI3Ks inhibitor with IC50s of 39 nM, 383 nM, 23 nM and 36 nM for PI3K.a., PI3K.b., PI3K.g., and PI3K.d..	False	COc1ccc(Cl)c(Nc2nc3ccccc3nc2NS(=O)(=O)c2cccc(NC(=O)C(C)(C)N)c2)c1
408411	408411:01:03_10.00	True	10.0	98	24.7	0.0	0.0	47.6	0.0	49.7	49.5	61.6	14.7	50.6	0.0	58.7	37.5	LCH	61.6		BI-2545 inhibits human ATX with an IC50 of 2.2 nM. In human whole blood BI-2545 inhibits Autotaxin with an IC50 of 29 nM and in rat whole blood with an IC50 of 96 nM.	True	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2nn[nH]c2c1
407896	407896:01:03_10.00	True	10.0	96	19.9	2.1	0.0	18.4	2.9	14.6	26.2	37.0	4.0	4.3	0.0	36.6	3.1	LCH	37.0	BPTES	it  is a selective inhibitor of Glutaminase GLS1 (KGA), which is found in the kidney and brain, and is positively regulated by myc and strongly expressed in many tumors and tumor cell lines. Glutaminase converts glutamine to glutamate, which is an important excitatory neurotransmitter in brain and can be further oxidized to a-ketoglutarate to feed the tricarboxylic acid (TCA) cycle and to glutathione, which is important for controlling the level of reactive oxygen species (ROS), particularly important for cancer cell growth. BPTES was found to slow growth of glioma cells. BPTES is a noncompetitive inhibitor with a Ki of 3 µM.	False	O=C(Cc1ccccc1)Nc1nnc(CCSCCc2nnc(NC(=O)Cc3ccccc3)s2)s1
407974	407974:01:03_10.00	True	10.0	100	18.5	0.0	0.0	49.6	0.0	51.2	43.5	56.2	18.8	34.6	0.0	57.6	30.3	Tubulin	57.6	GSK8814	it is a chemical probe for the ATAD2/2B bromodomain, with a binding constant pKd=8.1 as measured by ITC (Bamborough et al, 2016). GSK8814 displaces acetylated H4 peptide from the ATAD2 bromodomain with pIC50 =7.3 and is also active in BROMOscan with pKi=8.9. It is more than 100 fold selective over all other bromodomains in the BROMOscan. Importantly, it is more than 1000 fold selective over BRD4. GSK8814 shows cellular target engagement with an EC50 of 2 µM in a NanoBRET assay evaluating the interaction of the NanoLuc-ATAD2 bromodomain with histone H3.3-HaloTag.	True	CO[C@H]1CNC[C@@H](OCC2CCC(F)(F)CC2)[C@@H]1Nc1ncc(-c2cncc(C)c2)c2cc(C)c(=O)[nH]c12
394277	394277:01:05_10.00	True	10.0	81	78.6	0.0	0.0	72.3	0.0	68.4	23.6	87.7	22.8	53.7	0.0	73.9	56.6	LCH	87.7	Golvatinib (E7050)	Golvatinib is an inhibitor of c-Met and VEGFR-2 tyrosine kinase with IC50 values of 14nM and 16nM, respectively. The small molecule compound, golvatinib, is a dual inhibitor of both c-Met and VEGFR-2. It is developed as a therapeutic reagent with more potent antitumor activity. Golvatinib inhibits the autophosphorylation of c-Met in MKN45 cells and inhibits the phosphorylation of VEGFR-2 in HUVECs with IC50 values of 14nM and 16nM, respectively. Golvatinib also inhibits the growth of various tumor cells including MKN45, EBC-1, Hs746T and SNU-5. Besides that, golvatinib effectively suppresses the growth induced by HGF or VEGF with IC50 values of 17nM and 84nM.	False	CN1CCN(C2CCN(C(=O)Nc3ccc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)cn3)CC2)CC1
408406	408406:01:04_10.00	True	10.0	101	27.8	42.2	0.0	29.5	11.5	28.4	26.3	61.0	0.0	3.4	0.0	34.5	38.4	LCH	61.0		SYK propagates signal transduction for a number of immunoreceptor tyrosine-based activation motif¿dependent proinflammatory pathways. BI 1002494 is a potent inhibitor of SYK with an IC50 of 0.8 nM and inhibits in human whole blood the DNP/BSA (dinitroprusside / bovine serum albumine) induced expression of CD63 in basophils with an average IC50 of 115 nM (N=263) as well as in human B cells the goat anti-human IgD induced secretion of CD69 with an IC50 of 810 nM (N=36). A Kinase panel was run (Invitrogen 23/239 kinases hit > 50% INH @ 1 µM).	True	COc1cc(-c2cc3ncccc3c(O[C@H](C)[C@H]3CNC(=O)C3)n2)cc(OC)c1OC
407972	407972:01:03_10.00	True	10.0	103	15.0	63.3	0.0	0.0	60.2	0.0	33.5	0.0	0.0	0.0	74.2	0.0	0.0	Pyrimidine_Synth	74.2	FM-381	FM-381 is a potent covalent reversible inhibitor of JAK3 targeting the unique Cys909. FM-381 has an IC50 of 127 pM for JAK3, with 410, 2700 and 3600-fold selectivity over JAK1, JAK2 and TYK2, respectively.	False	CN(C)C(=O)/C(C#N)=C/c1ccc(-c2nc3cnc4[nH]ccc4c3n2C2CCCCC2)o1
392893	392893:01:06_10.00	True	10.0	96	31.4	58.5	0.0	10.0	49.1	9.7	30.8	53.7	0.0	0.0	21.3	23.7	30.2	AKT_PI3K_MTOR	58.5	Ipatasertib	Ipatasertib (GDC-0068) is a highly selective and ATP-competitive pan-Akt inhibitor with IC50s of 5, 18 and 8 nM for Akt1, Akt2 and Akt3, respectively.	True	CC(C)NC[C@@H](C(=O)N1CCN(c2ncnc3c2[C@H](C)C[C@H]3O)CC1)c1ccc(Cl)cc1
407873	407873:01:03_10.00	True	10.0	98	24.9	63.9	0.0	0.0	73.2	0.0	0.0	0.0	0.0	0.0	84.5	0.0	0.0	Pyrimidine_Synth	84.5	3PO	A cell-permeable dipyridinyl-propenone compound that selectively blocks PFK-2 (6-phosphofructo-2-kinase) activity of PFKFB3 isozyme over PFK-1 (6-phosphofructo-1-kinase) in a mixed-mode manner. Rapidly decreases fructose-2,6-bisphosphate (F-2,6-P2) and 2-deoxyglucose uptake, and lactate secretion; efficiently arrests proliferation of transformed cells (IC50 ~ 1.4 µM in NHBE-ht/LT/ras) and suppresses tumor growth in several xenograft mouse models (70 mg/kg, i.p.). The cytostatic and cytotoxic effects of 3PO is shown to be highly sensitive to the intracellular levels of F-6-P (fructose-6-phosphate) and F-2,6-P2.; Clem, B., et al. 2008. Mol. Cancer Ther. 7, 110.	False	O=C(/C=C/c1cccnc1)c1ccncc1
392758	392758:02:05_10.00	True	10.0	90	14.7	18.7	21.2	0.0	60.0	0.0	35.5	0.0	0.0	0.0	68.1	0.0	0.0	Pyrimidine_Synth	68.1	GNE-7915	GNE-7915 is a potent, selective and brain-penetrant inhibitor of LRRK2 with an IC50 of 9 nM.	False	CCNc1nc(Nc2cc(F)c(C(=O)N3CCOCC3)cc2OC)ncc1C(F)(F)F
407892	407892:01:03_10.00	True	10.0	94	38.7	0.0	0.0	65.9	0.0	67.1	24.7	80.8	27.6	41.2	0.0	70.5	45.7	LCH	80.8	Telaglenastat	Telaglenastat (CB-839) is a first-in-class, selective, reversible and orally active glutaminase 1 (GLS1) inhibitor. Telaglenastat selectively inhibits GLS1 splice variants KGA (kidney-type glutaminase) and GAC (glutaminase C) compared to GLS2. The IC50s are 23 nM and 28 nM for endogenous glutaminase in mouse kidney and brain, respectively. Telaglenastat inudces autophagy and has antitumor activity.	False	O=C(Cc1cccc(OC(F)(F)F)c1)Nc1ccc(CCCCc2nnc(NC(=O)Cc3ccccn3)s2)nn1
392754	392754:02:07_10.00	True	10.0	65	26.3	20.4	0.0	3.6	38.7	4.3	30.4	43.2	0.0	0.0	23.6	22.8	0.0	LCH	43.2	LDC000067	LDC000067 is a highly specific CDK9 inhibitor with an IC50 value of 44±10 nM in vitro.	False	COc1ccccc1-c1cc(Nc2cccc(CS(N)(=O)=O)c2)ncn1
394206	394206:01:05_10.00	True	10.0	54	43.4	16.1	39.0	0.0	42.8	0.0	16.9	0.0	0.0	0.0	56.6	0.0	0.0	Pyrimidine_Synth	56.6	Cdk/Crk Inhibitor, RGB-286147, Cdk7 Inhibitor IV	A cell-permeable pyrazolo-pyrimidinone compound that acts as a potent, selective, and ATP-competitive inhibitor of Cdks (IC50 = 48 nM, 15 nM, 9 nM, 10 nM, 71 nM, and 9 nM for Cdk1/B, Cdk2/E, Cdk3/E, Cdk5/p35, Cdk7/H/MAT1, and Cdk9, respectively). It inhibits Cdk4/D1, Cdk6/D3, and GSK-3ß only at much higher concentrations (IC50 = 839 nM, 282 nM, and 754 nM, respectively) and exhibits little activity towards a panel of 60 other kinases. A broad-spectrum growth inhibitor toward tumor cells, but not non-transformed quiescent fibroblasts.	False	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)nc(O)c12
407970	407970:01:03_10.00	True	10.0	106	31.4	0.0	0.0	55.9	0.0	59.9	30.8	73.0	15.4	32.8	0.0	62.0	35.4	LCH	73.0	A-395	A-395 is an antagonist of polycomb repressive complex 2 (PRC2) protein-protein interactions that potently inhibits the trimeric PRC2 complex (EZH2-EED-SUZ12) with an IC50 of 18 nM.	True	CN(C)[C@H]1CN(C2CCc3cccc(F)c32)C[C@@H]1c1ccc(N2CCN(S(C)(=O)=O)CC2)cc1
407438	407438:01:05_10.00	True	10.0	89	35.8	57.3	11.3	0.0	75.2	0.0	8.2	0.0	0.0	0.0	92.4	0.0	0.0	Pyrimidine_Synth	92.4	Brequinar sodium salt hydrate, Biphenquinate sodium hydrate, DuP 785 hydrate	Brequinar exhibits anti-neoplastic activity against refractory solid tumors in human and mouse models. Continuous treatment is required for depletion of pyrimidine pools in the cancer cells and tumor inhibition. Brequinar inhibits dihydroorotate dehydrogenase (DHODH), the fourth enzyme in the de novo pyrimidine biosynthesis pathway, preventing the synthesis of DNA and RNA. Brequinar has recently been found to have antiviral activity against a broad spectrum of viruses including flaviviruses (dengue virus, West Nile virus, yellow fever virus, and Powassan virus) and also a plus-strand RNA alphavirus (Western equine encephalitis virus) and a negative-strand RNA rhabdovirus (vesicular stomatitis virus).	False	Cc1c(-c2ccc(-c3ccccc3F)cc2)nc2ccc(F)cc2c1C(=O)O
392740	392740:02:05_10.00	True	10.0	90	75.3	0.0	0.0	75.5	0.0	71.4	18.3	89.3	30.3	50.0	0.0	75.0	60.8	LCH	89.3	WZ4003	WZ4003 is the first potent and highly specific NUAK kinase inhibitor with IC50 of 20 nM/100 nM for NUAK1 (ARK5)/NUAK2, without significant inhibition on other 139 kinases.	False	CCC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)ncc2Cl)c1
392722	392722:02:08_10.00	True	10.0	84	29.2	0.0	0.0	51.1	15.1	43.8	0.0	60.7	16.1	46.8	0.0	66.6	57.6	Tubulin	66.6	Triciribine	Triciribine is a DNA synthesis inhibitor, also inhibits Akt and HIV-1 with IC50 of 130 nM and 20 nM, respectively; does not inhibit PI3K/PDK1; 5000-fold less active in cells lacking adenosine kinase. Phase 1/2.	False	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23
407872	407872:01:03_10.00	True	10.0	108	23.3	13.6	0.0	9.5	8.3	7.0	44.5	44.8	0.0	0.0	12.4	26.0	0.0	LCH	44.8	Erastin	a cell-permeable piperazinyl-quinazolinone compound that exhibits oncogene-selective lethality. Shown to bind mitochondrial voltage-dependent anion channels (VDAC) and alter its gating; rapidly induce an oxidative, non-apoptotic cell death in several human tumors harboring activating mutations in the RAS-RAF-MEK signaling (EC50 = 6.0 µM in BJ-TERT/LT/ST/RASV12 cells).; Yagoda, N., et al. 2007. Nature 447, 864.	False	CCOc1ccccc1-n1c(C(C)N2CCN(C(=O)COc3ccc(Cl)cc3)CC2)nc2ccccc2c1=O
407736	407736:01:03_10.00	True	10.0	93	8.8	18.5	0.0	55.0	0.0	54.0	39.7	71.7	21.2	33.4	0.0	55.7	56.5	LCH	71.7	ML347	ML347(DN193719) is a highly selective ALK1/ALK2 inhibitor with IC50s of 46/32 nM; shows >300-fold selectivity for ALK2 vs. ALK3.IC50 value:Target: ALK1/ALK2ML347 has IC50s of 46 and 32 nM, respectively, against ALK1 and ALK2; however, the IC50 against ALK3 is 10,800 nM, >300-fold selective over ALK3. ML347 is completely inactive against allthe other kinases tested (with weak activity against ALK6, 9830 nM and KDR (VEGFR2)19,700 nM). ML347 is potent in the BMP4 cell assay (152 nM).	False	COc1ccc(-c2cnc3c(-c4cccc5ncccc45)cnn3c2)cc1
392895	392895:01:06_10.00	True	10.0	84	40.1	38.0	0.0	32.9	0.0	26.2	43.2	55.2	8.6	20.2	0.0	48.2	44.4	LCH	55.2	GSK2334470	GSK2334470 is a highly specific and potent inhibitor of PDK1 (3-Phosphoinositide dependent protein kinase-1). GSK2334470 can be used in cells to ablate T-loop phosphorylation and activate SGK, S6K1 and RSK as well as suppress the activation of Akt.	True	CNc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2C[C@@H](C(=O)NC3CCCCC3)CC[C@H]2C)n1
408408	408408:01:03_10.00	True	10.0	102	7.3	0.0	0.0	32.6	0.1	32.0	38.0	62.2	0.0	9.9	0.0	49.7	22.2	LCH	62.2	BI-1935	BI-1935 is a potent soluble epoxide hydrolase (sEH) inhibitor for diseases related to cardiovascular disease.	False	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O
407976	407976:01:03_10.00	True	10.0	99	6.4	0.0	0.0	44.8	11.6	46.6	20.9	74.6	7.4	10.9	0.0	54.3	32.0	LCH	74.6	PFI-5	it is a potent inhibitor of SMYD2 lysine methyltransferase. PFI-5 inhibits in vitro methylation of p53K370 with IC50 = 9 nM and has more than 100-fold selectivity over other histone methyltransferases and other non-epigenetic targets. PFI-5 inhibits the methylation of p53K370 in cells with IC50 = 0.9 µM.	True	Cc1cc2c(ncn2C2(C)CN(C(=O)c3ccn(CC4CCN([C@H]5C=CCCCC5)CC4)c3)C2)c(N)n1
393774	393774:01:11_10.00	True	10.0	87	84.1	0.0	0.0	83.2	0.0	78.9	17.7	86.4	39.0	61.6	0.0	83.6	64.1	LCH	86.4	Vps34-IN-1	Vps34-IN-1 is an inhibitor of Vps34 extracted from patent WO2012085815A1, compound example 16a, with an IC50 of 4 nM. Vps34-IN-1 modulates autophagy.	False	CC(C)(O)CNc1ncc(-c2ccnc(Nc3ccnc(Cl)c3)n2)c(CC2CC2)n1
408117	408117:01:02_10.00	True	10.0	95	7.9	17.1	0.0	3.4	0.0	0.0	39.2	24.1	0.0	0.0	13.1	11.6	0.0	HSP90	39.2	(±)-SLV 319	potent and selective CB1 receptor antagonist (Ki = 7.8 nM). Exhibits 1000-fold selectivity for CB1 over CB2 receptors. Inhibits CP 55,940-induced hypotension and WIN 55,212-2-induced hypothermia in vivo. Orally active.	False	C/N=C(/NS(=O)(=O)c1ccc(Cl)cc1)N1CC(c2ccccc2)C(c2ccc(Cl)cc2)=N1
392897	392897:01:08_10.00	True	10.0	82	47.5	81.8	0.0	0.0	61.8	0.0	17.5	12.0	0.0	0.0	55.0	0.0	12.2	AKT_PI3K_MTOR	81.8	BAY 80-6946, Copanlisib	BAY 80-6946 (Copanlisib) is a potent and highly selective reversible PI3K inhibitor for PI3Ka/ß with IC50 of 0.469 nM/3.72 nM. BAY 80-6946 is a phosphoinositide 3-kinase (PI3K) inhibitor with potential antineoplastic activity. BAY 86-9766 inhibits proliferation with IC50 of 147 nM in HuCCT-1 (KRASG12D ) and 137 nM in EGI-1 (KRASG12D ) cell lines. BAY 80-6946 is generally well tolerated through the MTD (maximum tolerated dose) of 0.8 mg/kg. PK (pharmacokinetics) results support weekly dosing. Grade 2/3 hyperglycemia in the first 24 hrs after receiving a dose is common at the MTD. PK, clinical SD and FDG-PET data are consistent with effective exposure and PI3K pathway inhibition.	False	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21
408405	408405:01:03_10.00	True	10.0	58	36.8	0.0	72.5	0.0	34.0	0.0	23.9	19.9	0.0	0.0	14.2	15.6	0.0	Aurora	72.5		BI 831266 is a potent Aurora B inhibitor with an IC50 of 42 nM.	True	CC(C)NC(=O)[C@H]1CCC[C@H]1Nc1nc(Nc2ccc(C(=O)N(C)C3CCN(C)CC3)cc2)ncc1Cl
392551	392551:02:06_10.00	True	10.0	52	43.9	21.5	42.2	0.0	55.7	0.0	5.1	0.0	0.0	0.0	62.6	0.0	0.0	Pyrimidine_Synth	62.6	PHA-793887	PHA-793887 is a pyrrolo[3,4-c]pyrazole that inhibits cyclin-dependent kinases Cdk2/cyclin A, Cdk2/cyclin E, Cdk5/p25, and Cdk7/cyclin H with IC50 values of 8, 8, 5, and 10 nM, respectively. It is more than 6-fold selective for these kinases over Cdk1/cyclin B, Cdk4/cyclin D1, Cdk9/cyclin T, and GSK3ß (IC50s = 60, 62, 138, and 79 nM, respectively). PHA-793887 is cytotoxic to human ovarian A2780, colon HCT116, pancreatic BX-PC3, and leukemic K562, KU812, KCL22, and TOM1 cells both in vitro and in xenograft models. This compound has been examined in patients with solid tumors in phase 1 clinical trials.	False	CC(C)CC(=O)Nc1[nH]nc2c1CN(C(=O)C1CCN(C)CC1)C2(C)C
407971	407971:01:03_10.00	True	10.0	103	19.2	30.1	0.0	45.2	0.0	37.7	42.0	50.7	10.3	25.5	0.0	47.2	51.5	Uncoupler	51.5	A-485	A-485 is a potent and selective catalytic inhibitor of p300/CBP with IC50s of 9.8nM and 2.6nM for p300 and CBP histone acetyltransferase (HAT), respectively.	True	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O
404609	404609:01:13_10.00	True	10.0	86	38.3	16.2	0.0	25.2	0.0	22.5	43.3	34.7	17.7	28.1	0.0	38.1	25.1	HSP90	43.3			True	CC/C1=C/C=C\C[C@@H](C)[C@H](O)[C@@](C)(O)C(=O)[C@@H](C)[C@H](O)[C@@H](C)C(=O)[C@@H](C)[C@H](O)[C@@H](C)/C=C/C(=O)O[C@@H]2C(C)[C@H](CCC1)O[C@]1(CC[C@H](C)[C@H](C[C@@H](C)O)O1)[C@H]2C
408401	408401:01:04_10.00	True	10.0	89	9.2	0.0	0.0	48.3	0.0	49.1	52.3	56.8	14.8	52.8	0.0	62.9	40.2	Tubulin	62.9		BI 99179 inhibits the FAS (type I fatty acid synthase) enzyme isolated form HeLa cells with an IC50 of 79 nM.	True	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1
331830	331830:02:14_10.00	True	10.0	58	28.2	30.4	0.0	42.1	0.0	49.5	53.9	55.6	26.5	27.9	0.0	60.4	60.7	Uncoupler	60.7	PD 407824	PD 407824 is a checkpoint kinase Chk1 and WEE1 inhibitor with IC50s of 47 and 97 nM, respectively. PD 407824 is a chemical BMP sensitizer and increases the sensitivity of cells to sub-threshold amounts of BMP4.	False	O=C1NC(=O)c2c1c(-c1ccccc1)cc1[nH]c3ccc(O)cc3c21
408409	408409:01:03_10.00	True	10.0	97	18.7	0.0	0.0	43.6	0.0	42.3	40.2	58.8	13.9	25.6	0.0	55.7	26.8	LCH	58.8		BI-1950 potently inhibits the binding of LFA-1 to ICAM-1 (intercellular adhesion molecule 1) with a KD value of 9 nM and the production of IL-2 in human PBMC and whole blood with an IC50 value of 3 nM and 120 nM, respectively.	True	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1
392892	392892:01:08_10.00	True	10.0	85	5.7	34.5	0.0	13.2	0.0	11.3	48.3	36.8	0.0	5.9	7.6	22.2	17.8	HSP90	48.3	Idelalisib	The phosphatidylinositol 3-kinase (PI3K) signaling pathway has central roles in cell growth, development, and survival. CAL-101 is a cell permeable inhibitor of the PI3K catalytic subunit p110d (IC50 = 2.5 nM) that demonstrates 40- to 300-fold selectivity against other PI3K class I enzymes (IC50s = 820, 565, and 89 nM for p110a, ß, and ?, respectively). At 1 µM it can block constitutive PI3K signaling in malignant B-cell lines and primary patient tumor cells, resulting in decreased phosphorylation of Akt and other downstream effectors, an increase in poly(ADP-ribose) polymerase, and apoptosis.It has also been shown to inhibit the chemotaxis of chronic lymphocytic leukemia cells and to downregulate the secretion of chemokines triggered by B-cell receptor signaling.	True	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1
280372	280372:09:13_10.00	True	10.0	102	9.3	34.5	0.0	51.3	0.0	47.9	37.9	70.9	5.3	45.9	0.0	54.8	71.9	Uncoupler	71.9	CGS 15943	CGS 15943 is an orally bioavailable non-xanthine Adenosine Receptor antagonist. Its Ki for human A1, A2A, A2B, and A3 Adenosine Receptors are 3.5, 4.2, 16, and 50 nM in transfected CHO cells, respectively. .	False	Nc1nc2ccc(Cl)cc2c2nc(-c3ccco3)nn12
407753	407753:01:02_10.00	True	10.0	75	38.2	37.2	30.6	0.0	93.0	0.0	0.0	0.0	0.0	0.0	76.2	0.0	0.0	DNA_Synth	93.0	SP2509	SP2509 is a potent and selective antagonist of lysine specific demethylase 1 (LSD1) with IC50 of 13 nM.	False	C/C(=N\NC(=O)c1cccc(S(=O)(=O)N2CCOCC2)c1)c1cc(Cl)ccc1O
408413	408413:01:03_10.00	True	10.0	90	19.5	0.0	0.0	29.8	0.0	37.1	39.0	57.0	5.6	21.5	0.0	42.0	13.1	LCH	57.0	BI-3812	BI-3812 is potent and efficacious BCL6 inhibitor, inhibiting the BTB domain of BCL6, with an IC50 of 3 nM; BI-3812 has antitumor activity.	False	CNC(=O)COc1cc2cc(Nc3nc(N4CCC(C(=O)N(C)C)CC4)ncc3Cl)cc(OC)c2n(C)c1=O
407880	407880:01:03_10.00	True	10.0	97	28.2	0.0	0.0	39.9	0.0	38.3	42.3	60.2	8.7	15.5	0.0	53.0	25.2	LCH	60.2	ML385	ML385 is a specific nuclear factor erythroid 2-related factor 2 (NRF2) inhibitor with an IC50 of 1.9 uM.	False	Cc1ccccc1C(=O)N1CCc2cc(-c3nc(NC(=O)Cc4ccc5c(c4)OCO5)sc3C)ccc21
394207	394207:01:06_10.00	True	10.0	65	82.2	0.0	9.6	63.6	0.0	66.3	17.2	80.2	29.4	50.2	0.0	71.0	27.6	LCH	80.2	HTH-01-015	HTH-01-015 is a selective NUAK1/ARK5 inhibitor (IC50 is 100 nM). HTH-01-015 inhibits NUAK1 with >100-fold higher potency than NUAK2 (IC50 of >10 uM).	False	Cc1nc(Nc2cnn(C3CCNCC3)c2)nc2c1N(C)C(=O)c1cc3ccccc3cc1N2C
408414	408414:01:04_10.00	True	10.0	104	7.4	0.0	0.0	39.7	0.0	41.9	47.0	51.8	14.7	49.9	0.0	57.6	32.3	Tubulin	57.6		BI-6901 is the first small molecule inhibitor of the chemokine receptor CCR10. BI-6901 inhibits the CCL27 dependent Ca2+ flux in CHO-K cells stably transfected with human CCR10 and aequorin with an pIC50 of 9.0.	True	CC1CCN(C(=O)[C@@H](CCn2cccc2C#N)NS(=O)(=O)c2cccc3[nH]ccc23)CC1
404608	404608:01:13_10.00	True	10.0	87	39.9	23.6	0.0	60.3	0.0	59.8	2.8	42.3	40.0	48.1	0.0	52.5	95.5	Uncoupler	95.5	FCCP	FCCP is an uncoupler of oxidative phosphorylation (OXPHOS) in mitochondria. FCCP induces activation of PINK1 leading to Parkin Ser65 phosphorylation.	False	N#CC(C#N)=NNc1ccc(OC(F)(F)F)cc1
281007	281007:04:02_10.00	True	10.0	51	58.2	0.0	39.2	15.0	0.0	25.3	60.4	22.0	10.4	47.6	0.0	50.0	10.9	HSP90	60.4	Taxol, Paclitaxel.	antitumor agent, promotes assembly of microtubules and inhibits tubulin disassembly process, antineoplastic.	True	CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C
246711	246711:08:04_10.00	True	10.0	103	9.5	0.0	0.0	67.4	0.0	63.0	40.5	69.4	31.4	49.9	0.0	72.1	55.3	Tubulin	72.1	Troglitazone	Troglitazone is a PPAR.g. agonist, with EC50s of 550 nM and 780 nM for human and murinePPAR.g. receptor, respectively.	False	Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2
382156	382156:02:08_10.00	True	10.0	87	69.9	0.0	0.0	60.9	0.0	57.3	35.9	57.5	22.8	66.3	0.0	72.9	42.6	Tubulin	72.9	CHIR-99021	CHIR-99021 (CT99021) is a potent and selective GSK-3.a./.b. inhibitor with IC50s of 10 nM and 6.7 nM. CHIR-99021 shows >500-fold selectivity for GSK-3 over CDC2, ERK2 and other protein kinases. CHIR-99021 is also a potent Wnt/.b.-catenin signaling pathway activator. CHIR-99021 enhances mouse and human embryonic stem cells self-renewal. CHIR-99021 induces autophagy.	False	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1
407875	407875:01:03_10.00	True	10.0	51	73.2	0.0	0.0	72.9	0.0	69.2	14.1	76.9	40.1	70.1	0.0	78.7	54.9	Tubulin	78.7	Piperlongumine	Piperlongumine is a natural alkaloid isolated from Piper longum Linn, possesses ant-inflammatory, antibacterial, antiangiogenic, antioxidant, antitumor, and antidiabetic activities. Piperlongumine induces ROS, and induces apoptosis in cancer cell lines. Piperlongumine shows anti-cardiac fibrosis activity, suppresses myofibroblast transformation via suppression of the ERK1/2 signaling pathway.	False	COc1cc(/C=C/C(=O)N2CCC=CC2=O)cc(OC)c1OC
394208	394208:01:06_10.00	True	10.0	76	71.0	0.0	0.0	59.7	0.0	58.1	17.9	84.4	18.7	39.2	0.0	65.7	46.2	LCH	84.4	AZ191	AZ191 is a potent inhibitor that selectively inhibits DYRK1B with IC50 of 17 nM.	False	COc1cc(N2CCN(C)CC2)ccc1Nc1nccc(-c2cn(C)c3cnccc23)n1
381944	381944:01:11_10.00	True	10.0	88	52.8	9.2	0.0	65.9	0.0	64.8	11.3	86.6	30.7	21.1	0.0	61.4	58.7	LCH	86.6	PI-103	PI-103 is a potent PI3K and mTOR inhibitor with IC50s of 8 nM, 88 nM, 48 nM, 150 nM, 20 nM, and 83 nM for p110.a., p110.b., p110.d., p110.g., mTORC1, and mTORC2. PI-103 also inhibits DNA-PK with an IC50 of 2 nM. PI-103 induces autophagy.	False	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1
392896	392896:01:08_10.00	True	10.0	94	18.1	67.1	0.0	22.5	20.7	19.3	16.2	47.2	0.0	12.1	5.4	24.5	61.0	AKT_PI3K_MTOR	67.1	Alpelisib	Alpelisib (BYL-719) is a potent, selective, and orally active PI3K.a. inhibitor. Alpelisib (BYL-719) shows efficacy in targeting PIK3CA-mutated cancer. Alpelisib (BYL-719) also inhibits p110.a./p110.g./p110.d./p110.b. with IC50s of 5/250/290/1200 nM, respectively. Antineoplastic activity.	True	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1
392636	392636:02:06_10.00	True	10.0	77	9.3	0.0	37.6	14.7	32.5	11.1	8.6	26.4	12.1	0.0	0.0	55.4	9.8	Tubulin	55.4	MK-5108	MK-5108 is a highly potent and specific inhibitor of Aurora A kinase with an IC50 value of 0.064 nM.	False	O=C(O)[C@]1(Cc2cccc(Nc3nccs3)n2)CC[C@@H](Oc2cccc(Cl)c2F)CC1
408116	408116:01:02_10.00	True	10.0	103	21.2	0.0	0.0	29.1	0.0	27.7	44.2	52.3	5.3	6.2	0.0	42.9	10.7	LCH	52.3	Rimonabant (Hydrochloride)	potent and selective cannabinoid CB1 receptor antagonist (Ki = 1.98 nM). Also acts as an inverse agonist reversing adenylyl cyclase inhibition by WIN 55,212-2 (Cat.No. 1038) (IC50 = 48 nM). Displays no activity at CB2 receptors. Reduces food intake and body weight in orally dosed non-obese Wistar rats.	False	Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1
408407	408407:01:04_10.00	True	10.0	86	7.1	17.1	14.7	0.0	69.7	0.0	28.9	17.2	0.0	0.0	49.2	8.3	0.0	DNA_Synth	69.7	BI-1347	BI-1347 is a potent CDK8 inhibitor extracted from patent WO2017202719A1, product I-003, has an IC50 of 1.1 nM.	False	CN(C)C(=O)Cn1cc(-c2ccc(-c3cncc4ccccc34)cc2)cn1
351488	351488:03:07_10.00	True	10.0	92	83.6	0.0	0.0	73.0	0.0	67.9	12.5	82.9	31.5	56.0	0.0	76.1	54.7	LCH	82.9	MK-2206 (dihydrochloride)	MK-2206 dihydrochloride (MK-2206 (2HCl)) is an orally active allosteric AKT inhibitor with IC50s of 5 nM, 12 nM, and 65 nM for AKT1, AKT2, and AKT3, respectively. MK-2206 dihydrochloride induces autophagy.	False	NC1(c2ccc(-c3nc4ccn5c(O)nnc5c4cc3-c3ccccc3)cc2)CCC1
392654	392654:02:06_10.00	True	10.0	75	31.6	27.8	49.3	0.0	81.9	0.0	4.7	0.0	0.0	0.0	78.4	0.0	0.0	DNA_Synth	81.9	BMS-265246	BMS-265246 is a potent and selective CDK1/2 inhibitor for CDK1/cyclin B and CDK2/cyclin E with IC50 of 6 nM and 9 nM, respectively. IC50 Value: 6 nM(for CDK1/cyclin B); 9 nM(for CDK2/cyclin E)Target: CDK1/2in vitro: BMS-265246 inhibits the activity of Cdk4/cycD (IC50 = 0.23 uM) and prevents A2780 Cytox with IC50 of 0.76 uM. BMS-265246 when bound to Cdk2, shows the inhibitor resides within the ATP purine binding site and forms important H-bonds with Leu83 on the protein backbone. BMS-265246 represents the most potent Cdk/Cdk2 selective analogue from this chemotype. A recent study shows that BMS-265246 inhibits cell proliferation with EC50 ranging from 0.293 uM-0.492 uM in HCT-116 cells. After treatment of BMS-265246, the dominant cell populations are G2-arrested cells having 4N DNA content, large round nuclei, and low DNA intensity.in vivo:	False	CCCCOc1c(C(=O)c2c(F)cc(C)cc2F)cnc2[nH]ncc12
382120	382120:02:04_10.00	True	10.0	91	45.9	0.0	0.0	66.5	0.0	62.9	45.5	73.7	21.6	45.9	0.0	75.4	53.7	Tubulin	75.4	DMH-1	DMH-1 is a potent and selective BMP inhibitor with IC50s of 27/107.9/<5/47.6 nM for ALK1/ALK2/ALK3/ALK6, respectively.	False	CC(C)Oc1ccc(-c2cnc3c(-c4ccnc5ccccc45)cnn3c2)cc1
382142	382142:01:03_10.00	True	10.0	74	31.1	65.7	0.0	0.0	92.4	0.0	1.8	0.0	0.0	0.0	63.2	0.0	0.2	DNA_Synth	92.4	CD437	CD437 is a selective Retinoic Acid Receptor .g. (RAR.g.) agonist.	False	O=C(O)c1ccc2cc(-c3ccc(O)c(C45CC6CC(CC(C6)C4)C5)c3)ccc2c1
382138	382138:01:03_10.00	True	10.0	101	12.3	45.8	8.5	0.0	77.0	0.0	8.2	0.0	0.0	0.0	71.6	0.0	0.0	DNA_Synth	77.0	PD0325901	PD0325901 (PD325901) is an orally active, selective and non-ATP-competitive MEK inhibitor with an IC50 of 0.33 nM. PD0325901 exhibits a Kiapp of 1 nM against activated MEK1 and MEK2. PD0325901 suppresses the expression of p-ERK1/2 and induces apoptosis. PD0325901 has anti-cancer activity for a broad spectrum of human tumor xenografts.	True	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F
382163	382163:01:03_10.00	True	10.0	106	10.4	0.0	0.0	83.1	0.0	81.5	13.8	76.9	45.2	62.5	0.0	67.9	74.0	BET	83.1	Ceramide	Ser/Thr protein phosphatase activator.	True	CCCCCCCCCCCCC/C=C/[C@H](O)[C@H](CO)NC(C)=O
382141	382141:01:03_10.00	True	10.0	100	7.1	0.0	0.0	41.8	0.0	38.0	0.0	33.0	22.6	38.6	0.0	41.2	28.9	BET	41.8	AM580	AM580 is a selective RAR.a. agonist with IC50 and EC50 of 8 nM and 0.36 nM, respectively. 	False	CC1(C)CCC(C)(C)c2cc(C(=O)Nc3ccc(C(=O)O)cc3)ccc21
382167	382167:01:03_10.00	True	10.0	98	5.0	0.0	47.5	21.3	3.1	20.1	15.9	26.8	9.5	25.1	0.0	47.6	0.0	Tubulin	47.6	RepSox	Potent and selective inhibitor of the TGF-ß type I receptor/ALK5 (IC50 values are 4 and 23 nM for TGF-ß type I receptor autophosphorylation and binding respectively). Selective for TGF-ß type I receptor over a range of kinases, including p38 MAPK, JNK1 and GSK3 (IC50 > 16 ¿M). Enhances the efficiency of cellular reprogramming; replaces Sox2 by inducing Nanog expression.; Identification of 1,5-Naphthyridine Derivatives as a Novel Series of Potent and Selective TGF-.beta. Type I Receptor Inhibitors.    J Med Chem (2004),  47(18),  4494-4506.	False	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1
382129	382129:01:03_10.00	True	10.0	100	7.1	65.1	0.0	0.0	73.1	0.0	0.0	0.0	0.0	0.0	80.8	0.0	0.0	Pyrimidine_Synth	80.8	Dexamethasone	anti-inflammatory glucocorticoid, induces differentiation of human MSCs.	True	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=CC4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
408119	408119:01:03_10.00	True	10.0	75	26.8	60.4	11.3	0.0	97.6	0.0	0.0	0.0	0.0	0.0	73.7	0.0	0.0	DNA_Synth	97.6	Gemcitabine HCl, LY188011	it has been used to treat pancreatic cancer and has demonstrated effective anti-tumor activity. Gemcitabine HCl is a DNA synthesis inhibitor with IC50 of 50 nM, 40 nM, 18 nM and 12 nM in PANC1, MIAPaCa2, BxPC3 and Capan2 cells, respectively. Gemcitabine induced NF-?B activity in BxPC-3, PANC-1, and MIA PaCa-2 cells and decreased the level of the NF-?B inhibitor I?Ba in BxPC-3 and PANC-1 cells. Treatment of BxPC-3 cells with low dose Gemcitabine for 48 hours results in a dose-dependent increase in NF-?B binding. In contrast, NF-?B DNA binding is decreased in BxPC-3 cells treated with the higher Gemcitabine doses for 48 h; however, 24-h treatment with these higher doses increases NF-?B binding in BxPC-3 cells.	True	Nc1ccn([C@@H]2O[C@H](CO)C(O)C2(F)F)c(=O)n1
382172	382172:01:03_10.00	True	10.0	93	7.3	0.0	11.9	0.0	14.5	12.8	33.9	14.6	0.0	5.4	12.8	4.8	0.0	HSP90	33.9	(±)-Blebbistatin	enhances survival of human pluripotent stem cells, selective inhibitor of myosin II ATPase activity.	False	Cc1ccc2c(c1)C(=O)C1(O)CCN(c3ccccc3)C1=N2
382173	382173:01:03_10.00	True	10.0	98	6.2	0.0	0.0	40.1	0.0	37.9	30.5	52.1	12.6	29.6	0.0	48.0	17.7	LCH	52.1	WIKI4	WIKI4 is a potent tankyrase inhibitor with an IC50 of 26 nM for TNKS2. WIKI4 potently inhibits Wnt/.b.-catenin signaling and that its half-maximal response dose is 75 nM. WIKI4 mediates its effects on Wnt/.b.-catenin signaling by inhibiting the enzymatic activity of TNKS2. WIKI4 is cytotoxic to SCLC cells with an IC50 value of 0.02 uM.	False	COc1ccc(-n2c(SCCCN3C(=O)c4cccc5cccc(c45)C3=O)nnc2-c2ccncc2)cc1
382155	382155:01:03_10.00	True	10.0	74	46.6	32.6	0.0	29.8	0.0	24.7	68.4	36.6	10.6	41.0	0.0	52.7	50.1	HSP90	68.4	BIO-acetoxime	selective GSK-3a/ß inhibitor, inhibits CD8+ T cell effector differentiation.	False	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)/Nc2ccccc2/1
382165	382165:01:03_10.00	True	10.0	88	30.7	69.0	0.0	0.0	91.5	0.0	9.5	0.0	0.0	0.0	89.6	0.0	0.0	DNA_Synth	91.5	IQ 1	enables Wnt/ß-catenin-driven expansion of ESCs, prevents spontaneous differentiation.	False	CC(=O)c1ccc(/N=N/C(C(N)=O)=C2/NC(C)(C)Cc3ccccc32)cc1
404608	404608:01:15_10.00	True	10.0	76	33.3	26.7	0.0	61.2	0.0	58.1	11.9	46.0	46.0	45.4	0.0	62.3	95.7	Uncoupler	95.7	FCCP	FCCP is an uncoupler of oxidative phosphorylation (OXPHOS) in mitochondria. FCCP induces activation of PINK1 leading to Parkin Ser65 phosphorylation.	False	N#CC(C#N)=NNc1ccc(OC(F)(F)F)cc1
381945	381945:01:12_10.00	True	10.0	102	46.5	0.0	0.0	74.7	0.0	77.3	37.8	63.5	34.6	61.0	0.0	63.7	66.8	HDAC	77.3	Purmorphamine	Purmorphamine (Shh Signaling Antagonist VI) is a smoothened/Smo receptor agonist with an EC50 of 1 uM.	False	c1ccc2c(Oc3nc(Nc4ccc(N5CCOCC5)cc4)c4ncn(C5CCCCC5)c4n3)cccc2c1
351488	351488:02:11_02.00	True	2.0	97	25.7	70.4	0.0	2.7	45.4	7.0	27.6	51.9	0.0	0.0	29.8	7.1	26.0	AKT_PI3K_MTOR	70.4	MK-2206 (dihydrochloride)	MK-2206 dihydrochloride (MK-2206 (2HCl)) is an orally active allosteric AKT inhibitor with IC50s of 5 nM, 12 nM, and 65 nM for AKT1, AKT2, and AKT3, respectively. MK-2206 dihydrochloride induces autophagy.	False	NC1(c2ccc(-c3nc4ccn5c(O)nnc5c4cc3-c3ccccc3)cc2)CCC1
382120	382120:01:07_10.00	True	10.0	97	16.2	0.0	0.0	72.2	0.0	67.2	33.6	68.7	40.8	50.5	0.0	77.4	47.2	Tubulin	77.4	DMH-1	DMH-1 is a potent and selective BMP inhibitor with IC50s of 27/107.9/<5/47.6 nM for ALK1/ALK2/ALK3/ALK6, respectively.	False	CC(C)Oc1ccc(-c2cnc3c(-c4ccnc5ccccc45)cnn3c2)cc1
394206	394206:01:06_10.00	True	10.0	50	47.3	24.8	44.2	0.0	67.0	0.0	21.2	0.0	0.0	0.0	62.4	0.0	0.0	DNA_Synth	67.0	Cdk/Crk Inhibitor, RGB-286147, Cdk7 Inhibitor IV	A cell-permeable pyrazolo-pyrimidinone compound that acts as a potent, selective, and ATP-competitive inhibitor of Cdks (IC50 = 48 nM, 15 nM, 9 nM, 10 nM, 71 nM, and 9 nM for Cdk1/B, Cdk2/E, Cdk3/E, Cdk5/p35, Cdk7/H/MAT1, and Cdk9, respectively). It inhibits Cdk4/D1, Cdk6/D3, and GSK-3ß only at much higher concentrations (IC50 = 839 nM, 282 nM, and 754 nM, respectively) and exhibits little activity towards a panel of 60 other kinases. A broad-spectrum growth inhibitor toward tumor cells, but not non-transformed quiescent fibroblasts.	False	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)nc(O)c12
286060	286060:01:16_10.00	True	10.0	97	20.4	0.0	0.0	59.2	0.0	59.7	9.7	82.9	25.6	9.3	0.0	61.0	22.8	LCH	82.9	Cyclopamine, V. californicum	it inhibits the Hedgehog signaling pathway with an IC50 of 46 nM, and blocks the activity of human Smo receptor expressed in CHO-K1 cells in [3H]Hh-Ag binding assay with an IC50 of 280 nM. Cyclopamine significantly inhibits Hedgehog pathway activity in a dose-dependent manner in gut-derived tumor cell lines expressing Patched (PTCH) mRNA, and induces growth inhibition of those tumor cell lines by 75-95% at the concentration of 3 µM, but ineffective towards the colon tumor cells without PTCH mRNA expression, suggesting the effects of Cyclopamine treatment are Hedgehog pathway related rather than generally cytotoxic. By blocking Hedgehog signaling through direct interaction with Smo, Cyclopamine (10 µM) inhibits the proliferation of SMOhigh Cyclopamine-responsive cell lines L3.6sl and Panc 05.04 by 75-80%, and increases the apoptosis by 2.5- to 3.5-fold, without affecting the BxPC3-SMOlow cell line. Cyclopamine treatment significantly decreases of Snail mRNA and increasea E-cadherin transcripts in the E3LZ10.7 cell line. Independent of inhibition of cell growth, Cyclopamine treatment significantly inhibits the invasive phenotype of Hedgehog-dependent L3.6pl cells, causing a >500-fold reduction in the number of transmigrating cells, but not that of the Hedgehog-independent cell line Panc-1.	False	CC1=C2C[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]2CC[C@]12O[C@@H]1C[C@H](C)CN[C@H]1[C@H]2C
407970	407970:01:04_10.00	True	10.0	92	31.3	0.0	0.0	60.7	0.0	62.1	22.0	85.9	20.1	30.2	0.0	60.8	31.8	LCH	85.9	A-395	A-395 is an antagonist of polycomb repressive complex 2 (PRC2) protein-protein interactions that potently inhibits the trimeric PRC2 complex (EZH2-EED-SUZ12) with an IC50 of 18 nM.	True	CN(C)[C@H]1CN(C2CCc3cccc(F)c32)C[C@@H]1c1ccc(N2CCN(S(C)(=O)=O)CC2)cc1
407872	407872:01:06_10.00	True	10.0	104	22.3	22.6	0.0	0.0	9.1	0.0	50.3	26.8	0.0	0.0	29.3	6.4	0.0	HSP90	50.3	Erastin	a cell-permeable piperazinyl-quinazolinone compound that exhibits oncogene-selective lethality. Shown to bind mitochondrial voltage-dependent anion channels (VDAC) and alter its gating; rapidly induce an oxidative, non-apoptotic cell death in several human tumors harboring activating mutations in the RAS-RAF-MEK signaling (EC50 = 6.0 µM in BJ-TERT/LT/ST/RASV12 cells).; Yagoda, N., et al. 2007. Nature 447, 864.	False	CCOc1ccccc1-n1c(C(C)N2CCN(C(=O)COc3ccc(Cl)cc3)CC2)nc2ccccc2c1=O
390582	390582:02:12_02.00	True	2.0	97	26.3	0.0	0.0	78.6	0.0	72.4	13.9	85.1	33.6	54.7	0.0	73.6	69.6	LCH	85.1	PIK-93	PIK-93 is the first potent, synthetic PI4K (PI4KIII.b.) inhibitor with IC50 of 19 nM, and also inhibits PI3K.g. and PI3K.a. with IC50 of 16 nM and 39 nM, respectively.	False	CC(=O)Nc1nc(C)c(-c2ccc(Cl)c(S(=O)(=O)NCCO)c2)s1
407875	407875:01:07_10.00	True	10.0	52	58.0	0.0	18.4	58.2	0.0	58.7	16.9	67.1	37.8	54.2	0.0	73.2	34.4	Tubulin	73.2	Piperlongumine	Piperlongumine is a natural alkaloid isolated from Piper longum Linn, possesses ant-inflammatory, antibacterial, antiangiogenic, antioxidant, antitumor, and antidiabetic activities. Piperlongumine induces ROS, and induces apoptosis in cancer cell lines. Piperlongumine shows anti-cardiac fibrosis activity, suppresses myofibroblast transformation via suppression of the ERK1/2 signaling pathway.	False	COc1cc(/C=C/C(=O)N2CCC=CC2=O)cc(OC)c1OC
382120	382120:02:05_10.00	True	10.0	97	19.7	0.0	0.0	69.6	0.0	67.3	43.5	70.2	29.2	59.9	0.0	74.0	57.2	Tubulin	74.0	DMH-1	DMH-1 is a potent and selective BMP inhibitor with IC50s of 27/107.9/<5/47.6 nM for ALK1/ALK2/ALK3/ALK6, respectively.	False	CC(C)Oc1ccc(-c2cnc3c(-c4ccnc5ccccc45)cnn3c2)cc1
382156	382156:02:11_10.00	True	10.0	97	70.8	0.0	0.0	70.1	0.0	66.9	25.5	61.2	37.8	64.1	0.0	76.7	42.5	Tubulin	76.7	CHIR-99021	CHIR-99021 (CT99021) is a potent and selective GSK-3.a./.b. inhibitor with IC50s of 10 nM and 6.7 nM. CHIR-99021 shows >500-fold selectivity for GSK-3 over CDC2, ERK2 and other protein kinases. CHIR-99021 is also a potent Wnt/.b.-catenin signaling pathway activator. CHIR-99021 enhances mouse and human embryonic stem cells self-renewal. CHIR-99021 induces autophagy.	False	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1
392894	392894:01:10_10.00	True	10.0	58	19.3	10.2	77.8	0.0	45.9	0.0	39.8	0.0	0.0	0.0	44.1	0.0	0.0	Aurora	77.8	BX-795 hydrochloride	BX-795 was initially characterized as a potent inhbitor of 3-phosphoinositide-dependent kinase-1. Additional studies with BX-795 have shown that the molecule is also a potent dual inhibitor of IKKe and TBK1 which are known to regulate the expression of interferons via the phosphorylation of interferon regulatory factor 3 (IRF3).	False	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1
404607	404607:01:10_10.00	True	10.0	73	45.9	62.8	0.0	0.0	82.5	0.0	26.1	0.0	0.0	0.0	93.8	0.0	0.0	Pyrimidine_Synth	93.8	Myxothiazol	it has been used as a complex IIIQo inhibitor in C. elegans cultures. It has also been used to analyze mitochondrial oxygen transport in rat cells. Myxothiazol, an antibiotic with activity against fungi and insects, is a strong inhibitor of mitochondrial cytochrome b/c1-segment of respiratory chain. Myxothiazol binds to the quinol oxidation (Qo) site of the bc1 complex, blocking electron transfer to the Rieske iron-sulfur protein in the mitochondrial respiratory chain. Oxygen consumption blockage leads to a cytostatic effect that could be reversed. Myxothiazol, as other Epothilones, which are known for their anti tumor activity, contains a thiazole ring that is formed by the incorporation of cysteine into the polyketide backbone.	True	CO/C(=C\C(N)=O)[C@H](C)[C@H](/C=C/c1csc(-c2csc([C@@H](C)/C=C/C=C/C(C)C)n2)n1)OC
407974	407974:01:04_10.00	True	10.0	97	19.2	0.0	0.0	36.6	0.0	43.1	44.2	41.6	18.8	21.2	0.0	48.4	16.1	Tubulin	48.4	GSK8814	it is a chemical probe for the ATAD2/2B bromodomain, with a binding constant pKd=8.1 as measured by ITC (Bamborough et al, 2016). GSK8814 displaces acetylated H4 peptide from the ATAD2 bromodomain with pIC50 =7.3 and is also active in BROMOscan with pKi=8.9. It is more than 100 fold selective over all other bromodomains in the BROMOscan. Importantly, it is more than 1000 fold selective over BRD4. GSK8814 shows cellular target engagement with an EC50 of 2 µM in a NanoBRET assay evaluating the interaction of the NanoLuc-ATAD2 bromodomain with histone H3.3-HaloTag.	True	CO[C@H]1CNC[C@@H](OCC2CCC(F)(F)CC2)[C@@H]1Nc1ncc(-c2cncc(C)c2)c2cc(C)c(=O)[nH]c12
156381	156381:02:02_10.00	True	10.0	96	5.5	46.7	0.0	0.0	66.0	0.0	7.7	0.0	0.0	0.0	46.7	10.1	23.3	DNA_Synth	66.0	Authipyrin	Authipyrin targets mitochondrial complex I directly, leading to the potent inhibition of mitochondrial respiration as well as autophagy.; Bioorg. Med. Chem. 2019, 27 (12), 2444-2448. https://doi.org/10.1016/j.bmc.2019.02.028	False	O=C(c1ccc2c(c1)OCCO2)C1CCN(c2ncnc3sccc23)CC1
382146	382146:01:04_10.00	True	10.0	88	33.5	0.0	0.0	59.6	0.0	72.1	26.3	75.3	41.7	31.3	0.0	53.4	48.6	LCH	75.3	SR 3677 dihydrochloride	SR-3677 is a potent ROCK inhibitor with an IC50 of 3 nM and 56 nM against ROCK-II and ROCK-I, respectively.	False	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1
407891	407891:01:03_10.00	True	10.0	94	17.1	1.6	0.0	52.4	0.0	48.1	34.9	65.3	13.0	22.8	0.0	56.2	40.2	LCH	65.3	TH1217	dCTPP1 Inhibitor.	False	Cc1nc2c([N+](=O)[O-])c(Cl)c(Cl)cc2n1Cc1ccc([B-]23OC(=O)C[N+]2(C)CC(=O)O3)cc1
406475	406475:01:07_10.00	True	10.0	68	9.8	0.0	42.6	0.0	36.9	6.8	21.6	21.2	7.2	0.0	6.8	32.7	0.0	Aurora	42.6	 2,4-Dinitrochlorobenzene, CDNB, ;DNCB	it has been used as alkylating agent to evaluate the depletion of intracellular erythrocyte glutathione (GSH). 1-Chloro-2,4-dinitrobenzene on incubation with erythrocyte undergoes conjugation with erythrocyte glutathione (GSH) to form 2,4-dinitrophenyl-S-glutathione. It is an irreversible inhibitor of human thioredoxin reductase.	False	O=[N+]([O-])c1ccc(Cl)c([N+](=O)[O-])c1
280639	280639:03:03_10.00	True	10.0	99	17.6	0.0	0.0	66.9	0.0	64.4	11.0	83.0	32.5	14.8	0.0	60.6	31.4	LCH	83.0	ML-7 (hydrochloride)	ML-7 hydrochloride is a naphthalene sulphonamide derivative, potently inhibits MLCK (IC50=300 nM). ML-7 hydrochloride also inhibits YAP/TAZ.	False	O=S(=O)(c1cccc2c(I)cccc12)N1CCCNCC1
407976	407976:01:04_10.00	True	10.0	102	8.5	0.0	0.0	54.2	0.0	59.2	29.9	79.6	0.0	36.9	0.0	54.9	31.1	LCH	79.6	PFI-5	it is a potent inhibitor of SMYD2 lysine methyltransferase. PFI-5 inhibits in vitro methylation of p53K370 with IC50 = 9 nM and has more than 100-fold selectivity over other histone methyltransferases and other non-epigenetic targets. PFI-5 inhibits the methylation of p53K370 in cells with IC50 = 0.9 µM.	True	Cc1cc2c(ncn2C2(C)CN(C(=O)c3ccn(CC4CCN([C@H]5C=CCCCC5)CC4)c3)C2)c(N)n1
407878	407878:01:05_10.00	True	10.0	91	5.7	59.0	26.4	0.0	79.1	0.0	10.9	0.0	0.0	0.0	87.2	0.0	0.0	Pyrimidine_Synth	87.2	Elesclomol	Elesclomol is an oxidative stress inducer that induces cancer cell apoptosis.	False	CN(NC(=O)CC(=O)NN(C)C(=S)c1ccccc1)C(=S)c1ccccc1
392896	392896:01:10_10.00	True	10.0	90	21.4	58.3	0.0	35.4	17.7	26.5	17.4	58.2	0.0	36.9	0.0	40.4	67.1	Uncoupler	67.1	Alpelisib	Alpelisib (BYL-719) is a potent, selective, and orally active PI3K.a. inhibitor. Alpelisib (BYL-719) shows efficacy in targeting PIK3CA-mutated cancer. Alpelisib (BYL-719) also inhibits p110.a./p110.g./p110.d./p110.b. with IC50s of 5/250/290/1200 nM, respectively. Antineoplastic activity.	True	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1
382156	382156:01:05_10.00	True	10.0	93	74.6	0.0	0.3	73.5	0.0	70.1	24.3	65.5	38.7	66.4	0.0	79.3	44.2	Tubulin	79.3	CHIR-99021	CHIR-99021 (CT99021) is a potent and selective GSK-3.a./.b. inhibitor with IC50s of 10 nM and 6.7 nM. CHIR-99021 shows >500-fold selectivity for GSK-3 over CDC2, ERK2 and other protein kinases. CHIR-99021 is also a potent Wnt/.b.-catenin signaling pathway activator. CHIR-99021 enhances mouse and human embryonic stem cells self-renewal. CHIR-99021 induces autophagy.	False	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1
391492	391492:02:06_10.00	True	10.0	88	47.3	0.0	0.0	75.1	0.0	73.1	18.3	91.0	34.3	48.2	0.0	73.6	61.6	LCH	91.0	SAR405	the activity of SAR405 was evaluated on a dedicated Vps34 cellular assay. Using a GFP-FYVE¿transfected HeLa cell line, treatment with SAR405 triggered the relocalization of GFP-FYVE inside the cell without affecting GFP intensity. Binding of SAR405 to the ATP site of protein and lipid kinases from the lysate of Jurkat cells was measured after incubation at 1 µM, which is more than 600-fold the KD for recombinant Vps34. Results confirmed very potent binding to endogenous Vps34 (>94% inhibition).	True	C[C@@H]1COCCN1c1cc(=O)n2c(n1)N(Cc1cncc(Cl)c1)[C@H](C(F)(F)F)CC2
351488	351488:03:09_10.00	True	10.0	89	71.8	0.0	0.0	72.1	0.0	70.3	14.1	91.3	32.1	37.2	0.0	69.8	48.9	LCH	91.3	MK-2206 (dihydrochloride)	MK-2206 dihydrochloride (MK-2206 (2HCl)) is an orally active allosteric AKT inhibitor with IC50s of 5 nM, 12 nM, and 65 nM for AKT1, AKT2, and AKT3, respectively. MK-2206 dihydrochloride induces autophagy.	False	NC1(c2ccc(-c3nc4ccn5c(O)nnc5c4cc3-c3ccccc3)cc2)CCC1
392892	392892:01:09_10.00	True	10.0	100	8.3	76.0	0.0	0.0	49.2	0.0	35.4	7.6	0.0	3.9	41.8	0.0	21.8	AKT_PI3K_MTOR	76.0	Idelalisib	The phosphatidylinositol 3-kinase (PI3K) signaling pathway has central roles in cell growth, development, and survival. CAL-101 is a cell permeable inhibitor of the PI3K catalytic subunit p110d (IC50 = 2.5 nM) that demonstrates 40- to 300-fold selectivity against other PI3K class I enzymes (IC50s = 820, 565, and 89 nM for p110a, ß, and ?, respectively). At 1 µM it can block constitutive PI3K signaling in malignant B-cell lines and primary patient tumor cells, resulting in decreased phosphorylation of Akt and other downstream effectors, an increase in poly(ADP-ribose) polymerase, and apoptosis.It has also been shown to inhibit the chemotaxis of chronic lymphocytic leukemia cells and to downregulate the secretion of chemokines triggered by B-cell receptor signaling.	True	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1
351488	351488:01:09_10.00	True	10.0	94	66.7	0.0	0.0	70.1	0.0	68.4	13.9	92.4	29.0	30.9	0.0	66.4	46.8	LCH	92.4	MK-2206 (dihydrochloride)	MK-2206 dihydrochloride (MK-2206 (2HCl)) is an orally active allosteric AKT inhibitor with IC50s of 5 nM, 12 nM, and 65 nM for AKT1, AKT2, and AKT3, respectively. MK-2206 dihydrochloride induces autophagy.	False	NC1(c2ccc(-c3nc4ccn5c(O)nnc5c4cc3-c3ccccc3)cc2)CCC1
394207	394207:01:08_10.00	True	10.0	70	74.4	0.0	22.7	64.7	0.0	69.4	16.6	81.6	34.4	44.4	0.0	70.2	16.6	LCH	81.6	HTH-01-015	HTH-01-015 is a selective NUAK1/ARK5 inhibitor (IC50 is 100 nM). HTH-01-015 inhibits NUAK1 with >100-fold higher potency than NUAK2 (IC50 of >10 uM).	False	Cc1nc(Nc2cnn(C3CCNCC3)c2)nc2c1N(C)C(=O)c1cc3ccccc3cc1N2C
390582	390582:01:09_10.00	True	10.0	97	37.7	49.5	0.0	51.2	0.0	45.7	23.1	73.0	4.9	41.0	0.0	48.9	70.9	LCH	73.0	PIK-93	PIK-93 is the first potent, synthetic PI4K (PI4KIII.b.) inhibitor with IC50 of 19 nM, and also inhibits PI3K.g. and PI3K.a. with IC50 of 16 nM and 39 nM, respectively.	False	CC(=O)Nc1nc(C)c(-c2ccc(Cl)c(S(=O)(=O)NCCO)c2)s1
393773	393773:01:08_10.00	True	10.0	95	21.2	40.0	0.0	47.4	0.0	46.0	36.6	66.9	7.8	24.4	0.0	49.2	59.6	LCH	66.9	Pilaralisib	Pilaralisib (XL147; SAR245408) is a potent and highly selective class I PI3Ks inhibitor with IC50s of 39 nM, 383 nM, 23 nM and 36 nM for PI3K.a., PI3K.b., PI3K.g., and PI3K.d..	False	COc1ccc(Cl)c(Nc2nc3ccccc3nc2NS(=O)(=O)c2cccc(NC(=O)C(C)(C)N)c2)c1
392893	392893:01:08_10.00	True	10.0	89	25.2	87.7	0.0	0.0	75.2	0.0	31.8	19.2	0.0	0.0	55.9	0.0	19.9	AKT_PI3K_MTOR	87.7	Ipatasertib	Ipatasertib (GDC-0068) is a highly selective and ATP-competitive pan-Akt inhibitor with IC50s of 5, 18 and 8 nM for Akt1, Akt2 and Akt3, respectively.	True	CC(C)NC[C@@H](C(=O)N1CCN(c2ncnc3c2[C@H](C)C[C@H]3O)CC1)c1ccc(Cl)cc1
407873	407873:01:07_10.00	True	10.0	95	17.4	76.0	0.0	0.0	81.4	0.0	10.6	0.0	0.0	0.0	86.0	0.0	0.0	Pyrimidine_Synth	86.0	3PO	A cell-permeable dipyridinyl-propenone compound that selectively blocks PFK-2 (6-phosphofructo-2-kinase) activity of PFKFB3 isozyme over PFK-1 (6-phosphofructo-1-kinase) in a mixed-mode manner. Rapidly decreases fructose-2,6-bisphosphate (F-2,6-P2) and 2-deoxyglucose uptake, and lactate secretion; efficiently arrests proliferation of transformed cells (IC50 ~ 1.4 µM in NHBE-ht/LT/ras) and suppresses tumor growth in several xenograft mouse models (70 mg/kg, i.p.). The cytostatic and cytotoxic effects of 3PO is shown to be highly sensitive to the intracellular levels of F-6-P (fructose-6-phosphate) and F-2,6-P2.; Clem, B., et al. 2008. Mol. Cancer Ther. 7, 110.	False	O=C(/C=C/c1cccnc1)c1ccncc1
394208	394208:01:08_10.00	True	10.0	80	69.6	3.2	0.0	56.2	0.0	56.1	20.1	86.2	14.1	29.1	0.0	60.7	42.6	LCH	86.2	AZ191	AZ191 is a potent inhibitor that selectively inhibits DYRK1B with IC50 of 17 nM.	False	COc1cc(N2CCN(C)CC2)ccc1Nc1nccc(-c2cn(C)c3cnccc23)n1
392897	392897:01:09_10.00	True	10.0	86	47.0	93.6	0.0	0.0	70.9	0.0	18.3	4.1	0.0	0.0	59.4	0.0	16.0	AKT_PI3K_MTOR	93.6	BAY 80-6946, Copanlisib	BAY 80-6946 (Copanlisib) is a potent and highly selective reversible PI3K inhibitor for PI3Ka/ß with IC50 of 0.469 nM/3.72 nM. BAY 80-6946 is a phosphoinositide 3-kinase (PI3K) inhibitor with potential antineoplastic activity. BAY 86-9766 inhibits proliferation with IC50 of 147 nM in HuCCT-1 (KRASG12D ) and 137 nM in EGI-1 (KRASG12D ) cell lines. BAY 80-6946 is generally well tolerated through the MTD (maximum tolerated dose) of 0.8 mg/kg. PK (pharmacokinetics) results support weekly dosing. Grade 2/3 hyperglycemia in the first 24 hrs after receiving a dose is common at the MTD. PK, clinical SD and FDG-PET data are consistent with effective exposure and PI3K pathway inhibition.	False	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21
392895	392895:01:07_10.00	True	10.0	84	43.4	62.8	0.0	14.7	28.6	6.2	43.2	53.1	0.0	4.9	16.5	34.7	36.9	AKT_PI3K_MTOR	62.8	GSK2334470	GSK2334470 is a highly specific and potent inhibitor of PDK1 (3-Phosphoinositide dependent protein kinase-1). GSK2334470 can be used in cells to ablate T-loop phosphorylation and activate SGK, S6K1 and RSK as well as suppress the activation of Akt.	True	CNc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2C[C@@H](C(=O)NC3CCCCC3)CC[C@H]2C)n1
382145	382145:01:04_10.00	True	10.0	97	5.5	49.7	0.0	0.0	43.6	0.0	28.1	21.0	0.0	0.7	31.5	0.0	9.3	AKT_PI3K_MTOR	49.7	Y-27632 dihydrochloride	selective p160ROCK inhibitor, increases survival rate of human embryonic stem cells undergoing cryopreservation.	True	C[C@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1
407972	407972:01:04_10.00	True	10.0	97	16.2	82.5	0.0	0.0	79.6	0.0	38.5	0.0	0.0	0.0	78.7	0.0	0.0	AKT_PI3K_MTOR	82.5	FM-381	FM-381 is a potent covalent reversible inhibitor of JAK3 targeting the unique Cys909. FM-381 has an IC50 of 127 pM for JAK3, with 410, 2700 and 3600-fold selectivity over JAK1, JAK2 and TYK2, respectively.	False	CN(C)C(=O)/C(C#N)=C/c1ccc(-c2nc3cnc4[nH]ccc4c3n2C2CCCCC2)o1
407889	407889:01:03_10.00	True	10.0	55	29.5	0.0	89.8	0.0	26.6	0.0	19.5	0.0	0.0	0.0	26.6	0.0	0.0	Aurora	89.8	H-1152 (dihydrochloride)	H-1152 dihydrochloride is a membrane-permeable and selective ROCK inhibitor, with a Ki value of 1.6 nM, and an IC50 value of 12 nM for ROCK2.	True	Cc1cncc2cccc(S(=O)(=O)N3CCCNC[C@@H]3C)c12
407953	407953:01:03_10.00	True	10.0	98	10.4	16.2	0.0	12.8	0.4	9.8	38.0	41.9	0.0	0.0	16.8	22.7	2.2	LCH	41.9	Myokinasib	inhibitor of MLCK.	False	CCOC(=O)[C@@]12Cc3c([nH]c4ccccc34)[C@@](C)(N1)[C@@H]([N+](=O)[O-])[C@@H]2c1c(C)cccc1C
406837	406837:01:07_10.00	True	10.0	103	5.5	0.0	12.2	11.7	28.7	5.8	2.4	31.8	11.8	0.0	7.5	29.4	0.0	LCH	31.8	Molidustat, BAY 85-3934	it is a potent hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor with IC50 of 480 nM, 280 nM, and 450 nM for PHD1, PHD2, and PHD, respectively. In vitro, Molidustat induces the transcription of hypoxia-sensitive genes in HeLa, A549, and Hep3B cells.	False	O=c1c(-n2ccnn2)c[nH]n1-c1cc(N2CCOCC2)ncn1
391492	391492:01:14_10.00	True	10.0	95	21.6	0.0	0.0	66.1	0.0	67.1	24.4	77.4	28.3	45.6	0.0	72.3	39.1	LCH	77.4	SAR405	the activity of SAR405 was evaluated on a dedicated Vps34 cellular assay. Using a GFP-FYVE¿transfected HeLa cell line, treatment with SAR405 triggered the relocalization of GFP-FYVE inside the cell without affecting GFP intensity. Binding of SAR405 to the ATP site of protein and lipid kinases from the lysate of Jurkat cells was measured after incubation at 1 µM, which is more than 600-fold the KD for recombinant Vps34. Results confirmed very potent binding to endogenous Vps34 (>94% inhibition).	True	C[C@@H]1COCCN1c1cc(=O)n2c(n1)N(Cc1cncc(Cl)c1)[C@H](C(F)(F)F)CC2
407863	407863:01:05_10.00	True	10.0	92	52.0	0.0	0.0	66.7	0.0	70.3	34.9	87.0	26.9	44.0	0.0	68.0	44.2	LCH	87.0	AZ82	AZ82 is a selective kinesin-like protein KIFC1 (HSET/KIFC1) inhibitor, with a Ki of 43 nM and an IC50 of 300 nM for KIFC1.	True	CCCc1cc(C(=O)N[C@H](Cc2ccc(-c3cccc(OC(F)(F)F)c3)nc2)C(=O)N[C@@H]2CCNC2)sc1C
406443	406443:01:09_10.00	True	10.0	92	5.0	72.5	1.4	0.0	84.5	0.0	26.0	0.0	0.0	0.0	87.5	0.0	0.0	Pyrimidine_Synth	87.5	KT 5720	Specific, cell-permeable inhibitor of protein kinase A (PKA). No significant effect on protein kinase C (PKC), protein kinase G (PKG) or myosin light chain kinase (MLCK).	True	CCCCCCOC(=O)[C@@]1(O)C[C@@H]2O[C@@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4
407971	407971:01:04_10.00	True	10.0	109	20.9	27.2	0.0	51.1	0.0	47.5	34.6	53.1	22.1	32.6	0.0	44.5	49.3	LCH	53.1	A-485	A-485 is a potent and selective catalytic inhibitor of p300/CBP with IC50s of 9.8nM and 2.6nM for p300 and CBP histone acetyltransferase (HAT), respectively.	True	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O
390583	390583:01:08_10.00	True	10.0	104	38.3	0.0	0.0	89.0	0.0	82.6	6.9	86.1	45.3	63.9	0.0	79.4	68.1	BET	89.0	T-00127-HEV1	novel inhibitor of phophatidylinositol 4-kinase beta (PI4Kß), antienterovirus.	False	COc1ccc(-c2c(C)nn3c(NCCN4CCOCC4)cc(C)nc23)cc1OC
382171	382171:02:10_10.00	True	10.0	99	7.6	35.8	17.2	0.0	71.3	0.0	0.0	0.0	0.0	0.0	83.0	0.0	0.0	Pyrimidine_Synth	83.0	GANT 58	GANT 58 is a potent Gli antagonist that inhibits GLI1-induced transcription with IC50 of 5 uM.	False	c1cc(-c2sc(-c3ccncc3)c(-c3ccncc3)c2-c2ccncc2)ccn1
409343	409343:01:02_01.00	True	1.0	96	5.4	0.0	0.0	21.0	0.0	10.5	28.8	38.2	0.0	16.4	0.0	34.6	0.0	LCH	38.2	BAY-309,control for BAY-826	negative control to BAY-826	False	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1
408428	408428:01:03_10.00	True	10.0	101	18.8	31.8	0.0	21.2	0.0	22.8	44.2	50.8	0.0	0.0	0.0	33.1	27.1	LCH	50.8	PF-670462	PF-670462 is a potent and selective inhibitor of casein kinase (CK1.e. and CK1.d.), with IC50s of 7.7 nM and 14 nM, respectively.	False	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCCCC2)n1
280372	280372:10:06_10.00	True	10.0	84	11.1	30.7	0.0	42.1	1.2	41.3	33.5	71.9	0.0	22.0	0.0	45.5	56.4	LCH	71.9	CGS 15943	CGS 15943 is an orally bioavailable non-xanthine Adenosine Receptor antagonist. Its Ki for human A1, A2A, A2B, and A3 Adenosine Receptors are 3.5, 4.2, 16, and 50 nM in transfected CHO cells, respectively. .	False	Nc1nc2ccc(Cl)cc2c2nc(-c3ccco3)nn12
101008	101008:01:23_10.00	True	10.0	79	5.4	0.0	6.2	26.4	4.3	21.6	31.2	38.8	7.2	0.0	0.0	59.9	5.6	Tubulin	59.9	Centrocountin 1	modulator of centrosome integrity; binds centrosome-associated proteins nucleophosmin (NPM) and Crm1.; Nat. Chem. Biol. 2012, 8, 179	True	COC(=O)C1=CC(C(=O)c2ccccc2O)=CN2CCc3c([nH]c4ccccc34)[C@@]12C(=O)OC
382167	382167:03:05_10.00	True	10.0	98	19.2	0.0	0.0	62.6	0.0	60.8	18.5	76.5	25.0	36.0	0.0	68.8	50.5	LCH	76.5	RepSox	Potent and selective inhibitor of the TGF-ß type I receptor/ALK5 (IC50 values are 4 and 23 nM for TGF-ß type I receptor autophosphorylation and binding respectively). Selective for TGF-ß type I receptor over a range of kinases, including p38 MAPK, JNK1 and GSK3 (IC50 > 16 ¿M). Enhances the efficiency of cellular reprogramming; replaces Sox2 by inducing Nanog expression.; Identification of 1,5-Naphthyridine Derivatives as a Novel Series of Potent and Selective TGF-.beta. Type I Receptor Inhibitors.    J Med Chem (2004),  47(18),  4494-4506.	False	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1
247256	247256:03:02_02.00	True	2.0	94	8.6	21.3	32.1	0.0	77.8	0.0	0.0	0.0	0.0	0.0	73.2	0.0	0.0	DNA_Synth	77.8	Deferoxamine mesylate	iron chelator, which does not readily bind iron from transferrin, hemoglobin, myoglobin or cytochrome. Rescues erastin-induced Ferroptosis.	False	CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN
408878	408878:01:03_10.00	True	10.0	73	31.1	14.1	0.0	18.7	57.5	19.0	26.9	57.6	0.0	0.0	7.0	43.1	19.9	LCH	57.6	SAR405838	SAR405838 is a highly potent and selective MDM2 inhibitor, binds to MDM2 with Ki= 0.88 nM and has high specificity over other proteins.IC50 value: 0.88 nM (Ki) Target: MDM2in vitro: SAR405838 potently inhibits cell growth in cancer cell lines, including SJSA-1 (IC50, 0.092 uM), RS4;11 (IC50, 0.089 uM), LNCaP (IC50, 0.27 uM), and HCT-116 (IC50, 0.20 uM) cells, and displays high selectivity over cancer cell lines with mutated or deleted p53, including SAOS-2 (IC50, >10 uM), PC-3 (IC50, >10 uM), SW620 (IC50, >10 uM), and HCT-116 (p53-/-) (IC50, >20 uM) cells. SAR405838 effectively induces apoptosis in the RS4;11 cell line. SAR405838 potently inhibits cell growth and induces dose-dependent apoptosis in the ABTR1 and ABTR2 sublines, albeit with modestly reduced potency compared with that in the control RS4;11 cell line.in vivo: At well-tolerated dose schedules, SAR405838 achieves either durable tumor regression or complete tumor growth inhibition in mouse xenograft models of SJSA-1 osteosarcoma, RS4;11 acute leukemia, LNCaP prostate cancer and HCT-116 colon cancer. Remarkably, a single oral dose of SAR405838 is sufficient to achieve complete tumor regression in the SJSA-1 model. In the SJSA-1 osteosarcoma, acute lymphoblastic leukemia RS4;11, LNCaP prostate cancer, and HCT-116 colon cancer xenograft model, MI-773 (p.o.) effectively inhibits tumor growth in a dose-dependent manner (10 mg/kg, 30 mg/kg, 50 mg/kg, 100 mg/kg, and 200 mg/kg,). 	True	CC(C)(C)C[C@@H]1N[C@@H](C(=O)N[C@H]2CC[C@H](O)CC2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12
408427	408427:01:03_10.00	True	10.0	59	46.1	38.1	0.0	0.0	39.0	2.0	36.4	27.1	0.0	0.0	30.1	12.7	18.4	DNA_Synth	39.0	SR 3029	a potent, highly specific CK1d/CK1e inhibitor (IC50 values 44 nM and 260 nM for CK1d, and CK1e, respectively), that selectively inhibits breast cancer cell growth and survival. SR-3029 exhibits in vitro and in vivo PK properties suitable for use in xenograft studies of human cancers, including brain cancers.	False	Fc1cccc(-n2cnc3c(NCc4nc5ccc(F)c(F)c5[nH]4)nc(N4CCOCC4)nc32)c1
408573	408573:01:04_10.00	True	10.0	52	24.2	0.0	89.0	0.0	23.6	0.0	8.5	0.0	0.0	0.0	25.8	0.0	0.0	Aurora	89.0	XMU-MP-1	XMU-MP-1 is a reversible and selective MST1/2 inhibitor with IC50s of 71.1 and 38.1 nM, respectively.	False	CN1C(=O)c2sccc2N(C)c2nc(Nc3ccc(S(N)(=O)=O)cc3)ncc21
409966	409966:01:03_10.00	True	10.0	87	26.3	59.2	16.5	0.0	79.0	0.0	31.4	0.0	0.0	0.0	86.4	0.0	0.0	Pyrimidine_Synth	86.4		Dihydroorotate dehydrogenase (DHODH; activity internally confirmed)	False	COc1cc(OC)c2c(c1Cl)OC1(CCC3(CC1C)OCCc1c3[nH]c3ccc(C)cc13)C2=O
410051	410051:01:03_02.00	True	2.0	89	37.0	18.1	0.0	32.8	8.1	25.7	1.2	24.4	22.5	47.3	0.0	42.9	58.6	Uncoupler	58.6	NH125	NH125 is a selective eEF-2 kinase inhibitor with IC50 of 60 nM, >125-fold selectivity over PKC, PKA, and CaMKII, and also a potent histidine kinase inhibitor.	False	CCCCCCCCCCCCCCCC[n+]1ccn(Cc2ccccc2)c1C
410094	410094:01:03_02.00	True	2.0	92	20.9	30.6	0.0	0.0	54.6	0.0	45.3	1.3	0.0	0.0	56.8	0.0	0.0	Pyrimidine_Synth	56.8	Belumosudil	Belumosudil (KD025) is a selective inhibitor of ROCK2 with IC50s of 105 nM and 24 uM for ROCK2 and ROCK1, respectively. Anti-fibrotic properties.	False	CC(C)NC(=O)COc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3ccccc3n2)c1
392714	392714:02:03_02.00	True	2.0	101	18.5	27.3	0.0	32.6	16.9	29.6	32.2	66.8	0.0	26.4	0.0	36.8	34.3	LCH	66.8	Ceritinib	Ceritinib (LDK378) is a selective, orally bioavailable, and ATP-competitive ALK tyrosine kinase inhibitor with an IC50 of 200 pM. Ceritinib (LDK378) also inhibits IGF-1R, InsR, and STK22D with IC50 values of 8, 7, and 23 nM, respectively. Ceritinib (LDK378) shows great antitumor potency.	False	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1
410753	410753:01:03_02.00	True	2.0	98	5.9	0.0	0.0	74.9	0.0	68.0	34.3	67.9	30.2	66.2	0.0	78.3	55.8	Tubulin	78.3	Cyclo(RGDyK) (trifluoroacetate)	Cyclo(RGDyK) trifluoroacetate is a potent and selective .a.V.b.3 integrin inhibitor with an IC50 of 20 nM.	True	NCCCC[C@@H]1NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC1=O
409850	409850:02:03_02.00	True	2.0	101	5.9	0.0	0.0	84.4	0.0	78.2	0.0	69.4	36.3	53.9	0.0	76.1	60.1	BET	84.4	PFI-1	PFI-1 is a selective BET (bromodomain-containing protein) inhibitor for BRD4 with IC50 of 0.22 uM in a cell-free assay.	False	COc1ccccc1S(=O)(=O)Nc1ccc2c(c1)CN(C)C(=O)N2
410694	410694:01:03_02.00	True	2.0	98	20.0	84.4	0.0	0.0	72.9	0.0	8.4	0.0	0.0	0.0	62.4	0.0	7.1	AKT_PI3K_MTOR	84.4	AZD8186	AZD8186 is a PI3K inhibitor, which potently inhibits PI3K.b. (IC50=4 nM) and PI3K.d. (IC5050=12 nM) with selectivity over PI3K.a. (IC50=35 nM) and PI3K.g. (IC50=675 nM).	True	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12
392609	392609:02:03_02.00	True	2.0	101	29.9	85.9	0.0	0.0	75.5	0.0	20.7	0.0	0.0	0.0	65.6	0.0	3.7	AKT_PI3K_MTOR	85.9	CCT128930	CCT128930 is a potent and selective inhibitor of Akt2 (IC50 6 nM) with 28-fold selectivity over the closely related PKA kinase (IC50 168 nM), as well as 20-fold selectivity over p70S6K (IC50 120 nM).	False	NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1
392693	392693:02:03_02.00	True	2.0	92	11.7	40.6	0.0	34.2	0.0	33.2	52.8	47.1	0.0	43.8	0.0	40.4	58.6	Uncoupler	58.6	Linsitinib	Linsitinib (OSI-906) is a potent, selective and orally bioavailable dual inhibitor of the IGF-1 receptor and insulin receptor (IR) with IC50s of 35 and 75 nM, respectively.	False	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1
410074	410074:01:03_02.00	True	2.0	68	46.1	0.0	0.0	61.4	0.0	64.1	52.4	49.3	52.1	50.7	0.0	89.7	59.1	Tubulin	89.7	SB225002	SB225002 is a potent, and selective CXCR2 antagonist with IC50 of 22 nM for inhibiting interleukin IL-8 binding to CXCR2, > 150-fold selectivity over the other 7-TMRs tested.	False	O=C(Nc1ccc([N+](=O)[O-])cc1O)Nc1ccccc1Br
407753	407753:02:03_02.00	True	2.0	85	24.7	39.3	21.8	0.0	95.5	0.0	0.0	0.0	0.0	0.0	69.1	0.0	0.0	DNA_Synth	95.5	SP2509	SP2509 is a potent and selective antagonist of lysine specific demethylase 1 (LSD1) with IC50 of 13 nM.	False	C/C(=N\NC(=O)c1cccc(S(=O)(=O)N2CCOCC2)c1)c1cc(Cl)ccc1O
410730	410730:01:03_02.00	True	2.0	98	12.6	68.2	0.0	0.0	71.3	0.0	35.5	0.0	0.0	0.0	57.0	0.0	0.0	DNA_Synth	71.3	Birinapant	Birinapant (TL32711), a bivalent Smac mimetic, is a potent antagonist for XIAP and cIAP1 with Kds of 45 nM and less than 1 nM, respectively. Birinapant (TL32711) induces the autoubiquitylation and proteasomal degradation of cIAP1 and cIAP2 in intact cells, which results in formation of a RIPK1: caspase-8 complex, caspase-8 activation, and induction of tumor cell death. Birinapant (TL32711) targets TRAF2-associated cIAPs and abrogates TNF-induced NF-.k.B activation.	True	CC[C@H](NC(=O)[C@H](C)NC)C(=O)N1C[C@@H](O)C[C@H]1Cc1c(-c2[nH]c3cc(F)ccc3c2C[C@@H]2C[C@H](O)CN2C(=O)[C@H](CC)NC(=O)[C@H](C)NC)[nH]c2cc(F)ccc12
410688	410688:01:03_02.00	True	2.0	100	29.9	71.9	6.3	0.0	82.0	0.0	8.8	0.0	0.0	0.0	78.8	0.0	0.0	DNA_Synth	82.0	Decernotinib	Decernotinib is a potent, orally active JAK3 inhibitor, with Kis of 2.5, 11, 13 and 11 nM for JAK3, JAK1, JAK2, and TYK2, respectively.	True	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F
410084	410084:01:03_02.00	True	2.0	55	71.7	0.0	47.1	42.3	0.0	50.2	44.3	70.0	15.8	34.8	0.0	64.4	2.8	LCH	70.0	BI-847325	BI-847325 is an ATP competitive dual inhibitor of MEK and aurora kinases (AK) with IC50 values of 4 and 15 nM for human MEK2 and AK-C, respectively.	False	CCNC(=O)C#Cc1ccc2c(/C(=N/c3ccc(CN(C)C)cc3)c3ccccc3)c(O)[nH]c2c1
410698	410698:01:03_02.00	True	2.0	101	8.1	0.0	0.0	28.4	0.0	23.3	48.2	30.5	0.0	41.7	0.0	38.8	20.1	HSP90	48.2	Nirogacestat	Nirogacestat (PF-3084014) is a reversible, orally bioavailable, noncompetitive, and selective .g.-secretase inhibitor with an IC50 of 6.2 nM. Inhibition of Notch signaling by Nirogacestat while minimizing gastrointestinal toxicity presents a promising approach for research of Notch receptor-dependent cancers.	True	CCC[C@H](N[C@H]1CCc2cc(F)cc(F)c2C1)C(=O)Nc1cn(C(C)(C)CNCC(C)(C)C)cn1
410083	410083:01:03_02.00	True	2.0	94	37.8	0.0	0.0	69.2	0.0	67.7	17.6	87.0	20.2	48.0	0.0	65.0	42.1	LCH	87.0	Endoxifen (hydrochloride)	Endoxifen hydrochloride is a key active metabolite of Tamoxifen (TAM) with higher affinity and specificity to estrogen receptor that also inhibits aromatase activity. Endoxifen hydrochloride has the potential for breast cancer study.	False	CC/C(=C(\c1ccc(O)cc1)c1ccc(OCCNC)cc1)c1ccccc1
382167	382167:04:03_02.00	True	2.0	98	9.2	0.0	16.1	52.1	0.0	53.8	15.1	23.8	44.2	46.4	0.0	61.3	24.3	Tubulin	61.3	RepSox	Potent and selective inhibitor of the TGF-ß type I receptor/ALK5 (IC50 values are 4 and 23 nM for TGF-ß type I receptor autophosphorylation and binding respectively). Selective for TGF-ß type I receptor over a range of kinases, including p38 MAPK, JNK1 and GSK3 (IC50 > 16 ¿M). Enhances the efficiency of cellular reprogramming; replaces Sox2 by inducing Nanog expression.; Identification of 1,5-Naphthyridine Derivatives as a Novel Series of Potent and Selective TGF-.beta. Type I Receptor Inhibitors.    J Med Chem (2004),  47(18),  4494-4506.	False	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1
339765	339765:02:03_02.00	True	2.0	53	61.8	0.0	0.0	67.1	0.0	74.4	9.0	33.7	92.8	53.2	0.0	67.9	54.2	Na_K-ATPase	92.8	Ouabain (Octahydrate)	Ouabain Octahydrate is an inhibitor of Na+/K+-ATPase, used for the treatment of congestive heart failure.	True	C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@@H](C6=CC(=O)OC6)CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)[C@H](O)[C@H](O)[C@H]1O
410058	410058:01:03_02.00	True	2.0	89	9.0	7.0	20.4	0.0	53.8	0.0	29.0	26.1	0.0	3.0	14.5	20.1	0.0	DNA_Synth	53.8	HO-3867	HO-3867 is a selective and potent STAT3 inhibitor and shows good antitumor activity.	False	CC1(C)C=C(CN2C/C(=C\c3ccc(F)cc3)C(=O)/C(=C/c3ccc(F)cc3)C2)C(C)(C)N1O
410762	410762:01:03_02.00	True	2.0	95	26.4	0.0	15.0	21.1	10.5	15.0	28.5	42.2	0.0	27.9	0.0	35.0	0.0	LCH	42.2	Linrodostat	Linrodostat (BMS-986205) is a selective and irreversible indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor with an IC50 value of 1.1 nM in IDO1-HEK293 cells. Linrodostat is well tolerated with potent pharmacodynamic activity in advanced cancers.	True	C[C@@H](C(=O)Nc1ccc(Cl)cc1)[C@H]1CC[C@@H](c2ccnc3ccc(F)cc32)CC1
410679	410679:01:03_02.00	True	2.0	95	33.9	0.0	0.0	91.3	0.0	86.1	0.7	68.7	63.6	62.5	0.0	85.7	68.5	BET	91.3	Birabresib	Birabresib (OTX-015) is a potent bromodomain (BRD2/3/4) inhibitor with IC50s ranging from 92 to 112 nM.	True	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)Nc1ccc(O)cc1)c1nnc(C)n1-2
392781	392781:02:03_02.00	True	2.0	102	35.2	16.0	0.0	61.1	0.0	63.3	48.2	55.2	21.5	55.7	0.0	50.1	63.6	Uncoupler	63.6	Fostamatinib	Fostamatinib (R788) is the oral prodrug of the active compound R406. R406 is an orally available and competitive Syk/FLT3 inhibitor with a Ki of 30 nM and an IC50 of 41 nM. R406 also inhibits Lyn (IC50=63 nM) and Lck (IC50=37 nM).	False	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC
409854	409854:02:03_02.00	True	2.0	95	9.2	0.0	0.0	61.3	0.0	61.3	34.1	75.2	2.4	45.5	0.0	62.8	37.2	LCH	75.2	SGC0946	SGC0946 is a highly potent and selective DOT1L methyltransferase inhibitor with IC50 of 0.3 nM; selectively kill mixed lineage leukaemia cells.IC50 value: 0.3 nM(DOT1L) Target: selective DOT1L inhibitorSGC 0946 is over 100-fold selective for other histone methyltransferases/HMTs. SGC 0946 potently reduces H3K79 dimethylation with IC50 of 2.6 nM in A431 cells, and 8.8 nM in MCF10A cells, which potently and selectively kills cells containing an MLL translocation. SGC 0946 is much more potent than its close analog EPZ004777, and serves as an excellent chemical probe for investigating DOT1L and further development of DOT1L inhibitors for cancer therapy.	True	CC(C)N(CCCNC(=O)Nc1ccc(C(C)(C)C)cc1)C[C@H]1O[C@@H](n2cc(Br)c3c(N)ncnc32)[C@H](O)[C@@H]1O
410685	410685:01:03_02.00	True	2.0	93	46.6	0.0	0.0	71.8	0.0	70.5	13.3	91.2	23.9	45.6	0.0	63.3	42.0	LCH	91.2	(S)-Crizotinib	(S)-Crizotinib is a potent and selective MTH1 (mutT homologue) inhibitor with an IC50 of 330 nM. (S)-Crizotinib disrupts nucleotide pool homeostasis via MTH1 inhibition, induces an increase in DNA single strand breaks, activates DNA repair in human colon carcinoma cells, and effectively suppresses tumour growth in animal models.	True	C[C@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl
410699	410699:01:03_02.00	True	2.0	96	6.7	0.0	0.0	29.4	0.0	20.2	32.7	47.5	0.0	33.0	0.0	41.2	20.7	LCH	47.5	PRT062607 (Hydrochloride)	PRT062607 Hydrochloride (P505-15 Hydrochloride) is a highly specific and potent inhibitor of purified Syk (IC50 1-2 nM).	True	NC(=O)c1cnc(N[C@@H]2CCCC[C@@H]2N)nc1Nc1cccc(-n2nccn2)c1
382120	382120:03:03_02.00	True	2.0	99	11.4	0.0	0.0	51.1	0.0	45.4	49.8	53.6	8.8	49.2	0.0	60.5	36.0	Tubulin	60.5	DMH-1	DMH-1 is a potent and selective BMP inhibitor with IC50s of 27/107.9/<5/47.6 nM for ALK1/ALK2/ALK3/ALK6, respectively.	False	CC(C)Oc1ccc(-c2cnc3c(-c4ccnc5ccccc45)cnn3c2)cc1
410700	410700:01:03_02.00	True	2.0	100	18.0	79.3	0.0	0.0	80.6	0.0	41.9	0.0	0.0	0.0	67.9	0.0	8.5	DNA_Synth	80.6	Cobimetinib (GDC-0973, RG7420)	Cobimetinib (GDC-0973, RG7420) is a potent and highly selective MEK1 inhibitor with IC50 of 4.2 nM, showing more than 100-fold selectively for MEK1 over MEK2 and showed no significant inhibition when tested against a panel of more than 100 of serine-threonine and tyrosine kinases. Phase 3.	True	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1
410626	410626:01:03_02.00	True	2.0	98	11.2	5.6	0.0	17.4	1.8	9.2	41.3	34.7	0.0	15.7	0.0	31.4	7.0	HSP90	41.3	Nebivolol HCl	Nebivolol HCl selectively inhibits ß1-adrenoceptor with IC50 of 0.8 nM.	True	O[C@@H](CNC[C@H](O)[C@H]1CCc2cc(F)ccc2O1)[C@@H]1CCc2cc(F)ccc2O1
280184	280184:02:03_02.00	True	2.0	101	5.2	14.5	21.7	0.0	69.5	0.0	22.7	0.8	0.0	0.0	43.5	2.0	0.0	DNA_Synth	69.5	PAC-1	PAC-1 is a procaspase-3 activator that induces apoptosis in cancer cells with an EC50 of 2.08 uM.	False	C=CCc1cccc(/C=N/NC(=O)CN2CCN(Cc3ccccc3)CC2)c1O
393774	393774:02:03_02.00	True	2.0	98	44.9	0.0	0.0	78.1	0.0	75.1	8.2	87.3	28.7	55.3	0.0	71.5	58.8	LCH	87.3	Vps34-IN-1	Vps34-IN-1 is an inhibitor of Vps34 extracted from patent WO2012085815A1, compound example 16a, with an IC50 of 4 nM. Vps34-IN-1 modulates autophagy.	False	CC(C)(O)CNc1ncc(-c2ccnc(Nc3ccnc(Cl)c3)n2)c(CC2CC2)n1
410689	410689:01:03_02.00	True	2.0	98	12.8	20.9	1.5	0.0	65.3	0.0	31.0	13.4	0.0	0.0	37.3	19.4	0.0	DNA_Synth	65.3	GSK 2830371	GSK 2830371 is a highly selective Wip1 phosphatase inhibitor with IC50 of 6 nM.	True	Cc1ncc(Cl)cc1NCc1ccc(C(=O)N[C@@H](CC2CCCC2)C(=O)NC2CC2)s1
392742	392742:02:03_02.00	True	2.0	110	69.1	0.0	0.0	81.4	0.0	82.8	19.3	87.2	43.8	53.1	0.0	74.7	63.2	LCH	87.2	VE-822	VE-822 is an ATR inhibitor with IC50 of 19 nM.	False	CNCc1ccc(-c2cc(-c3nc(-c4ccc(S(=O)(=O)C(C)C)cc4)cnc3N)on2)cc1
392718	392718:02:04_02.00	True	2.0	89	53.0	85.0	0.0	0.0	31.3	0.0	54.0	28.4	0.0	8.8	30.8	2.5	43.5	AKT_PI3K_MTOR	85.0	AZD3463	AZD3463 is a novel orally bioavailable ALK inhibitor with Ki of 0.75 nM, which also inhibits IGF1R with equivalent potency.	False	COc1cc(N2CCC(N)CC2)ccc1Nc1ncc(Cl)c(-c2c[nH]c3ccccc23)n1
409991	409991:01:03_02.00	True	2.0	104	11.7	0.0	0.0	22.6	0.0	20.0	32.2	47.6	0.0	10.9	0.0	36.7	3.9	LCH	47.6	AZ3146	AZ3146 is a reasonably potent and selective Mps1 inhibitor with IC50 of 35 nM for Mps1Cat.	False	COc1cc(OC2CCN(C)CC2)ccc1Nc1ncc2c(n1)n(C1CCCC1)c(=O)n2C
392578	392578:02:03_02.00	True	2.0	84	61.0	0.0	4.0	54.5	0.0	46.7	29.6	62.4	15.1	45.3	0.0	77.9	38.6	Tubulin	77.9	Gandotinib	Gandotinib (LY2784544) is a potent JAK2 inhibitor with IC50 of 3 nM. Gandotinib (LY2784544) also inhibits FLT3, FLT4, FGFR2, TYK2, and TRKB with IC50 of 4, 25, 32, 44, and 95 nM.	False	Cc1cc(Nc2cc(CN3CCOCC3)c3nc(C)c(Cc4ccc(Cl)cc4F)n3n2)[nH]n1
410080	410080:01:03_02.00	True	2.0	96	15.0	0.0	0.0	47.1	0.0	51.1	40.3	68.8	2.5	27.7	0.0	52.5	20.7	LCH	68.8	GSK503	GSK503 is a potent and specific inhibitor of EZH2 methyltransferase with Kiapp values of 3 to 27 nM.	False	Cc1cc(C)c(CNC(=O)c2cc(-c3ccc(N4CCN(C)CC4)nc3)cc3c2c(C)cn3C(C)C)c(O)n1
410757	410757:01:03_02.00	True	2.0	96	46.5	0.0	0.0	54.2	0.0	58.2	34.7	84.2	5.1	31.8	0.0	56.2	24.7	LCH	84.2	Tariquidar	Tariquidar (XR9576) is a potent and specific inhibitor of P-glycoprotein (P-gp) with the high affinity (Kd=5.1 nM).	False	COc1cc2c(cc1OC)CN(CCc1ccc(NC(=O)c3cc(OC)c(OC)cc3NC(=O)c3cnc4ccccc4c3)cc1)CC2
410075	410075:01:03_02.00	True	2.0	96	48.7	0.0	0.0	79.6	0.0	75.0	1.1	84.9	35.2	59.9	0.0	73.6	63.5	LCH	84.9	Vps34-PIK-III	Vps34-PIK-III is a potent and selective inhibitor of VPS34 with an IC50 of 18 nM.	False	Nc1ncc(-c2ccnc(Nc3ccncc3)n2)c(CC2CC2)n1
410608	410608:01:03_02.00	True	2.0	68	48.9	21.9	12.2	3.6	0.0	18.1	99.0	15.3	0.0	33.3	4.2	38.9	27.7	HSP90	99.0	Tanespimycin (17-AAG)	Tanespimycin (17-AAG) is a potent HSP90 inhibitor with IC50 of 5 nM in a cell-free assay, having a 100-fold higher binding affinity for HSP90 derived from tumour cells than HSP90 from normal cells. Phase 2.	True	C=CC/N=C1/C(=O)C=C2NC(=O)/C(C)=C/C=C\[C@H](OC)[C@@H](OC(N)=O)/C(C)=C/[C@H](C)[C@@H](O)[C@@H](OC)C[C@H](C)CC1=C2O
410072	410072:01:03_02.00	True	2.0	83	17.8	0.0	8.0	49.9	0.0	44.6	37.4	48.8	23.7	40.6	0.0	81.7	47.0	Tubulin	81.7	TH287	TH287 is a potent and selective inhibitor of MTH1, with an IC50 of 0.8 nM. TH287 is highly selective towards MTH1, with no relevant inhibition of MTH2, NUDT5, NUDT12, NUDT14, NUDT16, dCTPase, dUTPase and ITPA at 100 uM. TH287 could act as a chemotherapeutic agent for cancer research.	False	CNc1cc(-c2cccc(Cl)c2Cl)nc(N)n1
409860	409860:02:03_02.00	True	2.0	98	49.4	0.0	0.0	65.5	0.0	62.8	0.0	90.3	19.9	31.8	0.0	61.7	35.2	LCH	90.3	UNC0642	UNC0642 is a potent and selective lysine methyltransferases G9a and GLP inhibitor, with an IC50 of <2.5 nM for G9a.	False	COc1cc2c(NC3CCN(C(C)C)CC3)nc(N3CCC(F)(F)CC3)nc2cc1OCCCN1CCCC1
410082	410082:01:03_02.00	True	2.0	96	24.0	0.0	0.0	75.2	0.0	73.7	10.1	90.1	26.4	50.4	0.0	63.9	43.6	LCH	90.1	4-Hydroxytamoxifen (Afimoxifene)	4-Hydroxytamoxifen (Afimoxifene) is the active metabolite of tamoxifen and a selective estrogen receptor (ER) modulator that is widely used in the therapeutic and chemopreventive treatment of breast cancer.	False	CCC(=C(c1ccc(O)cc1)c1ccc(OCCN(C)C)cc1)c1ccccc1
410743	410743:01:03_02.00	True	2.0	98	40.8	0.0	0.0	78.1	0.0	76.7	42.2	77.7	34.9	56.7	0.0	81.8	56.9	Tubulin	81.8	LB42708	LB42708 is an orally active farnesyltransferase (FTase) inhibitor with IC50 of 0.8, 1.2, and 2.0 nM toward H-ras, N-ras, and K-ras, respectively.	False	O=C(c1cn(Cc2cncn2Cc2ccc(Br)cc2)cc1-c1cccc2ccccc12)N1CCOCC1
410064	410064:01:03_02.00	True	2.0	60	39.7	58.0	0.0	0.0	60.5	0.0	23.1	0.0	3.7	21.7	34.6	7.8	44.1	DNA_Synth	60.5	PTC-209 HBr	PTC-209 HBr is the hydrobromide salt of PTC-209, which is a potent and selective BMI-1 inhibitor with IC50 of 0.5 ¿M, and results in irreversible reduction of cancer-initiating cells (CICs).	False	COc1cc(Br)c(Nc2nc(-c3c(C)nc4ncccn34)cs2)c(Br)c1
410693	410693:01:03_02.00	True	2.0	105	7.1	14.8	0.0	61.4	0.0	62.3	21.2	41.2	47.6	48.9	0.0	48.6	71.0	Uncoupler	71.0	Ceralasertib	Ceralasertib (AZD6738) is an orally active and bioavailable inhibitor of ATR kinase with an IC50 of 1 nM.	True	C[C@@H]1COCCN1c1cc(C2([S@](C)(=N)=O)CC2)nc(-c2ccnc3[nH]ccc23)n1
263465	263465:02:03_02.00	True	2.0	96	10.7	23.0	0.0	28.2	0.0	39.4	65.4	29.8	17.3	41.6	0.0	39.1	50.4	HSP90	65.4	FLI-06	FLI-06 is a novel inhibitor of Notch signaling with EC50 of 2.3 ¿M.	False	CC1=C(C(=O)OC2CCCCC2)C(c2ccc([N+](=O)[O-])cc2)C2=C(CC(C)(C)CC2=O)N1
410696	410696:01:03_02.00	True	2.0	95	8.3	66.9	0.0	0.0	71.1	0.0	0.9	0.5	0.0	0.0	39.0	0.0	14.0	DNA_Synth	71.1	SB 239063	SB 239063 is a potent, selective and orally active p38 MAPK inhibitor, exhibits an IC50 of 44 nM for recombinant purified human p38.a., with equipotent inhibitory activity against p38.a. and p38.b.. SB 239063 has no effect on p38.g. or p38.d.. With anti-asthma activity and also be used to enhance memory which is impaired due to aging or medical conditions, such as, AD.	False	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1
410622	410622:01:03_02.00	True	2.0	98	11.7	0.0	7.4	19.1	0.0	15.6	34.3	36.6	0.0	28.2	0.0	28.0	0.0	LCH	36.6	Zosuquidar (LY335979) 3HCl	Zosuquidar (LY335979) 3HCl is a potent modulator of P-glycoprotein-mediated multi-drug resistance with Ki of 60 nM in a cell-free assay. Phase 3.	True	O[C@@H](COc1cccc2ncccc12)CN1CCN([C@@H]2c3ccccc3[C@@H]3[C@H](c4ccccc42)C3(F)F)CC1
407892	407892:02:03_02.00	True	2.0	102	9.0	16.6	0.0	38.4	0.0	31.0	14.5	53.1	0.0	32.5	0.0	40.8	35.7	LCH	53.1	Telaglenastat	Telaglenastat (CB-839) is a first-in-class, selective, reversible and orally active glutaminase 1 (GLS1) inhibitor. Telaglenastat selectively inhibits GLS1 splice variants KGA (kidney-type glutaminase) and GAC (glutaminase C) compared to GLS2. The IC50s are 23 nM and 28 nM for endogenous glutaminase in mouse kidney and brain, respectively. Telaglenastat inudces autophagy and has antitumor activity.	False	O=C(Cc1cccc(OC(F)(F)F)c1)Nc1ccc(CCCCc2nnc(NC(=O)Cc3ccccn3)s2)nn1
410071	410071:01:03_02.00	True	2.0	91	19.5	0.0	0.0	75.0	0.0	78.8	3.6	63.2	59.2	54.0	0.0	75.1	42.5	HDAC	78.8	SD-208	SD-208 is a selectiveTGF-.b.RI (ALK5)inhibitor withIC50of 48 nM, and > 100-fold selectivity over TGF-.b.RII.	False	Fc1ccc(Cl)cc1-c1nc(Nc2ccncc2)c2nccnc2n1
349416	349416:02:03_02.00	True	2.0	100	30.4	86.3	0.0	0.0	69.9	0.0	22.2	0.0	0.0	0.0	72.6	0.0	0.0	AKT_PI3K_MTOR	86.3	PYR-41	PYR-41 is a selective and cell permeable inhibitor of ubiquitin-activating enzyme E1 with an IC50 of < 10 uM, with little activity at E2 and E3.	False	CCOC(=O)c1ccc(N2NC(=O)/C(=C/c3ccc([N+](=O)[O-])o3)C2=O)cc1
410010	410010:01:03_02.00	True	2.0	96	50.8	0.0	0.0	66.3	0.0	63.2	11.9	87.9	23.6	39.7	0.0	60.9	37.3	LCH	87.9	Tenovin-6 (Hydrochloride)	Tenovin-6 Hydrochloride, an analog of Tenovin-1 (HY-13423), is an activator of p53 transcriptional activity. Tenovin-6 Hydrochloride inhibits the protein deacetylase activities of purified human SIRT1, SIRT2, and SIRT3 with IC50s of 21 uM, 10 uM, and 67 uM, respectively. Tenovin-6 Hydrochloride also inhibits dihydroorotate dehydrogenase (DHODH).	False	CN(C)CCCCC(=O)Nc1ccc(NC(=S)NC(=O)c2ccc(C(C)(C)C)cc2)cc1
410702	410702:01:03_02.00	True	2.0	65	44.9	28.9	11.1	0.0	0.0	9.0	98.2	2.1	0.0	22.9	18.6	21.0	21.2	HSP90	98.2	Luminespib	Luminespib (VER-52296) is a potent HSP90 inhibitor with IC50s of 7.8 and 21 nM for HSP90.a. and HSP90.b., respectively.	False	CCNC(=O)c1noc(-c2cc(C(C)C)c(O)cc2O)c1-c1ccc(CN2CCOCC2)cc1
410635	410635:01:03_02.00	True	2.0	96	11.4	16.6	0.0	41.5	0.0	44.3	57.0	54.3	0.0	48.0	0.0	50.1	49.7	HSP90	57.0	Sonidegib (Erismodegib, NVP-LDE225)	Sonidegib (Erismodegib, NVP-LDE225) is a Smoothened (Smo) antagonist, inhibiting Hedgehog (Hh) signaling with IC50 of 1.3 nM (mouse) and 2.5 nM (human) in cell-free assays, respectively. Phase 3.	False	Cc1c(C(=O)Nc2ccc(N3C[C@H](C)O[C@H](C)C3)nc2)cccc1-c1ccc(OC(F)(F)F)cc1
392462	392462:03:03_02.00	True	2.0	101	52.3	0.0	0.0	82.7	0.0	78.2	25.9	77.4	38.8	59.5	0.0	79.0	59.2	BET	82.7	PP2	PP2 is a reversible and ATP-competitive Src family kinases inhibitor with IC50s of 4 and 5 nM for Lck and Fyn, respectively.	False	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21
410624	410624:01:03_02.00	True	2.0	61	83.4	0.0	0.0	74.1	0.0	74.6	45.8	71.9	49.4	69.3	0.0	87.1	58.7	Tubulin	87.1	AZD-7762	AZD7762 is a potent and selective inhibitor of Chk1 with IC50 of 5 nM in a cell-free assay. It is equally potent against Chk2 and less potent against CAM, Yes, Fyn, Lyn, Hck and Lck. Phase 1.	True	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1
410069	410069:01:03_02.00	True	2.0	76	63.4	0.0	0.0	83.8	0.0	92.4	26.0	68.0	70.2	62.3	0.0	84.3	70.2	HDAC	92.4	CAY10603	CAY10603 (BML-281) is a potent and selective HDAC6 inhibitor, with an IC50 of 2 pM; CAY10603 (BML-281) also inhibits HDAC1, HDAC2, HDAC3, HDAC8, HDAC10, with IC50s of 271, 252, 0.42, 6851, 90.7 nM.	False	CC(C)(C)OC(=O)Nc1ccc(-c2cc(C(=O)NCCCCCCC(=O)NO)no2)cc1
410665	410665:01:03_02.00	True	2.0	97	6.7	52.6	6.8	0.0	53.0	0.0	38.3	0.0	0.0	17.1	35.4	0.0	4.0	DNA_Synth	53.0	GDC-0152	GDC-0152 is a potent antagonist of XIAP-BIR3, ML-IAP-BIR3, cIAP1-BIR3 and cIAP2-BIR3 with Ki of 28 nM, 14 nM, 17 nM and 43 nM in cell-free assays, respectively less affinity shown to cIAP1-BIR2 and cIAP2-BIR2. Phase 1.	True	CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)Nc1snnc1-c1ccccc1)C1CCCCC1
410017	410017:01:03_02.00	True	2.0	94	37.3	0.0	0.0	65.8	0.0	70.0	7.7	84.2	23.1	38.7	0.0	59.7	24.0	LCH	84.2	Tepotinib (EMD 1214063)	Tepotinib (EMD 1214063) is a potent and selective c-Met inhibitor with IC50 of 4 nM, >200-fold selective for c-Met than IRAK4, TrkA, Axl, IRAK1, and Mer. Phase 1.	False	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1
410664	410664:01:03_02.00	True	2.0	63	43.7	45.0	22.9	0.0	92.5	0.0	14.3	0.0	0.0	0.0	72.0	0.0	0.0	DNA_Synth	92.5	SN-38	SN-38 is an active metabolite of CPT-11, inhibits DNA topoisomerase I, DNA synthesis and causes frequent DNA single-strand breaks.	True	CCc1c2c(nc3ccc(O)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC
246646	246646:02:03_02.00	True	2.0	86	10.7	0.9	67.6	0.0	62.0	0.0	8.5	0.0	0.0	0.0	62.7	0.0	0.0	Aurora	67.6	Irinotecan (hydrochloride)	Irinotecan hydrochloride ((+)-Irinotecan hydrochloride) is a topoisomerase I inhibitor mainly used to treat colon cancer and rectal cancer.	True	CCc1c2c(nc3ccc(OC(=O)N4CCC(N5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC
410605	410605:01:03_02.00	True	2.0	97	22.1	76.4	0.0	0.0	74.6	0.0	54.4	0.0	0.0	0.0	63.3	0.0	0.1	AKT_PI3K_MTOR	76.4	GSK690693	GSK690693 is a pan-Akt inhibitor targeting Akt1/2/3 with IC50 of 2 nM/13 nM/9 nM in cell-free assays, also sensitive to the AGC kinase family: PKA, PrkX and PKC isozymes. Phase 1.	True	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21
382121	382121:02:03_02.00	True	2.0	101	23.3	0.9	0.0	60.0	0.0	54.2	34.4	71.8	9.0	51.5	0.0	65.3	49.3	LCH	71.8	Forskolin	Forskolin (Coleonol) is a potent adenylate cyclase activator with an IC50 of 41 nM and an EC50 of 0.5 uM for type I adenylyl cyclase. Forskolin is also an inducer of intracellular cAMP formation. Forskolin induces differentiation of various cell types and activates pregnane X receptor (PXR) and FXR. Forskolin exerts a inotropic effect on the heart, and has platelet antiaggregatory and antihypertensive actions. Forskolin also induces autophagy.	True	C=C[C@@]1(C)CC(=O)[C@@]2(O)[C@](C)(O1)[C@@H](OC(C)=O)[C@@H](O)[C@H]1C(C)(C)CC[C@H](O)[C@@]12C
410613	410613:01:03_02.00	True	2.0	72	66.1	0.0	0.0	61.9	0.0	54.7	35.4	55.0	39.1	50.3	0.0	90.8	57.8	Tubulin	90.8	2-Methoxyestradiol (2-MeOE2)	2-Methoxyestradiol (2-MeOE2) depolymerizes microtubules and blocks HIF-1¿ nuclear accumulation and HIF-transcriptional activity. Phase 2.	True	COc1cc2c(cc1O)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12
409844	409844:02:03_02.00	True	2.0	78	31.6	38.8	0.0	0.0	85.4	0.0	22.7	13.8	0.0	0.0	50.6	10.5	1.6	DNA_Synth	85.4	RG7112	RG7112 is a potent, selective, first clinical, orally active and blood-brain barrier crossed MDM2-p53 inhibitor, with an IC50 of 18 nM and a KD of 11 nM for binding to MDM2.	True	CCOc1cc(C(C)(C)C)ccc1C1=N[C@@](C)(c2ccc(Cl)cc2)[C@@](C)(c2ccc(Cl)cc2)N1C(=O)N1CCN(CCCS(C)(=O)=O)CC1
410032	410032:01:03_02.00	True	2.0	95	19.5	5.8	0.0	51.5	0.0	54.3	37.0	77.1	0.0	36.3	0.0	49.9	49.1	LCH	77.1	DBeQ	DBeQ is a selective, potent, reversible, and ATP-competitive p97 inhibitor, with an IC50 value of 1.5 uM and 1.6 uM for p97(wt) and p97(C522A), respectively; DBeQ also inhibits Vps4 with an IC50 of 11.5 uM.	False	c1ccc(CNc2nc(NCc3ccccc3)c3ccccc3n2)cc1
410066	410066:01:03_02.00	True	2.0	91	32.0	48.8	0.0	6.9	41.1	1.1	11.6	39.7	0.0	0.0	11.2	19.4	37.9	AKT_PI3K_MTOR	48.8	CL-387785	CL-387785(EKI785; WAY-EKI 785) is an irreversible inhibitor of EGFR with IC50 of 370 pM.	False	CC#CC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1
410633	410633:01:03_02.00	True	2.0	99	11.7	3.2	0.0	72.9	0.0	69.7	38.4	63.9	26.6	68.4	0.0	67.9	77.2	Uncoupler	77.2	Atorvastatin Calcium	Atorvastatin Calcium is an inhibitor of HMG-CoA reductase used as a cholesterol-lowering medication that blocks the production of cholesterol.	True	CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)O
410065	410065:01:03_02.00	True	2.0	54	66.3	0.0	39.5	52.7	0.0	66.8	47.1	34.9	55.3	47.1	0.0	79.4	25.1	Tubulin	79.4	Domatinostat	Domatinostat (4SC-202 free base) is a selective class I HDAC inhibitor with IC50 of 1.20 uM, 1.12 uM, and 0.57 uM for HDAC1, HDAC2, and HDAC3, respectively. It also displays inhibitory activity against Lysine specific demethylase 1 (LSD1).	False	Cn1cc(-c2ccc(S(=O)(=O)n3ccc(/C=C/C(=O)Nc4ccccc4N)c3)cc2)cn1
392637	392637:02:03_02.00	True	2.0	79	57.7	50.0	3.3	0.0	68.4	0.0	42.6	37.2	0.0	0.0	27.3	9.7	1.2	DNA_Synth	68.4	Crenolanib	Crenolanib (CP-868596) is a potent and selective inhibitor of PDGFR¿/ß with Kd of 2.1 nM/3.2 nM, also potently inhibits FLT3, sensitive to D842V mutation not V561D mutation, >100-fold more selective for PDGFR than c-Kit, VEGFR-2, TIE-2, FGFR-2, EGFR, erbB2, and Src.	False	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1
410035	410035:01:03_02.00	True	2.0	73	39.7	66.9	8.3	0.0	89.9	0.0	11.2	0.0	0.0	0.0	72.3	0.0	0.0	DNA_Synth	89.9	Selinexor (KPT-330)	Selinexor (KPT-330) is an orally bioavailable selective CRM1 inhibitor. Phase 2.	False	O=C(/C=C\n1cnc(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)n1)NNc1cnccn1
410285	410285:02:03_02.00	True	2.0	98	43.5	0.0	0.0	66.0	0.0	65.4	24.1	93.8	13.3	36.4	0.0	62.3	43.9	LCH	93.8	Nemiralisib	Nemiralisib (GSK2269557 free base) is a potent and highly selective PI3K.d. inhibitor with a pKi of 9.9.	False	CC(C)N1CCN(Cc2cnc(-c3cc(-c4cccc5[nH]ccc45)cc4[nH]ncc34)o2)CC1
410135	410135:01:03_02.00	True	2.0	97	9.7	22.6	0.0	24.3	25.2	23.1	3.7	49.1	0.0	20.1	0.0	24.8	30.0	LCH	49.1	TAK-580	TAK-580 (MLN 2480) is an orally active and selective inhibitor of pan-Raf kinase.	True	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1
410021	410021:01:03_02.00	True	2.0	65	37.1	62.7	7.7	0.0	89.3	0.0	0.3	0.0	0.0	0.0	69.2	0.0	0.0	DNA_Synth	89.3	KPT-185	KPT-185 is a selective CRM1 inhibitor that induces growth inhibition and apoptosis in a panel of NHL cell lines with a median IC50 ~25 nM.	False	COc1cc(-c2ncn(/C=C\C(=O)OC(C)C)n2)cc(C(F)(F)F)c1
410081	410081:01:03_02.00	True	2.0	90	15.2	61.8	2.7	0.0	85.9	0.0	45.8	0.0	0.0	0.0	73.4	0.0	0.0	DNA_Synth	85.9	AI-10-49	AI-10-49 is a protein-protein interaction inhibitor that selectively binds to CBF.b.-SMMHC and disrupts its binding to RUNX1 with a FRET IC50 of 0.26 uM.IC50 value: 0.26 uM Target: CBF.b.-SMMHC/RUNX1 interaction inhibitorAI-10-49 restores RUNX1 transcriptional activity, displays favorable pharmacokinetics,and delays leukemia progression in mice. Treatment of primary inv(16) AML patient blasts with AI-10-49 triggers selective cell death. These data suggest that direct inhibition of the oncogenic CBF.b.-SMMHC fusion protein may be an effective therapeutic approach for inv(16) AML, and they provide support for transcription factor targeted therapy in other cancers.	False	FC(F)(F)Oc1ccc2[nH]c(-c3ccc(OCCOCCOc4ccc(-c5nc6cc(OC(F)(F)F)ccc6[nH]5)nc4)cn3)nc2c1
410020	410020:01:03_02.00	True	2.0	69	52.3	41.4	9.3	0.0	92.7	0.0	15.8	0.0	0.0	0.0	61.6	0.0	0.0	DNA_Synth	92.7	SC144	SC144 is a first-in-class, orally active gp130 (IL6-beta) inhibitor. SC144 binds gp130, induces gp130 phosphorylation (S782) and deglycosylation, abrogates Stat3 phosphorylation and nuclear translocation, and further inhibits the expression of downstream target genes. SC144 shows potent inhibition of gp130 ligand-triggered signaling. SC144 induces apoptosis in human ovarian cancer cells.	False	O=C(NNc1nc2cc(F)ccc2n2cccc12)c1cnccn1
410632	410632:01:03_02.00	True	2.0	63	40.1	0.0	86.5	0.0	0.0	9.3	46.9	0.0	0.5	21.1	0.0	17.2	0.0	Aurora	86.5	ENMD-2076 L-(+)-Tartaric acid	ENMD-2076 L-(+)-Tartaric acid is the tartaric acid of ENMD-2076, selective activity against Aurora A and Flt3 with IC50 of 14 nM and 1.86 nM, 25-fold more selective for Aurora A than Aurora B and less potent to VEGFR2/KDR and VEGFR3, FGFR1 and FGFR2 and PDGFR¿. Phase 2.	True	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1
410026	410026:01:03_02.00	True	2.0	55	78.8	0.0	0.0	63.1	0.0	61.5	18.8	78.0	24.8	56.6	0.0	69.5	45.2	LCH	78.0	LDN-212854	LDN-212854 is a novel BMP inhibitor that exhibits substantially greater selectivity for BMP versus the TGF-.b. type I receptors; possesses a bias towards ALK2(IC50=1.3 nM) versus ALK1 and ALK3 compared to other inhibitors.IC50 value: 1.3 nM Target: ALK2 In vitro, LDN-212854 exhibits some selectivity for ALK2 in preference to other BMP type I receptors, ALK1 and ALK3, which may permit the interrogation of ALK2-mediated signaling, transcriptional activity and function. LDN-212854 potently inhibitsheterotopic ossification in an inducible transgenic mutant ALK2 mouse model of fibrodysplasia ossificans progressiva.	False	c1cc(-c2cnn3cc(-c4ccc(N5CCNCC5)cc4)cnc23)c2cccnc2c1
410666	410666:01:03_02.00	True	2.0	97	34.7	87.6	0.0	0.0	31.5	0.0	45.5	0.0	0.0	5.1	40.3	0.0	38.9	AKT_PI3K_MTOR	87.6	AZ20	AZ20 is a potent and selective inhibitor of ATR with an IC50 of 5 nM, and has 8-fold selectivity against mTOR (IC50=38 nM).	True	C[C@@H]1COCCN1c1cc(C2(S(C)(=O)=O)CC2)nc(-c2cccc3[nH]ccc23)n1
392585	392585:02:03_02.00	True	2.0	103	25.9	82.0	0.0	0.0	79.9	0.0	19.1	0.0	0.0	0.0	71.5	0.0	0.0	AKT_PI3K_MTOR	82.0	OSI-420	OSI-420 is the active metabolite of Erlotinib (EGFR inhibitor with IC50 of 2 nM).	False	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCO)cc23)c1
409852	409852:02:03_02.00	True	2.0	85	40.6	18.3	0.5	0.0	49.4	0.0	27.9	19.5	0.0	6.7	23.2	11.6	0.0	DNA_Synth	49.4	GSK-J4 (hydrochloride)	GSK-J4 hydrochloride is a potent dual inhibitor of H3K27me3/me2-demethylases JMJD3/KDM6B and UTX/KDM6A with IC50s of 8.6 and 6.6 uM, respectively. GSK-J4 hydrochloride inhibits LPS-induced TNF-.a. production in human primary macrophages with an IC50 of 9 uM. GSK-J4 hydrochloride is a cell permeable prodrug of GSK-J1.	False	CCOC(=O)CCNc1cc(N2CCc3ccccc3CC2)nc(-c2ccccn2)n1
410102	410102:01:03_02.00	True	2.0	71	45.9	5.8	13.6	21.1	0.0	38.3	97.2	30.3	8.3	36.8	0.0	55.4	34.8	HSP90	97.2	PU-H71	PU-H71 is a potent and selective inhibitor of HSP90 with IC50 of 51 nM. Phase 1.	False	CC(C)NCCCn1c(Sc2cc3c(cc2I)OCO3)nc2c(N)ncnc21
410073	410073:01:03_02.00	True	2.0	94	27.3	46.8	0.0	29.4	0.0	45.5	66.5	50.4	0.0	48.0	0.0	31.2	54.3	HSP90	66.5	LDC1267	LDC1267 is a highly selective TAM (Tyro3, Axl and Mer) kinase inhibitor with IC50s of <5 nM/8 nM/29 nM for Tyro3,Axl and Mer respectively.	False	CCOc1cn(-c2ccc(F)cc2C)nc1C(=O)Nc1ccc(Oc2ccnc3cc(OC)c(OC)cc23)c(F)c1
410749	410749:01:03_02.00	True	2.0	97	15.2	0.0	0.0	26.5	0.0	24.6	51.7	38.1	0.0	36.3	0.0	38.2	20.7	HSP90	51.7	SecinH3	SecinH3 is an antagonist of cytohesins with IC50s of 5.4 uM, 2.4 uM, 5.4 uM, 5.6 uM, 5.6 uM and 65 uM for hCyh1, hCyh2, mCyh3, hCyh3, drosophila steppke and yGea2-S7, respectively.	False	COc1nc(-c2ccc3c(c2)OCO3)n(-c2ccc(NC(=O)CSc3ccccc3)cc2)n1
392749	392749:02:03_02.00	True	2.0	95	11.6	60.6	0.0	0.0	82.8	0.0	16.9	0.0	0.0	0.0	61.7	0.0	0.0	DNA_Synth	82.8	Losmapimod	Losmapimod (GSK-AHAB) is a selective, potent, and orally active p38 MAPK inhibitor with pKis of 8.1 and 7.6 for p38.a. and p38.b., respectively.	False	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1
410714	410714:01:03_02.00	True	2.0	96	26.6	0.0	0.0	56.5	0.0	55.4	8.4	87.2	10.4	19.4	0.0	54.9	19.8	LCH	87.2	Mardepodect	PF-2545920 is a potent and selective PDE10A inhibitor with IC50 of 0.37 nM, with >1000-fold selectivity over the PDE.	False	Cn1cc(-c2ccncc2)c(-c2ccc(OCc3ccc4ccccc4n3)cc2)n1
410645	410645:01:03_02.00	True	2.0	95	24.7	0.0	0.0	50.9	0.0	45.7	20.6	69.3	6.2	39.0	0.0	59.5	33.5	LCH	69.3	NPS-2143	NPS-2143 (SB-262470A), an orally active calcilytic agent, is a selective and potent calcium ion-sensing receptor (CaSR) antagonist. NPS-2143 (SB-262470A) blocks increases in cytoplasmic Ca2+ concentrations (IC50=43 nM) elicited by activating the Ca2+ receptor in HEK 293 cells expressing the human Ca2+ receptor.	True	CC(C)(Cc1ccc2ccccc2c1)NC[C@@H](O)COc1cccc(Cl)c1C#N
410620	410620:01:03_02.00	True	2.0	96	7.8	23.1	0.0	33.1	0.0	41.6	52.7	43.1	0.0	51.2	0.0	31.1	41.0	HSP90	52.7	AZD 6482	AZD 6482 (KIN-193) is a potent and selective p110.b. inhibitor with an IC50 of 0.69 nM.	True	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1
410643	410643:01:03_02.00	True	2.0	87	22.3	2.2	20.6	10.3	20.1	18.4	40.7	24.0	11.9	31.6	0.2	28.6	23.4	HSP90	40.7	Rabusertib	Rabusertib (LY2603618) is a potent and selective inhibitor of Chk1 with an IC50 of 7 nM.	True	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1
392717	392717:02:03_02.00	True	2.0	92	53.2	0.0	0.0	61.7	0.0	71.6	32.6	62.5	40.6	54.0	0.0	60.0	58.7	HDAC	71.6	RKI-1447	RKI-1447 is a potent small molecule inhibitor of ROCK1 and ROCK2 with IC50 values of 14.5 nM and 6.2 nM, respectively. 	False	O=C(NCc1cccc(O)c1)Nc1nc(-c2ccncc2)cs1
247019	247019:04:03_02.00	True	2.0	100	5.2	0.0	0.0	28.5	2.2	16.3	23.9	43.6	0.0	14.9	0.0	42.1	12.0	LCH	43.6	Labetalol (hydrochloride)	Labetalol hydrochloride is a mixed alpha/beta adrenergic antagonist that is used to treat high blood pressure.	False	CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1
410668	410668:01:03_02.00	True	2.0	95	46.1	0.0	0.0	91.6	0.0	84.5	9.8	74.3	63.2	61.3	0.0	88.2	66.9	BET	91.6	(+)-JQ-1	(+)-JQ-1 (JQ1) is a potent, specific, and reversible BET bromodomain inhibitor, with IC50s of 77 and 33 nM for the first and second bromodomain (BRD4(1/2)). (+)-JQ-1 also activates autophagy.	True	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2
410736	410736:01:03_02.00	True	2.0	81	31.8	0.0	32.0	21.5	36.7	12.6	1.0	31.3	11.1	18.7	0.0	57.0	11.8	Tubulin	57.0	NSC697923	NSC697923 is a cell-permeable and selective inhibitor of the Ub-conjugating enzyme (E2) complex Ubc13-Uev1A.	False	Cc1ccc(S(=O)(=O)c2ccc([N+](=O)[O-])o2)cc1
392788	392788:02:03_02.00	True	2.0	89	27.8	85.8	0.0	0.0	64.7	0.0	49.2	8.7	0.0	0.0	48.8	0.0	24.9	AKT_PI3K_MTOR	85.8	CNX-2006	CNX-2006 is a mutant-selective and irreversible EGFR inhibitor with an IC50 below 20 nM for EGFRT790M.	False	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(NC4CN(CCF)C4)cc3OC)ncc2C(F)(F)F)c1
339727	339727:02:03_02.00	True	2.0	83	42.0	69.6	2.7	0.0	95.6	0.0	5.8	0.0	0.0	0.0	80.0	0.0	0.0	DNA_Synth	95.6	Methotrexate	Methotrexate (Amethopterin), an antimetabolite and antifolate agent, inhibits the enzyme dihydrofolate reductase, thereby preventing the conversion of folic acid into tetrahydrofolate, and inhibiting DNA synthesis. Methotrexate, also an immunosuppressant and antineoplastic agent, is used for the research of rheumatoid arthritis and a number of different cancers (such as acute lymphoblastic leukemia).	True	CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1
410733	410733:01:03_02.00	True	2.0	71	30.4	15.9	24.8	0.0	0.0	6.8	95.2	0.0	0.0	6.5	13.8	14.0	5.8	HSP90	95.2	NVP-HSP990	NVP-HSP990 is a potent and selective Hsp90 inhibitor, with IC50 values of 0.6, 0.8, and 8.5 nM for Hsp90.a., Hsp90.b., and Grp94, respectively.	True	COc1cccc(-c2cc(F)ccc2[C@H]2Cc3nc(N)nc(C)c3C(=O)N2)n1
410607	410607:01:03_02.00	True	2.0	88	45.8	93.0	0.0	0.0	71.2	0.0	36.6	0.0	0.0	0.0	69.1	0.0	13.0	AKT_PI3K_MTOR	93.0	Everolimus (RAD001)	Everolimus (RAD001) is an mTOR inhibitor of FKBP12 with IC50 of 1.6-2.4 nM in a cell-free assay.	True	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C
410027	410027:01:03_02.00	True	2.0	69	53.2	36.7	5.3	0.0	85.8	0.0	15.5	11.1	0.0	0.0	47.0	0.0	0.0	DNA_Synth	85.8	NSC319726	NSC319726 is a p53(R175) mutant reactivator, exhibits growth inhibition in cells expressing mutant p53, with IC50 of 8 nM for p53(R175) mutant, shows no inhibition for p53 wild-type cells.	False	C/C(=N\NC(=S)N1CCC1)c1ccccn1
410603	410603:01:03_02.00	True	2.0	94	42.1	0.0	0.0	52.6	0.0	50.3	15.3	88.8	0.0	25.2	0.0	49.2	28.0	LCH	88.8	PHA-665752	PHA-665752 is a selective, ATP-competitive, and active-site inhibitor of the catalytic activity of c-Met kinase (Ki=4 nM; IC50=9 nM). PHA-665752 exhibits >50-fold selectivity for c-Met compared with a panel of diverse tyrosine and serine-threonine kinases. PHA-665752 induces apoptosis and cell cycle arrest, and exhibits cytoreductive antitumor activity.	True	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1
410609	410609:01:03_02.00	True	2.0	52	78.8	16.2	0.0	18.7	30.3	24.1	41.4	30.9	16.1	37.4	0.0	40.6	25.9	HSP90	41.4	Delanzomib (CEP-18770)	Delanzomib (CEP-18770) is an orally active inhibitor of the chymotrypsin-like activity of proteasome with IC50 of 3.8 nM, with only marginal inhibition of the tryptic and peptidylglutamyl activities of the proteosome. Phase 1/2.	True	CC(C)[C@H](CNC(=O)[C@@H](NC(=O)c1cccc(-c2ccccc2)n1)[C@@H](C)O)B(O)O
410097	410097:01:03_02.00	True	2.0	94	27.6	0.0	0.0	72.2	0.0	74.7	43.5	71.6	17.9	63.4	0.0	66.9	62.0	HDAC	74.7	PLX7904	PLX7904 is a potent and selective BRAF inhibitor, with IC50 of appr 5 nM against BRAFV600E in mutant RAS expressing cells.	False	CCN(C)S(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4cnc(C5CC5)nc4)cc23)c1F
409853	409853:02:03_02.00	True	2.0	97	14.7	6.0	0.0	25.5	0.0	20.9	41.5	42.8	0.0	22.7	0.0	36.2	16.8	LCH	42.8	Tubacin	Tubacin is a potent and selective inhibitor of HDAC6, with an IC50 value of 4 nM and approximately 350-fold selectivity over HDAC1.	True	O=C(CCCCCCC(=O)Nc1ccc([C@@H]2O[C@H](c3ccc(CO)cc3)C[C@H](CSc3nc(-c4ccccc4)c(-c4ccccc4)o3)O2)cc1)NO
247041	247041:02:03_02.00	True	2.0	95	23.5	0.0	0.0	60.3	0.0	63.1	23.6	77.0	2.3	43.0	0.0	59.9	30.6	LCH	77.0	Clemastine (fumarate)	Clemastine (fumarate) (HS-592 (fumarate)) is a selective histamine H1 receptor antagonist with IC50 of 3 nM.	True	CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1
410602	410602:01:03_02.00	True	2.0	95	44.9	94.0	0.0	0.0	71.5	0.0	36.5	0.0	0.0	0.0	69.9	0.0	11.7	AKT_PI3K_MTOR	94.0	Temsirolimus (CCI-779, NSC 683864)	Temsirolimus (CCI-779, NSC 683864) is a specific mTOR inhibitor with IC50 of 1.76 ¿M in a cell-free assay.	True	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C
410057	410057:01:03_02.00	True	2.0	93	50.6	0.0	0.0	53.7	0.0	53.6	28.3	75.4	0.0	41.0	0.0	59.6	33.0	LCH	75.4	DDR1-IN-1	DDR1-IN-1 is a potent and selective DDR1 receptor tyrosine kinase inhibitor with an IC50 of 105 nM; 4-fold less potent for DDR2 (IC50 = 413 nM).	False	CCN1CCN(Cc2ccc(C(=O)Nc3ccc(C)c(Oc4ccc5c(c4)CC(=O)N5)c3)cc2C(F)(F)F)CC1
410739	410739:01:03_02.00	True	2.0	69	39.6	59.8	18.3	0.0	91.9	0.0	4.0	0.0	0.0	0.0	83.1	0.0	0.0	DNA_Synth	91.9	KPT-276	KPT-276 is an orally bioavailable selective CRM1 inhibitor.	False	O=C(/C=C\n1cnc(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)n1)N1CC(F)(F)C1
392893	392893:02:03_02.00	True	2.0	93	20.9	86.6	0.0	0.0	80.3	0.0	35.1	0.0	0.0	0.0	63.8	0.0	13.8	AKT_PI3K_MTOR	86.6	Ipatasertib	Ipatasertib (GDC-0068) is a highly selective and ATP-competitive pan-Akt inhibitor with IC50s of 5, 18 and 8 nM for Akt1, Akt2 and Akt3, respectively.	True	CC(C)NC[C@@H](C(=O)N1CCN(c2ncnc3c2[C@H](C)C[C@H]3O)CC1)c1ccc(Cl)cc1
410755	410755:01:03_02.00	True	2.0	99	21.2	0.0	6.3	11.1	0.0	8.7	45.6	25.6	0.0	9.5	0.0	25.9	0.6	HSP90	45.6	L755507	L-755,507 is characterized as a potent and selective ß3 adrenergic receptor partial agonist with EC50 of 0.43 nM. It is also recently identified to enhance CRISPR-mediated homology-directed repair (HDR) efficiency in human induced pluripotent stem cells (iPSCs) and other cell types.	True	CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1
392592	392592:02:03_02.00	True	2.0	98	38.3	0.0	0.0	74.9	0.0	76.3	56.7	70.0	26.2	62.1	0.0	75.2	62.2	HDAC	76.3	Ibrutinib (Racemate)	it is a potent and highly selective Btk inhibitor with IC50 of 0.5 nM, modestly potent to Bmx, CSK, FGR, BRK, HCK, less potent to EGFR, Yes, ErbB2, JAK3, etc.	False	C=CC(=O)N1CCCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1
246704	246704:02:03_02.00	True	2.0	94	10.0	0.0	0.0	63.8	0.0	53.5	17.6	66.2	17.6	47.5	0.0	72.5	51.1	Tubulin	72.5	Formoterol fumarate	ß2-agonist.	True	COc1ccc(C[C@H](C)NC[C@@H](O)c2ccc(O)c(NC=O)c2)cc1
382147	382147:04:03_02.00	True	2.0	98	15.5	54.4	0.0	0.0	42.2	0.0	32.2	21.8	0.0	2.8	29.0	0.0	26.2	AKT_PI3K_MTOR	54.4	GSK429286A	GSK429286A is a selective inhibitor of ROCK1 and ROCK2 with IC50 of 14 nM and 63 nM, respectively.; Development of dihydropyridone indazole amides as selective Rho-kinase inhibitors. J Med Chem. 2007 Jan 11;50(1):6-9.	False	CC1=C(C(=O)Nc2cc3cn[nH]c3cc2F)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1
392756	392756:02:03_02.00	True	2.0	93	5.4	49.6	0.0	0.0	58.2	0.0	52.3	0.0	0.0	0.0	69.2	0.0	0.0	Pyrimidine_Synth	69.2	CGI-1746	CGI-1746 is a potent and highly selective inhibitor of the Btk with IC50 of 1.9 nM.	False	Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cn(C)c(=O)c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1
392738	392738:02:03_02.00	True	2.0	97	12.4	57.7	0.0	18.3	0.0	15.5	61.9	21.1	0.0	39.8	0.0	25.6	57.8	HSP90	61.9	Spebrutinib	Spebrutinib (AVL-292; CC-292) is a covalent, orally active, and highly selective with an IC50 of 0.5 nM.	False	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCOC)cc3)ncc2F)c1
410623	410623:01:03_02.00	True	2.0	81	31.3	65.6	3.4	0.0	95.4	0.0	3.5	0.0	0.0	0.0	76.4	0.0	0.0	DNA_Synth	95.4	Pralatrexate	Pralatrexate is an antifolate and is a potent dihydrofolate reductasean (DHFR) inhibitor with a Ki of 13.4 pM. Pralatrexate is a substrate for folylpolyglutamate synthetase with improved cellular uptake and retention. Pralatrexate has antitumor activities and has the potential for relapsed/refractory T-cell lymphoma treatment.	True	C#CCC(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1
408410	408410:03:03_02.00	True	2.0	50	84.8	0.0	27.5	66.0	0.0	75.0	25.2	64.9	45.8	61.8	0.0	74.8	25.8	HDAC	75.0	BI 2536	BI 2536 is a dual PLK1 and BRD4 inhibitor with IC50s of 0.83 and 25 nM, respectively. BI-2536 suppresses IFNB (encoding IFN-.b.) gene transcription.	True	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1
410701	410701:01:03_02.00	True	2.0	104	49.2	0.0	0.0	68.5	0.0	71.5	28.6	77.7	15.5	53.3	0.0	64.9	40.9	LCH	77.7	Pimavanserin	Pimavanserin is a potent and selective serotonin 5-HT2A inverse agonist with pIC50 of 8.73, used to treat psychosis associated with Parkinson¿s disease.	False	CC(C)COc1ccc(CNC(=O)N(Cc2ccc(F)cc2)C2CCN(C)CC2)cc1
407872	407872:02:03_02.00	True	2.0	100	13.5	15.1	6.1	0.0	28.5	0.0	50.7	0.0	0.0	0.0	48.5	0.0	0.0	HSP90	50.7	Erastin	a cell-permeable piperazinyl-quinazolinone compound that exhibits oncogene-selective lethality. Shown to bind mitochondrial voltage-dependent anion channels (VDAC) and alter its gating; rapidly induce an oxidative, non-apoptotic cell death in several human tumors harboring activating mutations in the RAS-RAF-MEK signaling (EC50 = 6.0 µM in BJ-TERT/LT/ST/RASV12 cells).; Yagoda, N., et al. 2007. Nature 447, 864.	False	CCOc1ccccc1-n1c(C(C)N2CCN(C(=O)COc3ccc(Cl)cc3)CC2)nc2ccccc2c1=O
392582	392582:02:03_02.00	True	2.0	92	38.0	15.7	0.0	51.3	5.1	44.8	20.0	83.0	0.0	36.6	0.0	57.0	44.2	LCH	83.0	SGI-1776	SGI-1776 is an inhibitor of Pim kinases, with IC50s of 7 nM, 363 nM, and 69 nM for Pim-1, -2 and -3, respectively.	False	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1
409898	409898:01:02_10.00	True	10.0	86	17.1	30.9	22.2	0.0	63.3	0.0	51.0	25.1	0.0	0.0	45.9	0.0	0.0	DNA_Synth	63.3	CCT251545	it is an orally bioavailable inhibitor of Wnt signaling (IC50 = 5 nM). It is a potent and selective inhibitor of the human mediator complex-associated protein kinases Cdk8 and Cdk19. Through its effects on Cdk8 and Cdk19, CCT251545 alters Wnt pathway-regulated gene expression. It reduces tumor growth in COLO 205 human colon cancer xenografts after oral dosing (70 mg/kg bid) and in Wnt-dependent tumors.	False	Cn1cc(-c2ccc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)cc2)cn1
409889	409889:01:02_10.00	True	10.0	99	11.6	0.0	0.0	47.4	0.0	46.6	42.2	58.5	0.0	37.1	0.0	53.7	26.1	LCH	58.5	BAY-598	it is a selective inhibitor of SMYD2. It inhibits the methylation of p53 at lysine 370 in vitro and in whole cells with IC50 values of 27 nM and Structural Genomics Consortium (SGC) website for more information.	True	CCN(C(=O)CO)[C@H]1CN(/C(=N\C#N)Nc2cccc(OC(F)F)c2)N=C1c1ccc(Cl)c(Cl)c1
408406	408406:02:04_10.00	True	10.0	98	22.8	53.8	0.0	17.8	10.0	17.0	42.9	50.0	0.0	15.5	11.4	25.2	40.0	AKT_PI3K_MTOR	53.8		SYK propagates signal transduction for a number of immunoreceptor tyrosine-based activation motif¿dependent proinflammatory pathways. BI 1002494 is a potent inhibitor of SYK with an IC50 of 0.8 nM and inhibits in human whole blood the DNP/BSA (dinitroprusside / bovine serum albumine) induced expression of CD63 in basophils with an average IC50 of 115 nM (N=263) as well as in human B cells the goat anti-human IgD induced secretion of CD69 with an IC50 of 810 nM (N=36). A Kinase panel was run (Invitrogen 23/239 kinases hit > 50% INH @ 1 µM).	True	COc1cc(-c2cc3ncccc3c(O[C@H](C)[C@H]3CNC(=O)C3)n2)cc(OC)c1OC
409867	409867:01:02_10.00	True	10.0	97	11.2	0.0	0.0	45.4	2.2	40.5	8.5	63.3	18.3	26.1	0.0	51.9	25.6	LCH	63.3	A-366	A-366 is a potent, highly selective, peptide-competitive histone methyltransferase G9a inhibitor with IC50s of 3.3 and 38 nM for G9a and GLP (EHMT1), respectively. A-366 shows >1000-fold selectivity over 21 other methyltransferases. A-366 is also a potent, nanomolar inhibitor of the Spindlin1-H3K4me3-interaction (IC50=182.6 nM). A-366 displays high affinity at human histamine H3 receptor (Ki=17 nM) and shows subtype selectivity among subsets of the histaminergic and dopaminergic receptor families.	False	COc1cc2c(cc1OCCCN1CCCC1)N=C(N)C21CCC1
409883	409883:01:02_10.00	True	10.0	93	58.2	0.0	0.0	68.0	0.0	66.7	18.0	93.3	21.3	40.6	0.0	61.7	42.9	LCH	93.3	GSK484 (hydrochloride)	protein arginine deiminase 4 (PAD4) mediates the transformation of protein arginine into citrulline. GSK484 is a reversible inhibitor of PAD4 (IC50 = 50 nM) that binds to the low-calcium form of the enzyme. It is selective for PAD4 over PAD1-3. GSK484 blocks the citrullination of PAD4 target proteins in human neutrophils and inhibits the formation of neutrophil extracellular traps in both mouse and human neutrophils. It exhibits favorable pharmacokinetic profiles in mouse and rat. See the Structural Genomics Consortium (SGC) website for more information.	True	COc1cc(C(=O)N2CC[C@@H](O)[C@@H](N)C2)cc2nc(-c3cc4ccccc4n3CC3CC3)n(C)c12
409918	409918:01:02_10.00	True	10.0	91	49.9	0.0	0.0	66.0	0.0	67.1	17.9	91.7	23.2	41.4	0.0	67.0	40.8	LCH	91.7	GSK6853	GSK6853 is a potent and selective inhibitor of the BRPF1 bromodomain. GSK6853 shows excellent BRPF1 potency (pKd=9.5) and greater than 1600-fold selectivity over all other bromodomains.	True	COc1ccccc1C(=O)Nc1cc2c(cc1N1CCNC[C@H]1C)n(C)c(=O)n2C
280140	280140:02:03_10.00	True	10.0	67	56.3	20.6	0.0	40.0	0.0	44.5	77.9	49.0	18.7	45.9	0.0	62.7	55.0	HSP90	77.9	BIO	potent, selective, reversible, and ATP-competitive glycogen synthase kinase 3alpha/beta (GSK-3alpha/beta) inhibitor, maintains self-renewal and pluripotency of ESCs.	False	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O
410510	410510:01:04_10.00	True	10.0	96	11.6	0.9	0.0	64.6	0.0	56.4	12.7	75.5	14.5	48.6	0.0	72.1	54.0	LCH	75.5		it was synthesized during a campaign to develop third generation of ?2-agonists (KD = 84 pM). BI-167107 is not a selective beta2 agonist. BI-167107 is also very a active agonist of the ?1AR (IC50 = 3.2 nM) and shows some activity as ?1A antagonist (IC50 = 32 nM). BI-167107 showed also weaker activity on other targets: 5-HT transporter (IC50 = 6.1 µM), 5-HT1A (IC50 = 1.4 µM), 5-HT1B (IC50 = 0.25 µM), D2S (IC50 = 5.9 µM), dopamine transporter (IC50 = 7.2 µM), ? (MOP) (IC50 = 6.5 µM).	True	Cc1ccccc1CC(C)(C)NC[C@H](O)c1ccc(O)c2c1OCC(=O)N2
410201	410201:01:02_10.00	True	10.0	97	59.4	0.0	0.0	76.0	0.0	76.7	0.0	91.7	36.3	44.9	0.0	66.7	39.1	LCH	91.7		highly selective Sigma 1 receptor. Ki for S1R: 1.3 nM; S2R: 837 nM.	False	c1ccc(CNCC[C@@H]2CCN[C@H](c3ccccc3)C2)cc1
410286	410286:01:02_10.00	True	10.0	88	38.0	26.2	0.0	10.0	56.8	1.9	0.0	34.7	0.0	9.7	5.3	36.7	33.8	DNA_Synth	56.8	Triciribine hydrate, API-2, Akt/PKB Signaling Inhibitor-2, Inhibitor V, NSC 154020, TCN, VD-0002	it  is a highly selective Akt/PKB inhibitor, that selectively inhibits the cellular phosphorylation/activation of Akt1/2/3.	True	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@H](O)C3O)c3ccnc1c23
409838	409838:01:04_10.00	True	10.0	75	54.9	0.0	0.0	81.7	0.0	91.6	22.1	69.1	72.7	56.9	0.0	83.2	64.1	HDAC	91.6	ACY-738	ACY-738 is a potent, selective and orally-bioavailable HDAC6 inhibitor, with an IC50 of 1.7 nM; ACY-738 also inhibits HDAC1, HDAC2, and HDAC3, with IC50s of 94, 128, and 218 nM.	False	O=C(NO)c1cnc(NC2(c3ccccc3)CC2)nc1
409895	409895:01:02_10.00	True	10.0	95	33.7	0.0	0.0	73.3	0.0	73.1	0.0	78.9	46.5	46.4	0.0	69.2	30.2	LCH	78.9	MS023 (hydrochloride)	it is a potent, selective inhibitor of type I protein arginine methyltransferases (IC50s = 20, 119, 83, 8, and 8 nM for PRMT1, 3, 4, 6, and 8, respectively). It is inactive against type II and type III PRMTs, as well as other types of MTs. MS023 is active in cells, inhibiting the dimethylation of histone 4 at Arg3 by PRMT1 with an IC50 value of 9 nM. See the Structural Genomics Consortium (SGC) website for more information.	False	CC(C)Oc1ccc(-c2c[nH]cc2CN(C)CCN)cc1
409886	409886:01:02_10.00	True	10.0	101	37.0	0.0	0.0	69.4	0.0	67.7	24.6	78.5	20.7	48.3	0.0	72.2	54.9	LCH	78.5	I-BRD9	I-BRD9 is the first selective cellular chemical probe for BRD9 (pIC50=7.3).IC50 value: 7.3 (pIC50) Target: BRD9in vitro: I-BRD9 is a selective cell active chemical probe for bromodomain containing protein 9 inhibition. I-BRD9, the first selective cellular chemical probe for bromodomain-containing protein 9 (BRD9). I-BRD9 is identified through structure-based design, leading to greater than 700-fold selectivity over the BET family and 200-fold over the highly homologous bromodomain-containing protein 7 (BRD7). I-BRD9 is used to identify genes regulated by BRD9 in Kasumi-1 cells involved in oncology and immune response pathways and to the best of our knowledge, represents the first selective tool compound available to elucidate the cellular phenotype of BRD9 bromodomain inhibition.	False	CCn1cc(-c2cccc(C(F)(F)F)c2)c2sc(C(=N)NC3CCS(=O)(=O)CC3)cc2c1=O
409829	409829:01:03_10.00	True	10.0	88	6.9	0.0	43.8	13.7	40.3	9.7	0.0	21.7	12.8	13.0	0.0	38.4	0.0	Aurora	43.8	A-1155463	A-1155463 is a highly potent and selective BCL-XL inhibitor with an EC50 of 70 nM in Molt-4 cell.	False	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1
392721	392721:02:02_10.00	True	10.0	93	7.4	43.9	0.0	16.9	43.3	11.8	21.5	43.8	0.0	14.8	7.1	31.0	46.2	Uncoupler	46.2	Neflamapimod	Neflamapimod (VX-745) is a potent, blood-brain barrier penetrant, highly selective inhibitor of p38.a. inhibitor with an IC50 for p38.a. of 10 nM and for p38.b. of 220 nM. Neflamapimod (VX-745) possesses anti-inflammatory activity.	False	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl
382144	382144:01:03_10.00	True	10.0	94	6.7	10.7	0.0	33.2	0.0	33.4	5.0	24.6	8.1	41.2	0.0	30.4	42.6	Uncoupler	42.6	EC 23	synthetic retinoid, induces differentiation of stem cells, of hESCs.	False	CC1(C)CCC(C)(C)c2cc(C#Cc3ccc(C(=O)O)cc3)ccc21
382139	382139:01:03_10.00	True	10.0	96	6.9	46.0	0.0	7.9	15.6	11.5	31.9	29.8	0.0	7.6	0.0	17.8	29.9	AKT_PI3K_MTOR	46.0	SB 203580	SB 203580 (RWJ 64809) is a selective and ATP-competitive p38 MAPK inhibitor with IC50s of 50 nM and 500 nM for SAPK2a/p38 and SAPK2b/p38.b.2, respectively. SB 203580 inhibits LCK, GSK3.b. and PKB.a. with IC50s of 100-500-fold higher than that for SAPK2a/p38. SB 203580 does not disrupt JNK activity and is an autophagy and mitophagy activator.	False	CS(=O)c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1
246688	246688:07:03_10.00	True	10.0	66	67.7	0.0	0.0	78.0	0.0	93.6	35.9	66.5	65.3	63.5	0.0	79.1	56.5	HDAC	93.6	Vorinostat	Vorinostat (SAHA) is a potent and orally active pan-inhibitor of HDAC1, HDAC2 and HDAC3 (Class I), HDAC7 (Class II) and HDAC11 (Class IV), with ID50 values of 10 nM and 20 nM for HDAC1 and HDAC3, respectively. Vorinostat induces cell apoptosis. Vorinostat is also an effective inhibitor of human papillomaviruse (HPV)-18 DNA amplification.; Bradner et al., Chemical Phylogenetics of Histone Deacetylases. Nat. Chem. Biol. 6, 238-43 (2010).	False	O=C(CCCCCCC(=O)Nc1ccccc1)NO
409859	409859:01:03_10.00	True	10.0	97	13.0	4.5	0.0	35.7	0.0	27.5	29.2	47.6	0.0	33.3	0.0	43.5	20.7	LCH	47.6	SGC-CBP30	SGC-CBP30 is a potent and highly selective CBP/p300 bromodomain (Kds of 21 nM and 32 nM for CBP and p300, respectively) inhibitor, displaying 40-fold selectivity over the first bromodomain of BRD4 [BRD4(1)] bound. SGC-CBP30 strongly reduces secretion of IL-17A in Th17 cells and has anti-inflammatory effects.	True	COc1ccc(CCc2nc3cc(-c4c(C)noc4C)ccc3n2C[C@H](C)N2CCOCC2)cc1Cl
247165	247165:04:03_10.00	True	10.0	90	33.7	0.0	0.0	75.7	0.0	75.3	7.9	92.8	30.8	51.7	0.0	64.9	49.0	LCH	92.8	Fluoxetine hydrochloride, Prozac	selective serotonin reuptake inhibitor, 5-HT uptake inhibitor, induces differentiation of neuronal precursors.	False	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1
408952	408952:01:05_10.00	True	10.0	107	35.4	0.0	0.0	75.8	0.0	71.4	32.3	74.5	27.4	57.6	0.0	72.4	54.0	BET	75.8		BI-4659 is a potent inhibitor of Alk5 (TGFßR1) with an IC50 value of 19 nM and shows selectivity against a broad panel of other kinases. BI-4659 blocks the phosphorylation of Smad2 and Smad3 in HaCaT cells with an EC50 of 185 nM. Negative control = BI-4101	False	CCNC(=O)c1ccc2c(/C(=N/c3ccc(CN(C)C)cc3)c3ccccc3)c(O)[nH]c2c1
410518	410518:01:04_10.00	True	10.0	94	46.5	0.0	0.0	69.0	0.0	66.6	18.4	84.3	17.1	50.3	0.0	69.2	41.2	LCH	84.3	Crobenetine	it is a highly potent, selective, use- and voltage-dependent sodium channel blocker. The compound has a high selectivity for site 2 of the sodium channel and preferentially binds to the inactivated state of the channel with an IC50 of 77 nM based on patch clamp evaluations. In contrast, the binding at the resting state is only 18 µM. This exceptional selectivity of more than 230 fold for the different states of the sodium channel makes this compound unique compared with other sodium channel blockers. Therefore, BIII 890CL is able to discriminate between highly (over)activated, depolarized neurons and neurons with physiological membrane potentials.	True	C[C@@H](CN1CC[C@@]2(C)c3cccc(O)c3C[C@@H]1C2(C)C)OCc1ccccc1
339781	339781:02:03_10.00	True	10.0	66	27.1	17.1	21.8	0.0	69.3	0.0	0.0	0.0	4.7	4.2	32.2	13.0	2.8	DNA_Synth	69.3	5-Azacytidine	5-Azacytidine (Azacitidine; 5-AzaC; Ladakamycin) is a nucleoside analogue of cytidine that specifically inhibits DNA methylation. 5-Azacytidine is incorporated into DNA to covalently trap DNA methyltransferases and contributes to reverse epigenetic changes. 5-Azacytidine induces cell autophagy.	True	Nc1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1
409875	409875:01:02_10.00	True	10.0	63	49.1	0.0	97.1	0.0	20.1	0.0	14.9	0.0	0.0	0.0	7.3	0.0	0.0	Aurora	97.1	CFI-400945	it is an inhibitor of polo-like kinase 4 (PLK4, IC50 = 2.8 nM), a unique kinase that regulates centriole duplication during the cell cycle. CFI-400945 suffers from a poor kinome selectivity. While showing good selectivity against the other PLK-family members, this compound has some critical off-targets, most importantly AURKB. It does not inhibit other members of the PLK family (IC50s > 50 µM for PLK1, PLK2, and PLK3).	True	COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(/C=C/c4ccc(CN5C[C@H](C)O[C@H](C)C5)cc4)[nH]nc3c1)C(=O)N2
382152	382152:01:04_10.00	True	10.0	96	8.3	10.8	46.2	0.0	74.0	0.0	24.4	3.3	0.0	0.0	38.4	2.1	0.0	DNA_Synth	74.0	ID-8	ID-8 is an inhibitor of dual-specificity tyrosine phosphorylation-regulated kinase (DYRK). ID-8 sustains embryonic stem cell (ESC) self-renewal and pluripotency. ID-8 enhances Wnt-mediated hESC survival and proliferation via inhibition of DYRKs.	False	COc1ccc(-n2c(C)c([N+](=O)[O-])c3ccc(O)cc32)cc1
409809	409809:01:02_10.00	True	10.0	89	70.3	0.0	0.0	79.8	0.0	75.3	41.6	71.0	49.9	59.4	0.0	93.8	65.5	Tubulin	93.8		it is a dual inhibitor of AAK1 and BMP2K/BIKE. AAK1 is a serine/threonine kinase with broad tissue expression. AAK1 is involved in clathrin-mediated endocytosis, both by direct binding to clathrin and by phosphorylation of the medium subunit of AP-2 (adaptor protein 2). AAK1 has been identified as a negative regulator of Wnt signaling via mediation of LRP6 internalization. BIKE is broadly expressed, and it localizes to nuclear speckles. BIKE was originally identified as its expression was observed to increase upon bone morphogenic protein (BMP-2)-induced differentiation of a prechondroblastic cell line. The same study provided evidence for BIKE having an important regulatory role in attenuating the program of osteoblast differentiation.	False	CCN(CC)S(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1
409845	409845:01:03_10.00	True	10.0	78	24.7	30.1	20.9	0.0	89.7	0.0	9.3	0.0	0.0	0.0	57.6	0.0	0.0	DNA_Synth	89.7	AMG 232	it is a potent, selective and orally available inhibitor of p53-MDM2 interaction, with an IC50 of 0.6 nM. AMG 232 binds to MDM2 with a Kd of 0.045 nM.	True	CC(C)[C@@H](CS(=O)(=O)C(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1
409915	409915:01:02_10.00	True	10.0	72	63.7	0.0	0.0	77.2	0.0	74.9	32.3	65.7	57.2	59.9	0.0	95.9	58.2	Tubulin	95.9	TP-472	it is an inhibitor of bromodomain BRD9 (Kd = 33 nM; EC50 = 320 nM in a NanoBRET assay). It has >30-fold selectivity over all other bromodomain family members with the exception of the highly homologous BRD7 bromodomain (Kd = 340 nM in an isothermal titration calorimetry (ITC) assay). See the Structural Genomic Consortium (SGC) website for more information.	False	CC(=O)c1cc(-c2cc(C(=O)NC3CC3)ccc2C)c2ncccn12
409839	409839:01:03_10.00	True	10.0	102	13.3	40.2	0.0	41.8	0.0	33.0	9.8	47.3	5.2	34.5	0.0	40.5	52.2	Uncoupler	52.2	CPI-637	CPI-637 is a selective and potent CBP/EP300 bromodomain inhibitor with IC50 values of 0.03 uM, 0.051 uM and 11.0 uM for CBP, EP300 and BRD4 BD-1, respectively, and an EC50 of 0.3 uM for CBP.	True	C[C@@H]1CC(=O)Nc2cccc(-c3ccc4c(c3)c(-c3cnn(C)c3)nn4C)c2N1
409870	409870:01:02_10.00	True	10.0	99	34.2	0.0	0.0	70.6	0.0	71.5	10.5	94.0	24.0	34.0	0.0	62.3	31.4	LCH	94.0	Tazemetostat	Tazemetostat (EPZ-6438) is a potent, selective and orally available EZH2 inhibitor. Tazemetostat (EPZ-6438) inhibits the activity of human polycomb repressive complex 2 (PRC2)-containing wild-type EZH2 with a Ki value of 2.5 nM. Tazemetostat (EPZ-6438) inhibits EZH2 with IC50s of 11 and 16 nM in peptide assay and nucleosome assay, respectively. Tazemetostat (EPZ-6438) inhibits rat EZH2 with an IC50 of 4 nM. Tazemetostat (EPZ-6438) also inhibits EZH1 with an IC50 of 392 nM.	False	CCN(c1cc(-c2ccc(CN3CCOCC3)cc2)cc(C(=O)NCc2c(C)cc(C)nc2O)c1C)C1CCOCC1
409843	409843:01:04_10.00	True	10.0	71	28.5	40.1	30.9	0.0	90.9	0.0	12.7	0.0	0.0	0.0	64.2	0.0	0.0	DNA_Synth	90.9	Niraparib	Cell Cycle/DNA Damage. Epigenetics. Niraparib (MK-4827) is a highly potent PARP1 and PARP2 inhibitor with IC50s of 3.8 and 2.1 nM, respectively.	True	NC(=O)c1cccc2cn(-c3ccc([C@@H]4CCCNC4)cc3)nc12
409911	409911:01:02_10.00	True	10.0	96	26.4	7.1	0.0	75.6	0.0	73.5	17.7	81.2	29.4	58.3	0.0	68.0	68.1	LCH	81.2	GSK583	GSK583 is a highly potent, orally active and selective inhibitor of RIP2 Kinase, with IC50 of 5 nM. GSK583 inhibits both TNF-.a. and IL-6 production with an IC50 value of 200 nM.	False	CC(C)(C)S(=O)(=O)c1ccc2nccc(Nc3[nH]nc4ccc(F)cc34)c2c1
409913	409913:01:02_10.00	True	10.0	75	31.1	51.0	30.5	0.0	93.6	0.0	7.8	0.0	0.0	0.0	79.8	0.0	0.0	DNA_Synth	93.6	Talazoparib	Talazoparib (BMN-673) is a highly potent, orally available PARP1/2 inhibitor.Talazoparib inhibits PARP1 and PARP2 enzyme activity with Kis of 1.2 and 0.87 nM, respectively. Talazoparib has antitumor activity.	True	Cn1ncnc1[C@H]1c2nnc(O)c3cc(F)cc(c23)N[C@@H]1c1ccc(F)cc1
409853	409853:01:02_10.00	True	10.0	87	58.2	14.3	0.0	23.4	37.2	22.6	27.2	51.2	0.0	11.9	0.0	44.7	27.5	LCH	51.2	Tubacin	Tubacin is a potent and selective inhibitor of HDAC6, with an IC50 value of 4 nM and approximately 350-fold selectivity over HDAC1.	True	O=C(CCCCCCC(=O)Nc1ccc([C@@H]2O[C@H](c3ccc(CO)cc3)C[C@H](CSc3nc(-c4ccccc4)c(-c4ccccc4)o3)O2)cc1)NO
408953	408953:01:03_10.00	True	10.0	62	48.5	23.0	37.3	0.0	78.9	0.0	16.0	0.0	0.0	0.0	41.6	0.0	0.0	DNA_Synth	78.9		BI-5521 is a non-covalent ATP-competitive inhibitor of glycogen synthase kinase (GSK-3). BI-5521 is active on both isoforms GSK-3a and GSK-3ß with single digit nM potency. We could demonstrate glucose lowering efficacy of orally administered BI-5521 in rodents. Negative control = BI-4481.	False	CC(=O)c1ccc2[nH]c(O)c(/C(=N/C3CCN(C)CC3)c3ccc4c(c3)OCO4)c2c1
409888	409888:01:02_10.00	True	10.0	93	25.2	23.5	0.0	44.6	1.6	45.4	25.4	70.1	6.3	50.9	0.0	50.5	56.1	LCH	70.1	(S)-PFI-2 (hydrochloride)	SET domain-containing protein 7/9 (SET7/9) is a histone methyltransferase that monomethylates lysine 4 of histone H3, which generates a specific tag for epigenetic transcriptional activation. (R)-PFI-2 (Cay-14678) is a potent, cell-permeable inhibitor of SET7/9 (IC50 = 2 nM) that demonstrates greater than 1,000-fold selectivity over a panel of 18 other methyltransferases. (S)-PFI-2, the inactive enantiomer, is 500-fold less potent (IC50 = 1 µM) and may serve as a negative control. See the Structural Genomics Consortium (SGC) website for more information.	True	O=C([C@H](Cc1cccc(C(F)(F)F)c1)NS(=O)(=O)c1cc(F)c2c(c1)CCNC2)N1CCCC1
409896	409896:01:02_10.00	True	10.0	70	51.5	39.3	9.3	0.0	80.5	0.0	34.5	13.0	0.0	0.0	51.2	0.0	0.0	DNA_Synth	80.5	BLU9931	BLU9931 is a potent, highly selective, and irreversible fibroblast growth factor receptor 4 (FGFR4) inhibitor with an IC50 of 3 nM and a Kd of 6 nM. BLU9931 has significant antitumor activity.	False	C=CC(=O)Nc1cccc(C)c1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)ccc2n1
409919	409919:01:02_10.00	True	10.0	75	59.2	92.9	0.0	0.0	55.2	0.0	26.9	0.0	0.0	0.0	58.2	0.0	34.3	AKT_PI3K_MTOR	92.9	eCF309	it is an ATP-competitive inhibitor of mTOR (IC50 = 15 nM in vitro and in cells) with >65-fold selectivity over other kinases, including PI3Ks.	False	CCOC(Cn1nc(-c2ccc3oc(N)nc3c2)c2c(N)ncnc21)OCC
409851	409851:01:02_10.00	True	10.0	93	28.5	0.0	0.0	88.5	0.0	79.0	4.3	82.2	49.4	57.4	0.0	85.1	68.4	BET	88.5	I-BET151	I-BET151 is a BET bromodomain inhibitor which inhibits BRD4, BRD2, and BRD3 with pIC50 of 6.1, 6.3, and 6.6, respectively.	True	COc1cc2c(cc1-c1c(C)noc1C)ncc1nc(O)n([C@H](C)c3ccccn3)c12
409848	409848:01:02_10.00	True	10.0	84	19.7	28.2	51.9	0.0	81.1	0.0	0.0	0.0	0.0	0.0	72.3	0.0	0.0	DNA_Synth	81.1	Olaparib	Olaparib (AZD2281; KU0059436) is a potent and orally active PARP inhibitor with IC50s of 5 and 1 nM for PARP1 and PARP2, respectively. Olaparib is an autophagy and mitophagy activator.	False	O=C(c1cc(Cc2nnc(O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1
409847	409847:02:02_10.00	True	10.0	97	7.4	31.9	0.0	9.2	0.0	17.6	66.1	22.9	0.0	30.8	0.0	16.8	20.6	HSP90	66.1	PDD 00017273	PDD 00017273 is a potent inhibitor of Poly(ADP-ribose) Glycohydrolase (PARG), with an IC50 of 26 nM, and a KD of 1.45 nM.	False	Cc1cc(Cn2c(=O)n(Cc3cnc(C)s3)c(=O)c3cc(S(=O)(=O)NC4(C)CC4)ccc32)n(C)n1
409909	409909:01:02_10.00	True	10.0	96	35.4	50.5	0.0	9.0	38.0	7.5	47.4	48.5	0.0	7.6	14.5	30.4	30.6	AKT_PI3K_MTOR	50.5	Mps1-IN-1	Mps1-IN-1 is a potent, selective and ATP-competitive Mps1 kinase inhibitor, with an IC50 and a Kd of 367 nM and 27 nM.	False	COc1cc(N2CCC(O)CC2)ccc1Nc1cc(Nc2ccccc2S(=O)(=O)C(C)C)c2cc[nH]c2n1
409882	409882:01:02_10.00	True	10.0	80	51.3	23.4	0.0	47.2	20.6	43.9	36.1	72.2	9.4	34.8	0.0	61.8	60.7	LCH	72.2	MI-77301	it binds to MDM2 with a Ki value of 0.88 nM and blocks the MDM2-p53 interaction. It activates wild-type p53 in vitro and in xenograft tumor tissue of leukemia and solid tumors, leading to p53-dependent cell cycle arrest and/or apoptosis. In an SJSA-1 xenograft model of osteosarcoma, a single dose of 200 mg/kg MI-77301 induces complete tumor regression in mice by upregulating the pro-apoptotic protein PUMA.	True	CC(C)(C)C[C@@H]1N[C@@H](C(=O)NC2CCC(O)CC2)[C@H](c2cccc(Cl)c2F)C12C(=O)Nc1cc(Cl)ccc12
410516	410516:01:04_10.00	True	10.0	95	39.7	0.0	0.0	63.1	0.0	61.8	0.0	91.8	21.2	25.3	0.0	58.2	31.9	LCH	91.8		it is a very potent and highly selective inhibitor of the enzymatic activity of Cathepsin C. It blocks human CatC in vitro with an IC50 of 1.8 nM and shows > 1500x selectivity versus the related proteases Cathepsin B, F, H, K, L and S. BI-9740 displays no activity against 34 unrelated proteases from different classes up to a concentration of 10 µM. BI-9740 fully inhibits the production of active neutrophil elastase in the human U937 cell line with an IC50 of 5.4 nM.	True	CN1C(=O)Cc2ccc(-c3ccc(C[C@@H](C#N)NC(=O)[C@H]4N[C@@H]5CC[C@H]4C5)c(F)c3)cc21
409860	409860:01:02_10.00	True	10.0	73	84.5	0.0	0.0	72.1	0.0	70.0	0.0	83.8	35.6	47.8	0.0	71.2	45.5	LCH	83.8	UNC0642	UNC0642 is a potent and selective lysine methyltransferases G9a and GLP inhibitor, with an IC50 of <2.5 nM for G9a.	False	COc1cc2c(NC3CCN(C(C)C)CC3)nc(N3CCC(F)(F)CC3)nc2cc1OCCCN1CCCC1
409865	409865:01:02_10.00	True	10.0	64	78.1	0.0	34.7	31.8	28.2	29.6	4.3	41.6	25.1	22.8	0.0	63.9	13.0	Tubulin	63.9	Pevonedistat	Pevonedistat (MLN4924) is a potent and selective NEDD8-activating enzyme (NAE) inhibitor with an IC50 of 4.7 nM.	True	NS(=O)(=O)OC[C@@H]1C[C@@H](n2ccc3c(N[C@H]4CCc5ccccc54)ncnc32)C[C@@H]1O
280863	280863:03:05_10.00	True	10.0	98	37.5	28.2	0.0	33.2	7.6	36.0	39.5	72.6	0.0	16.0	0.0	44.0	31.0	LCH	72.6	PD 169316	PD 169316 is a potent, cell-permeable and selective p38 MAP kinase inhibitor, with IC50 of 89 nM. PD169316 selectively inhibits the kinase activity of the phosphorylated p38 without hindering upstream kinases to phosphorylate p38. PD169316 shows antiviral activity against Enterovirus71. PD169316 shows antiviral activity against Enterovirus71.	False	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1
410278	410278:01:02_10.00	True	10.0	100	13.8	78.2	0.0	0.0	79.5	0.0	28.2	5.8	0.0	0.0	50.2	0.0	1.7	DNA_Synth	79.5	SAR260301	potent, specific, reversible, and ATP-competitive inhibitor of Cdc2-like kinase (Clk).	True	C[C@H]1Cc2ccccc2N1C(=O)Cc1nc(=O)cc(N2CCOCC2)[nH]1
409903	409903:01:02_10.00	True	10.0	93	8.5	0.0	0.0	54.9	0.0	64.2	36.8	73.6	14.9	37.6	0.0	51.2	27.5	LCH	73.6	Infigratinib	Infigratinib (BGJ-398; NVP-BGJ398) is a potent inhibitor of the FGFR family with IC50s of 0.9 nM, 1.4 nM, 1 nM, and 60 nM for FGFR1, FGFR2, FGFR3, and FGFR4, respectively.	False	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1
409850	409850:01:02_10.00	True	10.0	93	43.0	0.0	0.0	91.8	0.0	86.5	11.3	74.1	51.7	70.2	0.0	87.6	66.8	BET	91.8	PFI-1	PFI-1 is a selective BET (bromodomain-containing protein) inhibitor for BRD4 with IC50 of 0.22 uM in a cell-free assay.	False	COc1ccccc1S(=O)(=O)Nc1ccc2c(c1)CN(C)C(=O)N2
280402	280402:04:03_10.00	True	10.0	92	20.0	47.6	0.0	0.0	55.9	0.0	58.0	0.0	0.0	8.1	52.4	0.0	10.1	HSP90	58.0	Cyclosporin A, Antibiotic S 7481F1	calcineurin phosphatase inhibitor, immunosuppressant, Increases efficiency of cardiomyocyte generation from ESCs.	False	C/C=C/CC(C)C(O)C1C(=O)NC(CC)C(=O)N(C)CC(=O)N(C)C(CC(C)C)C(=O)NC(C(C)C)C(=O)N(C)C(CC(C)C)C(=O)NC(C)C(=O)NC(C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(C(C)C)C(=O)N1C
409847	409847:01:02_10.00	True	10.0	89	14.3	7.9	58.6	0.0	69.6	0.0	42.1	0.0	0.0	0.0	63.4	0.0	0.0	DNA_Synth	69.6	PDD 00017273	PDD 00017273 is a potent inhibitor of Poly(ADP-ribose) Glycohydrolase (PARG), with an IC50 of 26 nM, and a KD of 1.45 nM.	False	Cc1cc(Cn2c(=O)n(Cc3cnc(C)s3)c(=O)c3cc(S(=O)(=O)NC4(C)CC4)ccc32)n(C)n1
409916	409916:01:02_10.00	True	10.0	93	79.8	0.0	0.0	73.7	0.0	76.4	18.5	91.8	30.6	49.0	0.0	69.9	38.5	LCH	91.8	TP-064	it is a potent inhibitor of protein arginine methyltransferase 4 (PRMT4, IC50 50 = 43 nM) in vitro. See the Structural Genomics Consortium (SGC) website for more information.	False	CNCCN1CCC(c2cc(CN(C)C(=O)c3cccc(Oc4ccccc4)c3)ccn2)CC1
409876	409876:01:02_10.00	True	10.0	77	15.2	33.7	0.0	0.0	4.6	1.8	59.7	0.0	0.0	7.4	25.8	0.0	23.9	HSP90	59.7	RGFP966	RGFP966 is a highly selective HDAC3 inhibitor with an IC50 of 80 nM and shows no inhibition to other HDACs at concentrations up to 15 µM.	False	Nc1cc(F)ccc1NC(=O)/C=C/c1cnn(C/C=C/c2ccccc2)c1
409854	409854:01:03_10.00	True	10.0	96	38.3	17.8	0.0	49.8	0.0	51.3	24.6	88.3	2.2	26.1	0.0	44.8	36.4	LCH	88.3	SGC0946	SGC0946 is a highly potent and selective DOT1L methyltransferase inhibitor with IC50 of 0.3 nM; selectively kill mixed lineage leukaemia cells.IC50 value: 0.3 nM(DOT1L) Target: selective DOT1L inhibitorSGC 0946 is over 100-fold selective for other histone methyltransferases/HMTs. SGC 0946 potently reduces H3K79 dimethylation with IC50 of 2.6 nM in A431 cells, and 8.8 nM in MCF10A cells, which potently and selectively kills cells containing an MLL translocation. SGC 0946 is much more potent than its close analog EPZ004777, and serves as an excellent chemical probe for investigating DOT1L and further development of DOT1L inhibitors for cancer therapy.	True	CC(C)N(CCCNC(=O)Nc1ccc(C(C)(C)C)cc1)C[C@H]1O[C@@H](n2cc(Br)c3c(N)ncnc32)[C@H](O)[C@@H]1O
382153	382153:01:03_10.00	True	10.0	101	5.2	27.8	0.0	21.9	0.0	26.8	53.4	14.6	0.0	50.7	0.0	26.9	51.8	HSP90	53.4	8-Bromo-cAMP, sodium salt	enhances reprogramming efficiency of human fibroblasts, cell-permeable cAMP analog.	True	Nc1ncnc2c1nc(Br)n2[C@@H]1O[C@@H]2COP(=O)(O)O[C@H]2[C@H]1O
382166	382166:01:03_10.00	True	10.0	89	29.5	14.7	0.0	36.6	0.0	57.2	48.7	45.6	26.7	44.2	0.0	34.0	50.3	HDAC	57.2	Thiazovivin	Thiazovivin is a potent ROCK inhibitor, which can protect human embryonic stem cells. Thiazovivin improves the efficiency of iPSC generation.	False	O=C(NCc1ccccc1)c1csc(Nc2ccncn2)n1
409814	409814:01:02_10.00	True	10.0	97	75.6	0.0	0.0	80.6	0.0	78.6	7.1	95.3	35.4	53.6	0.0	73.5	46.1	LCH	95.3	MRK-740	it is a potent inhibitor of PRDM9 with a peptide competitive MOA. MRK-740 inhibits in vitro methylation of H3K4 with IC50 = 85 nM and shows more than 100-fold selectivity over other histone methyltransferases and other non-epigenetic targets. MRK-740 inhibits the methylation of H3K4 in cells with IC50 = 0.8 µM.	False	COc1cc(OC)cc(-c2noc(N3CCN(C)C4(CCN(c5ccnc(C)c5)CC4)C3)n2)c1
410513	410513:01:02_10.00	True	10.0	97	13.8	43.9	0.0	42.4	0.0	42.8	32.6	69.8	3.2	25.2	0.0	41.2	51.0	LCH	69.8		negative control of BI 1002494.	True	COc1cc(-c2cc3ncccc3c(O[C@@H](C)[C@H]3CNC(=O)C3)n2)cc(OC)c1OC
409900	409900:01:02_10.00	True	10.0	99	20.9	37.8	0.0	15.7	6.8	4.2	48.0	32.4	0.0	16.9	0.0	32.7	31.3	HSP90	48.0	PF-CBP1	it is an inhibitor of the CBP and p300 bromodomains (IC50s = 125 and 363 nM, respectively). It displays greater than 100-fold selectivity for the bromodomain of CBP over those of BRD4 and a panel of other proteins. PF-CBP1 reduces the expression of inflammatory cytokines by LPS-stimulated primary macrophages. It also suppresses the expression of RGS4 (regulator of G protein signaling 4) in primary cortical neurons.	False	CCCOc1ccc(CCc2nc3cc(-c4c(C)noc4C)ccc3n2CCN2CCOCC2)cc1
409837	409837:01:03_10.00	True	10.0	97	13.1	0.0	0.0	42.4	0.0	46.4	48.5	56.0	13.5	17.8	0.0	51.6	15.6	LCH	56.0	GSK-5959	GSK-5959 is a potent, selective and cell permeable BRPF1 bromodomain inhibitor with an IC50 of ~ 80 nM.	False	COc1ccccc1C(=O)Nc1cc2c(cc1N1CCCCC1)n(C)c(=O)n2C
381945	381945:02:02_10.00	True	10.0	94	61.0	0.0	0.0	72.3	0.0	77.5	43.4	64.8	32.7	65.7	0.0	64.0	65.5	HDAC	77.5	Purmorphamine	Purmorphamine (Shh Signaling Antagonist VI) is a smoothened/Smo receptor agonist with an EC50 of 1 uM.	False	c1ccc2c(Oc3nc(Nc4ccc(N5CCOCC5)cc4)c4ncn(C5CCCCC5)c4n3)cccc2c1
280629	280629:02:04_10.00	True	10.0	84	41.8	80.1	0.0	0.0	57.8	0.0	56.5	0.0	0.0	0.0	51.8	0.0	20.6	AKT_PI3K_MTOR	80.1	Indirubin-3'-oxime	protein kinase inhibitor; inhibits cyclin-dependent kinases (IC50 = 0.18 - 3.33 µM) and GSK-3ß (IC50 = 0.19 µM). Inhibits CDK5- and GSK-3ß-mediated tau phosphorylation, a process over-active in Alzheimer disease states. Also inhibits AMPK, LCK and SGK. Induces cell cycle arrest and inhibits cell proliferation.	False	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\O
392559	392559:02:02_10.00	True	10.0	98	31.3	63.0	0.0	0.0	57.2	0.0	27.1	33.7	0.0	0.0	28.9	0.0	2.3	AKT_PI3K_MTOR	63.0	BIX02188	it is a potent inhibitor of MEK5 (IC50 = 4.3 nM) with reduced activity towards inhibition of ERK5 and TGFbetaR1 (IC50s = 810 and 1,800 nM, respectively). It does not inhibit the closely related kinases MEK1, MEK2, ERK2, and JNK2 (IC50s = > 6,300 nM). BIX02188 inhibits phosphorylation of ERK5 in a dose-dependent manner without affecting phosphorylation of ERK1/2, p38 MAPK, or JNK1/2.	False	CN(C)Cc1cccc(/N=C(/c2ccccc2)c2c(O)[nH]c3cc(C(N)=O)ccc23)c1
409912	409912:01:02_10.00	True	10.0	60	42.0	17.0	57.4	0.0	77.0	0.0	26.4	0.0	0.0	0.0	59.3	0.0	0.0	DNA_Synth	77.0	BAY-299	BAY-299 is a very potent, dual inhibitor with IC50s of 67 nM for BRPF2 bromodomains (BD), 8 nM for TAF1 BD2, and 106 nM for TAF1L BD2.	False	Cc1cc2c(cc1N1C(=O)c3cccc4c(CCCO)ccc(c34)C1=O)n(C)c(=O)n2C
409868	409868:01:02_10.00	True	10.0	103	24.4	0.0	0.0	69.8	0.0	69.2	9.0	92.1	30.5	34.0	0.0	66.3	38.4	LCH	92.1	OICR-9429	OICR-9429 is a novel small-molecule antagonist of the Wdr5-MLL interaction with IC50 of 5 uM. inhibit proliferation and induce differentiation .target: Wdr5IC 50: 5 uMIn vitro: OICR-9429 inhibit proliferation and induce differentiation in p30-expressing human AML cells. OICR-9429 cause a significant decrease in viability in the majority of patient cells with mutations in the N-terminal part of the CEBPA gene. OICR-9429 displays exquisite cellular selectivity and specificity in disrupting critical protein-protein interactions between WDR5.   reduce the viability of primary human AML cells with N-terminal C/EBP.a. mutations by about 50% (mean value, n = 8) at 5 uMIn vivo:The reference for OICR-9429 to mice (female NOD-SCID) is 3 mg/kg.	False	CN1CCN(c2ccc(-c3cccc(CN4CCOCC4)c3)cc2NC(=O)c2cnc(O)cc2C(F)(F)F)CC1
280945	280945:02:04_10.00	True	10.0	95	27.3	82.1	0.0	0.0	71.9	0.0	25.9	0.0	0.0	0.0	53.2	0.0	19.5	AKT_PI3K_MTOR	82.1	SP600125,  Anthrapyrazolone	selective c-Jun N-terminal kinase (c-JNK) inhibitor, prevents BMP9-induced osteogenic differentiation of MSCs.	False	O=C1c2ccccc2-c2n[nH]c3cccc1c23
382164	382164:01:04_10.00	True	10.0	97	31.8	0.0	0.0	55.1	0.0	56.4	30.0	61.1	6.4	38.5	0.0	59.4	34.5	LCH	61.1	Neurodazine	induces neurogenesis in mature skeletal muscle cells.	False	COc1ccc(-c2nc(-c3ccc(-c4cccc(Cl)c4)o3)[nH]c2-c2ccc(OC)cc2)cc1
409844	409844:01:03_10.00	True	10.0	80	44.9	31.5	0.0	11.5	55.3	6.4	46.5	44.1	0.0	8.5	19.3	44.7	38.0	DNA_Synth	55.3	RG7112	RG7112 is a potent, selective, first clinical, orally active and blood-brain barrier crossed MDM2-p53 inhibitor, with an IC50 of 18 nM and a KD of 11 nM for binding to MDM2.	True	CCOc1cc(C(C)(C)C)ccc1C1=N[C@@](C)(c2ccc(Cl)cc2)[C@@](C)(c2ccc(Cl)cc2)N1C(=O)N1CCN(CCCS(C)(=O)=O)CC1
409858	409858:01:02_10.00	True	10.0	97	16.2	0.0	0.0	46.5	0.0	41.6	23.4	66.8	0.0	22.9	0.0	52.2	23.3	LCH	66.8	I-CBP112 (hydrochloride)	it is a selective inhibitor of CBP and EP300 that directly binds their bromodomains (Kds = 0.142 and 0.625 µM, respectively). Developed by the Structural Genomics Consortium (SGC), this compound shows only weak cross-reactivity with the bromodomains of bromodomain and extra-terminal proteins and shows no interaction with other bromodomains.	True	CCC(=O)N1CCOc2c(cc(-c3ccc(OC)c(OC)c3)cc2OC[C@H]2CCCN(C)C2)C1
409863	409863:01:02_10.00	True	10.0	98	5.9	0.0	0.0	59.9	0.0	62.2	39.7	72.6	13.2	32.2	0.0	67.1	44.5	LCH	72.6	AGI-6780	it is a potent, selective inhibitor of mutant Isocitrate dehydrogenase with an IC50 value of 23 nM. It binds allosterically at the dimer interface of mutant IDH2-R140Q, inhibiting 2-HG formation in human glioblastoma U87 and TF-1 cells expressing IDH2-R140Q with IC50 values of 11 and 18 nM, respectively. In primary human acute myelogenous leukemia cells, AGI-6780 suppressed cell growth and induced differentiation of immature blast cells toward macrophage and granulocytic lineages.	False	O=C(Nc1cccc(C(F)(F)F)c1)Nc1cc(S(=O)(=O)NC2CC2)ccc1-c1ccsc1
409852	409852:01:02_10.00	True	10.0	80	46.3	15.4	0.0	1.9	44.0	0.0	26.0	27.1	0.0	10.9	12.9	21.9	0.0	DNA_Synth	44.0	GSK-J4 (hydrochloride)	GSK-J4 hydrochloride is a potent dual inhibitor of H3K27me3/me2-demethylases JMJD3/KDM6B and UTX/KDM6A with IC50s of 8.6 and 6.6 uM, respectively. GSK-J4 hydrochloride inhibits LPS-induced TNF-.a. production in human primary macrophages with an IC50 of 9 uM. GSK-J4 hydrochloride is a cell permeable prodrug of GSK-J1.	False	CCOC(=O)CCNc1cc(N2CCc3ccccc3CC2)nc(-c2ccccn2)n1
409864	409864:01:02_10.00	True	10.0	103	7.9	0.0	0.0	50.8	0.0	48.4	34.2	58.1	13.3	46.8	0.0	56.1	38.9	LCH	58.1	PFI-2 (hydrochloride)	PFI-2 hydrochloride is a a first-in-class, potent, highly selective, and cell-active inhibitor of the methyltransferase activity of SETD7 with IC50 of 2 nM, 500 fold active than (S)-PFI-2.IC50 value: 2 nM Target: SETD7(R)-PFI-2 is highly selective (>1,000-fold) for SETD7, over a panel of 18 other human protein methyltransferases and DNMT1, and was shown to be inactive against 134 additional ion channel, GPCR, and enzyme targets (<35% inhibition at 10 uM). (R)-PFI-2 binds to SETD7 only in the presence of SAM. PFI-766, a biotinylated variant of (R)-PFI-2 that retains the ability to bind and inhibit SETD7 (IC50 110 ± 26 nM in our in vitro enzymatic assay). PFI-766 engagement of endogenous SETD7 was also confirmed by mass spectrometry that supported the high specificity of the compound for endogenous SETD7.	True	O=C([C@@H](Cc1cccc(C(F)(F)F)c1)NS(=O)(=O)c1cc(F)c2c(c1)CCNC2)N1CCCC1
382127	382127:01:03_10.00	True	10.0	97	37.1	83.5	0.0	0.0	64.5	0.0	26.8	0.0	0.0	0.0	46.4	0.0	15.3	AKT_PI3K_MTOR	83.5	WHI-P154	WHI-P154 is a potent EGFR inhibitor, and also modestly blocks JAK3, with IC50s of 4 nM and 1.8 µM, respectively.	False	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC
409856	409856:01:04_01.00	True	1.0	97	13.1	8.3	0.0	18.2	6.1	9.7	29.9	40.7	0.0	16.1	0.0	35.0	7.0	LCH	40.7	GSK343	GSK343 is a highly potent and selective EZH2 inhibitor with an IC50 of 4 nM.	False	CCCc1cc(C)nc(O)c1CNC(=O)c1cc(-c2ccnc(N3CCN(C)CC3)c2)cc2c1cnn2C(C)C
392770	392770:02:03_02.00	True	2.0	85	58.2	88.1	0.0	0.0	42.1	0.0	17.6	0.0	0.0	0.0	53.7	0.0	23.6	AKT_PI3K_MTOR	88.1	VS-5584	VS-5584 is a pan-PI3K/mTOR kinase inhibitor with IC50s of 16 nM, 68 nM, 42 nM, 25 nM, and 37 nM for PI3K.a., PI3K.b., PI3K.d., PI3K.g. and mTOR, respectively. VS-5584 simultaneously blocks mTORC2 as well as mTORC1.	False	Cc1nc2c(-c3cnc(N)nc3)nc(N3CCOCC3)nc2n1C(C)C
392522	410128:01:03_02.00	True	2.0	61	40.6	0.0	92.9	0.0	29.7	0.0	7.7	0.0	0.0	0.0	16.0	0.0	0.0	Aurora	92.9	SNS-314	SNS-314 is a potent and selective aurora kinase inhibitor with IC50s of 9, 31, and 6 nM for aurora A, B and C, respectively.	False	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCNc2ncnc3ccsc23)s1
410139	410139:01:03_02.00	True	2.0	77	20.7	27.4	50.6	0.0	79.8	0.0	7.1	0.0	0.0	0.0	63.3	0.0	0.0	DNA_Synth	79.8	Niraparib (tosylate)	Niraparib tosylate (MK-4827 tosylate) is a highly potent and orally bioavailable PARP1 and PARP2 inhibitor with an IC50 of 3.8 and 2.1 nM, respectively. Niraparib tosylate leads to inhibition of repair of DNA damage, activates apoptosis and shows anti-tumor activity.	True	NC(=O)c1cccc2cn(-c3ccc([C@@H]4CCCNC4)cc3)nc12
392661	392661:02:03_02.00	True	2.0	105	5.5	18.1	0.0	41.2	0.0	44.4	20.0	71.2	2.0	0.0	0.0	27.2	30.9	LCH	71.2	AZD4547	AZD4547 is a novel selective FGFR inhibitor targeting FGFR1/2/3 with IC50 of 0.2 nM/2.5 nM/1.8 nM, weaker activity against FGFR4, VEGFR2(KDR), and little activity observed against IGFR, CDK2, and p38. Phase 1/2.	True	COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)n[nH]2)cc(OC)c1
392290	392290:02:03_02.00	True	2.0	100	6.7	47.8	0.0	11.2	0.0	12.7	57.7	30.5	0.0	22.1	0.0	13.1	32.9	HSP90	57.7	GSK2606414	GSK2606414 is a cell-permeable and orally available protein kinase R-like endoplasmic reticulum (ER) kinase (PERK) inhibitor with an IC50 of 0.4 nM.; Discovery of 7-Methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a Potent and Selective First-in-Class Inhibitor of Protein Kinase R (PKR)-like Endoplasmic Reticulum Kinase (PERK) J. Med. Chem. 2012	False	Cn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(C(F)(F)F)c2)c2c(N)ncnc21
392663	392663:02:03_02.00	True	2.0	91	7.4	30.3	0.0	44.0	0.0	37.3	35.8	52.3	17.8	50.3	0.0	60.9	64.7	Uncoupler	64.7	Dabrafenib	Dabrafenib (GSK2118436A) is an ATP-competitive inhibitor of Raf with IC50s of 5 nM and 0.6 nM for C-Raf and B-RafV600E, respectively.	False	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1
410043	410043:01:03_02.00	True	2.0	96	69.8	0.0	0.0	73.8	0.0	71.1	4.1	87.6	37.6	41.4	0.0	74.3	38.9	LCH	87.6	XMD17-109	XMD17-109 is a novel, specific ERK-5 inhibitor, with an IC50 of 162 nM.	False	CCOc1cc(C(=O)N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc2c(n1)N(C1CCCC1)c1ccccc1C(=O)N2C
392492	392492:02:03_02.00	True	2.0	99	39.2	84.3	0.0	0.0	36.3	0.0	26.2	13.4	0.0	0.0	38.4	0.0	36.9	AKT_PI3K_MTOR	84.3	Pictilisib	Pictilisib (GDC-0941) is a potent inhibitor of PI3K.a./.d. with an IC50 of 3 nM, with modest selectivity against p110.b. (11-fold) and p110.g. (25-fold).	False	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1
392495	392495:02:03_02.00	True	2.0	95	27.3	68.8	0.0	0.0	73.0	0.0	7.8	1.6	0.0	0.0	55.9	0.0	0.0	DNA_Synth	73.0	SU11274	SU11274 is a selective Met inhibitor with IC50 of 10 nM, no effects on PGDFRß, EGFR or Tie2.	False	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)c(C)c1C(=O)N1CCN(C)CC1
392477	392477:02:03_02.00	True	2.0	91	40.2	81.5	0.0	0.0	56.2	0.0	21.1	0.0	0.0	0.0	58.2	0.0	6.1	AKT_PI3K_MTOR	81.5	Ridaforolimus (Deforolimus, MK-8669)	Ridaforolimus (Deforolimus) is a selective mTOR inhibitor with IC50 of 0.2 nM; while not classified as a prodrug, mTOR inhibition and FKBP12 binding is similar to rapamycin.	False	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C
392684	392684:02:03_02.00	True	2.0	97	6.6	76.7	0.0	0.0	77.9	0.0	3.9	0.0	0.0	0.0	70.4	0.0	0.0	DNA_Synth	77.9	Icotinib	Icotinib (BPI-2009) is a potent and specific EGFR inhibitor with an IC50 of 5 nM; also inhibits mutant EGFRL858R, EGFRL858R/T790M, EGFRT790M and EGFRL861Q.	False	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1
392505	392505:02:03_02.00	True	2.0	90	27.8	68.5	0.0	0.0	74.9	0.0	20.7	0.0	0.0	0.0	77.3	0.0	0.0	Pyrimidine_Synth	77.3	OSU-03012 (AR-12)	OSU-03012 is a potent inhibitor of recombinant PDK-1 with IC50 of 5 ¿M and 2-fold increase in potency over OSU-02067.	False	NCC(=O)Nc1ccc(-n2nc(C(F)(F)F)cc2-c2ccc3c(ccc4ccccc43)c2)cc1
392762	392762:02:03_02.00	True	2.0	102	11.2	0.0	0.0	80.2	0.0	73.6	26.9	74.7	35.5	58.0	0.0	82.9	54.4	Tubulin	82.9	IM-12	IM-12 is an inhibitor of GSK-3.b., with an IC50 of 53 nM, and also enhances Wnt signalling.	False	Cc1[nH]c2ccccc2c1C1=C(NCCc2ccc(F)cc2)C(=O)N(C)C1=O
394208	394208:02:03_02.00	True	2.0	103	9.7	60.3	0.0	0.0	37.9	0.0	24.1	29.0	0.0	0.0	22.6	0.0	9.4	AKT_PI3K_MTOR	60.3	AZ191	AZ191 is a potent inhibitor that selectively inhibits DYRK1B with IC50 of 17 nM.	False	COc1cc(N2CCN(C)CC2)ccc1Nc1nccc(-c2cn(C)c3cnccc23)n1
409935	409935:01:02_02.00	True	2.0	82	17.6	0.0	0.0	78.1	0.0	74.2	31.4	66.8	57.3	64.5	0.0	78.7	63.1	Tubulin	78.7	Ionomycin	it is a selective calcium ionophore derived from Streptomyces conglobatus that mobilizes intracellular calcium stores. It is used as a research tool to raise the intracellular level of calcium, to study calcium transport across biological membranes, and to stimulate the intracellular production of cytokines.	True	C[C@H](C[C@H](C)C(=O)/C=C(\O)[C@H](C)C[C@H](C)C/C=C/[C@@H](C)[C@@H](O)[C@@H](C)[C@@H](O)C[C@@H]1CC[C@@](C)([C@H]2CC[C@@](C)([C@@H](C)O)O2)O1)C[C@H](C)CCC(=O)O
392675	392675:02:03_02.00	True	2.0	94	34.0	11.7	0.0	65.4	0.0	67.6	34.7	83.3	19.6	45.2	0.0	60.0	59.6	LCH	83.3	IKK 16	IKK 16 is a selective I.k.B kinase (IKK) inhibitor for IKK2, IKK complex and IKK1 with IC50s of 40 nM, 70 nM and 200 nM, respectively. IKK16 also inhibits leucine-rich repeat kinase-2 (LRRK2) with an IC50 of 50 nM.	False	O=C(c1ccc(Nc2nccc(-c3cc4ccccc4s3)n2)cc1)N1CCC(N2CCCC2)CC1
410146	410146:01:03_02.00	True	2.0	98	14.3	54.0	0.0	14.6	15.1	14.7	25.5	50.1	0.0	0.0	0.4	19.0	26.5	AKT_PI3K_MTOR	54.0	GSK2292767	GSK2292767 is a potent and selective PI3K¿ inhibitor.	False	COc1ncc(-c2cc(-c3ncc(CN4C[C@H](C)O[C@H](C)C4)o3)c3c[nH]nc3c2)cc1NS(C)(=O)=O
392793	392793:02:03_02.00	True	2.0	94	9.3	54.9	0.0	0.0	54.0	0.0	43.5	40.4	0.0	0.0	31.8	8.7	13.8	AKT_PI3K_MTOR	54.9	Osimertinib	Osimertinib (AZD-9291) is an irreversible and mutant selective EGFR inhibitor with IC50s of 12 and 1 nM against EGFRL858R and EGFRL858R/T790M, respectively.	False	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C
392551	392551:03:03_02.00	True	2.0	77	23.0	39.7	34.3	0.0	87.7	0.0	0.0	0.0	0.0	0.0	72.0	0.0	0.0	DNA_Synth	87.7	PHA-793887	PHA-793887 is a pyrrolo[3,4-c]pyrazole that inhibits cyclin-dependent kinases Cdk2/cyclin A, Cdk2/cyclin E, Cdk5/p25, and Cdk7/cyclin H with IC50 values of 8, 8, 5, and 10 nM, respectively. It is more than 6-fold selective for these kinases over Cdk1/cyclin B, Cdk4/cyclin D1, Cdk9/cyclin T, and GSK3ß (IC50s = 60, 62, 138, and 79 nM, respectively). PHA-793887 is cytotoxic to human ovarian A2780, colon HCT116, pancreatic BX-PC3, and leukemic K562, KU812, KCL22, and TOM1 cells both in vitro and in xenograft models. This compound has been examined in patients with solid tumors in phase 1 clinical trials.	False	CC(C)CC(=O)Nc1[nH]nc2c1CN(C(=O)C1CCN(C)CC1)C2(C)C
410691	410691:01:03_02.00	True	2.0	99	22.8	0.0	0.0	88.7	0.0	79.4	1.4	77.1	54.9	56.7	0.0	83.9	71.0	BET	88.7	GSK1324726A	GSK1324726A (I-BET726) is a highly selective inhibitor of BET family proteins with IC50 of 41 nM, 31 nM, and 22 nM for BRD2, BRD3, and BRD4, respectively.	True	CC(=O)N1c2ccc(-c3ccc(C(=O)O)cc3)cc2[C@H](Nc2ccc(Cl)cc2)C[C@@H]1C
410086	410086:01:03_02.00	True	2.0	54	50.6	39.2	34.5	0.0	78.5	0.0	0.0	0.0	0.0	0.0	61.4	0.0	0.0	DNA_Synth	78.5	Dubermatinib	Dubermatinib (TP-0903) is a potent and selective Axl receptor tyrosine kinase inhibitor with an IC50 value of 27 nM.	False	CN1CCN(Cc2ccc(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)N(C)C)n3)cc2)CC1
392321	392321:03:03_02.00	True	2.0	73	37.0	0.0	93.1	0.0	17.3	0.0	2.6	0.0	0.0	0.0	11.4	0.0	0.0	Aurora	93.1	ZM-447439	ZM-447439 is an aurora kinase inhibitor with IC50s of 110 and 130 nM for aurora A and B, respectively.; Thousands of chemical starting points for antimalarial lead identification. Nature. 2010 May 20;465(7296):305-10.	False	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1
410152	410152:01:03_02.00	True	2.0	98	66.7	0.0	0.0	73.2	0.0	70.1	14.2	86.5	33.8	42.0	0.0	72.6	57.3	LCH	86.5	Naquotinib(ASP8273)	Naquotinib(ASP8273) is an orally available, irreversible, mutant-selective, epidermal growth factor receptor (EGFR) inhibitor, with potential antineoplastic activity.	True	C=CC(=O)N1CC[C@@H](Oc2nc(Nc3ccc(N4CCC(N5CCN(C)CC5)CC4)cc3)c(C(N)=O)nc2CC)C1
410087	410087:01:03_02.00	True	2.0	60	44.6	58.5	18.8	0.0	59.8	0.0	41.4	0.0	0.0	0.0	50.7	0.0	0.0	DNA_Synth	59.8	SGI-7079	SGI-7079 is an Axl inhibitor, significantly inhibits the proliferation of SUM149 or KPL-4 cells with an IC50 of 0.43 or 0.16 uM, respectively.Ic50 value:Target: Axlin vitro: SGI-7079 treatment inhibits the phosphorylation of Axl at Tyr 702 upon Gas6 stimulation in SUM149 cells. The growth of SUM149 and KPL-4 in soft agar, one of the hallmark characteristics of cellular transformation and uncontrolled cell growth, is also significantly inhibited by SGI-7079 treatment. SGI-7079 treatment also significantly decreases the migration and invasion of SUM149 cells and the invasion of KPL-4 cells. Taken together, Axl inhibitor SGI-7079 significantly inhibits the proliferation, migration, and invasion of IBC cells, suggesting that Axl may be a promising therapeutic target in patients with IBC. in vivo: SGI-7079 inhibits tumor growth in a dose dependent manner, and at the maximum dose, inhibited tumor growth by 67%, compared to control. The combined inhibition of Axl (SGI-7079) plus EGFR (Erlotinib) is significantly more effective than either drug alone. Notably, SGI-7079 + Erlotinib (25/100 mg/kg) reduced the tumor growth by 82%. Axl blockade by SGI-7079 inhibits the growth of mesenchymal NSCLC xenograft tumors. 	False	Cc1c[nH]c2nc(Nc3ccc(N4CCN(C)CC4)c(F)c3)nc(-c3cccc(CC#N)c3)c12
392731	392731:02:03_02.00	True	2.0	95	30.1	0.0	0.0	71.6	0.0	71.4	16.1	90.3	28.5	38.9	0.0	65.3	40.3	LCH	90.3	EHop-016	EHop-016 is a potent and selective Rac GTPase Rac1 and Rac3 inhibitor. EHop-016 inhibits Rac1 activity with an IC50 of 1.1 uM in MDA-MB-435 cells. EHop-016 inhibits Vav2 interaction with Rac, Rac-activated PAK1, lamellipodia formation, and cell migration.	False	CCn1c2ccccc2c2cc(Nc3ccnc(NCCCN4CCOCC4)n3)ccc21
392683	392683:02:03_02.00	True	2.0	92	14.3	70.0	0.0	5.1	25.9	17.3	42.5	35.3	0.0	16.9	7.9	7.3	45.2	AKT_PI3K_MTOR	70.0	PF-573228	PF-573228 is a potent and selective FAK inhibitor with IC50 of 4 nM for purified recombinant catalytic fragment of FAK.	False	CS(=O)(=O)c1cccc(CNc2nc(Nc3ccc4c(c3)CCC(=O)N4)ncc2C(F)(F)F)c1
410041	410041:01:03_02.00	True	2.0	91	13.8	4.8	7.5	16.8	59.8	10.7	0.0	53.3	0.0	0.0	0.0	37.3	10.7	DNA_Synth	59.8	NMS-873	NMS-873 is a potent, selective allosteric VCP/p97 inhibitor with an IC50 value of 30 nM.	False	Cc1cc(OCc2nnc(SC3CCCC3)n2-c2cccnc2)ccc1-c1ccc(S(C)(=O)=O)cc1
410118	410118:01:03_02.00	True	2.0	91	11.4	1.8	0.0	61.4	0.0	60.4	11.8	77.2	10.8	41.4	0.0	61.0	52.9	LCH	77.2	VPS34 inhibitor 1 (Compound 19, PIK-III analogue)	VPS34 inhibitor 1 (Compound 19, PIK-III analogue) is a potent and selective inhibitor of VPS34 with an IC50 of 15 nM.	False	CC(C)(O)CNc1ncc(-c2ccnc(Nc3ccncc3)n2)c(CC2CC2)n1
392696	392696:02:03_02.00	True	2.0	97	30.4	81.6	0.0	0.0	36.6	0.0	29.1	13.0	0.0	0.0	35.5	0.0	35.5	AKT_PI3K_MTOR	81.6	ALK-IN-1	ALK-IN-1 (Brigatinib analog) is a potent and selective active inhibitor of anaplastic lymphoma kinase(ALK), Patent US20140066406 A1.	False	COc1cc(N2CCC(N(C)C)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1
409947	409947:01:03_02.00	True	2.0	68	53.2	0.0	0.0	79.9	0.0	92.6	25.3	67.5	68.8	60.3	0.0	79.4	62.1	HDAC	92.6	Belinostat	Belinostat (PXD101; PX105684) is a potent HDAC inhibitor with an IC50 of 27 nM in HeLa cell extracts.	False	O=C(/C=C/c1cccc(S(=O)(=O)Nc2ccccc2)c1)NO
410136	410136:01:03_02.00	True	2.0	101	7.8	44.7	0.0	33.7	3.1	33.5	4.5	59.8	0.0	8.4	0.0	29.0	42.0	LCH	59.8	IPI-3063	IPI-3063 is a potent and selective PI3K p110.d. inhibitor with an IC50 of 2.5±1.2 nM.	True	CC(C)n1c([C@H](C)Nc2ncnc(N)c2C#N)cc2cccc(-c3ccc(=O)n(C)c3)c2c1=O
410040	410040:01:03_02.00	True	2.0	79	44.9	46.1	4.3	0.0	77.5	0.0	24.1	0.1	0.0	0.0	55.8	0.0	0.0	DNA_Synth	77.5	JIB-04	JIB-04 is a pan-selective Jumonji histone demethylase inihibitor with IC50s of 230, 340, 855, 445, 435, 1100, and 290 nM for JARID1A, JMJD2E, JMJD3, JMJD2A, JMJD2B, JMJD2C, and JMJD2D, respectively.	False	Clc1ccc(N/N=C(\c2ccccc2)c2ccccn2)nc1
410103	410103:01:03_02.00	True	2.0	93	6.9	27.6	0.0	55.9	0.0	51.1	23.1	69.2	15.8	32.1	0.0	55.8	57.3	LCH	69.2	ASP3026	ASP3026 is a potent, selective and orally active inhibitor of anaplastic lymphoma kinase (ALK). ASP3026 induces apoptosis of tumor cells. ASP3026 can be used for the research of non-small cell lung cancer (NSCLC).	False	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1
410122	410122:01:03_02.00	True	2.0	85	5.2	0.0	29.2	0.0	43.7	5.2	0.0	6.2	1.7	0.0	13.0	12.4	0.0	DNA_Synth	43.7	WT-161	WT-161 is a potent and selective HDAC6 inhibitor with an IC50 of  0.40 nM.	False	O=C(CCCCCCC(=O)N/N=C/c1ccc(N(c2ccccc2)c2ccccc2)cc1)NO
409975	409975:01:03_02.00	True	2.0	80	34.9	0.0	0.0	70.7	0.0	71.2	34.9	48.9	60.4	47.8	0.0	78.8	62.0	Tubulin	78.8	Adavosertib	Adavosertib (AZD-1775; MK-1775) is a potent Wee1 inhibitor with an IC50 of 5.2 nM.	False	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1
247002	247002:10:03_02.00	True	2.0	96	7.1	25.6	0.0	14.7	15.8	14.0	2.1	23.7	0.0	7.6	0.0	26.9	25.5	Tubulin	26.9	Isotretinoin	anti-inflammatory and antitumor actions mediated through RAR-beta and RAR-alpha receptors, antiacne, antineoplastic.	False	CC1=C(/C=C/C(C)=C/C=C/C(C)=C\C(=O)O)C(C)(C)CCC1
410039	410039:01:03_02.00	True	2.0	76	32.5	0.0	0.0	53.0	0.0	60.5	20.3	81.6	21.8	31.1	0.0	55.6	38.3	LCH	81.6	SGI-1027	SGI-1027 is a DNA methyltransferase (DNMT) inhibitor, with IC50s of 7.5 µM, 8 µM, and 12.5 µM for DNMT3B, DNMT3A, and DNMT1 with poly(dI-dC) as substrate.	False	Cc1cc(Nc2ccc(NC(=O)c3ccc(Nc4ccnc5ccccc45)cc3)cc2)nc(N)n1
409946	409946:01:03_02.00	True	2.0	92	44.2	20.5	0.0	34.6	0.0	36.8	50.2	47.2	1.0	33.4	0.0	51.1	40.6	Tubulin	51.1	STF-62247	STF-62247 is an autophagy inducer that selectively cytotoxic to VHL-deficient renal cell carcinoma (IC50 of 0.625 uM and 16 uM in RCC4 and RCC4/VHL cells, respectively).	False	Cc1cccc(Nc2nc(-c3ccncc3)cs2)c1
409921	409921:01:02_02.00	True	2.0	67	38.0	0.0	0.0	77.0	0.0	72.0	1.4	77.9	54.5	44.1	0.0	80.6	58.3	Tubulin	80.6	MZ1	it is a hybrid compound that drives the selective proteasomal degradation of bromodomain-containing protein 4 (BRD4). It is characterized as a proteolysis-targeting chimera (PROTAC) and contains JQ-1, which binds bromo- and extra-terminal (BET) proteins, linked to a ligand for the E3 ubiquitin ligase VHL. MZ1 induces the selective degradation of BRD4 in HeLa cells when used at 0.1-0.5 µM. At concentrations of 2-10 µM, MZ1 causes the removal of BRD2, BRD3, and BRD4. BRD protein removal is evident within four hours of adding MZ1 and persists for at least 48 hours, unless MZ1 is removed.	True	Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)COCCOCCOCCNC(=O)C[C@@H]2N=C(c3ccc(Cl)cc3)c3c(sc(C)c3C)-n3c(C)nnc32)C(C)(C)C)cc1
394207	394207:02:03_02.00	True	2.0	90	22.6	0.0	0.0	54.3	0.0	46.5	17.4	69.5	25.7	22.9	0.0	78.2	28.3	Tubulin	78.2	HTH-01-015	HTH-01-015 is a selective NUAK1/ARK5 inhibitor (IC50 is 100 nM). HTH-01-015 inhibits NUAK1 with >100-fold higher potency than NUAK2 (IC50 of >10 uM).	False	Cc1nc(Nc2cnn(C3CCNCC3)c2)nc2c1N(C)C(=O)c1cc3ccccc3cc1N2C
410667	410667:01:02_02.00	True	2.0	94	6.4	0.0	0.0	48.0	0.0	47.9	14.2	76.9	14.9	10.7	0.0	53.5	13.6	LCH	76.9	GSK126	GSK126 (GSK2816126A) is a potent, highly selective inhibitor of EZH2 methyltransferase with an IC50 of 9.9 nM.	True	CC[C@H](C)n1cc(C)c2c(C(=O)NCc3c(C)cc(C)nc3O)cc(-c3ccc(N4CCNCC4)nc3)cc21
410661	410661:01:03_02.00	True	2.0	93	17.6	0.0	0.0	68.5	0.0	67.6	0.0	89.2	27.2	37.6	0.0	57.7	42.1	LCH	89.2	Sertraline HCl	Sertraline HCl is a 5-HT antagonist with Ki of 13 nM.	True	CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21
410145	410145:01:03_02.00	True	2.0	91	18.5	0.0	0.0	27.9	9.7	39.2	15.7	42.2	26.8	20.7	0.0	34.7	27.1	LCH	42.2	Y-39983 HCl	Y-39983 is a selective rho-associated protein kinase(ROCK) inhibitor with an IC50 of 3.6 nM.	True	C[C@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1
410658	410658:01:03_02.00	True	2.0	57	47.0	55.2	0.0	0.0	83.7	0.0	15.7	0.0	0.0	0.0	51.2	6.2	2.9	DNA_Synth	83.7	Daunorubicin HCl	Daunorubicin HCl inhibits both DNA and RNA synthesis and inhibits DNA synthesis with Ki of 0.02 ¿M in a cell-free assay.	True	COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1
392667	392667:02:03_02.00	True	2.0	91	37.5	55.1	0.0	0.0	60.1	0.0	31.5	23.0	0.0	0.0	25.2	6.9	6.9	DNA_Synth	60.1	CP-673451	CP-673451 is a potent and selective inhibitor of PDGFR with IC50s of 10 and 1 nM for PDGFR.a. and PDGFR.b., respectively.	False	COCCOc1ccc2c(c1)ncn2-c1ccc2cccc(N3CCC(N)CC3)c2n1
392481	392481:02:03_02.00	True	2.0	93	21.9	16.0	0.0	49.7	0.0	49.8	31.3	70.6	5.9	31.4	0.0	59.5	46.1	LCH	70.6	Nilotinib	Nilotinib (AMN-107) is a Bcr-Abl inhibitor with IC50 less than 30 nM.	False	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1
410157	410157:01:03_02.00	True	2.0	75	39.7	87.4	0.0	0.0	54.0	0.0	19.4	0.0	0.0	0.0	55.1	0.0	24.9	AKT_PI3K_MTOR	87.4	Elimusertib (hydrochloride)	Elimusertib (BAY 1895344) hydrochloride is a potent, orally available and selective ATR inhibitor, with IC50 of 7 nM. Anti-tumor activity.	True	C[C@@H]1COCCN1c1cc(-c2ccnn2C)c2ccnc(-c3cc[nH]n3)c2n1
410138	410138:01:03_02.00	True	2.0	96	23.3	76.0	0.0	0.0	34.4	0.0	29.5	19.8	0.0	0.0	37.0	0.0	13.3	AKT_PI3K_MTOR	76.0	Uprosertib	Uprosertib (GSK2141795) is a potent and selective pan-Akt inhibitor with IC50 values of 180/328/38 nM for Akt1/Akt2/Akt3, respectively.	True	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl
382166	382166:03:03_02.00	True	2.0	97	6.6	41.8	0.0	0.0	20.5	5.4	49.0	24.1	0.0	0.0	20.4	0.0	15.7	HSP90	49.0	Thiazovivin	Thiazovivin is a potent ROCK inhibitor, which can protect human embryonic stem cells. Thiazovivin improves the efficiency of iPSC generation.	False	O=C(NCc1ccccc1)c1csc(Nc2ccncn2)n1
410129	410129:01:03_02.00	True	2.0	85	53.4	0.0	0.0	75.2	0.0	70.2	25.9	77.6	52.1	47.5	0.0	91.8	52.1	Tubulin	91.8	Anlotinib (AL3818) dihydrochloride	Anlotinib (AL3818) is a highly potent and selective VEGFR2 inhibitor with IC50 less than 1 nM. It has broad-spectrum antitumor potential in clinical trials.	False	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ccnc2cc1OCC1(N)CC1
410005	410005:01:03_02.00	True	2.0	99	5.4	68.4	0.0	0.0	54.0	0.0	0.0	0.0	0.0	0.0	68.6	0.0	0.0	Pyrimidine_Synth	68.6	Rimonabant	Rimonabant is a selective antagonist of CB1 with IC50 of 13.6 nM and EC50 of 17.3 nM in hCB1 transfected HEK 293 membrane.	False	Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1
409952	409952:01:03_02.00	True	2.0	51	74.4	0.0	0.0	57.4	0.0	62.6	17.5	57.1	53.4	52.6	0.0	54.2	43.9	HDAC	62.6	Sepantronium (bromide)	Sepantronium bromide (YM-155) is a survivin inhibitor with an IC50 of 0.54 nM.	False	COCCn1c2c([n+](Cc3cnccn3)c1C)C(=O)c1ccccc1C2=O
392522	392522:02:03_02.00	True	2.0	60	30.6	0.0	92.5	0.0	35.4	0.0	0.9	0.0	0.0	0.0	23.0	0.0	0.0	Aurora	92.5	SNS-314	SNS-314 is a potent and selective aurora kinase inhibitor with IC50s of 9, 31, and 6 nM for aurora A, B and C, respectively.	False	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCNc2ncnc3ccsc23)s1
392597	392597:02:03_02.00	True	2.0	98	15.0	0.0	0.0	83.3	0.0	77.3	7.4	83.4	45.2	55.7	0.0	82.3	57.1	LCH	83.4	Fingolimod (hydrochloride)	Fingolimod hydrochloride (FTY720) is a sphingosine 1-phosphate (S1P) antagonist with an IC50 of 0.033 nM in K562 and NK cells. Fingolimod hydrochloride also is a pak1 activator.	False	CCCCCCCCc1ccc(CCC(N)(CO)CO)cc1
392475	392475:02:03_02.00	True	2.0	87	43.2	23.7	0.0	35.6	0.0	37.7	48.3	48.1	3.5	33.7	0.0	51.2	43.2	Tubulin	51.2	Bosutinib	Bosutinib is a dual Src/Abl inhibitor with IC50s of 1.2 nM and 1 nM, respectively.	False	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl
409956	409956:01:03_02.00	True	2.0	68	22.8	14.6	24.3	0.0	2.0	2.7	74.4	0.0	12.7	0.0	26.1	6.5	2.2	HSP90	74.4	Ganetespib	Ganetespib is a heat shock protein 90 (HSP90) inhibitor which exhibits potent cytotoxicity in a wide variety of hematological and solid tumor cell lines.	False	CC(C)c1cc(-c2nnc(O)n2-c2ccc3c(ccn3C)c2)c(O)cc1O
409879	409879:01:02_02.00	True	2.0	63	68.9	0.0	0.0	81.9	0.0	90.4	25.7	73.6	64.6	67.2	0.0	80.4	69.9	HDAC	90.4	Romidepsin	Romidepsin, also known as FK228, is a natural bicyclic depsipeptide that, following reduction, selectively inhibits class I histone deacetylases (HDACs). Reduction of a disulfide bond on romidepsin within the cell generates a zinc-binding thiol, allowing potent inhibition of HDACs 1, 2, 3, and 8 (IC50s = 53, 39, 53, and 26 nM, respectively), with less potency against HDACs 4, 6, 7, and 9 (IC50s = 470, 330, 3,200, and 12,000 nM, respectively). Through its effects on HDACs, romidepsin has anti-cancer activities, particularly against certain T cell lymphomas.	True	C/C=C1\NC(=O)[C@H]2CSSCC/C=C/[C@H](CC(=O)N[C@H](C(C)C)C(=O)N2)OC(=O)[C@H](C(C)C)NC1=O
410106	410106:01:03_02.00	True	2.0	96	9.3	0.0	2.6	50.6	0.0	48.2	0.0	58.3	32.9	16.9	0.0	52.1	11.3	LCH	58.3	MS023	MS023 is a potent, selective, and cell-active inhibitor of human type I protein arginine methyltransferases (PRMTs) inhibitor, with IC50s of 30, 119, 83, 4 and 5 nM for PRMT1, PRMT3, PRMT4, PRMT6, and PRMT8, respectively.	False	CC(C)Oc1ccc(-c2c[nH]cc2CN(C)CCN)cc1
410144	410144:01:03_02.00	True	2.0	95	23.0	84.7	0.0	0.0	75.9	0.0	21.4	0.0	0.0	0.0	76.2	0.0	0.0	AKT_PI3K_MTOR	84.7	CC-223	CC-223 is a potent, selective, and orally bioavailable inhibitor of mTOR kinase, with an IC50 value for mTOR kinase of 16 nM. CC-223 inhibits both mTORC1 and mTORC2.	False	CO[C@H]1CC[C@H](N2C(=O)CNc3ncc(-c4ccc(C(C)(C)O)nc4)nc32)CC1
411147	411147:01:03_10.00	True	10.0	98	75.1	0.0	0.0	82.7	0.0	79.3	19.9	93.8	37.7	51.9	0.0	77.0	56.8	LCH	93.8	Avapritinib	Avapritinib (BLU-285) is a highly potent, selective, and orally active KIT and PDGFRA activation loop mutant kinases inhibitor with IC50s of 0.27 and 0.24 nM for KIT D816V and PDGFRA D842V, respectively. Avapritinib (BLU-285) binds the active conformation of the kinase and shows antitumor activity. Avapritinib (BLU-285) attenuates the transport function of both ABCB1 and ABCG2.	True	Cn1cc(-c2cc3c(N4CCN(c5ncc([C@@](C)(N)c6ccc(F)cc6)cn5)CC4)ncnn3c2)cn1
411126	411126:01:03_10.00	True	10.0	59	73.4	0.0	0.0	59.5	0.0	56.8	22.5	82.2	22.7	32.0	0.0	68.9	40.2	LCH	82.2	Sunitinib	Sunitinib (SU 11248) is a multi-targeted receptor tyrosine kinase inhibitor with IC50s of 80 nM and 2 nM for VEGFR2 and PDGFR.b., respectively. Sunitinib, an ATP-competitive inhibitor, effectively inhibits autophosphorylation of Ire1.a. by inhibiting autophosphorylation and consequent RNase activation.	False	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C
411098	411098:01:03_10.00	True	10.0	51	39.7	20.9	14.3	17.1	9.9	31.8	43.8	29.8	19.2	11.6	0.0	35.8	16.7	HSP90	43.8	Midostaurin	Midostaurin (PKC412; CGP 41251) is a multi-targeted protein kinase inhibitor which inhibits PKC.a./.b./.g., Syk, Flk-1, Akt, PKA, c-Kit, c-Fgr, c-Src, FLT3, PDFR.b. and VEGFR1/2 with IC50s ranging from 22-500 nM.	True	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4
392528	392528:02:03_10.00	True	10.0	87	27.8	61.2	0.0	18.4	19.8	22.2	44.3	52.9	0.0	0.4	4.5	22.5	51.5	AKT_PI3K_MTOR	61.2	Regorafenib	Regorafenib (BAY 73-4506) is a multi-targeted receptor tyrosine kinase inhibitor with IC50s of 13/4.2/46, 22, 7, 1.5 and 2.5 nM for VEGFR1/2/3, PDGFR.b., Kit, RET and Raf-1, respectively.	False	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1
382185	382185:04:03_10.00	True	10.0	93	69.8	0.0	0.0	79.7	0.0	79.1	17.3	94.8	34.4	44.6	0.0	72.8	49.6	LCH	94.8	Aumitin	inhibits mitochondrial respiration by targeting complex I.; Chem. Sci. 2018, 9, 3014	False	Cc1cc(Nc2ccccc2)nc(Nc2ccc(NC(=O)c3ccccc3Cl)cc2)n1
392697	392697:02:03_10.00	True	10.0	85	32.1	42.1	0.0	42.6	0.0	53.2	39.7	58.9	17.4	40.4	0.0	38.7	64.2	Uncoupler	64.2	Capivasertib, AZD5363	it potently inhibits all isoforms of Akt(Akt1/Akt2/Akt3) with IC50 of 3 nM/8 nM/8 nM, similar to P70S6K/PKA and lower activity towards ROCK1/2. Phase 1/2.	False	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1
411161	411161:01:02_10.00	True	10.0	91	60.6	0.0	0.0	74.8	0.0	68.7	35.3	78.5	40.0	44.6	0.0	78.9	54.4	Tubulin	78.9	BMS-536924	BMS-536924 is an orally active, competitive and selective insulin-like growth factor receptor (IGF-1R) kinase and insulin receptor (IR) inhibitor with IC50s of 100 nM and 73 nM, respectively. BMS-536924 has anti-cancer activity.	True	Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NC[C@@H](O)c4cccc(Cl)c4)ccnc3O)nc12
392479	392479:02:03_10.00	True	10.0	90	75.5	0.0	0.0	74.3	0.0	75.1	20.9	91.0	37.9	47.4	0.0	75.4	48.6	LCH	91.0	Imatinib (Mesylate)	Imatinib Mesylate (STI571 Mesylate) is a tyrosine kinases inhibitor that inhibits c-Kit, Bcr-Abl, and PDGFR (IC50=100 nM) tyrosine kinases.	False	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1
392893	392893:03:03_10.00	True	10.0	89	23.0	59.9	0.0	29.0	28.8	26.3	31.5	66.3	0.0	17.9	0.2	36.0	49.6	LCH	66.3	Ipatasertib	Ipatasertib (GDC-0068) is a highly selective and ATP-competitive pan-Akt inhibitor with IC50s of 5, 18 and 8 nM for Akt1, Akt2 and Akt3, respectively.	True	CC(C)NC[C@@H](C(=O)N1CCN(c2ncnc3c2[C@H](C)C[C@H]3O)CC1)c1ccc(Cl)cc1
411129	411129:01:03_10.00	True	10.0	92	41.5	29.6	0.0	37.7	20.8	37.4	36.4	79.6	0.0	9.0	0.0	48.0	36.3	LCH	79.6	Borussertib	Borussertib is a covalent-allosteric and first-in-class inhibitor of protein kinase Akt, with an IC50 of 0.8 nM and a Ki of 2.2 nM for Aktwt.	False	C=CC(=O)Nc1ccc2nc(O)n(C3CCN(Cc4ccc(-c5nc6ccnc(O)c6cc5-c5ccccc5)cc4)CC3)c2c1
411127	411127:01:03_10.00	True	10.0	94	41.1	68.2	0.0	0.0	5.1	1.2	58.6	26.6	0.0	0.0	17.9	9.6	31.3	AKT_PI3K_MTOR	68.2	Ripretinib	Ripretinib (DCC-2618) is an orally bioavailable, selective KIT and PDGFRA switch-control inhibitor. Ripretinib (DCC-2618) targets and binds to both wild-type and mutant forms of KIT and PDGFRA specifically at their switch pocket binding sites, thereby preventing the switch from inactive to active conformations of these kinases and inactivating their wild-type and mutant forms. Ripretinib (DCC-2618) also inhibits multiple other kinase targets, such as FLT3 and KDR (or VEGFR-2). DCC-2618 exerts antineoplastic effect and induces apoptosis.	False	CCn1c(=O)c(-c2cc(NC(=O)Nc3ccccc3)c(F)cc2Br)cc2cnc(NC)cc21
392592	392592:03:03_10.00	True	10.0	98	52.3	0.0	0.0	79.1	0.0	77.4	47.7	71.4	42.3	54.6	0.0	80.3	54.5	Tubulin	80.3	Ibrutinib (Racemate)	it is a potent and highly selective Btk inhibitor with IC50 of 0.5 nM, modestly potent to Bmx, CSK, FGR, BRK, HCK, less potent to EGFR, Yes, ErbB2, JAK3, etc.	False	C=CC(=O)N1CCCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1
412259	412259:01:02_10.00	True	10.0	66	55.3	13.8	0.0	52.6	0.0	67.5	65.8	65.1	26.1	51.7	0.0	62.9	66.1	HDAC	67.5	BI-0319	BI-0319 is a degrader that tethers a highly selective PTK2 Kinase inhibitor BI-4464  to a CRL2VHL E3 ubiquitin ligase ligand, aimed at triggering the intracellular destruction of the focal adhesion tyrosine kinase (PTK2) protein.The binary affinities for BI-0319 to PTK2 and to the VCB complex CRL2VHL are 19 and 114 nM respectively. BI-0319 degrades the PTK2 protein in A549 cells with a DC50 of 243 nM to about 80%	False	COc1cc(C(=O)NCCOCCOCCOCC(=O)N[C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)NCc2ccc(-c3scnc3C)cc2)C(C)(C)C)ccc1Nc1ncc(C(F)(F)F)c(Oc2cccc3c2C(=O)CC3)n1
411901	411901:01:02_10.00	True	10.0	90	51.6	60.9	16.9	0.0	82.9	0.0	20.5	0.0	0.0	0.0	95.9	0.0	0.0	Pyrimidine_Synth	95.9		Dihydroorotate dehydrogenase (DHODH; activity internally confirmed)	False	CN1C(=O)C2(C(=O)N(Cc3ccncc3)c3ccc(OC(F)(F)F)cc32)c2ccccc21
412258	412258:01:03_10.00	True	10.0	101	50.4	0.0	0.0	68.5	0.0	68.3	25.1	95.2	26.2	34.8	0.0	68.4	40.0	LCH	95.2	ACBI1	ACBI1 is a potent and cooperative in vitro PROTAC degrader of the BAF chromatin remodeling ATPase subunits SMARCA2 and SMARCA4 as well as the facultative BAF complex subunit PBRM1. It harnesses the von-Hippel-Landau (VHL) E3 ligase to recruit its targets via their bromodomains and degrades its targets in the nanomolar range.	True	Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)C2(F)CC2)C(C)(C)C)c(OCCOc2ccc(CN3CCN(c4cc(-c5ccccc5O)nnc4N)CC3)cc2)c1
412270	412270:01:02_10.00	True	10.0	85	50.1	0.0	0.0	62.0	0.0	64.5	32.6	93.7	17.8	31.0	0.0	61.2	39.7	LCH	93.7	cis-ACBI1	cis-ACBI1 is the negative control to ACBI. The hydroxy proline of the VHL binding part is in the inactive cis-conformation, which prevents binding to VHL and thereby protein degradation.	True	Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@H](O)CN2C(=O)[C@@H](NC(=O)C2(F)CC2)C(C)(C)C)c(OCCOc2ccc(CN3CCN(c4cc(-c5ccccc5O)nnc4N)CC3)cc2)c1
280484	280484:02:03_10.00	True	10.0	57	42.1	35.7	31.3	0.0	63.8	0.0	48.1	2.1	0.0	0.0	48.2	0.0	0.0	DNA_Synth	63.8	Diphenyleneiodonium chloride	Diphenyleneiodonium chloride is a NADPH oxidase (NOX) inhibitor and also functions as a TRPA1 activator with an EC50 of 1 to 3 uM. Diphenyleneiodonium chloride selectively inhibits intracellular reactive oxygen species.	False	c1ccc2c(c1)[I+]c1ccccc1-2
412368	412368:01:02_10.00	True	10.0	81	47.2	62.0	0.0	0.0	70.9	0.0	23.7	0.0	0.0	0.0	82.8	0.0	0.0	Pyrimidine_Synth	82.8		Dihydroorotate dehydrogenase (DHODH; activity internally confirmed)	True	COc1ccc2[nH]c3c(c2c1)CCOC31CC[C@@]2(Oc3c(Cl)c(OC)cc(OC)c3C2=O)[C@H](C)C1
412263	412263:01:03_10.00	True	10.0	101	18.8	0.0	0.0	72.4	0.0	67.8	37.1	87.9	26.7	48.7	0.0	75.2	63.6	LCH	87.9	BI-3663	BI-3663 is a degrader that tethers a highly selective PTK2 Kinase inhibitor to a CRL4CRBN E3 ubiquitin ligase ligand, aimed at triggering the intracellular destruction of the focal adhesion tyrosine kinase (PTK2) protein. BI-3663 potently and rapidly induces reversible, long-lasting, and preferential removal of PTK2 in cells.	False	COc1cc(C(=O)NCCOCCOCCOCCC(=O)Nc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)ccc1Nc1ncc(C(F)(F)F)c(Oc2cccc3c2C(=O)CC3)n1
280949	280949:02:02_10.00	True	10.0	100	18.8	23.0	0.0	43.2	0.0	48.0	38.2	75.7	0.0	7.0	0.0	39.5	37.0	LCH	75.7	SB 202190	highly selective, potent and cell permeable p38 MAP kinase inhibitor.	False	Oc1ccc(-c2nc(-c3ccncc3)c(-c3ccc(F)cc3)[nH]2)cc1
412483	412483:01:02_10.00	True	10.0	90	83.2	0.0	0.0	76.8	0.0	75.6	26.7	87.3	33.9	60.3	0.0	75.3	60.8	LCH	87.3		cis-VZ185 is the (S)-hydroxy diastereoisomer of VZ185. While exhibiting comparable bromodomain binding affinity it no longer is able to bind and recruit the E3 ligase VHL and therefore does not induce the degradation of BRD7 and BRD9 proteins in cells.	True	COc1cc(-c2cn(C)c(=O)c3cnccc23)cc(OC)c1CN1CCN(CCCCCOc2cc(-c3scnc3C)ccc2CNC(=O)[C@@H]2C[C@H](O)CN2C(=O)[C@@H](NC(=O)C2(F)CC2)C(C)(C)C)CC1
412489	412489:01:02_10.00	True	10.0	98	61.1	0.0	0.0	74.5	0.0	72.9	33.2	70.6	42.8	63.4	0.0	73.9	68.8	BET	74.5	Salinomycin	Salinomycin (Procoxacin), a polyether potassium ionophore antibiotic, selectively inhibits the growth of gram-positive bacteria. Salinomycin is a potent inhibitor of Wnt/.b.-catenin signaling, blocks Wnt-induced LRP6 phosphorylation. Salinomycin (Procoxacin) shows selective activity against human cancer stem cells.	True	CC[C@@H](C(=O)[C@@H](C)[C@@H](O)[C@H](C)[C@@H]1O[C@@H]([C@@H](CC)C(=O)O)CC[C@@H]1C)[C@H]1O[C@]2(C=C[C@@H](O)[C@]3(CC[C@@](C)([C@H]4CC[C@](O)(CC)[C@H](C)O4)O3)O2)[C@H](C)C[C@@H]1C
412681	412681:01:04_10.00	True	10.0	92	37.7	0.0	0.0	69.0	0.0	65.5	23.8	87.2	27.0	32.1	0.0	70.5	34.8	LCH	87.2	Dasabuvir	Dasabuvir (ABT-333) is a nonnucleoside inhibitor of the RNA-dependent RNA polymerase encoded by the HCV NS5B gene, inhibits recombinant NS5B polymerases derived from HCV genotype 1a and 1b clinical isolates, with IC50 between 2.2 and 10.7 nM.	False	COc1c(-c2ccc3cc(NS(C)(=O)=O)ccc3c2)cc(-n2ccc(=O)[nH]c2=O)cc1C(C)(C)C
412477	412477:01:03_10.00	True	10.0	96	8.3	9.5	0.0	12.3	44.1	6.1	23.0	39.3	0.0	23.3	6.9	39.0	15.3	DNA_Synth	44.1		BI-4101 shows no inhibition of Alk5 in the Kinase Glow assay (IC50 > 50 µM) and therefore is a suitable negative control for in vitro experiments.	False	CCN(C)C(=O)c1ccc2c(/C(=N/C3CCN(C)CC3)c3ccccc3)c(O)[nH]c2c1
332505	332505:03:03_10.00	True	10.0	53	81.7	0.0	0.0	73.1	0.0	74.2	28.6	73.9	49.8	56.8	0.0	75.7	47.2	Tubulin	75.7	Sal003	Sal003 is a potent, specific and cell-permeable inhibitor of the eukaryotic translation initiation factor 2.a. (eIF2.a.) phosphatase. Sal003 is a derivative of salubrinal.	False	O=C(/C=C/c1ccccc1)NC(NC(=S)Nc1ccc(Cl)cc1)C(Cl)(Cl)Cl
408952	408952:02:03_10.00	True	10.0	100	51.5	0.0	0.0	81.6	0.0	72.7	21.7	80.1	35.7	63.5	0.0	82.0	52.5	Tubulin	82.0		BI-4659 is a potent inhibitor of Alk5 (TGFßR1) with an IC50 value of 19 nM and shows selectivity against a broad panel of other kinases. BI-4659 blocks the phosphorylation of Smad2 and Smad3 in HaCaT cells with an EC50 of 185 nM. Negative control = BI-4101	False	CCNC(=O)c1ccc2c(/C(=N/c3ccc(CN(C)C)cc3)c3ccccc3)c(O)[nH]c2c1
280402	280402:05:02_10.00	True	10.0	87	20.6	26.9	0.0	33.2	0.0	31.3	51.4	35.4	7.3	41.6	0.0	43.9	55.3	Uncoupler	55.3	Cyclosporin A, Antibiotic S 7481F1	calcineurin phosphatase inhibitor, immunosuppressant, Increases efficiency of cardiomyocyte generation from ESCs.	False	C/C=C/CC(C)C(O)C1C(=O)NC(CC)C(=O)N(C)CC(=O)N(C)C(CC(C)C)C(=O)NC(C(C)C)C(=O)N(C)C(CC(C)C)C(=O)NC(C)C(=O)NC(C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(C(C)C)C(=O)N1C
412482	412482:01:02_10.00	True	10.0	95	69.6	0.0	0.0	76.5	0.0	75.2	22.2	90.4	33.4	49.4	0.0	72.9	59.0	LCH	90.4		VZ185 is a potent, fast, and selective degrader of BRD9 and of its close homolog BRD7. VZ185 displays binary and ternary KD = 30 nM to VHL in both ITC and FP binding assays and degrades BRD9 and BRD7 proteins with DC50 values of 1.8 nM and 4.5 nM and Dmax of 95%.	True	COc1cc(-c2cn(C)c(=O)c3cnccc23)cc(OC)c1CN1CCN(CCCCCOc2cc(-c3scnc3C)ccc2CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)C2(F)CC2)C(C)(C)C)CC1
412490	412490:01:03_10.00	True	10.0	95	7.1	83.3	0.0	0.0	76.0	0.0	37.1	0.0	0.0	0.0	70.5	0.0	0.0	AKT_PI3K_MTOR	83.3	AZD-7648	AZD-7648 is a potent and selective DNA-PK inhibitor. Anti-tumor activity.	False	Cc1cc2ncnn2cc1Nc1ncc2c(n1)n(C1CCOCC1)c(=O)n2C
404607	404607:02:02_10.00	True	10.0	83	19.5	66.0	0.0	0.0	66.6	0.0	45.8	0.0	0.0	0.0	78.6	0.0	0.0	Pyrimidine_Synth	78.6	Myxothiazol	it has been used as a complex IIIQo inhibitor in C. elegans cultures. It has also been used to analyze mitochondrial oxygen transport in rat cells. Myxothiazol, an antibiotic with activity against fungi and insects, is a strong inhibitor of mitochondrial cytochrome b/c1-segment of respiratory chain. Myxothiazol binds to the quinol oxidation (Qo) site of the bc1 complex, blocking electron transfer to the Rieske iron-sulfur protein in the mitochondrial respiratory chain. Oxygen consumption blockage leads to a cytostatic effect that could be reversed. Myxothiazol, as other Epothilones, which are known for their anti tumor activity, contains a thiazole ring that is formed by the incorporation of cysteine into the polyketide backbone.	True	CO/C(=C\C(N)=O)[C@H](C)[C@H](/C=C/c1csc(-c2csc([C@@H](C)/C=C/C=C/C(C)C)n2)n1)OC
280136	280136:02:04_10.00	True	10.0	111	28.3	0.0	0.0	38.9	0.0	42.9	28.0	40.5	32.0	31.9	0.0	46.5	6.2	Tubulin	46.5	SB 525334	SB 525334 is a potent and selective transforming growth factor .b.1 receptor (ALK5) inhibitor with an IC50 of 14.3 nM.	False	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3nccnc3c2)n1
412489	412489:01:02_30.00	True	30.0	60	82.7	0.0	0.0	87.7	0.0	87.6	16.7	87.6	59.6	64.7	0.0	81.0	60.7	BET	87.7	Salinomycin	Salinomycin (Procoxacin), a polyether potassium ionophore antibiotic, selectively inhibits the growth of gram-positive bacteria. Salinomycin is a potent inhibitor of Wnt/.b.-catenin signaling, blocks Wnt-induced LRP6 phosphorylation. Salinomycin (Procoxacin) shows selective activity against human cancer stem cells.	True	CC[C@@H](C(=O)[C@@H](C)[C@@H](O)[C@H](C)[C@@H]1O[C@@H]([C@@H](CC)C(=O)O)CC[C@@H]1C)[C@H]1O[C@]2(C=C[C@@H](O)[C@]3(CC[C@@](C)([C@H]4CC[C@](O)(CC)[C@H](C)O4)O3)O2)[C@H](C)C[C@@H]1C
412681	412681:01:04_30.00	True	30.0	70	59.9	0.0	0.0	85.5	0.0	83.5	35.0	83.9	52.4	57.9	0.0	83.4	59.6	BET	85.5	Dasabuvir	Dasabuvir (ABT-333) is a nonnucleoside inhibitor of the RNA-dependent RNA polymerase encoded by the HCV NS5B gene, inhibits recombinant NS5B polymerases derived from HCV genotype 1a and 1b clinical isolates, with IC50 between 2.2 and 10.7 nM.	False	COc1c(-c2ccc3cc(NS(C)(=O)=O)ccc3c2)cc(-n2ccc(=O)[nH]c2=O)cc1C(C)(C)C
412477	412477:01:03_30.00	True	30.0	99	43.4	18.0	0.0	31.4	33.5	24.4	27.7	72.3	0.0	4.4	0.0	47.5	28.8	LCH	72.3		BI-4101 shows no inhibition of Alk5 in the Kinase Glow assay (IC50 > 50 µM) and therefore is a suitable negative control for in vitro experiments.	False	CCN(C)C(=O)c1ccc2c(/C(=N/C3CCN(C)CC3)c3ccccc3)c(O)[nH]c2c1
382150	382150:02:04_30.00	True	30.0	96	11.6	0.0	0.0	59.6	0.0	58.7	47.6	79.9	15.9	38.9	0.0	67.4	46.6	LCH	79.9	GW788388	selective inhibitor of TGF-ßRI.	False	O=C(NC1CCOCC1)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1
412484	412484:01:04_30.00	True	30.0	94	14.3	0.0	0.0	70.3	0.0	71.5	46.9	69.4	35.5	50.6	0.0	73.5	64.2	Tubulin	73.5		BI-0115 is a small molecule inhibitor of LOX-1 (lectin-like oxidized LDL receptor-1). BI-0115 shows an IC50 potency of 5.4 µM in the LOX-1 cellular uptake assay.	False	CCCN1C(=O)c2ccc(Cl)cc2Nc2ncccc21
408952	408952:02:03_30.00	True	30.0	105	73.9	0.0	0.0	82.7	0.0	78.8	24.5	88.7	38.8	59.6	0.0	78.6	49.9	LCH	88.7		BI-4659 is a potent inhibitor of Alk5 (TGFßR1) with an IC50 value of 19 nM and shows selectivity against a broad panel of other kinases. BI-4659 blocks the phosphorylation of Smad2 and Smad3 in HaCaT cells with an EC50 of 185 nM. Negative control = BI-4101	False	CCNC(=O)c1ccc2c(/C(=N/c3ccc(CN(C)C)cc3)c3ccccc3)c(O)[nH]c2c1
280427	280427:03:05_03.00	True	3.0	58	71.7	0.0	0.0	69.5	0.0	69.4	41.5	59.1	49.6	62.5	0.0	67.3	61.4	BET	69.5	Calcimycin, A23187, Calcium ionophore A23187	Ca2+ ionophore used to potentiate responses to NMDA, but not quisqualate glutamate receptors.	False	CNc1ccc2oc(C[C@H]3O[C@@]4(CC[C@H]3C)O[C@H]([C@H](C)C(=O)c3ccc[nH]3)[C@H](C)C[C@H]4C)nc2c1C(=O)O
280402	280402:05:02_30.00	True	30.0	83	29.7	35.1	0.0	47.2	0.0	48.4	53.5	39.3	22.0	60.3	0.0	50.7	79.0	Uncoupler	79.0	Cyclosporin A, Antibiotic S 7481F1	calcineurin phosphatase inhibitor, immunosuppressant, Increases efficiency of cardiomyocyte generation from ESCs.	False	C/C=C/CC(C)C(O)C1C(=O)NC(CC)C(=O)N(C)CC(=O)N(C)C(CC(C)C)C(=O)NC(C(C)C)C(=O)N(C)C(CC(C)C)C(=O)NC(C)C(=O)NC(C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(C(C)C)C(=O)N1C
412478	412478:01:03_30.00	True	30.0	87	8.3	33.1	0.0	0.0	18.2	11.5	64.5	21.6	0.0	0.0	30.6	0.0	7.3	HSP90	64.5		BI-0588 is one of the most potent and specific allosteric inhibitors of Hepatitis C Virus (HCV) polymerase known, as demonstrated by its cell-based antiviral replicon activity in the single-digit nM range for genotype(GT)-1.	True	CO[C@H]1CC[C@H](N(c2cc(F)c(Oc3ncc(Cn4nccn4)cc3C(F)(F)F)cc2C(=O)O)C(=O)[C@H]2CC[C@H](C)CC2)CC1
412480	412480:01:03_30.00	True	30.0	85	25.4	23.3	0.0	49.7	0.0	49.0	32.9	69.1	21.5	18.7	0.0	55.2	63.4	LCH	69.1	Faldaprevir	Faldaprevir (BI 201335) is a highly potent and selective Hepatitis C Virus NS3-NS4A protease inhibitor that can be used for both in vitro and in vivo pre-clinical experiments. It is a highly optimized noncovalent competitive inhibitor of NS3-NS4A proteases (HCV genotypes 1a and 1b) with Ki values in the low nanomolar range.	True	C=CC1C[C@]1(NC(=O)[C@@H]1C[C@@H](Oc2cc(-c3csc(NC(=O)C(C)C)n3)nc3c(Br)c(OC)ccc23)CN1C(=O)[C@@H](NC(=O)OC1CCCC1)C(C)(C)C)C(=O)O
412490	412490:01:03_30.00	True	30.0	89	36.6	92.0	0.0	0.0	67.3	0.0	33.8	0.0	0.0	0.0	71.9	0.0	4.7	AKT_PI3K_MTOR	92.0	AZD-7648	AZD-7648 is a potent and selective DNA-PK inhibitor. Anti-tumor activity.	False	Cc1cc2ncnn2cc1Nc1ncc2c(n1)n(C1CCOCC1)c(=O)n2C
404607	404607:02:02_30.00	True	30.0	67	64.8	0.0	0.0	82.5	0.0	87.9	40.2	80.0	57.2	54.8	0.0	76.2	67.8	HDAC	87.9	Myxothiazol	it has been used as a complex IIIQo inhibitor in C. elegans cultures. It has also been used to analyze mitochondrial oxygen transport in rat cells. Myxothiazol, an antibiotic with activity against fungi and insects, is a strong inhibitor of mitochondrial cytochrome b/c1-segment of respiratory chain. Myxothiazol binds to the quinol oxidation (Qo) site of the bc1 complex, blocking electron transfer to the Rieske iron-sulfur protein in the mitochondrial respiratory chain. Oxygen consumption blockage leads to a cytostatic effect that could be reversed. Myxothiazol, as other Epothilones, which are known for their anti tumor activity, contains a thiazole ring that is formed by the incorporation of cysteine into the polyketide backbone.	True	CO/C(=C\C(N)=O)[C@H](C)[C@H](/C=C/c1csc(-c2csc([C@@H](C)/C=C/C=C/C(C)C)n2)n1)OC
280136	280136:02:04_30.00	True	30.0	97	44.7	0.0	0.0	33.2	0.0	31.5	27.2	43.6	23.1	28.5	0.0	40.6	1.5	LCH	43.6	SB 525334	SB 525334 is a potent and selective transforming growth factor .b.1 receptor (ALK5) inhibitor with an IC50 of 14.3 nM.	False	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3nccnc3c2)n1
412681	412681:01:04_50.00	True	50.0	55	80.0	0.0	0.0	86.7	0.0	90.0	37.1	71.2	63.9	69.6	0.0	85.3	69.4	HDAC	90.0	Dasabuvir	Dasabuvir (ABT-333) is a nonnucleoside inhibitor of the RNA-dependent RNA polymerase encoded by the HCV NS5B gene, inhibits recombinant NS5B polymerases derived from HCV genotype 1a and 1b clinical isolates, with IC50 between 2.2 and 10.7 nM.	False	COc1c(-c2ccc3cc(NS(C)(=O)=O)ccc3c2)cc(-n2ccc(=O)[nH]c2=O)cc1C(C)(C)C
412487	412487:01:03_50.00	True	50.0	102	6.7	0.0	0.8	7.2	0.0	6.8	41.1	27.7	3.2	4.6	5.6	19.5	0.0	HSP90	41.1		BI-7656 serves as negative control to BI 207127 which is a highly potent and specific inhibitor of HCV polymerase activity (IC50 = 50 nM).	False	Cn1c(C2(NC(=O)c3ccc(NCC4CCCCC4)nc3)CCC2)nc2ccc(/C=C/C(=O)O)cc21
412477	412477:01:03_50.00	True	50.0	93	55.8	13.9	0.0	39.8	21.9	35.9	29.6	80.3	0.0	11.4	0.0	53.7	33.9	LCH	80.3		BI-4101 shows no inhibition of Alk5 in the Kinase Glow assay (IC50 > 50 µM) and therefore is a suitable negative control for in vitro experiments.	False	CCN(C)C(=O)c1ccc2c(/C(=N/C3CCN(C)CC3)c3ccccc3)c(O)[nH]c2c1
382150	382150:02:04_50.00	True	50.0	98	29.5	9.3	0.0	58.3	0.0	58.8	56.8	76.1	9.4	48.1	0.0	65.9	55.9	LCH	76.1	GW788388	selective inhibitor of TGF-ßRI.	False	O=C(NC1CCOCC1)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1
412484	412484:01:04_50.00	True	50.0	94	31.6	0.0	0.0	80.4	0.0	79.4	50.8	75.6	44.7	62.5	0.0	82.1	71.1	Tubulin	82.1		BI-0115 is a small molecule inhibitor of LOX-1 (lectin-like oxidized LDL receptor-1). BI-0115 shows an IC50 potency of 5.4 µM in the LOX-1 cellular uptake assay.	False	CCCN1C(=O)c2ccc(Cl)cc2Nc2ncccc21
412486	412486:01:04_50.00	True	50.0	77	15.5	55.2	0.0	0.0	49.9	0.0	57.8	0.0	0.0	0.0	50.1	2.1	5.5	HSP90	57.8	Deleobuvir	BI 207127 is a highly potent and specific inhibitor of genotype(GT)-1 HCV polymerase activity (IC50 = 50 nM) and of antiviral activity (EC50 values of 11 and 23 nM in cell-based replicon GT1b and GT1a assays, respectively).	False	Cn1c(C2(NC(=O)c3ccc4c(C5CCCC5)c(-c5ncc(Br)cn5)n(C)c4c3)CCC2)nc2ccc(/C=C/C(=O)O)cc21
408952	408952:02:03_50.00	True	50.0	90	76.2	0.0	0.0	83.1	0.0	81.1	28.1	88.2	41.0	56.6	0.0	80.4	52.9	LCH	88.2		BI-4659 is a potent inhibitor of Alk5 (TGFßR1) with an IC50 value of 19 nM and shows selectivity against a broad panel of other kinases. BI-4659 blocks the phosphorylation of Smad2 and Smad3 in HaCaT cells with an EC50 of 185 nM. Negative control = BI-4101	False	CCNC(=O)c1ccc2c(/C(=N/c3ccc(CN(C)C)cc3)c3ccccc3)c(O)[nH]c2c1
280402	280402:05:02_50.00	True	50.0	87	39.4	47.4	0.0	29.2	0.0	29.6	63.8	28.4	6.2	51.2	0.0	40.5	70.4	Uncoupler	70.4	Cyclosporin A, Antibiotic S 7481F1	calcineurin phosphatase inhibitor, immunosuppressant, Increases efficiency of cardiomyocyte generation from ESCs.	False	C/C=C/CC(C)C(O)C1C(=O)NC(CC)C(=O)N(C)CC(=O)N(C)C(CC(C)C)C(=O)NC(C(C)C)C(=O)N(C)C(CC(C)C)C(=O)NC(C)C(=O)NC(C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(C(C)C)C(=O)N1C
412478	412478:01:03_50.00	True	50.0	90	19.3	29.9	0.0	21.5	0.0	40.9	60.2	38.5	21.7	15.1	1.6	30.5	42.1	HSP90	60.2		BI-0588 is one of the most potent and specific allosteric inhibitors of Hepatitis C Virus (HCV) polymerase known, as demonstrated by its cell-based antiviral replicon activity in the single-digit nM range for genotype(GT)-1.	True	CO[C@H]1CC[C@H](N(c2cc(F)c(Oc3ncc(Cn4nccn4)cc3C(F)(F)F)cc2C(=O)O)C(=O)[C@H]2CC[C@H](C)CC2)CC1
412480	412480:01:03_50.00	True	50.0	71	42.7	0.0	0.0	74.9	0.0	78.3	22.4	72.9	51.6	51.4	0.0	65.4	76.8	HDAC	78.3	Faldaprevir	Faldaprevir (BI 201335) is a highly potent and selective Hepatitis C Virus NS3-NS4A protease inhibitor that can be used for both in vitro and in vivo pre-clinical experiments. It is a highly optimized noncovalent competitive inhibitor of NS3-NS4A proteases (HCV genotypes 1a and 1b) with Ki values in the low nanomolar range.	True	C=CC1C[C@]1(NC(=O)[C@@H]1C[C@@H](Oc2cc(-c3csc(NC(=O)C(C)C)n3)nc3c(Br)c(OC)ccc23)CN1C(=O)[C@@H](NC(=O)OC1CCCC1)C(C)(C)C)C(=O)O
412490	412490:01:03_50.00	True	50.0	89	41.1	93.1	0.0	0.0	57.2	0.0	27.2	0.0	0.0	0.0	63.2	0.0	18.4	AKT_PI3K_MTOR	93.1	AZD-7648	AZD-7648 is a potent and selective DNA-PK inhibitor. Anti-tumor activity.	False	Cc1cc2ncnn2cc1Nc1ncc2c(n1)n(C1CCOCC1)c(=O)n2C
280136	280136:02:04_50.00	True	50.0	90	45.9	0.0	0.0	30.0	0.0	30.6	32.6	41.1	19.2	31.6	0.0	38.9	1.5	LCH	41.1	SB 525334	SB 525334 is a potent and selective transforming growth factor .b.1 receptor (ALK5) inhibitor with an IC50 of 14.3 nM.	False	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3nccnc3c2)n1
280372	280372:10:12_02.00	True	2.0	98	8.8	0.0	0.0	74.0	0.0	76.6	1.0	66.8	51.1	39.8	0.0	60.7	57.9	HDAC	76.6	CGS 15943	CGS 15943 is an orally bioavailable non-xanthine Adenosine Receptor antagonist. Its Ki for human A1, A2A, A2B, and A3 Adenosine Receptors are 3.5, 4.2, 16, and 50 nM in transfected CHO cells, respectively. .	False	Nc1nc2ccc(Cl)cc2c2nc(-c3ccco3)nn12
247337	247337:01:08_02.00	True	2.0	92	7.6	0.0	0.0	71.4	0.0	73.4	0.0	75.1	46.3	38.8	0.0	49.8	47.0	LCH	75.1	Paroxetine (hydrochloride)	Paroxetine hydrochloride is a potent selective serotonin-reuptake inhibitor, commonly prescribed as an antidepressant and has GRK2 inhibitory ability with IC50 of 14uM.	True	Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1
413038	413038:01:04_02.00	True	2.0	83	15.5	15.6	25.7	0.0	63.2	0.0	14.9	24.1	0.0	8.5	15.6	23.1	0.0	DNA_Synth	63.2	Aminopurvalanol-a	Aminopurvalanol A is a selective, cell-permeable, and competitive cyclin-dependent kinase (CDK) inhibitor that potently inhibits Cdk1/cyclin B, Cdk2/cyclin A, Cdk2/cyclin E, and Cdk5/p35 (IC50s = 33, 33, 28, and 20 nM, respectively). It is over 90-fold selective for CDKs over ERK1, ERK2, PKC-.d., protein kinase A (PKA), casein kinase 1, insulin receptor tyrosine kinase (IC50s = 3.0-36 uM), and over 3,000-fold selective over a range of other kinases (IC50s > 100 uM). In antiproliferative assays in vitro, aminopurvalanol A inhibits growth of ovarian (IGROV1), leukemic (SR), lung (NCI-H522), and colonic (KM12) cells (GI50s = 470, 420, 1,000, and 30 nM, respectively). Aminopurvalanol A also inhibits mitotic division and preferentially arrests cells in the G2/M phase via Cdk1/cyclin B.	True	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1
413231	413231:02:02_50.00	True	50.0	78	55.6	0.0	0.0	66.1	0.0	70.7	42.7	56.8	41.6	64.3	0.0	65.7	75.6	Uncoupler	75.6	BML-277	BML-277 is a selective checkpoint kinase 2 (Chk2) inhibitor with an IC50 of 15 nM.	False	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1
413228	413228:01:04_02.00	True	2.0	100	16.6	0.0	0.0	65.7	0.0	68.4	36.3	75.3	20.6	46.0	0.0	66.4	52.0	LCH	75.3	CYM-5442	Sphingosine-1-phosphate (S1P) is an extracellular lipid mediator whose major effects are mediated through five distinct G protein-coupled receptors, S1P1/EDG-1, S1P2/EDG-5, S1P3/EDG-3, S1P4/EDG-6, and S1P5/EDG-8. CYM 5442 is a full agonist for S1P1 internalization, phosphorylation, and ubiquitination (EC50 = 1.35 nM). It is ineffective at S1P2, S1P3, S1P4, and S1P5 at concentrations up to 10 uM.2 CYM 5442 has been found to activate S1P1-mediated p42/p44 MAPK phosphorylation in CHO-K1 cells transfected with S1P1 with an EC50 value of 46 nM.	False	CCOc1ccc(-c2nc(-c3cccc4c3CCC4NCCO)no2)cc1OCC
413034	413034:01:03_02.00	True	2.0	93	23.0	0.0	0.0	55.5	0.0	54.2	1.5	79.2	18.2	34.1	0.0	57.5	36.0	LCH	79.2	DG-172 (hydrochloride)	DG-172 is an orally available inverse agonist of PPAR.b./.d. (IC50 = 27 nM), down-regulating transcription of ANGPTL4 in mouse myoblasts (IC50 = 9.5 nM). It alters the differentiation of bone marrow cells, augmenting GM-CSF-induced development into subsets of mature and immature dendritic cells. Inverse agonists of PPAR.b./.d., including DG-172, inhibit cancer cell invasion through suppression of ANGPTL4 expression.	False	CN1CCN(c2ccc(/C=C(\C#N)c3ccccc3Br)cc2)CC1
412999	412999:01:02_10.00	True	10.0	65	21.2	0.0	14.7	22.1	0.0	35.0	69.2	24.4	17.8	32.0	0.0	44.3	33.9	HSP90	69.2	Geldanamycin	Geldanamycin is a Hsp90 inhibitor with antimicrobial activity against many Gram-positive and some Gram-negative bacteria. Geldanamycin has anti-influenza virus H5N1 activities.	True	COC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C/C=C(\C)C(=O)/N=C(\C=C1O)C2=O
413026	413026:01:03_02.00	True	2.0	64	21.6	0.0	83.8	0.0	41.8	0.0	1.4	0.0	0.0	0.0	34.2	0.0	0.0	Aurora	83.8	PF-431396	PF-431396 is a pyrimidine-based dual inhibitor of nonreceptor tyrosine kinases FAK and PYK2 (IC50s = 2 and 11 nM, respectively). In ovariectomized rats, it has been shown to increase bone formation, promoting osteoblast recruitment and activity.	False	CN(c1ccccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O
413125	413125:02:02_01.00	True	1.0	108	21.9	0.0	0.0	60.4	0.0	61.4	24.0	86.5	17.3	31.9	0.0	61.9	45.6	LCH	86.5	BAY-293	BAY-293, a valuable chemical probe, blocks RAS activation via disruption of the KRAS-SOS1 interaction with an IC50 of 21 nM. BAY-293 is a potent inhibitor of Son of Sevenless 1 (SOS1). SOS1 is the guanine nucleotide exchange factor (GEF) and activator of RAS.	True	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1
412998	412998:01:02_10.00	True	10.0	106	33.2	0.0	0.0	76.3	0.0	76.3	18.3	79.8	38.1	42.4	0.0	74.7	51.8	LCH	79.8	Halopemide	Halopemide is a potent phospholipase D (PLD) inhibitor, with IC50s of 220 and 310 nM for human PLD1 and PLD2, respectively. Halopemid is a dopamine receptors antagonist, and acts a psychotropic agent.	False	O=C(NCCN1CCC(n2c(O)nc3cc(Cl)ccc32)CC1)c1ccc(F)cc1
413008	413008:01:02_10.00	True	10.0	100	64.1	0.0	0.0	81.4	0.0	80.7	25.3	82.5	42.4	61.6	0.0	80.9	59.9	LCH	82.5	Src Inhibitor 1	Src Inhibitor 1 is a potent and selective dual site Src tyrosine kinase inhibitor with IC50 values of 44 nM for Src and 88nM for Lck.	False	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC
413167	413167:01:02_01.00	True	1.0	108	5.2	0.0	0.0	20.3	0.0	15.8	23.1	29.3	2.3	21.1	0.0	20.1	0.0	LCH	29.3		negative control to BI-1950	True	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21
413014	413014:01:02_10.00	True	10.0	80	30.1	35.4	0.0	37.1	0.0	40.4	23.5	23.6	26.7	38.6	0.0	37.5	80.9	Uncoupler	80.9	NS 11021	NS 11021 is a potent and specific Ca2-activated big-conductance K Channels (KCa1.1 channels) activator. NS 11021 at concentrations above 0.3 uM activates KCa1.1 in a concentration-dependent manner by parallelshifting the channel activation curves to more negative potentials.	False	FC(F)(F)c1cc(NC(=S)Nc2ccc(Br)cc2-c2nn[nH]n2)cc(C(F)(F)F)c1
413119	413119:01:03_10.00	True	10.0	99	41.1	0.0	0.0	65.8	0.0	65.6	23.0	90.2	20.0	36.3	0.0	67.5	51.6	LCH	90.2	A 987306	Potent histamine H4 receptor antagonist (pKi values are 8.24 and 8.47 in human and rat H4 receptors respectively). Displays 162-fold, 620-fold, and > 1600-fold selectivity over human H3, H1 and H2 receptors.	True	Nc1nc2c(c(N3CCNCC3)n1)CCC1=C2[C@@H]2CCCC[C@@H]2O1
413171	413171:01:02_01.00	True	1.0	91	7.9	0.0	0.0	34.7	0.0	40.0	30.6	57.9	4.6	33.3	0.0	42.0	19.9	LCH	57.9		negative control to GSM1	True	COc1cc(-c2cn([C@H]3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1
413006	413006:01:02_10.00	True	10.0	74	45.1	30.4	0.0	0.0	54.3	0.0	17.5	21.7	0.0	3.7	28.7	12.7	1.2	DNA_Synth	54.3	ML228	ML228 (CID-46742353) is a potent the Hypoxia Inducible Factor (HIF) pathway activator with EC50 of 1 uM.  ML228 potently activates HIF in vitro as well as its downstream target VEGF.	False	c1ccc(-c2ccc(CNc3nc(-c4ccccn4)nnc3-c3ccccc3)cc2)cc1
413122	413122:01:03_10.00	True	10.0	74	35.1	0.0	24.9	45.9	0.0	48.7	0.0	45.1	43.9	24.7	0.0	60.0	7.1	Tubulin	60.0	Mirk-IN-1	Potent and selective DYRK1A/B inhibitor (IC50 values are 22 and 68 nM respectively). Selective for DYRK1A/B over a panel of other kinases. Reduces accumulation of quiescent Panc1 pancreatic cancer cells in G0 under serum free conditions. Also induces DNA damage and apoptosis in quiescent Panc1 cells.	False	COc1ncc2cc(C(=O)Nc3cc(C(=O)NCc4cccc(Cl)c4)ccc3Cl)c(O)nc2n1
413020	413020:01:02_10.00	True	10.0	92	9.7	17.2	35.6	0.0	82.6	0.0	0.0	0.0	0.0	0.0	63.4	0.0	0.0	DNA_Synth	82.6	Deferasirox	Deferasirox (ICL 670) is an orally available iron chelator used for the management of transfusional iron overload.	False	O=C(O)c1ccc(-n2nc(-c3ccccc3O)nc2-c2ccccc2O)cc1
410949	410949:02:03_10.00	True	10.0	95	6.4	49.8	0.0	0.0	62.1	0.0	3.5	7.3	0.0	22.2	26.7	0.0	18.7	DNA_Synth	62.1	WM-1119	WM-1119 is a highly potent and selective KAT6A inhibitor, with an IC50 of 0.25 uM for KAT6A in lymphoma cells, the binding KD values of WM-1119 with KAT6A, KAT5 and KAT7 are 2 nM, 2.2 uM, 0.5 uM , respectively.	False	O=C(NNS(=O)(=O)c1ccccc1F)c1cc(F)cc(-c2ccccn2)c1
413226	413226:01:02_10.00	True	10.0	73	30.4	49.4	0.3	0.0	82.6	0.0	4.6	9.6	0.0	0.0	51.9	0.0	0.5	DNA_Synth	82.6	NHTD	NHTD is an inhibitor of the KRAS-PDE.g. interaction which reduces aberrant KRAS signaling and suppresses tumor growth in vitro and in vivo.  https://doi.org/10.1002/ijc.32222	False	CC(C)(C)c1cc2oc3c(c2c(/C=N/NC(=O)c2ccc(O)cc2O)c1O)CCCC3
413192	413192:01:02_01.00	True	1.0	90	32.3	58.7	16.1	0.0	74.9	0.0	10.8	0.0	0.0	0.0	92.7	0.0	0.0	Pyrimidine_Synth	92.7		IPP/CNRS-A017 is an inhibitor of mitochondrial Dihydroorotate Dehydrogenase DHODH. IC50 = 25 nM (activity assay)	False	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F
413049	413049:01:04_10.00	True	10.0	110	6.0	3.9	0.0	43.7	0.0	34.4	35.4	36.8	1.3	34.9	0.0	41.2	39.7	BET	43.7	4-CMTB	(+/-)-4-CMTB is a positive allosteric modulator of free fatty acid receptor 2 (FFAR2/GPR43) with an EC50 value of 0.42 uM for [35S]GTP.g.S binding to 293 T-REx cell membranes expressing the human receptor. It selectively induces ERK1/2 phosphorylation in 293 T-REx cells expressing human FFAR2, but not FFAR1 or FFAR3.	False	CC(C)C(C(=O)Nc1nccs1)c1ccc(Cl)cc1
413051	413051:01:03_10.00	True	10.0	65	70.3	0.0	0.0	72.7	0.0	73.2	19.3	86.3	39.0	58.7	0.0	77.9	52.1	LCH	86.3	GSK-923295	GSK-923295 is a special, allosteric inhibitor of centromere-associated protein-E (CENP-E) kinesin motor ATPase activity, with Ki of 3.2±0.2 nM and 1.6± 0.1 nM for human and canine, respectively.	True	CC(C)Oc1ccc(C(=O)N[C@H](CNC(=O)CN(C)C)Cc2ccc(-c3cn4cccc([C@H](C)O)c4n3)cc2)cc1Cl
392568	392568:02:02_10.00	True	10.0	81	35.6	0.0	0.0	66.7	0.0	66.3	17.4	81.3	29.0	54.9	0.0	70.7	62.8	LCH	81.3	KU-60019	KU-60019 is an improved analogue of KU-55933, with IC50 of 6.3 nM for ATM in cell-free assays, 270- and 1600-fold more selective for ATM than DNA-PK and ATR,and is a highly effective radiosensitizer.	False	C[C@H]1CN(CC(=O)Nc2ccc3c(c2)Cc2cccc(-c4cc(=O)cc(N5CCOCC5)o4)c2S3)C[C@@H](C)O1
413214	413214:01:04_10.00	True	10.0	99	59.9	0.0	0.0	76.7	0.0	75.8	25.6	84.5	33.3	55.4	0.0	74.6	70.0	LCH	84.5	BAI1	BAI1 is a selective and allosteric inhibitor of BAX, an apoptosis regulator. BAI1 directly binds to BAX and allosterically inhibits BAX activation. BAI1 has the potential for the research of diseases mediated by BAX-dependent cell death.	False	OC(CN1CCNCC1)Cn1c2ccc(Br)cc2c2cc(Br)ccc21
413220	413220:01:04_10.00	True	10.0	80	83.6	0.0	0.0	77.1	0.0	73.5	12.3	86.1	36.6	50.7	0.0	74.6	56.3	LCH	86.1	CYM-50358	CYM50358 is a potent, selective antagonist of the sphingosine-1-phosphate receptor 4 (S1P4). CYM50358 inhibits S1P4 with an IC50 of 25 nM.	False	Cc1cc(CN)cc(C)c1NC(=O)c1ccc(-c2cc(Cl)ccc2Cl)o1
413048	413048:01:03_02.00	True	2.0	89	38.9	0.0	0.0	79.4	0.0	76.4	11.6	85.1	37.5	55.3	0.0	70.6	64.1	LCH	85.1	AC710	AC710 is a potent PDGFR inhibitor with Kds of 0.6, 1.57, 1, 1.3, 1.0 nM for FLT3, CSF1R, KIT, PDGFR.a. and PDGFR.b., respectively.	False	CCN1C(C)(C)CC(Oc2ccc(C(=O)Nc3ccc(NC(=O)Nc4cc(C(C)(C)C)on4)cc3)nc2)CC1(C)C
413221	413221:01:03_10.00	True	10.0	104	29.2	0.0	0.0	65.1	0.0	64.4	34.2	84.7	10.6	32.5	0.0	65.7	46.4	LCH	84.7	Conivaptan (hydrochloride)	Conivaptan (hydrochloride) is a non-peptide antagonist of vasopressin receptor, with Ki values of 0.48 and 3.04 nM for rat liver V1A receptor and rat kidney V2 receptor respectively.	False	Cc1nc2c([nH]1)-c1ccccc1N(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)CC2
413007	413007:01:04_10.00	True	10.0	56	23.8	0.4	55.0	0.0	57.1	0.0	41.2	6.0	0.0	0.0	33.9	7.2	0.0	DNA_Synth	57.1	Purvalanol A	Purvalanol A is a potent CDK inhibitor, which inhibits cdc2-cyclin B, cdk2-cyclin A, cdk2-cyclin E, cdk4-cyclin D1, and cdk5-p35 with IC50s of 4, 70, 35, 850, 75 nM, resepctively.	True	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1
413052	413052:01:03_10.00	True	10.0	96	6.9	29.1	0.0	24.9	36.5	24.6	12.6	59.1	0.0	26.2	0.0	38.2	30.8	LCH	59.1	AZD3229	AZD3229 is a potent pan-KIT mutant inhibitor for the treatment of gastrointestinal stromal tumors.	False	COCCOc1cc(F)c2c(Nc3ccc(NC(=O)Cn4cc(C(C)C)nn4)cc3)ncnc2c1
413118	413118:01:03_10.00	True	10.0	98	10.2	16.9	0.0	63.0	0.0	59.1	34.6	65.5	18.6	43.7	0.0	56.0	69.3	Uncoupler	69.3	FERb 033	Potent and selective ER.b. receptor agonist (Ki = 7.1 nM, EC50 = 4.8 nM). Displays 62-fold selectivity over ER.a..	False	O/N=C/c1ccc(-c2ccc(O)c(F)c2)c(Cl)c1O
413127	413127:01:03_10.00	True	10.0	93	29.2	0.0	0.0	73.8	0.0	73.2	11.7	75.8	28.4	69.4	0.0	68.1	51.2	LCH	75.8	MLi-2	MLi-2 is an orally active and highly selective LRRK2 inhibitor with an IC50 of 0.76 nM. MLi-2 has the potential for Parkinsons disease.	True	C[C@H]1CN(c2cc(-c3[nH]nc4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1
412997	412997:01:03_02.00	True	2.0	99	39.7	0.0	0.0	69.4	0.0	68.9	7.4	92.1	28.2	35.1	0.0	66.5	47.3	LCH	92.1	MCOPPB (hydrochloride)	The nociceptin/orphanin FQ peptide (NOP, ORL1, or OP4) receptor is a member of the opioid family of receptors that integrates the emotional components of anxiety, fear, and stress. MCOPPB is a potent agonist for the NOP receptor (pKi = 10.1, EC50 = 0.39 nM) with 12-, 270-, and >1,000-fold selectivity over the u-, Îº-, and .d.-opioid receptors.	True	CC1(N2CCC(n3c([C@@H]4CCCNC4)nc4ccccc43)CC2)CCCCCCC1
413231	413231:01:02_10.00	True	10.0	97	11.2	60.4	16.5	0.0	78.7	0.0	11.7	0.0	0.0	0.0	63.0	0.0	0.0	DNA_Synth	78.7	BML-277	BML-277 is a selective checkpoint kinase 2 (Chk2) inhibitor with an IC50 of 15 nM.	False	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1
413162	413162:01:02_01.00	True	1.0	99	12.4	18.1	0.0	48.6	0.0	45.0	24.8	69.3	9.3	35.6	0.0	49.7	45.9	LCH	69.3		negative control to Skepinone-L	False	CN(C(=O)c1ccccc1)c1cc(N(C)c2ccc3c(c2)CCc2ccc(C(=O)NCCN4CCOCC4)cc2C3=O)ccc1F
413126	413126:02:02_00.10	True	0.1	100	14.3	0.0	0.0	49.0	0.0	50.7	20.8	63.1	17.9	56.1	0.0	55.3	33.7	LCH	63.1		negative control to BAY-293	True	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1
247186	247186:03:04_10.00	True	10.0	75	32.3	45.4	11.7	0.0	88.7	0.0	0.0	0.0	0.0	0.0	57.8	0.0	0.0	DNA_Synth	88.7	Ciclopirox (olamine)	cell membrane proteins synthesis inhibitor, antifungal.	False	Cc1cc(C2CCCCC2)n(O)c(=O)c1
409343	409343:02:02_01.00	True	1.0	100	19.0	0.0	9.8	35.6	0.0	35.3	30.6	49.3	7.1	17.9	0.0	50.0	0.0	Tubulin	50.0	BAY-309,control for BAY-826	negative control to BAY-826	False	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1
413037	413037:01:04_02.00	True	2.0	97	5.4	30.9	30.3	0.0	78.3	0.0	0.0	0.0	0.0	0.0	55.7	0.0	0.0	DNA_Synth	78.3	A-205804	A-205804 is an orally bioavailable, potent and selective lead inhibitor of E-selectin and ICAM-1 expression, with an IC50 of 20 nM and 25 nM for E-selectin and ICAM-1, respectively. A-205804 can be used in the research of chronic inflammatory diseases.	False	Cc1ccc(Sc2cncc3sc(C(N)=O)cc23)cc1
413003	413003:01:03_10.00	True	10.0	82	24.4	45.8	37.4	0.0	79.5	0.0	1.5	0.0	0.0	0.0	84.6	0.0	0.0	Pyrimidine_Synth	84.6	Prasugrel	Prasugrel is a prodrug form of the platelet purinergic P2Y12 receptor antagonist R-99224. In vivo, prasugrel prevents thrombus formation (ED50 = 0.68 mg/kg) and increases tail bleeding time in rats.	False	CC(=O)Oc1cc2c(s1)CCN(C(C(=O)C1CC1)c1ccccc1F)C2
392568	392568:03:02_50.00	True	50.0	67	82.0	0.0	0.0	84.2	0.0	82.7	10.7	82.8	52.4	65.7	0.0	83.6	62.3	BET	84.2	KU-60019	KU-60019 is an improved analogue of KU-55933, with IC50 of 6.3 nM for ATM in cell-free assays, 270- and 1600-fold more selective for ATM than DNA-PK and ATR,and is a highly effective radiosensitizer.	False	C[C@H]1CN(CC(=O)Nc2ccc3c(c2)Cc2cccc(-c4cc(=O)cc(N5CCOCC5)o4)c2S3)C[C@@H](C)O1
413117	413117:01:03_10.00	True	10.0	95	12.4	0.0	0.0	18.0	0.0	8.2	31.6	35.2	0.0	1.6	0.0	33.7	3.0	LCH	35.2	CGP 53353	Selective inhibitor of PKC.b.II (IC50 values are 0.41 and 3.8 uM for PKC.b.II and PKC.b.I respectively). Also inhibits prionogenic Sup35 fibrillization (IC50 ~ 3.4 uM) and inhibits de novo A.b.42 assembly in vitro.	False	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21
413206	413206:01:02_01.00	True	1.0	101	9.2	22.1	0.0	55.6	0.0	56.0	36.1	62.9	16.3	40.7	0.0	58.3	69.4	Uncoupler	69.4		An inhibitor of MAPK14 with an IC50 = 0.2 nM (ELISA, cell free). NanoBRET: MAPK14 IC50 = 14.9 nM; MAPK11 IC50 = 16.9 nM. Negative control = FM-743	False	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4ccccc4)c3)cc1CC2
413029	413029:01:04_02.00	True	2.0	89	18.0	74.3	0.0	0.0	70.9	0.0	12.0	12.2	0.0	1.4	38.7	0.0	15.7	AKT_PI3K_MTOR	74.3	Lorlatinib	Lorlatinib (PF-06463922) is a selective, orally active, brain-penetrant and ATP-competitive ROS1/ALK inhibitor. Lorlatinib has Kis of <0.025 nM, <0.07 nM, and 0.7 nM for ROS1, wild type ALK, and ALKL1196M, respectively. Lorlatinib has anticancer activity.	True	C[C@H]1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CN(C)C(=O)c2ccc(F)cc21
413204	413204:01:02_01.00	True	1.0	73	38.2	0.0	21.1	37.6	10.4	39.2	0.0	40.7	39.8	26.1	0.0	59.7	14.1	Tubulin	59.7	CLK-IN-T3	CLK-IN-T3 is a high potent, selective, and stable CDC-like kinase (CLK) inhibitor with IC50s of 0.67 nM, 15 nM, and 110 nM for CLK1, CLK2, and CLK3 protein kinases, respectively. CLK-IN-T3 has anti-cancer activity.	False	CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5ccncc5)ccc4n3)cc2)CC1
412989	412989:01:02_10.00	True	10.0	90	8.3	0.0	0.0	74.5	0.0	72.1	26.2	76.6	34.6	45.0	0.0	71.1	49.4	LCH	76.6	OMDM-2	OMDM-2 is an endocannabinoid analog specifically designed to be a potent and selective inhibitor of the cellular uptake of arachidonoyl ethanolamide. Structurally, OMDM-2 is the amide of (R)-tyrosinol with oleic acid. In RBL-2H3 cells, OMDM-2 inhibits the cellular uptake of tritiated AEA with an IC50 of 3 uM, with negligible effects on the CB1 receptor and VR1.	True	CCCCCCCC/C=C\CCCCCCCC(=O)N[C@@H](CO)Cc1ccc(O)cc1
413161	413161:01:02_01.00	True	1.0	93	5.0	14.0	3.9	3.9	36.7	0.0	22.9	33.6	0.0	27.5	4.7	17.6	0.6	DNA_Synth	36.7		negative control to A1596586	True	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1
413000	413000:01:02_10.00	True	10.0	99	31.8	81.3	0.0	0.0	52.8	0.0	45.3	5.8	0.0	0.0	52.3	0.0	22.4	AKT_PI3K_MTOR	81.3	Arcyriaflavin-a	Arcyriaflavin A is an inhibitor of cyclin-dependent kinase 4 (CDK4; IC50 = 140 nM) and calcium/calmodulin-dependent protein kinase II (CaMKII; IC50 = 25 nM). It is selective for CDK4 and CaMKII over protein kinase A (PKA) and PKC (IC50s = >2 and >100 uM, respectively). In vitro, arcyriaflavin A inhibits replication of human cytomegalovirus (HCMV; IC50 = 200 nM), as well as proliferation of HCT116 and NCI H460 human carcinoma cells (IC50s = 850 and 590 nM, respectively).	False	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3ccccc3c21
413190	413190:01:02_03.00	True	3.0	104	11.1	33.4	0.0	48.0	0.0	51.0	32.6	76.9	0.0	30.0	0.0	50.4	53.2	LCH	76.9	BAY-985	BAY-985 is a highly potent, orally active and selective ATP-competitive dual inhibitor of TBK1 and IKK.e. with IC50s of 2/30 and 2 nM for TBK1 (low/high ATP) and IKK.e., respectively. Antitumor efficacy.	True	C[C@H](c1ccnc(Nc2nc3cc(-c4cc(N(C)C)ncn4)ccc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1
413038	413038:01:04_06.00	True	6.0	59	32.5	0.0	69.8	0.0	50.6	0.0	19.0	7.5	0.0	0.0	19.0	10.3	0.0	Aurora	69.8	Aminopurvalanol-a	Aminopurvalanol A is a selective, cell-permeable, and competitive cyclin-dependent kinase (CDK) inhibitor that potently inhibits Cdk1/cyclin B, Cdk2/cyclin A, Cdk2/cyclin E, and Cdk5/p35 (IC50s = 33, 33, 28, and 20 nM, respectively). It is over 90-fold selective for CDKs over ERK1, ERK2, PKC-.d., protein kinase A (PKA), casein kinase 1, insulin receptor tyrosine kinase (IC50s = 3.0-36 uM), and over 3,000-fold selective over a range of other kinases (IC50s > 100 uM). In antiproliferative assays in vitro, aminopurvalanol A inhibits growth of ovarian (IGROV1), leukemic (SR), lung (NCI-H522), and colonic (KM12) cells (GI50s = 470, 420, 1,000, and 30 nM, respectively). Aminopurvalanol A also inhibits mitotic division and preferentially arrests cells in the G2/M phase via Cdk1/cyclin B.	True	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1
413228	413228:01:04_06.00	True	6.0	96	71.2	0.0	0.0	87.5	0.0	88.4	24.6	87.5	47.2	62.1	0.0	80.1	66.7	HDAC	88.4	CYM-5442	Sphingosine-1-phosphate (S1P) is an extracellular lipid mediator whose major effects are mediated through five distinct G protein-coupled receptors, S1P1/EDG-1, S1P2/EDG-5, S1P3/EDG-3, S1P4/EDG-6, and S1P5/EDG-8. CYM 5442 is a full agonist for S1P1 internalization, phosphorylation, and ubiquitination (EC50 = 1.35 nM). It is ineffective at S1P2, S1P3, S1P4, and S1P5 at concentrations up to 10 uM.2 CYM 5442 has been found to activate S1P1-mediated p42/p44 MAPK phosphorylation in CHO-K1 cells transfected with S1P1 with an EC50 value of 46 nM.	False	CCOc1ccc(-c2nc(-c3cccc4c3CCC4NCCO)no2)cc1OCC
413053	413053:01:04_30.00	True	30.0	93	15.5	50.5	0.0	8.2	28.2	0.0	39.4	36.5	0.0	9.6	13.2	26.6	35.0	AKT_PI3K_MTOR	50.5	ONC212	ONC212, a fluorinated-ONC201 analogue, is a promising anti-cancer agent and also a selective agonist of GPR132. ONC212 also induces apoptosis.	False	O=C1C2=C(CCN(Cc3ccccc3)C2)N2CCN=C2N1Cc1ccc(C(F)(F)F)cc1
412996	412996:01:04_30.00	True	30.0	96	24.2	16.2	0.0	55.0	0.0	57.3	66.1	62.1	18.4	52.1	0.0	62.0	65.3	HSP90	66.1	FPS-ZM1	FPS-ZM1 is a high-affinity RAGE inhibitor with a Ki of 25 nM.	False	O=C(c1ccc(Cl)cc1)N(Cc1ccccc1)C1CCCCC1
413034	413034:01:03_06.00	True	6.0	98	68.4	0.0	0.0	83.7	0.0	82.3	1.5	92.0	43.6	52.4	0.0	75.8	47.8	LCH	92.0	DG-172 (hydrochloride)	DG-172 is an orally available inverse agonist of PPAR.b./.d. (IC50 = 27 nM), down-regulating transcription of ANGPTL4 in mouse myoblasts (IC50 = 9.5 nM). It alters the differentiation of bone marrow cells, augmenting GM-CSF-induced development into subsets of mature and immature dendritic cells. Inverse agonists of PPAR.b./.d., including DG-172, inhibit cancer cell invasion through suppression of ANGPTL4 expression.	False	CN1CCN(c2ccc(/C=C(\C#N)c3ccccc3Br)cc2)CC1
412999	412999:01:02_30.00	True	30.0	53	55.3	0.0	9.8	64.7	0.0	74.9	58.0	50.2	57.4	61.6	0.0	75.1	56.5	Tubulin	75.1	Geldanamycin	Geldanamycin is a Hsp90 inhibitor with antimicrobial activity against many Gram-positive and some Gram-negative bacteria. Geldanamycin has anti-influenza virus H5N1 activities.	True	COC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C/C=C(\C)C(=O)/N=C(\C=C1O)C2=O
413013	413013:01:03_30.00	True	30.0	93	12.6	12.5	0.0	17.7	0.0	20.9	65.0	38.2	0.0	7.6	0.2	40.7	18.1	HSP90	65.0	IWP L6	IWP L6 (PorcnInhibitorIII) is a Porcn inhibitor with an EC50 of 0.5 nM.	False	O=C(CSc1nc2c(c(=O)n1-c1ccccc1)SCC2)Nc1ccc(-c2ccccc2)cn1
413026	413026:01:03_06.00	True	6.0	50	46.6	0.0	53.3	0.0	50.8	0.0	0.0	13.0	5.3	0.0	7.3	21.6	0.0	Aurora	53.3	PF-431396	PF-431396 is a pyrimidine-based dual inhibitor of nonreceptor tyrosine kinases FAK and PYK2 (IC50s = 2 and 11 nM, respectively). In ovariectomized rats, it has been shown to increase bone formation, promoting osteoblast recruitment and activity.	False	CN(c1ccccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O
413195	413195:01:02_03.00	True	3.0	103	11.7	0.0	0.0	75.0	0.0	77.1	12.5	52.1	54.2	54.1	0.0	71.4	46.0	HDAC	77.1		TP-008 is an inhibitor of ACVR1B and TGFBR1. TGFBR1 pIC50 = 7.6 and ACVR1B pIC50 = 6.0	False	Cc1cnc(-c2cc(Cl)ccc2F)cc1-n1c(=O)n(CC(N)=O)c2cnccc21
413032	413032:01:03_30.00	True	30.0	102	17.6	43.6	0.0	46.4	1.5	41.6	32.2	64.5	2.0	40.6	0.0	51.1	61.4	LCH	64.5	NS309	NS309 is a potent and selective opener of the small or intermediate conductance Ca2+-activated K+ (SK or IK, respectively) channels, but displays no activity at BK channels.	False	O=Nc1c(O)[nH]c2c(Cl)c(Cl)ccc12
413125	413125:02:02_03.00	True	3.0	100	59.2	0.0	0.0	70.7	0.0	68.2	2.4	91.6	26.4	34.6	0.0	65.8	45.9	LCH	91.6	BAY-293	BAY-293, a valuable chemical probe, blocks RAS activation via disruption of the KRAS-SOS1 interaction with an IC50 of 21 nM. BAY-293 is a potent inhibitor of Son of Sevenless 1 (SOS1). SOS1 is the guanine nucleotide exchange factor (GEF) and activator of RAS.	True	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1
412998	412998:01:02_30.00	True	30.0	100	76.7	0.0	0.0	86.0	0.0	85.1	8.6	91.4	44.1	50.5	0.0	77.5	54.2	LCH	91.4	Halopemide	Halopemide is a potent phospholipase D (PLD) inhibitor, with IC50s of 220 and 310 nM for human PLD1 and PLD2, respectively. Halopemid is a dopamine receptors antagonist, and acts a psychotropic agent.	False	O=C(NCCN1CCC(n2c(O)nc3cc(Cl)ccc32)CC1)c1ccc(F)cc1
413115	413115:01:03_30.00	True	30.0	72	44.4	0.0	0.0	58.7	0.0	61.8	46.1	62.7	41.5	48.0	0.0	71.8	60.4	Tubulin	71.8	ZK 93423 hydrochloride	Potent benzodiazepine receptor agonist (IC50 = 1 nM). Non-selective between .a.1-, .a.2-, .a.3- and .a.5-subunit containing GABA-A receptors.	False	CCOC(=O)c1ncc2[nH]c3ccc(OCc4ccccc4)cc3c2c1COC
413005	413005:01:02_30.00	True	30.0	99	18.3	17.3	0.0	9.3	0.0	20.1	56.2	34.2	0.0	9.5	8.8	14.3	9.0	HSP90	56.2	BAM7	BAM7 is a direct and selective activator of proapoptotic BAX with an IC50 of 3.3 uM.	False	CCOc1ccccc1/N=N/c1c(C)nn(-c2nc(-c3ccccc3)cs2)c1O
413167	413167:01:02_03.00	True	3.0	102	16.4	0.0	0.0	59.1	0.0	62.3	44.4	48.4	42.1	38.7	0.0	57.9	32.3	HDAC	62.3		negative control to BI-1950	True	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21
412995	412995:01:04_06.00	True	6.0	104	15.4	0.0	0.0	68.5	0.0	69.7	33.2	49.5	48.0	60.5	0.0	75.5	42.4	Tubulin	75.5	SB-505124	SB-505124 is a selective inhibitor ofTGF-.b. Receptor type I receptor (ALK4, ALK5, ALK7), withIC50sof 129 nM and 47 nM forALK4, ALK5, respectively, but it does not inhibit ALK1, 2, 3, or 6.	False	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1
413014	413014:01:02_30.00	True	30.0	71	81.3	0.0	0.0	90.4	0.0	90.5	12.2	75.4	63.5	70.2	0.0	81.7	75.7	HDAC	90.5	NS 11021	NS 11021 is a potent and specific Ca2-activated big-conductance K Channels (KCa1.1 channels) activator. NS 11021 at concentrations above 0.3 uM activates KCa1.1 in a concentration-dependent manner by parallelshifting the channel activation curves to more negative potentials.	False	FC(F)(F)c1cc(NC(=S)Nc2ccc(Br)cc2-c2nn[nH]n2)cc(C(F)(F)F)c1
413119	413119:01:03_30.00	True	30.0	78	77.7	0.0	0.0	69.3	0.0	65.8	5.0	87.3	24.8	41.6	0.0	69.7	49.5	LCH	87.3	A 987306	Potent histamine H4 receptor antagonist (pKi values are 8.24 and 8.47 in human and rat H4 receptors respectively). Displays 162-fold, 620-fold, and > 1600-fold selectivity over human H3, H1 and H2 receptors.	True	Nc1nc2c(c(N3CCNCC3)n1)CCC1=C2[C@@H]2CCCC[C@@H]2O1
413171	413171:01:02_03.00	True	3.0	107	37.5	0.0	0.0	65.9	0.0	69.9	29.5	87.7	16.9	37.3	0.0	58.5	43.0	LCH	87.7		negative control to GSM1	True	COc1cc(-c2cn([C@H]3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1
413031	413031:01:04_06.00	True	6.0	110	16.1	68.8	0.0	0.0	36.4	0.0	47.0	25.9	0.0	0.0	33.8	0.0	8.7	AKT_PI3K_MTOR	68.8	CC-401	CC-401 is a potent inhibitor of all three JNK isoforms (Ki values range from 25 to 50 nM). It has at least 40-fold selectivity for JNK compared with other related kinases.	False	c1cc(OCCN2CCCCC2)cc(-c2[nH]nc3ccc(-c4nc[nH]n4)cc23)c1
413006	413006:01:02_30.00	True	30.0	60	60.1	0.4	0.0	50.9	0.0	55.2	6.4	37.4	50.8	45.4	0.0	53.8	75.7	Uncoupler	75.7	ML228	ML228 (CID-46742353) is a potent the Hypoxia Inducible Factor (HIF) pathway activator with EC50 of 1 uM.  ML228 potently activates HIF in vitro as well as its downstream target VEGF.	False	c1ccc(-c2ccc(CNc3nc(-c4ccccn4)nnc3-c3ccccc3)cc2)cc1
413181	413181:01:02_00.30	True	0.3	105	5.4	57.4	0.0	0.0	54.5	0.0	10.1	19.3	0.0	9.8	17.1	0.1	32.2	AKT_PI3K_MTOR	57.4	SR-318	SR-318 is a potent and highly selective p38 MAPK inhibitor with IC50s of 5 nM, 32 nM and 6.11 uM for p38.a., p38.b. and p38.a./.b., respectively. SR-318 potently inhibits the TNF-.a. release in whole blood with an IC50 of 283 nM. SR-318 has anti-cancer and anti-inflammatory activity.	False	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1
413211	413211:01:02_00.30	True	0.3	98	14.0	47.1	0.0	11.7	12.4	20.5	26.4	37.7	2.1	0.0	9.5	11.0	32.6	AKT_PI3K_MTOR	47.1	ROCK-IN-2	ROCK-IN-2 (Azaindole 1; TC-S 7001) is an orally active and ATP-competitive ROCK inhibitor with IC50s of 0.6 and 1.1nM for human ROCK-1 and ROCK-2, respectively.	False	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12
413122	413122:01:03_30.00	True	30.0	59	44.4	13.9	8.0	18.5	53.9	18.7	4.8	44.7	8.0	5.5	1.3	38.1	26.7	DNA_Synth	53.9	Mirk-IN-1	Potent and selective DYRK1A/B inhibitor (IC50 values are 22 and 68 nM respectively). Selective for DYRK1A/B over a panel of other kinases. Reduces accumulation of quiescent Panc1 pancreatic cancer cells in G0 under serum free conditions. Also induces DNA damage and apoptosis in quiescent Panc1 cells.	False	COc1ncc2cc(C(=O)Nc3cc(C(=O)NCc4cccc(Cl)c4)ccc3Cl)c(O)nc2n1
413020	413020:01:02_30.00	True	30.0	80	26.1	52.4	17.0	0.0	95.8	0.0	0.0	0.0	0.0	0.0	76.3	0.0	0.0	DNA_Synth	95.8	Deferasirox	Deferasirox (ICL 670) is an orally available iron chelator used for the management of transfusional iron overload.	False	O=C(O)c1ccc(-n2nc(-c3ccccc3O)nc2-c2ccccc2O)cc1
410949	410949:02:03_30.00	True	30.0	98	11.1	71.7	0.0	0.0	67.3	0.0	28.4	5.3	0.0	0.0	44.6	0.0	28.6	AKT_PI3K_MTOR	71.7	WM-1119	WM-1119 is a highly potent and selective KAT6A inhibitor, with an IC50 of 0.25 uM for KAT6A in lymphoma cells, the binding KD values of WM-1119 with KAT6A, KAT5 and KAT7 are 2 nM, 2.2 uM, 0.5 uM , respectively.	False	O=C(NNS(=O)(=O)c1ccccc1F)c1cc(F)cc(-c2ccccn2)c1
413192	413192:01:02_03.00	True	3.0	87	37.7	64.9	14.2	0.0	91.3	0.0	13.2	0.0	0.0	0.0	94.6	0.0	0.0	Pyrimidine_Synth	94.6		IPP/CNRS-A017 is an inhibitor of mitochondrial Dihydroorotate Dehydrogenase DHODH. IC50 = 25 nM (activity assay)	False	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F
413049	413049:01:04_30.00	True	30.0	96	45.1	0.0	0.0	82.8	0.0	81.0	43.8	71.2	43.7	66.3	0.0	81.4	67.1	BET	82.8	4-CMTB	(+/-)-4-CMTB is a positive allosteric modulator of free fatty acid receptor 2 (FFAR2/GPR43) with an EC50 value of 0.42 uM for [35S]GTP.g.S binding to 293 T-REx cell membranes expressing the human receptor. It selectively induces ERK1/2 phosphorylation in 293 T-REx cells expressing human FFAR2, but not FFAR1 or FFAR3.	False	CC(C)C(C(=O)Nc1nccs1)c1ccc(Cl)cc1
413150	413150:01:02_00.30	True	0.3	100	18.3	0.0	0.0	85.9	0.0	83.6	33.5	76.0	52.6	64.7	0.0	83.9	72.8	BET	85.9		negative control to TP-024	False	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1
413134	413134:02:04_30.00	True	30.0	96	11.4	0.0	0.0	85.7	0.0	85.9	29.3	75.0	54.4	56.4	0.0	81.8	61.4	HDAC	85.9	Ogerin negative control	Ogerin negative control is a structurally similar analog of ogerin (catalog no. SML1482). Ogerin is a selective positive allosteric modulator of an orphan GPCR, GPR68, also known as Ovarian cancer G-protein coupled receptor 1 (OGR1).	False	Nc1nc(NCc2ccccc2)nc(-c2cccc(CO)c2)n1
413015	413015:01:03_06.00	True	6.0	91	6.9	0.0	0.0	61.1	0.0	60.2	20.5	31.0	54.0	50.0	0.0	63.0	42.1	Tubulin	63.0	LY2109761	LY2109761 is an orally active, selective TGF-.b. receptor type I/II inhibitor with Kis of 38 nM and 300 nM, respectively.	False	c1ccc(-c2nn3c(c2-c2ccnc4cc(OCCN5CCOCC5)ccc24)CCC3)nc1
413221	413221:01:03_30.00	True	30.0	100	62.9	0.0	0.0	72.7	0.0	72.4	22.3	92.6	26.4	38.1	0.0	68.2	53.1	LCH	92.6	Conivaptan (hydrochloride)	Conivaptan (hydrochloride) is a non-peptide antagonist of vasopressin receptor, with Ki values of 0.48 and 3.04 nM for rat liver V1A receptor and rat kidney V2 receptor respectively.	False	Cc1nc2c([nH]1)-c1ccccc1N(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)CC2
413047	413047:01:02_30.00	True	30.0	87	36.6	0.0	0.0	69.0	0.0	66.5	48.0	70.9	26.6	55.5	0.0	70.2	68.7	LCH	70.9	Flindokalner	Flindokalner (BMS-204352) is a potassium channel modulator. Flindokalner is a positive modulator of all neuronal Kv7 channel subtypes expressed in HEK293 cells. Flindokalner is also a large conductance calcium-activated K channel (BKca) positive modulator. Flindokalner shows a negative modulatory activity at Kv7.1 channels (Ki=3.7 uM), and acts as a negative modulator of GABAA receptors. Flindokalner shows anxiolytic efficacy in vivo.	True	COc1ccc(Cl)cc1[C@]1(F)C(=O)Nc2cc(C(F)(F)F)ccc21
413007	413007:01:04_30.00	True	30.0	54	69.3	0.0	0.0	61.0	0.0	63.1	38.6	52.8	45.7	53.4	0.0	66.0	55.9	Tubulin	66.0	Purvalanol A	Purvalanol A is a potent CDK inhibitor, which inhibits cdc2-cyclin B, cdk2-cyclin A, cdk2-cyclin E, cdk4-cyclin D1, and cdk5-p35 with IC50s of 4, 70, 35, 850, 75 nM, resepctively.	True	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1
413052	413052:01:03_30.00	True	30.0	87	42.0	0.0	0.0	72.7	0.0	72.2	34.9	89.3	36.9	42.9	0.0	79.1	51.9	LCH	89.3	AZD3229	AZD3229 is a potent pan-KIT mutant inhibitor for the treatment of gastrointestinal stromal tumors.	False	COCCOc1cc(F)c2c(Nc3ccc(NC(=O)Cn4cc(C(C)C)nn4)cc3)ncnc2c1
413118	413118:01:03_30.00	True	30.0	91	44.9	1.9	0.0	76.4	0.0	78.5	42.4	76.3	39.0	62.6	0.0	68.3	75.5	HDAC	78.5	FERb 033	Potent and selective ER.b. receptor agonist (Ki = 7.1 nM, EC50 = 4.8 nM). Displays 62-fold selectivity over ER.a..	False	O/N=C/c1ccc(-c2ccc(O)c(F)c2)c(Cl)c1O
413127	413127:01:03_30.00	True	30.0	89	56.1	0.0	0.0	79.1	0.0	75.9	24.8	87.3	40.7	53.5	0.0	73.9	67.2	LCH	87.3	MLi-2	MLi-2 is an orally active and highly selective LRRK2 inhibitor with an IC50 of 0.76 nM. MLi-2 has the potential for Parkinsons disease.	True	C[C@H]1CN(c2cc(-c3[nH]nc4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1
413130	413130:01:02_03.00	True	3.0	88	7.4	0.0	0.0	71.9	0.0	76.4	50.9	56.1	48.9	56.9	0.0	72.0	67.7	HDAC	76.4		negative control to ABT-100	True	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1
413025	413025:01:02_30.00	True	30.0	98	10.7	0.0	0.7	67.3	0.0	69.8	7.3	73.5	37.3	31.4	0.0	64.8	29.0	LCH	73.5	CYM-5520	CYM 5520 is a noncompetitive allosteric agonist of S1P2 (EC50 = 0.48 uM) that does not display agonist activity towards S1P1, S1P3, S1P4, or S1P5.	False	Cc1cc(C(=O)Cn2cc(C#N)ccc2=O)c(C)n1Cc1ccccc1
412997	412997:01:03_06.00	True	6.0	98	82.0	0.0	0.0	76.4	0.0	75.8	0.0	88.1	33.8	42.2	0.0	70.9	43.3	LCH	88.1	MCOPPB (hydrochloride)	The nociceptin/orphanin FQ peptide (NOP, ORL1, or OP4) receptor is a member of the opioid family of receptors that integrates the emotional components of anxiety, fear, and stress. MCOPPB is a potent agonist for the NOP receptor (pKi = 10.1, EC50 = 0.39 nM) with 12-, 270-, and >1,000-fold selectivity over the u-, Îº-, and .d.-opioid receptors.	True	CC1(N2CCC(n3c([C@@H]4CCCNC4)nc4ccccc43)CC2)CCCCCCC1
413231	413231:01:02_30.00	True	30.0	88	27.3	5.9	0.0	59.0	0.0	68.0	50.9	63.8	33.0	43.2	0.0	61.4	69.2	Uncoupler	69.2	BML-277	BML-277 is a selective checkpoint kinase 2 (Chk2) inhibitor with an IC50 of 15 nM.	False	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1
413179	413179:01:02_03.00	True	3.0	103	7.4	0.0	0.0	70.6	0.0	71.4	24.5	60.2	53.4	40.1	0.0	63.2	45.7	HDAC	71.4		PPTN is an antagonist of P2RY14 (GPR105). IC50 = 0.5 nM (FLIPR assay). Negative control = PPTN-1-NC	False	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1
413162	413162:01:02_03.00	True	3.0	90	58.0	0.0	0.0	84.5	0.0	84.9	31.8	75.5	49.6	63.3	0.0	73.3	76.2	HDAC	84.9		negative control to Skepinone-L	False	CN(C(=O)c1ccccc1)c1cc(N(C)c2ccc3c(c2)CCc2ccc(C(=O)NCCN4CCOCC4)cc2C3=O)ccc1F
412994	412994:01:03_06.00	True	6.0	90	22.6	11.4	0.0	24.7	0.0	31.6	69.1	42.4	0.0	25.4	0.0	45.8	26.8	HSP90	69.1	Lonafarnib	Lonafarnib is an orally bioavailable farnesyl protein transferase (FPTase) inhibitor for H-ras, K-ras and N-ras with IC50 of 1.9 nM, 5.2 nM and 2.8 nM, respectively. Lonafarnib has anti-hepatitis delta virus (HDV) activities.	True	NC(=O)N1CCC(CC(=O)N2CCC([C@H]3c4ncc(Br)cc4CCc4cc(Cl)cc(Br)c43)CC2)CC1
413126	413126:02:02_00.30	True	0.3	98	37.5	0.0	0.0	75.4	0.0	76.8	13.2	93.4	36.1	41.4	0.0	66.1	46.0	LCH	93.4		negative control to BAY-293	True	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1
409341	409341:02:02_03.00	True	3.0	95	10.5	0.0	0.0	66.4	0.0	76.0	51.3	62.4	47.6	43.9	0.0	70.7	50.7	HDAC	76.0	ABT-100	ABT-100 is a potent, highly selective and orally active farnesyltransferase inhibitor. ABT-100 inhibits cell proliferation (IC50s of 2.2 nM, 3.8 nM, 5.9 nM, 6.9 nM, 9.2 nM, 70 nM and 818 nM for EJ-1, DLD-1, MDA-MB-231, HCT-116, MiaPaCa-2, PC-3, and DU-145 cells, respectively), increases apoptosis and decreases angiogenesis. ABT-100 possesses broad-spectrum antitumor activity.	True	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1
413231	413231:03:02_06.00	True	6.0	99	18.8	63.4	13.9	0.0	81.6	0.0	22.4	0.0	0.0	0.0	84.9	0.0	0.0	Pyrimidine_Synth	84.9	BML-277	BML-277 is a selective checkpoint kinase 2 (Chk2) inhibitor with an IC50 of 15 nM.	False	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1
247186	247186:03:04_30.00	True	30.0	75	59.2	34.4	3.1	0.0	83.9	0.0	9.1	13.8	0.0	0.0	48.2	0.0	0.0	DNA_Synth	83.9	Ciclopirox (olamine)	cell membrane proteins synthesis inhibitor, antifungal.	False	Cc1cc(C2CCCCC2)n(O)c(=O)c1
409343	409343:02:02_03.00	True	3.0	92	57.2	0.0	0.0	71.4	0.0	72.6	22.6	84.2	29.7	43.2	0.0	80.0	34.5	LCH	84.2	BAY-309,control for BAY-826	negative control to BAY-826	False	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1
413037	413037:01:04_06.00	True	6.0	99	12.3	24.2	40.0	0.0	87.3	0.0	0.0	0.0	0.0	0.0	66.3	0.0	0.0	DNA_Synth	87.3	A-205804	A-205804 is an orally bioavailable, potent and selective lead inhibitor of E-selectin and ICAM-1 expression, with an IC50 of 20 nM and 25 nM for E-selectin and ICAM-1, respectively. A-205804 can be used in the research of chronic inflammatory diseases.	False	Cc1ccc(Sc2cncc3sc(C(N)=O)cc23)cc1
413003	413003:01:03_30.00	True	30.0	81	40.1	52.2	25.3	0.0	90.7	0.0	0.0	0.0	0.0	0.0	87.4	0.0	0.0	DNA_Synth	90.7	Prasugrel	Prasugrel is a prodrug form of the platelet purinergic P2Y12 receptor antagonist R-99224. In vivo, prasugrel prevents thrombus formation (ED50 = 0.68 mg/kg) and increases tail bleeding time in rats.	False	CC(=O)Oc1cc2c(s1)CCN(C(C(=O)C1CC1)c1ccccc1F)C2
413117	413117:01:03_30.00	True	30.0	68	62.9	0.0	0.0	70.5	0.0	70.1	48.5	72.7	37.6	56.1	0.0	80.1	62.6	Tubulin	80.1	CGP 53353	Selective inhibitor of PKC.b.II (IC50 values are 0.41 and 3.8 uM for PKC.b.II and PKC.b.I respectively). Also inhibits prionogenic Sup35 fibrillization (IC50 ~ 3.4 uM) and inhibits de novo A.b.42 assembly in vitro.	False	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21
413206	413206:01:02_03.00	True	3.0	98	50.9	7.2	0.0	70.7	0.0	73.0	46.4	75.8	25.4	58.6	0.0	65.9	73.9	LCH	75.8		An inhibitor of MAPK14 with an IC50 = 0.2 nM (ELISA, cell free). NanoBRET: MAPK14 IC50 = 14.9 nM; MAPK11 IC50 = 16.9 nM. Negative control = FM-743	False	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4ccccc4)c3)cc1CC2
413121	413121:01:03_30.00	True	30.0	87	21.2	0.0	0.0	49.6	0.0	59.7	53.1	60.4	17.9	30.2	0.0	58.3	34.7	LCH	60.4	M 25	Potent Smoothened (Smo) receptor antagonist (IC50 = 5 nM). Inhibits the Hedgehog signaling pathway. Inhibits Shh induced Gli luciferase reporter activity in Shh-light 2 cells (IC50 = 5 nM). Antagonizes GSA-10 and SAG-mediated differentiation of the C3H10T1/2 cell line (IC50 values are 69 and 115 nM, respectively).	False	CCCC(CCC)C(=O)NCc1ccc2c(cnn2-c2ccccc2OC)c1
409363	409363:02:02_03.00	True	3.0	98	5.5	64.6	2.3	0.0	82.3	0.0	19.0	0.0	0.0	0.0	79.4	0.0	0.0	DNA_Synth	82.3	ERKi	inhibitor for ERK1 and ERK2	True	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1
413123	413123:01:03_30.00	True	30.0	89	7.8	54.4	4.6	0.0	86.6	0.0	25.5	0.0	0.0	0.0	67.9	0.0	0.0	DNA_Synth	86.6	TFC 007	Potent hematopoietic prostaglandin D synthase (H-PGDS) inhibitor (IC50 = 83 nM). Inhibits PGD2 production and late phase nasal blockage in an animal model of allergic rhinitis. Exhibits negligible effects on COX-1, COX-2, 5-LOX, LTC4 synthase, TXA2 synthase and microsomal prostaglandin E2 synthase.	False	O=C(Nc1ccc(N2CCC(C(=O)N3CCOCC3)CC2)cc1)c1cnc(Oc2ccccc2)nc1
413029	413029:01:04_06.00	True	6.0	95	30.1	83.8	0.0	0.0	77.9	0.0	20.7	0.0	0.0	0.0	61.4	0.0	0.3	AKT_PI3K_MTOR	83.8	Lorlatinib	Lorlatinib (PF-06463922) is a selective, orally active, brain-penetrant and ATP-competitive ROS1/ALK inhibitor. Lorlatinib has Kis of <0.025 nM, <0.07 nM, and 0.7 nM for ROS1, wild type ALK, and ALKL1196M, respectively. Lorlatinib has anticancer activity.	True	C[C@H]1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CN(C)C(=O)c2ccc(F)cc21
410949	410949:03:02_03.00	True	3.0	101	9.0	72.2	0.0	0.0	80.8	0.0	9.5	0.0	0.0	0.0	74.6	0.0	0.0	DNA_Synth	80.8	WM-1119	WM-1119 is a highly potent and selective KAT6A inhibitor, with an IC50 of 0.25 uM for KAT6A in lymphoma cells, the binding KD values of WM-1119 with KAT6A, KAT5 and KAT7 are 2 nM, 2.2 uM, 0.5 uM , respectively.	False	O=C(NNS(=O)(=O)c1ccccc1F)c1cc(F)cc(-c2ccccn2)c1
413204	413204:01:02_03.00	True	3.0	69	38.0	49.2	9.0	0.0	79.6	0.0	12.1	7.7	0.0	0.0	43.8	0.0	8.0	DNA_Synth	79.6	CLK-IN-T3	CLK-IN-T3 is a high potent, selective, and stable CDC-like kinase (CLK) inhibitor with IC50s of 0.67 nM, 15 nM, and 110 nM for CLK1, CLK2, and CLK3 protein kinases, respectively. CLK-IN-T3 has anti-cancer activity.	False	CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5ccncc5)ccc4n3)cc2)CC1
413149	413149:01:02_03.00	True	3.0	100	13.1	0.0	4.9	65.5	0.0	77.4	36.4	72.7	42.9	41.0	0.0	62.0	30.8	HDAC	77.4		negative control to BAY-985	False	CN(C)c1ncnc(-c2ccc3[nH]c(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)nc3c2)c1Cl
412989	412989:01:02_30.00	True	30.0	80	66.7	0.0	0.0	88.1	0.0	89.0	37.2	77.1	54.1	68.9	0.0	82.6	72.6	HDAC	89.0	OMDM-2	OMDM-2 is an endocannabinoid analog specifically designed to be a potent and selective inhibitor of the cellular uptake of arachidonoyl ethanolamide. Structurally, OMDM-2 is the amide of (R)-tyrosinol with oleic acid. In RBL-2H3 cells, OMDM-2 inhibits the cellular uptake of tritiated AEA with an IC50 of 3 uM, with negligible effects on the CB1 receptor and VR1.	True	CCCCCCCC/C=C\CCCCCCCC(=O)N[C@@H](CO)Cc1ccc(O)cc1
413161	413161:01:02_03.00	True	3.0	99	6.2	13.1	0.0	6.3	39.2	0.0	37.0	40.6	0.0	0.0	23.2	24.4	0.0	LCH	40.6		negative control to A1596586	True	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1
413208	413208:01:02_00.30	True	0.3	98	5.9	12.9	0.0	54.5	0.0	58.4	46.0	67.5	12.6	42.5	0.0	52.1	58.2	LCH	67.5	Defactinib	Defactinib (VS-6063; PF-04554878) is a novel FAK inhibitor with potential antiangiogenic and antineoplastic activities.	False	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1
413000	413000:01:02_30.00	True	30.0	86	57.9	63.4	0.0	7.4	38.5	3.6	42.0	43.4	0.0	20.9	16.9	26.5	41.6	AKT_PI3K_MTOR	63.4	Arcyriaflavin-a	Arcyriaflavin A is an inhibitor of cyclin-dependent kinase 4 (CDK4; IC50 = 140 nM) and calcium/calmodulin-dependent protein kinase II (CaMKII; IC50 = 25 nM). It is selective for CDK4 and CaMKII over protein kinase A (PKA) and PKC (IC50s = >2 and >100 uM, respectively). In vitro, arcyriaflavin A inhibits replication of human cytomegalovirus (HCMV; IC50 = 200 nM), as well as proliferation of HCT116 and NCI H460 human carcinoma cells (IC50s = 850 and 590 nM, respectively).	False	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3ccccc3c21
413190	413190:01:02_05.00	True	5.0	96	20.4	16.6	0.0	56.9	0.0	58.7	40.5	83.1	8.3	42.3	0.0	58.9	58.3	LCH	83.1	BAY-985	BAY-985 is a highly potent, orally active and selective ATP-competitive dual inhibitor of TBK1 and IKK.e. with IC50s of 2/30 and 2 nM for TBK1 (low/high ATP) and IKK.e., respectively. Antitumor efficacy.	True	C[C@H](c1ccnc(Nc2nc3cc(-c4cc(N(C)C)ncn4)ccc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1
413038	413038:01:04_10.00	True	10.0	56	46.1	0.0	60.1	0.0	51.2	0.0	9.3	15.2	0.0	0.0	10.4	25.8	0.0	Aurora	60.1	Aminopurvalanol-a	Aminopurvalanol A is a selective, cell-permeable, and competitive cyclin-dependent kinase (CDK) inhibitor that potently inhibits Cdk1/cyclin B, Cdk2/cyclin A, Cdk2/cyclin E, and Cdk5/p35 (IC50s = 33, 33, 28, and 20 nM, respectively). It is over 90-fold selective for CDKs over ERK1, ERK2, PKC-.d., protein kinase A (PKA), casein kinase 1, insulin receptor tyrosine kinase (IC50s = 3.0-36 uM), and over 3,000-fold selective over a range of other kinases (IC50s > 100 uM). In antiproliferative assays in vitro, aminopurvalanol A inhibits growth of ovarian (IGROV1), leukemic (SR), lung (NCI-H522), and colonic (KM12) cells (GI50s = 470, 420, 1,000, and 30 nM, respectively). Aminopurvalanol A also inhibits mitotic division and preferentially arrests cells in the G2/M phase via Cdk1/cyclin B.	True	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1
413139	413139:01:02_00.50	True	0.5	106	8.3	22.2	0.0	43.2	0.0	49.2	53.0	53.0	8.0	35.9	0.0	37.9	48.5	HSP90	53.0		negative control to BAY-899	True	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1
413228	413228:01:04_10.00	True	10.0	90	83.4	0.0	0.0	87.5	0.0	84.4	18.7	85.9	46.4	64.8	0.0	80.9	69.4	BET	87.5	CYM-5442	Sphingosine-1-phosphate (S1P) is an extracellular lipid mediator whose major effects are mediated through five distinct G protein-coupled receptors, S1P1/EDG-1, S1P2/EDG-5, S1P3/EDG-3, S1P4/EDG-6, and S1P5/EDG-8. CYM 5442 is a full agonist for S1P1 internalization, phosphorylation, and ubiquitination (EC50 = 1.35 nM). It is ineffective at S1P2, S1P3, S1P4, and S1P5 at concentrations up to 10 uM.2 CYM 5442 has been found to activate S1P1-mediated p42/p44 MAPK phosphorylation in CHO-K1 cells transfected with S1P1 with an EC50 value of 46 nM.	False	CCOc1ccc(-c2nc(-c3cccc4c3CCC4NCCO)no2)cc1OCC
413053	413053:01:04_50.00	True	50.0	95	31.8	13.3	0.0	53.7	0.0	48.5	39.6	68.2	10.4	41.3	0.0	53.7	54.0	LCH	68.2	ONC212	ONC212, a fluorinated-ONC201 analogue, is a promising anti-cancer agent and also a selective agonist of GPR132. ONC212 also induces apoptosis.	False	O=C1C2=C(CCN(Cc3ccccc3)C2)N2CCN=C2N1Cc1ccc(C(F)(F)F)cc1
412996	412996:01:04_50.00	True	50.0	87	51.5	6.9	0.0	57.4	0.0	59.7	66.7	62.4	26.5	59.4	0.0	69.7	65.1	Tubulin	69.7	FPS-ZM1	FPS-ZM1 is a high-affinity RAGE inhibitor with a Ki of 25 nM.	False	O=C(c1ccc(Cl)cc1)N(Cc1ccccc1)C1CCCCC1
413151	413151:01:02_05.00	True	5.0	105	10.4	10.0	1.2	0.0	0.0	0.0	8.0	0.0	5.9	0.0	41.5	0.0	0.0	Pyrimidine_Synth	41.5		negative control to IPP/CNRS-A017	False	Cc1c(Oc2ccc(F)cc2)c(OC(C)C)nn1-c1ccc(C2CC2)cn1
413223	413223:01:04_50.00	True	50.0	89	14.2	0.0	0.0	57.9	0.0	61.9	49.2	64.6	15.5	40.0	0.0	62.0	45.8	LCH	64.6	UCSF924	UCSF924 is a selective, high-affinity dopamine D4 receptor (DRD4) partial agonist (Ki = 3 nM for human D4) with a 7.4-fold bias toward arrestin recruitment over G.a.i (G.a.i/0; Gi/G0) signaling activation with respect to quinpirole. UCSF924 exhibits no detectable affinity for D2, D3 or the F261V/L328F D4 mutant and no agonist activity toward a panel of 320 nonolfactory GPCRs even at a high concentration of 1 uM.	False	Cc1ccc2nc(CNCCCOc3ccccc3)cc(O)c2c1
413034	413034:01:03_10.00	True	10.0	94	80.5	0.0	0.0	81.4	0.0	77.8	1.4	90.9	40.1	53.6	0.0	75.0	50.5	LCH	90.9	DG-172 (hydrochloride)	DG-172 is an orally available inverse agonist of PPAR.b./.d. (IC50 = 27 nM), down-regulating transcription of ANGPTL4 in mouse myoblasts (IC50 = 9.5 nM). It alters the differentiation of bone marrow cells, augmenting GM-CSF-induced development into subsets of mature and immature dendritic cells. Inverse agonists of PPAR.b./.d., including DG-172, inhibit cancer cell invasion through suppression of ANGPTL4 expression.	False	CN1CCN(c2ccc(/C=C(\C#N)c3ccccc3Br)cc2)CC1
413196	413196:01:02_05.00	True	5.0	99	6.0	25.9	0.0	9.8	0.0	18.7	62.7	13.9	6.8	25.6	0.0	22.3	35.5	HSP90	62.7			False	C1=CC2N=C(CN3CCC(c4nc(-c5cc6ccccc6o5)cs4)CC3)NC2N=C1
413013	413013:01:03_50.00	True	50.0	97	15.2	22.4	0.0	12.2	0.0	17.7	66.9	33.3	0.0	11.6	0.0	30.5	20.6	HSP90	66.9	IWP L6	IWP L6 (PorcnInhibitorIII) is a Porcn inhibitor with an EC50 of 0.5 nM.	False	O=C(CSc1nc2c(c(=O)n1-c1ccccc1)SCC2)Nc1ccc(-c2ccccc2)cn1
413026	413026:01:03_10.00	True	10.0	56	49.2	0.0	38.9	15.9	20.6	15.6	19.9	29.1	9.4	15.8	0.0	39.8	10.5	Tubulin	39.8	PF-431396	PF-431396 is a pyrimidine-based dual inhibitor of nonreceptor tyrosine kinases FAK and PYK2 (IC50s = 2 and 11 nM, respectively). In ovariectomized rats, it has been shown to increase bone formation, promoting osteoblast recruitment and activity.	False	CN(c1ccccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O
413195	413195:01:02_05.00	True	5.0	105	12.4	0.0	0.0	76.5	0.0	71.4	13.6	56.3	52.4	53.8	0.0	75.5	55.0	BET	76.5		TP-008 is an inhibitor of ACVR1B and TGFBR1. TGFBR1 pIC50 = 7.6 and ACVR1B pIC50 = 6.0	False	Cc1cnc(-c2cc(Cl)ccc2F)cc1-n1c(=O)n(CC(N)=O)c2cnccc21
413032	413032:01:03_50.00	True	50.0	100	38.2	7.8	0.0	67.7	0.0	66.3	43.4	71.5	26.1	61.2	0.0	64.1	65.5	LCH	71.5	NS309	NS309 is a potent and selective opener of the small or intermediate conductance Ca2+-activated K+ (SK or IK, respectively) channels, but displays no activity at BK channels.	False	O=Nc1c(O)[nH]c2c(Cl)c(Cl)ccc12
413125	413125:02:02_05.00	True	5.0	99	80.3	0.0	0.0	74.2	0.0	71.2	0.4	87.1	30.3	46.7	0.0	70.2	49.4	LCH	87.1	BAY-293	BAY-293, a valuable chemical probe, blocks RAS activation via disruption of the KRAS-SOS1 interaction with an IC50 of 21 nM. BAY-293 is a potent inhibitor of Son of Sevenless 1 (SOS1). SOS1 is the guanine nucleotide exchange factor (GEF) and activator of RAS.	True	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1
413213	413213:01:03_50.00	True	50.0	95	8.5	44.0	13.1	0.0	46.6	0.0	33.7	0.0	0.0	0.0	55.1	0.0	0.0	Pyrimidine_Synth	55.1	U-0521	Catechol-O-methyltransferase (COMT) inhibitor.	False	CC(C)C(=O)c1ccc(O)c(O)c1
413227	413227:01:03_50.00	True	50.0	94	13.5	0.0	7.8	27.0	0.0	29.4	40.2	43.0	0.0	16.0	0.0	42.7	9.3	LCH	43.0		BIIL 315 is a highly potent LTB4 receptor antagonist with high affinity (Ki = 1.9 nM). Therefore, BIIL315 is a perfect tool compound to study LTB4 antagonism in vitro. The molecule is derived from prodrug BIIL 284.	True	CC(C)(c1ccc(OCc2cccc(COc3ccc(C(=N)N)cc3)c2)cc1)c1ccc(O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)cc1
413005	413005:01:02_50.00	True	50.0	98	17.1	2.1	0.0	20.6	0.0	37.8	57.3	40.8	0.0	12.6	0.0	19.7	12.5	HSP90	57.3	BAM7	BAM7 is a direct and selective activator of proapoptotic BAX with an IC50 of 3.3 uM.	False	CCOc1ccccc1/N=N/c1c(C)nn(-c2nc(-c3ccccc3)cs2)c1O
413167	413167:01:02_05.00	True	5.0	100	24.9	0.0	0.0	72.5	0.0	70.2	44.6	66.9	41.6	51.3	0.0	70.5	51.2	BET	72.5		negative control to BI-1950	True	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21
412995	412995:01:04_10.00	True	10.0	99	28.2	0.0	0.0	63.8	0.0	59.8	26.8	58.1	38.3	54.4	0.0	69.6	35.4	Tubulin	69.6	SB-505124	SB-505124 is a selective inhibitor ofTGF-.b. Receptor type I receptor (ALK4, ALK5, ALK7), withIC50sof 129 nM and 47 nM forALK4, ALK5, respectively, but it does not inhibit ALK1, 2, 3, or 6.	False	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1
413138	413138:01:02_05.00	True	5.0	102	14.2	0.0	0.0	83.2	0.0	84.0	18.3	66.7	56.1	57.5	0.0	71.8	64.8	HDAC	84.0		negative control to PPTN	False	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12
413210	413210:01:02_05.00	True	5.0	102	5.2	0.0	0.0	73.3	0.0	61.5	5.4	71.3	34.4	43.5	0.0	68.3	38.6	BET	73.3		An inhibitor of PRKAA1 (Protein Kinase AMP-Activated Catalytic Subunit Alpha 1) (IC50 = 1.4 nM) and RPS6KA1 (Ribosomal Protein S6 Kinase A1) (IC50 = 9.1 nM). Negative control = BAY-974	False	CCc1ccccc1C(=O)Nc1[nH]nc2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12
413200	413200:01:02_05.00	True	5.0	103	5.0	0.0	0.0	61.5	0.0	55.7	27.5	64.1	14.1	56.2	0.0	61.2	55.1	LCH	64.1	A-967079	A-967079 is a selective TRPA1 receptor antagonist with IC50s of 67 nM and 289 nM at human and rat TRPA1 receptors, respectively, and has good penetration into the CNS.	False	CCC(=N\O)/C(C)=C/c1ccc(F)cc1
413119	413119:01:03_50.00	True	50.0	86	82.9	0.0	0.0	73.5	0.0	68.6	6.3	85.0	29.7	50.3	0.0	73.2	54.1	LCH	85.0	A 987306	Potent histamine H4 receptor antagonist (pKi values are 8.24 and 8.47 in human and rat H4 receptors respectively). Displays 162-fold, 620-fold, and > 1600-fold selectivity over human H3, H1 and H2 receptors.	True	Nc1nc2c(c(N3CCNCC3)n1)CCC1=C2[C@@H]2CCCC[C@@H]2O1
413171	413171:01:02_05.00	True	5.0	97	47.8	0.0	0.0	69.8	0.0	69.2	22.7	93.0	23.9	40.7	0.0	65.9	46.1	LCH	93.0		negative control to GSM1	True	COc1cc(-c2cn([C@H]3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1
413031	413031:01:04_10.00	True	10.0	99	26.1	42.5	0.0	8.5	23.0	20.0	54.0	57.3	0.0	0.0	3.1	21.1	21.0	LCH	57.3	CC-401	CC-401 is a potent inhibitor of all three JNK isoforms (Ki values range from 25 to 50 nM). It has at least 40-fold selectivity for JNK compared with other related kinases.	False	c1cc(OCCN2CCCCC2)cc(-c2[nH]nc3ccc(-c4nc[nH]n4)cc23)c1
413016	413016:01:02_50.00	True	50.0	84	33.5	0.0	0.0	60.4	0.0	61.8	9.8	89.6	20.3	26.3	0.0	59.2	38.1	LCH	89.6	NQDI-1	NQDI-1 inhibits apoptosis signal-regulating kinase 1 (ASK1) with a Ki of 500 nM and an IC50 of 3 uM.	False	CCOC(=O)c1c(O)nc2cccc3c2c1-c1ccccc1C3=O
413181	413181:01:02_00.50	True	0.5	100	8.6	61.8	0.0	0.0	72.1	0.0	23.8	14.8	0.0	0.0	37.9	0.0	19.2	DNA_Synth	72.1	SR-318	SR-318 is a potent and highly selective p38 MAPK inhibitor with IC50s of 5 nM, 32 nM and 6.11 uM for p38.a., p38.b. and p38.a./.b., respectively. SR-318 potently inhibits the TNF-.a. release in whole blood with an IC50 of 283 nM. SR-318 has anti-cancer and anti-inflammatory activity.	False	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1
413211	413211:01:02_00.50	True	0.5	92	23.3	5.1	0.0	52.0	0.0	61.1	40.7	64.9	33.5	44.8	0.0	57.7	56.5	LCH	64.9	ROCK-IN-2	ROCK-IN-2 (Azaindole 1; TC-S 7001) is an orally active and ATP-competitive ROCK inhibitor with IC50s of 0.6 and 1.1nM for human ROCK-1 and ROCK-2, respectively.	False	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12
413122	413122:01:03_50.00	True	50.0	69	42.3	2.4	24.6	5.2	64.0	6.6	0.0	29.1	8.5	0.0	9.5	26.5	8.6	DNA_Synth	64.0	Mirk-IN-1	Potent and selective DYRK1A/B inhibitor (IC50 values are 22 and 68 nM respectively). Selective for DYRK1A/B over a panel of other kinases. Reduces accumulation of quiescent Panc1 pancreatic cancer cells in G0 under serum free conditions. Also induces DNA damage and apoptosis in quiescent Panc1 cells.	False	COc1ncc2cc(C(=O)Nc3cc(C(=O)NCc4cccc(Cl)c4)ccc3Cl)c(O)nc2n1
413020	413020:01:02_50.00	True	50.0	71	35.1	45.7	26.3	0.0	95.0	0.0	0.0	0.0	0.0	0.0	76.3	0.0	0.0	DNA_Synth	95.0	Deferasirox	Deferasirox (ICL 670) is an orally available iron chelator used for the management of transfusional iron overload.	False	O=C(O)c1ccc(-n2nc(-c3ccccc3O)nc2-c2ccccc2O)cc1
410949	410949:02:03_50.00	True	50.0	97	6.2	64.2	0.0	0.0	49.4	0.0	26.4	11.9	0.0	0.2	25.9	0.0	34.0	AKT_PI3K_MTOR	64.2	WM-1119	WM-1119 is a highly potent and selective KAT6A inhibitor, with an IC50 of 0.25 uM for KAT6A in lymphoma cells, the binding KD values of WM-1119 with KAT6A, KAT5 and KAT7 are 2 nM, 2.2 uM, 0.5 uM , respectively.	False	O=C(NNS(=O)(=O)c1ccccc1F)c1cc(F)cc(-c2ccccn2)c1
413192	413192:01:02_05.00	True	5.0	88	42.3	61.0	17.5	0.0	85.5	0.0	13.6	0.0	0.0	0.0	95.6	0.0	0.0	Pyrimidine_Synth	95.6		IPP/CNRS-A017 is an inhibitor of mitochondrial Dihydroorotate Dehydrogenase DHODH. IC50 = 25 nM (activity assay)	False	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F
413004	413004:01:03_50.00	True	50.0	99	5.2	58.9	0.0	0.0	18.4	1.7	21.8	13.4	0.0	26.0	1.3	0.7	40.2	AKT_PI3K_MTOR	58.9	Ilomastat	Ilomastat (GM6001) is a potent and broad spectrum matrix metalloprotease (MMP) inhibitor, inhibits MMPs (IC50s, 1.5 nM for MMP-1; 1.1 nM for MMP-2; 1.9 nM for MMP-3; 0.5 nM for MMP-9), with a Ki of 0.4 nM for human skin fibroblast collagenase (MMP-1).	True	CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](CC(=O)NO)CC(C)C
413163	413163:01:02_05.00	True	5.0	104	17.4	0.0	0.0	65.8	0.0	58.0	24.0	68.0	16.0	38.6	0.0	60.6	44.7	LCH	68.0		negative control to BAY-1797	False	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1
413049	413049:01:04_50.00	True	50.0	90	64.4	0.0	0.0	81.2	0.0	78.5	35.5	72.4	46.3	71.8	0.0	83.5	64.4	Tubulin	83.5	4-CMTB	(+/-)-4-CMTB is a positive allosteric modulator of free fatty acid receptor 2 (FFAR2/GPR43) with an EC50 value of 0.42 uM for [35S]GTP.g.S binding to 293 T-REx cell membranes expressing the human receptor. It selectively induces ERK1/2 phosphorylation in 293 T-REx cells expressing human FFAR2, but not FFAR1 or FFAR3.	False	CC(C)C(C(=O)Nc1nccs1)c1ccc(Cl)cc1
413035	413035:01:02_50.00	True	50.0	103	10.2	0.0	0.0	55.5	0.0	54.6	0.0	69.1	27.9	8.0	0.0	44.5	46.1	LCH	69.1	Dalbavancin	Dalbavancin is a semisynthetic glycopeptide antibiotic. It inhibits the growth of Gram-positive bacteria in vitro, including S. pneumoniae, S. pyogenes, vancomycin-sensitive Enterococcus species, and various methicillin-resistant staphylococci (MIC50s = 0.03, <=0.002, 0.13, and 0.03-0.13 mg/L, respectively).	True	CN[C@H]1C(=O)N[C@@H]2Cc3ccc(cc3)Oc3cc4cc(c3O[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3NC(=O)CCCCCCCCC(C)C)Oc3ccc(cc3Cl)[C@@H](O)[C@@H]3NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@@H](NC2=O)c2cc(cc(O)c2Cl)Oc2cc1ccc2O)c1ccc(O)c(c1)-c1c(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]2O)cc(O)cc1[C@@H](C(=O)NCCCN(C)C)NC3=O
413150	413150:01:02_00.50	True	0.5	78	35.2	0.0	0.0	78.5	0.0	73.7	39.6	72.0	49.1	64.6	0.0	86.6	69.0	Tubulin	86.6		negative control to TP-024	False	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1
413155	413155:01:02_05.00	True	5.0	102	10.4	0.0	0.0	21.2	0.0	17.9	38.4	33.7	0.0	23.2	0.0	39.7	6.3	Tubulin	39.7			False	Cn1c(-c2csc(C3CCN(CC4=NC5C=CC=NC5N4)CC3)n2)nc2ccccc21
413134	413134:02:04_50.00	True	50.0	94	22.6	0.0	0.0	87.0	0.0	87.7	28.5	79.2	52.5	62.9	0.0	78.9	66.2	HDAC	87.7	Ogerin negative control	Ogerin negative control is a structurally similar analog of ogerin (catalog no. SML1482). Ogerin is a selective positive allosteric modulator of an orphan GPCR, GPR68, also known as Ovarian cancer G-protein coupled receptor 1 (OGR1).	False	Nc1nc(NCc2ccccc2)nc(-c2cccc(CO)c2)n1
413015	413015:01:03_10.00	True	10.0	101	7.1	0.0	0.0	53.0	0.0	50.7	26.8	26.0	49.4	55.9	0.0	56.3	45.9	Tubulin	56.3	LY2109761	LY2109761 is an orally active, selective TGF-.b. receptor type I/II inhibitor with Kis of 38 nM and 300 nM, respectively.	False	c1ccc(-c2nn3c(c2-c2ccnc4cc(OCCN5CCOCC5)ccc24)CCC3)nc1
413221	413221:01:03_50.00	True	50.0	85	75.0	0.0	0.0	76.4	0.0	73.6	17.1	91.2	30.0	45.6	0.0	69.4	57.8	LCH	91.2	Conivaptan (hydrochloride)	Conivaptan (hydrochloride) is a non-peptide antagonist of vasopressin receptor, with Ki values of 0.48 and 3.04 nM for rat liver V1A receptor and rat kidney V2 receptor respectively.	False	Cc1nc2c([nH]1)-c1ccccc1N(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)CC2
413116	413116:01:03_50.00	True	50.0	89	7.3	0.0	23.2	47.6	0.0	62.0	25.7	65.9	21.6	28.0	0.0	42.1	19.5	LCH	65.9	NSC 625987	Cyclin-dependent kinase (cdk) 4 inhibitor (IC50 = 0.2 uM at cdk4/cyclin D1). Displays > 500-fold selectivity over cdk2 (IC50 > 100 uM for cdc2/cyclin A, cdk2/cyclin A and cdk2/cyclin E).	False	COc1ccc(OC)c2c(S)c3ccccc3nc12
413047	413047:01:02_50.00	True	50.0	55	82.4	0.0	0.0	78.5	0.0	81.4	46.8	55.5	64.1	75.6	0.0	81.2	73.9	HDAC	81.4	Flindokalner	Flindokalner (BMS-204352) is a potassium channel modulator. Flindokalner is a positive modulator of all neuronal Kv7 channel subtypes expressed in HEK293 cells. Flindokalner is also a large conductance calcium-activated K channel (BKca) positive modulator. Flindokalner shows a negative modulatory activity at Kv7.1 channels (Ki=3.7 uM), and acts as a negative modulator of GABAA receptors. Flindokalner shows anxiolytic efficacy in vivo.	True	COc1ccc(Cl)cc1[C@]1(F)C(=O)Nc2cc(C(F)(F)F)ccc21
413052	413052:01:03_50.00	True	50.0	71	46.5	0.0	42.0	51.0	0.0	58.4	33.3	73.2	32.1	29.6	0.0	70.6	17.5	LCH	73.2	AZD3229	AZD3229 is a potent pan-KIT mutant inhibitor for the treatment of gastrointestinal stromal tumors.	False	COCCOc1cc(F)c2c(Nc3ccc(NC(=O)Cn4cc(C(C)C)nn4)cc3)ncnc2c1
413118	413118:01:03_50.00	True	50.0	89	57.3	7.9	0.0	71.9	0.0	72.9	46.0	74.5	31.3	60.8	0.0	65.3	73.4	LCH	74.5	FERb 033	Potent and selective ER.b. receptor agonist (Ki = 7.1 nM, EC50 = 4.8 nM). Displays 62-fold selectivity over ER.a..	False	O/N=C/c1ccc(-c2ccc(O)c(F)c2)c(Cl)c1O
413127	413127:01:03_50.00	True	50.0	61	81.3	0.0	0.0	82.3	0.0	80.0	28.5	86.2	46.8	60.2	0.0	78.6	68.4	LCH	86.2	MLi-2	MLi-2 is an orally active and highly selective LRRK2 inhibitor with an IC50 of 0.76 nM. MLi-2 has the potential for Parkinsons disease.	True	C[C@H]1CN(c2cc(-c3[nH]nc4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1
413130	413130:01:02_05.00	True	5.0	99	23.5	0.0	0.0	79.5	0.0	77.5	45.4	68.3	49.1	60.1	0.0	78.6	65.1	BET	79.5		negative control to ABT-100	True	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1
413025	413025:01:02_50.00	True	50.0	94	13.6	0.0	0.0	74.5	0.0	72.9	20.2	86.0	35.9	46.3	0.0	73.7	45.5	LCH	86.0	CYM-5520	CYM 5520 is a noncompetitive allosteric agonist of S1P2 (EC50 = 0.48 uM) that does not display agonist activity towards S1P1, S1P3, S1P4, or S1P5.	False	Cc1cc(C(=O)Cn2cc(C#N)ccc2=O)c(C)n1Cc1ccccc1
413159	413159:01:02_05.00	True	5.0	100	6.2	0.0	0.0	71.2	0.0	67.3	0.0	77.2	45.2	39.4	0.0	66.7	46.3	LCH	77.2		negative control to A-079	False	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1
413231	413231:01:02_50.00	True	50.0	80	74.6	0.0	0.0	71.0	0.0	73.7	49.7	58.6	53.3	63.3	0.0	72.4	75.6	Uncoupler	75.6	BML-277	BML-277 is a selective checkpoint kinase 2 (Chk2) inhibitor with an IC50 of 15 nM.	False	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1
413179	413179:01:02_05.00	True	5.0	104	26.4	0.0	0.0	81.4	0.0	78.7	16.0	64.7	61.0	58.0	0.0	72.5	61.3	BET	81.4		PPTN is an antagonist of P2RY14 (GPR105). IC50 = 0.5 nM (FLIPR assay). Negative control = PPTN-1-NC	False	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1
413162	413162:01:02_05.00	True	5.0	105	69.8	0.0	0.0	84.7	0.0	84.0	27.5	72.3	52.3	68.3	0.0	71.7	78.4	BET	84.7		negative control to Skepinone-L	False	CN(C(=O)c1ccccc1)c1cc(N(C)c2ccc3c(c2)CCc2ccc(C(=O)NCCN4CCOCC4)cc2C3=O)ccc1F
412994	412994:01:03_10.00	True	10.0	95	30.9	23.9	0.0	16.8	0.0	19.8	70.3	27.6	1.3	25.6	0.0	41.0	31.1	HSP90	70.3	Lonafarnib	Lonafarnib is an orally bioavailable farnesyl protein transferase (FPTase) inhibitor for H-ras, K-ras and N-ras with IC50 of 1.9 nM, 5.2 nM and 2.8 nM, respectively. Lonafarnib has anti-hepatitis delta virus (HDV) activities.	True	NC(=O)N1CCC(CC(=O)N2CCC([C@H]3c4ncc(Br)cc4CCc4cc(Cl)cc(Br)c43)CC2)CC1
413126	413126:02:02_00.50	True	0.5	106	53.9	0.0	0.0	70.4	0.0	67.3	6.2	94.1	24.3	35.4	0.0	63.1	45.2	LCH	94.1		negative control to BAY-293	True	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1
409341	409341:02:02_05.00	True	5.0	83	30.9	0.0	0.0	77.2	0.0	77.7	43.4	77.7	45.4	54.0	0.0	79.9	63.1	Tubulin	79.9	ABT-100	ABT-100 is a potent, highly selective and orally active farnesyltransferase inhibitor. ABT-100 inhibits cell proliferation (IC50s of 2.2 nM, 3.8 nM, 5.9 nM, 6.9 nM, 9.2 nM, 70 nM and 818 nM for EJ-1, DLD-1, MDA-MB-231, HCT-116, MiaPaCa-2, PC-3, and DU-145 cells, respectively), increases apoptosis and decreases angiogenesis. ABT-100 possesses broad-spectrum antitumor activity.	True	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1
413231	413231:03:02_10.00	True	10.0	90	16.8	53.3	29.6	0.0	79.6	0.0	34.4	0.0	0.0	0.0	78.9	0.0	0.0	DNA_Synth	79.6	BML-277	BML-277 is a selective checkpoint kinase 2 (Chk2) inhibitor with an IC50 of 15 nM.	False	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1
247186	247186:03:04_50.00	True	50.0	72	64.8	25.8	8.3	0.0	78.1	0.0	14.0	18.9	0.0	0.0	39.8	4.6	0.0	DNA_Synth	78.1	Ciclopirox (olamine)	cell membrane proteins synthesis inhibitor, antifungal.	False	Cc1cc(C2CCCCC2)n(O)c(=O)c1
409343	409343:02:02_05.00	True	5.0	77	81.5	0.0	0.0	80.7	0.0	76.8	25.1	86.7	41.5	57.3	0.0	85.8	54.3	LCH	86.7	BAY-309,control for BAY-826	negative control to BAY-826	False	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1
413037	413037:01:04_10.00	True	10.0	90	13.8	25.8	35.4	0.0	85.8	0.0	5.0	0.0	0.0	0.0	67.4	0.0	0.0	DNA_Synth	85.8	A-205804	A-205804 is an orally bioavailable, potent and selective lead inhibitor of E-selectin and ICAM-1 expression, with an IC50 of 20 nM and 25 nM for E-selectin and ICAM-1, respectively. A-205804 can be used in the research of chronic inflammatory diseases.	False	Cc1ccc(Sc2cncc3sc(C(N)=O)cc23)cc1
413219	413219:01:04_50.00	True	50.0	102	8.5	0.0	0.0	43.7	0.0	44.9	32.4	47.2	30.7	2.2	0.0	47.3	6.9	Tubulin	47.3	LDN-27219	LDN-27219 is a potent inhibitor of hTGase(Tissue transglutaminase) with an IC50 of 0.6 uM.IC50 value: 0.6 uM Target: hTGase inhibitorLDN-27219 is a potent inhibitor of the enzyme(hTGase), producing 100% inhibition at the screening concentration of 10 uM. To examine the enzyme selectivity of LDN-27219, it was tested as an inhibitor of coagulation Factor XIIIa and caspase 3. At concentrations as high as 50 íM, the compound had no effect on the activities of either of these enzymes. LDN-27219 was found to be nontoxic at concentrations as high as 100 íM in an assay that measures the viability of HT1080 cells, a fibrosarcoma tumor cell line.	False	NNC(=O)CSc1nc2scc(-c3ccccc3)c2c(=O)n1-c1ccccc1
413011	413011:01:02_50.00	True	50.0	97	5.2	24.3	0.0	0.0	15.2	0.0	30.0	1.2	0.0	0.0	23.2	0.0	0.0	HSP90	30.0	ML-193	ML-193 is a potent antagonist of GPR55 (IC50 = 221 nM). It displays selectivity for GPR55 over CB1, CB2, and GPR35. ML-193 inhibits GPR55-dependent ERK phosphorylation (IC50 = 65 nM) and blocks translocation of PKC.b.II. ML-193 blocks increases in intracellular calcium levels induced by lysophosphatidylinositol (LPI) in dissociated rat periaqueductal gray neurons and modulates pain perception in LPI-treated rats.	False	Cc1cc(C)c2nc(-c3ccccn3)cc(C(=O)Nc3ccc(S(=O)(=O)Nc4onc(C)c4C)cc3)c2c1
413003	413003:01:03_50.00	True	50.0	75	37.0	41.9	34.5	0.0	87.3	0.0	0.0	0.0	0.0	0.0	84.5	0.0	0.0	DNA_Synth	87.3	Prasugrel	Prasugrel is a prodrug form of the platelet purinergic P2Y12 receptor antagonist R-99224. In vivo, prasugrel prevents thrombus formation (ED50 = 0.68 mg/kg) and increases tail bleeding time in rats.	False	CC(=O)Oc1cc2c(s1)CCN(C(C(=O)C1CC1)c1ccccc1F)C2
413206	413206:01:02_05.00	True	5.0	94	67.7	1.7	0.0	77.6	0.0	76.9	42.0	72.4	37.4	66.1	0.0	69.6	78.1	Uncoupler	78.1		An inhibitor of MAPK14 with an IC50 = 0.2 nM (ELISA, cell free). NanoBRET: MAPK14 IC50 = 14.9 nM; MAPK11 IC50 = 16.9 nM. Negative control = FM-743	False	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4ccccc4)c3)cc1CC2
413121	413121:01:03_50.00	True	50.0	87	35.6	0.7	0.0	56.6	0.0	60.9	53.9	73.0	21.4	38.5	0.0	62.4	52.9	LCH	73.0	M 25	Potent Smoothened (Smo) receptor antagonist (IC50 = 5 nM). Inhibits the Hedgehog signaling pathway. Inhibits Shh induced Gli luciferase reporter activity in Shh-light 2 cells (IC50 = 5 nM). Antagonizes GSA-10 and SAG-mediated differentiation of the C3H10T1/2 cell line (IC50 values are 69 and 115 nM, respectively).	False	CCCC(CCC)C(=O)NCc1ccc2c(cnn2-c2ccccc2OC)c1
413029	413029:01:04_10.00	True	10.0	94	34.5	85.1	0.0	0.0	81.5	0.0	31.2	0.0	0.0	0.0	63.7	0.0	0.0	AKT_PI3K_MTOR	85.1	Lorlatinib	Lorlatinib (PF-06463922) is a selective, orally active, brain-penetrant and ATP-competitive ROS1/ALK inhibitor. Lorlatinib has Kis of <0.025 nM, <0.07 nM, and 0.7 nM for ROS1, wild type ALK, and ALKL1196M, respectively. Lorlatinib has anticancer activity.	True	C[C@H]1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CN(C)C(=O)c2ccc(F)cc21
410949	410949:03:02_05.00	True	5.0	101	8.6	68.5	0.0	0.0	65.3	0.0	17.9	0.0	0.0	0.0	78.9	0.0	0.0	Pyrimidine_Synth	78.9	WM-1119	WM-1119 is a highly potent and selective KAT6A inhibitor, with an IC50 of 0.25 uM for KAT6A in lymphoma cells, the binding KD values of WM-1119 with KAT6A, KAT5 and KAT7 are 2 nM, 2.2 uM, 0.5 uM , respectively.	False	O=C(NNS(=O)(=O)c1ccccc1F)c1cc(F)cc(-c2ccccn2)c1
413215	413215:01:02_50.00	True	50.0	89	5.9	0.0	15.9	10.8	0.0	15.1	54.0	22.8	0.0	22.8	0.0	35.3	14.3	HSP90	54.0	Nafamostat (mesylate)	Nafamostat mesylate, a synthetic serine protease inhibitor, is an anticoagulant. Nafamostat mesylate supresses T cell auto-reactivity  by decreasing granzyme activity and CTL cytolysis. Nafamostat mesylate blocks activation of SARS-CoV-2..	False	N=C(N)Nc1ccc(C(=O)Oc2ccc3cc(C(=N)N)ccc3c2)cc1
413204	413204:01:02_05.00	True	5.0	70	45.3	41.5	13.0	0.0	65.5	0.0	21.0	25.8	0.0	1.9	22.6	13.0	18.5	DNA_Synth	65.5	CLK-IN-T3	CLK-IN-T3 is a high potent, selective, and stable CDC-like kinase (CLK) inhibitor with IC50s of 0.67 nM, 15 nM, and 110 nM for CLK1, CLK2, and CLK3 protein kinases, respectively. CLK-IN-T3 has anti-cancer activity.	False	CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5ccncc5)ccc4n3)cc2)CC1
413169	413169:01:02_05.00	True	5.0	100	9.2	0.0	0.0	65.8	0.0	65.6	44.3	79.3	25.0	44.5	0.0	70.7	51.3	LCH	79.3		negative control to BAY-885	False	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1
413149	413149:01:02_05.00	True	5.0	93	9.2	0.0	0.0	53.8	0.0	62.7	47.1	75.5	27.7	32.8	0.0	65.3	37.1	LCH	75.5		negative control to BAY-985	False	CN(C)c1ncnc(-c2ccc3[nH]c(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)nc3c2)c1Cl
413208	413208:01:02_00.50	True	0.5	98	7.1	40.0	0.0	42.0	0.0	47.3	32.5	56.5	6.2	39.6	0.0	31.0	56.8	Uncoupler	56.8	Defactinib	Defactinib (VS-6063; PF-04554878) is a novel FAK inhibitor with potential antiangiogenic and antineoplastic activities.	False	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1
413222	413222:01:04_50.00	True	50.0	100	6.4	0.0	0.0	82.3	0.0	76.6	17.1	71.8	35.9	58.8	0.0	67.2	69.6	BET	82.3	Ogerin	Ogerin is a selective GPR68 positive allosteric modulator, with a pEC50 of 6.83. Ogerin shows inverse agonist and antagonist activity (Ki, 220 nM) at A2A receptoor and weak antagonist activity (Ki, 736 nM) at 5-HT2B receptor. Ogerin blocks recall in fear conditioning in mice.	False	Nc1nc(NCc2ccccc2)nc(-c2ccccc2CO)n1
413000	413000:01:02_50.00	True	50.0	90	67.2	52.1	0.0	21.0	18.3	23.4	48.8	50.2	0.0	36.4	0.0	37.8	49.1	AKT_PI3K_MTOR	52.1	Arcyriaflavin-a	Arcyriaflavin A is an inhibitor of cyclin-dependent kinase 4 (CDK4; IC50 = 140 nM) and calcium/calmodulin-dependent protein kinase II (CaMKII; IC50 = 25 nM). It is selective for CDK4 and CaMKII over protein kinase A (PKA) and PKC (IC50s = >2 and >100 uM, respectively). In vitro, arcyriaflavin A inhibits replication of human cytomegalovirus (HCMV; IC50 = 200 nM), as well as proliferation of HCT116 and NCI H460 human carcinoma cells (IC50s = 850 and 590 nM, respectively).	False	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3ccccc3c21
280865	280865:03:02_10.00	True	10.0	71	36.4	44.7	11.6	0.0	92.3	0.0	0.0	0.0	0.0	0.0	59.0	0.0	0.0	DNA_Synth	92.3	o-Phenanthroline	o-Phenanthroline (1,10-Phenanthroline), a metal chelator, prevents the induction of chromosomal aberrations in streptozotocin-treated cells. o-Phenanthroline (1,10-Phenanthroline) forms a red chelate with Fe2+ that absorbs maximally at 510 nm.	False	c1cnc2c(c1)ccc1cccnc12
245371	245371:02:05_10.00	True	10.0	93	18.1	3.8	9.2	0.0	31.5	0.0	29.2	5.5	0.0	3.9	29.1	8.3	0.0	DNA_Synth	31.5	Berberine (chloride hydrate)	Berberine chloride hydrate (Natural Yellow 18 chloride hydrate) is an alkaloid isolated from the Chinese herbal medicine Huanglian, as an antibiotic. Berberine chloride hydrate induces reactive oxygen species (ROS) generation and inhibits DNA topoisomerase. Antineoplastic properties.	False	COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2
413489	413489:01:03_10.00	True	10.0	101	9.5	0.0	0.0	34.3	0.0	31.6	34.7	35.5	7.5	33.6	0.0	40.0	29.9	Tubulin	40.0	Simeprevir	Simeprevir (TMC435) is an oral and potent HCV NS3/4A protease inhibitor with a Ki of 0.36 nM, and inhibits HCV replication with an EC50 of 7.8 nM.	True	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)NS(=O)(=O)C6CC6)C[C@H]5/C=C\CCCCN(C)C(=O)[C@@H]4C3)cc(-c3nc(C(C)C)cs3)nc2c1C
280865	280865:03:02_30.00	True	30.0	70	41.1	47.2	5.6	0.0	93.2	0.0	0.0	0.0	0.0	0.0	59.2	0.0	0.0	DNA_Synth	93.2	o-Phenanthroline	o-Phenanthroline (1,10-Phenanthroline), a metal chelator, prevents the induction of chromosomal aberrations in streptozotocin-treated cells. o-Phenanthroline (1,10-Phenanthroline) forms a red chelate with Fe2+ that absorbs maximally at 510 nm.	False	c1cnc2c(c1)ccc1cccnc12
245371	245371:02:05_30.00	True	30.0	91	25.4	0.9	5.0	3.8	12.6	0.0	23.8	21.4	7.4	12.7	0.0	17.2	0.0	HSP90	23.8	Berberine (chloride hydrate)	Berberine chloride hydrate (Natural Yellow 18 chloride hydrate) is an alkaloid isolated from the Chinese herbal medicine Huanglian, as an antibiotic. Berberine chloride hydrate induces reactive oxygen species (ROS) generation and inhibits DNA topoisomerase. Antineoplastic properties.	False	COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2
413489	413489:01:03_30.00	True	30.0	74	47.3	0.0	0.0	60.7	0.0	59.4	8.6	44.4	56.1	50.3	0.0	63.1	75.2	Uncoupler	75.2	Simeprevir	Simeprevir (TMC435) is an oral and potent HCV NS3/4A protease inhibitor with a Ki of 0.36 nM, and inhibits HCV replication with an EC50 of 7.8 nM.	True	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)NS(=O)(=O)C6CC6)C[C@H]5/C=C\CCCCN(C)C(=O)[C@@H]4C3)cc(-c3nc(C(C)C)cs3)nc2c1C
280865	280865:03:02_50.00	True	50.0	67	45.8	48.0	8.2	0.0	92.5	0.0	0.0	0.0	0.0	0.0	64.6	0.0	0.0	DNA_Synth	92.5	o-Phenanthroline	o-Phenanthroline (1,10-Phenanthroline), a metal chelator, prevents the induction of chromosomal aberrations in streptozotocin-treated cells. o-Phenanthroline (1,10-Phenanthroline) forms a red chelate with Fe2+ that absorbs maximally at 510 nm.	False	c1cnc2c(c1)ccc1cccnc12
245371	245371:02:05_50.00	True	50.0	97	31.8	1.9	6.3	0.0	21.1	0.0	23.0	17.8	3.4	8.6	6.9	13.8	0.0	HSP90	23.0	Berberine (chloride hydrate)	Berberine chloride hydrate (Natural Yellow 18 chloride hydrate) is an alkaloid isolated from the Chinese herbal medicine Huanglian, as an antibiotic. Berberine chloride hydrate induces reactive oxygen species (ROS) generation and inhibits DNA topoisomerase. Antineoplastic properties.	False	COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2
519820	519820:01:04_10.00	True	10.0	96	20.2	24.3	0.0	3.4	35.4	0.0	7.6	10.1	0.0	43.4	1.7	27.4	33.7	Protein_Synth	43.4		BI-8925 is a covalent inhibitor targeting Cys86 in the N-terminal executioner domain of the necroptosis effector protein mixed lineage kinase domain-like protein (MLKL). MLKL is locked in its auto-inhibited monomeric state by the packing of .a.-helix 6 against its four-helix bundle in the N-terminal executioner domain. Upon activation through phosphorylation in its C-terminal pseudokinase domain .a.-helix 6 unfolds and the N-terminal executioner domain can multimerize and integrate into the membrane, which finally leads to Necroptosis. BI-8925 inhibits necroptosis in Jurkat and U937 cells with an IC50 of 541 and 271 nM, respectively.	False	COCCOCn1c(S(C)(=O)=O)nc2c1c(=O)n(C)c(=O)n2C
519822	519822:01:02_10.00	True	10.0	98	24.7	0.0	0.0	56.5	0.0	62.8	25.4	78.8	16.9	24.0	0.0	56.2	25.9	LCH	78.8		Negative control to BIIE0246. BIIE0212 is a congeneric analogue from the same series of L-argininamides with similar physicochemical properties but with a more than 400-fold lower affinity towards the Y2 receptor3.	False	N=C(N)NCCC[C@H](NC(=O)CC1(CC(=O)N2CCN(C(c3ccccc3)c3ccccc3)CC2)CCCC1)C(=O)NCc1ccccc1
519821	519821:01:03_10.00	True	10.0	93	18.7	30.3	0.0	31.2	12.3	24.8	32.9	43.4	4.7	12.1	0.0	52.6	60.1	Uncoupler	60.1		BI-9774 is a highly potent and well characterized AMPK activator which can be used for in vitro and in vivo studies. BI-9774 displays an EC50 of 64 nM (Emax = 590 %) in an ADP-Glo kinase assay with human AMPK (.a.1.b.1.g.1) and an EC50 of 8 nM (Emax = 168 nM %) in a cellular GLUT4 translocation assay.	False	CS(C)(=O)=Nc1ccc(-c2ccc(-c3nc4[nH]c(O[C@@H]5CO[C@@H]6[C@H](O)CO[C@H]56)nc4cc3Cl)cc2)cc1
519809	519809:01:04_10.00	True	10.0	89	7.3	0.0	3.2	41.7	0.0	43.0	34.0	44.5	5.8	63.7	0.0	49.0	38.9	Protein_Synth	63.7		The in vivo molecule BI-1124 displays high potency in the inhibition of Cathepsin S (IC50 7 nM) and in the ovalbumin challenge T-cell assay (IC50 0.5 nM). Furthermore, BI-1124 has a superior PK profile and showed dose-dependent inhibition of the ovalbumin induced IL-2 secretion in a T cell receptor transgenic DO11 mouse model with an IC50 of 0.3 mg/kg. negative control = BI-1920	True	CCCN1CCC(C#N)(NC(=O)[C@H](CC(C)(C)C)NC(=O)N2CCOCC2)CC1
519815	519815:01:03_10.00	True	10.0	88	20.2	0.0	0.0	60.1	0.0	52.2	28.0	58.7	17.7	60.0	0.0	72.8	62.4	Tubulin	72.8	BI-4916	BI-4916 is a prodrug of BI-4924. BI-4924 is a NADH/NAD+-competitive PHGDH inhibitor.	True	CCOC(=O)CS(=O)(=O)c1ccc([C@@H](CO)NC(=O)c2cc3c(Cl)c(Cl)c(C)cc3n2C)cc1
410871	410871:04:03_10.00	True	10.0	60	81.7	0.0	2.6	72.2	0.0	73.0	34.0	69.8	44.6	64.5	0.0	79.3	51.0	Tubulin	79.3	Ilginatinib	Ilginatinib (NS-018) is a highly active and orally bioavailable JAK2 inhibitor, with an IC50 of 0.72 nM, 46-, 54-, and 31-fold selectivity for JAK2 over JAK1 (IC50, 33 nM), JAK3 (IC50, 39 nM), and Tyk2 (IC50, 22 nM).	False	C[C@H](Nc1cc(-c2cnn(C)c2)cc(Nc2cnccn2)n1)c1ccc(F)cc1
410990	410990:02:03_10.00	True	10.0	67	53.9	0.0	0.0	75.4	0.0	88.3	27.0	61.7	61.0	68.3	0.0	72.4	62.0	HDAC	88.3	LMK-235	LMK-235 is a potent and selective HDAC4/5 inhibitor, inhibits HDAC5, HDAC4, HDAC6, HDAC1, HDAC2, HDAC11 and HDAC8, with IC50s of 4.22 nM, 11.9 nM, 55.7 nM, 320 nM, 881 nM, 852 nM and 1278 nM, respectively, and is used in cancer research.	False	Cc1cc(C)cc(C(=O)NOCCCCCC(=O)NO)c1
410884	410884:02:04_10.00	True	10.0	50	80.7	0.0	10.6	72.3	0.0	81.5	37.0	67.0	53.2	60.7	0.0	81.3	42.4	HDAC	81.5	CF53	CF53 is a highly potent, selective and orally active inhibitor of BET protein, with a Ki of <1 nM, Kd of 2.2 nM and an IC50 of 2 nM for BRD4 BD1. CF53 binds to both the BD1 and BD2 domains of BRD2, BRD3, BRD4, and BRDT BET proteins with high affinities, very selective over non-BET bromodomain-containing proteins. CF53 shows potent anti-tumor activity both in vitro and in vivo.	False	COc1cc2c(cc1-c1c(C)noc1C)[nH]c1nc(C)nc(Nc3cc(C4CC4)nn3C)c12
410973	410973:02:02_02.00	True	2.0	73	28.5	0.0	0.0	70.0	0.0	67.4	31.0	62.7	52.1	61.6	0.0	90.5	58.1	Tubulin	90.5	TyK2-IN-2	TyK2-IN-2 is an inhibitor of TYK2, used for treatment of inflammatory and autoimmune diseases.	False	CNc1cc(Nc2cc(C)cc(C)c2)nn2c(C(N)=O)cnc12
519820	519820:01:04_30.00	True	30.0	79	15.0	49.1	14.7	0.0	71.4	0.0	21.1	0.0	0.0	0.0	41.8	0.0	7.4	DNA_Synth	71.4		BI-8925 is a covalent inhibitor targeting Cys86 in the N-terminal executioner domain of the necroptosis effector protein mixed lineage kinase domain-like protein (MLKL). MLKL is locked in its auto-inhibited monomeric state by the packing of .a.-helix 6 against its four-helix bundle in the N-terminal executioner domain. Upon activation through phosphorylation in its C-terminal pseudokinase domain .a.-helix 6 unfolds and the N-terminal executioner domain can multimerize and integrate into the membrane, which finally leads to Necroptosis. BI-8925 inhibits necroptosis in Jurkat and U937 cells with an IC50 of 541 and 271 nM, respectively.	False	COCCOCn1c(S(C)(=O)=O)nc2c1c(=O)n(C)c(=O)n2C
519822	519822:01:02_30.00	True	30.0	93	33.2	0.0	0.0	71.9	0.0	72.4	24.7	80.1	29.6	56.9	0.0	73.1	49.6	LCH	80.1		Negative control to BIIE0246. BIIE0212 is a congeneric analogue from the same series of L-argininamides with similar physicochemical properties but with a more than 400-fold lower affinity towards the Y2 receptor3.	False	N=C(N)NCCC[C@H](NC(=O)CC1(CC(=O)N2CCN(C(c3ccccc3)c3ccccc3)CC2)CCCC1)C(=O)NCc1ccccc1
519821	519821:01:03_30.00	True	30.0	87	14.2	5.1	0.0	42.4	0.0	35.7	41.8	41.0	16.6	26.7	0.0	60.7	58.6	Tubulin	60.7		BI-9774 is a highly potent and well characterized AMPK activator which can be used for in vitro and in vivo studies. BI-9774 displays an EC50 of 64 nM (Emax = 590 %) in an ADP-Glo kinase assay with human AMPK (.a.1.b.1.g.1) and an EC50 of 8 nM (Emax = 168 nM %) in a cellular GLUT4 translocation assay.	False	CS(C)(=O)=Nc1ccc(-c2ccc(-c3nc4[nH]c(O[C@@H]5CO[C@@H]6[C@H](O)CO[C@H]56)nc4cc3Cl)cc2)cc1
519815	519815:01:03_30.00	True	30.0	66	57.9	0.0	0.0	81.0	0.0	80.3	34.6	61.3	54.0	65.6	0.0	81.5	67.6	Tubulin	81.5	BI-4916	BI-4916 is a prodrug of BI-4924. BI-4924 is a NADH/NAD+-competitive PHGDH inhibitor.	True	CCOC(=O)CS(=O)(=O)c1ccc([C@@H](CO)NC(=O)c2cc3c(Cl)c(Cl)c(C)cc3n2C)cc1
410871	410871:04:03_30.00	True	30.0	54	77.7	0.0	0.0	79.5	0.0	77.0	31.5	69.2	47.8	69.4	0.0	81.0	60.7	Tubulin	81.0	Ilginatinib	Ilginatinib (NS-018) is a highly active and orally bioavailable JAK2 inhibitor, with an IC50 of 0.72 nM, 46-, 54-, and 31-fold selectivity for JAK2 over JAK1 (IC50, 33 nM), JAK3 (IC50, 39 nM), and Tyk2 (IC50, 22 nM).	False	C[C@H](Nc1cc(-c2cnn(C)c2)cc(Nc2cnccn2)n1)c1ccc(F)cc1
410990	410990:02:03_30.00	True	30.0	60	41.8	0.0	0.0	74.3	0.0	88.7	28.1	57.3	61.5	65.6	0.0	72.6	60.9	HDAC	88.7	LMK-235	LMK-235 is a potent and selective HDAC4/5 inhibitor, inhibits HDAC5, HDAC4, HDAC6, HDAC1, HDAC2, HDAC11 and HDAC8, with IC50s of 4.22 nM, 11.9 nM, 55.7 nM, 320 nM, 881 nM, 852 nM and 1278 nM, respectively, and is used in cancer research.	False	Cc1cc(C)cc(C(=O)NOCCCCCC(=O)NO)c1
408563	408563:02:02_30.00	True	30.0	88	7.6	50.1	0.0	0.0	74.8	0.0	16.0	0.0	0.0	0.0	44.3	0.0	6.2	DNA_Synth	74.8	2,4-Bis(1,1-dimethylethyl)phenol phosphate (bDtBPP)		False	CC(C)(C)c1ccc(OP(=O)(O)Oc2ccc(C(C)(C)C)cc2C(C)(C)C)c(C(C)(C)C)c1
410973	410973:02:02_06.00	True	6.0	61	45.4	0.0	0.0	73.0	0.0	76.3	41.4	54.8	60.6	72.3	0.0	90.9	55.2	Tubulin	90.9	TyK2-IN-2	TyK2-IN-2 is an inhibitor of TYK2, used for treatment of inflammatory and autoimmune diseases.	False	CNc1cc(Nc2cc(C)cc(C)c2)nn2c(C(N)=O)cnc12
519814	519814:01:02_30.00	True	30.0	96	5.2	0.0	0.0	51.6	0.0	52.4	46.5	46.8	23.0	57.4	0.0	63.0	38.0	Tubulin	63.0		BI-4420 is a structurally related negative control of BI-1046. The 2-furanyl substituent in BI-4420 compared to the N-Methyl imidazolyl ring renders it inactive on both human and mouse GPR142.	False	O=C(Nc1cccc(C(F)(F)F)c1)c1cccc(-n2cc(-c3ccco3)nn2)c1
411099	411099:01:12_00.30	True	0.3	92	5.4	0.0	0.0	61.9	0.0	51.6	37.4	44.0	24.7	60.2	0.0	58.3	61.6	BET	61.9	LDN193189 hydrochloride, DM-;3189	potent and selective ALK2 and ALK3 inhibitor (IC50 values are 5 and 30 nM, respectively); inhibits BMP4-mediated Smad1/5/8 activation. Exhibits >200-fold selectivity for BMP signaling over TGF-? signaling. Also exhibits selectivity over AMPK, PDGFR and MAPK signaling.	False	c1ccc2c(-c3cnn4cc(-c5ccc(N6CCNCC6)cc5)cnc34)ccnc2c1
519820	519820:01:04_50.00	True	50.0	61	30.1	39.2	25.9	0.0	75.7	0.0	18.7	0.0	0.0	0.0	36.5	2.3	6.3	DNA_Synth	75.7		BI-8925 is a covalent inhibitor targeting Cys86 in the N-terminal executioner domain of the necroptosis effector protein mixed lineage kinase domain-like protein (MLKL). MLKL is locked in its auto-inhibited monomeric state by the packing of .a.-helix 6 against its four-helix bundle in the N-terminal executioner domain. Upon activation through phosphorylation in its C-terminal pseudokinase domain .a.-helix 6 unfolds and the N-terminal executioner domain can multimerize and integrate into the membrane, which finally leads to Necroptosis. BI-8925 inhibits necroptosis in Jurkat and U937 cells with an IC50 of 541 and 271 nM, respectively.	False	COCCOCn1c(S(C)(=O)=O)nc2c1c(=O)n(C)c(=O)n2C
519821	519821:01:03_50.00	True	50.0	91	41.8	0.0	0.0	65.8	0.0	63.6	38.2	67.0	38.1	39.2	0.0	76.6	59.0	Tubulin	76.6		BI-9774 is a highly potent and well characterized AMPK activator which can be used for in vitro and in vivo studies. BI-9774 displays an EC50 of 64 nM (Emax = 590 %) in an ADP-Glo kinase assay with human AMPK (.a.1.b.1.g.1) and an EC50 of 8 nM (Emax = 168 nM %) in a cellular GLUT4 translocation assay.	False	CS(C)(=O)=Nc1ccc(-c2ccc(-c3nc4[nH]c(O[C@@H]5CO[C@@H]6[C@H](O)CO[C@H]56)nc4cc3Cl)cc2)cc1
519809	519809:01:04_50.00	True	50.0	97	21.6	0.0	0.0	56.8	0.0	55.3	23.3	78.6	9.4	31.8	0.0	64.6	41.6	LCH	78.6		The in vivo molecule BI-1124 displays high potency in the inhibition of Cathepsin S (IC50 7 nM) and in the ovalbumin challenge T-cell assay (IC50 0.5 nM). Furthermore, BI-1124 has a superior PK profile and showed dose-dependent inhibition of the ovalbumin induced IL-2 secretion in a T cell receptor transgenic DO11 mouse model with an IC50 of 0.3 mg/kg. negative control = BI-1920	True	CCCN1CCC(C#N)(NC(=O)[C@H](CC(C)(C)C)NC(=O)N2CCOCC2)CC1
410990	410990:02:03_50.00	True	50.0	60	63.7	0.0	0.0	79.3	0.0	91.9	27.6	66.1	65.1	61.3	0.0	75.7	58.6	HDAC	91.9	LMK-235	LMK-235 is a potent and selective HDAC4/5 inhibitor, inhibits HDAC5, HDAC4, HDAC6, HDAC1, HDAC2, HDAC11 and HDAC8, with IC50s of 4.22 nM, 11.9 nM, 55.7 nM, 320 nM, 881 nM, 852 nM and 1278 nM, respectively, and is used in cancer research.	False	Cc1cc(C)cc(C(=O)NOCCCCCC(=O)NO)c1
410884	410884:02:04_50.00	True	50.0	53	78.6	0.0	0.0	78.9	0.0	87.5	36.6	78.8	54.0	55.5	0.0	80.8	54.4	HDAC	87.5	CF53	CF53 is a highly potent, selective and orally active inhibitor of BET protein, with a Ki of <1 nM, Kd of 2.2 nM and an IC50 of 2 nM for BRD4 BD1. CF53 binds to both the BD1 and BD2 domains of BRD2, BRD3, BRD4, and BRDT BET proteins with high affinities, very selective over non-BET bromodomain-containing proteins. CF53 shows potent anti-tumor activity both in vitro and in vivo.	False	COc1cc2c(cc1-c1c(C)noc1C)[nH]c1nc(C)nc(Nc3cc(C4CC4)nn3C)c12
408563	408563:02:02_50.00	True	50.0	87	16.8	49.2	0.0	0.0	64.7	0.0	27.1	4.1	0.0	7.1	32.5	15.6	25.1	DNA_Synth	64.7	2,4-Bis(1,1-dimethylethyl)phenol phosphate (bDtBPP)		False	CC(C)(C)c1ccc(OP(=O)(O)Oc2ccc(C(C)(C)C)cc2C(C)(C)C)c(C(C)(C)C)c1
410973	410973:02:02_10.00	True	10.0	53	55.6	0.0	8.8	72.6	0.0	79.9	46.4	67.1	63.3	55.3	0.0	88.2	48.4	Tubulin	88.2	TyK2-IN-2	TyK2-IN-2 is an inhibitor of TYK2, used for treatment of inflammatory and autoimmune diseases.	False	CNc1cc(Nc2cc(C)cc(C)c2)nn2c(C(N)=O)cnc12
519814	519814:01:02_50.00	True	50.0	93	50.4	0.0	0.0	55.8	0.0	60.1	26.2	71.0	37.1	41.7	0.0	67.0	27.5	LCH	71.0		BI-4420 is a structurally related negative control of BI-1046. The 2-furanyl substituent in BI-4420 compared to the N-Methyl imidazolyl ring renders it inactive on both human and mouse GPR142.	False	O=C(Nc1cccc(C(F)(F)F)c1)c1cccc(-n2cc(-c3ccco3)nn2)c1
411099	411099:01:12_00.50	True	0.5	104	7.3	0.0	0.0	61.0	0.0	64.0	11.7	43.1	42.5	62.9	0.0	49.4	61.6	HDAC	64.0	LDN193189 hydrochloride, DM-;3189	potent and selective ALK2 and ALK3 inhibitor (IC50 values are 5 and 30 nM, respectively); inhibits BMP4-mediated Smad1/5/8 activation. Exhibits >200-fold selectivity for BMP signaling over TGF-? signaling. Also exhibits selectivity over AMPK, PDGFR and MAPK signaling.	False	c1ccc2c(-c3cnn4cc(-c5ccc(N6CCNCC6)cc5)cnc34)ccnc2c1
519808	519808:01:04_10.00	True	10.0	84	27.5	0.0	0.0	51.8	0.0	49.7	28.6	72.6	0.0	31.0	0.0	63.6	36.0	LCH	72.6		BI-1046 has been identified as a potent and selective GPR142 agonist which increases Gq-coupled signalling in cells of recombinant and endogenous receptor expression. BI-1046 displays high potency with an EC50 of 0.05 nM in an IP1-based cellular assay. The GPR142 agonistic activity of BI-1046 has been demonstrated to potentiate glucose-stimulated insulin secretion from mouse islets, a physiological response that translates into improved glucose tolerance in mice when investigated in an acute oral glucose tolerance test.	False	Cn1cncc1-c1cn(-c2cccc(C(=O)Nc3cccc(C(F)(F)F)c3)c2)nn1
519823	519823:01:02_10.00	True	10.0	94	9.8	0.0	4.2	35.3	0.0	41.6	39.5	44.2	9.1	24.6	0.0	41.7	4.6	LCH	44.2		BIIE0246 acts as a non-peptide neuropeptide Y (NPY) receptor antagonist with unprecedented affinity and high selectivity for the Y2R subtype. In ligand binding studies BIIE0246 was able to displace the specific binding of radiolabelled NPY from hY2 sites on SMS-KAN cells with an IC50 of 3.3 nM whereas no displacement was observed from human Y1, Y4 and Y5 specific binding sites in concentrations up to 1 .u.M.	False	N=C(N)NCCC[C@H](NC(=O)CC1(CC(=O)N2CCN(C3c4ccccc4NC(=O)c4ccccc43)CC2)CCCC1)C(=O)NCCn1c(=O)n(-c2ccccc2)n(-c2ccccc2)c1=O
408038	408038:02:04_10.00	True	10.0	90	34.7	0.0	0.0	74.3	0.0	74.2	37.5	80.4	34.0	63.5	0.0	70.2	71.4	LCH	80.4		MGH-CP1 is a potent and selective inhibitor of transcriptional enhanced associate domain (TEAD) palmitoylation. MGH-CP1 exhibits dose-dependent and potent inhibition of TEAD2/4 auto-palmitoylation in vitro with IC50 of 710 nM and 672 nM, respectively.	False	O=C(CSc1nc[nH]n1)Nc1ccc(C23CC4CC(CC(C4)C2)C3)cc1
519813	519813:01:03_10.00	True	10.0	101	11.6	17.6	0.0	21.4	4.8	6.0	26.1	38.5	0.0	4.2	0.0	35.8	19.8	LCH	38.5		BI-3257 is an inhibitor of HIV replication with nanomolar activity. It prevents the formation of the capsid core structure that encapsulates the viral genome and its associated enzymes, reverse transcriptase and integrase. BI-3257 binds to an induced pocket in the N-terminal domain of the capsid protein and induces significant structural changes (displacement of the .a.1-helix), likely affecting the protein-protein interactions that define the regular structures of the viral capsid core. The binding location of BI-3257-type compounds in the capsid monomer was elucidated by X-ray crystallography, and electron microscopy allowed the elucidation of its mode of action. Due to this innovative mechanism of viral replication, BI-3257 is equally potent against the wild-type as well as mutant viruses that are resistant to the four major classes of antiretroviral inhibitors	False	CCCn1cc(-c2cc(C3C(=O)N(CC)c4ccc(C(F)(F)F)cc4N(c4ccccc4)C3=O)cc(OC)c2O)cn1
410916	410916:02:02_02.00	True	2.0	70	47.7	0.0	4.2	73.4	0.0	86.3	21.9	64.7	57.7	61.1	0.0	73.3	54.2	HDAC	86.3	M344	M344 (D 237) is an inhibitor of histone deacetylase (IC50=100 nM) and an inducer of terminal cell fifferentiation.	False	CN(C)c1ccc(C(=O)NCCCCCCC(=O)NO)cc1
410753	410753:02:02_10.00	True	10.0	100	42.5	0.0	0.0	77.2	0.0	75.2	23.8	63.0	44.4	59.1	0.0	79.8	53.8	Tubulin	79.8	Cyclo(RGDyK) (trifluoroacetate)	Cyclo(RGDyK) trifluoroacetate is a potent and selective .a.V.b.3 integrin inhibitor with an IC50 of 20 nM.	True	NCCCC[C@@H]1NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC1=O
247256	247256:04:03_10.00	True	10.0	84	23.8	52.4	0.0	0.0	94.8	0.0	0.0	0.0	0.0	0.0	65.4	0.0	0.0	DNA_Synth	94.8	Deferoxamine mesylate	iron chelator, which does not readily bind iron from transferrin, hemoglobin, myoglobin or cytochrome. Rescues erastin-induced Ferroptosis.	False	CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN
410811	410811:02:02_02.00	True	2.0	62	47.0	0.0	0.4	74.7	0.0	86.7	21.7	67.6	59.5	58.9	0.0	74.6	54.4	HDAC	86.7	Scriptaid	Scriptaid is a potent histone deacetylase (HDAC) inhibitor, used in cancer research. Scriptaid is also a sensitizer to antivirals and has potential for epstein-barr virus (EBV)-associated lymphomas treatment.	False	O=C(CCCCCN1C(=O)c2cccc3cccc(c23)C1=O)NO
519808	519808:01:04_30.00	True	30.0	96	57.5	0.0	0.0	70.1	0.0	68.4	43.0	81.4	21.0	54.4	0.0	75.6	61.2	LCH	81.4		BI-1046 has been identified as a potent and selective GPR142 agonist which increases Gq-coupled signalling in cells of recombinant and endogenous receptor expression. BI-1046 displays high potency with an EC50 of 0.05 nM in an IP1-based cellular assay. The GPR142 agonistic activity of BI-1046 has been demonstrated to potentiate glucose-stimulated insulin secretion from mouse islets, a physiological response that translates into improved glucose tolerance in mice when investigated in an acute oral glucose tolerance test.	False	Cn1cncc1-c1cn(-c2cccc(C(=O)Nc3cccc(C(F)(F)F)c3)c2)nn1
519823	519823:01:02_30.00	True	30.0	98	25.4	0.0	0.0	60.5	0.0	65.7	35.2	65.2	35.5	46.1	0.0	60.8	20.1	HDAC	65.7		BIIE0246 acts as a non-peptide neuropeptide Y (NPY) receptor antagonist with unprecedented affinity and high selectivity for the Y2R subtype. In ligand binding studies BIIE0246 was able to displace the specific binding of radiolabelled NPY from hY2 sites on SMS-KAN cells with an IC50 of 3.3 nM whereas no displacement was observed from human Y1, Y4 and Y5 specific binding sites in concentrations up to 1 .u.M.	False	N=C(N)NCCC[C@H](NC(=O)CC1(CC(=O)N2CCN(C3c4ccccc4NC(=O)c4ccccc43)CC2)CCCC1)C(=O)NCCn1c(=O)n(-c2ccccc2)n(-c2ccccc2)c1=O
408038	408038:02:04_30.00	True	30.0	87	76.5	0.0	0.0	87.0	0.0	87.8	36.5	84.6	53.1	66.7	0.0	81.7	73.2	HDAC	87.8		MGH-CP1 is a potent and selective inhibitor of transcriptional enhanced associate domain (TEAD) palmitoylation. MGH-CP1 exhibits dose-dependent and potent inhibition of TEAD2/4 auto-palmitoylation in vitro with IC50 of 710 nM and 672 nM, respectively.	False	O=C(CSc1nc[nH]n1)Nc1ccc(C23CC4CC(CC(C4)C2)C3)cc1
519813	519813:01:03_30.00	True	30.0	93	5.9	0.0	0.0	45.9	0.0	39.9	36.1	54.4	14.3	32.9	0.0	52.0	37.1	LCH	54.4		BI-3257 is an inhibitor of HIV replication with nanomolar activity. It prevents the formation of the capsid core structure that encapsulates the viral genome and its associated enzymes, reverse transcriptase and integrase. BI-3257 binds to an induced pocket in the N-terminal domain of the capsid protein and induces significant structural changes (displacement of the .a.1-helix), likely affecting the protein-protein interactions that define the regular structures of the viral capsid core. The binding location of BI-3257-type compounds in the capsid monomer was elucidated by X-ray crystallography, and electron microscopy allowed the elucidation of its mode of action. Due to this innovative mechanism of viral replication, BI-3257 is equally potent against the wild-type as well as mutant viruses that are resistant to the four major classes of antiretroviral inhibitors	False	CCCn1cc(-c2cc(C3C(=O)N(CC)c4ccc(C(F)(F)F)cc4N(c4ccccc4)C3=O)cc(OC)c2O)cn1
519812	519812:01:03_30.00	True	30.0	97	7.3	45.1	5.0	0.0	79.2	0.0	19.7	0.0	0.0	0.0	69.2	0.0	0.0	DNA_Synth	79.2		BI-2081 is a partial agonist on GPR40 with a good in vitro potency (EC50 = 4 nM). The activation of GPR40 allows a glucose depending insulin secretion and BI-2081 significantly reduces the plasma glucose concentration in Zucker diabetic fatty rats. This mode of action allows a high anti-hyperglycemic efficacy with low risk for hypoglycemia. BI-2081 possesses a good in vitro and in vivo PK profile, which makes an oral application with high bioavailability possible. The structurally related BI-0340 is a suitable negative control due to its significant lower potency on GPR40.	False	Cc1cc(OCCC(C)(C)O)cc(C)c1-c1ccc(F)c2c1CC[C@H]2Oc1ccc2c(c1)OC[C@H]2CC(=O)O
410916	410916:02:02_06.00	True	6.0	65	56.6	0.0	3.8	76.5	0.0	90.7	27.5	60.3	61.6	66.9	0.0	75.0	58.8	HDAC	90.7	M344	M344 (D 237) is an inhibitor of histone deacetylase (IC50=100 nM) and an inducer of terminal cell fifferentiation.	False	CN(C)c1ccc(C(=O)NCCCCCCC(=O)NO)cc1
247256	247256:05:03_60.00	True	60.0	93	18.3	36.9	0.0	0.0	85.4	0.0	0.0	5.9	0.0	0.0	48.1	0.0	0.0	DNA_Synth	85.4	Deferoxamine mesylate	iron chelator, which does not readily bind iron from transferrin, hemoglobin, myoglobin or cytochrome. Rescues erastin-induced Ferroptosis.	False	CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN
410753	410753:02:02_30.00	True	30.0	98	77.2	0.0	0.0	89.3	0.0	87.1	25.8	70.4	56.5	68.8	0.0	87.4	61.6	BET	89.3	Cyclo(RGDyK) (trifluoroacetate)	Cyclo(RGDyK) trifluoroacetate is a potent and selective .a.V.b.3 integrin inhibitor with an IC50 of 20 nM.	True	NCCCC[C@@H]1NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC1=O
247256	247256:04:03_30.00	True	30.0	80	37.8	47.5	3.2	0.0	94.5	0.0	0.0	0.0	0.0	0.0	63.0	0.0	0.0	DNA_Synth	94.5	Deferoxamine mesylate	iron chelator, which does not readily bind iron from transferrin, hemoglobin, myoglobin or cytochrome. Rescues erastin-induced Ferroptosis.	False	CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN
410811	410811:02:02_06.00	True	6.0	63	66.1	0.0	0.0	75.4	0.0	89.5	29.6	67.9	60.1	62.7	0.0	74.5	56.9	HDAC	89.5	Scriptaid	Scriptaid is a potent histone deacetylase (HDAC) inhibitor, used in cancer research. Scriptaid is also a sensitizer to antivirals and has potential for epstein-barr virus (EBV)-associated lymphomas treatment.	False	O=C(CCCCCN1C(=O)c2cccc3cccc(c23)C1=O)NO
519808	519808:01:04_50.00	True	50.0	77	47.0	0.0	0.0	60.6	0.0	61.6	53.7	59.9	29.7	58.3	0.0	71.1	60.1	Tubulin	71.1		BI-1046 has been identified as a potent and selective GPR142 agonist which increases Gq-coupled signalling in cells of recombinant and endogenous receptor expression. BI-1046 displays high potency with an EC50 of 0.05 nM in an IP1-based cellular assay. The GPR142 agonistic activity of BI-1046 has been demonstrated to potentiate glucose-stimulated insulin secretion from mouse islets, a physiological response that translates into improved glucose tolerance in mice when investigated in an acute oral glucose tolerance test.	False	Cn1cncc1-c1cn(-c2cccc(C(=O)Nc3cccc(C(F)(F)F)c3)c2)nn1
519823	519823:01:02_50.00	True	50.0	104	6.2	0.0	0.0	61.0	0.0	55.4	27.8	59.6	22.4	57.6	0.0	56.4	29.6	BET	61.0		BIIE0246 acts as a non-peptide neuropeptide Y (NPY) receptor antagonist with unprecedented affinity and high selectivity for the Y2R subtype. In ligand binding studies BIIE0246 was able to displace the specific binding of radiolabelled NPY from hY2 sites on SMS-KAN cells with an IC50 of 3.3 nM whereas no displacement was observed from human Y1, Y4 and Y5 specific binding sites in concentrations up to 1 .u.M.	False	N=C(N)NCCC[C@H](NC(=O)CC1(CC(=O)N2CCN(C3c4ccccc4NC(=O)c4ccccc43)CC2)CCCC1)C(=O)NCCn1c(=O)n(-c2ccccc2)n(-c2ccccc2)c1=O
408038	408038:02:04_50.00	True	50.0	87	75.1	0.0	0.0	83.2	0.0	82.7	32.2	67.4	56.7	75.6	0.0	79.8	77.1	BET	83.2		MGH-CP1 is a potent and selective inhibitor of transcriptional enhanced associate domain (TEAD) palmitoylation. MGH-CP1 exhibits dose-dependent and potent inhibition of TEAD2/4 auto-palmitoylation in vitro with IC50 of 710 nM and 672 nM, respectively.	False	O=C(CSc1nc[nH]n1)Nc1ccc(C23CC4CC(CC(C4)C2)C3)cc1
410916	410916:02:02_10.00	True	10.0	64	48.4	0.0	0.0	72.9	0.0	85.4	28.6	54.6	61.2	75.5	0.0	74.3	59.4	HDAC	85.4	M344	M344 (D 237) is an inhibitor of histone deacetylase (IC50=100 nM) and an inducer of terminal cell fifferentiation.	False	CN(C)c1ccc(C(=O)NCCCCCCC(=O)NO)cc1
247256	247256:05:03_100.00	True	100.0	91	15.9	35.1	0.0	0.0	84.5	0.0	0.0	0.0	0.0	0.0	57.0	0.0	0.0	DNA_Synth	84.5	Deferoxamine mesylate	iron chelator, which does not readily bind iron from transferrin, hemoglobin, myoglobin or cytochrome. Rescues erastin-induced Ferroptosis.	False	CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN
410753	410753:02:02_50.00	True	50.0	88	67.5	0.0	0.0	83.5	0.0	77.1	29.8	59.5	49.9	77.9	0.0	84.5	63.6	Tubulin	84.5	Cyclo(RGDyK) (trifluoroacetate)	Cyclo(RGDyK) trifluoroacetate is a potent and selective .a.V.b.3 integrin inhibitor with an IC50 of 20 nM.	True	NCCCC[C@@H]1NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC1=O
247256	247256:04:03_50.00	True	50.0	84	25.9	46.4	12.9	0.0	94.1	0.0	0.0	0.0	0.0	0.0	67.1	0.0	0.0	DNA_Synth	94.1	Deferoxamine mesylate	iron chelator, which does not readily bind iron from transferrin, hemoglobin, myoglobin or cytochrome. Rescues erastin-induced Ferroptosis.	False	CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN
410811	410811:02:02_10.00	True	10.0	66	50.8	0.0	0.0	67.0	0.0	81.8	32.8	58.4	53.7	66.1	0.0	67.9	56.3	HDAC	81.8	Scriptaid	Scriptaid is a potent histone deacetylase (HDAC) inhibitor, used in cancer research. Scriptaid is also a sensitizer to antivirals and has potential for epstein-barr virus (EBV)-associated lymphomas treatment.	False	O=C(CCCCCN1C(=O)c2cccc3cccc(c23)C1=O)NO
245350	245350:01:08_01.00	True	1.0	65	22.8	31.4	41.9	0.0	78.9	0.0	7.2	0.0	0.0	0.0	70.1	0.0	0.0	DNA_Synth	78.9	(S)-(+)-Camptothecin	DNA topoisomerase I inhibitor.	False	CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1
246826	246826:01:07_01.00	True	1.0	100	7.3	0.0	2.2	35.3	0.0	34.6	31.7	45.6	0.0	30.9	0.0	39.3	10.7	LCH	45.6	Mefloquine	heme polymerase inhibitor, antimalarial.	False	OC(c1cc(C(F)(F)F)nc2c(C(F)(F)F)cccc12)C1CCCCN1
247128	247128:01:07_01.00	True	1.0	68	11.2	2.9	0.3	16.7	0.0	19.4	21.0	0.6	48.1	54.2	0.0	35.1	36.0	Protein_Synth	54.2	Digitoxigenin	Na+ K+ ATPase inhibitor.	True	C[C@]12CC[C@H](O)C[C@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](C3=CC(=O)OC3)CC[C@]12O
381944	381944:01:12_01.00	True	1.0	85	27.8	80.3	0.0	0.0	42.9	0.0	25.9	12.8	0.0	0.0	42.0	0.0	25.4	AKT_PI3K_MTOR	80.3	PI-103	PI-103 is a potent PI3K and mTOR inhibitor with IC50s of 8 nM, 88 nM, 48 nM, 150 nM, 20 nM, and 83 nM for p110.a., p110.b., p110.d., p110.g., mTORC1, and mTORC2. PI-103 also inhibits DNA-PK with an IC50 of 2 nM. PI-103 induces autophagy.	False	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1
394120	394120:01:11_01.00	True	1.0	93	13.1	0.0	0.0	41.2	0.0	44.4	40.1	51.1	12.8	47.7	0.0	49.5	22.9	LCH	51.1	Autoquin	Autoquin is an autophagy inhibitor (IC50 = 0.56 µM). It accumulates in lysosomes and inhibits their fusion with autophagosomes. In addition, autoquin sequesters Fe2+ in lysosomes, resulting in an increase of lysosomal reactive oxygen species and ultimately cell death.; Angew. Chem. Int. Ed. Engl. 2020, 59 (14), 5721-5729. https://doi.org/10.1002/anie.201913712	True	C=CC1CN2CCC1CC2[C@@H](O)c1cc(-c2ccc(F)cc2)nc2ccc(OC)cc12
393774	393774:01:13_01.00	True	1.0	88	21.9	0.0	0.0	77.4	0.0	76.4	16.8	83.5	39.1	59.7	0.0	76.1	71.4	LCH	83.5	Vps34-IN-1	Vps34-IN-1 is an inhibitor of Vps34 extracted from patent WO2012085815A1, compound example 16a, with an IC50 of 4 nM. Vps34-IN-1 modulates autophagy.	False	CC(C)(O)CNc1ncc(-c2ccnc(Nc3ccnc(Cl)c3)n2)c(CC2CC2)n1
247108	247108:01:07_01.00	True	1.0	101	17.3	0.0	0.0	56.8	0.0	59.5	34.2	71.0	15.4	43.8	0.0	57.7	38.8	LCH	71.0	Enclomiphene (citrate)	inhibition of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5) (IC50 = 2.226 µM); estrogen agonist/antagonist	False	CCN(CC)CCOc1ccc(/C(=C(/Cl)c2ccccc2)c2ccccc2)cc1
382169	382169:03:06_01.00	True	1.0	75	38.9	20.6	0.0	50.6	0.0	47.7	50.4	70.8	11.5	30.6	0.0	65.0	53.8	LCH	70.8	Ponatinib	Ponatinib (AP24534) is an orally active multi-targeted kinase inhibitor with IC50s of 0.37 nM, 1.1 nM, 1.5 nM, 2.2 nM, and 5.4 nM for Abl, PDGFR.a., VEGFR2, FGFR1, and Src, respectively.	False	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12
392551	392551:02:07_01.00	True	1.0	70	14.2	33.2	33.0	0.0	81.4	0.0	0.0	0.0	0.0	0.0	69.8	0.0	0.0	DNA_Synth	81.4	PHA-793887	PHA-793887 is a pyrrolo[3,4-c]pyrazole that inhibits cyclin-dependent kinases Cdk2/cyclin A, Cdk2/cyclin E, Cdk5/p25, and Cdk7/cyclin H with IC50 values of 8, 8, 5, and 10 nM, respectively. It is more than 6-fold selective for these kinases over Cdk1/cyclin B, Cdk4/cyclin D1, Cdk9/cyclin T, and GSK3ß (IC50s = 60, 62, 138, and 79 nM, respectively). PHA-793887 is cytotoxic to human ovarian A2780, colon HCT116, pancreatic BX-PC3, and leukemic K562, KU812, KCL22, and TOM1 cells both in vitro and in xenograft models. This compound has been examined in patients with solid tumors in phase 1 clinical trials.	False	CC(C)CC(=O)Nc1[nH]nc2c1CN(C(=O)C1CCN(C)CC1)C2(C)C
392660	392660:02:06_01.00	True	1.0	94	21.2	0.0	0.0	60.8	0.0	66.5	42.2	71.9	20.2	42.1	0.0	57.6	49.1	LCH	71.9	NVP-AEW541	NVP-AEW541 is a potent inhibitor of IGF-1R with IC50 of 0.15 uM, also inhibits InsR, with IC50 of 0.14 uM.	False	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1
280897	280897:07:06_01.00	True	1.0	55	51.5	0.0	1.8	76.7	0.0	75.9	28.7	61.1	61.0	56.9	0.0	93.5	52.8	Tubulin	93.5	Rotenone	Rotenone is an mitochondrial electron transport chain complex I inhibitor.  Rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production.	True	C=C(C)[C@H]1Cc2c(ccc3c2O[C@@H]2COc4cc(OC)c(OC)cc4[C@@H]2C3=O)O1
246784	246784:01:10_01.00	True	1.0	96	9.8	0.0	7.0	12.4	0.0	6.0	35.7	22.8	1.4	19.9	0.0	29.7	0.0	HSP90	35.7	Azelastine hydrochloride	H1 antihistamine (nonsedating), leucotriene synthesis blocker.	False	CN1CCCC(n2nc(Cc3ccc(Cl)cc3)c3ccccc3c2=O)CC1
246383	246383:01:13_01.00	True	1.0	92	22.1	0.0	0.0	45.3	0.0	48.9	32.0	71.2	13.6	31.0	0.0	51.8	22.7	LCH	71.2	Itraconazole	inhibits the fungal cytochrome P450 oxidase-mediated synthesis of ergosterol.	False	CCC(C)n1ncn(-c2ccc(N3CCN(c4ccc(OCC5COC(Cn6cncn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)cc2)c1=O
105096	105096:01:09_01.00	False	1.0	90	9.2	0.0	11.5	8.1	0.0	37.9	0.0	4.2	19.6	0.0	0.0	0.0	3.2	HDAC	37.9			False	CN(C)CCCSCCCCCC(=O)C(F)(F)F
381768	381768:01:37_01.00	True	1.0	87	39.2	0.0	14.9	52.7	0.0	46.5	17.5	51.6	16.0	52.4	0.0	66.1	33.8	Tubulin	66.1	Autophinib	Autophinib is a potent, selective autophagy inhibitor with IC50s of 90 nM and 40 nM for starvation- and Rapamycin-induced autophagy, respectively. Autophinib is also an ATP competitive Vacuolar Protein Sorting 34 (VPS34) inhibitor with an IC50 of 19 nM. Autophinib inhibits autophagy induced by starvation or Rapamycin by targeting VPS34.; Angew. Chem. Int. Ed. 2017, 56, 8153	False	Cc1cc(Nc2cc(Cl)nc(Oc3ccc([N+](=O)[O-])cc3)n2)[nH]n1
246579	246579:01:07_01.00	True	1.0	106	18.1	0.0	2.7	15.0	0.0	6.8	32.8	29.7	0.0	19.0	0.0	25.0	0.0	HSP90	32.8	Halofantrine hydrochloride	Halofantrine hydrochloride (SKF-102886) is a blocker of delayed rectifier potassium current via the inhibition of  human-ether-a-go-go-related gene (HERG) channel and a potent antimalarial compound.	False	CCCCN(CCCC)CCC(O)c1cc2c(Cl)cc(Cl)cc2c2cc(C(F)(F)F)ccc12
392705	392705:02:05_01.00	True	1.0	98	18.3	0.0	0.0	48.1	0.0	49.9	50.0	55.5	15.3	40.8	0.0	51.2	40.7	LCH	55.5	JNK-IN-8	JNK-IN-8 (JNK Inhibitor XVI) is a potent JNK inhibitor with IC50s of 4.7 nM, 18.7 nM, and 1 nM for JNK1, JNK2, and JNK3, respectively.	False	Cc1cc(NC(=O)c2cccc(NC(=O)/C=C/CN(C)C)c2)ccc1Nc1nccc(-c2cccnc2)n1
247100	247100:01:12_01.00	True	1.0	99	15.9	0.0	0.0	14.5	13.1	0.9	16.0	27.9	5.8	3.9	1.1	27.8	0.0	LCH	27.9	Dequalinium dichloride	selective blocker of apamin-sensitive K+ channels, Blocker of the apamin-sensitive small conductance Ca2+ activated K+ channel.	False	Cc1cc(N)c2ccccc2[n+]1CCCCCCCCCC[n+]1c(C)cc(N)c2ccccc21
246815	246815:01:12_01.00	True	1.0	98	15.9	0.0	0.0	27.1	0.0	18.1	28.1	41.3	0.0	21.4	0.0	40.6	11.1	LCH	41.3	Aripiprazole	antipsychotic, 5ht2a antagonist.	False	O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
247221	247221:01:09_01.00	True	1.0	60	21.8	0.0	0.0	48.5	0.0	52.4	4.5	31.2	74.1	52.7	0.0	53.3	47.7	Na_K-ATPase	74.1	Lanatoside C	Na+ K+ ATPase inhibitor.	True	CC(=O)O[C@H]1C[C@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@]5(C)[C@H]6C[C@@H](O)[C@]7(C)[C@@H](C8=CC(=O)OC8)CC[C@]7(O)[C@@H]6CC[C@@H]5C4)O[C@@H]3C)O[C@@H]2C)O[C@H](C)[C@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
392728	392728:02:08_01.00	True	1.0	68	29.0	41.0	7.5	0.0	78.0	0.0	29.7	10.2	0.0	0.0	48.8	9.0	0.0	DNA_Synth	78.0	Ro 31-8220 (mesylate)	Ro 31-8220 mesylate is a potent PKC inhibitor, with IC50s of 5, 24, 14, 27, 24 and 23 nM for PKC.a., PKC.b.I, PKC.b.II, PKC.g., PKC.e. and rat brain PKC, respectively. Ro 31-8220 also significantly inhibits MAPKAP-K1b, MSK1, S6K1 and GSK3.b. (IC50s, 3, 8, 15, and 38 nM, respectively), with no effect on MKK3, MKK4, MKK6 and MKK7.	False	Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21
408212	408212:01:06_01.00	True	1.0	94	40.9	0.0	0.0	58.5	0.0	60.0	25.9	75.9	21.8	36.6	0.0	65.2	35.7	LCH	75.9	Deltarasin	Deltarasin is an inhibitor ofKRAS-PDE.d. interaction withKdof 38 nM for binding to purified PDE.d..	True	c1ccc(Cn2c(-c3ccc(OC[C@H](C4CCNCC4)n4c(-c5ccccc5)nc5ccccc54)cc3)nc3ccccc32)cc1
246429	246429:01:09_01.00	True	1.0	101	9.2	0.0	0.0	45.2	0.2	48.1	25.0	68.1	11.4	41.7	0.0	49.2	38.6	LCH	68.1	Quinacrine (dihydrochloride)	Quinacrine (Mepacrine) dihydrochloride is an orally bioavailable antimalarial agent, which possess anticancer effect both in vitro and vivo. Quinacrine dihydrochloride suppresses NF-.k.B and activate p53 signaling, which results in the induction of the apoptosis.	False	CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12
246557	246557:01:07_01.00	True	1.0	80	17.6	0.0	0.0	53.7	0.0	44.7	34.1	49.2	36.8	38.9	0.0	79.8	53.4	Tubulin	79.8	Methiazole	Cytochrome P450 1A2 (AC50 = 501.19 nM), inhibition of Inhibitors of Vif-A3G Interactions	False	COC(=O)Nc1nc2cc(SC(C)C)ccc2[nH]1
246972	246972:01:08_01.00	True	1.0	55	53.5	0.0	35.4	56.6	0.0	64.5	37.7	45.9	52.9	47.9	0.0	82.6	26.0	Tubulin	82.6	Mebendazole	Mebendazole is a highly effective, broad-spectrum antihelmintic indicated for the treatment of nematode infestations; has been found as a hedgehog inhibitor.	False	COC(=O)Nc1nc2cc(C(=O)c3ccccc3)ccc2[nH]1
246688	246688:01:12_01.00	True	1.0	98	10.2	0.0	0.0	48.6	0.0	70.4	14.8	33.1	45.6	32.1	0.0	44.6	55.3	HDAC	70.4	Vorinostat	Vorinostat (SAHA) is a potent and orally active pan-inhibitor of HDAC1, HDAC2 and HDAC3 (Class I), HDAC7 (Class II) and HDAC11 (Class IV), with ID50 values of 10 nM and 20 nM for HDAC1 and HDAC3, respectively. Vorinostat induces cell apoptosis. Vorinostat is also an effective inhibitor of human papillomaviruse (HPV)-18 DNA amplification.; Bradner et al., Chemical Phylogenetics of Histone Deacetylases. Nat. Chem. Biol. 6, 238-43 (2010).	False	O=C(CCCCCCC(=O)Nc1ccccc1)NO
105083	105083:01:13_01.00	False	1.0	101	5.5	0.0	23.9	0.0	13.2	0.0	0.0	0.0	1.1	0.0	22.2	0.0	0.0	Aurora	23.9			False	CN(C)CCCSCCCCCCC(=O)C(F)(F)F
246923	246923:01:06_01.00	True	1.0	101	13.5	0.0	9.1	32.3	0.0	34.5	27.7	47.9	5.8	36.4	0.0	38.9	0.0	LCH	47.9	Ivermectin B1a	Ivermectin B1a, a derivative of Avermectin B1a (HY-15308), is a main component of Ivermectin (HY-15310). Ivermectin (MK-933) is a broad-spectrum anti-parasite agent. Ivermectin is a candidate therapeutic against SARS-CoV-2/COVID-19.	True	CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2
247014	247014:01:07_01.00	True	1.0	105	5.2	0.0	0.1	39.9	0.0	40.9	37.5	36.8	8.9	41.3	0.0	40.0	18.5	Protein_Synth	41.3	Clomipramine hydrochloride, Anafranil hydrochloride, Chloripramine	serotonin reuptake inhibitor, antidepressant, Noradrenaline reuptake inhibitor.	False	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21
280171	280171:03:02_01.00	True	1.0	83	54.7	0.0	0.0	63.7	0.0	61.6	3.0	85.9	26.3	28.4	0.0	67.3	33.6	LCH	85.9	BIX01294 (hydrochloride hydrate)	it is a selective inhibitor of G9a HMTase (IC50 = 1.7 µM). It less effectively inhibits the HMTase G9a-like protein (GLP, IC50 = 38 µM) and has no effect on other known HMTases. BIX01294 has been used in combination with the calcium channel activator BayK8644 to facilitate the generation of induced pluripotent stem cells from somatic cells in vitro.	False	COc1cc2nc(N3CCCN(C)CC3)nc(NC3CCN(Cc4ccccc4)CC3)c2cc1OC
246889	246889:01:09_01.00	True	1.0	91	12.4	0.0	5.2	49.4	0.0	57.0	37.6	48.1	21.6	45.0	0.0	52.9	18.7	HDAC	57.0	Loperamide (hydrochloride)	Loperamide (hydrochloride) (R-18553 (hydrochloride)) is an opioid receptor agonist. Loperamide hydrochloride is a selective and competitive human intestinal carboxylesterases (hiCE) inhibitor. Loperamide hydrochloride has anti-diarrheal effect.	False	CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1
407892	407892:01:05_01.00	True	1.0	94	6.9	5.9	0.0	2.8	1.7	0.0	0.0	0.0	12.4	12.6	12.9	0.0	0.0	Pyrimidine_Synth	12.9	Telaglenastat	Telaglenastat (CB-839) is a first-in-class, selective, reversible and orally active glutaminase 1 (GLS1) inhibitor. Telaglenastat selectively inhibits GLS1 splice variants KGA (kidney-type glutaminase) and GAC (glutaminase C) compared to GLS2. The IC50s are 23 nM and 28 nM for endogenous glutaminase in mouse kidney and brain, respectively. Telaglenastat inudces autophagy and has antitumor activity.	False	O=C(Cc1cccc(OC(F)(F)F)c1)Nc1ccc(CCCCc2nnc(NC(=O)Cc3ccccn3)s2)nn1
246456	246456:01:07_03.00	True	3.0	99	8.5	0.0	8.2	20.2	0.0	16.7	32.7	46.9	0.0	18.8	0.0	33.8	0.0	LCH	46.9	Cisapride	5-HT antagonist.	False	COc1cc(N)c(Cl)cc1C(=O)N[C@H]1CCN(CCCOc2ccc(F)cc2)C[C@H]1OC
104614	104614:02:16_03.00	True	3.0	88	12.8	0.0	0.0	48.6	0.0	53.6	28.0	37.6	28.8	61.1	0.0	81.8	32.5	Tubulin	81.8	Tubulexin A	target the chromosome segregation 1-like protein (CSE1L, CAS, exportin-2) and the vinca alkaloid binding site of a/ß-tubulin.; Angew. Chem. Int. Ed. 2013, 52, 410	False	COc1ccc(CC[C@H]2C[C@@H](OC(C)=O)C[C@@H](c3ccc(OCc4ccccc4)c(O)c3)O2)cc1
245350	245350:01:08_03.00	True	3.0	61	39.2	52.1	8.8	0.0	86.5	0.0	6.6	0.0	0.0	0.0	72.8	0.0	0.0	DNA_Synth	86.5	(S)-(+)-Camptothecin	DNA topoisomerase I inhibitor.	False	CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1
246439	246439:01:07_03.00	True	3.0	106	9.7	14.9	0.0	37.3	0.0	39.5	43.3	61.2	0.0	28.1	0.0	37.9	28.2	LCH	61.2	Lidoflazine	ca 2+ channel activator.	False	Cc1cccc(C)c1NC(=O)CN1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1
108066	108066:02:07_03.00	True	3.0	99	28.5	0.0	0.0	70.9	0.0	74.9	19.8	85.1	33.0	58.5	0.0	70.1	39.8	LCH	85.1	Metergoline	Metergoline is a serotonin (5-HT) receptor and dopamine receptors antagonist, with pKis of 8.64, 8.75 and 8.75 for 5-HT2A, 5-HT2B and 5-HT2C, respectively. Metergoline is a high-affinity ligand for the h5-HT7 receptor, with a Ki of 16 nM. Metergoline also is a reversible neural Na+ channels inhibitor. Metergoline is commonly used for the research of seasonal affective disorder, prolactin hormone regulation.	True	CN1C[C@H](CNC(=O)OCc2ccccc2)C[C@@H]2c3cccc4c3c(cn4C)C[C@H]21
246826	246826:01:07_03.00	True	3.0	101	26.8	0.0	0.0	68.7	0.0	65.2	26.1	76.2	24.6	58.3	0.0	66.1	41.3	LCH	76.2	Mefloquine	heme polymerase inhibitor, antimalarial.	False	OC(c1cc(C(F)(F)F)nc2c(C(F)(F)F)cccc12)C1CCCCN1
247122	247122:01:14_03.00	True	3.0	105	47.5	0.0	0.0	74.4	0.0	76.3	17.6	90.2	29.1	53.7	0.0	69.7	43.6	LCH	90.2	Suloctidil	inhibition of Arachidonate 15-lipoxygenase, type II; inhibition of Aldehyde dehydrogenase 1A1; agonist of Peroxisome proliferator-activated receptor delta	True	CCCCCCCCN[C@H](C)[C@@H](O)c1ccc(SC(C)C)cc1
247128	247128:01:07_03.00	True	3.0	53	42.8	0.0	0.0	62.5	0.0	69.1	2.4	32.8	89.5	71.6	0.0	65.8	48.9	Na_K-ATPase	89.5	Digitoxigenin	Na+ K+ ATPase inhibitor.	True	C[C@]12CC[C@H](O)C[C@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](C3=CC(=O)OC3)CC[C@]12O
381944	381944:01:12_03.00	True	3.0	86	50.8	80.1	0.0	15.2	18.0	19.8	23.1	42.4	0.1	1.9	15.5	9.4	56.8	AKT_PI3K_MTOR	80.1	PI-103	PI-103 is a potent PI3K and mTOR inhibitor with IC50s of 8 nM, 88 nM, 48 nM, 150 nM, 20 nM, and 83 nM for p110.a., p110.b., p110.d., p110.g., mTORC1, and mTORC2. PI-103 also inhibits DNA-PK with an IC50 of 2 nM. PI-103 induces autophagy.	False	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1
245492	245492:01:05_03.00	True	3.0	89	6.0	0.0	0.0	60.3	0.0	77.4	23.2	52.8	34.2	58.5	0.0	77.8	30.5	Tubulin	77.8	Haloperidol	dopamine receptor antagonist, antipsychotic, Dopamine antagonist, antidyskinetic, antipsychotic.	False	O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
394120	394120:01:11_03.00	True	3.0	99	25.7	0.0	0.0	68.4	0.0	68.3	23.8	77.4	29.5	55.7	0.0	65.8	35.6	LCH	77.4	Autoquin	Autoquin is an autophagy inhibitor (IC50 = 0.56 µM). It accumulates in lysosomes and inhibits their fusion with autophagosomes. In addition, autoquin sequesters Fe2+ in lysosomes, resulting in an increase of lysosomal reactive oxygen species and ultimately cell death.; Angew. Chem. Int. Ed. Engl. 2020, 59 (14), 5721-5729. https://doi.org/10.1002/anie.201913712	True	C=CC1CN2CCC1CC2[C@@H](O)c1cc(-c2ccc(F)cc2)nc2ccc(OC)cc12
393774	393774:01:13_03.00	True	3.0	98	66.8	0.0	0.0	80.3	0.0	79.4	12.0	91.6	37.3	62.1	0.0	74.8	59.8	LCH	91.6	Vps34-IN-1	Vps34-IN-1 is an inhibitor of Vps34 extracted from patent WO2012085815A1, compound example 16a, with an IC50 of 4 nM. Vps34-IN-1 modulates autophagy.	False	CC(C)(O)CNc1ncc(-c2ccnc(Nc3ccnc(Cl)c3)n2)c(CC2CC2)n1
247108	247108:01:07_03.00	True	3.0	99	60.6	0.0	0.0	75.9	0.0	75.3	11.4	94.7	33.6	55.5	0.0	67.9	44.2	LCH	94.7	Enclomiphene (citrate)	inhibition of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5) (IC50 = 2.226 µM); estrogen agonist/antagonist	False	CCN(CC)CCOc1ccc(/C(=C(/Cl)c2ccccc2)c2ccccc2)cc1
245391	245391:02:12_03.00	True	3.0	82	49.6	19.9	0.0	57.9	0.0	61.9	26.8	47.0	33.7	71.0	0.0	55.7	79.7	Uncoupler	79.7	Niclosamide	Niclosamide (BAY2353)is an orally bioavailable chlorinated salicylanilide, with anthelmintic and potential antineoplastic activity. Niclosamide (BAY2353) inhibits STAT3 with IC50 of 0.25 uM in HeLa cells and inhibits DNA replication in a cell-free assay.	False	O=C(Nc1ccc([N+](=O)[O-])cc1Cl)c1cc(Cl)ccc1O
246682	246682:01:08_03.00	True	3.0	89	20.6	0.0	0.0	59.2	0.0	61.9	20.6	72.6	19.9	54.3	0.0	68.8	35.1	LCH	72.6	Sertindole	Sertindole, a neuroleptic, is one of the newer antipsychotic medications available.Target: Multi-targetIn vitro studies showed that sertindole exerts a potent antagonism at serotonin 5-HT2A, 5-HT2C, dopamine D2, and .a.l adrenergic receptors. Sertindole offers an alternative treatment option for refractory patients given its good EPS profile, favorable metabolic profile, and comparable efficacy to risperidone. Due to cardiovascular safety concerns, sertindole is available as a second-line choice for patients intolerant to other antipsychotic agents . Sertindole should prove to be a very useful addition to the therapeutic options available for the treatment of psychotic disorders . Sertindole improves negative symptoms, and is also effective for the treatment of neuroleptic-resistant schizophrenia. Sertindole is generally well tolerated and is associated with a low rate of extrapyramidal symptoms (EPS). Thus, sertindole is a useful option in the treatment of patients with schizophrenia .	False	O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1
392551	392551:02:07_03.00	True	3.0	58	38.2	27.2	40.4	0.0	86.6	0.0	0.0	0.0	0.0	0.0	73.8	0.0	0.0	DNA_Synth	86.6	PHA-793887	PHA-793887 is a pyrrolo[3,4-c]pyrazole that inhibits cyclin-dependent kinases Cdk2/cyclin A, Cdk2/cyclin E, Cdk5/p25, and Cdk7/cyclin H with IC50 values of 8, 8, 5, and 10 nM, respectively. It is more than 6-fold selective for these kinases over Cdk1/cyclin B, Cdk4/cyclin D1, Cdk9/cyclin T, and GSK3ß (IC50s = 60, 62, 138, and 79 nM, respectively). PHA-793887 is cytotoxic to human ovarian A2780, colon HCT116, pancreatic BX-PC3, and leukemic K562, KU812, KCL22, and TOM1 cells both in vitro and in xenograft models. This compound has been examined in patients with solid tumors in phase 1 clinical trials.	False	CC(C)CC(=O)Nc1[nH]nc2c1CN(C(=O)C1CCN(C)CC1)C2(C)C
392660	392660:02:06_03.00	True	3.0	102	70.1	0.0	0.0	80.2	0.0	80.5	18.2	94.3	38.7	56.0	0.0	71.5	52.9	LCH	94.3	NVP-AEW541	NVP-AEW541 is a potent inhibitor of IGF-1R with IC50 of 0.15 uM, also inhibits InsR, with IC50 of 0.14 uM.	False	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1
246446	246446:01:07_03.00	True	3.0	86	25.9	0.0	0.0	71.3	0.0	77.5	15.4	72.6	45.0	61.6	0.0	74.4	28.4	HDAC	77.5	Methiothepin maleate	5-HT autoreceptor antagonist.	False	CSc1ccc2c(c1)C(N1CCN(C)CC1)Cc1ccccc1S2
246435	246435:01:06_03.00	True	3.0	103	16.2	0.0	0.0	52.7	0.0	57.8	19.0	86.0	16.0	29.3	0.0	53.0	20.7	LCH	86.0	Amodiaquine (dihydrochloride dihydrate)	Amodiaquine dihydrochloride dihydrate (Amodiaquin dihydrochloride dihydrate), a 4-aminoquinoline class of antimalarial agent, is a potent and orally active histamine N-methyltransferase inhibitor. Amodiaquine dihydrochloride dihydrate is also a Nurr1 agonist and specifically binds to Nurr1-LBD (ligand binding domain) with an EC50 of ~20 uM. Anti-inflammatory effect.	False	CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O
246784	246784:01:10_03.00	True	3.0	92	23.8	0.0	0.0	47.1	0.0	61.4	28.5	49.0	22.4	52.9	0.0	59.5	15.4	HDAC	61.4	Azelastine hydrochloride	H1 antihistamine (nonsedating), leucotriene synthesis blocker.	False	CN1CCCC(n2nc(Cc3ccc(Cl)cc3)c3ccccc3c2=O)CC1
247346	247346:01:08_03.00	True	3.0	105	17.8	0.0	0.0	57.1	0.0	66.9	24.5	73.0	26.1	52.8	0.0	60.1	21.2	LCH	73.0	Raloxifene (hydrochloride)	Raloxifene hydrochloride (Keoxifene hydrochloride) is a  second generationselective and orally active estrogen receptor modulator. Raloxifene hydrochloride produces estrogen-agonistic effects on bone and lipid metabolism and  estrogen-antagonistic effects on uterine endometrium and breast tissue.	False	O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12
246817	246817:01:08_03.00	True	3.0	110	10.4	0.0	0.0	57.1	0.9	56.5	9.4	86.8	14.1	19.5	0.0	56.0	43.4	LCH	86.8	Azithromycin	RNA translation inhibition, antibacterial.	False	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O
394277	394277:01:08_03.00	True	3.0	99	32.6	23.1	0.0	51.2	0.0	49.6	25.8	81.3	3.8	45.5	0.0	54.0	48.0	LCH	81.3	Golvatinib (E7050)	Golvatinib is an inhibitor of c-Met and VEGFR-2 tyrosine kinase with IC50 values of 14nM and 16nM, respectively. The small molecule compound, golvatinib, is a dual inhibitor of both c-Met and VEGFR-2. It is developed as a therapeutic reagent with more potent antitumor activity. Golvatinib inhibits the autophosphorylation of c-Met in MKN45 cells and inhibits the phosphorylation of VEGFR-2 in HUVECs with IC50 values of 14nM and 16nM, respectively. Golvatinib also inhibits the growth of various tumor cells including MKN45, EBC-1, Hs746T and SNU-5. Besides that, golvatinib effectively suppresses the growth induced by HGF or VEGF with IC50 values of 17nM and 84nM.	False	CN1CCN(C2CCN(C(=O)Nc3ccc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)cn3)CC2)CC1
247398	247398:01:08_03.00	True	3.0	102	6.7	27.2	0.0	52.4	0.0	46.3	14.3	71.1	13.3	26.1	0.0	44.5	41.5	LCH	71.1	Salmeterol	Salmeterol (GR33343X) is a potent and selective human .b.2 adrenoceptor agonist. Salmeterol shows potent stimulation of cAMP accumulation in CHO cells expressing human .b.2, .b.1 and .b.3 adrenoceptors with pEC50s of 9.6, 6.1, and 5.9, respectively.	False	OCc1cc(C(O)CNCCCCCCOCCCCc2ccccc2)ccc1O
246383	246383:01:13_03.00	True	3.0	96	73.1	0.0	0.0	79.5	0.0	79.7	16.0	91.0	38.3	66.1	0.0	71.7	53.4	LCH	91.0	Itraconazole	inhibits the fungal cytochrome P450 oxidase-mediated synthesis of ergosterol.	False	CCC(C)n1ncn(-c2ccc(N3CCN(c4ccc(OCC5COC(Cn6cncn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)cc2)c1=O
105096	105096:01:09_03.00	False	3.0	73	36.8	0.0	0.0	58.6	0.0	88.3	27.2	42.1	58.9	53.8	0.0	56.5	57.0	HDAC	88.3			False	CN(C)CCCSCCCCCC(=O)C(F)(F)F
381768	381768:01:37_03.00	True	3.0	77	76.3	0.0	19.0	47.0	2.5	40.8	15.4	52.6	12.3	54.4	0.0	69.2	31.5	Tubulin	69.2	Autophinib	Autophinib is a potent, selective autophagy inhibitor with IC50s of 90 nM and 40 nM for starvation- and Rapamycin-induced autophagy, respectively. Autophinib is also an ATP competitive Vacuolar Protein Sorting 34 (VPS34) inhibitor with an IC50 of 19 nM. Autophinib inhibits autophagy induced by starvation or Rapamycin by targeting VPS34.; Angew. Chem. Int. Ed. 2017, 56, 8153	False	Cc1cc(Nc2cc(Cl)nc(Oc3ccc([N+](=O)[O-])cc3)n2)[nH]n1
247224	247224:01:11_03.00	True	3.0	95	7.3	1.2	0.0	25.9	4.3	23.9	24.6	41.6	0.0	45.7	0.0	43.4	17.3	Protein_Synth	45.7	Avermectin B1a	ligand GABA receptors.	False	CC[C@H](C)[C@H]1O[C@]2(C=C[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)C(O[C@H]3C[C@H](OC)C(O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2
246579	246579:01:07_03.00	True	3.0	91	23.8	0.0	0.0	42.6	0.0	41.9	27.8	58.7	14.6	43.6	0.0	48.1	13.7	LCH	58.7	Halofantrine hydrochloride	Halofantrine hydrochloride (SKF-102886) is a blocker of delayed rectifier potassium current via the inhibition of  human-ether-a-go-go-related gene (HERG) channel and a potent antimalarial compound.	False	CCCCN(CCCC)CCC(O)c1cc2c(Cl)cc(Cl)cc2c2cc(C(F)(F)F)ccc12
246803	246803:01:09_03.00	True	3.0	90	9.0	0.0	3.1	51.2	0.0	66.6	13.6	54.4	34.7	46.3	0.0	67.8	32.8	Tubulin	67.8	Thimerosal	antiinfective, preservative.	False	CC[Hg]Sc1ccccc1C(=O)O
246667	246667:01:09_03.00	True	3.0	92	20.2	0.0	0.0	55.8	0.0	60.2	29.3	81.1	2.2	45.6	0.0	51.5	34.8	LCH	81.1	Imatinib	Imatinib (STI571) is an orally bioavailable tyrosine kinases inhibitor that selectively inhibits BCR/ABL, v-Abl, PDGFR and c-kit kinase activity. Imatinib (STI571) works by binding close to the ATP binding site, locking it in a closed or self-inhibited conformation, therefore inhibiting the enzyme activity of the protein semicompetitively. Imatinib also is an inhibitor of SARS-CoV and MERS-CoV.	False	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1
392705	392705:02:05_03.00	True	3.0	94	69.4	0.0	0.0	76.1	0.0	76.2	27.9	92.2	34.3	58.5	0.0	74.3	52.6	LCH	92.2	JNK-IN-8	JNK-IN-8 (JNK Inhibitor XVI) is a potent JNK inhibitor with IC50s of 4.7 nM, 18.7 nM, and 1 nM for JNK1, JNK2, and JNK3, respectively.	False	Cc1cc(NC(=O)c2cccc(NC(=O)/C=C/CN(C)C)c2)ccc1Nc1nccc(-c2cccnc2)n1
247100	247100:01:12_03.00	True	3.0	86	32.6	0.0	0.0	30.0	0.0	22.9	8.8	36.6	23.8	34.8	0.0	40.3	6.7	Tubulin	40.3	Dequalinium dichloride	selective blocker of apamin-sensitive K+ channels, Blocker of the apamin-sensitive small conductance Ca2+ activated K+ channel.	False	Cc1cc(N)c2ccccc2[n+]1CCCCCCCCCC[n+]1c(C)cc(N)c2ccccc21
246815	246815:01:12_03.00	True	3.0	95	16.2	0.0	0.0	65.3	0.0	68.5	28.0	75.1	25.4	41.7	0.0	64.0	32.6	LCH	75.1	Aripiprazole	antipsychotic, 5ht2a antagonist.	False	O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
392728	392728:02:08_03.00	True	3.0	52	54.6	41.7	11.2	0.0	42.0	0.0	42.3	29.5	0.0	7.2	15.8	28.9	18.6	HSP90	42.3	Ro 31-8220 (mesylate)	Ro 31-8220 mesylate is a potent PKC inhibitor, with IC50s of 5, 24, 14, 27, 24 and 23 nM for PKC.a., PKC.b.I, PKC.b.II, PKC.g., PKC.e. and rat brain PKC, respectively. Ro 31-8220 also significantly inhibits MAPKAP-K1b, MSK1, S6K1 and GSK3.b. (IC50s, 3, 8, 15, and 38 nM, respectively), with no effect on MKK3, MKK4, MKK6 and MKK7.	False	Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21
247028	247028:01:06_03.00	True	3.0	105	15.0	0.0	0.0	72.8	0.0	74.3	6.5	83.3	40.5	48.6	0.0	66.2	28.8	LCH	83.3	Spiperone	D2 antagonist, antipsychotic.	False	O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccc(F)cc1
247000	247000:01:07_03.00	True	3.0	99	15.0	0.0	4.3	66.7	0.0	71.1	15.8	80.3	20.9	46.0	0.0	64.6	19.1	LCH	80.3	Nortriptyline (hydrochloride)	Nortriptyline hydrochloride (Desmethylamitriptyline hydrochloride) is a tricyclic antidepressant and the main active metabolite of Amitriptyline, and used to relieve the symptoms of depression.	False	CNCCC=C1c2ccccc2CCc2ccccc21
246429	246429:01:09_03.00	True	3.0	88	52.0	10.3	0.0	40.2	34.6	39.2	1.5	80.4	3.9	11.2	0.0	48.7	26.5	LCH	80.4	Quinacrine (dihydrochloride)	Quinacrine (Mepacrine) dihydrochloride is an orally bioavailable antimalarial agent, which possess anticancer effect both in vitro and vivo. Quinacrine dihydrochloride suppresses NF-.k.B and activate p53 signaling, which results in the induction of the apoptosis.	False	CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12
246466	246466:01:07_03.00	True	3.0	102	42.1	0.0	0.0	63.9	0.0	70.5	19.5	87.4	25.0	45.6	0.0	63.8	26.5	LCH	87.4	Terconazole	sterol 14-demethylase inhibitor.	False	CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1
246688	246688:01:12_03.00	True	3.0	73	52.8	0.0	0.0	85.1	0.0	97.3	19.4	67.5	65.7	67.9	0.0	77.3	69.9	HDAC	97.3	Vorinostat	Vorinostat (SAHA) is a potent and orally active pan-inhibitor of HDAC1, HDAC2 and HDAC3 (Class I), HDAC7 (Class II) and HDAC11 (Class IV), with ID50 values of 10 nM and 20 nM for HDAC1 and HDAC3, respectively. Vorinostat induces cell apoptosis. Vorinostat is also an effective inhibitor of human papillomaviruse (HPV)-18 DNA amplification.; Bradner et al., Chemical Phylogenetics of Histone Deacetylases. Nat. Chem. Biol. 6, 238-43 (2010).	False	O=C(CCCCCCC(=O)Nc1ccccc1)NO
105083	105083:01:13_03.00	False	3.0	81	32.6	0.0	0.0	51.1	0.0	79.8	23.2	41.3	45.9	48.7	0.0	51.3	56.9	HDAC	79.8			False	CN(C)CCCSCCCCCCC(=O)C(F)(F)F
246923	246923:01:06_03.00	True	3.0	99	9.3	0.0	0.0	55.9	0.0	54.0	9.3	58.0	24.8	55.7	0.0	70.7	29.0	Tubulin	70.7	Ivermectin B1a	Ivermectin B1a, a derivative of Avermectin B1a (HY-15308), is a main component of Ivermectin (HY-15310). Ivermectin (MK-933) is a broad-spectrum anti-parasite agent. Ivermectin is a candidate therapeutic against SARS-CoV-2/COVID-19.	True	CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2
280171	280171:03:02_03.00	True	3.0	81	81.2	0.0	0.0	66.2	0.0	62.4	0.0	82.7	26.5	44.3	0.0	67.4	41.7	LCH	82.7	BIX01294 (hydrochloride hydrate)	it is a selective inhibitor of G9a HMTase (IC50 = 1.7 µM). It less effectively inhibits the HMTase G9a-like protein (GLP, IC50 = 38 µM) and has no effect on other known HMTases. BIX01294 has been used in combination with the calcium channel activator BayK8644 to facilitate the generation of induced pluripotent stem cells from somatic cells in vitro.	False	COc1cc2nc(N3CCCN(C)CC3)nc(NC3CCN(Cc4ccccc4)CC3)c2cc1OC
247027	247027:01:06_03.00	True	3.0	108	22.5	0.0	0.0	72.4	0.0	73.9	2.7	82.0	37.0	61.0	0.0	64.0	36.2	LCH	82.0	Perhexiline maleate	Ca2+ blocking agent, coronary vasodilator.	False	C1CCC(C(CC2CCCCN2)C2CCCCC2)CC1
246514	246514:01:10_03.00	True	3.0	97	34.5	0.0	0.0	82.5	0.0	80.9	26.1	67.8	48.8	74.6	0.0	80.7	62.7	BET	82.5	Fluvastatin sodium salt	HMG CoA reductase inhibitor.	True	CC(C)n1c(/C=C/[C@H](O)C[C@H](O)CC(=O)O)c(-c2ccc(F)cc2)c2ccccc21
246889	246889:01:09_03.00	True	3.0	103	30.1	0.0	0.0	51.2	0.0	56.9	36.1	73.2	6.0	42.7	0.0	61.8	25.5	LCH	73.2	Loperamide (hydrochloride)	Loperamide (hydrochloride) (R-18553 (hydrochloride)) is an opioid receptor agonist. Loperamide hydrochloride is a selective and competitive human intestinal carboxylesterases (hiCE) inhibitor. Loperamide hydrochloride has anti-diarrheal effect.	False	CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1
246628	246628:01:07_03.00	True	3.0	97	11.2	0.0	0.0	64.3	0.0	73.6	24.1	72.0	28.3	59.1	0.0	72.2	33.6	HDAC	73.6	Zuclopenthixol hydrochloride	antagonist at D1 and D2 dopamine receptors; inhibitory activity against Geminin, Aberrant vpr protein (HIV), Glucagon-like peptide 1 receptor, (Plasmodium falciparum)	False	OCCN1CCN(CC/C=C2/c3ccccc3Sc3ccc(Cl)cc32)CC1
407892	407892:01:05_03.00	True	3.0	102	19.3	0.0	0.0	65.9	0.0	67.3	10.2	71.9	30.6	52.1	0.0	68.5	42.5	LCH	71.9	Telaglenastat	Telaglenastat (CB-839) is a first-in-class, selective, reversible and orally active glutaminase 1 (GLS1) inhibitor. Telaglenastat selectively inhibits GLS1 splice variants KGA (kidney-type glutaminase) and GAC (glutaminase C) compared to GLS2. The IC50s are 23 nM and 28 nM for endogenous glutaminase in mouse kidney and brain, respectively. Telaglenastat inudces autophagy and has antitumor activity.	False	O=C(Cc1cccc(OC(F)(F)F)c1)Nc1ccc(CCCCc2nnc(NC(=O)Cc3ccccn3)s2)nn1
245372	245372:01:05_03.00	True	3.0	91	10.7	0.0	0.0	77.5	0.0	78.6	18.4	87.0	40.3	52.6	0.0	75.8	43.0	LCH	87.0	Perphenazine	Perphenazine is a typical antipsychotic drug, inhibits 5-HT2Areceptor, Alpha-1A adrenergic receptor, Dopamine receptor D2/D3, D2L receptor, and Histamine H1 receptor, with Ki values of 5.6, 10, 0.765/0.13, 3.4, and 8 nM, respectively.	False	OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1
246464	246464:01:07_03.00	True	3.0	105	8.6	0.0	0.0	71.7	0.0	67.9	10.5	84.5	18.4	39.3	0.0	63.5	36.8	LCH	84.5	Metixene hydrochloride hydrate	Metixene hydrochloride hydrate is an anticholinergic antiparkinsonian agent, potently inhibits binding of quinuclidinyl benzilate (QNB) to the muscarinic receptor in rat brain cortical tissue, with an IC50 of 55 nM and a Kd of 15 nM.	False	CN1CCCC(CC2c3ccccc3Sc3ccccc32)C1
246861	246861:01:12_03.00	True	3.0	100	19.2	0.0	0.0	57.9	0.0	59.6	25.2	78.4	17.1	40.7	0.0	62.7	21.0	LCH	78.4	Astemizole	Astemizole (R 43512), a second-generation antihistamine drug to diminish allergic symptoms with a long duration of action, is a histamine H1-receptor antagonist, with an IC50 of 4 nM. Astemizole also shows potent hERG K+ channel blocking activity with an IC50 of 0.9 nM. Astemizole has antipruritic effects.	False	COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1
247097	247097:02:09_01.00	True	1.0	53	51.1	51.8	21.1	0.0	83.8	0.0	6.1	0.0	0.0	0.0	84.4	0.0	0.0	Pyrimidine_Synth	84.4	Mitoxantrone (dihydrochloride)	Mitoxantrone dihydrochloride is a topoisomerase II inhibitor; also inhibits protein kinase C (PKC) activity with an IC50 of 8.5 uM.	False	O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21
351488	351488:03:10_01.00	True	1.0	97	18.3	73.6	0.0	0.0	49.8	0.0	35.3	32.0	0.0	0.0	43.4	0.0	16.2	AKT_PI3K_MTOR	73.6	MK-2206 (dihydrochloride)	MK-2206 dihydrochloride (MK-2206 (2HCl)) is an orally active allosteric AKT inhibitor with IC50s of 5 nM, 12 nM, and 65 nM for AKT1, AKT2, and AKT3, respectively. MK-2206 dihydrochloride induces autophagy.	False	NC1(c2ccc(-c3nc4ccn5c(O)nnc5c4cc3-c3ccccc3)cc2)CCC1
407863	407863:01:06_01.00	True	1.0	98	29.5	0.0	0.0	68.7	0.0	69.0	11.1	88.1	30.8	48.2	0.0	71.4	35.8	LCH	88.1	AZ82	AZ82 is a selective kinesin-like protein KIFC1 (HSET/KIFC1) inhibitor, with a Ki of 43 nM and an IC50 of 300 nM for KIFC1.	True	CCCc1cc(C(=O)N[C@H](Cc2ccc(-c3cccc(OC(F)(F)F)c3)nc2)C(=O)N[C@@H]2CCNC2)sc1C
347246	347246:01:08_01.00	True	1.0	94	44.7	0.0	0.0	78.2	0.0	74.7	4.2	90.3	39.4	52.0	0.0	72.1	39.2	LCH	90.3	SB 216641	5-HT1B antagonist.	False	COc1ccc(NC(=O)c2ccc(-c3ccc(-c4noc(C)n4)cc3C)cc2)cc1OCCN(C)C
344315	344315:01:05_01.00	False	1.0	96	0.3	0.0	0.0	31.0	0.0	28.2	6.7	19.6	19.5	63.5	0.0	30.2	30.0	Protein_Synth	63.5			False	O=C1NCc2ccccc2CN[C@@H](CO)C/C=C/COc2ccccc2CO1
246295	246295:01:17_01.00	True	1.0	97	8.8	0.0	0.0	39.9	0.0	35.4	27.8	41.7	19.9	34.1	0.0	48.8	15.8	Tubulin	48.8	Alexidine dihydrochloride	detergent.	False	CCCCC(CC)CNC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NCC(CC)CCCC
280128	280128:01:07_01.00	True	1.0	101	27.1	0.0	0.0	72.0	0.0	71.2	18.0	91.6	26.7	39.9	0.0	71.1	36.1	LCH	91.6	U-73343	inactive analog of U73122 (Rack 16, Well D06).	False	COc1ccc2c(c1)CCC1C2CC[C@@]2(C)C1CC[C@@H]2NCCCCCCN1C(=O)CCC1=O
280918	280918:01:08_01.00	True	1.0	92	16.6	0.0	0.0	62.5	0.0	60.1	5.8	89.3	14.9	36.2	0.0	63.1	36.6	LCH	89.3	Cortexolone maleate	D2 dopamine receptor antagonist.	False	COc1ccccc1N1CCN(CCCCNS(=O)(=O)c2cccc3c(N(C)C)cccc23)CC1
392895	392895:01:08_01.00	True	1.0	100	21.6	85.7	0.0	0.0	63.2	0.0	31.1	0.0	0.0	0.0	67.9	0.0	0.0	AKT_PI3K_MTOR	85.7	GSK2334470	GSK2334470 is a highly specific and potent inhibitor of PDK1 (3-Phosphoinositide dependent protein kinase-1). GSK2334470 can be used in cells to ablate T-loop phosphorylation and activate SGK, S6K1 and RSK as well as suppress the activation of Akt.	True	CNc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2C[C@@H](C(=O)NC3CCCCC3)CC[C@H]2C)n1
392897	392897:01:10_01.00	True	1.0	93	25.6	89.9	0.0	0.0	61.5	0.0	37.3	2.8	0.0	0.0	54.1	0.0	21.5	AKT_PI3K_MTOR	89.9	BAY 80-6946, Copanlisib	BAY 80-6946 (Copanlisib) is a potent and highly selective reversible PI3K inhibitor for PI3Ka/ß with IC50 of 0.469 nM/3.72 nM. BAY 80-6946 is a phosphoinositide 3-kinase (PI3K) inhibitor with potential antineoplastic activity. BAY 86-9766 inhibits proliferation with IC50 of 147 nM in HuCCT-1 (KRASG12D ) and 137 nM in EGI-1 (KRASG12D ) cell lines. BAY 80-6946 is generally well tolerated through the MTD (maximum tolerated dose) of 0.8 mg/kg. PK (pharmacokinetics) results support weekly dosing. Grade 2/3 hyperglycemia in the first 24 hrs after receiving a dose is common at the MTD. PK, clinical SD and FDG-PET data are consistent with effective exposure and PI3K pathway inhibition.	False	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21
407879	407879:01:06_01.00	True	1.0	95	5.2	50.8	0.0	0.0	0.0	4.6	46.6	0.0	0.0	13.2	18.0	0.0	35.2	AKT_PI3K_MTOR	50.8	RSL3	RSL3 ((1S,3R)-RSL3) is an inhibitor of glutathione peroxidase 4 (GPX4) (ferroptosis activator), reduces the expression of GPX4 protein, and induces ferroptotic death of head and neck cancer cell. RSL3 increases the expression of p62 and Nrf2 and inactivates Keap1 in HN3-rslR cells.	True	COC(=O)c1ccc([C@H]2c3[nH]c4ccccc4c3C[C@H](C(=O)OC)N2C(=O)CCl)cc1
246739	246739:01:09_01.00	True	1.0	102	14.0	0.0	0.0	67.3	0.0	60.6	2.7	89.6	22.4	32.2	0.0	65.6	40.1	LCH	89.6	Sertraline	5-HT uptake inhibitor.	True	CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21
382156	382156:02:12_01.00	True	1.0	100	6.6	0.0	3.1	58.5	0.0	49.4	0.0	31.0	52.7	53.1	0.0	61.1	23.0	Tubulin	61.1	CHIR-99021	CHIR-99021 (CT99021) is a potent and selective GSK-3.a./.b. inhibitor with IC50s of 10 nM and 6.7 nM. CHIR-99021 shows >500-fold selectivity for GSK-3 over CDC2, ERK2 and other protein kinases. CHIR-99021 is also a potent Wnt/.b.-catenin signaling pathway activator. CHIR-99021 enhances mouse and human embryonic stem cells self-renewal. CHIR-99021 induces autophagy.	False	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1
280346	280346:01:10_01.00	True	1.0	62	77.5	0.0	0.0	82.0	0.0	78.1	26.2	64.3	56.4	68.2	0.0	80.1	81.9	BET	82.0	Brefeldin A from Penicillium brefeldianum, BFA, Ascotoxin, Cyanein	fungal metabolite that disrupts the structure and function of the Golgi apparatus.	False	C[C@H]1CCC/C=C/C2C[C@H](O)C[C@@]2(O)C/C=C/C(=O)O1
280606	280606:01:07_01.00	True	1.0	96	6.2	0.0	0.0	44.4	0.0	42.9	10.1	24.1	35.8	55.9	0.0	58.0	21.3	Tubulin	58.0	Fenretinide	Fenretinide (4-HPR) is a synthetic retinoid deriverative, binding to the retinoic acid receptors (RAR) at concentrations necessary to induce cell death.	False	CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)Nc2ccc(O)cc2)C(C)(C)CCC1
280538	280538:01:09_01.00	True	1.0	93	10.0	43.3	41.9	0.0	79.0	0.0	2.4	0.0	0.0	0.0	73.5	0.0	0.0	DNA_Synth	79.0	Ellipticine	cytochrome P450 (CYP1A1)and DNA topoisomerase II inhibitor.	False	Cc1c2ccncc2c(C)c2c1[nH]c1ccccc12
280735	280735:01:07_01.00	True	1.0	98	11.7	25.6	0.0	41.8	0.0	31.1	15.1	38.3	30.0	8.3	0.0	65.2	60.8	Tubulin	65.2	2-methoxyestradiol	inhibitor of angiogenesis and endothelial cell proliferation.	False	COc1cc2c(cc1O)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12
280470	280470:01:09_01.00	True	1.0	98	9.0	0.0	32.3	0.0	0.0	0.0	0.0	0.0	22.2	0.0	26.7	0.0	0.0	Aurora	32.3	Dihydroouabain	sodium-potassium pump inhibitor.	False	C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@@H]4C(CC[C@]3(O)C2)[C@@]2(O)CC[C@H](C3COC(=O)C3)[C@@]2(C)C[C@H]4O)[C@H](O)[C@H](O)[C@H]1O
280575	280575:01:09_01.00	True	1.0	99	40.9	0.0	0.0	68.7	0.0	68.4	11.8	90.9	22.0	41.0	0.0	65.5	33.4	LCH	90.9	GR 127935 hydrochloride	selective 5-HT1B/1D serotonin receptor antagonist.	False	COc1ccc(NC(=O)c2ccc(-c3ccc(-c4noc(C)n4)cc3C)cc2)cc1N1CCN(C)CC1
280630	280630:01:11_01.00	True	1.0	91	12.1	16.2	0.0	50.1	0.0	38.3	13.0	43.8	31.2	36.1	0.0	79.1	68.4	Tubulin	79.1	IC261	IC261 is a selective, ATP-competitive CK1 inhibitor, with IC50s of 1 uM, 1 uM, 16 uM for Cki.d., Cki.e. and Cki.a.1, respectively.	False	COc1cc(OC)c(/C=C2/C(=O)Nc3ccccc32)c(OC)c1
280946	280946:03:06_01.00	True	1.0	71	36.3	10.8	0.0	6.7	26.3	4.4	28.1	27.4	6.4	25.0	0.7	21.1	0.0	HSP90	28.1	Sanguinarine chloride	inhibitor of Mg2+ and Na+/K+-ATPase, isolated from the leaves and stems of Macleaya cordata and microcarpa.	False	C[n+]1cc2c3c(ccc2c2ccc4cc5c(cc4c21)OCO5)OCO3
247369	247369:02:05_01.00	True	1.0	108	29.9	0.0	0.0	66.4	0.0	65.7	10.1	92.8	22.5	20.5	0.0	62.0	30.9	LCH	92.8	Fluspirilene	Fluspirilene is a non-competitive antagonist of L-type calcium channels with an IC50 of 0.03 uM. Fluspirileneis a long-acting injectable depot antipsychotic drug used for schizophrenia.	False	O=C1NCN(c2ccccc2)C12CCN(CCCC(c1ccc(F)cc1)c1ccc(F)cc1)CC2
245325	245325:03:08_01.00	True	1.0	106	8.1	0.0	0.0	33.0	0.0	28.4	34.5	47.3	0.1	20.6	0.0	39.6	5.6	LCH	47.3	Reserpine, Methyl reserpate	inhibits vesicular catecholine and serotonin uptake, antihypertensive.	False	COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC
246314	246314:01:11_01.00	True	1.0	95	77.5	0.0	0.0	72.8	0.0	74.3	26.3	71.9	41.3	65.2	0.0	72.7	65.6	HDAC	74.3	Monensin A sodium salt, Rumensin, Coban 45	it is a naturally occuring ionophorous antibiotic that preferentially forms complexes with monovalent cations to enable transport across lipid membranes. Through its ability to affect pH and the sodium-potassium balance of a cell, monensin can induce cell death in Gram-positive bacteria such as Micrococcus, Bacillus, and Staphylococcus (MICs = 1-12.5 µg/ml), reduce proliferation of P. falciparum and Coccicdium protozoa, and also prevent replication of certain viruses.	True	CC[C@@]1([C@@H]2O[C@@H]([C@H]3O[C@@](O)(CO)[C@H](C)C[C@@H]3C)C[C@@H]2C)CC[C@H]([C@]2(C)CC[C@]3(C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H](OC)[C@H](C)C(=O)O)O3)O2)O1
280921	280921:01:13_01.00	True	1.0	98	9.2	14.0	44.6	0.0	73.6	0.0	4.5	0.0	0.0	0.0	66.5	0.0	0.0	DNA_Synth	73.6	SU 9516	cylcin-dependent kinase-2 (Cdk-2) inhibitor, induces apoptosis in colon cancer cells.	False	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2
246994	246994:01:07_01.00	True	1.0	58	65.8	0.0	0.0	78.5	0.0	75.7	24.3	62.9	62.4	67.7	0.0	95.1	58.8	Tubulin	95.1	Albendazole	anthelmintic.	False	CCCSc1ccc2[nH]c(NC(=O)OC)nc2c1
280942	280942:01:05_01.00	True	1.0	103	7.8	6.5	0.0	69.9	0.0	59.2	19.6	76.8	16.9	51.2	0.0	71.2	59.1	LCH	76.8	Salmeterol (xinafoate)	beta2 Adrenoceptor agonist.	False	OCc1cc(C(O)CNCCCCCCOCCCCc2ccccc2)ccc1O
246732	246732:01:10_01.00	True	1.0	69	44.4	4.2	9.8	0.0	55.1	0.0	15.9	16.2	7.8	11.5	15.7	15.1	0.0	DNA_Synth	55.1	Pyrvinium pamoate	metabolic inhibitor.	False	Cc1cc(/C=C/c2ccc3cc(N(C)C)ccc3[n+]2C)c(C)n1-c1ccccc1
394207	394207:01:09_01.00	True	1.0	96	33.2	0.0	0.0	60.5	0.0	51.0	25.3	65.4	27.0	47.9	0.0	79.6	47.5	Tubulin	79.6	HTH-01-015	HTH-01-015 is a selective NUAK1/ARK5 inhibitor (IC50 is 100 nM). HTH-01-015 inhibits NUAK1 with >100-fold higher potency than NUAK2 (IC50 of >10 uM).	False	Cc1nc(Nc2cnn(C3CCNCC3)c2)nc2c1N(C)C(=O)c1cc3ccccc3cc1N2C
246459	246459:01:16_01.00	True	1.0	52	53.0	61.8	0.0	0.0	88.6	0.0	23.8	0.0	0.0	0.0	59.0	0.0	2.2	DNA_Synth	88.6	Daunorubicin hydrochloride	DNA intercaling.	False	COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1
351488	351488:03:10_03.00	True	3.0	98	36.8	35.2	0.0	48.4	3.1	52.5	33.8	81.2	10.5	28.6	0.0	48.9	53.7	LCH	81.2	MK-2206 (dihydrochloride)	MK-2206 dihydrochloride (MK-2206 (2HCl)) is an orally active allosteric AKT inhibitor with IC50s of 5 nM, 12 nM, and 65 nM for AKT1, AKT2, and AKT3, respectively. MK-2206 dihydrochloride induces autophagy.	False	NC1(c2ccc(-c3nc4ccn5c(O)nnc5c4cc3-c3ccccc3)cc2)CCC1
280660	280660:01:06_03.00	True	3.0	108	5.2	0.0	0.0	75.0	0.0	71.1	18.9	76.8	38.1	42.0	0.0	65.8	34.9	LCH	76.8	L-703,606, oxalate	potent and selective non-peptide NK-1 tachykinin receptor antagonist.	False	Ic1ccccc1CNC1C2CCN(CC2)C1C(c1ccccc1)c1ccccc1
407863	407863:01:06_03.00	True	3.0	93	58.4	0.0	0.0	74.5	0.0	74.3	34.2	88.7	25.4	58.0	0.0	75.6	54.9	LCH	88.7	AZ82	AZ82 is a selective kinesin-like protein KIFC1 (HSET/KIFC1) inhibitor, with a Ki of 43 nM and an IC50 of 300 nM for KIFC1.	True	CCCc1cc(C(=O)N[C@H](Cc2ccc(-c3cccc(OC(F)(F)F)c3)nc2)C(=O)N[C@@H]2CCNC2)sc1C
246332	246332:01:09_03.00	True	3.0	101	9.5	0.0	0.0	54.7	0.0	56.8	29.8	79.6	15.1	26.1	0.0	51.1	26.8	LCH	79.6	Dilazep dihydrochloride	adenosine uptake inhibitor.	False	COc1cc(C(=O)OCCCN2CCCN(CCCOC(=O)c3cc(OC)c(OC)c(OC)c3)CC2)cc(OC)c1OC
344315	344315:01:05_03.00	False	3.0	99	1.4	50.8	0.0	0.0	55.0	0.0	0.0	0.0	0.0	5.3	50.5	0.0	0.0	DNA_Synth	55.0			False	O=C1NCc2ccccc2CN[C@@H](CO)C/C=C/COc2ccccc2CO1
247042	247042:02:05_03.00	True	3.0	101	30.7	0.0	0.0	55.8	0.0	55.4	26.9	81.8	11.8	20.9	0.0	50.6	24.5	LCH	81.8	Pimozide	Ca2+ channel antagonist, antipsychotic, D2 dopamine receptor antagonist, Dopamine antagonist ?.	False	O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1
246295	246295:01:17_03.00	True	3.0	86	33.2	0.0	0.0	31.6	3.1	21.8	0.0	7.9	25.0	56.8	0.0	38.1	43.6	Protein_Synth	56.8	Alexidine dihydrochloride	detergent.	False	CCCCC(CC)CNC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NCC(CC)CCCC
280128	280128:01:07_03.00	True	3.0	94	59.9	0.0	0.0	78.5	0.0	76.1	17.6	96.2	33.8	54.6	0.0	73.8	52.5	LCH	96.2	U-73343	inactive analog of U73122 (Rack 16, Well D06).	False	COc1ccc2c(c1)CCC1C2CC[C@@]2(C)C1CC[C@@H]2NCCCCCCN1C(=O)CCC1=O
280918	280918:01:08_03.00	True	3.0	96	37.7	0.0	0.0	72.8	0.0	71.9	9.9	96.9	29.1	39.8	0.0	65.4	44.0	LCH	96.9	Cortexolone maleate	D2 dopamine receptor antagonist.	False	COc1ccccc1N1CCN(CCCCNS(=O)(=O)c2cccc3c(N(C)C)cccc23)CC1
392895	392895:01:08_03.00	True	3.0	86	32.8	84.0	0.0	0.0	71.2	0.0	40.5	0.0	0.0	0.0	69.1	0.0	0.0	AKT_PI3K_MTOR	84.0	GSK2334470	GSK2334470 is a highly specific and potent inhibitor of PDK1 (3-Phosphoinositide dependent protein kinase-1). GSK2334470 can be used in cells to ablate T-loop phosphorylation and activate SGK, S6K1 and RSK as well as suppress the activation of Akt.	True	CNc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2C[C@@H](C(=O)NC3CCCCC3)CC[C@H]2C)n1
283253	283253:01:06_03.00	True	3.0	95	5.4	0.7	0.0	46.0	13.1	40.4	8.6	77.0	0.0	15.9	0.0	54.8	33.6	LCH	77.0	Spiramycin I,Spiramycin II and, Spiramycin III	compound mixture, Ribosomal protein synthesis inhibitor.	True	CCC(=O)O[C@@H]1CC(=O)O[C@H](C)C/C=C/C=C/[C@H](OC2CCC(N(C)C)C(C)O2)[C@H](C)C[C@H](CC=O)[C@H](OC2OC(C)C(OC3CC(C)(O)C(O)C(C)O3)C(N(C)C)C2O)[C@H]1OC
392897	392897:01:10_03.00	True	3.0	84	51.5	93.5	0.0	0.0	69.2	0.0	16.3	0.0	0.0	0.0	62.6	0.0	12.9	AKT_PI3K_MTOR	93.5	BAY 80-6946, Copanlisib	BAY 80-6946 (Copanlisib) is a potent and highly selective reversible PI3K inhibitor for PI3Ka/ß with IC50 of 0.469 nM/3.72 nM. BAY 80-6946 is a phosphoinositide 3-kinase (PI3K) inhibitor with potential antineoplastic activity. BAY 86-9766 inhibits proliferation with IC50 of 147 nM in HuCCT-1 (KRASG12D ) and 137 nM in EGI-1 (KRASG12D ) cell lines. BAY 80-6946 is generally well tolerated through the MTD (maximum tolerated dose) of 0.8 mg/kg. PK (pharmacokinetics) results support weekly dosing. Grade 2/3 hyperglycemia in the first 24 hrs after receiving a dose is common at the MTD. PK, clinical SD and FDG-PET data are consistent with effective exposure and PI3K pathway inhibition.	False	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21
247050	247050:03:07_03.00	True	3.0	98	7.6	0.0	0.0	80.7	0.0	76.5	9.1	86.8	39.9	49.3	0.0	70.7	43.0	LCH	86.8	Fluphenazine dihydrochloride	dopamine receptor antagonist, antipsychotic, Dopamine antagonist, h1 antihistamine.	False	OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1
280861	280861:01:10_03.00	True	3.0	99	21.1	0.0	0.0	79.1	0.0	78.8	29.6	85.8	29.0	58.9	0.0	76.1	51.2	LCH	85.8	Prochlorperazine dimaleate	antipsychotic agent, used in the treatment of spastic gastrointestinal disorders.	False	CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1
407879	407879:01:06_03.00	True	3.0	74	26.6	46.9	0.0	4.3	21.7	15.1	68.4	19.5	0.0	48.4	10.1	21.6	43.3	HSP90	68.4	RSL3	RSL3 ((1S,3R)-RSL3) is an inhibitor of glutathione peroxidase 4 (GPX4) (ferroptosis activator), reduces the expression of GPX4 protein, and induces ferroptotic death of head and neck cancer cell. RSL3 increases the expression of p62 and Nrf2 and inactivates Keap1 in HN3-rslR cells.	True	COC(=O)c1ccc([C@H]2c3[nH]c4ccccc4c3C[C@H](C(=O)OC)N2C(=O)CCl)cc1
392740	392740:02:07_03.00	True	3.0	86	7.8	33.2	0.0	35.3	1.1	37.1	34.0	64.7	3.1	15.2	0.0	37.2	37.8	LCH	64.7	WZ4003	WZ4003 is the first potent and highly specific NUAK kinase inhibitor with IC50 of 20 nM/100 nM for NUAK1 (ARK5)/NUAK2, without significant inhibition on other 139 kinases.	False	CCC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)ncc2Cl)c1
245352	245352:03:14_03.00	True	3.0	90	51.5	0.0	0.0	82.1	0.0	76.6	11.1	59.3	55.5	77.9	0.0	83.1	47.0	Tubulin	83.1	Cantharidin	protein phosphatases inhibitor.	False	C[C@]12C(=O)OC(=O)[C@@]1(C)[C@@H]1CC[C@H]2O1
280718	280718:01:10_03.00	True	3.0	103	24.4	0.0	0.0	72.0	0.0	68.0	21.4	92.4	23.5	45.0	0.0	69.6	51.4	LCH	92.4	Metergoline	5-HT1/5-HT2 Serotonin receptor antagonist, analgesic, antipyretic.	False	CN1C[C@H](CNC(=O)OCc2ccccc2)C[C@@H]2c3cccc4c3c(cn4C)C[C@H]21
247256	247256:01:06_03.00	True	3.0	91	21.4	38.3	19.4	0.0	91.8	0.0	0.0	0.0	0.0	0.0	81.8	0.0	0.0	DNA_Synth	91.8	Deferoxamine mesylate	iron chelator, which does not readily bind iron from transferrin, hemoglobin, myoglobin or cytochrome. Rescues erastin-induced Ferroptosis.	False	CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN
408038	408038:01:08_03.00	True	3.0	101	8.8	22.5	0.0	51.1	0.0	56.2	33.5	66.6	17.9	47.9	0.0	46.6	53.8	LCH	66.6		MGH-CP1 is a potent and selective inhibitor of transcriptional enhanced associate domain (TEAD) palmitoylation. MGH-CP1 exhibits dose-dependent and potent inhibition of TEAD2/4 auto-palmitoylation in vitro with IC50 of 710 nM and 672 nM, respectively.	False	O=C(CSc1nc[nH]n1)Nc1ccc(C23CC4CC(CC(C4)C2)C3)cc1
350306	350306:01:04_03.00	True	3.0	97	43.9	0.0	0.0	72.3	0.0	71.8	9.0	95.9	32.1	35.3	0.0	67.0	41.7	LCH	95.9	SAG	SAG is a potent Smoothened (Smo) receptor agonist (EC50=3 nM; Kd=59 nM). SAG activates the Hedgehog signaling pathway and counteracts Cyclopamine (HY-17024) inhibition of Smo.	False	CN[C@H]1CC[C@H](N(Cc2cccc(-c3ccncc3)c2)C(=O)c2sc3ccccc3c2Cl)CC1
280729	280729:01:10_03.00	True	3.0	97	10.5	0.0	0.0	70.4	0.0	65.2	32.2	80.2	13.9	60.5	0.0	68.3	55.0	LCH	80.2	Mibefradil dihydrochloride, Ro 40-5967	T-type Ca2+ channel blocker.	False	COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C
246739	246739:01:09_03.00	True	3.0	93	44.0	0.0	0.0	77.6	0.0	75.5	3.4	95.3	36.2	52.2	0.0	66.6	45.4	LCH	95.3	Sertraline	5-HT uptake inhibitor.	True	CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21
382156	382156:02:12_03.00	True	3.0	105	55.4	0.0	6.3	79.1	0.0	73.7	0.0	57.1	52.6	70.3	0.0	77.0	41.3	BET	79.1	CHIR-99021	CHIR-99021 (CT99021) is a potent and selective GSK-3.a./.b. inhibitor with IC50s of 10 nM and 6.7 nM. CHIR-99021 shows >500-fold selectivity for GSK-3 over CDC2, ERK2 and other protein kinases. CHIR-99021 is also a potent Wnt/.b.-catenin signaling pathway activator. CHIR-99021 enhances mouse and human embryonic stem cells self-renewal. CHIR-99021 induces autophagy.	False	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1
280308	280308:01:06_03.00	True	3.0	86	14.2	0.0	0.0	80.2	0.0	76.5	19.4	88.5	38.5	61.3	0.0	77.6	59.5	LCH	88.5	Bromoacetyl alprenolol menthane	alkylating beta adrenoceptor antagonist.	False	C=CCc1ccccc1OCC(O)CN[C@]1(C)CCC[C@H](C(C)(C)NC(=O)CBr)C1
246690	246690:01:10_03.00	True	3.0	102	12.3	0.0	0.0	79.9	0.0	78.1	30.4	79.1	32.0	69.7	0.0	74.0	54.7	BET	79.9	Zotepine	dopamine D2/serotonin 5-HT2 antagonist.	False	CN(C)CCOC1=Cc2ccccc2Sc2ccc(Cl)cc21
280433	280433:01:07_03.00	True	3.0	91	44.7	0.0	0.0	87.3	0.0	80.2	0.0	63.9	60.8	72.0	0.0	83.8	56.6	BET	87.3	Cantharidic Acid	protein phosphatase 1 (PP1) and 2A (PP2A) inhibitor.	False	CC1(C(=O)O)C2CCC(O2)C1(C)C(=O)O
280346	280346:01:10_03.00	True	3.0	67	84.1	0.0	0.0	81.3	0.0	78.3	33.6	63.2	51.4	76.0	0.0	79.0	80.7	BET	81.3	Brefeldin A from Penicillium brefeldianum, BFA, Ascotoxin, Cyanein	fungal metabolite that disrupts the structure and function of the Golgi apparatus.	False	C[C@H]1CCC/C=C/C2C[C@H](O)C[C@@]2(O)C/C=C/C(=O)O1
280954	280954:01:07_03.00	True	3.0	79	30.7	6.2	0.0	60.1	0.0	53.3	36.0	53.0	36.5	56.6	0.0	88.0	68.1	Tubulin	88.0	SKF-96365	selective inhibitor of receptor-mediated and voltage-gated Ca2+ entry.	False	COc1ccc(CCCOC(Cn2ccnc2)c2ccc(OC)cc2)cc1
280428	280428:01:08_03.00	True	3.0	93	39.7	0.0	0.0	82.6	0.0	74.7	7.3	63.6	50.3	74.1	0.0	85.1	51.6	Tubulin	85.1	Cantharidin	protein phosphatase 2A inhibitor.	False	CC12C(=O)OC(=O)C1(C)C1CCC2O1
280760	280760:01:10_03.00	True	3.0	103	38.2	0.0	0.0	80.4	0.0	76.0	26.9	89.9	31.4	67.4	0.0	74.5	62.3	LCH	89.9	NNC 55-0396	selective T-type calcium channel inhibitor.	False	CC(C)c1cc(F)cc2c1C[C@](CCN(C)CCCc1nc3ccccc3[nH]1)(OC(=O)C1CC1)CC2
280690	280690:01:06_03.00	True	3.0	96	5.4	0.0	0.0	58.8	0.0	55.0	12.7	67.9	26.0	47.2	0.0	54.1	27.2	LCH	67.9	Methiothepin mesylate	5-HT1 Serotonin receptor antagonist, blocks serotonin autoreceptors.	False	CSc1ccc2c(c1)C(N1CCN(C)CC1)Cc1ccccc1S2
246805	246805:01:08_03.00	True	3.0	101	8.5	0.0	0.0	76.0	0.0	75.5	24.4	87.1	26.2	48.2	0.0	69.7	57.9	LCH	87.1	Toremifene	selective estrogen receptor modulator.	False	CN(C)CCOc1ccc(/C(=C(/CCCl)c2ccccc2)c2ccccc2)cc1
280492	280492:01:08_03.00	True	3.0	101	15.0	0.0	0.0	69.6	0.0	66.9	23.6	84.7	26.2	38.4	0.0	72.2	48.1	LCH	84.7	Dilazep hydrochloride, Cormelian	adenosine uptake inhibitor.	False	COc1cc(C(=O)OCCCN2CCCN(CCCOC(=O)c3cc(OC)c(OC)c(OC)c3)CC2)cc(OC)c1OC
280153	280153:01:08_03.00	True	3.0	101	53.2	0.0	0.0	75.2	0.0	72.4	27.7	90.0	22.9	56.4	0.0	74.4	49.8	LCH	90.0	LP44	A high affinity 5-HT7 receptor agonist.	False	CSc1ccccc1N1CCN(CCCCCC(=O)NC2CCCc3ccccc32)CC1
280606	280606:01:07_03.00	True	3.0	93	9.8	0.0	0.0	66.9	0.0	68.2	15.0	63.8	44.8	44.9	0.0	62.3	40.2	HDAC	68.2	Fenretinide	Fenretinide (4-HPR) is a synthetic retinoid deriverative, binding to the retinoic acid receptors (RAR) at concentrations necessary to induce cell death.	False	CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)Nc2ccc(O)cc2)C(C)(C)CCC1
280538	280538:01:09_03.00	True	3.0	67	38.0	50.7	35.7	0.0	87.7	0.0	12.0	0.0	0.0	0.0	79.7	0.0	0.0	DNA_Synth	87.7	Ellipticine	cytochrome P450 (CYP1A1)and DNA topoisomerase II inhibitor.	False	Cc1c2ccncc2c(C)c2c1[nH]c1ccccc12
280735	280735:01:07_03.00	True	3.0	60	67.7	0.0	0.0	78.3	0.0	77.4	26.6	59.8	65.7	67.9	0.0	95.4	56.4	Tubulin	95.4	2-methoxyestradiol	inhibitor of angiogenesis and endothelial cell proliferation.	False	COc1cc2c(cc1O)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12
280470	280470:01:09_03.00	True	3.0	83	30.7	24.6	1.6	0.0	13.7	0.0	0.0	0.0	35.1	4.0	24.4	0.0	7.4	Na_K-ATPase	35.1	Dihydroouabain	sodium-potassium pump inhibitor.	False	C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@@H]4C(CC[C@]3(O)C2)[C@@]2(O)CC[C@H](C3COC(=O)C3)[C@@]2(C)C[C@H]4O)[C@H](O)[C@H](O)[C@H]1O
280575	280575:01:09_03.00	True	3.0	96	74.8	0.0	0.0	82.1	0.0	80.1	17.1	95.9	33.5	59.0	0.0	75.3	49.6	LCH	95.9	GR 127935 hydrochloride	selective 5-HT1B/1D serotonin receptor antagonist.	False	COc1ccc(NC(=O)c2ccc(-c3ccc(-c4noc(C)n4)cc3C)cc2)cc1N1CCN(C)CC1
407875	407875:01:08_03.00	True	3.0	95	10.4	40.8	6.8	0.0	73.2	0.0	2.8	0.0	0.0	0.0	46.8	0.0	0.0	DNA_Synth	73.2	Piperlongumine	Piperlongumine is a natural alkaloid isolated from Piper longum Linn, possesses ant-inflammatory, antibacterial, antiangiogenic, antioxidant, antitumor, and antidiabetic activities. Piperlongumine induces ROS, and induces apoptosis in cancer cell lines. Piperlongumine shows anti-cardiac fibrosis activity, suppresses myofibroblast transformation via suppression of the ERK1/2 signaling pathway.	False	COc1cc(/C=C/C(=O)N2CCC=CC2=O)cc(OC)c1OC
280630	280630:01:11_03.00	True	3.0	66	64.4	0.0	0.0	81.3	0.0	76.3	29.1	61.6	58.0	73.8	0.0	92.2	69.6	Tubulin	92.2	IC261	IC261 is a selective, ATP-competitive CK1 inhibitor, with IC50s of 1 uM, 1 uM, 16 uM for Cki.d., Cki.e. and Cki.a.1, respectively.	False	COc1cc(OC)c(/C=C2/C(=O)Nc3ccccc32)c(OC)c1
247369	247369:02:05_03.00	True	3.0	101	57.2	0.0	0.0	69.6	0.0	68.8	13.6	96.4	22.9	36.9	0.0	62.6	36.4	LCH	96.4	Fluspirilene	Fluspirilene is a non-competitive antagonist of L-type calcium channels with an IC50 of 0.03 uM. Fluspirileneis a long-acting injectable depot antipsychotic drug used for schizophrenia.	False	O=C1NCN(c2ccccc2)C12CCN(CCCC(c1ccc(F)cc1)c1ccc(F)cc1)CC2
394208	394208:01:09_03.00	True	3.0	104	37.8	30.3	0.0	31.8	12.8	39.3	23.6	74.5	0.0	11.6	0.0	30.9	27.6	LCH	74.5	AZ191	AZ191 is a potent inhibitor that selectively inhibits DYRK1B with IC50 of 17 nM.	False	COc1cc(N2CCN(C)CC2)ccc1Nc1nccc(-c2cn(C)c3cnccc23)n1
245325	245325:03:08_03.00	True	3.0	91	5.9	0.0	0.0	31.4	0.0	32.8	32.4	54.7	8.5	6.3	0.0	34.7	4.8	LCH	54.7	Reserpine, Methyl reserpate	inhibits vesicular catecholine and serotonin uptake, antihypertensive.	False	COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC
247164	247164:01:10_03.00	True	3.0	96	10.9	0.0	0.0	70.0	0.0	72.6	27.6	86.3	32.3	34.2	0.0	68.6	38.3	LCH	86.3	Bromperidol	Bromperidol is a butyrophenone derivative, is a potent and long-acting neuroleptic, used as an antipsychotic in the treatment of schizophrenia.	False	O=C(CCCN1CCC(O)(c2ccc(Br)cc2)CC1)c1ccc(F)cc1
246414	246414:01:09_03.00	True	3.0	101	7.4	0.0	0.0	74.5	0.0	71.8	24.4	80.8	39.2	56.1	0.0	73.4	51.4	LCH	80.8	Fendiline (hydrochloride)	Fendiline hydrochloride is a nonselective calcium channel blocker.	False	CC(NCCC(c1ccccc1)c1ccccc1)c1ccccc1
246314	246314:01:11_03.00	True	3.0	79	81.9	0.0	0.0	82.3	0.0	82.0	24.4	80.2	46.6	70.8	0.0	77.6	67.4	BET	82.3	Monensin A sodium salt, Rumensin, Coban 45	it is a naturally occuring ionophorous antibiotic that preferentially forms complexes with monovalent cations to enable transport across lipid membranes. Through its ability to affect pH and the sodium-potassium balance of a cell, monensin can induce cell death in Gram-positive bacteria such as Micrococcus, Bacillus, and Staphylococcus (MICs = 1-12.5 µg/ml), reduce proliferation of P. falciparum and Coccicdium protozoa, and also prevent replication of certain viruses.	True	CC[C@@]1([C@@H]2O[C@@H]([C@H]3O[C@@](O)(CO)[C@H](C)C[C@@H]3C)C[C@@H]2C)CC[C@H]([C@]2(C)CC[C@]3(C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H](OC)[C@H](C)C(=O)O)O3)O2)O1
280921	280921:01:13_03.00	True	3.0	82	33.7	29.7	46.8	0.0	82.3	0.0	0.0	0.0	0.0	0.0	79.8	0.0	0.0	DNA_Synth	82.3	SU 9516	cylcin-dependent kinase-2 (Cdk-2) inhibitor, induces apoptosis in colon cancer cells.	False	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2
280942	280942:01:05_03.00	True	3.0	102	15.9	0.0	0.0	76.1	0.0	70.0	22.0	84.3	24.8	47.7	0.0	71.5	48.9	LCH	84.3	Salmeterol (xinafoate)	beta2 Adrenoceptor agonist.	False	OCc1cc(C(O)CNCCCCCCOCCCCc2ccccc2)ccc1O
246732	246732:01:10_03.00	True	3.0	55	70.5	0.0	0.0	52.6	1.8	54.0	10.2	65.4	31.8	50.9	0.0	62.3	36.6	LCH	65.4	Pyrvinium pamoate	metabolic inhibitor.	False	Cc1cc(/C=C/c2ccc3cc(N(C)C)ccc3[n+]2C)c(C)n1-c1ccccc1
392891	392891:01:14_03.00	True	3.0	91	17.8	0.0	0.0	66.8	0.0	66.6	36.7	82.4	21.7	47.7	0.0	69.1	53.8	LCH	82.4	Aumitin	inhibits mitochondrial respiration by targeting complex I.; Chem. Sci. 2018, 9, 3014	False	Cc1cc(Nc2ccccc2)nc(Nc2ccc(NC(=O)c3ccccc3Cl)cc2)n1
394207	394207:01:09_03.00	True	3.0	68	62.2	0.0	77.0	15.1	0.0	20.0	20.0	26.2	13.2	29.4	0.0	47.2	0.0	Aurora	77.0	HTH-01-015	HTH-01-015 is a selective NUAK1/ARK5 inhibitor (IC50 is 100 nM). HTH-01-015 inhibits NUAK1 with >100-fold higher potency than NUAK2 (IC50 of >10 uM).	False	Cc1nc(Nc2cnn(C3CCNCC3)c2)nc2c1N(C)C(=O)c1cc3ccccc3cc1N2C
245384	245384:02:09_03.00	True	3.0	86	15.4	24.7	45.2	0.0	82.3	0.0	2.7	0.0	0.0	0.0	66.4	0.0	0.0	DNA_Synth	82.3	Hycanthone	Hycanthone is a thioxanthenone DNA intercalator and inhibits RNA synthesis as well as the DNA topoisomerases I and II. Hycanthone inhibits nucleic acid biosynthesis and inhibits apurinic endonuclease-1 (APE1) by direct protein binding with a KD of 10 nM. Hycanthone is a bioactive metabolite of Lucanthone (HY-B2098) and has anti-schistosomal agent.	False	CCN(CC)CCNc1ccc(CO)c2sc3ccccc3c(=O)c12
105083	105083:01:14_10.00	False	10.0	59	53.0	0.0	0.0	76.4	0.0	84.6	28.6	62.1	57.0	70.0	0.0	73.3	74.7	HDAC	84.6			False	CN(C)CCCSCCCCCCC(=O)C(F)(F)F
287906	287906:02:15_10.00	True	10.0	101	10.2	0.0	0.0	60.6	0.0	57.0	30.3	77.7	17.1	29.3	0.0	60.6	49.7	LCH	77.7	Pipinib	Hedgehog pathway Inhibitor; targets PI4KIIIß.	False	COC(=O)c1ccc(Nc2nc(NC(C)C)nc3ccsc23)cc1
104614	104614:02:17_10.00	True	10.0	64	33.2	0.0	0.0	67.0	0.0	67.1	50.6	49.0	56.6	61.7	0.0	89.1	48.9	Tubulin	89.1	Tubulexin A	target the chromosome segregation 1-like protein (CSE1L, CAS, exportin-2) and the vinca alkaloid binding site of a/ß-tubulin.; Angew. Chem. Int. Ed. 2013, 52, 410	False	COc1ccc(CC[C@H]2C[C@@H](OC(C)=O)C[C@@H](c3ccc(OCc4ccccc4)c(O)c3)O2)cc1
392891	392891:01:15_10.00	True	10.0	99	69.8	0.0	0.0	82.8	0.0	79.0	25.0	88.2	35.9	52.2	0.0	77.3	68.4	LCH	88.2	Aumitin	inhibits mitochondrial respiration by targeting complex I.; Chem. Sci. 2018, 9, 3014	False	Cc1cc(Nc2ccccc2)nc(Nc2ccc(NC(=O)c3ccccc3Cl)cc2)n1
382185	382185:02:21_10.00	True	10.0	96	60.4	0.0	0.0	81.8	0.0	77.4	21.5	91.6	32.9	47.2	0.0	73.8	63.9	LCH	91.6	Aumitin	inhibits mitochondrial respiration by targeting complex I.; Chem. Sci. 2018, 9, 3014	False	Cc1cc(Nc2ccccc2)nc(Nc2ccc(NC(=O)c3ccccc3Cl)cc2)n1
106934	106934:01:13_10.00	True	10.0	87	20.4	0.0	0.0	32.1	0.0	26.4	19.7	37.8	24.1	24.2	0.0	36.2	0.6	LCH	37.8	Dynarrestin	inhibitor of cytoplasmic dyneins 1 and 2.; Cell Chem. Biol. 2018, 25, 357	False	CCOC(=O)c1sc(Nc2ccc(F)cc2F)nc1-c1ccc(N(CC)CC)cc1
381768	381768:01:40_10.00	True	10.0	66	60.3	0.0	2.8	60.6	0.0	57.5	27.2	53.9	42.1	60.7	0.0	82.3	48.2	Tubulin	82.3	Autophinib	Autophinib is a potent, selective autophagy inhibitor with IC50s of 90 nM and 40 nM for starvation- and Rapamycin-induced autophagy, respectively. Autophinib is also an ATP competitive Vacuolar Protein Sorting 34 (VPS34) inhibitor with an IC50 of 19 nM. Autophinib inhibits autophagy induced by starvation or Rapamycin by targeting VPS34.; Angew. Chem. Int. Ed. 2017, 56, 8153	False	Cc1cc(Nc2cc(Cl)nc(Oc3ccc([N+](=O)[O-])cc3)n2)[nH]n1
349684	349684:01:11_10.00	True	10.0	78	13.6	3.3	0.0	54.6	0.0	50.0	29.7	71.0	25.7	24.8	0.0	70.1	57.8	LCH	71.0	Autogramin-1	Autogramin-1 potently inhibits autophagy induced by either mTORC1 inhibition (Rapamycin; IC50=0.44 µM), or starvation (IC50=0.17 µM) via selectively targeting the cholesterol-binding StART domain of GRAMD1A.	False	CCCn1c(=O)[nH]c2cc(C(=O)Nc3nc4c(s3)CN(C(=O)OC(C)(C)C)CC4)ccc2c1=O
105096	105096:01:10_10.00	False	10.0	66	50.8	0.0	0.0	75.1	0.0	86.5	25.6	57.6	64.3	70.8	0.0	72.8	75.0	HDAC	86.5			False	CN(C)CCCSCCCCCC(=O)C(F)(F)F
285004	285004:01:11_10.00	True	10.0	92	14.0	66.1	0.0	0.0	75.2	0.0	0.0	9.7	0.0	0.0	50.8	0.0	25.1	DNA_Synth	75.2	Epiblastin A	inhibitor of casein kinases 1 (CK1) a/d/?.; Cell Chem. Biol. 2016, 23, 494	False	Nc1nc(N)c2nc(-c3cccc(Cl)c3)c(N)nc2n1
105083	105083:01:14_30.00	False	30.0	56	73.9	0.0	0.0	87.0	0.0	89.9	19.3	76.7	57.7	77.1	0.0	79.6	74.3	HDAC	89.9			False	CN(C)CCCSCCCCCCC(=O)C(F)(F)F
287906	287906:02:15_30.00	True	30.0	91	65.3	0.0	0.0	84.9	0.0	82.7	17.0	93.1	43.7	51.9	0.0	75.3	63.6	LCH	93.1	Pipinib	Hedgehog pathway Inhibitor; targets PI4KIIIß.	False	COC(=O)c1ccc(Nc2nc(NC(C)C)nc3ccsc23)cc1
101008	101008:01:22_30.00	True	30.0	75	54.2	0.0	0.0	72.1	0.0	71.6	52.0	63.7	53.8	50.3	0.0	91.9	57.5	Tubulin	91.9	Centrocountin 1	modulator of centrosome integrity; binds centrosome-associated proteins nucleophosmin (NPM) and Crm1.; Nat. Chem. Biol. 2012, 8, 179	True	COC(=O)C1=CC(C(=O)c2ccccc2O)=CN2CCc3c([nH]c4ccccc34)[C@@]12C(=O)OC
104614	104614:02:17_30.00	True	30.0	66	63.7	0.0	2.1	74.3	0.0	81.3	55.3	69.0	55.8	57.0	0.0	91.6	52.6	Tubulin	91.6	Tubulexin A	target the chromosome segregation 1-like protein (CSE1L, CAS, exportin-2) and the vinca alkaloid binding site of a/ß-tubulin.; Angew. Chem. Int. Ed. 2013, 52, 410	False	COc1ccc(CC[C@H]2C[C@@H](OC(C)=O)C[C@@H](c3ccc(OCc4ccccc4)c(O)c3)O2)cc1
392891	392891:01:15_30.00	True	30.0	54	75.1	0.0	0.0	86.4	0.0	88.4	18.5	86.2	50.4	57.5	0.0	77.5	72.9	HDAC	88.4	Aumitin	inhibits mitochondrial respiration by targeting complex I.; Chem. Sci. 2018, 9, 3014	False	Cc1cc(Nc2ccccc2)nc(Nc2ccc(NC(=O)c3ccccc3Cl)cc2)n1
382185	382185:02:21_30.00	True	30.0	61	68.6	0.0	0.0	83.5	0.0	81.3	9.2	92.6	44.2	48.3	0.0	72.8	62.4	LCH	92.6	Aumitin	inhibits mitochondrial respiration by targeting complex I.; Chem. Sci. 2018, 9, 3014	False	Cc1cc(Nc2ccccc2)nc(Nc2ccc(NC(=O)c3ccccc3Cl)cc2)n1
106934	106934:01:13_30.00	True	30.0	85	42.8	0.0	0.0	32.0	0.0	30.4	29.6	40.1	26.9	30.2	0.0	39.5	7.2	LCH	40.1	Dynarrestin	inhibitor of cytoplasmic dyneins 1 and 2.; Cell Chem. Biol. 2018, 25, 357	False	CCOC(=O)c1sc(Nc2ccc(F)cc2F)nc1-c1ccc(N(CC)CC)cc1
381768	381768:01:40_30.00	True	30.0	63	56.1	0.0	0.0	66.1	0.0	65.6	19.4	78.2	47.1	29.1	0.0	71.2	50.1	LCH	78.2	Autophinib	Autophinib is a potent, selective autophagy inhibitor with IC50s of 90 nM and 40 nM for starvation- and Rapamycin-induced autophagy, respectively. Autophinib is also an ATP competitive Vacuolar Protein Sorting 34 (VPS34) inhibitor with an IC50 of 19 nM. Autophinib inhibits autophagy induced by starvation or Rapamycin by targeting VPS34.; Angew. Chem. Int. Ed. 2017, 56, 8153	False	Cc1cc(Nc2cc(Cl)nc(Oc3ccc([N+](=O)[O-])cc3)n2)[nH]n1
337185	337185:02:16_30.00	True	30.0	96	9.2	0.0	0.0	48.0	0.0	49.1	34.2	57.8	33.0	7.5	0.0	49.9	30.8	LCH	57.8	Lipoxygenin	inhibitor of 5-lipoxygenase (5-LO) of the Wnt pathway.; Cell Chem. Biol. 2018, 95, 1095	False	COc1ncccc1-c1cnc(OC)c(C(O)c2ccc3ccccc3c2)c1OC
283242	283242:02:06_30.00	True	30.0	100	23.7	14.9	0.0	14.1	16.1	7.8	29.5	43.2	0.0	9.2	1.6	28.8	0.0	LCH	43.2	Englerin A	highly efficient, fast-acting, potent, selective, and direct stimulator of transient receptor potential canonical (TRPC) calcium channels TRPC4 and TRPC5.; Angew. Chem. Int. Ed. 2015, 54, 3787	False	CC(C)[C@@]12C[C@@H](OC(=O)CO)[C@@](C)(O1)[C@@H]1CC[C@@H](C)[C@H]1[C@@H]2OC(=O)/C=C/c1ccccc1
101009	101009:01:16_30.00	True	30.0	96	13.3	14.1	0.0	20.0	0.0	18.8	58.3	29.7	7.2	1.0	0.0	31.6	18.9	HSP90	58.3	Centrocountin 1	modulator of centrosome integrity; binds centrosome-associated proteins nucleophosmin (NPM) and Crm1.; Nat. Chem. Biol. 2012, 8, 179	True	COC(=O)C1=CC(C(=O)c2ccccc2O)=CN2CCc3c([nH]c4ccccc34)[C@]12C(=O)OC
246980	246980:07:05_30.00	True	30.0	72	21.8	0.0	0.0	54.0	0.0	55.4	46.7	49.1	53.2	32.2	0.0	86.2	47.4	Tubulin	86.2	Griseofulvin	Griseofulvin(Gris-PEG; Grifulvin) is a spirocyclic fungal natural product used in treatment of fungal dermatophytes; Antifungal drug.	True	COC1=CC(=O)C[C@@H](C)[C@]12Oc1c(Cl)c(OC)cc(OC)c1C2=O
105096	105096:01:10_30.00	False	30.0	65	67.5	0.0	0.0	87.1	0.0	92.3	16.7	78.0	63.3	73.4	0.0	78.8	72.2	HDAC	92.3			False	CN(C)CCCSCCCCCC(=O)C(F)(F)F
317004	317004:02:11_30.00	True	30.0	109	5.5	0.0	0.0	64.2	0.0	62.8	33.2	76.7	24.0	26.9	0.0	63.5	30.7	LCH	76.7	Smoothib	antagonist of the protein smoothened (SMO).; Angew. Chem. Int. Ed. 2017, 56, 13021	False	Cc1ccc(Cn2[nH]cc3nc(-c4ccc(N5CCN(C(=O)CCc6c[nH]c7ccccc67)CC5)cc4)nc2-3)cc1
350231	350231:01:11_30.00	True	30.0	103	16.6	4.7	0.0	43.6	0.0	43.2	61.7	53.5	13.8	37.9	0.0	56.6	38.0	HSP90	61.7		antagonist of the smoothened receptor (Smo) of the hedgehog (Hh) pathway.; Nature Comms., 2017, 8, 14043	False	C=C(C)[C@@H]1CO/C(=C2/C(=O)N(Cc3ccccc3)c3ccccc32)[C@H]1c1ccccc1
285004	285004:01:11_30.00	True	30.0	79	77.4	0.0	0.0	72.0	0.0	70.4	0.0	82.4	43.6	50.2	0.0	68.3	52.8	LCH	82.4	Epiblastin A	inhibitor of casein kinases 1 (CK1) a/d/?.; Cell Chem. Biol. 2016, 23, 494	False	Nc1nc(N)c2nc(-c3cccc(Cl)c3)c(N)nc2n1
105083	105083:01:14_50.00	False	50.0	58	83.9	0.0	0.0	88.4	0.0	88.1	16.3	82.4	54.6	73.0	0.0	81.9	69.1	BET	88.4			False	CN(C)CCCSCCCCCCC(=O)C(F)(F)F
287906	287906:02:15_50.00	True	50.0	78	76.2	0.0	0.0	83.3	0.0	80.4	25.5	91.2	42.1	53.5	0.0	76.7	68.0	LCH	91.2	Pipinib	Hedgehog pathway Inhibitor; targets PI4KIIIß.	False	COC(=O)c1ccc(Nc2nc(NC(C)C)nc3ccsc23)cc1
101008	101008:01:22_50.00	True	50.0	72	59.6	0.0	0.0	77.6	0.0	76.0	48.0	68.0	56.1	50.9	0.0	92.4	61.5	Tubulin	92.4	Centrocountin 1	modulator of centrosome integrity; binds centrosome-associated proteins nucleophosmin (NPM) and Crm1.; Nat. Chem. Biol. 2012, 8, 179	True	COC(=O)C1=CC(C(=O)c2ccccc2O)=CN2CCc3c([nH]c4ccccc34)[C@@]12C(=O)OC
104614	104614:02:17_50.00	True	50.0	60	68.9	0.0	0.0	77.4	0.0	81.3	53.0	73.9	54.1	58.7	0.0	92.4	53.2	Tubulin	92.4	Tubulexin A	target the chromosome segregation 1-like protein (CSE1L, CAS, exportin-2) and the vinca alkaloid binding site of a/ß-tubulin.; Angew. Chem. Int. Ed. 2013, 52, 410	False	COc1ccc(CC[C@H]2C[C@@H](OC(C)=O)C[C@@H](c3ccc(OCc4ccccc4)c(O)c3)O2)cc1
392891	392891:01:15_50.00	True	50.0	54	78.6	0.0	0.0	88.0	0.0	90.2	18.4	74.8	60.6	58.5	0.0	81.2	76.0	HDAC	90.2	Aumitin	inhibits mitochondrial respiration by targeting complex I.; Chem. Sci. 2018, 9, 3014	False	Cc1cc(Nc2ccccc2)nc(Nc2ccc(NC(=O)c3ccccc3Cl)cc2)n1
382185	382185:02:21_50.00	True	50.0	56	74.4	0.0	0.0	87.4	0.0	90.0	19.0	74.4	61.3	56.2	0.0	80.5	75.9	HDAC	90.0	Aumitin	inhibits mitochondrial respiration by targeting complex I.; Chem. Sci. 2018, 9, 3014	False	Cc1cc(Nc2ccccc2)nc(Nc2ccc(NC(=O)c3ccccc3Cl)cc2)n1
381768	381768:01:40_50.00	True	50.0	58	55.3	0.0	0.0	66.6	0.0	64.7	25.8	79.9	42.2	36.2	0.0	76.9	54.2	LCH	79.9	Autophinib	Autophinib is a potent, selective autophagy inhibitor with IC50s of 90 nM and 40 nM for starvation- and Rapamycin-induced autophagy, respectively. Autophinib is also an ATP competitive Vacuolar Protein Sorting 34 (VPS34) inhibitor with an IC50 of 19 nM. Autophinib inhibits autophagy induced by starvation or Rapamycin by targeting VPS34.; Angew. Chem. Int. Ed. 2017, 56, 8153	False	Cc1cc(Nc2cc(Cl)nc(Oc3ccc([N+](=O)[O-])cc3)n2)[nH]n1
337185	337185:02:16_50.00	True	50.0	84	28.3	0.0	0.0	70.4	0.0	69.9	40.1	86.5	31.2	38.4	0.0	72.4	57.0	LCH	86.5	Lipoxygenin	inhibitor of 5-lipoxygenase (5-LO) of the Wnt pathway.; Cell Chem. Biol. 2018, 95, 1095	False	COc1ncccc1-c1cnc(OC)c(C(O)c2ccc3ccccc3c2)c1OC
283242	283242:02:06_50.00	True	50.0	70	42.8	27.2	0.0	28.8	5.2	23.3	35.5	50.4	1.1	32.2	0.0	41.4	30.6	LCH	50.4	Englerin A	highly efficient, fast-acting, potent, selective, and direct stimulator of transient receptor potential canonical (TRPC) calcium channels TRPC4 and TRPC5.; Angew. Chem. Int. Ed. 2015, 54, 3787	False	CC(C)[C@@]12C[C@@H](OC(=O)CO)[C@@](C)(O1)[C@@H]1CC[C@@H](C)[C@H]1[C@@H]2OC(=O)/C=C/c1ccccc1
101009	101009:01:16_50.00	True	50.0	85	17.1	17.8	0.0	24.8	0.0	23.0	64.7	30.9	8.4	21.5	0.0	42.0	34.6	HSP90	64.7	Centrocountin 1	modulator of centrosome integrity; binds centrosome-associated proteins nucleophosmin (NPM) and Crm1.; Nat. Chem. Biol. 2012, 8, 179	True	COC(=O)C1=CC(C(=O)c2ccccc2O)=CN2CCc3c([nH]c4ccccc34)[C@]12C(=O)OC
246980	246980:07:05_50.00	True	50.0	68	34.2	0.0	7.8	64.0	0.0	68.4	42.2	50.4	64.7	50.6	0.0	88.4	52.0	Tubulin	88.4	Griseofulvin	Griseofulvin(Gris-PEG; Grifulvin) is a spirocyclic fungal natural product used in treatment of fungal dermatophytes; Antifungal drug.	True	COC1=CC(=O)C[C@@H](C)[C@]12Oc1c(Cl)c(OC)cc(OC)c1C2=O
105096	105096:01:10_50.00	False	50.0	55	81.9	0.0	0.0	87.3	0.0	88.2	17.4	81.4	56.2	71.3	0.0	80.7	68.5	HDAC	88.2			False	CN(C)CCCSCCCCCC(=O)C(F)(F)F
317004	317004:02:11_50.00	True	50.0	88	8.1	0.0	0.0	77.9	0.0	77.0	34.7	77.4	39.6	55.5	0.0	73.8	48.3	BET	77.9	Smoothib	antagonist of the protein smoothened (SMO).; Angew. Chem. Int. Ed. 2017, 56, 13021	False	Cc1ccc(Cn2[nH]cc3nc(-c4ccc(N5CCN(C(=O)CCc6c[nH]c7ccccc67)CC5)cc4)nc2-3)cc1
350231	350231:01:11_50.00	True	50.0	101	21.1	6.3	0.0	56.5	0.0	50.5	53.0	61.7	16.0	46.2	0.0	65.3	45.0	Tubulin	65.3		antagonist of the smoothened receptor (Smo) of the hedgehog (Hh) pathway.; Nature Comms., 2017, 8, 14043	False	C=C(C)[C@@H]1CO/C(=C2/C(=O)N(Cc3ccccc3)c3ccccc32)[C@H]1c1ccccc1
245846	245846:02:11_50.00	True	50.0	100	5.0	68.9	0.0	0.0	47.6	0.0	30.8	0.0	0.0	0.0	51.6	0.0	2.9	AKT_PI3K_MTOR	68.9		selective ATP-competitive inhibitor of MAP4K4.; Angew. Chem. Int. Ed. 2015, 54, 12398	False	CCCCCC(=O)c1c(O)c(-c2ccc(O)cc2)c[nH]c1=O
246972	246972:12:04_00.20	True	0.2	89	13.3	0.0	19.6	54.2	0.0	52.7	34.6	56.6	27.0	36.6	0.0	82.9	34.7	Tubulin	82.9	Mebendazole	Mebendazole is a highly effective, broad-spectrum antihelmintic indicated for the treatment of nematode infestations; has been found as a hedgehog inhibitor.	False	COC(=O)Nc1nc2cc(C(=O)c3ccccc3)ccc2[nH]1
410609	410609:01:04_00.20	True	0.2	61	57.2	39.2	0.0	19.1	41.1	23.7	30.1	26.9	10.7	29.5	2.6	36.4	54.3	Uncoupler	54.3	Delanzomib (CEP-18770)	Delanzomib (CEP-18770) is an orally active inhibitor of the chymotrypsin-like activity of proteasome with IC50 of 3.8 nM, with only marginal inhibition of the tryptic and peptidylglutamyl activities of the proteosome. Phase 1/2.	True	CC(C)[C@H](CNC(=O)[C@@H](NC(=O)c1cccc(-c2ccccc2)n1)[C@@H](C)O)B(O)O
410678	410678:01:05_00.20	True	0.2	84	5.7	0.0	33.4	40.9	20.0	43.8	4.3	46.8	19.9	28.9	0.0	62.5	19.7	Tubulin	62.5	ARQ 621	ARQ 621 is an allosteric, and selective Eg5 mitotic motor protein inhibitor. Phase 1.	True	C#CC[C@H](c1nc2cc(Cl)ccc2c(=O)n1Nc1ccccc1)N(CCCN)C(=O)c1cccc(Cl)c1F
410624	410624:01:04_00.20	True	0.2	93	33.2	0.0	0.0	69.8	0.0	75.6	42.7	69.2	47.9	65.3	0.0	67.7	63.6	HDAC	75.6	AZD-7762	AZD7762 is a potent and selective inhibitor of Chk1 with IC50 of 5 nM in a cell-free assay. It is equally potent against Chk2 and less potent against CAM, Yes, Fyn, Lyn, Hck and Lck. Phase 1.	True	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1
408410	408410:02:03_01.00	True	1.0	55	79.1	0.0	23.4	70.7	0.0	77.7	13.9	71.0	50.9	58.3	0.0	74.8	25.1	HDAC	77.7	BI 2536	BI 2536 is a dual PLK1 and BRD4 inhibitor with IC50s of 0.83 and 25 nM, respectively. BI-2536 suppresses IFNB (encoding IFN-.b.) gene transcription.	True	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1
409902	409902:01:03_01.00	True	1.0	93	61.3	45.7	0.0	37.7	0.0	47.4	45.3	71.5	2.9	29.3	0.0	40.3	52.5	LCH	71.5	URMC-099	URMC-099 is an orally bioavailable and potent mixed lineage kinase type 3 (MLK3) (IC50=14 nM) inhibitor with with excellent blood-brain barrier penetration properties.	False	CN1CCN(Cc2ccc(-c3cnc4[nH]cc(-c5ccc6[nH]ccc6c5)c4c3)cc2)CC1
409887	409887:01:04_01.00	True	1.0	96	44.2	0.0	0.0	60.3	0.0	60.2	24.6	83.1	13.1	37.5	0.0	66.3	31.5	LCH	83.1	DDR1-IN-1 (hydrat)	tThe discoidin domain receptor (DDR) tyrosine kinases are activated by matrix collagens and are important for cell proliferation, differentiation, adhesion, migration, and invasion. DDR1-IN-1 binds to DDR1 and inhibits DDR1 autophosphorylation with an IC50 value of 105 nM and an EC50 value of 87 nM. It demonstrates weaker inhibition for DDR2 (IC50 = 413 nM) and has a good selectivity profile against a panel of 451 kinases.	False	CCN1CCN(Cc2ccc(C(=O)Nc3ccc(C)c(Oc4ccc5c(c4)CC(=O)N5)c3)cc2C(F)(F)F)CC1
280171	280171:05:04_01.00	True	1.0	103	44.2	0.0	0.0	65.6	0.0	64.0	0.0	90.8	28.7	28.2	0.0	61.9	32.9	LCH	90.8	BIX01294 (hydrochloride hydrate)	it is a selective inhibitor of G9a HMTase (IC50 = 1.7 µM). It less effectively inhibits the HMTase G9a-like protein (GLP, IC50 = 38 µM) and has no effect on other known HMTases. BIX01294 has been used in combination with the calcium channel activator BayK8644 to facilitate the generation of induced pluripotent stem cells from somatic cells in vitro.	False	COc1cc2nc(N3CCCN(C)CC3)nc(NC3CCN(Cc4ccccc4)CC3)c2cc1OC
409865	409865:01:04_01.00	True	1.0	73	59.2	0.0	51.8	32.6	8.1	36.5	0.6	38.2	27.4	22.3	0.0	59.9	0.6	Tubulin	59.9	Pevonedistat	Pevonedistat (MLN4924) is a potent and selective NEDD8-activating enzyme (NAE) inhibitor with an IC50 of 4.7 nM.	True	NS(=O)(=O)OC[C@@H]1C[C@@H](n2ccc3c(N[C@H]4CCc5ccccc54)ncnc32)C[C@@H]1O
409846	409846:01:05_00.10	True	0.1	90	43.7	0.0	0.0	56.7	0.0	60.3	38.1	61.8	28.1	46.7	0.0	72.9	52.1	Tubulin	72.9	Jasplakinolide	Cell permeable, non-fluorescent F-actin probe. Potent inducer of actin polymerization and stabilization. Competes with phallotoxins for actin binding. Antifungal and antiparasitic compound. Antiproliferative and anticancer compound. Apoptosis enhancer/inducer. Tool used for autophagy/phagocytosis research.	True	C/C1=C\[C@H](C)C[C@H](C)OC(=O)C[C@H](c2ccc(O)cc2)NC(=O)[C@@H](Cc2c(Br)[nH]c3ccccc23)N(C)C(=O)[C@H](C)NC(=O)[C@@H](C)C1
410609	410609:01:05_00.20	True	0.2	57	65.8	36.3	0.0	22.1	39.6	25.3	32.3	30.2	11.6	32.3	0.3	40.6	54.3	Uncoupler	54.3	Delanzomib (CEP-18770)	Delanzomib (CEP-18770) is an orally active inhibitor of the chymotrypsin-like activity of proteasome with IC50 of 3.8 nM, with only marginal inhibition of the tryptic and peptidylglutamyl activities of the proteosome. Phase 1/2.	True	CC(C)[C@H](CNC(=O)[C@@H](NC(=O)c1cccc(-c2ccccc2)n1)[C@@H](C)O)B(O)O
246972	246972:12:05_00.20	True	0.2	87	9.5	0.0	33.3	44.3	0.0	44.1	17.3	38.5	26.4	31.9	0.0	73.2	27.8	Tubulin	73.2	Mebendazole	Mebendazole is a highly effective, broad-spectrum antihelmintic indicated for the treatment of nematode infestations; has been found as a hedgehog inhibitor.	False	COC(=O)Nc1nc2cc(C(=O)c3ccccc3)ccc2[nH]1
410043	410043:01:05_00.20	True	0.2	95	23.1	0.0	0.0	62.2	0.0	65.1	26.1	70.9	26.4	41.5	0.0	68.5	27.3	LCH	70.9	XMD17-109	XMD17-109 is a novel, specific ERK-5 inhibitor, with an IC50 of 162 nM.	False	CCOc1cc(C(=O)N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc2c(n1)N(C1CCCC1)c1ccccc1C(=O)N2C
410624	410624:01:05_00.20	True	0.2	93	34.2	0.0	0.0	64.8	0.0	73.3	45.3	63.4	45.5	67.5	0.0	61.3	63.8	HDAC	73.3	AZD-7762	AZD7762 is a potent and selective inhibitor of Chk1 with IC50 of 5 nM in a cell-free assay. It is equally potent against Chk2 and less potent against CAM, Yes, Fyn, Lyn, Hck and Lck. Phase 1.	True	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1
410285	410285:01:03_01.00	True	1.0	103	9.0	8.3	0.0	44.4	0.0	45.2	37.1	73.5	0.0	5.1	0.0	48.4	28.2	LCH	73.5	Nemiralisib	Nemiralisib (GSK2269557 free base) is a potent and highly selective PI3K.d. inhibitor with a pKi of 9.9.	False	CC(C)N1CCN(Cc2cnc(-c3cc(-c4cccc5[nH]ccc45)cc4[nH]ncc34)o2)CC1
409914	409914:01:03_01.00	True	1.0	96	6.6	0.0	0.0	48.6	0.0	55.8	46.2	61.4	18.8	16.1	0.0	51.8	28.6	LCH	61.4	AZ6102	AZ6102 is a potent dual TNKS1 and TNKS2 inhibitor, with IC50s of 3 nM and 1 nM, respectively, and alao has 100-fold selectivity against other PARP family enzymes, with IC50s of 2.0 uM, 0.5 uM, and >3 uM, for PARP1, PARP2, and PARP6, respectively.	True	Cc1cc(N2C[C@H](C)N[C@H](C)C2)ncc1-c1ccc(-c2nc(O)c3ccn(C)c3n2)cc1
408410	408410:03:05_00.20	True	0.2	50	78.8	0.0	39.4	61.2	0.0	70.8	15.8	59.3	46.4	53.0	0.0	71.3	16.7	Tubulin	71.3	BI 2536	BI 2536 is a dual PLK1 and BRD4 inhibitor with IC50s of 0.83 and 25 nM, respectively. BI-2536 suppresses IFNB (encoding IFN-.b.) gene transcription.	True	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1
409860	409860:01:03_01.00	True	1.0	89	30.2	0.0	0.0	60.8	0.0	60.4	0.0	87.9	28.7	20.9	0.0	57.7	30.2	LCH	87.9	UNC0642	UNC0642 is a potent and selective lysine methyltransferases G9a and GLP inhibitor, with an IC50 of <2.5 nM for G9a.	False	COc1cc2c(NC3CCN(C(C)C)CC3)nc(N3CCC(F)(F)CC3)nc2cc1OCCCN1CCCC1
339765	339765:02:05_00.20	True	0.2	61	55.8	43.9	0.0	0.0	28.8	7.7	3.9	0.0	44.4	24.4	16.8	0.0	40.4	Na_K-ATPase	44.4	Ouabain (Octahydrate)	Ouabain Octahydrate is an inhibitor of Na+/K+-ATPase, used for the treatment of congestive heart failure.	True	C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@@H](C6=CC(=O)OC6)CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)[C@H](O)[C@H](O)[C@H]1O
408410	408410:02:04_01.00	True	1.0	55	82.6	0.0	18.7	73.4	0.0	79.0	16.8	71.1	50.9	62.6	0.0	77.6	30.1	HDAC	79.0	BI 2536	BI 2536 is a dual PLK1 and BRD4 inhibitor with IC50s of 0.83 and 25 nM, respectively. BI-2536 suppresses IFNB (encoding IFN-.b.) gene transcription.	True	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1
409617	409617:01:04_01.00	True	1.0	97	60.4	0.0	0.0	68.7	0.0	70.7	23.6	83.6	18.4	50.4	0.0	66.8	35.8	LCH	83.6	Siramesine fumarate salt	Siramesine is an agonist of the sigma-2 (?2) receptor (IC50 = 0.19 nM). It is selective for ?2 over ?1 (IC50 = 17 nM) and related receptors and transporters.	False	Fc1ccc(-n2cc(CCCCN3CCC4(CC3)OCc3ccccc34)c3ccccc32)cc1
409832	409832:01:03_01.00	True	1.0	61	57.7	32.1	0.0	52.4	10.6	46.3	21.5	63.8	31.1	46.8	0.0	61.5	69.6	Uncoupler	69.6	CCT251236	CCT251236 is an orally available pirin ligand from a heat shock transcription factor 1 (hsf1) phenotypic screen with an IC50 of 19 nM for inhibition of HSF1-mediated HSP72 induction.	False	Cc1ccc(NC(=O)c2ccc3c(c2)OCCO3)cc1NC(=O)c1ccc2nc(OCCN3CCCC3)ccc2c1
391925	391925:03:05_00.20	True	0.2	62	73.7	0.0	21.7	71.7	0.0	73.5	30.9	68.8	50.7	58.6	0.0	90.9	41.1	Tubulin	90.9	TCS JNK 5a	inhibitor of c-Jun N-terminal kinase 2/3 (IC50 = 0.3/0.2 µM), Inhibitor of binding or entry into cells for Lassa Virus (IC50 = 0.2 µM); N-(3-Cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)amides as potent, selective, inhibitors of JNK2 and JNK3.  Bioorg Med Chem Lett.  (2007),  17(5),  1296-1301.	False	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2
410134	410134:01:04_00.20	True	0.2	56	77.4	10.4	0.0	50.9	0.0	52.1	33.7	49.8	33.9	56.3	0.0	62.8	61.5	Tubulin	62.8	Epoxomicin	Epoxomicin is a selective proteasome inhibitor with anti-inflammatory activity, inhibits primarily the CH-L activity of the 20S proteasome, while T-L and PGPH catalytic activities are also inhibited at 100- and 1000-fold reduced rate.	True	CC[C@H](C)[C@H](NC(=O)[C@H]([C@@H](C)CC)N(C)C(C)=O)C(=O)NC(=O)[C@@H](N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1)[C@@H](C)O
409846	409846:01:04_00.10	True	0.1	95	76.9	0.0	0.0	73.7	0.0	73.5	41.0	71.0	38.0	64.5	0.0	84.4	58.3	Tubulin	84.4	Jasplakinolide	Cell permeable, non-fluorescent F-actin probe. Potent inducer of actin polymerization and stabilization. Competes with phallotoxins for actin binding. Antifungal and antiparasitic compound. Antiproliferative and anticancer compound. Apoptosis enhancer/inducer. Tool used for autophagy/phagocytosis research.	True	C/C1=C\[C@H](C)C[C@H](C)OC(=O)C[C@H](c2ccc(O)cc2)NC(=O)[C@@H](Cc2c(Br)[nH]c3ccccc23)N(C)C(=O)[C@H](C)NC(=O)[C@@H](C)C1
408552	408552:01:08_01.00	True	1.0	94	9.7	0.0	0.0	65.2	0.0	58.9	2.8	81.8	29.4	31.7	0.0	71.0	33.8	LCH	81.8	Azaquindole-1	Azaquindole-1 inhibits starvation- and rapamycin-induced autophagy (IC50 = 0.04 and 0.1 µM, respectively) by targeting the lipid kinase VPS34 (IC50 = 0.35 µM).; Angew. Chem. Int. Ed. Engl. 2020. https://doi.org/10.1002/anie.202000364	True	COc1ccc2nccc([C@@H](O)[C@@H]3C[C@@H]4CCN3c3c4[nH]c4nc(C)c(Br)cc34)c2c1
409849	409849:01:05_01.00	True	1.0	95	56.5	0.0	0.0	69.2	0.0	66.7	2.0	92.8	29.6	35.0	0.0	65.1	36.6	LCH	92.8	UNC0638	UNC0638 selectively inhibits G9a and GLP histone methyltransferase activity with IC50s of less than 15 nM and 19 nM, respectively. UNC0638 has anti-FMDV (foot-and-mouth disease virus) and anti-VSV (vesicular stomatitis virus) activities.	False	COc1cc2c(NC3CCN(C(C)C)CC3)nc(C3CCCCC3)nc2cc1OCCCN1CCCC1
409860	409860:01:04_01.00	True	1.0	93	45.8	0.0	0.0	64.9	0.0	64.0	4.4	91.4	26.8	34.9	0.0	63.1	35.2	LCH	91.4	UNC0642	UNC0642 is a potent and selective lysine methyltransferases G9a and GLP inhibitor, with an IC50 of <2.5 nM for G9a.	False	COc1cc2c(NC3CCN(C(C)C)CC3)nc(N3CCC(F)(F)CC3)nc2cc1OCCCN1CCCC1
410692	410692:01:04_00.20	True	0.2	82	18.1	0.0	24.4	47.3	0.0	45.2	15.9	46.6	32.6	38.7	0.0	77.4	23.9	Tubulin	77.4	Picropodophyllin	Picropodophyllin (AXL1717) is a selective insulin-like growth factor-1 receptor (IGF-1R) inhibitor with an IC50 of 1 nM.	True	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC
409923	409923:01:04_01.00	True	1.0	61	78.1	0.0	0.0	62.3	0.0	61.0	34.1	77.4	25.2	45.8	0.0	70.1	51.6	LCH	77.4	THZ1	THZ1 is a selective and potent covalent CDK7 inhibitor with an IC50 of 3.2 nM. THZ1 also inhibits the closely related kinases CDK12 and CDK13 and downregulates MYC expression.	False	CN(C)C/C=C/C(=O)Nc1ccc(C(=O)Nc2cccc(Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)c2)cc1
410678	410678:01:04_00.20	True	0.2	84	9.3	0.0	39.7	25.9	26.2	25.6	11.2	31.7	19.4	27.1	0.0	54.9	13.1	Tubulin	54.9	ARQ 621	ARQ 621 is an allosteric, and selective Eg5 mitotic motor protein inhibitor. Phase 1.	True	C#CC[C@H](c1nc2cc(Cl)ccc2c(=O)n1Nc1ccccc1)N(CCCN)C(=O)c1cccc(Cl)c1F
410069	410069:01:05_00.20	True	0.2	99	15.4	0.0	0.0	84.2	0.0	85.6	1.4	67.3	61.5	54.2	0.0	82.7	49.5	HDAC	85.6	CAY10603	CAY10603 (BML-281) is a potent and selective HDAC6 inhibitor, with an IC50 of 2 pM; CAY10603 (BML-281) also inhibits HDAC1, HDAC2, HDAC3, HDAC8, HDAC10, with IC50s of 271, 252, 0.42, 6851, 90.7 nM.	False	CC(C)(C)OC(=O)Nc1ccc(-c2cc(C(=O)NCCCCCCC(=O)NO)no2)cc1
409908	409908:01:04_01.00	True	1.0	99	49.2	0.4	0.0	62.2	0.0	62.3	31.2	82.7	16.8	44.4	0.0	65.3	51.4	LCH	82.7	Bafetinib	Bafetinib is a Lyn and Bcr-Abl tyrosine kinase inhibitor with potential antineoplastic activity.	True	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1
339765	339765:02:04_00.20	True	0.2	68	48.5	42.5	0.0	0.0	35.9	0.5	5.5	0.0	42.3	25.5	21.2	0.0	34.9	AKT_PI3K_MTOR	42.5	Ouabain (Octahydrate)	Ouabain Octahydrate is an inhibitor of Na+/K+-ATPase, used for the treatment of congestive heart failure.	True	C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@@H](C6=CC(=O)OC6)CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)[C@H](O)[C@H](O)[C@H]1O
409891	409891:01:05_01.00	True	1.0	101	6.2	40.2	0.0	10.4	49.9	7.7	31.8	51.3	0.0	0.0	12.5	27.8	23.9	LCH	51.3	NVS-CECR2-1	it is a potent inhibitor of CECR2 (cat eye syndrome chromosome region, candidate 2), a component of chromatin complexes that regulate gene expression controlling development. It binds CECR2 with high affinity (IC50 = 0.047 µM by Alpha screen, Kd = 0.80 µM by ITC). NVS-CECR2-1 demonstrates no crossreactivity in a panel of 48 bromodomains and has no major activity in kinase, protease, and receptor panels. It shows robust activity in cells by FRAP assay, due to its slow off-rate, and has no acute toxicity. See the Structural Genomics Consortium (SGC) website for more information.	False	CCCS(=O)(=O)c1nc(NC2CC2)cc(-c2ccc3c(ccn3C3CC(C)(C)NC(C)(C)C3)c2)n1
392742	392742:02:05_00.20	True	0.2	109	46.1	0.0	0.0	85.4	0.0	84.6	29.7	86.2	45.7	62.1	0.0	77.8	68.6	LCH	86.2	VE-822	VE-822 is an ATR inhibitor with IC50 of 19 nM.	False	CNCc1ccc(-c2cc(-c3nc(-c4ccc(S(=O)(=O)C(C)C)cc4)cnc3N)on2)cc1
409910	409910:01:03_01.00	True	1.0	105	63.6	0.1	0.0	76.2	0.0	74.6	40.2	78.3	34.7	58.8	0.0	76.6	64.1	LCH	78.3	HG-9-91-01	HG-9-91-01 is a potent and highly selective salt-inducible kinase (SIK) inhibitor with IC50s of 0.92 nM, 6.6 nM and 9.6 nM for SIK1, SIK2 and SIK3 respectively.	False	COc1ccc(N(C(=O)Nc2c(C)cccc2C)c2cc(Nc3ccc(N4CCN(C)CC4)cc3)ncn2)c(OC)c1
409617	409617:01:05_01.00	True	1.0	98	50.6	0.0	0.0	72.3	0.0	72.2	20.5	85.3	26.2	52.7	0.0	70.4	41.4	LCH	85.3	Siramesine fumarate salt	Siramesine is an agonist of the sigma-2 (?2) receptor (IC50 = 0.19 nM). It is selective for ?2 over ?1 (IC50 = 17 nM) and related receptors and transporters.	False	Fc1ccc(-n2cc(CCCCN3CCC4(CC3)OCc3ccccc34)c3ccccc32)cc1
410084	410084:01:04_00.20	True	0.2	74	27.6	0.0	92.9	0.0	41.3	0.0	17.1	0.0	0.0	0.0	38.1	0.0	0.0	Aurora	92.9	BI-847325	BI-847325 is an ATP competitive dual inhibitor of MEK and aurora kinases (AK) with IC50 values of 4 and 15 nM for human MEK2 and AK-C, respectively.	False	CCNC(=O)C#Cc1ccc2c(/C(=N/c3ccc(CN(C)C)cc3)c3ccccc3)c(O)[nH]c2c1
410152	410152:01:04_00.20	True	0.2	100	15.5	65.1	0.0	0.0	48.2	0.0	25.7	13.4	0.0	0.0	49.3	0.0	0.0	AKT_PI3K_MTOR	65.1	Naquotinib(ASP8273)	Naquotinib(ASP8273) is an orally available, irreversible, mutant-selective, epidermal growth factor receptor (EGFR) inhibitor, with potential antineoplastic activity.	True	C=CC(=O)N1CC[C@@H](Oc2nc(Nc3ccc(N4CCC(N5CCN(C)CC5)CC4)cc3)c(C(N)=O)nc2CC)C1
409952	409952:01:05_00.20	True	0.2	55	70.3	18.7	0.0	49.7	0.0	53.4	38.3	59.8	35.0	51.3	0.0	51.2	50.9	LCH	59.8	Sepantronium (bromide)	Sepantronium bromide (YM-155) is a survivin inhibitor with an IC50 of 0.54 nM.	False	COCCn1c2c([n+](Cc3cnccn3)c1C)C(=O)c1ccccc1C2=O
408552	408552:01:09_01.00	True	1.0	93	9.8	0.0	0.0	70.5	0.0	62.8	6.6	83.9	32.2	27.8	0.0	68.2	35.6	LCH	83.9	Azaquindole-1	Azaquindole-1 inhibits starvation- and rapamycin-induced autophagy (IC50 = 0.04 and 0.1 µM, respectively) by targeting the lipid kinase VPS34 (IC50 = 0.35 µM).; Angew. Chem. Int. Ed. Engl. 2020. https://doi.org/10.1002/anie.202000364	True	COc1ccc2nccc([C@@H](O)[C@@H]3C[C@@H]4CCN3c3c4[nH]c4nc(C)c(Br)cc34)c2c1
410152	410152:01:05_00.20	True	0.2	100	25.4	71.8	0.0	0.0	50.8	0.0	6.8	0.0	0.0	0.0	62.0	0.0	0.0	AKT_PI3K_MTOR	71.8	Naquotinib(ASP8273)	Naquotinib(ASP8273) is an orally available, irreversible, mutant-selective, epidermal growth factor receptor (EGFR) inhibitor, with potential antineoplastic activity.	True	C=CC(=O)N1CC[C@@H](Oc2nc(Nc3ccc(N4CCC(N5CCN(C)CC5)CC4)cc3)c(C(N)=O)nc2CC)C1
409861	409861:01:03_01.00	True	1.0	100	45.4	0.0	0.0	56.2	0.0	57.9	15.7	89.9	18.4	15.6	0.0	54.4	20.8	LCH	89.9	UNC1999	UNC1999 is a SAM-competitive, potent and selective inhibitor of EZH2/1 with IC50s of <10 nM and 45 nM, repectively.	False	CCCc1cc(C)nc(O)c1CNC(=O)c1cc(-c2ccc(N3CCN(C(C)C)CC3)nc2)cc2c1cnn2C(C)C
410069	410069:01:06_00.20	True	0.2	95	25.2	0.0	0.0	86.3	0.0	85.0	7.8	73.2	58.7	56.4	0.0	88.0	51.9	Tubulin	88.0	CAY10603	CAY10603 (BML-281) is a potent and selective HDAC6 inhibitor, with an IC50 of 2 pM; CAY10603 (BML-281) also inhibits HDAC1, HDAC2, HDAC3, HDAC8, HDAC10, with IC50s of 271, 252, 0.42, 6851, 90.7 nM.	False	CC(C)(C)OC(=O)Nc1ccc(-c2cc(C(=O)NCCCCCCC(=O)NO)no2)cc1
409951	409951:02:08_01.00	True	1.0	105	5.0	0.0	0.0	55.5	0.0	47.4	22.5	63.6	23.9	40.0	0.0	63.3	36.7	LCH	63.6	SRT 1720	it is a selective activator of SIRT1 with an EC1.5 of 0.16 µM, and shows less potent activities on SIRT2 and SIRT3 with EC1.5s of 37 µM and 300 µM, respectively.	False	O=C(Nc1ccccc1-c1cn2c(CN3CCNCC3)csc2n1)c1cnc2ccccc2n1
409923	409923:01:05_01.00	True	1.0	67	75.6	0.0	0.0	63.3	0.0	60.9	30.1	77.8	28.0	45.8	0.0	70.3	52.5	LCH	77.8	THZ1	THZ1 is a selective and potent covalent CDK7 inhibitor with an IC50 of 3.2 nM. THZ1 also inhibits the closely related kinases CDK12 and CDK13 and downregulates MYC expression.	False	CN(C)C/C=C/C(=O)Nc1ccc(C(=O)Nc2cccc(Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)c2)cc1
409831	409831:01:03_01.00	True	1.0	101	32.0	0.0	0.0	52.8	0.0	55.4	11.2	83.3	19.2	9.2	0.0	51.6	9.6	LCH	83.3	JQEZ5	JQEZ5 is a potent and selective EZH2 lysine methyltransferase inhibitor. JQEZ5 SAM-competitive inhibition of polycomb repressive complex 2 (PRC2) with an IC50 of 80 nM. JQEZ5 has anti-tumor effects.	False	CCCc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(-c2ccc(N3CCN(C)CC3)nc2)nc2c1cnn2C(C)C
392742	392742:02:04_00.20	True	0.2	106	34.9	0.0	0.0	84.0	0.0	84.3	21.1	84.8	55.4	55.4	0.0	75.8	71.1	LCH	84.8	VE-822	VE-822 is an ATR inhibitor with IC50 of 19 nM.	False	CNCc1ccc(-c2cc(-c3nc(-c4ccc(S(=O)(=O)C(C)C)cc4)cnc3N)on2)cc1
409873	409873:01:03_01.00	True	1.0	100	51.6	0.0	0.0	74.5	0.0	73.4	11.6	96.6	36.7	47.2	0.0	66.0	43.8	LCH	96.6	LLY-507	LLY-507 is a potent and selective inhibitor of protein-lysine methyltransferase SMYD2. LLY-507 potently inhibits the ability of SMYD2 to methylate p53 peptide with an IC50 <15 nM. LLY-507 serves as a valuable chemical probe to aid in the dissection of SMYD2 function in cancer and other biological processes.	False	Cc1cn(CCN2CCN(c3ccccc3-c3cc(C#N)cc(C(=O)NCCCN4CCCC4)c3)CC2)c2ccccc12
409914	409914:01:04_01.00	True	1.0	106	6.6	0.0	0.0	65.1	0.0	66.2	44.2	69.1	29.5	46.1	0.0	69.8	47.5	Tubulin	69.8	AZ6102	AZ6102 is a potent dual TNKS1 and TNKS2 inhibitor, with IC50s of 3 nM and 1 nM, respectively, and alao has 100-fold selectivity against other PARP family enzymes, with IC50s of 2.0 uM, 0.5 uM, and >3 uM, for PARP1, PARP2, and PARP6, respectively.	True	Cc1cc(N2C[C@H](C)N[C@H](C)C2)ncc1-c1ccc(-c2nc(O)c3ccn(C)c3n2)cc1
381945	381945:02:03_01.00	True	1.0	112	6.4	6.9	0.0	0.0	0.0	0.0	26.6	9.4	0.0	0.0	18.1	2.3	0.0	HSP90	26.6	Purmorphamine	Purmorphamine (Shh Signaling Antagonist VI) is a smoothened/Smo receptor agonist with an EC50 of 1 uM.	False	c1ccc2c(Oc3nc(Nc4ccc(N5CCOCC5)cc4)c4ncn(C5CCCCC5)c4n3)cccc2c1
392766	392766:02:04_00.20	True	0.2	56	60.8	0.0	52.3	49.3	0.0	58.7	14.4	45.4	43.2	44.5	0.0	70.4	15.1	Tubulin	70.4	NMS-1286937	NMS-P937 (NMS1286937) is an orally available, selective Polo-like Kinase 1 (PLK1) inhibitor with IC50 of 2 nM, 5000-fold selectivity over PLK2/PLK3. Phase 1.	False	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3CCO)CC4)c2)CC1
409861	409861:01:04_01.00	True	1.0	100	47.3	0.0	0.0	60.4	0.0	62.3	18.6	92.7	20.7	24.2	0.0	58.8	26.4	LCH	92.7	UNC1999	UNC1999 is a SAM-competitive, potent and selective inhibitor of EZH2/1 with IC50s of <10 nM and 45 nM, repectively.	False	CCCc1cc(C)nc(O)c1CNC(=O)c1cc(-c2ccc(N3CCN(C(C)C)CC3)nc2)cc2c1cnn2C(C)C
409902	409902:01:04_01.00	True	1.0	95	61.7	42.1	0.0	41.2	0.0	49.3	41.2	75.9	4.4	27.2	0.0	42.4	52.2	LCH	75.9	URMC-099	URMC-099 is an orally bioavailable and potent mixed lineage kinase type 3 (MLK3) (IC50=14 nM) inhibitor with with excellent blood-brain barrier penetration properties.	False	CN1CCN(Cc2ccc(-c3cnc4[nH]cc(-c5ccc6[nH]ccc6c5)c4c3)cc2)CC1
409908	409908:01:03_01.00	True	1.0	100	48.9	0.0	0.0	64.9	0.0	64.6	26.0	85.2	21.1	43.0	0.0	67.7	47.9	LCH	85.2	Bafetinib	Bafetinib is a Lyn and Bcr-Abl tyrosine kinase inhibitor with potential antineoplastic activity.	True	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1
409887	409887:01:03_01.00	True	1.0	101	40.6	0.0	0.0	68.6	0.0	68.4	27.4	87.0	22.9	49.0	0.0	72.0	40.0	LCH	87.0	DDR1-IN-1 (hydrat)	tThe discoidin domain receptor (DDR) tyrosine kinases are activated by matrix collagens and are important for cell proliferation, differentiation, adhesion, migration, and invasion. DDR1-IN-1 binds to DDR1 and inhibits DDR1 autophosphorylation with an IC50 value of 105 nM and an EC50 value of 87 nM. It demonstrates weaker inhibition for DDR2 (IC50 = 413 nM) and has a good selectivity profile against a panel of 451 kinases.	False	CCN1CCN(Cc2ccc(C(=O)Nc3ccc(C)c(Oc4ccc5c(c4)CC(=O)N5)c3)cc2C(F)(F)F)CC1
407879	407879:02:03_01.00	True	1.0	93	6.9	65.9	0.0	0.0	52.5	0.0	53.2	3.7	0.0	0.0	47.4	0.0	23.8	AKT_PI3K_MTOR	65.9	RSL3	RSL3 ((1S,3R)-RSL3) is an inhibitor of glutathione peroxidase 4 (GPX4) (ferroptosis activator), reduces the expression of GPX4 protein, and induces ferroptotic death of head and neck cancer cell. RSL3 increases the expression of p62 and Nrf2 and inactivates Keap1 in HN3-rslR cells.	True	COC(=O)c1ccc([C@H]2c3[nH]c4ccccc4c3C[C@H](C(=O)OC)N2C(=O)CCl)cc1
410084	410084:01:05_00.20	True	0.2	69	31.8	0.0	91.5	0.0	46.7	0.0	16.9	0.0	0.0	0.0	40.4	0.0	0.0	Aurora	91.5	BI-847325	BI-847325 is an ATP competitive dual inhibitor of MEK and aurora kinases (AK) with IC50 values of 4 and 15 nM for human MEK2 and AK-C, respectively.	False	CCNC(=O)C#Cc1ccc2c(/C(=N/c3ccc(CN(C)C)cc3)c3ccccc3)c(O)[nH]c2c1
409873	409873:01:04_01.00	True	1.0	111	43.0	0.0	0.0	73.1	0.0	71.2	6.0	96.5	33.4	45.2	0.0	62.3	42.4	LCH	96.5	LLY-507	LLY-507 is a potent and selective inhibitor of protein-lysine methyltransferase SMYD2. LLY-507 potently inhibits the ability of SMYD2 to methylate p53 peptide with an IC50 <15 nM. LLY-507 serves as a valuable chemical probe to aid in the dissection of SMYD2 function in cancer and other biological processes.	False	Cc1cn(CCN2CCN(c3ccccc3-c3cc(C#N)cc(C(=O)NCCCN4CCCC4)c3)CC2)c2ccccc12
246961	246961:01:14_01.00	True	1.0	67	43.9	64.5	13.2	0.0	94.9	0.0	25.2	0.0	0.0	0.0	83.8	0.0	0.0	DNA_Synth	94.9	Camptothecin	Camptothecin (Campathecin) is a potent DNA enzyme topoisomerase I inhibitor, with an IC50 of 679 nM.	True	CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1
280171	280171:05:03_01.00	True	1.0	90	53.7	0.0	0.0	64.3	0.0	63.8	0.0	89.4	28.8	28.5	0.0	62.7	31.0	LCH	89.4	BIX01294 (hydrochloride hydrate)	it is a selective inhibitor of G9a HMTase (IC50 = 1.7 µM). It less effectively inhibits the HMTase G9a-like protein (GLP, IC50 = 38 µM) and has no effect on other known HMTases. BIX01294 has been used in combination with the calcium channel activator BayK8644 to facilitate the generation of induced pluripotent stem cells from somatic cells in vitro.	False	COc1cc2nc(N3CCCN(C)CC3)nc(NC3CCN(Cc4ccccc4)CC3)c2cc1OC
409879	409879:01:05_00.20	True	0.2	74	69.1	0.0	0.0	85.2	0.0	93.8	31.1	77.0	61.0	70.2	0.0	77.5	73.4	HDAC	93.8	Romidepsin	Romidepsin, also known as FK228, is a natural bicyclic depsipeptide that, following reduction, selectively inhibits class I histone deacetylases (HDACs). Reduction of a disulfide bond on romidepsin within the cell generates a zinc-binding thiol, allowing potent inhibition of HDACs 1, 2, 3, and 8 (IC50s = 53, 39, 53, and 26 nM, respectively), with less potency against HDACs 4, 6, 7, and 9 (IC50s = 470, 330, 3,200, and 12,000 nM, respectively). Through its effects on HDACs, romidepsin has anti-cancer activities, particularly against certain T cell lymphomas.	True	C/C=C1\NC(=O)[C@H]2CSSCC/C=C/[C@H](CC(=O)N[C@H](C(C)C)C(=O)N2)OC(=O)[C@H](C(C)C)NC1=O
409832	409832:01:04_01.00	True	1.0	55	58.5	30.7	0.0	53.7	10.0	47.8	23.5	66.1	30.3	48.5	0.0	63.2	68.1	Uncoupler	68.1	CCT251236	CCT251236 is an orally available pirin ligand from a heat shock transcription factor 1 (hsf1) phenotypic screen with an IC50 of 19 nM for inhibition of HSF1-mediated HSP72 induction.	False	Cc1ccc(NC(=O)c2ccc3c(c2)OCCO3)cc1NC(=O)c1ccc2nc(OCCN3CCCC3)ccc2c1
409865	409865:01:03_01.00	True	1.0	81	60.8	0.0	49.7	35.2	3.0	39.9	2.7	40.6	28.7	25.1	0.0	61.5	2.7	Tubulin	61.5	Pevonedistat	Pevonedistat (MLN4924) is a potent and selective NEDD8-activating enzyme (NAE) inhibitor with an IC50 of 4.7 nM.	True	NS(=O)(=O)OC[C@@H]1C[C@@H](n2ccc3c(N[C@H]4CCc5ccccc54)ncnc32)C[C@@H]1O
410043	410043:01:04_00.20	True	0.2	108	19.7	0.0	0.0	78.5	0.0	73.6	2.0	84.5	44.3	36.3	0.0	75.7	37.5	LCH	84.5	XMD17-109	XMD17-109 is a novel, specific ERK-5 inhibitor, with an IC50 of 162 nM.	False	CCOc1cc(C(=O)N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc2c(n1)N(C1CCCC1)c1ccccc1C(=O)N2C
409849	409849:01:04_01.00	True	1.0	96	55.4	0.0	0.0	68.8	0.0	67.0	1.9	92.8	30.3	33.8	0.0	65.7	34.5	LCH	92.8	UNC0638	UNC0638 selectively inhibits G9a and GLP histone methyltransferase activity with IC50s of less than 15 nM and 19 nM, respectively. UNC0638 has anti-FMDV (foot-and-mouth disease virus) and anti-VSV (vesicular stomatitis virus) activities.	False	COc1cc2c(NC3CCN(C(C)C)CC3)nc(C3CCCCC3)nc2cc1OCCCN1CCCC1
410134	410134:01:05_00.20	True	0.2	60	80.1	8.1	0.0	51.1	0.0	52.1	34.1	49.6	34.3	58.8	0.0	63.1	60.7	Tubulin	63.1	Epoxomicin	Epoxomicin is a selective proteasome inhibitor with anti-inflammatory activity, inhibits primarily the CH-L activity of the 20S proteasome, while T-L and PGPH catalytic activities are also inhibited at 100- and 1000-fold reduced rate.	True	CC[C@H](C)[C@H](NC(=O)[C@H]([C@@H](C)CC)N(C)C(C)=O)C(=O)NC(=O)[C@@H](N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1)[C@@H](C)O
410692	410692:01:05_00.20	True	0.2	87	14.9	0.0	39.8	42.5	0.0	44.6	25.2	46.9	31.0	27.1	0.0	76.3	9.5	Tubulin	76.3	Picropodophyllin	Picropodophyllin (AXL1717) is a selective insulin-like growth factor-1 receptor (IGF-1R) inhibitor with an IC50 of 1 nM.	True	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC
391925	391925:03:04_00.20	True	0.2	63	73.4	0.0	19.9	71.1	0.0	73.7	30.7	67.7	53.0	57.3	0.0	90.9	41.0	Tubulin	90.9	TCS JNK 5a	inhibitor of c-Jun N-terminal kinase 2/3 (IC50 = 0.3/0.2 µM), Inhibitor of binding or entry into cells for Lassa Virus (IC50 = 0.2 µM); N-(3-Cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)amides as potent, selective, inhibitors of JNK2 and JNK3.  Bioorg Med Chem Lett.  (2007),  17(5),  1296-1301.	False	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2
409951	409951:02:07_01.00	True	1.0	106	5.9	2.9	0.0	32.4	0.0	27.1	21.4	57.6	2.6	0.0	0.0	37.3	9.1	LCH	57.6	SRT 1720	it is a selective activator of SIRT1 with an EC1.5 of 0.16 µM, and shows less potent activities on SIRT2 and SIRT3 with EC1.5s of 37 µM and 300 µM, respectively.	False	O=C(Nc1ccccc1-c1cn2c(CN3CCNCC3)csc2n1)c1cnc2ccccc2n1
409910	409910:01:04_01.00	True	1.0	96	66.3	0.0	0.0	77.2	0.0	75.0	38.8	81.2	34.5	61.7	0.0	78.3	65.5	LCH	81.2	HG-9-91-01	HG-9-91-01 is a potent and highly selective salt-inducible kinase (SIK) inhibitor with IC50s of 0.92 nM, 6.6 nM and 9.6 nM for SIK1, SIK2 and SIK3 respectively.	False	COc1ccc(N(C(=O)Nc2c(C)cccc2C)c2cc(Nc3ccc(N4CCN(C)CC4)cc3)ncn2)c(OC)c1
409879	409879:01:04_00.20	True	0.2	69	69.3	0.0	0.0	86.5	0.0	95.3	30.2	76.3	63.9	70.5	0.0	78.9	72.4	HDAC	95.3	Romidepsin	Romidepsin, also known as FK228, is a natural bicyclic depsipeptide that, following reduction, selectively inhibits class I histone deacetylases (HDACs). Reduction of a disulfide bond on romidepsin within the cell generates a zinc-binding thiol, allowing potent inhibition of HDACs 1, 2, 3, and 8 (IC50s = 53, 39, 53, and 26 nM, respectively), with less potency against HDACs 4, 6, 7, and 9 (IC50s = 470, 330, 3,200, and 12,000 nM, respectively). Through its effects on HDACs, romidepsin has anti-cancer activities, particularly against certain T cell lymphomas.	True	C/C=C1\NC(=O)[C@H]2CSSCC/C=C/[C@H](CC(=O)N[C@H](C(C)C)C(=O)N2)OC(=O)[C@H](C(C)C)NC1=O
409952	409952:01:04_00.20	True	0.2	56	67.7	22.4	0.0	43.2	0.0	45.0	36.6	54.7	30.6	48.1	0.0	45.6	47.8	LCH	54.7	Sepantronium (bromide)	Sepantronium bromide (YM-155) is a survivin inhibitor with an IC50 of 0.54 nM.	False	COCCn1c2c([n+](Cc3cnccn3)c1C)C(=O)c1ccccc1C2=O
246961	246961:01:13_01.00	True	1.0	64	41.3	62.9	13.8	0.0	94.2	0.0	24.5	0.0	0.0	0.0	81.2	0.0	0.0	DNA_Synth	94.2	Camptothecin	Camptothecin (Campathecin) is a potent DNA enzyme topoisomerase I inhibitor, with an IC50 of 679 nM.	True	CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1
392766	392766:02:05_00.20	True	0.2	59	64.9	0.0	46.5	56.0	0.0	64.1	15.0	49.6	47.8	48.9	0.0	76.1	17.1	Tubulin	76.1	NMS-1286937	NMS-P937 (NMS1286937) is an orally available, selective Polo-like Kinase 1 (PLK1) inhibitor with IC50 of 2 nM, 5000-fold selectivity over PLK2/PLK3. Phase 1.	False	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3CCO)CC4)c2)CC1
409831	409831:01:04_01.00	True	1.0	103	34.9	0.0	0.0	52.9	0.0	57.0	26.4	81.1	9.0	20.5	0.0	53.3	18.6	LCH	81.1	JQEZ5	JQEZ5 is a potent and selective EZH2 lysine methyltransferase inhibitor. JQEZ5 SAM-competitive inhibition of polycomb repressive complex 2 (PRC2) with an IC50 of 80 nM. JQEZ5 has anti-tumor effects.	False	CCCc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(-c2ccc(N3CCN(C)CC3)nc2)nc2c1cnn2C(C)C
246972	246972:12:04_00.60	True	0.6	69	62.3	0.0	9.1	73.4	0.0	73.5	36.2	71.7	53.3	59.8	0.0	91.0	50.6	Tubulin	91.0	Mebendazole	Mebendazole is a highly effective, broad-spectrum antihelmintic indicated for the treatment of nematode infestations; has been found as a hedgehog inhibitor.	False	COC(=O)Nc1nc2cc(C(=O)c3ccccc3)ccc2[nH]1
410609	410609:01:04_00.60	True	0.6	60	71.2	29.3	0.0	26.8	32.7	30.0	37.2	34.5	18.6	40.4	0.0	45.7	51.1	Uncoupler	51.1	Delanzomib (CEP-18770)	Delanzomib (CEP-18770) is an orally active inhibitor of the chymotrypsin-like activity of proteasome with IC50 of 3.8 nM, with only marginal inhibition of the tryptic and peptidylglutamyl activities of the proteosome. Phase 1/2.	True	CC(C)[C@H](CNC(=O)[C@@H](NC(=O)c1cccc(-c2ccccc2)n1)[C@@H](C)O)B(O)O
410678	410678:01:05_00.60	True	0.6	55	71.0	0.0	33.4	64.3	0.0	68.2	8.4	56.6	55.6	51.3	0.0	78.5	27.1	Tubulin	78.5	ARQ 621	ARQ 621 is an allosteric, and selective Eg5 mitotic motor protein inhibitor. Phase 1.	True	C#CC[C@H](c1nc2cc(Cl)ccc2c(=O)n1Nc1ccccc1)N(CCCN)C(=O)c1cccc(Cl)c1F
410624	410624:01:04_00.60	True	0.6	76	74.8	0.0	0.0	76.3	0.0	77.5	37.3	80.9	51.2	68.2	0.0	80.5	63.6	LCH	80.9	AZD-7762	AZD7762 is a potent and selective inhibitor of Chk1 with IC50 of 5 nM in a cell-free assay. It is equally potent against Chk2 and less potent against CAM, Yes, Fyn, Lyn, Hck and Lck. Phase 1.	True	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1
408410	408410:02:03_03.00	True	3.0	60	81.9	0.0	12.4	73.6	0.0	77.1	18.2	77.4	44.5	62.6	0.0	74.2	36.2	LCH	77.4	BI 2536	BI 2536 is a dual PLK1 and BRD4 inhibitor with IC50s of 0.83 and 25 nM, respectively. BI-2536 suppresses IFNB (encoding IFN-.b.) gene transcription.	True	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1
409902	409902:01:03_03.00	True	3.0	86	67.0	39.8	0.0	36.3	0.0	46.7	44.7	65.6	0.1	37.8	0.0	36.1	50.0	LCH	65.6	URMC-099	URMC-099 is an orally bioavailable and potent mixed lineage kinase type 3 (MLK3) (IC50=14 nM) inhibitor with with excellent blood-brain barrier penetration properties.	False	CN1CCN(Cc2ccc(-c3cnc4[nH]cc(-c5ccc6[nH]ccc6c5)c4c3)cc2)CC1
409814	409814:01:03_03.00	True	3.0	108	18.0	0.0	0.0	73.5	0.0	68.4	17.6	92.4	20.8	45.2	0.0	69.1	41.6	LCH	92.4	MRK-740	it is a potent inhibitor of PRDM9 with a peptide competitive MOA. MRK-740 inhibits in vitro methylation of H3K4 with IC50 = 85 nM and shows more than 100-fold selectivity over other histone methyltransferases and other non-epigenetic targets. MRK-740 inhibits the methylation of H3K4 in cells with IC50 = 0.8 µM.	False	COc1cc(OC)cc(-c2noc(N3CCN(C)C4(CCN(c5ccnc(C)c5)CC4)C3)n2)c1
409887	409887:01:04_03.00	True	3.0	90	75.0	0.0	0.0	74.9	0.0	72.4	18.1	94.2	30.5	52.8	0.0	74.1	48.7	LCH	94.2	DDR1-IN-1 (hydrat)	tThe discoidin domain receptor (DDR) tyrosine kinases are activated by matrix collagens and are important for cell proliferation, differentiation, adhesion, migration, and invasion. DDR1-IN-1 binds to DDR1 and inhibits DDR1 autophosphorylation with an IC50 value of 105 nM and an EC50 value of 87 nM. It demonstrates weaker inhibition for DDR2 (IC50 = 413 nM) and has a good selectivity profile against a panel of 451 kinases.	False	CCN1CCN(Cc2ccc(C(=O)Nc3ccc(C)c(Oc4ccc5c(c4)CC(=O)N5)c3)cc2C(F)(F)F)CC1
280171	280171:05:04_03.00	True	3.0	88	77.5	0.0	0.0	67.5	0.0	64.1	0.0	82.0	31.1	43.0	0.0	68.0	38.0	LCH	82.0	BIX01294 (hydrochloride hydrate)	it is a selective inhibitor of G9a HMTase (IC50 = 1.7 µM). It less effectively inhibits the HMTase G9a-like protein (GLP, IC50 = 38 µM) and has no effect on other known HMTases. BIX01294 has been used in combination with the calcium channel activator BayK8644 to facilitate the generation of induced pluripotent stem cells from somatic cells in vitro.	False	COc1cc2nc(N3CCCN(C)CC3)nc(NC3CCN(Cc4ccccc4)CC3)c2cc1OC
409865	409865:01:04_03.00	True	3.0	64	72.4	0.0	27.5	48.7	5.2	46.7	5.4	55.3	32.1	37.5	0.0	71.5	25.2	Tubulin	71.5	Pevonedistat	Pevonedistat (MLN4924) is a potent and selective NEDD8-activating enzyme (NAE) inhibitor with an IC50 of 4.7 nM.	True	NS(=O)(=O)OC[C@@H]1C[C@@H](n2ccc3c(N[C@H]4CCc5ccccc54)ncnc32)C[C@@H]1O
410609	410609:01:05_00.60	True	0.6	60	73.7	23.3	0.0	32.6	21.1	35.9	40.9	38.2	21.3	45.8	0.0	49.8	52.6	Uncoupler	52.6	Delanzomib (CEP-18770)	Delanzomib (CEP-18770) is an orally active inhibitor of the chymotrypsin-like activity of proteasome with IC50 of 3.8 nM, with only marginal inhibition of the tryptic and peptidylglutamyl activities of the proteosome. Phase 1/2.	True	CC(C)[C@H](CNC(=O)[C@@H](NC(=O)c1cccc(-c2ccccc2)n1)[C@@H](C)O)B(O)O
409809	409809:01:04_03.00	True	3.0	98	5.2	0.0	0.0	56.3	0.0	49.8	10.6	56.1	39.1	16.0	0.0	69.2	26.9	Tubulin	69.2		it is a dual inhibitor of AAK1 and BMP2K/BIKE. AAK1 is a serine/threonine kinase with broad tissue expression. AAK1 is involved in clathrin-mediated endocytosis, both by direct binding to clathrin and by phosphorylation of the medium subunit of AP-2 (adaptor protein 2). AAK1 has been identified as a negative regulator of Wnt signaling via mediation of LRP6 internalization. BIKE is broadly expressed, and it localizes to nuclear speckles. BIKE was originally identified as its expression was observed to increase upon bone morphogenic protein (BMP-2)-induced differentiation of a prechondroblastic cell line. The same study provided evidence for BIKE having an important regulatory role in attenuating the program of osteoblast differentiation.	False	CCN(CC)S(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1
246972	246972:12:05_00.60	True	0.6	71	50.6	0.0	9.7	71.9	0.0	71.8	27.1	70.2	55.0	55.9	0.0	90.2	49.0	Tubulin	90.2	Mebendazole	Mebendazole is a highly effective, broad-spectrum antihelmintic indicated for the treatment of nematode infestations; has been found as a hedgehog inhibitor.	False	COC(=O)Nc1nc2cc(C(=O)c3ccccc3)ccc2[nH]1
409891	409891:01:04_03.00	True	3.0	73	80.1	0.0	0.0	73.3	0.0	68.3	13.2	81.9	36.5	58.6	0.0	76.6	54.3	LCH	81.9	NVS-CECR2-1	it is a potent inhibitor of CECR2 (cat eye syndrome chromosome region, candidate 2), a component of chromatin complexes that regulate gene expression controlling development. It binds CECR2 with high affinity (IC50 = 0.047 µM by Alpha screen, Kd = 0.80 µM by ITC). NVS-CECR2-1 demonstrates no crossreactivity in a panel of 48 bromodomains and has no major activity in kinase, protease, and receptor panels. It shows robust activity in cells by FRAP assay, due to its slow off-rate, and has no acute toxicity. See the Structural Genomics Consortium (SGC) website for more information.	False	CCCS(=O)(=O)c1nc(NC2CC2)cc(-c2ccc3c(ccn3C3CC(C)(C)NC(C)(C)C3)c2)n1
410043	410043:01:05_00.60	True	0.6	99	59.1	0.0	0.0	76.5	0.0	73.1	0.6	89.1	40.6	46.4	0.0	75.0	33.1	LCH	89.1	XMD17-109	XMD17-109 is a novel, specific ERK-5 inhibitor, with an IC50 of 162 nM.	False	CCOc1cc(C(=O)N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc2c(n1)N(C1CCCC1)c1ccccc1C(=O)N2C
410624	410624:01:05_00.60	True	0.6	73	77.0	0.0	0.0	75.0	0.0	76.4	34.7	82.0	47.4	66.5	0.0	79.2	59.3	LCH	82.0	AZD-7762	AZD7762 is a potent and selective inhibitor of Chk1 with IC50 of 5 nM in a cell-free assay. It is equally potent against Chk2 and less potent against CAM, Yes, Fyn, Lyn, Hck and Lck. Phase 1.	True	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1
410285	410285:01:04_03.00	True	3.0	102	36.4	0.0	0.0	60.9	0.0	61.0	16.3	94.4	19.2	22.5	0.0	56.7	36.1	LCH	94.4	Nemiralisib	Nemiralisib (GSK2269557 free base) is a potent and highly selective PI3K.d. inhibitor with a pKi of 9.9.	False	CC(C)N1CCN(Cc2cnc(-c3cc(-c4cccc5[nH]ccc45)cc4[nH]ncc34)o2)CC1
410285	410285:01:03_03.00	True	3.0	100	34.9	0.0	0.0	63.2	0.0	63.7	13.6	94.4	23.1	28.2	0.0	57.9	38.1	LCH	94.4	Nemiralisib	Nemiralisib (GSK2269557 free base) is a potent and highly selective PI3K.d. inhibitor with a pKi of 9.9.	False	CC(C)N1CCN(Cc2cnc(-c3cc(-c4cccc5[nH]ccc45)cc4[nH]ncc34)o2)CC1
409914	409914:01:03_03.00	True	3.0	90	75.1	0.0	0.0	80.8	0.0	77.9	30.9	85.4	43.2	64.5	0.0	84.4	60.8	LCH	85.4	AZ6102	AZ6102 is a potent dual TNKS1 and TNKS2 inhibitor, with IC50s of 3 nM and 1 nM, respectively, and alao has 100-fold selectivity against other PARP family enzymes, with IC50s of 2.0 uM, 0.5 uM, and >3 uM, for PARP1, PARP2, and PARP6, respectively.	True	Cc1cc(N2C[C@H](C)N[C@H](C)C2)ncc1-c1ccc(-c2nc(O)c3ccn(C)c3n2)cc1
409809	409809:01:05_03.00	True	3.0	85	7.6	0.0	15.6	59.7	0.0	58.3	18.3	52.6	48.9	24.0	0.0	78.0	20.6	Tubulin	78.0		it is a dual inhibitor of AAK1 and BMP2K/BIKE. AAK1 is a serine/threonine kinase with broad tissue expression. AAK1 is involved in clathrin-mediated endocytosis, both by direct binding to clathrin and by phosphorylation of the medium subunit of AP-2 (adaptor protein 2). AAK1 has been identified as a negative regulator of Wnt signaling via mediation of LRP6 internalization. BIKE is broadly expressed, and it localizes to nuclear speckles. BIKE was originally identified as its expression was observed to increase upon bone morphogenic protein (BMP-2)-induced differentiation of a prechondroblastic cell line. The same study provided evidence for BIKE having an important regulatory role in attenuating the program of osteoblast differentiation.	False	CCN(CC)S(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1
408410	408410:03:05_00.60	True	0.6	55	80.1	0.0	22.0	73.0	0.0	77.5	13.9	69.1	53.3	60.2	0.0	77.8	31.4	Tubulin	77.8	BI 2536	BI 2536 is a dual PLK1 and BRD4 inhibitor with IC50s of 0.83 and 25 nM, respectively. BI-2536 suppresses IFNB (encoding IFN-.b.) gene transcription.	True	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1
409860	409860:01:03_03.00	True	3.0	95	71.5	0.0	0.0	68.3	0.0	66.3	0.0	84.9	33.9	38.2	0.0	66.1	35.9	LCH	84.9	UNC0642	UNC0642 is a potent and selective lysine methyltransferases G9a and GLP inhibitor, with an IC50 of <2.5 nM for G9a.	False	COc1cc2c(NC3CCN(C(C)C)CC3)nc(N3CCC(F)(F)CC3)nc2cc1OCCCN1CCCC1
339765	339765:02:05_00.60	True	0.6	54	49.9	0.0	0.0	57.6	0.0	61.5	10.4	37.0	86.7	51.9	0.0	60.0	57.9	Na_K-ATPase	86.7	Ouabain (Octahydrate)	Ouabain Octahydrate is an inhibitor of Na+/K+-ATPase, used for the treatment of congestive heart failure.	True	C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@@H](C6=CC(=O)OC6)CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)[C@H](O)[C@H](O)[C@H]1O
408410	408410:02:04_03.00	True	3.0	57	82.2	0.0	13.8	73.5	0.0	77.4	17.9	76.8	44.8	60.8	0.0	74.3	34.5	HDAC	77.4	BI 2536	BI 2536 is a dual PLK1 and BRD4 inhibitor with IC50s of 0.83 and 25 nM, respectively. BI-2536 suppresses IFNB (encoding IFN-.b.) gene transcription.	True	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1
392542	392542:02:04_00.60	True	0.6	66	45.6	0.0	20.6	46.7	0.0	64.9	56.6	41.2	44.0	48.7	0.0	69.8	38.8	Tubulin	69.8	Rigosertib (ON-01910)	Rigosertib (ON-01910) is a non-ATP-competitive inhibitor of PLK1 with IC50 of 9 nM. It shows 30-fold greater selectivity against Plk2 and no activity to Plk3. Phase 3.	False	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1
409617	409617:01:04_03.00	True	3.0	89	78.1	0.0	0.0	80.5	0.0	74.9	13.2	89.8	34.7	62.6	0.0	75.5	57.5	LCH	89.8	Siramesine fumarate salt	Siramesine is an agonist of the sigma-2 (?2) receptor (IC50 = 0.19 nM). It is selective for ?2 over ?1 (IC50 = 17 nM) and related receptors and transporters.	False	Fc1ccc(-n2cc(CCCCN3CCC4(CC3)OCc3ccccc34)c3ccccc32)cc1
409832	409832:01:03_03.00	True	3.0	60	63.2	14.7	0.0	61.1	0.0	56.6	26.0	76.0	34.5	52.4	0.0	68.4	63.6	LCH	76.0	CCT251236	CCT251236 is an orally available pirin ligand from a heat shock transcription factor 1 (hsf1) phenotypic screen with an IC50 of 19 nM for inhibition of HSF1-mediated HSP72 induction.	False	Cc1ccc(NC(=O)c2ccc3c(c2)OCCO3)cc1NC(=O)c1ccc2nc(OCCN3CCCC3)ccc2c1
410613	410613:01:05_00.60	True	0.6	100	8.6	0.8	0.0	43.9	12.3	31.7	19.3	46.1	13.0	33.9	0.0	74.8	47.6	Tubulin	74.8	2-Methoxyestradiol (2-MeOE2)	2-Methoxyestradiol (2-MeOE2) depolymerizes microtubules and blocks HIF-1¿ nuclear accumulation and HIF-transcriptional activity. Phase 2.	True	COc1cc2c(cc1O)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12
408552	408552:01:08_03.00	True	3.0	90	67.5	0.0	0.0	76.7	0.0	70.0	7.8	86.5	36.2	56.4	0.0	80.7	44.4	LCH	86.5	Azaquindole-1	Azaquindole-1 inhibits starvation- and rapamycin-induced autophagy (IC50 = 0.04 and 0.1 µM, respectively) by targeting the lipid kinase VPS34 (IC50 = 0.35 µM).; Angew. Chem. Int. Ed. Engl. 2020. https://doi.org/10.1002/anie.202000364	True	COc1ccc2nccc([C@@H](O)[C@@H]3C[C@@H]4CCN3c3c4[nH]c4nc(C)c(Br)cc34)c2c1
410065	410065:01:05_00.60	True	0.6	70	49.9	0.0	23.9	55.6	0.0	61.6	29.7	49.0	53.8	40.1	0.0	81.8	28.5	Tubulin	81.8	Domatinostat	Domatinostat (4SC-202 free base) is a selective class I HDAC inhibitor with IC50 of 1.20 uM, 1.12 uM, and 0.57 uM for HDAC1, HDAC2, and HDAC3, respectively. It also displays inhibitory activity against Lysine specific demethylase 1 (LSD1).	False	Cn1cc(-c2ccc(S(=O)(=O)n3ccc(/C=C/C(=O)Nc4ccccc4N)c3)cc2)cn1
410613	410613:01:04_00.60	True	0.6	86	15.5	0.0	0.0	63.6	0.0	60.2	20.7	63.1	29.5	49.2	0.0	79.3	57.0	Tubulin	79.3	2-Methoxyestradiol (2-MeOE2)	2-Methoxyestradiol (2-MeOE2) depolymerizes microtubules and blocks HIF-1¿ nuclear accumulation and HIF-transcriptional activity. Phase 2.	True	COc1cc2c(cc1O)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12
409849	409849:01:05_03.00	True	3.0	97	80.0	0.0	0.0	72.1	0.0	69.2	0.0	84.5	34.3	44.6	0.0	68.1	41.3	LCH	84.5	UNC0638	UNC0638 selectively inhibits G9a and GLP histone methyltransferase activity with IC50s of less than 15 nM and 19 nM, respectively. UNC0638 has anti-FMDV (foot-and-mouth disease virus) and anti-VSV (vesicular stomatitis virus) activities.	False	COc1cc2c(NC3CCN(C(C)C)CC3)nc(C3CCCCC3)nc2cc1OCCCN1CCCC1
409860	409860:01:04_03.00	True	3.0	89	73.2	0.0	0.0	68.0	0.0	65.4	0.0	85.6	30.8	38.8	0.0	65.9	36.2	LCH	85.6	UNC0642	UNC0642 is a potent and selective lysine methyltransferases G9a and GLP inhibitor, with an IC50 of <2.5 nM for G9a.	False	COc1cc2c(NC3CCN(C(C)C)CC3)nc(N3CCC(F)(F)CC3)nc2cc1OCCCN1CCCC1
410692	410692:01:04_00.60	True	0.6	61	58.9	0.0	20.4	62.8	0.0	68.7	47.8	59.6	51.4	56.3	0.0	88.0	43.8	Tubulin	88.0	Picropodophyllin	Picropodophyllin (AXL1717) is a selective insulin-like growth factor-1 receptor (IGF-1R) inhibitor with an IC50 of 1 nM.	True	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC
410678	410678:01:04_00.60	True	0.6	62	68.7	0.0	35.3	59.2	0.0	63.0	7.9	55.0	48.6	52.1	0.0	75.5	25.2	Tubulin	75.5	ARQ 621	ARQ 621 is an allosteric, and selective Eg5 mitotic motor protein inhibitor. Phase 1.	True	C#CC[C@H](c1nc2cc(Cl)ccc2c(=O)n1Nc1ccccc1)N(CCCN)C(=O)c1cccc(Cl)c1F
410069	410069:01:05_00.60	True	0.6	94	45.6	0.0	0.0	82.9	0.0	84.1	9.5	76.2	55.3	57.8	0.0	80.6	58.8	HDAC	84.1	CAY10603	CAY10603 (BML-281) is a potent and selective HDAC6 inhibitor, with an IC50 of 2 pM; CAY10603 (BML-281) also inhibits HDAC1, HDAC2, HDAC3, HDAC8, HDAC10, with IC50s of 271, 252, 0.42, 6851, 90.7 nM.	False	CC(C)(C)OC(=O)Nc1ccc(-c2cc(C(=O)NCCCCCCC(=O)NO)no2)cc1
410105	410105:01:05_00.60	True	0.6	90	24.0	0.0	10.2	44.0	5.3	42.4	7.4	54.1	16.9	31.8	0.0	58.0	37.4	Tubulin	58.0	CB-5083	CB-5083 is a first-in-class, potent, selective, and orally bioavailable inhibitor of the p97 AAA ATPase/VCP.  CB-5083 selectively inhibits p97 through its D2 site with the IC50 of 11 nM	False	Cc1cc2c(C(N)=O)cccc2n1-c1nc2c(c(NCc3ccccc3)n1)COCC2
409908	409908:01:04_03.00	True	3.0	97	68.7	0.0	0.0	73.5	0.0	72.9	21.9	92.5	31.6	48.9	0.0	70.7	51.7	LCH	92.5	Bafetinib	Bafetinib is a Lyn and Bcr-Abl tyrosine kinase inhibitor with potential antineoplastic activity.	True	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1
339765	339765:02:04_00.60	True	0.6	55	50.8	0.0	0.0	58.7	0.0	64.3	3.4	38.7	88.3	48.2	0.0	58.0	59.9	Na_K-ATPase	88.3	Ouabain (Octahydrate)	Ouabain Octahydrate is an inhibitor of Na+/K+-ATPase, used for the treatment of congestive heart failure.	True	C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@@H](C6=CC(=O)OC6)CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)[C@H](O)[C@H](O)[C@H]1O
409891	409891:01:05_03.00	True	3.0	74	78.4	0.0	0.0	62.8	1.3	56.2	17.4	80.0	26.2	46.4	0.0	73.8	52.9	LCH	80.0	NVS-CECR2-1	it is a potent inhibitor of CECR2 (cat eye syndrome chromosome region, candidate 2), a component of chromatin complexes that regulate gene expression controlling development. It binds CECR2 with high affinity (IC50 = 0.047 µM by Alpha screen, Kd = 0.80 µM by ITC). NVS-CECR2-1 demonstrates no crossreactivity in a panel of 48 bromodomains and has no major activity in kinase, protease, and receptor panels. It shows robust activity in cells by FRAP assay, due to its slow off-rate, and has no acute toxicity. See the Structural Genomics Consortium (SGC) website for more information.	False	CCCS(=O)(=O)c1nc(NC2CC2)cc(-c2ccc3c(ccn3C3CC(C)(C)NC(C)(C)C3)c2)n1
392742	392742:02:05_00.60	True	0.6	115	60.8	0.0	0.0	81.2	0.0	81.7	22.7	91.5	43.6	55.4	0.0	73.6	61.6	LCH	91.5	VE-822	VE-822 is an ATR inhibitor with IC50 of 19 nM.	False	CNCc1ccc(-c2cc(-c3nc(-c4ccc(S(=O)(=O)C(C)C)cc4)cnc3N)on2)cc1
410065	410065:01:04_00.60	True	0.6	74	47.2	0.0	17.9	66.0	0.0	72.1	32.0	51.3	59.2	56.4	0.0	83.5	45.2	Tubulin	83.5	Domatinostat	Domatinostat (4SC-202 free base) is a selective class I HDAC inhibitor with IC50 of 1.20 uM, 1.12 uM, and 0.57 uM for HDAC1, HDAC2, and HDAC3, respectively. It also displays inhibitory activity against Lysine specific demethylase 1 (LSD1).	False	Cn1cc(-c2ccc(S(=O)(=O)n3ccc(/C=C/C(=O)Nc4ccccc4N)c3)cc2)cn1
409910	409910:01:03_03.00	True	3.0	94	70.5	0.0	0.0	76.5	0.0	75.3	38.6	82.6	34.8	57.2	0.0	78.0	63.7	LCH	82.6	HG-9-91-01	HG-9-91-01 is a potent and highly selective salt-inducible kinase (SIK) inhibitor with IC50s of 0.92 nM, 6.6 nM and 9.6 nM for SIK1, SIK2 and SIK3 respectively.	False	COc1ccc(N(C(=O)Nc2c(C)cccc2C)c2cc(Nc3ccc(N4CCN(C)CC4)cc3)ncn2)c(OC)c1
392542	392542:02:05_00.60	True	0.6	66	45.6	0.0	18.6	41.7	0.0	60.3	60.1	35.4	41.0	51.5	0.0	65.9	37.0	Tubulin	65.9	Rigosertib (ON-01910)	Rigosertib (ON-01910) is a non-ATP-competitive inhibitor of PLK1 with IC50 of 9 nM. It shows 30-fold greater selectivity against Plk2 and no activity to Plk3. Phase 3.	False	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1
409617	409617:01:05_03.00	True	3.0	90	80.7	0.0	0.0	75.9	0.0	72.6	18.5	87.7	31.3	63.2	0.0	74.0	53.7	LCH	87.7	Siramesine fumarate salt	Siramesine is an agonist of the sigma-2 (?2) receptor (IC50 = 0.19 nM). It is selective for ?2 over ?1 (IC50 = 17 nM) and related receptors and transporters.	False	Fc1ccc(-n2cc(CCCCN3CCC4(CC3)OCc3ccccc34)c3ccccc32)cc1
409814	409814:01:04_03.00	True	3.0	89	13.6	0.0	0.0	64.4	0.0	64.1	25.6	87.1	13.5	36.6	0.0	68.0	31.2	LCH	87.1	MRK-740	it is a potent inhibitor of PRDM9 with a peptide competitive MOA. MRK-740 inhibits in vitro methylation of H3K4 with IC50 = 85 nM and shows more than 100-fold selectivity over other histone methyltransferases and other non-epigenetic targets. MRK-740 inhibits the methylation of H3K4 in cells with IC50 = 0.8 µM.	False	COc1cc(OC)cc(-c2noc(N3CCN(C)C4(CCN(c5ccnc(C)c5)CC4)C3)n2)c1
410084	410084:01:04_00.60	True	0.6	67	37.0	0.0	79.9	0.0	24.9	3.7	40.7	25.3	0.0	0.0	2.0	23.8	0.0	Aurora	79.9	BI-847325	BI-847325 is an ATP competitive dual inhibitor of MEK and aurora kinases (AK) with IC50 values of 4 and 15 nM for human MEK2 and AK-C, respectively.	False	CCNC(=O)C#Cc1ccc2c(/C(=N/c3ccc(CN(C)C)cc3)c3ccccc3)c(O)[nH]c2c1
410152	410152:01:04_00.60	True	0.6	108	44.4	38.6	0.0	41.2	0.0	42.2	23.4	81.1	6.4	12.1	0.0	44.1	43.9	LCH	81.1	Naquotinib(ASP8273)	Naquotinib(ASP8273) is an orally available, irreversible, mutant-selective, epidermal growth factor receptor (EGFR) inhibitor, with potential antineoplastic activity.	True	C=CC(=O)N1CC[C@@H](Oc2nc(Nc3ccc(N4CCC(N5CCN(C)CC5)CC4)cc3)c(C(N)=O)nc2CC)C1
409915	409915:01:04_03.00	True	3.0	95	7.9	0.0	0.0	74.8	0.0	77.8	4.4	60.1	65.7	41.1	0.0	76.2	54.4	HDAC	77.8	TP-472	it is an inhibitor of bromodomain BRD9 (Kd = 33 nM; EC50 = 320 nM in a NanoBRET assay). It has >30-fold selectivity over all other bromodomain family members with the exception of the highly homologous BRD7 bromodomain (Kd = 340 nM in an isothermal titration calorimetry (ITC) assay). See the Structural Genomic Consortium (SGC) website for more information.	False	CC(=O)c1cc(-c2cc(C(=O)NC3CC3)ccc2C)c2ncccn12
409952	409952:01:05_00.60	True	0.6	54	82.4	0.0	0.0	67.3	0.0	69.0	20.3	68.3	53.9	61.0	0.0	63.9	52.0	HDAC	69.0	Sepantronium (bromide)	Sepantronium bromide (YM-155) is a survivin inhibitor with an IC50 of 0.54 nM.	False	COCCn1c2c([n+](Cc3cnccn3)c1C)C(=O)c1ccccc1C2=O
381945	381945:02:04_03.00	True	3.0	94	5.2	0.0	0.0	17.3	0.0	20.1	20.4	21.6	20.6	11.6	0.0	2.1	0.0	LCH	21.6	Purmorphamine	Purmorphamine (Shh Signaling Antagonist VI) is a smoothened/Smo receptor agonist with an EC50 of 1 uM.	False	c1ccc2c(Oc3nc(Nc4ccc(N5CCOCC5)cc4)c4ncn(C5CCCCC5)c4n3)cccc2c1
408552	408552:01:09_03.00	True	3.0	86	60.3	0.0	0.0	74.6	0.0	70.1	8.8	83.0	39.1	54.7	0.0	81.0	40.4	LCH	83.0	Azaquindole-1	Azaquindole-1 inhibits starvation- and rapamycin-induced autophagy (IC50 = 0.04 and 0.1 µM, respectively) by targeting the lipid kinase VPS34 (IC50 = 0.35 µM).; Angew. Chem. Int. Ed. Engl. 2020. https://doi.org/10.1002/anie.202000364	True	COc1ccc2nccc([C@@H](O)[C@@H]3C[C@@H]4CCN3c3c4[nH]c4nc(C)c(Br)cc34)c2c1
407879	407879:02:04_03.00	True	3.0	90	21.6	71.4	0.0	0.0	65.0	0.0	61.4	7.3	0.0	0.0	45.0	0.0	26.1	AKT_PI3K_MTOR	71.4	RSL3	RSL3 ((1S,3R)-RSL3) is an inhibitor of glutathione peroxidase 4 (GPX4) (ferroptosis activator), reduces the expression of GPX4 protein, and induces ferroptotic death of head and neck cancer cell. RSL3 increases the expression of p62 and Nrf2 and inactivates Keap1 in HN3-rslR cells.	True	COC(=O)c1ccc([C@H]2c3[nH]c4ccccc4c3C[C@H](C(=O)OC)N2C(=O)CCl)cc1
410152	410152:01:05_00.60	True	0.6	95	38.2	29.5	0.0	47.3	0.0	49.9	24.9	83.8	18.0	16.0	0.0	50.0	47.4	LCH	83.8	Naquotinib(ASP8273)	Naquotinib(ASP8273) is an orally available, irreversible, mutant-selective, epidermal growth factor receptor (EGFR) inhibitor, with potential antineoplastic activity.	True	C=CC(=O)N1CC[C@@H](Oc2nc(Nc3ccc(N4CCC(N5CCN(C)CC5)CC4)cc3)c(C(N)=O)nc2CC)C1
409861	409861:01:03_03.00	True	3.0	93	70.6	0.0	0.0	67.2	0.0	66.8	16.4	93.3	23.8	38.3	0.0	64.0	40.9	LCH	93.3	UNC1999	UNC1999 is a SAM-competitive, potent and selective inhibitor of EZH2/1 with IC50s of <10 nM and 45 nM, repectively.	False	CCCc1cc(C)nc(O)c1CNC(=O)c1cc(-c2ccc(N3CCN(C(C)C)CC3)nc2)cc2c1cnn2C(C)C
410069	410069:01:06_00.60	True	0.6	91	51.8	0.0	0.0	85.4	0.0	88.0	9.3	76.6	61.5	54.3	0.0	84.0	59.0	HDAC	88.0	CAY10603	CAY10603 (BML-281) is a potent and selective HDAC6 inhibitor, with an IC50 of 2 pM; CAY10603 (BML-281) also inhibits HDAC1, HDAC2, HDAC3, HDAC8, HDAC10, with IC50s of 271, 252, 0.42, 6851, 90.7 nM.	False	CC(C)(C)OC(=O)Nc1ccc(-c2cc(C(=O)NCCCCCCC(=O)NO)no2)cc1
409951	409951:02:08_03.00	True	3.0	89	81.5	0.0	0.0	68.7	0.0	67.3	22.4	83.3	28.3	56.4	0.0	75.0	47.2	LCH	83.3	SRT 1720	it is a selective activator of SIRT1 with an EC1.5 of 0.16 µM, and shows less potent activities on SIRT2 and SIRT3 with EC1.5s of 37 µM and 300 µM, respectively.	False	O=C(Nc1ccccc1-c1cn2c(CN3CCNCC3)csc2n1)c1cnc2ccccc2n1
409831	409831:01:03_03.00	True	3.0	82	78.9	0.0	0.0	78.1	0.0	76.6	6.1	92.0	45.9	55.5	0.0	76.0	46.6	LCH	92.0	JQEZ5	JQEZ5 is a potent and selective EZH2 lysine methyltransferase inhibitor. JQEZ5 SAM-competitive inhibition of polycomb repressive complex 2 (PRC2) with an IC50 of 80 nM. JQEZ5 has anti-tumor effects.	False	CCCc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(-c2ccc(N3CCN(C)CC3)nc2)nc2c1cnn2C(C)C
392742	392742:02:04_00.60	True	0.6	108	51.6	0.0	0.0	81.5	0.0	82.1	14.5	91.5	52.1	51.3	0.0	73.4	62.1	LCH	91.5	VE-822	VE-822 is an ATR inhibitor with IC50 of 19 nM.	False	CNCc1ccc(-c2cc(-c3nc(-c4ccc(S(=O)(=O)C(C)C)cc4)cnc3N)on2)cc1
409873	409873:01:03_03.00	True	3.0	98	80.0	0.0	0.0	75.9	0.0	72.4	14.7	89.7	31.1	55.2	0.0	71.7	53.2	LCH	89.7	LLY-507	LLY-507 is a potent and selective inhibitor of protein-lysine methyltransferase SMYD2. LLY-507 potently inhibits the ability of SMYD2 to methylate p53 peptide with an IC50 <15 nM. LLY-507 serves as a valuable chemical probe to aid in the dissection of SMYD2 function in cancer and other biological processes.	False	Cc1cn(CCN2CCN(c3ccccc3-c3cc(C#N)cc(C(=O)NCCCN4CCCC4)c3)CC2)c2ccccc12
409914	409914:01:04_03.00	True	3.0	88	67.9	0.0	0.0	81.1	0.0	76.8	23.7	86.7	43.1	62.3	0.0	83.2	62.4	LCH	86.7	AZ6102	AZ6102 is a potent dual TNKS1 and TNKS2 inhibitor, with IC50s of 3 nM and 1 nM, respectively, and alao has 100-fold selectivity against other PARP family enzymes, with IC50s of 2.0 uM, 0.5 uM, and >3 uM, for PARP1, PARP2, and PARP6, respectively.	True	Cc1cc(N2C[C@H](C)N[C@H](C)C2)ncc1-c1ccc(-c2nc(O)c3ccn(C)c3n2)cc1
409861	409861:01:04_03.00	True	3.0	92	68.7	0.0	0.0	66.5	0.0	65.2	14.7	92.9	21.9	36.9	0.0	64.1	40.3	LCH	92.9	UNC1999	UNC1999 is a SAM-competitive, potent and selective inhibitor of EZH2/1 with IC50s of <10 nM and 45 nM, repectively.	False	CCCc1cc(C)nc(O)c1CNC(=O)c1cc(-c2ccc(N3CCN(C(C)C)CC3)nc2)cc2c1cnn2C(C)C
409902	409902:01:04_03.00	True	3.0	89	67.2	40.1	0.0	37.2	0.0	47.8	44.0	65.0	2.2	39.9	0.0	36.3	51.3	LCH	65.0	URMC-099	URMC-099 is an orally bioavailable and potent mixed lineage kinase type 3 (MLK3) (IC50=14 nM) inhibitor with with excellent blood-brain barrier penetration properties.	False	CN1CCN(Cc2ccc(-c3cnc4[nH]cc(-c5ccc6[nH]ccc6c5)c4c3)cc2)CC1
409908	409908:01:03_03.00	True	3.0	95	67.5	0.0	0.0	73.7	0.0	72.7	21.8	92.0	29.9	52.3	0.0	70.7	52.5	LCH	92.0	Bafetinib	Bafetinib is a Lyn and Bcr-Abl tyrosine kinase inhibitor with potential antineoplastic activity.	True	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1
409887	409887:01:03_03.00	True	3.0	96	73.2	0.0	0.0	75.0	0.0	72.2	19.1	94.8	29.2	51.5	0.0	73.7	49.7	LCH	94.8	DDR1-IN-1 (hydrat)	tThe discoidin domain receptor (DDR) tyrosine kinases are activated by matrix collagens and are important for cell proliferation, differentiation, adhesion, migration, and invasion. DDR1-IN-1 binds to DDR1 and inhibits DDR1 autophosphorylation with an IC50 value of 105 nM and an EC50 value of 87 nM. It demonstrates weaker inhibition for DDR2 (IC50 = 413 nM) and has a good selectivity profile against a panel of 451 kinases.	False	CCN1CCN(Cc2ccc(C(=O)Nc3ccc(C)c(Oc4ccc5c(c4)CC(=O)N5)c3)cc2C(F)(F)F)CC1
409916	409916:01:03_03.00	True	3.0	107	22.1	0.0	0.0	75.9	0.0	76.9	16.1	93.1	39.0	49.7	0.0	70.8	40.9	LCH	93.1	TP-064	it is a potent inhibitor of protein arginine methyltransferase 4 (PRMT4, IC50 50 = 43 nM) in vitro. See the Structural Genomics Consortium (SGC) website for more information.	False	CNCCN1CCC(c2cc(CN(C)C(=O)c3cccc(Oc4ccccc4)c3)ccn2)CC1
407879	407879:02:03_03.00	True	3.0	87	23.1	74.7	0.0	0.0	73.2	0.0	55.9	0.0	0.0	0.0	56.8	0.0	18.3	AKT_PI3K_MTOR	74.7	RSL3	RSL3 ((1S,3R)-RSL3) is an inhibitor of glutathione peroxidase 4 (GPX4) (ferroptosis activator), reduces the expression of GPX4 protein, and induces ferroptotic death of head and neck cancer cell. RSL3 increases the expression of p62 and Nrf2 and inactivates Keap1 in HN3-rslR cells.	True	COC(=O)c1ccc([C@H]2c3[nH]c4ccccc4c3C[C@H](C(=O)OC)N2C(=O)CCl)cc1
410105	410105:01:04_00.60	True	0.6	95	29.5	0.0	7.6	47.4	7.2	43.8	4.1	58.8	15.9	32.5	0.0	59.8	37.6	Tubulin	59.8	CB-5083	CB-5083 is a first-in-class, potent, selective, and orally bioavailable inhibitor of the p97 AAA ATPase/VCP.  CB-5083 selectively inhibits p97 through its D2 site with the IC50 of 11 nM	False	Cc1cc2c(C(N)=O)cccc2n1-c1nc2c(c(NCc3ccccc3)n1)COCC2
410084	410084:01:05_00.60	True	0.6	70	50.1	0.0	81.2	0.0	25.7	1.2	45.1	24.5	0.0	0.0	3.1	27.1	0.0	Aurora	81.2	BI-847325	BI-847325 is an ATP competitive dual inhibitor of MEK and aurora kinases (AK) with IC50 values of 4 and 15 nM for human MEK2 and AK-C, respectively.	False	CCNC(=O)C#Cc1ccc2c(/C(=N/c3ccc(CN(C)C)cc3)c3ccccc3)c(O)[nH]c2c1
409873	409873:01:04_03.00	True	3.0	95	80.5	0.0	0.0	76.3	0.0	72.4	11.4	89.3	32.7	54.3	0.0	72.1	53.3	LCH	89.3	LLY-507	LLY-507 is a potent and selective inhibitor of protein-lysine methyltransferase SMYD2. LLY-507 potently inhibits the ability of SMYD2 to methylate p53 peptide with an IC50 <15 nM. LLY-507 serves as a valuable chemical probe to aid in the dissection of SMYD2 function in cancer and other biological processes.	False	Cc1cn(CCN2CCN(c3ccccc3-c3cc(C#N)cc(C(=O)NCCCN4CCCC4)c3)CC2)c2ccccc12
246961	246961:01:14_03.00	True	3.0	63	43.7	64.7	0.0	0.0	87.7	0.0	32.7	0.0	0.0	0.0	75.7	0.0	0.0	DNA_Synth	87.7	Camptothecin	Camptothecin (Campathecin) is a potent DNA enzyme topoisomerase I inhibitor, with an IC50 of 679 nM.	True	CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1
280171	280171:05:03_03.00	True	3.0	89	78.9	0.0	0.0	68.4	0.0	65.6	0.0	82.4	32.6	44.1	0.0	68.5	38.2	LCH	82.4	BIX01294 (hydrochloride hydrate)	it is a selective inhibitor of G9a HMTase (IC50 = 1.7 µM). It less effectively inhibits the HMTase G9a-like protein (GLP, IC50 = 38 µM) and has no effect on other known HMTases. BIX01294 has been used in combination with the calcium channel activator BayK8644 to facilitate the generation of induced pluripotent stem cells from somatic cells in vitro.	False	COc1cc2nc(N3CCCN(C)CC3)nc(NC3CCN(Cc4ccccc4)CC3)c2cc1OC
409879	409879:01:05_00.60	True	0.6	70	68.4	0.0	0.0	83.3	0.0	92.8	32.2	77.3	62.4	69.0	0.0	76.9	70.1	HDAC	92.8	Romidepsin	Romidepsin, also known as FK228, is a natural bicyclic depsipeptide that, following reduction, selectively inhibits class I histone deacetylases (HDACs). Reduction of a disulfide bond on romidepsin within the cell generates a zinc-binding thiol, allowing potent inhibition of HDACs 1, 2, 3, and 8 (IC50s = 53, 39, 53, and 26 nM, respectively), with less potency against HDACs 4, 6, 7, and 9 (IC50s = 470, 330, 3,200, and 12,000 nM, respectively). Through its effects on HDACs, romidepsin has anti-cancer activities, particularly against certain T cell lymphomas.	True	C/C=C1\NC(=O)[C@H]2CSSCC/C=C/[C@H](CC(=O)N[C@H](C(C)C)C(=O)N2)OC(=O)[C@H](C(C)C)NC1=O
409832	409832:01:04_03.00	True	3.0	59	64.6	15.6	0.0	59.9	0.0	55.2	26.6	74.1	34.2	53.4	0.0	67.4	63.2	LCH	74.1	CCT251236	CCT251236 is an orally available pirin ligand from a heat shock transcription factor 1 (hsf1) phenotypic screen with an IC50 of 19 nM for inhibition of HSF1-mediated HSP72 induction.	False	Cc1ccc(NC(=O)c2ccc3c(c2)OCCO3)cc1NC(=O)c1ccc2nc(OCCN3CCCC3)ccc2c1
409865	409865:01:03_03.00	True	3.0	66	71.8	0.0	28.1	49.3	4.7	47.5	3.9	56.1	33.9	36.0	0.0	71.5	26.3	Tubulin	71.5	Pevonedistat	Pevonedistat (MLN4924) is a potent and selective NEDD8-activating enzyme (NAE) inhibitor with an IC50 of 4.7 nM.	True	NS(=O)(=O)OC[C@@H]1C[C@@H](n2ccc3c(N[C@H]4CCc5ccccc54)ncnc32)C[C@@H]1O
410043	410043:01:04_00.60	True	0.6	107	50.9	0.0	0.0	72.4	0.0	69.6	0.0	88.5	35.7	34.6	0.0	71.1	27.9	LCH	88.5	XMD17-109	XMD17-109 is a novel, specific ERK-5 inhibitor, with an IC50 of 162 nM.	False	CCOc1cc(C(=O)N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc2c(n1)N(C1CCCC1)c1ccccc1C(=O)N2C
409849	409849:01:04_03.00	True	3.0	90	80.3	0.0	0.0	71.5	0.0	68.7	0.0	84.2	33.6	45.2	0.0	67.8	41.6	LCH	84.2	UNC0638	UNC0638 selectively inhibits G9a and GLP histone methyltransferase activity with IC50s of less than 15 nM and 19 nM, respectively. UNC0638 has anti-FMDV (foot-and-mouth disease virus) and anti-VSV (vesicular stomatitis virus) activities.	False	COc1cc2c(NC3CCN(C(C)C)CC3)nc(C3CCCCC3)nc2cc1OCCCN1CCCC1
408410	408410:03:04_00.60	True	0.6	51	79.4	0.0	24.1	69.3	0.0	74.5	14.7	67.7	50.6	59.0	0.0	75.2	27.5	Tubulin	75.2	BI 2536	BI 2536 is a dual PLK1 and BRD4 inhibitor with IC50s of 0.83 and 25 nM, respectively. BI-2536 suppresses IFNB (encoding IFN-.b.) gene transcription.	True	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1
410692	410692:01:05_00.60	True	0.6	65	60.8	0.0	16.2	63.2	0.0	69.5	47.5	60.8	51.3	57.1	0.0	88.8	47.1	Tubulin	88.8	Picropodophyllin	Picropodophyllin (AXL1717) is a selective insulin-like growth factor-1 receptor (IGF-1R) inhibitor with an IC50 of 1 nM.	True	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC
392578	392578:02:05_00.60	True	0.6	91	8.1	0.0	23.3	28.5	16.4	24.4	7.8	44.9	5.7	10.7	0.0	47.9	11.0	Tubulin	47.9	Gandotinib	Gandotinib (LY2784544) is a potent JAK2 inhibitor with IC50 of 3 nM. Gandotinib (LY2784544) also inhibits FLT3, FLT4, FGFR2, TYK2, and TRKB with IC50 of 4, 25, 32, 44, and 95 nM.	False	Cc1cc(Nc2cc(CN3CCOCC3)c3nc(C)c(Cc4ccc(Cl)cc4F)n3n2)[nH]n1
391925	391925:03:04_00.60	True	0.6	54	81.0	0.0	21.6	70.2	0.0	74.9	38.8	64.7	51.6	64.2	0.0	85.7	42.9	Tubulin	85.7	TCS JNK 5a	inhibitor of c-Jun N-terminal kinase 2/3 (IC50 = 0.3/0.2 µM), Inhibitor of binding or entry into cells for Lassa Virus (IC50 = 0.2 µM); N-(3-Cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)amides as potent, selective, inhibitors of JNK2 and JNK3.  Bioorg Med Chem Lett.  (2007),  17(5),  1296-1301.	False	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2
409910	409910:01:04_03.00	True	3.0	85	72.0	0.0	0.0	78.3	0.0	76.7	38.4	84.0	36.4	60.1	0.0	79.5	63.7	LCH	84.0	HG-9-91-01	HG-9-91-01 is a potent and highly selective salt-inducible kinase (SIK) inhibitor with IC50s of 0.92 nM, 6.6 nM and 9.6 nM for SIK1, SIK2 and SIK3 respectively.	False	COc1ccc(N(C(=O)Nc2c(C)cccc2C)c2cc(Nc3ccc(N4CCN(C)CC4)cc3)ncn2)c(OC)c1
409879	409879:01:04_00.60	True	0.6	71	68.2	0.0	0.0	82.9	0.0	92.2	30.8	77.6	61.6	69.3	0.0	76.1	69.2	HDAC	92.2	Romidepsin	Romidepsin, also known as FK228, is a natural bicyclic depsipeptide that, following reduction, selectively inhibits class I histone deacetylases (HDACs). Reduction of a disulfide bond on romidepsin within the cell generates a zinc-binding thiol, allowing potent inhibition of HDACs 1, 2, 3, and 8 (IC50s = 53, 39, 53, and 26 nM, respectively), with less potency against HDACs 4, 6, 7, and 9 (IC50s = 470, 330, 3,200, and 12,000 nM, respectively). Through its effects on HDACs, romidepsin has anti-cancer activities, particularly against certain T cell lymphomas.	True	C/C=C1\NC(=O)[C@H]2CSSCC/C=C/[C@H](CC(=O)N[C@H](C(C)C)C(=O)N2)OC(=O)[C@H](C(C)C)NC1=O
409916	409916:01:04_03.00	True	3.0	96	29.0	0.0	0.0	68.6	0.0	70.0	13.7	88.8	35.9	39.2	0.0	67.2	29.0	LCH	88.8	TP-064	it is a potent inhibitor of protein arginine methyltransferase 4 (PRMT4, IC50 50 = 43 nM) in vitro. See the Structural Genomics Consortium (SGC) website for more information.	False	CNCCN1CCC(c2cc(CN(C)C(=O)c3cccc(Oc4ccccc4)c3)ccn2)CC1
246961	246961:01:13_03.00	True	3.0	66	41.3	65.0	1.3	0.0	89.5	0.0	25.0	0.0	0.0	0.0	79.8	0.0	0.0	DNA_Synth	89.5	Camptothecin	Camptothecin (Campathecin) is a potent DNA enzyme topoisomerase I inhibitor, with an IC50 of 679 nM.	True	CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1
392766	392766:02:05_00.60	True	0.6	50	70.3	0.0	50.2	46.9	0.0	53.5	13.7	44.0	38.9	44.2	0.0	65.7	11.4	Tubulin	65.7	NMS-1286937	NMS-P937 (NMS1286937) is an orally available, selective Polo-like Kinase 1 (PLK1) inhibitor with IC50 of 2 nM, 5000-fold selectivity over PLK2/PLK3. Phase 1.	False	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3CCO)CC4)c2)CC1
409831	409831:01:04_03.00	True	3.0	82	80.0	0.0	0.0	76.8	0.0	75.8	9.6	92.3	42.8	55.6	0.0	76.5	45.4	LCH	92.3	JQEZ5	JQEZ5 is a potent and selective EZH2 lysine methyltransferase inhibitor. JQEZ5 SAM-competitive inhibition of polycomb repressive complex 2 (PRC2) with an IC50 of 80 nM. JQEZ5 has anti-tumor effects.	False	CCCc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(-c2ccc(N3CCN(C)CC3)nc2)nc2c1cnn2C(C)C
410005	410005:01:04_06.00	True	6.0	102	9.0	17.4	0.0	11.7	1.9	9.6	34.9	40.9	0.0	11.6	1.0	18.7	0.0	LCH	40.9	Rimonabant	Rimonabant is a selective antagonist of CB1 with IC50 of 13.6 nM and EC50 of 17.3 nM in hCB1 transfected HEK 293 membrane.	False	Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1
410752	410752:01:04_06.00	True	6.0	95	60.4	0.0	0.0	83.8	0.0	76.9	18.7	63.7	53.4	63.5	0.0	86.2	46.7	Tubulin	86.2	Cyclo (-RGDfK)	Cyclo (-RGDfK) is a potent and selective ¿vß3 integrin inhibitor.	True	NCCCC[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC1=O
247066	247066:11:04_06.00	True	6.0	102	6.4	0.0	0.0	81.5	0.0	70.2	8.8	65.1	42.9	63.0	0.0	71.0	63.8	BET	81.5	Triamterene	Na+ channel blocker, diuretic, Non competitive aldosterone antagonist.	False	Nc1nc(N)c2nc(-c3ccccc3)c(N)nc2n1
410106	410106:01:04_06.00	True	6.0	100	49.7	0.0	0.0	76.8	0.0	76.4	1.9	81.6	46.0	58.3	0.0	76.1	39.4	LCH	81.6	MS023	MS023 is a potent, selective, and cell-active inhibitor of human type I protein arginine methyltransferases (PRMTs) inhibitor, with IC50s of 30, 119, 83, 4 and 5 nM for PRMT1, PRMT3, PRMT4, PRMT6, and PRMT8, respectively.	False	CC(C)Oc1ccc(-c2c[nH]cc2CN(C)CCN)cc1
246883	246883:07:04_06.00	True	6.0	97	27.1	0.0	0.0	40.6	0.0	46.5	36.4	64.1	8.1	22.5	0.0	39.0	12.6	LCH	64.1	Fulvestrant	Fulvestrant (ICI 182780) is a pure antiestrogen and a potent estrogen receptor (ER) antagonist with an IC50 of 9.4 nM. Fulvestrant effectively inhibits the growth of ER-positive MCF-7 cells with an IC50 of 0.29 nM. Fulvestrant also induces autophagy and has antitumor efficacy.	True	C[C@]12CC[C@@H]3c4ccc(O)cc4C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@H]3[C@@H]1CC[C@@H]2O
410103	410103:01:04_06.00	True	6.0	76	45.8	0.0	0.0	68.7	0.0	58.9	23.9	76.9	28.1	51.4	0.0	74.4	56.2	LCH	76.9	ASP3026	ASP3026 is a potent, selective and orally active inhibitor of anaplastic lymphoma kinase (ALK). ASP3026 induces apoptosis of tumor cells. ASP3026 can be used for the research of non-small cell lung cancer (NSCLC).	False	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1
410633	410633:01:04_06.00	True	6.0	98	46.3	0.0	0.0	89.4	0.0	82.7	15.2	64.6	56.2	80.4	0.0	82.5	66.5	BET	89.4	Atorvastatin Calcium	Atorvastatin Calcium is an inhibitor of HMG-CoA reductase used as a cholesterol-lowering medication that blocks the production of cholesterol.	True	CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)O
410151	410151:01:04_06.00	True	6.0	100	11.2	67.0	0.0	0.0	74.7	0.0	16.0	0.0	0.0	0.0	69.1	0.0	0.0	DNA_Synth	74.7	CCT245737	CCT245737 is an orally active and seletive Chk1 inhibitor, with an IC50 of 1.3 nM.	True	N#Cc1cnc(Nc2cc(NC[C@H]3CNCCO3)c(C(F)(F)F)cn2)cn1
410654	410654:01:05_06.00	True	6.0	98	7.3	49.4	0.0	24.3	16.0	19.3	7.8	40.4	3.9	20.3	0.0	26.9	54.5	Uncoupler	54.5	(S)-Gossypol (acetic acid)	(S)-Gossypol is the isomer of a natural product Gossypol. (S)-Gossypol binds to the BH3-binding groove of Bcl-xL and Bcl-2 proteins with high affinity.	False	Cc1cc2c(C(C)C)c(O)c(O)c(C=O)c2c(O)c1-c1c(C)cc2c(C(C)C)c(O)c(O)c(C=O)c2c1O
410677	410677:01:03_06.00	True	6.0	60	46.3	11.7	61.0	0.0	54.5	0.0	39.0	22.6	0.0	0.0	34.6	3.3	0.0	Aurora	61.0	UNC2250	UNC2250 is a potent and selective Mer inhibitor with an IC50 of 1.7 nM, about 160- and 60-fold selectivity over the closely related kinases Axl/Tyro3.	False	CCCCNc1ncc(-c2ccc(CN3CCOCC3)cn2)c(NC2CCC(O)CC2)n1
247167	247167:11:04_06.00	True	6.0	97	53.4	0.0	0.0	90.7	0.0	85.3	21.0	70.1	57.2	79.6	0.0	85.3	68.3	BET	90.7	Lovastatin	Lovastatin is a cell-permeable HMG-CoA reductase inhibitor used to lower cholesterol.	True	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21
409954	409954:01:04_06.00	True	6.0	101	11.4	0.0	0.0	45.5	0.0	30.6	11.7	53.6	13.8	20.3	0.0	46.0	8.4	LCH	53.6	Ivacaftor	Ivacaftor (VX-770) is a potent and orally bioavailable CFTR potentiator, targeting G551D-CFTR and F508del-CFTR with EC50s of 100 nM and 25 nM, respectively.	False	CC(C)(C)c1cc(C(C)(C)C)c(NC(=O)c2cnc3ccccc3c2O)cc1O
280184	280184:02:04_06.00	True	6.0	80	19.2	37.8	29.9	0.0	91.8	0.0	0.0	0.0	0.0	0.0	76.6	0.0	0.0	DNA_Synth	91.8	PAC-1	PAC-1 is a procaspase-3 activator that induces apoptosis in cancer cells with an EC50 of 2.08 uM.	False	C=CCc1cccc(/C=N/NC(=O)CN2CCN(Cc3ccccc3)CC2)c1O
410142	410142:01:04_06.00	True	6.0	85	55.3	0.0	0.0	66.7	0.0	60.8	31.4	82.8	20.3	48.2	0.0	68.7	49.2	LCH	82.8	PRT-060318 2HCl	PRT-060318 (PRT318) is a novel selective inhibitor of the Syk tyrosine kinase with an IC50 of 4 nM, as an approach to HIT treatment.	True	Cc1cccc(Nc2nc(N[C@@H]3CCCC[C@@H]3N)ncc2C(N)=O)c1
392557	392557:02:04_06.00	True	6.0	100	38.2	6.8	0.0	72.6	0.0	66.8	32.7	72.7	29.7	54.3	0.0	72.0	68.9	LCH	72.7	Quizartinib	Quizartinib (AC220) is an orally active, highly selective and potent second-generation type II FLT3 tyrosine kinase inhibitor, with a Kd of 1.6 nM. Quizartinib inhibits wild-type FLT3 and FLT3-ITD autophosphorylation in MV4-11 cells with IC50s of 4.2 and 1.1 nM, respectively. Quizartinib can be linked to the VHL ligand via an optimized linker to form a PROTAC FLT3 degrader. Quizartinib induces apoptosis.	False	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1
410031	410031:02:03_30.00	True	30.0	96	39.9	0.0	0.0	60.9	0.0	64.4	49.5	61.6	24.0	40.6	0.0	63.1	48.9	HDAC	64.4	Opaganib (ABC294640)	orally bioavailable and selective sphingosine kinase-2 (SphK2) inhibitor with IC50 of approximately 60 µM.	False	O=C(NCc1ccncc1)C12CC3CC(C1)CC(c1ccc(Cl)cc1)(C3)C2
410513	410513:01:03_30.00	True	30.0	85	45.3	8.9	0.0	54.0	0.0	50.0	23.5	78.4	17.0	22.2	0.0	52.7	34.1	LCH	78.4		negative control of BI 1002494.	True	COc1cc(-c2cc3ncccc3c(O[C@@H](C)[C@H]3CNC(=O)C3)n2)cc(OC)c1OC
409867	409867:01:04_30.00	True	30.0	81	66.0	0.0	0.0	67.0	0.0	59.9	27.7	56.6	34.7	73.1	0.0	75.7	49.6	Tubulin	75.7	A-366	A-366 is a potent, highly selective, peptide-competitive histone methyltransferase G9a inhibitor with IC50s of 3.3 and 38 nM for G9a and GLP (EHMT1), respectively. A-366 shows >1000-fold selectivity over 21 other methyltransferases. A-366 is also a potent, nanomolar inhibitor of the Spindlin1-H3K4me3-interaction (IC50=182.6 nM). A-366 displays high affinity at human histamine H3 receptor (Ki=17 nM) and shows subtype selectivity among subsets of the histaminergic and dopaminergic receptor families.	False	COc1cc2c(cc1OCCCN1CCCC1)N=C(N)C21CCC1
410116	410116:01:04_06.00	True	6.0	93	24.4	60.6	18.7	0.0	76.9	0.0	21.8	0.0	0.0	0.0	75.8	0.0	0.0	DNA_Synth	76.9	Selonsertib	Selonsertib, an orally bioavailable, selective apoptosis signal-regulating kinase 1 (ASK1) inhibitor with a pIC50 of 8.3, has been evaluated as an experimental treatment for diabetic nephropathy and kidney fibrosis.	False	Cc1cc(F)c(C(=O)Nc2cccc(-c3nncn3C(C)C)n2)cc1-n1cnc(C2CC2)c1
409863	409863:01:04_30.00	True	30.0	52	83.4	0.0	0.0	89.9	0.0	89.9	15.4	68.9	62.1	71.7	0.0	82.7	76.6	BET	89.9	AGI-6780	it is a potent, selective inhibitor of mutant Isocitrate dehydrogenase with an IC50 value of 23 nM. It binds allosterically at the dimer interface of mutant IDH2-R140Q, inhibiting 2-HG formation in human glioblastoma U87 and TF-1 cells expressing IDH2-R140Q with IC50 values of 11 and 18 nM, respectively. In primary human acute myelogenous leukemia cells, AGI-6780 suppressed cell growth and induced differentiation of immature blast cells toward macrophage and granulocytic lineages.	False	O=C(Nc1cccc(C(F)(F)F)c1)Nc1cc(S(=O)(=O)NC2CC2)ccc1-c1ccsc1
409878	409878:01:04_30.00	True	30.0	98	43.4	0.0	0.0	69.6	0.0	68.1	37.9	65.7	31.2	47.8	0.0	66.1	44.1	BET	69.6	OF-1	OF-1 is a potent pan-BRPF bromodomain (BRD) inhibitor, with IC50 values of 270 nM, 1.2 uM for TRIM24 and BRPF1B, respectively.	False	COc1cc2c(cc1NS(=O)(=O)c1ccc(Br)cc1C)n(C)c(=O)n2C
410748	410748:01:04_06.00	True	6.0	76	58.4	0.0	0.0	81.9	0.0	76.6	39.4	66.2	53.1	59.6	0.0	92.3	58.4	Tubulin	92.3	TH588	TH588 is first-in-class nudix hydrolase family inhibitor that potently and selectively engage and inhibit the MTH1 (IC50= 5 nM).	False	Nc1nc(NC2CC2)cc(-c2cccc(Cl)c2Cl)n1
410622	410622:01:04_06.00	True	6.0	106	35.1	5.8	0.0	23.5	0.0	17.9	20.7	53.0	0.0	0.0	0.0	26.7	0.0	LCH	53.0	Zosuquidar (LY335979) 3HCl	Zosuquidar (LY335979) 3HCl is a potent modulator of P-glycoprotein-mediated multi-drug resistance with Ki of 60 nM in a cell-free assay. Phase 3.	True	O[C@@H](COc1cccc2ncccc12)CN1CCN([C@@H]2c3ccccc3[C@@H]3[C@H](c4ccccc42)C3(F)F)CC1
409854	409854:02:04_06.00	True	6.0	97	45.9	0.0	0.0	69.8	0.0	70.2	26.7	90.2	24.2	41.7	0.0	62.6	39.6	LCH	90.2	SGC0946	SGC0946 is a highly potent and selective DOT1L methyltransferase inhibitor with IC50 of 0.3 nM; selectively kill mixed lineage leukaemia cells.IC50 value: 0.3 nM(DOT1L) Target: selective DOT1L inhibitorSGC 0946 is over 100-fold selective for other histone methyltransferases/HMTs. SGC 0946 potently reduces H3K79 dimethylation with IC50 of 2.6 nM in A431 cells, and 8.8 nM in MCF10A cells, which potently and selectively kills cells containing an MLL translocation. SGC 0946 is much more potent than its close analog EPZ004777, and serves as an excellent chemical probe for investigating DOT1L and further development of DOT1L inhibitors for cancer therapy.	True	CC(C)N(CCCNC(=O)Nc1ccc(C(C)(C)C)cc1)C[C@H]1O[C@@H](n2cc(Br)c3c(N)ncnc32)[C@H](O)[C@@H]1O
410753	410753:01:04_06.00	True	6.0	97	70.8	0.0	0.0	79.4	0.0	73.8	19.3	57.1	49.6	72.5	0.0	84.8	42.1	Tubulin	84.8	Cyclo(RGDyK) (trifluoroacetate)	Cyclo(RGDyK) trifluoroacetate is a potent and selective .a.V.b.3 integrin inhibitor with an IC50 of 20 nM.	True	NCCCC[C@@H]1NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC1=O
410284	410284:01:03_30.00	True	30.0	106	19.2	0.0	0.0	50.3	0.0	47.2	23.5	64.7	14.2	23.5	0.0	51.2	22.7	LCH	64.7	IC-87114	IC-87114 is a potent and selective PI3K.d. inhibitor with IC50 of 0.5 uM.	False	Cc1ccccc1-n1c(Cn2cnc3c(N)ncnc32)nc2cccc(C)c2c1=O
382148	382148:02:04_06.00	True	6.0	98	9.8	0.0	0.0	65.8	0.0	67.5	19.8	43.4	55.5	44.0	0.0	68.0	27.2	Tubulin	68.0	SB-431542	SB-431542 is a potent and selective inhibitor of ALK5/TGF-.b. type I Receptor with an IC50 value of 94 nM.	False	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCO4)c(-c3ccccn3)[nH]2)cc1
246646	246646:02:04_06.00	True	6.0	77	22.1	26.8	52.5	0.0	84.1	0.0	0.0	0.0	0.0	0.0	73.2	0.0	0.0	DNA_Synth	84.1	Irinotecan (hydrochloride)	Irinotecan hydrochloride ((+)-Irinotecan hydrochloride) is a topoisomerase I inhibitor mainly used to treat colon cancer and rectal cancer.	True	CCc1c2c(nc3ccc(OC(=O)N4CCC(N5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC
410510	410510:01:05_30.00	True	30.0	102	53.0	0.0	0.0	76.8	0.0	72.2	16.3	79.1	35.1	55.2	0.0	74.8	48.0	LCH	79.1		it was synthesized during a campaign to develop third generation of ?2-agonists (KD = 84 pM). BI-167107 is not a selective beta2 agonist. BI-167107 is also very a active agonist of the ?1AR (IC50 = 3.2 nM) and shows some activity as ?1A antagonist (IC50 = 32 nM). BI-167107 showed also weaker activity on other targets: 5-HT transporter (IC50 = 6.1 µM), 5-HT1A (IC50 = 1.4 µM), 5-HT1B (IC50 = 0.25 µM), D2S (IC50 = 5.9 µM), dopamine transporter (IC50 = 7.2 µM), ? (MOP) (IC50 = 6.5 µM).	True	Cc1ccccc1CC(C)(C)NC[C@H](O)c1ccc(O)c2c1OCC(=O)N2
382167	382167:04:04_06.00	True	6.0	100	10.4	0.0	22.4	55.0	0.0	55.4	23.0	47.7	30.3	51.5	0.0	68.7	27.6	Tubulin	68.7	RepSox	Potent and selective inhibitor of the TGF-ß type I receptor/ALK5 (IC50 values are 4 and 23 nM for TGF-ß type I receptor autophosphorylation and binding respectively). Selective for TGF-ß type I receptor over a range of kinases, including p38 MAPK, JNK1 and GSK3 (IC50 > 16 ¿M). Enhances the efficiency of cellular reprogramming; replaces Sox2 by inducing Nanog expression.; Identification of 1,5-Naphthyridine Derivatives as a Novel Series of Potent and Selective TGF-.beta. Type I Receptor Inhibitors.    J Med Chem (2004),  47(18),  4494-4506.	False	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1
410512	410512:01:05_30.00	True	30.0	84	21.6	49.2	25.8	0.0	85.0	0.0	12.7	0.0	0.0	0.0	75.4	0.0	0.0	DNA_Synth	85.0		it is a highly potent inhibitor of human chymase (IC50 = 0.4 nM) that can be used to test biological hypotheses involving this target in vitro. Chymase plays an important and diverse role in the homeostasis for a number of cardiovascular processes and has been linked to heart failure. Chymase is a chymotrypsin-like serine protease that is stored in a latent form in the secretory granules of mast cells. Upon stimulation, it is released in its active form into the local tissue, contributing to the activation of TGF-ß, matrix metalloproteases and cytokines.	True	CC[C@H](CC(=O)O)n1c(=O)c2ncccc2n(Cc2cn(C)c3cc(C)cc(C)c23)c1=O
409896	409896:02:04_06.00	True	6.0	93	14.9	58.9	10.8	0.0	86.5	0.0	28.2	0.0	0.0	0.0	76.5	0.0	0.0	DNA_Synth	86.5	BLU9931	BLU9931 is a potent, highly selective, and irreversible fibroblast growth factor receptor 4 (FGFR4) inhibitor with an IC50 of 3 nM and a Kd of 6 nM. BLU9931 has significant antitumor activity.	False	C=CC(=O)Nc1cccc(C)c1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)ccc2n1
410699	410699:01:04_06.00	True	6.0	74	79.1	0.0	0.0	75.9	0.0	73.1	26.8	87.4	30.7	64.5	0.0	78.5	56.9	LCH	87.4	PRT062607 (Hydrochloride)	PRT062607 Hydrochloride (P505-15 Hydrochloride) is a highly specific and potent inhibitor of purified Syk (IC50 1-2 nM).	True	NC(=O)c1cnc(N[C@@H]2CCCC[C@@H]2N)nc1Nc1cccc(-n2nccn2)c1
280875	280875:01:09_30.00	True	30.0	85	48.5	0.0	0.0	46.1	0.0	49.4	31.4	65.5	14.9	34.0	0.0	50.7	23.6	LCH	65.5	Quinine sulfate	K+ channel blocker, antimalarial, anticholinergic, antihypertensive and hypoglycemic agent, alkaloid isolated from the bark of the Cinchona family of South American trees.	False	C=C[C@H]1CN2CC[C@H]1C[C@H]2[C@H](O)c1ccnc2ccc(OC)cc12
410278	410278:01:04_30.00	True	30.0	91	25.9	58.7	0.0	0.0	54.8	0.0	3.3	24.0	0.0	0.0	41.6	0.0	13.8	AKT_PI3K_MTOR	58.7	SAR260301	potent, specific, reversible, and ATP-competitive inhibitor of Cdc2-like kinase (Clk).	True	C[C@H]1Cc2ccccc2N1C(=O)Cc1nc(=O)cc(N2CCOCC2)[nH]1
382166	382166:03:04_06.00	True	6.0	94	16.2	7.4	0.0	29.0	0.0	48.1	29.0	39.5	31.8	12.8	0.0	22.2	32.9	HDAC	48.1	Thiazovivin	Thiazovivin is a potent ROCK inhibitor, which can protect human embryonic stem cells. Thiazovivin improves the efficiency of iPSC generation.	False	O=C(NCc1ccccc1)c1csc(Nc2ccncn2)n1
409829	409829:01:05_30.00	True	30.0	94	17.6	6.7	0.0	33.2	31.4	18.8	2.2	56.8	0.0	14.6	0.0	55.9	30.9	LCH	56.8	A-1155463	A-1155463 is a highly potent and selective BCL-XL inhibitor with an EC50 of 70 nM in Molt-4 cell.	False	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1
392290	392290:02:04_06.00	True	6.0	92	28.8	57.5	0.0	0.0	6.7	0.0	52.9	17.0	0.0	0.0	31.8	1.8	10.2	AKT_PI3K_MTOR	57.5	GSK2606414	GSK2606414 is a cell-permeable and orally available protein kinase R-like endoplasmic reticulum (ER) kinase (PERK) inhibitor with an IC50 of 0.4 nM.; Discovery of 7-Methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a Potent and Selective First-in-Class Inhibitor of Protein Kinase R (PKR)-like Endoplasmic Reticulum Kinase (PERK) J. Med. Chem. 2012	False	Cn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(C(F)(F)F)c2)c2c(N)ncnc21
410146	410146:01:05_06.00	True	6.0	100	33.3	9.6	0.0	65.4	0.0	57.5	25.6	77.9	28.8	35.7	0.0	72.0	58.2	LCH	77.9	GSK2292767	GSK2292767 is a potent and selective PI3K¿ inhibitor.	False	COc1ncc(-c2cc(-c3ncc(CN4C[C@H](C)O[C@H](C)C4)o3)c3c[nH]nc3c2)cc1NS(C)(=O)=O
286065	286065:03:04_06.00	True	6.0	95	14.2	67.8	4.7	0.0	83.2	0.0	17.5	0.0	0.0	0.0	80.1	0.0	0.0	DNA_Synth	83.2	CI-1040	CI-1040 (PD 184352) is an orally active, highly specific, small-molecule inhibitor of MEK with an IC50 of 17 nM for MEK1.	False	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl
410620	410620:01:04_06.00	True	6.0	107	6.6	79.9	0.0	0.0	65.0	0.0	4.6	0.0	0.0	0.0	73.4	0.0	0.0	AKT_PI3K_MTOR	79.9	AZD 6482	AZD 6482 (KIN-193) is a potent and selective p110.b. inhibitor with an IC50 of 0.69 nM.	True	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1
410014	410014:01:04_06.00	True	6.0	100	29.0	0.0	0.0	40.1	0.0	39.7	23.4	58.5	10.7	21.8	0.0	49.1	14.5	LCH	58.5	EPZ005687	EPZ005687 is a potent and selective inhibitor of EZH2 with Ki of 24 nM, and has 50-fold selectivity against EZH1 and 500-fold selectivity against 15 other protein methyltransferases.	False	Cc1cc(C)c(CNC(=O)c2cc(-c3ccc(CN4CCOCC4)cc3)cc3c2cnn3C2CCCC2)c(O)n1
409992	409992:01:05_06.00	True	6.0	84	6.2	24.9	53.4	0.0	72.5	0.0	3.2	0.0	0.0	0.0	64.6	0.0	0.0	DNA_Synth	72.5	Evofosfamide	Evofosfamide (TH-302) is a hypoxia-activated prodrug with IC50 of 10 uM and 1000 uM in hypoxia (N2) and normoxia (21% O2), respectively.	False	Cn1c(COP(=O)(NCCBr)NCCBr)cnc1[N+](=O)[O-]
410635	410635:01:05_06.00	True	6.0	102	23.8	0.0	0.0	68.7	0.0	63.5	31.5	67.6	28.3	48.6	0.0	62.9	47.7	BET	68.7	Sonidegib (Erismodegib, NVP-LDE225)	Sonidegib (Erismodegib, NVP-LDE225) is a Smoothened (Smo) antagonist, inhibiting Hedgehog (Hh) signaling with IC50 of 1.3 nM (mouse) and 2.5 nM (human) in cell-free assays, respectively. Phase 3.	False	Cc1c(C(=O)Nc2ccc(N3C[C@H](C)O[C@H](C)C3)nc2)cccc1-c1ccc(OC(F)(F)F)cc1
410696	410696:01:04_06.00	True	6.0	100	7.9	79.2	0.0	0.0	59.8	0.0	19.4	0.0	0.0	0.0	58.8	0.0	0.0	AKT_PI3K_MTOR	79.2	SB 239063	SB 239063 is a potent, selective and orally active p38 MAPK inhibitor, exhibits an IC50 of 44 nM for recombinant purified human p38.a., with equipotent inhibitory activity against p38.a. and p38.b.. SB 239063 has no effect on p38.g. or p38.d.. With anti-asthma activity and also be used to enhance memory which is impaired due to aging or medical conditions, such as, AD.	False	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1
392762	392762:02:04_06.00	True	6.0	95	75.5	0.0	0.0	86.7	0.0	81.9	33.8	68.1	49.3	70.2	0.0	85.6	61.2	BET	86.7	IM-12	IM-12 is an inhibitor of GSK-3.b., with an IC50 of 53 nM, and also enhances Wnt signalling.	False	Cc1[nH]c2ccccc2c1C1=C(NCCc2ccc(F)cc2)C(=O)N(C)C1=O
410200	410200:01:03_30.00	True	30.0	93	48.2	0.0	0.0	68.9	0.0	66.8	23.1	78.8	21.8	51.7	0.0	65.5	49.2	LCH	78.8	Fluspidine	Sigma 1 receptor ligand. Ki for S1R: 165 nM; S2R: 372 nM. It inhibits proliferation of MCF-7 cells, without cytotoxic effects.	False	FCCC1OC2(CCN(Cc3ccccc3)CC2)c2ccccc21
392684	392684:02:04_06.00	True	6.0	98	19.7	76.6	0.0	0.0	77.6	0.0	9.0	0.0	0.0	0.0	67.1	0.0	0.0	DNA_Synth	77.6	Icotinib	Icotinib (BPI-2009) is a potent and specific EGFR inhibitor with an IC50 of 5 nM; also inhibits mutant EGFRL858R, EGFRL858R/T790M, EGFRT790M and EGFRL861Q.	False	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1
410122	410122:01:05_06.00	True	6.0	64	82.0	0.0	0.0	90.3	0.0	89.6	12.4	73.3	66.0	68.9	0.0	90.5	66.2	Tubulin	90.5	WT-161	WT-161 is a potent and selective HDAC6 inhibitor with an IC50 of  0.40 nM.	False	O=C(CCCCCCC(=O)N/N=C/c1ccc(N(c2ccccc2)c2ccccc2)cc1)NO
410108	410108:01:04_06.00	True	6.0	96	5.0	72.4	0.0	0.0	67.4	0.0	7.2	2.0	0.0	0.0	47.8	0.0	10.7	AKT_PI3K_MTOR	72.4	BMS-582949	BMS-582949 is a potent and selective p38 mitogen-activated protein kinase (p38 MAPK) inhibitor with IC50 of 13nM,inhibiting both p38 kinase activity and activation of p38.	False	CCCNC(=O)c1cn2ncnc(Nc3cc(C(=O)NC4CC4)ccc3C)c2c1C
246704	246704:02:04_06.00	True	6.0	109	7.6	0.0	0.0	69.7	0.0	59.4	5.1	62.9	35.2	43.7	0.0	66.8	44.8	BET	69.7	Formoterol fumarate	ß2-agonist.	True	COc1ccc(C[C@H](C)NC[C@@H](O)c2ccc(O)c(NC=O)c2)cc1
385860	385860:02:05_06.00	True	6.0	85	5.9	16.8	0.0	0.0	22.8	0.0	16.7	8.0	0.0	0.0	22.5	0.0	0.0	DNA_Synth	22.8	BAY-876	BAY-876 is an orally active and selective glucose transporter 1 (GLUT1) inhibitor with an IC50 of 2 nM. BAY-876 is >130-fold more selective for GLUT1 than GLUT2, GLUT3, and GLUT4. BAY-876 is also a potent blocker of glycolytic metabolism and ovarian cancer growth.	False	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1
409837	409837:01:05_30.00	True	30.0	76	78.9	0.0	0.0	81.4	0.0	82.5	33.0	77.7	46.4	64.4	0.0	78.2	62.8	HDAC	82.5	GSK-5959	GSK-5959 is a potent, selective and cell permeable BRPF1 bromodomain inhibitor with an IC50 of ~ 80 nM.	False	COc1ccccc1C(=O)Nc1cc2c(cc1N1CCCCC1)n(C)c(=O)n2C
410693	410693:01:04_06.00	True	6.0	100	12.1	44.9	0.0	10.9	0.0	14.0	19.0	14.9	18.8	0.0	10.2	0.0	29.2	AKT_PI3K_MTOR	44.9	Ceralasertib	Ceralasertib (AZD6738) is an orally active and bioavailable inhibitor of ATR kinase with an IC50 of 1 nM.	True	C[C@@H]1COCCN1c1cc(C2([S@](C)(=N)=O)CC2)nc(-c2ccnc3[nH]ccc23)n1
410667	410667:01:03_06.00	True	6.0	95	76.5	0.0	0.0	77.9	0.0	76.7	19.8	88.3	33.8	52.5	0.0	70.4	49.9	LCH	88.3	GSK126	GSK126 (GSK2816126A) is a potent, highly selective inhibitor of EZH2 methyltransferase with an IC50 of 9.9 nM.	True	CC[C@H](C)n1cc(C)c2c(C(=O)NCc3c(C)cc(C)nc3O)cc(-c3ccc(N4CCNCC4)nc3)cc21
280166	280166:02:04_06.00	True	6.0	58	23.1	35.0	31.1	0.0	75.2	0.0	38.4	0.0	0.0	0.0	51.3	0.0	0.0	DNA_Synth	75.2	Stattic	Stattic is a potent STAT3 inhibitor and inhibits STAT3 phosphorylation (at Y705 and S727). Stattic inhibits the binding of a high affinity phosphopeptide for the SH2 domain of STAT3. Stattic ameliorates the renal dysfunction in Alport syndrome (AS) mice.	False	O=[N+]([O-])c1ccc2c(c1)S(=O)(=O)C=C2
280120	280120:02:04_06.00	True	6.0	51	40.8	0.0	0.0	66.4	0.0	61.3	21.7	41.7	58.3	76.0	0.0	74.6	64.2	Protein_Synth	76.0	MNS,;3,4-Methylenedioxy-beta-;nitrostyrene	src and Syk kinase inhibitor, prevents phosphorylation and cytoskeletal association of GPIIb/IIIa and talin.	False	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2
246886	246886:14:04_06.00	True	6.0	99	8.5	6.3	0.0	35.8	0.0	38.6	47.7	45.5	10.2	26.7	0.0	44.5	35.9	HSP90	47.7	Loratadine	Loratadine (SCH-29851) is a selective inverse peripheral histamine H1-receptor agonist with an IC50 of >32 uM. Loratadine has anti-dengue-virus (DENV) activity.	False	CCOC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc3cccnc32)CC1
410708	410708:01:04_06.00	True	6.0	98	31.6	0.0	0.0	46.3	0.0	49.8	34.5	70.8	2.6	22.4	0.0	47.2	24.7	LCH	70.8	AM1241	AM-1241 is a selective cannabinoid CB2 receptor agonist with Ki of 3.4 nM, exhibits 82-fold selectivity over CB1 receptor.	False	CN1CCCCC1Cn1cc(C(=O)c2cc([N+](=O)[O-])ccc2I)c2ccccc21
392679	392679:02:04_06.00	True	6.0	101	6.9	38.9	0.0	0.0	0.0	0.0	3.0	10.7	0.0	0.0	11.0	0.0	5.0	AKT_PI3K_MTOR	38.9	ZM 306416	ZM-306416 (CB 676475) is a potent inhibitor of VEGFR with IC50s of 0.1 and 2 uM for KDR and Flt, respectively. ZM-306416 is also a EGFR inhibitor with an IC50 of <10 nM.	False	COc1cc2ncnc(Nc3ccc(Cl)cc3F)c2cc1OC
392755	392755:02:04_06.00	True	6.0	91	38.5	0.0	0.0	74.5	0.0	70.5	24.4	64.5	37.8	55.5	0.0	70.6	42.8	BET	74.5	XMD8-92	XMD8-92 is a potent ERK5 (BMK1)/BRD4 inhibitor with Kds of 80 and 190 nM, respectively. XMD8-92 inhibits DCAMKL2, PLK4 and TNK1 with Kds of 190, 600 and 890 nM, respectively. Anti-cancer activity.	False	CCOc1cc(N2CCC(O)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C
409991	409991:01:04_06.00	True	6.0	109	51.8	0.0	0.0	66.3	0.0	66.6	23.7	83.5	25.9	42.8	0.0	68.2	42.9	LCH	83.5	AZ3146	AZ3146 is a reasonably potent and selective Mps1 inhibitor with IC50 of 35 nM for Mps1Cat.	False	COc1cc(OC2CCN(C)CC2)ccc1Nc1ncc2c(n1)n(C1CCCC1)c(=O)n2C
392683	392683:02:04_06.00	True	6.0	69	18.8	1.6	76.6	0.0	46.3	0.0	34.4	0.0	0.0	0.0	44.5	0.0	0.0	Aurora	76.6	PF-573228	PF-573228 is a potent and selective FAK inhibitor with IC50 of 4 nM for purified recombinant catalytic fragment of FAK.	False	CS(=O)(=O)c1cccc(CNc2nc(Nc3ccc4c(c3)CCC(=O)N4)ncc2C(F)(F)F)c1
410154	410154:01:04_06.00	True	6.0	94	16.4	0.0	0.0	81.6	0.0	81.6	7.8	78.4	48.2	56.9	0.0	72.8	57.6	BET	81.6	Asciminib	Asciminib (ABL001) is a potent and selective allosteric BCR-ABL1 inhibitor, which inhibits Ba/F3 cells grown with an IC50 of 0.25 nM.	True	O=C(Nc1ccc(OC(F)(F)Cl)cc1)c1cnc(N2CC[C@@H](O)C2)c(-c2cc[nH]n2)c1
394208	394208:02:04_06.00	True	6.0	94	50.1	10.3	0.0	52.0	0.0	53.8	19.9	85.8	10.3	25.6	0.0	54.2	42.4	LCH	85.8	AZ191	AZ191 is a potent inhibitor that selectively inhibits DYRK1B with IC50 of 17 nM.	False	COc1cc(N2CCN(C)CC2)ccc1Nc1nccc(-c2cn(C)c3cnccc23)n1
410649	410649:01:04_06.00	True	6.0	104	9.3	0.0	0.0	29.4	0.0	21.4	27.4	38.3	17.4	11.5	0.0	36.4	2.3	LCH	38.3	Dibenzazepine (YO-01027)	Dibenzazepine (YO-01027) is a dipeptidic ¿-secretase inhibitor with IC50 of 2.6 nM and 2.9 nM  in cell-free assays for APPL and Notch cleavage, respectively.	True	C[C@H](NC(=O)Cc1cc(F)cc(F)c1)C(=O)N[C@@H]1C(=O)N(C)c2ccccc2-c2ccccc21
410135	410135:01:04_06.00	True	6.0	93	8.8	58.8	0.0	15.4	31.7	13.4	9.5	43.1	0.0	10.2	0.0	13.6	44.5	AKT_PI3K_MTOR	58.8	TAK-580	TAK-580 (MLN 2480) is an orally active and selective inhibitor of pan-Raf kinase.	True	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1
409839	409839:01:06_30.00	True	30.0	95	76.3	0.0	0.0	81.5	0.0	77.7	29.0	73.8	41.0	68.2	0.0	78.7	54.6	BET	81.5	CPI-637	CPI-637 is a selective and potent CBP/EP300 bromodomain inhibitor with IC50 values of 0.03 uM, 0.051 uM and 11.0 uM for CBP, EP300 and BRD4 BD-1, respectively, and an EC50 of 0.3 uM for CBP.	True	C[C@@H]1CC(=O)Nc2cccc(-c3ccc4c(c3)c(-c3cnn(C)c3)nn4C)c2N1
392738	392738:02:04_06.00	True	6.0	70	48.4	0.0	0.0	72.8	0.0	61.3	27.6	60.0	46.2	44.3	0.0	76.3	54.7	Tubulin	76.3	Spebrutinib	Spebrutinib (AVL-292; CC-292) is a covalent, orally active, and highly selective with an IC50 of 0.5 nM.	False	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCOC)cc3)ncc2F)c1
247002	247002:10:04_06.00	True	6.0	95	6.2	7.8	0.0	27.9	0.0	25.2	2.2	22.1	21.1	32.9	0.0	23.1	26.0	Protein_Synth	32.9	Isotretinoin	anti-inflammatory and antitumor actions mediated through RAR-beta and RAR-alpha receptors, antiacne, antineoplastic.	False	CC1=C(/C=C/C(C)=C/C=C/C(C)=C\C(=O)O)C(C)(C)CCC1
410614	410614:01:04_06.00	True	6.0	109	57.9	0.0	0.0	76.8	0.0	71.0	16.4	80.9	30.5	57.1	0.0	71.7	50.7	LCH	80.9	Cinacalcet (hydrochloride)	Cinacalcet hydrochloride (AMG-073 hydrochloride) is an orally active, allosteric agonist of Ca receptor (CaR), used for cardiovascular disease treatment.	True	C[C@@H](NCCCc1cccc(C(F)(F)F)c1)c1cccc2ccccc12
392693	392693:02:05_06.00	True	6.0	94	35.1	1.5	0.0	73.1	0.0	66.4	34.9	78.4	27.4	50.9	0.0	70.4	64.7	LCH	78.4	Linsitinib	Linsitinib (OSI-906) is a potent, selective and orally bioavailable dual inhibitor of the IGF-1 receptor and insulin receptor (IR) with IC50s of 35 and 75 nM, respectively.	False	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1
410511	410511:01:03_30.00	True	30.0	88	34.2	46.3	3.8	0.0	60.3	0.0	32.0	0.0	0.0	0.0	78.3	0.0	0.0	Pyrimidine_Synth	78.3		negative control of BI-1942.	True	CC[C@@H](C(=O)OC)n1c(=O)c2ccccc2n(Cc2cn(C)c3cccc(C)c23)c1=O
392713	392713:02:04_06.00	True	6.0	76	45.8	0.0	0.0	74.4	0.0	66.2	33.6	63.0	41.0	51.2	0.0	77.6	80.1	Uncoupler	80.1	CGK733	CGK733 is a potent ATM/ATR inhibitor, used for the research of cancer.	False	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1
410141	410141:01:04_06.00	True	6.0	96	33.0	0.4	0.6	0.0	11.7	0.0	47.2	13.4	0.0	0.0	32.7	19.2	0.0	HSP90	47.2	VX-11e	VX-11e is a potent, selective, and orally bioavailable inhibitor of ERK with Ki < 2 nM.	True	Cc1cnc(Nc2ccc(F)cc2Cl)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1
246514	246514:02:04_06.00	True	6.0	95	65.5	0.0	0.0	89.9	0.0	85.8	19.7	70.1	59.3	68.7	0.0	85.7	69.1	BET	89.9	Fluvastatin sodium salt	HMG CoA reductase inhibitor.	True	CC(C)n1c(/C=C/[C@H](O)C[C@H](O)CC(=O)O)c(-c2ccc(F)cc2)c2ccccc21
409850	409850:02:04_06.00	True	6.0	96	32.1	0.0	0.0	92.7	0.0	86.4	1.0	66.7	62.7	57.2	0.0	83.0	72.9	BET	92.7	PFI-1	PFI-1 is a selective BET (bromodomain-containing protein) inhibitor for BRD4 with IC50 of 0.22 uM in a cell-free assay.	False	COc1ccccc1S(=O)(=O)Nc1ccc2c(c1)CN(C)C(=O)N2
410136	410136:01:05_06.00	True	6.0	98	32.0	18.7	0.0	58.6	0.0	54.4	14.6	81.2	19.3	30.8	0.0	63.2	57.8	LCH	81.2	IPI-3063	IPI-3063 is a potent and selective PI3K p110.d. inhibitor with an IC50 of 2.5±1.2 nM.	True	CC(C)n1c([C@H](C)Nc2ncnc(N)c2C#N)cc2cccc(-c3ccc(=O)n(C)c3)c2c1=O
392749	392749:02:04_06.00	True	6.0	83	7.3	62.7	0.0	0.0	72.7	0.0	30.6	11.7	0.0	0.0	51.0	0.0	6.5	DNA_Synth	72.7	Losmapimod	Losmapimod (GSK-AHAB) is a selective, potent, and orally active p38 MAPK inhibitor with pKis of 8.1 and 7.6 for p38.a. and p38.b., respectively.	False	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1
409859	409859:01:05_30.00	True	30.0	94	69.1	0.0	0.0	69.0	0.0	68.6	35.7	69.9	28.9	54.2	0.0	68.6	46.7	LCH	69.9	SGC-CBP30	SGC-CBP30 is a potent and highly selective CBP/p300 bromodomain (Kds of 21 nM and 32 nM for CBP and p300, respectively) inhibitor, displaying 40-fold selectivity over the first bromodomain of BRD4 [BRD4(1)] bound. SGC-CBP30 strongly reduces secretion of IL-17A in Th17 cells and has anti-inflammatory effects.	True	COc1ccc(CCc2nc3cc(-c4c(C)noc4C)ccc3n2C[C@H](C)N2CCOCC2)cc1Cl
409847	409847:01:04_30.00	True	30.0	86	25.6	0.0	42.3	0.0	52.7	0.0	38.3	19.5	0.0	0.0	37.6	2.2	0.0	DNA_Synth	52.7	PDD 00017273	PDD 00017273 is a potent inhibitor of Poly(ADP-ribose) Glycohydrolase (PARG), with an IC50 of 26 nM, and a KD of 1.45 nM.	False	Cc1cc(Cn2c(=O)n(Cc3cnc(C)s3)c(=O)c3cc(S(=O)(=O)NC4(C)CC4)ccc32)n(C)n1
410120	410120:01:04_06.00	True	6.0	96	39.6	0.0	0.0	72.1	0.0	67.8	35.7	71.6	27.2	54.4	0.0	70.8	52.8	BET	72.1	GSK-872	GSK-872 is a RIPK3 inhibitor, which binds RIP3 kinase domain with an IC50 of 1.8 nM, and inhibits kinase activity with an IC50 of 1.3 nM.	False	CC(C)S(=O)(=O)c1ccc2nccc(Nc3ccc4scnc4c3)c2c1
410731	410731:01:04_06.00	True	6.0	89	5.4	15.3	58.3	0.0	64.4	0.0	2.6	0.0	0.0	0.0	61.8	0.0	0.0	DNA_Synth	64.4	AZD-2461	AZD-2461 is a potent PARP inhibitor, with IC50s of 5 nM, 2 nM and 200 nM for PARP1, PARP2 and PARP3, respectively.	False	COC1CCN(C(=O)c2cc(Cc3nnc(O)c4ccccc34)ccc2F)CC1
392773	392773:02:04_06.00	True	6.0	98	20.2	65.9	0.0	0.0	80.7	0.0	21.1	0.0	0.0	0.0	76.7	0.0	0.0	DNA_Synth	80.7	Selumetinib	Selumetinib (AZD6244) is selective, non-ATP-competitive oral MEK1/2 inhibitor, with an IC50 of 14 nM for MEK1. Selumetinib (AZD6244) inhibits ERK1/2 phosphorylation.	False	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21
410626	410626:01:04_06.00	True	6.0	97	43.2	0.8	0.0	61.0	0.0	58.9	31.0	74.6	16.1	42.2	0.0	55.7	45.0	LCH	74.6	Nebivolol HCl	Nebivolol HCl selectively inhibits ß1-adrenoceptor with IC50 of 0.8 nM.	True	O[C@@H](CNC[C@H](O)[C@H]1CCc2cc(F)ccc2O1)[C@@H]1CCc2cc(F)ccc2O1
332505	332505:02:04_06.00	True	6.0	83	23.0	33.4	0.0	28.3	0.0	18.3	54.2	39.0	1.2	19.3	0.0	44.4	44.0	HSP90	54.2	Sal003	Sal003 is a potent, specific and cell-permeable inhibitor of the eukaryotic translation initiation factor 2.a. (eIF2.a.) phosphatase. Sal003 is a derivative of salubrinal.	False	O=C(/C=C/c1ccccc1)NC(NC(=S)Nc1ccc(Cl)cc1)C(Cl)(Cl)Cl
409872	409872:01:04_30.00	True	30.0	87	23.5	0.0	0.0	82.0	0.0	78.3	9.2	92.3	37.6	53.7	0.0	76.7	49.8	LCH	92.3	GSK-LSD1 (dihydrochloride)	GSK-LSD1 dihydrochloride is a potent, selective and irreversible lysine specific demethylase 1 (LSD1)  inhibitor with an IC50 of 16 nM.	True	c1ccc([C@@H]2C[C@H]2NC2CCNCC2)cc1
410698	410698:01:04_06.00	True	6.0	103	26.8	0.0	0.0	34.5	0.0	38.0	36.8	43.4	12.4	28.1	0.0	37.0	8.1	LCH	43.4	Nirogacestat	Nirogacestat (PF-3084014) is a reversible, orally bioavailable, noncompetitive, and selective .g.-secretase inhibitor with an IC50 of 6.2 nM. Inhibition of Notch signaling by Nirogacestat while minimizing gastrointestinal toxicity presents a promising approach for research of Notch receptor-dependent cancers.	True	CCC[C@H](N[C@H]1CCc2cc(F)cc(F)c2C1)C(=O)Nc1cn(C(C)(C)CNCC(C)(C)C)cn1
409984	409984:01:05_06.00	True	6.0	105	11.6	0.0	0.0	72.6	0.0	69.2	0.0	38.4	54.1	53.2	0.0	67.7	46.1	BET	72.6	Galunisertib	Galunisertib (LY2157299) is an oral and selective TGF-.b. receptor type I (TGF-.b.RI) kinase inhibitor with an IC50 of 56 nM.	False	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1
410118	410118:01:06_06.00	True	6.0	85	68.9	0.0	0.0	82.1	0.0	77.8	14.0	83.2	38.6	67.8	0.0	81.7	63.1	LCH	83.2	VPS34 inhibitor 1 (Compound 19, PIK-III analogue)	VPS34 inhibitor 1 (Compound 19, PIK-III analogue) is a potent and selective inhibitor of VPS34 with an IC50 of 15 nM.	False	CC(C)(O)CNc1ncc(-c2ccnc(Nc3ccncc3)n2)c(CC2CC2)n1
408956	408955:01:05_30.00	True	30.0	100	8.6	0.0	0.0	77.7	0.0	68.8	6.9	52.0	59.7	47.8	0.0	70.3	63.1	BET	77.7	BI-9564	BI-9564 is a selective, and cell-permeable BRD9 BD inhibitor, with Kd of 5.9 nM for BRD9, and IC50 of > 100 µM for BET family.	False	COc1cc(-c2cn(C)c(=O)c3cnccc23)c(OC)cc1CN(C)C
410741	410741:01:04_06.00	True	6.0	93	15.5	78.7	0.0	0.0	63.0	0.0	28.1	6.1	0.0	0.0	63.1	0.0	2.5	AKT_PI3K_MTOR	78.7	STF-118804	STF-118804 is a highly specific NAMPT inhibitor; reduces the viability of most B-ALL cell lines with IC50 <10 nM.IC50 value:Target: NAMPT inhibitorin vitro:  improves survival in an orthotopic xenotransplant model of high-risk acute lymphoblastic leukemia, and targets leukemia stem cells. STF-118804 displays distinctive cytotoxicity by inducing apoptosis without causing a phase-specific cell cycle arrest. Over-expression of NAMPT rendered 293T cells more resistant to STF-118804 resulting in a higher IC50 (106 nM, 95% CI 74151 nM) compared to control cells (17 nM, 95% CI 1323 nM), further confirming that NAMPT protein levels dictate sensitivity to STF-118804 .in vivo: STF-118804 displayed high efficacy in a xenograft model of ALL. Mice treated with STF-118804 over a 20-day period survived an average of 34 days longer than vehicle-treated animals. During treatment, bioimaging showed regression of tumor followed by suppression of disease. STF-118804 was tolerated in the efficacious dose range, and the absence of adverse physical or pathological effects indicated that toxicity was not limiting in a 20-day study of mock transplanted mice .	False	Cc1ccc(S(=O)(=O)Cc2nc(-c3ccc(C(=O)NCc4cccnc4)cc3)oc2C)cc1
410005	410005:01:04_10.00	True	10.0	95	15.7	0.0	0.0	39.7	0.0	33.4	33.5	58.6	12.3	26.7	0.0	47.9	9.7	LCH	58.6	Rimonabant	Rimonabant is a selective antagonist of CB1 with IC50 of 13.6 nM and EC50 of 17.3 nM in hCB1 transfected HEK 293 membrane.	False	Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1
410752	410752:01:04_10.00	True	10.0	97	65.3	0.0	0.0	84.7	0.0	79.5	14.8	61.8	56.5	62.4	0.0	86.2	45.5	Tubulin	86.2	Cyclo (-RGDfK)	Cyclo (-RGDfK) is a potent and selective ¿vß3 integrin inhibitor.	True	NCCCC[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC1=O
247066	247066:11:04_10.00	True	10.0	105	7.4	0.0	0.0	84.7	0.0	75.9	5.4	70.0	52.3	67.5	0.0	76.9	67.1	BET	84.7	Triamterene	Na+ channel blocker, diuretic, Non competitive aldosterone antagonist.	False	Nc1nc(N)c2nc(-c3ccccc3)c(N)nc2n1
410106	410106:01:04_10.00	True	10.0	107	48.0	0.0	0.0	79.8	0.0	76.0	1.0	88.1	46.0	51.5	0.0	74.9	37.7	LCH	88.1	MS023	MS023 is a potent, selective, and cell-active inhibitor of human type I protein arginine methyltransferases (PRMTs) inhibitor, with IC50s of 30, 119, 83, 4 and 5 nM for PRMT1, PRMT3, PRMT4, PRMT6, and PRMT8, respectively.	False	CC(C)Oc1ccc(-c2c[nH]cc2CN(C)CCN)cc1
246883	246883:07:04_10.00	True	10.0	109	40.2	0.0	0.0	59.8	0.0	63.0	42.1	74.8	20.6	43.2	0.0	57.4	35.7	LCH	74.8	Fulvestrant	Fulvestrant (ICI 182780) is a pure antiestrogen and a potent estrogen receptor (ER) antagonist with an IC50 of 9.4 nM. Fulvestrant effectively inhibits the growth of ER-positive MCF-7 cells with an IC50 of 0.29 nM. Fulvestrant also induces autophagy and has antitumor efficacy.	True	C[C@]12CC[C@@H]3c4ccc(O)cc4C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@H]3[C@@H]1CC[C@@H]2O
410103	410103:01:04_10.00	True	10.0	71	67.2	0.0	0.0	81.4	0.0	71.6	22.7	78.2	45.8	64.5	0.0	84.2	53.3	Tubulin	84.2	ASP3026	ASP3026 is a potent, selective and orally active inhibitor of anaplastic lymphoma kinase (ALK). ASP3026 induces apoptosis of tumor cells. ASP3026 can be used for the research of non-small cell lung cancer (NSCLC).	False	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1
410633	410633:01:04_10.00	True	10.0	96	77.4	0.0	0.0	89.3	0.0	87.6	17.4	71.7	59.1	73.7	0.0	85.6	63.2	BET	89.3	Atorvastatin Calcium	Atorvastatin Calcium is an inhibitor of HMG-CoA reductase used as a cholesterol-lowering medication that blocks the production of cholesterol.	True	CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)O
410151	410151:01:04_10.00	True	10.0	98	12.6	68.6	0.0	0.0	85.0	0.0	0.0	0.0	0.0	0.0	78.3	0.0	0.0	DNA_Synth	85.0	CCT245737	CCT245737 is an orally active and seletive Chk1 inhibitor, with an IC50 of 1.3 nM.	True	N#Cc1cnc(Nc2cc(NC[C@H]3CNCCO3)c(C(F)(F)F)cn2)cn1
410654	410654:01:05_10.00	True	10.0	91	35.1	7.7	0.0	67.4	0.0	58.7	0.0	79.3	29.1	43.0	0.0	67.8	62.1	LCH	79.3	(S)-Gossypol (acetic acid)	(S)-Gossypol is the isomer of a natural product Gossypol. (S)-Gossypol binds to the BH3-binding groove of Bcl-xL and Bcl-2 proteins with high affinity.	False	Cc1cc2c(C(C)C)c(O)c(O)c(C=O)c2c(O)c1-c1c(C)cc2c(C(C)C)c(O)c(O)c(C=O)c2c1O
263465	263465:02:05_10.00	True	10.0	74	83.4	0.0	0.0	86.7	0.0	87.1	33.4	74.2	59.7	65.6	0.0	83.5	75.1	HDAC	87.1	FLI-06	FLI-06 is a novel inhibitor of Notch signaling with EC50 of 2.3 ¿M.	False	CC1=C(C(=O)OC2CCCCC2)C(c2ccc([N+](=O)[O-])cc2)C2=C(CC(C)(C)CC2=O)N1
410677	410677:01:03_10.00	True	10.0	63	45.9	20.0	44.6	0.0	36.2	0.0	38.1	41.8	0.0	0.0	15.2	10.3	0.0	Aurora	44.6	UNC2250	UNC2250 is a potent and selective Mer inhibitor with an IC50 of 1.7 nM, about 160- and 60-fold selectivity over the closely related kinases Axl/Tyro3.	False	CCCCNc1ncc(-c2ccc(CN3CCOCC3)cn2)c(NC2CCC(O)CC2)n1
247167	247167:11:04_10.00	True	10.0	104	50.3	0.0	0.0	89.6	0.0	87.1	21.4	68.3	62.7	73.3	0.0	84.2	68.3	BET	89.6	Lovastatin	Lovastatin is a cell-permeable HMG-CoA reductase inhibitor used to lower cholesterol.	True	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21
280184	280184:02:04_10.00	True	10.0	79	26.9	44.3	26.3	0.0	93.7	0.0	0.0	0.0	0.0	0.0	82.1	0.0	0.0	DNA_Synth	93.7	PAC-1	PAC-1 is a procaspase-3 activator that induces apoptosis in cancer cells with an EC50 of 2.08 uM.	False	C=CCc1cccc(/C=N/NC(=O)CN2CCN(Cc3ccccc3)CC2)c1O
410142	410142:01:04_10.00	True	10.0	74	66.8	0.0	0.0	69.9	0.0	64.6	20.7	94.3	26.5	44.4	0.0	73.5	44.4	LCH	94.3	PRT-060318 2HCl	PRT-060318 (PRT318) is a novel selective inhibitor of the Syk tyrosine kinase with an IC50 of 4 nM, as an approach to HIT treatment.	True	Cc1cccc(Nc2nc(N[C@@H]3CCCC[C@@H]3N)ncc2C(N)=O)c1
392557	392557:02:04_10.00	True	10.0	97	37.7	0.0	0.0	77.9	0.0	73.8	39.4	67.4	44.0	57.0	0.0	75.9	55.9	BET	77.9	Quizartinib	Quizartinib (AC220) is an orally active, highly selective and potent second-generation type II FLT3 tyrosine kinase inhibitor, with a Kd of 1.6 nM. Quizartinib inhibits wild-type FLT3 and FLT3-ITD autophosphorylation in MV4-11 cells with IC50s of 4.2 and 1.1 nM, respectively. Quizartinib can be linked to the VHL ligand via an optimized linker to form a PROTAC FLT3 degrader. Quizartinib induces apoptosis.	False	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1
410031	410031:02:03_50.00	True	50.0	95	63.7	0.0	0.0	81.7	0.0	79.8	39.1	81.4	46.7	58.1	0.0	79.1	59.8	BET	81.7	Opaganib (ABC294640)	orally bioavailable and selective sphingosine kinase-2 (SphK2) inhibitor with IC50 of approximately 60 µM.	False	O=C(NCc1ccncc1)C12CC3CC(C1)CC(c1ccc(Cl)cc1)(C3)C2
410513	410513:01:03_50.00	True	50.0	75	51.6	0.0	2.9	52.7	0.0	53.7	20.5	83.6	24.3	21.6	0.0	53.0	11.4	LCH	83.6		negative control of BI 1002494.	True	COc1cc(-c2cc3ncccc3c(O[C@@H](C)[C@H]3CNC(=O)C3)n2)cc(OC)c1OC
409867	409867:01:04_50.00	True	50.0	69	79.1	0.0	0.0	80.0	0.0	76.6	37.2	65.6	49.6	77.1	0.0	83.4	59.0	Tubulin	83.4	A-366	A-366 is a potent, highly selective, peptide-competitive histone methyltransferase G9a inhibitor with IC50s of 3.3 and 38 nM for G9a and GLP (EHMT1), respectively. A-366 shows >1000-fold selectivity over 21 other methyltransferases. A-366 is also a potent, nanomolar inhibitor of the Spindlin1-H3K4me3-interaction (IC50=182.6 nM). A-366 displays high affinity at human histamine H3 receptor (Ki=17 nM) and shows subtype selectivity among subsets of the histaminergic and dopaminergic receptor families.	False	COc1cc2c(cc1OCCCN1CCCC1)N=C(N)C21CCC1
410116	410116:01:04_10.00	True	10.0	91	24.7	56.6	22.4	0.0	87.8	0.0	35.0	0.0	0.0	0.0	80.1	0.0	0.0	DNA_Synth	87.8	Selonsertib	Selonsertib, an orally bioavailable, selective apoptosis signal-regulating kinase 1 (ASK1) inhibitor with a pIC50 of 8.3, has been evaluated as an experimental treatment for diabetic nephropathy and kidney fibrosis.	False	Cc1cc(F)c(C(=O)Nc2cccc(-c3nncn3C(C)C)n2)cc1-n1cnc(C2CC2)c1
409878	409878:01:04_50.00	True	50.0	98	56.0	0.0	0.0	77.5	0.0	77.8	37.7	75.5	40.1	53.5	0.0	74.6	48.1	HDAC	77.8	OF-1	OF-1 is a potent pan-BRPF bromodomain (BRD) inhibitor, with IC50 values of 270 nM, 1.2 uM for TRIM24 and BRPF1B, respectively.	False	COc1cc2c(cc1NS(=O)(=O)c1ccc(Br)cc1C)n(C)c(=O)n2C
410748	410748:01:04_10.00	True	10.0	64	67.2	0.0	0.0	81.5	0.0	78.7	27.7	63.9	60.4	55.4	0.0	89.1	51.7	Tubulin	89.1	TH588	TH588 is first-in-class nudix hydrolase family inhibitor that potently and selectively engage and inhibit the MTH1 (IC50= 5 nM).	False	Nc1nc(NC2CC2)cc(-c2cccc(Cl)c2Cl)n1
410622	410622:01:04_10.00	True	10.0	98	47.5	0.0	0.0	62.7	0.0	60.4	31.3	78.5	28.3	34.4	0.0	59.6	42.1	LCH	78.5	Zosuquidar (LY335979) 3HCl	Zosuquidar (LY335979) 3HCl is a potent modulator of P-glycoprotein-mediated multi-drug resistance with Ki of 60 nM in a cell-free assay. Phase 3.	True	O[C@@H](COc1cccc2ncccc12)CN1CCN([C@@H]2c3ccccc3[C@@H]3[C@H](c4ccccc42)C3(F)F)CC1
409989	409989:01:04_10.00	True	10.0	110	13.3	0.0	0.0	37.1	0.0	30.7	0.0	53.0	32.0	0.0	0.0	31.4	0.0	LCH	53.0	PF-3845	PF-3845 is a potent, selective, irreversible and orally active inhibitor of fatty acid amide hydrolase (FAAH), with a Ki of 0.23 uM. PF-3845 is a covalent inhibitor that carbamylates FAAH's serine nucleophile. PF-3845 can reduce pain sensation, inflammation, and anxiety/depression without substantial effects on motility or cognition.	False	O=C(Nc1cccnc1)N1CCC(Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1
409854	409854:02:04_10.00	True	10.0	108	57.3	0.0	0.0	68.5	0.0	66.2	19.2	94.9	22.9	36.9	0.0	61.5	34.7	LCH	94.9	SGC0946	SGC0946 is a highly potent and selective DOT1L methyltransferase inhibitor with IC50 of 0.3 nM; selectively kill mixed lineage leukaemia cells.IC50 value: 0.3 nM(DOT1L) Target: selective DOT1L inhibitorSGC 0946 is over 100-fold selective for other histone methyltransferases/HMTs. SGC 0946 potently reduces H3K79 dimethylation with IC50 of 2.6 nM in A431 cells, and 8.8 nM in MCF10A cells, which potently and selectively kills cells containing an MLL translocation. SGC 0946 is much more potent than its close analog EPZ004777, and serves as an excellent chemical probe for investigating DOT1L and further development of DOT1L inhibitors for cancer therapy.	True	CC(C)N(CCCNC(=O)Nc1ccc(C(C)(C)C)cc1)C[C@H]1O[C@@H](n2cc(Br)c3c(N)ncnc32)[C@H](O)[C@@H]1O
410753	410753:01:04_10.00	True	10.0	84	76.3	0.0	0.0	86.3	0.0	82.6	19.3	64.7	56.8	70.4	0.0	88.0	48.0	Tubulin	88.0	Cyclo(RGDyK) (trifluoroacetate)	Cyclo(RGDyK) trifluoroacetate is a potent and selective .a.V.b.3 integrin inhibitor with an IC50 of 20 nM.	True	NCCCC[C@@H]1NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC1=O
410662	410662:01:04_10.00	True	10.0	102	9.8	0.0	0.0	60.8	0.0	58.3	24.4	66.6	31.1	20.8	0.0	59.7	20.4	LCH	66.6	Ticagrelor	Ticagrelor (AZD6140) is a reversible oral P2Y12 receptor antagonist for the treatment of platelet aggregation.	True	CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1
410284	410284:01:03_50.00	True	50.0	100	16.1	0.0	0.0	37.6	0.0	30.3	29.9	52.9	9.9	23.9	0.0	40.8	8.3	LCH	52.9	IC-87114	IC-87114 is a potent and selective PI3K.d. inhibitor with IC50 of 0.5 uM.	False	Cc1ccccc1-n1c(Cn2cnc3c(N)ncnc32)nc2cccc(C)c2c1=O
382148	382148:02:04_10.00	True	10.0	105	8.8	0.0	0.0	52.7	0.0	52.5	23.9	36.4	47.4	40.3	0.0	55.2	12.7	Tubulin	55.2	SB-431542	SB-431542 is a potent and selective inhibitor of ALK5/TGF-.b. type I Receptor with an IC50 value of 94 nM.	False	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCO4)c(-c3ccccn3)[nH]2)cc1
246646	246646:02:04_10.00	True	10.0	83	24.2	42.4	39.7	0.0	92.3	0.0	4.5	0.0	0.0	0.0	80.5	0.0	0.0	DNA_Synth	92.3	Irinotecan (hydrochloride)	Irinotecan hydrochloride ((+)-Irinotecan hydrochloride) is a topoisomerase I inhibitor mainly used to treat colon cancer and rectal cancer.	True	CCc1c2c(nc3ccc(OC(=O)N4CCC(N5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC
410510	410510:01:05_50.00	True	50.0	115	57.9	0.0	0.0	81.0	0.0	76.1	13.9	88.1	41.4	48.8	0.0	76.0	42.9	LCH	88.1		it was synthesized during a campaign to develop third generation of ?2-agonists (KD = 84 pM). BI-167107 is not a selective beta2 agonist. BI-167107 is also very a active agonist of the ?1AR (IC50 = 3.2 nM) and shows some activity as ?1A antagonist (IC50 = 32 nM). BI-167107 showed also weaker activity on other targets: 5-HT transporter (IC50 = 6.1 µM), 5-HT1A (IC50 = 1.4 µM), 5-HT1B (IC50 = 0.25 µM), D2S (IC50 = 5.9 µM), dopamine transporter (IC50 = 7.2 µM), ? (MOP) (IC50 = 6.5 µM).	True	Cc1ccccc1CC(C)(C)NC[C@H](O)c1ccc(O)c2c1OCC(=O)N2
410512	410512:01:05_50.00	True	50.0	76	36.4	44.3	18.6	0.0	82.0	0.0	19.8	1.4	0.0	0.0	63.8	0.0	0.0	DNA_Synth	82.0		it is a highly potent inhibitor of human chymase (IC50 = 0.4 nM) that can be used to test biological hypotheses involving this target in vitro. Chymase plays an important and diverse role in the homeostasis for a number of cardiovascular processes and has been linked to heart failure. Chymase is a chymotrypsin-like serine protease that is stored in a latent form in the secretory granules of mast cells. Upon stimulation, it is released in its active form into the local tissue, contributing to the activation of TGF-ß, matrix metalloproteases and cytokines.	True	CC[C@H](CC(=O)O)n1c(=O)c2ncccc2n(Cc2cn(C)c3cc(C)cc(C)c23)c1=O
409896	409896:02:04_10.00	True	10.0	94	20.9	66.7	0.0	0.0	84.4	0.0	24.1	0.0	0.0	0.0	76.6	0.0	0.0	DNA_Synth	84.4	BLU9931	BLU9931 is a potent, highly selective, and irreversible fibroblast growth factor receptor 4 (FGFR4) inhibitor with an IC50 of 3 nM and a Kd of 6 nM. BLU9931 has significant antitumor activity.	False	C=CC(=O)Nc1cccc(C)c1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)ccc2n1
410611	410611:01:04_10.00	True	10.0	97	16.4	0.0	0.0	71.5	0.0	64.9	37.1	61.0	52.3	35.8	0.0	81.2	40.7	Tubulin	81.2	Aprepitant	Aprepitant (MK-0869) is a selective and high-affinity neurokinin 1 receptor antagonist with a Kd of 86 pM.	True	C[C@@H](O[C@H]1OCCN(Cc2n[nH]c(O)n2)[C@H]1c1ccc(F)cc1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1
410699	410699:01:04_10.00	True	10.0	62	83.4	0.0	0.0	79.5	0.0	77.0	20.1	90.3	38.0	61.7	0.0	79.3	53.7	LCH	90.3	PRT062607 (Hydrochloride)	PRT062607 Hydrochloride (P505-15 Hydrochloride) is a highly specific and potent inhibitor of purified Syk (IC50 1-2 nM).	True	NC(=O)c1cnc(N[C@@H]2CCCC[C@@H]2N)nc1Nc1cccc(-n2nccn2)c1
280875	280875:01:09_50.00	True	50.0	81	57.5	0.0	0.0	61.7	0.0	63.3	24.8	84.2	27.5	37.1	0.0	60.2	31.2	LCH	84.2	Quinine sulfate	K+ channel blocker, antimalarial, anticholinergic, antihypertensive and hypoglycemic agent, alkaloid isolated from the bark of the Cinchona family of South American trees.	False	C=C[C@H]1CN2CC[C@H]1C[C@H]2[C@H](O)c1ccnc2ccc(OC)cc12
410044	410044:01:04_10.00	True	10.0	88	7.4	50.3	0.0	0.0	54.5	0.0	27.9	17.1	0.0	8.3	23.3	16.4	15.6	DNA_Synth	54.5	JSH-23	JSH-23 is an inhibitor of NF-¿B transcriptional activity with IC50 of 7.1 ¿M in RAW 264.7 cell line.	False	Cc1ccc(NCCCc2ccccc2)c(N)c1
410278	410278:01:04_50.00	True	50.0	89	35.1	82.8	0.0	0.0	59.8	0.0	16.7	10.5	0.0	0.0	56.7	0.0	7.6	AKT_PI3K_MTOR	82.8	SAR260301	potent, specific, reversible, and ATP-competitive inhibitor of Cdc2-like kinase (Clk).	True	C[C@H]1Cc2ccccc2N1C(=O)Cc1nc(=O)cc(N2CCOCC2)[nH]1
382166	382166:03:04_10.00	True	10.0	97	28.8	0.0	0.0	40.7	0.0	61.4	19.4	37.6	42.4	24.6	0.0	28.3	33.4	HDAC	61.4	Thiazovivin	Thiazovivin is a potent ROCK inhibitor, which can protect human embryonic stem cells. Thiazovivin improves the efficiency of iPSC generation.	False	O=C(NCc1ccccc1)c1csc(Nc2ccncn2)n1
409829	409829:01:05_50.00	True	50.0	70	18.1	9.9	0.0	32.2	38.5	30.0	2.8	53.0	20.3	1.9	0.0	51.5	35.5	LCH	53.0	A-1155463	A-1155463 is a highly potent and selective BCL-XL inhibitor with an EC50 of 70 nM in Molt-4 cell.	False	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1
392290	392290:02:04_10.00	True	10.0	98	38.5	43.4	0.0	7.4	0.8	0.7	51.8	39.9	0.0	0.0	14.3	22.3	14.1	HSP90	51.8	GSK2606414	GSK2606414 is a cell-permeable and orally available protein kinase R-like endoplasmic reticulum (ER) kinase (PERK) inhibitor with an IC50 of 0.4 nM.; Discovery of 7-Methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a Potent and Selective First-in-Class Inhibitor of Protein Kinase R (PKR)-like Endoplasmic Reticulum Kinase (PERK) J. Med. Chem. 2012	False	Cn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(C(F)(F)F)c2)c2c(N)ncnc21
410146	410146:01:05_10.00	True	10.0	87	51.5	0.0	0.0	80.6	0.0	74.2	24.8	88.8	43.5	51.7	0.0	82.0	57.5	LCH	88.8	GSK2292767	GSK2292767 is a potent and selective PI3K¿ inhibitor.	False	COc1ncc(-c2cc(-c3ncc(CN4C[C@H](C)O[C@H](C)C4)o3)c3c[nH]nc3c2)cc1NS(C)(=O)=O
286065	286065:03:04_10.00	True	10.0	101	15.9	70.5	0.5	0.0	86.5	0.0	6.5	0.0	0.0	0.0	87.4	0.0	0.0	Pyrimidine_Synth	87.4	CI-1040	CI-1040 (PD 184352) is an orally active, highly specific, small-molecule inhibitor of MEK with an IC50 of 17 nM for MEK1.	False	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl
410620	410620:01:04_10.00	True	10.0	100	13.5	81.3	0.0	0.0	78.1	0.0	20.0	0.0	0.0	0.0	69.4	0.0	0.0	AKT_PI3K_MTOR	81.3	AZD 6482	AZD 6482 (KIN-193) is a potent and selective p110.b. inhibitor with an IC50 of 0.69 nM.	True	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1
410014	410014:01:04_10.00	True	10.0	110	16.8	0.0	0.0	40.0	0.0	37.9	25.9	59.7	7.9	21.5	0.0	45.1	0.0	LCH	59.7	EPZ005687	EPZ005687 is a potent and selective inhibitor of EZH2 with Ki of 24 nM, and has 50-fold selectivity against EZH1 and 500-fold selectivity against 15 other protein methyltransferases.	False	Cc1cc(C)c(CNC(=O)c2cc(-c3ccc(CN4CCOCC4)cc3)cc3c2cnn3C2CCCC2)c(O)n1
409992	409992:01:05_10.00	True	10.0	88	10.4	46.4	38.4	0.0	84.1	0.0	0.0	0.0	0.0	0.0	80.3	0.0	0.0	DNA_Synth	84.1	Evofosfamide	Evofosfamide (TH-302) is a hypoxia-activated prodrug with IC50 of 10 uM and 1000 uM in hypoxia (N2) and normoxia (21% O2), respectively.	False	Cn1c(COP(=O)(NCCBr)NCCBr)cnc1[N+](=O)[O-]
410635	410635:01:05_10.00	True	10.0	101	26.1	0.0	0.0	79.6	0.0	75.5	25.0	76.6	45.6	53.6	0.0	70.6	50.6	BET	79.6	Sonidegib (Erismodegib, NVP-LDE225)	Sonidegib (Erismodegib, NVP-LDE225) is a Smoothened (Smo) antagonist, inhibiting Hedgehog (Hh) signaling with IC50 of 1.3 nM (mouse) and 2.5 nM (human) in cell-free assays, respectively. Phase 3.	False	Cc1c(C(=O)Nc2ccc(N3C[C@H](C)O[C@H](C)C3)nc2)cccc1-c1ccc(OC(F)(F)F)cc1
410696	410696:01:04_10.00	True	10.0	110	16.2	75.5	0.0	0.0	72.3	0.0	24.3	0.0	0.0	0.0	58.5	0.0	0.0	AKT_PI3K_MTOR	75.5	SB 239063	SB 239063 is a potent, selective and orally active p38 MAPK inhibitor, exhibits an IC50 of 44 nM for recombinant purified human p38.a., with equipotent inhibitory activity against p38.a. and p38.b.. SB 239063 has no effect on p38.g. or p38.d.. With anti-asthma activity and also be used to enhance memory which is impaired due to aging or medical conditions, such as, AD.	False	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1
392762	392762:02:04_10.00	True	10.0	84	77.9	0.0	0.0	86.4	0.0	84.1	36.4	71.7	51.2	71.3	0.0	87.4	57.1	Tubulin	87.4	IM-12	IM-12 is an inhibitor of GSK-3.b., with an IC50 of 53 nM, and also enhances Wnt signalling.	False	Cc1[nH]c2ccccc2c1C1=C(NCCc2ccc(F)cc2)C(=O)N(C)C1=O
410200	410200:01:03_50.00	True	50.0	96	70.8	0.0	0.0	72.7	0.0	68.5	20.0	87.3	26.3	48.0	0.0	69.6	47.5	LCH	87.3	Fluspidine	Sigma 1 receptor ligand. Ki for S1R: 165 nM; S2R: 372 nM. It inhibits proliferation of MCF-7 cells, without cytotoxic effects.	False	FCCC1OC2(CCN(Cc3ccccc3)CC2)c2ccccc21
392684	392684:02:04_10.00	True	10.0	109	23.3	75.2	0.0	0.0	73.8	0.0	20.0	0.0	0.0	0.0	66.3	0.0	0.0	AKT_PI3K_MTOR	75.2	Icotinib	Icotinib (BPI-2009) is a potent and specific EGFR inhibitor with an IC50 of 5 nM; also inhibits mutant EGFRL858R, EGFRL858R/T790M, EGFRT790M and EGFRL861Q.	False	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1
410108	410108:01:04_10.00	True	10.0	103	6.6	76.9	0.0	0.0	78.5	0.0	8.9	0.0	0.0	0.0	68.8	0.0	0.0	DNA_Synth	78.5	BMS-582949	BMS-582949 is a potent and selective p38 mitogen-activated protein kinase (p38 MAPK) inhibitor with IC50 of 13nM,inhibiting both p38 kinase activity and activation of p38.	False	CCCNC(=O)c1cn2ncnc(Nc3cc(C(=O)NC4CC4)ccc3C)c2c1C
246704	246704:02:04_10.00	True	10.0	104	17.3	0.0	0.0	80.1	0.0	74.2	0.0	71.8	45.9	46.0	0.0	75.2	37.3	BET	80.1	Formoterol fumarate	ß2-agonist.	True	COc1ccc(C[C@H](C)NC[C@@H](O)c2ccc(O)c(NC=O)c2)cc1
385860	385860:02:05_10.00	True	10.0	97	10.2	4.4	3.6	1.0	20.3	0.0	35.4	24.9	0.0	0.0	15.6	16.7	0.0	HSP90	35.4	BAY-876	BAY-876 is an orally active and selective glucose transporter 1 (GLUT1) inhibitor with an IC50 of 2 nM. BAY-876 is >130-fold more selective for GLUT1 than GLUT2, GLUT3, and GLUT4. BAY-876 is also a potent blocker of glycolytic metabolism and ovarian cancer growth.	False	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1
409837	409837:01:05_50.00	True	50.0	60	83.6	0.0	0.0	83.0	0.0	85.6	28.7	72.4	58.8	64.7	0.0	77.3	58.4	HDAC	85.6	GSK-5959	GSK-5959 is a potent, selective and cell permeable BRPF1 bromodomain inhibitor with an IC50 of ~ 80 nM.	False	COc1ccccc1C(=O)Nc1cc2c(cc1N1CCCCC1)n(C)c(=O)n2C
410693	410693:01:04_10.00	True	10.0	102	8.6	63.9	0.0	19.1	11.6	23.5	23.2	40.8	14.9	8.9	10.1	13.9	44.7	AKT_PI3K_MTOR	63.9	Ceralasertib	Ceralasertib (AZD6738) is an orally active and bioavailable inhibitor of ATR kinase with an IC50 of 1 nM.	True	C[C@@H]1COCCN1c1cc(C2([S@](C)(=N)=O)CC2)nc(-c2ccnc3[nH]ccc23)n1
410655	410655:01:04_10.00	True	10.0	103	5.0	51.5	0.0	0.0	24.2	0.0	18.8	19.7	0.0	0.0	22.6	5.7	6.5	AKT_PI3K_MTOR	51.5	SAR131675	SAR131675 is a potent and selective VEGFR3 inhibitor with an IC50 of 23 nM.	True	CCn1c(N)c(C(=O)NC)c(=O)c2ccc(C#C[C@@](C)(O)COC)nc21
246886	246886:14:04_10.00	True	10.0	107	8.3	20.8	0.0	48.2	0.0	46.4	48.8	61.8	19.8	25.2	0.0	57.1	44.9	LCH	61.8	Loratadine	Loratadine (SCH-29851) is a selective inverse peripheral histamine H1-receptor agonist with an IC50 of >32 uM. Loratadine has anti-dengue-virus (DENV) activity.	False	CCOC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc3cccnc32)CC1
410708	410708:01:04_10.00	True	10.0	103	49.7	0.0	0.0	64.7	0.0	61.8	17.1	91.7	20.4	24.5	0.0	56.7	32.0	LCH	91.7	AM1241	AM-1241 is a selective cannabinoid CB2 receptor agonist with Ki of 3.4 nM, exhibits 82-fold selectivity over CB1 receptor.	False	CN1CCCCC1Cn1cc(C(=O)c2cc([N+](=O)[O-])ccc2I)c2ccccc21
392679	392679:02:04_10.00	True	10.0	107	9.5	36.1	0.0	21.6	0.0	16.4	32.6	42.8	0.0	2.3	0.0	24.1	20.8	LCH	42.8	ZM 306416	ZM-306416 (CB 676475) is a potent inhibitor of VEGFR with IC50s of 0.1 and 2 uM for KDR and Flt, respectively. ZM-306416 is also a EGFR inhibitor with an IC50 of <10 nM.	False	COc1cc2ncnc(Nc3ccc(Cl)cc3F)c2cc1OC
392755	392755:02:04_10.00	True	10.0	91	51.5	0.0	0.0	63.1	0.0	62.2	26.3	65.2	28.7	45.4	0.0	64.0	35.1	LCH	65.2	XMD8-92	XMD8-92 is a potent ERK5 (BMK1)/BRD4 inhibitor with Kds of 80 and 190 nM, respectively. XMD8-92 inhibits DCAMKL2, PLK4 and TNK1 with Kds of 190, 600 and 890 nM, respectively. Anti-cancer activity.	False	CCOc1cc(N2CCC(O)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C
409991	409991:01:04_10.00	True	10.0	92	64.4	0.0	0.0	78.0	0.0	73.2	8.5	92.0	38.9	41.1	0.0	71.8	43.9	LCH	92.0	AZ3146	AZ3146 is a reasonably potent and selective Mps1 inhibitor with IC50 of 35 nM for Mps1Cat.	False	COc1cc(OC2CCN(C)CC2)ccc1Nc1ncc2c(n1)n(C1CCCC1)c(=O)n2C
392683	392683:02:04_10.00	True	10.0	69	26.6	20.7	64.4	0.0	48.8	0.0	52.6	0.0	0.0	0.0	51.3	0.0	0.0	Aurora	64.4	PF-573228	PF-573228 is a potent and selective FAK inhibitor with IC50 of 4 nM for purified recombinant catalytic fragment of FAK.	False	CS(=O)(=O)c1cccc(CNc2nc(Nc3ccc4c(c3)CCC(=O)N4)ncc2C(F)(F)F)c1
410154	410154:01:04_10.00	True	10.0	97	35.8	0.0	0.0	84.4	0.0	81.4	10.4	85.2	45.0	60.9	0.0	76.1	53.4	LCH	85.2	Asciminib	Asciminib (ABL001) is a potent and selective allosteric BCR-ABL1 inhibitor, which inhibits Ba/F3 cells grown with an IC50 of 0.25 nM.	True	O=C(Nc1ccc(OC(F)(F)Cl)cc1)c1cnc(N2CC[C@@H](O)C2)c(-c2cc[nH]n2)c1
394208	394208:02:04_10.00	True	10.0	87	68.2	0.1	0.0	61.6	0.0	61.4	22.1	86.8	19.9	38.8	0.0	62.9	45.0	LCH	86.8	AZ191	AZ191 is a potent inhibitor that selectively inhibits DYRK1B with IC50 of 17 nM.	False	COc1cc(N2CCN(C)CC2)ccc1Nc1nccc(-c2cn(C)c3cnccc23)n1
410649	410649:01:04_10.00	True	10.0	100	29.5	0.0	0.0	50.1	0.0	48.7	26.3	63.6	26.4	31.1	0.0	57.8	17.9	LCH	63.6	Dibenzazepine (YO-01027)	Dibenzazepine (YO-01027) is a dipeptidic ¿-secretase inhibitor with IC50 of 2.6 nM and 2.9 nM  in cell-free assays for APPL and Notch cleavage, respectively.	True	C[C@H](NC(=O)Cc1cc(F)cc(F)c1)C(=O)N[C@@H]1C(=O)N(C)c2ccccc2-c2ccccc21
410135	410135:01:04_10.00	True	10.0	107	21.9	47.1	0.0	19.8	40.2	13.3	2.7	54.0	0.0	0.0	9.1	23.2	29.2	LCH	54.0	TAK-580	TAK-580 (MLN 2480) is an orally active and selective inhibitor of pan-Raf kinase.	True	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1
409839	409839:01:06_50.00	True	50.0	89	74.1	0.0	0.0	83.1	0.0	77.4	25.1	80.0	42.4	57.9	0.0	78.1	48.9	BET	83.1	CPI-637	CPI-637 is a selective and potent CBP/EP300 bromodomain inhibitor with IC50 values of 0.03 uM, 0.051 uM and 11.0 uM for CBP, EP300 and BRD4 BD-1, respectively, and an EC50 of 0.3 uM for CBP.	True	C[C@@H]1CC(=O)Nc2cccc(-c3ccc4c(c3)c(-c3cnn(C)c3)nn4C)c2N1
392619	392619:02:04_10.00	True	10.0	105	7.6	4.8	0.0	44.1	0.0	34.7	25.8	70.0	1.5	21.3	0.0	51.2	21.2	LCH	70.0	Apatinib	Apatinib is an orally bioavailable, selective VEGFR2 inhibitor with IC50 of 1 nM.	False	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1
392738	392738:02:04_10.00	True	10.0	56	70.6	0.0	8.3	74.1	0.0	75.9	21.4	57.9	59.3	48.1	0.0	79.6	33.0	Tubulin	79.6	Spebrutinib	Spebrutinib (AVL-292; CC-292) is a covalent, orally active, and highly selective with an IC50 of 0.5 nM.	False	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCOC)cc3)ncc2F)c1
247002	247002:10:04_10.00	True	10.0	98	5.9	1.5	0.0	49.3	0.0	41.2	0.0	48.0	28.4	34.2	0.0	48.2	38.5	BET	49.3	Isotretinoin	anti-inflammatory and antitumor actions mediated through RAR-beta and RAR-alpha receptors, antiacne, antineoplastic.	False	CC1=C(/C=C/C(C)=C/C=C/C(C)=C\C(=O)O)C(C)(C)CCC1
410614	410614:01:04_10.00	True	10.0	102	76.0	0.0	0.0	83.7	0.0	77.8	13.7	92.5	35.4	59.2	0.0	74.2	52.5	LCH	92.5	Cinacalcet (hydrochloride)	Cinacalcet hydrochloride (AMG-073 hydrochloride) is an orally active, allosteric agonist of Ca receptor (CaR), used for cardiovascular disease treatment.	True	C[C@@H](NCCCc1cccc(C(F)(F)F)c1)c1cccc2ccccc12
392693	392693:02:05_10.00	True	10.0	94	34.0	7.8	0.0	68.7	0.0	59.7	34.9	82.2	26.5	39.4	0.0	68.6	54.1	LCH	82.2	Linsitinib	Linsitinib (OSI-906) is a potent, selective and orally bioavailable dual inhibitor of the IGF-1 receptor and insulin receptor (IR) with IC50s of 35 and 75 nM, respectively.	False	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1
410511	410511:01:03_50.00	True	50.0	86	31.1	51.5	1.9	0.0	64.1	0.0	35.3	0.0	0.0	0.0	75.7	0.0	0.0	Pyrimidine_Synth	75.7		negative control of BI-1942.	True	CC[C@@H](C(=O)OC)n1c(=O)c2ccccc2n(Cc2cn(C)c3cccc(C)c23)c1=O
392713	392713:02:04_10.00	True	10.0	74	43.2	0.0	0.0	77.6	0.0	74.8	29.2	51.0	57.2	60.2	0.0	70.5	86.1	Uncoupler	86.1	CGK733	CGK733 is a potent ATM/ATR inhibitor, used for the research of cancer.	False	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1
410141	410141:01:04_10.00	True	10.0	89	32.6	0.0	0.0	28.4	0.0	20.6	55.0	40.7	5.4	3.0	0.0	52.4	24.3	HSP90	55.0	VX-11e	VX-11e is a potent, selective, and orally bioavailable inhibitor of ERK with Ki < 2 nM.	True	Cc1cnc(Nc2ccc(F)cc2Cl)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1
246514	246514:02:04_10.00	True	10.0	107	77.9	0.0	0.0	90.6	0.0	89.0	12.2	73.1	61.5	70.1	0.0	87.7	60.9	BET	90.6	Fluvastatin sodium salt	HMG CoA reductase inhibitor.	True	CC(C)n1c(/C=C/[C@H](O)C[C@H](O)CC(=O)O)c(-c2ccc(F)cc2)c2ccccc21
410669	410669:01:04_10.00	True	10.0	111	5.9	68.8	0.0	0.1	40.0	0.0	16.8	33.9	0.0	0.0	21.5	7.3	32.3	AKT_PI3K_MTOR	68.8	Batimastat	Batimastat is a potent broad spectrum MMP inhibitor with IC50 of 3, 4, 4, 6, and 20 nM for MMP-1, MMP-2, MMP-9, MMP-7 and MMP-3, respectively.	True	CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)[C@H](CSc1cccs1)C(=O)NO
409850	409850:02:04_10.00	True	10.0	99	37.7	0.0	0.0	96.0	0.0	87.7	0.0	77.5	64.9	57.0	0.0	85.6	71.9	BET	96.0	PFI-1	PFI-1 is a selective BET (bromodomain-containing protein) inhibitor for BRD4 with IC50 of 0.22 uM in a cell-free assay.	False	COc1ccccc1S(=O)(=O)Nc1ccc2c(c1)CN(C)C(=O)N2
410136	410136:01:05_10.00	True	10.0	101	31.6	14.3	0.0	65.1	0.0	60.4	10.7	84.5	30.1	33.9	0.0	65.2	57.8	LCH	84.5	IPI-3063	IPI-3063 is a potent and selective PI3K p110.d. inhibitor with an IC50 of 2.5±1.2 nM.	True	CC(C)n1c([C@H](C)Nc2ncnc(N)c2C#N)cc2cccc(-c3ccc(=O)n(C)c3)c2c1=O
392749	392749:02:04_10.00	True	10.0	97	24.7	61.1	0.0	0.0	61.3	0.0	0.0	0.0	0.0	0.0	60.9	0.0	0.0	DNA_Synth	61.3	Losmapimod	Losmapimod (GSK-AHAB) is a selective, potent, and orally active p38 MAPK inhibitor with pKis of 8.1 and 7.6 for p38.a. and p38.b., respectively.	False	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1
409859	409859:01:05_50.00	True	50.0	82	76.2	0.0	0.0	80.8	0.0	80.9	37.6	79.6	43.8	57.5	0.0	78.6	51.8	HDAC	80.9	SGC-CBP30	SGC-CBP30 is a potent and highly selective CBP/p300 bromodomain (Kds of 21 nM and 32 nM for CBP and p300, respectively) inhibitor, displaying 40-fold selectivity over the first bromodomain of BRD4 [BRD4(1)] bound. SGC-CBP30 strongly reduces secretion of IL-17A in Th17 cells and has anti-inflammatory effects.	True	COc1ccc(CCc2nc3cc(-c4c(C)noc4C)ccc3n2C[C@H](C)N2CCOCC2)cc1Cl
409847	409847:01:04_50.00	True	50.0	90	29.5	0.0	4.7	22.7	0.0	26.6	43.1	48.7	0.0	20.7	0.0	35.8	0.0	LCH	48.7	PDD 00017273	PDD 00017273 is a potent inhibitor of Poly(ADP-ribose) Glycohydrolase (PARG), with an IC50 of 26 nM, and a KD of 1.45 nM.	False	Cc1cc(Cn2c(=O)n(Cc3cnc(C)s3)c(=O)c3cc(S(=O)(=O)NC4(C)CC4)ccc32)n(C)n1
410737	410737:01:04_10.00	True	10.0	104	10.9	3.1	0.0	43.2	0.0	39.3	0.0	64.5	23.7	0.0	0.0	44.6	34.7	LCH	64.5	OG-L002	OG-L002 is a potent and highly selective LSD1 inhibitor with an IC50 of 0.02 uM. OG-L002 is a potent monoamine oxidases (MAO) inhibitor with IC50s of 1.38 uM and 0.72 uM for MAO-A and MAO-B, respectively. OG-L002 potently inhibits the expression of HSV IE genes.	True	N[C@H]1C[C@@H]1c1ccc(-c2cccc(O)c2)cc1
410120	410120:01:04_10.00	True	10.0	102	41.6	0.0	0.0	84.8	0.0	77.5	25.2	78.3	44.7	56.7	0.0	79.7	52.0	BET	84.8	GSK-872	GSK-872 is a RIPK3 inhibitor, which binds RIP3 kinase domain with an IC50 of 1.8 nM, and inhibits kinase activity with an IC50 of 1.3 nM.	False	CC(C)S(=O)(=O)c1ccc2nccc(Nc3ccc4scnc4c3)c2c1
280945	280945:05:04_10.00	True	10.0	101	9.8	76.3	0.0	0.0	51.1	0.0	40.0	1.8	0.0	5.5	33.8	0.0	36.6	AKT_PI3K_MTOR	76.3	SP600125,  Anthrapyrazolone	selective c-Jun N-terminal kinase (c-JNK) inhibitor, prevents BMP9-induced osteogenic differentiation of MSCs.	False	O=C1c2ccccc2-c2n[nH]c3cccc1c23
410731	410731:01:04_10.00	True	10.0	92	13.1	27.0	41.7	0.0	72.0	0.0	0.0	0.0	0.0	0.0	73.8	0.0	0.0	Pyrimidine_Synth	73.8	AZD-2461	AZD-2461 is a potent PARP inhibitor, with IC50s of 5 nM, 2 nM and 200 nM for PARP1, PARP2 and PARP3, respectively.	False	COC1CCN(C(=O)c2cc(Cc3nnc(O)c4ccccc34)ccc2F)CC1
392773	392773:02:04_10.00	True	10.0	104	12.3	57.8	13.2	0.0	74.3	0.0	19.4	0.0	0.0	0.0	83.0	0.0	0.0	Pyrimidine_Synth	83.0	Selumetinib	Selumetinib (AZD6244) is selective, non-ATP-competitive oral MEK1/2 inhibitor, with an IC50 of 14 nM for MEK1. Selumetinib (AZD6244) inhibits ERK1/2 phosphorylation.	False	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21
410626	410626:01:04_10.00	True	10.0	98	57.5	0.0	0.0	74.2	0.0	71.1	31.7	87.8	31.6	48.5	0.0	67.3	55.1	LCH	87.8	Nebivolol HCl	Nebivolol HCl selectively inhibits ß1-adrenoceptor with IC50 of 0.8 nM.	True	O[C@@H](CNC[C@H](O)[C@H]1CCc2cc(F)ccc2O1)[C@@H]1CCc2cc(F)ccc2O1
332505	332505:02:04_10.00	True	10.0	89	62.9	4.3	0.0	33.1	0.0	30.6	36.3	48.0	20.1	35.0	0.0	46.8	19.3	LCH	48.0	Sal003	Sal003 is a potent, specific and cell-permeable inhibitor of the eukaryotic translation initiation factor 2.a. (eIF2.a.) phosphatase. Sal003 is a derivative of salubrinal.	False	O=C(/C=C/c1ccccc1)NC(NC(=S)Nc1ccc(Cl)cc1)C(Cl)(Cl)Cl
409872	409872:01:04_50.00	True	50.0	104	23.8	0.0	0.0	81.3	0.0	77.8	10.5	90.2	47.4	54.0	0.0	75.4	47.3	LCH	90.2	GSK-LSD1 (dihydrochloride)	GSK-LSD1 dihydrochloride is a potent, selective and irreversible lysine specific demethylase 1 (LSD1)  inhibitor with an IC50 of 16 nM.	True	c1ccc([C@@H]2C[C@H]2NC2CCNCC2)cc1
410698	410698:01:04_10.00	True	10.0	91	39.7	0.0	0.0	54.8	0.0	55.3	38.7	63.2	21.5	40.1	0.0	53.6	25.1	LCH	63.2	Nirogacestat	Nirogacestat (PF-3084014) is a reversible, orally bioavailable, noncompetitive, and selective .g.-secretase inhibitor with an IC50 of 6.2 nM. Inhibition of Notch signaling by Nirogacestat while minimizing gastrointestinal toxicity presents a promising approach for research of Notch receptor-dependent cancers.	True	CCC[C@H](N[C@H]1CCc2cc(F)cc(F)c2C1)C(=O)Nc1cn(C(C)(C)CNCC(C)(C)C)cn1
409984	409984:01:05_10.00	True	10.0	103	5.4	0.0	0.0	66.0	0.0	57.3	14.3	42.4	37.6	45.7	0.0	62.6	38.6	BET	66.0	Galunisertib	Galunisertib (LY2157299) is an oral and selective TGF-.b. receptor type I (TGF-.b.RI) kinase inhibitor with an IC50 of 56 nM.	False	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1
410118	410118:01:06_10.00	True	10.0	100	77.7	0.0	0.0	88.7	0.0	84.1	12.2	90.3	44.0	63.8	0.0	82.6	62.0	LCH	90.3	VPS34 inhibitor 1 (Compound 19, PIK-III analogue)	VPS34 inhibitor 1 (Compound 19, PIK-III analogue) is a potent and selective inhibitor of VPS34 with an IC50 of 15 nM.	False	CC(C)(O)CNc1ncc(-c2ccnc(Nc3ccncc3)n2)c(CC2CC2)n1
408956	408955:01:05_50.00	True	50.0	103	10.7	0.0	0.0	75.4	0.0	67.7	0.0	52.7	64.8	39.4	0.0	65.8	54.2	BET	75.4	BI-9564	BI-9564 is a selective, and cell-permeable BRD9 BD inhibitor, with Kd of 5.9 nM for BRD9, and IC50 of > 100 µM for BET family.	False	COc1cc(-c2cn(C)c(=O)c3cnccc23)c(OC)cc1CN(C)C
410741	410741:01:04_10.00	True	10.0	85	22.6	74.1	0.0	0.0	54.6	0.0	39.1	13.7	0.0	0.0	52.5	11.8	11.8	AKT_PI3K_MTOR	74.1	STF-118804	STF-118804 is a highly specific NAMPT inhibitor; reduces the viability of most B-ALL cell lines with IC50 <10 nM.IC50 value:Target: NAMPT inhibitorin vitro:  improves survival in an orthotopic xenotransplant model of high-risk acute lymphoblastic leukemia, and targets leukemia stem cells. STF-118804 displays distinctive cytotoxicity by inducing apoptosis without causing a phase-specific cell cycle arrest. Over-expression of NAMPT rendered 293T cells more resistant to STF-118804 resulting in a higher IC50 (106 nM, 95% CI 74151 nM) compared to control cells (17 nM, 95% CI 1323 nM), further confirming that NAMPT protein levels dictate sensitivity to STF-118804 .in vivo: STF-118804 displayed high efficacy in a xenograft model of ALL. Mice treated with STF-118804 over a 20-day period survived an average of 34 days longer than vehicle-treated animals. During treatment, bioimaging showed regression of tumor followed by suppression of disease. STF-118804 was tolerated in the efficacious dose range, and the absence of adverse physical or pathological effects indicated that toxicity was not limiting in a 20-day study of mock transplanted mice .	False	Cc1ccc(S(=O)(=O)Cc2nc(-c3ccc(C(=O)NCc4cccnc4)cc3)oc2C)cc1
247256	247256:03:04_06.00	True	6.0	105	24.9	49.0	0.0	0.0	93.7	0.0	0.0	0.0	0.0	0.0	74.7	0.0	0.0	DNA_Synth	93.7	Deferoxamine mesylate	iron chelator, which does not readily bind iron from transferrin, hemoglobin, myoglobin or cytochrome. Rescues erastin-induced Ferroptosis.	False	CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN
392661	392661:02:04_06.00	True	6.0	85	63.7	0.0	0.0	74.8	0.0	71.1	35.9	92.3	29.0	50.9	0.0	74.2	55.5	LCH	92.3	AZD4547	AZD4547 is a novel selective FGFR inhibitor targeting FGFR1/2/3 with IC50 of 0.2 nM/2.5 nM/1.8 nM, weaker activity against FGFR4, VEGFR2(KDR), and little activity observed against IGFR, CDK2, and p38. Phase 1/2.	True	COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)n[nH]2)cc(OC)c1
246980	246980:07:08_30.00	True	30.0	75	36.6	0.0	0.0	75.0	0.0	72.1	35.5	63.9	58.7	52.0	0.0	93.7	48.8	Tubulin	93.7	Griseofulvin	Griseofulvin(Gris-PEG; Grifulvin) is a spirocyclic fungal natural product used in treatment of fungal dermatophytes; Antifungal drug.	True	COC1=CC(=O)C[C@@H](C)[C@]12Oc1c(Cl)c(OC)cc(OC)c1C2=O
407872	407872:02:04_06.00	True	6.0	92	33.0	50.2	0.0	0.0	60.2	0.0	47.1	0.0	0.0	0.0	71.0	0.0	0.0	Pyrimidine_Synth	71.0	Erastin	a cell-permeable piperazinyl-quinazolinone compound that exhibits oncogene-selective lethality. Shown to bind mitochondrial voltage-dependent anion channels (VDAC) and alter its gating; rapidly induce an oxidative, non-apoptotic cell death in several human tumors harboring activating mutations in the RAS-RAF-MEK signaling (EC50 = 6.0 µM in BJ-TERT/LT/ST/RASV12 cells).; Yagoda, N., et al. 2007. Nature 447, 864.	False	CCOc1ccccc1-n1c(C(C)N2CCN(C(=O)COc3ccc(Cl)cc3)CC2)nc2ccccc2c1=O
392756	392756:02:04_06.00	True	6.0	95	29.4	70.0	0.0	0.0	59.7	0.0	48.3	0.0	0.0	0.0	70.0	0.0	0.0	AKT_PI3K_MTOR	70.0	CGI-1746	CGI-1746 is a potent and highly selective inhibitor of the Btk with IC50 of 1.9 nM.	False	Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cn(C)c(=O)c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1
407892	407892:02:04_06.00	True	6.0	99	27.5	0.0	0.0	57.2	0.0	52.0	5.8	79.1	19.3	16.0	0.0	52.6	24.4	LCH	79.1	Telaglenastat	Telaglenastat (CB-839) is a first-in-class, selective, reversible and orally active glutaminase 1 (GLS1) inhibitor. Telaglenastat selectively inhibits GLS1 splice variants KGA (kidney-type glutaminase) and GAC (glutaminase C) compared to GLS2. The IC50s are 23 nM and 28 nM for endogenous glutaminase in mouse kidney and brain, respectively. Telaglenastat inudces autophagy and has antitumor activity.	False	O=C(Cc1cccc(OC(F)(F)F)c1)Nc1ccc(CCCCc2nnc(NC(=O)Cc3ccccn3)s2)nn1
409889	409889:01:03_30.00	True	30.0	96	32.1	0.0	0.0	55.0	0.0	58.3	52.2	56.2	26.3	39.8	0.0	56.1	46.2	HDAC	58.3	BAY-598	it is a selective inhibitor of SMYD2. It inhibits the methylation of p53 at lysine 370 in vitro and in whole cells with IC50 values of 27 nM and Structural Genomics Consortium (SGC) website for more information.	True	CCN(C(=O)CO)[C@H]1CN(/C(=N\C#N)Nc2cccc(OC(F)F)c2)N=C1c1ccc(Cl)c(Cl)c1
246419	246419:01:08_30.00	True	30.0	94	37.0	0.0	0.0	42.0	0.0	42.8	25.5	67.7	13.3	29.2	0.0	47.2	13.7	LCH	67.7	Quinidine hydrochloride monohydrate	heme polymerase inhibitor.	True	C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12
392663	392663:02:04_06.00	True	6.0	90	31.3	0.0	0.0	78.5	0.0	68.9	29.1	65.7	44.8	71.8	0.0	81.3	76.9	Tubulin	81.3	Dabrafenib	Dabrafenib (GSK2118436A) is an ATP-competitive inhibitor of Raf with IC50s of 5 nM and 0.6 nM for C-Raf and B-RafV600E, respectively.	False	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1
409864	409864:01:03_30.00	True	30.0	98	63.9	0.0	0.0	79.9	0.0	78.8	24.3	93.1	37.6	52.8	0.0	71.7	51.5	LCH	93.1	PFI-2 (hydrochloride)	PFI-2 hydrochloride is a a first-in-class, potent, highly selective, and cell-active inhibitor of the methyltransferase activity of SETD7 with IC50 of 2 nM, 500 fold active than (S)-PFI-2.IC50 value: 2 nM Target: SETD7(R)-PFI-2 is highly selective (>1,000-fold) for SETD7, over a panel of 18 other human protein methyltransferases and DNMT1, and was shown to be inactive against 134 additional ion channel, GPCR, and enzyme targets (<35% inhibition at 10 uM). (R)-PFI-2 binds to SETD7 only in the presence of SAM. PFI-766, a biotinylated variant of (R)-PFI-2 that retains the ability to bind and inhibit SETD7 (IC50 110 ± 26 nM in our in vitro enzymatic assay). PFI-766 engagement of endogenous SETD7 was also confirmed by mass spectrometry that supported the high specificity of the compound for endogenous SETD7.	True	O=C([C@@H](Cc1cccc(C(F)(F)F)c1)NS(=O)(=O)c1cc(F)c2c(c1)CCNC2)N1CCCC1
392415	392415:03:04_06.00	True	6.0	90	20.2	30.7	24.6	0.0	13.7	0.0	46.6	0.0	0.0	0.0	28.8	0.0	0.0	HSP90	46.6	TPCA-1	TPCA-1 is a potent and selective inhibitor of IKK-2 with IC50 of 17.9 nM. TPCA-1 is an effective inhibitor of STAT3 phosphorylation, DNA binding, and transactivation.; Assessment of chemical coverage of kinome space and its implications for kinase drug discovery. J Med Chem. 2008 Dec 25;51(24):7898-914.	False	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O
409983	409983:01:04_06.00	True	6.0	84	15.2	23.9	32.2	0.0	77.6	0.0	0.0	5.4	0.0	0.0	46.3	0.0	0.0	DNA_Synth	77.6	AG-14361	AG14361 is a potent inhibitor of PARP1 with Ki of <5 nM in a cell-free assay. It is at least 1000-fold more potent than the benzamides.	False	CN(C)Cc1ccc(-c2nc3cccc4c3n2CCNC4=O)cc1
247019	247019:04:04_06.00	True	6.0	89	10.9	0.0	0.0	68.5	0.0	65.4	34.3	70.2	27.7	57.7	0.0	71.4	42.0	Tubulin	71.4	Labetalol (hydrochloride)	Labetalol hydrochloride is a mixed alpha/beta adrenergic antagonist that is used to treat high blood pressure.	False	CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1
410025	410025:01:04_06.00	True	6.0	112	7.4	0.0	0.0	36.5	0.0	25.1	29.0	44.3	5.1	21.2	0.0	36.7	10.7	LCH	44.3	BMS-911543	BMS-911543 is a selective JAK2 inhibitor, with IC50s of 1.1 nM, less selective at JAK1, JAK3 and TYK2 (IC50, 75, 360, 66 nM, respectively).	False	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21
408877	408877:01:04_30.00	True	30.0	94	9.3	0.0	0.0	25.0	0.0	24.8	15.0	24.3	32.3	0.0	0.0	33.7	3.7	Tubulin	33.7	Acid Ceramidase Inhibitor 17a, ;ARN14974	it is a benzoxazolone carboxamide that potently inhibits acid ceramidase (IC50 = 79 nM). This effect is persistent, as it inhibits acid ceramidase activity in cells for up to 24 hours. ARN14974 is extremely stable in buffers and plasma and shows good pharmacokinetics when administered intravenously or intraperitoneally in mice. It causes a significant reduction in acid ceramidase activity in multiple organs in mice, including brain, liver, heart, lungs, and kidney.	False	O=C(NCCCCc1ccccc1)n1c(=O)oc2cc(-c3ccc(F)cc3)ccc21
392695	392695:02:03_30.00	True	30.0	62	63.0	0.0	0.0	78.8	0.0	77.7	38.2	57.8	57.5	58.8	0.0	75.4	68.8	BET	78.8	Agerafenib	Agerafenib (CEP-32496; RXDX-105) is a highly potent and orally efficacious inhibitor of BRAFV600E with a Kd of 14 nM.	False	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC
409977	409977:01:04_06.00	True	6.0	88	32.5	0.0	2.5	55.5	0.0	61.3	54.6	53.6	30.9	53.3	0.0	73.4	25.0	Tubulin	73.4	Pimobendan	Pimobendan (UD-CG115) is a selective inhibitor of PDE3 with IC50 of 0.32 uM.	False	COc1ccc(-c2nc3cc(C4=NNC(=O)CC4C)ccc3[nH]2)cc1
392721	392721:02:03_30.00	True	30.0	99	51.8	16.5	0.0	53.8	0.0	46.2	37.0	71.1	0.8	50.7	0.0	60.5	58.4	LCH	71.1	Neflamapimod	Neflamapimod (VX-745) is a potent, blood-brain barrier penetrant, highly selective inhibitor of p38.a. inhibitor with an IC50 for p38.a. of 10 nM and for p38.b. of 220 nM. Neflamapimod (VX-745) possesses anti-inflammatory activity.	False	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl
280372	280372:10:07_30.00	True	30.0	94	38.2	47.0	0.0	50.5	0.0	48.3	41.1	68.5	8.7	56.0	0.0	49.1	73.0	Uncoupler	73.0	CGS 15943	CGS 15943 is an orally bioavailable non-xanthine Adenosine Receptor antagonist. Its Ki for human A1, A2A, A2B, and A3 Adenosine Receptors are 3.5, 4.2, 16, and 50 nM in transfected CHO cells, respectively. .	False	Nc1nc2ccc(Cl)cc2c2nc(-c3ccco3)nn12
407736	407736:02:04_06.00	True	6.0	93	10.5	0.0	0.0	64.9	0.0	65.1	48.6	78.4	25.3	37.2	0.0	71.0	48.8	LCH	78.4	ML347	ML347(DN193719) is a highly selective ALK1/ALK2 inhibitor with IC50s of 46/32 nM; shows >300-fold selectivity for ALK2 vs. ALK3.IC50 value:Target: ALK1/ALK2ML347 has IC50s of 46 and 32 nM, respectively, against ALK1 and ALK2; however, the IC50 against ALK3 is 10,800 nM, >300-fold selective over ALK3. ML347 is completely inactive against allthe other kinases tested (with weak activity against ALK6, 9830 nM and KDR (VEGFR2)19,700 nM). ML347 is potent in the BMP4 cell assay (152 nM).	False	COc1ccc(-c2cnc3c(-c4cccc5ncccc45)cnn3c2)cc1
101008	101008:01:24_30.00	True	30.0	76	71.0	0.0	0.0	77.3	0.0	76.7	47.8	62.4	55.5	59.0	0.0	88.9	52.8	Tubulin	88.9	Centrocountin 1	modulator of centrosome integrity; binds centrosome-associated proteins nucleophosmin (NPM) and Crm1.; Nat. Chem. Biol. 2012, 8, 179	True	COC(=O)C1=CC(C(=O)c2ccccc2O)=CN2CCc3c([nH]c4ccccc34)[C@@]12C(=O)OC
410077	410077:01:04_06.00	True	6.0	107	7.8	20.3	0.0	37.4	0.0	29.4	43.2	49.7	11.9	32.5	0.0	40.8	32.7	LCH	49.7	LY-2584702 (tosylate salt)	LY-2584702 tosylate salt is a selective ATP competitive inhibitor of p70S6K with an IC50 of 4 nM. In S6K1 enzyme assay, the IC50 of LY-2584702 is 2 nM.	False	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1
410680	410680:01:04_06.00	True	6.0	106	7.8	58.3	0.0	0.0	0.0	0.0	30.9	0.0	0.0	0.0	30.1	0.0	1.5	AKT_PI3K_MTOR	58.3	GNE-9605	GNE-9605 is a highly potent, selective, and brain-penetrant LRRK2 inhibitor with IC50 of 19 nM.IC50 value:Target: LRRK2GNE-9605 retained excellent predicted human metabolic stability when assayed in human liver microsomes and hepatocytes. Inaddition, no reversible or time-dependent inhibition of any of the major CYP isoforms was observed. The demonstrated metabolic stability, brain penetration across multiple species, and selectivity of these inhibitors support their use in preclinical efficacy and safety studies.	True	CNc1nc(Nc2cnn([C@H]3CCN(C4COC4)C[C@@H]3F)c2Cl)ncc1C(F)(F)F
409906	409906:01:03_30.00	True	30.0	73	84.1	0.0	0.0	78.3	0.0	74.0	34.1	64.6	52.1	73.8	0.0	79.7	75.5	Tubulin	79.7	BMX-IN-1	BMX-IN-1 is a selective, irreversible inhibitor of bone marrow tyrosine kinase on chromosome X (BMX) that targets Cys496 in the BMX ATP binding domain with an IC50 of 8 nM, also targets the related Brutons tyrosine kinase (BTK) with an IC50 value of 10.4 nM, but is more than 47-656-fold less potent against Blk, JAK3, EGFR, Itk, or Tec activity.	False	C=CC(=O)Nc1cc(-n2c(=O)ccc3cnc4ccc(-c5ccc(NS(C)(=O)=O)cc5)cc4c32)ccc1C
407896	407896:02:04_06.00	True	6.0	100	24.0	0.0	0.0	20.2	0.0	13.9	24.3	40.8	0.0	12.2	0.0	26.4	0.0	LCH	40.8	BPTES	it  is a selective inhibitor of Glutaminase GLS1 (KGA), which is found in the kidney and brain, and is positively regulated by myc and strongly expressed in many tumors and tumor cell lines. Glutaminase converts glutamine to glutamate, which is an important excitatory neurotransmitter in brain and can be further oxidized to a-ketoglutarate to feed the tricarboxylic acid (TCA) cycle and to glutathione, which is important for controlling the level of reactive oxygen species (ROS), particularly important for cancer cell growth. BPTES was found to slow growth of glioma cells. BPTES is a noncompetitive inhibitor with a Ki of 3 µM.	False	O=C(Cc1ccccc1)Nc1nnc(CCSCCc2nnc(NC(=O)Cc3ccccc3)s2)s1
392682	392682:02:04_06.00	True	6.0	96	42.8	0.0	0.0	33.6	4.0	23.9	21.3	70.7	0.0	4.6	0.0	51.5	6.8	LCH	70.7	Go 6983	Go 6983 is a pan-PKC inhibitor against for PKC.a., PKC.b., PKC.g., PKC.d. and PKC.z. with IC50 of 7 nM, 7 nM, 6 nM, 10 nM and 60 nM, respectively.	False	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C
382120	382120:03:04_06.00	True	6.0	87	33.7	0.0	0.0	73.9	0.0	71.5	44.6	73.0	37.3	59.6	0.0	79.3	48.4	Tubulin	79.3	DMH-1	DMH-1 is a potent and selective BMP inhibitor with IC50s of 27/107.9/<5/47.6 nM for ALK1/ALK2/ALK3/ALK6, respectively.	False	CC(C)Oc1ccc(-c2cnc3c(-c4ccnc5ccccc45)cnn3c2)cc1
410029	410029:01:04_06.00	True	6.0	81	48.2	0.0	0.0	63.9	0.0	61.4	35.3	80.2	29.8	34.6	0.0	78.3	37.0	LCH	80.2	Motolimod	Motolimod (VTX-2337;VTX-378) is a selective Toll-like receptor 8 (TLR8) agonist, with an EC50 of approximately 100 nM.	False	CCCN(CCC)C(=O)C1=Cc2ccc(-c3ccc(C(=O)N4CCCC4)cc3)cc2N=C(N)C1
410137	410137:01:04_06.00	True	6.0	102	9.2	30.4	0.0	0.0	0.0	6.2	34.4	0.0	0.0	7.2	13.9	0.0	22.1	HSP90	34.4	AZD3965	AZD3965 is a potent, selective and orally available monocarboxylate transporter 1 (MCT1) inhibitor with a binding affinity of 1.6 nM, 6-fold selective over MCT2. Phase 1.	True	Cc1[nH]nc(C(F)(F)F)c1Cc1sc2c(c1C(=O)N1CC(C)(C)CO1)c(=O)n(C)c(=O)n2C(C)C
409894	409894:01:03_30.00	True	30.0	97	25.6	0.0	0.0	47.2	0.0	43.1	18.9	69.8	18.1	13.8	0.0	54.1	12.4	LCH	69.8	GSK591	GSK591 (EPZ015866) is a potent and selective inhibitor of protein methyltransferase 5 (PRMT5) with an IC50 of 4 nM.	True	O=C(NC[C@H](O)CN1CCc2ccccc2C1)c1ccnc(NC2CCC2)c1
410147	410147:01:04_06.00	True	6.0	98	78.1	0.0	0.0	85.0	0.0	82.5	23.5	94.9	41.0	58.6	0.0	78.4	59.0	LCH	94.9	Ozanimod	Ozanimod (RPC-1063) is a potent and selective S1P1 and S1P5 receptor agonist with EC50s of 410 pM and 11 nM in [35S]-GTP.g.S binding, respectively.	True	CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@@H]4NCCO)no2)cc1C#N
101009	101009:01:19_30.00	True	30.0	89	30.9	0.0	0.0	48.3	0.0	47.0	57.4	49.3	21.1	41.1	0.0	58.9	34.5	Tubulin	58.9	Centrocountin 1	modulator of centrosome integrity; binds centrosome-associated proteins nucleophosmin (NPM) and Crm1.; Nat. Chem. Biol. 2012, 8, 179	True	COC(=O)C1=CC(C(=O)c2ccccc2O)=CN2CCc3c([nH]c4ccccc34)[C@]12C(=O)OC
410756	410756:01:04_06.00	True	6.0	111	11.7	33.9	0.0	0.0	32.7	0.0	0.0	0.0	0.0	0.0	54.5	0.0	0.0	Pyrimidine_Synth	54.5	GW9508	GW9508 is a potent and selective G protein-coupled receptors FFA1 (GPR40) and GPR120 agonist with pEC50s of 7.32 and 5.46, respectively. GW9508 shows ~100-fold selectivity for GPR40 over GPR120. GW9508 is inactive against other GPCRs, kinases, proteases, integrins and PPARs. GW9508 is a glucose-sensitive insulin secretagogue and an ATP-sensitive potassium (KATP) channels opener. Anti-inflammatory and anti-atherosclerotic activities.	False	O=C(O)CCc1ccc(NCc2cccc(Oc3ccccc3)c2)cc1
246626	246626:02:05_30.00	True	30.0	94	20.0	4.1	0.0	66.6	0.0	59.7	33.8	57.7	46.8	52.1	0.0	64.8	69.0	Uncoupler	69.0	Verteporfin, Visudyne	Photosensitizing Agent (used in conjunction with laser treatment to eliminate the abnormal blood vessels in the eye)	True	C=Cc1c(C)c2cc3nc(cc4[nH]c(cc5nc(cc1[nH]2)C(C)=C5CCC(=O)O)c(CCC(=O)OC)c4C)[C@@]1(C)C3=CC=C(C(=O)OC)[C@H]1C(=O)OC
392677	392677:02:04_06.00	True	6.0	85	17.6	27.0	50.9	0.0	67.0	0.0	22.5	0.0	0.0	0.0	55.6	0.0	0.0	DNA_Synth	67.0	BI-D1870	BI-D1870 is an ATP-competitive, cell permeable and brain penetrated inhibitor of RSK isoforms, with IC50s of 31 nM/24 nM/18 nM/15 nM for RSK1/RSK2/RSK3/RSK4, respectively.	False	CC(C)CCN1c2nc(Nc3cc(F)c(O)c(F)c3)ncc2N(C)C(=O)C1C
247070	247070:05:04_06.00	True	6.0	101	20.7	0.0	0.0	82.4	0.0	81.5	10.9	87.6	46.4	56.8	0.0	72.1	39.8	LCH	87.6	Desipramine hydrochloride	Desipramine hydrochloride is an inhibitor of norepinephrine transporter (NET), 5-HT transporter (SERT) and dopamine transporter (DAT) with Kis of 4, 61 and 78,720 nM, respectively.	False	CNCCCN1c2ccccc2CCc2ccccc21
392527	392527:02:04_06.00	True	6.0	98	61.8	8.2	0.0	74.5	0.0	71.4	29.4	92.9	30.4	51.3	0.0	69.8	63.3	LCH	92.9	WZ4002	WZ4002 is a mutant selective EGFR inhibitor with IC50s of 2, 8, 3 and 2 nM for EGFRL858R, EGFRL858R/T790M, EGFRE746_A750 and EGFRE746_A750/T790M, respectively.	False	C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)ncc2Cl)c1
410653	410653:01:04_06.00	True	6.0	100	10.5	9.6	0.0	0.0	32.5	0.0	21.5	22.5	0.0	0.0	28.3	10.9	0.0	DNA_Synth	32.5	Torcetrapib	Torcetrapib (CP-529414) is a selective, potent cholesteryl ester transfer protein (CETP) inhibitor.	True	CCOC(=O)N1c2ccc(C(F)(F)F)cc2[C@@H](N(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)C(=O)OC)C[C@H]1CC
409856	409856:01:05_03.00	True	3.0	102	42.7	0.0	0.0	76.1	0.0	73.1	13.7	95.2	37.3	44.4	0.0	68.0	43.2	LCH	95.2	GSK343	GSK343 is a highly potent and selective EZH2 inhibitor with an IC50 of 4 nM.	False	CCCc1cc(C)nc(O)c1CNC(=O)c1cc(-c2ccnc(N3CCN(C)CC3)c2)cc2c1cnn2C(C)C
350607	350607:02:04_06.00	True	6.0	94	7.1	39.9	32.5	0.0	82.8	0.0	15.4	0.0	0.0	0.0	81.1	0.0	0.0	DNA_Synth	82.8	Spautin-1	Spautin-1 is a specific and potent autophagy inhibitor which inhibits ubiquitin-specific peptidases, USP10 and USP13 with IC50s of 0.6-0.7 uM. 	False	Fc1ccc(CNc2ncnc3ccc(F)cc23)cc1
409892	409892:01:03_30.00	True	30.0	79	27.6	0.0	0.0	50.3	0.0	51.3	34.9	65.6	33.4	33.8	0.0	58.9	20.8	LCH	65.6	A-196	it is a selective inhibitor of SUV420H1 and SUV420H2 (IC50s = 25 and 144 nM, respectively) that is more than 100-fold selective over other histone methyltransferases and non-epigenetic targets. A-196 has been shown to inhibit the di- and tri-methylation of lysine 20 of histone H4 (H4K20me) in multiple cell lines with IC50 values less than 1 µM. See the Structural Genomics Consortium (SGC) website for more information.	False	Clc1cc2c(NC3CCCC3)nnc(-c3ccncc3)c2cc1Cl
409893	409893:01:03_30.00	True	30.0	99	43.0	0.0	0.0	87.4	0.0	84.3	0.7	82.1	60.6	68.5	0.0	80.8	46.5	BET	87.4	MS049 (hydrochloride)	it is a potent and selective inhibitor of PRMT4 (IC50 = 34 nM) and PRMT6 (IC50 = 43 nM). It is less active against additional type I PRMTs (IC50s = >130, >220, and 1.6 µM for PRMT1, PRMT3, and PRMT8, respectively) and displays no inhibition against type II or type III PRMTs nor any additional methyltransferases or nonepigenetic targets tested. MS049 has been shown to reduce the H3R2me2a mark in HEK293 cells with an IC50 value of 0.97 µM and also, unexpectedly, to reduce H4R3me2a in HEK293 cells. See the Structural Genomics Consortium (SGC) website for more information.	False	CNCCN1CCC(OCc2ccccc2)CC1
410689	410689:01:04_06.00	True	6.0	102	12.4	11.5	0.0	20.9	43.0	7.7	24.4	44.9	0.0	5.0	6.5	46.3	19.2	Tubulin	46.3	GSK 2830371	GSK 2830371 is a highly selective Wip1 phosphatase inhibitor with IC50 of 6 nM.	True	Cc1ncc(Cl)cc1NCc1ccc(C(=O)N[C@@H](CC2CCCC2)C(=O)NC2CC2)s1
247256	247256:03:04_10.00	True	10.0	80	24.5	51.4	4.4	0.0	93.3	0.0	0.0	0.0	0.0	0.0	74.9	0.0	0.0	DNA_Synth	93.3	Deferoxamine mesylate	iron chelator, which does not readily bind iron from transferrin, hemoglobin, myoglobin or cytochrome. Rescues erastin-induced Ferroptosis.	False	CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN
392661	392661:02:04_10.00	True	10.0	78	78.2	0.0	0.0	78.1	0.0	74.6	35.9	87.7	33.5	61.7	0.0	78.3	56.6	LCH	87.7	AZD4547	AZD4547 is a novel selective FGFR inhibitor targeting FGFR1/2/3 with IC50 of 0.2 nM/2.5 nM/1.8 nM, weaker activity against FGFR4, VEGFR2(KDR), and little activity observed against IGFR, CDK2, and p38. Phase 1/2.	True	COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)n[nH]2)cc(OC)c1
246980	246980:07:08_50.00	True	50.0	58	43.5	0.0	0.0	69.9	0.0	69.8	41.4	61.4	60.1	61.4	0.0	89.8	51.6	Tubulin	89.8	Griseofulvin	Griseofulvin(Gris-PEG; Grifulvin) is a spirocyclic fungal natural product used in treatment of fungal dermatophytes; Antifungal drug.	True	COC1=CC(=O)C[C@@H](C)[C@]12Oc1c(Cl)c(OC)cc(OC)c1C2=O
407872	407872:02:04_10.00	True	10.0	95	29.9	48.6	0.0	0.0	41.1	0.0	48.1	13.6	0.0	0.0	56.0	0.0	0.0	Pyrimidine_Synth	56.0	Erastin	a cell-permeable piperazinyl-quinazolinone compound that exhibits oncogene-selective lethality. Shown to bind mitochondrial voltage-dependent anion channels (VDAC) and alter its gating; rapidly induce an oxidative, non-apoptotic cell death in several human tumors harboring activating mutations in the RAS-RAF-MEK signaling (EC50 = 6.0 µM in BJ-TERT/LT/ST/RASV12 cells).; Yagoda, N., et al. 2007. Nature 447, 864.	False	CCOc1ccccc1-n1c(C(C)N2CCN(C(=O)COc3ccc(Cl)cc3)CC2)nc2ccccc2c1=O
392756	392756:02:04_10.00	True	10.0	89	29.5	72.1	0.0	0.0	47.2	0.0	51.2	3.3	0.0	0.0	59.1	0.0	0.0	AKT_PI3K_MTOR	72.1	CGI-1746	CGI-1746 is a potent and highly selective inhibitor of the Btk with IC50 of 1.9 nM.	False	Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cn(C)c(=O)c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1
407892	407892:02:04_10.00	True	10.0	96	35.8	0.0	0.0	67.3	0.0	64.5	16.3	81.6	26.6	39.5	0.0	65.3	39.1	LCH	81.6	Telaglenastat	Telaglenastat (CB-839) is a first-in-class, selective, reversible and orally active glutaminase 1 (GLS1) inhibitor. Telaglenastat selectively inhibits GLS1 splice variants KGA (kidney-type glutaminase) and GAC (glutaminase C) compared to GLS2. The IC50s are 23 nM and 28 nM for endogenous glutaminase in mouse kidney and brain, respectively. Telaglenastat inudces autophagy and has antitumor activity.	False	O=C(Cc1cccc(OC(F)(F)F)c1)Nc1ccc(CCCCc2nnc(NC(=O)Cc3ccccn3)s2)nn1
409889	409889:01:03_50.00	True	50.0	84	41.5	0.0	0.0	63.0	0.0	62.1	51.1	57.5	33.3	48.7	0.0	63.0	63.3	Uncoupler	63.3	BAY-598	it is a selective inhibitor of SMYD2. It inhibits the methylation of p53 at lysine 370 in vitro and in whole cells with IC50 values of 27 nM and Structural Genomics Consortium (SGC) website for more information.	True	CCN(C(=O)CO)[C@H]1CN(/C(=N\C#N)Nc2cccc(OC(F)F)c2)N=C1c1ccc(Cl)c(Cl)c1
246419	246419:01:08_50.00	True	50.0	91	45.9	0.9	0.0	43.5	0.0	46.1	28.7	66.2	12.8	35.6	0.0	45.1	20.9	LCH	66.2	Quinidine hydrochloride monohydrate	heme polymerase inhibitor.	True	C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12
392663	392663:02:04_10.00	True	10.0	84	25.6	0.0	0.0	78.1	0.0	70.0	25.0	65.9	46.4	72.6	0.0	80.7	69.8	Tubulin	80.7	Dabrafenib	Dabrafenib (GSK2118436A) is an ATP-competitive inhibitor of Raf with IC50s of 5 nM and 0.6 nM for C-Raf and B-RafV600E, respectively.	False	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1
409864	409864:01:03_50.00	True	50.0	98	72.4	0.0	0.0	82.8	0.0	78.7	25.5	90.5	35.3	61.1	0.0	73.6	61.8	LCH	90.5	PFI-2 (hydrochloride)	PFI-2 hydrochloride is a a first-in-class, potent, highly selective, and cell-active inhibitor of the methyltransferase activity of SETD7 with IC50 of 2 nM, 500 fold active than (S)-PFI-2.IC50 value: 2 nM Target: SETD7(R)-PFI-2 is highly selective (>1,000-fold) for SETD7, over a panel of 18 other human protein methyltransferases and DNMT1, and was shown to be inactive against 134 additional ion channel, GPCR, and enzyme targets (<35% inhibition at 10 uM). (R)-PFI-2 binds to SETD7 only in the presence of SAM. PFI-766, a biotinylated variant of (R)-PFI-2 that retains the ability to bind and inhibit SETD7 (IC50 110 ± 26 nM in our in vitro enzymatic assay). PFI-766 engagement of endogenous SETD7 was also confirmed by mass spectrometry that supported the high specificity of the compound for endogenous SETD7.	True	O=C([C@@H](Cc1cccc(C(F)(F)F)c1)NS(=O)(=O)c1cc(F)c2c(c1)CCNC2)N1CCCC1
410690	410690:01:04_10.00	True	10.0	94	8.5	31.2	45.2	0.0	72.1	0.0	0.0	0.0	0.0	0.0	72.7	0.0	0.0	Pyrimidine_Synth	72.7	PX-478 2HCl	PX-478 2HCl is an orally active, and selective hypoxia-inducible factor-1¿ (HIF-1¿) inhibitor. Phase 1.	True	N[C@@H](Cc1ccc([N+]([O-])(CCCl)CCCl)cc1)C(=O)O
392415	392415:03:04_10.00	True	10.0	70	23.8	0.0	79.6	0.0	4.5	0.0	26.2	0.0	0.0	0.0	19.6	0.0	0.0	Aurora	79.6	TPCA-1	TPCA-1 is a potent and selective inhibitor of IKK-2 with IC50 of 17.9 nM. TPCA-1 is an effective inhibitor of STAT3 phosphorylation, DNA binding, and transactivation.; Assessment of chemical coverage of kinome space and its implications for kinase drug discovery. J Med Chem. 2008 Dec 25;51(24):7898-914.	False	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O
409983	409983:01:04_10.00	True	10.0	81	7.6	25.9	47.7	0.0	76.1	0.0	11.6	0.0	0.0	0.0	52.8	0.0	0.0	DNA_Synth	76.1	AG-14361	AG14361 is a potent inhibitor of PARP1 with Ki of <5 nM in a cell-free assay. It is at least 1000-fold more potent than the benzamides.	False	CN(C)Cc1ccc(-c2nc3cccc4c3n2CCNC4=O)cc1
410025	410025:01:04_10.00	True	10.0	105	21.1	0.0	0.0	58.9	0.0	52.7	39.0	62.0	23.2	43.1	0.0	63.8	25.8	Tubulin	63.8	BMS-911543	BMS-911543 is a selective JAK2 inhibitor, with IC50s of 1.1 nM, less selective at JAK1, JAK3 and TYK2 (IC50, 75, 360, 66 nM, respectively).	False	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21
408877	408877:01:04_50.00	True	50.0	91	29.7	0.0	0.0	42.1	0.0	44.0	39.9	36.3	24.7	25.8	0.0	49.9	16.6	Tubulin	49.9	Acid Ceramidase Inhibitor 17a, ;ARN14974	it is a benzoxazolone carboxamide that potently inhibits acid ceramidase (IC50 = 79 nM). This effect is persistent, as it inhibits acid ceramidase activity in cells for up to 24 hours. ARN14974 is extremely stable in buffers and plasma and shows good pharmacokinetics when administered intravenously or intraperitoneally in mice. It causes a significant reduction in acid ceramidase activity in multiple organs in mice, including brain, liver, heart, lungs, and kidney.	False	O=C(NCCCCc1ccccc1)n1c(=O)oc2cc(-c3ccc(F)cc3)ccc21
409977	409977:01:04_10.00	True	10.0	82	27.1	0.0	0.0	61.8	0.0	57.0	42.2	57.3	39.2	53.3	0.0	80.3	38.8	Tubulin	80.3	Pimobendan	Pimobendan (UD-CG115) is a selective inhibitor of PDE3 with IC50 of 0.32 uM.	False	COc1ccc(-c2nc3cc(C4=NNC(=O)CC4C)ccc3[nH]2)cc1
392721	392721:02:03_50.00	True	50.0	85	47.8	18.9	0.0	54.6	0.0	46.7	45.3	62.4	9.5	54.6	0.0	63.5	64.0	Uncoupler	64.0	Neflamapimod	Neflamapimod (VX-745) is a potent, blood-brain barrier penetrant, highly selective inhibitor of p38.a. inhibitor with an IC50 for p38.a. of 10 nM and for p38.b. of 220 nM. Neflamapimod (VX-745) possesses anti-inflammatory activity.	False	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl
280372	280372:10:07_50.00	True	50.0	91	40.2	43.5	0.0	48.4	0.0	46.9	39.4	61.7	11.2	57.3	0.0	47.2	72.1	Uncoupler	72.1	CGS 15943	CGS 15943 is an orally bioavailable non-xanthine Adenosine Receptor antagonist. Its Ki for human A1, A2A, A2B, and A3 Adenosine Receptors are 3.5, 4.2, 16, and 50 nM in transfected CHO cells, respectively. .	False	Nc1nc2ccc(Cl)cc2c2nc(-c3ccco3)nn12
407736	407736:02:04_10.00	True	10.0	84	68.0	0.0	0.0	86.6	0.0	84.2	30.4	76.6	56.7	73.3	0.0	90.2	62.3	Tubulin	90.2	ML347	ML347(DN193719) is a highly selective ALK1/ALK2 inhibitor with IC50s of 46/32 nM; shows >300-fold selectivity for ALK2 vs. ALK3.IC50 value:Target: ALK1/ALK2ML347 has IC50s of 46 and 32 nM, respectively, against ALK1 and ALK2; however, the IC50 against ALK3 is 10,800 nM, >300-fold selective over ALK3. ML347 is completely inactive against allthe other kinases tested (with weak activity against ALK6, 9830 nM and KDR (VEGFR2)19,700 nM). ML347 is potent in the BMP4 cell assay (152 nM).	False	COc1ccc(-c2cnc3c(-c4cccc5ncccc45)cnn3c2)cc1
101008	101008:01:24_50.00	True	50.0	75	58.7	0.0	0.0	76.7	0.0	75.1	45.8	61.9	55.7	55.7	0.0	86.2	53.3	Tubulin	86.2	Centrocountin 1	modulator of centrosome integrity; binds centrosome-associated proteins nucleophosmin (NPM) and Crm1.; Nat. Chem. Biol. 2012, 8, 179	True	COC(=O)C1=CC(C(=O)c2ccccc2O)=CN2CCc3c([nH]c4ccccc34)[C@@]12C(=O)OC
410077	410077:01:04_10.00	True	10.0	92	9.0	3.0	0.0	54.8	0.0	53.1	53.1	56.5	24.7	51.8	0.0	56.1	48.7	LCH	56.5	LY-2584702 (tosylate salt)	LY-2584702 tosylate salt is a selective ATP competitive inhibitor of p70S6K with an IC50 of 4 nM. In S6K1 enzyme assay, the IC50 of LY-2584702 is 2 nM.	False	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1
409901	409901:02:04_10.00	True	10.0	99	7.9	0.0	21.0	17.7	0.3	17.2	38.5	39.1	0.0	16.9	0.0	34.2	0.0	LCH	39.1	CPI-360	CPI-360 is a potent, selective EZH2inhibitor with IC50 of 0.5 nM and 2.5 nM nM for wt EZH2 and Y641N EZH2, respectively.IC50 value: 0.5 nM, 2.5 nMTarget: EZH2in vitro: CPI-360 functions on the basis of S-adenosyl-Lmethionine(SAM)-competition, inhibits EZH1 about 100-fold less and shows exquisite selectivity across a large panel of histone lysine and arginine, and DNA methyltransferases. CPI-360 potently reduced global H3K27me3 and H3K27me2 levels in a dosedependent manner. CPI-360 effectively suppressed heavy H3K27me3 incorporation in KARPAS-422 cells without affecting total histone turnover. CPI-360 treatment causes time-dependent transcriptional changes in germinal center B cell-like diffuse large B cell lymphoma.in vivo: Twice daily, subcutaneous administration of 200 mg/kg ofCPI-360 reduced tumor growth (TGI 44%) of KARPAS-422 xenografts in mice without affecting body weight or causing any overt adverse effects. CPI-360 completely inhibits EZH2 catalytic activity, since we entirely suppress H3K27me3 turnover over time.	True	COc1cc(C)nc(O)c1CNC(=O)c1c(C)n([C@H](C)C2CCOCC2)c2ccccc12
407896	407896:02:04_10.00	True	10.0	96	30.9	0.0	0.0	25.7	0.0	23.5	40.7	36.3	0.0	38.3	0.0	32.4	10.2	HSP90	40.7	BPTES	it  is a selective inhibitor of Glutaminase GLS1 (KGA), which is found in the kidney and brain, and is positively regulated by myc and strongly expressed in many tumors and tumor cell lines. Glutaminase converts glutamine to glutamate, which is an important excitatory neurotransmitter in brain and can be further oxidized to a-ketoglutarate to feed the tricarboxylic acid (TCA) cycle and to glutathione, which is important for controlling the level of reactive oxygen species (ROS), particularly important for cancer cell growth. BPTES was found to slow growth of glioma cells. BPTES is a noncompetitive inhibitor with a Ki of 3 µM.	False	O=C(Cc1ccccc1)Nc1nnc(CCSCCc2nnc(NC(=O)Cc3ccccc3)s2)s1
392682	392682:02:04_10.00	True	10.0	84	45.9	0.0	0.0	37.7	0.0	32.1	37.6	71.3	0.0	21.8	0.0	61.2	15.8	LCH	71.3	Go 6983	Go 6983 is a pan-PKC inhibitor against for PKC.a., PKC.b., PKC.g., PKC.d. and PKC.z. with IC50 of 7 nM, 7 nM, 6 nM, 10 nM and 60 nM, respectively.	False	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C
382120	382120:03:04_10.00	True	10.0	98	26.8	0.0	0.0	52.5	0.0	48.1	50.3	50.8	20.0	57.7	0.0	57.4	36.9	Protein_Synth	57.7	DMH-1	DMH-1 is a potent and selective BMP inhibitor with IC50s of 27/107.9/<5/47.6 nM for ALK1/ALK2/ALK3/ALK6, respectively.	False	CC(C)Oc1ccc(-c2cnc3c(-c4ccnc5ccccc45)cnn3c2)cc1
410029	410029:01:04_10.00	True	10.0	82	56.5	0.0	0.0	70.1	0.0	66.4	41.3	76.0	39.7	48.8	0.0	82.3	50.4	Tubulin	82.3	Motolimod	Motolimod (VTX-2337;VTX-378) is a selective Toll-like receptor 8 (TLR8) agonist, with an EC50 of approximately 100 nM.	False	CCCN(CCC)C(=O)C1=Cc2ccc(-c3ccc(C(=O)N4CCCC4)cc3)cc2N=C(N)C1
410137	410137:01:04_10.00	True	10.0	98	12.4	38.7	0.0	0.0	0.0	0.0	17.9	0.0	0.0	0.0	31.7	0.0	2.4	AKT_PI3K_MTOR	38.7	AZD3965	AZD3965 is a potent, selective and orally available monocarboxylate transporter 1 (MCT1) inhibitor with a binding affinity of 1.6 nM, 6-fold selective over MCT2. Phase 1.	True	Cc1[nH]nc(C(F)(F)F)c1Cc1sc2c(c1C(=O)N1CC(C)(C)CO1)c(=O)n(C)c(=O)n2C(C)C
409894	409894:01:03_50.00	True	50.0	109	23.3	0.0	0.0	38.0	0.0	33.1	27.6	59.6	7.3	19.3	0.0	50.2	14.5	LCH	59.6	GSK591	GSK591 (EPZ015866) is a potent and selective inhibitor of protein methyltransferase 5 (PRMT5) with an IC50 of 4 nM.	True	O=C(NC[C@H](O)CN1CCc2ccccc2C1)c1ccnc(NC2CCC2)c1
101009	101009:01:19_50.00	True	50.0	91	32.8	0.0	0.0	56.1	0.0	51.6	55.3	54.8	23.4	49.3	0.0	66.4	41.0	Tubulin	66.4	Centrocountin 1	modulator of centrosome integrity; binds centrosome-associated proteins nucleophosmin (NPM) and Crm1.; Nat. Chem. Biol. 2012, 8, 179	True	COC(=O)C1=CC(C(=O)c2ccccc2O)=CN2CCc3c([nH]c4ccccc34)[C@]12C(=O)OC
246626	246626:02:05_50.00	True	50.0	80	23.7	6.3	0.0	42.3	0.0	39.6	18.3	30.4	39.7	31.5	0.0	31.2	48.3	Uncoupler	48.3	Verteporfin, Visudyne	Photosensitizing Agent (used in conjunction with laser treatment to eliminate the abnormal blood vessels in the eye)	True	C=Cc1c(C)c2cc3nc(cc4[nH]c(cc5nc(cc1[nH]2)C(C)=C5CCC(=O)O)c(CCC(=O)OC)c4C)[C@@]1(C)C3=CC=C(C(=O)OC)[C@H]1C(=O)OC
392677	392677:02:04_10.00	True	10.0	63	16.9	0.0	76.0	0.0	44.0	0.0	35.3	0.0	0.0	0.0	34.1	0.0	0.0	Aurora	76.0	BI-D1870	BI-D1870 is an ATP-competitive, cell permeable and brain penetrated inhibitor of RSK isoforms, with IC50s of 31 nM/24 nM/18 nM/15 nM for RSK1/RSK2/RSK3/RSK4, respectively.	False	CC(C)CCN1c2nc(Nc3cc(F)c(O)c(F)c3)ncc2N(C)C(=O)C1C
247070	247070:05:04_10.00	True	10.0	101	30.1	0.0	0.0	77.1	0.0	74.1	12.8	85.7	37.1	46.6	0.0	65.6	39.2	LCH	85.7	Desipramine hydrochloride	Desipramine hydrochloride is an inhibitor of norepinephrine transporter (NET), 5-HT transporter (SERT) and dopamine transporter (DAT) with Kis of 4, 61 and 78,720 nM, respectively.	False	CNCCCN1c2ccccc2CCc2ccccc21
392527	392527:02:04_10.00	True	10.0	75	84.3	0.0	0.0	83.1	0.0	78.7	24.7	86.0	41.3	61.7	0.0	80.3	64.2	LCH	86.0	WZ4002	WZ4002 is a mutant selective EGFR inhibitor with IC50s of 2, 8, 3 and 2 nM for EGFRL858R, EGFRL858R/T790M, EGFRE746_A750 and EGFRE746_A750/T790M, respectively.	False	C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)ncc2Cl)c1
410653	410653:01:04_10.00	True	10.0	97	11.1	0.0	3.7	27.1	4.9	18.7	28.5	39.9	14.6	32.6	0.0	48.5	4.6	Tubulin	48.5	Torcetrapib	Torcetrapib (CP-529414) is a selective, potent cholesteryl ester transfer protein (CETP) inhibitor.	True	CCOC(=O)N1c2ccc(C(F)(F)F)cc2[C@@H](N(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)C(=O)OC)C[C@H]1CC
409856	409856:01:05_05.00	True	5.0	89	66.0	0.0	0.0	76.5	0.0	74.6	20.7	92.1	36.8	52.1	0.0	71.3	50.9	LCH	92.1	GSK343	GSK343 is a highly potent and selective EZH2 inhibitor with an IC50 of 4 nM.	False	CCCc1cc(C)nc(O)c1CNC(=O)c1cc(-c2ccnc(N3CCN(C)CC3)c2)cc2c1cnn2C(C)C
350607	350607:02:04_10.00	True	10.0	96	6.2	23.1	29.3	0.0	77.4	0.0	6.3	0.0	0.0	0.0	51.7	0.0	0.0	DNA_Synth	77.4	Spautin-1	Spautin-1 is a specific and potent autophagy inhibitor which inhibits ubiquitin-specific peptidases, USP10 and USP13 with IC50s of 0.6-0.7 uM. 	False	Fc1ccc(CNc2ncnc3ccc(F)cc23)cc1
409892	409892:01:03_50.00	True	50.0	83	40.8	0.0	0.0	57.6	0.0	59.9	47.0	65.7	32.1	46.5	0.0	60.3	40.9	LCH	65.7	A-196	it is a selective inhibitor of SUV420H1 and SUV420H2 (IC50s = 25 and 144 nM, respectively) that is more than 100-fold selective over other histone methyltransferases and non-epigenetic targets. A-196 has been shown to inhibit the di- and tri-methylation of lysine 20 of histone H4 (H4K20me) in multiple cell lines with IC50 values less than 1 µM. See the Structural Genomics Consortium (SGC) website for more information.	False	Clc1cc2c(NC3CCCC3)nnc(-c3ccncc3)c2cc1Cl
409893	409893:01:03_50.00	True	50.0	96	29.9	0.0	0.0	87.0	0.0	83.2	18.3	84.2	46.0	67.5	0.0	81.9	55.8	BET	87.0	MS049 (hydrochloride)	it is a potent and selective inhibitor of PRMT4 (IC50 = 34 nM) and PRMT6 (IC50 = 43 nM). It is less active against additional type I PRMTs (IC50s = >130, >220, and 1.6 µM for PRMT1, PRMT3, and PRMT8, respectively) and displays no inhibition against type II or type III PRMTs nor any additional methyltransferases or nonepigenetic targets tested. MS049 has been shown to reduce the H3R2me2a mark in HEK293 cells with an IC50 value of 0.97 µM and also, unexpectedly, to reduce H4R3me2a in HEK293 cells. See the Structural Genomics Consortium (SGC) website for more information.	False	CNCCN1CCC(OCc2ccccc2)CC1
410689	410689:01:04_10.00	True	10.0	102	15.4	31.3	0.0	0.0	48.9	0.0	32.0	28.4	0.0	0.0	29.5	20.9	0.6	DNA_Synth	48.9	GSK 2830371	GSK 2830371 is a highly selective Wip1 phosphatase inhibitor with IC50 of 6 nM.	True	Cc1ncc(Cl)cc1NCc1ccc(C(=O)N[C@@H](CC2CCCC2)C(=O)NC2CC2)s1
410999	410999:01:03_00.20	True	0.2	89	60.6	0.0	0.0	97.2	0.0	91.1	9.0	80.6	59.8	72.6	0.0	83.2	71.6	BET	97.2	Mivebresib	Mivebresib (ABBV-075) is a potent and orally active bromodomain and extraterminal domain (BET) bromodomain inhibitor. Mivebresib binds to BRD4 with a Ki of 1.5 nM.	False	CCS(=O)(=O)Nc1ccc(Oc2ccc(F)cc2F)c(-c2cn(C)c(O)c3nccc2-3)c1
410840	410840:01:03_00.20	True	0.2	96	53.4	0.0	0.0	98.1	0.0	92.2	0.0	76.2	64.7	64.7	0.0	82.6	68.0	BET	98.1	MS417	MS417 is a BET-specific BRD4 inhibitor, binds to BRD4-BD1 and BRD4-BD2 with IC50s of 30, 46 nM and Kds of 36.1, 25.4 nM, respectively, with weak selectivity at CBP BRD (IC50, 32.7 µM).	False	COC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2c(sc(C)c2C)-n2c(C)nnc21
392651	392651:03:05_00.20	True	0.2	65	70.5	0.0	0.0	88.7	0.0	95.3	29.9	67.6	62.5	77.9	0.0	79.7	68.6	HDAC	95.3	Fimepinostat	Fimepinostat (CUDC-907) potently inhibits class I PI3Ks as well as classes I and II HDAC enzymes with an IC50 of  19/54/39 nM and 1.7/5.0/1.8/2.8 nM for PI3K.a./PI3K.b./PI3K.d. and HDAC1/HDAC2/HDAC3/HDAC10 , respectively.	False	COc1ccc(-c2nc(N3CCOCC3)c3sc(CN(C)c4ncc(C(=O)NO)cn4)cc3n2)cn1
410968	410968:01:03_00.20	True	0.2	100	40.9	0.0	0.0	97.6	0.0	90.6	7.2	76.0	57.3	68.2	0.0	85.0	71.3	BET	97.6	HJB97	HJB97 is a high-affinity BET inhibitor with Kis of 0.9 nM (BRD2 BD1), 0.27 nM (BRD2 BD2), 0.18 nM (BRD3 BD1), 0.21 nM (BRD3 BD2), 0.5 nM (BRD4 BD1), 1.0 nM (BRD4 BD2), respectively. HJB97 is  employed for the design of potential PROTAC BET degrader and has antitumor activity.	False	CCn1nc(C2CC2)cc1Nc1nc(C(=O)NC)nc2[nH]c3cc(-c4c(C)noc4C)c(OC)cc3c12
410861	410861:01:03_00.20	True	0.2	91	5.5	0.0	0.0	87.4	0.0	83.1	11.5	60.4	61.4	63.3	0.0	80.4	56.9	BET	87.4	Bromosporine	Bromosporine is a broad spectrum inhibitor for bromodomains with IC50 of 0.41 uM, 0.29 uM, 0.122 uM and 0.017 uM for BRD2, BRD4, BRD9 and CECR2, respectively.IC50 value: 0.41/0.29/0.122/0.017 uM (BRD2/BRD4/BRD9/CECR2) Target: BRD inhibitorIn cell-based assays, Bromosporine (1 uM) accelerates FRAP recovery of BRD4 and CREBBP, while shows no activities against TIF1.a., BAZ2A, and SMARCA2 even at 10 uM. Bromosporine shows moderate cytotoxicity in HeLa cells at 18 uM. Bromosporine, as a chemical probe for bromodomain functional assays, will be very useful in elucidating further biological roles of reader domains.	False	CCOC(=O)Nc1cc(-c2ccc(C)c(NS(C)(=O)=O)c2)nn2c(C)nnc12
411006	411006:01:03_00.20	True	0.2	104	44.4	0.0	0.0	90.4	0.0	84.1	22.9	72.0	50.4	68.6	0.0	81.5	63.6	BET	90.4	ARV-825	ARV-825 is a BRD4 degrader based on PROTAC technology. ARV-825 binds to BD1 and BD2 of BRD4 with Kds of 90 and 28 nM, respectively.	False	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)Nc1ccc(OCCOCCOCCOCCNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)cc1)c1nnc(C)n1-2
410868	410868:01:03_00.20	True	0.2	100	36.1	0.0	0.0	73.4	0.0	71.3	2.3	93.7	34.1	45.3	0.0	59.3	38.9	LCH	93.7	MI-503	MI-503 is a highly potent and orally bioavailable small molecule inhibitor of the menin-mLL interaction.	False	Cc1c(CN2CCC(Nc3ncnc4sc(CC(F)(F)F)cc34)CC2)ccc2c1cc(C#N)n2Cc1cn[nH]c1
410804	410804:01:03_00.20	True	0.2	79	49.2	0.0	0.0	90.5	0.0	96.7	19.5	66.0	67.6	66.9	0.0	79.9	72.3	HDAC	96.7	Trichostatin A	Trichostatin A (TSA) is a potent and specific inhibitor of HDAC class I/II, with an IC50 value of 1.8 nM for HDAC.	False	CC(/C=C/C(=O)NO)=C\[C@@H](C)C(=O)c1ccc(N(C)C)cc1
392595	392595:02:03_00.20	True	0.2	67	40.6	0.0	94.8	0.0	0.7	0.0	3.9	0.0	10.7	12.5	0.0	10.1	0.0	Aurora	94.8	AMG 900	AMG 900 is a potent and highly selective pan-Aurora kinases inhibitor with IC50 of 5 nM, 4 nM and 1 nM for Aurora A, B and C, respectively.	False	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1
410848	410848:01:03_00.20	True	0.2	105	6.6	9.4	4.7	0.0	9.4	0.0	0.0	0.0	2.9	0.0	44.2	0.0	0.0	Pyrimidine_Synth	44.2	CAY10602	CAY10602 is a SIRT1 activator. CAY10602 dose-dependently suppresses the NF-.k.B-dependent induction of TNF-.a. by lipopolysaccharide in THP-1 cells.	False	Nc1c(S(=O)(=O)c2ccccc2)c2nc3ccccc3nc2n1-c1ccc(F)cc1
410668	410668:02:03_00.20	True	0.2	100	38.2	0.0	0.0	96.8	0.0	90.9	6.7	74.9	62.2	63.8	0.0	86.3	63.6	BET	96.8	(+)-JQ-1	(+)-JQ-1 (JQ1) is a potent, specific, and reversible BET bromodomain inhibitor, with IC50s of 77 and 33 nM for the first and second bromodomain (BRD4(1/2)). (+)-JQ-1 also activates autophagy.	True	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2
410827	410827:01:03_00.20	True	0.2	94	32.1	0.0	0.0	95.4	0.0	86.5	8.7	72.8	60.2	64.1	0.0	87.3	67.4	BET	95.4	PLX51107	PLX51107 is a potent and selective BET inhibitor, with Kds of 1.6, 2.1, 1.7, and 5 nM for BD1 and 5.9, 6.2, 6.1, and 120 nM for BD2 of BRD2, BRD3, BRD4, and BRDT, respectively; PLX51107 also interacts with the bromodomains of CBP and EP300 (Kd, in the 100 nM range).	False	Cc1noc(C)c1-c1cnc2c(-c3ccc(C(=O)O)cc3)cn([C@@H](C)c3ccccn3)c2c1
410921	410921:01:03_00.20	True	0.2	96	14.7	0.0	0.0	63.9	0.0	62.7	28.1	82.1	18.5	40.1	0.0	68.2	39.4	LCH	82.1	MI-463	MI-463 is a highly potent and orally bioavailable small molecule inhibitor of the menin-mLL interaction.	False	Cc1c(CN2CCC(Nc3ncnc4sc(CC(F)(F)F)cc34)CC2)ccc2[nH]c(C#N)cc12
410879	410879:01:03_00.20	True	0.2	95	38.7	0.0	0.0	84.7	0.0	92.5	3.7	60.9	63.3	48.7	0.0	71.6	67.2	HDAC	92.5	Givinostat (hydrochloride monohydrate)	Givinostat hydrochloride monohydrate (ITF-2357 hydrochloride monohydrate) is a HDAC inhibitor with an IC50 of 198 and 157 nM for HDAC1 and HDAC3, respectively.	False	CCN(CC)Cc1ccc2cc(COC(=O)Nc3ccc(C(=O)NO)cc3)ccc2c1
410797	410797:01:03_00.20	True	0.2	96	6.7	0.0	0.0	75.7	0.0	74.8	5.8	88.9	42.4	31.0	0.0	62.6	39.7	LCH	88.9	BIX-01294	BIX-01294 is an inhibitor of G9a Histone Methyltransferase with an IC50 of 1.9 µM.	False	COc1cc2nc(N3CCCN(C)CC3)nc(NC3CCN(Cc4ccccc4)CC3)c2cc1OC
410940	410940:01:03_00.20	True	0.2	100	7.6	51.8	0.0	0.0	25.0	0.0	0.0	0.0	0.0	0.0	52.6	0.0	0.0	Pyrimidine_Synth	52.6	Reversine	Reversine is a novel class of ATP-competitive Aurora kinase inhibitor with IC50s of 400, 500 and 400 nM for Aurora A, Aurora B and Aurora C, respectively.	False	c1nc2c(NC3CCCCC3)nc(Nc3ccc(N4CCOCC4)cc3)nc2[nH]1
410084	410084:02:03_00.20	True	0.2	70	35.9	0.0	95.0	0.0	19.4	0.0	12.4	0.0	0.0	0.0	13.1	0.0	0.0	Aurora	95.0	BI-847325	BI-847325 is an ATP competitive dual inhibitor of MEK and aurora kinases (AK) with IC50 values of 4 and 15 nM for human MEK2 and AK-C, respectively.	False	CCNC(=O)C#Cc1ccc2c(/C(=N/c3ccc(CN(C)C)cc3)c3ccccc3)c(O)[nH]c2c1
410801	410801:01:04_00.20	True	0.2	75	57.0	0.0	0.0	83.4	0.0	96.8	23.5	60.0	67.6	70.5	0.0	71.4	68.3	HDAC	96.8	Panobinostat	Panobinostat (LBH589; NVP-LBH589) is a potent and orally active non-selective HDAC inhibitor, and has antineoplastic activities. Panobinostat induces HIV-1 virus production even at low concentration range 8-31 nM, stimulates HIV-1 expression in latently infected cells. Panobinostat induces cell apoptosis and autophagy. Panobinostat can be used for the study of refractory or relapsed multiple myeloma.	False	Cc1[nH]c2ccccc2c1CCNCc1ccc(/C=C/C(=O)NO)cc1
411004	411004:01:03_00.20	True	0.2	88	22.1	32.0	0.0	50.4	0.0	45.4	22.1	58.2	15.0	44.2	0.0	57.7	68.3	Uncoupler	68.3	CHZ868	CHZ868 is a type II JAK2 inhibitor with an IC50 of 0.17 uM in EPOR JAK2 WT Ba/F3 cell.	False	CC(=O)Nc1cc(Oc2ccc3c(nc(Nc4ccc(F)cc4F)n3C)c2C)ccn1
410875	410875:01:03_00.20	True	0.2	93	15.4	41.3	0.0	0.0	41.9	0.0	11.9	0.0	0.0	0.0	69.4	0.0	0.0	Pyrimidine_Synth	69.4	QC6352	QC6352 is an orally available, selective and potent KDM4C inhibitor with an IC50 of 35 nM.	False	CN(c1ccccc1)c1ccc2c(c1)CCC[C@H]2CNc1cnccc1C(=O)O
410973	410973:01:03_00.20	True	0.2	89	6.0	0.0	0.0	80.3	0.0	73.7	13.5	56.5	57.5	67.3	0.0	85.8	47.8	Tubulin	85.8	TyK2-IN-2	TyK2-IN-2 is an inhibitor of TYK2, used for treatment of inflammatory and autoimmune diseases.	False	CNc1cc(Nc2cc(C)cc(C)c2)nn2c(C(N)=O)cnc12
410843	410843:01:03_00.20	True	0.2	87	32.8	0.0	0.0	82.5	0.0	90.1	16.9	56.9	55.5	54.7	0.0	75.7	65.9	HDAC	90.1	Pracinostat	Pracinostat is a potent histone deacetylase (HDAC) inhibitor, with IC50s of 40-140 nM, used for cancer research.	False	CCCCc1nc2cc(/C=C/C(=O)NO)ccc2n1CCN(CC)CC
410916	410916:01:03_00.20	True	0.2	88	33.0	0.0	0.0	86.8	0.0	90.5	2.9	66.5	65.0	51.2	0.0	81.4	54.2	HDAC	90.5	M344	M344 (D 237) is an inhibitor of histone deacetylase (IC50=100 nM) and an inducer of terminal cell fifferentiation.	False	CN(C)c1ccc(C(=O)NCCCCCCC(=O)NO)cc1
410869	410869:01:03_00.20	True	0.2	99	7.6	67.0	0.0	0.0	45.7	0.0	16.3	0.0	0.0	0.0	66.1	0.0	0.0	AKT_PI3K_MTOR	67.0	Cerdulatinib	Cerdulatinib (PRT062070) is a selective Tyk2 inhibitor with an IC50 of 0.5 nM. Cerdulatinib (PRT062070) also is a dual JAK and SYK inhibitor with IC50s of 12, 6, 8 and 32 for JAK1, 2, 3 and SYK, respectively.	False	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1
410914	410914:01:03_00.20	True	0.2	80	33.2	0.0	95.5	0.0	2.5	0.0	2.6	0.0	2.2	0.0	1.9	0.0	0.0	Aurora	95.5	GSK-1070916	GSK-1070916 is a potent and selective ATP-competitive inhibitor of aurora B and aurora C with Kis of 0.38 and 1.5 nM, respectively, and is >250- fold selective over Aurora A.	False	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1
410080	410080:02:03_00.20	True	0.2	87	19.3	0.0	40.4	0.0	49.5	0.0	0.0	0.0	0.0	0.0	58.2	0.0	0.0	Pyrimidine_Synth	58.2	GSK503	GSK503 is a potent and specific inhibitor of EZH2 methyltransferase with Kiapp values of 3 to 27 nM.	False	Cc1cc(C)c(CNC(=O)c2cc(-c3ccc(N4CCN(C)CC4)nc3)cc3c2c(C)cn3C(C)C)c(O)n1
410818	410818:01:03_00.20	True	0.2	70	44.0	6.7	0.0	38.5	5.4	34.8	6.8	53.8	19.7	1.6	0.0	38.2	33.6	LCH	53.8	SB1317	SB1317 is a potent inhibitor of CDK2, JAK2, and FLT3 for the treatment of cancer, with IC50 of 13, 73, and 56 nM for CDK2, JAK2 and FLT3, respectively.	False	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1
409873	409873:02:03_00.20	True	0.2	91	10.2	0.0	6.7	42.0	0.0	50.7	27.9	61.1	21.3	25.3	0.0	46.5	2.3	LCH	61.1	LLY-507	LLY-507 is a potent and selective inhibitor of protein-lysine methyltransferase SMYD2. LLY-507 potently inhibits the ability of SMYD2 to methylate p53 peptide with an IC50 <15 nM. LLY-507 serves as a valuable chemical probe to aid in the dissection of SMYD2 function in cancer and other biological processes.	False	Cc1cn(CCN2CCN(c3ccccc3-c3cc(C#N)cc(C(=O)NCCCN4CCCC4)c3)CC2)c2ccccc12
410884	410884:01:03_00.20	True	0.2	95	52.5	0.0	0.0	97.3	0.0	90.1	0.0	77.9	62.9	61.0	0.0	83.2	69.3	BET	97.3	CF53	CF53 is a highly potent, selective and orally active inhibitor of BET protein, with a Ki of <1 nM, Kd of 2.2 nM and an IC50 of 2 nM for BRD4 BD1. CF53 binds to both the BD1 and BD2 domains of BRD2, BRD3, BRD4, and BRDT BET proteins with high affinities, very selective over non-BET bromodomain-containing proteins. CF53 shows potent anti-tumor activity both in vitro and in vivo.	False	COc1cc2c(cc1-c1c(C)noc1C)[nH]c1nc(C)nc(Nc3cc(C4CC4)nn3C)c12
410905	410905:01:03_00.20	True	0.2	101	28.3	0.0	0.0	96.5	0.0	88.1	0.0	78.6	54.0	62.6	0.0	82.8	63.4	BET	96.5	ABBV-744	ABBV-744 is a highly BDII-selective BET bromodomain inhibitor, used in the research of inflammatory diseases, cancer, and AIDS.	False	CCNC(=O)c1cc2c(-c3cc(C(C)(C)O)ccc3Oc3c(C)cc(F)cc3C)cn(C)c(O)c-2n1
392506	392506:02:03_00.20	True	0.2	87	6.4	0.0	0.0	69.1	0.0	60.1	30.1	60.2	42.0	53.3	0.0	85.2	64.3	Tubulin	85.2	Danusertib	Danusertib is a pyrrolo-pyrazole and aurora kinase inhibitor with IC50 of 13, 79, and 61 nM for Aurora A, B, and C, respectively.	False	CO[C@@H](C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1
410873	410873:01:03_00.20	True	0.2	96	21.9	54.9	0.0	23.7	0.0	22.2	28.6	34.0	0.0	24.6	0.0	17.5	45.4	AKT_PI3K_MTOR	54.9	-Oryzanol	.g.-Oryzanol is a potent DNA methyltransferases (DNMTs) inhibitor in the striatum of mice. .g.-Oryzanol significantly inhibits the activities of DNMT1 (IC50=3.2 uM), DNMT3a (IC50=22.3 uM).	False	COc1cc(/C=C/C(=O)O[C@H]2CC[C@]34CC35CC[C@]3(C)[C@@H]([C@H](C)CCC=C(C)C)CC[C@@]3(C)C5CCC4C2(C)C)ccc1O
410803	410803:01:03_00.20	True	0.2	70	63.6	0.0	0.0	87.1	0.0	97.6	31.2	67.8	63.5	73.2	0.0	77.6	70.4	HDAC	97.6	Quisinostat	Quisinostat (JNJ-26481585) is an orally available, potent HDAC inhibitor with IC50s of 0.11 nM, 0.33 nM, 0.64 nM, 0.46 nM, and 0.37 nM for HDAC1, HDAC2, HDAC4, HDAC10 and HDAC11, respectively.	False	Cn1cc(CNCC2CCN(c3ncc(C(=O)NO)cn3)CC2)c2ccccc21
392643	392643:02:03_00.20	True	0.2	93	9.2	0.0	49.2	0.0	3.1	0.0	40.0	0.0	0.0	1.5	0.0	35.8	0.0	Aurora	49.2	CCT 137690	CCT 137690 is a potent and orally available aurora kinase inhibitor with IC50s of 15, 25, and 19 nM for aurora A, B and C, respectively.	False	Cc1cc(CN2CCN(c3c(Br)cnc4[nH]c(-c5ccc(N6CCN(C)CC6)cc5)nc34)CC2)no1
409947	409947:02:03_00.20	True	0.2	91	31.4	0.0	0.0	86.9	0.0	88.1	0.0	65.2	62.6	44.1	0.0	80.0	49.6	HDAC	88.1	Belinostat	Belinostat (PXD101; PX105684) is a potent HDAC inhibitor with an IC50 of 27 nM in HeLa cell extracts.	False	O=C(/C=C/c1cccc(S(=O)(=O)Nc2ccccc2)c1)NO
410791	410791:01:03_00.20	True	0.2	69	35.2	34.5	39.6	0.0	90.6	0.0	2.5	0.0	0.0	0.0	71.1	0.0	0.0	DNA_Synth	90.6	Mitoxantrone	Mitoxantrone is a topoisomerase II inhibitor; also inhibits protein kinase C (PKC) activity with an IC50 of 8.5 uM.	False	O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21
392517	392517:02:03_00.20	True	0.2	78	40.8	0.0	94.4	0.0	0.0	0.0	4.6	0.0	3.6	0.0	3.9	0.0	0.0	Aurora	94.4	AT9283	AT9283 is a multi-targeted kinase inhibitor with potent activity against Aurora A/B, JAK2/3, Abl (T315I) and Flt3 (IC50s ranging from 1 to 30 nM). AT9283 inhibits growth and survival of multiple solid tumors in vitro and in vivo.	False	O=C(Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1)NC1CC1
410994	410994:01:03_00.20	True	0.2	87	20.7	0.0	0.0	89.9	0.0	77.6	5.0	74.5	52.6	56.6	0.0	83.3	72.0	BET	89.9	MZP-54	MZP-54 is a selective degrader of BRD3/4 based on PROTAC technology, with a Kd of 4 nM for Brd4BD2.	False	CC(=O)N1c2ccc(-c3ccc(C(=O)NCCOCCOCCOCC(=O)N[C@H](C(=O)N4C[C@H](O)C[C@H]4C(=O)NCc4ccc(-c5scnc5C)cc4)C(C)(C)C)cc3)cc2[C@H](Nc2ccc(Cl)cc2)C[C@@H]1C
410948	410948:01:03_00.20	True	0.2	90	10.4	0.0	0.0	73.8	0.0	59.1	0.2	74.7	34.0	28.9	0.0	70.0	59.5	LCH	74.7	dBET6	dBET6 is a highly potent, selective and cell-permeable degrader of BET based on PROTAC, with an IC50 of 14 nM, and has antitumor activity.	False	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)NCCCCCCCCNC(=O)COc1cccc3c1C(=O)N(C1CCC(=O)NC1=O)C3=O)c1nnc(C)n1-2
150900	150900:10:03_00.20	True	0.2	96	16.2	52.8	0.0	29.8	25.8	25.6	13.5	52.6	0.0	25.4	0.0	31.1	66.6	Uncoupler	66.6	Nicotinamide	Nicotinamide is a form of vitamin B3 that plays essential roles in cell physiology through facilitating NAD+ redox homeostasis and providing NAD+ as a substrate to a class of enzymes that catalyze non-redox reactions. Nicotinamide is an inhibitor of  SIRT1.	False	NC(=O)c1cccnc1
392558	392558:02:03_00.20	True	0.2	71	33.0	0.0	81.2	0.0	36.5	0.0	14.7	0.0	0.0	0.0	29.7	0.0	0.0	Aurora	81.2	Hesperadin	Hesperadin is an ATP competitive indolinone inhibitor of Aurora A and B. Hesperadin inhibits Aurora B with an IC50 of 250 nM.	False	CCS(=O)(=O)Nc1ccc2[nH]c(O)c(/C(=N/c3ccc(CN4CCCCC4)cc3)c3ccccc3)c2c1
410065	410065:02:03_00.20	True	0.2	78	50.4	0.0	7.8	77.0	0.0	77.9	29.8	54.4	58.1	67.9	0.0	90.3	43.0	Tubulin	90.3	Domatinostat	Domatinostat (4SC-202 free base) is a selective class I HDAC inhibitor with IC50 of 1.20 uM, 1.12 uM, and 0.57 uM for HDAC1, HDAC2, and HDAC3, respectively. It also displays inhibitory activity against Lysine specific demethylase 1 (LSD1).	False	Cn1cc(-c2ccc(S(=O)(=O)n3ccc(/C=C/C(=O)Nc4ccccc4N)c3)cc2)cn1
410824	410824:01:03_00.20	True	0.2	76	52.8	0.0	0.0	90.8	0.0	95.5	18.5	63.9	66.4	72.3	0.0	82.1	71.2	HDAC	95.5	Dacinostat	Dacinostat is a potent HDAC inhibitor, with an IC50 of 32 nM; Dacinostat also inhibits HDAC1 with an IC50 of 9 nM, and used in cancer research.	False	O=C(/C=C/c1ccc(CN(CCO)CCc2c[nH]c3ccccc23)cc1)NO
247097	247097:05:04_00.20	True	0.2	96	13.3	0.4	38.7	0.0	35.3	0.0	0.0	0.0	0.0	0.0	58.0	0.0	0.0	Pyrimidine_Synth	58.0	Mitoxantrone (dihydrochloride)	Mitoxantrone dihydrochloride is a topoisomerase II inhibitor; also inhibits protein kinase C (PKC) activity with an IC50 of 8.5 uM.	False	O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21
410069	410069:02:03_00.20	True	0.2	95	32.1	0.0	0.0	85.5	0.0	84.9	8.3	71.9	54.9	41.6	0.0	81.6	43.0	BET	85.5	CAY10603	CAY10603 (BML-281) is a potent and selective HDAC6 inhibitor, with an IC50 of 2 pM; CAY10603 (BML-281) also inhibits HDAC1, HDAC2, HDAC3, HDAC8, HDAC10, with IC50s of 271, 252, 0.42, 6851, 90.7 nM.	False	CC(C)(C)OC(=O)Nc1ccc(-c2cc(C(=O)NCCCCCCC(=O)NO)no2)cc1
410912	410912:01:03_00.20	True	0.2	64	54.6	35.5	21.5	0.0	68.3	0.0	0.0	0.0	0.0	0.0	54.6	0.0	0.0	DNA_Synth	68.3	RGB-286638 (free base)	RGB-286638 is a CDK inhibitor that inhibits the kinase activity of cyclin T1-CDK9, cyclin B1-CDK1, cyclin E-CDK2, cyclin D1-CDK4, cyclin E-CDK3, and p35-CDK5 with IC50s of 1, 2, 3, 4, 5 and 5 nM, respectively; also inhibits GSK-3.b., TAK1, Jak2 and MEK1, with IC50s of  3, 5, 50, and 54 nM.	False	COCCN1CCN(Cc2ccc(-c3[nH]nc4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1
410891	410891:01:03_00.20	True	0.2	83	22.8	19.3	60.7	0.0	82.2	0.0	6.8	0.0	0.0	0.0	68.8	0.0	0.0	DNA_Synth	82.2	Valrubicin	Valrubicin is a chemotherapy agent, inhibits TPA- and PDBu-induced PKC activation with IC50s of 0.85 and 1.25 uM, respectively, and has antitumor and antiinflammatory activity.	False	CCCCC(=O)OCC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O2)C1)C(=O)c1c(OC)cccc1C3=O
409856	409856:02:03_00.20	True	0.2	95	5.5	0.0	0.0	53.2	0.0	50.8	12.8	73.3	25.4	15.8	0.0	55.9	15.5	LCH	73.3	GSK343	GSK343 is a highly potent and selective EZH2 inhibitor with an IC50 of 4 nM.	False	CCCc1cc(C)nc(O)c1CNC(=O)c1cc(-c2ccnc(N3CCN(C)CC3)c2)cc2c1cnn2C(C)C
411008	411008:01:03_00.20	True	0.2	102	13.3	0.0	0.0	74.1	0.0	66.2	8.4	48.2	47.8	52.5	0.0	54.1	61.8	BET	74.1	A-485	A-485 is a potent and selective catalytic inhibitor of p300/CBP with IC50s of 9.8nM and 2.6nM for p300 and CBP histone acetyltransferase (HAT), respectively.	False	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O
410909	410909:01:03_00.20	True	0.2	95	9.0	0.0	0.0	88.9	0.0	81.6	9.5	68.5	50.1	66.7	0.0	81.8	61.1	BET	88.9	Molibresib (besylate)	Molibresib besylate (GSK 525762C; I-BET 762 besylate) is a BET bromodomain inhibitor with IC50 of 32.5-42.5 nM.	False	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21
410786	410786:01:03_00.20	True	0.2	71	49.2	10.6	0.0	31.7	10.5	23.5	15.7	44.2	10.7	0.5	0.0	41.2	31.3	LCH	44.2	CGP60474	CGP60474, a highly potent anti-endotoxemic agent, is a potent cyclin-dependent kinase (CDK) inhibitor (IC50 values are 26, 3, 4, 216, 10, 200 and 13 nM for CDK1/B, CDK2/E, CDK2/A, CDK4/D, CDK5/p25, CDK7/H and CDK9/T, respectively). CGP60474 is a selective and ATP-competitive PKC inhibitor.	False	OCCCNc1cc(-c2ccnc(Nc3cccc(Cl)c3)n2)ccn1
246688	246688:08:03_00.20	True	0.2	101	22.5	0.0	0.0	87.4	0.0	88.4	13.2	63.7	59.2	50.3	0.0	85.0	53.4	HDAC	88.4	Vorinostat	Vorinostat (SAHA) is a potent and orally active pan-inhibitor of HDAC1, HDAC2 and HDAC3 (Class I), HDAC7 (Class II) and HDAC11 (Class IV), with ID50 values of 10 nM and 20 nM for HDAC1 and HDAC3, respectively. Vorinostat induces cell apoptosis. Vorinostat is also an effective inhibitor of human papillomaviruse (HPV)-18 DNA amplification.; Bradner et al., Chemical Phylogenetics of Histone Deacetylases. Nat. Chem. Biol. 6, 238-43 (2010).	False	O=C(CCCCCCC(=O)Nc1ccccc1)NO
392522	392522:03:05_00.20	True	0.2	69	40.8	0.0	96.3	0.0	19.3	0.0	17.5	0.0	0.0	0.0	15.2	0.0	0.0	Aurora	96.3	SNS-314	SNS-314 is a potent and selective aurora kinase inhibitor with IC50s of 9, 31, and 6 nM for aurora A, B and C, respectively.	False	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCNc2ncnc3ccsc23)s1
392515	392515:02:03_00.20	True	0.2	87	39.6	0.0	0.0	77.3	0.0	72.6	20.0	69.5	45.2	57.5	0.0	88.2	61.9	Tubulin	88.2	Alisertib	Alisertib (MLN 8237) is an orally active and selective Aurora A kinase inhibitor (IC50=1.2 nM), which binds to Aurora A kinase resulting in mitotic spindle abnormalities, mitotic accumulation. Alisertib (MLN 8237) induces apoptosis and autophagy through targeting the AKT/mTOR/AMPK/p38 pathway in leukemic cells. Antitumor activity.	False	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O
410889	410889:01:03_00.20	True	0.2	72	50.3	0.0	0.0	56.1	0.0	81.3	34.3	57.6	49.9	36.0	0.0	49.6	56.2	HDAC	81.3	HDACs/mTOR Inhibitor 1	HDACs/mTOR Inhibitor 1 is a dual Histone Deacetylases (HDACs) and mammalian target of Rapamycin (mTOR) target inhibitor for treating hematologic malignancies, with IC50s of 0.19 nM, 1.8 nM, 1.2 nM and >500 nM for HDAC1, HDAC6, mTOR and PI3K.a., respectively. HDACs/mTOR Inhibitor 1 stimulates cell cycle arrest in G0/G1 phase and induce tumor cell apoptosis with low toxicity in vivo.	False	C[C@@H]1CN(C(=O)Nc2ccc(-c3nc(N4CCOCC4)c4cnn(CCCCCCC(=O)NO)c4n3)cc2)CCO1
410830	410830:01:03_00.20	True	0.2	86	18.3	31.2	48.1	0.0	86.6	0.0	10.4	0.0	0.0	0.0	74.9	0.0	0.0	DNA_Synth	86.6	Talazoparib tosylate	Talazoparib tosylate (BMN 673ts) is a novel, potent and orally available PARP1/2 inhibitor with an IC50 of 0.57 nM for PARP1.	False	Cn1ncnc1[C@H]1c2n[nH]c(=O)c3cc(F)cc(c23)N[C@@H]1c1ccc(F)cc1
410822	410822:01:05_00.20	True	0.2	86	43.2	17.1	0.0	68.8	0.0	63.1	26.0	71.0	31.5	61.0	0.0	69.6	79.3	Uncoupler	79.3	Phorbol 12-myristate 13-acetate	Phorbol 12-myristate 13-acetate (PMA), a phorbol ester, is a dual SphK and protein kinase C (PKC) activator. Phorbol 12-myristate 13-acetate induces differentiation in THP-1 cells.	False	CCCCCCCCCCCCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(C)=O
410946	410946:01:03_00.20	True	0.2	95	37.0	0.0	0.0	96.3	0.0	89.9	1.2	72.2	60.0	60.1	0.0	85.9	65.0	BET	96.3	INCB054329	INCB054329 is a potent BET inhibitor.	False	Cc1noc(C)c1-c1ccc2nc(O)n3c2c1OC[C@@H]3c1ccccn1
410784	410784:01:03_00.20	True	0.2	77	27.3	0.0	93.4	0.0	0.0	0.0	9.3	0.0	9.6	1.2	0.0	13.3	0.0	Aurora	93.4	Barasertib	Barasertib (AZD1152), a pro-drug of Barasertib-hQPA, is a highly selective Aurora B inhibitor with an IC50 of 0.37 nM in a cell-free assay. Barasertib (AZD1152) induces growth arrest and apoptosis in cancer cells.	False	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O
410799	410799:01:03_00.20	True	0.2	70	32.3	44.1	27.6	0.0	96.3	0.0	0.0	0.0	0.0	0.0	74.6	0.0	0.0	DNA_Synth	96.3	Doxorubicin (hydrochloride)	Doxorubicin (Hydroxydaunorubicin) hydrochloride, a cytotoxic anthracycline antibiotic, is an anti-cancer chemotherapy agent. Doxorubicin hydrochloride is a potent human DNA topoisomerase I and topoisomerase II inhibitor with IC50s of 0.8 uM and 2.67 uM, respectively. Doxorubicin hydrochloride reduces basal phosphorylation of AMPK and its downstream target acetyl-CoA carboxylase. Doxorubicin hydrochloride induces apoptosis and autophagy.	False	COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1
410841	410841:01:03_00.20	True	0.2	52	70.5	0.0	8.6	75.9	0.0	83.1	38.2	58.2	54.5	70.9	0.0	81.3	52.4	HDAC	83.1	HDAC6-IN-1	HDAC6-IN-1 is a potent and selective inhibitor for HDAC6 with an IC50 of 17 nM and shows 25-fold and 200-fold selectivity relative to HDAC1 (IC50=422 nM) and HDAC8 (IC50=3398 nM), respectively.	False	COc1ccc(N(C)c2nc(C)nc3ccccc23)cc1OCCCC(=O)NO
410856	410856:01:03_00.20	True	0.2	87	18.5	0.0	0.0	71.5	0.0	81.0	13.6	47.2	52.4	39.3	0.0	70.0	52.4	HDAC	81.0	HDAC-IN-3	HDAC-IN-3 is a histone deacetylase (HDAC) inhibitor, extracted from patent WO/2008040934 A1.Target: HDAC	False	O=C(CCc1ccc(CN[C@H](C(=O)OC2CCCC2)C2CCCCC2)cn1)NO
410886	410886:01:03_00.20	True	0.2	103	33.7	61.3	0.0	23.9	0.8	23.2	39.2	40.7	1.2	23.5	0.0	32.9	50.0	AKT_PI3K_MTOR	61.3	Midostaurin	Midostaurin (PKC412; CGP 41251) is a multi-targeted protein kinase inhibitor which inhibits PKC.a./.b./.g., Syk, Flk-1, Akt, PKA, c-Kit, c-Fgr, c-Src, FLT3, PDFR.b. and VEGFR1/2 with IC50s ranging from 22-500 nM.	False	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4
410837	410837:01:03_00.20	True	0.2	102	39.0	0.0	0.0	95.8	0.0	89.2	0.0	68.0	61.0	64.1	0.0	78.6	74.8	BET	95.8	GSK1324726A	GSK1324726A is a novel, potent, and selective inhibitor of BET proteins with high affinity to BRD2 (IC50=41 nM), BRD3 (IC50=31 nM), and BRD4 (IC50=22 nM).	False	CC(=O)N1c2ccc(-c3ccc(C(=O)O)cc3)cc2[C@H](Nc2ccc(Cl)cc2)C[C@@H]1C
410989	410989:01:03_00.20	True	0.2	96	17.3	39.5	0.0	40.2	20.0	29.6	5.1	66.6	0.0	33.6	0.0	42.5	57.3	LCH	66.6	TPPB	TPPB is a cell-permeable benzolactam-derived protein kinase C (PKC) activator with a Ki of 11.9 nM.	False	CC(C)[C@H]1C(=O)N[C@H](CO)Cc2cc(NC(=O)/C=C/C=C/c3ccc(C(F)(F)F)cc3)ccc2N1C
411007	411007:01:03_00.20	True	0.2	95	54.4	0.0	0.0	94.3	0.0	86.5	8.3	72.0	54.9	71.2	0.0	85.8	65.5	BET	94.3	INCB-057643	INCB-057643 is a novel, orally bioavailable BET inhibitor.	False	CN1C(=O)C(C)(C)Oc2c(-c3cn(C)c(O)c4nccc3-4)cc(S(C)(=O)=O)cc21
392507	392507:02:03_00.20	True	0.2	55	75.0	0.0	25.2	74.5	0.0	81.1	16.4	54.7	58.0	65.3	0.0	78.5	31.6	HDAC	81.1	BI 2536	BI 2536 is a dual PLK1 and BRD4 inhibitor with IC50s of 0.83 and 25 nM, respectively. BI-2536 suppresses IFNB (encoding IFN-.b.) gene transcription.	False	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1
392531	392531:02:03_00.20	True	0.2	97	21.9	0.0	0.0	83.7	0.0	87.8	8.1	58.8	61.2	62.2	0.0	75.3	67.5	HDAC	87.8	CUDC-101	CUDC-101 is a potent inhibitor of HDAC, EGFR, and HER2 with IC50s of 4.4, 2.4, and 15.7 nM, respectively.	False	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1
410947	410947:01:03_00.20	True	0.2	98	46.3	0.0	0.0	96.6	0.0	91.0	0.0	68.5	66.9	67.0	0.0	84.4	68.8	BET	96.6	(+)-JQ1 PA	(+)-JQ1 PA is a derivative of the Bromodomain and extra-terminal (BET) inhibitor JQ1, with an IC50 of 10.4 nM.	False	C#CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2c(sc(C)c2C)-n2c(C)nnc21
410990	410990:01:03_00.20	True	0.2	95	34.2	0.0	0.0	81.7	0.0	87.8	0.0	58.4	66.7	39.8	0.0	71.4	53.2	HDAC	87.8	LMK-235	LMK-235 is a potent and selective HDAC4/5 inhibitor, inhibits HDAC5, HDAC4, HDAC6, HDAC1, HDAC2, HDAC11 and HDAC8, with IC50s of 4.22 nM, 11.9 nM, 55.7 nM, 320 nM, 881 nM, 852 nM and 1278 nM, respectively, and is used in cancer research.	False	Cc1cc(C)cc(C(=O)NOCCCCCC(=O)NO)c1
410828	410828:01:03_00.20	True	0.2	95	14.3	4.7	22.3	0.0	18.0	0.0	0.0	0.0	3.2	0.0	45.3	0.0	0.0	Pyrimidine_Synth	45.3	Niraparib (tosylate)	Niraparib tosylate (MK-4827 tosylate) is a highly potent and orally bioavailable PARP1 and PARP2 inhibitor with an IC50 of 3.8 and 2.1 nM, respectively. Niraparib tosylate leads to inhibition of repair of DNA damage, activates apoptosis and shows anti-tumor activity.	False	NC(=O)c1cccc2cn(-c3ccc([C@@H]4CCCNC4)cc3)nc12
410985	410985:01:03_00.20	True	0.2	95	12.1	59.0	0.0	21.2	35.4	14.4	8.6	53.1	0.0	14.2	3.5	24.2	57.3	AKT_PI3K_MTOR	59.0	(-)-Indolactam V	(-)-Indolactam V is a PKC activator, with Kis of 3.36 nM, 1.03 µM for ¿-CRD2 (PKC¿ surrogate peptide), .g.-CRD2 (PKC.g. surrogate peptide), and Kds of 5.5 nM (¿-C1B), 7.7 nM (¿-C1B), 8.3 nM (.d.-C1B), 18.9 nM (.b.-C1A-long), 20.8 nM (.a.-C1A-long), 137 nM (.b.-C1B), 138 nM (.g.-C1A), 213 nM (.g.-C1B), and has antitumor activity.	False	CC(C)[C@H]1C(=O)N[C@H](CO)Cc2c[nH]c3cccc(c23)N1C
410896	410896:01:03_00.20	True	0.2	100	11.1	0.0	0.0	87.5	0.0	79.9	3.4	73.4	52.7	49.7	0.0	79.3	56.1	BET	87.5	BCI-121	BCI-121 is a SMYD3 inhibitor that impairs the proliferation of cancer cell.	False	NC(=O)C1CCN(CC(=O)Nc2ccc(Br)cc2)CC1
410941	410941:01:03_00.20	True	0.2	94	49.1	0.0	0.0	98.1	0.0	91.1	0.0	73.4	61.1	65.4	0.0	86.3	72.4	BET	98.1	BET bromodomain inhibitor	BET bromodomain inhibitor is a potent BET inhibitor extracted from patent WO/2015/153871A2, compound example 11.	False	Cc1noc2c1-c1ccc(-c3cnn(C)c3)cc1C(c1ccc(Cl)cc1)=N[C@H]2CC(N)=O
410871	410871:01:03_00.20	True	0.2	103	15.2	0.0	0.0	81.4	0.0	76.9	37.9	61.0	42.6	69.0	0.0	70.9	62.2	BET	81.4	Ilginatinib	Ilginatinib (NS-018) is a highly active and orally bioavailable JAK2 inhibitor, with an IC50 of 0.72 nM, 46-, 54-, and 31-fold selectivity for JAK2 over JAK1 (IC50, 33 nM), JAK3 (IC50, 39 nM), and Tyk2 (IC50, 22 nM).	False	C[C@H](Nc1cc(-c2cnn(C)c2)cc(Nc2cnccn2)n1)c1ccc(F)cc1
410034	410034:02:03_00.20	True	0.2	96	21.8	0.0	0.0	90.4	0.0	83.9	14.3	81.5	49.4	64.5	0.0	83.4	65.7	BET	90.4	NVP-TNKS656	NVP-TNKS656 is a highly potent, selective, and orally active TNKS2 inhibitor with IC50 of 6 nM, and is > 300 fold selectivity against PARP1 and PARP2.	False	COc1ccc(C(=O)C2CCN(CC(=O)N(Cc3nc(O)c4c(n3)CCOC4)CC3CC3)CC2)cc1
410811	410811:01:03_00.20	True	0.2	92	22.8	0.0	0.0	85.5	0.0	87.6	10.8	58.0	61.9	58.5	0.0	80.4	55.9	HDAC	87.6	Scriptaid	Scriptaid is a potent histone deacetylase (HDAC) inhibitor, used in cancer research. Scriptaid is also a sensitizer to antivirals and has potential for epstein-barr virus (EBV)-associated lymphomas treatment.	False	O=C(CCCCCN1C(=O)c2cccc3cccc(c23)C1=O)NO
410833	410833:01:03_00.20	True	0.2	97	9.3	6.9	0.0	60.7	0.0	52.7	8.4	64.6	11.0	50.8	0.0	54.4	52.5	LCH	64.6	Peficitinib	Peficitinib is an oral JAK inhibitor, with IC50s of 3.9, 5.0, 0.7 and 4.8 nM for JAK1, JAK2, JAK3 and Tyk2, respectively.	False	NC(=O)c1cnc2[nH]ccc2c1N[C@H]1[C@H]2C[C@H]3C[C@@H]1C[C@](O)(C3)C2
410944	410944:01:03_00.20	True	0.2	96	6.9	5.7	0.0	47.3	0.0	44.4	23.3	29.1	21.2	42.5	0.0	30.1	45.3	BET	47.3	GNE-049	GNE-049 is a highly potent and selective CBP inhibitor with an IC50 of 1.1 nM in TR-FRET assay. GNE-049 also inhibits BRET and BRD4(1) with IC50s of 12 nM and 4200 nM, respectively.	False	CC(=O)N1CCc2c(c(N3CCCc4cc(-c5cnn(C)c5)c(C(F)F)cc43)nn2C2CCOCC2)C1
392587	392587:02:03_00.20	True	0.2	81	33.7	0.0	0.0	82.6	0.0	75.2	28.6	74.5	50.9	63.0	0.0	89.8	68.3	Tubulin	89.8	AZ960	AZ960 is a potent and specific inhibitor of the JAK2 kinase with a Ki of 0.45 nM.	False	Cc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cc3)c(C#N)cc2F)n[nH]1
410957	410957:01:03_00.20	True	0.2	94	5.7	0.0	0.0	79.7	0.0	66.5	1.7	63.1	37.2	51.1	0.0	70.6	73.4	BET	79.7	BETd-246	BETd-246 is a second-generation BET bromodomain (BRD) inhibitor, exhibiting superior selectivity, potency and antitumor activity.	False	CCn1nc(C2CC2)cc1Nc1nc(C(=O)NCCCOCCOCCOCCCNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)nc2[nH]c3cc(-c4c(C)noc4C)c(OC)cc3c12
382124	382124:04:03_00.20	True	0.2	96	36.4	0.0	0.0	82.2	0.0	75.8	18.1	72.7	40.7	75.3	0.0	77.4	68.8	BET	82.2	A-769662	A-769662 is a potent, reversible AMPK activator with EC50 of 0.8 uM.	False	N#Cc1c(O)nc2scc(-c3ccc(-c4ccccc4O)cc3)c2c1O
410851	410851:01:03_00.20	True	0.2	96	10.7	0.0	0.0	83.4	0.0	81.0	26.8	65.6	41.6	61.3	0.0	78.3	56.5	BET	83.4	I-BET151	I-BET151 is a BET bromodomain inhibitor which inhibits BRD4, BRD2, and BRD3 with pIC50 of 6.1, 6.3, and 6.6, respectively.	False	COc1cc2c(cc1-c1c(C)noc1C)ncc1nc(O)n([C@H](C)c3ccccn3)c12
410936	410936:01:03_00.20	True	0.2	95	18.3	42.8	0.0	36.8	27.9	32.4	2.1	57.7	0.6	30.9	0.0	38.3	64.9	Uncoupler	64.9	MG 149	MG149 (Tip60 HAT inhibitor) is a selective and potent Tip60 inhibitor with IC50 of 74 uM, similar potentcy for MOF (IC50= 47 uM); little potent for PCAF and p300 (IC50 >200 uM).	False	CCCCCCCc1ccc(CCc2cccc(O)c2C(=O)O)cc1
410825	410825:01:03_00.20	True	0.2	96	32.0	0.0	0.0	95.4	0.0	88.9	0.0	71.7	67.0	58.1	0.0	84.1	64.0	BET	95.4	Birabresib	Birabresib (OTX-015) is a potent bromodomain (BRD2/3/4) inhibitor with IC50s ranging from 92 to 112 nM.	False	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)Nc1ccc(O)cc1)c1nnc(C)n1-2
410925	410925:01:03_00.20	True	0.2	97	31.1	0.0	0.0	92.2	0.0	86.2	0.0	80.2	63.6	50.2	0.0	82.6	62.4	BET	92.2	(Rac)-BAY1238097	(Rac)-BAY1238097 is a BET inhibitor, with an IC50 of 1.02 uM for BRD4. Used in cancer research.	False	CNC(=O)N1N=C(c2ccc(N3CCN(C)CC3)cc2)c2cc(OC)c(OC)cc2CC1C
410900	410900:01:03_00.20	True	0.2	100	37.0	0.0	0.0	96.0	0.0	91.0	0.0	71.5	67.2	54.2	0.0	81.9	63.3	BET	96.0	CPI-203	CPI-203 is a novel potent, selective and cell permeable inhibitor of BET bromodomain, with an IC50 value of appr 37 nM (BRD4 .a.-screen assay).	False	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(N)=O)c1nnc(C)n1-2
410924	410924:01:03_00.20	True	0.2	87	61.1	0.0	0.0	91.0	0.0	82.0	8.5	84.0	54.1	57.7	0.0	86.2	66.6	BET	91.0	ARV-771	ARV-771 is a potent BET degrader based on PROTAC technology with Kds of  34, 4.7, 8.3, 7.6, 9.6, and 7.6 nM for BRD2(1), BRD2(2), BRD3(1), BRD3(2), BRD4(1), and BRD4(2), respectively.	False	Cc1ncsc1-c1ccc([C@H](C)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)COCCCOCCNC(=O)C[C@@H]2N=C(c3ccc(Cl)cc3)c3c(sc(C)c3C)-n3c(C)nnc32)C(C)(C)C)cc1
410898	410898:01:03_00.20	True	0.2	98	7.8	0.0	12.6	0.0	0.0	0.0	0.0	0.0	14.1	0.0	19.2	0.0	0.0	Pyrimidine_Synth	19.2	Sulforaphane	Sulforaphane is an isothiocyanate present naturally in widely consumed vegetables; has shown anticancer and cardioprotective activities.	False	CS(=O)CCCCN=C=S
410885	410885:01:03_00.20	True	0.2	103	13.3	0.0	0.0	91.8	0.0	85.7	0.0	68.3	63.3	59.9	0.0	79.7	63.4	BET	91.8	BAY1238097	BAY1238097 is a potent and selective inhibitor of BET binding to histones and has strong anti-proliferative activity in different AML (acute myeloid leukemia) and MM (multiple myeloma) models through down-regulation of c-Myc levels and its downstream transcriptome (IC50 <100 nM).	False	CNC(=O)N1N=C(c2ccc(N3CCN(C)CC3)cc2)c2cc(OC)c(OC)cc2C[C@@H]1C
410999	410999:01:03_02.00	True	2.0	95	64.6	0.0	0.0	92.7	0.0	89.8	10.7	88.4	53.5	68.0	0.0	79.3	68.5	BET	92.7	Mivebresib	Mivebresib (ABBV-075) is a potent and orally active bromodomain and extraterminal domain (BET) bromodomain inhibitor. Mivebresib binds to BRD4 with a Ki of 1.5 nM.	False	CCS(=O)(=O)Nc1ccc(Oc2ccc(F)cc2F)c(-c2cn(C)c(O)c3nccc2-3)c1
410958	410958:01:03_02.00	True	2.0	56	83.1	0.0	0.0	87.8	0.0	92.1	33.2	73.9	64.4	70.2	0.0	91.0	59.5	HDAC	92.1	SGC-CBP30	SGC-CBP30 is a potent and highly selective CBP/p300 bromodomain (Kds of 21 nM and 32 nM for CBP and p300, respectively) inhibitor, displaying 40-fold selectivity over the first bromodomain of BRD4 [BRD4(1)] bound. SGC-CBP30 strongly reduces secretion of IL-17A in Th17 cells and has anti-inflammatory effects.	False	COc1ccc(CCc2nc3cc(-c4c(C)noc4C)ccc3n2C[C@H](C)N2CCOCC2)cc1Cl
410840	410840:01:03_02.00	True	2.0	103	53.5	0.0	0.0	96.9	0.0	92.5	0.0	80.9	61.5	64.7	0.0	79.7	65.5	BET	96.9	MS417	MS417 is a BET-specific BRD4 inhibitor, binds to BRD4-BD1 and BRD4-BD2 with IC50s of 30, 46 nM and Kds of 36.1, 25.4 nM, respectively, with weak selectivity at CBP BRD (IC50, 32.7 µM).	False	COC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2c(sc(C)c2C)-n2c(C)nnc21
392651	392651:03:05_02.00	True	2.0	60	81.9	0.0	0.0	91.1	0.0	94.1	21.6	80.5	61.5	71.5	0.0	84.6	66.7	HDAC	94.1	Fimepinostat	Fimepinostat (CUDC-907) potently inhibits class I PI3Ks as well as classes I and II HDAC enzymes with an IC50 of  19/54/39 nM and 1.7/5.0/1.8/2.8 nM for PI3K.a./PI3K.b./PI3K.d. and HDAC1/HDAC2/HDAC3/HDAC10 , respectively.	False	COc1ccc(-c2nc(N3CCOCC3)c3sc(CN(C)c4ncc(C(=O)NO)cn4)cc3n2)cn1
410968	410968:01:03_02.00	True	2.0	106	55.3	0.0	0.0	95.3	0.0	88.3	1.1	86.8	54.4	63.1	0.0	81.2	62.4	BET	95.3	HJB97	HJB97 is a high-affinity BET inhibitor with Kis of 0.9 nM (BRD2 BD1), 0.27 nM (BRD2 BD2), 0.18 nM (BRD3 BD1), 0.21 nM (BRD3 BD2), 0.5 nM (BRD4 BD1), 1.0 nM (BRD4 BD2), respectively. HJB97 is  employed for the design of potential PROTAC BET degrader and has antitumor activity.	False	CCn1nc(C2CC2)cc1Nc1nc(C(=O)NC)nc2[nH]c3cc(-c4c(C)noc4C)c(OC)cc3c12
410918	410918:01:03_02.00	True	2.0	99	21.2	56.5	0.0	0.0	51.9	0.0	35.3	0.0	0.0	0.0	79.0	0.0	0.0	Pyrimidine_Synth	79.0	Inauhzin	Inauhzin is a dual SirT1/IMPDH2 inhibitor, and acts as an activator p53, used in the research of cancer.	False	CCC(Sc1nnc2c(n1)[nH]c1ccccc12)C(=O)N1c2ccccc2Sc2ccccc21
392321	392321:04:03_02.00	True	2.0	69	39.0	0.0	89.4	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	5.9	0.0	Aurora	89.4	ZM-447439	ZM-447439 is an aurora kinase inhibitor with IC50s of 110 and 130 nM for aurora A and B, respectively.; Thousands of chemical starting points for antimalarial lead identification. Nature. 2010 May 20;465(7296):305-10.	False	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1
409861	409861:02:03_02.00	True	2.0	106	56.6	0.0	0.0	68.9	0.0	66.1	8.3	95.4	24.7	31.0	0.0	59.7	29.8	LCH	95.4	UNC1999	UNC1999 is a SAM-competitive, potent and selective inhibitor of EZH2/1 with IC50s of <10 nM and 45 nM, repectively.	False	CCCc1cc(C)nc(O)c1CNC(=O)c1cc(-c2ccc(N3CCN(C(C)C)CC3)nc2)cc2c1cnn2C(C)C
410991	410991:01:03_02.00	True	2.0	96	17.4	73.8	0.0	0.0	83.8	0.0	48.0	0.0	0.0	0.0	73.1	0.0	0.0	DNA_Synth	83.8			False	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)CNC(=O)CNC(=O)[C@@H](N)C(C)C)C(=O)O
411001	411001:01:03_02.00	True	2.0	98	6.2	0.0	15.7	58.0	0.0	65.3	0.0	34.4	38.9	25.3	0.0	61.7	25.1	HDAC	65.3	Nexturastat A	Nexturastat A is a potent and selective HDAC6 inhibitor with IC50 of 5 nM; no inhibition on other HDAC forms.IC50 value: 5 nM Target: HDAC6 inhibitorNexturastat A displayed low micromolar activity compared to the low nanomolar activity against HDAC6. Moreover, it also demonstrated high levels of selective inhibition against members of the related Class 2 HDAC isozymes reaching >1000-fold selective in some cases. Compared to the pan-selective HDACI LBH589, Nexturastat A is approximately 100-fold less potent in inducing murine B16 melanoma cell death.	False	CCCCN(Cc1ccc(C(=O)NO)cc1)C(=O)Nc1ccccc1
410861	410861:01:03_02.00	True	2.0	103	50.6	0.0	0.0	97.8	0.0	93.7	0.0	76.7	66.3	66.0	0.0	86.0	68.8	BET	97.8	Bromosporine	Bromosporine is a broad spectrum inhibitor for bromodomains with IC50 of 0.41 uM, 0.29 uM, 0.122 uM and 0.017 uM for BRD2, BRD4, BRD9 and CECR2, respectively.IC50 value: 0.41/0.29/0.122/0.017 uM (BRD2/BRD4/BRD9/CECR2) Target: BRD inhibitorIn cell-based assays, Bromosporine (1 uM) accelerates FRAP recovery of BRD4 and CREBBP, while shows no activities against TIF1.a., BAZ2A, and SMARCA2 even at 10 uM. Bromosporine shows moderate cytotoxicity in HeLa cells at 18 uM. Bromosporine, as a chemical probe for bromodomain functional assays, will be very useful in elucidating further biological roles of reader domains.	False	CCOC(=O)Nc1cc(-c2ccc(C)c(NS(C)(=O)=O)c2)nn2c(C)nnc12
410812	410812:01:03_02.00	True	2.0	96	16.8	0.0	26.8	0.0	0.0	25.8	8.8	0.0	27.5	0.0	0.0	0.0	0.0	Na_K-ATPase	27.5	Entinostat	Entinostat is an oral and selective class I HDAC inhibitor, with IC50s of 243 nM, 453 nM, and 248 nM for HDAC1, HDAC2, and HDAC3, respectively.	False	Nc1ccccc1NC(=O)c1ccc(CNC(=O)OCc2cccnc2)cc1
410805	410805:01:03_02.00	True	2.0	96	22.5	0.0	0.0	83.8	0.0	88.2	17.9	68.4	56.2	50.3	0.0	83.8	59.3	HDAC	88.2	Citarinostat	Citarinostat (ACY241) is a second generation potent, orally active and high-selective HDAC6 inhibitor with an IC50 of 2.6 nM (IC50s of 35 nM, 45 nM, 46 nM and 137 nM for HDAC1, HDAC2, HDAC3 and HDAC8, respectively). Citarinostat has anticancer effects.	False	O=C(CCCCCCNC(=O)c1cnc(N(c2ccccc2)c2ccccc2Cl)nc1)NO
394207	394207:03:03_02.00	True	2.0	102	53.5	0.0	0.0	82.2	0.0	74.9	9.9	87.8	39.8	51.5	0.0	82.0	42.2	LCH	87.8	HTH-01-015	HTH-01-015 is a selective NUAK1/ARK5 inhibitor (IC50 is 100 nM). HTH-01-015 inhibits NUAK1 with >100-fold higher potency than NUAK2 (IC50 of >10 uM).	False	Cc1nc(Nc2cnn(C3CCNCC3)c2)nc2c1N(C)C(=O)c1cc3ccccc3cc1N2C
410931	410931:01:03_02.00	True	2.0	107	8.6	0.0	0.0	39.4	0.0	26.8	5.6	37.7	21.7	26.7	0.0	32.2	12.4	BET	39.4	TPOP146	TPOP146 is a selective CBP/P300 benzoxazepine bromodomain inhibitor with Kd values of 134 nM and 5.02 uM for CBP and BRD4.	False	CCC(=O)N1CCOc2c(cc(-c3cc(OC)cc(OC)c3)cc2C(=O)N[C@H]2CCCN(C)C2)C1
410961	410961:01:03_02.00	True	2.0	106	9.8	0.0	0.0	74.3	0.0	67.1	0.0	86.0	26.9	47.0	0.0	68.0	38.9	LCH	86.0	Pinometostat	Pinometostat (EPZ-5676) is a potent DOT1L histone methyltransferase inhibitor with a Ki of 80 pM.	False	CC(C)N(C[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)[C@H]1C[C@@H](CCc2nc3cc(C(C)(C)C)ccc3[nH]2)C1
411006	411006:01:03_02.00	True	2.0	100	75.0	0.0	0.0	83.6	0.0	82.4	15.3	79.7	46.3	58.0	0.0	76.4	43.4	BET	83.6	ARV-825	ARV-825 is a BRD4 degrader based on PROTAC technology. ARV-825 binds to BD1 and BD2 of BRD4 with Kds of 90 and 28 nM, respectively.	False	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)Nc1ccc(OCCOCCOCCOCCNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)cc1)c1nnc(C)n1-2
410865	410865:01:03_02.00	True	2.0	107	30.7	24.9	0.0	49.8	0.0	52.4	41.8	78.8	7.8	26.3	0.0	41.1	38.6	LCH	78.8	JAK3-IN-1	JAK3-IN-1 is a potent, selective and orally active JAK3 inhibitor with an IC50 of 4.8 nM. JAK3-IN-1 shows over 180-fold more selective for JAK3 than JAK1 (IC50 of 896 nM) and JAK2 (IC50 of 1050 nM).	False	C=CC(=O)Nc1cccc(CNc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)ncc2Cl)c1
392636	392636:03:03_02.00	True	2.0	94	6.2	0.7	37.1	0.0	69.6	0.0	2.0	5.0	0.0	0.0	17.7	27.6	0.0	DNA_Synth	69.6	MK-5108	MK-5108 is a highly potent and specific inhibitor of Aurora A kinase with an IC50 value of 0.064 nM.	False	O=C(O)[C@]1(Cc2cccc(Nc3nccs3)n2)CC[C@@H](Oc2cccc(Cl)c2F)CC1
410890	410890:01:03_02.00	True	2.0	96	34.5	20.9	0.0	0.0	47.4	0.0	22.1	24.2	0.0	2.6	17.6	9.5	0.0	DNA_Synth	47.4	GSK-J4	GSK-J4 is a potent dual inhibitor of H3K27me3/me2-demethylases JMJD3/KDM6B and UTX/KDM6A with IC50s of 8.6 and 6.6 uM, respectively. GSK-J4 inhibits LPS-induced TNF-.a. production in human primary macrophages with an IC50 of 9 uM. GSK J4 is a cell permeable prodrug of GSK-J1. GSK-J4 induces endoplasmic reticulum stress-related apoptosis.	False	CCOC(=O)CCNc1cc(N2CCc3ccccc3CC2)nc(-c2ccccn2)n1
410903	410903:01:03_02.00	True	2.0	96	5.5	70.4	0.0	0.0	77.6	0.0	0.0	0.0	0.0	0.0	69.0	0.0	1.7	DNA_Synth	77.6	WM-8014	WM-8014 is an inhibitor of MOZ, a member of histone acetyltransferases, with an IC50 of 55 nM.	False	Cc1cc(-c2ccccc2)cc(C(=O)NNS(=O)(=O)c2ccccc2)c1F
392682	392682:03:03_02.00	True	2.0	101	15.0	0.0	1.6	24.8	21.3	3.8	0.0	45.0	0.0	0.0	0.0	45.1	0.0	Tubulin	45.1	Go 6983	Go 6983 is a pan-PKC inhibitor against for PKC.a., PKC.b., PKC.g., PKC.d. and PKC.z. with IC50 of 7 nM, 7 nM, 6 nM, 10 nM and 60 nM, respectively.	False	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C
410868	410868:01:03_02.00	True	2.0	103	81.7	0.0	0.0	81.8	0.0	78.9	3.2	94.7	36.1	52.0	0.0	70.1	46.1	LCH	94.7	MI-503	MI-503 is a highly potent and orally bioavailable small molecule inhibitor of the menin-mLL interaction.	False	Cc1c(CN2CCC(Nc3ncnc4sc(CC(F)(F)F)cc34)CC2)ccc2c1cc(C#N)n2Cc1cn[nH]c1
410872	410872:01:03_02.00	True	2.0	93	18.1	0.0	21.8	0.0	0.0	20.9	0.0	0.0	29.8	0.0	0.0	0.0	0.0	Na_K-ATPase	29.8	Tucidinostat	Tucidinostat (Chidamide) is a potent and orally bioavailable HDAC enzymes class I (HDAC1/2/3) and class IIb (HDAC10) inhibitor, with IC50s of 95, 160, 67 and 78 nM, less active on HDAC8 and HDAC11 (IC50s, 733 nM, 432 nM, respectively), and shows no effect on HDAC4/5/6/7/9.	False	Nc1cc(F)ccc1NC(=O)c1ccc(CNC(=O)/C=C/c2cccnc2)cc1
410806	410806:01:03_02.00	True	2.0	94	28.0	0.0	0.0	85.0	0.0	89.7	0.0	59.9	67.2	52.1	0.0	77.9	56.2	HDAC	89.7	Ricolinostat	Ricolinostat (ACY-1215) is a potent and selective HDAC6 inhibitor, with an IC50 of 5 nM. ACY-1215 also inhibits HDAC1, HDAC2, and HDAC3 with IC50s of 58, 48, and 51 nM, respectively.	False	O=C(CCCCCCNC(=O)c1cnc(N(c2ccccc2)c2ccccc2)nc1)NO
410804	410804:01:03_02.00	True	2.0	66	58.7	0.0	0.0	84.8	0.0	98.4	23.0	68.8	67.9	68.1	0.0	74.9	64.0	HDAC	98.4	Trichostatin A	Trichostatin A (TSA) is a potent and specific inhibitor of HDAC class I/II, with an IC50 value of 1.8 nM for HDAC.	False	CC(/C=C/C(=O)NO)=C\[C@@H](C)C(=O)c1ccc(N(C)C)cc1
392578	392578:03:03_02.00	True	2.0	96	57.7	0.0	4.8	75.4	0.0	68.8	17.7	68.8	34.5	54.8	0.0	83.9	37.0	Tubulin	83.9	Gandotinib	Gandotinib (LY2784544) is a potent JAK2 inhibitor with IC50 of 3 nM. Gandotinib (LY2784544) also inhibits FLT3, FLT4, FGFR2, TYK2, and TRKB with IC50 of 4, 25, 32, 44, and 95 nM.	False	Cc1cc(Nc2cc(CN3CCOCC3)c3nc(C)c(Cc4ccc(Cl)cc4F)n3n2)[nH]n1
392595	392595:02:03_02.00	True	2.0	69	35.6	0.0	91.8	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	Aurora	91.8	AMG 900	AMG 900 is a potent and highly selective pan-Aurora kinases inhibitor with IC50 of 5 nM, 4 nM and 1 nM for Aurora A, B and C, respectively.	False	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1
410668	410668:02:03_02.00	True	2.0	93	62.0	0.0	0.0	97.1	0.0	92.9	0.0	83.2	62.7	62.4	0.0	84.1	60.7	BET	97.1	(+)-JQ-1	(+)-JQ-1 (JQ1) is a potent, specific, and reversible BET bromodomain inhibitor, with IC50s of 77 and 33 nM for the first and second bromodomain (BRD4(1/2)). (+)-JQ-1 also activates autophagy.	True	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2
410943	410943:01:03_02.00	True	2.0	108	12.6	8.5	0.0	61.8	0.0	54.3	19.8	45.1	30.5	58.2	0.0	52.8	57.3	BET	61.8	GNE-781	GNE-781 is an orally active, highly potent and selective CBP inhibitor with an IC50 of 0.94 nM in TR-FRET assay. GNE-781 also inhibits BRET and BRD4(1) with IC50s of 6.2 nM and 5100 nM, respectively. GNE-781 displays antitumor activity in an MOLM-16 AML xenograft model.	False	CNC(=O)N1CCc2c(c(N3CCCc4cc(-c5cnn(C)c5)c(C(F)F)cc43)nn2C2CCOCC2)C1
410802	410802:01:03_02.00	True	2.0	81	24.4	21.7	0.0	0.0	48.8	0.0	25.9	20.1	6.7	15.4	11.4	11.5	0.0	DNA_Synth	48.8	NSC 228155	NSC 228155 is an activator of EGFR, binds to the extracellular region of EGFR and enhance tyrosine phosphorylation of EGFR. NSC 228155 is also a potent inhibitor of KIX-KID interaction, inhibits kinase-inducible domain (KID) from CREB and KID-interacting domain (KIX) from CBP, with an IC50 of 0.36 uM.	False	O=[N+]([O-])c1ccc(Sc2cccc[n+]2[O-])c2nonc12
410827	410827:01:03_02.00	True	2.0	96	53.5	0.0	0.0	97.8	0.0	92.1	0.1	79.9	60.4	73.6	0.0	84.3	72.1	BET	97.8	PLX51107	PLX51107 is a potent and selective BET inhibitor, with Kds of 1.6, 2.1, 1.7, and 5 nM for BD1 and 5.9, 6.2, 6.1, and 120 nM for BD2 of BRD2, BRD3, BRD4, and BRDT, respectively; PLX51107 also interacts with the bromodomains of CBP and EP300 (Kd, in the 100 nM range).	False	Cc1noc(C)c1-c1cnc2c(-c3ccc(C(=O)O)cc3)cn([C@@H](C)c3ccccn3)c2c1
410966	410966:01:03_02.00	True	2.0	90	41.5	79.3	0.0	0.0	38.1	0.0	45.4	0.0	0.0	0.0	48.6	0.0	11.3	AKT_PI3K_MTOR	79.3	Gusacitinib	Gusacitinib (ASN-002) is an orally active and potent dual inhibitor of spleen tyrosine kinase (SYK) and janus kinase (JAK) with IC50 values of 5-46 nM. Gusacitinib has anti-cancer activity in both solid and hematological tumor types.	False	N#CCC1CCN(c2nc(Nc3ccc(N4CCC(O)CC4)cc3)c3c(O)nncc3n2)CC1
410921	410921:01:03_02.00	True	2.0	106	76.2	0.0	0.0	79.0	0.0	76.3	8.8	95.9	32.4	48.2	0.0	67.8	40.1	LCH	95.9	MI-463	MI-463 is a highly potent and orally bioavailable small molecule inhibitor of the menin-mLL interaction.	False	Cc1c(CN2CCC(Nc3ncnc4sc(CC(F)(F)F)cc34)CC2)ccc2[nH]c(C#N)cc12
410879	410879:01:03_02.00	True	2.0	72	68.0	0.0	0.0	85.0	0.0	98.3	28.9	72.9	61.9	72.2	0.0	75.7	63.4	HDAC	98.3	Givinostat (hydrochloride monohydrate)	Givinostat hydrochloride monohydrate (ITF-2357 hydrochloride monohydrate) is a HDAC inhibitor with an IC50 of 198 and 157 nM for HDAC1 and HDAC3, respectively.	False	CCN(CC)Cc1ccc2cc(COC(=O)Nc3ccc(C(=O)NO)cc3)ccc2c1
410797	410797:01:03_02.00	True	2.0	90	82.0	0.0	0.0	70.1	0.0	67.2	0.0	85.4	31.3	37.3	0.0	66.1	31.9	LCH	85.4	BIX-01294	BIX-01294 is an inhibitor of G9a Histone Methyltransferase with an IC50 of 1.9 µM.	False	COc1cc2nc(N3CCCN(C)CC3)nc(NC3CCN(Cc4ccccc4)CC3)c2cc1OC
410940	410940:01:03_02.00	True	2.0	79	29.9	38.6	48.3	0.0	46.1	0.0	46.5	0.0	0.0	0.0	60.6	0.0	0.0	Pyrimidine_Synth	60.6	Reversine	Reversine is a novel class of ATP-competitive Aurora kinase inhibitor with IC50s of 400, 500 and 400 nM for Aurora A, Aurora B and Aurora C, respectively.	False	c1nc2c(NC3CCCCC3)nc(Nc3ccc(N4CCOCC4)cc3)nc2[nH]1
410084	410084:02:03_02.00	True	2.0	63	80.5	0.0	20.9	71.1	0.0	75.0	26.3	82.6	39.9	57.0	0.0	79.2	22.3	LCH	82.6	BI-847325	BI-847325 is an ATP competitive dual inhibitor of MEK and aurora kinases (AK) with IC50 values of 4 and 15 nM for human MEK2 and AK-C, respectively.	False	CCNC(=O)C#Cc1ccc2c(/C(=N/c3ccc(CN(C)C)cc3)c3ccccc3)c(O)[nH]c2c1
410801	410801:01:04_02.00	True	2.0	68	65.3	0.0	0.0	85.9	0.0	98.1	23.1	73.6	65.3	70.9	0.0	76.2	66.3	HDAC	98.1	Panobinostat	Panobinostat (LBH589; NVP-LBH589) is a potent and orally active non-selective HDAC inhibitor, and has antineoplastic activities. Panobinostat induces HIV-1 virus production even at low concentration range 8-31 nM, stimulates HIV-1 expression in latently infected cells. Panobinostat induces cell apoptosis and autophagy. Panobinostat can be used for the study of refractory or relapsed multiple myeloma.	False	Cc1[nH]c2ccccc2c1CCNCc1ccc(/C=C/C(=O)NO)cc1
409838	409838:02:03_02.00	True	2.0	94	23.5	0.0	0.0	80.3	0.0	76.4	0.0	64.5	51.0	57.1	0.0	81.2	59.1	Tubulin	81.2	ACY-738	ACY-738 is a potent, selective and orally-bioavailable HDAC6 inhibitor, with an IC50 of 1.7 nM; ACY-738 also inhibits HDAC1, HDAC2, and HDAC3, with IC50s of 94, 128, and 218 nM.	False	O=C(NO)c1cnc(NC2(c3ccccc3)CC2)nc1
411004	411004:01:03_02.00	True	2.0	90	22.8	58.8	0.0	2.2	35.0	0.0	42.1	29.0	0.0	12.6	11.1	15.8	36.9	AKT_PI3K_MTOR	58.8	CHZ868	CHZ868 is a type II JAK2 inhibitor with an IC50 of 0.17 uM in EPOR JAK2 WT Ba/F3 cell.	False	CC(=O)Nc1cc(Oc2ccc3c(nc(Nc4ccc(F)cc4F)n3C)c2C)ccn1
410875	410875:01:03_02.00	True	2.0	90	15.0	57.9	0.0	0.0	57.7	0.0	9.0	0.0	0.0	0.0	77.4	0.0	0.0	Pyrimidine_Synth	77.4	QC6352	QC6352 is an orally available, selective and potent KDM4C inhibitor with an IC50 of 35 nM.	False	CN(c1ccccc1)c1ccc2c(c1)CCC[C@H]2CNc1cnccc1C(=O)O
410973	410973:01:03_02.00	True	2.0	67	73.4	0.0	0.0	85.9	0.0	86.8	26.3	69.9	62.3	69.3	0.0	94.7	48.8	Tubulin	94.7	TyK2-IN-2	TyK2-IN-2 is an inhibitor of TYK2, used for treatment of inflammatory and autoimmune diseases.	False	CNc1cc(Nc2cc(C)cc(C)c2)nn2c(C(N)=O)cnc12
410843	410843:01:03_02.00	True	2.0	73	55.8	0.0	0.0	85.8	0.0	98.2	22.2	69.2	65.7	65.9	0.0	73.1	65.0	HDAC	98.2	Pracinostat	Pracinostat is a potent histone deacetylase (HDAC) inhibitor, with IC50s of 40-140 nM, used for cancer research.	False	CCCCc1nc2cc(/C=C/C(=O)NO)ccc2n1CCN(CC)CC
410916	410916:01:03_02.00	True	2.0	74	54.1	0.0	0.0	86.1	0.0	98.8	22.9	68.1	65.8	70.6	0.0	78.1	62.3	HDAC	98.8	M344	M344 (D 237) is an inhibitor of histone deacetylase (IC50=100 nM) and an inducer of terminal cell fifferentiation.	False	CN(C)c1ccc(C(=O)NCCCCCCC(=O)NO)cc1
410869	410869:01:03_02.00	True	2.0	98	26.3	64.5	0.0	0.0	17.2	0.0	40.5	0.0	0.0	0.0	40.4	0.0	0.0	AKT_PI3K_MTOR	64.5	Cerdulatinib	Cerdulatinib (PRT062070) is a selective Tyk2 inhibitor with an IC50 of 0.5 nM. Cerdulatinib (PRT062070) also is a dual JAK and SYK inhibitor with IC50s of 12, 6, 8 and 32 for JAK1, 2, 3 and SYK, respectively.	False	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1
410914	410914:01:03_02.00	True	2.0	66	40.2	0.0	85.0	14.1	0.0	30.5	26.2	32.3	5.4	13.5	0.0	38.1	0.0	Aurora	85.0	GSK-1070916	GSK-1070916 is a potent and selective ATP-competitive inhibitor of aurora B and aurora C with Kis of 0.38 and 1.5 nM, respectively, and is >250- fold selective over Aurora A.	False	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1
410080	410080:02:03_02.00	True	2.0	60	83.1	0.0	0.0	83.8	0.0	81.9	10.1	74.8	59.0	56.6	0.0	83.1	57.9	BET	83.8	GSK503	GSK503 is a potent and specific inhibitor of EZH2 methyltransferase with Kiapp values of 3 to 27 nM.	False	Cc1cc(C)c(CNC(=O)c2cc(-c3ccc(N4CCN(C)CC4)nc3)cc3c2c(C)cn3C(C)C)c(O)n1
410987	410987:01:03_02.00	True	2.0	98	7.6	0.0	8.0	58.5	0.0	57.5	0.0	66.2	30.4	26.6	0.0	64.4	22.0	LCH	66.2	C-7280948	C-7280948 is a selective and potent protein methyltransferase1 (PRMT1) inhibitor with an IC50 value of 12.75 uM.	False	Nc1ccc(S(=O)(=O)NCCc2ccccc2)cc1
410818	410818:01:03_02.00	True	2.0	59	59.8	0.0	0.0	62.6	0.0	58.6	0.0	70.3	42.1	33.2	0.0	63.4	44.6	LCH	70.3	SB1317	SB1317 is a potent inhibitor of CDK2, JAK2, and FLT3 for the treatment of cancer, with IC50 of 13, 73, and 56 nM for CDK2, JAK2 and FLT3, respectively.	False	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1
409873	409873:02:03_02.00	True	2.0	103	70.6	0.0	0.0	75.0	0.0	72.9	10.6	95.6	29.0	45.7	0.0	66.4	38.2	LCH	95.6	LLY-507	LLY-507 is a potent and selective inhibitor of protein-lysine methyltransferase SMYD2. LLY-507 potently inhibits the ability of SMYD2 to methylate p53 peptide with an IC50 <15 nM. LLY-507 serves as a valuable chemical probe to aid in the dissection of SMYD2 function in cancer and other biological processes.	False	Cc1cn(CCN2CCN(c3ccccc3-c3cc(C#N)cc(C(=O)NCCCN4CCCC4)c3)CC2)c2ccccc12
392736	392736:02:03_02.00	True	2.0	93	16.1	47.2	0.0	0.0	2.0	0.0	42.3	0.0	0.0	0.0	51.8	0.0	0.0	Pyrimidine_Synth	51.8	TAK-632	TAK-632 is a potent pan-RAF inhibitor with IC50 of 1.4, 2.4 and 8.3 nM for CRAF, BRAFV600E, BRAFWT, respectively.	False	N#Cc1c(Oc2ccc(F)c(NC(=O)Cc3cccc(C(F)(F)F)c3)c2)ccc2nc(NC(=O)C3CC3)sc12
382127	382127:03:03_02.00	True	2.0	93	14.2	70.1	12.8	0.0	91.0	0.0	29.3	0.0	0.0	0.0	82.0	0.0	0.0	DNA_Synth	91.0	WHI-P154	WHI-P154 is a potent EGFR inhibitor, and also modestly blocks JAK3, with IC50s of 4 nM and 1.8 µM, respectively.	False	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC
410884	410884:01:03_02.00	True	2.0	67	71.5	0.0	0.0	93.0	0.0	93.2	13.1	79.4	66.3	67.8	0.0	90.8	55.3	HDAC	93.2	CF53	CF53 is a highly potent, selective and orally active inhibitor of BET protein, with a Ki of <1 nM, Kd of 2.2 nM and an IC50 of 2 nM for BRD4 BD1. CF53 binds to both the BD1 and BD2 domains of BRD2, BRD3, BRD4, and BRDT BET proteins with high affinities, very selective over non-BET bromodomain-containing proteins. CF53 shows potent anti-tumor activity both in vitro and in vivo.	False	COc1cc2c(cc1-c1c(C)noc1C)[nH]c1nc(C)nc(Nc3cc(C4CC4)nn3C)c12
410905	410905:01:03_02.00	True	2.0	94	22.3	0.0	0.0	81.9	0.0	73.6	4.0	76.6	47.1	45.7	0.0	75.3	46.3	BET	81.9	ABBV-744	ABBV-744 is a highly BDII-selective BET bromodomain inhibitor, used in the research of inflammatory diseases, cancer, and AIDS.	False	CCNC(=O)c1cc2c(-c3cc(C(C)(C)O)ccc3Oc3c(C)cc(F)cc3C)cn(C)c(O)c-2n1
392506	392506:02:03_02.00	True	2.0	63	25.4	0.0	94.1	0.0	5.2	0.0	14.3	0.0	0.0	0.0	0.7	0.0	0.0	Aurora	94.1	Danusertib	Danusertib is a pyrrolo-pyrazole and aurora kinase inhibitor with IC50 of 13, 79, and 61 nM for Aurora A, B, and C, respectively.	False	CO[C@@H](C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1
410873	410873:01:03_02.00	True	2.0	102	55.6	47.8	0.0	52.7	0.0	56.2	36.7	60.6	24.4	43.8	0.0	50.1	69.2	Uncoupler	69.2	-Oryzanol	.g.-Oryzanol is a potent DNA methyltransferases (DNMTs) inhibitor in the striatum of mice. .g.-Oryzanol significantly inhibits the activities of DNMT1 (IC50=3.2 uM), DNMT3a (IC50=22.3 uM).	False	COc1cc(/C=C/C(=O)O[C@H]2CC[C@]34CC35CC[C@]3(C)[C@@H]([C@H](C)CCC=C(C)C)CC[C@@]3(C)C5CCC4C2(C)C)ccc1O
410883	410883:01:03_02.00	True	2.0	94	41.1	0.0	0.0	96.8	0.0	91.8	0.0	78.4	65.3	61.8	0.0	84.5	65.2	BET	96.8	Y06036	Y06036 is a potent and selective BET inhibitor, which binds to the BRD4(1) bromodomain with Kd value of 82 nM. Antitumor activity.	False	COc1cc2onc(C)c2cc1NS(=O)(=O)c1cc(Br)ccc1OC
269940	269940:02:03_02.00	True	2.0	102	8.6	0.0	0.0	44.3	0.0	41.9	41.1	42.7	19.1	32.3	0.0	48.1	31.7	Tubulin	48.1	JW 55	JW 55 is a potent and selective .b.-catenin signaling pathway inhibitor, which functions via inhibition of the PARP domain of tankyrase 1 and tankyrase 2 (TNKS1/2). JW 55 decreases auto-PARsylation of TNKS1/2 in vitro with IC50s of 1.9 uM and 830 nM respectively. 	False	COc1ccc(C2(CNC(=O)c3ccc(NC(=O)c4ccco4)cc3)CCOCC2)cc1
410803	410803:01:03_02.00	True	2.0	68	61.3	0.0	0.0	84.2	0.0	97.5	26.9	71.6	65.5	71.0	0.0	74.3	69.7	HDAC	97.5	Quisinostat	Quisinostat (JNJ-26481585) is an orally available, potent HDAC inhibitor with IC50s of 0.11 nM, 0.33 nM, 0.64 nM, 0.46 nM, and 0.37 nM for HDAC1, HDAC2, HDAC4, HDAC10 and HDAC11, respectively.	False	Cn1cc(CNCC2CCN(c3ncc(C(=O)NO)cn3)CC2)c2ccccc21
392643	392643:02:03_02.00	True	2.0	63	49.9	0.0	51.8	45.1	0.0	56.3	22.8	73.7	13.9	28.0	0.0	50.1	1.7	LCH	73.7	CCT 137690	CCT 137690 is a potent and orally available aurora kinase inhibitor with IC50s of 15, 25, and 19 nM for aurora A, B and C, respectively.	False	Cc1cc(CN2CCN(c3c(Br)cnc4[nH]c(-c5ccc(N6CCN(C)CC6)cc5)nc34)CC2)no1
409947	409947:02:03_02.00	True	2.0	80	54.7	0.0	0.0	88.2	0.0	98.6	19.5	69.5	65.5	67.6	0.0	79.7	62.6	HDAC	98.6	Belinostat	Belinostat (PXD101; PX105684) is a potent HDAC inhibitor with an IC50 of 27 nM in HeLa cell extracts.	False	O=C(/C=C/c1cccc(S(=O)(=O)Nc2ccccc2)c1)NO
392520	392520:02:03_02.00	True	2.0	72	35.2	0.0	90.2	0.0	5.9	0.0	0.0	0.0	0.8	0.0	0.0	3.9	0.0	Aurora	90.2	Barasertib-HQPA	Barasertib-HQPA (AZD2811) is a highly selective?Aurora B?inhibitor with?an IC50?of 0.37 nM in a cell-free assay, and shows 3700-fold selectivity for Aurora B over Aurora A.	False	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1
410820	410820:01:03_02.00	True	2.0	89	29.5	0.0	29.4	0.0	0.0	0.0	0.0	0.0	12.4	0.0	28.3	0.0	0.0	Aurora	29.4	RG2833	RG2833 is a brain-penetrant HDAC inhibitor with IC50s of 60 nM and 50 nM for HDAC1 and HDAC3, respectively. The Ki values for HDAC1 and HDAC3 are 32 and 5 nM, respectively.	False	Cc1ccc(C(=O)NCCCCCC(=O)Nc2ccccc2N)cc1
410791	410791:01:03_02.00	True	2.0	55	62.9	35.3	0.0	7.4	27.7	0.0	5.0	22.1	15.6	0.0	28.8	13.7	18.8	AKT_PI3K_MTOR	35.3	Mitoxantrone	Mitoxantrone is a topoisomerase II inhibitor; also inhibits protein kinase C (PKC) activity with an IC50 of 8.5 uM.	False	O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21
392517	392517:02:03_02.00	True	2.0	67	32.5	0.0	89.1	0.0	5.6	0.0	19.5	0.0	0.0	0.0	4.7	0.0	0.0	Aurora	89.1	AT9283	AT9283 is a multi-targeted kinase inhibitor with potent activity against Aurora A/B, JAK2/3, Abl (T315I) and Flt3 (IC50s ranging from 1 to 30 nM). AT9283 inhibits growth and survival of multiple solid tumors in vitro and in vivo.	False	O=C(Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1)NC1CC1
410962	410962:01:03_02.00	True	2.0	93	15.9	2.1	0.0	32.5	0.0	34.5	58.2	41.2	0.0	29.8	0.0	43.5	18.8	HSP90	58.2	BB-Cl-Amidine (hydrochloride)	BB-Cl-Amidine hydrochloride is a peptidylarginine deminase (PAD) inhibitor.	False	N=C(CCl)NCCC[C@H](NC(=O)c1ccc(-c2ccccc2)cc1)c1nc2ccccc2[nH]1
392734	392734:02:03_02.00	True	2.0	111	5.2	0.0	0.0	29.4	0.0	28.4	8.8	23.1	21.2	22.7	0.0	19.0	9.6	BET	29.4	XL019	XL019is a potentorally active, and selective JAK2 inhibitor, with IC50s of 2.2, 134.3, and 214.2 nM for JAK2, JAK1 and JAK3, respectively. XL019 shows 50-fold or greater selectivity for JAK2, versus a panel of over 100 serine/threonine and tyrosine kinases, including other members of the JAK family. XL019 potently inhibits STAT3 and STAT5 phosphorylation in cells harboring either JAK2V617F or wild-type JAK2.	False	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)[C@@H]1CCCN1
392771	392771:02:03_02.00	True	2.0	101	12.8	44.7	0.0	0.0	47.9	0.0	19.3	20.2	0.0	0.0	25.0	0.8	0.0	DNA_Synth	47.9	Bisindolylmaleimide I	Bisindolylmaleimide I (GF109203X) is a highly selective, cell-permeable, and reversible protein kinase C (PKC) inhibitor with a Ki of 14 nM.	False	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21
410994	410994:01:03_02.00	True	2.0	64	41.5	0.0	0.0	67.9	0.0	60.2	0.0	82.8	34.3	29.4	0.0	63.1	41.9	LCH	82.8	MZP-54	MZP-54 is a selective degrader of BRD3/4 based on PROTAC technology, with a Kd of 4 nM for Brd4BD2.	False	CC(=O)N1c2ccc(-c3ccc(C(=O)NCCOCCOCCOCC(=O)N[C@H](C(=O)N4C[C@H](O)C[C@H]4C(=O)NCc4ccc(-c5scnc5C)cc4)C(C)(C)C)cc3)cc2[C@H](Nc2ccc(Cl)cc2)C[C@@H]1C
410948	410948:01:03_02.00	True	2.0	86	27.3	0.0	0.0	81.0	0.0	69.5	0.0	86.3	44.0	37.7	0.0	76.8	60.2	LCH	86.3	dBET6	dBET6 is a highly potent, selective and cell-permeable degrader of BET based on PROTAC, with an IC50 of 14 nM, and has antitumor activity.	False	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)NCCCCCCCCNC(=O)COc1cccc3c1C(=O)N(C1CCC(=O)NC1=O)C3=O)c1nnc(C)n1-2
150900	150900:10:03_02.00	True	2.0	87	57.9	0.0	0.0	81.1	0.0	77.0	12.1	80.1	45.9	71.7	0.0	77.3	71.2	BET	81.1	Nicotinamide	Nicotinamide is a form of vitamin B3 that plays essential roles in cell physiology through facilitating NAD+ redox homeostasis and providing NAD+ as a substrate to a class of enzymes that catalyze non-redox reactions. Nicotinamide is an inhibitor of  SIRT1.	False	NC(=O)c1cccnc1
410965	410965:01:03_02.00	True	2.0	93	14.7	12.0	0.0	61.3	0.0	50.0	0.0	76.7	26.6	8.4	0.0	56.2	49.8	LCH	76.7	PROTAC BET Degrader-1	PROTAC BET Degrader-1 is a potent BET degrader based on PROTAC, decreasing BRD2, BRD3, and BRD4 protein levels at low concentration.	False	CCn1nc(C2CC2)cc1Nc1nc(C(=O)NCCCCNC(=O)COc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)nc2[nH]c3cc(-c4c(C)noc4C)c(OC)cc3c12
410860	410860:01:03_02.00	True	2.0	67	21.4	0.0	90.7	0.0	21.5	0.0	28.4	0.0	0.0	0.0	21.5	0.0	0.0	Aurora	90.7	CCT241736	CCT241736 is a potent and orally bioavailable dual FLT3 and Aurora kinase inhibitor, which inhibits Aurora kinases (Aurora-A Kd, 7.5 nM, IC50, 38 nM; Aurora-B Kd, 48 nM), FLT3 kinase (Kd, 6.2 nM), and FLT3 mutants including FLT3-ITD (Kd, 38 nM) and FLT3(D835Y) (Kd, 14 nM).	False	Cc1nn(C)cc1-c1nc2c(N3CCN(Cc4ccc(Cl)cc4)CC3)c(Cl)cnc2[nH]1
410997	410997:01:03_02.00	True	2.0	96	6.6	0.0	0.0	52.7	0.0	50.6	0.0	80.0	18.3	0.0	0.0	45.3	18.5	LCH	80.0	ORY-1001(trans)	ORY-1001 trans is a selective irreversible lysine (K)-specific demethylase 1A (KDM1A/LSD1) inhibitor.	False	N[C@H]1CC[C@H](N[C@@H]2C[C@H]2c2ccccc2)CC1
410942	410942:01:03_02.00	True	2.0	90	12.8	12.7	0.0	64.7	0.0	55.5	11.2	80.7	19.7	28.3	0.0	60.6	54.0	LCH	80.7	BRD4 degrader AT1	BRD4 degrader AT1 is a highly selective Brd4 degrader based on PROTAC technology, with a Kd of 44 nM for Brd4BD2 in cells.	False	CC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCc1ccc(-c2scnc2C)cc1)C(C)(C)SCCCCCCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2c(sc(C)c2C)-n2c(C)nnc21
392558	392558:02:03_02.00	True	2.0	61	63.2	0.0	19.0	59.4	0.0	60.8	31.5	63.7	43.6	31.5	0.0	75.5	16.5	Tubulin	75.5	Hesperadin	Hesperadin is an ATP competitive indolinone inhibitor of Aurora A and B. Hesperadin inhibits Aurora B with an IC50 of 250 nM.	False	CCS(=O)(=O)Nc1ccc2[nH]c(O)c(/C(=N/c3ccc(CN4CCCCC4)cc3)c3ccccc3)c2c1
410065	410065:02:03_02.00	True	2.0	56	53.5	0.0	11.0	64.1	0.0	82.3	39.4	49.1	58.7	53.5	0.0	71.7	42.9	HDAC	82.3	Domatinostat	Domatinostat (4SC-202 free base) is a selective class I HDAC inhibitor with IC50 of 1.20 uM, 1.12 uM, and 0.57 uM for HDAC1, HDAC2, and HDAC3, respectively. It also displays inhibitory activity against Lysine specific demethylase 1 (LSD1).	False	Cn1cc(-c2ccc(S(=O)(=O)n3ccc(/C=C/C(=O)Nc4ccccc4N)c3)cc2)cn1
410014	410014:02:03_02.00	True	2.0	103	6.2	0.5	0.0	16.7	0.0	12.9	44.3	36.0	0.0	21.0	0.0	26.6	0.0	HSP90	44.3	EPZ005687	EPZ005687 is a potent and selective inhibitor of EZH2 with Ki of 24 nM, and has 50-fold selectivity against EZH1 and 500-fold selectivity against 15 other protein methyltransferases.	False	Cc1cc(C)c(CNC(=O)c2cc(-c3ccc(CN4CCOCC4)cc3)cc3c2cnn3C2CCCC2)c(O)n1
410810	410810:01:03_02.00	True	2.0	89	7.9	0.0	25.0	1.9	0.0	26.5	21.1	0.0	22.5	12.7	0.0	0.0	0.0	HDAC	26.5	Tacedinaline	Tacedinaline (N-acetyldinaline) is an inhibitor of the histone deacetylase (HDAC) with IC50s of 0.9, 0.9, 1.2 uM for recombinant HDAC 1, 2 and 3 respectively.	False	CC(=O)Nc1ccc(C(=O)Nc2ccccc2N)cc1
410824	410824:01:03_02.00	True	2.0	66	62.2	0.0	0.0	85.5	0.0	98.7	24.2	71.5	65.8	72.7	0.0	75.6	64.2	HDAC	98.7	Dacinostat	Dacinostat is a potent HDAC inhibitor, with an IC50 of 32 nM; Dacinostat also inhibits HDAC1 with an IC50 of 9 nM, and used in cancer research.	False	O=C(/C=C/c1ccc(CN(CCO)CCc2c[nH]c3ccccc23)cc1)NO
410945	410945:01:03_02.00	True	2.0	97	5.5	34.1	0.0	20.5	0.0	13.2	49.2	35.2	0.0	16.2	2.1	32.6	37.6	HSP90	49.2	Sirt2-IN-1	Sirt2-IN-1 (Compound 9) is a sirtuin 2 (Sirt2) inhibitor with an IC50 of 163 nM.	False	Cc1cc(C)nc(SCC(=O)Nc2ncc(Cc3cccc(OCc4cn(Cc5ccccc5)nn4)c3)s2)n1
410782	410782:01:03_02.00	True	2.0	95	8.8	71.4	0.0	0.0	41.4	0.0	49.1	0.0	0.0	0.0	49.3	0.0	19.0	AKT_PI3K_MTOR	71.4	JANEX-1	JANEX-1 (WHI-P131) is a potent and specific JAK3 inhibitor (estimated Ki=2.3 uM). JANEX-1 (WHI-P131) shows potent JAK3-inhibitory activity (IC50 of 78 uM), does not inhibit JAK1 and JAK2.	False	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC
392590	392590:02:03_02.00	True	2.0	60	71.5	27.5	0.0	14.4	39.5	25.7	43.1	42.5	3.2	25.6	0.0	27.8	20.9	HSP90	43.1	Momelotinib	Momelotinib (CYT387) is an ATP-competitive inhibitor of JAK1/JAK2 with IC50a of 11 nM and 18 nM,respectively. CYT387 shows much less activity against JAK3.	False	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1
410956	410956:01:03_02.00	True	2.0	85	13.0	67.8	0.0	0.0	88.5	0.0	7.5	0.0	0.0	0.0	81.0	0.0	0.0	DNA_Synth	88.5	NCGC00244536	NCGC00244536 is a potent KDM4B inhibitor with an IC50 of 10 nM.	False	O=C(NCCCc1ccccc1)c1cccc(-c2cc(O)c3ncccc3c2)c1
409848	409848:02:03_02.00	True	2.0	94	7.8	22.9	51.9	0.0	76.0	0.0	14.7	0.0	0.0	0.0	71.9	0.0	0.0	DNA_Synth	76.0	Olaparib	Olaparib (AZD2281; KU0059436) is a potent and orally active PARP inhibitor with IC50s of 5 and 1 nM for PARP1 and PARP2, respectively. Olaparib is an autophagy and mitophagy activator.	False	O=C(c1cc(Cc2nnc(O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1
247097	247097:05:04_02.00	True	2.0	64	51.1	0.0	4.1	35.9	0.0	33.6	3.5	46.3	29.4	4.5	0.0	42.5	17.8	LCH	46.3	Mitoxantrone (dihydrochloride)	Mitoxantrone dihydrochloride is a topoisomerase II inhibitor; also inhibits protein kinase C (PKC) activity with an IC50 of 8.5 uM.	False	O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21
409877	409877:03:03_02.00	True	2.0	99	7.9	85.4	0.0	0.0	70.3	0.0	0.0	0.0	0.0	0.0	79.0	0.0	0.0	AKT_PI3K_MTOR	85.4	SGC707	SGC707 is a first-in-class PRMT3 chemical probe which is a potent, selective, and cell-active allosteric inhibitor of PRMT3 with IC50 of 31 nM.IC50 value: 31 nMTarget: PRMT3in vitro: SGC707 is the first PRMT3 chemical probe. SGC707 is a potent PRMT3 inhibitor (IC50=31±2 nM, KD=53±2 nM) with outstanding selectivity (selective against 31 other methyltransferases and more than 250 non-epigenetic targets). SGC707 can engage PRMT3 and effectively inhibit its catalytic activity in cells and that overexpressed PRMT3 can methylate histone H4 in cells. SGC707 stabilizes PRMT3 in both HEK293 and A549 cells with EC50 values of 1.3 uM and 1.6 uM in PRMT3 InCELL Hunter Assays.in vivo: SGC707 is bioavailable and suitable for animal studies. This well characterized chemical probe is an excellent tool to further study the role of PRMT3 in health and disease. We assessed in vivo pharmacokinetic (PK) properties of SGC707. Intraperitoneal injection of SGC707 at 30 mg/kg gave good plasma exposure in CD-1 male mice over 6 h with the peak plasma level of 38000 nM. The plasma level of SGC707 at 6 h post injection was 208 nM, more than 2-fold higher than its IC50 value in the cellular assay and the half-life of SGC707 was about 1 h. This mdose was well tolerated by the test animals. These results suggest that SGC707 is suitable for animal studies in addition to cell-based studies.	False	O=C(NCC(=O)N1CCCC1)Nc1ccc2cnccc2c1
410919	410919:01:03_02.00	True	2.0	94	79.6	0.0	0.0	70.0	0.0	69.6	21.5	89.1	26.7	43.8	0.0	64.8	39.4	LCH	89.1	666-15	666-15 is a potent and selective CREB inhibitor with an IC50 of 81 nM. 666-15 suppresses tumor growth in a breast cancer xenograft model.	False	NCCCOc1cc2ccccc2cc1C(=O)NCCOc1cc2ccccc2cc1C(=O)Nc1ccc(Cl)cc1O
410069	410069:02:03_02.00	True	2.0	70	63.0	0.0	0.0	86.3	0.0	98.1	27.9	67.6	61.7	69.4	0.0	79.6	58.7	HDAC	98.1	CAY10603	CAY10603 (BML-281) is a potent and selective HDAC6 inhibitor, with an IC50 of 2 pM; CAY10603 (BML-281) also inhibits HDAC1, HDAC2, HDAC3, HDAC8, HDAC10, with IC50s of 271, 252, 0.42, 6851, 90.7 nM.	False	CC(C)(C)OC(=O)Nc1ccc(-c2cc(C(=O)NCCCCCCC(=O)NO)no2)cc1
410932	410932:01:03_02.00	True	2.0	97	9.2	41.3	0.0	0.6	51.4	0.0	24.2	23.9	0.0	0.0	28.6	23.7	40.3	DNA_Synth	51.4	MK8722	MK8722 is a potent and systemic pan-AMPK activator.	False	O[C@@H]1CO[C@@H]2[C@H](Oc3nc4cc(Cl)c(-c5ccc(-c6ccccc6)cc5)nc4[nH]3)CO[C@H]12
410122	410122:02:03_02.00	True	2.0	83	11.6	0.0	0.0	69.0	0.0	81.2	20.2	63.5	51.3	42.8	0.0	72.7	43.0	HDAC	81.2	WT-161	WT-161 is a potent and selective HDAC6 inhibitor with an IC50 of  0.40 nM.	False	O=C(CCCCCCC(=O)N/N=C/c1ccc(N(c2ccccc2)c2ccccc2)cc1)NO
410912	410912:01:03_02.00	True	2.0	66	54.9	47.1	8.9	0.0	79.7	0.0	10.0	2.7	0.0	0.0	52.1	0.0	0.0	DNA_Synth	79.7	RGB-286638 (free base)	RGB-286638 is a CDK inhibitor that inhibits the kinase activity of cyclin T1-CDK9, cyclin B1-CDK1, cyclin E-CDK2, cyclin D1-CDK4, cyclin E-CDK3, and p35-CDK5 with IC50s of 1, 2, 3, 4, 5 and 5 nM, respectively; also inhibits GSK-3.b., TAK1, Jak2 and MEK1, with IC50s of  3, 5, 50, and 54 nM.	False	COCCN1CCN(Cc2ccc(-c3[nH]nc4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1
409850	409850:03:03_02.00	True	2.0	103	5.5	0.0	0.0	74.7	0.0	69.3	0.0	52.5	49.1	38.8	0.0	61.6	37.5	BET	74.7	PFI-1	PFI-1 is a selective BET (bromodomain-containing protein) inhibitor for BRD4 with IC50 of 0.22 uM in a cell-free assay.	False	COc1ccccc1S(=O)(=O)Nc1ccc2c(c1)CN(C)C(=O)N2
410844	410844:01:03_02.00	True	2.0	107	9.0	8.3	0.0	49.9	0.0	45.0	33.7	72.3	0.0	24.2	0.0	45.9	25.6	LCH	72.3	IACS-9571 (hydrochloride)	IACS-9571 (ASIS-P040) hydrochloride is a potent and selective inhibitor of TRIM24 and BRPF1, with an IC50 of 8 nM for TRIM24, and Kds of 31 nM and 14 nM for TRIM24 and BRPF1, respectively.	False	CCCOc1cc(OCCCCN(C)C)cc(Oc2cc3c(cc2NS(=O)(=O)c2ccc(OC)c(OC)c2)n(C)c(=O)n3C)c1
246435	246435:02:03_02.00	True	2.0	104	12.6	0.0	0.0	71.8	0.0	72.0	17.9	91.7	27.6	39.8	0.0	61.8	48.1	LCH	91.7	Amodiaquine (dihydrochloride dihydrate)	Amodiaquine dihydrochloride dihydrate (Amodiaquin dihydrochloride dihydrate), a 4-aminoquinoline class of antimalarial agent, is a potent and orally active histamine N-methyltransferase inhibitor. Amodiaquine dihydrochloride dihydrate is also a Nurr1 agonist and specifically binds to Nurr1-LBD (ligand binding domain) with an EC50 of ~20 uM. Anti-inflammatory effect.	False	CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O
410891	410891:01:03_02.00	True	2.0	70	36.1	53.1	15.5	0.0	96.8	0.0	0.0	0.0	0.0	0.0	76.1	0.0	0.0	DNA_Synth	96.8	Valrubicin	Valrubicin is a chemotherapy agent, inhibits TPA- and PDBu-induced PKC activation with IC50s of 0.85 and 1.25 uM, respectively, and has antitumor and antiinflammatory activity.	False	CCCCC(=O)OCC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O2)C1)C(=O)c1c(OC)cccc1C3=O
409856	409856:02:03_02.00	True	2.0	98	45.6	0.0	0.0	64.3	0.0	62.0	4.2	93.4	22.7	24.2	0.0	57.2	21.4	LCH	93.4	GSK343	GSK343 is a highly potent and selective EZH2 inhibitor with an IC50 of 4 nM.	False	CCCc1cc(C)nc(O)c1CNC(=O)c1cc(-c2ccnc(N3CCN(C)CC3)c2)cc2c1cnn2C(C)C
411008	411008:01:03_02.00	True	2.0	109	18.8	26.7	0.0	58.6	0.0	52.2	21.2	49.1	30.8	37.8	0.0	48.6	60.1	Uncoupler	60.1	A-485	A-485 is a potent and selective catalytic inhibitor of p300/CBP with IC50s of 9.8nM and 2.6nM for p300 and CBP histone acetyltransferase (HAT), respectively.	False	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O
410897	410897:01:03_02.00	True	2.0	62	74.6	0.0	0.0	81.2	0.0	88.0	43.2	71.4	57.2	69.0	0.0	91.1	48.9	Tubulin	91.1	GSK484	GSK484 is a peptidylarginine deiminase 4 (PAD4) inhibitor. GSK484 demonstrates high affinity binding to PAD4 with IC50s of 50 nM in the absence of Calcium. In the presence of 2 mM Calcium, notably lower potency (250 nM) is observed.	False	COc1cc(C(=O)N2CC[C@@H](O)[C@@H](N)C2)cc2nc(-c3cc4ccccc4n3CC3CC3)n(C)c12
410909	410909:01:03_02.00	True	2.0	105	40.6	0.0	0.0	95.2	0.0	87.7	0.0	81.1	51.4	67.9	0.0	82.4	70.6	BET	95.2	Molibresib (besylate)	Molibresib besylate (GSK 525762C; I-BET 762 besylate) is a BET bromodomain inhibitor with IC50 of 32.5-42.5 nM.	False	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21
410786	410786:01:03_02.00	True	2.0	69	61.8	0.0	0.0	38.5	3.9	30.6	2.1	53.3	18.2	6.4	0.0	45.7	27.7	LCH	53.3	CGP60474	CGP60474, a highly potent anti-endotoxemic agent, is a potent cyclin-dependent kinase (CDK) inhibitor (IC50 values are 26, 3, 4, 216, 10, 200 and 13 nM for CDK1/B, CDK2/E, CDK2/A, CDK4/D, CDK5/p25, CDK7/H and CDK9/T, respectively). CGP60474 is a selective and ATP-competitive PKC inhibitor.	False	OCCCNc1cc(-c2ccnc(Nc3cccc(Cl)c3)n2)ccn1
246688	246688:08:03_02.00	True	2.0	76	53.5	0.0	0.0	86.5	0.0	98.8	18.2	67.7	66.3	67.1	0.0	76.7	61.7	HDAC	98.8	Vorinostat	Vorinostat (SAHA) is a potent and orally active pan-inhibitor of HDAC1, HDAC2 and HDAC3 (Class I), HDAC7 (Class II) and HDAC11 (Class IV), with ID50 values of 10 nM and 20 nM for HDAC1 and HDAC3, respectively. Vorinostat induces cell apoptosis. Vorinostat is also an effective inhibitor of human papillomaviruse (HPV)-18 DNA amplification.; Bradner et al., Chemical Phylogenetics of Histone Deacetylases. Nat. Chem. Biol. 6, 238-43 (2010).	False	O=C(CCCCCCC(=O)Nc1ccccc1)NO
410954	410954:01:03_02.00	True	2.0	96	32.3	0.0	0.0	94.7	0.0	89.5	0.0	78.5	62.5	59.4	0.0	85.4	65.5	BET	94.7	(S)-JQ-35	(S)-JQ-35 (TEN-010) is an inhibitor of the Bromodomain and Extra-Terminal (BET) family bromodomain-containing proteins with potential antineoplastic activity.	False	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)NCCCN1CCN(C)CC1)c1nnc(C)n1-2
410793	410793:01:03_02.00	True	2.0	104	6.2	0.0	0.0	80.4	0.0	73.4	9.2	62.9	39.5	41.9	0.0	62.4	59.3	BET	80.4	Tranylcypromine (hemisulfate)	Tranylcypromine hemisulfate is an irreversible, nonselective MAO inhibitor used in the treatment of depression.	False	N[C@@H]1C[C@H]1c1ccccc1
392522	392522:03:05_02.00	True	2.0	68	47.3	0.0	91.1	0.0	28.6	0.0	18.1	0.0	0.0	0.0	21.2	0.0	0.0	Aurora	91.1	SNS-314	SNS-314 is a potent and selective aurora kinase inhibitor with IC50s of 9, 31, and 6 nM for aurora A, B and C, respectively.	False	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCNc2ncnc3ccsc23)s1
392515	392515:02:03_02.00	True	2.0	65	43.4	0.0	75.6	26.5	0.0	37.0	2.0	25.1	15.0	39.6	0.0	43.7	0.0	Aurora	75.6	Alisertib	Alisertib (MLN 8237) is an orally active and selective Aurora A kinase inhibitor (IC50=1.2 nM), which binds to Aurora A kinase resulting in mitotic spindle abnormalities, mitotic accumulation. Alisertib (MLN 8237) induces apoptosis and autophagy through targeting the AKT/mTOR/AMPK/p38 pathway in leukemic cells. Antitumor activity.	False	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O
410983	410983:01:03_02.00	True	2.0	106	14.0	53.0	0.0	11.0	25.9	6.7	32.3	48.6	0.0	0.0	15.7	13.0	21.9	AKT_PI3K_MTOR	53.0	LXS196	LXS196 is a potent, selective and orally active protein kinase C (PKC) inhibitor, with IC50 values of 1.9 nM, 0.4 nM and 3.1 uM for PKC.a., PKC.q. and GSK3.b., respectively. LXS196 has the potential for uveal melanoma research.	False	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3ncccc3C(F)(F)F)cnc2N)CC1
410830	410830:01:03_02.00	True	2.0	80	25.6	44.4	34.4	0.0	92.8	0.0	14.9	0.0	0.0	0.0	81.2	0.0	0.0	DNA_Synth	92.8	Talazoparib tosylate	Talazoparib tosylate (BMN 673ts) is a novel, potent and orally available PARP1/2 inhibitor with an IC50 of 0.57 nM for PARP1.	False	Cn1ncnc1[C@H]1c2n[nH]c(=O)c3cc(F)cc(c23)N[C@@H]1c1ccc(F)cc1
410822	410822:01:05_02.00	True	2.0	93	36.4	40.1	0.0	53.9	0.0	55.5	32.9	72.2	15.1	49.1	0.0	52.8	69.5	LCH	72.2	Phorbol 12-myristate 13-acetate	Phorbol 12-myristate 13-acetate (PMA), a phorbol ester, is a dual SphK and protein kinase C (PKC) activator. Phorbol 12-myristate 13-acetate induces differentiation in THP-1 cells.	False	CCCCCCCCCCCCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(C)=O
410946	410946:01:03_02.00	True	2.0	105	53.9	0.0	0.0	98.0	0.0	91.7	0.0	82.5	59.4	68.5	0.0	85.6	68.4	BET	98.0	INCB054329	INCB054329 is a potent BET inhibitor.	False	Cc1noc(C)c1-c1ccc2nc(O)n3c2c1OC[C@@H]3c1ccccn1
410910	410910:01:03_02.00	True	2.0	99	14.3	49.9	7.8	0.0	48.9	0.0	37.6	7.5	0.0	0.0	51.9	0.0	0.0	Pyrimidine_Synth	51.9	ACY-957	ACY-957 is an orally active and selective inhibitor of HDAC1 and HDAC2, with IC50s of 7 nM, 18 nM, and 1300 nM against HDAC1/2/3, respectively, and shows no inhibition on HDAC4/5/6/7/8/9.	False	Nc1ccc(-c2cccs2)cc1NC(=O)c1ccc2nc(N3CCNCC3)ccc2c1
410817	410817:01:03_02.00	True	2.0	89	21.4	0.0	21.6	0.0	0.0	0.0	16.7	0.0	11.5	0.0	29.4	0.0	0.0	Pyrimidine_Synth	29.4	SR-4370	SR-4370 is an inhibitor of HDAC, with IC50s of 0.13 µM, 0.58 µM, 0.006 µM, 2.3 µM, and 3.4 µM for HDAC1, HDAC2, HDAC3, HDAC8, and HDAC6, respectively.	False	CCCCNNC(=O)c1ccc(-c2cccc(F)c2F)cc1
410937	410937:01:03_02.00	True	2.0	92	29.2	11.6	0.0	31.7	19.6	16.8	30.4	53.9	0.0	15.4	0.0	52.0	23.6	LCH	53.9	PF-06700841 (P-Tosylate)	PF-06700841 P-Tosylate is a potent dual  Janus kinase 1 (JAK1) and TYK2 inhibitor with IC50s of 17 nM and 23 nM, respectively. PF-06700841 P-Tosylate also inhibits JAK2 and JAK3 with IC50s of 77 nM and 6.49 uM, respectively.	False	Cn1cc(Nc2nccc(N3CC4CCC(C3)N4C(=O)[C@@H]3CC3(F)F)n2)cn1
407753	407753:03:03_02.00	True	2.0	87	29.7	47.2	18.7	0.0	95.7	0.0	0.0	0.0	0.0	0.0	80.4	0.0	0.0	DNA_Synth	95.7	SP2509	SP2509 is a potent and selective antagonist of lysine specific demethylase 1 (LSD1) with IC50 of 13 nM.	False	C/C(=N\NC(=O)c1cccc(S(=O)(=O)N2CCOCC2)c1)c1cc(Cl)ccc1O
392665	392665:02:03_02.00	True	2.0	94	24.2	34.8	0.0	39.9	0.0	40.1	32.8	80.4	0.0	20.0	0.0	38.9	37.2	LCH	80.4	CEP-33779	CEP-33779 is a novel, selective, and orally bioavailable inhibitor of JAK2 with an IC50 of 1.8±0.6 nM.	False	CN1CCN(c2cccc(Nc3nc4c(-c5ccc(S(C)(=O)=O)cc5)cccn4n3)c2)CC1
392785	392785:02:03_02.00	True	2.0	109	7.4	27.1	18.7	0.0	65.0	0.0	1.6	0.0	0.0	0.0	62.7	0.0	0.0	DNA_Synth	65.0	Sotrastaurin	Sotrastaurin (AEB071) is a potent and orally-active pan-PKC inhibitor, with Kis of 0.22 nM, 0.64 nM, 0.95 nM, 1.8 nM, 2.1 nM and 3.2 nM for PKC.q., PKC.b., PKC.a., PKC.h., PKC.d. and PKC.e., respectively.	False	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1
410784	410784:01:03_02.00	True	2.0	70	32.3	0.0	95.7	0.0	15.8	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	Aurora	95.7	Barasertib	Barasertib (AZD1152), a pro-drug of Barasertib-hQPA, is a highly selective Aurora B inhibitor with an IC50 of 0.37 nM in a cell-free assay. Barasertib (AZD1152) induces growth arrest and apoptosis in cancer cells.	False	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O
410867	410867:01:03_02.00	True	2.0	92	19.3	0.0	14.8	7.7	0.0	40.6	14.0	0.0	32.4	2.9	0.0	0.0	1.9	HDAC	40.6	CXD101	CXD101 is a potent, selective and orally active class I HDAC inhibitor with IC50s of 63 nM, 570 nM and 550 nM for HDAC1, HDAC2 and HDAC3, respectively. CXD101 has no activity against HDAC class II. CXD101 has antitumor activity.	False	Cc1nn(C)cc1CN1CCC(c2ccc(C(=O)Nc3ccccc3N)cc2)CC1
392744	392744:02:03_02.00	True	2.0	84	10.5	0.0	53.5	0.0	40.1	0.0	7.9	1.6	0.0	0.0	3.6	33.6	0.0	Aurora	53.5	MK-8745	MK-8745 is an aurora A kinase inhibitor with an IC50 of 0.6 nM.	False	O=C(c1cccc(Cl)c1F)N1CCN(Cc2cccc(Nc3nccs3)n2)CC1
410799	410799:01:03_02.00	True	2.0	56	51.8	59.0	0.0	0.0	81.1	0.0	20.8	2.9	0.0	0.0	54.6	1.9	6.5	DNA_Synth	81.1	Doxorubicin (hydrochloride)	Doxorubicin (Hydroxydaunorubicin) hydrochloride, a cytotoxic anthracycline antibiotic, is an anti-cancer chemotherapy agent. Doxorubicin hydrochloride is a potent human DNA topoisomerase I and topoisomerase II inhibitor with IC50s of 0.8 uM and 2.67 uM, respectively. Doxorubicin hydrochloride reduces basal phosphorylation of AMPK and its downstream target acetyl-CoA carboxylase. Doxorubicin hydrochloride induces apoptosis and autophagy.	False	COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1
410996	410996:01:03_02.00	True	2.0	92	11.4	32.7	0.0	30.9	9.9	34.1	43.4	60.1	0.0	27.1	0.0	34.3	35.1	LCH	60.1	HDAC8-IN-1	HDAC8-IN-1 is a HDAC8 inhibitor with an IC50 of 27.2 nM.	False	COc1ccc(/C=C/C(=O)NO)c(-c2ccc(-c3ccccc3)cc2)c1
409860	409860:03:03_02.00	True	2.0	103	25.0	0.0	0.0	64.9	0.0	61.5	0.0	92.4	22.3	29.6	0.0	58.6	29.0	LCH	92.4	UNC0642	UNC0642 is a potent and selective lysine methyltransferases G9a and GLP inhibitor, with an IC50 of <2.5 nM for G9a.	False	COc1cc2c(NC3CCN(C(C)C)CC3)nc(N3CCC(F)(F)CC3)nc2cc1OCCCN1CCCC1
410841	410841:01:03_02.00	True	2.0	52	82.2	0.0	0.0	85.2	0.0	87.6	27.1	75.9	52.3	70.1	0.0	80.4	67.0	HDAC	87.6	HDAC6-IN-1	HDAC6-IN-1 is a potent and selective inhibitor for HDAC6 with an IC50 of 17 nM and shows 25-fold and 200-fold selectivity relative to HDAC1 (IC50=422 nM) and HDAC8 (IC50=3398 nM), respectively.	False	COc1ccc(N(C)c2nc(C)nc3ccccc23)cc1OCCCC(=O)NO
409914	409914:02:03_02.00	True	2.0	95	18.5	0.0	0.0	52.3	0.0	54.9	34.6	64.6	23.2	29.1	0.0	60.0	14.7	LCH	64.6	AZ6102	AZ6102 is a potent dual TNKS1 and TNKS2 inhibitor, with IC50s of 3 nM and 1 nM, respectively, and alao has 100-fold selectivity against other PARP family enzymes, with IC50s of 2.0 uM, 0.5 uM, and >3 uM, for PARP1, PARP2, and PARP6, respectively.	True	Cc1cc(N2C[C@H](C)N[C@H](C)C2)ncc1-c1ccc(-c2nc(O)c3ccn(C)c3n2)cc1
410856	410856:01:03_02.00	True	2.0	72	56.5	0.0	0.0	83.9	0.0	98.9	23.6	70.5	66.1	67.6	0.0	75.3	59.1	HDAC	98.9	HDAC-IN-3	HDAC-IN-3 is a histone deacetylase (HDAC) inhibitor, extracted from patent WO/2008040934 A1.Target: HDAC	False	O=C(CCc1ccc(CN[C@H](C(=O)OC2CCCC2)C2CCCCC2)cn1)NO
410106	410106:02:03_02.00	True	2.0	96	9.8	0.0	3.8	63.3	0.0	63.2	0.0	60.7	40.6	49.3	0.0	68.6	24.7	Tubulin	68.6	MS023	MS023 is a potent, selective, and cell-active inhibitor of human type I protein arginine methyltransferases (PRMTs) inhibitor, with IC50s of 30, 119, 83, 4 and 5 nM for PRMT1, PRMT3, PRMT4, PRMT6, and PRMT8, respectively.	False	CC(C)Oc1ccc(-c2c[nH]cc2CN(C)CCN)cc1
407972	407972:02:03_02.00	True	2.0	90	7.1	66.2	0.0	0.0	72.8	0.0	47.5	0.0	0.0	0.0	69.2	0.0	0.0	DNA_Synth	72.8	FM-381	FM-381 is a potent covalent reversible inhibitor of JAK3 targeting the unique Cys909. FM-381 has an IC50 of 127 pM for JAK3, with 410, 2700 and 3600-fold selectivity over JAK1, JAK2 and TYK2, respectively.	False	CN(C)C(=O)/C(C#N)=C/c1ccc(-c2nc3cnc4[nH]ccc4c3n2C2CCCCC2)o1
410993	410993:01:03_02.00	True	2.0	98	6.6	73.5	0.0	0.0	29.4	0.0	54.4	7.8	0.0	3.5	24.8	11.7	39.9	AKT_PI3K_MTOR	73.5	IOX1	IOX1, 5-Carboxy-8-hydroxyquinoline, is a potent broad¿spectrum inhibitor of 2OG oxygenases, including the JmjC demethylases. IOX1 inhibits KDM4C, KDM4E, KDM2A, KDM3A and KDM6B with IC50 values of 0.6 µM, 2.3 µM, 1.8 µM, 0.1 µM and 1.4 µM, respectively.	False	O=C(O)c1ccc(O)c2ncccc12
410886	410886:01:03_02.00	True	2.0	60	39.6	20.5	4.7	27.1	0.0	44.0	55.3	28.5	19.6	49.9	0.0	38.5	27.6	HSP90	55.3	Midostaurin	Midostaurin (PKC412; CGP 41251) is a multi-targeted protein kinase inhibitor which inhibits PKC.a./.b./.g., Syk, Flk-1, Akt, PKA, c-Kit, c-Fgr, c-Src, FLT3, PDFR.b. and VEGFR1/2 with IC50s ranging from 22-500 nM.	False	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4
410995	410995:01:03_02.00	True	2.0	100	19.2	0.0	0.0	87.6	0.0	86.2	31.4	73.5	55.2	71.7	0.0	82.1	72.3	BET	87.6	GNE-272	GNE-272 is a potent and selective CBP/EP300 inhibitor with IC50 values of 0.02, 0.03 and 13 uM for CBP, EP300 and BRD4, respectively. GNE-272 is also a selective in vivo probe for CBP/EP300.	False	CC(=O)N1CCc2c(c(Nc3ccc(-c4cnn(C)c4)cc3F)nn2[C@H]2CCOC2)C1
410949	410949:01:03_02.00	True	2.0	97	8.5	73.4	0.0	0.0	83.5	0.0	19.7	0.0	0.0	0.0	63.8	0.0	13.0	DNA_Synth	83.5	WM-1119	WM-1119 is a highly potent and selective KAT6A inhibitor, with an IC50 of 0.25 uM for KAT6A in lymphoma cells, the binding KD values of WM-1119 with KAT6A, KAT5 and KAT7 are 2 nM, 2.2 uM, 0.5 uM , respectively.	False	O=C(NNS(=O)(=O)c1ccccc1F)c1cc(F)cc(-c2ccccn2)c1
410887	410887:01:03_02.00	True	2.0	96	6.0	0.0	0.0	62.7	0.0	62.9	41.2	77.9	7.0	49.8	0.0	70.9	46.3	LCH	77.9	DDP-38003 (trihydrochloride)	DDP-38003 trihydrochloride is an novel, orally available inhibitor of histone lysine-specific demethylase 1A (KDM1A/LSD1) with an IC50 of 84 nM.	False	CN1CCN(c2ccc(C(=O)Nc3ccc([C@@H]4C[C@H]4N)cc3)cc2)CC1
410978	410978:01:03_02.00	True	2.0	100	5.9	58.6	0.0	0.0	38.3	0.0	33.7	0.0	0.0	2.5	43.7	0.0	0.0	AKT_PI3K_MTOR	58.6	Delgocitinib	Delgocitinib is a novel and specific JAK inhibitor with IC50s of 2.8, 2.6, 13 and 58 nM for JAK1, JAK2, JAK3 and Tyk2, respectively.	False	C[C@H]1CN(C(=O)CC#N)[C@]12CCN(c1ncnc3[nH]ccc13)C2
410837	410837:01:03_02.00	True	2.0	100	53.5	0.0	0.0	97.1	0.0	92.9	0.0	78.1	61.9	64.3	0.0	79.7	68.8	BET	97.1	GSK1324726A	GSK1324726A is a novel, potent, and selective inhibitor of BET proteins with high affinity to BRD2 (IC50=41 nM), BRD3 (IC50=31 nM), and BRD4 (IC50=22 nM).	False	CC(=O)N1c2ccc(-c3ccc(C(=O)O)cc3)cc2[C@H](Nc2ccc(Cl)cc2)C[C@@H]1C
410904	410904:01:03_02.00	True	2.0	93	32.6	54.4	0.0	0.0	93.5	0.0	0.0	0.0	0.0	0.0	70.7	0.0	0.0	DNA_Synth	93.5	NCGC00247743	NCGC00247743 is a histone lysine demethylase KDM4 inhibitor.	False	CN(C)CCCCCCNC(=O)c1cccc(-c2cc(O)c3ncccc3c2)c1
410989	410989:01:03_02.00	True	2.0	84	80.8	0.0	0.0	85.7	0.0	83.7	19.2	82.4	52.3	73.8	0.0	87.1	60.7	Tubulin	87.1	TPPB	TPPB is a cell-permeable benzolactam-derived protein kinase C (PKC) activator with a Ki of 11.9 nM.	False	CC(C)[C@H]1C(=O)N[C@H](CO)Cc2cc(NC(=O)/C=C/C=C/c3ccc(C(F)(F)F)cc3)ccc2N1C
409849	409849:02:03_02.00	True	2.0	98	73.9	0.0	0.0	71.3	0.0	67.7	0.0	88.0	30.9	34.5	0.0	63.4	32.4	LCH	88.0	UNC0638	UNC0638 selectively inhibits G9a and GLP histone methyltransferase activity with IC50s of less than 15 nM and 19 nM, respectively. UNC0638 has anti-FMDV (foot-and-mouth disease virus) and anti-VSV (vesicular stomatitis virus) activities.	False	COc1cc2c(NC3CCN(C(C)C)CC3)nc(C3CCCCC3)nc2cc1OCCCN1CCCC1
411007	411007:01:03_02.00	True	2.0	103	60.4	0.0	0.0	97.3	0.0	93.0	0.0	79.9	63.4	72.1	0.0	83.5	65.1	BET	97.3	INCB-057643	INCB-057643 is a novel, orally bioavailable BET inhibitor.	False	CN1C(=O)C(C)(C)Oc2c(-c3cn(C)c(O)c4nccc3-4)cc(S(C)(=O)=O)cc21
410933	410933:01:03_02.00	True	2.0	100	18.1	87.0	0.0	0.0	63.4	0.0	38.3	0.0	0.0	0.0	67.3	0.0	1.4	AKT_PI3K_MTOR	87.0	BRD 4354 (ditrifluoroacetate)	BRD 4354 (ditrifluoroacetate) is a moderately potent inhibitor of HDAC5 and HDAC9, with IC50s of 0.85 and 1.88 µM, respectively.	False	CCN1CCN(C(c2cccnc2)c2cc(Cl)c3cccnc3c2O)CC1
392507	392507:02:03_02.00	True	2.0	56	82.7	0.0	7.7	81.5	0.0	86.9	11.3	75.7	55.4	65.4	0.0	78.1	35.9	HDAC	86.9	BI 2536	BI 2536 is a dual PLK1 and BRD4 inhibitor with IC50s of 0.83 and 25 nM, respectively. BI-2536 suppresses IFNB (encoding IFN-.b.) gene transcription.	False	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1
392531	392531:02:03_02.00	True	2.0	82	62.7	0.0	0.0	86.8	0.0	97.4	28.5	69.6	61.2	63.8	0.0	75.6	59.3	HDAC	97.4	CUDC-101	CUDC-101 is a potent inhibitor of HDAC, EGFR, and HER2 with IC50s of 4.4, 2.4, and 15.7 nM, respectively.	False	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1
410947	410947:01:03_02.00	True	2.0	93	54.9	0.0	0.0	97.8	0.0	93.8	0.0	79.3	63.9	64.6	0.0	81.9	66.0	BET	97.8	(+)-JQ1 PA	(+)-JQ1 PA is a derivative of the Bromodomain and extra-terminal (BET) inhibitor JQ1, with an IC50 of 10.4 nM.	False	C#CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2c(sc(C)c2C)-n2c(C)nnc21
410990	410990:01:03_02.00	True	2.0	80	55.4	0.0	0.0	88.1	0.0	98.4	22.5	70.2	63.1	67.4	0.0	79.2	60.4	HDAC	98.4	LMK-235	LMK-235 is a potent and selective HDAC4/5 inhibitor, inhibits HDAC5, HDAC4, HDAC6, HDAC1, HDAC2, HDAC11 and HDAC8, with IC50s of 4.22 nM, 11.9 nM, 55.7 nM, 320 nM, 881 nM, 852 nM and 1278 nM, respectively, and is used in cancer research.	False	Cc1cc(C)cc(C(=O)NOCCCCCC(=O)NO)c1
410881	410881:01:03_02.00	True	2.0	67	33.3	0.0	86.6	0.0	0.0	0.4	3.2	0.0	9.4	4.2	0.0	23.8	0.0	Aurora	86.6	SAR-20347	SAR-20347 is an inhibitor of TYK2, JAK1, JAK2 and JAK3 with IC50s of 0.6, 23, 26 and 41 nM, respectively.	False	NC(=O)c1nc(-c2c(F)cccc2Cl)oc1Nc1ccc(C(=O)N2CCOCC2)cc1
410828	410828:01:03_02.00	True	2.0	84	14.5	20.4	51.2	0.0	79.4	0.0	27.7	0.0	0.0	0.0	65.3	0.0	0.0	DNA_Synth	79.4	Niraparib (tosylate)	Niraparib tosylate (MK-4827 tosylate) is a highly potent and orally bioavailable PARP1 and PARP2 inhibitor with an IC50 of 3.8 and 2.1 nM, respectively. Niraparib tosylate leads to inhibition of repair of DNA damage, activates apoptosis and shows anti-tumor activity.	False	NC(=O)c1cccc2cn(-c3ccc([C@@H]4CCCNC4)cc3)nc12
410985	410985:01:03_02.00	True	2.0	94	54.2	0.0	0.0	81.9	0.0	77.7	4.2	81.4	47.8	72.7	0.0	77.3	72.7	BET	81.9	(-)-Indolactam V	(-)-Indolactam V is a PKC activator, with Kis of 3.36 nM, 1.03 µM for ¿-CRD2 (PKC¿ surrogate peptide), .g.-CRD2 (PKC.g. surrogate peptide), and Kds of 5.5 nM (¿-C1B), 7.7 nM (¿-C1B), 8.3 nM (.d.-C1B), 18.9 nM (.b.-C1A-long), 20.8 nM (.a.-C1A-long), 137 nM (.b.-C1B), 138 nM (.g.-C1A), 213 nM (.g.-C1B), and has antitumor activity.	False	CC(C)[C@H]1C(=O)N[C@H](CO)Cc2c[nH]c3cccc(c23)N1C
410839	410839:01:03_02.00	True	2.0	102	27.8	75.7	0.0	0.0	61.3	0.0	28.7	35.3	0.0	0.0	35.6	0.0	22.9	AKT_PI3K_MTOR	75.7	VTX-27	VTX-27 is a selective protein kinase C .q. (PKC .q.) inhibitor, with Kis of 0.08 nM and 16 nM for PKC .q. and PKC .d..	False	CC(C)[C@@](C)(O)[C@@H]1CN(c2nc(-c3[nH]nc4ncccc34)c(F)cc2Cl)CCN1
410979	410979:01:03_02.00	True	2.0	84	17.8	0.0	47.8	24.8	31.9	21.7	1.4	30.9	0.0	13.9	0.0	56.3	1.3	Tubulin	56.3	LY3295668	LY3295668 (AK-01) is a potent, orally active and highly specific Aurora-A kinase inhibitor, with Ki values of 0.8 nM and 1038 nM for AurA and AurB, respectively.	False	Cc1cc(Nc2ccc(F)c(C[C@@]3(C(=O)O)CCN(Cc4cccc(Cl)c4F)[C@H](C)C3)n2)n[nH]1
410896	410896:01:03_02.00	True	2.0	102	44.2	0.0	0.0	97.0	0.0	91.9	0.0	81.6	61.6	59.9	0.0	83.5	62.4	BET	97.0	BCI-121	BCI-121 is a SMYD3 inhibitor that impairs the proliferation of cancer cell.	False	NC(=O)C1CCN(CC(=O)Nc2ccc(Br)cc2)CC1
410941	410941:01:03_02.00	True	2.0	108	57.0	0.0	0.0	96.8	0.0	91.0	0.0	84.8	57.4	61.2	0.0	82.5	61.8	BET	96.8	BET bromodomain inhibitor	BET bromodomain inhibitor is a potent BET inhibitor extracted from patent WO/2015/153871A2, compound example 11.	False	Cc1noc2c1-c1ccc(-c3cnn(C)c3)cc1C(c1ccc(Cl)cc1)=N[C@H]2CC(N)=O
410846	410846:01:03_02.00	True	2.0	97	67.0	0.0	0.0	85.9	0.0	83.1	0.0	91.3	50.1	56.1	0.0	73.9	48.7	LCH	91.3	Tenovin-6	Tenovin-6, an analog of Tenovin-1 (HY-13423), is an activator of p53 transcriptional activity. Tenovin-6 inhibits the protein deacetylase activities of purified human SIRT1, SIRT2, and SIRT3 with IC50s of 21 uM, 10 uM, and 67 uM, respectively. Tenovin-6 also inhibits dihydroorotate dehydrogenase (DHODH).	False	CN(C)CCCCC(=O)Nc1ccc(NC(=S)NC(=O)c2ccc(C(C)(C)C)cc2)cc1
410871	410871:01:03_02.00	True	2.0	95	78.1	0.0	0.0	85.1	0.0	79.1	26.5	74.4	44.0	74.7	0.0	86.1	49.8	Tubulin	86.1	Ilginatinib	Ilginatinib (NS-018) is a highly active and orally bioavailable JAK2 inhibitor, with an IC50 of 0.72 nM, 46-, 54-, and 31-fold selectivity for JAK2 over JAK1 (IC50, 33 nM), JAK3 (IC50, 39 nM), and Tyk2 (IC50, 22 nM).	False	C[C@H](Nc1cc(-c2cnn(C)c2)cc(Nc2cnccn2)n1)c1ccc(F)cc1
410034	410034:02:03_02.00	True	2.0	98	33.5	0.0	0.0	68.3	0.0	65.0	31.2	66.4	20.3	59.9	0.0	68.5	48.7	Tubulin	68.5	NVP-TNKS656	NVP-TNKS656 is a highly potent, selective, and orally active TNKS2 inhibitor with IC50 of 6 nM, and is > 300 fold selectivity against PARP1 and PARP2.	False	COc1ccc(C(=O)C2CCN(CC(=O)N(Cc3nc(O)c4c(n3)CCOC4)CC3CC3)CC2)cc1
410811	410811:01:03_02.00	True	2.0	78	52.3	0.0	0.0	87.9	0.0	97.7	17.9	70.3	66.2	62.3	0.0	79.4	57.2	HDAC	97.7	Scriptaid	Scriptaid is a potent histone deacetylase (HDAC) inhibitor, used in cancer research. Scriptaid is also a sensitizer to antivirals and has potential for epstein-barr virus (EBV)-associated lymphomas treatment.	False	O=C(CCCCCN1C(=O)c2cccc3cccc(c23)C1=O)NO
410833	410833:01:03_02.00	True	2.0	106	23.0	72.3	0.0	0.0	60.6	0.0	31.1	0.0	0.0	0.0	53.1	0.0	0.0	AKT_PI3K_MTOR	72.3	Peficitinib	Peficitinib is an oral JAK inhibitor, with IC50s of 3.9, 5.0, 0.7 and 4.8 nM for JAK1, JAK2, JAK3 and Tyk2, respectively.	False	NC(=O)c1cnc2[nH]ccc2c1N[C@H]1[C@H]2C[C@H]3C[C@@H]1C[C@](O)(C3)C2
409870	409870:02:03_02.00	True	2.0	74	53.0	0.0	0.0	57.4	0.0	56.5	27.7	70.3	32.2	42.9	0.0	68.4	29.9	LCH	70.3	Tazemetostat	Tazemetostat (EPZ-6438) is a potent, selective and orally available EZH2 inhibitor. Tazemetostat (EPZ-6438) inhibits the activity of human polycomb repressive complex 2 (PRC2)-containing wild-type EZH2 with a Ki value of 2.5 nM. Tazemetostat (EPZ-6438) inhibits EZH2 with IC50s of 11 and 16 nM in peptide assay and nucleosome assay, respectively. Tazemetostat (EPZ-6438) inhibits rat EZH2 with an IC50 of 4 nM. Tazemetostat (EPZ-6438) also inhibits EZH1 with an IC50 of 392 nM.	False	CCN(c1cc(-c2ccc(CN3CCOCC3)cc2)cc(C(=O)NCc2c(C)cc(C)nc2O)c1C)C1CCOCC1
410944	410944:01:03_02.00	True	2.0	96	5.9	12.2	0.0	41.9	0.0	34.1	0.4	15.4	27.2	29.3	0.0	25.6	42.9	Uncoupler	42.9	GNE-049	GNE-049 is a highly potent and selective CBP inhibitor with an IC50 of 1.1 nM in TR-FRET assay. GNE-049 also inhibits BRET and BRD4(1) with IC50s of 12 nM and 4200 nM, respectively.	False	CC(=O)N1CCc2c(c(N3CCCc4cc(-c5cnn(C)c5)c(C(F)F)cc43)nn2C2CCOCC2)C1
392587	392587:02:03_02.00	True	2.0	61	64.4	0.0	40.2	40.4	0.0	56.9	62.8	46.1	19.3	54.6	0.0	65.2	23.9	Tubulin	65.2	AZ960	AZ960 is a potent and specific inhibitor of the JAK2 kinase with a Ki of 0.45 nM.	False	Cc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cc3)c(C#N)cc2F)n[nH]1
410957	410957:01:03_02.00	True	2.0	76	47.3	0.0	0.0	79.7	0.0	72.9	0.0	85.5	49.0	43.4	0.0	74.7	48.7	LCH	85.5	BETd-246	BETd-246 is a second-generation BET bromodomain (BRD) inhibitor, exhibiting superior selectivity, potency and antitumor activity.	False	CCn1nc(C2CC2)cc1Nc1nc(C(=O)NCCCOCCOCCOCCCNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)nc2[nH]c3cc(-c4c(C)noc4C)c(OC)cc3c12
382124	382124:04:03_02.00	True	2.0	75	12.1	10.3	0.0	48.0	0.0	57.7	47.2	50.6	47.5	23.6	0.0	57.2	54.3	HDAC	57.7	A-769662	A-769662 is a potent, reversible AMPK activator with EC50 of 0.8 uM.	False	N#Cc1c(O)nc2scc(-c3ccc(-c4ccccc4O)cc3)c2c1O
392546	392546:02:03_02.00	True	2.0	84	13.8	0.0	62.6	20.4	0.0	21.3	37.7	13.4	15.5	18.3	0.0	57.0	0.0	Aurora	62.6	PHA-680632	PHA-680632 is an aurora kinase inhibitor with IC50s of 27, 135 and 120 nM for aurora A, B and C, respectively.	False	CCc1cccc(CC)c1NC(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1
409912	409912:02:03_02.00	True	2.0	80	13.8	10.0	64.4	0.0	73.4	0.0	11.8	0.0	0.0	0.0	64.8	0.0	0.0	DNA_Synth	73.4	BAY-299	BAY-299 is a very potent, dual inhibitor with IC50s of 67 nM for BRPF2 bromodomains (BD), 8 nM for TAF1 BD2, and 106 nM for TAF1L BD2.	False	Cc1cc2c(cc1N1C(=O)c3cccc4c(CCCO)ccc(c34)C1=O)n(C)c(=O)n2C
410851	410851:01:03_02.00	True	2.0	98	56.1	0.0	0.0	97.9	0.0	92.8	0.0	82.9	60.1	67.9	0.0	85.7	66.7	BET	97.9	I-BET151	I-BET151 is a BET bromodomain inhibitor which inhibits BRD4, BRD2, and BRD3 with pIC50 of 6.1, 6.3, and 6.6, respectively.	False	COc1cc2c(cc1-c1c(C)noc1C)ncc1nc(O)n([C@H](C)c3ccccn3)c12
410936	410936:01:03_02.00	True	2.0	87	53.9	0.0	0.0	81.0	0.0	77.1	6.9	78.7	46.6	72.4	0.0	77.1	71.1	BET	81.0	MG 149	MG149 (Tip60 HAT inhibitor) is a selective and potent Tip60 inhibitor with IC50 of 74 uM, similar potentcy for MOF (IC50= 47 uM); little potent for PCAF and p300 (IC50 >200 uM).	False	CCCCCCCc1ccc(CCc2cccc(O)c2C(=O)O)cc1
410825	410825:01:03_02.00	True	2.0	90	70.3	0.0	0.0	92.7	0.0	86.2	0.0	85.5	56.6	62.1	0.0	85.7	63.7	BET	92.7	Birabresib	Birabresib (OTX-015) is a potent bromodomain (BRD2/3/4) inhibitor with IC50s ranging from 92 to 112 nM.	False	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)Nc1ccc(O)cc1)c1nnc(C)n1-2
410917	410917:01:03_02.00	True	2.0	100	38.9	0.0	0.0	68.1	0.0	65.1	0.0	92.3	28.4	33.8	0.0	63.1	31.3	LCH	92.3	UNC 0631	UNC 0631 is a potent histone methyltransferase G9a inhibitor with an IC50 of 4 nM. UNC 0631 potently reduces H3K9me2 levels in MDA-MB-231 cells with an IC50 of 25 nM.	False	COc1cc2c(NC3CCN(CC4CCCCC4)CC3)nc(N3CCCN(C(C)C)CC3)nc2cc1OCCCN1CCCCC1
410925	410925:01:03_02.00	True	2.0	90	75.1	0.0	0.0	92.8	0.0	87.5	3.3	84.9	56.2	67.4	0.0	83.9	53.6	BET	92.8	(Rac)-BAY1238097	(Rac)-BAY1238097 is a BET inhibitor, with an IC50 of 1.02 uM for BRD4. Used in cancer research.	False	CNC(=O)N1N=C(c2ccc(N3CCN(C)CC3)cc2)c2cc(OC)c(OC)cc2CC1C
410900	410900:01:03_02.00	True	2.0	92	60.6	0.0	0.0	96.7	0.0	91.1	0.0	84.7	57.7	64.2	0.0	83.9	61.8	BET	96.7	CPI-203	CPI-203 is a novel potent, selective and cell permeable inhibitor of BET bromodomain, with an IC50 value of appr 37 nM (BRD4 .a.-screen assay).	False	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(N)=O)c1nnc(C)n1-2
409831	409831:02:03_02.00	True	2.0	100	55.4	0.0	0.0	71.5	0.0	71.2	8.8	93.0	32.2	38.0	0.0	62.8	26.5	LCH	93.0	JQEZ5	JQEZ5 is a potent and selective EZH2 lysine methyltransferase inhibitor. JQEZ5 SAM-competitive inhibition of polycomb repressive complex 2 (PRC2) with an IC50 of 80 nM. JQEZ5 has anti-tumor effects.	False	CCCc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(-c2ccc(N3CCN(C)CC3)nc2)nc2c1cnn2C(C)C
410924	410924:01:03_02.00	True	2.0	64	46.1	0.7	0.0	44.9	14.8	38.5	0.0	70.8	14.0	2.2	0.0	45.8	22.3	LCH	70.8	ARV-771	ARV-771 is a potent BET degrader based on PROTAC technology with Kds of  34, 4.7, 8.3, 7.6, 9.6, and 7.6 nM for BRD2(1), BRD2(2), BRD3(1), BRD3(2), BRD4(1), and BRD4(2), respectively.	False	Cc1ncsc1-c1ccc([C@H](C)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)COCCCOCCNC(=O)C[C@@H]2N=C(c3ccc(Cl)cc3)c3c(sc(C)c3C)-n3c(C)nnc32)C(C)(C)C)cc1
392545	392545:02:03_02.00	True	2.0	93	56.1	0.0	0.0	65.8	0.0	63.0	14.4	93.0	19.6	34.0	0.0	63.3	41.9	LCH	93.0	TCS7010	TCS7010 is a potent and highly selective Aurora A inhibitor with with an IC50 of 3.4 nM.	False	CCN1CCN(C(=O)Cc2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC1
410882	410882:01:03_02.00	True	2.0	108	55.4	0.0	0.0	87.2	0.0	82.0	6.4	80.1	48.7	57.3	0.0	80.2	51.4	BET	87.2	Y06137	Y06137 is a potent and selective BET inhibitor for treatment of castration-resistant prostate cancer (CRPC). Y06137 binds to the BRD4(1) bromodomain with a Kd of 81 nM.	False	Cc1noc2ccc(-c3nc4ccc(N5CCOC[C@@H]5C)cc4n3CC3CCCCC3)cc12
410854	410854:01:03_02.00	True	2.0	94	7.8	0.0	14.9	0.0	0.0	0.0	11.8	0.0	9.4	0.0	8.8	0.0	0.0	Aurora	14.9	Pimelic Diphenylamide 106	Pimelic Diphenylamide 106 is a slow, tight-binding inhibitor of class I HDAC (HDAC 1, 2, and 3, with IC50 values of 150 nM , 760nM, and 370 nM, respectively), demonstrating no activity against class II HDACs.IC50 value: 150 nM (HDAC1), 370 nM (HDAC3), 760nM(HDAC2)Target: HDAC  in vitro: Pimelic Diphenylamide 106 has preference toward HDAC3 with Ki of  14 nM, 15 times lower than the Ki for HDAC1. Pimelic Diphenylamide 106 exhibits weaker inhibitory activities against HDAC 8 with IC50 of 5 uM after a 3-h preincubation with HDAC8.	False	Cc1ccc(NC(=O)CCCCCC(=O)Nc2ccccc2N)cc1
410852	410852:01:03_02.00	True	2.0	90	8.6	0.0	0.0	53.1	0.0	45.6	0.0	61.0	19.1	45.2	0.0	50.0	32.3	LCH	61.0	UNC0646	UNC0646 is a potent and selective histone methyltransferase G9a inhibitor with an IC50 of 6 nM. UNC0646 is also a potent GLP inhibitor (IC50 <15 nM) and highly selective for G9a/GLP over SETD7, SUV39H2, SETD8 and PRMT3. UNC0646 reduces H3K9me2 levels in MDA-MB-231 cells with an IC50 of 26 nM.	False	COc1cc2c(NC3CCN(C4CCCCC4)CC3)nc(N3CCCN(C(C)C)CC3)nc2cc1OCCCN1CCCCC1
410899	410899:01:03_02.00	True	2.0	84	35.6	53.1	13.6	0.0	96.9	0.0	0.0	0.0	0.0	0.0	78.9	0.0	0.0	DNA_Synth	96.9	AS8351	AS8351 is a KDM5B inhibitor, which can induce and sustain active chromatin marks to facilitate the induction of cardiomyocyte-like cells.	False	O=C(N/N=C/c1c(O)ccc2ccccc12)c1ccncc1
410885	410885:01:03_02.00	True	2.0	99	48.4	0.0	0.0	97.0	0.0	90.5	0.0	80.6	61.2	63.9	0.0	81.3	65.4	BET	97.0	BAY1238097	BAY1238097 is a potent and selective inhibitor of BET binding to histones and has strong anti-proliferative activity in different AML (acute myeloid leukemia) and MM (multiple myeloma) models through down-regulation of c-Myc levels and its downstream transcriptome (IC50 <100 nM).	False	CNC(=O)N1N=C(c2ccc(N3CCN(C)CC3)cc2)c2cc(OC)c(OC)cc2C[C@@H]1C
410974	410974:01:03_02.00	True	2.0	102	38.3	0.0	0.0	59.0	0.0	56.3	19.4	80.9	14.4	27.3	0.0	60.0	17.0	LCH	80.9	GSK126	GSK126 (GSK2816126A) is a potent, highly selective inhibitor of EZH2 methyltransferase with an IC50 of 9.9 nM.	False	CC[C@H](C)n1cc(C)c2c(C(=O)NCc3c(C)cc(C)nc3O)cc(-c3ccc(N4CCNCC4)nc3)cc21
411126	411126:01:05_01.00	True	1.0	99	31.6	54.6	0.0	0.0	33.9	0.0	23.9	12.8	0.0	0.0	29.8	0.0	0.2	AKT_PI3K_MTOR	54.6	Sunitinib	Sunitinib (SU 11248) is a multi-targeted receptor tyrosine kinase inhibitor with IC50s of 80 nM and 2 nM for VEGFR2 and PDGFR.b., respectively. Sunitinib, an ATP-competitive inhibitor, effectively inhibits autophosphorylation of Ire1.a. by inhibiting autophosphorylation and consequent RNase activation.	False	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C
392479	392479:02:04_01.00	True	1.0	89	15.9	0.0	1.1	34.5	0.0	39.4	35.6	55.6	0.0	29.3	0.0	43.8	20.4	LCH	55.6	Imatinib (Mesylate)	Imatinib Mesylate (STI571 Mesylate) is a tyrosine kinases inhibitor that inhibits c-Kit, Bcr-Abl, and PDGFR (IC50=100 nM) tyrosine kinases.	False	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1
280882	280882:03:09_01.00	True	1.0	83	33.3	12.6	26.9	0.0	41.7	0.0	22.1	7.5	0.0	0.0	35.7	0.0	0.0	DNA_Synth	41.7	Ro 41-0960	specific, reversible, orally-active COMT-inhibitor.	False	O=C(c1cc(O)c(O)c([N+](=O)[O-])c1)c1ccccc1F
411147	411147:01:11_01.00	True	1.0	99	45.4	0.0	0.0	61.8	0.0	57.7	20.9	68.5	19.6	48.2	0.0	60.9	38.8	LCH	68.5	Avapritinib	Avapritinib (BLU-285) is a highly potent, selective, and orally active KIT and PDGFRA activation loop mutant kinases inhibitor with IC50s of 0.27 and 0.24 nM for KIT D816V and PDGFRA D842V, respectively. Avapritinib (BLU-285) binds the active conformation of the kinase and shows antitumor activity. Avapritinib (BLU-285) attenuates the transport function of both ABCB1 and ABCG2.	True	Cn1cc(-c2cc3c(N4CCN(c5ncc([C@@](C)(N)c6ccc(F)cc6)cn5)CC4)ncnn3c2)cn1
280533	280533:01:10_01.00	True	1.0	59	57.5	0.0	0.0	55.3	0.0	50.4	16.3	29.8	46.5	96.8	0.0	55.7	49.6	Protein_Synth	96.8	Emetine dihydrochloride hydrate	apoptosis inducer, RNA-Protein translation inhibitor.	False	CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21
247300	247300:01:15_01.00	True	1.0	73	46.6	0.0	0.0	66.3	0.0	65.7	19.8	40.5	45.2	98.7	0.0	59.5	59.7	Protein_Synth	98.7	Cycloheximide	protein synthesis inhibitor.	False	C[C@H]1C[C@H](C)C(=O)[C@H]([C@H](O)CC2CC(=O)NC(=O)C2)C1
411099	411099:01:05_01.00	True	1.0	79	51.6	0.0	0.0	73.5	0.0	72.4	29.1	62.2	37.5	91.4	0.0	71.1	60.5	Protein_Synth	91.4	LDN193189 hydrochloride, DM-;3189	potent and selective ALK2 and ALK3 inhibitor (IC50 values are 5 and 30 nM, respectively); inhibits BMP4-mediated Smad1/5/8 activation. Exhibits >200-fold selectivity for BMP signaling over TGF-? signaling. Also exhibits selectivity over AMPK, PDGFR and MAPK signaling.	False	c1ccc2c(-c3cnn4cc(-c5ccc(N6CCNCC6)cc5)cnc34)ccnc2c1
280874	280874:01:08_01.00	True	1.0	103	23.1	0.0	7.0	47.6	0.0	57.2	36.4	36.3	36.4	46.9	0.0	46.8	12.5	HDAC	57.2	Quinidine sulfate	Na+ channel blocker and Class I antiarrythmic, alkaloid isolated from the bark of the Cinchona family of South American trees.	False	C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12
411161	411161:01:04_01.00	True	1.0	108	22.1	5.5	0.0	37.1	0.0	34.9	17.9	43.6	17.0	10.8	0.0	16.9	16.1	LCH	43.6	BMS-536924	BMS-536924 is an orally active, competitive and selective insulin-like growth factor receptor (IGF-1R) kinase and insulin receptor (IR) inhibitor with IC50s of 100 nM and 73 nM, respectively. BMS-536924 has anti-cancer activity.	True	Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NC[C@@H](O)c4cccc(Cl)c4)ccnc3O)nc12
382169	382169:04:04_01.00	True	1.0	73	69.3	0.0	0.0	70.6	0.0	71.1	34.6	74.0	33.0	61.8	0.0	73.1	44.8	LCH	74.0	Ponatinib	Ponatinib (AP24534) is an orally active multi-targeted kinase inhibitor with IC50s of 0.37 nM, 1.1 nM, 1.5 nM, 2.2 nM, and 5.4 nM for Abl, PDGFR.a., VEGFR2, FGFR1, and Src, respectively.	False	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12
411515	411515:01:05_01.00	True	1.0	94	25.7	0.0	0.2	50.6	0.0	62.8	43.6	43.1	38.2	52.2	0.0	50.6	23.7	HDAC	62.8	Vacquinol-1 dihydrochloride	Vacquinol-1 (NSC13316) is a brain penetrant inducer of catastrophic vacuolization in glioblastoma cells (GCs). Vacquinol-1 displays high cytotoxicity to GCs; it induces cell death by membrane ruffling, cell rounding, massive macropinocytic vacuole accumulation, ATP depletion, and cytoplasmic membrane rupture of GCs. Vacquinol-1 originally was developed as an antimalarial compound.; Gilbertson R J. Cell 157(2), 289-290 (2014)	False	OC(c1cc(-c2ccc(Cl)cc2)nc2ccccc12)C1CCCCN1
412264	412264:01:04_01.00	True	1.0	92	15.2	0.0	0.0	41.9	0.0	50.9	49.6	57.8	6.9	28.6	0.0	47.4	41.9	LCH	57.8	BI-4206	BI-4206 is the (S) hydroxy diastereoisomer of BI-0319 and serves as a negative control for BI-0319 and for BI-3663. While exhibiting BI-0319 comparable PTK2 binding affinity it no longer is able to bind and recruit VCB and therefore is not degrading PTK2 proteins in cells.	True	COc1cc(C(=O)NCCOCCOCCOCC(=O)N[C@H](C(=O)N2C[C@@H](O)C[C@H]2C(=O)NCc2ccc(-c3scnc3C)cc2)C(C)(C)C)ccc1Nc1ncc(C(F)(F)F)c(Oc2cccc3c2C(=O)CC3)n1
411126	411126:01:05_03.00	True	3.0	88	56.5	30.0	0.0	41.3	0.0	42.8	43.0	69.3	2.0	32.4	0.0	43.4	44.9	LCH	69.3	Sunitinib	Sunitinib (SU 11248) is a multi-targeted receptor tyrosine kinase inhibitor with IC50s of 80 nM and 2 nM for VEGFR2 and PDGFR.b., respectively. Sunitinib, an ATP-competitive inhibitor, effectively inhibits autophosphorylation of Ire1.a. by inhibiting autophosphorylation and consequent RNase activation.	False	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C
392479	392479:02:04_03.00	True	3.0	97	34.9	0.0	0.0	45.0	0.0	53.4	47.0	59.4	3.1	43.1	0.0	52.5	35.0	LCH	59.4	Imatinib (Mesylate)	Imatinib Mesylate (STI571 Mesylate) is a tyrosine kinases inhibitor that inhibits c-Kit, Bcr-Abl, and PDGFR (IC50=100 nM) tyrosine kinases.	False	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1
280882	280882:03:09_03.00	True	3.0	63	55.6	0.0	43.4	5.3	19.7	17.9	37.5	43.7	0.0	0.7	0.0	20.0	0.0	LCH	43.7	Ro 41-0960	specific, reversible, orally-active COMT-inhibitor.	False	O=C(c1cc(O)c(O)c([N+](=O)[O-])c1)c1ccccc1F
411147	411147:01:11_03.00	True	3.0	101	65.5	0.0	0.0	69.2	0.0	69.4	34.3	71.7	27.2	58.1	0.0	69.1	53.0	LCH	71.7	Avapritinib	Avapritinib (BLU-285) is a highly potent, selective, and orally active KIT and PDGFRA activation loop mutant kinases inhibitor with IC50s of 0.27 and 0.24 nM for KIT D816V and PDGFRA D842V, respectively. Avapritinib (BLU-285) binds the active conformation of the kinase and shows antitumor activity. Avapritinib (BLU-285) attenuates the transport function of both ABCB1 and ABCG2.	True	Cn1cc(-c2cc3c(N4CCN(c5ncc([C@@](C)(N)c6ccc(F)cc6)cn5)CC4)ncnn3c2)cn1
382185	382185:04:07_03.00	True	3.0	95	20.0	0.0	0.0	46.6	0.0	56.0	48.7	58.8	12.1	23.9	0.0	50.7	31.8	LCH	58.8	Aumitin	inhibits mitochondrial respiration by targeting complex I.; Chem. Sci. 2018, 9, 3014	False	Cc1cc(Nc2ccccc2)nc(Nc2ccc(NC(=O)c3ccccc3Cl)cc2)n1
247300	247300:01:15_03.00	True	3.0	63	46.3	0.0	0.0	45.1	0.0	49.7	18.9	26.3	40.2	92.3	0.0	38.0	47.9	Protein_Synth	92.3	Cycloheximide	protein synthesis inhibitor.	False	C[C@H]1C[C@H](C)C(=O)[C@H]([C@H](O)CC2CC(=O)NC(=O)C2)C1
280874	280874:01:08_03.00	True	3.0	102	25.2	0.0	0.3	39.2	0.0	43.3	33.0	26.3	29.0	54.8	0.0	44.2	29.7	Protein_Synth	54.8	Quinidine sulfate	Na+ channel blocker and Class I antiarrythmic, alkaloid isolated from the bark of the Cinchona family of South American trees.	False	C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12
411161	411161:01:04_03.00	True	3.0	92	42.5	0.0	0.0	65.5	0.0	63.2	32.0	61.8	31.2	50.8	0.0	61.3	54.8	BET	65.5	BMS-536924	BMS-536924 is an orally active, competitive and selective insulin-like growth factor receptor (IGF-1R) kinase and insulin receptor (IR) inhibitor with IC50s of 100 nM and 73 nM, respectively. BMS-536924 has anti-cancer activity.	True	Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NC[C@@H](O)c4cccc(Cl)c4)ccnc3O)nc12
411515	411515:01:05_03.00	True	3.0	105	71.7	0.0	0.0	69.2	0.0	74.4	39.0	64.5	37.3	69.4	0.0	69.5	56.4	HDAC	74.4	Vacquinol-1 dihydrochloride	Vacquinol-1 (NSC13316) is a brain penetrant inducer of catastrophic vacuolization in glioblastoma cells (GCs). Vacquinol-1 displays high cytotoxicity to GCs; it induces cell death by membrane ruffling, cell rounding, massive macropinocytic vacuole accumulation, ATP depletion, and cytoplasmic membrane rupture of GCs. Vacquinol-1 originally was developed as an antimalarial compound.; Gilbertson R J. Cell 157(2), 289-290 (2014)	False	OC(c1cc(-c2ccc(Cl)cc2)nc2ccccc12)C1CCCCN1
412264	412264:01:04_03.00	True	3.0	89	58.9	0.0	0.0	69.9	0.0	77.4	47.0	78.5	34.4	54.6	0.0	68.5	62.6	LCH	78.5	BI-4206	BI-4206 is the (S) hydroxy diastereoisomer of BI-0319 and serves as a negative control for BI-0319 and for BI-3663. While exhibiting BI-0319 comparable PTK2 binding affinity it no longer is able to bind and recruit VCB and therefore is not degrading PTK2 proteins in cells.	True	COc1cc(C(=O)NCCOCCOCCOCC(=O)N[C@H](C(=O)N2C[C@@H](O)C[C@H]2C(=O)NCc2ccc(-c3scnc3C)cc2)C(C)(C)C)ccc1Nc1ncc(C(F)(F)F)c(Oc2cccc3c2C(=O)CC3)n1
385860	385860:02:08_02.00	True	2.0	98	6.0	29.3	17.8	0.0	67.6	0.0	2.3	0.0	0.0	0.0	61.2	0.0	0.0	DNA_Synth	67.6	BAY-876	BAY-876 is an orally active and selective glucose transporter 1 (GLUT1) inhibitor with an IC50 of 2 nM. BAY-876 is >130-fold more selective for GLUT1 than GLUT2, GLUT3, and GLUT4. BAY-876 is also a potent blocker of glycolytic metabolism and ovarian cancer growth.	False	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1
385860	385860:02:08_06.00	True	6.0	88	10.9	39.4	0.0	0.0	59.5	0.0	37.1	3.9	0.0	0.0	45.3	0.0	0.0	DNA_Synth	59.5	BAY-876	BAY-876 is an orally active and selective glucose transporter 1 (GLUT1) inhibitor with an IC50 of 2 nM. BAY-876 is >130-fold more selective for GLUT1 than GLUT2, GLUT3, and GLUT4. BAY-876 is also a potent blocker of glycolytic metabolism and ovarian cancer growth.	False	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1
247300	247300:01:16_10.00	True	10.0	53	51.6	50.1	0.9	0.0	56.2	0.0	15.9	0.0	0.0	43.5	31.5	0.0	26.9	DNA_Synth	56.2	Cycloheximide	protein synthesis inhibitor.	False	C[C@H]1C[C@H](C)C(=O)[C@H]([C@H](O)CC2CC(=O)NC(=O)C2)C1
409966	409966:01:11_10.00	True	10.0	81	34.2	54.8	15.8	0.0	83.4	0.0	18.2	0.0	0.0	0.0	95.8	0.0	0.0	Pyrimidine_Synth	95.8		Dihydroorotate dehydrogenase (DHODH; activity internally confirmed)	False	COc1cc(OC)c2c(c1Cl)OC1(CCC3(CC1C)OCCc1c3[nH]c3ccc(C)cc13)C2=O
280533	280533:01:11_10.00	True	10.0	52	77.7	0.0	0.0	67.9	0.0	64.4	17.2	62.5	41.0	78.6	0.0	73.7	68.1	Protein_Synth	78.6	Emetine dihydrochloride hydrate	apoptosis inducer, RNA-Protein translation inhibitor.	False	CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21
280874	280874:01:09_10.00	True	10.0	100	35.8	0.0	0.0	28.6	0.0	30.9	26.6	55.3	3.0	22.7	0.0	34.3	0.0	LCH	55.3	Quinidine sulfate	Na+ channel blocker and Class I antiarrythmic, alkaloid isolated from the bark of the Cinchona family of South American trees.	False	C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12
247300	247300:01:16_30.00	True	30.0	54	45.6	45.6	0.0	0.0	50.6	0.0	21.4	0.0	0.0	43.5	24.3	3.7	33.1	DNA_Synth	50.6	Cycloheximide	protein synthesis inhibitor.	False	C[C@H]1C[C@H](C)C(=O)[C@H]([C@H](O)CC2CC(=O)NC(=O)C2)C1
409966	409966:01:11_30.00	True	30.0	93	31.8	67.8	0.0	0.0	83.1	0.0	29.2	0.0	0.0	0.0	88.3	0.0	0.0	Pyrimidine_Synth	88.3		Dihydroorotate dehydrogenase (DHODH; activity internally confirmed)	False	COc1cc(OC)c2c(c1Cl)OC1(CCC3(CC1C)OCCc1c3[nH]c3ccc(C)cc13)C2=O
280533	280533:01:11_30.00	True	30.0	52	76.7	0.0	0.0	73.3	0.0	71.4	10.4	81.4	46.1	66.5	0.0	75.4	64.3	LCH	81.4	Emetine dihydrochloride hydrate	apoptosis inducer, RNA-Protein translation inhibitor.	False	CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21
280874	280874:01:09_30.00	True	30.0	87	66.3	0.0	0.0	66.5	0.0	66.2	14.7	92.2	21.9	37.5	0.0	60.8	34.5	LCH	92.2	Quinidine sulfate	Na+ channel blocker and Class I antiarrythmic, alkaloid isolated from the bark of the Cinchona family of South American trees.	False	C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12
247300	247300:01:16_50.00	True	50.0	50	38.5	58.0	0.0	0.0	48.5	0.0	20.7	0.0	4.9	29.5	26.2	2.0	41.7	AKT_PI3K_MTOR	58.0	Cycloheximide	protein synthesis inhibitor.	False	C[C@H]1C[C@H](C)C(=O)[C@H]([C@H](O)CC2CC(=O)NC(=O)C2)C1
409966	409966:01:11_50.00	True	50.0	73	37.1	52.0	0.0	10.1	3.3	14.7	61.3	25.5	5.2	26.7	17.7	22.9	52.1	HSP90	61.3		Dihydroorotate dehydrogenase (DHODH; activity internally confirmed)	False	COc1cc(OC)c2c(c1Cl)OC1(CCC3(CC1C)OCCc1c3[nH]c3ccc(C)cc13)C2=O
280874	280874:01:09_50.00	True	50.0	93	84.3	0.0	0.0	72.2	0.0	69.0	13.8	90.5	23.7	47.8	0.0	66.3	43.3	LCH	90.5	Quinidine sulfate	Na+ channel blocker and Class I antiarrythmic, alkaloid isolated from the bark of the Cinchona family of South American trees.	False	C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12
413220	413220:01:05_01.00	True	1.0	99	8.3	0.0	0.0	60.9	0.0	59.2	19.1	68.8	22.4	59.8	0.0	62.4	38.5	LCH	68.8	CYM-50358	CYM50358 is a potent, selective antagonist of the sphingosine-1-phosphate receptor 4 (S1P4). CYM50358 inhibits S1P4 with an IC50 of 25 nM.	False	Cc1cc(CN)cc(C)c1NC(=O)c1ccc(-c2cc(Cl)ccc2Cl)o1
412394	412394:01:04_01.00	True	1.0	96	36.6	0.0	0.0	69.9	0.0	71.8	21.7	86.6	24.0	50.1	0.0	70.1	48.6	LCH	86.6	Deltasonamide 2	Deltasonamide 2 is a competitive, high affinity PDE-.d. inhibitor with a Kd of ~385 pM.	True	CNc1nccc(CN([C@H]2CC[C@H](N)CC2)S(=O)(=O)c2ccc(S(=O)(=O)N(Cc3ccc(Cl)cc3)C3CCCC3)cc2)n1
280484	280484:02:05_01.00	True	1.0	82	7.8	32.0	45.9	0.0	78.5	0.0	30.2	0.0	0.0	0.0	75.0	0.0	0.0	DNA_Synth	78.5	Diphenyleneiodonium chloride	Diphenyleneiodonium chloride is a NADPH oxidase (NOX) inhibitor and also functions as a TRPA1 activator with an EC50 of 1 to 3 uM. Diphenyleneiodonium chloride selectively inhibits intracellular reactive oxygen species.	False	c1ccc2c(c1)[I+]c1ccccc1-2
413106	413106:01:03_01.00	True	1.0	94	61.1	0.0	0.0	81.0	0.0	78.8	15.3	86.2	37.5	63.7	0.0	77.1	59.1	LCH	86.2	Azeliragon	Azeliragon (TTP488) is an orally bioavailable inhibitor of the receptor for advanced glycation end products (RAGE) in development as a potential treatment to slow disease progression in patients with mild Alzheimers disease (AD). Azeliragon also can cross the blood-brain barrier (BBB).	False	CCCCc1nc(-c2ccc(OCCCN(CC)CC)cc2)cn1-c1ccc(Oc2ccc(Cl)cc2)cc1
413100	413100:01:03_01.00	True	1.0	103	10.4	63.1	0.0	0.0	78.8	0.0	24.8	0.0	0.0	0.0	68.1	0.0	0.0	DNA_Synth	78.8	Afuresertib	Afuresertib (GSK2110183) is an orally bioavailable, selective, ATP-competitive and potent pan-Akt kinase inhibitor with Kis of 0.08/2/2.6 nM for Akt1/Akt2/Akt3, respectively.	True	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl
281034	281034:01:12_00.01	True	0.01	53	56.6	0.0	1.5	74.7	0.0	77.3	26.5	55.7	60.6	71.0	0.0	91.0	55.8	Tubulin	91.0	Vinblastine sulfate salt, VLB	inhibitor of microtubule assembly.	False	CCC1(O)CC2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)C3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1
413021	413021:01:03_01.00	True	1.0	86	16.9	22.1	29.6	0.0	68.6	0.0	0.0	0.0	0.0	0.0	43.2	0.0	0.0	DNA_Synth	68.6	NSC-632839	NSC 632839 inhibits USP2 and USP7 as well as the ubiquitin-like SUMO peptidase SENP2 with EC50 values of 45, 37, and 9.8 uM, respectively. It is reported to inhibit apoptosis through a Bcl-2-dependent and apoptosome-independent pathway of caspase activation (IC50 = 15.7 uM in cells sensitized by E1A, an adenoviral oncogene).	False	Cc1ccc(/C=C2/CNC/C(=C/c3ccc(C)cc3)C2=O)cc1
413093	413093:01:04_01.00	True	1.0	88	14.5	67.1	2.2	0.0	70.9	0.0	8.6	0.0	0.0	0.0	78.7	0.0	0.0	Pyrimidine_Synth	78.7	GK921	GK921 is a transglutaminase 2 (TGase) inhibitor with an IC50 of 7.71 uM for human recombinant TGase 2.	False	C(#Cc1nc2ncccc2nc1OCCN1CCCC1)c1ccccc1
412270	412270:01:03_01.00	True	1.0	110	47.8	0.0	0.0	69.2	0.0	71.6	20.2	84.6	31.1	36.3	0.0	66.1	35.4	LCH	84.6	cis-ACBI1	cis-ACBI1 is the negative control to ACBI. The hydroxy proline of the VHL binding part is in the inactive cis-conformation, which prevents binding to VHL and thereby protein degradation.	True	Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@H](O)CN2C(=O)[C@@H](NC(=O)C2(F)CC2)C(C)(C)C)c(OCCOc2ccc(CN3CCN(c4cc(-c5ccccc5O)nnc4N)CC3)cc2)c1
411515	411515:01:08_01.00	True	1.0	94	5.4	0.0	3.7	57.9	0.0	59.9	11.0	66.5	28.7	46.3	0.0	53.4	13.4	LCH	66.5	Vacquinol-1 dihydrochloride	Vacquinol-1 (NSC13316) is a brain penetrant inducer of catastrophic vacuolization in glioblastoma cells (GCs). Vacquinol-1 displays high cytotoxicity to GCs; it induces cell death by membrane ruffling, cell rounding, massive macropinocytic vacuole accumulation, ATP depletion, and cytoplasmic membrane rupture of GCs. Vacquinol-1 originally was developed as an antimalarial compound.; Gilbertson R J. Cell 157(2), 289-290 (2014)	False	OC(c1cc(-c2ccc(Cl)cc2)nc2ccccc12)C1CCCCN1
413125	413125:01:04_01.00	True	1.0	95	46.1	0.0	0.0	70.3	0.0	68.4	12.5	92.9	28.3	38.5	0.0	67.8	47.9	LCH	92.9	BAY-293	BAY-293, a valuable chemical probe, blocks RAS activation via disruption of the KRAS-SOS1 interaction with an IC50 of 21 nM. BAY-293 is a potent inhibitor of Son of Sevenless 1 (SOS1). SOS1 is the guanine nucleotide exchange factor (GEF) and activator of RAS.	True	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1
411901	411901:01:07_01.00	True	1.0	101	11.1	1.5	5.2	0.0	20.0	0.0	22.9	0.0	0.0	0.0	46.5	0.0	0.0	Pyrimidine_Synth	46.5		Dihydroorotate dehydrogenase (DHODH; activity internally confirmed)	False	CN1C(=O)C2(C(=O)N(Cc3ccncc3)c3ccc(OC(F)(F)F)cc32)c2ccccc21
412992	412992:01:04_01.00	True	1.0	54	40.1	38.7	3.9	0.0	47.2	0.0	6.2	0.0	1.9	22.1	33.6	0.0	12.6	DNA_Synth	47.2	Anisomycin	Anisomycin is a potent protein synthesis inhibitor which interferes with protein and DNA synthesis by inhibiting peptidyl transferase or the 80S ribosome system. Anisomycin is a JNK activator, which increases phospho-JNK. Anisomycin is a bacterial antibiotic isolated from Streptomyces griseolus.	True	COc1ccc(C[C@H]2NC[C@H](O)[C@H]2OC(C)=O)cc1
245354	245354:03:12_00.10	True	0.1	67	58.2	0.0	0.0	75.9	0.0	75.3	25.2	61.8	57.6	67.3	0.0	93.9	53.5	Tubulin	93.9	Nocodazole	Nocodazole (Oncodazole) is a rapidly-reversible inhibitor of microtubule. Nocodazole binds to .b.-tubulin and disrupts microtubule assembly/disassembly dynamics, which prevents mitosis and induces apoptosis in tumor cells. Nocodazole inhibits Bcr-Abl, and activates CRISPR/Cas9.	False	COC(=O)Nc1nc2cc(C(=O)c3cccs3)ccc2[nH]1
281038	281038:01:16_00.01	True	0.01	59	40.4	0.0	4.6	70.1	0.0	71.9	34.7	56.5	53.0	68.5	0.0	92.7	54.8	Tubulin	92.7	Vincristine sulfate, VCR	inhibitor of microtubule assembly.	False	CCC1(O)CC2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)C3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1
413085	413085:01:03_01.00	True	1.0	104	6.6	0.0	0.0	77.1	0.0	68.7	20.0	68.4	35.2	65.3	0.0	76.8	54.2	BET	77.1	NVS-PAK1-1	NVS-PAK1-1 is a potent and selective allosteric PAK1 inhibitor with an IC50 of 5 nM.	True	CC(C)NC(=O)N1CC[C@H](NC2=Nc3cc(F)ccc3N(CC(F)F)c3ccc(Cl)cc32)C1
413224	413224:01:03_00.20	True	0.2	73	37.8	70.4	0.0	15.7	28.9	17.6	11.4	32.1	9.1	21.4	11.8	18.0	58.1	AKT_PI3K_MTOR	70.4	7-hydroxystaurosporine	A cell-permeable Staurosporine derived anticancer agent that reversibly and ATP-competitively inhibits several protein kinases.	True	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O
408952	408952:02:04_01.00	True	1.0	93	64.2	0.0	0.0	80.9	0.0	78.4	29.0	72.7	40.0	73.4	0.0	82.3	56.8	Tubulin	82.3		BI-4659 is a potent inhibitor of Alk5 (TGFßR1) with an IC50 value of 19 nM and shows selectivity against a broad panel of other kinases. BI-4659 blocks the phosphorylation of Smad2 and Smad3 in HaCaT cells with an EC50 of 185 nM. Negative control = BI-4101	False	CCNC(=O)c1ccc2c(/C(=N/c3ccc(CN(C)C)cc3)c3ccccc3)c(O)[nH]c2c1
413051	413051:01:04_01.00	True	1.0	54	68.2	0.0	17.5	68.1	0.0	74.1	17.2	59.7	57.7	68.7	0.0	84.1	35.2	Tubulin	84.1	GSK-923295	GSK-923295 is a special, allosteric inhibitor of centromere-associated protein-E (CENP-E) kinesin motor ATPase activity, with Ki of 3.2±0.2 nM and 1.6± 0.1 nM for human and canine, respectively.	True	CC(C)Oc1ccc(C(=O)N[C@H](CNC(=O)CN(C)C)Cc2ccc(-c3cn4cccc([C@H](C)O)c4n3)cc2)cc1Cl
413006	413006:01:03_01.00	True	1.0	71	42.1	45.2	11.1	0.0	94.1	0.0	0.0	0.0	0.0	0.0	68.7	0.0	0.0	DNA_Synth	94.1	ML228	ML228 (CID-46742353) is a potent the Hypoxia Inducible Factor (HIF) pathway activator with EC50 of 1 uM.  ML228 potently activates HIF in vitro as well as its downstream target VEGF.	False	c1ccc(-c2ccc(CNc3nc(-c4ccccn4)nnc3-c3ccccc3)cc2)cc1
412483	412483:01:04_01.00	True	1.0	98	33.5	0.0	0.0	80.1	0.0	78.9	18.7	89.6	35.5	54.9	0.0	77.6	52.8	LCH	89.6		cis-VZ185 is the (S)-hydroxy diastereoisomer of VZ185. While exhibiting comparable bromodomain binding affinity it no longer is able to bind and recruit the E3 ligase VHL and therefore does not induce the degradation of BRD7 and BRD9 proteins in cells.	True	COc1cc(-c2cn(C)c(=O)c3cnccc23)cc(OC)c1CN1CCN(CCCCCOc2cc(-c3scnc3C)ccc2CNC(=O)[C@@H]2C[C@H](O)CN2C(=O)[C@@H](NC(=O)C2(F)CC2)C(C)(C)C)CC1
413126	413126:01:04_01.00	True	1.0	99	53.4	0.0	0.0	74.1	0.0	73.2	10.6	91.9	32.7	42.2	0.0	70.4	45.9	LCH	91.9		negative control to BAY-293	True	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1
413124	413124:01:04_01.00	True	1.0	80	47.0	0.0	0.0	74.7	0.0	66.9	31.9	66.4	47.8	62.9	0.0	92.7	63.8	Tubulin	92.7	KG 5	PDGFR.b. and B-Raf allosteric inhibitor. Also inhibits c-Raf, FLT3 and KIT. Disrupts blood vessel formation in zebrafish embryos and inhibits angiogenesis in a mouse angiogenesis model. Inhibits growth of renal and pancreatic tumors in mice. Also arrests cells in prometaphase.	False	CSc1nc(N)cc(Oc2ccc(-c3n[nH]c(Nc4cccc(C(F)(F)F)c4)n3)cc2)n1
392568	392568:03:03_05.00	True	5.0	90	33.9	0.0	0.0	69.1	0.0	67.2	18.8	79.6	25.6	66.4	0.0	67.6	54.7	LCH	79.6	KU-60019	KU-60019 is an improved analogue of KU-55933, with IC50 of 6.3 nM for ATM in cell-free assays, 270- and 1600-fold more selective for ATM than DNA-PK and ATR,and is a highly effective radiosensitizer.	False	C[C@H]1CN(CC(=O)Nc2ccc3c(c2)Cc2cccc(-c4cc(=O)cc(N5CCOCC5)o4)c2S3)C[C@@H](C)O1
412489	412489:01:04_01.00	True	1.0	100	35.9	4.6	0.0	43.3	0.0	50.0	38.8	28.2	29.4	61.9	0.0	39.0	53.4	Protein_Synth	61.9	Salinomycin	Salinomycin (Procoxacin), a polyether potassium ionophore antibiotic, selectively inhibits the growth of gram-positive bacteria. Salinomycin is a potent inhibitor of Wnt/.b.-catenin signaling, blocks Wnt-induced LRP6 phosphorylation. Salinomycin (Procoxacin) shows selective activity against human cancer stem cells.	True	CC[C@@H](C(=O)[C@@H](C)[C@@H](O)[C@H](C)[C@@H]1O[C@@H]([C@@H](CC)C(=O)O)CC[C@@H]1C)[C@H]1O[C@]2(C=C[C@@H](O)[C@]3(CC[C@@](C)([C@H]4CC[C@](O)(CC)[C@H](C)O4)O3)O2)[C@H](C)C[C@@H]1C
412259	412259:01:04_01.00	True	1.0	95	6.9	0.0	0.0	73.7	0.0	69.4	31.3	69.4	22.5	61.0	0.0	76.9	69.6	Tubulin	76.9	BI-0319	BI-0319 is a degrader that tethers a highly selective PTK2 Kinase inhibitor BI-4464  to a CRL2VHL E3 ubiquitin ligase ligand, aimed at triggering the intracellular destruction of the focal adhesion tyrosine kinase (PTK2) protein.The binary affinities for BI-0319 to PTK2 and to the VCB complex CRL2VHL are 19 and 114 nM respectively. BI-0319 degrades the PTK2 protein in A549 cells with a DC50 of 243 nM to about 80%	False	COc1cc(C(=O)NCCOCCOCCOCC(=O)N[C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)NCc2ccc(-c3scnc3C)cc2)C(C)(C)C)ccc1Nc1ncc(C(F)(F)F)c(Oc2cccc3c2C(=O)CC3)n1
412258	412258:01:08_01.00	True	1.0	105	50.9	0.0	0.0	69.8	0.0	71.2	13.7	81.4	32.1	51.3	0.0	71.1	37.6	LCH	81.4	ACBI1	ACBI1 is a potent and cooperative in vitro PROTAC degrader of the BAF chromatin remodeling ATPase subunits SMARCA2 and SMARCA4 as well as the facultative BAF complex subunit PBRM1. It harnesses the von-Hippel-Landau (VHL) E3 ligase to recruit its targets via their bromodomains and degrades its targets in the nanomolar range.	True	Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)C2(F)CC2)C(C)(C)C)c(OCCOc2ccc(CN3CCN(c4cc(-c5ccccc5O)nnc4N)CC3)cc2)c1
280427	280427:03:06_00.10	True	0.1	83	6.6	0.0	1.7	59.9	0.0	60.2	32.0	56.2	34.6	61.4	0.0	65.4	41.1	Tubulin	65.4	Calcimycin, A23187, Calcium ionophore A23187	Ca2+ ionophore used to potentiate responses to NMDA, but not quisqualate glutamate receptors.	False	CNc1ccc2oc(C[C@H]3O[C@@]4(CC[C@H]3C)O[C@H]([C@H](C)C(=O)c3ccc[nH]3)[C@H](C)C[C@H]4C)nc2c1C(=O)O
413111	413111:01:03_00.20	True	0.2	89	36.8	9.9	0.0	21.9	28.1	28.6	0.0	29.4	16.2	41.1	0.0	34.4	43.7	Uncoupler	43.7	Ingenol Mebutate	Ingenol Mebutate is an active ingredient in Euphorbia peplus, acts as a potent PKC modulator, with Kis of 0.3, 0.105, 0.162, 0.376, and 0.171 nM for PKC-.a., PKC-.b., PKC-.g., PKC-.d., and PKC-.e., respectively, and has antiinflammatory and antitumor activity.	True	C/C=C(/C)C(=O)O[C@H]1C(C)=C[C@]23C(=O)[C@@H](C=C(CO)[C@@H](O)[C@]12O)[C@H]1[C@@H](C[C@H]3C)C1(C)C
411399	411399:01:04_01.00	True	1.0	76	79.8	0.0	9.9	78.5	0.0	78.2	14.6	57.7	54.3	66.6	0.0	81.8	40.7	Tubulin	81.8	Cytochalasin B, Phomin		True	C=C1[C@@H](C)C2[C@H](Cc3ccccc3)NC(=O)[C@]23OC(=O)/C=C/[C@@H](O)CCC[C@@H](C)C/C=C/C3[C@@H]1O
246732	246732:02:05_01.00	True	1.0	54	54.2	0.0	39.2	0.0	62.8	0.0	17.3	14.6	0.0	0.0	32.4	8.0	0.0	DNA_Synth	62.8	Pyrvinium pamoate	metabolic inhibitor.	False	Cc1cc(/C=C/c2ccc3cc(N(C)C)ccc3[n+]2C)c(C)n1-c1ccccc1
413220	413220:01:05_03.00	True	3.0	84	49.7	0.0	0.0	77.5	0.0	77.0	25.6	85.5	33.6	63.6	0.0	75.2	59.5	LCH	85.5	CYM-50358	CYM50358 is a potent, selective antagonist of the sphingosine-1-phosphate receptor 4 (S1P4). CYM50358 inhibits S1P4 with an IC50 of 25 nM.	False	Cc1cc(CN)cc(C)c1NC(=O)c1ccc(-c2cc(Cl)ccc2Cl)o1
413008	413008:01:03_03.00	True	3.0	104	42.0	0.0	0.0	89.0	0.0	89.2	19.8	87.8	49.3	59.6	0.0	81.4	60.6	HDAC	89.2	Src Inhibitor 1	Src Inhibitor 1 is a potent and selective dual site Src tyrosine kinase inhibitor with IC50 values of 44 nM for Src and 88nM for Lck.	False	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC
413096	413096:01:04_03.00	True	3.0	94	17.8	0.0	0.0	67.1	0.0	69.9	16.5	85.0	28.5	40.7	0.0	61.1	29.8	LCH	85.0	BAN-ORL-24	BAN ORL 24 is a potent and selective NOP receptor antagonist. (IC50 values are 0.27, 2500, 6700 and > 10000 nM for NOP, .k.-, .m.- and .d.-receptors respectively). BAN ORL 24 inhibits nociceptin-induced stimulation of [35S]-GTP.g.S binding and Ca2+ mobilization in CHO cells in vitro.	True	O=C(NCCCN1CCC2(CC1)OCc1ccccc12)[C@H]1CCCN1Cc1ccccc1
280484	280484:02:05_03.00	True	3.0	67	30.4	0.0	61.7	0.0	25.3	12.2	42.1	7.8	8.9	33.5	1.5	35.5	0.0	Aurora	61.7	Diphenyleneiodonium chloride	Diphenyleneiodonium chloride is a NADPH oxidase (NOX) inhibitor and also functions as a TRPA1 activator with an EC50 of 1 to 3 uM. Diphenyleneiodonium chloride selectively inhibits intracellular reactive oxygen species.	False	c1ccc2c(c1)[I+]c1ccccc1-2
413100	413100:01:03_03.00	True	3.0	96	14.7	85.0	0.0	0.0	55.8	0.0	38.7	14.1	0.0	0.0	52.1	0.0	23.3	AKT_PI3K_MTOR	85.0	Afuresertib	Afuresertib (GSK2110183) is an orally bioavailable, selective, ATP-competitive and potent pan-Akt kinase inhibitor with Kis of 0.08/2/2.6 nM for Akt1/Akt2/Akt3, respectively.	True	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl
413231	413231:02:03_15.00	True	15.0	88	12.1	32.4	26.1	0.0	67.5	0.0	36.9	0.0	0.0	0.0	58.1	0.0	0.0	DNA_Synth	67.5	BML-277	BML-277 is a selective checkpoint kinase 2 (Chk2) inhibitor with an IC50 of 15 nM.	False	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1
413018	413018:01:03_03.00	True	3.0	62	52.8	32.6	8.9	0.0	39.2	0.0	32.1	7.8	5.4	19.8	26.9	0.0	0.0	DNA_Synth	39.2	Ryuvidine	Ryuvidine is an inhibitor of SETD8 (IC50 = 0.5 uM) that suppresses monomethylation of H4K20 in vitro. It less potently inhibits cyclin-dependent kinase 4 (Cdk4; IC50 = 6 uM for Cdk4/cyclin D1). Over several hours of treatment, ryuvidine suppresses the expression of cell division cycle 7-related kinase (Cdc7), resulting in an ATM-dependent checkpoint response and arrest of cell cycling in S phase.	False	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1
412270	412270:01:03_03.00	True	3.0	106	61.5	0.0	0.0	74.1	0.0	74.9	24.1	94.2	29.2	42.7	0.0	68.0	49.1	LCH	94.2	cis-ACBI1	cis-ACBI1 is the negative control to ACBI. The hydroxy proline of the VHL binding part is in the inactive cis-conformation, which prevents binding to VHL and thereby protein degradation.	True	Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@H](O)CN2C(=O)[C@@H](NC(=O)C2(F)CC2)C(C)(C)C)c(OCCOc2ccc(CN3CCN(c4cc(-c5ccccc5O)nnc4N)CC3)cc2)c1
411515	411515:01:08_03.00	True	3.0	83	59.8	0.0	0.0	75.9	0.0	75.0	19.3	82.3	36.8	64.4	0.0	77.6	58.3	LCH	82.3	Vacquinol-1 dihydrochloride	Vacquinol-1 (NSC13316) is a brain penetrant inducer of catastrophic vacuolization in glioblastoma cells (GCs). Vacquinol-1 displays high cytotoxicity to GCs; it induces cell death by membrane ruffling, cell rounding, massive macropinocytic vacuole accumulation, ATP depletion, and cytoplasmic membrane rupture of GCs. Vacquinol-1 originally was developed as an antimalarial compound.; Gilbertson R J. Cell 157(2), 289-290 (2014)	False	OC(c1cc(-c2ccc(Cl)cc2)nc2ccccc12)C1CCCCN1
413102	413102:01:02_03.00	True	3.0	51	72.2	0.0	34.0	50.0	0.0	58.8	46.4	34.9	45.5	72.4	0.0	70.1	36.3	Protein_Synth	72.4	Epothilone B	Epothilone B is a microtubule stabilizer with a Ki of 0.71uM. It acts by binding to the .a..b.-tubulin heterodimer subunit which causes decreasing of .a..b.-tubulin dissociation.	True	C/C(=C/c1csc(C)n1)[C@@H]1C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@H](O)[C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)O1
413214	413214:01:05_03.00	True	3.0	88	32.6	0.0	0.0	84.0	0.0	85.2	18.9	83.2	49.6	62.7	0.0	77.5	61.0	HDAC	85.2	BAI1	BAI1 is a selective and allosteric inhibitor of BAX, an apoptosis regulator. BAI1 directly binds to BAX and allosterically inhibits BAX activation. BAI1 has the potential for the research of diseases mediated by BAX-dependent cell death.	False	OC(CN1CCNCC1)Cn1c2ccc(Br)cc2c2cc(Br)ccc21
245363	245363:03:14_00.03	True	0.03	80	23.0	0.0	30.1	19.2	0.0	43.7	57.9	11.9	33.2	32.8	0.0	38.4	13.3	HSP90	57.9	Colchicine	prevents tubulin polymerization, antimitotic, antigout agent.	False	COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1[C@@H](NC(C)=O)CC2
413023	413023:01:03_03.00	True	3.0	99	70.8	0.0	0.0	83.9	0.0	81.3	21.4	91.2	37.5	65.4	0.0	76.7	66.1	LCH	91.2	NNC 55-0396	NNC 55-0396, Mibefradil derivative, is a highly selective T-type calcium channel blocker; displays IC50 values of 6.8 and > 100 uM for inhibition of Cav3.1 T-type channels and HVA currents respectively in INS-1 cells. IC50 value: 6.8 nMTarget: Cav3.1 T-type channelNNC 55-0396 can be an essential tool in preventing human ovarian cancer cell proliferation as a result of its ability to inhibit the function of T-type Ca2+ channels. It is believed that NNC 55-0396 may functions by dissolving in or passing through the plasma membrane of cells.	True	CC(C)[C@H]1c2ccc(F)cc2CC[C@@]1(CCN(C)CCCc1nc2ccccc2[nH]1)OC(=O)C1CC1
413085	413085:01:03_03.00	True	3.0	91	38.7	0.0	0.0	69.9	0.0	63.5	29.6	76.6	31.9	49.0	0.0	76.2	60.7	LCH	76.6	NVS-PAK1-1	NVS-PAK1-1 is a potent and selective allosteric PAK1 inhibitor with an IC50 of 5 nM.	True	CC(C)NC(=O)N1CC[C@H](NC2=Nc3cc(F)ccc3N(CC(F)F)c3ccc(Cl)cc32)C1
413224	413224:01:03_00.60	True	0.6	59	42.8	62.3	0.0	5.9	39.3	6.3	18.4	16.5	11.0	20.8	20.6	24.9	51.5	AKT_PI3K_MTOR	62.3	7-hydroxystaurosporine	A cell-permeable Staurosporine derived anticancer agent that reversibly and ATP-competitively inhibits several protein kinases.	True	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O
408952	408952:02:04_03.00	True	3.0	89	69.3	0.0	0.0	81.9	0.0	79.4	35.1	78.7	41.5	63.0	0.0	82.2	61.0	Tubulin	82.2		BI-4659 is a potent inhibitor of Alk5 (TGFßR1) with an IC50 value of 19 nM and shows selectivity against a broad panel of other kinases. BI-4659 blocks the phosphorylation of Smad2 and Smad3 in HaCaT cells with an EC50 of 185 nM. Negative control = BI-4101	False	CCNC(=O)c1ccc2c(/C(=N/c3ccc(CN(C)C)cc3)c3ccccc3)c(O)[nH]c2c1
413051	413051:01:04_03.00	True	3.0	53	78.1	0.0	5.0	74.5	0.0	77.8	20.5	69.7	58.4	64.1	0.0	88.2	44.5	Tubulin	88.2	GSK-923295	GSK-923295 is a special, allosteric inhibitor of centromere-associated protein-E (CENP-E) kinesin motor ATPase activity, with Ki of 3.2±0.2 nM and 1.6± 0.1 nM for human and canine, respectively.	True	CC(C)Oc1ccc(C(=O)N[C@H](CNC(=O)CN(C)C)Cc2ccc(-c3cn4cccc([C@H](C)O)c4n3)cc2)cc1Cl
413119	413119:01:04_03.00	True	3.0	101	25.0	0.0	0.0	71.7	0.0	68.6	22.7	87.5	23.1	41.4	0.0	72.3	51.5	LCH	87.5	A 987306	Potent histamine H4 receptor antagonist (pKi values are 8.24 and 8.47 in human and rat H4 receptors respectively). Displays 162-fold, 620-fold, and > 1600-fold selectivity over human H3, H1 and H2 receptors.	True	Nc1nc2c(c(N3CCNCC3)n1)CCC1=C2[C@@H]2CCCC[C@@H]2O1
413006	413006:01:03_03.00	True	3.0	71	65.5	26.3	5.2	0.0	79.2	0.0	10.5	11.9	0.0	0.0	50.0	0.0	0.0	DNA_Synth	79.2	ML228	ML228 (CID-46742353) is a potent the Hypoxia Inducible Factor (HIF) pathway activator with EC50 of 1 uM.  ML228 potently activates HIF in vitro as well as its downstream target VEGF.	False	c1ccc(-c2ccc(CNc3nc(-c4ccccn4)nnc3-c3ccccc3)cc2)cc1
412483	412483:01:04_03.00	True	3.0	94	67.2	0.0	0.0	79.2	0.0	78.9	16.1	95.5	36.2	50.0	0.0	72.5	56.5	LCH	95.5		cis-VZ185 is the (S)-hydroxy diastereoisomer of VZ185. While exhibiting comparable bromodomain binding affinity it no longer is able to bind and recruit the E3 ligase VHL and therefore does not induce the degradation of BRD7 and BRD9 proteins in cells.	True	COc1cc(-c2cn(C)c(=O)c3cnccc23)cc(OC)c1CN1CCN(CCCCCOc2cc(-c3scnc3C)ccc2CNC(=O)[C@@H]2C[C@H](O)CN2C(=O)[C@@H](NC(=O)C2(F)CC2)C(C)(C)C)CC1
412482	412482:01:04_03.00	True	3.0	95	52.0	0.0	0.0	78.7	0.0	77.6	13.2	95.6	35.2	44.6	0.0	71.2	47.9	LCH	95.6		VZ185 is a potent, fast, and selective degrader of BRD9 and of its close homolog BRD7. VZ185 displays binary and ternary KD = 30 nM to VHL in both ITC and FP binding assays and degrades BRD9 and BRD7 proteins with DC50 values of 1.8 nM and 4.5 nM and Dmax of 95%.	True	COc1cc(-c2cn(C)c(=O)c3cnccc23)cc(OC)c1CN1CCN(CCCCCOc2cc(-c3scnc3C)ccc2CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)C2(F)CC2)C(C)(C)C)CC1
413007	413007:01:05_03.00	True	3.0	84	34.2	3.7	11.5	27.6	29.7	20.6	39.8	47.8	0.0	35.7	0.0	56.2	34.7	Tubulin	56.2	Purvalanol A	Purvalanol A is a potent CDK inhibitor, which inhibits cdc2-cyclin B, cdk2-cyclin A, cdk2-cyclin E, cdk4-cyclin D1, and cdk5-p35 with IC50s of 4, 70, 35, 850, 75 nM, resepctively.	True	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1
392568	392568:03:03_15.00	True	15.0	84	70.5	0.0	0.0	83.2	0.0	81.1	18.3	89.7	44.4	59.0	0.0	80.5	65.2	LCH	89.7	KU-60019	KU-60019 is an improved analogue of KU-55933, with IC50 of 6.3 nM for ATM in cell-free assays, 270- and 1600-fold more selective for ATM than DNA-PK and ATR,and is a highly effective radiosensitizer.	False	C[C@H]1CN(CC(=O)Nc2ccc3c(c2)Cc2cccc(-c4cc(=O)cc(N5CCOCC5)o4)c2S3)C[C@@H](C)O1
413088	413088:01:04_03.00	True	3.0	67	33.3	0.0	20.6	0.0	31.0	0.0	28.9	14.6	12.1	15.1	10.5	15.6	0.0	DNA_Synth	31.0	SU3327	SU3327 is a potent, selective and substrate-competitive JNK inhibitor with an IC50 of 0.7 uM. SU3327 also inhibits protein-protein interactions between JNK and JNK Interacting Protein (JIP) with an IC50 of 239 nM. SU3327 shows less active against p38.a. and Akt kinase.	False	Nc1nnc(Sc2ncc([N+](=O)[O-])s2)s1
412489	412489:01:04_03.00	True	3.0	92	56.1	8.7	0.0	59.2	0.0	60.8	37.0	57.6	34.1	56.0	0.0	61.0	66.1	Uncoupler	66.1	Salinomycin	Salinomycin (Procoxacin), a polyether potassium ionophore antibiotic, selectively inhibits the growth of gram-positive bacteria. Salinomycin is a potent inhibitor of Wnt/.b.-catenin signaling, blocks Wnt-induced LRP6 phosphorylation. Salinomycin (Procoxacin) shows selective activity against human cancer stem cells.	True	CC[C@@H](C(=O)[C@@H](C)[C@@H](O)[C@H](C)[C@@H]1O[C@@H]([C@@H](CC)C(=O)O)CC[C@@H]1C)[C@H]1O[C@]2(C=C[C@@H](O)[C@]3(CC[C@@](C)([C@H]4CC[C@](O)(CC)[C@H](C)O4)O3)O2)[C@H](C)C[C@@H]1C
332505	332505:03:05_03.00	True	3.0	88	5.5	17.2	0.0	22.6	0.0	25.8	55.8	16.5	10.8	30.1	0.0	30.0	31.4	HSP90	55.8	Sal003	Sal003 is a potent, specific and cell-permeable inhibitor of the eukaryotic translation initiation factor 2.a. (eIF2.a.) phosphatase. Sal003 is a derivative of salubrinal.	False	O=C(/C=C/c1ccccc1)NC(NC(=S)Nc1ccc(Cl)cc1)C(Cl)(Cl)Cl
412259	412259:01:04_03.00	True	3.0	94	37.0	0.0	0.0	85.5	0.0	84.9	36.5	78.3	47.7	67.0	0.0	84.7	65.3	BET	85.5	BI-0319	BI-0319 is a degrader that tethers a highly selective PTK2 Kinase inhibitor BI-4464  to a CRL2VHL E3 ubiquitin ligase ligand, aimed at triggering the intracellular destruction of the focal adhesion tyrosine kinase (PTK2) protein.The binary affinities for BI-0319 to PTK2 and to the VCB complex CRL2VHL are 19 and 114 nM respectively. BI-0319 degrades the PTK2 protein in A549 cells with a DC50 of 243 nM to about 80%	False	COc1cc(C(=O)NCCOCCOCCOCC(=O)N[C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)NCc2ccc(-c3scnc3C)cc2)C(C)(C)C)ccc1Nc1ncc(C(F)(F)F)c(Oc2cccc3c2C(=O)CC3)n1
412258	412258:01:08_03.00	True	3.0	90	64.6	0.0	0.0	78.9	0.0	79.1	19.2	93.7	38.1	47.4	0.0	76.4	50.1	LCH	93.7	ACBI1	ACBI1 is a potent and cooperative in vitro PROTAC degrader of the BAF chromatin remodeling ATPase subunits SMARCA2 and SMARCA4 as well as the facultative BAF complex subunit PBRM1. It harnesses the von-Hippel-Landau (VHL) E3 ligase to recruit its targets via their bromodomains and degrades its targets in the nanomolar range.	True	Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)C2(F)CC2)C(C)(C)C)c(OCCOc2ccc(CN3CCN(c4cc(-c5ccccc5O)nnc4N)CC3)cc2)c1
413019	413019:01:04_03.00	True	3.0	92	5.0	56.4	12.3	0.0	86.5	0.0	0.0	0.0	0.0	0.0	72.7	0.0	0.0	DNA_Synth	86.5	BVT948	BVT948 is a protein tyrosine phosphatase (PTP) inhibitor which can also inhibit several cytochrome P450 (P450) isoforms and lysine methyltransferase SETD8 (KMT5A).	False	CC1(C)C(=O)N=C2C1=C(O)C(=O)c1ccccc12
412264	412264:01:06_03.00	True	3.0	94	45.3	0.0	0.0	69.0	0.0	73.3	51.7	77.8	35.6	58.7	0.0	69.6	63.4	LCH	77.8	BI-4206	BI-4206 is the (S) hydroxy diastereoisomer of BI-0319 and serves as a negative control for BI-0319 and for BI-3663. While exhibiting BI-0319 comparable PTK2 binding affinity it no longer is able to bind and recruit VCB and therefore is not degrading PTK2 proteins in cells.	True	COc1cc(C(=O)NCCOCCOCCOCC(=O)N[C@H](C(=O)N2C[C@@H](O)C[C@H]2C(=O)NCc2ccc(-c3scnc3C)cc2)C(C)(C)C)ccc1Nc1ncc(C(F)(F)F)c(Oc2cccc3c2C(=O)CC3)n1
280427	280427:03:06_00.30	True	0.3	75	61.1	0.0	0.0	57.0	0.0	60.2	39.9	56.7	41.4	56.4	0.0	60.1	43.2	HDAC	60.2	Calcimycin, A23187, Calcium ionophore A23187	Ca2+ ionophore used to potentiate responses to NMDA, but not quisqualate glutamate receptors.	False	CNc1ccc2oc(C[C@H]3O[C@@]4(CC[C@H]3C)O[C@H]([C@H](C)C(=O)c3ccc[nH]3)[C@H](C)C[C@H]4C)nc2c1C(=O)O
413111	413111:01:03_00.60	True	0.6	89	26.1	59.5	0.0	0.0	75.5	0.0	5.8	5.8	0.0	0.0	41.3	0.0	29.0	DNA_Synth	75.5	Ingenol Mebutate	Ingenol Mebutate is an active ingredient in Euphorbia peplus, acts as a potent PKC modulator, with Kis of 0.3, 0.105, 0.162, 0.376, and 0.171 nM for PKC-.a., PKC-.b., PKC-.g., PKC-.d., and PKC-.e., respectively, and has antiinflammatory and antitumor activity.	True	C/C=C(/C)C(=O)O[C@H]1C(C)=C[C@]23C(=O)[C@@H](C=C(CO)[C@@H](O)[C@]12O)[C@H]1[C@@H](C[C@H]3C)C1(C)C
412368	412368:01:08_03.00	True	3.0	94	39.0	64.9	4.1	0.0	85.1	0.0	11.1	0.0	0.0	0.0	97.1	0.0	0.0	Pyrimidine_Synth	97.1		Dihydroorotate dehydrogenase (DHODH; activity internally confirmed)	True	COc1ccc2[nH]c3c(c2c1)CCOC31CC[C@@]2(Oc3c(Cl)c(OC)cc(OC)c3C2=O)[C@H](C)C1
413008	413008:01:03_10.00	True	10.0	102	79.1	0.0	0.0	88.9	0.0	89.5	25.3	84.5	53.6	61.7	0.0	86.0	58.5	HDAC	89.5	Src Inhibitor 1	Src Inhibitor 1 is a potent and selective dual site Src tyrosine kinase inhibitor with IC50 values of 44 nM for Src and 88nM for Lck.	False	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC
413096	413096:01:04_10.00	True	10.0	94	47.8	0.0	0.0	78.0	0.0	79.1	17.7	93.4	40.0	51.1	0.0	74.8	49.6	LCH	93.4	BAN-ORL-24	BAN ORL 24 is a potent and selective NOP receptor antagonist. (IC50 values are 0.27, 2500, 6700 and > 10000 nM for NOP, .k.-, .m.- and .d.-receptors respectively). BAN ORL 24 inhibits nociceptin-induced stimulation of [35S]-GTP.g.S binding and Ca2+ mobilization in CHO cells in vitro.	True	O=C(NCCCN1CCC2(CC1)OCc1ccccc12)[C@H]1CCCN1Cc1ccccc1
280484	280484:02:05_10.00	True	10.0	57	40.4	50.4	33.4	0.0	84.1	0.0	40.8	0.0	0.0	0.0	74.6	0.0	0.0	DNA_Synth	84.1	Diphenyleneiodonium chloride	Diphenyleneiodonium chloride is a NADPH oxidase (NOX) inhibitor and also functions as a TRPA1 activator with an EC50 of 1 to 3 uM. Diphenyleneiodonium chloride selectively inhibits intracellular reactive oxygen species.	False	c1ccc2c(c1)[I+]c1ccccc1-2
413100	413100:01:03_10.00	True	10.0	85	42.0	24.0	0.0	57.6	0.0	55.9	28.8	87.4	14.6	31.9	0.0	55.4	57.7	LCH	87.4	Afuresertib	Afuresertib (GSK2110183) is an orally bioavailable, selective, ATP-competitive and potent pan-Akt kinase inhibitor with Kis of 0.08/2/2.6 nM for Akt1/Akt2/Akt3, respectively.	True	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl
413231	413231:02:03_50.00	True	50.0	81	53.4	0.0	0.0	59.4	0.0	66.2	59.7	49.7	47.7	55.9	0.0	71.5	74.6	Uncoupler	74.6	BML-277	BML-277 is a selective checkpoint kinase 2 (Chk2) inhibitor with an IC50 of 15 nM.	False	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1
413018	413018:01:03_10.00	True	10.0	54	50.3	0.0	0.0	26.4	0.0	34.7	19.3	31.6	40.9	47.5	0.0	28.5	26.7	Protein_Synth	47.5	Ryuvidine	Ryuvidine is an inhibitor of SETD8 (IC50 = 0.5 uM) that suppresses monomethylation of H4K20 in vitro. It less potently inhibits cyclin-dependent kinase 4 (Cdk4; IC50 = 6 uM for Cdk4/cyclin D1). Over several hours of treatment, ryuvidine suppresses the expression of cell division cycle 7-related kinase (Cdc7), resulting in an ATM-dependent checkpoint response and arrest of cell cycling in S phase.	False	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1
413107	413107:01:03_10.00	True	10.0	95	17.4	8.9	0.0	56.9	0.0	54.6	26.6	84.5	8.9	29.2	0.0	59.5	49.7	LCH	84.5	Ibutamoren mesylate	Ibutamoren (Mesylate) is a potent, non-peptide Growth hormone secretagogue receptor (GHSR) agonist.	True	CC(C)(N)C(=O)N[C@H](COCc1ccccc1)C(=O)N1CCC2(CC1)CN(S(C)(=O)=O)c1ccccc12
412270	412270:01:03_10.00	True	10.0	93	56.8	0.0	0.0	74.5	0.0	74.4	18.5	96.3	31.1	39.8	0.0	66.4	49.5	LCH	96.3	cis-ACBI1	cis-ACBI1 is the negative control to ACBI. The hydroxy proline of the VHL binding part is in the inactive cis-conformation, which prevents binding to VHL and thereby protein degradation.	True	Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@H](O)CN2C(=O)[C@@H](NC(=O)C2(F)CC2)C(C)(C)C)c(OCCOc2ccc(CN3CCN(c4cc(-c5ccccc5O)nnc4N)CC3)cc2)c1
413102	413102:01:02_10.00	True	10.0	52	66.0	0.0	32.7	44.5	0.0	55.5	54.4	34.6	46.6	64.3	0.0	71.2	32.0	Tubulin	71.2	Epothilone B	Epothilone B is a microtubule stabilizer with a Ki of 0.71uM. It acts by binding to the .a..b.-tubulin heterodimer subunit which causes decreasing of .a..b.-tubulin dissociation.	True	C/C(=C/c1csc(C)n1)[C@@H]1C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@H](O)[C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)O1
413214	413214:01:05_10.00	True	10.0	74	75.0	0.0	0.0	85.6	0.0	86.2	22.4	88.3	49.5	67.0	0.0	80.8	69.8	LCH	88.3	BAI1	BAI1 is a selective and allosteric inhibitor of BAX, an apoptosis regulator. BAI1 directly binds to BAX and allosterically inhibits BAX activation. BAI1 has the potential for the research of diseases mediated by BAX-dependent cell death.	False	OC(CN1CCNCC1)Cn1c2ccc(Br)cc2c2cc(Br)ccc21
245363	245363:03:14_00.10	True	0.1	51	55.8	0.0	13.9	51.6	0.0	63.9	48.0	50.6	36.0	60.7	0.0	60.7	48.9	HDAC	63.9	Colchicine	prevents tubulin polymerization, antimitotic, antigout agent.	False	COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1[C@@H](NC(C)=O)CC2
411901	411901:01:07_10.00	True	10.0	96	31.3	53.2	7.6	0.0	74.4	0.0	25.0	0.0	0.0	0.0	89.0	0.0	0.0	Pyrimidine_Synth	89.0		Dihydroorotate dehydrogenase (DHODH; activity internally confirmed)	False	CN1C(=O)C2(C(=O)N(Cc3ccncc3)c3ccc(OC(F)(F)F)cc32)c2ccccc21
413085	413085:01:03_10.00	True	10.0	85	41.8	11.0	0.0	59.0	0.0	50.7	31.9	73.4	22.4	38.4	0.0	76.4	63.0	Tubulin	76.4	NVS-PAK1-1	NVS-PAK1-1 is a potent and selective allosteric PAK1 inhibitor with an IC50 of 5 nM.	True	CC(C)NC(=O)N1CC[C@H](NC2=Nc3cc(F)ccc3N(CC(F)F)c3ccc(Cl)cc32)C1
413091	413091:01:04_10.00	True	10.0	78	74.6	0.0	0.0	82.6	0.0	80.5	21.1	91.6	44.8	61.1	0.0	83.1	62.0	LCH	91.6	RO1138452	RO1138452 is a potent and selective IP (prostacyclin) receptor antagonist. RO1138452 displays high affinity for IP receptors. In human platelets, pKi is 9.3±0.1; in a recombinant IP receptor system, pKi is 8.7±0.06.	False	CC(C)Oc1ccc(Cc2ccc(NC3=NCCN3)cc2)cc1
408952	408952:02:04_10.00	True	10.0	100	76.5	0.0	0.0	83.3	0.0	82.6	30.3	78.1	46.2	64.6	0.0	82.1	57.4	BET	83.3		BI-4659 is a potent inhibitor of Alk5 (TGFßR1) with an IC50 value of 19 nM and shows selectivity against a broad panel of other kinases. BI-4659 blocks the phosphorylation of Smad2 and Smad3 in HaCaT cells with an EC50 of 185 nM. Negative control = BI-4101	False	CCNC(=O)c1ccc2c(/C(=N/c3ccc(CN(C)C)cc3)c3ccccc3)c(O)[nH]c2c1
413119	413119:01:04_10.00	True	10.0	100	43.7	0.0	0.0	71.8	0.0	68.9	9.5	96.1	25.5	39.2	0.0	66.0	49.1	LCH	96.1	A 987306	Potent histamine H4 receptor antagonist (pKi values are 8.24 and 8.47 in human and rat H4 receptors respectively). Displays 162-fold, 620-fold, and > 1600-fold selectivity over human H3, H1 and H2 receptors.	True	Nc1nc2c(c(N3CCNCC3)n1)CCC1=C2[C@@H]2CCCC[C@@H]2O1
413006	413006:01:03_10.00	True	10.0	65	54.4	27.6	0.0	0.0	70.9	0.0	12.0	19.2	0.0	0.0	35.2	9.1	0.0	DNA_Synth	70.9	ML228	ML228 (CID-46742353) is a potent the Hypoxia Inducible Factor (HIF) pathway activator with EC50 of 1 uM.  ML228 potently activates HIF in vitro as well as its downstream target VEGF.	False	c1ccc(-c2ccc(CNc3nc(-c4ccccn4)nnc3-c3ccccc3)cc2)cc1
412483	412483:01:04_10.00	True	10.0	107	80.5	0.0	0.0	80.4	0.0	80.0	23.7	91.9	34.9	56.8	0.0	74.1	60.8	LCH	91.9		cis-VZ185 is the (S)-hydroxy diastereoisomer of VZ185. While exhibiting comparable bromodomain binding affinity it no longer is able to bind and recruit the E3 ligase VHL and therefore does not induce the degradation of BRD7 and BRD9 proteins in cells.	True	COc1cc(-c2cn(C)c(=O)c3cnccc23)cc(OC)c1CN1CCN(CCCCCOc2cc(-c3scnc3C)ccc2CNC(=O)[C@@H]2C[C@H](O)CN2C(=O)[C@@H](NC(=O)C2(F)CC2)C(C)(C)C)CC1
412482	412482:01:04_10.00	True	10.0	98	64.2	0.0	0.0	80.3	0.0	81.0	20.7	93.6	38.5	48.0	0.0	72.6	59.2	LCH	93.6		VZ185 is a potent, fast, and selective degrader of BRD9 and of its close homolog BRD7. VZ185 displays binary and ternary KD = 30 nM to VHL in both ITC and FP binding assays and degrades BRD9 and BRD7 proteins with DC50 values of 1.8 nM and 4.5 nM and Dmax of 95%.	True	COc1cc(-c2cn(C)c(=O)c3cnccc23)cc(OC)c1CN1CCN(CCCCCOc2cc(-c3scnc3C)ccc2CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)C2(F)CC2)C(C)(C)C)CC1
413007	413007:01:05_10.00	True	10.0	57	61.0	0.0	36.3	36.7	0.0	42.2	43.4	42.4	23.2	56.0	0.0	64.1	27.0	Tubulin	64.1	Purvalanol A	Purvalanol A is a potent CDK inhibitor, which inhibits cdc2-cyclin B, cdk2-cyclin A, cdk2-cyclin E, cdk4-cyclin D1, and cdk5-p35 with IC50s of 4, 70, 35, 850, 75 nM, resepctively.	True	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1
412489	412489:01:04_10.00	True	10.0	90	63.7	0.0	0.0	66.4	0.0	68.1	35.7	72.0	40.8	56.1	0.0	70.0	64.9	LCH	72.0	Salinomycin	Salinomycin (Procoxacin), a polyether potassium ionophore antibiotic, selectively inhibits the growth of gram-positive bacteria. Salinomycin is a potent inhibitor of Wnt/.b.-catenin signaling, blocks Wnt-induced LRP6 phosphorylation. Salinomycin (Procoxacin) shows selective activity against human cancer stem cells.	True	CC[C@@H](C(=O)[C@@H](C)[C@@H](O)[C@H](C)[C@@H]1O[C@@H]([C@@H](CC)C(=O)O)CC[C@@H]1C)[C@H]1O[C@]2(C=C[C@@H](O)[C@]3(CC[C@@](C)([C@H]4CC[C@](O)(CC)[C@H](C)O4)O3)O2)[C@H](C)C[C@@H]1C
332505	332505:03:05_10.00	True	10.0	78	47.0	13.5	0.0	24.6	0.0	26.1	42.0	41.9	21.0	32.3	0.0	43.0	22.1	Tubulin	43.0	Sal003	Sal003 is a potent, specific and cell-permeable inhibitor of the eukaryotic translation initiation factor 2.a. (eIF2.a.) phosphatase. Sal003 is a derivative of salubrinal.	False	O=C(/C=C/c1ccccc1)NC(NC(=S)Nc1ccc(Cl)cc1)C(Cl)(Cl)Cl
412259	412259:01:04_10.00	True	10.0	68	57.7	0.0	0.0	48.9	0.0	64.6	63.5	51.6	36.3	58.6	0.0	57.9	60.6	HDAC	64.6	BI-0319	BI-0319 is a degrader that tethers a highly selective PTK2 Kinase inhibitor BI-4464  to a CRL2VHL E3 ubiquitin ligase ligand, aimed at triggering the intracellular destruction of the focal adhesion tyrosine kinase (PTK2) protein.The binary affinities for BI-0319 to PTK2 and to the VCB complex CRL2VHL are 19 and 114 nM respectively. BI-0319 degrades the PTK2 protein in A549 cells with a DC50 of 243 nM to about 80%	False	COc1cc(C(=O)NCCOCCOCCOCC(=O)N[C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)NCc2ccc(-c3scnc3C)cc2)C(C)(C)C)ccc1Nc1ncc(C(F)(F)F)c(Oc2cccc3c2C(=O)CC3)n1
412258	412258:01:08_10.00	True	10.0	91	59.1	0.0	0.0	78.6	0.0	78.9	17.0	95.7	38.1	46.2	0.0	73.2	51.5	LCH	95.7	ACBI1	ACBI1 is a potent and cooperative in vitro PROTAC degrader of the BAF chromatin remodeling ATPase subunits SMARCA2 and SMARCA4 as well as the facultative BAF complex subunit PBRM1. It harnesses the von-Hippel-Landau (VHL) E3 ligase to recruit its targets via their bromodomains and degrades its targets in the nanomolar range.	True	Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)C2(F)CC2)C(C)(C)C)c(OCCOc2ccc(CN3CCN(c4cc(-c5ccccc5O)nnc4N)CC3)cc2)c1
413019	413019:01:04_10.00	True	10.0	65	44.6	36.2	7.4	0.0	36.8	0.0	33.2	0.0	0.9	16.2	27.9	0.0	7.5	DNA_Synth	36.8	BVT948	BVT948 is a protein tyrosine phosphatase (PTP) inhibitor which can also inhibit several cytochrome P450 (P450) isoforms and lysine methyltransferase SETD8 (KMT5A).	False	CC1(C)C(=O)N=C2C1=C(O)C(=O)c1ccccc12
245354	245354:03:11_00.10	True	0.1	69	61.3	0.0	0.0	75.2	0.0	74.2	30.4	57.8	61.8	66.4	0.0	94.0	57.4	Tubulin	94.0	Nocodazole	Nocodazole (Oncodazole) is a rapidly-reversible inhibitor of microtubule. Nocodazole binds to .b.-tubulin and disrupts microtubule assembly/disassembly dynamics, which prevents mitosis and induces apoptosis in tumor cells. Nocodazole inhibits Bcr-Abl, and activates CRISPR/Cas9.	False	COC(=O)Nc1nc2cc(C(=O)c3cccs3)ccc2[nH]1
280427	280427:03:06_01.00	True	1.0	62	75.0	0.0	0.0	64.4	0.0	67.0	47.7	60.1	49.9	62.5	0.0	69.1	64.8	Tubulin	69.1	Calcimycin, A23187, Calcium ionophore A23187	Ca2+ ionophore used to potentiate responses to NMDA, but not quisqualate glutamate receptors.	False	CNc1ccc2oc(C[C@H]3O[C@@]4(CC[C@H]3C)O[C@H]([C@H](C)C(=O)c3ccc[nH]3)[C@H](C)C[C@H]4C)nc2c1C(=O)O
413111	413111:01:03_02.00	True	2.0	96	31.3	72.0	0.0	0.0	85.5	0.0	5.3	0.0	0.0	0.0	75.0	0.0	0.0	DNA_Synth	85.5	Ingenol Mebutate	Ingenol Mebutate is an active ingredient in Euphorbia peplus, acts as a potent PKC modulator, with Kis of 0.3, 0.105, 0.162, 0.376, and 0.171 nM for PKC-.a., PKC-.b., PKC-.g., PKC-.d., and PKC-.e., respectively, and has antiinflammatory and antitumor activity.	True	C/C=C(/C)C(=O)O[C@H]1C(C)=C[C@]23C(=O)[C@@H](C=C(CO)[C@@H](O)[C@]12O)[C@H]1[C@@H](C[C@H]3C)C1(C)C
412368	412368:01:08_10.00	True	10.0	80	31.3	68.0	0.0	0.0	71.5	0.0	38.9	0.0	0.0	0.0	71.7	0.0	9.7	Pyrimidine_Synth	71.7		Dihydroorotate dehydrogenase (DHODH; activity internally confirmed)	True	COc1ccc2[nH]c3c(c2c1)CCOC31CC[C@@]2(Oc3c(Cl)c(OC)cc(OC)c3C2=O)[C@H](C)C1
410916	410916:02:04_00.20	True	0.2	93	5.9	0.0	0.0	35.5	0.0	56.9	0.0	13.4	44.8	3.9	0.0	34.3	39.2	HDAC	56.9	M344	M344 (D 237) is an inhibitor of histone deacetylase (IC50=100 nM) and an inducer of terminal cell fifferentiation.	False	CN(C)c1ccc(C(=O)NCCCCCCC(=O)NO)cc1
407889	407889:01:05_01.00	True	1.0	91	16.9	58.1	0.0	0.0	26.5	17.2	43.2	18.2	0.0	14.9	13.8	0.0	38.3	AKT_PI3K_MTOR	58.1	H-1152 (dihydrochloride)	H-1152 dihydrochloride is a membrane-permeable and selective ROCK inhibitor, with a Ki value of 1.6 nM, and an IC50 value of 12 nM for ROCK2.	True	Cc1cncc2cccc(S(=O)(=O)N3CCCNC[C@@H]3C)c12
411125	411125:01:07_01.00	True	1.0	103	21.2	52.9	0.0	20.3	19.8	19.8	25.0	62.8	0.0	8.1	4.8	16.7	22.5	LCH	62.8	Miransertib HCl, ARQ 092	it is a novel, orally bioavailable and selective AKT pathway inhibitor exhibiting a manageable safety profile among patients with advanced solid tumors. ARQ 092 blocks membrane translocation of inactive AKT and even dephosphorylates the membrane-associated active form, thereby perturbing AKT activity. Treatment with 50-500 nM ARQ 092 significantly blocks aMß2 integrin function in neutrophils and reduces P-selectin exposure and glycoprotein Ib/IX/V-mediated agglutination in platelets. In a large panel of diverse cancer cell lines, ARQ 092 inhibits proliferation across multiple tumor types but are most potent in leukemia, breast, endometrial, and colorectal cancer cell lines. Moreover, inhibition by ARQ 092 is more prevalent in cancer cell lines containing PIK3CA/PIK3R1 mutations compared to those with wt-PIK3CA/PIK3R1 or PTEN mutations. ARQ 092 targets the PI3K/AKT pathway and AKT specifically and reduces phosphorylation of GSK3a and GSK3ß in mutation-positive cells.	False	Nc1ncccc1-c1nc2ccc(-c3ccccc3)nc2n1-c1ccc(C2(N)CCC2)cc1
410145	410145:01:05_00.20	True	0.2	100	13.3	65.3	0.0	0.0	46.6	0.0	27.3	0.0	0.0	0.0	53.4	0.0	0.0	AKT_PI3K_MTOR	65.3	Y-39983 HCl	Y-39983 is a selective rho-associated protein kinase(ROCK) inhibitor with an IC50 of 3.6 nM.	True	C[C@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1
410940	410940:02:04_01.00	True	1.0	102	23.3	75.7	0.0	0.0	39.5	0.0	33.8	0.0	0.0	0.0	43.6	0.0	11.4	AKT_PI3K_MTOR	75.7	Reversine	Reversine is a novel class of ATP-competitive Aurora kinase inhibitor with IC50s of 400, 500 and 400 nM for Aurora A, Aurora B and Aurora C, respectively.	False	c1nc2c(NC3CCCCC3)nc(Nc3ccc(N4CCOCC4)cc3)nc2[nH]1
520860	520860:01:03_01.00	True	1.0	71	63.7	0.0	41.3	22.3	35.2	23.1	0.0	32.9	17.8	17.8	0.0	52.0	8.5	Tubulin	52.0	TAS4464	TAS4464 is a highly potent and selective inhibitor of NEDD8 activating enzyme (NAE), with an IC50 of 0.955 nM.	True	CCOc1cccc(F)c1C#Cc1cn([C@@H]2O[C@H](CNS(N)(=O)=O)[C@@H](O)[C@H]2O)c2ncnc(N)c12
410884	410884:02:06_01.00	True	1.0	76	76.7	0.0	0.0	91.8	0.0	87.3	0.0	82.1	65.5	68.6	0.0	91.1	63.3	BET	91.8	CF53	CF53 is a highly potent, selective and orally active inhibitor of BET protein, with a Ki of <1 nM, Kd of 2.2 nM and an IC50 of 2 nM for BRD4 BD1. CF53 binds to both the BD1 and BD2 domains of BRD2, BRD3, BRD4, and BRDT BET proteins with high affinities, very selective over non-BET bromodomain-containing proteins. CF53 shows potent anti-tumor activity both in vitro and in vivo.	False	COc1cc2c(cc1-c1c(C)noc1C)[nH]c1nc(C)nc(Nc3cc(C4CC4)nn3C)c12
520873	520873:02:02_00.10	True	0.1	111	6.6	63.8	0.0	0.0	40.8	0.0	11.1	0.0	0.0	0.0	53.6	0.0	0.0	AKT_PI3K_MTOR	63.8	BAY1125976	BAY1125976 is a selective allosteric Akt1/Akt2 inhibitor; inhibits Akt1 and Akt2 activity with IC50 values of 5.2 nM and 18 nM at 10 uM ATP, respectively.	False	NC(=O)c1ccc2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)n2n1
520860	520860:02:02_00.10	True	0.1	79	54.7	0.0	53.6	38.9	0.0	47.4	6.2	32.0	36.8	39.8	0.0	61.1	7.7	Tubulin	61.1	TAS4464	TAS4464 is a highly potent and selective inhibitor of NEDD8 activating enzyme (NAE), with an IC50 of 0.955 nM.	True	CCOc1cccc(F)c1C#Cc1cn([C@@H]2O[C@H](CNS(N)(=O)=O)[C@@H](O)[C@H]2O)c2ncnc(N)c12
520875	520875:01:03_01.00	True	1.0	97	19.2	0.0	0.0	80.5	0.0	76.7	17.7	88.7	39.4	53.2	0.0	72.9	56.7	LCH	88.7	Centrinone-B	Centrinone-B (LCR-323) is a potent and highly selective PLK4 inhibitor, with a Ki of 0.59 nM.	False	COc1c(Nc2cc(C)[nH]n2)nc(Sc2ccc(S(=O)(=O)Cc3cccc([N+](=O)[O-])c3F)cc2F)nc1N1CCCCC1
408952	408952:01:16_00.10	True	0.1	97	5.9	0.0	0.0	75.9	0.0	71.6	4.0	55.3	61.6	42.2	0.0	70.3	53.3	BET	75.9		BI-4659 is a potent inhibitor of Alk5 (TGFßR1) with an IC50 value of 19 nM and shows selectivity against a broad panel of other kinases. BI-4659 blocks the phosphorylation of Smad2 and Smad3 in HaCaT cells with an EC50 of 185 nM. Negative control = BI-4101	False	CCNC(=O)c1ccc2c(/C(=N/c3ccc(CN(C)C)cc3)c3ccccc3)c(O)[nH]c2c1
520873	520873:01:02_01.00	True	1.0	88	12.1	63.9	0.0	0.0	56.2	5.6	37.1	29.1	0.0	9.9	24.8	0.0	27.8	AKT_PI3K_MTOR	63.9	BAY1125976	BAY1125976 is a selective allosteric Akt1/Akt2 inhibitor; inhibits Akt1 and Akt2 activity with IC50 values of 5.2 nM and 18 nM at 10 uM ATP, respectively.	False	NC(=O)c1ccc2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)n2n1
410624	410624:03:07_01.00	True	1.0	83	73.4	0.0	0.0	80.3	0.0	81.2	32.1	78.5	55.9	71.7	0.0	83.6	65.5	Tubulin	83.6	AZD-7762	AZD7762 is a potent and selective inhibitor of Chk1 with IC50 of 5 nM in a cell-free assay. It is equally potent against Chk2 and less potent against CAM, Yes, Fyn, Lyn, Hck and Lck. Phase 1.	True	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1
409865	409865:03:02_00.10	True	0.1	77	27.8	0.0	30.9	19.3	24.1	20.6	0.0	22.1	14.0	2.7	0.0	48.0	9.1	Tubulin	48.0	Pevonedistat	Pevonedistat (MLN4924) is a potent and selective NEDD8-activating enzyme (NAE) inhibitor with an IC50 of 4.7 nM.	True	NS(=O)(=O)OC[C@@H]1C[C@@H](n2ccc3c(N[C@H]4CCc5ccccc54)ncnc32)C[C@@H]1O
410990	410990:02:05_01.00	True	1.0	77	54.1	0.0	0.0	83.4	0.0	95.4	18.8	67.3	70.5	65.8	0.0	78.4	67.1	HDAC	95.4	LMK-235	LMK-235 is a potent and selective HDAC4/5 inhibitor, inhibits HDAC5, HDAC4, HDAC6, HDAC1, HDAC2, HDAC11 and HDAC8, with IC50s of 4.22 nM, 11.9 nM, 55.7 nM, 320 nM, 881 nM, 852 nM and 1278 nM, respectively, and is used in cancer research.	False	Cc1cc(C)cc(C(=O)NOCCCCCC(=O)NO)c1
409865	409865:02:04_00.10	True	0.1	92	12.6	0.0	31.7	14.6	18.1	21.1	0.0	10.9	21.7	1.7	0.0	39.7	12.4	Tubulin	39.7	Pevonedistat	Pevonedistat (MLN4924) is a potent and selective NEDD8-activating enzyme (NAE) inhibitor with an IC50 of 4.7 nM.	True	NS(=O)(=O)OC[C@@H]1C[C@@H](n2ccc3c(N[C@H]4CCc5ccccc54)ncnc32)C[C@@H]1O
410811	410811:02:04_00.20	True	0.2	91	15.2	0.0	10.1	41.2	0.0	57.7	0.0	28.8	51.5	0.0	0.0	33.8	22.1	HDAC	57.7	Scriptaid	Scriptaid is a potent histone deacetylase (HDAC) inhibitor, used in cancer research. Scriptaid is also a sensitizer to antivirals and has potential for epstein-barr virus (EBV)-associated lymphomas treatment.	False	O=C(CCCCCN1C(=O)c2cccc3cccc(c23)C1=O)NO
410871	410871:04:05_01.00	True	1.0	93	48.4	0.0	0.0	88.5	0.0	82.3	21.6	78.3	52.8	66.3	0.0	81.2	65.8	BET	88.5	Ilginatinib	Ilginatinib (NS-018) is a highly active and orally bioavailable JAK2 inhibitor, with an IC50 of 0.72 nM, 46-, 54-, and 31-fold selectivity for JAK2 over JAK1 (IC50, 33 nM), JAK3 (IC50, 39 nM), and Tyk2 (IC50, 22 nM).	False	C[C@H](Nc1cc(-c2cnn(C)c2)cc(Nc2cnccn2)n1)c1ccc(F)cc1
520859	520859:02:02_00.30	True	0.3	68	51.6	0.0	9.7	52.3	0.0	58.5	0.7	52.8	45.2	51.7	0.0	58.3	42.9	HDAC	58.5	TAK-243	TAK-243 (MLN7243) is a first-in-class, selective ubiquitin activating enzyme, UAE (UBA1) inhibitor (IC50=1 nM), which blocks ubiquitin conjugation, disrupting monoubiquitin signaling as well as global protein ubiquitination. TAK-243 (MLN7243) induces endoplasmic reticulum (ER) stress, abrogates NF-.k.B pathway activation and promotes apoptosis.	True	NS(=O)(=O)OC[C@H]1C[C@@H](Nc2ccnc3cc(-c4cccc(SC(F)(F)F)c4)nn23)[C@H](O)[C@@H]1O
410916	410916:02:04_00.60	True	0.6	86	33.2	0.0	0.0	76.4	0.0	85.4	8.3	59.9	63.5	41.3	0.0	75.8	65.2	HDAC	85.4	M344	M344 (D 237) is an inhibitor of histone deacetylase (IC50=100 nM) and an inducer of terminal cell fifferentiation.	False	CN(C)c1ccc(C(=O)NCCCCCCC(=O)NO)cc1
407889	407889:01:05_03.00	True	3.0	80	18.8	0.0	59.4	0.0	8.9	1.2	44.0	0.0	8.5	0.9	3.9	18.6	0.0	Aurora	59.4	H-1152 (dihydrochloride)	H-1152 dihydrochloride is a membrane-permeable and selective ROCK inhibitor, with a Ki value of 1.6 nM, and an IC50 value of 12 nM for ROCK2.	True	Cc1cncc2cccc(S(=O)(=O)N3CCCNC[C@@H]3C)c12
411125	411125:01:07_03.00	True	3.0	95	46.3	7.7	0.0	66.4	0.0	64.9	28.4	88.5	23.1	42.4	0.0	61.4	52.5	LCH	88.5	Miransertib HCl, ARQ 092	it is a novel, orally bioavailable and selective AKT pathway inhibitor exhibiting a manageable safety profile among patients with advanced solid tumors. ARQ 092 blocks membrane translocation of inactive AKT and even dephosphorylates the membrane-associated active form, thereby perturbing AKT activity. Treatment with 50-500 nM ARQ 092 significantly blocks aMß2 integrin function in neutrophils and reduces P-selectin exposure and glycoprotein Ib/IX/V-mediated agglutination in platelets. In a large panel of diverse cancer cell lines, ARQ 092 inhibits proliferation across multiple tumor types but are most potent in leukemia, breast, endometrial, and colorectal cancer cell lines. Moreover, inhibition by ARQ 092 is more prevalent in cancer cell lines containing PIK3CA/PIK3R1 mutations compared to those with wt-PIK3CA/PIK3R1 or PTEN mutations. ARQ 092 targets the PI3K/AKT pathway and AKT specifically and reduces phosphorylation of GSK3a and GSK3ß in mutation-positive cells.	False	Nc1ncccc1-c1nc2ccc(-c3ccccc3)nc2n1-c1ccc(C2(N)CCC2)cc1
410145	410145:01:05_00.60	True	0.6	98	11.4	46.7	0.0	0.0	35.5	0.0	19.2	2.3	0.0	0.0	37.8	0.0	1.7	AKT_PI3K_MTOR	46.7	Y-39983 HCl	Y-39983 is a selective rho-associated protein kinase(ROCK) inhibitor with an IC50 of 3.6 nM.	True	C[C@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1
280897	280897:07:11_00.30	True	0.3	77	35.6	0.0	0.0	70.3	0.0	65.1	11.2	60.6	59.1	53.9	0.0	88.7	54.2	Tubulin	88.7	Rotenone	Rotenone is an mitochondrial electron transport chain complex I inhibitor.  Rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production.	True	C=C(C)[C@H]1Cc2c(ccc3c2O[C@@H]2COc4cc(OC)c(OC)cc4[C@@H]2C3=O)O1
410940	410940:02:04_03.00	True	3.0	67	30.9	14.3	75.4	0.0	47.5	0.0	23.7	0.0	0.0	0.0	50.8	0.0	0.0	Aurora	75.4	Reversine	Reversine is a novel class of ATP-competitive Aurora kinase inhibitor with IC50s of 400, 500 and 400 nM for Aurora A, Aurora B and Aurora C, respectively.	False	c1nc2c(NC3CCCCC3)nc(Nc3ccc(N4CCOCC4)cc3)nc2[nH]1
520860	520860:01:03_03.00	True	3.0	67	63.2	0.0	30.5	25.4	32.3	24.4	0.0	38.8	24.1	22.0	0.0	54.4	15.7	Tubulin	54.4	TAS4464	TAS4464 is a highly potent and selective inhibitor of NEDD8 activating enzyme (NAE), with an IC50 of 0.955 nM.	True	CCOc1cccc(F)c1C#Cc1cn([C@@H]2O[C@H](CNS(N)(=O)=O)[C@@H](O)[C@H]2O)c2ncnc(N)c12
520873	520873:02:02_00.30	True	0.3	105	6.9	78.8	0.0	0.0	83.3	0.0	0.0	0.0	0.0	0.0	79.6	0.0	0.0	DNA_Synth	83.3	BAY1125976	BAY1125976 is a selective allosteric Akt1/Akt2 inhibitor; inhibits Akt1 and Akt2 activity with IC50 values of 5.2 nM and 18 nM at 10 uM ATP, respectively.	False	NC(=O)c1ccc2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)n2n1
520860	520860:02:02_00.30	True	0.3	74	50.1	0.0	51.8	27.9	5.4	32.9	0.0	29.2	31.2	29.5	0.0	53.7	5.1	Tubulin	53.7	TAS4464	TAS4464 is a highly potent and selective inhibitor of NEDD8 activating enzyme (NAE), with an IC50 of 0.955 nM.	True	CCOc1cccc(F)c1C#Cc1cn([C@@H]2O[C@H](CNS(N)(=O)=O)[C@@H](O)[C@H]2O)c2ncnc(N)c12
520875	520875:01:03_03.00	True	3.0	98	49.9	0.0	0.0	81.9	0.0	79.4	23.7	87.5	37.8	55.3	0.0	71.1	55.4	LCH	87.5	Centrinone-B	Centrinone-B (LCR-323) is a potent and highly selective PLK4 inhibitor, with a Ki of 0.59 nM.	False	COc1c(Nc2cc(C)[nH]n2)nc(Sc2ccc(S(=O)(=O)Cc3cccc([N+](=O)[O-])c3F)cc2F)nc1N1CCCCC1
408952	408952:01:16_00.30	True	0.3	105	18.5	0.0	0.0	87.5	0.0	80.2	21.6	66.0	57.6	66.8	0.0	84.1	64.1	BET	87.5		BI-4659 is a potent inhibitor of Alk5 (TGFßR1) with an IC50 value of 19 nM and shows selectivity against a broad panel of other kinases. BI-4659 blocks the phosphorylation of Smad2 and Smad3 in HaCaT cells with an EC50 of 185 nM. Negative control = BI-4101	False	CCNC(=O)c1ccc2c(/C(=N/c3ccc(CN(C)C)cc3)c3ccccc3)c(O)[nH]c2c1
520873	520873:01:02_03.00	True	3.0	101	19.9	60.7	0.0	12.1	39.2	15.9	29.8	51.0	0.0	20.3	12.7	11.5	34.7	AKT_PI3K_MTOR	60.7	BAY1125976	BAY1125976 is a selective allosteric Akt1/Akt2 inhibitor; inhibits Akt1 and Akt2 activity with IC50 values of 5.2 nM and 18 nM at 10 uM ATP, respectively.	False	NC(=O)c1ccc2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)n2n1
410624	410624:03:07_03.00	True	3.0	56	81.0	0.0	0.0	80.6	0.0	85.4	23.9	70.4	67.4	70.6	0.0	87.8	50.3	Tubulin	87.8	AZD-7762	AZD7762 is a potent and selective inhibitor of Chk1 with IC50 of 5 nM in a cell-free assay. It is equally potent against Chk2 and less potent against CAM, Yes, Fyn, Lyn, Hck and Lck. Phase 1.	True	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1
409865	409865:03:02_00.30	True	0.3	86	34.2	0.0	53.7	22.4	0.0	28.3	0.0	20.5	34.0	22.6	0.0	48.4	0.0	Aurora	53.7	Pevonedistat	Pevonedistat (MLN4924) is a potent and selective NEDD8-activating enzyme (NAE) inhibitor with an IC50 of 4.7 nM.	True	NS(=O)(=O)OC[C@@H]1C[C@@H](n2ccc3c(N[C@H]4CCc5ccccc54)ncnc32)C[C@@H]1O
410990	410990:02:05_03.00	True	3.0	61	59.8	0.0	0.0	76.8	0.0	93.7	23.0	61.9	68.1	69.9	0.0	70.2	63.2	HDAC	93.7	LMK-235	LMK-235 is a potent and selective HDAC4/5 inhibitor, inhibits HDAC5, HDAC4, HDAC6, HDAC1, HDAC2, HDAC11 and HDAC8, with IC50s of 4.22 nM, 11.9 nM, 55.7 nM, 320 nM, 881 nM, 852 nM and 1278 nM, respectively, and is used in cancer research.	False	Cc1cc(C)cc(C(=O)NOCCCCCC(=O)NO)c1
409865	409865:02:04_00.30	True	0.3	90	28.8	0.0	49.8	26.6	0.0	32.7	0.0	20.8	35.9	26.4	0.0	51.8	6.4	Tubulin	51.8	Pevonedistat	Pevonedistat (MLN4924) is a potent and selective NEDD8-activating enzyme (NAE) inhibitor with an IC50 of 4.7 nM.	True	NS(=O)(=O)OC[C@@H]1C[C@@H](n2ccc3c(N[C@H]4CCc5ccccc54)ncnc32)C[C@@H]1O
410811	410811:02:04_00.60	True	0.6	89	25.6	0.0	0.0	75.6	0.0	82.0	9.8	63.6	61.0	35.5	0.0	77.0	64.1	HDAC	82.0	Scriptaid	Scriptaid is a potent histone deacetylase (HDAC) inhibitor, used in cancer research. Scriptaid is also a sensitizer to antivirals and has potential for epstein-barr virus (EBV)-associated lymphomas treatment.	False	O=C(CCCCCN1C(=O)c2cccc3cccc(c23)C1=O)NO
410871	410871:04:05_03.00	True	3.0	83	75.3	0.0	0.0	84.0	0.0	76.2	27.8	74.9	49.8	71.2	0.0	85.1	63.1	Tubulin	85.1	Ilginatinib	Ilginatinib (NS-018) is a highly active and orally bioavailable JAK2 inhibitor, with an IC50 of 0.72 nM, 46-, 54-, and 31-fold selectivity for JAK2 over JAK1 (IC50, 33 nM), JAK3 (IC50, 39 nM), and Tyk2 (IC50, 22 nM).	False	C[C@H](Nc1cc(-c2cnn(C)c2)cc(Nc2cnccn2)n1)c1ccc(F)cc1
520874	520874:01:04_10.00	True	10.0	95	7.4	0.0	10.0	65.3	0.0	70.6	29.5	39.9	41.0	64.3	0.0	64.0	34.5	HDAC	70.6	Apcin	Apcin, a ligand of Cdc20, is an anaphase-promoting complex/cyclosome (APC/C(Cdc20)) E3 ligase activity inhibitor. Apcin competitively inhibits APC/C-dependent ubiquitylation by binding to Cdc20 and preventing substrate recognition. Apcin occupies the D-box-binding pocket on the side face of the WD40-domain and can prolong mitosis.	False	Cc1ncc([N+](=O)[O-])n1CCOC(=O)NC(Nc1ncccn1)C(Cl)(Cl)Cl
411147	411147:03:03_01.00	True	1.0	105	28.8	0.0	0.0	46.5	0.0	48.8	39.9	51.3	8.3	46.8	0.0	50.3	37.5	LCH	51.3	Avapritinib	Avapritinib (BLU-285) is a highly potent, selective, and orally active KIT and PDGFRA activation loop mutant kinases inhibitor with IC50s of 0.27 and 0.24 nM for KIT D816V and PDGFRA D842V, respectively. Avapritinib (BLU-285) binds the active conformation of the kinase and shows antitumor activity. Avapritinib (BLU-285) attenuates the transport function of both ABCB1 and ABCG2.	True	Cn1cc(-c2cc3c(N4CCN(c5ncc([C@@](C)(N)c6ccc(F)cc6)cn5)CC4)ncnn3c2)cn1
410916	410916:02:04_02.00	True	2.0	66	46.3	0.0	0.0	75.0	0.0	87.8	21.4	60.4	59.1	60.5	0.0	71.1	55.7	HDAC	87.8	M344	M344 (D 237) is an inhibitor of histone deacetylase (IC50=100 nM) and an inducer of terminal cell fifferentiation.	False	CN(C)c1ccc(C(=O)NCCCCCCC(=O)NO)cc1
407889	407889:01:05_10.00	True	10.0	59	26.8	0.0	77.0	0.0	0.0	9.4	22.4	0.0	12.1	14.3	0.0	0.0	0.0	Aurora	77.0	H-1152 (dihydrochloride)	H-1152 dihydrochloride is a membrane-permeable and selective ROCK inhibitor, with a Ki value of 1.6 nM, and an IC50 value of 12 nM for ROCK2.	True	Cc1cncc2cccc(S(=O)(=O)N3CCCNC[C@@H]3C)c12
410145	410145:01:05_02.00	True	2.0	88	18.0	0.0	0.0	28.4	0.0	46.1	19.2	43.1	20.1	36.3	0.0	30.0	24.8	HDAC	46.1	Y-39983 HCl	Y-39983 is a selective rho-associated protein kinase(ROCK) inhibitor with an IC50 of 3.6 nM.	True	C[C@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1
280897	280897:07:11_01.00	True	1.0	58	53.2	0.0	14.4	72.1	0.0	77.9	30.0	57.4	58.2	70.0	0.0	86.1	48.9	Tubulin	86.1	Rotenone	Rotenone is an mitochondrial electron transport chain complex I inhibitor.  Rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production.	True	C=C(C)[C@H]1Cc2c(ccc3c2O[C@@H]2COc4cc(OC)c(OC)cc4[C@@H]2C3=O)O1
410940	410940:02:04_10.00	True	10.0	68	26.1	1.9	51.9	0.0	15.0	3.1	37.8	19.3	0.0	12.3	1.1	7.4	0.0	Aurora	51.9	Reversine	Reversine is a novel class of ATP-competitive Aurora kinase inhibitor with IC50s of 400, 500 and 400 nM for Aurora A, Aurora B and Aurora C, respectively.	False	c1nc2c(NC3CCCCC3)nc(Nc3ccc(N4CCOCC4)cc3)nc2[nH]1
520860	520860:01:03_10.00	True	10.0	60	58.0	0.0	11.1	58.7	0.0	62.8	12.2	63.2	51.3	49.3	0.0	72.4	45.0	Tubulin	72.4	TAS4464	TAS4464 is a highly potent and selective inhibitor of NEDD8 activating enzyme (NAE), with an IC50 of 0.955 nM.	True	CCOc1cccc(F)c1C#Cc1cn([C@@H]2O[C@H](CNS(N)(=O)=O)[C@@H](O)[C@H]2O)c2ncnc(N)c12
520873	520873:02:02_01.00	True	1.0	97	7.3	76.3	0.0	0.0	69.0	0.0	40.7	12.3	0.0	4.4	45.3	0.0	22.6	AKT_PI3K_MTOR	76.3	BAY1125976	BAY1125976 is a selective allosteric Akt1/Akt2 inhibitor; inhibits Akt1 and Akt2 activity with IC50 values of 5.2 nM and 18 nM at 10 uM ATP, respectively.	False	NC(=O)c1ccc2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)n2n1
520860	520860:02:02_01.00	True	1.0	72	54.4	0.0	43.7	14.6	39.5	15.6	4.3	32.5	11.0	17.2	0.0	47.3	2.2	Tubulin	47.3	TAS4464	TAS4464 is a highly potent and selective inhibitor of NEDD8 activating enzyme (NAE), with an IC50 of 0.955 nM.	True	CCOc1cccc(F)c1C#Cc1cn([C@@H]2O[C@H](CNS(N)(=O)=O)[C@@H](O)[C@H]2O)c2ncnc(N)c12
520875	520875:01:03_10.00	True	10.0	90	57.2	0.0	0.0	79.3	0.0	78.7	34.8	78.0	37.8	59.8	0.0	70.5	64.9	BET	79.3	Centrinone-B	Centrinone-B (LCR-323) is a potent and highly selective PLK4 inhibitor, with a Ki of 0.59 nM.	False	COc1c(Nc2cc(C)[nH]n2)nc(Sc2ccc(S(=O)(=O)Cc3cccc([N+](=O)[O-])c3F)cc2F)nc1N1CCCCC1
408952	408952:01:16_01.00	True	1.0	101	51.8	0.0	0.0	80.0	0.0	76.2	32.1	71.7	39.7	67.7	0.0	80.2	55.7	Tubulin	80.2		BI-4659 is a potent inhibitor of Alk5 (TGFßR1) with an IC50 value of 19 nM and shows selectivity against a broad panel of other kinases. BI-4659 blocks the phosphorylation of Smad2 and Smad3 in HaCaT cells with an EC50 of 185 nM. Negative control = BI-4101	False	CCNC(=O)c1ccc2c(/C(=N/c3ccc(CN(C)C)cc3)c3ccccc3)c(O)[nH]c2c1
520873	520873:01:02_10.00	True	10.0	94	53.7	0.2	0.0	64.5	0.0	63.1	21.0	89.2	18.7	38.1	0.0	63.0	49.4	LCH	89.2	BAY1125976	BAY1125976 is a selective allosteric Akt1/Akt2 inhibitor; inhibits Akt1 and Akt2 activity with IC50 values of 5.2 nM and 18 nM at 10 uM ATP, respectively.	False	NC(=O)c1ccc2nc(-c3ccc(C4(N)CCC4)cc3)c(-c3ccccc3)n2n1
281049	281049:01:09_10.00	True	10.0	95	5.4	59.5	0.0	0.0	68.4	0.0	2.7	0.0	0.0	0.0	59.4	0.0	6.8	DNA_Synth	68.4	Y-27632 2HCl	highly potent, cell-permeable, and selective Rho-associated coiled-coil forming protein serine/threonine kinase (ROCK) inhibitor. Also inhibits ROCK-II with equal potency. The inhibition is competitive with respect to ATP.	False	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1
520875	520875:02:02_01.00	True	1.0	105	27.5	0.0	0.0	71.1	0.0	72.5	26.3	79.8	18.7	47.9	0.0	63.6	47.7	LCH	79.8	Centrinone-B	Centrinone-B (LCR-323) is a potent and highly selective PLK4 inhibitor, with a Ki of 0.59 nM.	False	COc1c(Nc2cc(C)[nH]n2)nc(Sc2ccc(S(=O)(=O)Cc3cccc([N+](=O)[O-])c3F)cc2F)nc1N1CCCCC1
410094	410094:01:06_02.00	True	2.0	90	15.9	9.1	11.9	0.0	37.5	0.0	36.0	16.8	0.0	12.9	24.9	15.1	0.0	DNA_Synth	37.5	Belumosudil	Belumosudil (KD025) is a selective inhibitor of ROCK2 with IC50s of 105 nM and 24 uM for ROCK2 and ROCK1, respectively. Anti-fibrotic properties.	False	CC(C)NC(=O)COc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3ccccc3n2)c1
409865	409865:03:02_01.00	True	1.0	74	40.2	0.0	56.2	13.5	14.6	19.2	7.6	19.4	18.3	34.3	0.0	44.1	0.7	Aurora	56.2	Pevonedistat	Pevonedistat (MLN4924) is a potent and selective NEDD8-activating enzyme (NAE) inhibitor with an IC50 of 4.7 nM.	True	NS(=O)(=O)OC[C@@H]1C[C@@H](n2ccc3c(N[C@H]4CCc5ccccc54)ncnc32)C[C@@H]1O
410990	410990:02:05_10.00	True	10.0	59	51.6	0.0	0.0	75.2	0.0	88.7	18.1	62.5	59.4	65.7	0.0	67.1	58.3	HDAC	88.7	LMK-235	LMK-235 is a potent and selective HDAC4/5 inhibitor, inhibits HDAC5, HDAC4, HDAC6, HDAC1, HDAC2, HDAC11 and HDAC8, with IC50s of 4.22 nM, 11.9 nM, 55.7 nM, 320 nM, 881 nM, 852 nM and 1278 nM, respectively, and is used in cancer research.	False	Cc1cc(C)cc(C(=O)NOCCCCCC(=O)NO)c1
409865	409865:02:04_01.00	True	1.0	75	47.5	0.0	49.9	34.6	0.0	41.2	12.5	38.0	32.9	38.8	0.0	59.0	9.7	Tubulin	59.0	Pevonedistat	Pevonedistat (MLN4924) is a potent and selective NEDD8-activating enzyme (NAE) inhibitor with an IC50 of 4.7 nM.	True	NS(=O)(=O)OC[C@@H]1C[C@@H](n2ccc3c(N[C@H]4CCc5ccccc54)ncnc32)C[C@@H]1O
411129	411129:01:05_10.00	True	10.0	94	16.6	68.1	0.0	0.0	69.5	0.0	24.7	37.5	0.0	0.0	36.1	1.2	15.4	DNA_Synth	69.5	Borussertib	Borussertib is a covalent-allosteric and first-in-class inhibitor of protein kinase Akt, with an IC50 of 0.8 nM and a Ki of 2.2 nM for Aktwt.	False	C=CC(=O)Nc1ccc2nc(O)n(C3CCN(Cc4ccc(-c5nc6ccnc(O)c6cc5-c5ccccc5)cc4)CC3)c2c1
410811	410811:02:04_02.00	True	2.0	66	50.4	0.0	0.0	77.5	0.0	87.7	20.7	66.6	58.5	56.7	0.0	74.1	53.0	HDAC	87.7	Scriptaid	Scriptaid is a potent histone deacetylase (HDAC) inhibitor, used in cancer research. Scriptaid is also a sensitizer to antivirals and has potential for epstein-barr virus (EBV)-associated lymphomas treatment.	False	O=C(CCCCCN1C(=O)c2cccc3cccc(c23)C1=O)NO
410871	410871:04:05_10.00	True	10.0	53	84.3	0.0	0.7	79.4	0.0	80.7	22.0	74.3	54.3	64.9	0.0	81.4	49.7	Tubulin	81.4	Ilginatinib	Ilginatinib (NS-018) is a highly active and orally bioavailable JAK2 inhibitor, with an IC50 of 0.72 nM, 46-, 54-, and 31-fold selectivity for JAK2 over JAK1 (IC50, 33 nM), JAK3 (IC50, 39 nM), and Tyk2 (IC50, 22 nM).	False	C[C@H](Nc1cc(-c2cnn(C)c2)cc(Nc2cnccn2)n1)c1ccc(F)cc1
246815	246815:01:04_10.00	True	10.0	110	61.1	0.0	0.0	82.3	0.0	81.9	24.3	85.6	42.8	55.6	0.0	73.2	58.8	LCH	85.6	Aripiprazole	antipsychotic, 5ht2a antagonist.	False	O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
246876	246876:01:04_10.00	True	10.0	86	21.1	2.1	0.0	57.0	0.0	49.7	28.9	57.7	31.5	45.1	0.0	86.2	57.4	Tubulin	86.2	Ethynyl Estradiol	Ethynyl Estradiol (17.a.-Ethynylestradiol;Ethynylestradiol) is an orally bio-active estrogen used in almost all modern formulations of combined oral contraceptive pills.Target: Estrogen ReceptorEthynyl Estradiol (17.a.-Ethynylestradiol;Ethynylestradiol), also sometimes written as ethinylestradiol, ethynyl estradiol, or ethinyl estradiol, is a derivative of 17.b.-estradiol (E2), the major endogenous estrogen in humans. Ethynyl Estradiol (17.a.-Ethynylestradiol;Ethynylestradiol) is an orally bioactive estrogen used in many formulations of combined oral contraceptive pills. It is one of the most commonly used medications for this purpose. Transdermal ethinyl estradiol carries a greater risk of clot formation and venous thromboembolism than 17 beta estradiol, which some have theorized to be related to different amounts of hepatic metabolism after absorption. The same contraindications and precautions apply for EE as with other estrogen medications.Ethynyl Estradiol was a preparation of Ethynyl Estradiol alone that was used for the management of menopausal symptoms and female hypogonadism. Ethynyl Estradiol (17.a.-Ethynylestradiol;Ethynylestradiol) is released into the environment as a xenoestrogen from the urine and feces of people who take it as a medication. The major concern with unopposed estrogen is of endometrial cancer. As such, the medication is generally prescribed with progesterone in the setting of birth control. The first orally active semisynthetic steroidal estrogen, Ethynyl Estradiol, the 17.a.-ethynyl analog of E2, was synthesized in 1938 by Hans Herloff Inhoffen and Walter Hohlweg at Schering AG in Berlin.	True	C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@@]21C
247293	247293:01:04_10.00	True	10.0	107	25.7	0.0	0.0	76.8	0.0	75.6	17.1	85.5	37.4	48.0	0.0	62.5	51.6	LCH	85.5	Proadifen (hydrochloride)	inhibitor of microsomal drug metabolism, Cytochrome P450 mono-oxygenases inhibitor, cytochrome p450 inhibitor, ca antagonist.	False	CCCC(C(=O)OCCN(CC)CC)(c1ccccc1)c1ccccc1
245325	245325:02:04_10.00	True	10.0	97	51.3	0.0	0.0	74.2	0.0	75.8	36.5	84.1	35.1	50.6	0.0	67.9	55.0	LCH	84.1	Reserpine, Methyl reserpate	inhibits vesicular catecholine and serotonin uptake, antihypertensive.	False	COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC
247224	247224:01:04_10.00	True	10.0	83	30.6	11.8	0.0	61.3	0.0	56.2	36.7	68.8	25.9	44.5	0.0	66.0	62.9	LCH	68.8	Avermectin B1a	ligand GABA receptors.	False	CC[C@H](C)[C@H]1O[C@]2(C=C[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)C(O[C@H]3C[C@H](OC)C(O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2
246818	246818:01:04_10.00	True	10.0	105	31.3	0.0	0.0	75.7	0.0	75.3	19.4	87.4	34.1	50.3	0.0	67.0	51.6	LCH	87.4	Benztropine mesylate	anticholinergic.	False	CN1[C@H]2CC[C@@H]1C[C@H](OC(c1ccccc1)c1ccccc1)C2
151729	151729:02:04_10.00	True	10.0	99	5.2	7.0	0.0	59.9	0.0	48.7	31.6	63.0	16.3	39.6	0.0	64.6	58.8	Tubulin	64.6	Dopamine hydrochloride	endogenous neurotransmitter, beta 1 receptors stimulator, cardiotonic, antihypotensive.	False	NCCc1ccc(O)c(O)c1
247349	247349:01:04_10.00	True	10.0	64	23.5	25.4	15.8	0.0	53.7	0.0	0.0	0.0	0.0	13.2	43.3	0.0	0.0	DNA_Synth	53.7	Azacytidine-5	antimetabolite.	True	Nc1ncn(C2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1
246667	246667:01:04_10.00	True	10.0	106	56.8	0.0	0.0	76.0	0.0	78.8	27.7	89.9	33.5	51.8	0.0	69.3	50.7	LCH	89.9	Imatinib	Imatinib (STI571) is an orally bioavailable tyrosine kinases inhibitor that selectively inhibits BCR/ABL, v-Abl, PDGFR and c-kit kinase activity. Imatinib (STI571) works by binding close to the ATP binding site, locking it in a closed or self-inhibited conformation, therefore inhibiting the enzyme activity of the protein semicompetitively. Imatinib also is an inhibitor of SARS-CoV and MERS-CoV.	False	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1
246814	246814:01:04_10.00	True	10.0	98	15.2	7.8	0.0	57.8	0.0	59.2	24.3	79.6	18.1	35.0	0.0	57.7	53.0	LCH	79.6	Amlodipine	calcium channel blocker.	False	CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl
246719	246719:01:04_10.00	True	10.0	69	29.9	59.4	12.1	0.0	97.1	0.0	0.0	0.0	0.0	0.0	75.3	0.0	0.0	DNA_Synth	97.1	Fludarabine	Fludarabine (NSC 118218) is a DNA synthesis inhibitor, which also inhibits phosphorylation of STAT1. Fludarabine, a pro-drug, is converted metabolically by dephosphorylation to the antimetabolite, F-ara-A.	True	Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O
247339	247339:01:04_10.00	True	10.0	93	5.5	0.0	0.0	40.6	0.0	32.5	1.0	39.5	24.3	34.2	0.0	41.3	24.9	Tubulin	41.3	Roxithromycin	ribosomal protein synthesis inhibitor, antibacterial.	False	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)/C(=N\OCOCCOC)[C@H](C)[C@@H](O)[C@]1(C)O
246913	246913:01:04_10.00	True	10.0	109	6.4	6.8	0.0	60.6	0.0	54.7	29.2	61.7	13.6	63.2	0.0	61.1	63.3	Uncoupler	63.3	(±)-Epinephrine hydrochloride, (±)-Adrenalin hydrochloride	adrenoceptor agonist, non-selective agonist of all adrenergic receptors.	False	CNCC(O)c1ccc(O)c(O)c1
247024	247024:01:04_10.00	True	10.0	107	6.0	22.8	0.0	44.3	5.5	33.4	21.9	59.8	1.0	30.6	0.0	57.2	52.9	LCH	59.8	Fenoterol (hydrobromide)	Fenoterol hydrobromide (Th-1165a), a sympathomimetic agent, is a selective and orally active .b.2-adrenoceptor agonist. Fenoterol hydrobromide is an effective bronchodilator and can be used for bronchospasm associated with asthma, bronchitis and other obstructive airway diseases research.	False	CC(Cc1ccc(O)cc1)NCC(O)c1cc(O)cc(O)c1
246628	246628:01:04_10.00	True	10.0	102	58.4	0.0	0.0	78.8	0.0	77.6	21.8	92.1	38.7	47.0	0.0	72.4	55.5	LCH	92.1	Zuclopenthixol hydrochloride	antagonist at D1 and D2 dopamine receptors; inhibitory activity against Geminin, Aberrant vpr protein (HIV), Glucagon-like peptide 1 receptor, (Plasmodium falciparum)	False	OCCN1CCN(CC/C=C2/c3ccccc3Sc3ccc(Cl)cc32)CC1
247272	247272:01:04_10.00	True	10.0	100	6.6	8.0	0.0	56.0	0.0	49.3	33.5	66.3	5.7	38.8	0.0	62.8	54.3	LCH	66.3	Isoetharine mesylate	beta-Adrenoceptor agonist, bronchodilator, Beta adrenergic agonist.	False	CCC(NC(C)C)C(O)c1ccc(O)c(O)c1
246344	246344:01:04_10.00	True	10.0	113	19.3	0.0	0.0	75.4	0.0	75.9	25.3	79.1	35.0	44.8	0.0	69.3	44.0	LCH	79.1	Drofenine hydrochloride	Affinity for the Muscarinic acetylcholine receptor, inhibitory activity against DNA-(apurinic or apyrimidinic site) lyase	False	CCN(CC)CCOC(=O)C(c1ccccc1)C1CCCCC1
246682	246682:01:05_10.00	True	10.0	92	83.1	0.0	0.0	83.7	0.0	82.6	22.0	87.1	42.3	63.4	0.0	77.9	64.6	LCH	87.1	Sertindole	Sertindole, a neuroleptic, is one of the newer antipsychotic medications available.Target: Multi-targetIn vitro studies showed that sertindole exerts a potent antagonism at serotonin 5-HT2A, 5-HT2C, dopamine D2, and .a.l adrenergic receptors. Sertindole offers an alternative treatment option for refractory patients given its good EPS profile, favorable metabolic profile, and comparable efficacy to risperidone. Due to cardiovascular safety concerns, sertindole is available as a second-line choice for patients intolerant to other antipsychotic agents . Sertindole should prove to be a very useful addition to the therapeutic options available for the treatment of psychotic disorders . Sertindole improves negative symptoms, and is also effective for the treatment of neuroleptic-resistant schizophrenia. Sertindole is generally well tolerated and is associated with a low rate of extrapyramidal symptoms (EPS). Thus, sertindole is a useful option in the treatment of patients with schizophrenia .	False	O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1
247284	247284:01:04_10.00	True	10.0	88	13.0	13.8	58.7	0.0	79.3	0.0	0.0	0.0	0.0	0.0	67.5	0.0	0.0	DNA_Synth	79.3	Vidarabine	adenosine antimetabolite.	True	Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O
246366	246366:01:04_10.00	True	10.0	69	29.9	42.3	33.4	0.0	94.6	0.0	0.0	0.0	0.0	0.0	79.5	0.0	0.0	DNA_Synth	94.6	Topotecan	DNA topoisomerase type 1 inhibitor.	True	CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CN(C)C)c(O)ccc3nc2-1
247346	247346:01:04_10.00	True	10.0	97	70.3	0.0	0.0	75.3	0.0	76.1	24.5	89.2	33.9	45.5	0.0	72.5	48.8	LCH	89.2	Raloxifene (hydrochloride)	Raloxifene hydrochloride (Keoxifene hydrochloride) is a  second generationselective and orally active estrogen receptor modulator. Raloxifene hydrochloride produces estrogen-agonistic effects on bone and lipid metabolism and  estrogen-antagonistic effects on uterine endometrium and breast tissue.	False	O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12
246882	246882:01:04_10.00	True	10.0	110	21.8	0.0	0.0	72.7	0.0	82.4	13.3	78.0	43.8	53.5	0.0	61.4	47.3	HDAC	82.4	Formestane	aromatase inhibitors.	True	C[C@]12CC[C@H]3[C@@H](CCC4=C(O)C(=O)CC[C@@]43C)[C@@H]1CCC2=O
247033	247033:01:04_10.00	True	10.0	99	21.6	0.0	0.0	64.1	0.0	64.8	13.3	91.1	27.0	29.7	0.0	62.8	37.2	LCH	91.1	Trazodone (hydrochloride)	Trazodone (hydrochloride) (AF-1161) is an antidepressant belonging to the class of serotonin receptor antagonists and reuptake inhibitors for treatment of anxiety disorders.	False	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12
246752	246752:01:04_10.00	True	10.0	71	19.5	32.5	40.3	0.0	79.3	0.0	2.4	0.0	0.0	0.0	60.2	0.0	0.0	DNA_Synth	79.3	Oxyphenbutazone	Oxyphenbutazone is a phenylbutazone derivative, with anti-inflammatory effect. Oxyphenbutazone is a non-selective COX inhibitor. Oxyphenbutazone selectively kills non-replicating Mycobaterium tuberculosis.	False	CCCCC1C(=O)N(c2ccccc2)N(c2ccc(O)cc2)C1=O
246703	246703:01:04_10.00	True	10.0	107	10.7	73.9	0.0	0.0	80.1	0.0	0.0	0.0	0.0	0.0	83.2	0.0	0.0	Pyrimidine_Synth	83.2	Fluocinolone (Acetonide)	Fluocinolone Acetonide is a glucocorticoid derivative used topically in the treatment of various skin disorders.Target: Glucocorticoid ReceptorFluocinolone acetonide is a corticosteroid primarily used in dermatology to reduce skin inflammation and relieve itching. It is a synthetic hydrocortisone derivative. The fluorine substitution at position 9 in the steroid nucleus greatly enhances its activity. A typical dosage strength used in dermatology is 0.01-0.025%. One such cream is sold under the brand name Flucort-N and includes the antibiotic neomycin. The Glucocorticoid Receptor(GR) binding affinity (IC50) for Fluocinolone Acetonide(FA) was 2.0 nM, respectively. The values is similar to the GR transactivation EC50 of 0.7 nM for FA, respectively [1, 2].	True	CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1
246624	246624:01:04_10.00	True	10.0	107	6.4	1.0	0.0	35.0	0.0	31.8	45.8	52.4	0.0	20.9	0.0	48.0	30.8	LCH	52.4	Tribenoside	vitamin.	False	CCOC1O[C@H]([C@@H](COCc2ccccc2)OCc2ccccc2)[C@H](OCc2ccccc2)[C@H]1O
246346	246346:01:04_10.00	True	10.0	103	59.4	0.0	0.0	78.3	0.0	77.6	18.4	90.8	36.8	58.7	0.0	71.3	55.7	LCH	90.8	Thiethylperazine malate	adrenergic antagonist.	False	CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2
246809	246809:01:04_10.00	True	10.0	108	9.5	41.4	1.9	0.0	47.5	0.0	0.0	0.0	0.0	0.0	72.4	0.0	0.0	Pyrimidine_Synth	72.4	5-Fluorouracil, 5-FU	thymidylate synthetase inhibitor, leads to accumulation of cells in S phase, Thymidylate Synthase inibitor, antineoplastic, pyrimidine antimetabolite.	False	O=c1[nH]cc(F)c(=O)[nH]1
245381	245381:02:04_10.00	True	10.0	107	6.2	0.0	0.0	60.7	0.0	55.6	10.6	72.7	20.4	38.4	0.0	59.6	40.4	LCH	72.7	Flunarizine dihydrochloride	Ca2+/Na+ channel blocker, vasodilator.	False	Fc1ccc(C(c2ccc(F)cc2)N2CCN(C/C=C/c3ccccc3)CC2)cc1
247340	247340:01:04_10.00	True	10.0	96	10.7	72.0	0.0	0.0	80.1	0.0	11.8	0.0	0.0	0.0	81.5	0.0	0.0	Pyrimidine_Synth	81.5	Beclometasone dipropionate	Betamethasone dipropionate, the prodrug of Betamethasone, is an orally active and potent glucocorticoid with anti-inflammatory and immunosuppressive activity. Betamethasone appears to be an effective inhibitor of LPS-induced inflammation and MMP release.	True	CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@@]21C
246768	246768:01:04_10.00	True	10.0	97	5.4	0.0	0.0	59.0	0.0	54.3	35.8	66.1	8.9	38.6	0.0	61.2	43.3	LCH	66.1	(±)-Synephrine	alpha-Adrenoceptor agonist, vasoconstrictor, Adrenergic receptor agonist.	False	CNCC(O)c1ccc(O)cc1
246961	246961:01:04_10.00	True	10.0	63	33.3	49.3	20.0	0.0	93.1	0.0	8.8	0.0	0.0	0.0	81.1	0.0	0.0	DNA_Synth	93.1	Camptothecin	Camptothecin (Campathecin) is a potent DNA enzyme topoisomerase I inhibitor, with an IC50 of 679 nM.	True	CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1
246660	246660:01:04_10.00	True	10.0	60	39.7	58.3	15.7	0.0	97.5	0.0	0.0	0.0	0.0	0.0	81.6	0.0	0.0	DNA_Synth	97.5	Gemcitabine	Gemcitabine (LY 188011) is a pyrimidine nucleoside analog antimetabolite and an antineoplastic agent. Gemcitabine inhibits DNA synthesis and repair, resulting in autophagyand apoptosis.	True	Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1
246688	246688:01:04_10.00	True	10.0	64	59.1	0.0	0.0	79.5	0.0	91.2	23.3	64.9	59.1	58.1	0.0	75.0	55.1	HDAC	91.2	Vorinostat	Vorinostat (SAHA) is a potent and orally active pan-inhibitor of HDAC1, HDAC2 and HDAC3 (Class I), HDAC7 (Class II) and HDAC11 (Class IV), with ID50 values of 10 nM and 20 nM for HDAC1 and HDAC3, respectively. Vorinostat induces cell apoptosis. Vorinostat is also an effective inhibitor of human papillomaviruse (HPV)-18 DNA amplification.; Bradner et al., Chemical Phylogenetics of Histone Deacetylases. Nat. Chem. Biol. 6, 238-43 (2010).	False	O=C(CCCCCCC(=O)Nc1ccccc1)NO
246957	246957:01:04_10.00	True	10.0	94	6.4	14.7	0.0	52.8	0.0	45.7	19.3	62.1	13.8	33.4	0.0	53.3	49.8	LCH	62.1	Salbutamol, Albuterol	beta2-Adrenoceptor agonist, Beta adrenergic agonist, bronchodilator, tocolytic.	False	CC(C)(C)NCC(O)c1ccc(O)c(CO)c1
246533	246533:01:04_10.00	True	10.0	106	5.5	57.6	9.9	0.0	65.7	0.0	19.0	0.0	0.0	0.0	79.5	0.0	0.0	Pyrimidine_Synth	79.5	Clocortolone pivalate	glucocorticoid receptor agonist.	False	C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@H]1C(=O)COC(=O)C(C)(C)C
246895	246895:01:04_10.00	True	10.0	103	10.7	0.0	0.0	72.1	0.0	61.0	17.8	67.9	14.9	48.9	0.0	65.0	66.6	BET	72.1	Nylidrin	sympathomimetic, beta-adrenergic agonist.	False	CC(CCc1ccccc1)NC(C)C(O)c1ccc(O)cc1
246828	246828:01:04_10.00	True	10.0	97	64.6	0.0	0.0	74.5	0.0	75.6	25.3	91.7	28.3	50.0	0.0	69.5	52.5	LCH	91.7	Carvedilol	Carvedilol (BM 14190) is a non-selective .b./.a.-1 blocker. Carvedilol inhibits lipid peroxidation in a dose-dependent manner with an IC50 of 5 uM. Carvedilol is a multiple action antihypertensive agent with potential use in angina and congestive heart failure. Carvedilol is an autophagy inducer that inhibits the NLRP3 inflammasome.	False	COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12
246774	246774:01:04_10.00	True	10.0	105	5.9	18.4	0.0	53.4	0.0	49.3	39.5	61.5	6.3	57.6	0.0	55.0	61.4	LCH	61.5	(-)-Isoproterenol hydrochloride	adrenergic Agonist.	True	CC(C)NC[C@H](O)c1ccc(O)c(O)c1
246615	246615:01:04_10.00	True	10.0	113	18.1	0.0	0.0	60.4	0.0	60.6	35.7	66.4	16.3	42.7	0.0	61.0	49.1	LCH	66.4	Rifabutin	RNA-polymerase inhibitor.	True	CCC(C)N1CCC2(CC1)N=C1C(=C3NC(=O)/C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)/C=C/O[C@@]4(C)Oc5c(C)c(O)c(c1c5C4=O)C3=O)N2
246894	246894:01:04_10.00	True	10.0	97	7.1	55.7	0.0	0.0	49.7	0.0	29.3	9.2	0.0	0.0	44.3	10.6	24.5	AKT_PI3K_MTOR	55.7	Norgestimate	Progesterone receptor agonist; Estrogen receptor agonist; Androgen Receptor agonist	True	C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=NO)CC[C@@H]4[C@H]3CC[C@@]21CC
246606	246606:01:04_10.00	True	10.0	100	54.1	0.0	0.0	73.1	0.0	74.0	26.1	92.3	30.1	43.7	0.0	67.5	49.7	LCH	92.3	Piperacetazine	Piperacetazine is an antipsychotic prodrug, used forschizophrenia.	False	CC(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2
246332	246332:01:04_10.00	True	10.0	102	53.5	0.0	0.0	74.1	0.0	76.2	27.1	85.9	36.4	48.2	0.0	69.5	47.7	LCH	85.9	Dilazep dihydrochloride	adenosine uptake inhibitor.	False	COc1cc(C(=O)OCCCN2CCCN(CCCOC(=O)c3cc(OC)c(OC)c(OC)c3)CC2)cc(OC)c1OC
247307	247307:01:04_10.00	True	10.0	102	26.3	0.0	0.0	82.3	0.0	80.4	15.7	88.5	41.9	52.2	0.0	71.4	55.4	LCH	88.5	Trimipramine (maleate)	Trimipramine maleate is a 5-HT receptor antagonist, with pKis of 6.39, 8.10, 4.66 for 5-HT1C, 5-HT2 and 5-HT1A, respectively.	False	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21
247023	247023:01:04_10.00	True	10.0	100	9.7	69.8	0.0	0.0	78.1	0.0	11.9	0.0	0.0	0.0	82.0	0.0	0.0	Pyrimidine_Synth	82.0	Fludrocortisone acetate	Glucocorticoid receptor (IC50 = 20 nM); Mineralocorticoid receptor agonist	True	CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)C3(F)[C@@H](O)C[C@@]21C
246817	246817:01:04_10.00	True	10.0	106	45.4	0.0	0.0	67.4	0.0	68.1	18.3	91.2	26.8	32.4	0.0	64.5	43.8	LCH	91.2	Azithromycin	RNA translation inhibition, antibacterial.	False	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O
246420	246420:01:04_10.00	True	10.0	85	11.4	0.0	0.0	70.2	0.0	74.9	16.6	59.7	42.5	51.4	0.0	61.7	45.6	HDAC	74.9	Metaraminol bitartrate	adrenergic agonist.	True	C[C@H](N)[C@H](O)c1cccc(O)c1
247265	247265:01:04_10.00	True	10.0	105	7.4	0.0	0.0	63.2	0.0	66.9	37.4	59.8	21.4	53.6	0.0	57.3	39.7	HDAC	66.9	Levonordefrin	adrenergic receptor agonist, vasoconstrictor.	False	C[C@H](N)[C@H](O)c1ccc(O)c(O)c1
247300	247300:01:04_10.00	True	10.0	60	32.3	55.2	0.5	0.0	58.2	0.0	14.0	0.0	0.0	19.2	54.1	0.0	5.4	DNA_Synth	58.2	Cycloheximide	protein synthesis inhibitor.	False	C[C@H]1C[C@H](C)C(=O)[C@H]([C@H](O)CC2CC(=O)NC(=O)C2)C1
247331	247331:01:04_10.00	True	10.0	100	27.6	0.0	0.0	78.6	0.0	76.4	26.6	81.1	39.2	49.7	0.0	71.3	51.3	LCH	81.1	Ethopropazine hydrochloride	anticholinergic, Butyrylcholinesterase inhibitor, antiparkinsonian, antiparkinsonian, anticholinergic.	False	CCN(CC)C(C)CN1c2ccccc2Sc2ccccc21
246704	246704:01:04_10.00	True	10.0	106	8.6	4.5	0.0	59.2	0.0	49.7	4.3	57.8	17.7	33.6	0.0	56.6	59.0	BET	59.2	Formoterol fumarate	ß2-agonist.	True	COc1ccc(C[C@H](C)NC[C@@H](O)c2ccc(O)c(NC=O)c2)cc1
247192	247192:01:05_10.00	True	10.0	57	44.4	0.0	3.7	70.1	0.0	71.8	12.4	59.5	45.9	52.9	0.0	78.7	45.8	Tubulin	78.7	Parthenolide	Parthenolide is a sesquiterpene lactone found in the medicinal herb Feverfew. Parthenolide exhibits anti-inflammatory activity by inhibiting NF-.k.B activation; also inhibits HDAC1 protein without affecting other class I/II HDACs.	True	C=C1C(=O)O[C@H]2[C@H]1CC/C(C)=C/CC[C@@]1(C)O[C@H]21
246741	246741:01:04_30.00	True	30.0	89	6.9	75.2	0.0	0.0	52.7	0.0	18.0	4.1	0.0	0.0	48.2	0.0	12.7	AKT_PI3K_MTOR	75.2	Alprostadil	prostaglandin receptor agonist.	False	CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O
246911	246911:01:04_30.00	True	30.0	76	32.8	36.5	0.0	50.4	0.0	49.4	45.6	35.1	33.1	58.0	0.0	57.8	88.5	Uncoupler	88.5	Triclosan	Triclosan is an antibacterial and antifungal agent found in consumer products, including soaps, detergents, toys, and surgical cleaning treatments.	False	Oc1cc(Cl)ccc1Oc1ccc(Cl)cc1Cl
247326	247326:01:04_30.00	True	30.0	102	12.8	58.7	0.0	0.0	63.3	0.0	0.0	0.0	0.0	0.0	79.1	0.0	0.0	Pyrimidine_Synth	79.1	Ifosfamide	antineoplastic.	False	O=P1(NCCCl)OCCCN1CCCl
246876	246876:01:04_30.00	True	30.0	69	67.0	0.0	3.5	83.8	0.0	84.8	24.0	70.2	63.7	61.5	0.0	90.6	49.2	Tubulin	90.6	Ethynyl Estradiol	Ethynyl Estradiol (17.a.-Ethynylestradiol;Ethynylestradiol) is an orally bio-active estrogen used in almost all modern formulations of combined oral contraceptive pills.Target: Estrogen ReceptorEthynyl Estradiol (17.a.-Ethynylestradiol;Ethynylestradiol), also sometimes written as ethinylestradiol, ethynyl estradiol, or ethinyl estradiol, is a derivative of 17.b.-estradiol (E2), the major endogenous estrogen in humans. Ethynyl Estradiol (17.a.-Ethynylestradiol;Ethynylestradiol) is an orally bioactive estrogen used in many formulations of combined oral contraceptive pills. It is one of the most commonly used medications for this purpose. Transdermal ethinyl estradiol carries a greater risk of clot formation and venous thromboembolism than 17 beta estradiol, which some have theorized to be related to different amounts of hepatic metabolism after absorption. The same contraindications and precautions apply for EE as with other estrogen medications.Ethynyl Estradiol was a preparation of Ethynyl Estradiol alone that was used for the management of menopausal symptoms and female hypogonadism. Ethynyl Estradiol (17.a.-Ethynylestradiol;Ethynylestradiol) is released into the environment as a xenoestrogen from the urine and feces of people who take it as a medication. The major concern with unopposed estrogen is of endometrial cancer. As such, the medication is generally prescribed with progesterone in the setting of birth control. The first orally active semisynthetic steroidal estrogen, Ethynyl Estradiol, the 17.a.-ethynyl analog of E2, was synthesized in 1938 by Hans Herloff Inhoffen and Walter Hohlweg at Schering AG in Berlin.	True	C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@@]21C
247293	247293:01:04_30.00	True	30.0	97	68.2	0.0	0.0	78.6	0.0	74.5	9.0	95.6	32.2	47.7	0.0	68.6	52.5	LCH	95.6	Proadifen (hydrochloride)	inhibitor of microsomal drug metabolism, Cytochrome P450 mono-oxygenases inhibitor, cytochrome p450 inhibitor, ca antagonist.	False	CCCC(C(=O)OCCN(CC)CC)(c1ccccc1)c1ccccc1
245325	245325:02:04_30.00	True	30.0	81	74.1	0.0	0.0	77.8	0.0	77.3	20.4	91.7	36.1	46.5	0.0	71.6	59.0	LCH	91.7	Reserpine, Methyl reserpate	inhibits vesicular catecholine and serotonin uptake, antihypertensive.	False	COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC
247224	247224:01:04_30.00	True	30.0	92	35.4	23.0	0.0	59.3	0.0	52.2	35.8	73.8	12.9	49.3	0.0	62.3	59.7	LCH	73.8	Avermectin B1a	ligand GABA receptors.	False	CC[C@H](C)[C@H]1O[C@]2(C=C[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)C(O[C@H]3C[C@H](OC)C(O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2
247426	247426:01:04_30.00	True	30.0	96	26.6	0.0	0.0	80.4	0.0	79.8	37.6	68.2	44.2	60.8	0.0	73.5	68.3	BET	80.4	Chloroguanide hydrochloride	dihydrofolate réductase inhibitor, antimalarial.	False	CC(C)NC(=N)NC(=N)Nc1ccc(Cl)cc1
246818	246818:01:04_30.00	True	30.0	97	72.5	0.0	0.0	80.0	0.0	77.1	6.9	95.3	35.5	46.2	0.0	70.3	52.2	LCH	95.3	Benztropine mesylate	anticholinergic.	False	CN1[C@H]2CC[C@@H]1C[C@H](OC(c1ccccc1)c1ccccc1)C2
151729	151729:02:04_30.00	True	30.0	104	7.9	0.0	0.0	73.0	0.0	66.0	0.0	69.6	42.5	39.8	0.0	65.6	55.9	BET	73.0	Dopamine hydrochloride	endogenous neurotransmitter, beta 1 receptors stimulator, cardiotonic, antihypotensive.	False	NCCc1ccc(O)c(O)c1
247318	247318:01:04_30.00	True	30.0	104	19.3	26.4	0.0	0.0	29.7	0.0	0.0	0.0	0.0	0.0	53.6	0.0	0.0	Pyrimidine_Synth	53.6	Sulfamonomethoxine	Sulfamonomethoxine is a long acting sulfonamide antibacterial agent, used in blood kinetic studies,and blocks the synthesis of folic acid by inhibiting synthetase of dihydropteroate.	False	COc1cc(NS(=O)(=O)c2ccc(N)cc2)ncn1
246602	246602:01:04_30.00	True	30.0	106	12.4	7.9	0.0	0.0	17.8	0.0	0.0	7.3	0.0	0.0	23.4	0.0	0.0	Pyrimidine_Synth	23.4	Oxprenolol (hydrochloride)	Oxprenolol hydrochloride (Ba 39089) is an orally bioavailable .b.-adrenergic receptor (.b.-AR) antagonist with a Ki of 7.10 nM in a radioligand binding assay using rat heart muscle.	False	C=CCOc1ccccc1OCC(O)CNC(C)C
246983	246983:01:04_30.00	True	30.0	93	15.7	0.0	0.0	75.5	0.0	70.4	11.0	79.6	28.9	58.8	0.0	77.3	43.5	LCH	79.6	Phentolamine hydrochloride	alpha adrenergic antagonist, antihypertensive.	False	Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1
246988	246988:01:04_30.00	True	30.0	102	25.7	0.0	0.0	73.3	0.0	68.6	7.8	94.3	19.2	32.8	0.0	65.9	41.4	LCH	94.3	Orphenadrine hydrochloride	muscarinic acetylcholine receptor antagonist, H1 histamine receptor antagonist, H1 antogonist.	False	Cc1ccccc1C(OCCN(C)C)c1ccccc1
247349	247349:01:04_30.00	True	30.0	76	34.5	0.0	2.5	47.4	0.0	37.6	0.0	40.1	36.8	54.5	0.0	64.8	43.9	Tubulin	64.8	Azacytidine-5	antimetabolite.	True	Nc1ncn(C2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1
246891	246891:01:04_30.00	True	30.0	95	21.4	72.3	0.0	0.0	67.9	0.0	26.4	0.0	0.0	0.0	67.5	0.0	0.0	AKT_PI3K_MTOR	72.3	Mitotane	Mitotane(2,4-DDD), an isomer of DDD and derivative of DDT, is an antineoplastic medication used in the treatment of adrenocortical carcinoma.IC50 value: Target: Mitotane alters steroid peripheral metabolism, directly suppresses the adrenal cortex and alters cortisone metabolism leading to hypocortisolism. Side effects as reported by Schteinberg et al. include anorexia and nausea (88%), diarrhea (38%), vomiting (23%), decreased memory and ability to concentrate (50%), rash (23%), gynecomastia (50%), arthralgia (19%), and leukopenia (7%).	False	Clc1ccc(C(c2ccccc2Cl)C(Cl)Cl)cc1
246819	246819:01:04_30.00	True	30.0	106	6.4	0.0	0.0	76.6	0.0	74.6	29.7	73.9	33.7	60.5	0.0	65.9	61.7	BET	76.6	Bicalutamide	Bicalutamide is an orally active non-steroidal androgen receptor (AR) antagonist. Bicalutamide can be used for the research of prostate cancer.	False	CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1
246873	246873:01:04_30.00	True	30.0	111	16.4	39.3	0.0	0.0	38.5	0.0	0.0	0.0	0.0	0.0	60.2	0.0	0.0	Pyrimidine_Synth	60.2	Doxycycline hydrochloride	inhibitory activity against Nuclear receptor ROR-gamma	True	C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21
246967	246967:01:04_30.00	True	30.0	52	69.6	0.0	12.2	74.5	0.0	81.3	35.8	64.4	53.4	69.4	0.0	82.0	49.0	Tubulin	82.0	Fenbendazole	Fenbendazole is a broad spectrum benzimidazole anthelmintic used against gastrointestinal parasites.Target: AntiparasiticFenbendazole is a broad spectrum benzimidazole anthelmintic used against gastrointestinal parasites including: giardia, roundworms, hookworms, whipworms, the taenia species of tapeworms(It is effective against the Taenia species of tapeworm but not against the common tapeworm, Dipylidium caninum.), pinworms, aelurostrongylus, paragonimiasis, strongyles and strongyloides and can be administered to sheep, cattle, horses, fish, dogs, cats, rabbits and seals. Drug interactions may occur if using bromsalan flukicides such as dibromsalan and tribromsalan. Abortions in cattle and death in sheep have been reported after using these medications together. Fenbendazole is poorly absorbed from the gastrointestinal tract in most species. The LD50 in laboratory animals exceeds 10 g/kg when administered orally. From Wikipedia.	False	COC(=O)Nc1nc2cc(Sc3ccccc3)ccc2[nH]1
247303	247303:01:04_30.00	True	30.0	88	14.7	0.0	4.6	56.7	0.0	48.7	12.8	61.7	32.8	19.9	0.0	78.7	25.3	Tubulin	78.7	Dienestrol	nuclear receptor ligand, estrogen.	False	C/C=C(C(=C/C)/c1ccc(O)cc1)\c1ccc(O)cc1
246719	246719:01:04_30.00	True	30.0	76	24.4	61.3	4.6	0.0	94.9	0.0	0.0	0.0	0.0	0.0	71.5	0.0	0.0	DNA_Synth	94.9	Fludarabine	Fludarabine (NSC 118218) is a DNA synthesis inhibitor, which also inhibits phosphorylation of STAT1. Fludarabine, a pro-drug, is converted metabolically by dephosphorylation to the antimetabolite, F-ara-A.	True	Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O
246563	246563:01:04_30.00	True	30.0	97	8.6	33.1	0.0	0.0	41.6	0.0	0.0	0.0	0.0	0.0	47.0	0.0	0.0	Pyrimidine_Synth	47.0	Benzathine benzylpenicillin	peptidoglycan synthesis inhibitor.	True	CC1(C)S[C@@H]2[C@H](NC(=O)COc3ccccc3)C(=O)N2C1C(=O)O
247339	247339:01:04_30.00	True	30.0	104	7.4	0.0	0.0	56.9	0.0	56.3	0.0	71.2	34.0	27.7	0.0	51.4	12.9	LCH	71.2	Roxithromycin	ribosomal protein synthesis inhibitor, antibacterial.	False	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)/C(=N\OCOCCOC)[C@H](C)[C@@H](O)[C@]1(C)O
246888	246888:01:04_30.00	True	30.0	104	21.1	28.0	0.0	39.3	8.5	41.1	29.6	81.4	0.0	6.9	0.0	38.7	34.8	LCH	81.4	Melengestrol acetate	Androgen Receptor agonist; glucocorticoid receptor agonist	True	C=C1C[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]2(C)[C@@]1(OC(C)=O)C(C)=O
246913	246913:01:04_30.00	True	30.0	100	8.5	0.0	0.0	77.2	0.0	68.7	0.0	74.6	35.8	57.4	0.0	70.0	52.6	BET	77.2	(±)-Epinephrine hydrochloride, (±)-Adrenalin hydrochloride	adrenoceptor agonist, non-selective agonist of all adrenergic receptors.	False	CNCC(O)c1ccc(O)c(O)c1
247024	247024:01:04_30.00	True	30.0	100	10.9	0.0	0.0	73.5	0.0	65.5	0.0	78.3	43.3	39.0	0.0	66.3	45.1	LCH	78.3	Fenoterol (hydrobromide)	Fenoterol hydrobromide (Th-1165a), a sympathomimetic agent, is a selective and orally active .b.2-adrenoceptor agonist. Fenoterol hydrobromide is an effective bronchodilator and can be used for bronchospasm associated with asthma, bronchitis and other obstructive airway diseases research.	False	CC(Cc1ccc(O)cc1)NCC(O)c1cc(O)cc(O)c1
247272	247272:01:04_30.00	True	30.0	98	7.4	0.0	0.0	75.0	0.0	59.8	0.0	73.0	23.0	57.8	0.0	69.2	50.2	BET	75.0	Isoetharine mesylate	beta-Adrenoceptor agonist, bronchodilator, Beta adrenergic agonist.	False	CCC(NC(C)C)C(O)c1ccc(O)c(O)c1
246980	246980:01:04_30.00	True	30.0	76	29.2	0.0	0.0	72.4	0.0	67.4	29.6	60.3	55.9	50.7	0.0	89.5	46.9	Tubulin	89.5	Griseofulvin	Griseofulvin(Gris-PEG; Grifulvin) is a spirocyclic fungal natural product used in treatment of fungal dermatophytes; Antifungal drug.	True	COC1=CC(=O)C[C@@H](C)[C@]12Oc1c(Cl)c(OC)cc(OC)c1C2=O
246307	246307:01:04_30.00	True	30.0	85	11.6	0.0	0.0	68.9	0.0	67.0	8.6	66.8	45.4	24.9	0.0	78.2	36.5	Tubulin	78.2	Hexestrol	nuclear receptor ligand.	False	CCC(c1ccc(O)cc1)C(CC)c1ccc(O)cc1
246344	246344:01:04_30.00	True	30.0	98	63.6	0.0	0.0	77.8	0.0	75.0	12.4	96.8	27.7	49.5	0.0	68.0	47.6	LCH	96.8	Drofenine hydrochloride	Affinity for the Muscarinic acetylcholine receptor, inhibitory activity against DNA-(apurinic or apyrimidinic site) lyase	False	CCN(CC)CCOC(=O)C(c1ccccc1)C1CCCCC1
247284	247284:01:04_30.00	True	30.0	69	27.1	57.4	18.4	0.0	95.3	0.0	0.8	0.0	0.0	0.0	77.6	0.0	0.0	DNA_Synth	95.3	Vidarabine	adenosine antimetabolite.	True	Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O
246366	246366:01:04_30.00	True	30.0	67	32.6	63.9	5.4	0.0	93.4	0.0	18.6	0.0	0.0	0.0	80.3	0.0	0.0	DNA_Synth	93.4	Topotecan	DNA topoisomerase type 1 inhibitor.	True	CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CN(C)C)c(O)ccc3nc2-1
246882	246882:01:04_30.00	True	30.0	101	16.6	0.0	0.0	45.2	0.0	46.2	0.0	76.3	15.7	0.0	0.0	34.2	17.0	LCH	76.3	Formestane	aromatase inhibitors.	True	C[C@]12CC[C@H]3[C@@H](CCC4=C(O)C(=O)CC[C@@]43C)[C@@H]1CCC2=O
247033	247033:01:04_30.00	True	30.0	101	61.0	0.0	0.0	73.5	0.0	72.6	3.1	94.8	36.1	47.6	0.0	67.7	39.9	LCH	94.8	Trazodone (hydrochloride)	Trazodone (hydrochloride) (AF-1161) is an antidepressant belonging to the class of serotonin receptor antagonists and reuptake inhibitors for treatment of anxiety disorders.	False	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12
246896	246896:01:04_30.00	True	30.0	94	39.0	0.0	0.0	70.9	0.0	70.7	10.1	94.5	31.2	26.7	0.0	60.2	31.0	LCH	94.5	Olanzapine	may involve antagonism at serotonin receptors, antipsychotic.	False	Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1
246981	246981:01:04_30.00	True	30.0	100	33.0	0.0	0.0	47.0	0.0	51.3	40.9	75.7	0.0	26.1	0.0	53.7	30.6	LCH	75.7	Clemizole hydrochloride	H1 Histamine receptor antagonist, H1 antagonist.	False	Clc1ccc(Cn2c(CN3CCCC3)nc3ccccc32)cc1
246703	246703:01:04_30.00	True	30.0	92	14.3	56.0	12.2	0.0	75.9	0.0	11.1	0.0	0.0	0.0	87.2	0.0	0.0	Pyrimidine_Synth	87.2	Fluocinolone (Acetonide)	Fluocinolone Acetonide is a glucocorticoid derivative used topically in the treatment of various skin disorders.Target: Glucocorticoid ReceptorFluocinolone acetonide is a corticosteroid primarily used in dermatology to reduce skin inflammation and relieve itching. It is a synthetic hydrocortisone derivative. The fluorine substitution at position 9 in the steroid nucleus greatly enhances its activity. A typical dosage strength used in dermatology is 0.01-0.025%. One such cream is sold under the brand name Flucort-N and includes the antibiotic neomycin. The Glucocorticoid Receptor(GR) binding affinity (IC50) for Fluocinolone Acetonide(FA) was 2.0 nM, respectively. The values is similar to the GR transactivation EC50 of 0.7 nM for FA, respectively [1, 2].	True	CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1
246624	246624:01:04_30.00	True	30.0	95	37.0	10.7	0.0	49.5	0.0	54.2	51.8	56.6	10.6	42.9	0.0	55.4	54.0	LCH	56.6	Tribenoside	vitamin.	False	CCOC1O[C@H]([C@@H](COCc2ccccc2)OCc2ccccc2)[C@H](OCc2ccccc2)[C@H]1O
246809	246809:01:04_30.00	True	30.0	100	41.6	49.2	0.0	0.0	58.4	0.0	0.0	0.0	0.0	0.0	67.2	0.0	0.0	Pyrimidine_Synth	67.2	5-Fluorouracil, 5-FU	thymidylate synthetase inhibitor, leads to accumulation of cells in S phase, Thymidylate Synthase inibitor, antineoplastic, pyrimidine antimetabolite.	False	O=c1[nH]cc(F)c(=O)[nH]1
245381	245381:02:04_30.00	True	30.0	100	40.1	0.0	0.0	63.8	0.0	55.9	1.2	89.3	18.5	29.6	0.0	55.5	33.8	LCH	89.3	Flunarizine dihydrochloride	Ca2+/Na+ channel blocker, vasodilator.	False	Fc1ccc(C(c2ccc(F)cc2)N2CCN(C/C=C/c3ccccc3)CC2)cc1
247208	247208:01:05_30.00	True	30.0	86	20.9	0.0	0.0	65.2	0.0	53.1	29.2	60.8	35.4	41.4	0.0	90.9	51.4	Tubulin	90.9	Vinburnine	Cytochrome P450 2D6; Cytochrome P450 3A4; Pregnane X receptor activation; (Plasmodium falciparum)	True	CC[C@]12CCCN3CCc4c(n(c5ccccc45)C(=O)C1)[C@@H]32
247340	247340:01:04_30.00	True	30.0	101	17.4	46.8	0.0	0.0	30.7	0.0	38.0	28.1	0.0	0.0	33.4	9.8	3.9	AKT_PI3K_MTOR	46.8	Beclometasone dipropionate	Betamethasone dipropionate, the prodrug of Betamethasone, is an orally active and potent glucocorticoid with anti-inflammatory and immunosuppressive activity. Betamethasone appears to be an effective inhibitor of LPS-induced inflammation and MMP release.	True	CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@@]21C
247045	247045:01:04_30.00	True	30.0	107	37.7	0.0	0.0	74.7	0.0	71.3	10.2	94.2	29.7	41.5	0.0	68.3	36.8	LCH	94.2	Ifenprodil tartrate	adrenergic antagonist.	False	CC(C(O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1
246961	246961:01:04_30.00	True	30.0	73	38.7	66.4	4.7	0.0	92.4	0.0	10.0	0.0	0.0	0.0	84.6	0.0	0.0	DNA_Synth	92.4	Camptothecin	Camptothecin (Campathecin) is a potent DNA enzyme topoisomerase I inhibitor, with an IC50 of 679 nM.	True	CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1
246660	246660:01:04_30.00	True	30.0	73	30.9	62.5	8.6	0.0	96.4	0.0	0.0	0.0	0.0	0.0	77.3	0.0	0.0	DNA_Synth	96.4	Gemcitabine	Gemcitabine (LY 188011) is a pyrimidine nucleoside analog antimetabolite and an antineoplastic agent. Gemcitabine inhibits DNA synthesis and repair, resulting in autophagyand apoptosis.	True	Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1
246688	246688:01:04_30.00	True	30.0	59	66.3	0.0	0.0	87.4	0.0	94.7	21.8	73.6	66.5	69.1	0.0	78.7	67.9	HDAC	94.7	Vorinostat	Vorinostat (SAHA) is a potent and orally active pan-inhibitor of HDAC1, HDAC2 and HDAC3 (Class I), HDAC7 (Class II) and HDAC11 (Class IV), with ID50 values of 10 nM and 20 nM for HDAC1 and HDAC3, respectively. Vorinostat induces cell apoptosis. Vorinostat is also an effective inhibitor of human papillomaviruse (HPV)-18 DNA amplification.; Bradner et al., Chemical Phylogenetics of Histone Deacetylases. Nat. Chem. Biol. 6, 238-43 (2010).	False	O=C(CCCCCCC(=O)Nc1ccccc1)NO
246957	246957:01:04_30.00	True	30.0	97	15.5	0.0	0.0	69.2	0.0	55.9	7.5	80.0	8.2	50.4	0.0	63.6	51.6	LCH	80.0	Salbutamol, Albuterol	beta2-Adrenoceptor agonist, Beta adrenergic agonist, bronchodilator, tocolytic.	False	CC(C)(C)NCC(O)c1ccc(O)c(CO)c1
246533	246533:01:04_30.00	True	30.0	92	19.5	75.9	0.0	0.0	79.5	0.0	0.4	0.0	0.0	0.0	87.3	0.0	0.0	Pyrimidine_Synth	87.3	Clocortolone pivalate	glucocorticoid receptor agonist.	False	C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@H]1C(=O)COC(=O)C(C)(C)C
246986	246986:01:04_30.00	True	30.0	109	5.7	18.2	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	37.7	0.0	0.0	Pyrimidine_Synth	37.7	Ofloxacin	Ofloxacin (Hoe-280) is a fluoroquinolone whose primary mechanism of action is inhibition of bacterial DNA gyrase.	False	CC1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23
246557	246557:01:04_30.00	True	30.0	52	67.4	0.0	26.7	69.2	0.0	77.0	31.3	54.5	58.0	60.2	0.0	81.0	37.4	Tubulin	81.0	Methiazole	Cytochrome P450 1A2 (AC50 = 501.19 nM), inhibition of Inhibitors of Vif-A3G Interactions	False	COC(=O)Nc1nc2cc(SC(C)C)ccc2[nH]1
246895	246895:01:04_30.00	True	30.0	102	41.3	0.0	0.0	85.4	0.0	81.5	15.0	89.1	38.0	54.4	0.0	80.1	49.1	LCH	89.1	Nylidrin	sympathomimetic, beta-adrenergic agonist.	False	CC(CCc1ccccc1)NC(C)C(O)c1ccc(O)cc1
246835	246835:01:04_30.00	True	30.0	99	16.2	0.0	0.0	70.8	0.0	72.5	19.3	91.6	29.6	27.2	0.0	61.6	40.2	LCH	91.6	Buspirone (hydrochloride)	5-HT1A Serotonin receptor agonist, non-benzodiazepine anxiolytic, serotonin receptor agonist, 5ht1a receptor agonist.	False	O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1
246603	246603:01:04_30.00	True	30.0	50	69.1	0.0	0.0	81.3	0.0	83.6	29.8	71.2	56.1	70.3	0.0	80.1	66.2	HDAC	83.6	Parbendazole	Parbendazole is a potent inhibitor of microtubule assembly, destabilizes tubulin, with an EC50 of 8.79nM, and exhibits a broad-spectrum anthelmintic activity.	False	CCCCc1ccc2[nH]c(NC(=O)OC)nc2c1
246774	246774:01:04_30.00	True	30.0	90	18.3	0.0	0.0	73.1	0.0	64.2	7.9	74.9	22.4	62.1	0.0	70.4	50.9	LCH	74.9	(-)-Isoproterenol hydrochloride	adrenergic Agonist.	True	CC(C)NC[C@H](O)c1ccc(O)c(O)c1
246615	246615:01:04_30.00	True	30.0	95	36.4	0.0	0.0	82.3	0.0	81.4	29.7	88.7	41.0	55.8	0.0	78.2	51.5	LCH	88.7	Rifabutin	RNA-polymerase inhibitor.	True	CCC(C)N1CCC2(CC1)N=C1C(=C3NC(=O)/C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)/C=C/O[C@@]4(C)Oc5c(C)c(O)c(c1c5C4=O)C3=O)N2
246894	246894:01:04_30.00	True	30.0	93	15.4	23.9	0.0	51.1	0.0	48.8	37.0	44.5	43.6	43.6	0.0	67.2	62.6	Tubulin	67.2	Norgestimate	Progesterone receptor agonist; Estrogen receptor agonist; Androgen Receptor agonist	True	C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=NO)CC[C@@H]4[C@H]3CC[C@@]21CC
246606	246606:01:04_30.00	True	30.0	95	84.6	0.0	0.0	82.4	0.0	80.3	9.7	90.1	37.4	51.1	0.0	76.3	54.1	LCH	90.1	Piperacetazine	Piperacetazine is an antipsychotic prodrug, used forschizophrenia.	False	CC(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2
247001	247001:01:04_30.00	True	30.0	92	10.9	7.9	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	32.2	0.0	0.0	Pyrimidine_Synth	32.2	Niflumic acid	Niflumic acid, a Ca2+-activated Cl- channel blocker, is an analgesic and anti-inflammatory agent used in the treatment of rheumatoid arthritis.Target: Othersniflumic acid, an inhibitor of calcium-activated chloride currents. Niflumic acid does not block directly calcium channels or activate potassium channels. Niflumic acid selectively reduces a component of noradrenaline- and 5-HT-induced pressor responses by inhibiting a mechanism which leads to the opening of voltage-gated calcium channels . Niflumic acid molecule is completely buried in the substrate-binding hydrophobic channel. The conformations of the binding site in PLA(2) as well as that of niflumic acid are not altered upon binding . Niflumic acid (NFA) produces biphasic behavior on human CLC-K channels that suggests the presence of two functionally different binding sites: an activating site and a blocking site .	False	O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1
246490	246490:01:04_30.00	True	30.0	100	12.4	0.0	0.0	69.4	0.0	68.9	28.3	73.1	27.7	55.3	0.0	71.0	35.4	LCH	73.1	Diphenidol (hydrochloride)	Muscarinic acetylcholine receptor M4 (Ki = 912.01 nM), Muscarinic acetylcholine receptor M5 (Ki = 1288.25 nM), selectivity towards Muscarinic acetylcholine receptor M1, M2, M3	False	OC(CCCN1CCCCC1)(c1ccccc1)c1ccccc1
247307	247307:01:04_30.00	True	30.0	102	57.9	0.0	0.0	78.5	0.0	75.9	0.5	95.0	35.9	43.7	0.0	66.6	46.0	LCH	95.0	Trimipramine (maleate)	Trimipramine maleate is a 5-HT receptor antagonist, with pKis of 6.39, 8.10, 4.66 for 5-HT1C, 5-HT2 and 5-HT1A, respectively.	False	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21
247023	247023:01:04_30.00	True	30.0	102	11.6	64.2	0.0	0.0	77.9	0.0	10.5	0.0	0.0	0.0	85.2	0.0	0.0	Pyrimidine_Synth	85.2	Fludrocortisone acetate	Glucocorticoid receptor (IC50 = 20 nM); Mineralocorticoid receptor agonist	True	CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)C3(F)[C@@H](O)C[C@@]21C
246864	246864:01:04_30.00	True	30.0	91	11.4	12.8	0.0	13.2	10.3	0.0	4.2	33.1	0.0	0.0	3.2	26.7	4.1	LCH	33.1	Celecoxib	Celecoxib,a selective non-steroidal anti-inflammatory drug (NSAID), is a selective COX-2 inhibitor with an IC50 of 40 nM.	False	Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1
246666	246666:01:04_30.00	True	30.0	85	16.6	64.4	0.0	0.0	73.5	0.0	8.6	0.0	0.0	0.0	57.7	0.0	0.0	DNA_Synth	73.5	Idebenone	Idebenone is a synthetic variant of coenzyme Q10 (CoQ10), which initially developed for the treatment of Alzheimer's disease and other cognitive defects.Target: OthersIdebenone is a synthetic variant of coenzyme Q10 (CoQ10), which initially developed for the treatment of Alzheimer's disease and other cognitive defects. Idebenone was generally well tolerated with similar numbers of adverse events in each group. One child receiving high-dose idebenone developed neutropenia after 6 months, which resolved after discontinuation of treatment. 8OH2dG concentrations were not increased, and did not significantly change with idebenone treatment . The 2-year efficacy and safety of idebenone were studied in a prospective, randomized, double-blind multicentre study in 3 parallel groups of patients with dementia of the Alzheimer type (DAT) of mild to moderate degree. A total of 450 patients were randomized to either placebo for 12 months, followed by idebenone 90 mg tid for another 12 months (n = 153) or idebenone 90 mg tid for 24 months (n = 148) or 120 mg tid for 24 months (n = 149). idebenone showed statistically significant dose-dependent improvement in the primary efficacy variable ADAS-Total and in all the secondary efficacy variables .	False	COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O
246428	246428:01:04_30.00	True	30.0	93	26.8	0.0	0.0	81.1	0.0	73.6	6.4	68.1	50.4	65.6	0.0	83.4	57.8	Tubulin	83.4	Riluzole hydrochloride	glutamate antagonist.	False	Nc1nc2ccc(OC(F)(F)F)cc2s1
246434	246434:01:04_30.00	True	30.0	101	6.9	0.0	0.0	71.9	0.0	71.2	0.0	74.9	44.0	26.8	0.0	60.9	23.7	LCH	74.9	Bufexamac	inhibition of 5-lipoxygenase in rat basophilic leukemia cells (RBL-1) (IC50 = 128.82 nM); inhibition of M17 leucyl aminopeptidase of BioAssays Plasmodium falciparum  (IC50 < 1000 nM); Antiproliferative activity against HaCaT keratinocytes (IC50 > 5000 nM)	False	CCCCOc1ccc(CC(=O)NO)cc1
247345	247345:01:04_30.00	True	30.0	104	11.6	31.6	2.5	0.0	36.9	0.0	0.0	0.0	0.0	0.0	55.4	0.0	0.0	Pyrimidine_Synth	55.4	Gabapentin	anticonvulsant that may modulate certain types of Ca2+ channel currents, analgesic, GABA receptor ligand.	False	NCC1(CC(=O)O)CCCCC1
246817	246817:01:04_30.00	True	30.0	100	56.5	0.0	0.0	70.7	0.0	69.3	0.0	89.9	32.4	29.9	0.0	66.5	38.6	LCH	89.9	Azithromycin	RNA translation inhibition, antibacterial.	False	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O
246420	246420:01:04_30.00	True	30.0	99	6.7	0.0	0.0	70.7	0.0	58.8	0.0	71.1	28.8	49.6	0.0	63.2	47.0	LCH	71.1	Metaraminol bitartrate	adrenergic agonist.	True	C[C@H](N)[C@H](O)c1cccc(O)c1
247265	247265:01:04_30.00	True	30.0	105	10.4	0.0	0.0	53.0	0.0	50.7	5.6	55.5	13.6	34.5	0.0	38.9	39.0	LCH	55.5	Levonordefrin	adrenergic receptor agonist, vasoconstrictor.	False	C[C@H](N)[C@H](O)c1ccc(O)c(O)c1
246875	246875:01:04_30.00	True	30.0	106	7.9	57.7	0.0	0.0	55.7	0.0	0.0	0.0	0.0	0.0	64.5	0.0	0.0	Pyrimidine_Synth	64.5	Enoxacin	antibacterial.	False	CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)nc21
247300	247300:01:04_30.00	True	30.0	63	37.1	45.7	0.0	31.5	2.5	25.1	19.3	19.1	35.7	57.3	0.0	42.0	71.6	Uncoupler	71.6	Cycloheximide	protein synthesis inhibitor.	False	C[C@H]1C[C@H](C)C(=O)[C@H]([C@H](O)CC2CC(=O)NC(=O)C2)C1
247331	247331:01:04_30.00	True	30.0	97	54.2	0.0	0.0	82.7	0.0	80.7	7.8	96.9	41.4	49.4	0.0	70.8	49.7	LCH	96.9	Ethopropazine hydrochloride	anticholinergic, Butyrylcholinesterase inhibitor, antiparkinsonian, antiparkinsonian, anticholinergic.	False	CCN(CC)C(C)CN1c2ccccc2Sc2ccccc21
246704	246704:01:04_30.00	True	30.0	98	30.2	0.0	0.0	86.1	0.0	80.5	0.0	81.0	52.7	52.1	0.0	75.6	49.0	BET	86.1	Formoterol fumarate	ß2-agonist.	True	COc1ccc(C[C@H](C)NC[C@@H](O)c2ccc(O)c(NC=O)c2)cc1
246616	246616:01:04_30.00	True	30.0	102	14.3	68.2	0.0	0.0	77.3	0.0	0.0	0.0	0.0	0.0	82.2	0.0	0.0	Pyrimidine_Synth	82.2	Rimexolone	glucocorticoid receptor agonist.	True	CCC(=O)[C@@]1(C)[C@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C
247358	247358:01:05_10.00	True	10.0	60	30.7	0.0	34.8	0.0	8.7	0.0	0.0	0.0	53.8	12.7	19.3	0.0	0.0	Na_K-ATPase	53.8	Digoxigenin	mainly used as a non-isotopic label for DNA.	False	C[C@]12CC[C@H](O)C[C@H]1CC[C@@H]1[C@@H]2C[C@@H](O)[C@]2(C)[C@@H](C3=CC(=O)OC3)CC[C@]12O
247342	247342:01:05_10.00	True	10.0	103	10.0	0.0	0.0	74.4	0.0	73.7	32.4	83.4	34.8	43.5	0.0	72.4	47.9	LCH	83.4	Doxazosin mesylate	alpha1 adrenoceptor blocker, Alpha 1 adrenergic antagonist, antihypertensive.	False	COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC
246763	246763:01:05_10.00	True	10.0	94	8.8	26.9	47.5	0.0	72.6	0.0	0.0	0.0	0.0	0.0	77.7	0.0	0.0	Pyrimidine_Synth	77.7	Chlorambucil	DNA crosslinker, induces apoptosis, DNA replication inhibitor, antineoplastic, alkylating agent.	False	O=C(O)CCCc1ccc(N(CCCl)CCCl)cc1
247072	247072:01:04_10.00	True	10.0	98	42.0	0.0	0.0	77.9	0.0	74.2	10.0	92.8	35.3	47.8	0.0	68.7	57.3	LCH	92.8	Maprotiline (hydrochloride)	Maprotiline hydrochloride is a selective noradrenalin re-uptake inhibitor and a tetracyclic antidepressant.Target: OthersMaprotiline (sold as Deprilept, Ludiomil, Psymion) is a tetracyclic antidepressant (TeCA). However, Maprotiline's fourth ring is spurious, as formed by a bridge across the central tricyclic ring. It is a strong norepinephrine reuptake inhibitor with only weak effects on serotonin and dopamine reuptake. It exerts strong blocking effect at H1 receptors, moderate at 5-HT2 and alpha1 and weak blocking effect at D2 and mACh postsynaptic receptors [1, 2].	False	CNCCC[C@]12CC[C@H](c3ccccc31)c1ccccc12
247095	247095:01:04_10.00	True	10.0	98	7.9	0.0	0.0	59.8	0.0	64.3	53.0	65.2	26.7	41.3	0.0	60.6	38.0	LCH	65.2	Nicardipine hydrochloride, YC-93 hydrochloride	L-type Ca2+ channel antagonist, antihypertensive, vasodilator.	False	COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1
247020	247020:01:04_10.00	True	10.0	97	24.4	0.0	0.0	57.6	0.0	56.2	23.8	76.6	11.9	33.1	0.0	61.2	31.7	LCH	76.6	Cinnarizine	Cinnarizine is an antihistamine and a calcium channel blocker, promote cerebral blood flow, used to treat cerebral apoplexy, post-trauma cerebral symptoms, and cerebral arteriosclerosis.	False	C(=C/c1ccccc1)\CN1CCN(C(c2ccccc2)c2ccccc2)CC1
247104	247104:01:04_10.00	True	10.0	93	6.0	33.6	0.0	47.2	0.0	37.9	36.5	64.0	0.0	43.0	0.0	56.4	58.5	LCH	64.0	Terbutaline hemisulfate	beta-Adrenoceptor agonist, bronchodilator, Beta-2 adrenergic agonist.	False	CC(C)(C)NCC(O)c1cc(O)cc(O)c1
247109	247109:01:04_10.00	True	10.0	97	69.3	0.0	0.0	85.0	0.0	81.9	18.3	90.3	43.6	66.8	0.0	77.5	61.8	LCH	90.3	Prochlorperazine dimaleate	dopamine antagonist.	False	CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1
247089	247089:01:04_10.00	True	10.0	83	33.3	73.9	1.1	0.0	94.8	0.0	10.3	0.0	0.0	0.0	80.9	0.0	0.0	DNA_Synth	94.8	Methotrexate(+/-)	dehydrofolate reductase inhibitor, antineoplastic, antirheumatic, folic acid antagonist.	False	CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)NC(CCC(=O)O)C(=O)O)cc1
246902	246902:01:04_10.00	True	10.0	96	22.3	41.7	0.0	25.2	9.8	19.9	17.3	41.4	0.0	5.1	0.0	31.1	54.0	Uncoupler	54.0	Mercaptopurine	inhibits purine nucleotide synthesis and metabolism, antineoplastic, purine antimetabolite.	False	S=c1[nH]cnc2nc[nH]c12
246398	246398:01:04_10.00	True	10.0	70	43.5	53.3	0.0	24.4	13.1	19.3	36.6	24.6	18.0	44.8	0.0	42.4	69.9	Uncoupler	69.9	Thioguanosine	antimetabolite.	True	Nc1nc(S)c2ncn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1
247225	247225:01:05_10.00	True	10.0	86	6.7	67.2	0.0	0.0	76.6	0.0	29.4	5.2	0.0	0.0	59.4	0.0	0.0	DNA_Synth	76.6	Nisoldipine	vasodilator (coronary).	False	COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1c1ccccc1[N+](=O)[O-]
247197	247197:01:04_10.00	True	10.0	102	30.4	0.0	0.0	68.9	0.0	69.0	36.6	72.4	27.1	41.8	0.0	68.0	47.3	LCH	72.4	Oxethazaine	Oxethazaine (Oxetacaine), a precursor of phentermineacidic,  is an acid-resistent and orally active analgesic agent. Oxethazaine (Oxetacaine) has the potential for the relief of pain associated withpeptic ulcer diseaseoresophagitis.	False	CN(C(=O)CN(CCO)CC(=O)N(C)C(C)(C)Cc1ccccc1)C(C)(C)Cc1ccccc1
247083	247083:01:04_10.00	True	10.0	106	11.7	79.0	0.0	0.0	70.5	0.0	11.2	0.0	0.0	0.0	79.7	0.0	0.0	Pyrimidine_Synth	79.7	Betamethasone	Betamethasone is a synthetic glucocorticoid with anti-inflammatory and immunosuppressive activities. Betamethasone accelerates fetal lung maturation and induces gene expression and apoptosis.	True	C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
246904	246904:01:05_10.00	True	10.0	91	57.7	2.3	0.0	47.6	0.0	53.7	47.5	36.8	28.6	54.4	0.0	48.2	61.1	Uncoupler	61.1	Hexachlorophene	antiinfective (topical).	False	Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl
247337	247337:01:04_10.00	True	10.0	99	37.0	0.0	0.0	77.6	0.0	72.8	10.2	89.2	35.5	49.7	0.0	68.2	60.4	LCH	89.2	Paroxetine (hydrochloride)	Paroxetine hydrochloride is a potent selective serotonin-reuptake inhibitor, commonly prescribed as an antidepressant and has GRK2 inhibitory ability with IC50 of 14uM.	True	Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1
247070	247070:01:04_10.00	True	10.0	100	34.4	0.0	0.0	80.2	0.0	76.1	10.8	86.8	32.6	55.3	0.0	69.5	53.0	LCH	86.8	Desipramine hydrochloride	Desipramine hydrochloride is an inhibitor of norepinephrine transporter (NET), 5-HT transporter (SERT) and dopamine transporter (DAT) with Kis of 4, 61 and 78,720 nM, respectively.	False	CNCCCN1c2ccccc2CCc2ccccc21
246439	246439:01:04_10.00	True	10.0	103	70.1	0.0	0.0	79.7	0.0	76.8	19.1	93.1	32.6	55.4	0.0	70.0	58.2	LCH	93.1	Lidoflazine	ca 2+ channel activator.	False	Cc1cccc(C)c1NC(=O)CN1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1
246436	246436:01:04_10.00	True	10.0	101	7.3	32.4	0.0	0.0	48.0	0.0	35.7	5.9	0.0	0.0	39.4	4.6	0.0	DNA_Synth	48.0	Clofilium tosylate	Clofilium tosylate, a potassium channel blocker, induces apoptosis of human promyelocytic leukemia (HL-60) cells via Bcl-2-insensitive activation of caspase-3. Antiarrhythmic agent.	False	CCCCCCC[N+](CC)(CC)CCCCc1ccc(Cl)cc1
246414	246414:01:04_10.00	True	10.0	94	76.2	0.0	0.0	83.0	0.0	79.4	24.8	84.2	38.9	74.4	0.0	75.1	69.0	LCH	84.2	Fendiline (hydrochloride)	Fendiline hydrochloride is a nonselective calcium channel blocker.	False	CC(NCCC(c1ccccc1)c1ccccc1)c1ccccc1
246648	246648:01:06_10.00	True	10.0	96	5.9	24.0	0.0	36.9	0.0	27.3	28.3	56.4	0.0	19.1	0.0	40.9	34.1	LCH	56.4	Alfacalcidol	bone resorption inhibitor.	True	C=C1/C(=C/C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CCCC(C)C)C[C@@H](O)C[C@@H]1O
247229	247229:01:05_10.00	True	10.0	102	14.3	4.4	0.0	66.3	0.0	55.2	20.7	71.8	16.5	48.1	0.0	67.1	63.7	LCH	71.8	Isoxsuprine hydrochloride	Isoxsuprine hydrochloride is a beta-adrenergic receptor agonist with Kis of 13.65 .m. and 3.48 .m. for myometrial and placcntal beta-adrenergic receptor, respectively. Isoxsuprine hydrochloride is also a NMDA receptor antagonist.	False	CC(COc1ccccc1)NC(C)C(O)c1ccc(O)cc1
246785	246785:01:04_10.00	True	10.0	67	41.5	59.7	14.0	0.0	97.1	0.0	0.0	0.0	0.0	0.0	79.8	0.0	0.0	DNA_Synth	97.1	Cytarabine	Cytarabine, a nucleoside analog, causes S phase cell cycle arrest and inhibits DNA polymerase. Cytarabine inhibits DNA synthesis with an IC50 of 16 nM. Cytarabine has antiviral effects against HSV.	True	Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1
247206	247206:01:04_10.00	True	10.0	105	10.0	62.2	8.1	0.0	68.7	0.0	0.0	0.0	0.0	0.0	84.6	0.0	0.0	Pyrimidine_Synth	84.6	Isoflupredone acetate		True	CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
247243	247243:01:05_10.00	True	10.0	82	70.3	0.0	0.0	83.6	0.0	78.9	23.8	70.9	59.7	68.0	0.0	80.9	69.7	BET	83.6	Benzethonium chloride	Benzethonium chloride inhibit human recombinant .a.7 and .a.4.b.2 neuronal nicotinic acetylcholine receptors in Xenopus oocytes.	False	CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1
247387	247387:01:04_10.00	True	10.0	90	16.1	67.8	4.2	0.0	85.7	0.0	16.1	0.0	0.0	0.0	68.0	0.0	0.0	DNA_Synth	85.7	Idazoxan hydrochloride, RX 781094	I2-imidazoline agonist, I1-imidazoline antagonist, alpha2-Adrenergic antagonist, Alpha2 agonist.	False	c1ccc2c(c1)OCC(C1=NCCN1)O2
247042	247042:01:04_10.00	True	10.0	86	83.1	0.0	0.0	82.2	0.0	81.6	25.5	91.2	38.1	59.4	0.0	76.6	62.0	LCH	91.2	Pimozide	Ca2+ channel antagonist, antipsychotic, D2 dopamine receptor antagonist, Dopamine antagonist ?.	False	O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1
247398	247398:01:04_10.00	True	10.0	90	39.9	0.0	0.0	76.7	0.0	73.0	17.4	87.4	32.6	52.0	0.0	68.5	56.0	LCH	87.4	Salmeterol	Salmeterol (GR33343X) is a potent and selective human .b.2 adrenoceptor agonist. Salmeterol shows potent stimulation of cAMP accumulation in CHO cells expressing human .b.2, .b.1 and .b.3 adrenoceptors with pEC50s of 9.6, 6.1, and 5.9, respectively.	False	OCc1cc(C(O)CNCCCCCCOCCCCc2ccccc2)ccc1O
246405	246405:01:04_10.00	True	10.0	96	50.3	0.0	0.0	73.0	0.0	71.6	17.6	95.2	29.1	42.5	0.0	69.4	46.6	LCH	95.2	Thioproperazine dimesylate	dopamine antagonist.	False	CN1CCN(CCCN2c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1
247100	247100:01:06_10.00	True	10.0	92	43.0	0.0	0.0	18.9	0.0	13.9	11.7	27.6	26.1	16.5	0.0	31.8	0.0	Tubulin	31.8	Dequalinium dichloride	selective blocker of apamin-sensitive K+ channels, Blocker of the apamin-sensitive small conductance Ca2+ activated K+ channel.	False	Cc1cc(N)c2ccccc2[n+]1CCCCCCCCCC[n+]1c(C)cc(N)c2ccccc21
246294	246294:01:04_10.00	True	10.0	79	30.2	0.0	45.0	0.0	43.2	0.0	0.0	0.0	17.9	0.0	26.5	0.0	0.0	Aurora	45.0	Azaguanine-8	purine antimetabolite.	False	Nc1nc2[nH]nnc2c(=O)[nH]1
245384	245384:02:04_10.00	True	10.0	66	56.0	0.0	12.7	33.3	33.6	37.1	3.5	72.5	6.6	1.3	0.0	41.1	13.2	LCH	72.5	Hycanthone	Hycanthone is a thioxanthenone DNA intercalator and inhibits RNA synthesis as well as the DNA topoisomerases I and II. Hycanthone inhibits nucleic acid biosynthesis and inhibits apurinic endonuclease-1 (APE1) by direct protein binding with a KD of 10 nM. Hycanthone is a bioactive metabolite of Lucanthone (HY-B2098) and has anti-schistosomal agent.	False	CCN(CC)CCNc1ccc(CO)c2sc3ccccc3c(=O)c12
246889	246889:01:05_10.00	True	10.0	98	63.7	0.0	0.0	80.2	0.0	79.5	15.7	95.3	40.3	50.7	0.0	71.8	54.2	LCH	95.3	Loperamide (hydrochloride)	Loperamide (hydrochloride) (R-18553 (hydrochloride)) is an opioid receptor agonist. Loperamide hydrochloride is a selective and competitive human intestinal carboxylesterases (hiCE) inhibitor. Loperamide hydrochloride has anti-diarrheal effect.	False	CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1
247260	247260:01:04_10.00	True	10.0	98	11.6	59.7	8.7	0.0	63.4	0.0	16.2	0.0	0.0	0.0	71.7	0.0	0.0	Pyrimidine_Synth	71.7	Flumethasone	antagonist of Androgen Receptor; modulation of microRNA 21; antagonist of Hypoxia-inducible factor 1 alpha	False	C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
247098	247098:01:04_10.00	True	10.0	92	46.1	5.3	0.0	48.0	0.0	49.3	34.2	69.5	16.5	35.9	0.0	53.7	36.2	LCH	69.5	Vanoxerine (dihydrochloride)	Vanoxerine dihydrochloride (GBR-12909 dihydrochloride) is a competitive, potent, and highly selective dopamine reuptake inhibitor (Ki=1 nM). Vanoxerine dihydrochloride (GBR-12909 dihydrochloride) binds to the target site on the dopamine transporter (DAT).	False	Fc1ccc(C(OCCN2CCN(CCCc3ccccc3)CC2)c2ccc(F)cc2)cc1
246445	246445:01:04_10.00	True	10.0	101	8.1	0.0	0.0	38.5	0.0	38.6	32.2	59.9	0.0	13.9	0.0	47.2	13.6	LCH	59.9	Ketanserin tartrate hydrate	5-HT2 antagonist.	False	O=C(c1ccc(F)cc1)C1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1
246304	246304:01:04_10.00	True	10.0	100	27.6	0.0	0.0	74.7	0.0	73.1	23.4	90.4	27.3	53.1	0.0	65.5	52.4	LCH	90.4	Cloperastine hydrochloride	histamine antagonist.	False	Clc1ccc(C(OCCN2CCCCC2)c2ccccc2)cc1
246577	246577:01:05_10.00	True	10.0	98	15.2	26.4	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.0	32.8	0.0	0.0	Pyrimidine_Synth	32.8	Gabexate mesilate	serine protease inhibitor.	False	CCOC(=O)c1ccc(OC(=O)CCCCCNC(=N)N)cc1
246435	246435:01:04_10.00	True	10.0	87	78.2	0.0	0.0	73.1	0.0	71.1	6.4	88.8	30.8	41.8	0.0	68.7	44.6	LCH	88.8	Amodiaquine (dihydrochloride dihydrate)	Amodiaquine dihydrochloride dihydrate (Amodiaquin dihydrochloride dihydrate), a 4-aminoquinoline class of antimalarial agent, is a potent and orally active histamine N-methyltransferase inhibitor. Amodiaquine dihydrochloride dihydrate is also a Nurr1 agonist and specifically binds to Nurr1-LBD (ligand binding domain) with an EC50 of ~20 uM. Anti-inflammatory effect.	False	CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O
247050	247050:01:04_10.00	True	10.0	105	66.7	0.0	0.0	82.1	0.0	80.6	19.9	93.7	38.0	57.8	0.0	73.5	59.4	LCH	93.7	Fluphenazine dihydrochloride	dopamine receptor antagonist, antipsychotic, Dopamine antagonist, h1 antihistamine.	False	OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1
246549	246549:01:05_10.00	True	10.0	98	28.3	38.9	0.0	18.3	58.1	17.2	15.2	62.3	0.0	0.0	9.2	31.2	24.9	LCH	62.3	Beta-Escin	Solute carrier organic anion transporter family member 1B1 (IC50 = 1.412 µM) and 1B3 (IC50 = 3.388 µM)	False	CC(=O)O[C@H]1C(OC=C(C)C(=O)O)C(C)(C)CC2C3=CCC4C5(C)CCC(OC6O[C@H](C(=O)O)[C@@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@](C)(CO)C5CCC4(C)[C@]3(C)C[C@@H](O)C21CO
247085	247085:01:05_10.00	True	10.0	89	54.2	0.0	0.0	78.0	0.0	76.2	20.5	89.8	35.3	58.1	0.0	72.0	62.6	LCH	89.8	Bepridil hydrochloride	Bepridil hydrochloride (CERM 1978) is a calcium channel blocker, with antianginal activity.	False	CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1
245386	245386:02:04_10.00	True	10.0	103	18.0	0.0	0.0	83.8	0.0	80.4	20.1	85.6	45.4	59.1	0.0	78.2	59.9	LCH	85.6	Clozapine	atypical neuroleptic agent which display greater affinity for the D4 dopamine receptors over D2 or D3, 5-HT antagonist, antipsychotic.	False	CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
247073	247073:01:04_10.00	True	10.0	88	53.4	0.0	0.0	79.6	0.0	77.3	12.2	94.3	39.3	51.7	0.0	70.9	54.8	LCH	94.3	Chlorprothixene hydrochloride	D2 dopamine receptor antagonist, antipsychotic.	False	CN(C)CC/C=C1\c2ccccc2Sc2ccc(Cl)cc21
247196	247196:01:04_10.00	True	10.0	102	21.8	0.0	0.0	71.2	0.0	72.2	14.8	83.6	41.4	36.2	0.0	56.7	47.4	LCH	83.6	Acepromazine maleate	dopaminergic antagonist ?, sedative.	False	CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2
247361	247361:01:04_10.00	True	10.0	110	18.5	0.0	0.0	68.6	0.0	65.0	10.9	86.6	30.6	33.1	0.0	62.5	35.7	LCH	86.6	Promethazine hydrochloride	H1 Histamine receptor antagonist, anticholinergic, antihistaminic.	False	CC(CN1c2ccccc2Sc2ccccc21)N(C)C
246470	246470:01:05_10.00	True	10.0	107	6.9	24.9	0.0	0.0	5.6	0.0	0.0	7.2	0.0	0.0	13.1	0.0	0.0	AKT_PI3K_MTOR	24.9	Direct Blue 1	Direct Blue 1 (Chicago Sky Blue 6B) is a counterstain for background autofluorescence in immunofluorescence histochemistry. Direct Blue 1, structurally related to glutamate, is a potent and competitive VGLUT inhibitor without affecting plasma membrane transporters. Direct Blue 1 is the first small molecule PrP ligand capable of inhibiting A.b. binding.	False	COc1cc(-c2ccc(/N=N/c3ccc4c(S(=O)(=O)O)cc(S(=O)(=O)O)c(N)c4c3O)c(OC)c2)ccc1/N=N/c1ccc2c(S(=O)(=O)O)cc(S(=O)(=O)O)c(N)c2c1O
246509	246509:01:04_10.00	True	10.0	96	28.2	0.0	0.0	73.4	0.0	72.0	16.4	92.0	32.8	40.1	0.0	65.5	49.2	LCH	92.0	Methotrimeprazine maleat salt	Glutaminase kidney isoform, mitochondrial; Isocitrate dehydrogenase [NADP] cytoplasmic	False	COc1ccc2c(c1)N(C[C@H](C)CN(C)C)c1ccccc1S2
247227	247227:01:04_10.00	True	10.0	93	6.2	55.9	0.0	25.2	5.6	28.2	56.2	33.2	0.0	39.7	0.0	35.7	67.9	Uncoupler	67.9	Miconazole	sterol 14-demethylase inhibitor.	False	Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1
246330	246330:01:04_10.00	True	10.0	92	20.0	0.0	0.0	42.6	0.0	42.4	33.5	65.1	1.5	13.7	0.0	51.1	23.7	LCH	65.1	Dihydroergotamine tartrate	serotonine antagonist.	True	CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)CC2c3cccc4[nH]cc(c34)C[C@H]21
246383	246383:01:04_10.00	True	10.0	97	71.5	0.0	0.0	81.2	0.0	79.5	19.9	91.0	37.7	59.3	0.0	71.6	61.7	LCH	91.0	Itraconazole	inhibits the fungal cytochrome P450 oxidase-mediated synthesis of ergosterol.	False	CCC(C)n1ncn(-c2ccc(N3CCN(c4ccc(OCC5COC(Cn6cncn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)cc2)c1=O
246514	246514:01:05_10.00	True	10.0	102	77.9	0.0	0.0	89.8	0.0	86.0	27.4	81.2	52.0	68.4	0.0	85.4	72.5	BET	89.8	Fluvastatin sodium salt	HMG CoA reductase inhibitor.	True	CC(C)n1c(/C=C/[C@H](O)C[C@H](O)CC(=O)O)c(-c2ccc(F)cc2)c2ccccc21
247101	247101:01:04_10.00	True	10.0	99	27.5	0.0	0.0	60.2	0.0	59.5	13.2	90.8	19.1	26.9	0.0	57.9	30.9	LCH	90.8	Ketoconazole	potent inhibitor of cytochrome P450c17 enzyme, antifungal agent, Cytochrome P450c17 inhibitor.	False	CC(=O)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1
247256	247256:01:04_10.00	True	10.0	80	36.3	48.5	7.5	0.0	96.0	0.0	0.0	0.0	0.0	0.0	72.7	0.0	0.0	DNA_Synth	96.0	Deferoxamine mesylate	iron chelator, which does not readily bind iron from transferrin, hemoglobin, myoglobin or cytochrome. Rescues erastin-induced Ferroptosis.	False	CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN
247200	247200:01:04_10.00	True	10.0	99	8.3	1.0	0.0	57.5	0.0	52.0	10.5	61.8	33.0	13.4	0.0	46.4	40.3	LCH	61.8	Lobeline alpha (-) hydrochoride	nicotinic receptor ligand.	True	CN1[C@H](C[C@H](O)c2ccccc2)CCC[C@@H]1CC(=O)c1ccccc1
246446	246446:01:04_10.00	True	10.0	93	68.0	0.0	0.0	77.3	0.0	74.3	18.6	93.1	29.6	55.2	0.0	69.4	56.1	LCH	93.1	Methiothepin maleate	5-HT autoreceptor antagonist.	False	CSc1ccc2c(c1)C(N1CCN(C)CC1)Cc1ccccc1S2
246690	246690:01:04_10.00	True	10.0	101	52.7	0.0	0.0	79.2	0.0	75.8	17.5	92.6	37.0	51.8	0.0	70.4	58.9	LCH	92.6	Zotepine	dopamine D2/serotonin 5-HT2 antagonist.	False	CN(C)CCOC1=Cc2ccccc2Sc2ccc(Cl)cc21
246403	246403:01:04_10.00	True	10.0	98	15.0	63.5	0.0	0.0	84.1	0.0	0.0	0.0	0.0	0.0	65.7	0.0	0.0	DNA_Synth	84.1	Idoxuridine	Idoxuridine (5-Iodo-2-deoxyuridine) is an antiviral agent for feline herpesvirus type-1 with IC50 of 4.3 uM.Target: herpesvirus type-1Idoxuridine is mainly used topically to treat herpes simplex keratitis. Epithelial lesions, especially initial attacks presenting with a dendritic ulcer, are most responsive to therapy, while infection with stromal involvement are less responsive. Idoxuridine is ineffective against herpes simplex virus type 2 and varicella-zoster.	True	O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1I
247369	247369:01:04_10.00	True	10.0	88	79.8	0.0	0.0	78.3	0.0	78.3	29.8	90.0	33.0	58.8	0.0	72.7	62.8	LCH	90.0	Fluspirilene	Fluspirilene is a non-competitive antagonist of L-type calcium channels with an IC50 of 0.03 uM. Fluspirileneis a long-acting injectable depot antipsychotic drug used for schizophrenia.	False	O=C1NCN(c2ccccc2)C12CCN(CCCC(c1ccc(F)cc1)c1ccc(F)cc1)CC2
246379	246379:01:04_10.00	True	10.0	100	13.8	22.3	10.8	0.0	31.5	0.0	0.0	0.0	0.0	0.0	48.3	0.0	0.0	Pyrimidine_Synth	48.3	Carbadox	Carbadox is a quinoxaline-di-N-oxide antibiotic compound which is widely fed to nursery-age pigs to control enteric diseases and improve feed efficiency.	False	COC(=O)N/N=C/c1c[n+]([O-])c2ccccc2[n+]1[O-]
247086	247086:01:04_10.00	True	10.0	95	28.0	74.3	0.0	0.0	81.2	0.0	24.3	0.0	0.0	0.0	60.9	0.0	10.1	DNA_Synth	81.2	Pyrimethamine	Pyrimethamine (RP4753) interferes with tetrahydrofolic acid synthesis from folic acid by inhibiting the enzyme dihydrofolate reductase (DHFR). It is used against protozoal infections. IC50 = 15.4 nM (Plasmodium falciparum)	False	CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1
246433	246433:01:04_10.00	True	10.0	106	14.3	0.0	0.0	72.3	0.0	67.8	16.5	84.8	22.9	36.4	0.0	66.2	51.4	LCH	84.8	Diperodon hydrochloride	Sodium channel alpha subunits; brain (Types I, II, III) (IC50 = 1300 nM) and inhibition of Anandamide amidohydrolase	False	O=C(Nc1ccccc1)OCC(CN1CCCCC1)OC(=O)Nc1ccccc1
246419	246419:01:04_10.00	True	10.0	96	10.4	13.5	5.7	0.0	33.0	0.0	31.1	25.5	0.0	11.9	15.6	15.0	0.0	DNA_Synth	33.0	Quinidine hydrochloride monohydrate	heme polymerase inhibitor.	True	C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12
247044	247044:01:04_10.00	True	10.0	110	18.1	0.0	0.0	63.7	0.0	65.9	18.3	90.5	27.3	26.2	0.0	57.4	31.5	LCH	90.5	Mebeverine hydrochloride	phosphodiesterase inhibitor, muscle relaxant (smooth).	False	CCN(CCCCOC(=O)c1ccc(OC)c(OC)c1)C(C)Cc1ccc(OC)cc1
247108	247108:01:04_10.00	True	10.0	100	84.3	0.0	0.0	84.1	0.0	81.2	11.5	88.9	41.8	68.9	0.0	77.7	60.5	LCH	88.9	Enclomiphene (citrate)	inhibition of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5) (IC50 = 2.226 µM); estrogen agonist/antagonist	False	CCN(CC)CCOc1ccc(/C(=C(/Cl)c2ccccc2)c2ccccc2)cc1
247400	247400:01:04_10.00	True	10.0	101	5.4	0.0	57.6	0.0	3.6	0.0	27.1	9.7	0.0	0.0	0.0	34.5	0.0	Aurora	57.6	Prazosin hydrochloride	peripheral alpha1 adrenoceptor antagonist, Adrenergic receptor antagonist, antihypertensive.	False	COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC
247391	247391:01:04_10.00	True	10.0	101	32.1	0.0	0.0	79.0	0.0	75.6	15.6	90.5	31.9	56.0	0.0	70.1	52.6	LCH	90.5	Protriptyline (hydrochloride)	Protriptyline hydrochloride is a tricyclic antidepressant (TCA), specifically a secondary amine, for the treatment of depression and ADHD. Unique among the TCAs, protriptyline tends to be energizing instead of sedating, used for narcolepsy to achieve a wakefulness-promoting effect.	False	CNCCCC1c2ccccc2C=Cc2ccccc21
247014	247014:01:04_10.00	True	10.0	93	59.4	0.0	0.0	81.5	0.0	77.0	20.4	89.8	35.6	64.0	0.0	72.2	58.7	LCH	89.8	Clomipramine hydrochloride, Anafranil hydrochloride, Chloripramine	serotonin reuptake inhibitor, antidepressant, Noradrenaline reuptake inhibitor.	False	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21
246449	246449:01:04_10.00	True	10.0	102	5.9	22.8	0.0	50.0	3.2	39.5	18.3	63.4	3.2	37.3	0.0	59.2	55.0	LCH	63.4	Clenbuterol hydrochloride	beta adrenergic agonist.	False	CC(C)(C)NCC(O)c1cc(Cl)c(N)c(Cl)c1
246492	246492:01:04_10.00	True	10.0	97	19.7	0.0	7.7	2.1	0.0	0.0	27.0	20.0	11.0	6.1	0.0	15.1	0.0	HSP90	27.0	1,4-Chrysenequinone	1,4-Chrysenequinone, a polycyclic aromatic quinone, acts as an activator of aryl hydrocarbon receptor (AhR).	False	O=C1C=CC(=O)c2c1ccc1c2ccc2ccccc21
247067	247067:01:04_10.00	True	10.0	103	21.8	0.0	0.0	47.9	0.0	57.4	49.3	70.4	7.1	35.7	0.0	58.4	32.7	LCH	70.4	Domperidone	peripheral dopamine receptor antagonist that does not cross the blood-brain barrier, anti-emetic, Dopamine Antagonists, antiemetic.	False	O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1
246314	246314:01:04_10.00	True	10.0	90	63.2	0.0	0.0	62.9	0.0	65.3	32.3	52.8	45.2	58.4	0.0	58.3	61.8	HDAC	65.3	Monensin A sodium salt, Rumensin, Coban 45	it is a naturally occuring ionophorous antibiotic that preferentially forms complexes with monovalent cations to enable transport across lipid membranes. Through its ability to affect pH and the sodium-potassium balance of a cell, monensin can induce cell death in Gram-positive bacteria such as Micrococcus, Bacillus, and Staphylococcus (MICs = 1-12.5 µg/ml), reduce proliferation of P. falciparum and Coccicdium protozoa, and also prevent replication of certain viruses.	True	CC[C@@]1([C@@H]2O[C@@H]([C@H]3O[C@@](O)(CO)[C@H](C)C[C@@H]3C)C[C@@H]2C)CC[C@H]([C@]2(C)CC[C@]3(C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H](OC)[C@H](C)C(=O)O)O3)O2)O1
245391	245391:02:04_10.00	True	10.0	75	40.4	12.0	0.0	64.6	0.0	67.5	24.9	43.7	44.7	59.0	0.0	52.9	80.5	Uncoupler	80.5	Niclosamide	Niclosamide (BAY2353)is an orally bioavailable chlorinated salicylanilide, with anthelmintic and potential antineoplastic activity. Niclosamide (BAY2353) inhibits STAT3 with IC50 of 0.25 uM in HeLa cells and inhibits DNA replication in a cell-free assay.	False	O=C(Nc1ccc([N+](=O)[O-])cc1Cl)c1cc(Cl)ccc1O
246840	246840:01:04_10.00	True	10.0	92	7.6	61.4	0.0	0.0	63.0	0.0	0.9	0.0	0.0	0.0	78.0	0.0	0.0	Pyrimidine_Synth	78.0	Dexamethasone acetate	Dexamethasone acetate (Dexamethasone 21-acetate) is a glucocorticoid receptor agonist. Dexamethasone acetate has the potential for ophthalmic infections treatment.	True	CC(=O)OCC(=O)[C@@]1(O)[C@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
246899	246899:01:05_10.00	True	10.0	100	67.5	0.0	0.0	83.2	0.0	80.3	10.7	91.3	43.8	65.4	0.0	75.0	59.5	LCH	91.3	Tamoxifen (Citrate)	Tamoxifen Citrate (ICI 46474) is an orally active, selective estrogen receptor modulator (SERM) which blocks estrogen action in breast cells and can activate estrogen activity in other cells, such as bone, liver, and uterine cells.Tamoxifen Citrate is a potent Hsp90 activator and enhances the Hsp90 molecular chaperone ATPase activity. Tamoxifen Citrate also potent inhibits infectious EBOV Zaire and Marburg (MARV) with IC50 of 0.1 uM and 1.8 uM, respectively. Tamoxifen Citrate activates autophagy and induces apoptosis.	False	CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1
283253	283253:01:04_10.00	True	10.0	99	35.4	0.0	0.0	60.5	0.0	60.1	10.3	91.9	18.9	24.2	0.0	60.1	34.6	LCH	91.9	Spiramycin I,Spiramycin II and, Spiramycin III	compound mixture, Ribosomal protein synthesis inhibitor.	True	CCC(=O)O[C@@H]1CC(=O)O[C@H](C)C/C=C/C=C/[C@H](OC2CCC(N(C)C)C(C)O2)[C@H](C)C[C@H](CC=O)[C@H](OC2OC(C)C(OC3CC(C)(O)C(O)C(C)O3)C(N(C)C)C2O)[C@H]1OC
247358	247358:01:05_30.00	True	30.0	53	44.4	0.0	0.0	62.1	0.0	61.4	0.0	31.9	91.7	42.1	0.0	59.9	55.8	Na_K-ATPase	91.7	Digoxigenin	mainly used as a non-isotopic label for DNA.	False	C[C@]12CC[C@H](O)C[C@H]1CC[C@@H]1[C@@H]2C[C@@H](O)[C@]2(C)[C@@H](C3=CC(=O)OC3)CC[C@]12O
247099	247099:01:04_30.00	True	30.0	105	42.8	0.0	0.0	64.0	0.0	65.1	20.9	81.5	15.7	39.9	0.0	61.8	32.8	LCH	81.5	Carbetapentane (citrate)	Carbetapentane citrate is a selective inhibitor of the cough, with mild atropine-like effect and local anesthesia effect.	False	CCN(CC)CCOCCOC(=O)C1(c2ccccc2)CCCC1
246491	246491:01:04_30.00	True	30.0	103	16.1	0.0	0.0	76.6	0.0	66.8	1.5	90.7	26.2	37.6	0.0	67.8	45.0	LCH	90.7	Oxybuprocaine hydrochloride	Oxybuprocaine hydrochloride (Benoxinate hydrochloride) reversibly blocks sodium channels and prevents propagation of painful nerve impulses in the cornea, conjunctiva, and sclera. Oxybuprocaine hydrochloride is used especially in ophthalmology and otolaryngology.	False	CCCCOc1cc(C(=O)OCCN(CC)CC)ccc1N
246448	246448:01:04_30.00	True	30.0	93	32.5	0.0	0.0	60.6	0.0	57.8	26.9	60.9	28.2	44.3	0.0	67.5	22.3	Tubulin	67.5	Clebopride maleate	Inhibition of Dopamine D2 receptor (IC50 = 17 nM); Inhibition of human ERG ( IC50 = 602.56 nM 6.22); Inhibiton of Acetylcholinesterase (IC50 = 890 nM)	False	COc1cc(N)c(Cl)cc1C(=O)NC1CCN(Cc2ccccc2)CC1
245357	245357:02:04_30.00	True	30.0	98	23.5	0.0	0.0	43.0	0.0	44.2	25.6	52.9	11.0	36.8	0.0	48.5	25.1	LCH	52.9	Benfluorex (hydrochloride)	Benfluorex hydrochloride (JP-992 hydrochloride) is a hepatic nuclear factor 4 alpha (HNF4.a.) activator.	False	CC(Cc1cccc(C(F)(F)F)c1)NCCOC(=O)c1ccccc1
247091	247091:01:04_30.00	True	30.0	89	16.1	38.3	0.0	18.6	15.5	19.0	24.4	41.8	7.5	26.3	1.9	23.9	41.7	LCH	41.8	Clofazimine	antibacterial, antilepretic, antituberculosis.	False	CC(C)/N=c1\cc2n(-c3ccc(Cl)cc3)c3ccccc3nc-2cc1Nc1ccc(Cl)cc1
247378	247378:01:04_30.00	True	30.0	92	24.9	0.0	0.0	38.7	0.0	39.1	50.0	48.3	23.6	36.5	0.0	63.8	22.5	Tubulin	63.8	Nitrendipine	Ca2+ channel blocker, antihypertensive, Calcium channel blocker.	False	CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc([N+](=O)[O-])c1
247095	247095:01:04_30.00	True	30.0	87	74.4	0.0	0.0	67.5	0.0	71.7	43.0	81.7	22.8	49.9	0.0	69.2	55.6	LCH	81.7	Nicardipine hydrochloride, YC-93 hydrochloride	L-type Ca2+ channel antagonist, antihypertensive, vasodilator.	False	COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1
247077	247077:01:04_30.00	True	30.0	89	15.4	8.2	0.0	43.5	0.0	39.7	45.0	58.7	0.0	35.4	0.0	45.2	41.4	LCH	58.7	Dobutamine (hydrochloride)	Dobutamine hydrochloride is a synthetic catecholamine that acts on .a.1-AR, .b.1-AR, .b.2-AR (.a.-1, .b.-1 and.b.-2 adrenoceptors). Dobutamine hydrochloride is a selective .b.1-AR agonist, relatively weak activity at .a.1-AR and .b.2-AR. Dobutamine hydrochloride can increase cardiac output and correct hypoperfusion.	False	CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1
247020	247020:01:04_30.00	True	30.0	97	9.5	0.0	0.0	46.3	0.0	38.6	20.5	63.0	2.9	32.5	0.0	51.1	12.4	LCH	63.0	Cinnarizine	Cinnarizine is an antihistamine and a calcium channel blocker, promote cerebral blood flow, used to treat cerebral apoplexy, post-trauma cerebral symptoms, and cerebral arteriosclerosis.	False	C(=C/c1ccccc1)\CN1CCN(C(c2ccccc2)c2ccccc2)CC1
247092	247092:01:04_30.00	True	30.0	100	34.4	0.0	0.0	59.7	0.0	60.4	23.3	84.2	17.5	38.4	0.0	61.6	35.5	LCH	84.2	Naftidrofuryl (oxalate)	Naftidrofuryl oxalate (Nafronyl oxalate salt) is a drug used in the management of peripheral and cerebral vascular disorders as a vasodilator, enhance cellular oxidative capacity, and may also be a 5-HT2 receptor antagonist.	False	CCN(CC)CCOC(=O)C(Cc1cccc2ccccc12)CC1CCCO1
247278	247278:01:04_30.00	True	30.0	97	12.8	27.8	0.0	0.0	13.4	0.0	36.8	34.5	0.0	0.0	20.1	11.2	0.0	HSP90	36.8	Chlorotrianisene	nuclear receptor ligand, estrogen.	False	COc1ccc(C(Cl)=C(c2ccc(OC)cc2)c2ccc(OC)cc2)cc1
247036	247036:01:04_30.00	True	30.0	86	31.6	13.3	0.0	34.6	0.0	26.6	52.3	42.6	5.9	41.5	0.0	50.8	44.4	HSP90	52.3	Mifepristone	Mifepristone (RU486) is a progesterone receptor (PR) and glucocorticoid receptor (GR) antagonist with IC50s of 0.2 nM and 2.6 nM in in vitro assay.	True	CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C
247388	247388:01:04_30.00	True	30.0	93	9.3	1.9	0.0	48.2	0.0	49.3	34.0	58.3	19.8	48.4	0.0	52.8	42.4	LCH	58.3	Quinapril (hydrochloride)	Quinapril (hydrochloride) (CI-906) is a prodrug that belongs to the angiotensin-converting enzyme (ACE) inhibitor class of medications.	True	CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2ccccc2C[C@H]1C(=O)O
247104	247104:01:04_30.00	True	30.0	100	5.9	0.0	0.0	62.7	0.0	50.6	7.9	64.8	17.5	49.5	0.0	66.9	54.0	Tubulin	66.9	Terbutaline hemisulfate	beta-Adrenoceptor agonist, bronchodilator, Beta-2 adrenergic agonist.	False	CC(C)(C)NCC(O)c1cc(O)cc(O)c1
247109	247109:01:04_30.00	True	30.0	102	78.8	0.0	0.0	76.4	0.0	72.6	9.9	92.6	31.9	47.8	0.0	70.6	51.1	LCH	92.6	Prochlorperazine dimaleate	dopamine antagonist.	False	CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1
247380	247380:01:04_30.00	True	30.0	100	15.9	0.0	0.0	25.8	0.0	18.7	40.0	36.2	5.2	11.4	0.0	44.5	0.1	Tubulin	44.5	Nimodipine	potent L-type Ca2+ channel antagonist, Calcium channel blocker, vasodilator.	False	COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1
246301	246301:01:05_30.00	True	30.0	92	10.9	42.2	0.0	8.7	22.0	3.0	37.5	41.6	0.0	20.3	0.0	20.9	11.0	AKT_PI3K_MTOR	42.2	Calcipotriene	viamin D receptor (VDR) affinity.	False	C=C1/C(=C\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)/C=C/[C@@H](O)C2CC2)C[C@@H](O)C[C@@H]1O
247089	247089:01:04_30.00	True	30.0	98	17.4	58.8	3.2	0.0	88.5	0.0	0.0	0.0	0.0	0.0	75.0	0.0	0.0	DNA_Synth	88.5	Methotrexate(+/-)	dehydrofolate reductase inhibitor, antineoplastic, antirheumatic, folic acid antagonist.	False	CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)NC(CCC(=O)O)C(=O)O)cc1
246315	246315:01:06_30.00	True	30.0	99	10.4	0.1	0.0	40.3	0.0	36.4	1.8	23.2	12.6	47.0	0.0	39.7	60.6	Uncoupler	60.6	Merbromin	inhibitory activity against tyrosyl-DNA phosphodiesterase 1, vitamin D receptor and 15-hLO-2 (15-human lipoxygenase 2)	False	O=C1OC2(c3cc(Br)c(O)cc3Oc3c2cc(Br)c(O)c3[Hg]O)c2ccccc21
246398	246398:01:04_30.00	True	30.0	94	26.9	77.2	0.0	0.0	20.1	0.3	35.8	8.3	0.0	21.9	19.9	0.0	54.6	AKT_PI3K_MTOR	77.2	Thioguanosine	antimetabolite.	True	Nc1nc(S)c2ncn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1
247225	247225:01:05_30.00	True	30.0	68	52.5	8.6	8.4	1.5	62.4	0.0	29.1	35.3	0.0	7.9	16.3	28.2	0.0	DNA_Synth	62.4	Nisoldipine	vasodilator (coronary).	False	COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1c1ccccc1[N+](=O)[O-]
247197	247197:01:04_30.00	True	30.0	97	79.3	0.0	0.0	81.3	0.0	76.3	24.8	79.8	43.6	71.0	0.0	77.0	69.0	BET	81.3	Oxethazaine	Oxethazaine (Oxetacaine), a precursor of phentermineacidic,  is an acid-resistent and orally active analgesic agent. Oxethazaine (Oxetacaine) has the potential for the relief of pain associated withpeptic ulcer diseaseoresophagitis.	False	CN(C(=O)CN(CCO)CC(=O)N(C)C(C)(C)Cc1ccccc1)C(C)(C)Cc1ccccc1
246904	246904:01:05_30.00	True	30.0	88	54.9	17.4	0.0	69.2	0.0	65.8	41.0	52.2	37.8	64.4	0.0	64.6	88.2	Uncoupler	88.2	Hexachlorophene	antiinfective (topical).	False	Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl
247070	247070:01:04_30.00	True	30.0	94	82.9	0.0	0.0	77.3	0.0	73.3	11.5	92.0	28.7	50.5	0.0	71.5	52.1	LCH	92.0	Desipramine hydrochloride	Desipramine hydrochloride is an inhibitor of norepinephrine transporter (NET), 5-HT transporter (SERT) and dopamine transporter (DAT) with Kis of 4, 61 and 78,720 nM, respectively.	False	CNCCCN1c2ccccc2CCc2ccccc21
247133	247133:01:04_30.00	True	30.0	84	20.2	0.0	0.0	71.8	0.0	64.3	15.8	55.3	68.8	39.9	0.0	87.5	54.2	Tubulin	87.5	Estradiol	Estradiol is a steroid sex hormone vital to the maintenance of fertility and secondary sexual characteristics in females. Estradiol upregulates IL-6 expression through the estrogen receptor .b. (ER.b.) pathway.	True	C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O
246436	246436:01:04_30.00	True	30.0	89	21.2	0.0	0.0	38.9	0.0	37.6	24.9	47.4	8.8	45.9	0.0	40.9	25.8	LCH	47.4	Clofilium tosylate	Clofilium tosylate, a potassium channel blocker, induces apoptosis of human promyelocytic leukemia (HL-60) cells via Bcl-2-insensitive activation of caspase-3. Antiarrhythmic agent.	False	CCCCCCC[N+](CC)(CC)CCCCc1ccc(Cl)cc1
247309	247309:01:05_30.00	True	30.0	94	34.9	27.7	0.0	50.8	0.0	53.1	55.2	58.4	18.7	56.7	0.0	51.7	69.3	Uncoupler	69.3	Sulconazole (mononitrate)	Sulconazole mononitrate ((±)-Sulconazole mononitrate), an imidazole derivative, is a broad-spectrum fungicide and is inhibitory to certain gram-positive anaerobes. Sulconazole mononitrate can be used for the research of dermatomycoses, pityriasis versicolor, and cutaneous candidiasis.	False	Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1
247088	247088:01:04_30.00	True	30.0	94	29.0	0.0	0.0	66.4	0.0	63.3	22.0	78.9	13.6	45.3	0.0	63.3	43.2	LCH	78.9	Ketotifen (fumarate)	Ketotifen (HC 20511) fumarate is a second-generation noncompetitive H1-antihistamine and mast cell stabilizer, which is used to prevent asthma attacks.	False	CN1CCC(=C2c3ccccc3CC(=O)c3sccc32)CC1
246648	246648:01:06_30.00	True	30.0	103	18.7	13.6	0.0	53.0	0.0	46.2	45.4	58.4	13.6	62.7	0.0	63.0	63.1	Uncoupler	63.1	Alfacalcidol	bone resorption inhibitor.	True	C=C1/C(=C/C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CCCC(C)C)C[C@@H](O)C[C@@H]1O
247028	247028:01:04_30.00	True	30.0	98	20.4	0.0	0.0	54.5	0.0	47.0	7.6	75.4	7.5	26.7	0.0	62.1	16.4	LCH	75.4	Spiperone	D2 antagonist, antipsychotic.	False	O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccc(F)cc1
247229	247229:01:05_30.00	True	30.0	97	32.5	0.0	0.0	69.2	0.0	62.4	17.8	75.5	22.4	46.4	0.0	71.1	40.4	LCH	75.5	Isoxsuprine hydrochloride	Isoxsuprine hydrochloride is a beta-adrenergic receptor agonist with Kis of 13.65 .m. and 3.48 .m. for myometrial and placcntal beta-adrenergic receptor, respectively. Isoxsuprine hydrochloride is also a NMDA receptor antagonist.	False	CC(COc1ccccc1)NC(C)C(O)c1ccc(O)cc1
247148	247148:01:04_30.00	True	30.0	102	42.1	0.0	0.0	71.3	0.0	66.4	18.7	85.9	19.9	43.9	0.0	67.5	41.3	LCH	85.9	Dicyclomine hydrochloride	competitive muscarinic acetylcholine receptor antagonist, Anticholinergic.	False	CCN(CC)CCOC(=O)C1(C2CCCCC2)CCCCC1
246785	246785:01:04_30.00	True	30.0	74	29.4	53.3	31.9	0.0	93.6	0.0	3.0	0.0	0.0	0.0	78.0	0.0	0.0	DNA_Synth	93.6	Cytarabine	Cytarabine, a nucleoside analog, causes S phase cell cycle arrest and inhibits DNA polymerase. Cytarabine inhibits DNA synthesis with an IC50 of 16 nM. Cytarabine has antiviral effects against HSV.	True	Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1
247206	247206:01:04_30.00	True	30.0	102	17.3	45.1	10.1	0.0	45.0	0.0	0.0	0.0	0.0	0.0	74.1	0.0	0.0	Pyrimidine_Synth	74.1	Isoflupredone acetate		True	CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
247107	247107:01:04_30.00	True	30.0	62	24.2	21.6	55.5	0.0	79.9	0.0	18.9	0.0	0.0	0.0	65.7	0.0	0.0	DNA_Synth	79.9	Etoposide	Etoposide (VP-16; VP-16-213) is an anti-cancer chemotherapy agent. Etoposide inhibits topoisomerase II, thus stopping DNA replication. Etoposide induces cell cycle arrest, apoptosis and autophagy.	True	COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O
247064	247064:01:04_30.00	True	30.0	90	10.0	0.0	0.0	43.3	15.1	31.7	0.0	55.9	30.0	28.2	0.0	60.8	34.3	Tubulin	60.8	N6-Methyladenosine	N6-Methyladenosine is the most prevalent internal (non-cap) modification present in the messenger RNA (mRNA) of all higher eukaryotes. N6-Methyladenosine can modifies viral RNAs and has antiviral activities.	True	CNc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O
246437	246437:01:04_30.00	True	30.0	101	22.8	0.0	0.0	67.9	0.0	65.8	26.3	77.2	38.9	48.0	0.0	70.6	47.2	LCH	77.2	Dextromethorphan hydrobromide monohydrate	opioid ligand.	True	COc1ccc2c(c1)[C@]13CCCC[C@@H]1[C@H](C2)N(C)CC3
247042	247042:01:04_30.00	True	30.0	89	32.0	0.0	0.0	48.8	0.0	49.9	33.7	67.2	0.0	35.5	0.0	53.9	18.2	LCH	67.2	Pimozide	Ca2+ channel antagonist, antipsychotic, D2 dopamine receptor antagonist, Dopamine antagonist ?.	False	O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1
246422	246422:01:04_30.00	True	30.0	94	9.7	0.0	0.0	46.2	0.0	37.7	0.0	43.3	22.7	32.4	0.0	41.1	42.3	BET	46.2	Trichlorfon	cholinesterase inhibitor.	False	COP(=O)(OC)C(O)C(Cl)(Cl)Cl
246500	246500:01:04_30.00	True	30.0	105	18.7	0.0	0.0	50.1	0.0	51.3	37.1	66.3	10.7	35.5	0.0	58.7	29.5	LCH	66.3	Racecadotril	enkephalinase inhibitor.	False	CC(=O)SCC(Cc1ccccc1)C(=O)NCC(=O)OCc1ccccc1
246405	246405:01:04_30.00	True	30.0	93	83.2	0.0	0.0	72.5	0.0	70.1	16.3	88.6	27.9	46.7	0.0	70.0	49.9	LCH	88.6	Thioproperazine dimesylate	dopamine antagonist.	False	CN1CCN(CCCN2c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1
245387	245387:02:04_30.00	True	30.0	104	15.9	6.2	12.5	0.0	17.1	0.0	37.4	13.9	0.0	0.0	22.3	11.3	0.0	HSP90	37.4	Tolnaftate	Tolnaftate (NP-27) is a synthetic thiocarbamate used as an anti-fungal agent. .	False	Cc1cccc(N(C)C(=S)Oc2ccc3ccccc3c2)c1
246442	246442:01:04_30.00	True	30.0	102	5.9	0.0	0.0	73.8	0.0	65.0	10.4	79.1	26.9	48.1	0.0	74.6	48.6	LCH	79.1	Ambroxol hydrochloride	Inhibiton of: Cytochrome P450 2D6 (IC50 = 557.4 nM); (cytochrome P450 1A2); Serotonin transporter (IC50 = 3391 nM); Beta-glucocerebrosidase (IC50 = 4100 nM)	False	Nc1c(Br)cc(Br)cc1CN[C@H]1CC[C@H](O)CC1
247100	247100:01:06_30.00	True	30.0	78	68.6	0.0	0.0	80.4	0.0	74.7	0.0	65.8	64.5	65.1	0.0	77.8	69.3	BET	80.4	Dequalinium dichloride	selective blocker of apamin-sensitive K+ channels, Blocker of the apamin-sensitive small conductance Ca2+ activated K+ channel.	False	Cc1cc(N)c2ccccc2[n+]1CCCCCCCCCC[n+]1c(C)cc(N)c2ccccc21
247069	247069:01:04_30.00	True	30.0	96	5.7	0.0	0.0	31.7	0.0	28.4	25.0	52.3	0.0	11.2	0.0	38.3	10.2	LCH	52.3	Methapyrilene hydrochloride	H1 Histamine receptor antagonist, Histamine H1 antagonist, h1 antihistamine.	False	CN(C)CCN(Cc1cccs1)c1ccccn1
246664	246664:01:04_30.00	True	30.0	104	16.1	0.0	0.0	65.8	0.0	59.2	6.0	90.2	14.5	35.0	0.0	56.4	40.6	LCH	90.2	Escitalopram	selective serotonin reuptake inhibitor.	True	CN(C)CCC[C@@]1(c2ccc(F)cc2)OCc2cc(C#N)ccc21
247260	247260:01:04_30.00	True	30.0	101	6.4	36.7	26.0	0.0	51.9	0.0	7.2	0.0	0.0	0.0	71.1	0.0	0.0	Pyrimidine_Synth	71.1	Flumethasone	antagonist of Androgen Receptor; modulation of microRNA 21; antagonist of Hypoxia-inducible factor 1 alpha	False	C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
247098	247098:01:04_30.00	True	30.0	75	82.6	0.0	0.0	75.6	0.0	74.7	26.4	82.9	30.1	61.2	0.0	70.8	66.3	LCH	82.9	Vanoxerine (dihydrochloride)	Vanoxerine dihydrochloride (GBR-12909 dihydrochloride) is a competitive, potent, and highly selective dopamine reuptake inhibitor (Ki=1 nM). Vanoxerine dihydrochloride (GBR-12909 dihydrochloride) binds to the target site on the dopamine transporter (DAT).	False	Fc1ccc(C(OCCN2CCN(CCCc3ccccc3)CC2)c2ccc(F)cc2)cc1
246445	246445:01:04_30.00	True	30.0	100	29.5	0.0	0.0	52.9	0.0	51.8	27.3	81.5	1.5	27.5	0.0	52.4	20.3	LCH	81.5	Ketanserin tartrate hydrate	5-HT2 antagonist.	False	O=C(c1ccc(F)cc1)C1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1
246304	246304:01:04_30.00	True	30.0	93	77.7	0.0	0.0	74.9	0.0	71.7	17.3	89.4	26.9	52.8	0.0	69.3	57.5	LCH	89.4	Cloperastine hydrochloride	histamine antagonist.	False	Clc1ccc(C(OCCN2CCCCC2)c2ccccc2)cc1
246549	246549:01:05_30.00	True	30.0	82	81.7	0.0	0.0	74.7	0.0	70.0	11.3	86.0	33.9	51.6	0.0	77.1	55.0	LCH	86.0	Beta-Escin	Solute carrier organic anion transporter family member 1B1 (IC50 = 1.412 µM) and 1B3 (IC50 = 3.388 µM)	False	CC(=O)O[C@H]1C(OC=C(C)C(=O)O)C(C)(C)CC2C3=CCC4C5(C)CCC(OC6O[C@H](C(=O)O)[C@@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@](C)(CO)C5CCC4(C)[C@]3(C)C[C@@H](O)C21CO
245386	245386:02:04_30.00	True	30.0	102	72.9	0.0	0.0	72.5	0.0	71.4	22.5	89.1	23.9	48.4	0.0	68.1	49.5	LCH	89.1	Clozapine	atypical neuroleptic agent which display greater affinity for the D4 dopamine receptors over D2 or D3, 5-HT antagonist, antipsychotic.	False	CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
246998	246998:01:04_30.00	True	30.0	105	19.7	0.0	0.0	68.7	0.0	65.2	20.2	81.4	19.2	38.1	0.0	63.7	33.2	LCH	81.4	Alprenolol (hydrochloride)	Alprenolol (hydrochloride) is a non-selective beta blocker as well as 5-HT1A receptor antagonist.The reference for administration is 10 mg/kg.	False	C=CCc1ccccc1OCC(O)CNC(C)C
247196	247196:01:04_30.00	True	30.0	105	63.6	0.0	0.0	73.6	0.0	70.6	12.1	94.4	24.8	40.6	0.0	66.8	45.4	LCH	94.4	Acepromazine maleate	dopaminergic antagonist ?, sedative.	False	CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2
247361	247361:01:04_30.00	True	30.0	99	57.2	0.0	0.0	73.7	0.0	67.9	4.2	94.0	25.1	40.7	0.0	63.5	45.5	LCH	94.0	Promethazine hydrochloride	H1 Histamine receptor antagonist, anticholinergic, antihistaminic.	False	CC(CN1c2ccccc2Sc2ccccc21)N(C)C
246519	246519:01:04_30.00	True	30.0	108	5.0	8.4	2.1	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.4	0.0	0.0	AKT_PI3K_MTOR	8.4	Ethoxyquin	Ethoxyquin is an antioxidant which has been used in animal feed for many years and also an inhibitor of heat shock protein 90 (Hsp90).	False	CCOc1ccc2c(c1)C(C)=CC(C)(C)N2
246509	246509:01:04_30.00	True	30.0	101	67.9	0.0	0.0	75.7	0.0	71.2	5.7	91.3	30.5	44.2	0.0	66.8	52.6	LCH	91.3	Methotrimeprazine maleat salt	Glutaminase kidney isoform, mitochondrial; Isocitrate dehydrogenase [NADP] cytoplasmic	False	COc1ccc2c(c1)N(C[C@H](C)CN(C)C)c1ccccc1S2
247227	247227:01:04_30.00	True	30.0	89	39.9	13.0	0.0	58.1	0.0	58.4	51.6	67.6	26.7	53.4	0.0	65.8	54.9	LCH	67.6	Miconazole	sterol 14-demethylase inhibitor.	False	Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1
246330	246330:01:04_30.00	True	30.0	100	68.9	0.0	0.0	66.8	0.0	66.2	23.5	90.4	16.9	40.4	0.0	64.7	41.0	LCH	90.4	Dihydroergotamine tartrate	serotonine antagonist.	True	CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)CC2c3cccc4[nH]cc(c34)C[C@H]21
246383	246383:01:04_30.00	True	30.0	106	5.2	0.0	0.0	33.8	2.2	31.2	0.0	65.2	0.0	10.2	0.0	37.6	6.7	LCH	65.2	Itraconazole	inhibits the fungal cytochrome P450 oxidase-mediated synthesis of ergosterol.	False	CCC(C)n1ncn(-c2ccc(N3CCN(c4ccc(OCC5COC(Cn6cncn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)cc2)c1=O
246514	246514:01:05_30.00	True	30.0	93	83.2	0.0	0.0	85.3	0.0	82.3	3.8	75.6	60.0	67.4	0.0	86.4	59.9	Tubulin	86.4	Fluvastatin sodium salt	HMG CoA reductase inhibitor.	True	CC(C)n1c(/C=C/[C@H](O)C[C@H](O)CC(=O)O)c(-c2ccc(F)cc2)c2ccccc21
247101	247101:01:04_30.00	True	30.0	102	70.6	0.0	0.0	79.3	0.0	73.8	9.0	94.4	32.5	51.4	0.0	69.5	53.7	LCH	94.4	Ketoconazole	potent inhibitor of cytochrome P450c17 enzyme, antifungal agent, Cytochrome P450c17 inhibitor.	False	CC(=O)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1
247256	247256:01:04_30.00	True	30.0	88	45.6	44.2	22.8	0.0	92.6	0.0	0.0	0.0	0.0	0.0	73.6	0.0	0.0	DNA_Synth	92.6	Deferoxamine mesylate	iron chelator, which does not readily bind iron from transferrin, hemoglobin, myoglobin or cytochrome. Rescues erastin-induced Ferroptosis.	False	CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN
247200	247200:01:04_30.00	True	30.0	102	26.3	0.0	0.0	52.7	0.0	58.0	31.4	70.3	7.2	33.1	0.0	52.9	29.0	LCH	70.3	Lobeline alpha (-) hydrochoride	nicotinic receptor ligand.	True	CN1[C@H](C[C@H](O)c2ccccc2)CCC[C@@H]1CC(=O)c1ccccc1
246552	246552:01:04_30.00	True	30.0	99	12.6	0.0	0.0	41.4	0.0	40.3	13.7	66.5	0.0	21.3	0.0	44.4	20.4	LCH	66.5	Adrenosterone	Adrenosterone ((+)-Adrenosterone) is a steroid hormone with weak androgenic effect. Adrenosterone is a dietary supplement that can decrease fat and increase muscle mass. Adrenosterone also is a selective and competitive inhibitor of hydroxysteroid (11-beta) dehydrogenase 1 (HSD11.b.1).	True	C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CCC2=O
247082	247082:01:04_30.00	True	30.0	99	28.8	0.0	0.0	42.2	0.0	46.3	41.0	61.6	1.7	26.1	0.0	53.8	12.3	LCH	61.6	Droperidol	alpha adrenergic antagonist, neuroleptic.	False	O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1
246403	246403:01:04_30.00	True	30.0	100	14.5	62.0	0.0	0.0	86.5	0.0	0.0	0.0	0.0	0.0	71.7	0.0	0.0	DNA_Synth	86.5	Idoxuridine	Idoxuridine (5-Iodo-2-deoxyuridine) is an antiviral agent for feline herpesvirus type-1 with IC50 of 4.3 uM.Target: herpesvirus type-1Idoxuridine is mainly used topically to treat herpes simplex keratitis. Epithelial lesions, especially initial attacks presenting with a dendritic ulcer, are most responsive to therapy, while infection with stromal involvement are less responsive. Idoxuridine is ineffective against herpes simplex virus type 2 and varicella-zoster.	True	O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1I
247369	247369:01:04_30.00	True	30.0	99	55.6	0.0	0.0	62.0	0.0	59.1	17.0	90.5	9.5	33.6	0.0	57.0	34.0	LCH	90.5	Fluspirilene	Fluspirilene is a non-competitive antagonist of L-type calcium channels with an IC50 of 0.03 uM. Fluspirileneis a long-acting injectable depot antipsychotic drug used for schizophrenia.	False	O=C1NCN(c2ccccc2)C12CCN(CCCC(c1ccc(F)cc1)c1ccc(F)cc1)CC2
247086	247086:01:04_30.00	True	30.0	87	18.5	26.4	0.0	0.0	69.2	0.0	24.4	32.7	0.0	0.0	28.8	22.0	1.9	DNA_Synth	69.2	Pyrimethamine	Pyrimethamine (RP4753) interferes with tetrahydrofolic acid synthesis from folic acid by inhibiting the enzyme dihydrofolate reductase (DHFR). It is used against protozoal infections. IC50 = 15.4 nM (Plasmodium falciparum)	False	CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1
246433	246433:01:04_30.00	True	30.0	102	56.1	0.0	0.0	68.7	0.0	65.8	24.0	89.4	17.1	42.4	0.0	64.9	44.4	LCH	89.4	Diperodon hydrochloride	Sodium channel alpha subunits; brain (Types I, II, III) (IC50 = 1300 nM) and inhibition of Anandamide amidohydrolase	False	O=C(Nc1ccccc1)OCC(CN1CCCCC1)OC(=O)Nc1ccccc1
246710	246710:01:04_30.00	True	30.0	105	10.5	0.0	0.0	64.8	0.0	59.2	0.0	84.0	21.5	25.9	0.0	48.2	38.0	LCH	84.0	Atomoxetine (hydrochloride)	Atomoxetine hydrochloride is a potent and selective noradrenalin re-uptake inhibitor (Ki values are 5, 77 and 1451 nM for inhibition of radioligand binding to human NET, SERT and DAT respectively). IC50 value: 5 nM (Ki for human NET)Target: NETAtomoxetine displays minimal affinity for a range of other neurotransmitter receptors and transporters (Ki > 1 uM). Atomoxetine is antidepressant and a commonly used non-stimulant treatment for Attention deficit hyperactivity disorder (ADHD).	True	CNCC[C@@H](Oc1ccccc1C)c1ccccc1
246378	246378:01:04_30.00	True	30.0	97	52.5	0.0	0.0	65.8	0.0	68.0	32.0	84.3	23.9	43.9	0.0	67.5	43.0	LCH	84.3	Nefazodone (hydrochloride)	Nefazodone hydrochloride (BMY-13754) is a potent and selective 5HT2A (Ki=5.8 nM) antagonist with moderate inhibition of 5-HT and noradrenaline uptake (IC50 of 290 and 300 nM, respectively). Nefazodone hydrochloride is a phenylpiperazine antidepressant with less alpha-adrenergic blocking activity.	False	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1
247060	247060:01:04_30.00	True	30.0	93	17.6	29.3	0.0	8.9	21.3	13.9	29.4	0.0	17.0	39.1	6.9	20.4	48.7	Uncoupler	48.7	Zidovudine	Zidovudine is a nucleoside reverse transcriptase inhibitor (NRTI), widely used to treat HIV infection. Zidovudine increases CRISPR/Cas9-mediated editing frequency.	True	Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O
246700	246700:01:05_30.00	True	30.0	94	23.0	1.9	0.0	23.0	0.0	17.2	45.0	43.3	0.0	20.2	0.0	44.5	9.1	HSP90	45.0	Etretinate	Etretinate(Ro 10-9359) is a second-generation retinoid that has the potential for severe psoriasis treatment.	False	CCOC(=O)/C=C(C)/C=C/C=C(C)/C=C/c1c(C)cc(OC)c(C)c1C
246878	246878:01:04_30.00	True	30.0	93	6.2	0.3	12.7	11.0	34.2	0.0	10.6	34.5	0.0	4.3	0.0	33.1	0.0	LCH	34.5	Exemestane	Exemestane (FCE 24304) is a selective, irreversible and orally active steroidal aromatase inhibitor with IC50s of 30 nM and 40 nM for human placental and rat ovarian aromatase, respectively. Exemestane can be used for hormone-dependent breast cancer research.	True	C=C1C[C@@H]2[C@H](CC[C@]3(C)C(=O)CC[C@@H]23)[C@@]2(C)C=CC(=O)C=C12
246849	246849:01:04_30.00	True	30.0	97	7.9	0.0	0.0	75.9	0.0	70.6	13.5	78.6	21.4	55.0	0.0	72.0	48.3	LCH	78.6	Rimantadine	DNDI: Malaria in Vitro, 72 hour (Plasmodium falciparum); DNDI: HAT in Vitro, 72 hour (Trypanosoma brucei rhodesiense)	False	CC(N)[C@]12C[C@H]3C[C@H](C[C@H](C3)C1)C2
246419	246419:01:04_30.00	True	30.0	89	37.3	0.0	0.0	35.5	0.0	33.1	24.9	59.7	0.0	25.2	0.0	42.6	7.8	LCH	59.7	Quinidine hydrochloride monohydrate	heme polymerase inhibitor.	True	C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12
247044	247044:01:04_30.00	True	30.0	101	70.1	0.0	0.0	67.0	0.0	67.3	22.8	89.1	17.9	42.2	0.0	66.1	38.5	LCH	89.1	Mebeverine hydrochloride	phosphodiesterase inhibitor, muscle relaxant (smooth).	False	CCN(CCCCOC(=O)c1ccc(OC)c(OC)c1)C(C)Cc1ccc(OC)cc1
247397	247397:01:04_30.00	True	30.0	104	5.4	0.0	15.9	0.0	24.7	0.0	25.2	4.7	0.0	0.0	37.4	0.4	0.0	Pyrimidine_Synth	37.4	Phenoxybenzamine (hydrochloride)	Phenoxybenzamine hydrochloride is a selective antagonist of both .a.-adrenoceptor and calmodulin that is commonly used for the treatment of hypertension, specifically caused by pheochromocytoma.	False	CC(COc1ccccc1)N(CCCl)Cc1ccccc1
247391	247391:01:04_30.00	True	30.0	95	81.0	0.0	0.0	75.3	0.0	71.1	5.9	90.8	31.2	47.5	0.0	71.2	50.4	LCH	90.8	Protriptyline (hydrochloride)	Protriptyline hydrochloride is a tricyclic antidepressant (TCA), specifically a secondary amine, for the treatment of depression and ADHD. Unique among the TCAs, protriptyline tends to be energizing instead of sedating, used for narcolepsy to achieve a wakefulness-promoting effect.	False	CNCCCC1c2ccccc2C=Cc2ccccc21
247014	247014:01:04_30.00	True	30.0	91	84.1	0.0	0.0	75.4	0.0	72.0	18.5	88.5	28.5	52.0	0.0	71.5	55.0	LCH	88.5	Clomipramine hydrochloride, Anafranil hydrochloride, Chloripramine	serotonin reuptake inhibitor, antidepressant, Noradrenaline reuptake inhibitor.	False	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21
246728	246728:01:04_30.00	True	30.0	100	5.5	28.8	0.0	17.0	0.0	23.0	61.9	42.8	0.0	26.9	0.0	27.2	31.0	HSP90	61.9	Ethynodiol diacetate	Ethynodiol diacetate (Ethynodiol acetate) is a steroidal progestin which is used as a hormonal contraceptive, it has relatively little or no potency as an androgen,has significant estrogenic effects.	True	C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=C[C@@H](OC(C)=O)CC[C@@H]4[C@H]3CC[C@@]21C
246449	246449:01:04_30.00	True	30.0	105	12.1	0.0	0.0	62.5	0.0	52.5	25.1	67.6	11.4	52.1	0.0	67.1	50.0	LCH	67.6	Clenbuterol hydrochloride	beta adrenergic agonist.	False	CC(C)(C)NCC(O)c1cc(Cl)c(N)c(Cl)c1
246736	246736:01:04_30.00	True	30.0	87	44.7	0.0	0.0	77.9	0.0	73.8	34.8	73.9	54.3	54.8	0.0	92.2	55.7	Tubulin	92.2	Diethylstilbestrol	Diethylstilbestrol (Stilbestrol), a synthetic nonsteroidal estrogen used in the treatment of menopausal and postmenopausal disorders.Target: Estrogen Receptor/ERRDiethylstilbestrol (DES), a synthetic estrogen that was used in pregnancy, is a prototype endocrine-disrupting chemical. Although prenatal exposure to DES is known to increase risks of vaginal/cervical adenocarcinoma and adverse reproductive outcomes in women, and urogenital anomalies in men, data on nonreproductive medical conditions are lacking. Comparing persons exposed prenatally to DES with those who were not exposed, the hazard ratios were 1.21 (95% confidence interval = 0.96-1.54) for diabetes, 1.27 (1.00-1.62) for all cardiovascular disease, 1.18 (0.88-1.59) for coronary artery disease, 1.28 (0.88-1.86) for myocardial infarction, 1.12 (1.02-1.22) for high cholesterol, 1.14 (1.02-1.28) for hypertension, 1.24 (0.99-1.54) for osteoporosis, and 1.30 (0.95-1.79) for fractures. The associations did not differ by dose and timing of DES exposure, nor, in the women, by the presence or absence of vaginal epithelial changes (a marker of DES host susceptibility) . The role of prenatal exposure to DES as an environmental risk factor for psychiatric disorders requires more evidence before any conclusions can be drawn .	False	CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1
247067	247067:01:04_30.00	True	30.0	95	72.9	0.0	0.0	63.7	0.0	65.7	27.8	87.7	15.9	36.9	0.0	62.6	37.1	LCH	87.7	Domperidone	peripheral dopamine receptor antagonist that does not cross the blood-brain barrier, anti-emetic, Dopamine Antagonists, antiemetic.	False	O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1
246314	246314:01:04_30.00	True	30.0	90	69.6	0.0	0.0	67.5	0.0	67.2	27.7	63.8	41.0	58.6	0.0	69.5	64.8	Tubulin	69.5	Monensin A sodium salt, Rumensin, Coban 45	it is a naturally occuring ionophorous antibiotic that preferentially forms complexes with monovalent cations to enable transport across lipid membranes. Through its ability to affect pH and the sodium-potassium balance of a cell, monensin can induce cell death in Gram-positive bacteria such as Micrococcus, Bacillus, and Staphylococcus (MICs = 1-12.5 µg/ml), reduce proliferation of P. falciparum and Coccicdium protozoa, and also prevent replication of certain viruses.	True	CC[C@@]1([C@@H]2O[C@@H]([C@H]3O[C@@](O)(CO)[C@H](C)C[C@@H]3C)C[C@@H]2C)CC[C@H]([C@]2(C)CC[C@]3(C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H](OC)[C@H](C)C(=O)O)O3)O2)O1
246382	246382:01:04_30.00	True	30.0	105	16.2	3.2	0.0	1.7	8.8	0.0	5.2	29.9	0.0	0.0	4.6	9.9	0.0	LCH	29.9	Liranaftate	Liranaftate (Piritetrate) is a squalene epoxidase inhibitor with anti-fungicidal activities. Liranaftate can be used for the research of dermatophytes. Liranaftate also suppresses fungal element-promoted production of IL-8 and experimental inflammation.	False	COc1cccc(N(C)C(=S)Oc2ccc3c(c2)CCCC3)n1
247209	247209:01:04_30.00	True	30.0	93	19.5	0.0	0.0	48.3	0.0	60.5	50.2	55.3	1.5	42.4	0.0	57.5	31.0	HDAC	60.5	Quipazine dimaleate salt	5-HT agonist.	False	c1ccc2nc(N3CCNCC3)ccc2c1
283253	283253:01:04_30.00	True	30.0	93	67.5	0.0	0.0	64.6	0.0	62.5	2.5	89.3	23.0	33.3	0.0	62.0	34.3	LCH	89.3	Spiramycin I,Spiramycin II and, Spiramycin III	compound mixture, Ribosomal protein synthesis inhibitor.	True	CCC(=O)O[C@@H]1CC(=O)O[C@H](C)C/C=C/C=C/[C@H](OC2CCC(N(C)C)C(C)O2)[C@H](C)C[C@H](CC=O)[C@H](OC2OC(C)C(OC3CC(C)(O)C(O)C(C)O3)C(N(C)C)C2O)[C@H]1OC
247074	247074:01:04_30.00	True	30.0	107	7.9	0.0	0.0	75.4	0.0	60.9	0.0	77.3	28.5	45.4	0.0	68.7	51.4	LCH	77.3	Ritodrine hydrochloride	beta2 agonist.	False	C[C@H](NCCc1ccc(O)cc1)[C@H](O)c1ccc(O)cc1
246996	246996:01:04_30.00	True	30.0	104	8.1	0.0	0.0	39.6	0.0	34.0	0.0	37.8	6.8	18.7	0.0	18.6	8.3	BET	39.6	Bupropion hydrochloride	selective dopamine reuptake inhibitor, antidepressant.	False	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1
247190	247190:01:06_10.00	True	10.0	107	9.5	0.0	0.0	44.4	1.1	43.7	0.0	73.9	19.0	0.0	0.0	38.0	18.9	LCH	73.9	Pregnenolone	Pregnenolone (3.b.-Hydroxy-5-pregnen-20-one) is a powerful neurosteroid, the main precursor of various steroid hormones including steroid ketones. Pregnenolone acts as a signaling-specific inhibitor of cannabinoid CB1 receptor, inhibits the effects of tetrahydrocannabinol (THC) that are mediated by the CB1 receptors. Pregnenolone can protect the brain from cannabis intoxication.	True	CC(=O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
246897	246897:01:04_10.00	True	10.0	100	20.9	0.0	0.0	75.9	0.0	76.0	2.7	80.8	46.0	38.3	0.0	64.4	40.8	LCH	80.8	Opipramol, dihydrochloride	sigma1, sigma2 receptor agonist, an antagonist at D2, 5HT2, and H1 receptors, atypical antidepressant, antipsychotic, and axiolytic.	False	OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1
108066	108066:02:04_10.00	True	10.0	99	57.2	0.0	0.0	80.7	0.0	78.6	3.9	94.0	40.3	49.3	0.0	69.1	49.5	LCH	94.0	Metergoline	Metergoline is a serotonin (5-HT) receptor and dopamine receptors antagonist, with pKis of 8.64, 8.75 and 8.75 for 5-HT2A, 5-HT2B and 5-HT2C, respectively. Metergoline is a high-affinity ligand for the h5-HT7 receptor, with a Ki of 16 nM. Metergoline also is a reversible neural Na+ channels inhibitor. Metergoline is commonly used for the research of seasonal affective disorder, prolactin hormone regulation.	True	CN1C[C@H](CNC(=O)OCc2ccccc2)C[C@@H]2c3cccc4c3c(cn4C)C[C@H]21
246646	246646:01:04_10.00	True	10.0	70	35.8	31.2	50.5	0.0	86.7	0.0	0.6	0.0	0.0	0.0	80.3	0.0	0.0	DNA_Synth	86.7	Irinotecan (hydrochloride)	Irinotecan hydrochloride ((+)-Irinotecan hydrochloride) is a topoisomerase I inhibitor mainly used to treat colon cancer and rectal cancer.	True	CCc1c2c(nc3ccc(OC(=O)N4CCC(N5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC
246430	246430:01:04_10.00	True	10.0	94	30.4	0.0	0.0	74.9	0.0	70.9	11.2	91.8	29.2	47.0	0.0	66.3	46.6	LCH	91.8	Pimethixene maleate	Pimethixene maleate is antihistamine and antiserotonergic compound, acts as an antimigraine agent.Pimethixene maleate is a highly potent antagonist of 5-HT1A, 5-HT2A, 5-HT2B, 5-HT2C, histamine H1, dopamine D2 and D4.4 as well as muscarinic M1 and M2 receptors, with pKis of 7.63, 10.22, 10.44, 8.42, 10.14, 8.19, 7.54, 8.61 and 9.38, respectively.	False	CN1CCC(=C2c3ccccc3Sc3ccccc32)CC1
247178	247178:01:04_10.00	True	10.0	94	18.1	0.0	0.0	64.4	0.0	68.1	20.9	87.2	24.1	36.4	0.0	60.5	27.3	LCH	87.2	Pirenperone, R-47,465	5-HT2 Serotonin receptor antagonist, 5-HT2 antagonist, 5ht2 receptor antagonist.	False	Cc1nc2ccccn2c(=O)c1CCN1CCC(C(=O)c2ccc(F)cc2)CC1
247186	247186:01:04_10.00	True	10.0	82	37.8	51.6	13.9	0.0	97.9	0.0	0.0	0.0	0.0	0.0	75.0	0.0	0.0	DNA_Synth	97.9	Ciclopirox (olamine)	cell membrane proteins synthesis inhibitor, antifungal.	False	Cc1cc(C2CCCCC2)n(O)c(=O)c1
247251	247251:01:04_10.00	True	10.0	100	39.0	0.0	0.0	76.7	0.0	73.1	1.1	89.9	39.1	43.2	0.0	64.0	48.7	LCH	89.9	Imipramine hydrochloride	tricyclic antidepressant, blocks reuptake of serotonin and norepinephrine, 5-HT transport inhibitor.	False	CN(C)CCCN1c2ccccc2CCc2ccccc21
247035	247035:01:04_10.00	True	10.0	103	18.7	0.0	0.0	70.3	0.0	67.7	0.0	88.8	31.2	39.1	0.0	62.5	38.1	LCH	88.8	Benzydamine hydrochloride	5-HT receptor antagonist, analgesic, antipyretic, antiinflammatory.	False	CN(C)CCCOc1nn(Cc2ccccc2)c2ccccc12
246456	246456:01:04_10.00	True	10.0	97	35.8	0.0	0.0	76.5	0.0	75.3	15.1	91.4	36.9	41.4	0.0	71.2	38.7	LCH	91.4	Cisapride	5-HT antagonist.	False	COc1cc(N)c(Cl)cc1C(=O)N[C@H]1CCN(CCCOc2ccc(F)cc2)C[C@H]1OC
246805	246805:01:04_10.00	True	10.0	86	61.0	0.0	0.0	81.0	0.0	79.1	0.0	91.7	46.0	55.9	0.0	69.4	53.6	LCH	91.7	Toremifene	selective estrogen receptor modulator.	False	CN(C)CCOc1ccc(/C(=C(/CCCl)c2ccccc2)c2ccccc2)cc1
246513	246513:01:05_10.00	True	10.0	95	23.0	0.0	0.0	24.7	14.0	19.3	0.0	29.1	34.9	0.0	0.0	29.9	5.3	Na_K-ATPase	34.9	Propidium iodide	detergent.	False	CC[N+](C)(CC)CCC[n+]1c(-c2ccccc2)c2cc(N)ccc2c2ccc(N)cc21
247041	247041:01:04_10.00	True	10.0	98	43.5	0.0	0.0	77.6	0.0	75.1	1.2	93.0	40.7	48.6	0.0	67.2	52.2	LCH	93.0	Clemastine (fumarate)	Clemastine (fumarate) (HS-592 (fumarate)) is a selective histamine H1 receptor antagonist with IC50 of 3 nM.	True	CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1
247128	247128:01:04_10.00	True	10.0	55	31.1	0.0	33.2	9.8	0.0	18.5	0.0	0.0	75.7	13.7	0.0	14.8	0.0	Na_K-ATPase	75.7	Digitoxigenin	Na+ K+ ATPase inhibitor.	True	C[C@]12CC[C@H](O)C[C@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](C3=CC(=O)OC3)CC[C@]12O
247066	247066:01:05_10.00	True	10.0	106	8.1	0.0	0.0	79.3	0.0	74.7	24.9	74.9	36.0	59.4	0.0	68.3	67.3	BET	79.3	Triamterene	Na+ channel blocker, diuretic, Non competitive aldosterone antagonist.	False	Nc1nc(N)c2nc(-c3ccccc3)c(N)nc2n1
246554	246554:01:05_10.00	True	10.0	95	12.8	0.0	1.5	49.1	0.0	50.4	0.0	76.2	25.7	0.0	0.0	42.5	13.0	LCH	76.2	Dehydroisoandrosterone 3-acetate	Dehydroepiandrosterone 3-acetate is a testosterone/estrogen precursor and known modulator of vertebrate aggression.	True	CC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CCC(=O)[C@@]4(C)CC[C@@H]32)C1
245373	245373:02:04_10.00	True	10.0	105	7.3	0.0	0.0	53.1	0.1	46.9	0.0	77.6	14.6	13.2	0.0	57.7	35.8	LCH	77.6	Oxybutynin Chloride	muscarinic acetylcholine receptor antagonist, Anticholinergic.	False	CCN(CC)CC#CCOC(=O)C(O)(c1ccccc1)C1CCCCC1
247159	247159:01:04_10.00	True	10.0	107	7.3	0.0	0.0	66.5	0.0	59.6	1.5	61.0	39.2	43.1	0.0	57.5	42.2	BET	66.5	Biperiden hydrochloride	anticholinergic.	False	OC(CCN1CCCCC1)(c1ccccc1)C1C[C@@H]2C=C[C@H]1C2
246426	246426:01:04_10.00	True	10.0	90	17.8	0.0	0.0	82.5	0.0	77.5	17.9	87.0	42.1	57.7	0.0	74.3	63.7	LCH	87.0	Glafenine (hydrochloride)	Glafenine hydrochloride is a non-narcotic analgesic and non-steroidal anti-inflammatory drug. It is an ABCG2 inhibitor with an IC50 of 3.2 uM.	False	O=C(OCC(O)CO)c1ccccc1Nc1ccnc2cc(Cl)ccc12
245389	245389:02:04_10.00	True	10.0	105	5.7	0.0	0.0	61.4	0.0	53.8	20.5	57.1	29.3	50.7	0.0	59.9	44.5	BET	61.4	Procyclidine (hydrochloride)	Procyclidine hydrochloride is a potent anti-cholinergic agent, and is also known to have NMDA antagonist properties.	False	OC(CCN1CCCC1)(c1ccccc1)C1CCCCC1
247382	247382:01:04_10.00	True	10.0	101	8.8	0.0	0.0	87.8	0.0	84.9	15.9	76.1	52.8	63.5	0.0	78.8	66.3	BET	87.8	Thioperamide maleate, MR 12842	potent and selective H3 histamine receptor antagonist that crosses the blood brain barrier, H3 antagonist.	False	S=C(NC1CCCCC1)N1CCC(c2c[nH]cn2)CC1
246734	246734:01:04_10.00	True	10.0	102	16.1	0.0	12.3	44.3	0.0	49.0	18.5	10.7	43.5	63.9	0.0	37.9	27.6	Protein_Synth	63.9	Colistin sulfate	performs membrane ionophores.	False	CC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(C(C)O)NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)C(C(C)C)CNC(=O)C(CC(C)C)NC(=O)C(CCN)NC1=O)C(C)O
246784	246784:01:04_10.00	True	10.0	94	56.1	0.0	0.0	80.4	0.0	79.9	6.7	92.3	45.0	50.3	0.0	70.0	49.2	LCH	92.3	Azelastine hydrochloride	H1 antihistamine (nonsedating), leucotriene synthesis blocker.	False	CN1CCCC(n2nc(Cc3ccc(Cl)cc3)c3ccccc3c2=O)CC1
246466	246466:01:04_10.00	True	10.0	94	79.1	0.0	0.0	80.9	0.0	78.8	1.9	92.0	41.6	53.9	0.0	72.7	48.8	LCH	92.0	Terconazole	sterol 14-demethylase inhibitor.	False	CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1
107987	107987:02:05_10.00	True	10.0	95	37.0	0.0	0.0	78.7	0.0	74.2	36.4	77.3	38.0	58.4	0.0	75.1	59.4	BET	78.7	Vatalanib	protein kinase inhibitor.	False	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1
247127	247127:01:04_10.00	True	10.0	84	24.7	53.6	0.0	1.6	32.7	0.0	47.4	11.2	0.0	18.6	21.2	23.0	46.4	AKT_PI3K_MTOR	53.6	Cyclosporin A	IL 2 synthesis inhibitor.	True	C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C
246337	246337:01:04_10.00	True	10.0	94	5.5	0.0	13.6	42.7	11.1	40.8	0.0	53.5	24.9	8.1	0.0	45.0	18.4	LCH	53.5	Epirizole	inhibition of ROR gamma transcriptional activity, agonist of Nuclear factor NF-kappa-B p105 subunit, (Fungicidal activity against Magnaporthe oryzae)	False	COc1cc(C)nc(-n2nc(C)cc2OC)n1
247375	247375:01:04_10.00	True	10.0	83	22.3	43.2	28.4	0.0	95.8	0.0	3.6	0.0	0.0	0.0	76.1	0.0	0.0	DNA_Synth	95.8	Monobenzone	Monobenzone is a potent skin depigmenting agent. Monobenzone induces depigmentation and active human vitiligo and exhibits good potential for vitiligo research.	False	Oc1ccc(OCc2ccccc2)cc1
247280	247280:01:04_10.00	True	10.0	107	30.6	0.0	0.0	79.0	0.0	75.5	0.0	91.2	36.1	54.3	0.0	66.6	45.4	LCH	91.2	Dibucaine	Dibucaine (Cinchocaine) is a sodium channel inhibitor. Dibucaine is a potent SChE inhibitor.	False	CCCCOc1cc(C(=O)NCCN(CC)CC)c2ccccc2n1
246421	246421:01:04_10.00	True	10.0	95	42.0	0.0	0.0	77.1	0.0	73.4	1.4	90.3	37.4	48.9	0.0	64.5	50.1	LCH	90.3	Homochlorcyclizine dihydrochloride	H1 antagonist.	False	CN1CCCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1
246464	246464:01:04_10.00	True	10.0	100	55.3	0.0	0.0	79.6	0.0	76.3	0.0	93.0	38.7	47.9	0.0	69.7	53.1	LCH	93.0	Metixene hydrochloride hydrate	Metixene hydrochloride hydrate is an anticholinergic antiparkinsonian agent, potently inhibits binding of quinuclidinyl benzilate (QNB) to the muscarinic receptor in rat brain cortical tissue, with an IC50 of 55 nM and a Kd of 15 nM.	False	CN1CCCC(CC2c3ccccc3Sc3ccccc32)C1
246297	246297:01:04_10.00	True	10.0	91	33.0	86.2	0.0	0.0	84.1	0.0	16.3	0.0	0.0	0.0	72.8	0.0	0.0	AKT_PI3K_MTOR	86.2	Erlotinib	Erlotinib (CP-358774) is a directly acting EGFR tyrosine kinase inhibitor, with an IC50 of 2 nM for human EGFR. Erlotinib reduces EGFR autophosphorylation in intact tumor cells with an IC50 of 20 nM. Erlotinib is used for the treatment of non-small cell lung cancer.	False	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1
246453	246453:01:04_10.00	True	10.0	99	20.9	0.0	0.0	73.7	0.0	72.7	10.4	88.8	37.0	45.8	0.0	65.9	41.5	LCH	88.8	Benperidol	dopamine antagonist.	False	O=C(CCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1
246537	246537:01:04_10.00	True	10.0	95	28.2	0.0	0.0	79.9	0.0	75.0	0.0	90.7	40.1	56.1	0.0	67.9	53.0	LCH	90.7	Dimethisoquin hydrochloride	Inhibitory activity against Geminin, Proto-oncogene c-JUN	False	CCCCc1cc2ccccc2c(OCCN(C)C)n1
247177	247177:01:04_10.00	True	10.0	95	41.5	0.0	0.0	80.4	0.0	76.6	0.0	91.8	40.9	51.2	0.0	67.5	53.0	LCH	91.8	Triflupromazine (hydrochloride)	Triflupromazine hydrochloride is an antipsychotic medication, which are Dopamine D1/D2 receptor antagonists.	False	CN(C)CCCN1c2ccccc2Sc2ccc(C(F)(F)F)cc21
247167	247167:01:04_10.00	True	10.0	100	7.3	0.0	0.0	75.7	0.0	68.7	19.4	78.5	40.8	42.8	0.0	69.4	49.9	LCH	78.5	Lovastatin	Lovastatin is a cell-permeable HMG-CoA reductase inhibitor used to lower cholesterol.	True	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21
247212	247212:01:04_10.00	True	10.0	97	9.2	47.5	0.0	12.6	48.8	0.0	21.3	44.5	0.0	2.1	13.8	34.6	34.9	DNA_Synth	48.8	Nifedipine	L-type Ca2+ channel blocker, vasodilator, L-type Ca2+ channels blocker, antianginal, antihypertensive.	False	COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1[N+](=O)[O-]
247161	247161:01:04_10.00	True	10.0	102	8.8	0.0	0.0	67.3	0.0	57.2	13.4	78.9	26.7	46.2	0.0	68.0	54.3	LCH	78.9	Metaproterenol (hemisulfate)	Metaproterenol hemisulfate (Orciprenaline hemisulfate) is a direct-acting sympathomimetic and a .b.2-adrenergic receptor (.b.2AR)  agonist with an IC50 of 68 nM. Metaproterenol hemisulfate also has anti-inflammatory activity.	False	CC(C)NCC(O)c1cc(O)cc(O)c1
247374	247374:01:04_10.00	True	10.0	96	9.3	6.6	0.0	56.9	1.0	48.6	23.6	75.4	12.7	46.1	0.0	66.5	53.3	LCH	75.4	(+)-Isoproterenol (+)-bitartrate salt	adernergic receptor agonist.	True	CC(C)NC[C@@H](O)c1ccc(O)c(O)c1
246465	246465:01:04_10.00	True	10.0	96	67.0	0.0	0.0	81.9	0.0	79.3	3.5	89.7	42.7	50.4	0.0	71.8	54.7	LCH	89.7	Norcyclobenzaprine	Inhibitory activity against: Cytochrome P450 2D6, Glucagon-like peptide 1 receptor, Cytochrome P450 1A, Prelamin-A/C, Histone acetyltransferase GCN5, Ataxin-2	False	CNCCC=C1c2ccccc2C=Cc2ccccc21
247146	247146:01:04_10.00	True	10.0	97	10.4	48.4	0.0	18.3	36.7	9.2	26.6	36.0	0.0	36.9	0.0	31.5	50.6	Uncoupler	50.6	Primaquine diphosphate	heme polymerase inhibitor, antimalarial.	False	COc1cc(NC(C)CCCN)c2ncccc2c1
246480	246480:01:04_10.00	True	10.0	92	9.5	0.0	8.6	47.8	0.0	46.6	0.0	55.8	35.0	25.2	0.0	62.0	15.1	Tubulin	62.0	Pentamidine isethionate	Inhibition of TDP1 (qHTS), AR	False	N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1
247017	247017:01:04_10.00	True	10.0	105	7.8	73.3	0.0	0.0	75.4	0.0	6.4	0.0	0.0	0.0	84.2	0.0	0.0	Pyrimidine_Synth	84.2	Prednisolone	Glucocorticoid receptor (IC50 = 0.526 nM); Interleukin-6 (IC50 = 4.2 nM); ADAM17 (IC50 = 14.9 nM); Mineralocorticoid receptor (IC50 = 44 nM)	True	C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO
246536	246536:01:04_10.00	True	10.0	100	5.2	58.0	0.0	0.0	36.6	0.0	25.2	0.0	0.0	0.0	61.5	0.0	0.0	Pyrimidine_Synth	61.5	Diflorasone Diacetate	Glucocorticoid receptor (Ki = 2.907 nM), Progesterone receptor (Ki = 15 nM)	False	CC(=O)OCC(=O)[C@@]1(OC(C)=O)[C@@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
247135	247135:01:04_10.00	True	10.0	90	33.9	0.0	0.0	77.6	0.0	74.8	0.8	90.4	45.1	49.4	0.0	66.9	48.1	LCH	90.4	Cyclobenzaprine (hydrochloride)	Cyclobenzaprine hydrochloride (MK130 hydrochloride) is a skeletal muscle relaxant and a central nervous system (CNS) depressant.Target: 5-HT Receptor 2ACyclobenzaprine hydrochloride is a skeletal muscle relaxant and a central nervous system (CNS) depressant. Cyclobenzaprine hydrochloride was thought to be an alpha 2-adrenoceptor agonist that reduced muscle tone by decreasing the activity of descending noradrenergic neurons. Cyclobenzaprine hydrochloride reduced the monosynaptic reflex amplitude dose dependently and this effect was not inhibited by the alpha 2-adrenoceptor antagonists idazoxan and yohimbine. Cyclobenzaprine-induced monosynaptic reflex depression was not attenuated by noradrenergic neuronal lesions produced by 6-hydroxydopamine. Cyclobenzaprine hydrochloride is a 5-HT2 receptor antagonist and that its muscle relaxant effect is due to inhibition of serotonergic, not noradrenergic, descending systems in the spinal cord . The inhibitory effects of Cyclobenzaprine hydrochloride on mono- and polysynaptic reflex potentials are due to the inhibition of descending serotonergic systems through 5-HT(2) receptors in the spinal cord .	False	CN(C)CCC=C1c2ccccc2C=Cc2ccccc21
246696	246696:01:06_10.00	True	10.0	102	5.4	50.8	8.3	0.0	73.9	0.0	0.0	0.0	0.0	0.0	78.4	0.0	0.0	Pyrimidine_Synth	78.4	Diclazuril	Diclazuril (R-64433), a benzeneacetonitrile derivative, is a potent and orally active anticoccidial agent. Diclazuril can be used for the research of certain infectious and parasitic diseases, including coccidiosis, acute toxoplasmosis, equine protozoal pyoencephalitis (EPM) et.al.	False	N#CC(c1ccc(Cl)cc1)c1c(Cl)cc(-n2ncc(=O)[nH]c2=O)cc1Cl
247000	247000:01:04_10.00	True	10.0	105	52.3	0.0	0.0	80.8	0.0	77.6	0.0	92.1	40.0	53.9	0.0	68.5	50.6	LCH	92.1	Nortriptyline (hydrochloride)	Nortriptyline hydrochloride (Desmethylamitriptyline hydrochloride) is a tricyclic antidepressant and the main active metabolite of Amitriptyline, and used to relieve the symptoms of depression.	False	CNCCC=C1c2ccccc2CCc2ccccc21
247008	247008:01:04_10.00	True	10.0	108	5.2	0.0	0.0	73.2	0.0	70.4	5.2	86.0	26.2	54.1	0.0	66.8	43.2	LCH	86.0	Doxepin (Hydrochloride)	Doxepin hydrochloride is an orally active tricyclic antidepressant agent. Doxepin hydrochloride is a potent and selective histamine receptor H1 antagonist. Doxepin hydrochloride is also a potent CYP450 inhibitor and significantly inhibits CYP450 2C19 and 1A2.	False	CN(C)CC/C=C1\c2ccccc2COc2ccccc21
246653	246653:01:05_10.00	True	10.0	105	49.2	0.0	0.0	86.3	0.0	82.3	31.9	81.6	44.8	63.9	0.0	79.5	70.0	BET	86.3	Atorvastatin	HMG-CoA reductase inhibition.	False	CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)O
247132	247132:01:04_10.00	True	10.0	101	22.1	0.0	0.0	66.9	0.0	64.9	0.0	90.9	27.7	30.4	0.0	58.6	36.8	LCH	90.9	Epiandrosterone	inhibition of Estradiol 17-beta-dehydrogenase 3 (IC50 = 330 nM); GABA-A receptor; anion channel (IC50 = 4.14 µM)	True	C[C@]12CC[C@H]3[C@@H](CC[C@H]4C[C@@H](O)CC[C@@]43C)[C@@H]1CCC2=O
247215	247215:01:04_10.00	True	10.0	99	8.1	57.4	17.9	0.0	74.5	0.0	0.2	0.0	0.0	0.0	85.9	0.0	0.0	Pyrimidine_Synth	85.9	Flunisolide	Glucocorticoid receptor agonist (IC50 = 5.33 nM)	False	CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1
246671	246671:01:04_10.00	True	10.0	99	14.2	0.0	0.0	73.4	0.0	73.0	38.8	73.9	36.4	51.6	0.0	70.3	58.5	LCH	73.9	Lacidipine	dihydropyridinr calcium channel blocker.	False	CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC)C1c1ccccc1/C=C/C(=O)OC(C)(C)C
246559	246559:01:04_10.00	True	10.0	93	47.2	0.0	0.0	81.3	0.0	78.4	4.2	89.1	40.0	53.1	0.0	72.5	51.5	LCH	89.1	S(-)Eticlopride hydrochloride	dopamine receptor antagonist.	True	CCc1cc(Cl)c(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1O
247034	247034:01:04_10.00	True	10.0	107	9.0	0.0	0.0	71.8	0.0	62.3	9.8	83.8	14.3	44.2	0.0	69.3	49.8	LCH	83.8	Pergolide (mesylate)	Pergolide mesylate (Pergolide methanesulfonate), an Ergoline derivative, is a potent and orally active dopamine D1 and D2 receptors agonist. Pergolide mesylate can be used for Parkinson's disease and hyperprolactinaemia research.	True	CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21
247214	247214:01:04_10.00	True	10.0	89	46.1	0.0	0.0	79.2	0.0	76.1	1.6	91.4	42.3	51.1	0.0	68.0	51.9	LCH	91.4	Chlorpromazine hydrochloride	non selective compound: intended target=DRD2, number of targets=174. Dopamine receptor antagonist, anti-emetic, antipsychotic, Dopamine antagonist. Chlorpromazine hydrochloride is used as a substitute for benzidine, o-dianisidine and o-tolidine in the determination of microquantities of hemoglobin and peroxidase.; Wang et al., Evidence-based and quantitative prioritization of tool compounds in phenotypic drug discovery Cell Chem. Biol. 23, 862-874 (2016).	False	CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21
246350	246350:01:04_30.00	True	30.0	89	14.3	0.0	0.0	50.7	0.0	50.7	24.4	78.8	19.8	40.4	0.0	57.9	35.4	LCH	78.8	Harmaline hydrochloride dihydrate	monoamine oxydase inhibitor.	False	COc1ccc2c3c([nH]c2c1)C(C)=NCC3
246697	246697:01:04_30.00	True	30.0	98	30.7	0.0	0.0	53.0	0.0	50.1	56.5	61.7	15.7	44.7	0.0	67.7	40.7	Tubulin	67.7	Efavirenz	reverse transcriptase inhibitor.	True	O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1
246897	246897:01:04_30.00	True	30.0	95	49.2	0.0	0.0	65.5	0.0	65.3	23.4	89.6	24.0	37.0	0.0	68.3	41.5	LCH	89.6	Opipramol, dihydrochloride	sigma1, sigma2 receptor agonist, an antagonist at D2, 5HT2, and H1 receptors, atypical antidepressant, antipsychotic, and axiolytic.	False	OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1
247090	247090:01:04_30.00	True	30.0	102	7.4	10.7	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	19.4	0.0	0.0	Pyrimidine_Synth	19.4	Methylergometrine maleate	5-HT antagonist.	True	CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1
246646	246646:01:04_30.00	True	30.0	66	28.7	29.5	44.7	0.0	88.2	0.0	10.4	0.0	0.0	0.0	66.1	0.0	0.0	DNA_Synth	88.2	Irinotecan (hydrochloride)	Irinotecan hydrochloride ((+)-Irinotecan hydrochloride) is a topoisomerase I inhibitor mainly used to treat colon cancer and rectal cancer.	True	CCc1c2c(nc3ccc(OC(=O)N4CCC(N5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC
247238	247238:01:04_30.00	True	30.0	97	29.0	0.0	0.0	69.3	0.0	72.1	33.5	82.8	26.7	52.2	0.0	65.0	50.0	LCH	82.8	Trihexyphenidyl (hydrochloride)	Trihexyphenidyl hydrochloride is an antiparkinsonian agent of the antimuscarinic class, binds to the M1 muscarinic receptor.	False	OC(CCN1CCCCC1)(c1ccccc1)C1CCCCC1
246430	246430:01:04_30.00	True	30.0	87	63.6	0.0	0.0	72.5	0.0	73.4	25.0	92.4	31.2	43.2	0.0	70.9	50.6	LCH	92.4	Pimethixene maleate	Pimethixene maleate is antihistamine and antiserotonergic compound, acts as an antimigraine agent.Pimethixene maleate is a highly potent antagonist of 5-HT1A, 5-HT2A, 5-HT2B, 5-HT2C, histamine H1, dopamine D2 and D4.4 as well as muscarinic M1 and M2 receptors, with pKis of 7.63, 10.22, 10.44, 8.42, 10.14, 8.19, 7.54, 8.61 and 9.38, respectively.	False	CN1CCC(=C2c3ccccc3Sc3ccccc32)CC1
246424	246424:01:04_30.00	True	30.0	96	36.6	0.0	0.0	70.7	0.0	72.0	26.4	88.1	23.0	44.1	0.0	63.2	47.4	LCH	88.1	Mebhydrolin (napadisylate)	Mebhydrolin napadisylate is a specific histamine H1 receptor antagonist.	False	CN1CCc2c(c3ccccc3n2Cc2ccccc2)C1
247178	247178:01:04_30.00	True	30.0	93	27.5	0.0	0.0	44.9	0.0	53.6	37.4	65.1	12.9	27.3	0.0	53.4	17.2	LCH	65.1	Pirenperone, R-47,465	5-HT2 Serotonin receptor antagonist, 5-HT2 antagonist, 5ht2 receptor antagonist.	False	Cc1nc2ccccn2c(=O)c1CCN1CCC(C(=O)c2ccc(F)cc2)CC1
108099	108099:02:04_30.00	True	30.0	98	5.4	14.8	0.0	36.6	28.3	26.6	2.9	67.7	1.3	18.4	0.0	47.0	27.9	LCH	67.7	Nomifensine (maleate)	Nomifensine maleate is a selective inhibitor of dopamine uptake, used in adult attention deficit disorder. 	False	CN1Cc2c(N)cccc2C(c2ccccc2)C1
247186	247186:01:04_30.00	True	30.0	70	51.8	23.4	15.2	0.0	81.8	0.0	17.8	8.4	0.0	0.0	54.3	0.0	0.0	DNA_Synth	81.8	Ciclopirox (olamine)	cell membrane proteins synthesis inhibitor, antifungal.	False	Cc1cc(C2CCCCC2)n(O)c(=O)c1
247251	247251:01:04_30.00	True	30.0	96	47.0	0.0	0.0	68.8	0.0	67.2	19.2	93.2	23.3	35.6	0.0	64.4	43.5	LCH	93.2	Imipramine hydrochloride	tricyclic antidepressant, blocks reuptake of serotonin and norepinephrine, 5-HT transport inhibitor.	False	CN(C)CCCN1c2ccccc2CCc2ccccc21
247035	247035:01:04_30.00	True	30.0	98	64.1	0.0	0.0	72.6	0.0	73.2	16.6	91.1	31.9	49.4	0.0	71.8	46.9	LCH	91.1	Benzydamine hydrochloride	5-HT receptor antagonist, analgesic, antipyretic, antiinflammatory.	False	CN(C)CCCOc1nn(Cc2ccccc2)c2ccccc12
246429	246429:01:05_30.00	True	30.0	74	59.9	0.0	0.0	53.4	5.5	53.3	8.5	82.5	20.2	21.7	0.0	62.3	30.0	LCH	82.5	Quinacrine (dihydrochloride)	Quinacrine (Mepacrine) dihydrochloride is an orally bioavailable antimalarial agent, which possess anticancer effect both in vitro and vivo. Quinacrine dihydrochloride suppresses NF-.k.B and activate p53 signaling, which results in the induction of the apoptosis.	False	CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12
246456	246456:01:04_30.00	True	30.0	95	16.6	0.0	9.8	2.4	14.4	0.0	27.3	25.0	0.0	0.0	14.6	21.1	0.0	HSP90	27.3	Cisapride	5-HT antagonist.	False	COc1cc(N)c(Cl)cc1C(=O)N[C@H]1CCN(CCCOc2ccc(F)cc2)C[C@H]1OC
246526	246526:01:04_30.00	True	30.0	99	5.2	0.0	10.7	17.9	0.0	10.7	36.0	34.0	0.0	9.0	0.0	33.8	0.0	HSP90	36.0	Carteolol hydrochloride	Adrenergic receptor beta antagonist (ARB1, ARB2, ARB3)	False	CC(C)(C)NCC(O)COc1cccc2c1CCC(=O)N2
246521	246521:01:04_30.00	True	30.0	92	13.3	0.0	25.4	0.0	42.0	0.0	39.7	28.0	0.0	0.0	23.1	24.0	0.0	DNA_Synth	42.0	Atracurium (besylate)	Atracurium Besylate is a neuromuscular blocking agent with ED95 of 0.2 mg/kg. Target: nAChRAtracurium besylate is a neuromuscular-blocking drug or skeletal muscle relaxant in the category of non-depolarizing neuromuscular-blocking drugs, used adjunctively in anesthesia to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. Atracurium is classified as an intermediate-duration non-depolarizing neuromuscular-blocking agent . A 14C radiolabeled metabolism study in cats confirmed the lack of hepatic or renal involvement in the metabolism of atracurium: radioactivity eliminated in bile and urine was predominantly from metabolites rather than the unchanged parent drug .	False	COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC
246702	246702:01:04_30.00	True	30.0	69	27.6	0.0	0.0	56.2	0.0	50.2	36.9	57.6	45.4	38.5	0.0	88.6	49.9	Tubulin	88.6	Flubendazole	Flubendazole is a safe and efficacious anthelmintic drug, which is widely used for anthelmintic to human, rodents and ruminants. Flubendazole exerts anticancer activities by mechanisms including inhibition of microtubule function. Flubendazole induces p53-mediated apoptosis and arrests G2/M cell cycle.	False	COC(=O)Nc1nc2cc(C(=O)c3ccc(F)cc3)ccc2[nH]1
246496	246496:01:04_30.00	True	30.0	101	8.1	0.0	0.0	40.9	0.0	36.4	14.8	62.0	9.6	9.5	0.0	49.2	3.6	LCH	62.0	Dicloxacillin sodium salt	bacterial transpeptidase inhibitor.	True	Cc1onc(-c2c(Cl)cccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)O)C(C)(C)S[C@H]12
246352	246352:01:04_30.00	True	30.0	100	10.4	0.0	0.0	53.9	0.0	49.4	24.2	76.8	2.9	36.2	0.0	54.8	37.8	LCH	76.8	Harmane hydrochloride	imidazoline receptors ligand.	False	Cc1nccc2c1[nH]c1ccccc12
246513	246513:01:05_30.00	True	30.0	103	11.7	0.0	0.0	17.6	0.0	12.0	0.0	18.7	17.6	0.0	0.0	14.8	0.0	LCH	18.7	Propidium iodide	detergent.	False	CC[N+](C)(CC)CCC[n+]1c(-c2ccccc2)c2cc(N)ccc2c2ccc(N)cc21
246903	246903:01:04_30.00	True	30.0	94	30.1	0.0	0.0	29.2	16.6	29.2	31.9	63.8	0.0	18.4	0.0	43.0	11.9	LCH	63.8	Nicergoline	Nicergoline, an ergoline derivative ester of bromonicotinic acid, is a potent, selective and orally active antagonist of .a.1A-adrenoceptor. Nicergoline has vasodilator effects. Nicergoline also has ameliorative effects on cognitive function in mouse models of Alzheimer's disease.	True	CO[C@]12C[C@@H](COC(=O)c3cncc(Br)c3)CN(C)[C@@H]1Cc1cn(C)c3cccc2c13
247147	247147:01:04_30.00	True	30.0	98	34.7	0.0	0.0	59.1	0.0	59.7	24.4	83.2	13.9	24.6	0.0	61.6	41.8	LCH	83.2	Progesterone	Progesterone is a steroid hormone that regulates the menstrual cycle and is crucial for pregnancy.	True	CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
247041	247041:01:04_30.00	True	30.0	90	80.1	0.0	0.0	78.3	0.0	75.0	18.7	91.0	36.8	51.7	0.0	77.9	58.0	LCH	91.0	Clemastine (fumarate)	Clemastine (fumarate) (HS-592 (fumarate)) is a selective histamine H1 receptor antagonist with IC50 of 3 nM.	True	CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1
246847	246847:01:04_30.00	True	30.0	91	24.7	0.0	0.0	36.5	0.0	42.3	41.6	54.8	0.0	26.0	0.0	51.1	19.5	LCH	54.8	Quetiapine	dopamine and serotonin receptors antagonist, antipsychotic: 5ht antagonist, dopamine antagonist, h1-antihistamine, alpha adrenergic blocker.	False	OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1
247066	247066:01:05_30.00	True	30.0	93	18.1	31.7	0.0	13.0	56.6	0.9	24.3	43.8	0.0	13.6	11.6	36.9	33.2	DNA_Synth	56.6	Triamterene	Na+ channel blocker, diuretic, Non competitive aldosterone antagonist.	False	Nc1nc(N)c2nc(-c3ccccc3)c(N)nc2n1
247141	247141:01:04_30.00	True	30.0	98	31.3	0.0	0.0	47.7	0.0	42.2	26.8	67.1	2.3	33.3	0.0	53.7	25.4	LCH	67.1	Meclizine hydrochloride	histamine antagonist, antiemetic.	False	Cc1cccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)c1
245373	245373:02:04_30.00	True	30.0	94	42.8	0.0	0.0	73.3	0.0	70.7	19.2	93.8	35.4	46.1	0.0	72.3	49.4	LCH	93.8	Oxybutynin Chloride	muscarinic acetylcholine receptor antagonist, Anticholinergic.	False	CCN(CC)CC#CCOC(=O)C(O)(c1ccccc1)C1CCCCC1
247159	247159:01:04_30.00	True	30.0	104	34.7	0.0	0.0	68.5	0.0	70.1	31.0	76.8	31.2	43.0	0.0	69.6	47.9	LCH	76.8	Biperiden hydrochloride	anticholinergic.	False	OC(CCN1CCCCC1)(c1ccccc1)C1C[C@@H]2C=C[C@H]1C2
246695	246695:01:04_30.00	True	30.0	97	6.9	0.0	0.0	56.9	0.0	57.5	20.7	78.5	6.0	29.5	0.0	57.9	26.9	LCH	78.5	Dibenzepine hydrochloride	Proto-oncogene c-JUN	False	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21
246426	246426:01:04_30.00	True	30.0	92	41.3	0.0	0.0	68.6	0.0	68.7	41.6	83.0	17.3	54.1	0.0	70.4	61.3	LCH	83.0	Glafenine (hydrochloride)	Glafenine hydrochloride is a non-narcotic analgesic and non-steroidal anti-inflammatory drug. It is an ABCG2 inhibitor with an IC50 of 3.2 uM.	False	O=C(OCC(O)CO)c1ccccc1Nc1ccnc2cc(Cl)ccc12
245389	245389:02:04_30.00	True	30.0	96	40.6	0.0	0.0	72.1	0.0	77.2	32.8	81.6	27.3	51.6	0.0	67.5	48.0	LCH	81.6	Procyclidine (hydrochloride)	Procyclidine hydrochloride is a potent anti-cholinergic agent, and is also known to have NMDA antagonist properties.	False	OC(CCN1CCCC1)(c1ccccc1)C1CCCCC1
246784	246784:01:04_30.00	True	30.0	90	79.3	0.0	0.0	75.6	0.0	75.0	23.5	90.1	34.5	49.8	0.0	75.8	54.8	LCH	90.1	Azelastine hydrochloride	H1 antihistamine (nonsedating), leucotriene synthesis blocker.	False	CN1CCCC(n2nc(Cc3ccc(Cl)cc3)c3ccccc3c2=O)CC1
246466	246466:01:04_30.00	True	30.0	107	49.9	0.0	0.0	68.9	0.0	69.0	15.8	90.7	28.9	42.9	0.0	69.1	41.8	LCH	90.7	Terconazole	sterol 14-demethylase inhibitor.	False	CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1
247009	247009:01:04_30.00	True	30.0	106	6.9	0.0	0.0	45.8	0.0	45.1	13.3	59.4	19.5	22.5	0.0	54.3	18.8	LCH	59.4	Dyclonine (hydrochloride)	Dyclonine hydrochloride (Dyclocaine hydrochloride) is an effective component of Runhou tablets. Dyclonine hydrochloride has significant bactericidal and fungicidal activity.	False	CCCCOc1ccc(C(=O)CCN2CCCCC2)cc1
246525	246525:01:04_30.00	True	30.0	88	40.8	8.1	0.0	62.3	0.0	60.6	45.1	83.7	17.3	45.7	0.0	66.2	59.3	LCH	83.7	Butoconazole (nitrate)	Butoconazole nitrate (RS 35887), an imidazole antifungal agent, is active against Candida spp. and effective against vaginal infections due to Candida albicans. Butoconazole nitrate is presumed to function as other imidazole derivatives via inhibition of steroid synthesis.	False	Clc1ccc(CCC(Cn2ccnc2)Sc2c(Cl)cccc2Cl)cc1
246707	246707:01:04_30.00	True	30.0	97	23.1	0.0	0.0	33.6	15.1	28.5	21.8	60.5	0.0	16.9	0.0	48.6	11.0	LCH	60.5	Lofexidine	Lofexidine is a selective .a.2-receptor agonist, commonly used to alleviate the physical symptoms of heroin and other types of opioid withdrawal.	False	CC(Oc1c(Cl)cccc1Cl)C1=NCCN1
107987	107987:02:05_30.00	True	30.0	79	75.0	0.0	0.0	78.2	0.0	78.6	51.9	72.0	46.0	64.8	0.0	85.1	64.1	Tubulin	85.1	Vatalanib	protein kinase inhibitor.	False	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1
247127	247127:01:04_30.00	True	30.0	85	11.4	15.1	23.7	0.0	49.9	0.0	52.2	0.0	0.0	1.5	52.0	0.0	0.0	HSP90	52.2	Cyclosporin A	IL 2 synthesis inhibitor.	True	C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C
247375	247375:01:04_30.00	True	30.0	72	23.0	48.4	33.5	0.0	93.1	0.0	0.0	0.0	0.0	0.0	76.9	0.0	0.0	DNA_Synth	93.1	Monobenzone	Monobenzone is a potent skin depigmenting agent. Monobenzone induces depigmentation and active human vitiligo and exhibits good potential for vitiligo research.	False	Oc1ccc(OCc2ccccc2)cc1
246355	246355:01:04_30.00	True	30.0	98	14.3	4.6	7.3	0.0	41.1	0.0	33.8	14.6	0.0	0.0	34.2	8.0	0.0	DNA_Synth	41.1	Heptaminol (hydrochloride)	Heptaminol hydrochloride is a vasoconstrictor, used in the treatment of low blood pressure, particularly orthostatic hypotension.in vivo: In the rat, Heptaminol hydrochloride prevents orthostatic hypotension, and increases the noradrenaline plasma concentration. In bovine chromaffin cells maintained in primary cultures, Heptaminol hydrochloride is found to be a competitive inhibitor of noradrenaline uptake.	False	CC(N)CCCC(C)(C)O
246868	246868:01:04_30.00	True	30.0	84	80.3	0.0	0.0	79.3	0.0	79.4	24.5	92.1	40.5	55.9	0.0	77.3	58.1	LCH	92.1	Terfenadine	Terfenadine ((±)-Terfenadine) is a potent open-channel blocker of hERG with an IC50 of 204 nM. Terfenadine, an H1 histamine receptor antagonist, acts as a potent apoptosis inducer in melanoma cells through modulation of Ca2+ homeostasis. Terfenadine induces ROS-dependent apoptosis, simultaneously activates Caspase-4, -2, -9.	False	CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1
247081	247081:01:05_30.00	True	30.0	101	16.9	0.0	0.0	18.9	0.0	15.1	33.3	37.1	0.0	3.2	0.0	33.1	0.0	LCH	37.1	Troleandomycin	ribosomal protein synthesis inhibitor.	True	CO[C@H]1C[C@H](O[C@@H]2[C@@H](C)C(=O)O[C@H](C)[C@H](C)[C@H](OC(C)=O)[C@@H](C)C(=O)[C@]3(CO3)C[C@H](C)[C@H](O[C@@H]3O[C@H](C)C[C@H](N(C)C)[C@H]3OC(C)=O)[C@H]2C)O[C@@H](C)[C@@H]1OC(C)=O
246722	246722:01:04_30.00	True	30.0	94	12.4	14.6	0.0	13.9	0.0	8.3	56.2	31.9	0.0	0.0	0.0	34.0	15.5	HSP90	56.2	Felodipine, Plendil	L-type calcium channel blocker, L-type Ca2+ channels blocker.	False	CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl
247280	247280:01:04_30.00	True	30.0	109	71.2	0.0	0.0	77.1	0.0	75.8	15.2	92.9	35.3	56.5	0.0	74.8	49.6	LCH	92.9	Dibucaine	Dibucaine (Cinchocaine) is a sodium channel inhibitor. Dibucaine is a potent SChE inhibitor.	False	CCCCOc1cc(C(=O)NCCN(CC)CC)c2ccccc2n1
247233	247233:01:04_30.00	True	30.0	98	24.0	0.0	0.0	54.6	0.0	57.0	27.2	82.4	16.8	29.8	0.0	56.2	34.1	LCH	82.4	Citalopram (hydrobromide)	Citalopram hydrobromide is an antidepressant drug of the selective serotonin reuptake inhibitor (SSRI) class. It has US FDA approval to treat major depression.	False	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21
246421	246421:01:04_30.00	True	30.0	74	83.8	0.0	0.0	77.7	0.0	77.9	26.9	89.6	37.0	54.5	0.0	78.6	57.9	LCH	89.6	Homochlorcyclizine dihydrochloride	H1 antagonist.	False	CN1CCCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1
246404	246404:01:04_30.00	True	30.0	91	15.2	5.5	0.0	67.1	0.0	71.3	43.2	80.7	35.6	55.8	0.0	61.9	66.3	LCH	80.7	Isoconazole	sterol 14-demethylase inhibitor.	False	Clc1ccc(C(Cn2ccnc2)OCc2c(Cl)cccc2Cl)c(Cl)c1
246297	246297:01:04_30.00	True	30.0	76	38.0	55.7	0.0	5.4	53.4	2.9	37.5	57.8	0.0	0.0	16.8	25.7	23.9	LCH	57.8	Erlotinib	Erlotinib (CP-358774) is a directly acting EGFR tyrosine kinase inhibitor, with an IC50 of 2 nM for human EGFR. Erlotinib reduces EGFR autophosphorylation in intact tumor cells with an IC50 of 20 nM. Erlotinib is used for the treatment of non-small cell lung cancer.	False	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1
247018	247018:01:04_30.00	True	30.0	92	16.8	1.7	0.0	37.7	0.0	37.2	47.2	54.6	0.0	36.8	0.0	51.2	36.7	LCH	54.6	Fenofibrate	Fenofibrate is a selective PPAR.a. agonist with an EC50 of 30 uM. Fenofibrate also inhibits human cytochrome P450 isoforms, with IC50s of 0.2, 0.7, 9.7, 4.8 and 142.1 uM for CYP2C19, CYP2B6, CYP2C9, CYP2C8, and CYP3A4, respectively.	False	CC(C)OC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1
247039	247039:01:04_30.00	True	30.0	91	26.6	32.2	0.0	38.9	0.0	41.3	66.4	56.2	6.0	42.9	0.0	47.0	55.4	HSP90	66.4	Econazole nitrate	ergosterol synthesis inhibition, antifungal.	False	Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1
246453	246453:01:04_30.00	True	30.0	106	56.3	0.0	0.0	60.9	0.0	66.3	28.8	85.3	21.0	37.0	0.0	63.4	31.2	LCH	85.3	Benperidol	dopamine antagonist.	False	O=C(CCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1
246537	246537:01:04_30.00	True	30.0	95	59.8	0.0	0.0	78.6	0.0	75.0	12.7	96.2	37.1	56.3	0.0	72.5	58.6	LCH	96.2	Dimethisoquin hydrochloride	Inhibitory activity against Geminin, Proto-oncogene c-JUN	False	CCCCc1cc2ccccc2c(OCCN(C)C)n1
247145	247145:01:04_30.00	True	30.0	96	10.0	0.0	0.0	48.3	0.0	46.8	19.1	73.0	2.3	20.8	0.0	52.5	14.1	LCH	73.0	Brompheniramine (maleate)	Brompheniramine ((±)-Brompheniramine) maleate is a potent and orally active antihistamine of the propylamine class. Brompheniramine maleate is a selective histamine H1 receptor antagonist with a Kd of 6.06 nM. Brompheniramine maleate has anticholinergic, antidepressant and analgesia properties and can be used for allergic rhinitis research.	False	CN(C)CCC(c1ccc(Br)cc1)c1ccccn1
247212	247212:01:04_30.00	True	30.0	91	7.8	51.1	0.0	0.0	68.2	0.0	12.2	30.9	0.0	0.0	28.2	0.0	0.0	DNA_Synth	68.2	Nifedipine	L-type Ca2+ channel blocker, vasodilator, L-type Ca2+ channels blocker, antianginal, antihypertensive.	False	COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1[N+](=O)[O-]
246484	246484:01:04_30.00	True	30.0	74	27.3	38.8	28.5	0.0	88.1	0.0	16.7	0.0	0.0	0.0	66.9	0.0	0.0	DNA_Synth	88.1	Nifuroxazide	Nifuroxazide is an effective inhibitor of STAT3, also exerts potent anti-tumor and anti-metastasis activity.	False	O=C(N/N=C/c1ccc([N+](=O)[O-])o1)c1ccc(O)cc1
246846	246846:01:05_30.00	True	30.0	100	33.0	0.0	0.0	51.7	0.0	58.4	40.3	71.5	10.7	27.8	0.0	59.6	32.0	LCH	71.5	Loxapine (succinate)	Loxapine Succinate is a D2DR and D4DR inhibitor, serotonergic receptor antagonist and also a dibenzoxazepine anti-psychotic agent.IC50 value: Target: D2DR/D4DR; 5-HT receptorin vitro: In the presence of Loxapine, [3H]ketanserin binds to 5-HT2 receptor in Frontal cortex of brain in human and bovine with ki value of 6.2 nM and 6.6 nM, respectively. Loxapine has the rank order of potency for the various receptors appears to be as follows:5-HT2D4>>>D1>D2 in comparing competition experiments involving the human membranes . Loxapine 0.2 uM, 2 uM and 20 uM reduces IL-1beta secretion by LPS-activated mixed glia cultures after 1 and 3 days of exposure. Loxapine in concentrations of 0.2 uM, 2 uM and 20 uM reduces IL-2 secretion in mixed glia cultures after 1 and 3 days of exposure, and additionally Loxapine decreases IL-1beta and IL-2 secretion in LPS-induced microglia cultures in concentrations of 2 uM, 10 uM and 20 uM .in vivo: Loxapine (5 mg/kg) induces a very significant reduction (more than 50%) of serotonin (S2) receptor density after 4 weeks or 10 weeks of daily injection in the rat. Loxapine (5 mg/kg) does not change dopamine receptor density but greatly reduces serotonin receptor density by 47% in the brain of rats .	False	CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1
247161	247161:01:04_30.00	True	30.0	102	7.6	0.0	0.0	59.6	0.0	53.3	25.0	72.6	18.4	52.7	0.0	64.9	48.3	LCH	72.6	Metaproterenol (hemisulfate)	Metaproterenol hemisulfate (Orciprenaline hemisulfate) is a direct-acting sympathomimetic and a .b.2-adrenergic receptor (.b.2AR)  agonist with an IC50 of 68 nM. Metaproterenol hemisulfate also has anti-inflammatory activity.	False	CC(C)NCC(O)c1cc(O)cc(O)c1
247374	247374:01:04_30.00	True	30.0	101	6.4	9.9	0.0	58.2	0.0	52.2	30.2	73.1	13.0	54.7	0.0	66.2	60.8	LCH	73.1	(+)-Isoproterenol (+)-bitartrate salt	adernergic receptor agonist.	True	CC(C)NC[C@@H](O)c1ccc(O)c(O)c1
247146	247146:01:04_30.00	True	30.0	50	80.0	0.0	0.0	57.5	0.0	59.8	29.7	62.8	41.2	58.8	0.0	64.8	45.7	Tubulin	64.8	Primaquine diphosphate	heme polymerase inhibitor, antimalarial.	False	COc1cc(NC(C)CCCN)c2ncccc2c1
246480	246480:01:04_30.00	True	30.0	93	17.6	0.0	0.0	26.3	0.0	25.3	29.3	46.3	6.6	22.4	0.0	43.3	0.9	LCH	46.3	Pentamidine isethionate	Inhibition of TDP1 (qHTS), AR	False	N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1
246832	246832:01:04_30.00	True	30.0	89	21.4	66.8	11.8	0.0	87.2	0.0	17.2	0.0	0.0	0.0	77.4	0.0	0.0	DNA_Synth	87.2	Spironolactone	aldosterone antagonist.	True	CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34CCC(=O)O4)[C@@H]21
246377	246377:01:04_30.00	True	30.0	95	15.9	11.9	0.0	47.3	0.0	39.2	45.4	63.0	2.7	34.3	0.0	55.6	48.7	LCH	63.0	Rifapentine	Rifapentine (DL 473) is an antibiotic compound used in the treatment of tuberculosis.Target: AntibacterialRifapentine inhibits DNA-dependent RNA polymerase activity in susceptible cells. Specifically, it interacts with bacterial RNA polymerase but does not inhibit the mammalian enzyme. A review of alternative regimens for prevention of active tuberculosis in HIV-negative individuals with latent TB found that a weekly, directly observed regimen of rifapentine with isoniazid for three months was as effective as a daily, self -administered regimen of isoniazid for nine months. But the rifapentine-isoniazid regimen had higher rates of treatment completion and lower rates of hepatotoxicity . However the rates of treatment-limiting adverse events were higher in the rifapentine-isoniazid regimen .	True	CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C6CCCC6)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C
246536	246536:01:04_30.00	True	30.0	95	5.4	36.4	0.0	0.0	52.5	0.0	31.3	15.2	0.0	0.0	51.2	0.0	0.0	DNA_Synth	52.5	Diflorasone Diacetate	Glucocorticoid receptor (Ki = 2.907 nM), Progesterone receptor (Ki = 15 nM)	False	CC(=O)OCC(=O)[C@@]1(OC(C)=O)[C@@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
247135	247135:01:04_30.00	True	30.0	95	64.1	0.0	0.0	74.8	0.0	74.5	15.8	95.1	32.6	43.2	0.0	72.0	47.7	LCH	95.1	Cyclobenzaprine (hydrochloride)	Cyclobenzaprine hydrochloride (MK130 hydrochloride) is a skeletal muscle relaxant and a central nervous system (CNS) depressant.Target: 5-HT Receptor 2ACyclobenzaprine hydrochloride is a skeletal muscle relaxant and a central nervous system (CNS) depressant. Cyclobenzaprine hydrochloride was thought to be an alpha 2-adrenoceptor agonist that reduced muscle tone by decreasing the activity of descending noradrenergic neurons. Cyclobenzaprine hydrochloride reduced the monosynaptic reflex amplitude dose dependently and this effect was not inhibited by the alpha 2-adrenoceptor antagonists idazoxan and yohimbine. Cyclobenzaprine-induced monosynaptic reflex depression was not attenuated by noradrenergic neuronal lesions produced by 6-hydroxydopamine. Cyclobenzaprine hydrochloride is a 5-HT2 receptor antagonist and that its muscle relaxant effect is due to inhibition of serotonergic, not noradrenergic, descending systems in the spinal cord . The inhibitory effects of Cyclobenzaprine hydrochloride on mono- and polysynaptic reflex potentials are due to the inhibition of descending serotonergic systems through 5-HT(2) receptors in the spinal cord .	False	CN(C)CCC=C1c2ccccc2C=Cc2ccccc21
246696	246696:01:06_30.00	True	30.0	95	11.9	45.4	0.1	0.0	63.8	0.0	0.0	0.0	0.0	0.0	74.6	0.0	0.0	Pyrimidine_Synth	74.6	Diclazuril	Diclazuril (R-64433), a benzeneacetonitrile derivative, is a potent and orally active anticoccidial agent. Diclazuril can be used for the research of certain infectious and parasitic diseases, including coccidiosis, acute toxoplasmosis, equine protozoal pyoencephalitis (EPM) et.al.	False	N#CC(c1ccc(Cl)cc1)c1c(Cl)cc(-n2ncc(=O)[nH]c2=O)cc1Cl
247008	247008:01:04_30.00	True	30.0	104	36.3	0.0	0.0	73.6	0.0	73.4	15.1	93.6	31.8	46.0	0.0	69.0	46.1	LCH	93.6	Doxepin (Hydrochloride)	Doxepin hydrochloride is an orally active tricyclic antidepressant agent. Doxepin hydrochloride is a potent and selective histamine receptor H1 antagonist. Doxepin hydrochloride is also a potent CYP450 inhibitor and significantly inhibits CYP450 2C19 and 1A2.	False	CN(C)CC/C=C1\c2ccccc2COc2ccccc21
246653	246653:01:05_30.00	True	30.0	97	82.2	0.0	0.0	87.1	0.0	88.4	16.7	80.1	62.4	61.7	0.0	87.3	63.6	HDAC	88.4	Atorvastatin	HMG-CoA reductase inhibition.	False	CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)O
247019	247019:01:04_30.00	True	30.0	105	31.6	0.0	0.0	59.9	0.0	56.8	15.7	80.8	13.1	30.0	0.0	63.4	33.0	LCH	80.8	Labetalol (hydrochloride)	Labetalol hydrochloride is a mixed alpha/beta adrenergic antagonist that is used to treat high blood pressure.	False	CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1
247132	247132:01:04_30.00	True	30.0	97	14.7	0.0	0.0	62.5	0.0	63.6	3.1	89.0	27.5	25.7	0.0	61.2	32.8	LCH	89.0	Epiandrosterone	inhibition of Estradiol 17-beta-dehydrogenase 3 (IC50 = 330 nM); GABA-A receptor; anion channel (IC50 = 4.14 µM)	True	C[C@]12CC[C@H]3[C@@H](CC[C@H]4C[C@@H](O)CC[C@@]43C)[C@@H]1CCC2=O
247215	247215:01:04_30.00	True	30.0	108	11.2	50.2	12.0	0.0	77.0	0.0	0.0	0.0	0.0	0.0	79.6	0.0	0.0	Pyrimidine_Synth	79.6	Flunisolide	Glucocorticoid receptor agonist (IC50 = 5.33 nM)	False	CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1
246559	246559:01:04_30.00	True	30.0	102	65.5	0.0	0.0	70.3	0.0	71.1	26.2	87.8	25.2	50.2	0.0	70.6	49.9	LCH	87.8	S(-)Eticlopride hydrochloride	dopamine receptor antagonist.	True	CCc1cc(Cl)c(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1O
247034	247034:01:04_30.00	True	30.0	97	21.1	0.0	0.0	53.9	0.0	52.1	28.8	71.2	13.0	37.0	0.0	58.6	32.8	LCH	71.2	Pergolide (mesylate)	Pergolide mesylate (Pergolide methanesulfonate), an Ergoline derivative, is a potent and orally active dopamine D1 and D2 receptors agonist. Pergolide mesylate can be used for Parkinson's disease and hyperprolactinaemia research.	True	CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21
246826	246826:01:04_10.00	True	10.0	63	84.6	0.0	0.0	90.1	0.0	88.7	24.3	84.5	54.7	70.7	0.0	83.0	70.8	BET	90.1	Mefloquine	heme polymerase inhibitor, antimalarial.	False	OC(c1cc(C(F)(F)F)nc2c(C(F)(F)F)cccc12)C1CCCCN1
246610	246610:01:04_10.00	True	10.0	95	5.4	61.8	6.6	0.0	77.0	0.0	16.1	0.0	0.0	0.0	79.8	0.0	0.0	Pyrimidine_Synth	79.8	Prednicarbate	glucocorticoid receptor agonist.	True	CCOC(=O)O[C@]1(C(=O)COC(=O)CC)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C
246746	246746:01:04_10.00	True	10.0	94	20.2	0.0	0.0	72.6	0.0	71.4	14.9	70.6	43.0	56.0	0.0	63.8	52.8	BET	72.6	Cyproheptadine (hydrochloride)	Cyproheptadine hydrochloride is a 5-HT2A receptor antagonist, with antidepressant and antiserotonergic effects. Cyproheptadine hydrochloride has antiplatelet and thromboprotective activities. Cyproheptadine hydrochloride can be used for the research of thromboembolic disorders.	False	CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1
246562	246562:01:04_10.00	True	10.0	104	10.9	0.0	0.0	52.8	0.0	56.2	14.5	88.9	7.3	20.7	0.0	48.5	35.9	LCH	88.9	Alfadolone acetate	nociception blocker.	True	CC(=O)OCC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3C(=O)C[C@]12C
246469	246469:01:04_10.00	True	10.0	100	8.1	0.0	0.0	60.5	0.0	58.2	0.0	65.6	47.0	23.5	0.0	59.8	29.9	LCH	65.6	Ampicillin trihydrate	Antimicrobal activity against: Staphylococcus aureus. Bacillus subtillis, Klebsiella pneumoniae, Escherichia coli, etc.	True	CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)O
247164	247164:01:04_10.00	True	10.0	101	60.1	0.0	0.0	80.6	0.0	80.2	10.0	96.8	39.1	50.1	0.0	69.9	46.0	LCH	96.8	Bromperidol	Bromperidol is a butyrophenone derivative, is a potent and long-acting neuroleptic, used as an antipsychotic in the treatment of schizophrenia.	False	O=C(CCCN1CCC(O)(c2ccc(Br)cc2)CC1)c1ccc(F)cc1
246579	246579:01:04_10.00	True	10.0	90	52.7	0.0	0.0	68.4	0.0	65.8	21.0	80.8	26.9	61.1	0.0	66.8	45.7	LCH	80.8	Halofantrine hydrochloride	Halofantrine hydrochloride (SKF-102886) is a blocker of delayed rectifier potassium current via the inhibition of  human-ether-a-go-go-related gene (HERG) channel and a potent antimalarial compound.	False	CCCCN(CCCC)CCC(O)c1cc2c(Cl)cc(Cl)cc2c2cc(C(F)(F)F)ccc12
245372	245372:02:04_10.00	True	10.0	102	54.4	0.0	0.0	84.6	0.0	83.3	14.2	93.4	44.7	56.9	0.0	74.8	56.3	LCH	93.4	Perphenazine	Perphenazine is a typical antipsychotic drug, inhibits 5-HT2Areceptor, Alpha-1A adrenergic receptor, Dopamine receptor D2/D3, D2L receptor, and Histamine H1 receptor, with Ki values of 5.6, 10, 0.765/0.13, 3.4, and 8 nM, respectively.	False	OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1
246866	246866:01:04_10.00	True	10.0	90	32.0	0.0	0.0	58.3	0.0	65.4	59.9	60.5	19.2	53.2	0.0	63.7	47.0	HDAC	65.4	Cilnidipine	slow-acting Ca2+ channel blocker, antihypertensive, vasodilator. Does not inhibit PKC.	False	COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC/C=C/c2ccccc2)C1c1cccc([N+](=O)[O-])c1
247275	247275:01:04_10.00	True	10.0	99	5.9	0.0	0.0	77.1	0.0	75.2	20.7	78.0	33.0	41.3	0.0	67.6	52.5	LCH	78.0	Phenazopyridine (hydrochloride)	Phenazopyridine hydrochloride is a chemical, which has a local analgesic effect, often used to alleviate the pain, irritation, discomfort, or urgency caused by urinary tract infections, surgery, or injury to the urinary tract.	False	Nc1ccc(/N=N/c2ccccc2)c(N)n1
246739	246739:01:04_10.00	True	10.0	95	75.8	0.0	0.0	82.7	0.0	79.7	8.2	93.6	39.5	57.6	0.0	74.4	61.6	LCH	93.6	Sertraline	5-HT uptake inhibitor.	True	CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21
246890	246890:01:04_10.00	True	10.0	96	12.3	0.0	0.0	61.2	0.0	65.7	0.0	59.1	53.7	20.9	0.0	47.4	44.7	HDAC	65.7	Mevastatin	Mevastatin (Compactin) is a first HMG-CoA reductase inhibitor that belongs to the statins class. Mevastatin is a lipid-lowering agent, and induces apoptosis, arrests cancer cells in G0/G1 phase. Mevastatin also increases endothelial nitric oxide synthase (eNOS) mRNA and protein levels. Mevastatin has antitumor activity and has the potential for cardiovascular diseases treatment.	True	CC[C@H](C)C(=O)O[C@H]1CCC=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21
246617	246617:01:04_10.00	True	10.0	92	24.4	0.0	0.0	59.4	0.0	64.8	56.2	64.9	24.0	44.7	0.0	62.6	58.1	LCH	64.9	Saquinavir mesylate	protease inhibitor.	False	CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1
246711	246711:01:04_10.00	True	10.0	97	8.1	72.2	0.0	0.0	35.1	0.0	37.7	20.4	0.0	0.0	30.8	0.0	18.6	AKT_PI3K_MTOR	72.2	Troglitazone	Troglitazone is a PPAR.g. agonist, with EC50s of 550 nM and 780 nM for human and murinePPAR.g. receptor, respectively.	False	Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2
247154	247154:01:04_10.00	True	10.0	97	7.6	15.0	8.2	0.0	27.9	0.0	25.2	13.3	0.0	0.0	25.6	0.0	0.0	DNA_Synth	27.9	Artemisinin	Artemisinin (Qinghaosu), a sesquiterpene lactone,  is an anti-malarial drug isolated from the aerial parts of Artemisia annua L. plants. Artemisinin inhibits AKT signaling pathway by decreasing pAKT in a dose-dependent manner. Artemisinin reduces cancer cell proliferation, migration, invasion, tumorigenesis and metastasis and has neuroprotective effects.	True	C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@]32OO4
246885	246885:01:04_10.00	True	10.0	70	56.6	0.0	0.0	75.4	0.0	66.7	11.6	54.3	44.3	68.2	0.0	74.6	71.7	BET	75.4	Chlorhexidine	Chlorhexidine is an antibacterial used as an antiseptic and for other applications. Chlorhexidine is used to clean the skin after an injury, before surgery, or before an injection. Chlorhexidine is also used to clean the hands before a procedure.	False	N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1
246353	246353:01:04_10.00	True	10.0	82	12.6	0.0	15.0	44.0	10.4	51.2	20.9	68.8	3.4	37.2	0.0	48.9	29.0	LCH	68.8	Harmine hydrochloride	Interleukin-8 inhibitor (IC50 = 6.96 µM)	False	COc1ccc2c(c1)[nH]c1c(C)nccc12
247296	247296:01:04_10.00	True	10.0	110	9.0	73.2	0.0	0.0	64.8	0.0	16.0	0.0	0.0	0.0	79.3	0.0	0.0	Pyrimidine_Synth	79.3	Clobetasol propionate	Glucocorticoid receptor (IC50 = 1.456 nM); Progesterone receptor (IC50 = 3.17 nM)	False	CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
246872	246872:01:04_10.00	True	10.0	91	26.4	0.0	0.0	75.7	0.0	76.9	24.6	81.5	39.9	55.5	0.0	68.6	61.3	LCH	81.5	Desloratadine	H1-antihistamine.	False	Clc1ccc2c(c1)CCc1cccnc1C2=C1CCNCC1
247395	247395:01:04_10.00	True	10.0	98	10.0	33.1	0.0	29.0	23.2	26.0	10.0	51.8	0.0	16.0	0.0	34.9	55.3	Uncoupler	55.3	Azathioprine	antimetabolite.	False	Cn1cnc([N+](=O)[O-])c1Sc1ncnc2[nH]cnc12
246898	246898:01:04_10.00	True	10.0	95	5.5	29.7	0.0	21.1	29.0	7.2	29.1	33.1	7.3	8.9	2.8	65.6	44.5	Tubulin	65.6	Oxfendazole	Oxfendazole is the sulfoxide form of fenbendazole which is a broad spectrum benzimidazole anthelmintic. Target: AntiparasiticOxfendazole is the sulfoxide form of fenbendazole, a broad spectrum benzimidazole anthelmintic. Its main use is for protecting livestock against roundworm, strongyles and pinworms.. Pigs in the treated group received Oxfendazole orally at 30 mg/kg dose. At five days post-treatment, animals were sacrificed and the clinical efficacy of the Oxfendazole treatment was established following the currently available WAAVP guidelines for a controlled efficacy test. None of the animals involved in this experiment showed any adverse events during the study. Oxfendazole treatment given as a single 30 mg/kg oral dose showed a 100% efficacy against all the nematode parasites present in the three experiments. In conclusion, under the current experimental conditions, Oxfendazole orally administered to naturally parasitized piglets at a single dose of 30 mg/kg was safe and highly efficacious (100%) against adult stages of A. suum, Oesophagostomum spp., T. suis and Metastrongylus spp . 	False	COC(=O)Nc1nc2cc(S(=O)c3ccccc3)ccc2[nH]1
247221	247221:01:04_10.00	True	10.0	50	42.5	0.0	3.3	47.2	0.0	56.2	0.0	19.7	95.5	31.4	0.0	54.3	29.1	Na_K-ATPase	95.5	Lanatoside C	Na+ K+ ATPase inhibitor.	True	CC(=O)O[C@H]1C[C@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@]5(C)[C@H]6C[C@@H](O)[C@]7(C)[C@@H](C8=CC(=O)OC8)CC[C@]7(O)[C@@H]6CC[C@@H]5C4)O[C@@H]3C)O[C@@H]2C)O[C@H](C)[C@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
246618	246618:01:04_10.00	True	10.0	94	14.0	25.5	0.0	48.9	0.0	56.0	63.1	60.6	10.9	47.4	0.0	54.0	63.0	HSP90	63.1	Sertaconazole (nitrate)	ergosterol synthesis inhibitor.	False	Clc1ccc(C(Cn2ccnc2)OCc2csc3c(Cl)cccc23)c(Cl)c1
247423	247423:01:04_10.00	True	10.0	99	11.6	0.0	0.0	62.3	0.0	65.2	0.0	69.7	42.8	37.8	0.0	51.8	46.6	LCH	69.7	Pizotyline malate	5ht antagonist, antimigraine.	False	CN1CCC(=C2c3ccccc3CCc3sccc32)CC1
246742	246742:01:04_10.00	True	10.0	107	25.4	0.0	0.0	76.1	0.0	71.8	14.0	89.7	35.7	40.6	0.0	66.5	52.0	LCH	89.7	Amoxapine	Amoxapine is a tetracyclic antidepressant of the dibenzoxazepine family, though it is often classified as a secondary amine tricyclic antidepressant.	False	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2
246551	246551:01:04_10.00	True	10.0	53	39.9	0.0	5.8	37.9	0.0	47.1	0.0	5.9	92.2	28.2	0.0	43.9	19.9	Na_K-ATPase	92.2	Proscillaridin;A	inhibitory activicardiac glycoside, Na+ / K+ -ATPase inhibitorty against Nuclear factor erythroid 2-related factor 2 and Mothers against decapentaplegic homolog 3	False	C[C@@H]1O[C@@H](O[C@@H]2C=C3CC[C@@H]4[C@H](CC[C@]5(C)[C@@H](c6ccc(=O)oc6)CC[C@]45O)[C@@]3(C)CC2)[C@H](O)[C@H](O)[C@H]1O
246354	246354:01:04_10.00	True	10.0	101	9.8	0.0	15.9	54.1	0.0	61.7	14.2	70.6	32.8	28.4	0.0	54.0	27.6	LCH	70.6	Harmol hydrochloride	liver conjugation probe.	False	Cc1nccc2c1[nH]c1cc(O)ccc12
247234	247234:01:04_10.00	True	10.0	94	34.7	0.0	0.0	82.0	0.0	81.8	0.4	87.2	50.1	61.5	0.0	67.7	59.5	LCH	87.2	Promazine hydrochloride	D2 dopamine receptor antagonist, phenothiazine antipsychotic, Dopamine receptor antagonist.	False	CN(C)CCCN1c2ccccc2Sc2ccccc21
246641	246641:01:04_10.00	True	10.0	104	10.4	32.2	0.0	0.0	20.7	0.0	0.0	0.0	0.0	0.0	46.8	0.0	0.0	Pyrimidine_Synth	46.8	Nandrolone	Androgen receptor (IC50 = 3.149 nM); Progesterone receptor (IC50 = 171.5 nM)	True	C[C@]12CC[C@@H]3[C@H]4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@H]2O
247240	247240:01:04_10.00	True	10.0	79	75.8	0.0	0.0	87.8	0.0	83.8	17.5	73.6	58.9	76.3	0.0	80.7	72.5	BET	87.8	Methylbenzethonium chloride	detergent, antiinfective.	False	Cc1cc(C(C)(C)CC(C)(C)C)ccc1OCCOCC[N+](C)(C)Cc1ccccc1
246723	246723:01:04_10.00	True	10.0	96	9.7	54.2	0.0	0.0	69.7	0.0	0.0	0.0	0.0	0.0	62.5	0.0	0.0	DNA_Synth	69.7	Dacarbazine	Dacarbazine(DTIC-Dome; DTIC) is an antineoplastic agent. It has significant activity against melanomas.Target: Nucleoside antimetabolite/analogApproved: May 1975Dacarbazine (DTIC) is the only single-agent approved by the Food and Drug Administration for treating metastatic melanoma. With DTIC as single agent, an approximately 20% objective response rate can be achieved with median response duration of 5 to 6 months and complete response rates of 5% . Dacarbazine (DTIC) has activity in advanced previously untreated pancreatic islet cell tumors . In the intent-to-treat population, median survival time was 7.7 months for patients treated with temozolomide and 6.4 months for those treated with DTIC (hazards ratio, 1.18; 95% confidence interval [CI], 0.92 to 1.52). Median PFS time was significantly longer in the temozolomide-treated group (1.9 months) than in the DTIC-treated group (1.5 months) (P = .012; hazards ratio, 1.37; 95% CI, 1.07 to 1.75) .	False	CN(C)/N=N/c1[nH]cnc1C(N)=O
246575	246575:01:04_10.00	True	10.0	103	8.6	69.1	0.0	0.0	67.0	0.0	12.7	0.0	0.0	0.0	79.6	0.0	0.0	Pyrimidine_Synth	79.6	Fluticasone (propionate)	Fluticasone propionate, a potent topical anti-inflammatory corticosteroid, is a selective glucocorticoid receptor agonist, with an absolute affinity (KD) of 0.5 nM. Fluticasone propionate shows little or no activity at other steroid receptors. Anti-viral activity.	True	CCC(=O)O[C@]1(C(=O)SCF)[C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
246855	246855:01:04_10.00	True	10.0	85	30.4	70.2	1.9	0.0	93.8	0.0	9.6	0.0	0.0	0.0	77.5	0.0	0.0	DNA_Synth	93.8	Methotrexate, Methylaminopterin, MTX	folic acid antagonist.	False	CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1
246481	246481:01:04_10.00	True	10.0	94	56.5	0.0	0.0	80.0	0.0	79.9	15.9	95.6	41.3	55.8	0.0	72.6	50.3	LCH	95.6	DO 897/99	D3 antagonist.	False	COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1
246923	246923:01:04_10.00	True	10.0	83	24.4	4.3	0.0	63.2	0.0	60.3	29.2	70.4	32.0	55.8	0.0	69.1	62.9	LCH	70.4	Ivermectin B1a	Ivermectin B1a, a derivative of Avermectin B1a (HY-15308), is a main component of Ivermectin (HY-15310). Ivermectin (MK-933) is a broad-spectrum anti-parasite agent. Ivermectin is a candidate therapeutic against SARS-CoV-2/COVID-19.	True	CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2
246498	246498:01:04_10.00	True	10.0	85	27.1	67.9	0.0	0.0	71.9	0.0	42.8	0.0	0.0	0.0	75.5	0.0	0.0	Pyrimidine_Synth	75.5	Mometasone furoate	Anti-inflammatory potency	False	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)CCl
246877	246877:01:04_10.00	True	10.0	97	6.0	0.0	0.0	62.5	0.0	65.7	15.9	83.9	31.8	25.6	0.0	50.4	27.9	LCH	83.9	(±)-Verapamil hydrochloride	L-type Ca2+ channel modulator, adrenoceptor antagonist, antiarryhthmic, cardiac depressant, coronary vasodilator, Alpha1 antagonist, adrenegic blocker, ca channel blocker, coronary vasodilator, antiarrhythmic.	False	COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC
247231	247231:01:04_10.00	True	10.0	88	14.2	0.0	0.0	65.2	0.0	60.9	11.0	81.0	29.4	39.4	0.0	68.5	54.9	LCH	81.0	Nitrarine dihydrochloride	inhibition of human Butyrylcholinesterase (IC50 = 9.01 µM);	True	c1ccc2c3c([nH]c2c1)[C@H]1C2CCC([C@@H]4CCCN[C@H]24)N1CC3
246567	246567:01:04_10.00	True	10.0	103	36.3	0.0	0.0	79.5	0.0	78.2	2.7	93.7	40.8	53.6	0.0	67.9	51.3	LCH	93.7	Deptropine citrate	inhibitor of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-1 (PLIN1) (IC50 = 1.915 mM)	False	CN1[C@H]2CC[C@@H]1CC(OC1c3ccccc3CCc3ccccc31)C2
246478	246478:01:04_10.00	True	10.0	95	11.7	0.0	0.0	65.5	0.0	66.5	6.5	81.9	32.7	32.1	0.0	55.6	36.0	LCH	81.9	Mesoridazine besylate	D antagonist.	False	CN1CCCCC1CCN1c2ccccc2Sc2ccc(S(C)=O)cc21
246755	246755:01:04_10.00	True	10.0	69	32.6	59.6	14.2	0.0	96.9	0.0	0.0	0.0	0.0	0.0	77.6	0.0	0.0	DNA_Synth	96.9	Trifluridine	Trifluridine (Trifluorothymidine; 5-Trifluorothymidine; TFT) is an irreversible thymidylate synthase inhibitor, and thereby suppresses DNA synthesis. Trifluridine is an antiviral drug for herpes simplex virus (HSV) infection.	True	O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1C(F)(F)F
246373	246373:01:04_10.00	True	10.0	94	11.1	0.0	0.0	55.5	0.0	54.6	21.0	51.4	23.6	50.3	0.0	52.6	41.6	BET	55.5	Acitretin	binds to nuclear receptors that regulate gene transcription.	False	COc1cc(C)c(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)c(C)c1C
247241	247241:01:04_10.00	True	10.0	91	54.9	0.0	0.0	78.0	0.0	77.5	14.8	90.6	37.4	55.6	0.0	66.0	57.6	LCH	90.6	Chlorcyclizine hydrochloride	histamine antagonist, h1-antihistamine.	False	CN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1
245492	245492:02:04_10.00	True	10.0	101	56.5	0.0	0.0	79.9	0.0	78.1	16.6	94.9	38.1	52.5	0.0	75.1	46.3	LCH	94.9	Haloperidol	dopamine receptor antagonist, antipsychotic, Dopamine antagonist, antidyskinetic, antipsychotic.	False	O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
246879	246879:01:04_10.00	True	10.0	82	43.0	66.2	6.5	0.0	95.5	0.0	0.4	0.0	0.0	0.0	83.2	0.0	0.0	DNA_Synth	95.5	Floxuridine	Floxuridine (5-Fluorouracil 2'-deoxyriboside) is apyrimidineanalogand known as anoncology antimetabolite. Floxuridine inhibits Poly(ADP-Ribose) polymerase and induces DNA damage by activating the ATM and ATR checkpoint signaling pathways in vitro. Floxuridine is a extreamly potent inhibitor for S. aureus infection and induces cell apoptosis. Floxuridine has antiviral effects against HSV and CMV.	True	O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1F
246883	246883:01:04_10.00	True	10.0	104	23.1	0.0	0.0	51.1	0.0	59.4	51.3	71.7	12.2	25.3	0.0	48.1	37.3	LCH	71.7	Fulvestrant	Fulvestrant (ICI 182780) is a pure antiestrogen and a potent estrogen receptor (ER) antagonist with an IC50 of 9.4 nM. Fulvestrant effectively inhibits the growth of ER-positive MCF-7 cells with an IC50 of 0.29 nM. Fulvestrant also induces autophagy and has antitumor efficacy.	True	C[C@]12CC[C@@H]3c4ccc(O)cc4C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@H]3[C@@H]1CC[C@@H]2O
246389	246389:01:04_10.00	True	10.0	71	33.5	52.4	11.9	0.0	95.5	0.0	0.0	0.0	0.0	0.0	64.9	0.0	0.0	DNA_Synth	95.5	Cladribine	inhibits the enzyme adenosine deaminase.	True	Nc1nc(Cl)nc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1
247288	247288:01:04_10.00	True	10.0	110	5.4	80.6	0.0	0.0	65.0	0.0	19.3	0.0	0.0	0.0	71.5	0.0	0.0	AKT_PI3K_MTOR	80.6	Alclometasone dipropionate	corticoïde.	False	CCC(=O)OCC(=O)C1(OC(=O)CC)[C@H](C)C[C@H]2[C@H]3[C@H]([C@@H](O)C[C@@]21C)[C@@]1(C)C=CC(=O)C=C1C[C@H]3Cl
246371	246371:01:04_10.00	True	10.0	93	5.0	0.0	11.9	39.6	0.0	45.5	14.0	68.6	15.9	10.9	0.0	43.0	1.0	LCH	68.6	Methoxy-6-harmalan	benzodiazepine receptor ligand.	False	COc1ccc2[nH]c3c(c2c1)CCN=C3C
246538	246538:01:04_10.00	True	10.0	96	18.5	5.1	0.0	49.9	15.6	44.2	3.6	78.3	2.5	19.4	0.0	56.3	39.5	LCH	78.3	Dipivefrin hydrochloride	Beta-2 adrenergic receptor agonist (EC50 = 7.13 µM)	False	CNCC(O)c1ccc(OC(=O)C(C)(C)C)c(OC(=O)C(C)(C)C)c1
246461	246461:01:04_10.00	True	10.0	92	24.4	0.0	0.0	75.3	0.0	73.7	16.0	93.3	26.1	50.6	0.0	68.3	47.1	LCH	93.3	Dosulepin hydrochloride	inhibitor of Hepatitix C Virus (Target unchecked), Plasmodium falciparum, MADH3	False	CN(C)CC/C=C1\c2ccccc2CSc2ccccc21
247155	247155:01:04_10.00	True	10.0	92	32.8	0.0	0.0	78.4	0.0	77.6	9.4	90.1	36.5	42.2	0.0	69.0	39.2	LCH	90.1	Propafenone hydrochloride	blocks hKv1.5 and ATP-sensitive K+ channels, beta-adrenoceptor antagonist, Beta adrenergic antagonist, antiarrhythmic.	False	CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1
246761	246761:01:04_10.00	True	10.0	97	6.2	0.0	0.0	66.8	0.0	62.7	7.1	82.5	29.8	34.6	0.0	65.2	35.5	LCH	82.5	(R)-Propranolol hydrochloride	adrenergic receptor antagonist.	False	CC(C)NC[C@@H](O)COc1cccc2ccccc12
246486	246486:01:04_10.00	True	10.0	86	59.9	0.0	0.0	75.2	0.0	73.1	14.9	92.1	31.4	61.7	0.0	69.1	61.7	LCH	92.1	Prenylamine lactate	ca 2+ channel activator.	False	CC(Cc1ccccc1)NCCC(c1ccccc1)c1ccccc1
246940	246940:01:04_10.00	True	10.0	96	11.1	0.0	0.0	69.7	0.0	65.2	7.7	85.7	29.0	35.5	0.0	62.5	49.1	LCH	85.7	Alverine (citrate)	Alverine citrate is a 5-HT1A receptor antagonist, with an IC50 of 101 nM.	False	CCN(CCCc1ccccc1)CCCc1ccccc1
246886	246886:01:04_10.00	True	10.0	90	16.2	24.8	0.0	47.1	0.0	52.2	51.3	65.9	15.3	26.1	0.0	58.8	57.3	LCH	65.9	Loratadine	Loratadine (SCH-29851) is a selective inverse peripheral histamine H1-receptor agonist with an IC50 of >32 uM. Loratadine has anti-dengue-virus (DENV) activity.	False	CCOC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc3cccnc32)CC1
246811	246811:01:04_10.00	True	10.0	92	9.7	37.2	0.0	24.9	0.0	24.8	49.3	41.1	5.6	16.0	0.0	26.7	31.1	HSP90	49.3	Bromocryptine mesylate	prolactin inhibitor.	True	CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12
246857	246857:01:04_10.00	True	10.0	104	7.9	20.3	0.0	60.7	0.0	48.0	17.2	74.5	9.2	38.6	0.0	66.1	67.1	LCH	74.5	Tulobuterol	beta-2-adrenergic receptor agonist.	False	CC(C)(C)NCC(O)c1ccccc1Cl
246387	246387:01:04_10.00	True	10.0	57	61.1	0.0	26.7	38.8	0.0	47.9	56.3	31.2	41.6	48.5	0.0	69.8	32.0	Tubulin	69.8	Docetaxel	binds to microtubules.	True	CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@](O)([C@@H](OC(=O)c4ccccc4)[C@@H]12)C3(C)C
247425	247425:01:04_10.00	True	10.0	107	7.3	0.0	0.0	75.0	0.0	70.6	0.8	82.4	33.8	29.3	0.0	61.6	43.7	LCH	82.4	Fluvoxamine (maleate)	Fluvoxamine maleate (DU-23000 maleate) is an antidepressant which functions pharmacologically as a selective serotonin reuptake inhibitor.	False	COCCCC/C(=N\OCCN)c1ccc(C(F)(F)F)cc1
246604	246604:01:04_10.00	True	10.0	107	26.4	0.0	0.0	71.1	0.0	69.0	0.0	90.8	31.3	38.5	0.0	55.5	43.7	LCH	90.8	Penbutolol sulfate	adrenergic receptor antagonist.	False	CC(C)(C)NCC(O)COc1ccccc1C1CCCC1
246363	246363:01:04_30.00	True	30.0	99	26.9	0.0	0.0	42.4	0.0	47.8	59.4	55.8	4.4	36.1	0.0	55.0	33.0	HSP90	59.4	Tracazolate hydrochloride	GABA receptor modulator.	False	CCCCNc1c(C(=O)OCC)c(C)nc2c1cnn2CC
246588	246588:01:04_30.00	True	30.0	104	9.5	0.0	0.0	68.0	0.0	61.3	0.0	86.5	37.4	31.0	0.0	62.8	35.8	LCH	86.5	Levopropoxyphene napsylate	Mu opioid receptor agonist	False	CCC(=O)OC(Cc1ccccc1)(c1ccccc1)C(C)CN(C)C
246343	246343:01:04_30.00	True	30.0	82	30.9	0.0	0.0	72.1	0.0	70.1	37.2	72.1	32.5	57.6	0.0	77.8	39.6	Tubulin	77.8	Etofenamate	cyclooxygenase inhibitor.	False	O=C(OCCOCCO)c1ccccc1Nc1cccc(C(F)(F)F)c1
246610	246610:01:04_30.00	True	30.0	91	11.9	48.0	0.0	0.0	52.5	0.0	55.5	18.3	0.0	0.0	47.6	1.0	0.0	HSP90	55.5	Prednicarbate	glucocorticoid receptor agonist.	True	CCOC(=O)O[C@]1(C(=O)COC(=O)CC)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C
246746	246746:01:04_30.00	True	30.0	99	67.9	0.0	0.0	77.6	0.0	76.2	18.7	97.6	37.3	45.7	0.0	72.1	51.2	LCH	97.6	Cyproheptadine (hydrochloride)	Cyproheptadine hydrochloride is a 5-HT2A receptor antagonist, with antidepressant and antiserotonergic effects. Cyproheptadine hydrochloride has antiplatelet and thromboprotective activities. Cyproheptadine hydrochloride can be used for the research of thromboembolic disorders.	False	CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1
246562	246562:01:04_30.00	True	30.0	88	28.7	0.0	0.0	60.9	0.0	60.7	16.2	94.1	20.0	26.5	0.0	57.7	37.8	LCH	94.1	Alfadolone acetate	nociception blocker.	True	CC(=O)OCC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3C(=O)C[C@]12C
246579	246579:01:04_30.00	True	30.0	79	74.1	0.0	0.0	75.0	0.0	70.9	13.5	87.7	37.4	57.1	0.0	75.6	57.5	LCH	87.7	Halofantrine hydrochloride	Halofantrine hydrochloride (SKF-102886) is a blocker of delayed rectifier potassium current via the inhibition of  human-ether-a-go-go-related gene (HERG) channel and a potent antimalarial compound.	False	CCCCN(CCCC)CCC(O)c1cc2c(Cl)cc(Cl)cc2c2cc(C(F)(F)F)ccc12
246600	246600:01:04_30.00	True	30.0	98	14.9	2.1	0.0	30.2	0.0	39.6	56.4	51.5	0.0	30.0	0.0	47.3	30.5	HSP90	56.4	Nomegestrol acetate	Nomegestrol acetate is a potent, highly selective progestogen, which is characterized as a full agonist at the progesterone receptor, with no or minimal binding to other steroid receptors, including the androgen and glucocorticoid receptors.	True	CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C
246724	246724:01:04_30.00	True	30.0	100	8.5	0.0	0.0	57.3	0.0	59.1	24.7	83.2	11.0	29.7	0.0	58.7	34.6	LCH	83.2	Dirithromycin	ribosomal protein synthesis inhibitor.	True	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)[C@@H]2N[C@@H](COCCOC)O[C@H]([C@H]2C)[C@]1(C)O
246632	246632:01:04_30.00	True	30.0	95	25.6	0.0	0.0	56.0	0.0	55.8	27.0	71.0	8.1	41.4	0.0	66.2	27.0	LCH	71.0	Pronethalol hydrochloride	adrenergic receptor antagonist.	False	CC(C)NCC(O)c1ccc2ccccc2c1
247421	247421:01:04_30.00	True	30.0	98	6.2	0.0	0.0	66.3	0.0	65.8	27.3	72.5	22.1	48.8	0.0	65.2	57.1	LCH	72.5	Memantine hydrochloride	antagonist of NMDA glutamate receptors, stimulates dopamine release, Dopaminergic agonist, muscle relaxant (skeletal).	False	CC12CC3CC(C)(C1)CC(N)(C3)C2
246718	246718:01:04_30.00	True	30.0	70	66.5	6.7	0.0	60.4	0.0	65.8	50.5	73.9	27.1	51.5	0.0	67.9	56.1	LCH	73.9	Oxiconazole nitrate	Oxiconazole nitrate is a broad spectrum antifungal which can inhibit the growth of T. tonsurans and T. rubrum with MIC90s of 0.25 and 0.5 .m.g/mL, respectively.	False	Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1
246348	246348:01:04_30.00	True	30.0	87	5.9	0.0	21.1	34.9	20.5	29.2	0.0	42.4	24.8	4.8	0.0	44.0	11.7	Tubulin	44.0	Tiletamine hydrochloride	NMDA receptor antagonist.	False	CCNC1(c2cccs2)CCCCC1=O
246365	246365:01:04_30.00	True	30.0	102	20.9	0.0	0.0	46.9	0.0	50.4	34.4	65.2	12.6	38.3	0.0	58.9	25.3	LCH	65.2	Lobelanidine hydrochloride	nicotinic ligand.	False	CN1C(CC(O)c2ccccc2)CCCC1CC(O)c1ccccc1
246866	246866:01:04_30.00	True	30.0	74	69.3	0.0	0.0	59.3	0.0	71.3	67.8	60.8	26.1	56.9	0.0	67.4	66.7	HDAC	71.3	Cilnidipine	slow-acting Ca2+ channel blocker, antihypertensive, vasodilator. Does not inhibit PKC.	False	COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC/C=C/c2ccccc2)C1c1cccc([N+](=O)[O-])c1
247275	247275:01:04_30.00	True	30.0	102	28.8	0.0	0.0	85.2	0.0	80.6	26.5	84.3	45.2	54.1	0.0	81.7	61.4	BET	85.2	Phenazopyridine (hydrochloride)	Phenazopyridine hydrochloride is a chemical, which has a local analgesic effect, often used to alleviate the pain, irritation, discomfort, or urgency caused by urinary tract infections, surgery, or injury to the urinary tract.	False	Nc1ccc(/N=N/c2ccccc2)c(N)n1
246890	246890:01:04_30.00	True	30.0	92	55.8	0.0	0.0	90.7	0.0	87.4	22.0	83.2	59.9	68.5	0.0	87.0	75.0	BET	90.7	Mevastatin	Mevastatin (Compactin) is a first HMG-CoA reductase inhibitor that belongs to the statins class. Mevastatin is a lipid-lowering agent, and induces apoptosis, arrests cancer cells in G0/G1 phase. Mevastatin also increases endothelial nitric oxide synthase (eNOS) mRNA and protein levels. Mevastatin has antitumor activity and has the potential for cardiovascular diseases treatment.	True	CC[C@H](C)C(=O)O[C@H]1CCC=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21
246617	246617:01:04_30.00	True	30.0	87	40.1	13.3	0.0	58.7	0.0	65.9	53.3	74.5	32.4	37.4	0.0	60.2	60.9	LCH	74.5	Saquinavir mesylate	protease inhibitor.	False	CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1
246711	246711:01:04_30.00	True	30.0	98	22.8	44.5	0.0	20.3	0.0	25.2	46.9	53.9	0.0	1.7	0.0	19.1	26.4	LCH	53.9	Troglitazone	Troglitazone is a PPAR.g. agonist, with EC50s of 550 nM and 780 nM for human and murinePPAR.g. receptor, respectively.	False	Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2
247248	247248:01:04_30.00	True	30.0	95	47.8	0.0	0.0	68.2	0.0	64.0	19.2	76.9	21.9	53.9	0.0	75.3	48.8	LCH	76.9	Pramocaine (hydrochloride)	Pramocaine hydrochloride decreases the permeability of neuronal membranes to sodium ions, blocking both initiation and conduction of nerve impulses.	False	CCCCOc1ccc(OCCCN2CCOCC2)cc1
247154	247154:01:04_30.00	True	30.0	89	6.6	6.4	11.7	0.0	24.5	0.0	25.0	16.9	7.3	15.6	7.6	7.2	0.0	HSP90	25.0	Artemisinin	Artemisinin (Qinghaosu), a sesquiterpene lactone,  is an anti-malarial drug isolated from the aerial parts of Artemisia annua L. plants. Artemisinin inhibits AKT signaling pathway by decreasing pAKT in a dose-dependent manner. Artemisinin reduces cancer cell proliferation, migration, invasion, tumorigenesis and metastasis and has neuroprotective effects.	True	C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@]32OO4
246820	246820:01:04_30.00	True	30.0	85	26.3	37.2	0.0	28.2	0.0	27.0	63.5	53.7	0.0	31.6	0.0	44.6	48.3	HSP90	63.5	Bifonazole	antifungal, calmodulin antagonist.	False	c1ccc(-c2ccc(C(c3ccccc3)n3ccnc3)cc2)cc1
246598	246598:01:04_30.00	True	30.0	90	20.2	0.0	0.0	51.1	0.0	55.0	49.3	63.7	11.2	33.9	0.0	60.1	31.3	LCH	63.7	Moricizine hydrochloride	sodium channel inhibitor.	False	CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2
246353	246353:01:04_30.00	True	30.0	79	33.2	32.3	6.4	10.6	54.0	21.0	33.7	57.4	0.0	2.3	9.2	28.9	22.8	LCH	57.4	Harmine hydrochloride	Interleukin-8 inhibitor (IC50 = 6.96 µM)	False	COc1ccc2c(c1)[nH]c1c(C)nccc12
247296	247296:01:04_30.00	True	30.0	98	20.2	70.0	0.0	0.0	47.0	0.0	47.9	0.0	0.0	0.0	67.7	0.0	0.0	AKT_PI3K_MTOR	70.0	Clobetasol propionate	Glucocorticoid receptor (IC50 = 1.456 nM); Progesterone receptor (IC50 = 3.17 nM)	False	CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
246872	246872:01:04_30.00	True	30.0	93	57.3	0.0	0.0	68.4	0.0	70.7	37.8	89.6	26.7	48.1	0.0	69.8	53.0	LCH	89.6	Desloratadine	H1-antihistamine.	False	Clc1ccc2c(c1)CCc1cccnc1C2=C1CCNCC1
247395	247395:01:04_30.00	True	30.0	95	5.7	15.9	0.0	26.2	21.9	26.3	41.1	51.0	0.0	35.0	0.0	42.0	41.2	LCH	51.0	Azathioprine	antimetabolite.	False	Cn1cnc([N+](=O)[O-])c1Sc1ncnc2[nH]cnc12
246898	246898:01:04_30.00	True	30.0	66	57.2	0.0	3.1	69.8	0.0	70.7	47.5	64.4	53.0	55.4	0.0	95.7	50.4	Tubulin	95.7	Oxfendazole	Oxfendazole is the sulfoxide form of fenbendazole which is a broad spectrum benzimidazole anthelmintic. Target: AntiparasiticOxfendazole is the sulfoxide form of fenbendazole, a broad spectrum benzimidazole anthelmintic. Its main use is for protecting livestock against roundworm, strongyles and pinworms.. Pigs in the treated group received Oxfendazole orally at 30 mg/kg dose. At five days post-treatment, animals were sacrificed and the clinical efficacy of the Oxfendazole treatment was established following the currently available WAAVP guidelines for a controlled efficacy test. None of the animals involved in this experiment showed any adverse events during the study. Oxfendazole treatment given as a single 30 mg/kg oral dose showed a 100% efficacy against all the nematode parasites present in the three experiments. In conclusion, under the current experimental conditions, Oxfendazole orally administered to naturally parasitized piglets at a single dose of 30 mg/kg was safe and highly efficacious (100%) against adult stages of A. suum, Oesophagostomum spp., T. suis and Metastrongylus spp . 	False	COC(=O)Nc1nc2cc(S(=O)c3ccccc3)ccc2[nH]1
247242	247242:01:04_30.00	True	30.0	98	27.3	0.0	0.0	74.3	0.0	72.7	16.0	95.7	31.2	41.0	0.0	69.7	53.4	LCH	95.7	Diphenylpyraline hydrochloride	H1 antagonist, antihistaminic.	False	CN1CCC(OC(c2ccccc2)c2ccccc2)CC1
246618	246618:01:04_30.00	True	30.0	60	74.6	0.0	0.0	61.9	0.0	65.4	54.9	69.0	35.8	61.2	0.0	72.4	52.2	Tubulin	72.4	Sertaconazole (nitrate)	ergosterol synthesis inhibitor.	False	Clc1ccc(C(Cn2ccnc2)OCc2csc3c(Cl)cccc23)c(Cl)c1
247423	247423:01:04_30.00	True	30.0	102	59.9	0.0	0.0	71.7	0.0	70.0	20.8	96.6	26.5	37.6	0.0	67.7	47.2	LCH	96.6	Pizotyline malate	5ht antagonist, antimigraine.	False	CN1CCC(=C2c3ccccc3CCc3sccc32)CC1
246742	246742:01:04_30.00	True	30.0	101	24.4	0.0	0.0	55.3	0.0	57.9	29.2	78.1	16.4	24.6	0.0	55.8	21.6	LCH	78.1	Amoxapine	Amoxapine is a tetracyclic antidepressant of the dibenzoxazepine family, though it is often classified as a secondary amine tricyclic antidepressant.	False	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2
246458	246458:01:04_30.00	True	30.0	96	15.2	0.0	0.0	70.6	0.0	68.4	18.0	77.5	30.9	56.4	0.0	72.5	58.3	LCH	77.5	Cyclizine hydrochloride	H1 antagonist.	False	CN1CCN(C(c2ccccc2)c2ccccc2)CC1
246351	246351:01:04_30.00	True	30.0	87	5.0	26.9	0.0	15.2	13.6	18.0	26.7	20.7	8.0	14.1	0.0	25.1	31.4	Uncoupler	31.4	Harmalol hydrochloride dihydrate	inhibitory activity against Ubiquitin carboxyl-terminal hydrolase 2, Caspase-1, Caspase-7	False	CC1=NCCc2c1[nH]c1cc(O)ccc21
247419	247419:01:04_30.00	True	30.0	101	52.2	0.0	0.0	69.4	0.0	70.4	23.7	89.1	20.7	41.6	0.0	68.5	38.4	LCH	89.1	Naftopidil dihydrochloride, KT-611 dihydrochloride	alpha1 Adrenoceptor antagonist, antihypertensive, Alpha1 agonist.	False	COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1
246354	246354:01:04_30.00	True	30.0	83	14.5	19.0	10.4	21.2	26.9	30.9	15.0	48.9	3.7	32.1	0.0	24.6	25.1	LCH	48.9	Harmol hydrochloride	liver conjugation probe.	False	Cc1nccc2c1[nH]c1cc(O)ccc12
247413	247413:01:04_30.00	True	30.0	100	32.6	16.4	0.0	0.0	16.1	0.0	0.0	24.3	0.0	0.0	23.0	0.0	0.0	LCH	24.3	Methacycline hydrochloride	protein synthesis inhibitor, antibacterial.	False	C=C1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@H]12
247234	247234:01:04_30.00	True	30.0	92	76.2	0.0	0.0	78.7	0.0	76.6	19.5	95.6	34.0	49.0	0.0	73.9	54.9	LCH	95.6	Promazine hydrochloride	D2 dopamine receptor antagonist, phenothiazine antipsychotic, Dopamine receptor antagonist.	False	CN(C)CCCN1c2ccccc2Sc2ccccc21
245383	245383:02:04_30.00	True	30.0	102	16.8	0.0	0.0	75.1	0.0	72.7	4.2	93.3	39.6	44.9	0.0	70.2	46.9	LCH	93.3	Xylometazoline (hydrochloride)	Xylometazoline hydrochloride is an .a.-adrenoceptor agonist commonly used as nasal decongestant.Target: .a.-AdrenoceptorXylometazoline hydrochloride is a nasal decongestant spray that constricts nasal blood vessels and increases nasal airflow, enabling patients with a blocked nose to breathe more easily. Xylometazoline hydrochloride is an effective and well-tolerated decongestant nasal spray that significantly relieved nasal congestion compared with placebo in the common cold and provided long-lasting relief with just 1 spray, helping patients to breathe more easily for a longer period of time . Xylometazoline hydrochloride exhibits in radioligand competition studies higher affinities than the catecholamines adrenaline and noradrenaline at most .a.-adrenoceptor subtypes. Xylometazoline behaved at .a.(2B) -adrenoceptors as full agonists .	False	Cc1cc(C(C)(C)C)cc(C)c1CC1=NCCN1
246507	246507:01:04_30.00	True	30.0	94	34.7	0.0	0.0	76.7	0.0	75.0	16.4	96.7	32.8	47.3	0.0	68.0	52.2	LCH	96.7	Chloropyramine hydrochloride	Chloropyramine hydrochloride is a histamine receptor H1 antagonist which can also inhibit the biochemical function of  VEGFR-3 and FAK.	False	CN(C)CCN(Cc1ccc(Cl)cc1)c1ccccn1
246855	246855:01:04_30.00	True	30.0	80	35.2	55.3	22.8	0.0	93.4	0.0	2.3	0.0	0.0	0.0	81.3	0.0	0.0	DNA_Synth	93.4	Methotrexate, Methylaminopterin, MTX	folic acid antagonist.	False	CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1
246661	246661:01:04_30.00	True	30.0	94	40.6	25.2	0.0	52.5	0.0	58.6	55.2	52.7	15.3	59.7	0.0	49.4	70.9	Uncoupler	70.9	Gestrinone	Estrogen receptor agonist; androgen receptor agonist, Mineralocorticoid receptor antagonist	False	C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3C=C[C@@]21CC
246481	246481:01:04_30.00	True	30.0	94	84.1	0.0	0.0	75.4	0.0	74.4	20.6	91.6	31.3	48.1	0.0	74.2	45.9	LCH	91.6	DO 897/99	D3 antagonist.	False	COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1
247334	247334:01:04_30.00	True	30.0	97	8.6	0.0	0.0	7.2	7.2	0.0	38.1	26.5	0.0	18.6	4.7	22.4	0.0	HSP90	38.1	Levobunolol (hydrochloride)	Levobunolol hydrochloride is a non-selective beta blocker. It is used topically to manage glaucoma.	True	CC(C)(C)NC[C@H](O)COc1cccc2c1CCCC2=O
246764	246764:01:04_30.00	True	30.0	98	24.4	0.0	0.0	78.7	0.0	75.4	12.6	94.9	33.0	48.1	0.0	72.9	46.5	LCH	94.9	(S)-Propranolol hydrochloride	active beta-adrenoceptor receptor blocking enantiomer, 5-HT1 serotonin receptor antagonist, Beta-adrenergic blocking agent, antihypertensive, antianginal, antiarrhythmic.	False	CC(C)NC[C@H](O)COc1cccc2ccccc12
247410	247410:01:04_30.00	True	30.0	93	7.1	0.0	0.0	70.4	0.0	71.3	33.1	79.1	17.4	54.2	0.0	70.2	62.4	LCH	79.1	Guanabenz (Acetate)	Guanabenz (Acetate) (BR-750) is an alpha-2 selective adrenergic agonist used as an antihypertensive agent.	False	N=C(N)N/N=C/c1c(Cl)cccc1Cl
247012	247012:01:05_30.00	True	30.0	87	17.3	82.3	0.0	0.0	59.1	0.0	42.9	0.0	0.0	0.0	64.9	0.0	7.5	AKT_PI3K_MTOR	82.3	Clotrimazole	specific inhibitor of Ca2+-activated K+ channels, Specific inhibitor of Ca2+ activated K+ channels, antifungal.	False	Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1
247195	247195:01:04_30.00	True	30.0	97	29.9	0.0	0.0	61.5	0.0	64.3	31.2	83.8	14.5	41.1	0.0	66.1	35.7	LCH	83.8	Tetracaine hydrochloride	local anesthetic, anesthetic (local).	False	CCCCNc1ccc(C(=O)OCCN(C)C)cc1
246498	246498:01:04_30.00	True	30.0	79	30.2	50.3	11.0	0.0	76.2	0.0	58.4	0.0	0.0	0.0	78.6	0.0	0.0	Pyrimidine_Synth	78.6	Mometasone furoate	Anti-inflammatory potency	False	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)CCl
246910	246910:01:04_30.00	True	30.0	99	7.3	0.0	0.0	45.5	0.0	45.6	43.9	53.5	6.8	51.9	0.0	55.5	39.1	Tubulin	55.5	Rifaximin	Rifaximin(Xifaxan) is an orally administered, semi-synthetic, nonsystemic antibiotic derived from rifamycin SV with antibacterial activity.IC50 Value:Target: RNA polymerase; antibacterialRifaximin is a semisynthetic, rifamycin-based non-systemic antibiotic, meaning that very little of the drug will pass the gastrointestinal wall into the circulation as is common for other types of orally administered antibiotics. It is used in the treatment of traveler's diarrhea and hepatic encephalopathy, for which it received orphan drug status from the U.S. Food and Drug Administration in 1998. Rifaximin interferes with transcription by binding to the .b.-subunit of bacterial RNA polymerase. This results in the blockage of the translocation step that normally follows the formation of the first phosphodiester bond, which occurs in the transcription process. From Wikipedia.	True	CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c5c(nc6cc(C)ccn65)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C
246877	246877:01:04_30.00	True	30.0	94	49.6	0.0	0.0	65.5	0.0	65.9	24.6	94.7	18.9	30.4	0.0	62.2	36.4	LCH	94.7	(±)-Verapamil hydrochloride	L-type Ca2+ channel modulator, adrenoceptor antagonist, antiarryhthmic, cardiac depressant, coronary vasodilator, Alpha1 antagonist, adrenegic blocker, ca channel blocker, coronary vasodilator, antiarrhythmic.	False	COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC
247231	247231:01:04_30.00	True	30.0	79	41.5	0.0	0.0	66.3	0.0	62.5	22.4	87.0	24.7	43.3	0.0	74.4	43.8	LCH	87.0	Nitrarine dihydrochloride	inhibition of human Butyrylcholinesterase (IC50 = 9.01 µM);	True	c1ccc2c3c([nH]c2c1)[C@H]1C2CCC([C@@H]4CCCN[C@H]24)N1CC3
246921	246921:01:04_30.00	True	30.0	88	43.2	0.0	0.0	65.9	0.0	66.8	16.2	94.1	27.0	32.9	0.0	65.0	33.1	LCH	94.1	Erythromycin	Erythromycin is a macrolide antibiotic produced by actinomyceteStreptomyces erythreuswith a broad spectrum of antimicrobial activity. Erythromycin acts by binding to bacterial 50S ribosomal subunits and inhibitsRNA-dependent protein synthesisby blockage of transpeptidation and/or translocation reactions, without affecting synthesis of nucleic acid.	True	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
246567	246567:01:04_30.00	True	30.0	87	81.9	0.0	0.0	79.4	0.0	76.2	15.6	92.7	36.9	50.0	0.0	76.8	55.1	LCH	92.7	Deptropine citrate	inhibitor of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-1 (PLIN1) (IC50 = 1.915 mM)	False	CN1[C@H]2CC[C@@H]1CC(OC1c3ccccc3CCc3ccccc31)C2
246478	246478:01:04_30.00	True	30.0	100	42.3	0.0	0.0	66.4	0.0	64.6	22.8	95.2	22.6	33.3	0.0	64.6	40.9	LCH	95.2	Mesoridazine besylate	D antagonist.	False	CN1CCCCC1CCN1c2ccccc2Sc2ccc(S(C)=O)cc21
246753	246753:01:04_30.00	True	30.0	91	9.8	26.1	4.3	0.0	48.1	0.0	41.3	12.1	0.0	0.0	54.3	3.3	0.0	Pyrimidine_Synth	54.3	Danazol	Danazol is a derivative of the synthetic steroid ethisterone, that suppresses the production of gonadotrophins, and has some weak androgenic effects.	True	C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C
246715	246715:01:04_30.00	True	30.0	91	24.4	0.0	0.0	62.7	0.0	60.8	55.9	69.4	29.1	38.8	0.0	78.0	41.7	Tubulin	78.0	Nilvadipine	calcium channel blocker.	False	COC(=O)C1=C(C#N)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1
246755	246755:01:04_30.00	True	30.0	70	33.9	57.1	24.7	0.0	95.7	0.0	0.0	0.0	0.0	0.0	80.1	0.0	0.0	DNA_Synth	95.7	Trifluridine	Trifluridine (Trifluorothymidine; 5-Trifluorothymidine; TFT) is an irreversible thymidylate synthase inhibitor, and thereby suppresses DNA synthesis. Trifluridine is an antiviral drug for herpes simplex virus (HSV) infection.	True	O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1C(F)(F)F
247222	247222:01:04_30.00	True	30.0	88	38.3	9.7	0.0	59.9	0.0	59.8	32.6	88.9	15.9	35.5	0.0	62.8	50.9	LCH	88.9	Benzamil hydrochloride	selective and potent blocker of Na+/H+ and Na+/Ca2+ channels, Na+ channel blocker.	False	N/C(=N\C(=O)c1nc(Cl)c(N)nc1N)NCc1ccccc1
246373	246373:01:04_30.00	True	30.0	101	16.1	11.1	0.0	40.4	0.0	42.2	39.9	49.7	0.0	39.9	0.0	43.5	36.7	LCH	49.7	Acitretin	binds to nuclear receptors that regulate gene transcription.	False	COc1cc(C)c(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)c(C)c1C
246585	246585:01:04_30.00	True	30.0	110	11.1	0.0	0.0	30.7	0.0	30.0	48.6	50.2	2.1	16.1	0.0	43.5	4.7	LCH	50.2	Isradipine	calcium channel inhibitor.	False	COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc2nonc12
246401	246401:01:04_30.00	True	30.0	98	18.0	8.2	0.0	31.0	0.0	35.2	60.8	48.5	1.1	39.4	0.0	45.3	30.1	HSP90	60.8	Josamycin	ribosomal protein synthesis inhibitor.	True	CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(OC(=O)CC(C)C)[C@@H](O)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O)/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]1OC(C)=O
247241	247241:01:04_30.00	True	30.0	93	51.8	0.0	0.0	74.9	0.0	72.8	16.8	97.9	31.3	42.1	0.0	66.8	53.2	LCH	97.9	Chlorcyclizine hydrochloride	histamine antagonist, h1-antihistamine.	False	CN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1
246680	246680:01:04_30.00	True	30.0	100	24.2	0.0	0.0	56.4	0.0	62.5	28.6	76.1	18.8	41.6	0.0	63.0	31.2	LCH	76.1	Reboxetine mesylate	norepinephrine reuptake inhibitor.	True	CCOc1ccccc1O[C@@H](c1ccccc1)[C@H]1CNCCO1
246494	246494:01:04_30.00	True	30.0	101	24.2	0.0	0.0	80.4	0.0	78.6	19.1	90.9	41.9	48.3	0.0	75.0	47.7	LCH	90.9	Zimelidine dihydrochloride monohydrate	5-HT uptake inhibitor.	False	CN(C)C/C=C(\c1ccc(Br)cc1)c1cccnc1
246360	246360:01:04_30.00	True	30.0	90	37.5	0.0	0.0	67.7	0.0	70.2	30.0	88.4	27.3	46.7	0.0	71.8	42.0	LCH	88.4	Hydroxyzine dihydrochloride	H1 antogonist.	False	OCCOCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1
247220	247220:01:04_30.00	True	30.0	97	8.8	51.5	3.9	0.0	75.7	0.0	0.0	0.0	0.0	0.0	62.7	0.0	0.0	DNA_Synth	75.7	Halcinonide	Halcinonide (SQ-18566) is a high potency corticosteroid used topically in the treatment of certain skin conditions.	True	CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)CC[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CCl)O1
246631	246631:01:04_30.00	True	30.0	96	21.2	0.0	0.0	71.8	0.0	71.1	14.6	94.1	30.1	32.9	0.0	63.0	39.9	LCH	94.1	Pirlindole mesylate	monoamine oxidase inhibitor.	False	Cc1ccc2c(c1)c1c3n2CCNC3CCC1
246879	246879:01:04_30.00	True	30.0	75	42.8	60.5	21.9	0.0	91.5	0.0	6.2	0.0	0.0	0.0	83.7	0.0	0.0	DNA_Synth	91.5	Floxuridine	Floxuridine (5-Fluorouracil 2'-deoxyriboside) is apyrimidineanalogand known as anoncology antimetabolite. Floxuridine inhibits Poly(ADP-Ribose) polymerase and induces DNA damage by activating the ATM and ATR checkpoint signaling pathways in vitro. Floxuridine is a extreamly potent inhibitor for S. aureus infection and induces cell apoptosis. Floxuridine has antiviral effects against HSV and CMV.	True	O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1F
246883	246883:01:04_30.00	True	30.0	96	22.8	0.0	0.0	53.1	0.0	61.9	47.2	78.3	9.6	32.2	0.0	57.7	35.6	LCH	78.3	Fulvestrant	Fulvestrant (ICI 182780) is a pure antiestrogen and a potent estrogen receptor (ER) antagonist with an IC50 of 9.4 nM. Fulvestrant effectively inhibits the growth of ER-positive MCF-7 cells with an IC50 of 0.29 nM. Fulvestrant also induces autophagy and has antitumor efficacy.	True	C[C@]12CC[C@@H]3c4ccc(O)cc4C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@H]3[C@@H]1CC[C@@H]2O
246389	246389:01:04_30.00	True	30.0	66	41.3	41.1	22.7	0.0	90.6	0.0	0.0	0.0	0.0	0.0	51.1	0.0	0.0	DNA_Synth	90.6	Cladribine	inhibits the enzyme adenosine deaminase.	True	Nc1nc(Cl)nc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1
246371	246371:01:04_30.00	True	30.0	95	43.4	0.0	0.0	68.6	0.0	65.9	20.8	93.3	28.4	39.3	0.0	67.2	41.8	LCH	93.3	Methoxy-6-harmalan	benzodiazepine receptor ligand.	False	COc1ccc2[nH]c3c(c2c1)CCN=C3C
246538	246538:01:04_30.00	True	30.0	90	50.6	0.0	0.0	62.1	0.0	61.5	23.5	89.1	18.6	40.8	0.0	67.2	39.9	LCH	89.1	Dipivefrin hydrochloride	Beta-2 adrenergic receptor agonist (EC50 = 7.13 µM)	False	CNCC(O)c1ccc(OC(=O)C(C)(C)C)c(OC(=O)C(C)(C)C)c1
246461	246461:01:04_30.00	True	30.0	76	74.6	0.0	0.0	77.6	0.0	75.7	15.4	94.7	37.1	47.1	0.0	74.6	51.8	LCH	94.7	Dosulepin hydrochloride	inhibitor of Hepatitix C Virus (Target unchecked), Plasmodium falciparum, MADH3	False	CN(C)CC/C=C1\c2ccccc2CSc2ccccc21
247155	247155:01:04_30.00	True	30.0	93	78.4	0.0	0.0	73.0	0.0	72.3	17.8	95.5	27.6	42.7	0.0	70.5	45.8	LCH	95.5	Propafenone hydrochloride	blocks hKv1.5 and ATP-sensitive K+ channels, beta-adrenoceptor antagonist, Beta adrenergic antagonist, antiarrhythmic.	False	CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1
246761	246761:01:04_30.00	True	30.0	102	47.5	0.0	0.0	69.7	0.0	68.9	26.4	86.9	22.3	41.6	0.0	71.3	38.7	LCH	86.9	(R)-Propranolol hydrochloride	adrenergic receptor antagonist.	False	CC(C)NC[C@@H](O)COc1cccc2ccccc12
246940	246940:01:04_30.00	True	30.0	96	40.9	0.0	0.0	79.2	0.0	78.6	16.2	95.8	38.4	45.3	0.0	71.3	47.3	LCH	95.8	Alverine (citrate)	Alverine citrate is a 5-HT1A receptor antagonist, with an IC50 of 101 nM.	False	CCN(CCCc1ccccc1)CCCc1ccccc1
246854	246854:01:04_30.00	True	30.0	94	17.4	0.0	0.0	33.3	0.0	31.9	24.9	47.8	14.2	29.8	0.0	45.9	2.2	LCH	47.8	Sildenafil	cGMP specific phosphodiesterase type 5 (PDE5) inhibitor, erectile dysfunction therapy.	False	CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12
246760	246760:01:04_30.00	True	30.0	102	10.5	10.1	0.0	20.6	0.0	26.4	50.7	42.8	0.0	23.0	0.0	31.5	19.6	HSP90	50.7	Cyproterone acetate	androgen receptor antagonist.	True	CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)C5CC5[C@]4(C)[C@H]3CC[C@@]21C
246886	246886:01:04_30.00	True	30.0	95	8.3	27.9	0.0	30.9	0.0	45.1	62.4	40.7	14.8	50.1	0.0	39.7	46.7	HSP90	62.4	Loratadine	Loratadine (SCH-29851) is a selective inverse peripheral histamine H1-receptor agonist with an IC50 of >32 uM. Loratadine has anti-dengue-virus (DENV) activity.	False	CCOC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc3cccnc32)CC1
246811	246811:01:04_30.00	True	30.0	76	31.1	34.2	0.0	23.4	0.2	25.0	59.2	53.1	0.0	25.5	0.0	39.9	31.0	HSP90	59.2	Bromocryptine mesylate	prolactin inhibitor.	True	CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12
246859	246859:01:04_30.00	True	30.0	108	34.2	0.0	0.0	50.7	0.0	56.4	38.6	67.7	14.0	37.9	0.0	58.3	27.8	LCH	67.7	Vardenafil	PDE5 inhibitor.	False	CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12
246857	246857:01:04_30.00	True	30.0	96	8.3	0.0	0.0	57.9	0.0	49.0	22.3	73.7	8.5	42.5	0.0	69.3	49.4	LCH	73.7	Tulobuterol	beta-2-adrenergic receptor agonist.	False	CC(C)(C)NCC(O)c1ccccc1Cl
246387	246387:01:04_30.00	True	30.0	63	64.2	0.0	30.1	23.5	0.0	34.6	73.2	29.6	17.5	43.6	0.0	59.8	24.4	HSP90	73.2	Docetaxel	binds to microtubules.	True	CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@](O)([C@@H](OC(=O)c4ccccc4)[C@@H]12)C3(C)C
247425	247425:01:04_30.00	True	30.0	97	35.6	0.0	0.0	69.6	0.0	67.0	23.4	94.0	22.8	41.2	0.0	67.4	46.7	LCH	94.0	Fluvoxamine (maleate)	Fluvoxamine maleate (DU-23000 maleate) is an antidepressant which functions pharmacologically as a selective serotonin reuptake inhibitor.	False	COCCCC/C(=N\OCCN)c1ccc(C(F)(F)F)cc1
246867	246867:01:04_30.00	True	30.0	103	12.4	0.0	0.0	42.5	0.0	40.5	43.9	47.6	21.4	46.8	0.0	58.4	28.8	Tubulin	58.4	Clarithromycin	translation of peptides inhibitor, antibacterial.	False	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
246754	246754:01:04_30.00	True	30.0	97	35.2	0.0	0.0	66.7	0.0	65.7	14.1	91.3	25.2	39.2	0.0	67.5	38.5	LCH	91.3	Piperidolate (hydrochloride)	Piperidolate hydrochloride is an antimuscarinic, inhibits intestinal cramp induced by acetylcholine (rats and dogs).	False	CCN1CCCC(OC(=O)C(c2ccccc2)c2ccccc2)C1
247168	247168:01:04_30.00	True	30.0	87	21.9	3.0	0.0	65.0	0.0	64.9	51.0	70.8	36.4	41.6	0.0	70.1	55.6	LCH	70.8	Budesonide	Budesonide, an inhaled glucocortical steroid, is an orally active glucocorticoid receptor agonist. Budesonide decreases the size of lung tumors, reverses DNA hypomethylation and modulates mRNA expression of genes. Budesonide is an anti-inflammatory agent used for asthma.	True	CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1
246626	246626:01:04_30.00	True	30.0	100	6.0	0.0	5.3	6.3	34.3	0.0	35.0	29.8	0.0	12.9	2.8	26.6	0.0	HSP90	35.0	Verteporfin, Visudyne	Photosensitizing Agent (used in conjunction with laser treatment to eliminate the abnormal blood vessels in the eye)	True	C=Cc1c(C)c2cc3nc(cc4[nH]c(cc5nc(cc1[nH]2)C(C)=C5CCC(=O)O)c(CCC(=O)OC)c4C)[C@@]1(C)C3=CC=C(C(=O)OC)[C@H]1C(=O)OC
246604	246604:01:04_30.00	True	30.0	91	79.3	0.0	0.0	82.7	0.0	79.0	17.3	94.6	39.3	54.2	0.0	78.2	60.1	LCH	94.6	Penbutolol sulfate	adrenergic receptor antagonist.	False	CC(C)(C)NCC(O)COc1ccccc1C1CCCC1
247216	247216:01:04_30.00	True	30.0	105	6.7	43.1	0.0	0.0	63.2	0.0	15.4	0.0	0.0	0.0	74.5	0.0	0.0	Pyrimidine_Synth	74.5	Flurandrenolide	Glucocorticoid receptor agonist (IC50 = 4.447 nM); Progesterone receptor (IC50 = 172 nM)	True	CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1
247336	247336:01:04_30.00	True	30.0	96	16.4	0.0	0.0	66.2	0.0	70.3	6.9	88.8	37.9	24.5	0.0	57.6	40.6	LCH	88.8	Equilin	Estradiol 17-beta-dehydrogenase 1; Estrogen receptor beta; Testis-specific androgen-binding protein	False	C[C@]12CC[C@H]3C(=CCc4cc(O)ccc43)[C@@H]1CCC2=O
246825	246825:01:04_30.00	True	30.0	97	19.7	21.5	0.0	4.8	47.2	3.5	43.8	49.8	0.0	0.0	16.2	24.8	3.9	LCH	49.8	Canrenone	Canrenone (Aldadiene; SC9376; SC14266) is an aldosterone antagonist extensively used as a diuretic agent.	True	C[C@]12CC[C@H]3[C@@H](C=CC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@]21CCC(=O)O1
280558	280558:01:03_10.00	True	10.0	95	19.3	0.0	0.0	71.9	0.0	65.5	28.1	81.5	18.1	59.7	0.0	74.6	59.4	LCH	81.5	Forskolin	activates adenylate cyclase, antihypertensive and vasodilator, isolated from Coleus forskohlii.	False	C=CC1(C)CC(=O)C2(O)C(C)(O1)C(OC(C)=O)C(O)C1C(C)(C)CCC(O)C12C
280858	280858:01:03_10.00	True	10.0	95	23.3	0.0	0.0	69.6	0.0	68.1	20.6	82.8	27.2	36.0	0.0	69.8	35.4	LCH	82.8	Pergolide methanesulfonate, propylergoline methanesulfonate	dopamine receptor agonist, antiparkinsonian.	False	CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21
280982	280982:01:03_10.00	True	10.0	88	22.5	43.0	0.0	44.8	0.4	34.6	18.9	37.9	25.3	36.9	0.0	55.2	88.8	Uncoupler	88.8	Tyrphostin AG 879	Tyrphostin AG 879 (AG 879) is a tyrosine kinase inhibitor that inhibits TrKA phosphorylation (IC50 of 10 uM), but not TrKB and TrKC. Tyrphostin AG 879 is also a selective ErbB2 tyrosine kinase inhibitor with an IC50 of 1 uM, and has at least 500-fold higher selectivity to ErbB2 than EGFR. Tyrphostin AG 879 has anticancer activity.	False	CC(C)(C)c1cc(/C=C(\C#N)C(N)=S)cc(C(C)(C)C)c1O
247342	247342:02:04_10.00	True	10.0	99	18.5	0.0	0.0	64.9	0.0	66.3	29.2	75.1	30.7	26.7	0.0	71.9	33.1	LCH	75.1	Doxazosin mesylate	alpha1 adrenoceptor blocker, Alpha 1 adrenergic antagonist, antihypertensive.	False	COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC
280399	280399:01:03_10.00	True	10.0	56	68.7	0.0	0.0	62.3	0.0	59.4	19.5	82.4	37.5	21.7	0.0	68.2	35.6	LCH	82.4	CGP-74514A hydrochloride	Cdk1 inhibitor.	False	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21
280571	280571:01:03_10.00	True	10.0	103	36.4	0.0	0.0	68.2	0.0	71.2	27.1	91.6	29.0	29.5	0.0	63.0	32.4	LCH	91.6	GW2974	GW2974 is a dual selective inhibitor of EGFR and Neu (ErbB-2) receptor tyrosine kinases.  Receptor protein-tyrosine kinase erbB-2/4 (IC50 = 0.02/0.02 µM),  Epidermal growth factor receptor erbB1 (IC50 = 0.21 µM); Indazolylamino quinazolines and pyridopyrimidines as inhibitors of the EGFr and c-erbB-2.  Bioorg Med Chem Lett.  (2001),  11(11),  1401-1405.	False	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1
247066	247066:02:03_10.00	True	10.0	101	11.7	0.0	0.0	84.6	0.0	82.3	23.4	71.8	45.6	61.9	0.0	75.0	60.3	BET	84.6	Triamterene	Na+ channel blocker, diuretic, Non competitive aldosterone antagonist.	False	Nc1nc(N)c2nc(-c3ccccc3)c(N)nc2n1
245381	245381:03:03_10.00	True	10.0	99	15.9	0.0	0.0	35.3	0.0	31.5	23.1	59.1	0.0	21.3	0.0	39.1	0.0	LCH	59.1	Flunarizine dihydrochloride	Ca2+/Na+ channel blocker, vasodilator.	False	Fc1ccc(C(c2ccc(F)cc2)N2CCN(C/C=C/c3ccccc3)CC2)cc1
247234	247234:02:03_10.00	True	10.0	101	24.5	0.0	0.0	76.4	0.0	74.3	10.9	94.4	41.6	39.2	0.0	69.1	42.0	LCH	94.4	Promazine hydrochloride	D2 dopamine receptor antagonist, phenothiazine antipsychotic, Dopamine receptor antagonist.	False	CN(C)CCCN1c2ccccc2Sc2ccccc21
280998	280998:01:03_10.00	True	10.0	102	7.1	0.0	0.0	78.0	0.0	76.1	22.7	79.0	33.6	48.4	0.0	75.6	46.8	LCH	79.0	Tulobuterol (hydrochloride)	Tulobuterol hydrochloride (C-78) is a long-acting .b.2-adrenoceptor agonist, which reduces the frequency of exacerbations of chronic obstructive pulmonary disease and bronchial asthma. Tulobuterol hydrochloride is also a sympathomimetic agent used as a transdermal patch, increases normal diaphragm muscle strength. Tulobuterol hydrochloride inhibit rhinovirus replication and modulate airway inflammation.	False	CC(C)(C)NCC(O)c1ccccc1Cl
280104	280104:01:03_10.00	True	10.0	98	40.1	0.0	0.0	85.6	0.0	83.9	12.6	91.8	50.6	48.5	0.0	78.4	49.3	LCH	91.8	N-Desmethylclozapine	N-Desmethylclozapine is a major active metabolite of the atypical antipsychotic drug Clozapine. N-Desmethylclozapine is a potent, allosteric and partial M1 receptors agonist (EC50=115 nM) and is able to potentiate hippocampal N-methyl-d-aspartate (NMDA) receptor currents through M1 receptor activation. N-Desmethylclozapine is also a .d.-opioid agonist.	False	Clc1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2
108102	108102:02:03_10.00	True	10.0	93	29.5	0.0	0.0	81.3	0.0	74.6	8.7	88.6	37.3	57.8	0.0	77.4	44.9	LCH	88.6	Trequinsin hydrochloride HL 725	phosphodiesterase III (PDE III) inhibitor.	False	COc1cc2c(cc1OC)-c1c/c(=N\c3c(C)cc(C)cc3C)n(C)c(=O)n1CC2
247251	247251:02:03_10.00	True	10.0	100	13.1	0.0	0.0	74.0	0.0	71.3	17.0	92.4	37.5	45.5	0.0	71.4	44.9	LCH	92.4	Imipramine hydrochloride	tricyclic antidepressant, blocks reuptake of serotonin and norepinephrine, 5-HT transport inhibitor.	False	CN(C)CCCN1c2ccccc2CCc2ccccc21
280525	280525:01:03_10.00	True	10.0	101	11.6	0.0	0.0	82.8	0.0	81.6	18.6	87.2	39.4	62.3	0.0	75.3	54.3	LCH	87.2	FLB 131	potent and selective D2 dopamine receptor antagonist.	False	CCc1cc(Cl)c(OC)c(C(=O)NC[C@@H]2CCN(CC)C2)c1O
247391	247391:02:03_10.00	True	10.0	101	10.5	0.0	0.0	61.8	0.0	55.9	0.0	86.6	28.9	18.2	0.0	51.7	27.4	LCH	86.6	Protriptyline (hydrochloride)	Protriptyline hydrochloride is a tricyclic antidepressant (TCA), specifically a secondary amine, for the treatment of depression and ADHD. Unique among the TCAs, protriptyline tends to be energizing instead of sedating, used for narcolepsy to achieve a wakefulness-promoting effect.	False	CNCCCC1c2ccccc2C=Cc2ccccc21
280514	280514:01:03_10.00	True	10.0	97	7.1	0.0	0.0	68.0	0.0	66.6	8.0	73.3	35.5	44.4	0.0	59.4	56.1	LCH	73.3	(R,R)-cis-Diethyl tetrahydro-2,8-chrysenediol	potent estrogen receptor beta antagonist, potent partial agonist at estrogen receptor alpha.	False	CC[C@@H]1Cc2cc(O)ccc2C2=C1c1ccc(O)cc1C[C@H]2CC
280349	280349:01:03_10.00	True	10.0	100	7.4	0.0	0.0	66.6	0.0	64.4	6.3	88.2	30.0	32.1	0.0	59.0	25.9	LCH	88.2	Benztropine mesylate	muscarinic acetylcholine receptor antagonist.	False	CN1C2CCC1CC(OC(c1ccccc1)c1ccccc1)C2
247165	247165:02:03_10.00	True	10.0	101	47.5	0.0	0.0	76.5	0.0	72.8	8.5	96.2	34.4	41.3	0.0	66.9	46.6	LCH	96.2	Fluoxetine hydrochloride, Prozac	selective serotonin reuptake inhibitor, 5-HT uptake inhibitor, induces differentiation of neuronal precursors.	False	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1
247067	247067:02:03_10.00	True	10.0	93	12.1	0.0	0.0	45.3	0.0	50.3	34.3	55.6	26.2	12.1	0.0	51.8	4.8	LCH	55.6	Domperidone	peripheral dopamine receptor antagonist that does not cross the blood-brain barrier, anti-emetic, Dopamine Antagonists, antiemetic.	False	O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1
280092	280092:01:03_10.00	True	10.0	98	5.4	56.1	0.0	0.0	81.6	0.0	18.1	0.0	0.0	0.0	62.5	0.0	0.0	DNA_Synth	81.6	Supercinnamaldehyde	transient receptor potential ankyrin 1 (TRPA1) receptor activator, covalently modifies cysteines to acitvate channel.	False	CC(=O)/C=C1\C(=O)N(C)c2ccccc21
280847	280847:01:03_10.00	True	10.0	96	15.7	0.0	0.0	84.0	0.0	86.4	31.7	73.9	54.7	65.0	0.0	81.0	57.5	HDAC	86.4	PDMP hydrochloride	glucosylceramide synthase inhibitor, blocks formation of glucosylceramide from ceramide.	False	CCCCCCCCCC(=O)NC(CN1CCOCC1)[C@H](O)c1ccccc1
247050	247050:03:03_10.00	True	10.0	108	56.5	0.0	0.0	80.6	0.0	80.7	18.7	95.7	40.7	49.7	0.0	72.2	47.9	LCH	95.7	Fluphenazine dihydrochloride	dopamine receptor antagonist, antipsychotic, Dopamine antagonist, h1 antihistamine.	False	OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1
247307	247307:02:03_10.00	True	10.0	94	13.8	0.0	0.0	71.5	0.0	64.6	15.7	91.0	24.9	37.4	0.0	70.2	45.0	LCH	91.0	Trimipramine (maleate)	Trimipramine maleate is a 5-HT receptor antagonist, with pKis of 6.39, 8.10, 4.66 for 5-HT1C, 5-HT2 and 5-HT1A, respectively.	False	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21
247098	247098:02:03_10.00	True	10.0	93	47.2	0.0	0.0	57.9	0.0	57.0	30.9	83.8	17.6	38.1	0.0	61.0	37.8	LCH	83.8	Vanoxerine (dihydrochloride)	Vanoxerine dihydrochloride (GBR-12909 dihydrochloride) is a competitive, potent, and highly selective dopamine reuptake inhibitor (Ki=1 nM). Vanoxerine dihydrochloride (GBR-12909 dihydrochloride) binds to the target site on the dopamine transporter (DAT).	False	Fc1ccc(C(OCCN2CCN(CCCc3ccccc3)CC2)c2ccc(F)cc2)cc1
280564	280564:01:03_10.00	True	10.0	94	20.0	0.0	0.0	87.1	0.0	84.2	25.8	81.3	47.2	60.4	0.0	84.8	60.8	BET	87.1	Formoterol	beta2-Adrenoceptor agonist.	False	C[C@@H](Cc1ccc(C=O)cc1)NC[C@@H](O)c1ccc(O)c(NCO)c1
247177	247177:02:03_10.00	True	10.0	100	45.3	0.0	0.0	78.2	0.0	75.9	10.1	97.5	39.9	46.1	0.0	66.5	46.4	LCH	97.5	Triflupromazine (hydrochloride)	Triflupromazine hydrochloride is an antipsychotic medication, which are Dopamine D1/D2 receptor antagonists.	False	CN(C)CCCN1c2ccccc2Sc2ccc(C(F)(F)F)cc21
280581	280581:01:03_10.00	True	10.0	94	32.6	0.0	0.0	73.5	0.0	73.8	11.0	94.4	40.2	47.9	0.0	68.0	40.8	LCH	94.4	GBR 12935 (dihydrochloride)	GBR 12935 dihydrochloride is a potent, and selective dopamine reuptake inhibitor.IC50 value: Target: dopamine reuptake inhibitorin vitro: The calculated Kd of [3H]GBR-12935 binding to CYP2D6 was 42.2 nM, indicating that GBR-12935 has a high affinity for CYP2D6. The binding of [3H]GBR-12935 to CYP2D6 was decreased partially by substrates or inhibitors of CYP2D isoforms (quinine, quinidine, propranolol, bufuralol, imipramine, and desipramine) . Co-perfusion of 100 microM GBR 12909 or GBR 12935 with either 100 microM sulpiride or raclopride produced a significant reduction in the GBR 12909 or GBR 12935 induced increase in the extracellular levels of dopamine to basal levels. In vitro, GBR 12909 (1-9 nM) dose-dependently inhibited active uptake of [3H]dopamine in homogenates of the nucleus accumbens .in vivo: GBR 12935 elevated locomotion to a greater extent in C57BL/6J mice at the maximally active dose of 10 mg/kg. Locomotor stimulation by GBR 12935 remained consistent in both strains with repeated injections. DBA/2J mice became sensitized to cocaine-induced stereotypy with repeated injections. Cocaine induced no stereotypy in C57BL/6J mice on any test day. No stereotypies were induced by GBR 12935 in either strain on any test day .	False	c1ccc(CCCN2CCN(CCOC(c3ccccc3)c3ccccc3)CC2)cc1
280345	280345:01:03_10.00	True	10.0	93	10.9	75.9	1.3	0.0	82.1	0.0	11.7	0.0	0.0	0.0	90.9	0.0	0.0	Pyrimidine_Synth	90.9	Betamethasone, 9alpha-Fluoro-16beta-methylprednisolone	SAID (steroidal anti-inflammatory drug), glucocorticoid.	False	C[C@H]1CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
247104	247104:02:03_10.00	True	10.0	99	13.1	0.0	0.0	65.9	0.0	62.2	25.7	73.8	17.6	55.1	0.0	70.5	46.5	LCH	73.8	Terbutaline hemisulfate	beta-Adrenoceptor agonist, bronchodilator, Beta-2 adrenergic agonist.	False	CC(C)(C)NCC(O)c1cc(O)cc(O)c1
280672	280672:01:03_10.00	True	10.0	101	45.8	0.0	0.0	69.8	0.0	71.0	21.7	91.0	31.2	34.1	0.0	66.3	34.9	LCH	91.0	L-765,314	potent, selective alpha-1B adrenoceptor antagonist.	False	COc1cc2nc(N3CCN(C(=O)OCc4ccccc4)C(C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC
280648	280648:01:03_10.00	True	10.0	106	6.2	0.0	0.0	80.5	0.0	69.6	9.4	72.5	39.0	70.8	0.0	75.2	62.3	BET	80.5	S(+)-Isoproterenol (+)-bitartrate	sympathomimetic amine acting almost exclusively on beta adrenoceptors, bronchodilator, less active enantiomer of Isoproterenol.	False	CC(C)NC[C@@H](O)c1ccc(O)c(O)c1
105397	105397:02:03_10.00	True	10.0	98	11.4	81.6	0.0	0.0	62.0	0.0	25.3	15.8	0.0	0.0	40.2	0.0	32.9	AKT_PI3K_MTOR	81.6	AG-1478	AG-1478 (Tyrphostin AG-1478) is a selective EGFR tyrosine kinase inhibitor with IC50 of 3 nM. AG-1478 has antiviral effects against HCV and encephalomyocarditis virus (EMCV).	False	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC
280331	280331:01:03_10.00	True	10.0	97	9.8	0.0	0.0	32.1	0.0	38.5	45.5	50.7	18.6	15.5	0.0	34.1	0.6	LCH	50.7	(+)-Bromocriptine methanesulfonate	D2 dopamine receptor agonist, inhibits prolaction secretion.	False	CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12
280343	280343:01:03_10.00	True	10.0	92	6.9	16.9	24.0	0.0	65.6	0.0	7.6	2.0	0.0	8.0	16.8	22.4	1.8	DNA_Synth	65.6	BAY 11-7085	BAY 11-7085 (BAY 11-7083) is an inhibitor of NF-.k.B activation and phosphorylation of I.k.B.a.; it stabilizes I.k.B.a. with an IC50 of 10 uM.	False	CC(C)(C)c1ccc(S(=O)(=O)/C=C/C#N)cc1
280850	280850:01:03_10.00	True	10.0	90	43.2	0.0	0.0	71.5	0.0	70.6	12.5	96.3	36.2	35.0	0.0	62.9	41.6	LCH	96.3	Propionylpromazine hydrochloride	D2 dopamine receptor antagonist, phenothiazine antipsychotic.	False	CCC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2
280562	280562:01:03_10.00	True	10.0	89	5.2	0.0	0.0	42.6	0.0	41.9	27.4	44.8	17.5	31.6	0.0	50.3	26.7	Tubulin	50.3	Flupirtine (Maleate)	Flupirtine Maleate is an indirect N-methyl-D-aspartate receptor (NMDAR) antagonist. It is a brain penetrant, and orally bioavailable, non-opioid and centrally acting analgesic agent.	False	CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)nc1N
247024	247024:02:03_10.00	True	10.0	104	7.3	0.0	0.0	81.0	0.0	73.1	6.5	75.5	41.2	66.4	0.0	75.1	62.8	BET	81.0	Fenoterol (hydrobromide)	Fenoterol hydrobromide (Th-1165a), a sympathomimetic agent, is a selective and orally active .b.2-adrenoceptor agonist. Fenoterol hydrobromide is an effective bronchodilator and can be used for bronchospasm associated with asthma, bronchitis and other obstructive airway diseases research.	False	CC(Cc1ccc(O)cc1)NCC(O)c1cc(O)cc(O)c1
280106	280106:01:03_10.00	True	10.0	79	46.1	0.0	0.0	47.9	0.0	33.1	9.8	42.5	2.5	29.4	0.0	47.5	56.1	Uncoupler	56.1	AC-93253 iodide	potent, cell permeable, subtype selective retinoic acid receptor (RARalpha) agonist.	False	CC[n+]1c(/C=C/C=C2/N(C)c3ccccc3C2(C)C)sc2ccccc21
280407	280407:01:03_10.00	True	10.0	102	7.8	0.0	0.0	52.5	0.0	52.7	13.3	77.5	15.2	7.9	0.0	49.3	37.7	LCH	77.5	CNS-1102, Cerestat, Aptiganel hydrochloride	noncompetitive NMDA glutamate receptor antagonist.	False	CCc1cccc(N(C)C(=N)Nc2cccc3ccccc23)c1
280107	280107:01:03_10.00	True	10.0	97	5.4	58.1	5.6	0.0	79.4	0.0	24.7	0.0	0.0	0.0	82.0	0.0	0.0	Pyrimidine_Synth	82.0	UCL 2077	slow afterhyperpolarization (sAHP) channel blocker.	False	c1ccc(C(NCc2cccnc2)(c2ccccc2)c2ccccc2)cc1
280322	280322:01:03_10.00	True	10.0	106	9.3	65.3	7.1	0.0	80.8	0.0	12.9	0.0	0.0	0.0	89.0	0.0	0.0	Pyrimidine_Synth	89.0	Beclomethasone	anti-inflammatory glucocorticoid.	False	C[C@H]1CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
280510	280510:01:03_10.00	True	10.0	86	5.4	28.2	23.1	0.0	74.5	0.0	17.7	1.5	0.0	4.5	33.9	2.4	0.0	DNA_Synth	74.5	Dephostatin	CD45 protein tyrosine kinase inhibitor.	False	CN(N=O)c1cc(O)ccc1O
247425	247425:02:03_10.00	True	10.0	103	5.2	0.0	0.0	72.2	0.0	67.5	25.3	81.1	26.8	59.1	0.0	71.5	49.7	LCH	81.1	Fluvoxamine (maleate)	Fluvoxamine maleate (DU-23000 maleate) is an antidepressant which functions pharmacologically as a selective serotonin reuptake inhibitor.	False	COCCCC/C(=N\OCCN)c1ccc(C(F)(F)F)cc1
280856	280856:01:03_10.00	True	10.0	83	26.4	20.3	0.0	18.0	41.7	18.1	32.0	40.1	16.8	20.0	0.0	38.9	16.9	DNA_Synth	41.7	Ammonium pyrrolidinedithiocarbamate, APDC	prevents induction of nitric oxide synthase (NOS) by inhibiting translation of NOS mRNA.	False	S=C(S)N1CCCC1
280509	280509:01:03_10.00	True	10.0	100	7.9	0.0	0.0	52.6	0.0	51.9	28.2	68.0	17.6	36.1	0.0	66.4	42.9	LCH	68.0	(±) trans-U-50488 methanesulfonate	selective kappa opioid receptor agonist.	False	CN(C(=O)Cc1ccc(Cl)c(Cl)c1)[C@H]1CCCC[C@@H]1N1CCCC1
246866	246866:02:03_10.00	True	10.0	94	27.8	0.0	0.0	59.4	0.0	67.0	42.6	65.1	28.3	38.2	0.0	63.2	33.8	HDAC	67.0	Cilnidipine	slow-acting Ca2+ channel blocker, antihypertensive, vasodilator. Does not inhibit PKC.	False	COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC/C=C/c2ccccc2)C1c1cccc([N+](=O)[O-])c1
280340	280340:01:03_10.00	True	10.0	95	16.4	68.2	0.0	0.0	85.0	0.0	0.0	0.0	0.0	0.0	59.1	0.0	10.2	DNA_Synth	85.0	5-Bromo-2'-deoxyuridine, Br-dU	thymidine analog, incorporated into DNA during S-phase of cell cycle.	False	O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1Br
280645	280645:01:03_10.00	True	10.0	99	7.9	0.0	0.0	73.6	0.0	64.6	16.6	73.3	39.7	67.3	0.0	75.9	61.9	Tubulin	75.9	(-)-Isoproterenol hydrochloride, (-)-Isoprenaline hydrochloride	beta-Adrenoceptor agonist, increases cytosolic cAMP.	False	CC(C)NC[C@H](O)c1ccc(O)c(O)c1
280550	280550:01:03_10.00	True	10.0	108	25.0	0.0	0.0	70.5	0.0	65.0	1.6	93.9	31.1	31.9	0.0	58.3	38.5	LCH	93.9	S-(+)-Fluoxetine hydrochloride	selective serotonin reuptake inhibitor.	False	CNCC[C@H](Oc1ccc(C(F)(F)F)cc1)c1ccccc1
280852	280852:01:03_10.00	True	10.0	85	37.5	22.2	0.0	59.9	4.5	53.1	16.9	74.6	25.3	45.1	0.0	69.2	72.6	LCH	74.6	Phorbol 12-myristate 13-acetate, PMA	activates protein kinase C in vivo and in vitro, strong NO promoter, promotes expression of iNOS in cultured hepatocytes, T lymphocyte activator.	False	CCCCCCCCCCCCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@@]3(O)C(=O)C(C)=C[C@H]32)[C@@H]2C(C)(C)[C@]12OC(C)=O
280466	280466:01:04_10.00	True	10.0	91	20.7	0.0	0.0	67.5	0.0	62.7	19.2	81.9	23.7	37.7	0.0	63.1	30.4	LCH	81.9	Dihydroergocristine methanesulfonate	ergot alkaloid, vasoconstrictor, partial agonist at dopaminergic receptors and adrenoceptors, antagonist at serotonergic receptors.	False	CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O
280545	280545:01:03_10.00	True	10.0	102	35.6	0.0	0.0	74.1	0.0	72.7	19.3	87.3	36.3	42.6	0.0	69.1	34.7	LCH	87.3	cis-(Z)-Flupenthixol dihydrochloride	dopamine receptor antagonist, antipsychotic.	False	OCCN1CCN(CC/C=C2/c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1
247033	247033:02:03_10.00	True	10.0	101	17.4	0.0	0.0	65.3	0.0	64.9	1.0	90.9	32.5	25.6	0.0	56.4	31.0	LCH	90.9	Trazodone (hydrochloride)	Trazodone (hydrochloride) (AF-1161) is an antidepressant belonging to the class of serotonin receptor antagonists and reuptake inhibitors for treatment of anxiety disorders.	False	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12
280177	280177:01:03_10.00	True	10.0	100	32.1	0.0	0.0	74.9	0.0	74.3	17.1	94.4	34.4	38.3	0.0	68.7	40.0	LCH	94.4	Aprindine hydrochloride, Amidonal	class Ib antiarrhythmic and hERG channel blocker.	False	CCN(CC)CCCN(c1ccccc1)C1Cc2ccccc2C1
280999	280999:01:03_10.00	True	10.0	103	8.3	61.4	6.7	0.0	72.6	0.0	0.0	0.0	0.0	0.0	86.5	0.0	0.0	Pyrimidine_Synth	86.5	Triamcinolone, Fluoxyprednisolone	synthetic glucocorticoid agonist, inducer of gene expression and apoptosis.	False	C[C@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO
247369	247369:02:03_10.00	True	10.0	104	67.7	0.0	0.0	71.2	0.0	70.9	21.1	94.6	24.7	38.1	0.0	64.4	42.1	LCH	94.6	Fluspirilene	Fluspirilene is a non-competitive antagonist of L-type calcium channels with an IC50 of 0.03 uM. Fluspirileneis a long-acting injectable depot antipsychotic drug used for schizophrenia.	False	O=C1NCN(c2ccccc2)C12CCN(CCCC(c1ccc(F)cc1)c1ccc(F)cc1)CC2
246791	246791:02:03_30.00	True	30.0	102	20.0	0.0	0.0	45.5	0.0	50.6	19.3	66.9	15.4	20.3	0.0	40.3	0.5	LCH	66.9	Chlorpheniramine (maleate)	Chlorpheniramine maleate is an histamine H1 receptor antagonist with IC50 of 12 nM.Target: Histamine H1 ReceptorChlorpheniramine inhibits the proliferation of MCF-7, MDA-MB 231, and Ehrlich cells in a dose-response manner, and significantly reduces the ornithine decarboxylase mRNA translation by 50%-70% at the 250 uM . Chlorpheniramine displaces of [3H]pyrilamine from human histamine receptor subtype 1 expressed in CHO cells with IC50 of 66 nM. Chlorpheniramine displays antimalarial activity against CQS strain (D6) and MDR strain (Dd2) of P. falciparum with IC50 of 61.2 uM and 3.9 uM, respectively. Chlorpheniramine displays cytotoxicity against the proliferation of concanavalin A-induced murine splenic lymphocytes with IC50 of 33.4 uM .Oral administration of Chlorpheniramine inhibits histamine-induced mortality in guinea pigs with an ED50 of 0.17 mg/kg . Oral administration of Chlorpheniramine (10 mg/kg) significantly inhibits short-duration scratching in BALB/c mice stimulated by ovalbumin active cutaneous anaphylaxis and in ICR mice subcutaneously injected with histamine, but not long-duration scratching seen in NC/Nga mice, in contrast to that of dexamethasone or tacrolimus .	False	CN(C)CCC(c1ccc(Cl)cc1)c1ccccn1
280113	280113:01:03_30.00	True	30.0	88	18.5	0.0	0.0	70.1	0.0	75.4	37.5	68.6	25.8	54.9	0.0	68.1	54.5	HDAC	75.4	NS8593 hydrochloride	blocks small conductance Ca2+ activated K+ channels.	False	c1ccc2c(c1)CCC[C@H]2Nc1nc2ccccc2[nH]1
280453	280453:01:03_30.00	True	30.0	106	12.4	7.4	0.0	28.8	2.0	25.1	2.9	13.2	10.4	50.2	0.0	30.9	50.9	Uncoupler	50.9	SKF 38393 (hydrochloride)	SKF 38393 hydrochloride is a selective agonist of the dopamine D1 receptor (D1DR) with an IC50 of 110 nM.	False	Oc1cc2c(cc1O)C(c1ccccc1)CNCC2
280404	280404:01:03_30.00	True	30.0	94	11.6	0.0	0.0	57.0	0.0	50.6	13.7	68.5	27.8	36.1	0.0	59.4	32.2	LCH	68.5	8-(4-Chlorophenylthio)-cAMP sodium	membrane-permeable analog of cAMP.	False	Nc1ncnc2c1nc(Sc1ccc(Cl)cc1)n2C1OC2COP(=O)(O)O[C@@H]2[C@@H]1O
280338	280338:01:03_30.00	True	30.0	89	10.0	0.0	0.0	33.5	0.0	38.9	31.6	59.0	0.0	19.9	0.0	34.5	16.7	LCH	59.0	Benazoline oxalate	I2 Imidazoline receptor agonist.	False	Cc1sc2ccccc2c1CC1=NCCN1
280314	280314:01:03_30.00	True	30.0	95	10.0	21.6	26.0	0.0	78.3	0.0	17.8	14.7	0.0	0.0	44.9	0.0	0.0	DNA_Synth	78.3	R(+)-6-Bromo-APB hydrobromide	D1 Dopamine receptor agonist.	False	C=CCN1CCc2c(cc(O)c(O)c2Br)[C@@H](c2ccccc2)C1
280315	280315:01:03_30.00	True	30.0	100	37.8	0.0	0.0	58.9	0.0	60.3	26.4	80.3	18.3	40.7	0.0	60.2	25.6	LCH	80.3	BTCP hydrochloride	selective blocker of dopamine reuptake.	False	c1ccc2sc(C3(N4CCCCC4)CCCCC3)cc2c1
280512	280512:01:03_30.00	True	30.0	86	14.3	12.6	0.0	39.1	0.0	37.5	43.4	73.6	0.0	12.1	0.0	54.9	36.2	LCH	73.6	Danazol	anterior pituitary suppressant, weak androgen.	False	C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5CC4(C)[C@H]3CCC21C
280558	280558:01:03_30.00	True	30.0	94	43.0	0.0	0.0	68.6	0.0	65.7	34.9	75.5	26.5	54.7	0.0	76.6	56.5	Tubulin	76.6	Forskolin	activates adenylate cyclase, antihypertensive and vasodilator, isolated from Coleus forskohlii.	False	C=CC1(C)CC(=O)C2(O)C(C)(O1)C(OC(C)=O)C(O)C1C(C)(C)CCC(O)C12C
280858	280858:01:03_30.00	True	30.0	106	33.2	0.0	0.0	48.0	0.0	45.4	24.3	68.7	9.8	24.1	0.0	52.8	21.0	LCH	68.7	Pergolide methanesulfonate, propylergoline methanesulfonate	dopamine receptor agonist, antiparkinsonian.	False	CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21
280572	280572:01:03_30.00	True	30.0	92	6.6	1.1	0.0	47.0	0.0	38.5	21.2	58.9	14.2	31.2	0.0	56.5	37.0	LCH	58.9	L-Glutamic acid hydrochloride	endogenous excitatory amino acid neurotransmitter.	False	N[C@@H](CCC(=O)O)C(=O)O
280982	280982:01:03_30.00	True	30.0	78	51.1	9.9	0.0	68.1	0.0	67.0	23.7	43.6	48.2	65.0	0.0	61.8	91.2	Uncoupler	91.2	Tyrphostin AG 879	Tyrphostin AG 879 (AG 879) is a tyrosine kinase inhibitor that inhibits TrKA phosphorylation (IC50 of 10 uM), but not TrKB and TrKC. Tyrphostin AG 879 is also a selective ErbB2 tyrosine kinase inhibitor with an IC50 of 1 uM, and has at least 500-fold higher selectivity to ErbB2 than EGFR. Tyrphostin AG 879 has anticancer activity.	False	CC(C)(C)c1cc(/C=C(\C#N)C(N)=S)cc(C(C)(C)C)c1O
280503	280503:01:03_30.00	True	30.0	95	6.7	0.0	0.0	69.7	0.0	64.7	10.1	77.7	22.9	35.2	0.0	72.8	36.3	LCH	77.7	DL-erythro-Dihydrosphingosine, DL-Sphinganine	protein kinase C, phospholipase A2, and phospholipase D inhibitor.	False	CCCCCCCCCCCCCCC[C@H](O)[C@H](N)CO
280989	280989:01:03_30.00	True	30.0	82	28.0	34.7	17.5	0.0	69.2	0.0	16.9	0.0	0.0	0.0	46.0	0.0	0.0	DNA_Synth	69.2	Tyrphostin AG 527, Tyrphostin B44	protein tyrosine kinase inhibitor.	False	C[C@@H](NC(=O)/C(C#N)=C/c1ccc(O)c(O)c1)c1ccccc1
280454	280454:01:03_30.00	True	30.0	96	18.5	2.5	0.0	23.9	8.8	21.2	30.9	56.0	0.0	10.8	0.0	34.9	0.1	LCH	56.0	R(+)-SCH-23390 hydrochloride	selective D1 dopamine receptor antagonist.	False	CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1
280571	280571:01:03_30.00	True	30.0	88	76.2	0.0	0.0	69.1	0.0	75.9	42.3	73.6	31.7	52.3	0.0	70.0	48.1	HDAC	75.9	GW2974	GW2974 is a dual selective inhibitor of EGFR and Neu (ErbB-2) receptor tyrosine kinases.  Receptor protein-tyrosine kinase erbB-2/4 (IC50 = 0.02/0.02 µM),  Epidermal growth factor receptor erbB1 (IC50 = 0.21 µM); Indazolylamino quinazolines and pyridopyrimidines as inhibitors of the EGFr and c-erbB-2.  Bioorg Med Chem Lett.  (2001),  11(11),  1401-1405.	False	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1
247007	247007:02:03_30.00	True	30.0	99	19.2	0.0	0.0	43.3	0.0	46.4	31.5	62.6	5.5	26.1	0.0	50.2	12.4	LCH	62.6	Triprolidine hydrochloride	potent H1 histamine receptor antagonist, H1 antagonist, antihistaminic.	False	Cc1ccc(/C(=C\CN2CCCC2)c2ccccn2)cc1
280561	280561:01:03_30.00	True	30.0	93	30.9	42.4	0.0	0.0	48.6	0.0	0.0	0.0	0.0	0.0	64.1	0.0	0.0	Pyrimidine_Synth	64.1	5-Fluoro-5'-deoxyuridine, Doxifluridine	Doxifluridine (5'-deoxy-5-fluorouridine) is a second generation nucleoside analog prodrug. It is a fluoropyrimidine derivative of 5-FU, an FDA-approved antimetabolite. Doxifluridine was designed to improve oral bioavailability in order to avoid dihydropyrimidine dehydrogenase degradation in the digestive system. Doxifluridine is an antitumor agent efficient in tumors and cell lines and is used as a cytostatic agent in chemotherapy in some countries.	False	C[C@H]1O[C@@H](n2cc(F)c(=O)[nH]c2=O)[C@H](O)[C@@H]1O
280943	280943:01:03_30.00	True	30.0	97	23.7	20.0	0.0	15.9	0.0	11.7	56.4	37.2	0.0	11.7	0.2	33.7	13.2	HSP90	56.4	SB 222200	non-peptide NK3 tachykinin receptor antagonist.	False	CC[C@H](NC(=O)c1c(C)c(-c2ccccc2)nc2ccccc12)c1ccccc1
280529	280529:01:03_30.00	True	30.0	62	30.1	33.6	45.8	0.0	88.0	0.0	4.7	0.0	0.0	0.0	70.5	0.0	0.0	DNA_Synth	88.0	Etoposide, Lastet	topoisomerase II inhibitor, induces apoptosis, cell cycle inhibitor.	False	COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@@]5(O)C[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O
247066	247066:02:03_30.00	True	30.0	93	24.7	27.5	0.0	35.6	12.7	21.0	26.2	53.9	0.0	36.2	0.0	45.8	53.3	LCH	53.9	Triamterene	Na+ channel blocker, diuretic, Non competitive aldosterone antagonist.	False	Nc1nc(N)c2nc(-c3ccccc3)c(N)nc2n1
280387	280387:01:03_30.00	True	30.0	99	70.8	0.0	0.0	74.4	0.0	69.1	17.2	89.4	24.4	56.0	0.0	74.2	54.1	LCH	89.4	ML-9	ML-9 is a  selective and potent  inhibitor of Akt kinase, inhibits myosin light-chain kinase (MLCK) and stromal interaction molecule 1 (STIM1) activity. ML-9 inhibits inhibits MLCK, PKA and PKC activity with Ki values of  4, 32 and 54uM, respectively. ML-9 induces autophagy by stimulating autophagosome formation and inhibiting their degradation.</br>	False	O=S(=O)(c1cccc2c(Cl)cccc12)N1CCCNCC1
247065	247065:02:03_30.00	True	30.0	95	29.2	0.0	0.0	59.8	0.0	59.2	23.3	66.5	19.5	41.5	0.0	65.2	35.8	LCH	66.5	Guanfacine (hydrochloride)	Guanfacine hydrochloride, an anti-hypertensive agent, is a selective .a.2A-adrenoceptor agonist with Kd of 31 nM and displays 60-fold selectivity over .a.2B-adrenoceptors. IC50 Value: 31 nM(Kd)Target: Adrenergic ReceptorGuanfacine is a sympatholytic. It is a selective .a.2A receptor agonist. These receptors are concentrated heavily in the prefrontal cortex and the locus coeruleus, with the potential to improve attention resulting from interaction with receptors in the former. Guanfacine lowers both systolic and diastolic blood pressure by activating the central nervous system .a.2A norepinephrine autoreceptors, which results in reduced peripheral sympathetic outflow and thus a reduction in peripheral sympathetic tone. From Wikipedia	False	N=C(N)NC(=O)Cc1c(Cl)cccc1Cl
245381	245381:03:03_30.00	True	30.0	100	51.5	0.0	0.0	57.6	0.0	55.0	23.0	73.7	19.5	38.8	0.0	57.7	31.4	LCH	73.7	Flunarizine dihydrochloride	Ca2+/Na+ channel blocker, vasodilator.	False	Fc1ccc(C(c2ccc(F)cc2)N2CCN(C/C=C/c3ccccc3)CC2)cc1
280452	280452:01:03_30.00	True	30.0	90	26.4	64.0	0.0	0.0	85.2	0.0	25.3	0.0	0.0	0.0	77.8	0.0	0.0	DNA_Synth	85.2	R(-)-N-Allylnorapomorphine hydrobromide	dopamine receptor agonist.	False	C=CCN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3
280380	280380:01:03_30.00	True	30.0	104	21.4	0.0	0.0	79.5	0.0	73.8	22.2	79.1	37.6	57.1	0.0	77.3	53.4	BET	79.5	6-Chloromelatonin	melatonin receptor agonist.	False	COc1cc2c(CCNC(C)=O)c[nH]c2cc1Cl
247234	247234:02:03_30.00	True	30.0	93	82.6	0.0	0.0	80.2	0.0	80.1	20.4	91.8	36.4	52.7	0.0	75.4	52.0	LCH	91.8	Promazine hydrochloride	D2 dopamine receptor antagonist, phenothiazine antipsychotic, Dopamine receptor antagonist.	False	CN(C)CCCN1c2ccccc2Sc2ccccc21
280318	280318:01:03_30.00	True	30.0	88	67.0	0.0	0.0	69.8	0.0	68.9	30.6	83.5	29.6	46.6	0.0	67.7	44.9	LCH	83.5	(±)-Butaclamol hydrochloride, AY 23028	dopamine receptor antagonist, selective for D2 over D1.	False	CC(C)(C)[C@]1(O)CCN2C[C@H]3c4ccccc4CCc4cccc(c43)[C@@H]2C1
280085	280085:01:03_30.00	True	30.0	66	23.7	30.4	10.5	0.0	80.9	0.0	16.1	7.4	0.0	0.0	45.3	16.3	1.3	DNA_Synth	80.9	TBBz	cell-permeable casein kinase 2 (CK2) inhibitor.	False	Brc1c(Br)c(Br)c2[nH]cnc2c1Br
280402	280402:01:03_30.00	True	30.0	88	29.4	45.1	0.0	3.9	29.5	0.0	46.9	21.9	0.0	14.2	24.3	28.5	34.0	HSP90	46.9	Cyclosporin A, Antibiotic S 7481F1	calcineurin phosphatase inhibitor, immunosuppressant, Increases efficiency of cardiomyocyte generation from ESCs.	False	C/C=C/CC(C)C(O)C1C(=O)NC(CC)C(=O)N(C)CC(=O)N(C)C(CC(C)C)C(=O)NC(C(C)C)C(=O)N(C)C(CC(C)C)C(=O)NC(C)C(=O)NC(C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(C(C)C)C(=O)N1C
280998	280998:01:03_30.00	True	30.0	107	12.8	0.0	0.0	49.2	0.0	45.8	17.9	61.4	14.5	17.2	0.0	50.4	21.0	LCH	61.4	Tulobuterol (hydrochloride)	Tulobuterol hydrochloride (C-78) is a long-acting .b.2-adrenoceptor agonist, which reduces the frequency of exacerbations of chronic obstructive pulmonary disease and bronchial asthma. Tulobuterol hydrochloride is also a sympathomimetic agent used as a transdermal patch, increases normal diaphragm muscle strength. Tulobuterol hydrochloride inhibit rhinovirus replication and modulate airway inflammation.	False	CC(C)(C)NCC(O)c1ccccc1Cl
280532	280532:01:03_30.00	True	30.0	107	25.2	0.0	0.0	50.1	0.0	53.1	32.6	58.2	16.5	32.6	0.0	52.4	18.6	LCH	58.2	Eliprodil	Eliprodil(SL-820715) is a non-competitive NR2B-NMDA receptor antagonist(IC50=1 uM), less potent for NR2A- and NR2C-containing receptors(IC50> 100 uM).IC50 value:Target: NR2B-NMDA antagonistHuman N-type Ca2+ channel currents were inhibited by ifenprodil and eliprodil with IC50 values of 50 microM and 10 microM respectively whereas P-type Ca2+ channel currents were inhibited reversibly by ifenprodil and eliprodil with approximate IC50 values of 60 microM and 9 microM respectively. eliprodil (1 microm) produced a moderate reverse rate-dependent prolongation of the action potential duration (7.4+/-1.5, 8.9+/-2.1 and 9.9+/-1.8% at cycle lengths of 300, 1000 and 5000 ms, respectively; n=9).	False	OC(CN1CCC(Cc2ccc(F)cc2)CC1)c1ccc(Cl)cc1
280531	280531:01:03_30.00	True	30.0	85	9.0	38.2	0.0	0.0	50.3	0.0	36.1	17.8	0.0	0.0	56.6	0.0	0.0	Pyrimidine_Synth	56.6	Etazolate hydrochloride	phosphodiesterase inhibitor.	False	CCOC(=O)c1cnc2c(cnn2CC)c1NN=C(C)C
280104	280104:01:03_30.00	True	30.0	93	72.9	0.0	0.0	75.2	0.0	75.4	23.5	91.3	30.8	44.2	0.0	72.9	53.6	LCH	91.3	N-Desmethylclozapine	N-Desmethylclozapine is a major active metabolite of the atypical antipsychotic drug Clozapine. N-Desmethylclozapine is a potent, allosteric and partial M1 receptors agonist (EC50=115 nM) and is able to potentiate hippocampal N-methyl-d-aspartate (NMDA) receptor currents through M1 receptor activation. N-Desmethylclozapine is also a .d.-opioid agonist.	False	Clc1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2
280348	280348:01:03_30.00	True	30.0	97	5.2	0.0	0.0	62.6	0.0	53.4	49.2	52.5	22.0	65.8	0.0	72.7	59.8	Tubulin	72.7	8-Bromo-cAMP sodium	membrane-permeable analog of cAMP.	False	Nc1ncnc2c1nc(Br)n2C1OC2COP(=O)(O)O[C@@H]2C1O
108102	108102:02:03_30.00	True	30.0	106	46.3	0.0	0.0	63.6	0.0	63.9	32.5	75.7	21.8	43.3	0.0	65.8	48.4	LCH	75.7	Trequinsin hydrochloride HL 725	phosphodiesterase III (PDE III) inhibitor.	False	COc1cc2c(cc1OC)-c1c/c(=N\c3c(C)cc(C)cc3C)n(C)c(=O)n1CC2
280090	280090:01:03_30.00	True	30.0	102	67.4	0.0	0.0	73.9	0.0	76.6	29.7	84.1	29.7	56.0	0.0	70.7	48.4	LCH	84.1	Biperiden (Hydrochloride)	Biperiden Hydrochloride (KL 373 Hydrochloride) is an antiparkinsonian agent, which is the selective central M1 cholinoreceptors blocker.Target: M1 receptorsBiperiden is an antiparkinsonian agent of the anticholinergic type. It is used for the adjunctive treatment of all forms of Parkinson's disease (postencephalitic, idiopathic, and arteriosclerotic). Biperiden has an atropine-like blocking effect on all peripheral structures which are parasympathetic-innervate. It also has a prominent central blocking effect on M1 receptors .Biperiden (0.11 mg/kg), benactyzine (0.3 mg/kg),caramiphen (10 mg/kg), procyclidine (3 mg/kg), and trihexyphenidyl (0.12 mg/kg) separately and each in combination with physostigmine (0.1 mg/kg) is  to make a comparative assessment of potential cognitive effects. The results showed that benactyzine, caramiphen, and trihexyphenidyl reduced rats' innate preference for novelty, whereas biperiden and procyclidine did not .Clinical indications: parkinsonismFDA Approved Date:  Toxicity: Drowsiness; vertigo; headache; dizziness	False	OC(CCN1CCCCC1)(c1ccccc1)C1CC2C=CC1C2
280091	280091:01:03_30.00	True	30.0	88	37.8	0.0	0.0	32.7	0.0	33.7	37.7	53.7	9.9	19.2	0.0	45.5	7.1	LCH	53.7	DAPH, CGP 52411	protein tyrosine kinase inhibitor, specific for EGFR, Also inhibits amyloid beta fibril formation.	False	O=C1NC(=O)c2cc(Nc3ccccc3)c(Nc3ccccc3)cc21
280576	280576:01:03_30.00	True	30.0	94	49.1	0.0	0.0	69.6	0.0	71.0	22.3	84.9	31.4	40.5	0.0	66.6	33.2	LCH	84.9	GR 113808	5-HT4 serotonin receptor antagonist.	False	Cn1cc(C(=O)OCC2CCN(CCNS(C)(=O)=O)CC2)c2ccccc21
280353	280353:01:03_30.00	True	30.0	81	84.6	0.0	0.0	74.2	0.0	76.1	25.2	87.6	32.5	49.9	0.0	72.6	42.4	LCH	87.6	BP 897	partially selective D3 dopamine receptor agonist.	False	COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1
281001	281001:01:03_30.00	True	30.0	103	7.4	0.0	0.0	40.5	0.0	46.2	26.4	48.5	24.4	13.2	0.0	45.0	0.0	LCH	48.5	F3	nicotinic acetylcholine receptor antagonist.	False	CC(COc1ccc(/C=C/c2ccccc2)cc1)[N+](C)(C)C
280901	280901:01:04_30.00	True	30.0	105	61.7	0.0	0.0	78.5	0.0	75.9	23.5	86.1	37.7	60.9	0.0	76.9	55.4	LCH	86.1	1-(1-Naphthyl)piperazine hydrochloride	5-HT2 serotonin receptor antagonist.	False	c1ccc2c(N3CCNCC3)cccc2c1
247251	247251:02:03_30.00	True	30.0	91	73.6	0.0	0.0	79.0	0.0	77.1	16.6	94.3	34.6	52.1	0.0	73.6	50.7	LCH	94.3	Imipramine hydrochloride	tricyclic antidepressant, blocks reuptake of serotonin and norepinephrine, 5-HT transport inhibitor.	False	CN(C)CCCN1c2ccccc2CCc2ccccc21
280525	280525:01:03_30.00	True	30.0	86	82.6	0.0	0.0	74.6	0.0	74.0	24.1	85.6	34.3	62.1	0.0	75.1	52.9	LCH	85.6	FLB 131	potent and selective D2 dopamine receptor antagonist.	False	CCc1cc(Cl)c(OC)c(C(=O)NC[C@@H]2CCN(CC)C2)c1O
280449	280449:01:03_30.00	True	30.0	80	42.8	24.9	20.1	0.0	56.1	0.0	0.0	0.0	0.0	0.0	69.1	0.0	0.0	Pyrimidine_Synth	69.1	R(-)-2,10,11-Trihydroxyaporphine hybrobromide	D2 dopamine receptor agonist.	False	CN1CCc2cc(O)cc3c2[C@H]1Cc1ccc(O)c(O)c1-3
280409	280409:01:03_30.00	True	30.0	97	5.4	38.4	0.0	15.5	46.5	3.8	0.0	29.8	2.0	9.4	3.1	25.1	48.9	Uncoupler	48.9	9-cyclopentyladenine, 9-CP-Ade	cell-permeable, non-competitive adenylyl cyclase inhibitor, targets the P-site domain.	False	Nc1ncnc2c1ncn2C1CCCC1
281047	281047:01:03_30.00	True	30.0	93	21.9	0.0	2.6	10.1	0.0	4.1	37.2	27.1	0.0	14.4	0.0	20.8	0.0	HSP90	37.2	YS-035 hydrochloride	L-type Ca2+ channel blocker, verapamil derivative.	False	COc1ccc(CCN(C)CCc2ccc(OC)c(OC)c2)cc1OC
247391	247391:02:03_30.00	True	30.0	99	77.4	0.0	0.0	80.3	0.0	78.3	9.5	94.2	38.3	48.8	0.0	75.6	49.7	LCH	94.2	Protriptyline (hydrochloride)	Protriptyline hydrochloride is a tricyclic antidepressant (TCA), specifically a secondary amine, for the treatment of depression and ADHD. Unique among the TCAs, protriptyline tends to be energizing instead of sedating, used for narcolepsy to achieve a wakefulness-promoting effect.	False	CNCCCC1c2ccccc2C=Cc2ccccc21
280949	280949:01:03_30.00	True	30.0	91	28.7	33.2	0.0	29.0	6.3	30.8	42.9	73.3	0.0	3.4	0.0	38.7	31.0	LCH	73.3	SB 202190	highly selective, potent and cell permeable p38 MAP kinase inhibitor.	False	Oc1ccc(-c2nc(-c3ccncc3)c(-c3ccc(F)cc3)[nH]2)cc1
280382	280382:01:03_30.00	True	30.0	98	14.5	0.0	0.0	17.7	2.9	7.1	42.2	38.9	0.0	14.5	0.0	38.7	7.2	HSP90	42.2	PK 11195	PK 11195 (RP 52028) is a ligand of translocator protein (TSPO), which targets Leishmania chemotherapy, with IC50s of 14.2 uM, 8.2 uM, 3.5 uM for L. amazonensis, L. major and L. braziliensis, respectively.	False	CCC(C)N(C)C(=O)c1cc2ccccc2c(-c2ccccc2Cl)n1
280349	280349:01:03_30.00	True	30.0	97	63.2	0.0	0.0	69.5	0.0	72.9	22.7	87.9	30.7	42.8	0.0	67.0	42.8	LCH	87.9	Benztropine mesylate	muscarinic acetylcholine receptor antagonist.	False	CN1C2CCC1CC(OC(c1ccccc1)c1ccccc1)C2
247049	247049:02:03_30.00	True	30.0	104	6.0	0.0	0.0	53.5	0.0	48.2	29.7	64.5	3.2	26.5	0.0	50.8	28.3	LCH	64.5	Glibenclamide	Glibenclamide is a selective inhibitor of ATP-sensitive K+ channel.	False	COc1ccc(Cl)cc1C(=O)NCCc1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1
247067	247067:02:03_30.00	True	30.0	95	57.0	0.0	0.0	61.0	0.0	68.5	35.8	83.9	26.1	34.6	0.0	64.1	33.5	LCH	83.9	Domperidone	peripheral dopamine receptor antagonist that does not cross the blood-brain barrier, anti-emetic, Dopamine Antagonists, antiemetic.	False	O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1
246835	246835:02:03_30.00	True	30.0	93	20.0	0.0	15.4	24.2	0.0	28.6	30.3	46.2	0.0	15.7	0.0	37.0	0.0	LCH	46.2	Buspirone (hydrochloride)	5-HT1A Serotonin receptor agonist, non-benzodiazepine anxiolytic, serotonin receptor agonist, 5ht1a receptor agonist.	False	O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1
280309	280309:01:03_30.00	True	30.0	95	34.5	0.0	0.0	45.1	0.0	51.8	37.3	71.0	8.3	24.0	0.0	52.4	21.4	LCH	71.0	Benoxathian hydrochloride	selective alpha1 adrenoceptor antagonist.	False	COc1cccc(OC)c1OCCNCC1CSc2ccccc2O1
280092	280092:01:03_30.00	True	30.0	50	24.2	17.3	42.3	0.0	75.1	0.0	5.5	0.0	0.0	0.0	49.8	0.0	0.0	DNA_Synth	75.1	Supercinnamaldehyde	transient receptor potential ankyrin 1 (TRPA1) receptor activator, covalently modifies cysteines to acitvate channel.	False	CC(=O)/C=C1\C(=O)N(C)c2ccccc21
280847	280847:01:03_30.00	True	30.0	89	68.4	0.0	0.0	77.5	0.0	80.2	31.5	82.5	38.7	58.9	0.0	74.6	46.8	LCH	82.5	PDMP hydrochloride	glucosylceramide synthase inhibitor, blocks formation of glucosylceramide from ceramide.	False	CCCCCCCCCC(=O)NC(CN1CCOCC1)[C@H](O)c1ccccc1
280355	280355:01:03_30.00	True	30.0	100	19.3	0.0	0.0	26.4	0.0	26.9	42.1	37.0	1.7	10.3	0.0	35.8	0.0	HSP90	42.1	BRL 15572	potent and selective 5-HT1D serotonin receptor antagonist.	False	OC(CN1CCN(c2cccc(Cl)c2)CC1)C(c1ccccc1)c1ccccc1
247094	247094:02:03_30.00	True	30.0	102	20.7	0.0	0.0	46.4	0.0	51.7	32.6	59.1	10.9	30.1	0.0	50.3	15.4	LCH	59.1	Betaxolol hydrochloride	selective beta1 adrenoceptor antagonist, Beta adrenergic antagonist.	False	CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1
247018	247018:02:03_30.00	True	30.0	93	33.9	0.0	0.0	55.2	0.0	52.2	36.3	67.8	3.8	48.9	0.0	66.9	38.1	LCH	67.8	Fenofibrate	Fenofibrate is a selective PPAR.a. agonist with an EC50 of 30 uM. Fenofibrate also inhibits human cytochrome P450 isoforms, with IC50s of 0.2, 0.7, 9.7, 4.8 and 142.1 uM for CYP2C19, CYP2B6, CYP2C9, CYP2C8, and CYP3A4, respectively.	False	CC(C)OC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1
280447	280447:01:03_30.00	True	30.0	93	33.7	0.0	0.0	53.0	0.0	54.7	37.9	74.1	5.6	41.9	0.0	58.3	30.9	LCH	74.1	R(-)-Apocodeine hydrochloride	dopamine receptor agonist, apomorphine metabolite.	False	COc1ccc2c(c1O)-c1cccc3c1[C@@H](C2)N(C)CC3
247307	247307:02:03_30.00	True	30.0	75	84.6	0.0	0.0	77.8	0.0	75.6	18.9	89.5	33.7	50.0	0.0	76.1	50.8	LCH	89.5	Trimipramine (maleate)	Trimipramine maleate is a 5-HT receptor antagonist, with pKis of 6.39, 8.10, 4.66 for 5-HT1C, 5-HT2 and 5-HT1A, respectively.	False	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21
280544	280544:01:03_30.00	True	30.0	88	37.8	0.0	0.0	79.1	0.0	72.4	25.1	65.6	53.6	53.4	0.0	92.2	62.9	Tubulin	92.2	beta-Estradiol, Dihydrofolliculin	major estrogen sectreted by premenopausal ovary.	False	C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O
280564	280564:01:03_30.00	True	30.0	107	44.9	0.0	0.0	79.1	0.0	73.0	17.3	75.8	32.4	63.1	0.0	80.6	56.5	Tubulin	80.6	Formoterol	beta2-Adrenoceptor agonist.	False	C[C@@H](Cc1ccc(C=O)cc1)NC[C@@H](O)c1ccc(O)c(NCO)c1
280581	280581:01:03_30.00	True	30.0	77	83.8	0.0	0.0	85.2	0.0	85.2	29.0	81.2	47.0	66.2	0.0	80.4	68.6	BET	85.2	GBR 12935 (dihydrochloride)	GBR 12935 dihydrochloride is a potent, and selective dopamine reuptake inhibitor.IC50 value: Target: dopamine reuptake inhibitorin vitro: The calculated Kd of [3H]GBR-12935 binding to CYP2D6 was 42.2 nM, indicating that GBR-12935 has a high affinity for CYP2D6. The binding of [3H]GBR-12935 to CYP2D6 was decreased partially by substrates or inhibitors of CYP2D isoforms (quinine, quinidine, propranolol, bufuralol, imipramine, and desipramine) . Co-perfusion of 100 microM GBR 12909 or GBR 12935 with either 100 microM sulpiride or raclopride produced a significant reduction in the GBR 12909 or GBR 12935 induced increase in the extracellular levels of dopamine to basal levels. In vitro, GBR 12909 (1-9 nM) dose-dependently inhibited active uptake of [3H]dopamine in homogenates of the nucleus accumbens .in vivo: GBR 12935 elevated locomotion to a greater extent in C57BL/6J mice at the maximally active dose of 10 mg/kg. Locomotor stimulation by GBR 12935 remained consistent in both strains with repeated injections. DBA/2J mice became sensitized to cocaine-induced stereotypy with repeated injections. Cocaine induced no stereotypy in C57BL/6J mice on any test day. No stereotypies were induced by GBR 12935 in either strain on any test day .	False	c1ccc(CCCN2CCN(CCOC(c3ccccc3)c3ccccc3)CC2)cc1
280993	280993:01:03_30.00	True	30.0	87	15.7	39.1	16.7	0.0	86.7	0.0	12.1	4.3	0.0	0.0	58.5	0.0	0.0	DNA_Synth	86.7	Tyrphostin AG 808	protein tyrosine kinase inhibitor.	False	N#C/C(=C\c1c[nH]c2ccccc12)C(=O)c1ccc(O)c(O)c1
280859	280859:01:03_30.00	True	30.0	94	8.1	27.3	0.0	22.9	12.9	21.5	45.4	57.9	0.0	1.6	0.0	38.4	24.0	LCH	57.9	6(5H)-Phenanthridinone	poly(ADP-ribose) Polymerase (PARP) inhibitor.	False	Oc1nc2ccccc2c2ccccc12
280987	280987:01:03_30.00	True	30.0	64	40.4	38.8	45.9	0.0	85.5	0.0	7.1	0.0	0.0	0.0	81.8	0.0	0.0	DNA_Synth	85.5	N-p-Tosyl-L-phenylalanine chloromethyl ketone, TPCK	blocks LPS- or cytokine-induced activation of nuclear factor kB (NFkB), which, blocks the induction of iNOS and COX-2 transcription, blocks activation of pp70s6k by all mitogens.	False	Cc1ccc(S(=O)(=O)N[C@@H](Cc2ccccc2)C(=O)CCl)cc1
280984	280984:01:03_30.00	True	30.0	90	10.4	60.4	8.5	0.0	83.8	0.0	16.6	0.0	0.0	0.0	69.7	0.0	0.0	DNA_Synth	83.8	AG-490	AG-490 is a tyrosine kinase inhibitor that inhibits EGFR, Stat-3 and JAK2/3.	False	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1
280164	280164:01:03_30.00	True	30.0	63	76.9	0.0	0.0	85.7	0.0	86.4	32.3	69.8	60.3	68.8	0.0	89.0	63.5	Tubulin	89.0	K114	A fluorescent, amyloid-specific dye, an analogue of Congo Red and BSB that recognizes amyloid lesions and allows the quantitative monitoring of the formation of amyloid fibrils assembled from the Aß peptide, a-synuclein, and tau.	False	Oc1ccc(/C=C/c2ccc(/C=C/c3ccc(O)cc3)c(Br)c2)cc1
247104	247104:02:03_30.00	True	30.0	93	21.1	0.0	0.0	59.4	0.0	50.4	22.2	63.2	19.1	61.3	0.0	69.7	54.2	Tubulin	69.7	Terbutaline hemisulfate	beta-Adrenoceptor agonist, bronchodilator, Beta-2 adrenergic agonist.	False	CC(C)(C)NCC(O)c1cc(O)cc(O)c1
246722	246722:02:03_30.00	True	30.0	99	17.4	0.0	0.0	41.1	0.0	38.7	58.0	43.6	17.8	39.1	0.0	61.4	28.1	Tubulin	61.4	Felodipine, Plendil	L-type calcium channel blocker, L-type Ca2+ channels blocker.	False	CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl
280400	280400:01:03_30.00	True	30.0	92	29.2	0.0	0.0	38.9	0.0	50.0	45.9	62.1	8.6	27.1	0.0	44.5	17.9	LCH	62.1	Cyproterone acetate	androgen antagonist, synthetic steroid.	False	CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C
280546	280546:01:03_30.00	True	30.0	102	7.8	0.0	0.0	80.3	0.0	68.3	2.3	68.4	41.8	61.0	0.0	78.0	57.7	BET	80.3	Furafylline	cytochrome P4501A2 inhibitor.	False	Cc1nc2c([nH]1)c(=O)n(C)c(=O)n2Cc1ccco1
280672	280672:01:03_30.00	True	30.0	91	79.6	0.0	0.0	64.7	0.0	68.7	30.6	84.9	25.0	45.9	0.0	67.9	45.1	LCH	84.9	L-765,314	potent, selective alpha-1B adrenoceptor antagonist.	False	COc1cc2nc(N3CCN(C(=O)OCc4ccccc4)C(C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC
280648	280648:01:03_30.00	True	30.0	107	8.1	0.1	0.0	57.6	0.0	47.9	20.8	66.3	14.0	41.9	0.0	59.2	44.0	LCH	66.3	S(+)-Isoproterenol (+)-bitartrate	sympathomimetic amine acting almost exclusively on beta adrenoceptors, bronchodilator, less active enantiomer of Isoproterenol.	False	CC(C)NC[C@@H](O)c1ccc(O)c(O)c1
105397	105397:02:03_30.00	True	30.0	80	60.8	9.6	0.0	52.8	0.0	50.4	57.9	40.1	25.8	63.4	0.0	61.9	70.7	Uncoupler	70.7	AG-1478	AG-1478 (Tyrphostin AG-1478) is a selective EGFR tyrosine kinase inhibitor with IC50 of 3 nM. AG-1478 has antiviral effects against HCV and encephalomyocarditis virus (EMCV).	False	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC
280331	280331:01:03_30.00	True	30.0	91	28.2	0.6	0.0	43.8	0.0	38.9	45.6	53.0	19.3	27.3	0.0	49.8	31.6	LCH	53.0	(+)-Bromocriptine methanesulfonate	D2 dopamine receptor agonist, inhibits prolaction secretion.	False	CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12
247222	247222:02:03_30.00	True	30.0	99	12.3	44.1	0.0	14.9	0.0	5.5	34.6	28.5	0.0	18.2	0.0	20.1	38.0	AKT_PI3K_MTOR	44.1	Benzamil hydrochloride	selective and potent blocker of Na+/H+ and Na+/Ca2+ channels, Na+ channel blocker.	False	N/C(=N\C(=O)c1nc(Cl)c(N)nc1N)NCc1ccccc1
259672	259672:02:03_30.00	True	30.0	87	14.5	0.0	0.0	79.4	0.0	80.9	14.9	87.6	49.1	42.7	0.0	69.5	47.7	LCH	87.6	Estrone, Folliculin	luteolytic estrogen produced by the corpus luteum.	False	C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CCC2=O
246969	246969:02:03_30.00	True	30.0	89	20.9	0.0	3.5	27.2	1.6	22.6	22.2	18.7	13.5	57.2	0.0	40.3	35.5	Protein_Synth	57.2	Fenspiride hydrochloride	alpha-Adrenoceptor antagonist, NSAID, Bradykinin antagonist, antiinflammatory, bronchodilator.	False	O=C1NCC2(CCN(CCc3ccccc3)CC2)O1
280995	280995:01:03_30.00	True	30.0	85	10.0	54.3	15.9	0.0	87.3	0.0	17.9	0.0	0.0	0.0	72.0	0.0	0.0	DNA_Synth	87.3	Tyrphostin AG 835, Tyrphostin B50	protein tyrosine kinase inhibitor.	False	C[C@H](NC(=O)/C(C#N)=C/c1ccc(O)c(O)c1)c1ccccc1
280850	280850:01:03_30.00	True	30.0	84	84.6	0.0	0.0	78.4	0.0	77.4	22.9	88.3	37.9	51.2	0.0	77.2	54.6	LCH	88.3	Propionylpromazine hydrochloride	D2 dopamine receptor antagonist, phenothiazine antipsychotic.	False	CCC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2
280339	280339:01:03_30.00	True	30.0	86	19.3	0.0	0.0	51.3	0.0	45.8	37.1	70.1	19.5	38.0	0.0	75.1	49.5	Tubulin	75.1	BWB70C	selective inhibitor of 5-lipoxygenase.	False	CC(/C=C/c1cccc(Oc2ccc(F)cc2)c1)N(O)C(N)=O
280562	280562:01:03_30.00	True	30.0	95	24.4	4.3	0.0	7.1	15.7	0.0	33.3	26.8	0.0	2.2	13.0	24.3	0.0	HSP90	33.3	Flupirtine (Maleate)	Flupirtine Maleate is an indirect N-methyl-D-aspartate receptor (NMDAR) antagonist. It is a brain penetrant, and orally bioavailable, non-opioid and centrally acting analgesic agent.	False	CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)nc1N
247148	247148:02:03_30.00	True	30.0	97	58.7	0.0	0.0	79.2	0.0	78.8	24.0	83.2	36.0	54.7	0.0	72.9	44.5	LCH	83.2	Dicyclomine hydrochloride	competitive muscarinic acetylcholine receptor antagonist, Anticholinergic.	False	CCN(CC)CCOC(=O)C1(C2CCCCC2)CCCCC1
247024	247024:02:03_30.00	True	30.0	113	6.4	1.9	0.0	54.8	0.0	47.8	16.7	67.5	13.5	34.2	0.0	52.8	36.0	LCH	67.5	Fenoterol (hydrobromide)	Fenoterol hydrobromide (Th-1165a), a sympathomimetic agent, is a selective and orally active .b.2-adrenoceptor agonist. Fenoterol hydrobromide is an effective bronchodilator and can be used for bronchospasm associated with asthma, bronchitis and other obstructive airway diseases research.	False	CC(Cc1ccc(O)cc1)NCC(O)c1cc(O)cc(O)c1
280114	280114:01:03_30.00	True	30.0	53	63.6	0.0	5.6	21.6	8.0	21.7	34.5	38.8	13.3	33.2	0.0	35.6	10.4	LCH	38.8	Phenserine	selective, non-competitive acetylcholinesterase (AChE) inhibitor.	False	CN1CC[C@@]2(C)c3cc(OC(=O)Nc4ccccc4)ccc3N(C)[C@@H]12
280646	280646:01:03_30.00	True	30.0	97	12.3	38.8	0.0	32.8	17.0	24.4	31.3	65.0	0.0	27.1	0.0	43.6	43.4	LCH	65.0	H-7	potent Inhibitor of cyclic nucleotide dependent protein kinase (PKA) and protein kinase C (PKC).	False	CC1CNCCN1S(=O)(=O)c1cccc2cnccc12
280407	280407:01:03_30.00	True	30.0	96	53.7	0.0	0.0	68.1	0.0	69.4	25.8	92.6	24.8	38.4	0.0	66.6	46.5	LCH	92.6	CNS-1102, Cerestat, Aptiganel hydrochloride	noncompetitive NMDA glutamate receptor antagonist.	False	CCc1cccc(N(C)C(=N)Nc2cccc3ccccc23)c1
280519	280519:01:03_30.00	True	30.0	95	37.1	0.0	0.0	73.8	0.0	68.2	34.3	75.2	27.4	54.7	0.0	76.8	53.9	Tubulin	76.8	DCEBIO	increases epithelial chloride secretion through the synergistic activation of a basolateral membrane-located K+ channel (hlK1) and an apical membrane Cl- conductance.	False	CCn1c(=O)[nH]c2cc(Cl)c(Cl)cc21
246998	246998:02:04_30.00	True	30.0	105	81.3	0.0	0.0	37.4	10.8	31.2	29.2	37.0	5.5	62.5	0.0	52.4	48.3	Protein_Synth	62.5	Alprenolol (hydrochloride)	Alprenolol (hydrochloride) is a non-selective beta blocker as well as 5-HT1A receptor antagonist.The reference for administration is 10 mg/kg.	False	C=CCc1ccccc1OCC(O)CNC(C)C
280455	280455:01:03_30.00	True	30.0	96	39.9	0.0	0.0	64.5	0.0	58.8	30.0	73.4	17.0	56.2	0.0	68.0	48.0	LCH	73.4	(±)-DOI hydrochloride	potent and selective 5-HT2 serotonin receptor agonist that crosses the blood brain barrier.	False	COc1cc(CC(C)N)c(OC)cc1I
280341	280341:01:03_30.00	True	30.0	98	6.6	0.0	0.6	34.3	0.0	37.1	31.4	36.4	6.7	27.5	0.0	37.3	0.0	Tubulin	37.3	(+)-Brompheniramine maleate, Dexbrompheniramine maleate	H1 Histamine receptor antagonist.	False	CN(C)CC[C@@H](c1ccc(Br)cc1)c1ccccn1
280347	280347:01:03_30.00	True	30.0	104	34.5	0.0	0.0	58.1	0.0	54.8	48.8	58.5	25.1	38.3	0.0	63.5	41.6	Tubulin	63.5	Budesonide	anti-inflammatory glucocorticoid.	False	CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1
280107	280107:01:03_30.00	True	30.0	83	30.4	45.2	0.0	0.0	29.2	0.0	57.2	13.2	0.0	15.0	36.5	18.0	13.9	HSP90	57.2	UCL 2077	slow afterhyperpolarization (sAHP) channel blocker.	False	c1ccc(C(NCc2cccnc2)(c2ccccc2)c2ccccc2)cc1
280510	280510:01:03_30.00	True	30.0	75	37.0	21.0	26.2	0.0	85.5	0.0	25.8	1.5	0.0	0.0	58.0	0.0	0.0	DNA_Synth	85.5	Dephostatin	CD45 protein tyrosine kinase inhibitor.	False	CN(N=O)c1cc(O)ccc1O
280448	280448:01:03_30.00	True	30.0	97	7.6	69.1	0.0	0.0	77.0	0.0	38.6	0.0	0.0	0.0	69.9	0.0	0.0	DNA_Synth	77.0	R(-)-Propylnorapomorphine hydrochloride, R(-)-NPA hydrochloride	highly potent and selective D2 dopamine receptor agonist.	False	CCCN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3
247425	247425:02:03_30.00	True	30.0	94	60.3	0.0	0.0	65.0	0.0	66.7	32.9	81.0	20.1	52.6	0.0	67.7	48.4	LCH	81.0	Fluvoxamine (maleate)	Fluvoxamine maleate (DU-23000 maleate) is an antidepressant which functions pharmacologically as a selective serotonin reuptake inhibitor.	False	COCCCC/C(=N\OCCN)c1ccc(C(F)(F)F)cc1
280450	280450:01:03_30.00	True	30.0	80	24.5	9.2	18.8	0.0	55.8	0.0	0.0	16.6	0.0	0.0	40.7	0.0	0.0	DNA_Synth	55.8	R(-)-TNPA HBr, R(-)-2-OH-NPA hydrobromide	potent and selective D2 dopamine receptor agonist.	False	CCCN1CCc2cc(O)cc3c2[C@H]1Cc1ccc(O)c(O)c1-3
280856	280856:01:03_30.00	True	30.0	91	19.9	10.9	14.0	0.0	59.6	0.0	27.5	13.2	0.0	0.1	42.6	6.9	0.0	DNA_Synth	59.6	Ammonium pyrrolidinedithiocarbamate, APDC	prevents induction of nitric oxide synthase (NOS) by inhibiting translation of NOS mRNA.	False	S=C(S)N1CCCC1
280554	280554:01:03_30.00	True	30.0	93	27.5	0.0	3.2	24.7	0.8	19.3	31.7	13.3	2.7	52.8	0.0	38.1	37.2	Protein_Synth	52.8	p-Fluoro-L-phenylalanine, 4-Fluoro-L-phenylalanine	substrate for tyrosine hydroxylase, arrests cells at G2.	False	N[C@@H](Cc1ccc(F)cc1)C(=O)O
280889	280889:01:04_30.00	True	30.0	102	6.6	0.0	0.0	75.0	0.0	67.0	4.8	70.2	33.5	52.1	0.0	64.3	49.6	BET	75.0	Ritodrine hydrochloride	beta2-Adrenoceptor agonist, relaxes uterine muscle contractions.	False	C[C@@H](NCCc1ccc(O)cc1)[C@@H](O)c1ccc(O)cc1
247238	247238:02:03_30.00	True	30.0	104	50.6	0.0	0.0	69.2	0.0	73.6	33.1	75.3	25.4	49.5	0.0	63.7	39.7	LCH	75.3	Trihexyphenidyl (hydrochloride)	Trihexyphenidyl hydrochloride is an antiparkinsonian agent of the antimuscarinic class, binds to the M1 muscarinic receptor.	False	OC(CCN1CCCCC1)(c1ccccc1)C1CCCCC1
280509	280509:01:03_30.00	True	30.0	108	68.9	0.0	0.0	75.5	0.0	75.3	17.8	91.6	32.3	46.1	0.0	70.8	46.4	LCH	91.6	(±) trans-U-50488 methanesulfonate	selective kappa opioid receptor agonist.	False	CN(C(=O)Cc1ccc(Cl)c(Cl)c1)[C@H]1CCCC[C@@H]1N1CCCC1
280863	280863:01:04_30.00	True	30.0	102	28.3	15.1	0.0	22.1	27.1	18.6	27.8	62.1	0.0	1.9	0.0	38.1	11.1	LCH	62.1	PD 169316	PD 169316 is a potent, cell-permeable and selective p38 MAP kinase inhibitor, with IC50 of 89 nM. PD169316 selectively inhibits the kinase activity of the phosphorylated p38 without hindering upstream kinases to phosphorylate p38. PD169316 shows antiviral activity against Enterovirus71. PD169316 shows antiviral activity against Enterovirus71.	False	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1
246866	246866:02:03_30.00	True	30.0	87	49.4	0.0	0.0	53.8	0.0	63.9	60.2	51.3	26.8	46.8	0.0	55.0	48.4	HDAC	63.9	Cilnidipine	slow-acting Ca2+ channel blocker, antihypertensive, vasodilator. Does not inhibit PKC.	False	COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC/C=C/c2ccccc2)C1c1cccc([N+](=O)[O-])c1
280209	280209:01:03_30.00	True	30.0	106	5.5	0.0	0.0	72.8	0.0	73.1	6.1	58.0	44.1	49.7	0.0	65.4	37.4	HDAC	73.1	S(-)-p-Bromotetramisole oxalate, R 30402 oxalate	potent alkaline phosphatase inhibitor.	False	Brc1ccc([C@H]2CN3CCSC3=N2)cc1
280547	280547:01:03_30.00	True	30.0	100	21.2	0.0	0.0	34.0	0.0	32.1	41.9	47.7	3.6	17.0	0.0	52.9	15.1	Tubulin	52.9	FPL 64176	potent L-type Ca2+ channel activator.	False	COC(=O)c1c(C)[nH]c(C)c1C(=O)c1ccccc1Cc1ccccc1
280340	280340:01:03_30.00	True	30.0	103	15.7	65.4	0.0	0.0	85.1	0.0	3.5	0.0	0.0	0.0	62.9	0.0	6.2	DNA_Synth	85.1	5-Bromo-2'-deoxyuridine, Br-dU	thymidine analog, incorporated into DNA during S-phase of cell cycle.	False	O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1Br
280645	280645:01:03_30.00	True	30.0	89	6.9	0.0	0.0	64.8	0.0	58.2	26.5	67.2	19.7	62.9	0.0	68.2	58.8	Tubulin	68.2	(-)-Isoproterenol hydrochloride, (-)-Isoprenaline hydrochloride	beta-Adrenoceptor agonist, increases cytosolic cAMP.	False	CC(C)NC[C@H](O)c1ccc(O)c(O)c1
280986	280986:01:03_30.00	True	30.0	86	13.1	59.2	0.0	0.0	75.7	0.0	23.4	0.3	0.0	0.0	49.0	6.8	27.0	DNA_Synth	75.7	AG-494	AG-494 (Tyrphostin AG 494) is a potent and selective EGFR tyrosine kinase inhibitor (IC50=0.7 uM). AG-494 inhibits the autophosphorylation of EGFR, ErbB2, HER1-2 and PDGF-R with IC50s 1.1, 39, 45 and 6 uM, respectively. AG-494 blocks Cdk2 activation and inhibits EGF-dependent DNA synthesis.	False	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)Nc1ccccc1
247321	247321:02:03_30.00	True	30.0	92	6.4	0.0	1.5	25.1	4.1	19.1	20.1	27.4	19.0	43.0	0.0	43.4	28.6	Tubulin	43.4	Propantheline bromide	muscarinic acetylcholine receptor antagonist, antispasmodic, Muscarinic antagonist, anticholinergic.	False	CC(C)[N+](C)(CCOC(=O)C1c2ccccc2Oc2ccccc21)C(C)C
280466	280466:01:04_30.00	True	30.0	102	72.2	0.0	0.0	72.8	0.0	74.3	24.2	89.5	30.7	42.5	0.0	69.0	41.0	LCH	89.5	Dihydroergocristine methanesulfonate	ergot alkaloid, vasoconstrictor, partial agonist at dopaminergic receptors and adrenoceptors, antagonist at serotonergic receptors.	False	CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O
280319	280319:01:03_30.00	True	30.0	109	12.6	0.0	0.0	49.1	0.0	44.1	19.3	66.5	11.6	34.7	0.0	51.1	27.4	LCH	66.5	BRL 37344 sodium	selective beta3 adrenoceptor agonist.	False	CC(Cc1ccc(OCC(=O)O)cc1)NCC(O)c1cccc(Cl)c1
280545	280545:01:03_30.00	True	30.0	90	84.3	0.0	0.0	75.6	0.0	75.6	25.0	87.5	34.2	51.0	0.0	73.9	48.4	LCH	87.5	cis-(Z)-Flupenthixol dihydrochloride	dopamine receptor antagonist, antipsychotic.	False	OCCN1CCN(CC/C=C2/c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1
247033	247033:02:03_30.00	True	30.0	99	50.6	0.0	0.0	70.2	0.0	72.7	17.5	89.9	30.5	40.8	0.0	68.8	38.0	LCH	89.9	Trazodone (hydrochloride)	Trazodone (hydrochloride) (AF-1161) is an antidepressant belonging to the class of serotonin receptor antagonists and reuptake inhibitors for treatment of anxiety disorders.	False	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12
280951	280951:01:04_30.00	True	30.0	94	38.9	0.0	0.0	79.2	0.0	74.4	33.5	78.6	44.4	61.6	0.0	85.0	61.2	Tubulin	85.0	Spiperone hydrochloride, R 5147 hydrochloride, Spiroperidol hydrochloride	selective D2 dopamine receptor antagonist.	False	O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccc(F)cc1
280177	280177:01:03_30.00	True	30.0	106	79.4	0.0	0.0	79.2	0.0	79.8	22.7	90.4	34.2	52.8	0.0	74.1	52.6	LCH	90.4	Aprindine hydrochloride, Amidonal	class Ib antiarrhythmic and hERG channel blocker.	False	CCN(CC)CCCN(c1ccccc1)C1Cc2ccccc2C1
280115	280115:01:03_30.00	True	30.0	92	19.9	15.1	0.0	22.1	0.8	17.7	32.5	51.3	0.0	0.0	0.0	35.9	12.3	LCH	51.3	JX401	potent, non-cytotoxic, membrane permeable p38a MAPK inhibitor.	False	COc1cc(SC)ccc1C(=O)N1CCC(Cc2ccccc2)CC1
246809	246809:02:03_30.00	True	30.0	84	31.6	45.7	0.0	0.0	63.1	0.0	0.0	0.0	0.0	0.0	73.6	0.0	0.0	Pyrimidine_Synth	73.6	5-Fluorouracil, 5-FU	thymidylate synthetase inhibitor, leads to accumulation of cells in S phase, Thymidylate Synthase inibitor, antineoplastic, pyrimidine antimetabolite.	False	O=c1[nH]cc(F)c(=O)[nH]1
280983	280983:01:03_30.00	True	30.0	104	11.7	1.0	3.6	11.1	23.6	8.9	32.0	21.2	6.0	34.2	0.0	34.7	28.5	Tubulin	34.7	Tetraethylammonium (chloride)	Tetraethylammonium chloride is a non-selective potassium channel blocker. Tetraethylammonium chloride is a good substrate for organic cation transporter (OCTN1). Tetraethylammonium chloride antitumor properties.	False	CC[N+](CC)(CC)CC
280383	280383:01:03_30.00	True	30.0	97	12.3	0.0	0.0	59.5	0.0	52.8	20.3	60.9	31.0	46.6	0.0	65.5	41.3	Tubulin	65.5	CGP-7930	positive allosteric modulator of GABA-B receptors.	False	CC(C)(CO)Cc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1
280101	280101:01:03_30.00	True	30.0	92	7.9	26.7	5.5	0.0	29.7	0.0	42.8	0.0	0.0	0.0	57.6	0.0	0.0	Pyrimidine_Synth	57.6	Mephetyl tetrazole	potent and selective Kv1.5 potassium channel blocker.	False	COc1ccc(CCn2nnnc2C2(c3ccc(C)cc3)CC2)cc1
280985	280985:01:03_30.00	True	30.0	101	9.5	0.0	0.0	44.6	0.0	41.0	25.0	40.5	12.3	50.5	0.0	50.4	39.4	Protein_Synth	50.5	TTNPB	TTNPB is a highly potent RAR agonist. Competitive binding assays using human RARs yield IC50s of .a.=5.1 nM, .b.= 4.5 nM, and .g.=9.3 nM, respectively.	False	C/C(=C\c1ccc(C(=O)O)cc1)c1ccc2c(c1)C(C)(C)CCC2(C)C
247387	247387:02:03_30.00	True	30.0	78	20.7	56.3	19.3	0.0	85.2	0.0	22.9	0.0	0.0	0.0	58.7	0.0	0.0	DNA_Synth	85.2	Idazoxan hydrochloride, RX 781094	I2-imidazoline agonist, I1-imidazoline antagonist, alpha2-Adrenergic antagonist, Alpha2 agonist.	False	c1ccc2c(c1)OCC(C1=NCCN1)O2
280524	280524:01:03_30.00	True	30.0	72	46.6	20.8	13.1	4.2	70.4	0.0	6.1	48.2	0.0	0.0	12.0	23.4	0.0	DNA_Synth	70.4	(-)-Eseroline fumarate	metabolite of physostigmine (eserine), potent analgesic, cholinesterase inhibitor.	True	CN1CC[C@@]2(C)c3cc(O)ccc3N(C)[C@@H]12
246764	246764:02:03_30.00	True	30.0	104	53.2	0.0	0.0	70.7	0.0	73.1	22.8	81.6	30.2	45.6	0.0	65.1	34.2	LCH	81.6	(S)-Propranolol hydrochloride	active beta-adrenoceptor receptor blocking enantiomer, 5-HT1 serotonin receptor antagonist, Beta-adrenergic blocking agent, antihypertensive, antianginal, antiarrhythmic.	False	CC(C)NC[C@H](O)COc1cccc2ccccc12
281049	281049:01:03_10.00	True	10.0	102	13.3	67.7	0.0	0.0	54.7	0.0	18.9	8.8	0.0	0.0	38.0	0.0	20.3	AKT_PI3K_MTOR	67.7	Y-27632 2HCl	highly potent, cell-permeable, and selective Rho-associated coiled-coil forming protein serine/threonine kinase (ROCK) inhibitor. Also inhibits ROCK-II with equal potency. The inhibition is competitive with respect to ATP.	False	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1
280884	280884:01:03_10.00	True	10.0	96	5.9	0.0	0.0	41.5	0.0	39.9	0.0	69.9	9.8	0.0	0.0	42.4	18.3	LCH	69.9	Riluzole, Rilutek	it is a glutamate release inhibitor with neuroprotective, anticonvulsant, anxiolytic and anesthetic qualities. Riluzole inhibits the release of glutamic acid from cultured neurons, and from brain slices. These effects may be partly due to inactivation of voltage-dependent sodium channels on glutamatergic nerve terminals, as well as activation of a G-protein-dependent signal transduction process. Electrophysiologic experiments performed on isolated excitatory amino acid receptors expressed in the Xenopus oocyte have revealed that Riluzole inhibits currents evoked by N-methyl-D-aspartate (NMDA) (IC50 = 18 µM) and kainic acid (IC50 = 167 µM). Riluzole has been shown to stabilize inactivated sodium channels in frog sciatic nerve, in rat cerebellar granule cells, and on recombinant rat sodium channels expressed in Xenopus oocytes (Ki = 0.2 µM). Riluzole also blocks some of the postsynaptic effects of glutamic acid by noncompetitive blockade of NMDA receptors. Tiluzole protects cultured neurons from anoxic damage, from the toxic effects of glutamic-acid-uptake inhibitors, and from the toxic factor in the CSF of patients with amyotrophic lateral sclerosis.	False	Nc1nc2ccc(OC(F)(F)F)cc2s1
280489	280489:01:03_10.00	True	10.0	103	5.9	0.0	2.9	51.5	0.0	54.2	14.9	23.8	51.2	41.6	0.0	35.9	25.1	HDAC	54.2	asym-Dimethylarginine hydrochloride ADMA	reversible inhibitor of nitric oxide synthetase in vivo and in vitro.	False	CN(C)C(=N)NCCC[C@H](N)C(=O)O
246897	246897:02:03_10.00	True	10.0	87	9.5	0.0	0.0	67.6	0.0	67.9	20.3	82.7	28.7	34.4	0.0	66.6	35.2	LCH	82.7	Opipramol, dihydrochloride	sigma1, sigma2 receptor agonist, an antagonist at D2, 5HT2, and H1 receptors, atypical antidepressant, antipsychotic, and axiolytic.	False	OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1
245350	245350:02:03_10.00	True	10.0	65	28.5	43.4	32.2	0.0	93.0	0.0	0.0	0.0	0.0	0.0	83.0	0.0	0.0	DNA_Synth	93.0	(S)-(+)-Camptothecin	DNA topoisomerase I inhibitor.	False	CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1
280896	280896:01:03_10.00	True	10.0	85	15.0	50.8	10.0	0.0	89.2	0.0	5.8	0.0	0.0	0.0	59.3	0.0	0.0	DNA_Synth	89.2	Roscovitine	potent, selective inhibitor of cyclin-dependent kinases (CDKs).	False	CC[C@@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1
280866	280866:01:03_10.00	True	10.0	89	70.5	0.0	0.0	87.7	0.0	86.0	14.0	86.6	51.6	54.1	0.0	77.2	64.2	BET	87.7	Paroxetine hydrochloride hemihydrate (MW = 374.83)	selective serotonin reuptake inhibitor, antidepressant Sold with permission of GlaxoSmithKline. Actual molecular weight = 374.83 to account for 1/2 mole of water.	False	Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1
247135	247135:02:03_10.00	True	10.0	103	37.0	0.0	0.0	79.4	0.0	77.1	9.2	94.4	38.0	49.0	0.0	67.4	46.3	LCH	94.4	Cyclobenzaprine (hydrochloride)	Cyclobenzaprine hydrochloride (MK130 hydrochloride) is a skeletal muscle relaxant and a central nervous system (CNS) depressant.Target: 5-HT Receptor 2ACyclobenzaprine hydrochloride is a skeletal muscle relaxant and a central nervous system (CNS) depressant. Cyclobenzaprine hydrochloride was thought to be an alpha 2-adrenoceptor agonist that reduced muscle tone by decreasing the activity of descending noradrenergic neurons. Cyclobenzaprine hydrochloride reduced the monosynaptic reflex amplitude dose dependently and this effect was not inhibited by the alpha 2-adrenoceptor antagonists idazoxan and yohimbine. Cyclobenzaprine-induced monosynaptic reflex depression was not attenuated by noradrenergic neuronal lesions produced by 6-hydroxydopamine. Cyclobenzaprine hydrochloride is a 5-HT2 receptor antagonist and that its muscle relaxant effect is due to inhibition of serotonergic, not noradrenergic, descending systems in the spinal cord . The inhibitory effects of Cyclobenzaprine hydrochloride on mono- and polysynaptic reflex potentials are due to the inhibition of descending serotonergic systems through 5-HT(2) receptors in the spinal cord .	False	CN(C)CCC=C1c2ccccc2C=Cc2ccccc21
245386	245386:03:03_10.00	True	10.0	110	7.8	0.0	0.0	75.5	0.0	69.6	5.9	79.2	42.8	33.3	0.0	64.9	51.7	LCH	79.2	Clozapine	atypical neuroleptic agent which display greater affinity for the D4 dopamine receptors over D2 or D3, 5-HT antagonist, antipsychotic.	False	CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
280086	280086:01:03_10.00	True	10.0	98	44.0	0.0	0.0	70.4	0.0	69.4	38.3	76.6	24.0	48.2	0.0	70.9	50.1	LCH	76.6	Lercanidipine hydrochloride hemihydrate	L-type (Cav1.2b) vascular calcium channel antagonist.	False	COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)(C)CN(C)CCC(c2ccccc2)c2ccccc2)C1c1cccc([N+](=O)[O-])c1
280734	280734:01:04_10.00	True	10.0	96	7.3	0.0	0.0	63.7	0.0	63.5	9.6	71.4	29.8	49.5	0.0	65.3	40.8	LCH	71.4	GW9662	GW9662 is a potent and selective PPAR.g. antagonist with an IC50 of 3.3 nM, showing 10 and 1000-fold selectivity over PPAR.a. and PPAR.d., respectively.	False	O=C(Nc1ccccc1)c1cc([N+](=O)[O-])ccc1Cl
280904	280904:01:03_10.00	True	10.0	95	11.9	0.0	0.0	56.4	0.0	55.1	31.3	67.4	37.9	24.5	0.0	57.6	31.1	LCH	67.4	PAPP, LY-165,163, p-Aminophenethyl-m-trifluoromethylphenyl piperazine	selective 5-HT1A serotonin receptor agonist.	False	Nc1ccc(CCN2CCN(c3cccc(C(F)(F)F)c3)CC2)cc1
280961	280961:01:03_10.00	True	10.0	102	52.5	0.0	0.0	74.3	0.0	69.8	17.8	88.6	28.3	40.7	0.0	67.4	48.5	LCH	88.6	SR 59230A oxalate	beta3-Adrenoceptor antagonist.	False	CCc1ccccc1OC[C@@H](O)CN[C@H]1CCc2ccccc2C1
280484	280484:01:03_10.00	True	10.0	53	34.9	43.3	19.6	0.0	47.1	0.0	37.8	0.0	0.0	0.0	44.8	0.0	0.0	DNA_Synth	47.1	Diphenyleneiodonium chloride	Diphenyleneiodonium chloride is a NADPH oxidase (NOX) inhibitor and also functions as a TRPA1 activator with an EC50 of 1 to 3 uM. Diphenyleneiodonium chloride selectively inhibits intracellular reactive oxygen species.	False	c1ccc2c(c1)[I+]c1ccccc1-2
281013	281013:01:04_10.00	True	10.0	89	35.8	0.0	0.0	86.4	0.0	83.3	2.7	88.1	45.4	58.7	0.0	76.3	55.3	LCH	88.1	3-Tropanyl-3,5-dichlorobenzoate	selective 5-HT3 serotonin receptor antagonist.	False	CN1C2CCC1CC(OC(=O)c1cc(Cl)cc(Cl)c1)C2
280293	280293:01:03_10.00	True	10.0	68	33.5	58.5	17.1	0.0	97.5	0.0	0.0	0.0	0.0	0.0	78.6	0.0	0.0	DNA_Synth	97.5	Ancitabine hydrochloride, Cyclocytidine hydrochloride, Cyclo-C	antineoplastic.	False	N=c1ccn2c(n1)OC1[C@@H](O)[C@@H](CO)O[C@H]12
280418	280418:01:03_10.00	True	10.0	77	45.4	0.0	0.0	66.8	0.0	59.3	27.7	63.4	41.7	40.8	0.0	88.3	59.1	Tubulin	88.3	7-Chloro-4-hydroxy-2-phenyl-1,8-naphthyridine	A1 adenosine receptor antagonist.	False	Oc1cc(-c2ccccc2)nc2nc(Cl)ccc12
280942	280942:01:03_10.00	True	10.0	95	57.9	0.0	0.0	84.7	0.0	81.3	15.2	93.1	42.2	51.9	0.0	75.0	59.7	LCH	93.1	Salmeterol (xinafoate)	beta2 Adrenoceptor agonist.	False	OCc1cc(C(O)CNCCCCCCOCCCCc2ccccc2)ccc1O
280925	280925:01:03_10.00	True	10.0	94	34.7	0.0	0.0	79.2	0.0	78.7	17.7	79.5	44.0	52.8	0.0	69.7	66.1	LCH	79.5	DL-Stearoylcarnitine chloride	protein kinase C (PKC) inhibitor.	False	CCCCCCCCCCCCCCCCCC(=O)OC(CC(=O)O)C[N+](C)(C)C
280427	280427:01:04_10.00	True	10.0	57	60.3	3.4	0.0	33.9	0.0	37.0	45.6	35.1	24.7	46.5	0.0	36.8	30.9	Protein_Synth	46.5	Calcimycin, A23187, Calcium ionophore A23187	Ca2+ ionophore used to potentiate responses to NMDA, but not quisqualate glutamate receptors.	False	CNc1ccc2oc(C[C@H]3O[C@@]4(CC[C@H]3C)O[C@H]([C@H](C)C(=O)c3ccc[nH]3)[C@H](C)C[C@H]4C)nc2c1C(=O)O
280865	280865:01:03_10.00	True	10.0	71	44.2	46.1	11.6	0.0	96.0	0.0	0.0	0.0	0.0	0.0	63.2	0.0	0.0	DNA_Synth	96.0	o-Phenanthroline	o-Phenanthroline (1,10-Phenanthroline), a metal chelator, prevents the induction of chromosomal aberrations in streptozotocin-treated cells. o-Phenanthroline (1,10-Phenanthroline) forms a red chelate with Fe2+ that absorbs maximally at 510 nm.	False	c1cnc2c(c1)ccc1cccnc12
280173	280173:01:04_10.00	True	10.0	72	22.3	57.7	0.0	0.0	62.2	0.0	37.3	20.6	0.0	0.0	47.2	0.0	2.0	DNA_Synth	62.2	BAY 61-3606 hydrochloride hydrate	Spleen tyrosine kinase (Syk) inhibitor; anti-inflammatory. Syk plays a major role in inflammation pathways via receptors for the Fc portion of immunoglobulins, as well as B cell signaling. It is orally active, potent (Ki 7.5 nM), and highly selective for Syk vs other kinases (Lyn, Fyn, Src, Itk, Btk; Ki¿s).	False	COc1ccc(-c2cc3ncc(C)n3c(Nc3ncccc3C(N)=O)n2)cc1OC
280757	280757:01:04_10.00	True	10.0	89	34.7	0.0	0.0	63.5	0.0	61.7	10.7	92.7	19.2	25.6	0.0	59.2	41.5	LCH	92.7	Naloxonazine dihydrochloride	potent mu1 opioid receptor antagonist.	False	C=CCN1CC[C@]23c4c5ccc(O)c4O[C@@H]2/C(=N/N=C2\CC[C@@]4(O)C6Cc7ccc(O)c8c7[C@@]4(CCN6CC=C)[C@@H]2O8)CC[C@@]3(O)C1C5
280947	280947:01:03_10.00	True	10.0	103	56.1	0.0	0.0	79.7	0.0	75.1	8.6	94.8	36.5	48.9	0.0	69.7	53.8	LCH	94.8	Sertraline hydrochloride	selective serotonin reuptake inhibitor, antidepressant, 5ht uptake inhibitor.	False	CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21
280140	280140:01:03_10.00	True	10.0	76	65.1	0.0	0.0	68.7	0.0	68.8	50.3	63.3	44.0	51.7	0.0	72.4	55.0	Tubulin	72.4	BIO	potent, selective, reversible, and ATP-competitive glycogen synthase kinase 3alpha/beta (GSK-3alpha/beta) inhibitor, maintains self-renewal and pluripotency of ESCs.	False	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O
280959	280959:01:03_10.00	True	10.0	92	7.6	0.6	0.0	51.7	0.0	47.5	33.5	59.3	20.6	38.0	0.0	56.4	45.4	LCH	59.3	(-)-Scopolamine methyl bromide, Hyoscine methyl bromide	competitive muscarinic acetylcholine receptor antagonist.	False	C[N+]1(C)C2CC(OC(=O)[C@H](CO)c3ccccc3)CC1C1OC12
280384	280384:01:04_10.00	True	10.0	97	6.4	0.0	0.0	60.0	0.0	54.7	18.0	61.8	16.6	34.6	0.0	68.8	57.5	Tubulin	68.8	CGP-13501	positive allosteric modulator of GABA-B receptors.	False	CC(C)(C=O)Cc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1
246828	246828:02:03_10.00	True	10.0	104	56.0	0.0	0.0	76.9	0.0	78.5	26.0	91.4	33.6	48.3	0.0	71.5	46.4	LCH	91.4	Carvedilol	Carvedilol (BM 14190) is a non-selective .b./.a.-1 blocker. Carvedilol inhibits lipid peroxidation in a dose-dependent manner with an IC50 of 5 uM. Carvedilol is a multiple action antihypertensive agent with potential use in angina and congestive heart failure. Carvedilol is an autophagy inducer that inhibits the NLRP3 inflammasome.	False	COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12
280991	280991:01:04_10.00	True	10.0	91	6.2	9.5	0.0	0.0	0.0	6.4	24.6	0.0	0.0	11.3	6.4	0.0	9.0	HSP90	24.6	AG 555	AG 555 (Tyrphostin AG 555), a potent antiretroviral drug, is a potent and selective inhibitor of EGFR and blocks Cdk2 activation.	False	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCCCc1ccccc1
280629	280629:01:03_10.00	True	10.0	89	31.1	68.7	0.0	0.0	25.4	0.0	45.4	3.2	0.0	6.9	22.9	10.7	38.5	AKT_PI3K_MTOR	68.7	Indirubin-3'-oxime	protein kinase inhibitor; inhibits cyclin-dependent kinases (IC50 = 0.18 - 3.33 µM) and GSK-3ß (IC50 = 0.19 µM). Inhibits CDK5- and GSK-3ß-mediated tau phosphorylation, a process over-active in Alzheimer disease states. Also inhibits AMPK, LCK and SGK. Induces cell cycle arrest and inhibits cell proliferation.	False	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\O
280390	280390:01:03_10.00	True	10.0	105	31.8	0.0	0.0	74.1	0.0	68.9	6.2	93.9	36.7	39.7	0.0	62.4	50.3	LCH	93.9	Chlorprothixene hydrochloride	D2 dopamine receptor antagonist, blocks a subset of GABA-A receptors in rat cortex that is also blocked by clozapine.	False	CN(C)CC/C=C1/c2ccccc2Sc2cc(Cl)ccc21
280128	280128:01:04_10.00	True	10.0	99	51.3	0.0	0.0	79.5	0.0	77.9	5.2	93.6	44.9	45.5	0.0	68.9	42.8	LCH	93.6	U-73343	inactive analog of U73122 (Rack 16, Well D06).	False	COc1ccc2c(c1)CCC1C2CC[C@@]2(C)C1CC[C@@H]2NCCCCCCN1C(=O)CCC1=O
280304	280304:01:03_10.00	True	10.0	61	44.7	13.1	46.8	0.0	75.7	0.0	6.0	13.4	0.0	0.0	41.7	0.0	0.0	DNA_Synth	75.7	Amsacrine (hydrochloride)	Amsacrine hydrochloride (m-AMSA hydrochloride; acridinyl anisidide hydrochloride) is an inhibitor of topoisomerase II, and acts as an antineoplastic agent which can intercalates into the DNA of tumor cells.	False	COc1cc(NS(C)(=O)=O)ccc1Nc1c2ccccc2nc2ccccc12
280793	280793:01:03_10.00	True	10.0	71	28.7	1.0	0.0	42.3	19.9	37.5	3.8	59.1	7.9	21.5	0.0	49.3	37.1	LCH	59.1	N-Oleoyldopamine, OLDA	endogenous vanilloid, weak CB1 cannabinoid receptor ligand.	False	CCCCCCCC/C=C\CCCCCCCC(=O)NCCc1ccc(O)c(O)c1
280583	280583:01:04_10.00	True	10.0	92	48.2	0.0	0.0	85.6	0.0	82.4	13.0	92.0	49.1	53.8	0.0	72.7	54.3	LCH	92.0	Hexahydro-sila-difenidol hydrochloride, p-fluoro analog, p-F-HHSiD hydrochloride	high affinity muscarinic acetylcholine receptor antagonist, but displays altered selectivity (M3 > M1 > M2).	False	O[Si](CCCN1CCCCC1)(c1ccc(F)cc1)C1CCCCC1
280370	280370:01:03_10.00	True	10.0	100	9.0	0.0	0.0	54.7	0.0	57.4	56.7	57.8	23.7	47.5	0.0	61.0	53.0	Tubulin	61.0	Capsazepine	Capsazepine is a synthetic analogue of the sensory neurone excitotoxin, and an antagonist of TRPV1 receptor with an IC50 of 562 nM.	False	Oc1cc2c(cc1O)CN(C(=S)NCCc1ccc(Cl)cc1)CCC2
246801	246801:02:03_10.00	True	10.0	88	33.9	0.0	8.2	32.8	1.0	35.3	26.1	61.0	0.0	12.0	0.0	45.0	1.9	LCH	61.0	Ziprasidone, Hydrochloride	dopamine D2/serotonin 5-HT2 antagonist, atypical antipsychotic, FDA approved for the treatment of schizophrenia.	False	O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1
280428	280428:01:03_10.00	True	10.0	77	83.9	0.0	0.0	89.6	0.0	88.3	5.6	72.3	62.8	65.7	0.0	87.6	55.4	BET	89.6	Cantharidin	protein phosphatase 2A inhibitor.	False	CC12C(=O)OC(=O)C1(C)C1CCC2O1
280960	280960:01:04_10.00	True	10.0	94	19.3	14.3	0.0	59.5	0.0	54.7	43.5	67.6	21.5	34.5	0.0	69.5	64.3	Tubulin	69.5	SU 4312	vascular endothelial growth factor (VEGF) receptor protein tyrosine kinase 1/2 (KDR) and platelet derived growth factor (PDGF) receptor inhibitor.	False	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1
280762	280762:01:05_10.00	True	10.0	75	5.4	0.0	23.6	4.9	59.3	0.0	5.1	25.5	2.3	4.5	10.3	39.8	0.0	DNA_Synth	59.3	NSC 95397	selective, irreversible Cdc25 dual specificity phosphatase inhibitor.	False	O=C1C(SCCO)=C(SCCO)C(=O)c2ccccc21
280483	280483:01:03_10.00	True	10.0	96	8.3	0.0	0.0	63.9	0.0	66.3	18.1	65.2	49.4	35.1	0.0	59.8	29.7	HDAC	66.3	Dihydroergotamine methanesulfonate	ergot alkaloid, vasoconstrictor, competitive serotonin receptor antagonist, partial agonist at alpha adrenoceptors and D2 dopamine receptors, vasoconstrictor, antimigraine.	False	CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21
280440	280440:01:03_10.00	True	10.0	78	12.1	51.3	0.0	0.0	61.5	0.0	18.8	0.0	0.0	0.0	44.3	0.0	4.3	DNA_Synth	61.5	Pyrocatechol, Catechol	carcinogen, causes DNA strand breakage.	False	Oc1ccccc1O
247070	247070:02:03_10.00	True	10.0	85	34.4	0.0	0.0	81.9	0.0	78.4	3.5	88.4	45.2	47.2	0.0	67.3	53.8	LCH	88.4	Desipramine hydrochloride	Desipramine hydrochloride is an inhibitor of norepinephrine transporter (NET), 5-HT transporter (SERT) and dopamine transporter (DAT) with Kis of 4, 61 and 78,720 nM, respectively.	False	CNCCCN1c2ccccc2CCc2ccccc21
280907	280907:01:03_10.00	True	10.0	94	13.3	56.6	0.0	17.6	27.0	1.3	10.4	23.2	0.0	21.1	4.6	34.9	65.1	Uncoupler	65.1	(±)-6-Chloro-PB hydrobromide, (±)-SKF-81297 hydrobromide	D1 dopamine receptor agonist.	False	Oc1cc2c(c(Cl)c1O)CCNCC2c1ccccc1
280126	280126:01:04_10.00	True	10.0	59	13.6	0.0	50.7	0.0	57.0	0.0	2.5	0.0	10.6	0.0	46.2	0.0	0.0	DNA_Synth	57.0	CCG-2046	Inhibitor of regulator of G-protein signaling 4 (RGS4)	False	CCCC1(C)C(C#N)(C#N)C1(C#N)C#N
280918	280918:01:03_10.00	True	10.0	89	60.1	0.0	0.0	76.3	0.0	73.6	12.9	95.5	29.5	45.4	0.0	67.2	48.0	LCH	95.5	Cortexolone maleate	D2 dopamine receptor antagonist.	False	COc1ccccc1N1CCN(CCCCNS(=O)(=O)c2cccc3c(N(C)C)cccc23)CC1
246746	246746:02:03_10.00	True	10.0	101	30.6	0.0	0.0	77.2	0.0	74.5	8.4	73.3	39.0	51.0	0.0	60.2	49.4	BET	77.2	Cyproheptadine (hydrochloride)	Cyproheptadine hydrochloride is a 5-HT2A receptor antagonist, with antidepressant and antiserotonergic effects. Cyproheptadine hydrochloride has antiplatelet and thromboprotective activities. Cyproheptadine hydrochloride can be used for the research of thromboembolic disorders.	False	CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1
280360	280360:01:03_10.00	True	10.0	105	19.3	0.0	0.0	80.6	0.0	76.7	8.7	88.4	42.8	44.5	0.0	70.6	42.9	LCH	88.4	CGS-12066A maleate	5-HT1B Serotonin receptor agonist.	False	CN1CCN(c2nc3cc(C(F)(F)F)ccc3n3cccc23)CC1
280621	280621:01:04_10.00	True	10.0	93	55.1	0.0	0.0	83.0	0.0	78.9	8.9	94.2	40.6	51.9	0.0	70.1	57.5	LCH	94.2	Indatraline hydrochloride, Lu 19-005	potent inhibitor of dopamine, norepinephrine and serotonin reuptake.	False	CN[C@@H]1C[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21
280438	280438:01:03_10.00	True	10.0	91	52.5	0.0	0.0	79.6	0.0	74.8	7.4	94.4	39.3	44.3	0.0	67.8	53.9	LCH	94.4	Clemastine fumarate	H1 Histamine receptor antagonist.	False	CN1CCCC1CCOC(C)(c1ccccc1)c1ccc(Cl)cc1
280233	280233:01:03_10.00	True	10.0	84	40.4	4.5	0.0	66.8	0.0	60.6	1.0	84.1	28.1	35.8	0.0	62.1	60.2	LCH	84.1	A-77636 hydrochloride	potent, orally active D1 dopamine receptor agonist.	False	NC[C@@H]1O[C@H](C23CC4CC(CC(C4)C2)C3)Cc2c1ccc(O)c2O
280929	280929:01:03_10.00	True	10.0	91	5.0	37.8	0.0	6.6	53.0	0.0	0.0	32.8	0.0	0.0	17.4	10.5	14.9	DNA_Synth	53.0	SKF 83959 hydrobromide	atypical D1 dopamine receptor agonist, displays antagonist activity in vitro and agonist activity in vivo.	False	Cc1cccc(C2CN(C)CCc3c2cc(O)c(O)c3Cl)c1
280732	280732:01:03_10.00	True	10.0	102	11.4	0.0	0.0	47.4	0.0	49.7	32.0	70.4	18.0	20.7	0.0	49.9	16.7	LCH	70.4	Gallopamil (hydrochloride)	Gallopamil hydrochloride (Methoxyverapamil hydrochloride), a methoxy derivative of Verapamil, is a phenylalkylamine calcium antagonist. Gallopamil hydrochloride inhibits acid secretion in a concentration-dependent manner with an IC50 of 10.9 uM. Gallopamil hydrochloride is a potent antiarrhythmic and vasodilator agent.	False	COc1ccc(CCN(C)CCCC(C#N)(c2cc(OC)c(OC)c(OC)c2)C(C)C)cc1OC
280441	280441:01:03_10.00	True	10.0	63	26.9	34.2	45.5	0.0	83.8	0.0	16.0	0.0	0.0	0.0	80.8	0.0	0.0	DNA_Synth	83.8	Z-L-Phe chloromethyl ketone, ZPCK	bovine chymotrypsin A-gamma inhibitor.	False	O=C(N[C@@H](Cc1ccccc1)C(=O)CCl)OCc1ccccc1
280902	280902:01:03_10.00	True	10.0	95	6.6	0.0	0.0	46.3	0.0	40.6	16.0	72.8	17.1	11.1	0.0	50.7	19.5	LCH	72.8	Ketanserin tartrate, R 41468	selective 5-HT2 serotonin receptor blocker.	False	O=C(c1ccc(F)cc1)C1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1
280193	280193:01:03_10.00	True	10.0	95	33.5	0.0	0.0	64.3	0.0	65.4	38.1	78.9	24.3	48.5	0.0	66.5	52.2	LCH	78.9	Fulvestrant	selective estrogen receptor downregulator (SERD). First pure antiestrogen with no agonistic activity both in vitro and in vivo.	False	C[C@]12CC[C@@H]3c4ccc(O)cc4C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@H]3[C@@H]1CC[C@@H]2O
280097	280097:01:03_10.00	True	10.0	89	63.2	0.0	0.0	80.4	0.0	75.7	12.5	92.7	39.8	49.2	0.0	72.2	59.3	LCH	92.7	Ebastine	nonsedating histamine H1 receptor antagonist without cardiac side effects at 5X effective dose.	False	CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1
246957	246957:02:03_10.00	True	10.0	100	5.2	22.1	0.0	54.4	0.0	48.1	11.7	60.6	23.4	34.9	0.0	47.7	54.0	LCH	60.6	Salbutamol, Albuterol	beta2-Adrenoceptor agonist, Beta adrenergic agonist, bronchodilator, tocolytic.	False	CC(C)(C)NCC(O)c1ccc(O)c(CO)c1
280482	280482:01:03_10.00	True	10.0	108	6.6	0.0	0.0	49.8	0.0	44.0	4.8	48.0	26.4	32.0	0.0	41.6	38.0	BET	49.8	Dextromethorphan hydrobromide monohydrate	allosteric antagonist at NMDA-controlled ion channels.	False	COc1ccc2c(c1)C13CCCCC1C(C2)N(C)CC3
280740	280740:01:04_10.00	True	10.0	99	15.9	3.2	0.0	45.4	17.3	41.7	11.1	78.2	4.9	7.7	0.0	51.0	28.9	LCH	78.2	MDL 28170, Z-Val-Phe-CHO	cell permeable calpain I and II inhibitor.	False	CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@H](C=O)Cc1ccccc1
280435	280435:01:03_10.00	True	10.0	103	5.4	0.0	5.0	56.6	0.0	61.0	20.9	26.7	45.3	44.8	0.0	47.0	34.5	HDAC	61.0	Cephradine, Cefradin, SQ-11436	semisynthetic cephalosporin antibiotic, interferes with cell wall synthesis.	False	CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)C(N)C3=CCC=CC3)[C@H]2SC1
280342	280342:01:03_10.00	True	10.0	96	11.7	0.0	0.0	72.5	0.0	67.1	17.3	76.1	36.3	39.4	0.0	67.8	50.5	LCH	76.1	BRL 52537 hydrochloride	kappa/mu opioid receptor agonist.	False	O=C(Cc1ccc(Cl)c(Cl)c1)N1CCCCC1CN1CCCC1
280096	280096:01:03_10.00	True	10.0	92	8.3	0.0	0.0	46.2	2.2	52.8	45.1	65.0	8.4	49.5	0.0	55.5	44.6	LCH	65.0	DMAT	DMAT is a potent and specific CK2 inhibitor with an IC50 value of 130 nM.	False	CN(C)c1nc2c(Br)c(Br)c(Br)c(Br)c2[nH]1
280379	280379:01:03_10.00	True	10.0	107	7.1	0.0	0.0	73.9	0.0	74.6	15.7	80.4	48.1	46.4	0.0	66.1	51.7	LCH	80.4	Chloro-IB-MECA	A3 adenosine receptor agonist.	False	CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCc4ccc(I)cc4)nc(Cl)nc32)[C@H](O)[C@@H]1O
280420	280420:01:03_10.00	True	10.0	63	29.4	57.2	18.4	0.0	97.7	0.0	0.0	0.0	0.0	0.0	75.9	0.0	0.0	DNA_Synth	97.7	Cytosine-1-beta-D-arabinofuranoside hydrochloride, Arabinocytidine hydrochloride, Arabinosylcytosine hydrochloride, Ara-C hydrochloride	selective inhibitor of DNA synthesis.	False	Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1
280302	280302:01:03_10.00	True	10.0	102	23.1	3.8	0.0	54.6	0.0	54.9	33.9	78.6	0.0	26.9	0.0	55.6	48.1	LCH	78.6	5-(N,N-hexamethylene)amiloride	Na+/ H+ antiport inhibitor.	False	NC(N)=NC(=O)c1nc(Cl)c(N2CCCCCC2)nc1N
247014	247014:02:03_10.00	True	10.0	94	53.7	0.0	0.0	82.2	0.0	78.2	13.7	91.5	40.1	52.0	0.0	68.9	56.1	LCH	91.5	Clomipramine hydrochloride, Anafranil hydrochloride, Chloripramine	serotonin reuptake inhibitor, antidepressant, Noradrenaline reuptake inhibitor.	False	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21
280958	280958:01:03_10.00	True	10.0	98	10.5	45.4	0.0	40.9	0.0	32.8	36.2	63.3	1.3	22.1	0.0	50.8	55.3	LCH	63.3	Semaxinib	Semaxinib (SU5416) is a potent and selective inhibitor of VEGFR (Flk-1/KDR) with an IC50 of 1.23 uM.	False	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1
280153	280153:01:04_10.00	True	10.0	95	65.8	0.0	0.0	81.0	0.0	78.2	18.5	93.4	39.0	50.0	0.0	73.7	51.4	LCH	93.4	LP44	A high affinity 5-HT7 receptor agonist.	False	CSc1ccccc1N1CCN(CCCCCC(=O)NC2CCCc3ccccc32)CC1
247099	247099:02:03_10.00	True	10.0	98	12.3	0.0	0.0	73.4	0.0	72.7	19.6	84.7	28.9	47.9	0.0	72.0	45.2	LCH	84.7	Carbetapentane (citrate)	Carbetapentane citrate is a selective inhibitor of the cough, with mild atropine-like effect and local anesthesia effect.	False	CCN(CC)CCOCCOC(=O)C1(c2ccccc2)CCCC1
280434	280434:01:03_10.00	True	10.0	91	8.5	29.1	0.0	22.4	0.0	23.5	38.0	18.6	7.6	33.9	0.0	27.3	48.4	Uncoupler	48.4	Caffeic acid phenethyl ester	Caffeic acid phenethyl ester is a NF-.k.B inhibitor.	False	O=C(/C=C/c1ccc(O)c(O)c1)OCCc1ccccc1
280913	280913:01:03_10.00	True	10.0	61	12.4	36.0	0.0	23.5	26.9	17.1	28.4	46.6	0.0	13.9	4.0	37.0	37.2	LCH	46.6	SB-366791, Vanilloid receptor-1 antagonist	vanilloid receptor-1 (VR1) antagonist.	False	COc1ccc(NC(=O)/C=C/c2ccc(Cl)cc2)cc1
280941	280941:01:03_10.00	True	10.0	107	5.4	6.1	0.0	56.0	0.0	49.0	17.1	68.7	24.0	39.8	0.0	56.8	47.2	LCH	68.7	Albuterol hemisulfate, Salbutamol hemisulfate	beta Adrenoceptor agonist.	False	CC(C)(C)NCC(O)c1ccc(O)c(CO)c1
280187	280187:01:04_10.00	True	10.0	89	10.2	76.6	0.0	0.0	42.5	0.0	0.2	0.0	0.0	0.0	45.8	0.0	22.2	AKT_PI3K_MTOR	76.6	CGP 57380	cell-permeable, selective mitogen-activated protein kinase-interacting kinase 1 (MNK1) inhibitor.	False	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12
280470	280470:01:03_10.00	True	10.0	59	28.8	0.0	44.5	0.0	0.0	9.1	0.0	0.0	61.5	16.2	0.0	0.0	0.0	Na_K-ATPase	61.5	Dihydroouabain	sodium-potassium pump inhibitor.	False	C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@@H]4C(CC[C@]3(O)C2)[C@@]2(O)CC[C@H](C3COC(=O)C3)[C@@]2(C)C[C@H]4O)[C@H](O)[C@H](O)[C@H]1O
280729	280729:01:04_10.00	True	10.0	89	73.4	0.0	0.0	82.5	0.0	79.1	19.9	92.6	37.5	52.2	0.0	73.9	60.7	LCH	92.6	Mibefradil dihydrochloride, Ro 40-5967	T-type Ca2+ channel blocker.	False	COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C
280171	280171:01:05_10.00	True	10.0	52	79.3	0.0	0.0	81.2	0.0	80.0	0.0	85.7	49.8	49.0	0.0	73.1	50.9	LCH	85.7	BIX01294 (hydrochloride hydrate)	it is a selective inhibitor of G9a HMTase (IC50 = 1.7 µM). It less effectively inhibits the HMTase G9a-like protein (GLP, IC50 = 38 µM) and has no effect on other known HMTases. BIX01294 has been used in combination with the calcium channel activator BayK8644 to facilitate the generation of induced pluripotent stem cells from somatic cells in vitro.	False	COc1cc2nc(N3CCCN(C)CC3)nc(NC3CCN(Cc4ccccc4)CC3)c2cc1OC
280954	280954:01:03_10.00	True	10.0	53	72.9	0.0	0.0	81.0	0.0	83.9	24.3	65.2	65.1	60.4	0.0	90.0	49.0	Tubulin	90.0	SKF-96365	selective inhibitor of receptor-mediated and voltage-gated Ca2+ entry.	False	COc1ccc(CCCOC(Cn2ccnc2)c2ccc(OC)cc2)cc1
280122	280122:01:04_10.00	True	10.0	79	12.4	5.3	0.0	53.4	0.0	39.8	4.8	65.9	22.0	18.9	0.0	48.8	31.6	LCH	65.9	JFD00244	A SIRT (sirtuin, human silent information regulator) inhibitor.	False	O=C1c2ccccc2C(=O)c2c(NCCc3ccc(O)cc3)ccc(NCCc3ccc(O)cc3)c21
280158	280158:01:04_30.00	True	30.0	67	45.6	44.3	16.0	0.0	95.4	0.0	0.0	0.0	0.0	0.0	69.8	0.0	0.0	DNA_Synth	95.4	ARP 101	it is a selective inhibitor of the MMP-2 (metalloproteinase-2 ) and, to lesser extent, MMP-9 (metalloproteinase-9). ARP 101 has shown ~250 fold selectivity of MMP-2 over MMP-1 and ~100 fold of MMP-9 over MMP-1.  ARP 101 has diverse physiological roles including wound healing, cancer metastasis, angiogenesis, tissue remodeling in development and embryogenesis. IC50 = 0.81 nM on MMP-2.	False	CC(C)ON([C@@H](C(=O)NO)C(C)C)S(=O)(=O)c1ccc(-c2ccccc2)cc1
280365	280365:01:03_30.00	True	30.0	96	17.1	27.1	22.8	0.0	79.7	0.0	22.5	0.0	0.0	0.0	70.2	0.0	0.0	DNA_Synth	79.7	SKF-82958 (hydrobromide)	SKF-82958 ((±)-SKF 82958) hydrobromide is a dopamine D1 receptor full agonist (K0.5=4 nM), displays selective  for D1 over D2 receptors (K0.5=73 nM). SKF-82958 hydrobromide induces dopamine D1 receptor-dependent adenylate cyclase activity in rat striatal membranes (EC50=491 nM).	False	C=CCN1CCc2c(cc(O)c(O)c2Cl)C(c2ccccc2)C1
246798	246798:02:03_30.00	True	30.0	92	16.2	0.0	12.9	31.4	3.3	32.3	23.6	25.2	22.3	46.9	0.0	44.7	40.5	Protein_Synth	46.9	Tizanidine HCl	alpha2-adrenoceptor agonist.	False	Clc1ccc2nsnc2c1NC1=NCCN1
280970	280970:01:03_30.00	True	30.0	93	24.7	0.0	0.0	30.2	0.0	26.3	47.7	43.7	4.5	17.9	0.0	42.2	5.7	HSP90	47.7	Tracazolate	non-benzodiazepine anxiolytic which has a high differential between sedative and anxiolytic doses.	False	CCCCNc1c(C(=O)OCC)c(C)nc2c1cnn2CC
281049	281049:01:03_30.00	True	30.0	95	19.3	56.2	0.0	0.0	50.4	0.0	19.1	0.0	0.0	0.0	57.3	0.0	0.0	Pyrimidine_Synth	57.3	Y-27632 2HCl	highly potent, cell-permeable, and selective Rho-associated coiled-coil forming protein serine/threonine kinase (ROCK) inhibitor. Also inhibits ROCK-II with equal potency. The inhibition is competitive with respect to ATP.	False	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1
280869	280869:01:03_30.00	True	30.0	108	8.8	0.0	22.6	33.1	0.0	43.7	44.6	24.1	7.4	30.6	0.0	29.4	7.8	HSP90	44.6	Psora-4	potent Kv1.3 potassium channel inhibitor.	False	O=c1ccc2c(OCCCCc3ccccc3)c3ccoc3cc2o1
280884	280884:01:03_30.00	True	30.0	93	42.3	0.0	0.0	73.1	0.0	72.7	39.4	66.5	32.9	65.9	0.0	77.0	45.3	Tubulin	77.0	Riluzole, Rilutek	it is a glutamate release inhibitor with neuroprotective, anticonvulsant, anxiolytic and anesthetic qualities. Riluzole inhibits the release of glutamic acid from cultured neurons, and from brain slices. These effects may be partly due to inactivation of voltage-dependent sodium channels on glutamatergic nerve terminals, as well as activation of a G-protein-dependent signal transduction process. Electrophysiologic experiments performed on isolated excitatory amino acid receptors expressed in the Xenopus oocyte have revealed that Riluzole inhibits currents evoked by N-methyl-D-aspartate (NMDA) (IC50 = 18 µM) and kainic acid (IC50 = 167 µM). Riluzole has been shown to stabilize inactivated sodium channels in frog sciatic nerve, in rat cerebellar granule cells, and on recombinant rat sodium channels expressed in Xenopus oocytes (Ki = 0.2 µM). Riluzole also blocks some of the postsynaptic effects of glutamic acid by noncompetitive blockade of NMDA receptors. Tiluzole protects cultured neurons from anoxic damage, from the toxic effects of glutamic-acid-uptake inhibitors, and from the toxic factor in the CSF of patients with amyotrophic lateral sclerosis.	False	Nc1nc2ccc(OC(F)(F)F)cc2s1
280914	280914:01:03_30.00	True	30.0	91	16.9	10.5	8.1	0.0	35.5	0.0	17.1	16.9	1.1	3.8	18.2	4.4	0.0	DNA_Synth	35.5	Nitroprusside (disodium dihydrate)	Nitroprusside disodium dehydrate (Sodium nitroprusside dihydrate) is a vasodilator that available for the research of acute hypertension, heart failure. Nitroprusside disodium dehydrate acts as a nitric oxide (NO) donor in a rat intestinal ischemia reperfusion model.	False	N#C[Fe]C#N
280934	280934:01:04_30.00	True	30.0	89	21.2	68.0	16.9	0.0	93.6	0.0	8.1	0.0	0.0	0.0	84.6	0.0	0.0	DNA_Synth	93.6	Spironolactone	competitive antagonist of the cytoplasmic aldosterone receptor, diuretic.	False	CC(=O)SC1CC2=CC(=O)CC[C@]2(C)C2CC[C@@]3(C)C(CC[C@@]34CCC(=O)O4)C12
280389	280389:01:03_30.00	True	30.0	93	6.0	0.0	0.0	70.7	0.0	63.0	2.5	67.8	50.5	51.4	0.0	70.4	47.8	BET	70.7	1-(4-Chlorobenzyl)-5-methoxy-2-methylindole-3-acetic acid	NSAID, putative inhibitor of multidrug resistance-associated protein 1 (MRP1).	False	COc1ccc2c(c1)c(CC(=O)O)c(C)n2Cc1ccc(Cl)cc1
280082	280082:01:03_30.00	True	30.0	97	5.4	0.0	0.0	57.3	0.0	51.5	35.8	67.8	6.0	27.4	0.0	60.5	48.1	LCH	67.8	CBIQ	activates cystic fibrosis transmembrane conductance regulator (CFTR) and the intermediate-conductance calcium-sensitive K+ channel.	False	Clc1nccc2c1ccc1ccccc12
246897	246897:02:03_30.00	True	30.0	92	60.1	0.0	0.0	77.1	0.0	76.3	19.7	94.7	37.5	47.1	0.0	71.0	43.1	LCH	94.7	Opipramol, dihydrochloride	sigma1, sigma2 receptor agonist, an antagonist at D2, 5HT2, and H1 receptors, atypical antidepressant, antipsychotic, and axiolytic.	False	OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1
280864	280864:01:03_30.00	True	30.0	95	7.3	34.3	0.0	0.0	39.7	0.0	0.0	0.0	17.0	0.0	30.9	0.0	5.8	DNA_Synth	39.7	Paromomycin sulfate	oligosacchiride-type antibiotic, interferes with protein synthesis.	False	NCC1OC(O[C@@H]2[C@H](O)C(OC3C(O)C(N)CC(N)C3OC3OC(CO)C(O)C(O)C3N)O[C@@H]2CO)C(N)C(O)C1O
280905	280905:01:03_30.00	True	30.0	97	10.5	0.0	0.0	57.4	0.0	60.2	38.2	70.3	17.3	43.5	0.0	59.8	30.1	LCH	70.3	Spiroxatrine, R 5188	partial 5-HT1A serotonin receptor agonist.	False	O=C1NCN(c2ccccc2)C12CCN(CC1COc3ccccc3O1)CC2
280474	280474:01:03_30.00	True	30.0	92	31.8	0.0	0.0	38.9	0.0	43.7	45.0	61.1	1.6	21.2	0.0	48.1	5.7	LCH	61.1	Droperidol	D1, D2 dopamine receptor antagonist.	False	O=C(CCCN1C=CC(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1
245350	245350:02:03_30.00	True	30.0	55	39.0	48.7	18.4	0.0	87.0	0.0	11.8	0.0	0.0	0.0	60.2	0.0	0.0	DNA_Synth	87.0	(S)-(+)-Camptothecin	DNA topoisomerase I inhibitor.	False	CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1
280197	280197:01:04_30.00	True	30.0	101	21.4	0.0	0.0	32.7	0.0	31.5	36.9	54.8	3.8	10.6	0.0	35.5	0.8	LCH	54.8	SANT-1	SANT-1, a potent Smo antagonist, inhibits Hedgehog signaling. SANT-1 shows IC50s of 20 nM and 30 nM in Shh-LIGHT2 and SmoA1-LIGHT2 assay, respectively.	False	Cc1nn(-c2ccccc2)c(C)c1/C=N/N1CCN(Cc2ccccc2)CC1
280896	280896:01:03_30.00	True	30.0	62	40.2	20.8	48.9	0.0	83.3	0.0	38.1	0.0	0.0	0.0	62.7	0.0	0.0	DNA_Synth	83.3	Roscovitine	potent, selective inhibitor of cyclin-dependent kinases (CDKs).	False	CC[C@@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1
280366	280366:01:03_30.00	True	30.0	101	13.3	0.0	0.0	33.8	0.0	33.1	27.2	43.3	11.4	14.1	0.0	36.4	8.4	LCH	43.3	CGS-21680 hydrochloride	A2a adenosine receptor agonist.	False	CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(NCCc4ccc(CCC(=O)O)cc4)nc32)C(O)[C@H]1O
247135	247135:02:03_30.00	True	30.0	85	81.5	0.0	0.0	75.3	0.0	72.8	14.8	90.6	33.4	49.1	0.0	72.2	47.5	LCH	90.6	Cyclobenzaprine (hydrochloride)	Cyclobenzaprine hydrochloride (MK130 hydrochloride) is a skeletal muscle relaxant and a central nervous system (CNS) depressant.Target: 5-HT Receptor 2ACyclobenzaprine hydrochloride is a skeletal muscle relaxant and a central nervous system (CNS) depressant. Cyclobenzaprine hydrochloride was thought to be an alpha 2-adrenoceptor agonist that reduced muscle tone by decreasing the activity of descending noradrenergic neurons. Cyclobenzaprine hydrochloride reduced the monosynaptic reflex amplitude dose dependently and this effect was not inhibited by the alpha 2-adrenoceptor antagonists idazoxan and yohimbine. Cyclobenzaprine-induced monosynaptic reflex depression was not attenuated by noradrenergic neuronal lesions produced by 6-hydroxydopamine. Cyclobenzaprine hydrochloride is a 5-HT2 receptor antagonist and that its muscle relaxant effect is due to inhibition of serotonergic, not noradrenergic, descending systems in the spinal cord . The inhibitory effects of Cyclobenzaprine hydrochloride on mono- and polysynaptic reflex potentials are due to the inhibition of descending serotonergic systems through 5-HT(2) receptors in the spinal cord .	False	CN(C)CCC=C1c2ccccc2C=Cc2ccccc21
245386	245386:03:03_30.00	True	30.0	93	66.0	0.0	0.0	76.7	0.0	76.5	28.4	92.4	32.9	51.7	0.0	71.7	48.3	LCH	92.4	Clozapine	atypical neuroleptic agent which display greater affinity for the D4 dopamine receptors over D2 or D3, 5-HT antagonist, antipsychotic.	False	CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
280086	280086:01:03_30.00	True	30.0	80	82.2	0.0	0.0	82.3	0.0	80.8	39.0	79.6	43.3	74.1	0.0	80.7	72.7	BET	82.3	Lercanidipine hydrochloride hemihydrate	L-type (Cav1.2b) vascular calcium channel antagonist.	False	COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)(C)CN(C)CCC(c2ccccc2)c2ccccc2)C1c1cccc([N+](=O)[O-])c1
246768	246768:02:03_30.00	True	30.0	108	5.2	0.0	0.0	65.0	0.0	61.3	5.5	68.6	33.7	42.0	0.0	65.2	32.1	LCH	68.6	(±)-Synephrine	alpha-Adrenoceptor agonist, vasoconstrictor, Adrenergic receptor agonist.	False	CNCC(O)c1ccc(O)cc1
280734	280734:01:04_30.00	True	30.0	82	52.0	0.0	0.0	80.7	0.0	77.7	19.8	74.7	55.4	66.8	0.0	84.0	52.0	Tubulin	84.0	GW9662	GW9662 is a potent and selective PPAR.g. antagonist with an IC50 of 3.3 nM, showing 10 and 1000-fold selectivity over PPAR.a. and PPAR.d., respectively.	False	O=C(Nc1ccccc1)c1cc([N+](=O)[O-])ccc1Cl
280094	280094:01:03_30.00	True	30.0	86	9.8	0.0	1.6	53.2	0.0	49.7	10.2	46.9	41.6	57.8	0.0	60.3	35.9	Tubulin	60.3	GR 79236X	A1 adenosine receptor agonist.	False	OC[C@H]1OC(n2cnc3c(N[C@H]4CCC[C@@H]4O)ncnc32)[C@H](O)[C@@H]1O
280904	280904:01:03_30.00	True	30.0	101	45.4	0.0	0.0	62.4	0.0	63.2	47.6	71.7	29.3	42.9	0.0	66.0	37.6	LCH	71.7	PAPP, LY-165,163, p-Aminophenethyl-m-trifluoromethylphenyl piperazine	selective 5-HT1A serotonin receptor agonist.	False	Nc1ccc(CCN2CCN(c3cccc(C(F)(F)F)c3)CC2)cc1
281013	281013:01:04_30.00	True	30.0	99	79.6	0.0	0.0	83.5	0.0	81.2	20.1	88.6	43.4	64.5	0.0	77.4	57.3	LCH	88.6	3-Tropanyl-3,5-dichlorobenzoate	selective 5-HT3 serotonin receptor antagonist.	False	CN1C2CCC1CC(OC(=O)c1cc(Cl)cc(Cl)c1)C2
280306	280306:01:03_30.00	True	30.0	92	12.8	0.0	0.0	66.8	0.0	66.5	25.4	90.0	16.3	44.2	0.0	63.8	48.1	LCH	90.0	Antozoline hydrochloride	imidazoline agonist, more potent than efaroxan in inducing insulin release from beta cells, H1 histamine receptor antagonist.	False	c1ccc(CN(Cc2ncc[nH]2)c2ccccc2)cc1
247416	247416:02:03_30.00	True	30.0	59	10.0	0.0	39.3	5.3	32.2	18.2	31.6	12.4	25.0	36.0	0.0	27.3	10.2	Aurora	39.3	Disulfiram	Disulfiram (Tetraethylthiuram disulfide) is a specific inhibitor ofaldehyde-dehydrogenase (ALDH1), used for the treatment of chronic alcoholism by producing an acute sensitivity to alcohol. Disulfiram inhibits gasdermin D (GSDMD) pore formation in liposomes and inflammasome-mediated pyroptosis and IL-1.b. secretion in human and mouse cells[1-4].	False	CCN(CC)C(=S)SSC(=S)N(CC)CC
280221	280221:01:03_30.00	True	30.0	88	6.4	27.7	46.0	0.0	76.1	0.0	0.0	0.0	0.0	0.0	78.1	0.0	0.0	Pyrimidine_Synth	78.1	S(-)-Atenolol	beta1 adrenoceptor antagonist.	False	CC(C)NC[C@H](O)COc1ccc(CC(N)=O)cc1
280293	280293:01:03_30.00	True	30.0	61	31.3	58.2	21.0	0.0	96.7	0.0	0.2	0.0	0.0	0.0	77.4	0.0	0.0	DNA_Synth	96.7	Ancitabine hydrochloride, Cyclocytidine hydrochloride, Cyclo-C	antineoplastic.	False	N=c1ccn2c(n1)OC1[C@@H](O)[C@@H](CO)O[C@H]12
280418	280418:01:03_30.00	True	30.0	63	61.1	0.0	0.0	77.6	0.0	70.4	28.1	68.8	52.6	57.6	0.0	94.9	66.3	Tubulin	94.9	7-Chloro-4-hydroxy-2-phenyl-1,8-naphthyridine	A1 adenosine receptor antagonist.	False	Oc1cc(-c2ccccc2)nc2nc(Cl)ccc12
280594	280594:01:04_30.00	True	30.0	96	8.5	0.0	0.0	62.1	0.0	65.1	0.0	51.1	40.9	39.6	0.0	53.0	52.0	HDAC	65.1	Hydralazine hydrochloride	non-selective MAO-A/B inhibitor, antihypertensive.	False	NNc1nncc2ccccc12
280963	280963:01:03_30.00	True	30.0	94	5.0	0.0	0.0	48.4	0.0	51.6	31.3	59.7	23.8	29.6	0.0	51.7	14.5	LCH	59.7	SKF89976A (hydrochloride)	SKF89976A hydrochloride is a selective GABA transporter (GAT-1) inhibitor with IC50s of 0.28 uM, 137.34 uM and 202.8 uM for GAT-1, GAT-2 and GAT-3 in CHO cells, respectively.	False	O=C(O)C1CCCN(CCC=C(c2ccccc2)c2ccccc2)C1
280925	280925:01:03_30.00	True	30.0	92	33.2	2.3	0.0	63.0	0.0	63.3	38.0	64.4	28.3	61.8	0.0	65.0	69.7	Uncoupler	69.7	DL-Stearoylcarnitine chloride	protein kinase C (PKC) inhibitor.	False	CCCCCCCCCCCCCCCCCC(=O)OC(CC(=O)O)C[N+](C)(C)C
247020	247020:02:03_30.00	True	30.0	92	23.5	0.0	0.7	30.0	0.0	28.0	24.3	47.3	6.2	26.6	0.0	40.7	0.0	LCH	47.3	Cinnarizine	Cinnarizine is an antihistamine and a calcium channel blocker, promote cerebral blood flow, used to treat cerebral apoplexy, post-trauma cerebral symptoms, and cerebral arteriosclerosis.	False	C(=C/c1ccccc1)\CN1CCN(C(c2ccccc2)c2ccccc2)CC1
280865	280865:01:03_30.00	True	30.0	68	44.2	43.7	17.0	0.0	96.1	0.0	0.0	0.0	0.0	0.0	63.5	0.0	0.0	DNA_Synth	96.1	o-Phenanthroline	o-Phenanthroline (1,10-Phenanthroline), a metal chelator, prevents the induction of chromosomal aberrations in streptozotocin-treated cells. o-Phenanthroline (1,10-Phenanthroline) forms a red chelate with Fe2+ that absorbs maximally at 510 nm.	False	c1cnc2c(c1)ccc1cccnc12
280220	280220:01:03_30.00	True	30.0	100	14.5	60.0	21.2	0.0	87.0	0.0	0.0	0.0	0.0	0.0	75.4	0.0	0.0	DNA_Synth	87.0	Arecaidine propargyl ester hydrobromide, APE	potent muscarinic acetylcholine receptor agonist exhibiting a slight selectivity for M2 receptors.	False	C#CCOC(=O)C1=CCCN(C)C1
280173	280173:01:04_30.00	True	30.0	65	46.3	24.2	0.0	18.1	27.6	24.0	47.6	54.7	0.0	12.9	1.6	37.9	30.9	LCH	54.7	BAY 61-3606 hydrochloride hydrate	Spleen tyrosine kinase (Syk) inhibitor; anti-inflammatory. Syk plays a major role in inflammation pathways via receptors for the Fc portion of immunoglobulins, as well as B cell signaling. It is orally active, potent (Ki 7.5 nM), and highly selective for Syk vs other kinases (Lyn, Fyn, Src, Itk, Btk; Ki¿s).	False	COc1ccc(-c2cc3ncc(C)n3c(Nc3ncccc3C(N)=O)n2)cc1OC
280879	280879:01:04_30.00	True	30.0	85	54.2	1.7	0.0	64.8	0.0	66.1	30.7	89.6	27.3	39.6	0.0	58.0	48.1	LCH	89.6	Ritanserin	Ritanserin (R 55667) is a highly potent, relatively selective, orally active, long acting antagonist of 5-HT2 receptor, with an IC50 of 0.9 nM, less active on Histamine H1, Dopamine D2, Adrenergic .a.1, Adrenergic .a.2 receptors.	False	Cc1nc2sccn2c(=O)c1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1
280917	280917:01:03_30.00	True	30.0	92	10.5	0.0	13.2	51.5	0.0	54.6	42.0	55.7	18.0	61.2	0.0	60.1	37.7	Protein_Synth	61.2	SB-215505	selective 5-HT2B serotonin receptor antagonist, 100-fold higher affinity at 2B versus 2C.	False	Cc1cc2c(cc1Cl)N(C(=O)Nc1ccnc3ccccc13)CC2
280959	280959:01:03_30.00	True	30.0	99	10.4	0.0	0.0	74.4	0.0	65.6	25.6	79.2	27.4	48.4	0.0	77.4	53.1	LCH	79.2	(-)-Scopolamine methyl bromide, Hyoscine methyl bromide	competitive muscarinic acetylcholine receptor antagonist.	False	C[N+]1(C)C2CC(OC(=O)[C@H](CO)c3ccccc3)CC1C1OC12
280384	280384:01:04_30.00	True	30.0	108	10.9	12.9	0.0	54.2	0.0	51.6	24.9	46.7	30.3	45.8	0.0	43.8	48.3	BET	54.2	CGP-13501	positive allosteric modulator of GABA-B receptors.	False	CC(C)(C=O)Cc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1
280356	280356:01:03_30.00	True	30.0	99	17.4	0.0	10.9	27.3	0.0	26.9	12.6	18.3	20.2	54.3	0.0	36.4	31.1	Protein_Synth	54.3	OXA-22 iodide	potent muscarinic acetylcholine receptor agonist.	False	C[C@@H]1O[C@H](C[N+](C)(C)C)CS1
280991	280991:01:04_30.00	True	30.0	85	14.0	39.6	36.5	0.0	83.2	0.0	25.6	0.0	0.0	0.0	72.6	0.0	0.0	DNA_Synth	83.2	AG 555	AG 555 (Tyrphostin AG 555), a potent antiretroviral drug, is a potent and selective inhibitor of EGFR and blocks Cdk2 activation.	False	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCCCc1ccccc1
280992	280992:01:04_30.00	True	30.0	97	15.4	53.8	11.3	0.0	83.8	0.0	37.4	0.0	0.0	0.0	62.5	0.0	0.0	DNA_Synth	83.8	Tyrphostin AG 698, Tyrphostin B52	EGFR protein tyrosine kinase inhibitor.	False	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCCc1ccccc1
280421	280421:01:03_30.00	True	30.0	81	7.1	0.0	2.7	33.9	18.6	27.5	4.7	41.1	21.1	34.9	0.0	56.2	22.6	Tubulin	56.2	Cefaclor	semi-synthetic cephalosporin antibiotic, interferes with cell wall synthesis.	False	NC(C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(Cl)CS[C@H]12)c1ccccc1
281012	281012:01:03_30.00	True	30.0	88	28.3	0.0	0.0	71.4	0.0	72.1	15.8	88.5	29.1	46.5	0.0	63.7	39.6	LCH	88.5	Tomoxetine	norepinephrine reuptake blocker.	False	CNCCC(Oc1ccccc1C)c1ccccc1
280629	280629:01:03_30.00	True	30.0	63	46.8	40.4	0.0	0.0	0.0	0.0	66.4	0.2	0.0	0.0	32.2	0.0	2.8	HSP90	66.4	Indirubin-3'-oxime	protein kinase inhibitor; inhibits cyclin-dependent kinases (IC50 = 0.18 - 3.33 µM) and GSK-3ß (IC50 = 0.19 µM). Inhibits CDK5- and GSK-3ß-mediated tau phosphorylation, a process over-active in Alzheimer disease states. Also inhibits AMPK, LCK and SGK. Induces cell cycle arrest and inhibits cell proliferation.	False	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\O
280081	280081:01:03_30.00	True	30.0	91	21.9	0.0	0.0	34.5	0.0	39.0	34.6	66.3	0.7	12.7	0.0	40.1	11.2	LCH	66.3	R 59-022	R 59-022 (DKGI-I) is a diacylglycerol kinase inhibitor (IC50=2.8 uM). R 59-022 is a 5-HTR antagonist, and activates protein kinase C (PKC). R 59-022 potentiates thrombin-induced diacylglycerol production in platelets and inhibits phosphatidic acid production in neutrophils.	False	Cc1nc2sccn2c(=O)c1CCN1CCC(=C(c2ccccc2)c2ccc(F)cc2)CC1
280371	280371:01:03_30.00	True	30.0	110	5.0	9.9	0.0	0.0	0.0	0.0	18.5	16.6	0.0	0.0	10.2	0.0	0.0	HSP90	18.5	8-(3-Chlorostyryl)caffeine, CSC	Selective adenosine A2A receptor antagonist and monoamine oxidase B (MAO-B) inhibitor (Ki values are 54 and 28200 nM at rat A2A and A1 receptors respectively and Ki ~ 100 nM at MAO-B). Potently protects against quinolinic acid-induced (Cat. No. 0225) neuronal damage and is neuroprotective in the MPTP model of Parkinson's disease.	False	Cn1c(=O)c2c(nc(/C=C/c3cccc(Cl)c3)n2C)n(C)c1=O
280128	280128:01:04_30.00	True	30.0	88	73.4	0.0	0.0	77.2	0.0	75.1	20.8	93.4	35.3	51.1	0.0	74.0	48.4	LCH	93.4	U-73343	inactive analog of U73122 (Rack 16, Well D06).	False	COc1ccc2c(c1)CCC1C2CC[C@@]2(C)C1CC[C@@H]2NCCCCCCN1C(=O)CCC1=O
280793	280793:01:03_30.00	True	30.0	58	58.9	0.0	0.0	62.8	0.0	59.1	31.8	69.1	31.2	62.9	0.0	72.9	53.7	Tubulin	72.9	N-Oleoyldopamine, OLDA	endogenous vanilloid, weak CB1 cannabinoid receptor ligand.	False	CCCCCCCC/C=C\CCCCCCCC(=O)NCCc1ccc(O)c(O)c1
280583	280583:01:04_30.00	True	30.0	86	83.2	0.0	0.0	81.7	0.0	80.1	26.3	87.9	39.8	61.5	0.0	75.9	59.1	LCH	87.9	Hexahydro-sila-difenidol hydrochloride, p-fluoro analog, p-F-HHSiD hydrochloride	high affinity muscarinic acetylcholine receptor antagonist, but displays altered selectivity (M3 > M1 > M2).	False	O[Si](CCCN1CCCCC1)(c1ccc(F)cc1)C1CCCCC1
280574	280574:01:04_30.00	True	30.0	96	30.9	0.0	0.0	50.4	0.0	49.4	29.3	65.3	5.8	35.7	0.0	55.4	30.0	LCH	65.3	Guanidinyl-naltrindole di-trifluoroacetate	selective kappa opioid receptor antagonist.	False	N=C(N)Nc1ccc2[nH]c3c(c2c1)C[C@@]1(O)[C@H]2Cc4ccc(O)c5c4[C@@]1(CCN2CC1CC1)[C@H]3O5
280911	280911:01:03_30.00	True	30.0	95	16.6	0.0	0.0	79.8	0.0	74.9	25.3	81.3	40.3	59.2	0.0	78.7	52.9	LCH	81.3	SDZ-205,557 hydrochloride	potent and selective 5-HT4 serotonin receptor antagonist.	False	CCN(CC)CCOC(=O)c1cc(Cl)c(N)cc1OC
280370	280370:01:03_30.00	True	30.0	86	8.1	0.0	0.0	35.2	0.0	53.9	63.9	41.8	13.5	43.2	0.0	50.4	35.7	HSP90	63.9	Capsazepine	Capsazepine is a synthetic analogue of the sensory neurone excitotoxin, and an antagonist of TRPV1 receptor with an IC50 of 562 nM.	False	Oc1cc2c(cc1O)CN(C(=S)NCCc1ccc(Cl)cc1)CCC2
280816	280816:01:03_30.00	True	30.0	111	11.7	0.0	0.0	56.9	0.0	55.3	29.5	75.5	11.5	27.9	0.0	59.3	38.7	LCH	75.5	PNU-37887A	selective Kir 6.1/SUR2B potassium channel inhibitor.	False	C1CCC(N/C(=N\C23CC4CC(CC(C4)C2)C3)N2CCOCC2)CC1
280960	280960:01:04_30.00	True	30.0	79	80.3	0.0	0.0	78.1	0.0	75.5	40.8	74.8	39.7	64.1	0.0	86.1	53.7	Tubulin	86.1	SU 4312	vascular endothelial growth factor (VEGF) receptor protein tyrosine kinase 1/2 (KDR) and platelet derived growth factor (PDGF) receptor inhibitor.	False	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1
280483	280483:01:03_30.00	True	30.0	100	49.2	0.0	0.0	61.3	0.0	62.6	29.7	83.0	27.0	30.8	0.0	61.5	29.3	LCH	83.0	Dihydroergotamine methanesulfonate	ergot alkaloid, vasoconstrictor, competitive serotonin receptor antagonist, partial agonist at alpha adrenoceptors and D2 dopamine receptors, vasoconstrictor, antimigraine.	False	CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21
280175	280175:01:03_30.00	True	30.0	90	10.5	0.0	0.0	62.8	0.0	60.0	31.2	74.3	15.5	58.2	0.0	66.9	41.9	LCH	74.3	L-Beta-threo-benzyl-aspartate	preferential EAAT3 excitatory amino acid transporter inhibitor.	False	N[C@H](C(=O)O)[C@H](Cc1ccccc1)C(=O)O
247012	247012:02:03_30.00	True	30.0	85	40.2	49.4	0.0	12.1	0.0	12.3	59.7	23.5	10.4	33.7	2.3	25.5	41.5	HSP90	59.7	Clotrimazole	specific inhibitor of Ca2+-activated K+ channels, Specific inhibitor of Ca2+ activated K+ channels, antifungal.	False	Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1
280440	280440:01:03_30.00	True	30.0	72	23.8	50.8	29.1	0.0	95.2	0.0	12.2	0.0	0.0	0.0	79.3	0.0	0.0	DNA_Synth	95.2	Pyrocatechol, Catechol	carcinogen, causes DNA strand breakage.	False	Oc1ccccc1O
247070	247070:02:03_30.00	True	30.0	84	75.3	0.0	0.0	81.9	0.0	77.6	9.7	94.0	39.6	51.6	0.0	74.6	56.3	LCH	94.0	Desipramine hydrochloride	Desipramine hydrochloride is an inhibitor of norepinephrine transporter (NET), 5-HT transporter (SERT) and dopamine transporter (DAT) with Kis of 4, 61 and 78,720 nM, respectively.	False	CNCCCN1c2ccccc2CCc2ccccc21
280468	280468:01:03_30.00	True	30.0	95	31.1	0.0	0.0	63.2	0.0	65.9	32.9	81.0	24.8	41.2	0.0	60.0	37.2	LCH	81.0	WB-4101 hydrochloride	alpha1A Adrenoceptor antagonist.	False	COc1cccc(OC)c1OCCNCC1COc2ccccc2O1
280907	280907:01:03_30.00	True	30.0	74	17.6	42.5	7.3	0.0	93.1	0.0	0.0	0.0	0.0	0.0	64.6	0.0	0.0	DNA_Synth	93.1	(±)-6-Chloro-PB hydrobromide, (±)-SKF-81297 hydrobromide	D1 dopamine receptor agonist.	False	Oc1cc2c(c(Cl)c1O)CCNCC2c1ccccc1
280918	280918:01:03_30.00	True	30.0	90	81.3	0.0	0.0	76.9	0.0	76.0	24.3	87.8	34.2	53.5	0.0	71.3	55.1	LCH	87.8	Cortexolone maleate	D2 dopamine receptor antagonist.	False	COc1ccccc1N1CCN(CCCCNS(=O)(=O)c2cccc3c(N(C)C)cccc23)CC1
280424	280424:01:03_30.00	True	30.0	96	17.8	0.0	0.0	28.2	0.0	27.4	39.3	45.3	0.0	12.6	0.0	42.1	11.2	LCH	45.3	N-(2-[4-(4-Chlorophenyl)piperazin-1-yl]ethyl)-3-methoxybenzamide	selective D4 dopamine receptor agonist.	False	COc1cccc(C(=O)NCCN2CCN(c3ccc(Cl)cc3)CC2)c1
246746	246746:02:03_30.00	True	30.0	91	77.0	0.0	0.0	79.5	0.0	77.7	17.7	93.9	35.2	52.2	0.0	73.3	52.1	LCH	93.9	Cyproheptadine (hydrochloride)	Cyproheptadine hydrochloride is a 5-HT2A receptor antagonist, with antidepressant and antiserotonergic effects. Cyproheptadine hydrochloride has antiplatelet and thromboprotective activities. Cyproheptadine hydrochloride can be used for the research of thromboembolic disorders.	False	CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1
280360	280360:01:03_30.00	True	30.0	98	81.7	0.0	0.0	79.8	0.0	78.1	24.0	88.6	35.8	58.2	0.0	74.2	54.0	LCH	88.6	CGS-12066A maleate	5-HT1B Serotonin receptor agonist.	False	CN1CCN(c2nc3cc(C(F)(F)F)ccc3n3cccc23)CC1
280088	280088:01:03_30.00	True	30.0	97	16.1	14.0	4.9	10.0	18.3	23.5	0.0	33.9	7.5	0.0	0.0	0.0	11.2	LCH	33.9	AS-252424	AS-252424 is a potent and selective PI3K.g. inhibitor with an IC50 of 30±10 nM.	False	O=C1NC(=O)/C(=C/c2ccc(-c3ccc(F)cc3O)o2)S1
280868	280868:01:03_30.00	True	30.0	102	9.3	48.9	0.0	0.0	32.7	0.0	0.0	0.0	0.0	0.0	32.4	0.0	0.6	AKT_PI3K_MTOR	48.9	Pyridostigmine bromide	cholinesterase inhibitor, cholinergic.	False	CN(C)C(=O)Oc1ccc[n+](C)c1
280929	280929:01:03_30.00	True	30.0	85	25.4	31.7	18.1	0.0	87.9	0.0	14.3	18.1	0.0	0.0	52.0	0.0	0.0	DNA_Synth	87.9	SKF 83959 hydrobromide	atypical D1 dopamine receptor agonist, displays antagonist activity in vitro and agonist activity in vivo.	False	Cc1cccc(C2CN(C)CCc3c2cc(O)c(O)c3Cl)c1
280732	280732:01:03_30.00	True	30.0	97	49.1	0.0	0.0	53.4	0.0	58.9	33.4	80.4	17.0	23.7	0.0	53.5	20.1	LCH	80.4	Gallopamil (hydrochloride)	Gallopamil hydrochloride (Methoxyverapamil hydrochloride), a methoxy derivative of Verapamil, is a phenylalkylamine calcium antagonist. Gallopamil hydrochloride inhibits acid secretion in a concentration-dependent manner with an IC50 of 10.9 uM. Gallopamil hydrochloride is a potent antiarrhythmic and vasodilator agent.	False	COc1ccc(CCN(C)CCCC(C#N)(c2cc(OC)c(OC)c(OC)c2)C(C)C)cc1OC
280926	280926:01:03_30.00	True	30.0	81	29.5	24.5	7.0	0.0	45.8	0.0	14.0	1.8	0.0	32.7	5.3	18.9	30.8	DNA_Synth	45.8	Spermidine trihydrochloride	binds to the polyamine modulatory site of the NMDA glutamate receptor.	False	NCCCCNCCCN
280196	280196:01:03_30.00	True	30.0	90	9.8	0.0	0.0	41.4	0.0	37.4	13.7	43.1	32.3	43.5	0.0	52.6	28.9	Tubulin	52.6	Clonidine hydrochloride	alpha2 Adrenoceptor agonist, antihypertensive.	False	Clc1cccc(Cl)c1N=C1NCCN1
280627	280627:01:04_30.00	True	30.0	95	33.9	0.0	0.0	70.8	0.0	67.8	25.3	89.9	26.1	46.7	0.0	65.2	53.2	LCH	89.9	3-(1H-Imidazol-4-yl)propyl di(p-fluorophenyl)methyl ether hydrochloride	H3 Histamine receptor antagonist.	False	Fc1ccc(C(OCCCc2c[nH]cn2)c2ccc(F)cc2)cc1
280902	280902:01:03_30.00	True	30.0	103	43.2	0.0	0.0	55.2	0.0	59.6	30.3	77.7	20.5	31.2	0.0	56.8	18.0	LCH	77.7	Ketanserin tartrate, R 41468	selective 5-HT2 serotonin receptor blocker.	False	O=C(c1ccc(F)cc1)C1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1
280016	280016:01:03_30.00	True	30.0	97	40.6	0.0	0.0	67.9	0.0	69.2	25.7	76.1	30.8	44.5	0.0	63.9	28.8	LCH	76.1	LY-53,857 maleate	potent and selective 5-HT2 serotonin receptor antagonist.	False	CC(O)C(C)OC(=O)[C@@H]1C[C@@H]2c3cccc4c3c(cn4C(C)C)C[C@H]2N(C)C1
280193	280193:01:03_30.00	True	30.0	86	53.4	0.0	0.0	68.4	0.0	71.8	36.9	81.5	33.4	50.0	0.0	67.1	42.5	LCH	81.5	Fulvestrant	selective estrogen receptor downregulator (SERD). First pure antiestrogen with no agonistic activity both in vitro and in vivo.	False	C[C@]12CC[C@@H]3c4ccc(O)cc4C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@H]3[C@@H]1CC[C@@H]2O
280916	280916:01:03_30.00	True	30.0	99	7.6	0.0	0.0	48.2	0.0	56.2	55.9	55.2	10.8	33.4	0.0	55.9	18.7	HDAC	56.2	SB 204741	5-HT2B serontonin receptor antagonist.	False	Cc1cc(NC(=O)Nc2ccc3c(ccn3C)c2)sn1
280392	280392:01:03_30.00	True	30.0	82	6.9	31.8	48.3	0.0	71.4	0.0	5.4	0.0	0.0	0.0	67.7	0.0	0.0	DNA_Synth	71.4	CB 1954	prodrug activated by NAD(P)H quinone oxidoreductase-2.	False	NC(=O)c1cc(N2CC2)c([N+](=O)[O-])cc1[N+](=O)[O-]
246795	246795:02:03_30.00	True	30.0	85	7.8	0.0	9.4	33.7	0.0	30.0	19.8	39.0	21.6	28.4	0.0	54.9	19.0	Tubulin	54.9	Aniracetam	increases ion conductance through AMPA glutamate receptors, reported to display anti-amnesic acitivty, cognitive enhancer.	False	COc1ccc(C(=O)N2CCCC2=O)cc1
280482	280482:01:03_30.00	True	30.0	90	31.8	0.0	0.0	79.9	0.0	75.3	14.9	89.7	43.0	54.4	0.0	70.3	50.0	LCH	89.7	Dextromethorphan hydrobromide monohydrate	allosteric antagonist at NMDA-controlled ion channels.	False	COc1ccc2c(c1)C13CCCCC1C(C2)N(C)CC3
280412	280412:01:03_30.00	True	30.0	90	18.0	0.0	0.0	57.1	0.0	60.7	19.9	83.2	17.1	33.6	0.0	55.1	22.4	LCH	83.2	(+)-Chlorpheniramine maleate	H1 Histamine receptor antagonist, active isomer.	False	CN(C)CC[C@@H](c1ccc(Cl)cc1)c1ccccn1
280740	280740:01:04_30.00	True	30.0	95	44.0	0.0	0.0	54.6	0.0	52.5	11.0	89.4	12.8	23.0	0.0	56.9	24.7	LCH	89.4	MDL 28170, Z-Val-Phe-CHO	cell permeable calpain I and II inhibitor.	False	CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@H](C=O)Cc1ccccc1
281022	281022:01:03_30.00	True	30.0	104	52.8	0.0	0.0	75.0	0.0	73.4	17.9	96.2	32.9	42.5	0.0	63.9	42.8	LCH	96.2	(-)-cis-(1S,2R)-U-50488 tartrate	potent sigma receptor ligand.	False	CN(C(=O)Cc1ccc(Cl)c(Cl)c1)[C@@H]1CCCC[C@@H]1N1CCCC1
280342	280342:01:03_30.00	True	30.0	95	57.3	0.0	0.0	82.8	0.0	80.2	17.7	92.6	40.8	54.1	0.0	74.6	50.4	LCH	92.6	BRL 52537 hydrochloride	kappa/mu opioid receptor agonist.	False	O=C(Cc1ccc(Cl)c(Cl)c1)N1CCCCC1CN1CCCC1
280096	280096:01:03_30.00	True	30.0	63	34.7	24.0	22.0	0.0	77.3	0.0	26.2	8.1	0.0	0.0	57.1	0.0	0.0	DNA_Synth	77.3	DMAT	DMAT is a potent and specific CK2 inhibitor with an IC50 value of 130 nM.	False	CN(C)c1nc2c(Br)c(Br)c(Br)c(Br)c2[nH]1
280379	280379:01:03_30.00	True	30.0	87	29.7	0.0	0.0	73.1	0.0	73.1	35.1	71.4	46.0	51.0	0.0	67.5	64.9	BET	73.1	Chloro-IB-MECA	A3 adenosine receptor agonist.	False	CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCc4ccc(I)cc4)nc(Cl)nc32)[C@H](O)[C@@H]1O
280413	280413:01:03_30.00	True	30.0	84	34.5	49.5	0.0	25.2	33.2	15.5	10.7	30.6	5.0	31.3	0.0	43.8	71.6	Uncoupler	71.6	2-CADO	adenosine receptor agonist with selectivity for A1 over A2.	False	Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](CO)[C@H](O)C1O
280420	280420:01:03_30.00	True	30.0	66	34.9	58.2	19.7	0.0	97.1	0.0	0.0	0.0	0.0	0.0	79.6	0.0	0.0	DNA_Synth	97.1	Cytosine-1-beta-D-arabinofuranoside hydrochloride, Arabinocytidine hydrochloride, Arabinosylcytosine hydrochloride, Ara-C hydrochloride	selective inhibitor of DNA synthesis.	False	Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1
247233	247233:02:03_30.00	True	30.0	102	29.4	0.0	0.0	65.9	0.0	64.3	20.7	88.6	23.4	37.4	0.0	60.5	36.7	LCH	88.6	Citalopram (hydrobromide)	Citalopram hydrobromide is an antidepressant drug of the selective serotonin reuptake inhibitor (SSRI) class. It has US FDA approval to treat major depression.	False	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21
281009	281009:01:04_30.00	True	30.0	81	6.4	7.5	57.8	0.0	68.2	0.0	8.4	0.0	0.0	0.0	50.3	0.0	0.0	DNA_Synth	68.2	Tyrphostin 51	EGFR tyrosine kinase inhibitor.	False	N#CC(C#N)=C/C(N)=C(/C#N)c1cc(O)c(O)c(O)c1
280958	280958:01:03_30.00	True	30.0	99	24.5	70.7	0.0	0.0	18.8	0.0	31.9	23.4	0.0	0.0	18.5	1.6	29.9	AKT_PI3K_MTOR	70.7	Semaxinib	Semaxinib (SU5416) is a potent and selective inhibitor of VEGFR (Flk-1/KDR) with an IC50 of 1.23 uM.	False	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1
280481	280481:01:03_30.00	True	30.0	103	9.0	0.0	0.0	15.4	0.0	7.4	37.9	32.8	0.0	16.6	0.0	28.9	0.0	HSP90	37.9	Diltiazem hydrochloride	Ca2+ channel antagonist selective for slow, or L-type, channels, stimulates 1,4-dihydropyridine binding to Ca2+ channels, coronary vasodilator.	False	COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1
247077	247077:02:03_30.00	True	30.0	90	15.7	0.0	0.0	38.6	0.0	36.1	44.1	55.4	2.8	21.6	0.0	46.8	18.9	LCH	55.4	Dobutamine (hydrochloride)	Dobutamine hydrochloride is a synthetic catecholamine that acts on .a.1-AR, .b.1-AR, .b.2-AR (.a.-1, .b.-1 and.b.-2 adrenoceptors). Dobutamine hydrochloride is a selective .b.1-AR agonist, relatively weak activity at .a.1-AR and .b.2-AR. Dobutamine hydrochloride can increase cardiac output and correct hypoperfusion.	False	CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1
247217	247217:02:03_30.00	True	30.0	95	8.5	0.0	0.0	69.0	0.0	66.3	18.2	89.1	29.3	32.6	0.0	64.2	50.5	LCH	89.1	Diphenhydramine (hydrochloride)	Diphenhydramine hydrochloride, a histamine H1 antagonist used as an antiemetic, antitussive, for dermatoses and pruritus, for hypersensitivity reactions, as a hypnotic, an antiparkinson, and as an ingredient in common cold preparations.Target: Histamine H1 receptorDiphenhydramine hydrochloride, a histamine H1 antagonist used as an antiemetic, antitussive, for dermatoses and pruritus, for hypersensitivity reactions, as a hypnotic, an antiparkinson, and as an ingredient in common cold preparations. It has some undesired antimuscarinic and sedative effects. Diphenhydramine competes with free histamine for binding at HA-receptor sites. This antagonizes the effects of histamine on HA-receptors, leading to a reduction of the negative symptoms brought on by histamine HA-receptor binding.	False	CN(C)CCOC(c1ccccc1)c1ccccc1
247099	247099:02:03_30.00	True	30.0	93	63.6	0.0	0.0	73.3	0.0	71.4	13.8	89.8	33.6	52.7	0.0	69.8	41.3	LCH	89.8	Carbetapentane (citrate)	Carbetapentane citrate is a selective inhibitor of the cough, with mild atropine-like effect and local anesthesia effect.	False	CCN(CC)CCOCCOC(=O)C1(c2ccccc2)CCCC1
280434	280434:01:03_30.00	True	30.0	67	29.2	0.0	36.9	0.0	57.7	0.0	41.2	13.5	0.0	7.5	22.5	31.9	0.0	DNA_Synth	57.7	Caffeic acid phenethyl ester	Caffeic acid phenethyl ester is a NF-.k.B inhibitor.	False	O=C(/C=C/c1ccc(O)c(O)c1)OCCc1ccccc1
280913	280913:01:03_30.00	True	30.0	92	49.1	0.6	0.0	62.6	0.0	70.1	57.7	71.6	21.1	54.2	0.0	60.9	57.1	LCH	71.6	SB-366791, Vanilloid receptor-1 antagonist	vanilloid receptor-1 (VR1) antagonist.	False	COc1ccc(NC(=O)/C=C/c2ccc(Cl)cc2)cc1
280941	280941:01:03_30.00	True	30.0	85	19.3	0.0	0.0	56.5	0.0	49.8	26.4	67.2	20.3	50.3	0.0	68.9	44.6	Tubulin	68.9	Albuterol hemisulfate, Salbutamol hemisulfate	beta Adrenoceptor agonist.	False	CC(C)(C)NCC(O)c1ccc(O)c(CO)c1
280187	280187:01:04_30.00	True	30.0	93	26.9	70.0	0.0	0.0	19.5	3.1	18.2	11.3	0.0	0.0	17.6	0.0	50.0	AKT_PI3K_MTOR	70.0	CGP 57380	cell-permeable, selective mitogen-activated protein kinase-interacting kinase 1 (MNK1) inhibitor.	False	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12
280956	280956:01:03_30.00	True	30.0	76	50.4	0.0	0.0	72.5	0.0	69.6	16.6	67.1	44.2	64.7	0.0	78.4	38.5	Tubulin	78.4	SB 205384	GABA-A receptor modulator selective for the alpha3beta2gamma2 subunit combination.	False	CC#CCOC(=O)c1c(C)nc2sc3c(c2c1N)CCC(O)C3
280470	280470:01:03_30.00	True	30.0	50	50.6	0.0	6.4	27.0	0.0	43.0	0.0	0.0	87.4	24.5	0.0	21.5	26.5	Na_K-ATPase	87.4	Dihydroouabain	sodium-potassium pump inhibitor.	False	C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@@H]4C(CC[C@]3(O)C2)[C@@]2(O)CC[C@H](C3COC(=O)C3)[C@@]2(C)C[C@H]4O)[C@H](O)[C@H](O)[C@H]1O
280219	280219:01:03_30.00	True	30.0	97	64.2	0.0	0.0	78.9	0.0	77.6	16.0	92.9	42.5	52.5	0.0	74.1	50.2	LCH	92.9	Aminobenztropine, ABT	high affinity muscarinic acetylcholine receptor ligand.	False	CN1C2CCC1CC(OC(c1ccccc1)c1ccccc1N)C2
280423	280423:01:03_30.00	True	30.0	92	8.8	0.0	7.1	33.8	0.0	26.8	26.3	36.3	20.0	33.7	0.0	55.0	24.1	Tubulin	55.0	McN-A-343	M1 muscarinic acetylcholine receptor agonist.	False	C[N+](C)(C)CC#CCOC(=O)Nc1cccc(Cl)c1
280950	280950:01:03_30.00	True	30.0	88	19.2	0.0	0.0	32.2	0.0	33.2	31.9	57.8	0.0	18.7	0.0	43.5	9.9	LCH	57.8	SB 269970 hydrochloride	selective 5-HT7 serotonin receptor antagonist.	False	CC1CCN(CC[C@H]2CCCN2S(=O)(=O)c2cccc(O)c2)CC1
246981	246981:02:03_30.00	True	30.0	92	53.9	0.0	0.0	55.0	0.0	59.5	42.7	75.5	8.9	47.0	0.0	58.6	38.3	LCH	75.5	Clemizole hydrochloride	H1 Histamine receptor antagonist, H1 antagonist.	False	Clc1ccc(Cn2c(CN3CCCC3)nc3ccccc32)cc1
280301	280301:01:03_30.00	True	30.0	106	7.9	0.0	0.0	75.2	0.0	65.1	11.8	76.5	26.0	57.1	0.0	69.1	61.2	LCH	76.5	L(-)-Norepinephrine bitartrate, (-)-Arterenol bitartrate, Noradrenaline bitartrate	adrenergic neurotransmitter, vasoconstrictor.	False	NC[C@H](O)c1ccc(O)c(O)c1
280225	280225:01:03_30.00	True	30.0	91	40.2	0.0	0.0	68.6	0.0	67.3	12.4	87.9	36.9	43.1	0.0	70.9	39.2	LCH	87.9	Alaproclate hydrochloride	potent and selective serotonin reuptake inhibitor.	False	CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1
247015	247015:02:03_30.00	True	30.0	107	5.0	0.0	10.0	10.2	0.0	5.1	45.5	8.0	0.0	27.9	0.0	23.4	0.0	HSP90	45.5	Doxylamine (succinate)	Doxylamine (succinate) is a first generation antihistamine; can be used by itself as a short-term sedative and in combination with other drugs to provide night-time allergy and cold relief.	False	CN(C)CCOC(C)(c1ccccc1)c1ccccn1
280122	280122:01:04_30.00	True	30.0	94	67.9	0.0	0.0	69.3	0.0	66.7	39.0	54.8	38.8	66.9	0.0	61.3	67.7	BET	69.3	JFD00244	A SIRT (sirtuin, human silent information regulator) inhibitor.	False	O=C1c2ccccc2C(=O)c2c(NCCc3ccc(O)cc3)ccc(NCCc3ccc(O)cc3)c21
280372	280372:01:03_10.00	True	10.0	94	14.2	52.0	0.0	39.1	0.0	38.7	18.0	59.2	18.8	20.8	0.0	32.7	59.8	Uncoupler	59.8	CGS 15943	CGS 15943 is an orally bioavailable non-xanthine Adenosine Receptor antagonist. Its Ki for human A1, A2A, A2B, and A3 Adenosine Receptors are 3.5, 4.2, 16, and 50 nM in transfected CHO cells, respectively. .	False	Nc1nc2ccc(Cl)cc2c2nc(-c3ccco3)nn12
247373	247373:02:03_10.00	True	10.0	98	6.2	0.0	0.0	57.2	0.0	63.7	0.0	64.8	49.4	29.5	0.0	43.5	45.3	LCH	64.8	Nisoxetine hydrochloride, LY-94,939	potent and selective norepinephrine reuptake blocker, Noradrenaline reuptake inhibitor.	False	CNCCC(Oc1ccccc1OC)c1ccccc1
280263	280263:01:03_10.00	True	10.0	105	12.8	52.2	0.0	10.1	18.3	3.3	0.0	24.6	0.0	0.0	7.6	5.2	44.9	AKT_PI3K_MTOR	52.2	3-Amino-1-propanesulfonic acid sodium	GABA-A receptor agonist.	False	NCCCS(=O)(=O)O
247293	247293:02:03_10.00	True	10.0	104	29.7	0.0	0.0	74.3	0.0	71.9	3.9	90.3	38.5	35.1	0.0	59.8	43.0	LCH	90.3	Proadifen (hydrochloride)	inhibitor of microsomal drug metabolism, Cytochrome P450 mono-oxygenases inhibitor, cytochrome p450 inhibitor, ca antagonist.	False	CCCC(C(=O)OCCN(CC)CC)(c1ccccc1)c1ccccc1
280215	280215:01:03_10.00	True	10.0	106	20.0	0.0	0.0	81.4	0.0	78.9	14.9	89.5	37.3	56.6	0.0	77.7	51.1	LCH	89.5	TMB-8 hydrochloride	intracellular Ca2+ antagonist, inhibits calmodulin-sensitive Ca2+-ATPase activity, protein kinase C inhibitor.	False	CCN(CC)CCCCCCCCOC(=O)c1cc(OC)c(OC)c(OC)c1
280318	280318:02:03_10.00	True	10.0	104	43.5	0.0	0.0	76.5	0.0	72.6	12.3	93.9	31.3	47.0	0.0	66.7	54.3	LCH	93.9	(±)-Butaclamol hydrochloride, AY 23028	dopamine receptor antagonist, selective for D2 over D1.	False	CC(C)(C)[C@]1(O)CCN2C[C@H]3c4ccccc4CCc4cccc(c43)[C@@H]2C1
280796	280796:01:03_10.00	True	10.0	50	61.1	0.0	0.0	71.7	0.0	76.8	0.0	41.8	88.4	54.8	0.0	74.2	46.4	Na_K-ATPase	88.4	Ouabain, Acocantherine	blocks movement of the H5 and H6 transmembrane domains of Na+-K+ ATPases.	False	C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@@H](C6=CC(=O)OC6)CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)[C@H](O)[C@H](O)[C@H]1O
280267	280267:01:03_10.00	True	10.0	98	6.7	37.3	0.0	32.3	6.0	26.2	0.0	46.1	15.9	12.0	0.0	32.0	54.7	Uncoupler	54.7	Azathioprine	purine analog, purine synthesis inhibitor, immunosuppressant.	False	Cn1cnc([N+](=O)[O-])c1Sc1ncnc2nc[nH]c12
280245	280245:01:03_10.00	True	10.0	87	9.3	18.7	0.0	39.6	0.0	35.8	0.0	42.2	8.9	14.5	0.0	31.5	44.5	Uncoupler	44.5	(±)-Norepinephrine (+)bitartrate, (±)-Arterenol (+)bitartrate, (±)-Noradrenalin (+)bitartrate	adrenergic neurotransmitter.	False	NCC(O)c1ccc(O)c(O)c1
246855	246855:02:03_10.00	True	10.0	94	34.2	73.5	0.0	0.0	94.5	0.0	8.5	0.0	0.0	0.0	80.2	0.0	0.0	DNA_Synth	94.5	Methotrexate, Methylaminopterin, MTX	folic acid antagonist.	False	CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1
245391	245391:03:03_10.00	True	10.0	92	17.8	24.4	0.0	45.3	0.0	51.7	33.6	26.9	33.8	47.6	0.0	36.5	72.6	Uncoupler	72.6	Niclosamide	Niclosamide (BAY2353)is an orally bioavailable chlorinated salicylanilide, with anthelmintic and potential antineoplastic activity. Niclosamide (BAY2353) inhibits STAT3 with IC50 of 0.25 uM in HeLa cells and inhibits DNA replication in a cell-free assay.	False	O=C(Nc1ccc([N+](=O)[O-])cc1Cl)c1cc(Cl)ccc1O
280127	280127:01:04_10.00	True	10.0	101	21.9	0.0	0.0	65.5	0.0	63.6	34.7	86.7	20.7	37.6	0.0	59.6	41.6	LCH	86.7	ABT-702 dihydrochloride	ABT-702 dihydrochloride is a potent adenosine kinase (AK) inhibitor (IC50=1.7 nM).	False	Nc1ncnc2nc(-c3ccc(N4CCOCC4)nc3)cc(-c3cccc(Br)c3)c12
280690	280690:01:03_10.00	True	10.0	97	53.4	0.0	0.0	79.0	0.0	74.7	11.5	95.6	34.3	52.5	0.0	67.4	55.5	LCH	95.6	Methiothepin mesylate	5-HT1 Serotonin receptor antagonist, blocks serotonin autoreceptors.	False	CSc1ccc2c(c1)C(N1CCN(C)CC1)Cc1ccccc1S2
245373	245373:03:03_10.00	True	10.0	103	7.3	0.0	0.0	70.4	0.0	67.3	10.0	85.2	26.6	43.7	0.0	62.7	41.5	LCH	85.2	Oxybutynin Chloride	muscarinic acetylcholine receptor antagonist, Anticholinergic.	False	CCN(CC)CC#CCOC(=O)C(O)(c1ccccc1)C1CCCCC1
280708	280708:01:03_10.00	True	10.0	107	35.1	0.0	0.0	86.9	0.0	81.8	20.6	83.0	45.4	57.0	0.0	77.0	67.3	BET	86.9	Mevastatin, Compactin	antibiotic, inhibits post-translational prenylation of proteins such as Ras and geranylgeranylation of Rho.	False	CC[C@H](C)C(=O)O[C@H]1CCC=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21
280789	280789:01:03_10.00	True	10.0	103	52.3	0.0	0.0	82.4	0.0	79.1	18.0	95.5	40.0	57.8	0.0	71.1	57.5	LCH	95.5	(±)-Octoclothepin maleate	D2 Dopamine receptor antagonist, serotonin receptor antagonist.	False	CN1CCN(C2Cc3ccccc3Sc3ccc(Cl)cc32)CC1
246889	246889:02:03_10.00	True	10.0	107	42.8	0.0	0.0	70.3	0.0	67.1	10.5	95.8	26.7	37.6	0.0	62.1	42.8	LCH	95.8	Loperamide (hydrochloride)	Loperamide (hydrochloride) (R-18553 (hydrochloride)) is an opioid receptor agonist. Loperamide hydrochloride is a selective and competitive human intestinal carboxylesterases (hiCE) inhibitor. Loperamide hydrochloride has anti-diarrheal effect.	False	CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1
280968	280968:01:03_10.00	True	10.0	91	35.8	0.0	0.0	75.1	0.0	73.3	18.1	96.4	26.1	50.4	0.0	68.2	45.0	LCH	96.4	Trifluperidol hydrochloride, R 2498 hydrochloride, Triperidol hydrochloride	dopamine receptor antagonist, antipsychotic.	False	O=C(CCCN1CCC(O)(c2cccc(C(F)(F)F)c2)CC1)c1ccc(F)cc1
247419	247419:02:03_10.00	True	10.0	106	6.4	0.0	0.0	46.3	0.0	42.8	18.5	72.2	16.0	13.0	0.0	48.1	18.5	LCH	72.2	Naftopidil dihydrochloride, KT-611 dihydrochloride	alpha1 Adrenoceptor antagonist, antihypertensive, Alpha1 agonist.	False	COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1
280791	280791:01:03_10.00	True	10.0	96	6.9	0.0	0.0	50.2	0.0	51.4	0.0	64.6	24.0	3.8	0.0	42.7	31.9	LCH	64.6	Olomoucine	potent and selective inhibitor of cdc2, cdk and cyclin-dependent kinases.	False	Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc21
280973	280973:01:03_10.00	True	10.0	73	47.5	9.5	0.0	66.2	0.0	66.8	17.3	40.5	49.6	57.7	0.0	55.1	87.1	Uncoupler	87.1	Tyrphostin A9	Tyrphostin A9, a PDGFR inhibitor, is a potent inducer of mitochondrial fission. Tyrphostin A9 emerged as the most potent and selective of 51 tyrosine kinase inhibitors tested against the TNF-induced respiratory burst. Tyrphostin A9 has anti-influenza virus activities.	False	CC(C)(C)c1cc(C=C(C#N)C#N)cc(C(C)(C)C)c1O
280321	280321:01:03_10.00	True	10.0	102	33.2	0.0	0.0	76.9	0.0	72.2	5.5	94.3	35.9	43.5	0.0	65.4	48.2	LCH	94.3	BW 723C86	5-HT2B serotonin receptor agonist.	False	CC(N)Cc1c[nH]c2ccc(OCc3cccs3)cc12
247101	247101:02:03_10.00	True	10.0	92	21.4	0.0	0.0	59.6	0.0	59.1	15.4	90.6	24.1	24.3	0.0	55.1	31.6	LCH	90.6	Ketoconazole	potent inhibitor of cytochrome P450c17 enzyme, antifungal agent, Cytochrome P450c17 inhibitor.	False	CC(=O)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1
281043	281043:01:03_10.00	True	10.0	96	19.0	78.2	0.0	0.0	68.6	0.0	4.8	21.5	0.0	0.0	48.1	0.0	15.7	AKT_PI3K_MTOR	78.2	Wortmannin from Penicillium funiculosum	potent and specific phosphatidylinositol 3-kinase (P13-K) inhibitor.	False	COC[C@H]1OC(=O)c2coc3c2[C@@]1(C)C1=C(C3=O)C2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O
280756	280756:01:03_10.00	True	10.0	96	7.9	0.0	5.9	43.8	0.0	41.4	1.5	63.1	6.0	3.1	0.0	52.3	10.0	LCH	63.1	NS-1619	selective large conductance Ca2+-activated K+-channel activator.	False	O=c1[nH]c2cc(C(F)(F)F)ccc2n1-c1cc(C(F)(F)F)ccc1O
280540	280540:01:03_10.00	True	10.0	100	34.2	67.8	12.5	0.0	79.2	0.0	0.0	0.0	0.0	0.0	76.1	0.0	0.0	DNA_Synth	79.2	rac-2-Ethoxy-3-octadecanamido-1-propylphosphocholine	protein kinase C (PKC) inhibitor.	False	CCCCCCCCCCCCCCCCCC(=O)NCC(COP(=O)(O)OCC[N+](C)(C)C)OCC
245383	245383:03:03_10.00	True	10.0	103	5.0	0.0	0.0	46.6	0.0	48.9	0.0	57.2	33.8	0.0	0.0	26.1	25.8	LCH	57.2	Xylometazoline (hydrochloride)	Xylometazoline hydrochloride is an .a.-adrenoceptor agonist commonly used as nasal decongestant.Target: .a.-AdrenoceptorXylometazoline hydrochloride is a nasal decongestant spray that constricts nasal blood vessels and increases nasal airflow, enabling patients with a blocked nose to breathe more easily. Xylometazoline hydrochloride is an effective and well-tolerated decongestant nasal spray that significantly relieved nasal congestion compared with placebo in the common cold and provided long-lasting relief with just 1 spray, helping patients to breathe more easily for a longer period of time . Xylometazoline hydrochloride exhibits in radioligand competition studies higher affinities than the catecholamines adrenaline and noradrenaline at most .a.-adrenoceptor subtypes. Xylometazoline behaved at .a.(2B) -adrenoceptors as full agonists .	False	Cc1cc(C(C)(C)C)cc(C)c1CC1=NCCN1
277596	277596:02:03_10.00	True	10.0	58	64.6	0.0	0.8	29.9	0.0	36.7	24.5	31.2	39.5	47.7	0.0	31.6	18.2	Protein_Synth	47.7	-Lapachone	.b.-Lapachone (ARQ-501;NSC-26326) is a naturally occurring O-naphthoquinone, acts as a topoisomerase I inhibitor, and induces apoptosis by inhibiting cell cycle progression.	False	CC1(C)CCC2=C(O1)c1ccccc1C(=O)C2=O
280754	280754:01:03_10.00	True	10.0	105	17.3	0.0	0.0	71.1	0.0	73.2	1.1	87.4	40.7	34.7	0.0	56.4	48.6	LCH	87.4	Naltriben methanesulfonate, NTB	highly selective delta2 opioid receptor antagonist.	False	Oc1ccc2c3c1O[C@H]1c4oc5ccccc5c4C[C@@]4(O)C(C2)N(CC2CC2)CCC314
280258	280258:01:03_10.00	True	10.0	100	8.6	10.9	0.0	51.2	0.0	53.6	30.6	75.8	9.0	33.1	0.0	48.8	51.7	LCH	75.8	EIPA	EIPA (L593754) is a TRPP3 channel inhibitor with an IC50 of 10.5 uM. EIPA also inhibits Na+/H+-exchanger (NHE) and macropinocytosis.	False	CCN(c1nc(N)c(C(=O)N=C(N)N)nc1Cl)C(C)C
246899	246899:02:04_10.00	True	10.0	92	69.3	0.0	0.0	84.2	0.0	79.9	7.4	92.7	45.2	61.6	0.0	74.3	63.3	LCH	92.7	Tamoxifen (Citrate)	Tamoxifen Citrate (ICI 46474) is an orally active, selective estrogen receptor modulator (SERM) which blocks estrogen action in breast cells and can activate estrogen activity in other cells, such as bone, liver, and uterine cells.Tamoxifen Citrate is a potent Hsp90 activator and enhances the Hsp90 molecular chaperone ATPase activity. Tamoxifen Citrate also potent inhibits infectious EBOV Zaire and Marburg (MARV) with IC50 of 0.1 uM and 1.8 uM, respectively. Tamoxifen Citrate activates autophagy and induces apoptosis.	False	CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1
280189	280189:01:03_10.00	True	10.0	101	13.1	1.1	0.0	58.1	0.0	58.0	34.4	80.5	21.6	21.4	0.0	54.7	39.2	LCH	80.5	SCH 58261	SCH 58261 is a potent, selective and competitive antagonist of adenosine A2A receptor with an IC50 of 15 nM, and displays 323-, 53- and 100-fold more selective for A2A receptor than A1, A2B, and A3 receptors, respectively.	False	Nc1nc2c(cnn2CCc2ccccc2)c2nc(-c3ccco3)nn12
281037	281037:01:03_10.00	True	10.0	97	5.4	0.0	0.0	60.5	0.0	61.2	19.3	51.7	34.3	36.0	0.0	40.0	45.9	HDAC	61.2	Vancomycin hydrochloride from Streptomyces orientalis, Cancocin hydrochloride	amphoteric glycopeptide antibiotic, interefers with cell wall syntehsis by bind to peptidoglycan.	False	CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O
280541	280541:01:03_10.00	True	10.0	105	14.0	3.6	0.0	70.2	0.0	68.2	7.8	78.6	23.1	47.5	0.0	61.9	67.5	LCH	78.6	(-)-Epinephrine bitartrate, Adrenaline bitartrate	endogenous hormone and neurotransmitter.	False	CNC[C@H](O)c1ccc(O)c(O)c1
280753	280753:01:03_10.00	True	10.0	100	20.0	0.0	0.0	70.1	0.0	63.1	0.0	84.1	24.3	40.5	0.0	65.9	53.0	LCH	84.1	Nylidrin (hydrochloride)	Nylidrin hydrochloride was an effective inhibitor of IgE-mediated release of histamine from passively sensitized rat peritoneal mast cells and human basophils, and of IgG1-mediated release of histamine from passively sensitized guinea pig lung slices.	False	CC(CCc1ccccc1)NC(C)C(O)c1ccc(O)cc1
280151	280151:01:03_10.00	True	10.0	101	27.8	0.0	0.0	87.6	0.0	80.0	0.0	75.9	53.5	58.6	0.0	76.9	58.3	BET	87.6	SB 242084 (hydrochloride)	SB 242084 hydrochloride is a 5-HT2C receptor antagonist(pKi=9.0) that displays 158- and 100-fold selectivity over 5-HT2A and 5-HT2B receptors respectively.IC50 value: 9.0(pKi) Target: 5-HT2C antagonistin vitro: SB 242084 had over 100-fold selectivity over a range of other 5-HT, dopamine and adrenergic receptors. In studies of 5-HT-stimulated phosphatidylinositol hydrolysis using SH-SY5Y cells stably expressing the cloned human 5-HT2C receptor, SB 242084 acted as an antagonist with a pKb of 9.3, which closely resembled its corresponding receptor binding affinity .in vivo: SB 242084 potently inhibited m-chlorophenylpiperazine (mCPP, 7 mgkg i.p. 20 min pre-test)-induced hypolocomotion in rats, a model of in vivo central 5-HT2C receptor function, with an ID50 of 0.11 mg/kg i.p., and 2.0 mg/kg p.o. SB 242084 (0.1-1 mg/kg i.p.) exhibited an anxiolytic-like profile in the rat social interaction test, increasing time spent in social interaction, but having no effect on locomotion. SB 242084 (0.1-1 mg/kg i.p.) also markedly increased punished responding in a rat Geller-Seifter conflict test of anxiety, but had no consistent effect on unpunished responding .	False	Cc1cc2c(cc1Cl)N(C(=O)Nc1ccc(Oc3cccnc3C)nc1)CC2
280136	280136:01:03_10.00	True	10.0	100	21.4	0.0	0.0	30.9	0.0	30.5	23.7	42.4	28.4	25.5	0.0	38.8	8.9	LCH	42.4	SB 525334	SB 525334 is a potent and selective transforming growth factor .b.1 receptor (ALK5) inhibitor with an IC50 of 14.3 nM.	False	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3nccnc3c2)n1
280257	280257:01:03_10.00	True	10.0	66	26.6	2.0	28.1	0.0	60.3	0.0	0.0	0.0	18.3	4.1	22.2	4.8	0.0	DNA_Synth	60.3	5-Azacytidine	5-Azacytidine (Azacitidine; 5-AzaC; Ladakamycin) is a nucleoside analogue of cytidine that specifically inhibits DNA methylation. 5-Azacytidine is incorporated into DNA to covalently trap DNA methyltransferases and contributes to reverse epigenetic changes. 5-Azacytidine induces cell autophagy.	False	Nc1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1
280819	280819:01:03_10.00	True	10.0	109	18.0	0.0	0.0	28.5	10.0	15.3	0.0	49.3	0.0	4.2	0.0	39.5	0.0	LCH	49.3	Pentamidine isethionate	NMDA glutamate receptor antagonist, neuroprotective agent, antimicrobial agent prescribed for the treatment of AIDS-associated Pneumocystis carinii pneumonia.	False	N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1
245325	245325:03:03_10.00	True	10.0	87	42.7	0.0	0.0	70.6	0.0	72.3	38.5	88.1	30.3	45.9	0.0	65.9	49.2	LCH	88.1	Reserpine, Methyl reserpate	inhibits vesicular catecholine and serotonin uptake, antihypertensive.	False	COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC
280179	280179:01:03_10.00	True	10.0	94	33.3	0.0	0.0	84.9	0.0	83.0	19.9	85.2	47.8	58.1	0.0	72.1	60.1	LCH	85.2	AMG9810	AMG9810 is a selective and competitive vanilloid receptor 1 (TRPV1) antagonist with IC50 values of 24.5 and 85.6 nM for human and rat TRPV1, repectively.	False	CC(C)(C)c1ccc(/C=C/C(=O)Nc2ccc3c(c2)OCCO3)cc1
246877	246877:02:03_10.00	True	10.0	103	11.1	0.0	0.0	54.2	0.0	54.4	17.1	85.3	19.0	14.5	0.0	53.0	14.5	LCH	85.3	(±)-Verapamil hydrochloride	L-type Ca2+ channel modulator, adrenoceptor antagonist, antiarryhthmic, cardiac depressant, coronary vasodilator, Alpha1 antagonist, adrenegic blocker, ca channel blocker, coronary vasodilator, antiarrhythmic.	False	COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC
280821	280821:01:03_10.00	True	10.0	82	15.0	0.0	0.0	46.6	0.0	44.2	2.8	44.5	25.7	23.9	0.0	60.2	47.5	Tubulin	60.2	Parthenolide	inhibits serotonin release from platelets, inhibits production of leukotriene B4 and thromboxane B2.	False	C=C1C(=O)O[C@H]2[C@H]1CC/C(C)=C\CC[C@@]1(C)O[C@H]21
280944	280944:01:03_10.00	True	10.0	96	48.7	0.0	0.0	82.2	0.0	79.5	9.8	93.9	43.5	51.4	0.0	69.6	51.7	LCH	93.9	SKF 95282 dimaleate, Zolantidine	H2 Histamine receptor antagonist.	False	c1cc(CN2CCCCC2)cc(OCCCNc2nc3ccccc3s2)c1
246886	246886:02:03_10.00	True	10.0	98	10.9	47.8	0.0	29.0	0.0	36.4	57.2	46.2	3.4	25.8	0.0	37.5	57.0	HSP90	57.2	Loratadine	Loratadine (SCH-29851) is a selective inverse peripheral histamine H1-receptor agonist with an IC50 of >32 uM. Loratadine has anti-dengue-virus (DENV) activity.	False	CCOC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc3cccnc32)CC1
281035	281035:01:03_10.00	True	10.0	103	8.5	0.0	0.0	80.4	0.0	73.8	7.0	87.5	32.0	60.3	0.0	69.1	55.6	LCH	87.5	VER-3323 hemifumarate salt	5-HT2C/5-HT2B serotonin receptor agonist.	False	C[C@H](N)CN1CCc2ccc(Br)cc21
280936	280936:01:03_10.00	True	10.0	94	18.7	74.7	0.0	0.0	89.5	0.0	0.0	0.0	0.0	0.0	75.7	0.0	0.0	DNA_Synth	89.5	SB 415286	SB 415286 is a potent and selective cell permeable inhibitor of GSK-3.a., with an IC50 of 77.5 nM, and a Ki of 30.75 nM; SB 415286 is equally effective at inhibiting human GSK-3.a. and GSK-3.b..	False	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1
281048	281048:01:03_10.00	True	10.0	74	17.3	0.0	35.2	9.6	47.2	6.1	0.0	25.2	15.6	0.0	2.0	34.9	0.0	DNA_Synth	47.2	Lificiguat	Lificiguat binds to the .b. subunit of soluble guanylyl cyclase(sGC) with Kd of 0.6-1.1 uM in the presence of CO.	False	OCc1ccc(-c2nn(Cc3ccccc3)c3ccccc23)o1
280823	280823:01:03_10.00	True	10.0	103	10.7	0.0	0.0	80.9	0.0	74.9	29.4	75.9	31.0	63.2	0.0	72.3	56.8	BET	80.9	Propranolol (hydrochloride)	Propranolol hydrochloride is a nonselective .b.-adrenergic receptor (.b.AR) antagonist, has high affinity for the .b.1AR and .b.2AR with Ki values of 1.8 nM and 0.8 nM, respectively. Propranolol hydrochloride inhibits [3H]-DHA binding to rat brain membrane preparation with an IC50 of 12 nM. Propranolol hydrochloride is used for study of hypertension, pheochromocytoma, myocardial infarction, cardiac arrhythmias, angina pectoris, and hypertrophic cardiomyopathy.	False	CC(C)NCC(O)COc1cccc2ccccc12
280186	280186:01:03_10.00	True	10.0	94	18.0	59.7	17.1	0.0	91.2	0.0	0.4	0.0	0.0	0.0	87.5	0.0	0.0	DNA_Synth	91.2	A-134974 dihydrochloride hydrate	it is a novel and selective adenosine kinase (AK) inhibitor with IC50 = 60 pM. Systemic A-134974 (i.p.) dose dependently reduced hyperalgesia (ED50= 1 ¿mol/kg) and at higher doses, reduced locomotor activity (ED50 = 16 ¿mol/kg). Administration of A-134974 intrathecally (i.t.) was more potent (ED50= 6 nmol) at producing antihyperalgesia than delivering the compound by intracerebralventricular (ED50 = 100 nmol, i.c.v.) or intraplantar (ED50 >300 nmol) routes. In contrast, i.c.v. administration of A-134974 was more effective in reducing locomotor activity than i.t. administration (ED50 values were 1 and >100 nmol, respectively). Increasing the pretreatment time for i.t.-delivered A-134974 caused a greater reduction in locomotor activity (ED50= 10 nmol). This was due to diffusion of A-134974 (i.t.) to supraspinal sites. These data demonstrate that the novel AK inhibitor A-134974 potently reduces thermal hyperalgesia primarily through interactions with spinal sites, whereas its ability to depress locomotor activity is predominantly mediated by supraspinal sites.	False	Nc1ncnc2c1c(I)cn2[C@@H]1C[C@H](N)[C@@H](O)[C@H]1O
280252	280252:01:04_10.00	True	10.0	107	5.5	0.0	0.0	32.3	0.5	42.3	0.0	41.1	37.1	0.0	0.0	26.6	28.4	HDAC	42.3	Aurintricarboxylic acid	Aurintricarboxylic acid is a nanomolar-potency, allosteric antagonist with selectivity towards .a..b.-methylene-ATP-sensitive P2X1Rs and P2X3Rs, with IC50s of 8.6 nM and 72.9 nM for rP2X1R and rP2X3R, respectively. Aurintricarboxylic acid is a potent anti-influenza agent by directly inhibiting the neuraminidase. Aurintricarboxylic acid is an inhibitor of topoisomerase II and apoptosis. Aurintricarboxylic acid is a selective inhibitor of the TWEAK-Fn14 signaling pathway.Aurintricarboxylic acid also acts as a cystathionine-lyase (CSE) inhibitor with an IC50 of 0.6 uM. Aurintricarboxylic acid is a modifier of miRNAs that regulate miRNA function, with an IC50 of 0.47 uM .	False	O=C(O)C1=CC(=C(c2ccc(O)c(C(=O)O)c2)c2ccc(O)c(C(=O)O)c2)C=CC1=O
247422	247422:02:03_10.00	True	10.0	88	6.4	57.8	0.0	15.4	11.9	15.9	21.1	21.9	2.2	25.0	0.0	16.8	56.7	AKT_PI3K_MTOR	57.8	Mianserin (hydrochloride)	Mianserin hydrochloride (Org GB 94) is a H1 receptor inverse agonist and is a psychoactive agent of the tetracyclic antidepressant.	False	CN1CCN2c3ccccc3Cc3ccccc3C2C1
281039	281039:01:03_10.00	True	10.0	72	53.2	0.0	0.0	67.5	0.0	63.4	30.3	51.3	47.3	56.2	0.0	64.9	74.1	Uncoupler	74.1	( R)-(+)-WIN 55,212-2 mesylate	high affinity cannabinoid receptor agonist.	False	Cc1c(C(=O)c2cccc3ccccc23)c2cccc3c2n1[C@H](CN1CCOCC1)CO3
280655	280655:01:03_10.00	True	10.0	98	5.7	47.3	0.0	16.2	13.4	9.7	53.9	22.1	0.0	16.9	6.6	37.6	58.1	Uncoupler	58.1	JWH-015	selective CB2 cannabinoid receptor agonist.	False	CCCn1c(C)c(C(=O)c2ccc3ccccc3c2)c2ccccc21
281030	281030:01:03_10.00	True	10.0	91	32.8	0.0	0.0	68.8	0.0	67.5	14.8	91.4	32.6	36.0	0.0	62.1	35.3	LCH	91.4	U-74389G maleate	free radical lipid peroxidation inhibitor.	False	C[C@]12C=CC(=O)C=C1CC[C@@H]1C2=CC[C@]2(C)[C@@H](C(=O)CN3CCN(c4cc(N5CCCC5)nc(N5CCCC5)n4)CC3)CC[C@@H]12
247042	247042:02:03_10.00	True	10.0	92	66.8	0.0	0.0	78.7	0.0	75.7	20.1	93.5	32.6	50.2	0.0	70.1	57.4	LCH	93.5	Pimozide	Ca2+ channel antagonist, antipsychotic, D2 dopamine receptor antagonist, Dopamine antagonist ?.	False	O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1
247155	247155:02:03_10.00	True	10.0	105	20.4	0.0	0.0	61.2	0.0	56.7	3.0	86.9	24.7	15.7	0.0	53.1	24.9	LCH	86.9	Propafenone hydrochloride	blocks hKv1.5 and ATP-sensitive K+ channels, beta-adrenoceptor antagonist, Beta adrenergic antagonist, antiarrhythmic.	False	CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1
280275	280275:01:03_10.00	True	10.0	96	16.2	0.0	0.0	67.9	0.0	71.3	0.0	85.8	41.1	30.8	0.0	56.0	38.4	LCH	85.8	4-Androsten-4-ol-3,17-dione, 4-OH-A	aromatase inhibitor.	False	CC12CCC3C(CCC4=C(O)C(=O)CCC43C)C1CCC2=O
280678	280678:01:03_10.00	True	10.0	101	25.7	0.0	0.0	79.6	0.0	75.7	18.6	92.6	30.9	49.5	0.0	69.0	59.1	LCH	92.6	L-687,384 hydrochloride	putative sigma-1 receptor agonist.	False	c1ccc(CN2CCC3(CCCc4ccccc43)CC2)cc1
280935	280935:01:03_10.00	True	10.0	94	26.1	0.0	7.5	34.0	22.1	19.1	0.0	41.4	9.9	7.2	0.0	49.5	16.7	Tubulin	49.5	SB216763	potent, selective, cell permeable inhibitor of glycogen synthetase kinase-3 (GSK-3).	False	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21
281040	281040:01:03_10.00	True	10.0	99	16.8	0.0	0.0	36.6	0.0	47.1	49.9	47.8	17.1	17.0	0.0	40.8	6.2	HSP90	49.9	WIN 62,577	NK1 tachykinin receptor antagonist.	False	C[C@]12CCC3C(CCC4=Cc5nc6nc7ccccc7n6cc5C[C@@]43C)[C@@H]1CC[C@@]2(O)C#N
280670	280670:01:03_30.00	True	30.0	96	34.5	0.0	0.0	27.1	0.0	32.9	48.9	48.7	0.0	25.2	0.0	41.8	10.3	HSP90	48.9	LY-367,265	inhibits serotonin reuptake, 5-HT2A serotonin receptor antagonist.	False	O=S1(=O)N(CCN2CC=C(c3c[nH]c4cc(F)ccc34)CC2)c2cccc3c2N1CCC3
280372	280372:01:03_30.00	True	30.0	86	34.2	30.2	0.0	57.3	0.0	61.8	46.9	71.6	17.6	55.5	0.0	55.1	68.4	LCH	71.6	CGS 15943	CGS 15943 is an orally bioavailable non-xanthine Adenosine Receptor antagonist. Its Ki for human A1, A2A, A2B, and A3 Adenosine Receptors are 3.5, 4.2, 16, and 50 nM in transfected CHO cells, respectively. .	False	Nc1nc2ccc(Cl)cc2c2nc(-c3ccco3)nn12
247095	247095:02:03_30.00	True	30.0	101	36.3	0.0	0.0	41.7	0.0	48.0	45.1	55.2	8.2	31.5	0.0	50.9	23.9	LCH	55.2	Nicardipine hydrochloride, YC-93 hydrochloride	L-type Ca2+ channel antagonist, antihypertensive, vasodilator.	False	COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1
247373	247373:02:03_30.00	True	30.0	110	14.9	0.0	0.0	72.6	0.0	65.3	8.1	84.9	39.5	46.6	0.0	60.8	39.1	LCH	84.9	Nisoxetine hydrochloride, LY-94,939	potent and selective norepinephrine reuptake blocker, Noradrenaline reuptake inhibitor.	False	CNCCC(Oc1ccccc1OC)c1ccccc1
280278	280278:01:03_30.00	True	30.0	93	39.4	2.5	0.0	54.4	0.0	57.3	32.0	75.4	18.6	52.2	0.0	57.1	51.8	LCH	75.4	A-315456	selective alpha 1D-adrenoceptor antagonist.	False	CCS(=O)(=O)Nc1cccc(C(=C2CCCCC2)c2cnc[nH]2)c1
280539	280539:01:03_30.00	True	30.0	84	34.7	47.9	39.0	0.0	71.9	0.0	7.5	0.0	0.0	0.0	72.3	0.0	0.0	Pyrimidine_Synth	72.3	rac-2-Ethoxy-3-hexadecanamido-1-propylphosphocholine	protein kinase C (PKC) inhibitor.	False	CCCCCCCCCCCCCCCC(=O)NCC(COP(=O)(O)OCC[N+](C)(C)C)OCC
247198	247198:02:03_30.00	True	30.0	101	6.0	0.0	0.0	66.1	0.0	59.1	25.6	76.2	22.8	37.2	0.0	69.5	35.0	LCH	76.2	Papaverine hydrochloride	phosphodiesterase inhibitor, muscle relaxant (smooth), cerebral vasodilator.	False	COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC
280661	280661:01:03_30.00	True	30.0	111	12.6	3.1	0.0	56.0	0.0	55.5	25.9	79.2	18.2	30.8	0.0	55.9	33.7	LCH	79.2	Levallorphan tartrate	opioid receptor antagonist.	False	C=CCN1CC[C@]23CCCCC2[C@H]1Cc1ccc(O)cc13
281016	281016:01:03_30.00	True	30.0	87	6.4	0.0	0.0	61.8	0.0	60.7	31.9	66.3	29.6	57.6	0.0	65.9	36.6	LCH	66.3	Sodium Taurocholate	multi-drug resistance conjugate pathway modulator.	False	C[C@H](CCC(=O)NCCS(=O)(=O)O)C1CCC2C3C(C[C@H](O)C21C)C1(C)CC[C@@H](O)CC1C[C@H]3O
247293	247293:02:03_30.00	True	30.0	83	74.4	0.0	0.0	74.2	0.0	72.1	23.8	91.2	28.6	51.2	0.0	69.8	51.8	LCH	91.2	Proadifen (hydrochloride)	inhibitor of microsomal drug metabolism, Cytochrome P450 mono-oxygenases inhibitor, cytochrome p450 inhibitor, ca antagonist.	False	CCCC(C(=O)OCCN(CC)CC)(c1ccccc1)c1ccccc1
281023	281023:01:03_30.00	True	30.0	98	17.8	0.0	0.0	36.9	0.0	37.9	26.0	64.0	3.2	18.7	0.0	48.6	7.5	LCH	64.0	S(-)-UH-301 hydrochloride	potent and selective 5-HT1A serotonin receptor antagonist.	False	CCCN(CCC)[C@H]1CCc2c(F)ccc(O)c2C1
281011	281011:01:05_30.00	True	30.0	87	7.6	27.7	33.4	0.0	53.2	0.0	24.2	0.0	0.0	0.0	58.7	0.0	0.0	Pyrimidine_Synth	58.7	Tyrphostin AG 538	insulin growth factor 1 (IGF-1) receptor protein tyrosine kinase inhibitor.	False	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)c1ccc(O)c(O)c1
280215	280215:01:03_30.00	True	30.0	100	68.9	0.0	0.0	65.1	0.0	65.6	22.8	80.9	21.6	41.3	0.0	65.3	38.8	LCH	80.9	TMB-8 hydrochloride	intracellular Ca2+ antagonist, inhibits calmodulin-sensitive Ca2+-ATPase activity, protein kinase C inhibitor.	False	CCN(CC)CCCCCCCCOC(=O)c1cc(OC)c(OC)c(OC)c1
280626	280626:01:03_30.00	True	30.0	96	11.6	0.0	0.0	67.8	0.0	64.3	31.0	64.2	43.9	56.1	0.0	73.0	52.5	Tubulin	73.0	IB-MECA	selective A3 adenosine receptor agonist.	False	CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCc4cccc(I)c4)ncnc32)C(O)[C@H]1O
280318	280318:02:03_30.00	True	30.0	92	82.2	0.0	0.0	73.9	0.0	72.0	28.0	85.6	30.9	55.8	0.0	72.3	51.2	LCH	85.6	(±)-Butaclamol hydrochloride, AY 23028	dopamine receptor antagonist, selective for D2 over D1.	False	CC(C)(C)[C@]1(O)CCN2C[C@H]3c4ccccc4CCc4cccc(c43)[C@@H]2C1
280291	280291:01:03_30.00	True	30.0	103	5.2	34.3	0.0	0.0	17.0	0.0	0.0	0.0	5.8	0.0	34.0	0.0	0.0	AKT_PI3K_MTOR	34.3	Allopurinol	xanthine oxidase inhibitor, inhibits the final step in uric acid biosynthesis.	False	Oc1ncnc2[nH]ncc12
246855	246855:02:03_30.00	True	30.0	93	28.8	56.0	27.3	0.0	94.6	0.0	17.0	0.0	0.0	0.0	81.0	0.0	0.0	DNA_Synth	94.6	Methotrexate, Methylaminopterin, MTX	folic acid antagonist.	False	CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1
245391	245391:03:03_30.00	True	30.0	74	65.6	1.5	0.0	76.7	0.0	72.4	27.6	57.9	50.8	70.1	0.0	73.2	86.6	Uncoupler	86.6	Niclosamide	Niclosamide (BAY2353)is an orally bioavailable chlorinated salicylanilide, with anthelmintic and potential antineoplastic activity. Niclosamide (BAY2353) inhibits STAT3 with IC50 of 0.25 uM in HeLa cells and inhibits DNA replication in a cell-free assay.	False	O=C(Nc1ccc([N+](=O)[O-])cc1Cl)c1cc(Cl)ccc1O
281019	281019:01:03_30.00	True	30.0	103	30.1	0.0	0.0	48.9	0.0	49.7	30.1	74.1	11.1	21.2	0.0	54.2	17.6	LCH	74.1	U-69593	selective kappa opioid receptor agonist.	False	CN(C(=O)Cc1ccccc1)[C@@H]1CC[C@]2(CCCO2)C[C@H]1N1CCCC1
280375	280375:01:03_30.00	True	30.0	84	5.5	0.0	6.5	51.5	0.0	62.1	20.8	59.1	31.5	35.1	0.0	55.9	17.2	HDAC	62.1	CGP 20712A methanesulfonate	selective beta1-adrenoceptor antagonist.	False	Cn1cc(C(F)(F)F)nc1-c1ccc(OCC(O)CNCCOc2ccc(O)c(C(N)=O)c2)cc1
280127	280127:01:04_30.00	True	30.0	91	46.5	0.0	0.0	43.1	0.0	47.9	48.0	65.2	1.8	33.3	0.0	51.8	29.7	LCH	65.2	ABT-702 dihydrochloride	ABT-702 dihydrochloride is a potent adenosine kinase (AK) inhibitor (IC50=1.7 nM).	False	Nc1ncnc2nc(-c3ccc(N4CCOCC4)nc3)cc(-c3cccc(Br)c3)c12
280256	280256:01:03_30.00	True	30.0	96	15.4	12.1	0.0	10.4	26.9	13.4	25.0	4.4	12.2	36.6	6.3	24.6	33.3	Protein_Synth	36.6	3'-Azido-3'-deoxythymidine, Azidothymidine, AZT	reverse transcriptase inhibitor, active against HIV-1 virus.	False	Cc1cn([C@H]2C[C@@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O
280690	280690:01:03_30.00	True	30.0	83	84.3	0.0	0.0	79.2	0.0	76.3	21.6	88.0	37.7	54.8	0.0	77.2	58.9	LCH	88.0	Methiothepin mesylate	5-HT1 Serotonin receptor antagonist, blocks serotonin autoreceptors.	False	CSc1ccc2c(c1)C(N1CCN(C)CC1)Cc1ccccc1S2
280759	280759:01:03_30.00	True	30.0	102	16.2	0.0	0.0	63.4	0.0	61.3	42.3	63.0	25.7	60.6	0.0	69.5	45.7	Tubulin	69.5	NS-2028	NS-2028 is a highly selective soluble Guanylyl Cyclase (sGC) inhibitor with IC50 values of 30 nM and 200 nM for basal and NO-stimulated enzyme activity. NS-2028 inhibits soluble Guanylyl Cyclase activity in homogenates of mouse cerebellum and neuronal NO synthase with IC50 values of 17 nM and 20 nM. NS-2028 inhibits 3-morpholino-sydnonimine (SIN-1)-elicited formation of cyclic GMP in human cultured umbilical vein endothelial cells with an IC50 of 30 nM. NS-2028 is commonly used in the research of nitric oxide signaling pathways, it inhibits NO-dependent relaxant responses in non-vascular smooth muscle completely (1 uM). NS-2028 reduces vascular endothelial growth factor-induced angiogenesis and permeability.	False	O=c1onc2n1-c1cc(Br)ccc1OC2
245373	245373:03:03_30.00	True	30.0	104	77.2	0.0	0.0	69.2	0.0	69.3	31.8	83.6	25.3	51.9	0.0	69.2	44.8	LCH	83.6	Oxybutynin Chloride	muscarinic acetylcholine receptor antagonist, Anticholinergic.	False	CCN(CC)CC#CCOC(=O)C(O)(c1ccccc1)C1CCCCC1
280708	280708:01:03_30.00	True	30.0	101	82.4	0.0	0.0	86.9	0.0	83.3	19.4	76.8	59.6	68.8	0.0	87.7	66.8	Tubulin	87.7	Mevastatin, Compactin	antibiotic, inhibits post-translational prenylation of proteins such as Ras and geranylgeranylation of Rho.	False	CC[C@H](C)C(=O)O[C@H]1CCC=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21
281028	281028:01:03_30.00	True	30.0	73	43.9	0.0	16.5	21.5	34.5	13.6	40.1	42.3	0.0	25.4	0.0	54.5	8.1	Tubulin	54.5	U-75302	BLT1 leukotriene receptor agonist.	False	CCCCC/C=C\CC(O)/C=C/c1cccc(CC(O)CCCCO)n1
280246	280246:01:03_30.00	True	30.0	84	10.2	23.4	42.7	0.0	60.8	0.0	0.0	0.0	0.0	0.0	50.5	0.0	0.0	DNA_Synth	60.8		poly(ADP-ribose) polymerase (PARP) inhibitor.	False	Nc1ccc2c3c(cccc13)C(=O)NC2=O
280968	280968:01:03_30.00	True	30.0	95	84.6	0.0	0.0	73.7	0.0	72.9	24.3	86.2	29.8	52.2	0.0	71.5	46.6	LCH	86.2	Trifluperidol hydrochloride, R 2498 hydrochloride, Triperidol hydrochloride	dopamine receptor antagonist, antipsychotic.	False	O=C(CCCN1CCC(O)(c2cccc(C(F)(F)F)c2)CC1)c1ccc(F)cc1
108034	108034:02:03_30.00	True	30.0	103	14.2	0.0	0.0	49.3	0.0	49.2	35.4	60.8	18.8	37.8	0.0	59.9	35.8	LCH	60.8		MAO inhibitor.	False	COc1ccc2[nH]c3c(c2c1)CCNC3
280280	280280:01:03_30.00	True	30.0	96	13.6	32.5	0.0	20.6	17.9	8.3	29.8	39.1	3.0	31.1	0.0	36.9	23.7	LCH	39.1	Actinonin	leucine aminopeptidase inhibitor.	False	CCCCC[C@H](CC(=O)NO)C(=O)N[C@H](C(=O)N1CCC[C@H]1CO)C(C)C
280827	280827:01:03_30.00	True	30.0	95	6.9	20.0	0.0	48.9	0.0	55.1	38.3	77.5	4.5	42.9	0.0	44.3	49.8	LCH	77.5	5-alpha-THDOC	positive allosteric modulator of GABA-A receptors.	False	C[C@]12CC[C@@H](O)C[C@@H]1CCC1C2CC[C@@]2(C)C1CC[C@@H]2C(=O)CO
280259	280259:01:03_30.00	True	30.0	77	42.0	0.0	0.0	56.9	0.0	57.0	8.0	55.8	43.6	55.4	0.0	66.3	57.0	Tubulin	66.3	Gabaculine hydrochloride	GABA transaminase inhibitor, conformationally constrained GABA analog.	False	NC1C=CC=C(C(=O)O)C1
281042	281042:01:03_30.00	True	30.0	95	27.3	0.0	0.0	26.2	0.0	22.6	31.1	50.0	0.0	10.6	0.0	38.5	1.4	LCH	50.0	WAY-100635 maleate	highly selective 5-HT1A serotonin receptor antagonist.	False	COc1ccccc1N1CCN(CCN(C(=O)C2CCCCC2)c2ccccn2)CC1
247419	247419:02:03_30.00	True	30.0	96	72.2	0.0	0.0	59.9	0.0	64.1	35.3	73.3	18.6	46.5	0.0	62.7	36.9	LCH	73.3	Naftopidil dihydrochloride, KT-611 dihydrochloride	alpha1 Adrenoceptor antagonist, antihypertensive, Alpha1 agonist.	False	COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1
246979	246979:02:03_30.00	True	30.0	98	36.1	0.0	0.0	76.7	0.0	73.8	23.3	83.9	24.1	58.0	0.0	69.9	54.2	LCH	83.9	Oxymetazoline hydrochloride	partial alpha2A adrenoceptor agonist, agonist at serotonin 5-HT1A, 5-HT1B and 5-HT1D receptors and a mixed agonist-antagonist at 5-HT2C receptors, Partial alpha2A agonist, adrenergic agonist, nasal decongestant.	False	Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1
280190	280190:01:03_30.00	True	30.0	95	31.6	0.0	0.0	43.8	0.0	48.9	32.1	69.6	6.7	24.4	0.0	52.2	9.7	LCH	69.6	Caroverine hydrochloride	nonselective NMDA and AMPA glutamate receptor antagonist.	False	CCN(CC)CCn1c(=O)c(Cc2ccc(OC)cc2)nc2ccccc21
280973	280973:01:03_30.00	True	30.0	70	79.3	0.0	0.0	87.4	0.0	84.4	22.5	75.8	54.5	72.1	0.0	82.5	82.2	BET	87.4	Tyrphostin A9	Tyrphostin A9, a PDGFR inhibitor, is a potent inducer of mitochondrial fission. Tyrphostin A9 emerged as the most potent and selective of 51 tyrosine kinase inhibitors tested against the TNF-induced respiratory burst. Tyrphostin A9 has anti-influenza virus activities.	False	CC(C)(C)c1cc(C=C(C#N)C#N)cc(C(C)(C)C)c1O
281021	281021:01:03_30.00	True	30.0	96	69.4	0.0	0.0	65.0	0.0	66.9	32.2	81.4	22.3	47.6	0.0	66.6	41.1	LCH	81.4	U-62066, Spiradoline mesylate	highly selective kappa opioid receptor agonist, antitussive.	False	CN(C(=O)Cc1ccc(Cl)c(Cl)c1)[C@@H]1CC[C@]2(CCCO2)C[C@H]1N1CCCC1
280321	280321:01:03_30.00	True	30.0	84	78.8	0.0	0.0	78.3	0.0	75.3	26.1	90.4	36.0	58.1	0.0	77.4	58.8	LCH	90.4	BW 723C86	5-HT2B serotonin receptor agonist.	False	CC(N)Cc1c[nH]c2ccc(OCc3cccs3)cc12
247361	247361:02:03_30.00	True	30.0	93	72.7	0.0	0.0	78.6	0.0	74.0	14.8	93.7	34.6	48.1	0.0	72.1	54.2	LCH	93.7	Promethazine hydrochloride	H1 Histamine receptor antagonist, anticholinergic, antihistaminic.	False	CC(CN1c2ccccc2Sc2ccccc21)N(C)C
280266	280266:01:03_30.00	True	30.0	82	10.5	25.0	31.5	0.0	50.8	0.0	27.4	0.0	0.0	0.0	60.4	0.0	0.0	Pyrimidine_Synth	60.4	5-(N,N-Dimethyl)amiloride hydrochloride, DMA	selective blocker of Na+/H+ antiport.	False	CN(C)c1nc(N)c(C(=O)N=C(N)N)nc1Cl
280671	280671:01:03_30.00	True	30.0	93	40.2	0.0	3.4	27.2	0.0	29.8	36.8	49.3	0.0	29.0	0.0	41.3	5.1	LCH	49.3	LY310762	LY310762 is a 5-HT1D receptor antagonist with Ki of 249 nM, having a weaker affinity for 5-HT1B receptor.IC50 value: 249 nM (Ki) Target: 5-HT1D in vitro: LY310762 has a higher affinity for the guinea pig 5-HT1D receptor than for the 5-HT1B receptor. LY310762 potentiates the potassium-induced [3H]5-HT outflow from guinea pig cortical slices with an EC50 of 30 nM. The maximum potentiation of the potassium-induced outflow which is obtained with LY310762 is about 40% . LY310762 blocks the decreased EPSC amplitude induced by Sumatriptan . in vivo: Systemic administration of LY310762 (10 mg/kg i.p.) produces a further significant enhancement in the 5-HT response to fluoxetine (20 mg/kg i.p.) when compared to animals receiving a control vehicle injection. In fluoxetine treated animals, levels of 5-HT increases from 312±43% to a maximum of 683% after LY310762. In control animals, levels of 5-HT remains unchanged (250%). LY310762 administered alone also significantly increases basal levels of 5-HT above vehicle controls, reaching a maximum of 258% compared to the pre-injection control .	False	CC1(C)C(=O)N(CCN2CCC(C(=O)c3ccc(F)cc3)CC2)c2ccccc21
247101	247101:02:03_30.00	True	30.0	84	80.5	0.0	0.0	73.6	0.0	75.1	29.7	87.0	29.4	52.4	0.0	71.2	53.5	LCH	87.0	Ketoconazole	potent inhibitor of cytochrome P450c17 enzyme, antifungal agent, Cytochrome P450c17 inhibitor.	False	CC(=O)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1
280756	280756:01:03_30.00	True	30.0	95	6.9	0.0	6.7	52.0	0.0	57.8	2.6	48.0	30.0	34.0	0.0	54.7	11.4	HDAC	57.8	NS-1619	selective large conductance Ca2+-activated K+-channel activator.	False	O=c1[nH]c2cc(C(F)(F)F)ccc2n1-c1cc(C(F)(F)F)ccc1O
280969	280969:01:03_30.00	True	30.0	91	24.5	0.0	0.0	79.5	0.0	77.0	21.7	81.6	40.6	59.8	0.0	74.8	53.1	LCH	81.6	3-Tropanyl-indole-3-carboxylate hydrochloride, Navoban, Tropisetron	selective 5-HT3 serotonin receptor antagonist.	False	CN1C2CCC1CC(OC(=O)c1c[nH]c3ccccc13)C2
280076	280076:01:03_30.00	True	30.0	108	20.9	0.0	0.0	36.0	0.0	41.1	57.9	40.5	9.6	34.1	0.0	48.3	22.0	HSP90	57.9	YM 976	phosphodiesterase type IV (PDE4) inhibitor. Exhibits anti-inflammatory activity without emesis.	False	CCc1ccc2c(-c3cccc(Cl)c3)nc(=O)n(CC)c2n1
280214	280214:01:03_30.00	True	30.0	86	9.0	0.0	24.8	27.5	0.0	29.4	39.9	32.0	17.2	29.5	0.0	48.1	12.1	Tubulin	48.1	S-(4-Nitrobenzyl)-6-thioguanosine	potent adenosine transport inhibitor.	False	Nc1nc(SCc2ccc([N+](=O)[O-])cc2)c2ncn([C@@H]3O[C@H](CO)[C@H](O)C3O)c2n1
280540	280540:01:03_30.00	True	30.0	94	34.0	48.3	32.7	0.0	70.6	0.0	0.0	0.0	0.0	0.0	79.1	0.0	0.0	Pyrimidine_Synth	79.1	rac-2-Ethoxy-3-octadecanamido-1-propylphosphocholine	protein kinase C (PKC) inhibitor.	False	CCCCCCCCCCCCCCCCCC(=O)NCC(COP(=O)(O)OCC[N+](C)(C)C)OCC
245383	245383:03:03_30.00	True	30.0	102	15.2	0.0	0.0	67.4	0.0	61.0	0.0	88.9	32.9	22.7	0.0	55.1	26.8	LCH	88.9	Xylometazoline (hydrochloride)	Xylometazoline hydrochloride is an .a.-adrenoceptor agonist commonly used as nasal decongestant.Target: .a.-AdrenoceptorXylometazoline hydrochloride is a nasal decongestant spray that constricts nasal blood vessels and increases nasal airflow, enabling patients with a blocked nose to breathe more easily. Xylometazoline hydrochloride is an effective and well-tolerated decongestant nasal spray that significantly relieved nasal congestion compared with placebo in the common cold and provided long-lasting relief with just 1 spray, helping patients to breathe more easily for a longer period of time . Xylometazoline hydrochloride exhibits in radioligand competition studies higher affinities than the catecholamines adrenaline and noradrenaline at most .a.-adrenoceptor subtypes. Xylometazoline behaved at .a.(2B) -adrenoceptors as full agonists .	False	Cc1cc(C(C)(C)C)cc(C)c1CC1=NCCN1
280622	280622:01:03_30.00	True	30.0	102	39.6	0.0	0.0	69.2	0.0	68.9	25.1	84.3	26.2	50.7	0.0	69.4	42.2	LCH	84.3	Iofetamine hydrochloride	reference standard, radio-iodinated iofetamine is used to image brain blood flow.	False	CC(C)NC(C)Cc1ccc(I)cc1
280754	280754:01:03_30.00	True	30.0	99	82.4	0.0	0.0	70.8	0.0	69.8	16.6	88.5	28.5	42.2	0.0	68.0	39.2	LCH	88.5	Naltriben methanesulfonate, NTB	highly selective delta2 opioid receptor antagonist.	False	Oc1ccc2c3c1O[C@H]1c4oc5ccccc5c4C[C@@]4(O)C(C2)N(CC2CC2)CCC314
280258	280258:01:03_30.00	True	30.0	94	72.2	0.0	0.0	62.8	0.0	67.0	33.5	85.4	16.2	43.5	0.0	63.1	45.8	LCH	85.4	EIPA	EIPA (L593754) is a TRPP3 channel inhibitor with an IC50 of 10.5 uM. EIPA also inhibits Na+/H+-exchanger (NHE) and macropinocytosis.	False	CCN(c1nc(N)c(C(=O)N=C(N)N)nc1Cl)C(C)C
280189	280189:01:03_30.00	True	30.0	74	65.1	0.0	2.5	61.2	0.0	62.7	31.1	71.3	31.6	51.0	0.0	74.6	36.8	Tubulin	74.6	SCH 58261	SCH 58261 is a potent, selective and competitive antagonist of adenosine A2A receptor with an IC50 of 15 nM, and displays 323-, 53- and 100-fold more selective for A2A receptor than A1, A2B, and A3 receptors, respectively.	False	Nc1nc2c(cnn2CCc2ccccc2)c2nc(-c3ccco3)nn12
246846	246846:02:03_30.00	True	30.0	95	51.1	0.0	0.0	55.5	0.0	59.7	39.0	70.9	13.3	43.2	0.0	60.7	36.5	LCH	70.9	Loxapine (succinate)	Loxapine Succinate is a D2DR and D4DR inhibitor, serotonergic receptor antagonist and also a dibenzoxazepine anti-psychotic agent.IC50 value: Target: D2DR/D4DR; 5-HT receptorin vitro: In the presence of Loxapine, [3H]ketanserin binds to 5-HT2 receptor in Frontal cortex of brain in human and bovine with ki value of 6.2 nM and 6.6 nM, respectively. Loxapine has the rank order of potency for the various receptors appears to be as follows:5-HT2D4>>>D1>D2 in comparing competition experiments involving the human membranes . Loxapine 0.2 uM, 2 uM and 20 uM reduces IL-1beta secretion by LPS-activated mixed glia cultures after 1 and 3 days of exposure. Loxapine in concentrations of 0.2 uM, 2 uM and 20 uM reduces IL-2 secretion in mixed glia cultures after 1 and 3 days of exposure, and additionally Loxapine decreases IL-1beta and IL-2 secretion in LPS-induced microglia cultures in concentrations of 2 uM, 10 uM and 20 uM .in vivo: Loxapine (5 mg/kg) induces a very significant reduction (more than 50%) of serotonin (S2) receptor density after 4 weeks or 10 weeks of daily injection in the rat. Loxapine (5 mg/kg) does not change dopamine receptor density but greatly reduces serotonin receptor density by 47% in the brain of rats .	False	CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1
280541	280541:01:03_30.00	True	30.0	97	8.1	0.0	0.0	67.1	0.0	68.5	37.7	71.6	14.3	49.8	0.0	62.8	49.8	LCH	71.6	(-)-Epinephrine bitartrate, Adrenaline bitartrate	endogenous hormone and neurotransmitter.	False	CNC[C@H](O)c1ccc(O)c(O)c1
280753	280753:01:03_30.00	True	30.0	95	66.1	0.0	0.0	81.8	0.0	77.6	25.8	85.8	40.8	61.2	0.0	79.7	55.7	LCH	85.8	Nylidrin (hydrochloride)	Nylidrin hydrochloride was an effective inhibitor of IgE-mediated release of histamine from passively sensitized rat peritoneal mast cells and human basophils, and of IgG1-mediated release of histamine from passively sensitized guinea pig lung slices.	False	CC(CCc1ccccc1)NC(C)C(O)c1ccc(O)cc1
247365	247365:02:03_30.00	True	30.0	91	9.3	0.0	6.3	35.0	0.0	35.9	33.6	58.2	0.0	32.2	0.0	44.2	8.1	LCH	58.2	Pindolol	Pindolol (LB-46) is a nonselective .b.-blocker with partial beta-adrenergic receptor agonist activity, also functions as a 5-HT1A receptor weak partial antagonist (Ki=33nM).	False	CC(C)NCC(O)COc1cccc2[nH]ccc12
281051	281051:01:03_30.00	True	30.0	94	39.2	0.0	0.0	61.7	0.0	66.2	32.3	78.5	18.3	44.2	0.0	65.4	31.1	LCH	78.5	Zimelidine dihydrochloride	serotonin reuptake inhibitor, antidepressant.	False	CN(C)C/C=C(/c1ccc(Br)cc1)c1cccnc1
280673	280673:01:03_30.00	True	30.0	90	39.4	0.0	0.0	62.8	0.0	68.0	33.5	73.3	25.1	45.8	0.0	63.4	40.2	LCH	73.3	alpha-Lobeline hydrochloride, (-)-Lobeline hydrochloride	neuronal nicotinic acetylcholine receptor agonist.	False	CN1[C@H](C[C@H](O)c2ccccc2)CCC[C@@H]1CC(=O)c1ccccc1
280151	280151:01:03_30.00	True	30.0	85	74.4	0.0	0.0	81.4	0.0	77.6	36.9	74.9	39.2	65.7	0.0	80.7	64.9	BET	81.4	SB 242084 (hydrochloride)	SB 242084 hydrochloride is a 5-HT2C receptor antagonist(pKi=9.0) that displays 158- and 100-fold selectivity over 5-HT2A and 5-HT2B receptors respectively.IC50 value: 9.0(pKi) Target: 5-HT2C antagonistin vitro: SB 242084 had over 100-fold selectivity over a range of other 5-HT, dopamine and adrenergic receptors. In studies of 5-HT-stimulated phosphatidylinositol hydrolysis using SH-SY5Y cells stably expressing the cloned human 5-HT2C receptor, SB 242084 acted as an antagonist with a pKb of 9.3, which closely resembled its corresponding receptor binding affinity .in vivo: SB 242084 potently inhibited m-chlorophenylpiperazine (mCPP, 7 mgkg i.p. 20 min pre-test)-induced hypolocomotion in rats, a model of in vivo central 5-HT2C receptor function, with an ID50 of 0.11 mg/kg i.p., and 2.0 mg/kg p.o. SB 242084 (0.1-1 mg/kg i.p.) exhibited an anxiolytic-like profile in the rat social interaction test, increasing time spent in social interaction, but having no effect on locomotion. SB 242084 (0.1-1 mg/kg i.p.) also markedly increased punished responding in a rat Geller-Seifter conflict test of anxiety, but had no consistent effect on unpunished responding .	False	Cc1cc2c(cc1Cl)N(C(=O)Nc1ccc(Oc3cccnc3C)nc1)CC2
280109	280109:01:03_30.00	True	30.0	94	18.5	0.0	0.0	48.9	0.0	52.3	35.1	48.5	9.7	41.2	0.0	51.9	36.5	HDAC	52.3	Epinastine (hydrochloride)	Epinastine hydrochloride (WAL801 hydrochloride) is an antihistamine and mast cell stabilizer. Epinastine hydrochloride is a potent, selective and orally-active histamine H1 receptor antagonist. Epinastine hydrochloride also inhibits IL-8 release and has an antiallergic action.	False	NC1=NCC2c3ccccc3Cc3ccccc3N12
280136	280136:01:03_30.00	True	30.0	92	54.1	0.0	0.0	29.6	0.0	27.7	33.9	41.0	17.4	33.9	0.0	41.1	3.8	Tubulin	41.1	SB 525334	SB 525334 is a potent and selective transforming growth factor .b.1 receptor (ALK5) inhibitor with an IC50 of 14.3 nM.	False	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3nccnc3c2)n1
280257	280257:01:03_30.00	True	30.0	62	29.4	0.0	26.1	9.9	31.9	4.3	0.0	0.0	34.3	39.5	0.0	33.6	16.7	Protein_Synth	39.5	5-Azacytidine	5-Azacytidine (Azacitidine; 5-AzaC; Ladakamycin) is a nucleoside analogue of cytidine that specifically inhibits DNA methylation. 5-Azacytidine is incorporated into DNA to covalently trap DNA methyltransferases and contributes to reverse epigenetic changes. 5-Azacytidine induces cell autophagy.	False	Nc1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1
280819	280819:01:03_30.00	True	30.0	82	57.0	0.0	4.3	39.4	0.0	36.3	31.8	40.8	18.4	53.1	0.0	56.6	24.7	Tubulin	56.6	Pentamidine isethionate	NMDA glutamate receptor antagonist, neuroprotective agent, antimicrobial agent prescribed for the treatment of AIDS-associated Pneumocystis carinii pneumonia.	False	N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1
281024	281024:01:03_30.00	True	30.0	92	61.8	0.0	0.0	70.9	0.0	68.6	28.5	88.5	23.9	49.7	0.0	69.0	51.4	LCH	88.5	(-)-trans-(1S,2S)-U-50488 hydrochloride	potent kappa opioid receptor agonist, more potent enantiomer of (±)-trans-U-50488.	False	CN(C(=O)Cc1ccc(Cl)c(Cl)c1)[C@H]1CCCC[C@@H]1N1CCCC1
245325	245325:03:03_30.00	True	30.0	67	80.5	0.0	0.0	68.9	0.0	68.9	29.1	81.3	30.2	52.3	0.0	70.3	55.4	LCH	81.3	Reserpine, Methyl reserpate	inhibits vesicular catecholine and serotonin uptake, antihypertensive.	False	COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC
247368	247368:02:03_30.00	True	30.0	96	6.7	0.0	0.0	52.7	0.0	58.0	35.4	56.5	28.3	43.0	0.0	54.0	18.6	HDAC	58.0	Urapidil (hydrochloride)	Urapidil HCl is an .a.1-adrenoceptor antagonist and 5-HT1A receptor agonist.Target: .a.1-adrenoceptor; 5-HT1A receptorUrapidil hydrochloride is a hydrochloride salt form of urapidil which is .a.1-adrenoceptor antagonist and 5-HT1A receptor agonist with pIC50 of 6.13 and 6.4 respectively. Urapidil has an alpha-blocking effect but, unlike other alpha-blockers, also has a central sympatholytic effect mediated via stimulation of serotonin 5HT1A receptors in the central nervous system . Urapidil has an alpha-blocking effect but, unlike other alpha-blockers, also has a central sympatholytic effect mediated via stimulation of serotonin 5HT1A receptors in the central nervous system. Several studies have suggested that oral urapidil is effective and well tolerated when used as second-line therapy in patients with BP inadequately controlled with other agents. Urapidil has also been shown to improve glucose and lipid metabolism in hypertensive patients with concomitant diabetes and/or hyperlipidemia .	False	COc1ccccc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1
280129	280129:01:03_30.00	True	30.0	102	27.8	0.0	0.0	68.1	0.0	66.9	51.7	62.9	37.4	68.4	0.0	77.3	54.2	Tubulin	77.3	Olvanil, N-Vannilyloleoylamide	vanilloid receptor agonist.	False	CCCCCCCC/C=C\CCCCCCCC(=O)NCc1ccc(O)c(OC)c1
280710	280710:01:03_30.00	True	30.0	88	7.3	42.5	2.4	0.0	34.7	0.0	22.3	0.0	0.0	0.0	40.1	0.0	0.0	AKT_PI3K_MTOR	42.5	MK-886	potent and specific inhibitor of leukotriene biosynthesis.	False	CC(C)c1ccc2c(c1)c(SC(C)(C)C)c(CC(C)(C)C(=O)O)n2Cc1ccc(Cl)cc1
280755	280755:01:03_30.00	True	30.0	100	7.4	5.9	2.7	1.1	0.0	6.3	38.4	27.4	0.0	0.0	11.1	12.9	0.0	HSP90	38.4	Naloxone benzoylhydrazone	kappa3 Opioid receptor agonist, mixed mu opioid receptor agonist/antagonist.	False	C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2/C(=N/NC(=O)c2ccccc2)CC[C@@]3(O)[C@H]1C5
280179	280179:01:03_30.00	True	30.0	93	73.4	0.0	0.0	81.1	0.0	80.3	36.6	84.2	36.5	59.0	0.0	76.8	61.6	LCH	84.2	AMG9810	AMG9810 is a selective and competitive vanilloid receptor 1 (TRPV1) antagonist with IC50 values of 24.5 and 85.6 nM for human and rat TRPV1, repectively.	False	CC(C)(C)c1ccc(/C=C/C(=O)Nc2ccc3c(c2)OCCO3)cc1
280155	280155:01:03_30.00	True	30.0	94	17.6	0.0	12.0	36.8	0.0	47.4	47.5	43.9	5.1	26.9	0.0	47.7	11.7	Tubulin	47.7	PNU-282987	selective alpha7 nicotinic acetylcholine receptor (nAChR) agonist.	False	O=C(N[C@H]1CN2CCC1CC2)c1ccc(Cl)cc1
246877	246877:02:03_30.00	True	30.0	103	57.7	0.0	0.0	56.0	0.0	59.9	31.7	80.1	13.2	36.1	0.0	57.2	29.0	LCH	80.1	(±)-Verapamil hydrochloride	L-type Ca2+ channel modulator, adrenoceptor antagonist, antiarryhthmic, cardiac depressant, coronary vasodilator, Alpha1 antagonist, adrenegic blocker, ca channel blocker, coronary vasodilator, antiarrhythmic.	False	COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC
247088	247088:02:03_30.00	True	30.0	105	39.6	0.0	0.0	60.5	0.0	63.0	34.4	75.6	15.6	43.1	0.0	59.9	40.8	LCH	75.6	Ketotifen (fumarate)	Ketotifen (HC 20511) fumarate is a second-generation noncompetitive H1-antihistamine and mast cell stabilizer, which is used to prevent asthma attacks.	False	CN1CCC(=C2c3ccccc3CC(=O)c3sccc32)CC1
281025	281025:01:03_30.00	True	30.0	99	27.5	0.0	0.0	54.1	0.0	57.7	29.8	76.9	12.0	36.0	0.0	55.9	22.8	LCH	76.9	U-101958 maleate	selective D4 dopamine receptor antagonist.	False	CC(C)Oc1cccnc1N(C)C1CCN(Cc2ccccc2)CC1
280815	280815:01:03_30.00	True	30.0	94	46.3	0.0	0.0	70.9	0.0	70.5	23.5	86.3	20.7	45.8	0.0	69.1	49.8	LCH	86.3	Progesterone	suppresses ovulation, induces maturation and secretory activity of the uterine endothelium.	False	CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
247019	247019:02:03_30.00	True	30.0	94	21.9	0.0	0.0	52.2	0.0	56.4	34.0	63.5	18.1	41.9	0.0	60.8	27.3	LCH	63.5	Labetalol (hydrochloride)	Labetalol hydrochloride is a mixed alpha/beta adrenergic antagonist that is used to treat high blood pressure.	False	CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1
280134	280134:01:03_30.00	True	30.0	91	12.8	0.0	17.1	13.3	5.0	6.2	32.8	38.0	0.0	16.2	0.0	31.8	0.0	LCH	38.0	CyPPA	cyPPA is a positive modulator of small conductance Ca2+-activated K2+ channels, selective for SK3 and SK2.	False	Cc1cc(NC2CCCCC2)nc(-n2nc(C)cc2C)n1
280832	280832:01:03_30.00	True	30.0	86	10.2	19.5	0.0	36.8	0.0	49.8	49.2	29.7	35.4	51.2	0.0	40.7	63.3	Uncoupler	63.3	1-Phenyl-3-(2-thiazolyl)-2-thiourea	dopamine beta-hydroxylase inhibitor.	False	S=C(Nc1ccccc1)Nc1nccs1
280282	280282:01:03_30.00	True	30.0	92	48.4	0.0	0.0	58.6	0.0	63.2	38.2	81.4	15.6	39.1	0.0	62.2	34.8	LCH	81.4	Amperozide hydrochloride	atypical antipsychotic drug with high affinity for serotonin receptors and low affinity for D2 dopamine receptors.	False	CCNC(=O)N1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1
280260	280260:01:03_30.00	True	30.0	82	23.1	0.0	0.5	30.8	0.0	31.0	50.3	46.5	1.2	36.4	0.0	51.1	19.0	Tubulin	51.1	Docebenone	Docebenone (AA 861) is a potent, selective and orally active 5-LO (5-lipoxygenase) inhibitor.	False	CC1=C(C)C(=O)C(CCCCC#CCCCC#CCO)=C(C)C1=O
280580	280580:01:03_30.00	True	30.0	96	68.2	0.0	0.0	67.7	0.0	66.4	22.5	89.7	23.2	42.4	0.0	65.6	40.1	LCH	89.7	GR 4661	5-HT1D serotonin receptor agonist.	False	COc1ccc(CNC(=O)/C=C/c2ccc3[nH]cc(CCN(C)C)c3c2)cc1
247382	247382:02:03_30.00	True	30.0	96	5.4	0.0	0.0	76.8	0.0	64.8	10.8	61.3	53.8	65.1	0.0	77.8	64.2	Tubulin	77.8	Thioperamide maleate, MR 12842	potent and selective H3 histamine receptor antagonist that crosses the blood brain barrier, H3 antagonist.	False	S=C(NC1CCCCC1)N1CCC(c2c[nH]cn2)CC1
245345	245345:03:03_30.00	True	30.0	97	18.1	0.0	0.0	22.5	0.0	22.3	39.6	42.2	0.6	24.3	0.0	35.7	0.0	LCH	42.2	Praziquantel	Ca2+ Ionophore, anthelmintic, Modulates cell membrane permeability.	False	O=C(C1CCCCC1)N1CC(=O)N2CCc3ccccc3C2C1
280185	280185:01:03_30.00	True	30.0	107	5.4	0.0	0.0	65.0	0.0	65.1	27.8	67.8	26.5	50.9	0.0	63.5	33.2	LCH	67.8	(+)-Norfenfluramine hydrochloride	the major hepatic metabolite of (+)-fenfluramine and is primarily responsible for the anorexic effect, as well as side effects, (+)-norfenfluramine causes vasoconstriction and a blood pressure increase.	False	C[C@H](N)Cc1cccc(C(F)(F)F)c1
246886	246886:02:03_30.00	True	30.0	78	48.9	0.0	0.0	64.8	0.0	67.3	56.4	63.1	38.3	48.5	0.0	77.7	61.4	Tubulin	77.7	Loratadine	Loratadine (SCH-29851) is a selective inverse peripheral histamine H1-receptor agonist with an IC50 of >32 uM. Loratadine has anti-dengue-virus (DENV) activity.	False	CCOC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc3cccnc32)CC1
280677	280677:01:03_30.00	True	30.0	95	20.6	0.0	0.0	46.4	0.0	48.2	35.9	70.0	4.8	31.8	0.0	55.6	21.0	LCH	70.0	LE 300	potent, selective D1 dopamine receptor antagonist.	False	CN1CCc2ccccc2Cc2[nH]c3ccccc3c2CC1
281035	281035:01:03_30.00	True	30.0	91	59.1	0.0	0.0	76.7	0.0	71.7	22.0	89.1	27.9	56.7	0.0	73.0	56.0	LCH	89.1	VER-3323 hemifumarate salt	5-HT2C/5-HT2B serotonin receptor agonist.	False	C[C@H](N)CN1CCc2ccc(Br)cc21
246988	246988:02:03_30.00	True	30.0	100	39.0	0.0	0.0	70.8	0.0	71.1	25.8	84.2	20.5	53.0	0.0	67.4	41.1	LCH	84.2	Orphenadrine hydrochloride	muscarinic acetylcholine receptor antagonist, H1 histamine receptor antagonist, H1 antogonist.	False	Cc1ccccc1C(OCCN(C)C)c1ccccc1
280936	280936:01:03_30.00	True	30.0	81	30.1	46.6	33.1	0.0	79.8	0.0	16.6	0.0	0.0	0.0	58.5	0.0	0.0	DNA_Synth	79.8	SB 415286	SB 415286 is a potent and selective cell permeable inhibitor of GSK-3.a., with an IC50 of 77.5 nM, and a Ki of 30.75 nM; SB 415286 is equally effective at inhibiting human GSK-3.a. and GSK-3.b..	False	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1
281048	281048:01:03_30.00	True	30.0	79	29.2	0.0	26.3	0.0	49.9	0.0	47.3	20.8	0.0	9.7	20.9	34.5	0.0	DNA_Synth	49.9	Lificiguat	Lificiguat binds to the .b. subunit of soluble guanylyl cyclase(sGC) with Kd of 0.6-1.1 uM in the presence of CO.	False	OCc1ccc(-c2nn(Cc3ccccc3)c3ccccc23)o1
280823	280823:01:03_30.00	True	30.0	100	59.6	0.0	0.0	63.8	0.0	65.7	33.0	75.6	17.7	46.7	0.0	67.3	39.3	LCH	75.6	Propranolol (hydrochloride)	Propranolol hydrochloride is a nonselective .b.-adrenergic receptor (.b.AR) antagonist, has high affinity for the .b.1AR and .b.2AR with Ki values of 1.8 nM and 0.8 nM, respectively. Propranolol hydrochloride inhibits [3H]-DHA binding to rat brain membrane preparation with an IC50 of 12 nM. Propranolol hydrochloride is used for study of hypertension, pheochromocytoma, myocardial infarction, cardiac arrhythmias, angina pectoris, and hypertrophic cardiomyopathy.	False	CC(C)NCC(O)COc1cccc2ccccc12
280829	280829:01:03_30.00	True	30.0	101	5.0	0.0	0.0	45.2	0.0	43.6	1.4	19.8	45.9	51.6	0.0	47.0	46.6	Protein_Synth	51.6	8-Phenyltheophylline	selective A1 adenosine receptor antagonist.	False	Cn1c(=O)c2[nH]c(-c3ccccc3)nc2n(C)c1=O
280186	280186:01:03_30.00	True	30.0	57	39.0	22.5	55.9	0.0	83.7	0.0	0.0	0.0	0.0	0.0	72.3	0.0	0.0	DNA_Synth	83.7	A-134974 dihydrochloride hydrate	it is a novel and selective adenosine kinase (AK) inhibitor with IC50 = 60 pM. Systemic A-134974 (i.p.) dose dependently reduced hyperalgesia (ED50= 1 ¿mol/kg) and at higher doses, reduced locomotor activity (ED50 = 16 ¿mol/kg). Administration of A-134974 intrathecally (i.t.) was more potent (ED50= 6 nmol) at producing antihyperalgesia than delivering the compound by intracerebralventricular (ED50 = 100 nmol, i.c.v.) or intraplantar (ED50 >300 nmol) routes. In contrast, i.c.v. administration of A-134974 was more effective in reducing locomotor activity than i.t. administration (ED50 values were 1 and >100 nmol, respectively). Increasing the pretreatment time for i.t.-delivered A-134974 caused a greater reduction in locomotor activity (ED50= 10 nmol). This was due to diffusion of A-134974 (i.t.) to supraspinal sites. These data demonstrate that the novel AK inhibitor A-134974 potently reduces thermal hyperalgesia primarily through interactions with spinal sites, whereas its ability to depress locomotor activity is predominantly mediated by supraspinal sites.	False	Nc1ncnc2c1c(I)cn2[C@@H]1C[C@H](N)[C@@H](O)[C@H]1O
280657	280657:01:03_30.00	True	30.0	91	52.3	0.0	0.0	42.3	0.0	52.2	52.2	54.4	6.6	44.9	0.0	53.7	32.9	LCH	54.4	K 185	melatonin receptor antagonist.	False	CCCC(=O)NCCc1c2n(c3ccc(OC)cc13)CCCc1ccccc1-2
280252	280252:01:04_30.00	True	30.0	108	23.0	19.9	0.0	8.2	0.0	31.8	0.0	7.7	30.5	0.0	0.0	0.0	24.6	HDAC	31.8	Aurintricarboxylic acid	Aurintricarboxylic acid is a nanomolar-potency, allosteric antagonist with selectivity towards .a..b.-methylene-ATP-sensitive P2X1Rs and P2X3Rs, with IC50s of 8.6 nM and 72.9 nM for rP2X1R and rP2X3R, respectively. Aurintricarboxylic acid is a potent anti-influenza agent by directly inhibiting the neuraminidase. Aurintricarboxylic acid is an inhibitor of topoisomerase II and apoptosis. Aurintricarboxylic acid is a selective inhibitor of the TWEAK-Fn14 signaling pathway.Aurintricarboxylic acid also acts as a cystathionine-lyase (CSE) inhibitor with an IC50 of 0.6 uM. Aurintricarboxylic acid is a modifier of miRNAs that regulate miRNA function, with an IC50 of 0.47 uM .	False	O=C(O)C1=CC(=C(c2ccc(O)c(C(=O)O)c2)c2ccc(O)c(C(=O)O)c2)C=CC1=O
247422	247422:02:03_30.00	True	30.0	68	16.4	21.0	0.0	48.1	0.0	55.8	60.5	50.7	38.3	54.3	0.0	62.8	69.2	Uncoupler	69.2	Mianserin (hydrochloride)	Mianserin hydrochloride (Org GB 94) is a H1 receptor inverse agonist and is a psychoactive agent of the tetracyclic antidepressant.	False	CN1CCN2c3ccccc3Cc3ccccc3C2C1
281039	281039:01:03_30.00	True	30.0	64	79.8	0.0	0.0	71.2	0.0	73.2	43.0	51.9	54.6	65.9	0.0	74.2	68.5	Tubulin	74.2	( R)-(+)-WIN 55,212-2 mesylate	high affinity cannabinoid receptor agonist.	False	Cc1c(C(=O)c2cccc3ccccc23)c2cccc3c2n1[C@H](CN1CCOCC1)CO3
280655	280655:01:03_30.00	True	30.0	75	70.5	0.0	0.0	65.9	0.0	68.5	51.8	67.2	38.1	53.7	0.0	81.1	56.4	Tubulin	81.1	JWH-015	selective CB2 cannabinoid receptor agonist.	False	CCCn1c(C)c(C(=O)c2ccc3ccccc3c2)c2ccccc21
281030	281030:01:03_30.00	True	30.0	85	77.9	0.0	0.0	70.5	0.0	68.7	24.5	88.9	28.0	46.5	0.0	69.6	46.6	LCH	88.9	U-74389G maleate	free radical lipid peroxidation inhibitor.	False	C[C@]12C=CC(=O)C=C1CC[C@@H]1C2=CC[C@]2(C)[C@@H](C(=O)CN3CCN(c4cc(N5CCCC5)nc(N5CCCC5)n4)CC3)CC[C@@H]12
280668	280668:01:03_30.00	True	30.0	98	34.5	0.0	0.0	48.0	0.0	52.6	50.9	56.9	14.7	37.0	0.0	53.9	40.0	LCH	56.9	L-162,313	non-peptide AT1 angiotensin II receptor agonist.	False	CCCCOC(=O)NS(=O)(=O)c1sc(CC(C)C)cc1-c1ccc(Cn2c(CC)nc3c(C)cc(C)nc32)cc1
247042	247042:02:03_30.00	True	30.0	79	84.1	0.0	0.0	77.2	0.0	78.4	36.4	79.8	36.7	63.2	0.0	75.9	63.2	LCH	79.8	Pimozide	Ca2+ channel antagonist, antipsychotic, D2 dopamine receptor antagonist, Dopamine antagonist ?.	False	O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1
280181	280181:01:03_30.00	True	30.0	90	6.4	2.5	0.0	14.8	0.0	10.7	29.9	39.4	0.5	0.0	5.2	20.4	0.0	LCH	39.4	A-68930 hydrochloride	selective D1 dopamine receptor agonist.	False	NC[C@@H]1O[C@H](c2ccccc2)Cc2c1ccc(O)c2O
247155	247155:02:03_30.00	True	30.0	100	72.7	0.0	0.0	62.9	0.0	64.2	25.5	85.5	17.9	38.2	0.0	63.0	37.6	LCH	85.5	Propafenone hydrochloride	blocks hKv1.5 and ATP-sensitive K+ channels, beta-adrenoceptor antagonist, Beta adrenergic antagonist, antiarrhythmic.	False	CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1
280654	280654:01:03_30.00	True	30.0	88	13.3	0.0	0.5	29.3	0.0	36.6	49.5	38.5	4.4	46.2	0.0	41.2	21.1	HSP90	49.5	JL-18	clozapine analog which is 25 fold selective for the D4 dopamine receptor versus the D2 dopamine receptor.	False	Cc1ccc2c(c1)C(N1CCN(C)CC1)=Nc1cccnc1N2
280275	280275:01:03_30.00	True	30.0	100	33.7	0.0	0.0	64.8	0.0	62.4	9.7	89.8	27.1	31.7	0.0	65.1	34.9	LCH	89.8	4-Androsten-4-ol-3,17-dione, 4-OH-A	aromatase inhibitor.	False	CC12CCC3C(CCC4=C(O)C(=O)CCC43C)C1CCC2=O
280678	280678:01:03_30.00	True	30.0	101	68.0	0.0	0.0	66.9	0.0	66.2	26.7	87.3	19.5	45.1	0.0	65.9	48.5	LCH	87.3	L-687,384 hydrochloride	putative sigma-1 receptor agonist.	False	c1ccc(CN2CCC3(CCCc4ccccc43)CC2)cc1
280935	280935:01:03_30.00	True	30.0	80	67.5	0.0	7.8	51.3	0.0	43.6	31.0	57.6	18.7	43.2	0.0	73.4	32.0	Tubulin	73.4	SB216763	potent, selective, cell permeable inhibitor of glycogen synthetase kinase-3 (GSK-3).	False	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21
281040	281040:01:03_30.00	True	30.0	87	39.0	0.0	0.0	44.0	0.0	49.0	39.2	63.3	16.4	26.3	0.0	50.3	14.1	LCH	63.3	WIN 62,577	NK1 tachykinin receptor antagonist.	False	C[C@]12CCC3C(CCC4=Cc5nc6nc7ccccc7n6cc5C[C@@]43C)[C@@H]1CC[C@@]2(O)C#N
280967	280967:01:03_10.00	True	10.0	59	57.2	0.0	76.3	17.4	0.0	23.2	7.8	28.9	6.5	11.8	0.0	40.3	0.0	Aurora	76.3	SU6656	SU6656 is a Src family kinases inhibitor with IC50s of 280, 20, 130, 170 nM for Src, Yes, Lyn, and Fyn, respectively. SU6656 inhibits FAK phosphorylation at Y576/577, Y925, Y861 sites. SU6656 also inhibits p-AKT.	False	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2
281031	281031:01:04_10.00	True	10.0	90	28.7	0.0	0.0	76.4	0.0	73.6	0.0	80.5	42.5	51.0	0.0	71.8	45.8	LCH	80.5	U-73122	phospholipase C and A2 inhibitor that inhibits the hydrolysis of PPI to IP3, leading to a decrease in cytosolic free Ca2+.	False	COc1ccc2c(c1)CCC1C2CC[C@@]2(C)C1CC[C@@H]2NCCCCCCN1C(=O)C=CC1=O
280660	280660:01:03_10.00	True	10.0	86	63.9	0.0	0.0	80.9	0.0	78.2	13.8	95.3	39.4	52.8	0.0	71.4	59.1	LCH	95.3	L-703,606, oxalate	potent and selective non-peptide NK-1 tachykinin receptor antagonist.	False	Ic1ccccc1CNC1C2CCN(CC2)C1C(c1ccccc1)c1ccccc1
280811	280811:01:03_10.00	True	10.0	96	24.7	0.0	0.0	68.7	0.0	62.3	0.5	76.8	11.1	48.1	0.0	50.6	47.6	LCH	76.8	Phenamil methanesulfonate	irreversible inhibitor of amiloride-sensitive Na+ channels, derivative of amiloride.	False	N=C(NC(=O)c1nc(Cl)c(N)nc1N)Nc1ccccc1
280773	280773:01:03_10.00	True	10.0	91	11.1	56.6	0.0	0.0	57.8	0.0	31.6	10.9	0.0	0.0	40.9	0.0	11.4	DNA_Synth	57.8	Nordihydroguaiaretic acid from Larrea divaricata (creosote bush), NDGA	lipoxygenase inhibitor.	False	C[C@@H](Cc1ccc(O)c(O)c1)[C@H](C)Cc1ccc(O)c(O)c1
280120	280120:01:03_10.00	True	10.0	65	18.8	6.3	38.9	0.0	73.1	0.0	0.0	0.0	10.5	0.0	47.7	0.0	0.0	DNA_Synth	73.1	MNS,;3,4-Methylenedioxy-beta-;nitrostyrene	src and Syk kinase inhibitor, prevents phosphorylation and cytoskeletal association of GPIIb/IIIa and talin.	False	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2
280706	280706:01:03_10.00	True	10.0	86	21.2	0.0	0.0	65.4	0.0	58.0	0.0	81.0	26.7	30.3	0.0	62.0	23.0	LCH	81.0	MRS 1523	selective A3 adenosine receptor antagonist in rat.	False	CCCOC(=O)c1c(-c2ccccc2)nc(CC)c(C(=O)SCC)c1CCC
280707	280707:01:03_10.00	True	10.0	73	19.7	34.0	47.6	0.0	86.9	0.0	0.0	0.0	0.0	0.0	70.6	0.0	0.0	DNA_Synth	86.9	Melphalan, L-Phenylalanine mustard	antineoplastic, forms DNA intrastrand crosslinks by bifunctional alkylation in 5'-GGC sequences.	False	NC(Cc1ccc(N(CCCl)CCCl)cc1)C(=O)O
280184	280184:01:03_10.00	True	10.0	91	25.4	41.0	22.7	0.0	94.5	0.0	0.0	0.0	0.0	0.0	79.2	0.0	0.0	DNA_Synth	94.5	PAC-1	PAC-1 is a procaspase-3 activator that induces apoptosis in cancer cells with an EC50 of 2.08 uM.	False	C=CCc1cccc(/C=N/NC(=O)CN2CCN(Cc3ccccc3)CC2)c1O
247000	247000:02:03_10.00	True	10.0	98	44.2	0.0	0.0	79.5	0.0	76.5	0.0	92.0	39.7	47.3	0.0	67.0	44.9	LCH	92.0	Nortriptyline (hydrochloride)	Nortriptyline hydrochloride (Desmethylamitriptyline hydrochloride) is a tricyclic antidepressant and the main active metabolite of Amitriptyline, and used to relieve the symptoms of depression.	False	CNCCC=C1c2ccccc2CCc2ccccc21
245372	245372:03:03_10.00	True	10.0	85	79.1	0.0	0.0	86.4	0.0	82.5	3.6	90.6	44.8	57.3	0.0	77.0	61.1	LCH	90.6	Perphenazine	Perphenazine is a typical antipsychotic drug, inhibits 5-HT2Areceptor, Alpha-1A adrenergic receptor, Dopamine receptor D2/D3, D2L receptor, and Histamine H1 receptor, with Ki values of 5.6, 10, 0.765/0.13, 3.4, and 8 nM, respectively.	False	OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1
280494	280494:01:03_10.00	True	10.0	76	23.7	46.8	21.5	0.0	93.7	0.0	0.0	0.0	0.0	0.0	66.8	0.0	0.0	DNA_Synth	93.7	DMNQ	DMNQ is a redox cycling agent that generates both superoxide and hydrogen peroxide intracellularly in a concentration dependent manner. DMNQ increases ROS generation.	False	COC1=C(OC)C(=O)c2ccccc2C1=O
280945	280945:01:04_10.00	True	10.0	95	9.2	71.0	0.0	0.0	41.8	0.0	48.3	10.3	0.0	10.8	25.5	0.0	33.4	AKT_PI3K_MTOR	71.0	SP600125,  Anthrapyrazolone	selective c-Jun N-terminal kinase (c-JNK) inhibitor, prevents BMP9-induced osteogenic differentiation of MSCs.	False	O=C1c2ccccc2-c2n[nH]c3cccc1c23
280149	280149:01:03_10.00	True	10.0	85	24.2	0.0	0.0	61.7	0.0	59.9	20.8	78.8	1.9	36.0	0.0	63.7	37.8	LCH	78.8	AMN082	selective allosteric mGluR7 receptor agonist.	False	c1ccc(C(NCCNC(c2ccccc2)c2ccccc2)c2ccccc2)cc1
280665	280665:01:03_10.00	True	10.0	106	52.8	0.0	0.0	80.0	0.0	76.1	6.8	94.7	32.3	50.5	0.0	65.4	46.3	LCH	94.7	L-741626	L-741626 is a selective D2 dopamine receptor antagonist, with the Ki values of 2.4, 100 and 220 nM for human D2, D3 and D4 receptors respectively.	False	OC1(c2ccc(Cl)cc2)CCN(Cc2c[nH]c3ccccc23)CC1
280641	280641:01:03_10.00	True	10.0	84	20.0	0.0	0.0	68.1	0.0	62.2	0.0	79.8	37.2	20.4	0.0	56.5	29.5	LCH	79.8	Ifenprodil tartrate	blocks the polyamine binding site associated with the NMDA glutamate receptor, neuroprotective.	False	CC(C(O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1
280491	280491:01:03_10.00	True	10.0	84	24.4	0.0	0.0	57.3	0.0	49.9	0.0	70.3	32.2	19.6	0.0	52.2	34.6	LCH	70.3	(-)-alpha-Methylnorepinephrine, Levonordefrin	active enantiomer, adrenoceptor agonist, vasoconstrictor, antihypertensive.	False	CC(N)[C@H](O)c1ccc(O)c(O)c1
280751	280751:01:03_10.00	True	10.0	105	7.1	0.0	0.0	61.5	0.0	59.5	21.1	79.8	8.2	38.3	0.0	54.4	42.0	LCH	79.8	Naltrindole hydrochloride, NTI hydrochloride	highly selective, non-peptide delta opioid receptor antagonist that is active when administered peripherally.	False	Oc1ccc2c3c1O[C@H]1c4[nH]c5ccccc5c4C[C@@]4(O)C(C2)N(CC2CC2)CCC314
280599	280599:01:03_10.00	True	10.0	98	7.3	69.5	0.4	0.0	84.4	0.0	13.8	0.0	0.0	0.0	88.0	0.0	0.0	Pyrimidine_Synth	88.0	Hydrocortisone, Cortisol	primary glucocorticoid secreted by the adrenal cortex.	False	C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO
245492	245492:03:03_10.00	True	10.0	93	68.4	0.0	0.0	82.7	0.0	80.2	7.3	95.3	38.9	55.5	0.0	72.1	47.3	LCH	95.3	Haloperidol	dopamine receptor antagonist, antipsychotic, Dopamine antagonist, antidyskinetic, antipsychotic.	False	O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
280694	280694:01:03_10.00	True	10.0	93	13.3	0.0	0.0	66.2	0.0	61.0	1.1	54.7	31.9	43.7	0.0	49.1	38.0	BET	66.2	3-Methoxy-morphanin hydrochloride, nor-Dextromethorphan hydrochloride	metabolite of dextromethorphan.	False	COc1ccc2c(c1)[C@@]13CCCC[C@H]1[C@@H](C2)NCC3
280799	280799:01:03_10.00	True	10.0	105	6.7	0.0	0.0	80.6	0.0	77.5	16.8	66.7	45.6	48.4	0.0	67.4	56.0	BET	80.6	2-Phenylaminoadenosine, CV-1808	selective A2 adenosine receptor agonist, potent vasodilator, weak inhibitor of adenosine uptake by rat cerebral cortical synaptosomes.	False	Nc1nc(Nc2ccccc2)nc2c1ncn2[C@@H]1O[C@H](CO)[C@H](O)C1O
280552	280552:01:04_10.00	True	10.0	100	24.7	0.0	0.0	60.8	0.0	59.6	7.1	89.9	22.1	25.6	0.0	54.9	32.2	LCH	89.9	Fiduxosin hydrochloride	alpha1-Adrenoceptor antagonist.	False	COc1cccc2c1[C@@H]1CN(CCCCn3c(=O)[nH]c4c(sc5ncc(-c6ccccc6)nc54)c3=O)C[C@@H]1CO2
247100	247100:02:05_10.00	True	10.0	84	55.4	0.0	0.0	25.8	0.0	23.0	14.1	31.7	26.7	31.9	0.0	36.7	5.6	Tubulin	36.7	Dequalinium dichloride	selective blocker of apamin-sensitive K+ channels, Blocker of the apamin-sensitive small conductance Ca2+ activated K+ channel.	False	Cc1cc(N)c2ccccc2[n+]1CCCCCCCCCC[n+]1c(C)cc(N)c2ccccc21
247272	247272:02:03_10.00	True	10.0	95	6.2	18.2	0.0	51.5	2.6	43.0	36.7	67.6	0.8	49.2	0.0	63.2	60.2	LCH	67.6	Isoetharine mesylate	beta-Adrenoceptor agonist, bronchodilator, Beta adrenergic agonist.	False	CCC(NC(C)C)C(O)c1ccc(O)c(O)c1
280614	280614:01:03_10.00	True	10.0	66	14.5	37.9	28.4	0.0	84.6	0.0	6.6	0.0	0.0	0.0	61.1	0.0	0.0	DNA_Synth	84.6	Hydroquinone, 1,4-Benzenediol	arachidonate 12-Lipoxygenase inhibitor, antioxidant.	False	Oc1ccc(O)cc1
280697	280697:01:03_10.00	True	10.0	88	20.0	0.0	0.0	42.3	32.2	32.3	0.0	57.7	0.2	16.0	0.0	57.3	30.2	LCH	57.7	Metrifudil	adenosine receptor agonist which displays some selectivity for the A2 receptor type.	False	Cc1ccccc1CNc1ncnc2c1ncn2C1OC(CO)C(O)C1O
280718	280718:01:03_10.00	True	10.0	99	76.3	0.0	0.0	83.4	0.0	79.6	5.1	94.4	40.0	53.2	0.0	71.4	51.0	LCH	94.4	Metergoline	5-HT1/5-HT2 Serotonin receptor antagonist, analgesic, antipyretic.	False	CN1C[C@H](CNC(=O)OCc2ccccc2)C[C@@H]2c3cccc4c3c(cn4C)C[C@H]21
247002	247002:02:03_10.00	True	10.0	98	6.7	1.1	0.0	36.1	0.0	32.2	0.0	32.9	19.9	25.3	0.0	34.5	29.3	BET	36.1	Isotretinoin	anti-inflammatory and antitumor actions mediated through RAR-beta and RAR-alpha receptors, antiacne, antineoplastic.	False	CC1=C(/C=C/C(C)=C/C=C/C(C)=C\C(=O)O)C(C)(C)CCC1
280872	280872:01:03_10.00	True	10.0	105	9.7	0.0	0.0	18.5	0.0	16.9	9.8	18.3	0.0	10.1	0.0	0.0	0.0	BET	18.5	Quinelorane dihydrochloride, LY-163,502	D2 Dopamine receptor agonist, 2-aminopyridine analog of Quinpirole.	False	CCCN1CCC[C@@H]2Cc3nc(N)ncc3C[C@H]21
280161	280161:01:03_10.00	True	10.0	101	41.3	0.0	0.0	77.6	0.0	74.3	5.1	93.5	31.7	56.5	0.0	69.0	42.5	LCH	93.5	LP 12 hydrochloride hydrate	5-HT7 receptor agonist displaying selectivity over D2, 5-HT1A and 5-HT2A receptors.	False	O=C(CCCCCN1CCN(c2ccccc2-c2ccccc2)CC1)NC1CCCc2ccccc21
280921	280921:01:04_10.00	True	10.0	56	45.3	16.8	63.8	0.0	78.8	0.0	4.5	0.0	0.0	0.0	78.2	0.0	0.0	DNA_Synth	78.8	SU 9516	cylcin-dependent kinase-2 (Cdk-2) inhibitor, induces apoptosis in colon cancer cells.	False	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2
247178	247178:02:03_10.00	True	10.0	104	15.2	0.0	0.0	68.7	0.0	66.2	4.8	89.4	30.2	40.0	0.0	61.8	35.4	LCH	89.4	Pirenperone, R-47,465	5-HT2 Serotonin receptor antagonist, 5-HT2 antagonist, 5ht2 receptor antagonist.	False	Cc1nc2ccccn2c(=O)c1CCN1CCC(C(=O)c2ccc(F)cc2)CC1
247072	247072:02:03_10.00	True	10.0	97	36.6	0.0	0.0	78.9	0.0	72.8	0.0	92.6	34.2	51.4	0.0	66.0	49.3	LCH	92.6	Maprotiline (hydrochloride)	Maprotiline hydrochloride is a selective noradrenalin re-uptake inhibitor and a tetracyclic antidepressant.Target: OthersMaprotiline (sold as Deprilept, Ludiomil, Psymion) is a tetracyclic antidepressant (TeCA). However, Maprotiline's fourth ring is spurious, as formed by a bridge across the central tricyclic ring. It is a strong norepinephrine reuptake inhibitor with only weak effects on serotonin and dopamine reuptake. It exerts strong blocking effect at H1 receptors, moderate at 5-HT2 and alpha1 and weak blocking effect at D2 and mACh postsynaptic receptors [1, 2].	False	CNCCC[C@]12CC[C@H](c3ccccc31)c1ccccc12
280638	280638:01:03_10.00	True	10.0	103	9.2	22.7	0.0	32.1	2.6	17.0	11.3	44.1	0.0	19.0	0.0	41.8	34.3	LCH	44.1	R(-)-Isoproterenol (+)-bitartrate	sympathomimetic amine acting almost exclusively on beta adrenoceptors, bronchodilator, active enantiomer of Isoproterenol.	False	CC(C)NC[C@H](O)c1ccc(O)c(O)c1
280121	280121:01:03_10.00	True	10.0	86	72.7	0.0	0.0	76.2	0.0	73.7	0.0	90.4	37.9	46.7	0.0	68.0	43.3	LCH	90.4	N-Methylhistaprodifen dioxalate salt	H1 histamine receptor agonist.	False	CNCCc1c[nH]c(CCC(c2ccccc2)c2ccccc2)n1
280745	280745:01:03_10.00	True	10.0	107	11.6	47.3	0.0	0.0	12.3	0.0	46.8	17.1	0.0	3.1	24.6	7.6	12.6	AKT_PI3K_MTOR	47.3	Mifepristone, RU-486	progesterone receptor antagonist.	False	CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C
280874	280874:01:03_10.00	True	10.0	96	33.9	0.0	0.0	57.6	0.0	59.9	17.7	75.5	22.6	41.1	0.0	58.2	19.6	LCH	75.5	Quinidine sulfate	Na+ channel blocker and Class I antiarrythmic, alkaloid isolated from the bark of the Cinchona family of South American trees.	False	C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12
280701	280701:01:03_10.00	True	10.0	95	7.6	0.0	0.0	3.4	0.0	0.6	0.0	0.0	0.0	2.1	0.0	0.0	0.0	BET	3.4	(-)-Naproxen sodium	COX-1 and COX-2 inhibitor.	False	COc1ccc2cc([C@H](C)C(=O)O)ccc2c1
280733	280733:01:03_10.00	True	10.0	84	13.3	41.5	15.1	0.0	88.6	0.0	0.0	0.0	0.0	0.0	58.7	0.0	0.0	DNA_Synth	88.6	Metrazoline oxalate	potent and selective imidazoline binding site ligand.	False	Cc1ccccc1/C=C/C1=NCCN1
280683	280683:01:03_10.00	True	10.0	89	41.5	0.0	0.0	54.0	0.0	51.0	0.0	53.3	44.1	43.4	0.0	53.1	26.0	BET	54.0	Methoctramine tetrahydrochloride	selective M2 muscarinic acetylcholine receptor antagonist.	False	COc1ccccc1CNCCCCCCNCCCCCCCCNCCCCCCNCc1ccccc1OC
247071	247071:02:03_10.00	True	10.0	99	7.1	0.0	0.0	40.6	0.0	42.6	0.0	41.7	0.0	28.6	0.0	22.8	39.3	HDAC	42.6	Clorgyline hydrochloride	Clorgyline hydrochloride is an irreversible and selective inhibitor of monoamine oxidase A (MAO-A) that is used in scientific research; structurally related to Pargyline.	False	C#CCN(C)CCCOc1ccc(Cl)cc1Cl
280785	280785:01:03_10.00	True	10.0	88	6.7	18.4	0.0	0.0	19.9	0.0	0.0	0.0	7.4	0.0	31.2	0.0	0.0	Pyrimidine_Synth	31.2	Nimustine hydrochloride, ACNU	antineoplastic, bifunctional nitrosourea alkylating anticancer agent.	False	Cc1ncc(CNC(=O)N(CCCl)N=O)c(N)n1
280642	280642:01:03_10.00	True	10.0	96	7.4	5.6	0.0	57.3	0.0	48.2	25.3	68.3	8.3	51.5	0.0	65.8	53.8	LCH	68.3	Isoprenaline (hydrochloride)	Isoprenaline hydrochloride is a non-selective .b.-adrenergic receptor agonist with potent peripheral vasodilator, bronchodilator, and cardiac stimulating activities.	False	CC(C)NCC(O)c1ccc(O)c(O)c1
280492	280492:01:03_10.00	True	10.0	91	72.7	0.0	0.0	81.9	0.0	81.0	9.0	94.8	43.1	51.6	0.0	73.8	49.8	LCH	94.8	Dilazep hydrochloride, Cormelian	adenosine uptake inhibitor.	False	COc1cc(C(=O)OCCCN2CCCN(CCCOC(=O)c3cc(OC)c(OC)c(OC)c3)CC2)cc(OC)c1OC
280962	280962:01:03_10.00	True	10.0	93	5.0	0.0	0.0	46.8	0.0	40.8	19.8	61.8	19.6	20.6	0.0	56.6	26.9	LCH	61.8	SB 218795	non-peptide NK3 tachykinin receptor antagonist.	False	COC(=O)[C@H](NC(=O)c1cc(-c2ccccc2)nc2ccccc12)c1ccccc1
280841	280841:01:03_10.00	True	10.0	92	11.1	0.0	0.0	73.6	0.0	65.6	17.8	79.9	35.9	55.2	0.0	75.5	60.7	LCH	79.9	Phenylephrine hydrochloride	alpha1 Adrenoceptor agonist, mydriatic, decongestant.	False	CNC[C@H](O)c1cccc(O)c1
280767	280767:01:03_10.00	True	10.0	85	12.3	0.0	0.0	59.2	0.0	52.1	8.7	85.4	4.5	32.8	0.0	61.9	36.5	LCH	85.4	NAN-190 (hydrobromide)	NAN-190 hydrobromide is a serotonin receptor 5-HT antagonist. NAN-190 is a selective antagonist of 5-HT1A.	False	COc1ccccc1N1CCN(CCCCN2C(=O)c3ccccc3C2=O)CC1
280912	280912:01:04_10.00	True	10.0	99	15.7	4.4	0.0	0.0	0.0	5.1	21.2	0.0	3.9	33.0	0.0	0.0	0.8	Protein_Synth	33.0	SB 206553 hydrochloride	potent 5-HT2C/5-HT2B serotonin receptor antagonist.	False	Cn1ccc2cc3c(cc21)CCN3C(=O)Nc1cccnc1
280606	280606:01:03_10.00	True	10.0	85	45.6	0.0	0.0	72.0	0.0	79.9	41.7	70.4	41.3	51.9	0.0	73.5	51.7	HDAC	79.9	Fenretinide	Fenretinide (4-HPR) is a synthetic retinoid deriverative, binding to the retinoic acid receptors (RAR) at concentrations necessary to induce cell death.	False	CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)Nc2ccc(O)cc2)C(C)(C)CCC1
280130	280130:01:04_10.00	True	10.0	98	17.4	10.2	20.2	0.0	15.1	0.0	6.8	0.0	0.0	0.0	46.5	0.0	0.0	Pyrimidine_Synth	46.5	Ro 90-7501	inhibits amyloid beta42 (Abeta42) fibril formation.	False	Nc1ccc(-c2nc3ccc(-c4nc5cc(N)ccc5[nH]4)cc3[nH]2)cc1
245512	245512:02:03_10.00	True	10.0	92	7.8	0.0	0.0	66.2	0.0	66.0	0.0	58.1	50.1	47.4	0.0	59.0	30.3	BET	66.2	Norcantharidin	demethylated form of cantharidin with antitumor properties, potent inhibitor of the serine/threonine protein phosphatase 2A (PP2A).	False	O=C1OC(=O)C2C3CCC(O3)C12
280871	280871:01:03_10.00	True	10.0	106	9.0	0.0	0.0	54.4	0.0	49.2	14.8	56.1	0.0	42.9	0.0	31.3	41.1	LCH	56.1	Quipazine, 6-nitro-, maleate	potent and selective serotonin reuptake inhibitor.	False	O=[N+]([O-])c1ccc2nc(N3CCNCC3)ccc2c1
280615	280615:01:03_10.00	True	10.0	103	11.2	15.4	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.6	0.0	0.0	0.0	AKT_PI3K_MTOR	15.4	5-Hydroxy-L-tryptophan	serotonin precursor, antidepressant, anti-epileptic.	False	N[C@@H](Cc1c[nH]c2ccc(O)cc12)C(=O)O
247008	247008:02:03_10.00	True	10.0	101	5.2	0.0	0.0	54.0	0.0	51.7	1.0	73.1	13.4	28.6	0.0	62.3	20.7	LCH	73.1	Doxepin (Hydrochloride)	Doxepin hydrochloride is an orally active tricyclic antidepressant agent. Doxepin hydrochloride is a potent and selective histamine receptor H1 antagonist. Doxepin hydrochloride is also a potent CYP450 inhibitor and significantly inhibits CYP450 2C19 and 1A2.	False	CN(C)CC/C=C1\c2ccccc2COc2ccccc21
280500	280500:01:03_10.00	True	10.0	100	14.3	3.8	0.0	65.3	0.0	60.1	40.2	76.9	4.3	59.7	0.0	63.5	57.6	LCH	76.9	N-Methyldopamine hydrochloride, Epinine hydrochloride	dopamine receptor agonist.	False	CNCCc1ccc(O)c(O)c1
280199	280199:01:03_10.00	True	10.0	93	5.5	0.0	59.2	0.0	42.4	0.0	3.9	0.0	0.0	5.8	7.6	13.7	0.0	Aurora	59.2	BAY 11-7082	BAY 11-7082 is an I.k.B.a. phosphorylation and NF-.k.B inhibitor. BAY 11-7082 selectively and irreversibly inhibits the TNF-.a.-induced phosphorylation of I.k.B-.a., and decreases NF-.k.B and expression of adhesion molecules. BAY 11-7082 inhibits ubiquitin-specific protease USP7 and USP21 (IC50=0.19, 0.96 uM, respectively). BAY 11-7082 inhibits gasdermin D (GSDMD) pore formation in liposomes and inflammasome-mediated pyroptosis and IL-1.b. secretion in human and mouse cells.	False	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1
280198	280198:01:03_10.00	True	10.0	86	50.9	0.0	0.0	79.3	0.0	76.5	20.8	90.3	33.1	53.3	0.0	70.4	46.8	LCH	90.3	GW405833 hydrochloride	it is a selective cannabanoid CB2 receptor agonist; analgesic. GW405833 binds with high affinity at both human and rat CB2 receptors (Ki¿s 3.9 and 3.6 nM); acts as a partial agonist (50% inhibition of forskolin-stimulated cAMP formation compared to full agonist CP55,940). GW405833 has potent analgesic activity in rat models of inflammatory, neuropathic and incisional pain; devoid of CNS effects common with CB1 agonists.	False	COc1ccc2c(c1)c(CCN1CCOCC1)c(C)n2C(=O)c1cccc(Cl)c1Cl
280178	280178:01:03_10.00	True	10.0	107	16.2	72.7	0.0	17.4	5.5	7.9	37.1	27.5	0.0	31.0	4.7	21.9	62.3	AKT_PI3K_MTOR	72.7	NU6027	selective cyclin-dependent kinase-2 (CDK2) inhibitor.	False	Nc1nc(N)c(N=O)c(OCC2CCCCC2)n1
280695	280695:01:03_10.00	True	10.0	72	9.8	0.0	3.0	40.2	0.0	46.2	24.3	67.1	15.5	13.6	0.0	50.2	13.6	LCH	67.1	p-MPPI hydrochloride	selective 5-HT1A serotonin receptor antagonist which crosses the blood-brain barrier.	False	COc1ccccc1N1CCN(CCN(C(=O)c2ccc(I)cc2)c2ccccn2)CC1
280967	280967:01:03_30.00	True	30.0	58	81.2	0.0	28.5	69.9	0.0	73.5	37.3	72.0	43.9	58.8	0.0	84.3	30.3	Tubulin	84.3	SU6656	SU6656 is a Src family kinases inhibitor with IC50s of 280, 20, 130, 170 nM for Src, Yes, Lyn, and Fyn, respectively. SU6656 inhibits FAK phosphorylation at Y576/577, Y925, Y861 sites. SU6656 also inhibits p-AKT.	False	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2
247195	247195:02:03_30.00	True	30.0	99	38.0	0.0	0.0	84.4	0.0	77.9	4.0	84.3	47.7	51.6	0.0	85.9	49.6	Tubulin	85.9	Tetracaine hydrochloride	local anesthetic, anesthetic (local).	False	CCCCNc1ccc(C(=O)OCCN(C)C)cc1
280160	280160:01:03_30.00	True	30.0	77	82.6	0.0	0.0	60.2	0.0	60.5	19.7	71.0	40.4	48.4	0.0	72.0	27.6	Tubulin	72.0	SID7969543	A SF-1 (or NR5A1) inhibitor.	False	CCOC(=O)C(C)Oc1cccc2c(=O)n(CC(=O)Nc3ccc4c(c3)OCCO4)ccc12
281031	281031:01:04_30.00	True	30.0	78	70.3	0.0	0.0	72.3	0.0	69.9	8.9	84.0	43.9	49.3	0.0	73.6	39.8	LCH	84.0	U-73122	phospholipase C and A2 inhibitor that inhibits the hydrolysis of PPI to IP3, leading to a decrease in cytosolic free Ca2+.	False	COc1ccc2c(c1)CCC1C2CC[C@@]2(C)C1CC[C@@H]2NCCCCCCN1C(=O)C=CC1=O
280811	280811:01:03_30.00	True	30.0	94	68.2	0.0	0.0	69.3	0.0	65.2	23.7	93.6	19.0	51.4	0.0	68.4	52.5	LCH	93.6	Phenamil methanesulfonate	irreversible inhibitor of amiloride-sensitive Na+ channels, derivative of amiloride.	False	N=C(NC(=O)c1nc(Cl)c(N)nc1N)Nc1ccccc1
280773	280773:01:03_30.00	True	30.0	97	10.7	10.7	6.6	11.7	2.5	23.1	61.2	35.3	0.0	23.1	0.0	31.4	19.6	HSP90	61.2	Nordihydroguaiaretic acid from Larrea divaricata (creosote bush), NDGA	lipoxygenase inhibitor.	False	C[C@@H](Cc1ccc(O)c(O)c1)[C@H](C)Cc1ccc(O)c(O)c1
280706	280706:01:03_30.00	True	30.0	108	33.3	0.0	0.0	66.3	0.0	57.9	6.1	80.5	20.5	43.6	0.0	70.1	23.7	LCH	80.5	MRS 1523	selective A3 adenosine receptor antagonist in rat.	False	CCCOC(=O)c1c(-c2ccccc2)nc(CC)c(C(=O)SCC)c1CCC
280569	280569:01:03_30.00	True	30.0	100	6.7	0.2	0.0	33.7	0.0	28.7	21.3	62.7	6.9	8.6	0.0	39.8	7.4	LCH	62.7	GYKI 52466 hydrochloride	selective AMPA/kainate glutamate receptor antagonist, anticonvulsant, skeletal muscle relaxant.	False	CC1=NN=C(c2ccc(N)cc2)c2cc3c(cc2C1)OCO3
280707	280707:01:03_30.00	True	30.0	69	27.1	44.3	37.7	0.0	91.5	0.0	15.8	0.0	0.0	0.0	72.4	0.0	0.0	DNA_Synth	91.5	Melphalan, L-Phenylalanine mustard	antineoplastic, forms DNA intrastrand crosslinks by bifunctional alkylation in 5'-GGC sequences.	False	NC(Cc1ccc(N(CCCl)CCCl)cc1)C(=O)O
280184	280184:01:03_30.00	True	30.0	72	48.4	40.9	16.5	0.0	96.4	0.0	0.0	0.0	0.0	0.0	68.3	0.0	0.0	DNA_Synth	96.4	PAC-1	PAC-1 is a procaspase-3 activator that induces apoptosis in cancer cells with an EC50 of 2.08 uM.	False	C=CCc1cccc(/C=N/NC(=O)CN2CCN(Cc3ccccc3)CC2)c1O
280162	280162:01:03_30.00	True	30.0	92	11.1	0.0	9.0	66.1	0.0	67.3	20.0	67.7	42.2	38.8	0.0	79.1	38.9	Tubulin	79.1	Org 27569	Org 27569 is a potent CB1 receptor allosteric modulator, which increases agonist binding, yet blocks agonist-induced CB1 signaling. 	False	CCc1c(C(=O)NCCc2ccc(N3CCCCC3)cc2)[nH]c2ccc(Cl)cc12
108014	108014:02:03_30.00	True	30.0	76	55.4	0.0	2.7	72.0	0.0	72.5	38.2	64.0	50.9	72.1	0.0	83.9	55.1	Tubulin	83.9	Rutaecarpine	Rutaecarpine, an alkaloid of Evodia rutaecarpa, is an inhibitor of COX-2 with an IC50 value of 0.28 uM.	False	O=c1c2ccccc2nc2n1CCc1c-2[nH]c2ccccc12
280586	280586:01:03_30.00	True	30.0	100	10.2	0.0	0.0	67.7	0.0	62.0	9.0	83.4	24.6	44.5	0.0	67.2	27.8	LCH	83.4	R-(+)-8-Hydroxy-DPAT hydrobromide	full 5-HT1A serotonin receptor agonist, active enantiomer of (±)-8-hydroxy-DPAT.	False	CCCN(CCC)[C@@H]1CCc2cccc(O)c2C1
247331	247331:02:03_30.00	True	30.0	99	32.0	0.0	0.0	74.4	0.0	70.7	14.4	90.3	37.5	32.3	0.0	68.3	34.2	LCH	90.3	Ethopropazine hydrochloride	anticholinergic, Butyrylcholinesterase inhibitor, antiparkinsonian, antiparkinsonian, anticholinergic.	False	CCN(CC)C(C)CN1c2ccccc2Sc2ccccc21
247380	247380:02:03_30.00	True	30.0	85	11.2	0.0	8.7	15.4	0.0	11.1	32.4	33.2	0.0	6.4	0.0	28.0	0.0	LCH	33.2	Nimodipine	potent L-type Ca2+ channel antagonist, Calcium channel blocker, vasodilator.	False	COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1
247000	247000:02:03_30.00	True	30.0	93	80.7	0.0	0.0	89.6	0.0	85.5	5.6	93.0	52.9	61.7	0.0	80.9	62.8	LCH	93.0	Nortriptyline (hydrochloride)	Nortriptyline hydrochloride (Desmethylamitriptyline hydrochloride) is a tricyclic antidepressant and the main active metabolite of Amitriptyline, and used to relieve the symptoms of depression.	False	CNCCC=C1c2ccccc2CCc2ccccc21
280875	280875:01:03_30.00	True	30.0	91	18.8	0.0	11.4	14.0	1.8	11.8	29.4	30.8	9.6	27.5	0.0	26.3	0.0	LCH	30.8	Quinine sulfate	K+ channel blocker, antimalarial, anticholinergic, antihypertensive and hypoglycemic agent, alkaloid isolated from the bark of the Cinchona family of South American trees.	False	C=C[C@H]1CN2CC[C@H]1C[C@H]2[C@H](O)c1ccnc2ccc(OC)cc12
280494	280494:01:03_30.00	True	30.0	53	57.0	24.6	0.0	14.8	11.6	19.8	34.1	30.0	20.5	35.8	0.0	18.4	20.3	Protein_Synth	35.8	DMNQ	DMNQ is a redox cycling agent that generates both superoxide and hydrogen peroxide intracellularly in a concentration dependent manner. DMNQ increases ROS generation.	False	COC1=C(OC)C(=O)c2ccccc2C1=O
280637	280637:01:03_30.00	True	30.0	103	10.4	0.0	0.0	69.2	0.0	73.0	8.3	87.7	40.4	28.5	0.0	52.9	35.5	LCH	87.7	IMID-4F hydrochloride	imidazoline-based K(ATP) channel blocker.	False	Fc1ccc(CN(C2=NCCN2)c2c(Cl)cccc2Cl)cc1
280945	280945:01:04_30.00	True	30.0	64	20.7	52.8	38.0	0.0	59.1	0.0	58.6	0.0	0.0	8.8	40.8	0.0	0.0	DNA_Synth	59.1	SP600125,  Anthrapyrazolone	selective c-Jun N-terminal kinase (c-JNK) inhibitor, prevents BMP9-induced osteogenic differentiation of MSCs.	False	O=C1c2ccccc2-c2n[nH]c3cccc1c23
280149	280149:01:03_30.00	True	30.0	98	60.1	0.0	0.0	63.0	0.0	61.8	29.5	87.4	16.5	38.3	0.0	63.5	37.2	LCH	87.4	AMN082	selective allosteric mGluR7 receptor agonist.	False	c1ccc(C(NCCNC(c2ccccc2)c2ccccc2)c2ccccc2)cc1
280641	280641:01:03_30.00	True	30.0	108	63.0	0.0	0.0	73.3	0.0	72.2	22.6	93.3	30.1	45.0	0.0	68.8	39.1	LCH	93.3	Ifenprodil tartrate	blocks the polyamine binding site associated with the NMDA glutamate receptor, neuroprotective.	False	CC(C(O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1
280491	280491:01:03_30.00	True	30.0	102	8.1	0.0	0.0	72.0	0.0	64.5	2.1	76.5	34.0	48.0	0.0	69.5	46.5	LCH	76.5	(-)-alpha-Methylnorepinephrine, Levonordefrin	active enantiomer, adrenoceptor agonist, vasoconstrictor, antihypertensive.	False	CC(N)[C@H](O)c1ccc(O)c(O)c1
280495	280495:01:03_30.00	True	30.0	105	7.9	47.3	16.4	0.0	79.5	0.0	0.0	0.0	0.0	0.0	66.9	0.0	0.0	DNA_Synth	79.5	Daphnetin	Daphnetin (7,8-dihydroxycoumarin), one coumarin derivative isolated from plants of the Genus Daphne, is a protein kinase inhibitor, with IC50s of 7.67 uM, 9.33 uM and 25.01 uM for EGFR, PKA and PKC in vitro, respectively. Daphnetin (7,8-dihydroxycoumarin) is a secondary metabolite of plants used in folk medicine to counter inflammatory and allergic diseases, also has has the potential in the treatment of coagulation disorders, rheumatoid arthritis with anti-malarian and anti-pyretic properties.	False	O=c1ccc2ccc(O)c(O)c2o1
280117	280117:01:03_30.00	True	30.0	95	24.5	0.0	0.0	56.3	0.0	54.4	13.7	71.1	23.6	32.7	0.0	58.4	12.6	LCH	71.1	Paliperidone	Paliperidone (9-Hydroxyrisperidone), the major active metabolite of Risperidone, is a dopamine D2 antagonist and 5-HT2A antagonist. Paliperidone is also active as an antagonist at .a.1 and .a.2 adrenergic receptors and H1-histaminergic receptors. Paliperidone, a antipsychotic agent, shows efficacy against schizophrenia.	False	Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O
280751	280751:01:03_30.00	True	30.0	105	37.1	0.0	0.0	74.0	0.0	70.4	17.5	95.8	29.5	39.4	0.0	64.2	44.4	LCH	95.8	Naltrindole hydrochloride, NTI hydrochloride	highly selective, non-peptide delta opioid receptor antagonist that is active when administered peripherally.	False	Oc1ccc2c3c1O[C@H]1c4[nH]c5ccccc5c4C[C@@]4(O)C(C2)N(CC2CC2)CCC314
247378	247378:02:03_30.00	True	30.0	96	6.6	0.0	0.0	44.6	0.0	43.5	48.1	61.0	27.2	25.5	0.0	70.8	31.1	Tubulin	70.8	Nitrendipine	Ca2+ channel blocker, antihypertensive, Calcium channel blocker.	False	CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc([N+](=O)[O-])c1
280599	280599:01:03_30.00	True	30.0	91	5.9	49.9	11.5	0.0	75.6	0.0	0.0	0.0	0.0	0.0	81.3	0.0	0.0	Pyrimidine_Synth	81.3	Hydrocortisone, Cortisol	primary glucocorticoid secreted by the adrenal cortex.	False	C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO
245492	245492:03:03_30.00	True	30.0	97	62.0	0.0	0.0	76.0	0.0	74.4	18.5	94.7	34.1	45.8	0.0	70.6	39.5	LCH	94.7	Haloperidol	dopamine receptor antagonist, antipsychotic, Dopamine antagonist, antidyskinetic, antipsychotic.	False	O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
247410	247410:02:03_30.00	True	30.0	96	42.0	0.0	0.0	74.5	0.0	73.7	27.7	88.2	29.8	49.6	0.0	76.1	46.2	LCH	88.2	Guanabenz (Acetate)	Guanabenz (Acetate) (BR-750) is an alpha-2 selective adrenergic agonist used as an antihypertensive agent.	False	N=C(N)N/N=C/c1c(Cl)cccc1Cl
280694	280694:01:03_30.00	True	30.0	98	25.4	0.0	0.0	84.1	0.0	78.3	0.3	81.3	62.0	52.1	0.0	73.1	53.1	BET	84.1	3-Methoxy-morphanin hydrochloride, nor-Dextromethorphan hydrochloride	metabolite of dextromethorphan.	False	COc1ccc2c(c1)[C@@]13CCCC[C@H]1[C@@H](C2)NCC3
280799	280799:01:03_30.00	True	30.0	105	12.3	4.9	0.0	77.0	0.0	78.8	38.1	67.7	45.5	58.5	0.0	65.9	75.8	HDAC	78.8	2-Phenylaminoadenosine, CV-1808	selective A2 adenosine receptor agonist, potent vasodilator, weak inhibitor of adenosine uptake by rat cerebral cortical synaptosomes.	False	Nc1nc(Nc2ccccc2)nc2c1ncn2[C@@H]1O[C@H](CO)[C@H](O)C1O
280552	280552:01:04_30.00	True	30.0	90	76.5	0.0	0.0	79.1	0.0	78.5	10.6	91.8	42.5	49.1	0.0	70.2	49.8	LCH	91.8	Fiduxosin hydrochloride	alpha1-Adrenoceptor antagonist.	False	COc1cccc2c1[C@@H]1CN(CCCCn3c(=O)[nH]c4c(sc5ncc(-c6ccccc6)nc54)c3=O)C[C@@H]1CO2
247100	247100:02:05_30.00	True	30.0	83	59.1	0.0	0.0	44.5	0.0	39.6	7.4	43.9	35.4	47.9	0.0	53.5	25.7	Tubulin	53.5	Dequalinium dichloride	selective blocker of apamin-sensitive K+ channels, Blocker of the apamin-sensitive small conductance Ca2+ activated K+ channel.	False	Cc1cc(N)c2ccccc2[n+]1CCCCCCCCCC[n+]1c(C)cc(N)c2ccccc21
280711	280711:01:03_30.00	True	30.0	105	8.3	11.7	0.0	0.0	17.1	0.0	24.3	0.0	0.0	0.0	44.3	0.0	0.0	Pyrimidine_Synth	44.3	Methylergonovine maleate, Methergine maleate	dopamine antagonist, ergot alkaloid which interacts with serotonergic, dopaminergic and alpha-adrenergic systems, oxytocic.	False	CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1
247272	247272:02:03_30.00	True	30.0	97	6.7	0.0	0.0	52.7	0.0	48.6	35.0	68.4	10.7	40.0	0.0	60.4	36.5	LCH	68.4	Isoetharine mesylate	beta-Adrenoceptor agonist, bronchodilator, Beta adrenergic agonist.	False	CCC(NC(C)C)C(O)c1ccc(O)c(O)c1
280614	280614:01:03_30.00	True	30.0	80	21.4	45.8	28.6	0.0	85.8	0.0	28.5	0.0	0.0	0.0	55.1	0.0	0.0	DNA_Synth	85.8	Hydroquinone, 1,4-Benzenediol	arachidonate 12-Lipoxygenase inhibitor, antioxidant.	False	Oc1ccc(O)cc1
280663	280663:01:03_30.00	True	30.0	105	37.0	0.0	0.0	72.8	0.0	74.9	32.1	79.8	31.8	53.7	0.0	72.8	41.8	LCH	79.8	L-750,667 trihydrochloride	selective D4 dopamine receptor antagonist.	False	Ic1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1
280697	280697:01:03_30.00	True	30.0	103	49.9	0.0	0.0	57.7	1.3	51.4	0.0	61.4	43.4	33.1	0.0	70.8	38.5	Tubulin	70.8	Metrifudil	adenosine receptor agonist which displays some selectivity for the A2 receptor type.	False	Cc1ccccc1CNc1ncnc2c1ncn2C1OC(CO)C(O)C1O
247002	247002:02:03_30.00	True	30.0	103	7.9	39.8	0.0	11.4	30.5	8.5	11.0	32.2	0.0	12.6	8.2	12.5	18.8	AKT_PI3K_MTOR	39.8	Isotretinoin	anti-inflammatory and antitumor actions mediated through RAR-beta and RAR-alpha receptors, antiacne, antineoplastic.	False	CC1=C(/C=C/C(C)=C/C=C/C(C)=C\C(=O)O)C(C)(C)CCC1
280639	280639:01:03_30.00	True	30.0	108	57.9	0.0	0.0	82.2	0.0	77.4	9.5	94.8	37.9	57.2	0.0	77.7	48.9	LCH	94.8	ML-7 (hydrochloride)	ML-7 hydrochloride is a naphthalene sulphonamide derivative, potently inhibits MLCK (IC50=300 nM). ML-7 hydrochloride also inhibits YAP/TAZ.	False	O=S(=O)(c1cccc2c(I)cccc12)N1CCCNCC1
280898	280898:01:03_30.00	True	30.0	91	13.0	9.4	0.0	57.5	0.0	58.0	37.8	82.1	11.9	46.1	0.0	59.8	55.3	LCH	82.1	Ro 8-4304	NR2B-selective, noncompetitive NMDA receptor antagonist.	False	NC(=O)c1ccc(OCC(O)CN2CC=C(c3ccc(F)cc3)CC2)cc1
280124	280124:01:03_30.00	True	30.0	86	10.0	1.9	0.0	29.0	0.0	27.8	48.7	59.1	0.0	24.6	0.0	44.6	13.6	LCH	59.1	CPNQ	prevents huntingtin-mediated proteosome dysfunction and reduces alpha-synuclein-mediated toxicity, promotes inclusion formation in cellular models of Huntington's and Parkinson's disease.	False	O=C(c1ccc(Cl)cc1)N1CCN(c2ccc([N+](=O)[O-])c3ncccc23)CC1
280921	280921:01:04_30.00	True	30.0	57	49.4	50.5	31.1	0.0	82.3	0.0	9.3	0.0	0.0	0.0	74.0	0.0	0.0	DNA_Synth	82.3	SU 9516	cylcin-dependent kinase-2 (Cdk-2) inhibitor, induces apoptosis in colon cancer cells.	False	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2
247178	247178:02:03_30.00	True	30.0	103	37.8	0.0	0.0	62.6	0.0	65.2	29.4	88.8	21.8	33.3	0.0	62.6	30.1	LCH	88.8	Pirenperone, R-47,465	5-HT2 Serotonin receptor antagonist, 5-HT2 antagonist, 5ht2 receptor antagonist.	False	Cc1nc2ccccn2c(=O)c1CCN1CCC(C(=O)c2ccc(F)cc2)CC1
247072	247072:02:03_30.00	True	30.0	91	82.0	0.0	0.0	83.5	0.0	79.6	12.5	93.1	39.0	55.2	0.0	75.7	59.5	LCH	93.1	Maprotiline (hydrochloride)	Maprotiline hydrochloride is a selective noradrenalin re-uptake inhibitor and a tetracyclic antidepressant.Target: OthersMaprotiline (sold as Deprilept, Ludiomil, Psymion) is a tetracyclic antidepressant (TeCA). However, Maprotiline's fourth ring is spurious, as formed by a bridge across the central tricyclic ring. It is a strong norepinephrine reuptake inhibitor with only weak effects on serotonin and dopamine reuptake. It exerts strong blocking effect at H1 receptors, moderate at 5-HT2 and alpha1 and weak blocking effect at D2 and mACh postsynaptic receptors [1, 2].	False	CNCCC[C@]12CC[C@H](c3ccccc31)c1ccccc12
280638	280638:01:03_30.00	True	30.0	96	8.5	0.0	0.0	58.5	0.0	55.5	33.0	72.9	11.5	45.4	0.0	62.7	39.5	LCH	72.9	R(-)-Isoproterenol (+)-bitartrate	sympathomimetic amine acting almost exclusively on beta adrenoceptors, bronchodilator, active enantiomer of Isoproterenol.	False	CC(C)NC[C@H](O)c1ccc(O)c(O)c1
280891	280891:01:03_30.00	True	30.0	103	9.8	0.0	0.0	41.0	0.0	43.1	57.1	42.8	19.2	39.9	0.0	53.4	32.0	HSP90	57.1	REV 5901	leukotriene D4 receptor antagonist.	False	CCCCCC(O)c1cccc(OCc2ccc3ccccc3n2)c1
281027	281027:01:04_30.00	True	30.0	94	6.9	39.7	0.0	0.0	65.1	0.0	45.8	6.9	0.0	0.0	48.9	0.0	0.7	DNA_Synth	65.1	U0126	specific inhibitor of MEK1 and MEK2 (MAP kinase kinase, MAPKK), also inhibits a constitutively active, mutant form of MEK.	False	N#CC(=C(\N)Sc1ccccc1N)/C(C#N)=C(/N)Sc1ccccc1N
280745	280745:01:03_30.00	True	30.0	85	27.1	18.6	0.0	34.8	0.0	25.5	57.5	46.7	12.0	44.7	0.0	57.3	45.7	HSP90	57.5	Mifepristone, RU-486	progesterone receptor antagonist.	False	CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C
280273	280273:01:03_30.00	True	30.0	91	7.6	0.0	2.3	52.0	0.0	51.0	0.0	43.9	52.4	51.4	0.0	60.1	44.7	Tubulin	60.1	L-732,138	competitive antagonist at substance P receptors, approximately 1000-fold more potent at cloned human NK-1 receptors than at cloned human NK-2 and NK-3 receptors.	False	CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)OCc1cc(C(F)(F)F)cc(C(F)(F)F)c1
280874	280874:01:03_30.00	True	30.0	83	66.3	0.0	0.0	56.7	0.0	57.8	22.8	83.6	20.1	37.7	0.0	55.5	27.9	LCH	83.6	Quinidine sulfate	Na+ channel blocker and Class I antiarrythmic, alkaloid isolated from the bark of the Cinchona family of South American trees.	False	C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12
280163	280163:01:03_30.00	True	30.0	102	5.4	52.5	14.6	0.0	72.7	0.0	34.4	0.0	0.0	0.0	59.1	0.0	0.0	DNA_Synth	72.7	SMER28	SMER28 is a positive regulator of autophagy acting via an mTOR-independent mechanism. SMER28 prevents the accumulation of amyloid beta peptide.	False	C=CCNc1ncnc2ccc(Br)cc12
280733	280733:01:03_30.00	True	30.0	74	21.4	20.9	39.1	0.0	85.8	0.0	0.0	0.0	0.0	0.0	51.3	0.0	0.0	DNA_Synth	85.8	Metrazoline oxalate	potent and selective imidazoline binding site ligand.	False	Cc1ccccc1/C=C/C1=NCCN1
280683	280683:01:03_30.00	True	30.0	93	53.9	0.0	0.0	55.2	0.0	50.9	3.0	48.3	43.9	50.9	0.0	54.2	24.9	BET	55.2	Methoctramine tetrahydrochloride	selective M2 muscarinic acetylcholine receptor antagonist.	False	COc1ccccc1CNCCCCCCNCCCCCCCCNCCCCCCNCc1ccccc1OC
247071	247071:02:03_30.00	True	30.0	107	11.6	0.0	0.0	55.8	0.0	60.5	20.4	35.6	46.3	48.9	0.0	58.6	50.3	HDAC	60.5	Clorgyline hydrochloride	Clorgyline hydrochloride is an irreversible and selective inhibitor of monoamine oxidase A (MAO-A) that is used in scientific research; structurally related to Pargyline.	False	C#CCN(C)CCCOc1ccc(Cl)cc1Cl
280602	280602:01:03_30.00	True	30.0	92	17.4	4.7	0.0	50.8	0.0	60.5	54.7	73.7	21.7	40.1	0.0	55.8	38.8	LCH	73.7	PPT	specific estrogen receptor alpha (ERalpha) agonist.	False	CCCc1c(-c2ccc(O)cc2)nn(-c2ccc(O)cc2)c1-c1ccc(O)cc1
280642	280642:01:03_30.00	True	30.0	105	8.8	0.0	0.0	60.9	0.0	52.7	18.0	71.9	15.5	55.5	0.0	69.5	50.5	LCH	71.9	Isoprenaline (hydrochloride)	Isoprenaline hydrochloride is a non-selective .b.-adrenergic receptor agonist with potent peripheral vasodilator, bronchodilator, and cardiac stimulating activities.	False	CC(C)NCC(O)c1ccc(O)c(O)c1
280633	280633:01:03_30.00	True	30.0	99	13.8	66.3	0.0	0.0	65.0	0.0	33.5	11.4	0.0	0.0	43.2	0.0	0.0	AKT_PI3K_MTOR	66.3	HA-100	inhibitor of protein kinase A (PKA), protein kinase C (PKC) and myosin light chain kinase (MLCK).	False	O=S(=O)(c1cccc2ncccc12)N1CCNCC1
280962	280962:01:03_30.00	True	30.0	100	32.6	0.0	0.0	41.3	0.0	44.9	40.1	63.5	3.2	27.1	0.0	49.4	17.9	LCH	63.5	SB 218795	non-peptide NK3 tachykinin receptor antagonist.	False	COC(=O)[C@H](NC(=O)c1cc(-c2ccccc2)nc2ccccc12)c1ccccc1
280841	280841:01:03_30.00	True	30.0	100	9.0	0.0	0.0	77.4	0.0	72.4	8.5	77.3	38.2	64.2	0.0	70.4	54.2	BET	77.4	Phenylephrine hydrochloride	alpha1 Adrenoceptor agonist, mydriatic, decongestant.	False	CNC[C@H](O)c1cccc(O)c1
280767	280767:01:03_30.00	True	30.0	106	16.9	0.0	0.0	63.0	0.0	62.3	11.4	90.5	11.1	32.8	0.0	60.4	29.0	LCH	90.5	NAN-190 (hydrobromide)	NAN-190 hydrobromide is a serotonin receptor 5-HT antagonist. NAN-190 is a selective antagonist of 5-HT1A.	False	COc1ccccc1N1CCN(CCCCN2C(=O)c3ccccc3C2=O)CC1
280130	280130:01:04_30.00	True	30.0	91	40.6	21.1	31.3	0.0	44.6	0.0	10.2	0.0	0.0	0.0	68.7	0.0	0.0	Pyrimidine_Synth	68.7	Ro 90-7501	inhibits amyloid beta42 (Abeta42) fibril formation.	False	Nc1ccc(-c2nc3ccc(-c4nc5cc(N)ccc5[nH]4)cc3[nH]2)cc1
280894	280894:01:03_30.00	True	30.0	91	20.9	2.5	0.0	46.0	2.1	43.1	22.1	81.1	0.0	25.9	0.0	51.1	28.9	LCH	81.1	Ro 25-6981 hydrochloride	NR2B-selective, NMDA glutamate receptor antagonist.	False	C[C@@H](CN1CCC(Cc2ccccc2)CC1)[C@@H](O)c1ccc(O)cc1
280148	280148:01:03_30.00	True	30.0	92	13.0	0.0	0.0	54.8	0.0	55.3	48.7	48.4	31.2	57.7	0.0	63.4	59.7	Tubulin	63.4	CI-976	potent and selective acyl coenzyme A: cholesterol acyltransferase inhibitor.	False	CCCCCCCCCCC(C)(C)C(=O)Nc1c(OC)cc(OC)cc1OC
280750	280750:01:03_30.00	True	30.0	105	6.7	65.7	0.0	0.0	76.6	0.0	14.0	0.0	0.0	0.0	51.5	0.0	5.0	DNA_Synth	76.6	H-8 dihydrochloride	potent inhibitor of cAMP- and cGMP-dependent protein kinase.	False	CNCCNS(=O)(=O)c1cccc2cnccc12
280801	280801:01:03_30.00	True	30.0	107	10.9	0.0	0.0	65.4	0.0	63.5	10.0	74.2	39.8	43.2	0.0	74.2	32.8	LCH	74.2	S(-)-3PPP hydrochloride, Preclamol hydrochloride	dopamine autoreceptor agonist, postsynaptic dopamine receptor antagonist.	False	CCCN1CCC[C@@H](c2cccc(O)c2)C1
245512	245512:02:03_30.00	True	30.0	115	40.6	0.0	0.0	78.2	0.0	71.5	0.0	62.5	52.4	65.2	0.0	78.7	33.7	Tubulin	78.7	Norcantharidin	demethylated form of cantharidin with antitumor properties, potent inhibitor of the serine/threonine protein phosphatase 2A (PP2A).	False	O=C1OC(=O)C2C3CCC(O3)C12
280871	280871:01:03_30.00	True	30.0	99	9.7	3.5	0.0	52.1	0.0	51.6	35.7	72.6	14.1	39.9	0.0	52.7	40.1	LCH	72.6	Quipazine, 6-nitro-, maleate	potent and selective serotonin reuptake inhibitor.	False	O=[N+]([O-])c1ccc2nc(N3CCNCC3)ccc2c1
280802	280802:01:03_30.00	True	30.0	95	44.0	0.0	0.0	67.8	0.0	64.0	24.3	90.6	19.6	38.8	0.0	65.9	43.9	LCH	90.6	(±)-PPHT hydrochloride	potent D2 dopamine receptor agonist.	False	CCCN(CCc1ccccc1)C1CCc2c(O)cccc2C1
280165	280165:01:03_30.00	True	30.0	100	37.5	0.0	0.0	61.5	0.0	56.2	21.1	87.3	22.3	22.5	0.0	57.9	38.9	LCH	87.3	A-3 (hydrochloride)	A-3 hydrochloride is a potent, cell-permeable, reversible, ATP-competitive non-selective antagonist of various kinases. It against PKA (Ki=4.3 uM), casein kinase II (Ki=5.1 uM) and myosin light chain kinase (MLCK) (Ki=7.4 uM). A-3 hydrochloride also inhibits PKC and casein kinase I with Ki values of 47 uM and 80 uM, respectively.	False	NCCNS(=O)(=O)c1cccc2c(Cl)cccc12
247008	247008:02:03_30.00	True	30.0	101	22.6	0.0	0.0	71.0	0.0	68.6	0.0	90.7	40.3	44.6	0.0	59.7	33.5	LCH	90.7	Doxepin (Hydrochloride)	Doxepin hydrochloride is an orally active tricyclic antidepressant agent. Doxepin hydrochloride is a potent and selective histamine receptor H1 antagonist. Doxepin hydrochloride is also a potent CYP450 inhibitor and significantly inhibits CYP450 2C19 and 1A2.	False	CN(C)CC/C=C1\c2ccccc2COc2ccccc21
280118	280118:01:03_30.00	True	30.0	96	8.6	0.0	0.0	75.0	0.0	72.4	42.2	63.6	34.0	66.1	0.0	76.2	68.6	Tubulin	76.2	Ciproxifan hydrochloride	H3 histamine receptor antagonist.	False	O=C(c1ccc(OCCCc2c[nH]cn2)cc1)C1CC1
280500	280500:01:03_30.00	True	30.0	91	7.1	0.0	0.0	55.2	0.0	56.1	30.2	70.2	17.9	52.9	0.0	60.9	37.9	LCH	70.2	N-Methyldopamine hydrochloride, Epinine hydrochloride	dopamine receptor agonist.	False	CNCCc1ccc(O)c(O)c1
280705	280705:01:03_30.00	True	30.0	102	5.9	10.0	0.0	19.0	0.0	16.6	48.3	38.5	5.4	22.9	0.0	30.7	3.2	HSP90	48.3	MRS 1845, N-Propargylnitrendipene	store-operated calcium (SOC) channel inhibitor.	False	C#CCN1C(C)=C(C(=O)OC)C(c2cccc([N+](=O)[O-])c2)C(C(=O)OCC)=C1C
280611	280611:01:03_30.00	True	30.0	89	11.6	0.0	0.0	71.0	0.0	69.8	25.0	82.0	26.7	45.5	0.0	72.8	37.6	LCH	82.0	(±)-7-Hydroxy-DPAT hydrobromide, (±)-7-OH-DPAT HBr, (±)-Hydroxy-dipropylaminotetralin hydrobromide	selective D3 dopamine receptor agonist.	False	CCCN(CCC)C1CCc2ccc(O)cc2C1
281007	281007:01:03_30.00	True	30.0	58	53.2	7.6	39.0	10.6	0.0	23.0	73.0	32.2	5.9	31.8	0.0	48.7	13.5	HSP90	73.0	Taxol, Paclitaxel.	antitumor agent, promotes assembly of microtubules and inhibits tubulin disassembly process, antineoplastic.	True	CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C
280198	280198:01:03_30.00	True	30.0	100	83.4	0.0	0.0	87.3	0.0	83.5	22.3	92.0	44.3	63.4	0.0	79.3	60.8	LCH	92.0	GW405833 hydrochloride	it is a selective cannabanoid CB2 receptor agonist; analgesic. GW405833 binds with high affinity at both human and rat CB2 receptors (Ki¿s 3.9 and 3.6 nM); acts as a partial agonist (50% inhibition of forskolin-stimulated cAMP formation compared to full agonist CP55,940). GW405833 has potent analgesic activity in rat models of inflammatory, neuropathic and incisional pain; devoid of CNS effects common with CB1 agonists.	False	COc1ccc2c(c1)c(CCN1CCOCC1)c(C)n2C(=O)c1cccc(Cl)c1Cl
280915	280915:01:04_30.00	True	30.0	100	21.6	0.0	0.0	56.0	0.0	49.4	38.6	52.6	38.3	37.5	0.0	80.9	31.9	Tubulin	80.9	SB 200646 hydrochloride	5-HT 2C/2B serotonin receptor antagonist.	False	CN1CCc2cc(NC(=O)Nc3cccnc3)ccc21
280159	280159:01:03_30.00	True	30.0	97	8.5	0.0	0.0	60.7	0.0	59.7	36.9	62.6	46.6	42.3	0.0	72.7	44.6	Tubulin	72.7	BF-170 hydrochloride	exhibits 3-fold greater binding affinity to tau than amyloid beta fibrils. Does not inhibit amyloid beta.	False	Nc1ccc(-c2ccc3ccccc3n2)cc1
280178	280178:01:03_30.00	True	30.0	80	39.6	80.7	0.0	10.9	15.4	6.0	41.8	33.9	0.0	26.4	9.9	18.3	61.4	AKT_PI3K_MTOR	80.7	NU6027	selective cyclin-dependent kinase-2 (CDK2) inhibitor.	False	Nc1nc(N)c(N=O)c(OCC2CCCCC2)n1
280695	280695:01:03_30.00	True	30.0	104	28.3	0.0	0.0	53.5	0.0	54.8	17.1	86.8	26.2	17.5	0.0	52.1	19.4	LCH	86.8	p-MPPI hydrochloride	selective 5-HT1A serotonin receptor antagonist which crosses the blood-brain barrier.	False	COc1ccccc1N1CCN(CCN(C(=O)c2ccc(I)cc2)c2ccccn2)CC1
392775	392775:01:09_00.20	True	0.2	97	8.8	0.0	1.9	30.2	0.0	32.4	36.5	42.0	10.8	22.8	0.0	40.7	2.9	LCH	42.0	GSK1904529A	GSK1904529A is a potent, selective, orally active, and ATP-competitive inhibitor of insulin-like growth factor-1 receptor (IGF-1R) and insulin receptor (IR), with IC50s of 27 and 25 nM, respectively. GSK1904529A shows poor activity (IC50>1 uM) in 45 other serine/threonine and tyrosine kinases. GSK1904529A exhibits anti-tumor activity.	False	CCc1cc(Nc2nccc(-c3c(-c4ccc(OC)c(C(=O)Nc5c(F)cccc5F)c4)nc4ccccn34)n2)c(OC)cc1N1CCC(N2CCN(S(C)(=O)=O)CC2)CC1
392556	392556:01:09_00.20	True	0.2	87	8.3	46.3	4.1	0.0	82.9	0.0	0.0	0.0	0.0	0.0	71.7	0.0	0.0	DNA_Synth	82.9	AT7519	AT7519 is a multi-CDK inhibitor for CDK1, 2, 4, 6 and 9 with IC50 of 10-210 nM. It is less potent to CDK3 and little active to CDK7. Phase 1.	False	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl
392782	392782:01:09_00.20	True	0.2	95	23.3	53.2	0.0	22.2	8.8	24.8	48.1	40.4	0.0	37.0	0.0	38.7	55.5	Uncoupler	55.5	CHIR-124	CHIR-124 is a novel and potent Chk1 inhibitor with IC50 of 0.3 nM. It shows 2,000-fold selectivity against Chk2, 500- to 5,000-fold less activity against CDK2/4 and Cdc2.	False	O=c1[nH]c2ccc(Cl)cc2c(N[C@@H]2CN3CCC2CC3)c1-c1nc2ccccc2[nH]1
392667	392667:01:09_00.20	True	0.2	106	5.9	46.6	0.0	0.0	20.7	0.0	47.2	15.7	0.0	0.0	32.0	0.0	0.0	HSP90	47.2	CP-673451	CP-673451 is a potent and selective inhibitor of PDGFR with IC50s of 10 and 1 nM for PDGFR.a. and PDGFR.b., respectively.	False	COCCOc1ccc2c(c1)ncn2-c1ccc2cccc(N3CCC(N)CC3)c2n1
392158	392158:01:02_00.20	True	0.2	82	24.2	25.0	0.0	6.9	15.4	25.7	23.8	22.3	22.7	13.5	6.1	7.8	29.7	Uncoupler	29.7		inhibitor of Akt1/2/3 (IC50 = 0.003/0.063/0.002 µM); Discovery of 5-pyrrolopyridinyl-2-thiophenecarboxamides as potent AKT kinase inhibitors. Bioorg Med Chem Lett. 2009 Apr 15;19(8):2244-8.	True	COc1ccc(C[C@@H](CN)NC(=O)c2cc(Br)c(-c3ccnc4[nH]ccc34)s2)cc1
392664	392664:01:09_00.20	True	0.2	91	8.3	0.0	16.0	10.5	0.0	30.0	5.9	0.0	20.4	3.9	0.0	4.3	16.6	HDAC	30.0	BYL719	BYL719 is a potent and selective PI3K¿ inhibitor with IC50 of 5 nM, and minimal effect on PI3Kß/¿/¿. Phase 1/2.	False	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1
392593	392593:01:09_00.20	True	0.2	92	7.3	25.1	0.0	29.8	14.7	17.5	9.9	36.1	9.7	10.6	0.0	58.8	43.0	Tubulin	58.8	TAK-901	TAK-901 is a multi-targeted aurora inhibitor with IC50s of 21 and 15 nM for aurora A and B, respectively.	False	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1
392681	392681:01:09_00.20	True	0.2	112	7.1	0.0	0.0	63.5	0.0	67.7	23.9	37.0	58.8	50.7	0.0	58.4	54.0	HDAC	67.7	PF-477736	PF-477736 is a selective, potent and ATP-competitive Chk1 inhibitor with Ki of 0.49 nM and also inhibits VEGFR2, Aurora-A, FGFR3, Flt3, Fms (CSF1R), Ret and Yes. It shows ~100-fold selectivity for Chk1 than Chk2. Phase 1.	False	Cn1cc(-c2[nH]c3cc(NC(=O)[C@H](N)C4CCCCC4)cc4c3c2C=NNC4=O)cn1
392315	392315:01:02_00.20	True	0.2	94	5.2	41.2	0.0	11.2	11.4	18.4	36.9	19.9	0.0	42.1	0.0	14.1	45.6	Uncoupler	45.6		inhibitor of Rho-associated protein kinase 1 (IC50 = 0.002 µM); Potent, Selective and Orally Bioavailable Dihydropyrimidine Inhibitors of Rho Kinase (ROCK1) as Potential Therapeutic Agents for Cardiovascular Diseases.    J Med Chem. 2008,  51(21),  6631-6634.	False	COc1cc(C2=NC(C)=C(C(=O)Nc3ccc4[nH]ncc4c3)C(c3ccc(Cl)cc3F)N2)ccn1
392577	392577:01:09_00.20	True	0.2	98	17.8	76.6	0.0	0.0	35.2	0.0	31.2	0.0	0.0	6.1	31.0	0.0	46.3	AKT_PI3K_MTOR	76.6	RAF265	RAF265 is a potent RAF/VEGFR2 inhibitor.	False	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4nc(C(F)(F)F)c[nH]4)c3)ccc21
392566	392566:01:09_00.20	True	0.2	109	10.9	58.0	0.0	0.0	43.4	0.0	7.4	0.0	0.0	0.0	44.2	0.0	4.9	AKT_PI3K_MTOR	58.0	AT7867	AT7867 is a potent ATP-competitive inhibitor of Akt1/Akt2/Akt3 and p70S6K/PKA with IC50s of 32 nM/17 nM/47 nM and 85 nM/20 nM, respectively.	False	Clc1ccc(C2(c3ccc(-c4cn[nH]c4)cc3)CCNCC2)cc1
392505	392505:01:09_00.20	True	0.2	96	9.8	13.8	0.0	0.0	0.0	0.0	29.3	0.0	10.3	0.0	41.8	0.0	0.0	Pyrimidine_Synth	41.8	OSU-03012 (AR-12)	OSU-03012 is a potent inhibitor of recombinant PDK-1 with IC50 of 5 ¿M and 2-fold increase in potency over OSU-02067.	False	NCC(=O)Nc1ccc(-n2nc(C(F)(F)F)cc2-c2ccc3c(ccc4ccccc43)c2)cc1
392483	392483:01:10_00.20	True	0.2	100	47.0	95.2	0.0	0.0	72.1	0.0	23.1	0.0	0.0	0.0	74.2	0.0	10.2	AKT_PI3K_MTOR	95.2	Rapamycin (Sirolimus)	Rapamycin (Sirolimus, AY-22989, WY-090217) is a specific mTOR inhibitor with IC50 of ~0.1 nM.	False	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C
392341	392341:01:02_00.20	True	0.2	93	14.9	51.1	20.7	0.0	90.4	0.0	0.0	0.0	0.0	0.0	81.1	0.0	0.0	DNA_Synth	90.4		inhibitor of MAP kinase p38 alpha (IC50 = 0.17 µM); Pyrimidinylimidazole inhibitors of p38: cyclic N-1 imidazole substituents enhance p38 kinase inhibition and oral activity. Bioorg Med Chem Lett. 2001 Nov 5;11(21):2867-70.	False	CC(C)N1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1
390582	390582:02:09_00.20	True	0.2	96	28.8	0.0	0.0	85.3	0.0	81.6	3.1	85.5	49.4	55.8	0.0	75.6	58.6	LCH	85.5	PIK-93	PIK-93 is the first potent, synthetic PI4K (PI4KIII.b.) inhibitor with IC50 of 19 nM, and also inhibits PI3K.g. and PI3K.a. with IC50 of 16 nM and 39 nM, respectively.	False	CC(=O)Nc1nc(C)c(-c2ccc(Cl)c(S(=O)(=O)NCCO)c2)s1
392532	392532:01:09_00.20	True	0.2	69	43.5	46.2	2.5	0.0	70.1	0.0	9.3	9.7	0.0	0.0	37.2	0.0	1.0	DNA_Synth	70.1	PIK-75 (hydrochloride)	PIK-75 hydrochloride is a reversible DNA-PK and p110.a.-selective inhibitor, which inhibits DNA-PK, p110.a. and p110.g. with IC50s of 2, 5.8 and 76 nM, respectively. PIK-75 hydrochloride inhibits p110.a. >200-fold more potently than p110.b. (IC50=1.3 uM). PIK-75 hydrochloride induces apoptosis.	False	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnc2ccc(Br)cn12
392654	392654:01:09_00.20	True	0.2	97	14.9	36.0	35.7	0.0	89.5	0.0	8.8	0.0	0.0	0.0	72.3	0.0	0.0	DNA_Synth	89.5	BMS-265246	BMS-265246 is a potent and selective CDK1/2 inhibitor for CDK1/cyclin B and CDK2/cyclin E with IC50 of 6 nM and 9 nM, respectively. IC50 Value: 6 nM(for CDK1/cyclin B); 9 nM(for CDK2/cyclin E)Target: CDK1/2in vitro: BMS-265246 inhibits the activity of Cdk4/cycD (IC50 = 0.23 uM) and prevents A2780 Cytox with IC50 of 0.76 uM. BMS-265246 when bound to Cdk2, shows the inhibitor resides within the ATP purine binding site and forms important H-bonds with Leu83 on the protein backbone. BMS-265246 represents the most potent Cdk/Cdk2 selective analogue from this chemotype. A recent study shows that BMS-265246 inhibits cell proliferation with EC50 ranging from 0.293 uM-0.492 uM in HCT-116 cells. After treatment of BMS-265246, the dominant cell populations are G2-arrested cells having 4N DNA content, large round nuclei, and low DNA intensity.in vivo:	False	CCCCOc1c(C(=O)c2c(F)cc(C)cc2F)cnc2[nH]ncc12
392355	392355:01:02_00.20	True	0.2	103	26.1	0.0	7.9	61.1	0.0	60.2	14.5	50.8	48.5	50.9	0.0	67.3	13.5	Tubulin	67.3		inhibitor of TGF-beta receptor type I (Alk5) (IC50 = 0.025 µM); Design of novel quinazoline derivatives and related analogues as potent and selective ALK5 inhibitors. Bioorg Med Chem Lett. 2009 Apr 15;19(8):2277-81.	False	Cc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3ccccc3n2)n1
392542	392542:01:09_00.20	True	0.2	59	66.1	0.0	35.5	63.3	0.0	74.2	43.1	61.8	54.4	44.1	0.0	83.7	28.2	Tubulin	83.7	Rigosertib (ON-01910)	Rigosertib (ON-01910) is a non-ATP-competitive inhibitor of PLK1 with IC50 of 9 nM. It shows 30-fold greater selectivity against Plk2 and no activity to Plk3. Phase 3.	False	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1
392347	392347:01:02_00.20	True	0.2	95	7.1	17.8	0.0	31.6	19.0	25.8	3.2	53.5	0.0	33.1	0.0	38.5	32.5	LCH	53.5		inhibitor of GSK3-beta (IC50 = 0.01 µM), inhibitor of Cyclin-dependent kinase 2/4 (IC50 = 0.01/0.25 µM); N-Phenyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amines as Potent and Selective Inhibitors of Glycogen Synthase Kinase 3 with Good Cellular Efficacy.    J Med Chem (2004),  47(19),  4716-4730.	False	FC(F)(F)c1cc(Br)cc(Nc2nccc(-c3cnn4ncccc34)n2)c1
280140	280140:03:09_00.20	True	0.2	107	8.5	0.0	0.0	63.4	0.0	53.5	0.0	38.9	52.9	26.7	0.0	60.2	19.3	BET	63.4	BIO	potent, selective, reversible, and ATP-competitive glycogen synthase kinase 3alpha/beta (GSK-3alpha/beta) inhibitor, maintains self-renewal and pluripotency of ESCs.	False	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O
392716	392716:01:09_00.20	True	0.2	89	45.8	0.0	0.0	65.6	0.0	66.7	48.6	63.9	39.9	46.7	0.0	74.7	43.1	Tubulin	74.7	GZD824 (dimesylate)	GZD824 dimesylate (HQP1351 dimesylate) is an orally bioavailable pan-Bcr-Abl inhibitor with potency against a wide range of Bcr-Abl mutants and the native enzyme (IC50=0.34 nM). GZD824 dimesylate has antitumor activity.	False	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2[nH]ncc2c1
392770	392770:01:09_00.20	True	0.2	100	36.4	96.0	0.0	0.0	71.5	0.0	29.9	0.0	0.0	0.0	69.5	0.0	13.3	AKT_PI3K_MTOR	96.0	VS-5584	VS-5584 is a pan-PI3K/mTOR kinase inhibitor with IC50s of 16 nM, 68 nM, 42 nM, 25 nM, and 37 nM for PI3K.a., PI3K.b., PI3K.d., PI3K.g. and mTOR, respectively. VS-5584 simultaneously blocks mTORC2 as well as mTORC1.	False	Cc1nc2c(-c3cnc(N)nc3)nc(N3CCOCC3)nc2n1C(C)C
392634	392634:01:09_00.20	True	0.2	81	51.5	95.4	0.0	0.0	48.2	0.0	26.0	0.0	0.0	0.0	56.6	0.0	32.5	AKT_PI3K_MTOR	95.4	Sapanisertib	Sapanisertib (INK-128; MLN0128; TAK-228) is an orally available, ATP-dependent mTOR1/2 inhibitor with an IC50 of 1 nM for mTOR kinase.	False	CC(C)n1nc(-c2ccc3oc(N)nc3c2)c2c(N)ncnc21
382169	382169:02:09_00.20	True	0.2	95	28.5	74.8	0.0	0.0	42.2	0.0	58.5	28.2	0.0	0.0	27.3	9.0	29.2	AKT_PI3K_MTOR	74.8	Ponatinib	Ponatinib (AP24534) is an orally active multi-targeted kinase inhibitor with IC50s of 0.37 nM, 1.1 nM, 1.5 nM, 2.2 nM, and 5.4 nM for Abl, PDGFR.a., VEGFR2, FGFR1, and Src, respectively.	False	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12
392718	392718:01:09_00.20	True	0.2	114	11.6	72.7	0.0	0.0	23.2	2.1	47.4	20.2	0.0	7.6	27.3	0.0	36.4	AKT_PI3K_MTOR	72.7	AZD3463	AZD3463 is a novel orally bioavailable ALK inhibitor with Ki of 0.75 nM, which also inhibits IGF1R with equivalent potency.	False	COc1cc(N2CCC(N)CC2)ccc1Nc1ncc(Cl)c(-c2c[nH]c3ccccc23)n1
392591	392591:01:09_00.20	True	0.2	92	13.6	0.0	0.0	65.7	0.0	60.3	0.9	65.0	43.3	45.8	0.0	75.4	49.0	Tubulin	75.4	SB590885	SB590885 is a potent B-Raf inhibitor with Ki of 0.16 nM, 11-fold greater selectivity for B-Raf over c-Raf, no inhibition to other human kinases.	False	CN(C)CCOc1ccc(-c2nc(-c3ccc4c(c3)CC/C4=N\O)c(-c3ccncc3)[nH]2)cc1
392683	392683:01:09_00.20	True	0.2	108	5.5	35.3	0.0	34.6	0.0	56.1	43.5	34.5	15.6	55.7	0.0	19.7	62.4	Uncoupler	62.4	PF-573228	PF-573228 is a potent and selective FAK inhibitor with IC50 of 4 nM for purified recombinant catalytic fragment of FAK.	False	CS(=O)(=O)c1cccc(CNc2nc(Nc3ccc4c(c3)CCC(=O)N4)ncc2C(F)(F)F)c1
392558	392558:01:09_00.20	True	0.2	66	32.3	0.0	83.3	0.0	48.8	0.0	9.7	0.0	0.0	0.0	36.6	0.0	0.0	Aurora	83.3	Hesperadin	Hesperadin is an ATP competitive indolinone inhibitor of Aurora A and B. Hesperadin inhibits Aurora B with an IC50 of 250 nM.	False	CCS(=O)(=O)Nc1ccc2[nH]c(O)c(/C(=N/c3ccc(CN4CCCCC4)cc3)c3ccccc3)c2c1
392749	392749:01:09_00.20	True	0.2	99	7.9	32.5	0.0	34.0	27.6	32.3	20.0	49.7	13.4	23.8	0.0	47.7	59.7	Uncoupler	59.7	Losmapimod	Losmapimod (GSK-AHAB) is a selective, potent, and orally active p38 MAPK inhibitor with pKis of 8.1 and 7.6 for p38.a. and p38.b., respectively.	False	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1
392644	392644:01:09_00.20	True	0.2	86	51.3	63.9	0.0	40.2	0.0	41.9	29.0	59.7	19.8	28.7	0.0	33.9	66.0	Uncoupler	66.0	BGT226 (maleate)	BGT226 (NVP-BGT226 maleate) is a PI3K (with IC50s of 4 nM, 63 nM and 38 nM for PI3K.a., PI3K.b. and PI3K.g.) /mTOR dual inhibitor which displays potent growth-inhibitory activity against human head and neck cancer cells.	False	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1
392625	392625:01:09_00.20	True	0.2	50	71.8	0.0	31.5	67.7	0.0	77.8	33.6	65.7	52.4	53.7	0.0	80.8	33.2	Tubulin	80.8	Tirbanibulin	Tirbanibulin (KX2-391) is an inhibitor of Src that targets the peptide substrate site of Src, with GI50 of 9-60 nM in cancer cell lines.	False	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1
392055	392055:01:02_00.20	True	0.2	93	9.0	0.0	2.6	62.4	0.0	65.5	0.0	32.4	53.1	46.4	0.0	59.1	32.6	HDAC	65.5		inhibitor of TGF-beta receptor type I (ALK5) (IC50 = 0.03 µM), inhibitor of Yes1 kinase (IC50 = 4.6 µM); Discovery of 4-{4-[3-(pyridin-2-yl)-1H-pyrazol-4-yl]pyridin-2-yl}-N-(tetrahydro-2H- pyran-4-yl)benzamide (GW788388): a potent, selective, and orally active transforming growth factor-beta type I receptor inhibitor.    J Med Chem (2006),  49(7),  2210-21.	False	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1
392795	392795:01:09_00.20	True	0.2	92	5.5	16.6	51.7	0.0	82.8	0.0	0.0	0.0	0.0	0.0	66.2	0.0	0.0	DNA_Synth	82.8	CX-6258 HCl	CX-6258 HCl is a potent, orally efficacious pan-Pim kinase inhibitor with IC50 of 5 nM, 25 nM and 16 nM for Pim1, Pim2, and Pim3, respectively.	False	CN1CCCN(C(=O)c2cccc(-c3ccc(/C=C4/C(=O)Nc5ccc(Cl)cc54)o3)c2)CC1
392584	392584:01:09_00.20	True	0.2	89	5.4	13.4	0.0	46.8	0.0	45.8	28.6	72.0	7.6	30.3	0.0	59.7	48.0	LCH	72.0	NVP-BHG712	NVP-BHG712 is an oral active EphB4 kinase autophosphorylation inhibitor, with IC50 values of 3.3 nM and 3.0 nM for EphA2 and EphB4, respectively.	False	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1Nc1nc(-c2cccnc2)nc2c1cnn2C
392641	392641:01:09_00.20	True	0.2	89	10.0	42.2	0.0	38.8	19.4	28.4	4.6	49.4	20.4	21.5	0.0	57.5	69.3	Uncoupler	69.3	Milciclib	PHA-848125 is a potent, ATP-competitive CDK inhibitor for CDK2 with IC50 of 45 nM. It is >3-fold more selective for CDK2 than CDK1, 2, 4, 5, and 7. Phase 2.	False	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2
410624	392561:01:09_00.20	True	0.2	111	11.2	0.0	0.0	70.4	0.0	69.2	35.9	55.4	43.9	51.6	0.0	59.8	58.3	BET	70.4	AZD-7762	AZD7762 is a potent and selective inhibitor of Chk1 with IC50 of 5 nM in a cell-free assay. It is equally potent against Chk2 and less potent against CAM, Yes, Fyn, Lyn, Hck and Lck. Phase 1.	True	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1
392176	392176:01:02_00.20	True	0.2	105	7.8	35.1	0.0	11.3	20.0	3.4	16.5	34.9	0.0	0.0	0.0	31.9	24.9	AKT_PI3K_MTOR	35.1		inhibitor of Vascular endothelial growth factor receptor 2 (IC50 = 0.0035 µM), inhibitor of Tyrosine-protein kinase TIE-2 (IC50 = 0.0069 µM), also inhibits c-RAF (IC50 = 0.7 µM); Discovery of Novel Benzimidazoles as Potent Inhibitors of TIE-2 and VEGFR-2 Tyrosine Kinase Receptors.    J Med Chem (2007),  50(18),  4453-4470.	False	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)ccc2[nH]1
351488	351488:02:09_00.20	True	0.2	96	5.7	78.6	0.0	0.0	80.1	0.0	27.3	0.0	0.0	0.0	69.2	0.0	8.1	DNA_Synth	80.1	MK-2206 (dihydrochloride)	MK-2206 dihydrochloride (MK-2206 (2HCl)) is an orally active allosteric AKT inhibitor with IC50s of 5 nM, 12 nM, and 65 nM for AKT1, AKT2, and AKT3, respectively. MK-2206 dihydrochloride induces autophagy.	False	NC1(c2ccc(-c3nc4ccn5c(O)nnc5c4cc3-c3ccccc3)cc2)CCC1
392637	392637:01:09_00.20	True	0.2	100	6.9	51.9	0.0	0.0	42.2	0.0	15.8	0.0	0.0	0.0	57.5	0.0	0.0	Pyrimidine_Synth	57.5	Crenolanib	Crenolanib (CP-868596) is a potent and selective inhibitor of PDGFR¿/ß with Kd of 2.1 nM/3.2 nM, also potently inhibits FLT3, sensitive to D842V mutation not V561D mutation, >100-fold more selective for PDGFR than c-Kit, VEGFR-2, TIE-2, FGFR-2, EGFR, erbB2, and Src.	False	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1
392732	392732:01:09_00.20	True	0.2	104	9.7	70.3	0.0	0.0	78.7	0.0	2.3	0.0	0.0	0.0	58.0	0.0	2.6	DNA_Synth	78.7	Skepinone-L	Skepinone-L is a selective p38¿-MAPK inhibitor with IC50 of 5 nM.	False	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21
391824	391824:01:02_00.20	True	0.2	100	9.8	0.0	5.3	58.3	0.0	60.1	0.0	27.1	57.8	32.5	0.0	56.8	21.6	HDAC	60.1		inhibitor of TGF-beta receptor type I (Alk5) (IC50 = 0.02 µM); Design of novel quinazoline derivatives and related analogues as potent and selective ALK5 inhibitors. Bioorg Med Chem Lett. 2009 Apr 15;19(8):2277-81.	False	Cc1csc(-c2nc(Nc3ccncc3)c3ccccc3n2)n1
392211	392211:01:02_00.20	True	0.2	102	5.4	0.0	0.0	36.5	14.0	35.1	17.5	55.7	26.7	22.1	0.0	54.6	37.7	LCH	55.7		inhibitor of PI3Kalpha/beta/delta (IC50 = 5/0.1/0.4 µM); Synthesis and structure-activity relationships of imidazo[1,2-a]pyrimidin-5(1H)-ones as a novel series of beta isoform selective phosphatidylinositol 3-kinase inhibitors. Bioorg Med Chem Lett. 2012 Mar 15;22(6):2230-4.	False	O=c1cc(N2CCOCC2)nc2n(Cc3cccc(F)c3)ccn12
392614	392614:01:09_00.20	True	0.2	83	21.4	28.6	40.5	0.0	91.4	0.0	6.5	0.0	0.0	0.0	61.6	0.0	0.0	DNA_Synth	91.4	R547	R547 is a potent, selective and oral orally bioavailable ATP-competitive CDK inhibitor, with Kis of 2 nM, 3 nM and 1 nM  for CDK1/cyclin B, CDK2/cyclin E and CDK4/cyclin D1, respectively.	False	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N
392580	392580:01:09_00.20	True	0.2	53	62.7	0.0	62.5	42.1	0.0	56.6	15.4	38.3	40.0	34.4	0.0	57.1	0.0	Aurora	62.5	GSK461364	GSK461364 inhibits purified Plk1 with Ki of 2.2 nM. It is more than 1000-fold selective against Plk2/3. Phase 1.	False	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F
392531	392531:01:09_00.20	True	0.2	88	18.3	0.0	0.0	74.4	0.0	77.8	22.5	67.7	48.9	42.3	0.0	78.9	47.8	Tubulin	78.9	CUDC-101	CUDC-101 is a potent inhibitor of HDAC, EGFR, and HER2 with IC50s of 4.4, 2.4, and 15.7 nM, respectively.	False	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1
392696	392696:01:09_00.20	True	0.2	99	11.2	74.4	0.0	3.9	32.9	9.4	37.0	29.0	0.0	13.5	22.2	3.4	47.8	AKT_PI3K_MTOR	74.4	ALK-IN-1	ALK-IN-1 (Brigatinib analog) is a potent and selective active inhibitor of anaplastic lymphoma kinase(ALK), Patent US20140066406 A1.	False	COc1cc(N2CCC(N(C)C)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1
392775	392775:01:09_02.00	True	2.0	101	26.4	0.0	0.0	56.4	0.0	57.3	21.9	73.0	24.5	28.0	0.0	55.3	18.3	LCH	73.0	GSK1904529A	GSK1904529A is a potent, selective, orally active, and ATP-competitive inhibitor of insulin-like growth factor-1 receptor (IGF-1R) and insulin receptor (IR), with IC50s of 27 and 25 nM, respectively. GSK1904529A shows poor activity (IC50>1 uM) in 45 other serine/threonine and tyrosine kinases. GSK1904529A exhibits anti-tumor activity.	False	CCc1cc(Nc2nccc(-c3c(-c4ccc(OC)c(C(=O)Nc5c(F)cccc5F)c4)nc4ccccn34)n2)c(OC)cc1N1CCC(N2CCN(S(C)(=O)=O)CC2)CC1
392788	392788:01:09_02.00	True	2.0	101	14.3	74.6	0.0	0.0	59.9	0.0	31.4	21.9	0.0	0.0	50.9	0.0	0.2	AKT_PI3K_MTOR	74.6	CNX-2006	CNX-2006 is a mutant-selective and irreversible EGFR inhibitor with an IC50 below 20 nM for EGFRT790M.	False	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(NC4CN(CCF)C4)cc3OC)ncc2C(F)(F)F)c1
392556	392556:01:09_02.00	True	2.0	67	47.0	27.0	0.0	0.0	36.2	0.0	2.9	15.5	3.5	0.0	24.4	10.6	2.7	DNA_Synth	36.2	AT7519	AT7519 is a multi-CDK inhibitor for CDK1, 2, 4, 6 and 9 with IC50 of 10-210 nM. It is less potent to CDK3 and little active to CDK7. Phase 1.	False	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl
280973	280973:03:09_02.00	True	2.0	102	5.4	31.6	0.0	53.9	0.0	52.0	28.7	42.3	29.3	50.1	0.0	43.9	83.0	Uncoupler	83.0	Tyrphostin A9	Tyrphostin A9, a PDGFR inhibitor, is a potent inducer of mitochondrial fission. Tyrphostin A9 emerged as the most potent and selective of 51 tyrosine kinase inhibitors tested against the TNF-induced respiratory burst. Tyrphostin A9 has anti-influenza virus activities.	False	CC(C)(C)c1cc(C=C(C#N)C#N)cc(C(C)(C)C)c1O
392440	392440:01:02_02.00	True	2.0	99	11.2	0.0	0.0	57.7	0.0	61.6	29.5	88.3	17.3	20.0	0.0	58.5	28.1	LCH	88.3		inhibitor of PERK cytoplasmic domain mediated EIF2alpha phosphorylation (IC50 = 0.0009 µM); Discovery of 7-Methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a Potent and Selective First-in-Class Inhibitor of Protein Kinase R (PKR)-like Endoplasmic Reticulum Kinase (PERK) J. Med. Chem. 2012	False	Nc1ncc(-c2cn[nH]c2)c2scc(-c3ccc4c(c3)CCN4C(=O)Cc3ccccc3)c12
392782	392782:01:09_02.00	True	2.0	77	38.2	85.4	0.0	0.0	70.8	0.0	40.2	0.0	0.0	0.0	63.8	0.0	5.9	AKT_PI3K_MTOR	85.4	CHIR-124	CHIR-124 is a novel and potent Chk1 inhibitor with IC50 of 0.3 nM. It shows 2,000-fold selectivity against Chk2, 500- to 5,000-fold less activity against CDK2/4 and Cdc2.	False	O=c1[nH]c2ccc(Cl)cc2c(N[C@@H]2CN3CCC2CC3)c1-c1nc2ccccc2[nH]1
392233	392233:01:02_02.00	True	2.0	92	8.8	57.6	0.0	0.0	47.7	0.0	17.8	2.8	0.0	9.2	34.6	0.0	30.3	AKT_PI3K_MTOR	57.6		inhibitor of Rho-associated protein kinase 1 (IC50 = 0.003 µM); Potent, Selective and Orally Bioavailable Dihydropyrimidine Inhibitors of Rho Kinase (ROCK1) as Potential Therapeutic Agents for Cardiovascular Diseases.    J Med Chem. 2008,  51(21),  6631-6634.	False	COc1ccc(C2=NC(C)=C(C(=O)Nc3ccc4[nH]ncc4c3)C(c3ccc(Cl)cc3F)N2)cn1
392777	392777:01:09_02.00	True	2.0	100	9.7	58.8	14.3	0.0	80.6	0.0	6.9	0.0	0.0	0.0	77.4	0.0	0.0	DNA_Synth	80.6	PD318088	PD318088 is a potent, allosteric and non-ATP competitive MEK1/2 inhibitor, an analog of PD184352 (HY-50295). PD318088 binds simultaneously with ATP in a region of the MEK1 active site that is adjacent to the ATP-binding site. PD318088 can be used for cancer research.	False	O=C(NOCC(O)CO)c1cc(Br)c(F)c(F)c1Nc1ccc(I)cc1F
392503	392503:01:09_02.00	True	2.0	95	16.2	0.0	0.0	78.1	0.0	71.0	17.8	76.1	37.0	65.9	0.0	80.5	63.0	Tubulin	80.5	GDC-0879	GDC-0879 is a potent and selective B-Raf inhibitor with an IC50 of 0.13 nM.	False	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1
392667	392667:01:09_02.00	True	2.0	92	39.6	47.2	4.9	0.0	65.1	0.0	27.6	30.7	0.0	0.0	34.1	3.3	0.0	DNA_Synth	65.1	CP-673451	CP-673451 is a potent and selective inhibitor of PDGFR with IC50s of 10 and 1 nM for PDGFR.a. and PDGFR.b., respectively.	False	COCCOc1ccc2c(c1)ncn2-c1ccc2cccc(N3CCC(N)CC3)c2n1
392158	392158:01:02_02.00	True	2.0	67	45.8	0.0	9.2	32.6	0.0	45.8	14.1	33.5	43.6	20.4	0.0	32.5	16.1	HDAC	45.8		inhibitor of Akt1/2/3 (IC50 = 0.003/0.063/0.002 µM); Discovery of 5-pyrrolopyridinyl-2-thiophenecarboxamides as potent AKT kinase inhibitors. Bioorg Med Chem Lett. 2009 Apr 15;19(8):2244-8.	True	COc1ccc(C[C@@H](CN)NC(=O)c2cc(Br)c(-c3ccnc4[nH]ccc34)s2)cc1
392497	392497:01:09_02.00	True	2.0	90	30.2	0.0	0.0	69.8	0.0	68.7	32.0	88.3	27.2	41.1	0.0	68.7	48.7	LCH	88.3	NVP-ADW742	NVP-ADW742 (ADW742) is an orally active, selective IGF-1R tyrosine kinase inhibitor with an IC50 of 0.17 uM. NVP-ADW742 inhibits insulin receptor (InsR) with an IC50 of 2.8 uM. NVP-ADW742 induces pleiotropic antiproliferative/proapoptotic biologic sequelae in tumor cells.	False	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](CN2CCCC2)C1
392286	392286:01:02_02.00	True	2.0	77	25.7	0.0	0.0	77.9	0.0	71.2	28.2	75.8	49.6	52.3	0.0	91.8	53.6	Tubulin	91.8		inhibitor of Vascular endothelial growth factor receptor 2 (IC50 = 0.0076 µM), inhibitor of Tyrosine-protein kinase TIE-2 (IC50 = 0.39 µM); Discovery of Novel Benzimidazoles as Potent Inhibitors of TIE-2 and VEGFR-2 Tyrosine Kinase Receptors.    J Med Chem (2007),  50(18),  4453-4470.	False	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cc(F)ccc4F)cc3)ccc2[nH]1
391910	391910:01:02_02.00	True	2.0	95	5.9	8.7	0.0	45.2	16.0	45.2	33.9	70.9	8.4	33.4	0.0	63.2	51.7	LCH	70.9		inhibitor of Insulin-like growth factor I receptor (IC50 = 0.0008 µM); Optimization of a series of 4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidine inhibitors of IGF-1R: elimination of an acid-mediated decomposition pathway.  Bioorg Med Chem Lett.  (2009),  19(2),  373-7.	False	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2
392664	392664:01:09_02.00	True	2.0	77	41.3	0.0	0.0	81.2	0.0	90.6	15.9	62.3	65.6	45.9	0.0	69.0	73.6	HDAC	90.6	BYL719	BYL719 is a potent and selective PI3K¿ inhibitor with IC50 of 5 nM, and minimal effect on PI3Kß/¿/¿. Phase 1/2.	False	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1
392593	392593:01:09_02.00	True	2.0	58	51.8	0.0	19.3	73.9	0.0	73.1	8.4	63.6	56.0	52.5	0.0	80.0	30.2	Tubulin	80.0	TAK-901	TAK-901 is a multi-targeted aurora inhibitor with IC50s of 21 and 15 nM for aurora A and B, respectively.	False	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1
392415	392415:02:09_02.00	True	2.0	96	7.4	75.8	0.0	0.0	47.8	0.0	15.5	0.0	0.0	0.0	46.9	0.0	19.0	AKT_PI3K_MTOR	75.8	TPCA-1	TPCA-1 is a potent and selective inhibitor of IKK-2 with IC50 of 17.9 nM. TPCA-1 is an effective inhibitor of STAT3 phosphorylation, DNA binding, and transactivation.; Assessment of chemical coverage of kinome space and its implications for kinase drug discovery. J Med Chem. 2008 Dec 25;51(24):7898-914.	False	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O
392681	392681:01:09_02.00	True	2.0	79	57.2	0.0	0.0	79.2	0.0	74.4	37.3	69.8	53.7	61.7	0.0	80.7	69.8	Tubulin	80.7	PF-477736	PF-477736 is a selective, potent and ATP-competitive Chk1 inhibitor with Ki of 0.49 nM and also inhibits VEGFR2, Aurora-A, FGFR3, Flt3, Fms (CSF1R), Ret and Yes. It shows ~100-fold selectivity for Chk1 than Chk2. Phase 1.	False	Cn1cc(-c2[nH]c3cc(NC(=O)[C@H](N)C4CCCCC4)cc4c3c2C=NNC4=O)cn1
392629	392629:01:09_02.00	True	2.0	97	9.0	82.1	0.0	0.0	83.4	0.0	1.3	0.0	0.0	0.0	72.3	0.0	3.0	DNA_Synth	83.4	CH5132799	CH5132799 is a selective class I PI3K inhibitor. CH5132799 inhibits class I PI3Ks, particularly PI3K.a., with an IC50 of 14 nM.	False	CS(=O)(=O)N1CCc2c(-c3cnc(N)nc3)nc(N3CCOCC3)nc21
392315	392315:01:02_02.00	True	2.0	95	13.3	31.6	0.0	18.6	29.2	27.8	13.8	33.8	8.4	15.3	1.7	20.0	44.4	Uncoupler	44.4		inhibitor of Rho-associated protein kinase 1 (IC50 = 0.002 µM); Potent, Selective and Orally Bioavailable Dihydropyrimidine Inhibitors of Rho Kinase (ROCK1) as Potential Therapeutic Agents for Cardiovascular Diseases.    J Med Chem. 2008,  51(21),  6631-6634.	False	COc1cc(C2=NC(C)=C(C(=O)Nc3ccc4[nH]ncc4c3)C(c3ccc(Cl)cc3F)N2)ccn1
392577	392577:01:09_02.00	True	2.0	98	17.3	83.6	0.0	0.0	58.0	0.0	30.9	0.0	0.0	0.0	62.0	0.0	7.8	AKT_PI3K_MTOR	83.6	RAF265	RAF265 is a potent RAF/VEGFR2 inhibitor.	False	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4nc(C(F)(F)F)c[nH]4)c3)ccc21
392738	392738:01:09_02.00	True	2.0	101	5.0	26.9	0.0	48.9	0.0	45.4	54.6	50.8	12.7	39.7	0.0	48.3	62.7	Uncoupler	62.7	Spebrutinib	Spebrutinib (AVL-292; CC-292) is a covalent, orally active, and highly selective with an IC50 of 0.5 nM.	False	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCOC)cc3)ncc2F)c1
391888	391888:01:02_02.00	True	2.0	97	28.0	0.0	0.0	86.5	0.0	77.9	6.5	74.3	47.2	67.2	0.0	79.0	72.4	BET	86.5		inhibitor of PIP4K2A (IC50 = 0.02 µM), inhibitor of cRaf1 kinase (IC50 = 0.04 µM), inhibitor of Yes1 kinase (IC50 = 0.46 µM); The discovery of potent cRaf1 kinase inhibitors.  Bioorg Med Chem Lett.  (2000),  10(3),  223-226.	False	O=C1Nc2ccc(C(=O)c3ccco3)cc2/C1=C\c1cc(Cl)c(O)c(Cl)c1
392081	392081:01:02_02.00	True	2.0	101	14.5	0.0	0.0	84.5	0.0	77.2	0.0	77.9	42.4	63.9	0.0	70.3	66.6	BET	84.5		inhibitor of Cyclin-dependent kinase 1/2 (IC50 = 0.06/0.012 µM); Oxindole-Based Inhibitors of Cyclin-Dependent Kinase 2 (CDK2): Design, Synthesis, Enzymatic Activities, and X-ray Crystallographic Analysis.    J Med Chem (2001),  44(25),  4339-4358.	False	NS(=O)(=O)c1ccc(/N=N\c2c(O)[nH]c3ccc(C(=O)NCCc4c[nH]cn4)cc23)cc1
392543	392543:01:09_02.00	True	2.0	97	5.9	55.1	27.1	0.0	71.6	0.0	14.1	0.0	0.0	0.0	71.5	0.0	0.0	DNA_Synth	71.6	Ki8751	Ki8751 is a potent VEGFR2 inhibitor with an IC50 of 0.9 nM.	False	COc1cc2nccc(Oc3ccc(NC(=O)Nc4ccc(F)cc4F)c(F)c3)c2cc1OC
392566	392566:01:09_02.00	True	2.0	81	52.3	0.0	0.0	50.6	0.0	61.4	13.0	44.4	50.7	36.2	0.0	46.0	36.9	HDAC	61.4	AT7867	AT7867 is a potent ATP-competitive inhibitor of Akt1/Akt2/Akt3 and p70S6K/PKA with IC50s of 32 nM/17 nM/47 nM and 85 nM/20 nM, respectively.	False	Clc1ccc(C2(c3ccc(-c4cn[nH]c4)cc3)CCNCC2)cc1
392728	392728:01:09_02.00	True	2.0	67	44.4	26.5	0.0	17.0	22.6	6.3	19.3	34.2	11.9	0.0	5.8	39.5	26.7	Tubulin	39.5	Ro 31-8220 (mesylate)	Ro 31-8220 mesylate is a potent PKC inhibitor, with IC50s of 5, 24, 14, 27, 24 and 23 nM for PKC.a., PKC.b.I, PKC.b.II, PKC.g., PKC.e. and rat brain PKC, respectively. Ro 31-8220 also significantly inhibits MAPKAP-K1b, MSK1, S6K1 and GSK3.b. (IC50s, 3, 8, 15, and 38 nM, respectively), with no effect on MKK3, MKK4, MKK6 and MKK7.	False	Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21
392717	392717:01:09_02.00	True	2.0	82	35.8	0.0	0.0	60.0	0.0	69.5	9.9	54.4	51.4	47.7	0.0	50.6	50.9	HDAC	69.5	RKI-1447	RKI-1447 is a potent small molecule inhibitor of ROCK1 and ROCK2 with IC50 values of 14.5 nM and 6.2 nM, respectively. 	False	O=C(NCc1cccc(O)c1)Nc1nc(-c2ccncc2)cs1
392505	392505:01:09_02.00	True	2.0	93	13.0	59.9	0.0	0.0	81.6	0.0	35.8	0.0	0.0	0.0	78.1	0.0	0.0	DNA_Synth	81.6	OSU-03012 (AR-12)	OSU-03012 is a potent inhibitor of recombinant PDK-1 with IC50 of 5 ¿M and 2-fold increase in potency over OSU-02067.	False	NCC(=O)Nc1ccc(-n2nc(C(F)(F)F)cc2-c2ccc3c(ccc4ccccc43)c2)cc1
392572	392572:01:09_02.00	True	2.0	90	27.5	0.0	0.0	69.7	0.0	62.7	31.7	88.7	21.7	44.8	0.0	70.7	51.4	LCH	88.7	NVP-BSK805 (dihydrochloride)	NVP-BSK805 dihydrochloride is an ATP-competitive JAK2 inhibitor, with IC50s of 0.48 nM, 31.63 nM, 18.68 nM, and 10.76 nM for JAK2 JH1 (JAK homology 1), JAK1 JH1, JAK3 JH1, and TYK2 JH1, respectively.	False	Fc1cc(-c2cccc3ncc(-c4cnn(C5CCNCC5)c4)nc23)cc(F)c1CN1CCOCC1
391818	391818:01:02_02.00	True	2.0	53	66.8	0.0	29.3	63.4	0.0	71.2	15.9	72.8	41.6	61.6	0.0	68.3	28.7	LCH	72.8		inhibitor of PLK1 kinase (IC50 = 0.002 µM); Heteroaryl-linked 5-(1H-benzimidazol-1-yl)-2-thiophenecarboxamides: potent inhibitors of polo-like kinase 1 (PLK1) with improved drug-like properties. Bioorg Med Chem Lett. 2010 Aug 1;20(15):4587-92.	True	C[C@@H](Oc1cc(-n2cnc3cc(-c4ccnc(N5CCN(C)CC5)c4)ccc32)sc1C(N)=O)c1ccccc1Cl
392675	392675:01:09_02.00	True	2.0	101	48.0	0.0	0.0	76.9	0.0	75.1	28.5	95.0	34.0	49.4	0.0	70.1	63.1	LCH	95.0	IKK 16	IKK 16 is a selective I.k.B kinase (IKK) inhibitor for IKK2, IKK complex and IKK1 with IC50s of 40 nM, 70 nM and 200 nM, respectively. IKK16 also inhibits leucine-rich repeat kinase-2 (LRRK2) with an IC50 of 50 nM.	False	O=C(c1ccc(Nc2nccc(-c3cc4ccccc4s3)n2)cc1)N1CCC(N2CCCC2)CC1
392590	392590:01:09_02.00	True	2.0	84	19.0	60.7	0.0	0.0	77.7	0.0	32.2	12.7	0.0	0.0	53.8	0.0	8.3	DNA_Synth	77.7	Momelotinib	Momelotinib (CYT387) is an ATP-competitive inhibitor of JAK1/JAK2 with IC50a of 11 nM and 18 nM,respectively. CYT387 shows much less activity against JAK3.	False	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1
392483	392483:01:10_02.00	True	2.0	98	32.3	94.0	0.0	0.0	74.0	0.0	10.0	0.0	0.0	0.0	73.8	0.0	6.3	AKT_PI3K_MTOR	94.0	Rapamycin (Sirolimus)	Rapamycin (Sirolimus, AY-22989, WY-090217) is a specific mTOR inhibitor with IC50 of ~0.1 nM.	False	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C
391922	391922:01:02_02.00	True	2.0	55	36.3	0.0	55.2	37.5	0.0	51.7	33.8	44.0	38.9	29.7	0.0	57.0	3.9	Tubulin	57.0		inhibitor of Insulin-like growth factor I receptor (IC50 = 0.0002 µM); Optimization of a series of 4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidine inhibitors of IGF-1R: elimination of an acid-mediated decomposition pathway.  Bioorg Med Chem Lett.  (2009),  19(2),  373-7.	False	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2
392254	392254:01:02_02.00	True	2.0	99	5.4	77.2	0.0	0.0	72.0	0.0	2.7	0.0	0.0	0.0	63.4	0.0	0.0	AKT_PI3K_MTOR	77.2	PD153035 (Hydrochloride)	PD153035 Hydrochloride (SU-5271 Hydrochloride) is a potent EGFR inhibitor with Ki and IC50 of 6 and 25 pM, respectively.; Binding mode of the 4-anilinoquinazoline class of protein kinase inhibitor: X-ray crystallographic studies of 4-anilinoquinazolines bound to cyclin-dependent kinase 2 and p38 kinase. J Med Chem. 2000 Jan 13;43(1):133-8.	False	COc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OC
392663	392663:01:09_02.00	True	2.0	94	14.2	0.0	0.0	78.1	0.0	72.1	36.9	69.3	38.9	68.7	0.0	75.5	72.7	BET	78.1	Dabrafenib	Dabrafenib (GSK2118436A) is an ATP-competitive inhibitor of Raf with IC50s of 5 nM and 0.6 nM for C-Raf and B-RafV600E, respectively.	False	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1
392685	392685:01:09_02.00	True	2.0	99	5.4	59.2	0.0	0.0	80.5	0.0	19.6	0.0	0.0	0.0	61.2	0.0	0.0	DNA_Synth	80.5	TAK-715	TAK-715 is a p38 MAPK inhibitor for p38¿ with IC50 of 7.1 nM, 28-fold more selective for p38¿ over p38ß, no inhibition to p38¿/¿, JNK1, ERK1, IKKß, MEKK1 or TAK1. Phase 2.	False	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1
392215	392215:01:02_02.00	True	2.0	88	9.0	1.0	0.0	55.3	0.0	53.9	17.7	81.8	22.6	32.5	0.0	61.8	49.1	LCH	81.8		inhibitor of MAP kinase p38 alpha (IC50 = 0.13 µM); Pyrazolo[1,5-a]pyridines as p38 Kinase Inhibitors.    Organic Letters  (2005),  7(21),  4753-4756.	False	CN1CCN(CCCNc2nccc(-c3c(-c4ccc(F)cc4)nn4cc(C(F)(F)F)ccc34)n2)CC1
392341	392341:01:02_02.00	True	2.0	88	16.8	56.7	24.1	0.0	93.3	0.0	0.0	0.0	0.0	0.0	77.0	0.0	0.0	DNA_Synth	93.3		inhibitor of MAP kinase p38 alpha (IC50 = 0.17 µM); Pyrimidinylimidazole inhibitors of p38: cyclic N-1 imidazole substituents enhance p38 kinase inhibition and oral activity. Bioorg Med Chem Lett. 2001 Nov 5;11(21):2867-70.	False	CC(C)N1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1
392026	392026:01:02_02.00	True	2.0	98	8.5	0.0	0.0	82.9	0.0	72.0	19.7	62.3	45.0	66.5	0.0	80.7	59.5	BET	82.9		inhibitor of GSK3-beta (IC50 = 0.003 µM); Novel pyrazolopyrimidine derivatives as GSK-3 inhibitors.  Bioorg Med Chem Lett.  (2004),  14(9),  2121-2125.	False	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1
392672	392672:01:09_02.00	True	2.0	93	28.0	10.8	0.0	71.2	0.0	67.9	35.3	52.6	44.9	63.8	0.0	64.2	90.3	Uncoupler	90.3	IMD-0354	IMD-0354 (IKK2 Inhibitor V) is a selective IKK.b. inhibitor which inhibits NF-.k.B activity. IMD0354 inhibits TNF-.a. induced NF-.k.B transcription activity with an IC50 of 1.2 uM.	False	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O
392413	392413:01:02_02.00	True	2.0	62	49.1	0.0	48.7	31.0	1.5	42.2	36.5	54.2	8.7	28.3	0.0	48.4	0.0	LCH	54.2		inhibitor of PLK1/3 kinase (IC50 = 0.002/0.025 µM); Heteroaryl-linked 5-(1H-benzimidazol-1-yl)-2-thiophenecarboxamides: potent inhibitors of polo-like kinase 1 (PLK1) with improved drug-like properties. Bioorg Med Chem Lett. 2010 Aug 1;20(15):4587-92.	True	C[C@@H](Oc1cc(-n2cnc3ccc(-c4ccncc4)cc32)sc1C(N)=O)c1ccccc1Cl
391852	391852:01:02_02.00	True	2.0	92	5.4	63.5	0.0	0.0	73.7	0.0	10.3	0.2	0.0	0.5	39.4	0.0	21.6	DNA_Synth	73.7		inhibitor of PI3Kalpha/beta/gamma/delta (IC50 = 0.4/0.0013/0.16/0.01 µM); Synthesis and structure-activity relationships of 1,2,4-triazolo[1,5-a]pyrimidin-7(3H)-ones as novel series of potent ß isoform selective phosphatidylinositol 3-kinase inhibitors. Bioorg Med Chem Lett. 2012 May 1;22(9):3198-202.	True	Cc1c(Cn2c(C)nn3c(=O)cc(N4CCO[C@H](C)C4)nc23)cccc1C(F)(F)F
392449	392449:01:02_02.00	True	2.0	99	9.7	85.4	0.0	0.0	79.2	0.0	20.5	0.0	0.0	0.0	75.5	0.0	0.0	AKT_PI3K_MTOR	85.4		inhibitor of PI3Kalpha/beta/gamma/delta (IC50 = 0.32/0.002/0.25/0.025 µM); Synthesis and structure-activity relationships of 1,2,4-triazolo[1,5-a]pyrimidin-7(3H)-ones as novel series of potent ß isoform selective phosphatidylinositol 3-kinase inhibitors. Bioorg Med Chem Lett. 2012 May 1;22(9):3198-202.	False	Cc1nn2c(=O)cc(N3CCO[C@H](C)C3)nc2n1Cc1cccc(Cl)c1Cl
390582	390582:02:09_02.00	True	2.0	94	26.8	0.0	0.0	87.4	0.0	80.3	5.4	82.4	46.8	65.9	0.0	74.8	70.4	BET	87.4	PIK-93	PIK-93 is the first potent, synthetic PI4K (PI4KIII.b.) inhibitor with IC50 of 19 nM, and also inhibits PI3K.g. and PI3K.a. with IC50 of 16 nM and 39 nM, respectively.	False	CC(=O)Nc1nc(C)c(-c2ccc(Cl)c(S(=O)(=O)NCCO)c2)s1
392343	392343:01:02_02.00	True	2.0	79	28.7	0.0	19.0	60.3	0.0	66.2	58.0	53.5	38.1	46.2	0.0	82.4	33.3	Tubulin	82.4		inhibitor of PLK1 kinase (IC50 = 0.035 µM); Discovery of thiophene inhibitors of polo-like kinase. Bioorg Med Chem Lett. 2009 Feb 1;19(3):1018-21.	False	COc1ccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)cc1
392532	392532:01:09_02.00	True	2.0	54	47.8	60.6	0.0	0.0	54.1	0.0	0.0	0.0	0.0	0.0	59.9	0.0	0.0	AKT_PI3K_MTOR	60.6	PIK-75 (hydrochloride)	PIK-75 hydrochloride is a reversible DNA-PK and p110.a.-selective inhibitor, which inhibits DNA-PK, p110.a. and p110.g. with IC50s of 2, 5.8 and 76 nM, respectively. PIK-75 hydrochloride inhibits p110.a. >200-fold more potently than p110.b. (IC50=1.3 uM). PIK-75 hydrochloride induces apoptosis.	False	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnc2ccc(Br)cn12
391884	391884:01:02_02.00	True	2.0	96	10.2	41.8	31.9	0.0	90.1	0.0	0.0	0.0	0.0	0.0	70.7	0.0	0.0	DNA_Synth	90.1		inhibitor of CDK2/4 (IC50 = 1/1 µM); Synthesis and evaluation of pyrazolo[1,5-b]pyridazines as selective cyclin dependent kinase inhibitors.  Bioorg Med Chem Lett.  (2008),  18(21),  5758-5762.	False	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1
392288	392288:01:02_02.00	True	2.0	96	6.2	82.0	0.0	0.0	75.2	0.0	26.3	0.0	0.0	0.0	64.6	0.0	3.4	AKT_PI3K_MTOR	82.0		inhibitor of 3-phosphoinositide dependent protein kinase-1 (IC50 = 0.003 µM), inhibitor of ROCK1 (IC50 = 0.2 µM); Structure-based design of potent and selective 3-phosphoinositide-dependent kinase-1 (PDK1) inhibitors. J Med Chem. 2011 Mar 24;54(6):1871-95.	True	C[C@@H]1CC[C@H](C(=O)NC2CCCCC2)CN1c1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1
392654	392654:01:09_02.00	True	2.0	81	25.6	46.1	29.5	0.0	94.4	0.0	0.0	0.0	0.0	0.0	82.8	0.0	0.0	DNA_Synth	94.4	BMS-265246	BMS-265246 is a potent and selective CDK1/2 inhibitor for CDK1/cyclin B and CDK2/cyclin E with IC50 of 6 nM and 9 nM, respectively. IC50 Value: 6 nM(for CDK1/cyclin B); 9 nM(for CDK2/cyclin E)Target: CDK1/2in vitro: BMS-265246 inhibits the activity of Cdk4/cycD (IC50 = 0.23 uM) and prevents A2780 Cytox with IC50 of 0.76 uM. BMS-265246 when bound to Cdk2, shows the inhibitor resides within the ATP purine binding site and forms important H-bonds with Leu83 on the protein backbone. BMS-265246 represents the most potent Cdk/Cdk2 selective analogue from this chemotype. A recent study shows that BMS-265246 inhibits cell proliferation with EC50 ranging from 0.293 uM-0.492 uM in HCT-116 cells. After treatment of BMS-265246, the dominant cell populations are G2-arrested cells having 4N DNA content, large round nuclei, and low DNA intensity.in vivo:	False	CCCCOc1c(C(=O)c2c(F)cc(C)cc2F)cnc2[nH]ncc12
392796	392796:01:09_02.00	True	2.0	101	12.6	45.8	17.4	0.0	77.2	0.0	8.1	0.0	0.0	0.0	82.2	0.0	0.0	Pyrimidine_Synth	82.2	Refametinib (RDEA119, Bay ;86-9766)	Refametinib (RDEA119, Bay 86-9766) is a potent, ATP non-competitive and highly selective inhibitor of MEK1 and MEK2 with IC50 of 19 nM and 47 nM, respectively.	False	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1
392355	392355:01:02_02.00	True	2.0	98	29.9	0.0	0.0	19.6	0.0	16.7	26.7	32.4	15.8	18.9	0.0	30.5	0.0	LCH	32.4		inhibitor of TGF-beta receptor type I (Alk5) (IC50 = 0.025 µM); Design of novel quinazoline derivatives and related analogues as potent and selective ALK5 inhibitors. Bioorg Med Chem Lett. 2009 Apr 15;19(8):2277-81.	False	Cc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3ccccc3n2)n1
392036	392036:01:02_02.00	True	2.0	87	35.8	59.1	20.5	0.0	80.2	0.0	0.0	0.0	0.0	0.0	84.8	0.0	0.0	Pyrimidine_Synth	84.8		SB220025 is a synthetic small molecule potent and selective inhibitor of the p38 mitogen-activated protein kinase (MAPK, IC50 = 60nM), 50-1000-fold selective over other MAP kinases. Potent inhibitor of angiogenesis, inflammatory cytokine production, and TNF-¿ production.; Pyrimidinylimidazole inhibitors of p38: cyclic N-1 imidazole substituents enhance p38 kinase inhibition and oral activity.  Bioorg Med Chem Lett.  (2001),  11(21),  2867-2870.	False	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1
391886	391886:01:02_02.00	True	2.0	88	21.4	52.6	21.2	0.0	88.6	0.0	13.5	0.0	0.0	0.0	76.7	0.0	0.0	DNA_Synth	88.6		inhibitor of MAP kinase p38 alpha (IC50 = 0.086 µM); Pyrimidinylimidazole inhibitors of p38: cyclic N-1 imidazole substituents enhance p38 kinase inhibition and oral activity.  Bioorg Med Chem Lett.  (2001),  11(21),  2867-2870.	False	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1
392642	392642:01:09_02.00	True	2.0	90	16.1	67.5	0.0	0.0	79.7	0.0	11.9	12.9	0.0	0.0	51.1	0.0	0.0	DNA_Synth	79.7	AZ 628	AZ 628 is a pan-Raf kinase inhibitor with IC50s of 105, 34 and 29 nM for B-Raf, B-RafV600E, and c-Raf-1, respectively.	False	Cc1ccc(NC(=O)c2cccc(C(C)(C)C#N)c2)cc1Nc1ccc2ncn(C)c(=O)c2c1
392542	392542:01:09_02.00	True	2.0	54	68.2	0.0	0.0	82.4	0.0	82.6	25.2	75.4	55.4	65.3	0.0	78.4	70.8	HDAC	82.6	Rigosertib (ON-01910)	Rigosertib (ON-01910) is a non-ATP-competitive inhibitor of PLK1 with IC50 of 9 nM. It shows 30-fold greater selectivity against Plk2 and no activity to Plk3. Phase 3.	False	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1
392660	392660:01:09_02.00	True	2.0	102	29.7	0.0	0.0	77.2	0.0	74.3	27.6	92.3	32.3	51.6	0.0	67.4	56.9	LCH	92.3	NVP-AEW541	NVP-AEW541 is a potent inhibitor of IGF-1R with IC50 of 0.15 uM, also inhibits InsR, with IC50 of 0.14 uM.	False	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1
392618	392618:01:09_02.00	True	2.0	92	46.3	0.0	0.0	86.4	0.0	79.6	28.4	76.1	48.5	60.6	0.0	84.3	57.5	BET	86.4	TWS119	TWS119 is a specific inhibitor of GSK-3.b., with an IC50 of 30 nM, and activates the wnt/.b.-catenin pathway.	False	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1
392347	392347:01:02_02.00	True	2.0	77	17.6	15.3	0.0	55.7	1.3	45.6	19.6	73.9	17.2	34.5	0.0	67.6	55.8	LCH	73.9		inhibitor of GSK3-beta (IC50 = 0.01 µM), inhibitor of Cyclin-dependent kinase 2/4 (IC50 = 0.01/0.25 µM); N-Phenyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amines as Potent and Selective Inhibitors of Glycogen Synthase Kinase 3 with Good Cellular Efficacy.    J Med Chem (2004),  47(19),  4716-4730.	False	FC(F)(F)c1cc(Br)cc(Nc2nccc(-c3cnn4ncccc34)n2)c1
392231	392231:01:02_02.00	True	2.0	100	9.7	72.7	0.0	0.0	55.5	0.0	30.4	38.6	0.0	0.0	30.4	0.0	28.2	AKT_PI3K_MTOR	72.7		inhibitor of Ribosomal protein S6 kinase alpha 1 (IC50 = 0.044 µM), inhibitor of Akt1 (IC50 = 0.33 µM); Identification of 4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a Novel Inhibitor of AKT Kinase.   J Med Chem. 2008,  51(18),  5663-5679.	False	CCn1c(-c2nonc2N)nc2c(-c3ccccc3)ncc(OCCCN)c21
392578	392578:01:09_02.00	True	2.0	88	29.0	0.0	0.0	74.1	0.0	64.5	24.3	66.9	37.5	54.5	0.0	85.0	55.7	Tubulin	85.0	Gandotinib	Gandotinib (LY2784544) is a potent JAK2 inhibitor with IC50 of 3 nM. Gandotinib (LY2784544) also inhibits FLT3, FLT4, FGFR2, TYK2, and TRKB with IC50 of 4, 25, 32, 44, and 95 nM.	False	Cc1cc(Nc2cc(CN3CCOCC3)c3nc(C)c(Cc4ccc(Cl)cc4F)n3n2)[nH]n1
392705	392705:01:09_02.00	True	2.0	99	40.8	0.0	0.0	67.9	0.0	68.0	42.4	77.2	23.5	44.8	0.0	62.2	49.7	LCH	77.2	JNK-IN-8	JNK-IN-8 (JNK Inhibitor XVI) is a potent JNK inhibitor with IC50s of 4.7 nM, 18.7 nM, and 1 nM for JNK1, JNK2, and JNK3, respectively.	False	Cc1cc(NC(=O)c2cccc(NC(=O)/C=C/CN(C)C)c2)ccc1Nc1nccc(-c2cccnc2)n1
280140	280140:03:09_02.00	True	2.0	98	24.0	0.0	0.0	70.4	0.0	59.0	19.9	58.0	38.8	60.9	0.0	80.1	57.6	Tubulin	80.1	BIO	potent, selective, reversible, and ATP-competitive glycogen synthase kinase 3alpha/beta (GSK-3alpha/beta) inhibitor, maintains self-renewal and pluripotency of ESCs.	False	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O
392482	392482:01:09_02.00	True	2.0	102	7.9	0.7	0.0	58.8	0.0	61.9	54.6	61.2	13.3	60.1	0.0	53.6	55.0	HDAC	61.9	Pazopanib (Hydrochloride)	Pazopanib Hydrochloride (GW786034 Hydrochloride) is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFR.b., c-Kit, FGFR1, and c-Fms with an IC50 of 10, 30, 47, 84, 74, 140 and 146 nM, respectively.	False	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O
392745	392745:01:09_02.00	True	2.0	94	9.2	0.0	0.0	58.0	0.0	62.4	0.0	58.7	34.4	27.8	0.0	47.6	57.3	HDAC	62.4	GNF-5	GNF-5 is a selective and allosteric Bcr-Abl inhibitor with IC50 of 220 nM.	False	O=C(NCCO)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1
392661	392661:01:09_02.00	True	2.0	99	5.5	11.8	0.0	39.9	0.0	43.5	17.2	71.0	13.6	0.0	0.0	26.5	21.8	LCH	71.0	AZD4547	AZD4547 is a novel selective FGFR inhibitor targeting FGFR1/2/3 with IC50 of 0.2 nM/2.5 nM/1.8 nM, weaker activity against FGFR4, VEGFR2(KDR), and little activity observed against IGFR, CDK2, and p38. Phase 1/2.	True	COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)n[nH]2)cc(OC)c1
392763	392763:01:09_02.00	True	2.0	98	7.4	7.9	0.0	43.7	0.0	31.7	10.7	61.9	14.7	27.4	0.0	45.9	25.6	LCH	61.9	Afatinib (BIBW2992)	Afatinib (BIBW2992) irreversibly inhibits EGFR/HER2 including EGFR(wt), EGFR(L858R), EGFR(L858R/T790M) and HER2 with IC50 of 0.5 nM, 0.4 nM, 10 nM and 14 nM, respectively; 100-fold more active against Gefitinib-resistant L858R-T790M EGFR mutant. Phase 3.	False	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1
392687	392687:01:09_02.00	True	2.0	96	6.7	15.1	0.0	64.6	0.0	64.9	41.0	66.8	26.6	52.8	0.0	52.5	69.8	Uncoupler	69.8	Pazopanib	Pazopanib (GW786034) is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFR.b., c-Kit, FGFR1, and c-Fms with IC50s of 10, 30, 47, 84, 74, 140 and 146 nM, respectively.   	False	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O
392716	392716:01:09_02.00	True	2.0	74	77.9	0.0	0.0	86.5	0.0	83.1	32.6	85.5	50.3	69.4	0.0	87.5	60.6	Tubulin	87.5	GZD824 (dimesylate)	GZD824 dimesylate (HQP1351 dimesylate) is an orally bioavailable pan-Bcr-Abl inhibitor with potency against a wide range of Bcr-Abl mutants and the native enzyme (IC50=0.34 nM). GZD824 dimesylate has antitumor activity.	False	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2[nH]ncc2c1
391864	391864:01:02_02.00	True	2.0	101	53.9	0.0	0.0	81.7	0.0	76.0	18.0	63.2	49.8	79.7	0.0	84.8	56.3	Tubulin	84.8		GSK-3 inhibitor (IC50 = 0.006 µM), GSK-3 beta inhibitor (IC50 = 0.012 µM); Synthesis and evaluation of novel heterocyclic inhibitors of GSK-3.  Bioorg Med Chem Lett.  (2006),  16(8),  2091-2094.	False	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1
391915	391915:01:02_02.00	True	2.0	74	29.9	0.0	1.7	59.3	0.0	52.1	42.8	60.0	24.8	42.8	0.0	87.3	41.7	Tubulin	87.3		inhibitor of Vascular endothelial growth factor receptor 2 (IC50 = 0.0029 µM), inhibitor of Tyrosine-protein kinase TIE-2 (IC50 = 0.018 µM); Discovery of Novel Benzimidazoles as Potent Inhibitors of TIE-2 and VEGFR-2 Tyrosine Kinase Receptors.    J Med Chem (2007),  50(18),  4453-4470.	False	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4[nH]c(NC(=O)OC)nc4c3)cc2)c1
391918	391918:01:02_02.00	True	2.0	55	63.2	0.0	35.0	67.1	0.0	76.5	32.3	54.9	53.6	58.4	0.0	83.5	30.9	Tubulin	83.5		inhibitor of Vascular endothelial growth factor receptor 2 (IC50 = 0.032 µM), inhibitor of Tyrosine-protein kinase TIE-2 (IC50 = 3.2 µM); Discovery of Novel Benzimidazoles as Potent Inhibitors of TIE-2 and VEGFR-2 Tyrosine Kinase Receptors.    J Med Chem (2007),  50(18),  4453-4470.	False	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1
392657	392657:01:09_02.00	True	2.0	94	5.0	0.0	2.5	41.2	0.0	54.0	53.2	55.1	13.6	15.2	0.0	44.3	19.6	LCH	55.1	TAK-285	TAK-285 is a potent, selective, ATP-competitive and orally active HER2 and EGFR(HER1) inhibitor with IC50 of 17 nM and 23 nM, respectively. TAK-285 is >10-fold selectivity for HER1/2 than HER4, and less potent to MEK1/5, c-Met, Aurora B, Lck, CSK etc. TAK-285 has effective antitumor activity. TAK-285 can cross the blood-brain barrier (BBB).	False	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21
392770	392770:01:09_02.00	True	2.0	84	44.6	91.5	0.0	0.0	39.5	0.0	23.1	0.0	0.0	0.0	50.0	0.0	32.5	AKT_PI3K_MTOR	91.5	VS-5584	VS-5584 is a pan-PI3K/mTOR kinase inhibitor with IC50s of 16 nM, 68 nM, 42 nM, 25 nM, and 37 nM for PI3K.a., PI3K.b., PI3K.d., PI3K.g. and mTOR, respectively. VS-5584 simultaneously blocks mTORC2 as well as mTORC1.	False	Cc1nc2c(-c3cnc(N)nc3)nc(N3CCOCC3)nc2n1C(C)C
392665	392665:01:09_02.00	True	2.0	103	9.5	70.7	0.0	0.0	49.2	0.0	37.2	0.0	0.0	0.0	65.7	0.0	0.0	AKT_PI3K_MTOR	70.7	CEP-33779	CEP-33779 is a novel, selective, and orally bioavailable inhibitor of JAK2 with an IC50 of 1.8±0.6 nM.	False	CN1CCN(c2cccc(Nc3nc4c(-c5ccc(S(C)(=O)=O)cc5)cccn4n3)c2)CC1
392714	392714:01:09_02.00	True	2.0	95	21.9	17.3	0.0	42.9	0.0	43.3	32.5	70.1	9.4	13.8	0.0	48.2	35.4	LCH	70.1	Ceritinib	Ceritinib (LDK378) is a selective, orally bioavailable, and ATP-competitive ALK tyrosine kinase inhibitor with an IC50 of 200 pM. Ceritinib (LDK378) also inhibits IGF-1R, InsR, and STK22D with IC50 values of 8, 7, and 23 nM, respectively. Ceritinib (LDK378) shows great antitumor potency.	False	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1
392442	392442:01:02_02.00	True	2.0	96	13.8	51.9	11.5	0.0	78.2	0.0	21.1	18.4	0.0	0.0	56.8	0.0	0.0	DNA_Synth	78.2		inhibitor of Vascular endothelial growth factor receptor 2 (IC50 = 0.004 µM); Discovery of a novel and potent series of dianilinopyrimidineurea and urea isostere inhibitors of VEGFR2 tyrosine kinase.  Bioorg Med Chem Lett.  (2005),  15(15),  3519-3523.	False	CN1CCN(Cc2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1
392634	392634:01:09_02.00	True	2.0	77	52.8	86.2	0.0	0.0	23.2	0.0	18.0	0.0	0.0	0.0	44.1	0.0	32.6	AKT_PI3K_MTOR	86.2	Sapanisertib	Sapanisertib (INK-128; MLN0128; TAK-228) is an orally available, ATP-dependent mTOR1/2 inhibitor with an IC50 of 1 nM for mTOR kinase.	False	CC(C)n1nc(-c2ccc3oc(N)nc3c2)c2c(N)ncnc21
382169	382169:02:09_02.00	True	2.0	63	64.6	0.0	0.0	83.3	0.0	79.6	28.3	93.3	46.4	50.7	0.0	81.5	58.9	LCH	93.3	Ponatinib	Ponatinib (AP24534) is an orally active multi-targeted kinase inhibitor with IC50s of 0.37 nM, 1.1 nM, 1.5 nM, 2.2 nM, and 5.4 nM for Abl, PDGFR.a., VEGFR2, FGFR1, and Src, respectively.	False	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12
391798	391798:01:02_02.00	True	2.0	87	23.0	72.8	0.0	0.0	68.9	0.0	23.3	18.5	0.0	0.0	48.5	0.0	21.0	AKT_PI3K_MTOR	72.8		inhibitor of CDK2/4 (IC50 = 0.23/0.045 µM), GSK-3 beta inhibitor (IC50 = 0.85 µM); Synthesis and evaluation of pyrazolo[1,5-b]pyridazines as selective cyclin dependent kinase inhibitors.  Bioorg Med Chem Lett.  (2008),  18(21),  5758-5762.	False	CC(C)Oc1ccc2c(-c3ccnc(Nc4ccc(N5CCN(C)CC5)cc4)n3)cnn2n1
392776	392776:01:09_02.00	True	2.0	100	35.9	0.0	0.0	75.7	0.0	66.6	6.5	65.3	46.6	57.6	0.0	82.3	49.0	Tubulin	82.3	CHIR-99021 (CT99021) HCl	CHIR-99021 HCl (CT99021) is hydrochloride of CHIR-99021, which is a GSK-3¿/ß inhibitor with IC50 of 10 nM/6.7 nM; ability to distinguish between GSK-3 and its closest homologs Cdc2 and ERK2.	False	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1
392562	392562:01:09_02.00	True	2.0	101	11.6	57.2	0.0	15.3	0.0	10.7	23.8	32.5	0.0	9.4	0.0	6.7	34.4	AKT_PI3K_MTOR	57.2	R406 (free base)	R406 free base is an orally available and competitive Syk/FLT3 inhibitor for ATP binding with a Ki of 30 nM, potently inhibits Syk kinase activity in vitro with an IC50 of 41 nM, measured at an ATP concentration corresponding to its Km value. R406 free base reduces immune complex-mediated inflammation. R406 free base also inhibits Lyn (IC50=63 nM) and Lck (IC50=37 nM).	False	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC
392718	392718:01:09_02.00	True	2.0	88	41.6	69.8	0.0	26.2	3.1	26.8	42.3	53.3	4.8	8.1	4.2	27.2	54.0	AKT_PI3K_MTOR	69.8	AZD3463	AZD3463 is a novel orally bioavailable ALK inhibitor with Ki of 0.75 nM, which also inhibits IGF1R with equivalent potency.	False	COc1cc(N2CCC(N)CC2)ccc1Nc1ncc(Cl)c(-c2c[nH]c3ccccc23)n1
392591	392591:01:09_02.00	True	2.0	100	38.3	0.0	0.0	74.9	0.0	69.4	5.4	92.7	33.9	46.0	0.0	72.0	48.0	LCH	92.7	SB590885	SB590885 is a potent B-Raf inhibitor with Ki of 0.16 nM, 11-fold greater selectivity for B-Raf over c-Raf, no inhibition to other human kinases.	False	CN(C)CCOc1ccc(-c2nc(-c3ccc4c(c3)CC/C4=N\O)c(-c3ccncc3)[nH]2)cc1
392684	392684:01:09_02.00	True	2.0	94	6.7	72.4	3.8	0.0	87.6	0.0	3.3	0.0	0.0	0.0	82.6	0.0	0.0	DNA_Synth	87.6	Icotinib	Icotinib (BPI-2009) is a potent and specific EGFR inhibitor with an IC50 of 5 nM; also inhibits mutant EGFRL858R, EGFRL858R/T790M, EGFRT790M and EGFRL861Q.	False	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1
392607	392607:01:09_02.00	True	2.0	82	5.7	60.9	0.0	21.4	21.1	15.5	46.2	34.6	0.0	14.2	5.0	49.0	61.2	Uncoupler	61.2	Buparlisib	Buparlisib (BKM120; NVP-BKM120) is a pan-class I PI3K inhibitor, with IC50s of 52, 166, 116 and 262 nM for p110.a., p110.b., p110.d. and p110.g., respectively.	False	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1
392386	392386:01:02_02.00	True	2.0	98	16.9	0.0	4.6	3.8	11.6	0.0	32.6	19.0	0.0	4.0	11.8	21.2	0.0	HSP90	32.6		inhibitor of TGF-beta receptor type I (Alk5) (IC50 = 0.65 µM); Design of novel quinazoline derivatives and related analogues as potent and selective ALK5 inhibitors. Bioorg Med Chem Lett. 2009 Apr 15;19(8):2277-81.	False	Cc1cccc(-c2nc(Nc3ccc4ncsc4c3)c3ccccc3n2)n1
392462	392462:02:09_02.00	True	2.0	100	21.1	0.0	0.0	75.9	0.0	66.1	24.6	63.4	40.8	52.7	0.0	74.2	61.5	BET	75.9	PP2	PP2 is a reversible and ATP-competitive Src family kinases inhibitor with IC50s of 4 and 5 nM for Lck and Fyn, respectively.	False	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21
246667	246667:11:09_02.00	True	2.0	94	8.8	16.1	0.0	52.3	0.8	48.5	39.2	74.2	2.4	36.7	0.0	62.1	55.3	LCH	74.2	Imatinib	Imatinib (STI571) is an orally bioavailable tyrosine kinases inhibitor that selectively inhibits BCR/ABL, v-Abl, PDGFR and c-kit kinase activity. Imatinib (STI571) works by binding close to the ATP binding site, locking it in a closed or self-inhibited conformation, therefore inhibiting the enzyme activity of the protein semicompetitively. Imatinib also is an inhibitor of SARS-CoV and MERS-CoV.	False	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1
392652	392652:01:09_02.00	True	2.0	82	25.4	76.5	0.0	0.0	65.5	0.0	40.8	0.0	0.0	0.0	54.5	0.0	0.0	AKT_PI3K_MTOR	76.5	Dovitinib (TKI-258) Dilactic Acid	Dovitinib Dilactic acid (TKI258 Dilactic acid) is the Dilactic acid of Dovitinib, which is a multitargeted RTK inhibitor, mostly for class III (FLT3/c-Kit) with IC50 of 1 nM/2 nM, also potent to class IV (FGFR1/3) and class V (VEGFR1-4) RTKs with IC50 of 8-13 nM, less potent to InsR, EGFR, c-Met, EphA2, Tie2, IGFR1 and HER2. Phase 4.	False	CN1CCN(c2ccc3[nH]c(-c4c(O)nc5cccc(F)c5c4N)nc3c2)CC1
392597	392597:01:09_02.00	True	2.0	94	52.2	0.0	0.0	83.2	0.0	79.5	32.2	78.5	41.5	64.6	0.0	81.2	63.3	BET	83.2	Fingolimod (hydrochloride)	Fingolimod hydrochloride (FTY720) is a sphingosine 1-phosphate (S1P) antagonist with an IC50 of 0.033 nM in K562 and NK cells. Fingolimod hydrochloride also is a pak1 activator.	False	CCCCCCCCc1ccc(CCC(N)(CO)CO)cc1
392683	392683:01:09_02.00	True	2.0	95	9.2	53.7	0.0	8.9	39.5	17.2	50.0	46.3	0.0	9.8	13.6	15.1	31.9	AKT_PI3K_MTOR	53.7	PF-573228	PF-573228 is a potent and selective FAK inhibitor with IC50 of 4 nM for purified recombinant catalytic fragment of FAK.	False	CS(=O)(=O)c1cccc(CNc2nc(Nc3ccc4c(c3)CCC(=O)N4)ncc2C(F)(F)F)c1
392755	392755:01:10_02.00	True	2.0	101	10.4	0.0	0.0	84.3	0.0	74.1	2.0	76.8	49.6	45.7	0.0	78.1	56.2	BET	84.3	XMD8-92	XMD8-92 is a potent ERK5 (BMK1)/BRD4 inhibitor with Kds of 80 and 190 nM, respectively. XMD8-92 inhibits DCAMKL2, PLK4 and TNK1 with Kds of 190, 600 and 890 nM, respectively. Anti-cancer activity.	False	CCOc1cc(N2CCC(O)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C
392558	392558:01:09_02.00	True	2.0	50	61.5	0.0	0.0	77.5	0.0	77.2	21.1	74.1	62.1	42.4	0.0	82.5	40.5	Tubulin	82.5	Hesperadin	Hesperadin is an ATP competitive indolinone inhibitor of Aurora A and B. Hesperadin inhibits Aurora B with an IC50 of 250 nM.	False	CCS(=O)(=O)Nc1ccc2[nH]c(O)c(/C(=N/c3ccc(CN4CCCCC4)cc3)c3ccccc3)c2c1
392004	392004:01:02_02.00	True	2.0	93	9.2	34.2	1.9	0.0	63.6	0.0	34.2	31.6	0.0	0.0	35.3	17.2	0.0	DNA_Synth	63.6		inhibitor of MAP kinase p38 alpha (IC50 = 0.015 µM); Phenoxypyrimidine inhibitors of p38.alpha. kinase synthesis and statistical evaluation of the p38 inhibitory potencies of a series of 1-(piperidin-4-yl)-4-(4-fluorophenyl)-5-(2-phenoxypyrimidin-4-yl) imidazoles.  Bioorg Med Chem Lett.  (2001),  11(9),  1123-1126.	False	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C
392734	392734:01:09_02.00	True	2.0	94	7.3	0.0	0.0	22.1	0.0	23.3	45.0	28.7	0.0	25.9	0.0	30.0	9.9	HSP90	45.0	XL019	XL019is a potentorally active, and selective JAK2 inhibitor, with IC50s of 2.2, 134.3, and 214.2 nM for JAK2, JAK1 and JAK3, respectively. XL019 shows 50-fold or greater selectivity for JAK2, versus a panel of over 100 serine/threonine and tyrosine kinases, including other members of the JAK family. XL019 potently inhibits STAT3 and STAT5 phosphorylation in cells harboring either JAK2V617F or wild-type JAK2.	False	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)[C@@H]1CCCN1
392321	392321:02:09_02.00	True	2.0	70	27.6	0.0	93.5	0.0	11.3	0.0	0.8	0.0	3.1	0.0	4.8	0.0	0.0	Aurora	93.5	ZM-447439	ZM-447439 is an aurora kinase inhibitor with IC50s of 110 and 130 nM for aurora A and B, respectively.; Thousands of chemical starting points for antimalarial lead identification. Nature. 2010 May 20;465(7296):305-10.	False	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1
392262	392262:01:02_02.00	True	2.0	93	7.6	66.3	0.0	0.0	66.7	0.0	20.5	6.9	0.0	0.0	58.1	0.0	2.5	DNA_Synth	66.7		inhibitor of Akt1 (IC50 = 0.05 µM); Discovery of 5-pyrrolopyridinyl-2-thiophenecarboxamides as potent AKT kinase inhibitors. Bioorg Med Chem Lett. 2009 Apr 15;19(8):2244-8.	False	NCC(NC(=O)c1cc(-c2ccccc2)c(-c2ccnc3[nH]ccc23)s1)c1ccccc1
392206	392206:01:02_02.00	True	2.0	100	10.7	18.8	0.0	63.5	0.0	59.3	0.0	73.3	28.8	42.4	0.0	57.5	69.6	LCH	73.3		inhibitor of PI3Kalpha/beta/gamma/delta (IC50 = 0.63/0.0013/0.5/0.05 µM); Synthesis and structure-activity relationships of 1,2,4-triazolo[1,5-a]pyrimidin-7(3H)-ones as novel series of potent ß isoform selective phosphatidylinositol 3-kinase inhibitors. Bioorg Med Chem Lett. 2012 May 1;22(9):3198-202.	False	Cc1nn2c(=O)cc(N3CCOCC3)nc2n1Cc1cccc(Cl)c1Cl
392712	392712:01:09_02.00	True	2.0	92	40.6	0.0	0.0	86.1	0.0	78.6	22.3	72.4	45.4	64.6	0.0	83.5	56.8	BET	86.1	PP1	PP1 is a potent, and Src family-selective tyrosine kinase inhibitor with IC50 of 5 and 6 nM for Lck and Fyn, respectively.	False	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1
392744	392744:01:09_02.00	True	2.0	89	5.2	0.0	60.2	5.3	17.5	4.0	24.2	11.7	0.0	4.5	0.0	33.9	0.0	Aurora	60.2	MK-8745	MK-8745 is an aurora A kinase inhibitor with an IC50 of 0.6 nM.	False	O=C(c1cccc(Cl)c1F)N1CCN(Cc2cccc(Nc3nccs3)n2)CC1
392795	392795:01:09_02.00	True	2.0	64	47.7	12.1	37.9	0.0	67.3	0.1	26.0	35.9	0.0	0.0	23.9	13.1	0.0	DNA_Synth	67.3	CX-6258 HCl	CX-6258 HCl is a potent, orally efficacious pan-Pim kinase inhibitor with IC50 of 5 nM, 25 nM and 16 nM for Pim1, Pim2, and Pim3, respectively.	False	CN1CCCN(C(=O)c2cccc(-c3ccc(/C=C4/C(=O)Nc5ccc(Cl)cc54)o3)c2)CC1
392584	392584:01:09_02.00	True	2.0	100	48.0	0.0	0.0	79.4	0.0	78.5	26.3	93.3	41.9	48.0	0.0	79.0	57.9	LCH	93.3	NVP-BHG712	NVP-BHG712 is an oral active EphB4 kinase autophosphorylation inhibitor, with IC50 values of 3.3 nM and 3.0 nM for EphA2 and EphB4, respectively.	False	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1Nc1nc(-c2cccnc2)nc2c1cnn2C
392641	392641:01:09_02.00	True	2.0	79	31.6	0.7	0.0	49.6	0.0	38.0	20.2	53.8	35.1	15.9	0.0	67.1	39.1	Tubulin	67.1	Milciclib	PHA-848125 is a potent, ATP-competitive CDK inhibitor for CDK2 with IC50 of 45 nM. It is >3-fold more selective for CDK2 than CDK1, 2, 4, 5, and 7. Phase 2.	False	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2
410624	392561:01:09_02.00	True	2.0	75	69.8	0.0	0.0	84.3	0.0	83.3	30.8	82.1	57.7	63.3	0.0	86.0	61.1	Tubulin	86.0	AZD-7762	AZD7762 is a potent and selective inhibitor of Chk1 with IC50 of 5 nM in a cell-free assay. It is equally potent against Chk2 and less potent against CAM, Yes, Fyn, Lyn, Hck and Lck. Phase 1.	True	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1
351488	351488:02:09_02.00	True	2.0	94	20.4	32.9	0.0	43.8	21.7	38.7	26.6	76.4	3.5	20.2	0.0	51.4	49.9	LCH	76.4	MK-2206 (dihydrochloride)	MK-2206 dihydrochloride (MK-2206 (2HCl)) is an orally active allosteric AKT inhibitor with IC50s of 5 nM, 12 nM, and 65 nM for AKT1, AKT2, and AKT3, respectively. MK-2206 dihydrochloride induces autophagy.	False	NC1(c2ccc(-c3nc4ccn5c(O)nnc5c4cc3-c3ccccc3)cc2)CCC1
392533	392533:01:09_02.00	True	2.0	96	6.7	54.8	9.3	0.0	76.9	0.0	31.0	0.0	0.0	0.0	56.6	0.0	0.0	DNA_Synth	76.9	Tivozanib	Tivozanib (AV-951; KRN951) is a highly potent and selective VEGFR 1/2/3 inhibitor with IC50s of 0.21, 0.16, and 0.24 nM in cell assay, respectively.	False	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC
392637	392637:01:09_02.00	True	2.0	76	39.6	34.0	19.8	0.0	61.7	0.0	20.9	38.7	0.0	0.0	24.9	0.0	0.0	DNA_Synth	61.7	Crenolanib	Crenolanib (CP-868596) is a potent and selective inhibitor of PDGFR¿/ß with Kd of 2.1 nM/3.2 nM, also potently inhibits FLT3, sensitive to D842V mutation not V561D mutation, >100-fold more selective for PDGFR than c-Kit, VEGFR-2, TIE-2, FGFR-2, EGFR, erbB2, and Src.	False	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1
392732	392732:01:09_02.00	True	2.0	98	9.0	52.9	2.4	0.0	79.6	0.0	13.5	0.0	0.0	0.0	58.8	0.0	0.0	DNA_Synth	79.6	Skepinone-L	Skepinone-L is a selective p38¿-MAPK inhibitor with IC50 of 5 nM.	False	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21
391983	391983:01:02_02.00	True	2.0	96	23.8	0.0	0.0	55.7	0.0	54.8	34.3	64.2	16.9	38.3	0.0	62.7	29.0	LCH	64.2		inhibitor of Yes1 kinase (IC50 = 0.03 µM); N-Phenyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amines as Potent and Selective Inhibitors of Glycogen Synthase Kinase 3 with Good Cellular Efficacy.    J Med Chem (2004),  47(19),  4716-4730.	False	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1
392645	392645:01:09_02.00	True	2.0	93	29.2	6.6	0.0	67.1	0.0	65.1	21.4	86.7	32.3	29.1	0.0	64.8	62.4	LCH	86.7	YM-201636	YM-201636 is a potent and selective PIKfyve inhibitor with an IC50 of 33 nM. YM-201636 also inhibits p110.a. with an IC50 of 3.3 uM. YM-201636 inhibits retroviral replication.	False	Nc1ccc(C(=O)Nc2cccc(-c3nc(N4CCOCC4)c4oc5ncccc5c4n3)c2)cn1
392762	392762:01:09_02.00	True	2.0	97	36.1	0.0	0.0	85.2	0.0	78.6	26.2	74.0	49.1	62.2	0.0	86.3	59.8	Tubulin	86.3	IM-12	IM-12 is an inhibitor of GSK-3.b., with an IC50 of 53 nM, and also enhances Wnt signalling.	False	Cc1[nH]c2ccccc2c1C1=C(NCCc2ccc(F)cc2)C(=O)N(C)C1=O
392614	392614:01:09_02.00	True	2.0	68	20.4	65.7	0.0	0.0	88.7	0.0	10.9	0.0	0.0	0.0	74.5	0.0	0.0	DNA_Synth	88.7	R547	R547 is a potent, selective and oral orally bioavailable ATP-competitive CDK inhibitor, with Kis of 2 nM, 3 nM and 1 nM  for CDK1/cyclin B, CDK2/cyclin E and CDK4/cyclin D1, respectively.	False	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N
392580	392580:01:09_02.00	True	2.0	61	42.8	0.0	54.0	27.2	5.4	42.9	24.7	50.3	12.2	29.9	0.0	34.3	0.3	Aurora	54.0	GSK461364	GSK461364 inhibits purified Plk1 with Ki of 2.2 nM. It is more than 1000-fold selective against Plk2/3. Phase 1.	False	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F
392682	392682:01:09_02.00	True	2.0	101	7.1	10.1	0.0	27.3	0.0	10.2	17.1	49.6	0.0	12.1	0.0	42.9	10.4	LCH	49.6	Go 6983	Go 6983 is a pan-PKC inhibitor against for PKC.a., PKC.b., PKC.g., PKC.d. and PKC.z. with IC50 of 7 nM, 7 nM, 6 nM, 10 nM and 60 nM, respectively.	False	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C
392724	392724:01:09_02.00	True	2.0	101	7.6	51.9	15.8	0.0	76.9	0.0	10.2	0.0	0.0	0.0	76.5	0.0	0.0	DNA_Synth	76.9	Binimetinib	Binimetinib (MEK162) is an oral and selective MEK1/2 inhibitor. Binimetinib (MEK162) inhibits MEK with an IC50 of 12 nM.	False	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21
392741	392741:01:09_02.00	True	2.0	100	15.5	83.4	0.0	3.3	13.1	0.0	45.1	18.4	0.0	4.8	26.6	8.5	50.0	AKT_PI3K_MTOR	83.4	AZ20	AZ20 is a novel potent and selective inhibitor of ATR kinase with IC50 of 5 nM, 8-fold selectivity over mTOR.	False	C[C@@H]1COCCN1c1cc(C2(S(C)(=O)=O)CC2)nc(-c2cccc3[nH]ccc23)n1
392531	392531:01:09_02.00	True	2.0	75	52.2	0.0	0.0	90.2	0.0	95.1	17.1	75.6	65.8	67.0	0.0	81.1	70.4	HDAC	95.1	CUDC-101	CUDC-101 is a potent inhibitor of HDAC, EGFR, and HER2 with IC50s of 4.4, 2.4, and 15.7 nM, respectively.	False	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1
391892	391892:01:02_02.00	True	2.0	98	6.2	56.6	0.0	0.0	62.9	0.0	1.6	0.0	0.0	0.0	54.4	0.0	6.4	DNA_Synth	62.9		inhibitor of Rho-associated protein kinase 1 (IC50 = 0.008 µM), inhibitor of RPS6KA1/B1 (IC50 = 0.09/0.59 µM); Development of Dihydropyridone Indazole Amides as Selective Rho-Kinase Inhibitors.    J Med Chem (2007),  50(1),  6-9.	False	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1
392696	392696:01:09_02.00	True	2.0	83	30.2	81.7	0.0	0.0	41.0	0.0	21.0	15.4	0.0	0.0	39.2	1.4	38.7	AKT_PI3K_MTOR	81.7	ALK-IN-1	ALK-IN-1 (Brigatinib analog) is a potent and selective active inhibitor of anaplastic lymphoma kinase(ALK), Patent US20140066406 A1.	False	COc1cc(N2CCC(N(C)C)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1
392056	392056:01:02_00.20	True	0.2	99	10.2	0.0	0.0	70.8	0.0	68.0	0.0	64.1	59.9	40.6	0.0	65.4	37.6	BET	70.8		inhibitor of GSK3-beta (IC50 = 0.016 µM); Novel pyrazolopyrimidine derivatives as GSK-3 inhibitors.  Bioorg Med Chem Lett.  (2004),  14(9),  2121-2125.	False	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1
392742	392742:01:09_00.20	True	0.2	105	7.4	0.0	0.0	72.2	0.0	72.6	9.9	60.2	58.2	50.5	0.0	56.1	57.7	HDAC	72.6	VE-822	VE-822 is an ATR inhibitor with IC50 of 19 nM.	False	CNCc1ccc(-c2cc(-c3nc(-c4ccc(S(=O)(=O)C(C)C)cc4)cnc3N)on2)cc1
392757	392757:01:09_00.20	True	0.2	92	34.7	66.5	0.0	0.0	71.9	0.0	0.0	0.0	0.0	0.0	62.2	0.0	0.0	DNA_Synth	71.9	PF-3758309	PF-03758309 is a potent, ATP-competitive, pyrrolopyrazole inhibitor of PAK4  with IC50 of 1.3 nM.	False	Cc1nc(Nc2n[nH]c3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1
392656	392656:01:09_00.20	True	0.2	96	28.0	94.0	0.0	0.0	74.0	0.0	28.1	0.0	0.0	0.0	67.1	0.0	17.0	AKT_PI3K_MTOR	94.0	AZD2014	AZD2014 is a novel mTOR inhibitor with IC50 of 2.8 nM; highly selective against multiple PI3K isoforms (¿/ß/¿/¿). Phase 2.	False	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1
392522	392522:01:09_00.20	True	0.2	75	38.9	0.0	96.7	0.0	22.7	0.0	9.0	0.0	0.0	0.0	21.3	0.0	0.0	Aurora	96.7	SNS-314	SNS-314 is a potent and selective aurora kinase inhibitor with IC50s of 9, 31, and 6 nM for aurora A, B and C, respectively.	False	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCNc2ncnc3ccsc23)s1
392481	392481:01:09_00.20	True	0.2	98	16.6	25.5	0.0	0.0	31.0	0.0	0.0	21.1	7.1	0.0	17.3	0.0	0.0	DNA_Synth	31.0	Nilotinib	Nilotinib (AMN-107) is a Bcr-Abl inhibitor with IC50 less than 30 nM.	False	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1
385860	385860:01:01_00.20	True	0.2	79	50.1	0.0	0.0	73.0	0.0	71.8	2.2	73.1	58.0	52.0	0.0	75.3	61.3	Tubulin	75.3	BAY-876	BAY-876 is an orally active and selective glucose transporter 1 (GLUT1) inhibitor with an IC50 of 2 nM. BAY-876 is >130-fold more selective for GLUT1 than GLUT2, GLUT3, and GLUT4. BAY-876 is also a potent blocker of glycolytic metabolism and ovarian cancer growth.	False	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1
391929	391929:01:03_00.20	True	0.2	64	49.6	24.4	1.2	1.5	44.8	0.0	5.4	23.9	6.3	0.0	12.6	16.6	11.9	DNA_Synth	44.8		inhibitor of CDK2/4 (IC50 = 0.004/0.006 µM), GSK-3 beta inhibitor (IC50 = 0.016 µM); Synthesis and evaluation of pyrazolo[1,5-b]pyridazines as selective cyclin dependent kinase inhibitors.  Bioorg Med Chem Lett.  (2008),  18(21),  5758-5762.	False	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1
392477	392477:01:09_00.20	True	0.2	99	43.7	96.0	0.0	0.0	69.4	0.0	23.7	0.0	0.0	0.0	73.3	0.0	5.5	AKT_PI3K_MTOR	96.0	Ridaforolimus (Deforolimus, MK-8669)	Ridaforolimus (Deforolimus) is a selective mTOR inhibitor with IC50 of 0.2 nM; while not classified as a prodrug, mTOR inhibition and FKBP12 binding is similar to rapamycin.	False	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C
392774	392774:01:09_00.20	True	0.2	103	14.2	46.1	9.4	0.0	53.1	0.0	0.0	0.0	0.0	0.0	69.4	0.0	0.0	Pyrimidine_Synth	69.4	PD0325901	PD0325901 (PD325901) is selective and non ATP-competitive MEK inhibitor with IC50 of 0.33 nM, roughly 500-fold more potent than CI-1040 on phosphorylation of ERK1 and ERK2. Phase 1/2.	False	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F
392708	392708:01:09_00.20	True	0.2	95	20.6	93.7	0.0	0.0	77.7	0.0	16.7	0.0	0.0	0.0	72.7	0.0	7.7	AKT_PI3K_MTOR	93.7	GDC-0349	GDC-0349 is a potent and selective ATP-competitive inhibitor of mTOR with Ki of 3.8 nM, 790-fold inhibitory effect against PI3K¿ and other 266 kinases. Phase 1.	False	CCNC(=O)Nc1ccc(-c2nc3c(c(N4CCOC[C@@H]4C)n2)CCN(C2COC2)C3)cc1
392761	392761:01:09_00.20	True	0.2	93	45.4	95.5	0.0	0.0	61.5	0.0	18.7	0.0	0.0	0.0	70.9	0.0	7.9	AKT_PI3K_MTOR	95.5	Zotarolimus(ABT-578)	Zotarolimus (ABT-578) is an analogue of rapamycin, and inhibits FKBP-12 binding with IC50 of 2.8 nM.	False	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@H](n3cnnn3)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C
392764	392764:01:09_00.20	True	0.2	98	57.5	91.8	0.0	0.0	59.0	0.0	11.2	0.0	0.0	0.0	70.7	0.0	2.1	AKT_PI3K_MTOR	91.8	Temsirolimus (CCI-779, NSC 683864)	Temsirolimus (CCI-779) is a specific mTOR inhibitor with IC50 of 1.76 ¿M.	False	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C
381944	381944:02:09_00.20	True	0.2	95	13.6	68.4	0.0	0.0	44.8	0.0	0.0	0.0	0.0	0.0	58.0	0.0	0.0	AKT_PI3K_MTOR	68.4	PI-103	PI-103 is a potent PI3K and mTOR inhibitor with IC50s of 8 nM, 88 nM, 48 nM, 150 nM, 20 nM, and 83 nM for p110.a., p110.b., p110.d., p110.g., mTORC1, and mTORC2. PI-103 also inhibits DNA-PK with an IC50 of 2 nM. PI-103 induces autophagy.	False	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1
392616	392616:01:09_00.20	True	0.2	90	51.5	96.8	0.0	0.0	55.2	0.0	24.8	0.0	0.0	0.0	61.3	0.0	23.1	AKT_PI3K_MTOR	96.8	WYE-132	WYE-132 (WYE-125132) is a highly potent, ATP-competitive, and specific mTOR kinase inhibitor (IC50: 0.19±0.07 nM; >5,000-fold selective versus PI3Ks). WYE-132 (WYE-125132) inhibits mTORC1 and mTORC2.	False	CNC(=O)Nc1ccc(-c2nc(N3CC4CCC(C3)O4)c3cnn(C4CCC5(CC4)OCCO5)c3n2)cc1
246673	246673:02:09_00.20	True	0.2	107	9.8	13.5	0.0	0.0	0.0	0.0	0.0	14.8	4.0	0.0	9.4	0.0	0.0	LCH	14.8	Lapatinib (ditosylate)	Lapatinib ditosylate (GW572016 ditosylate) is a potent inhibitor of the ErbB-2 and EGFR tyrosine kinase domains with IC50 values against purified EGFR and ErbB-2 of 10.2 and 9.8 nM, respectively.	False	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1
392608	392608:01:10_00.20	True	0.2	105	13.1	45.0	13.5	0.0	58.9	0.0	0.0	0.0	0.0	0.0	72.7	0.0	0.0	Pyrimidine_Synth	72.7	TAK-733	TAK-733 is a potent and selective MEK allosteric site inhibitor for MEK1 with IC50 of 3.2 nM, inactive to Abl1, AKT3, c-RAF, CamK1, CDK2, c-Met, etc. Phase 1.	False	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21
392421	392421:01:02_00.20	True	0.2	102	13.1	24.1	7.6	0.0	25.6	0.0	0.0	0.0	0.0	0.0	55.9	0.0	0.0	Pyrimidine_Synth	55.9		inhibitor of PERK cytoplasmic domain mediated EIF2alpha phosphorylation (IC50 = 0.0002 µM); Discovery of 7-Methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a Potent and Selective First-in-Class Inhibitor of Protein Kinase R (PKR)-like Endoplasmic Reticulum Kinase (PERK) J. Med. Chem. 2012	False	Cn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(F)c2)c2c(N)ncnc21
392715	392715:01:09_00.20	True	0.2	96	25.7	57.9	0.0	0.0	85.9	0.0	0.0	0.0	0.0	0.0	64.5	0.0	0.0	DNA_Synth	85.9	LY2835219	LY2835219 is a potent and selective inhibitor of CDK4 and CDK6 with IC50 of 2 nM and 10 nM, respectively.	False	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1
392015	392015:01:02_00.20	True	0.2	95	9.2	29.4	39.8	0.0	90.1	0.0	17.8	0.0	0.0	0.0	74.8	0.0	0.0	DNA_Synth	90.1		inhibitor of Cyclin-dependent kinase 1/2 (IC50 = 0.029/0.0028 µM); Oxindole-Based Inhibitors of Cyclin-Dependent Kinase 2 (CDK2): Design, Synthesis, Enzymatic Activities, and X-ray Crystallographic Analysis.    J Med Chem (2001),  44(25),  4339-4358.	False	NS(=O)(=O)c1ccc(/N=C\c2c(O)[nH]c3ccc4ncsc4c23)cc1
391921	391921:01:02_00.20	True	0.2	103	6.7	4.7	0.0	0.0	0.0	0.0	0.0	0.1	23.2	0.0	10.9	0.0	0.0	Na_K-ATPase	23.2		inhibitor of CDK4 (IC50 = 0.4 µM), also inhibits firefly luciferase (IC50 = 4.6 µM); Synthesis and evaluation of pyrazolo[1,5-b]pyridazines as selective cyclin dependent kinase inhibitors.  Bioorg Med Chem Lett.  (2008),  18(21),  5758-5762.	False	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1
336227	336227:02:09_00.20	True	0.2	88	6.6	37.2	0.0	0.0	35.8	0.0	0.0	0.0	0.0	0.0	53.3	0.0	0.0	Pyrimidine_Synth	53.3	TG100-115	TG100-115 is a selective PI3K.g./PI3K.d. inhibitor with IC50s of 83 and 235 nM, respectively.	False	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1
392797	392797:01:09_00.20	True	0.2	101	6.4	69.5	0.0	0.0	63.3	0.0	17.5	0.0	0.0	0.0	58.8	0.0	0.0	AKT_PI3K_MTOR	69.5	WH-4-023	WH-4-023 is a potent and selective dual Lck/Src inhibitor with IC50 of 2 nM/6 nM for Lck and Src kinase respectively; little inhibition on p38.a. and KDR. 	False	COc1ccc(N(C(=O)Oc2c(C)cccc2C)c2ccnc(Nc3ccc(N4CCN(C)CC4)cc3)n2)c(OC)c1
392638	392638:01:09_00.20	True	0.2	93	25.9	93.5	0.0	0.0	72.2	0.0	24.0	0.0	0.0	0.0	70.5	0.0	9.5	AKT_PI3K_MTOR	93.5	PF-04691502	PF-04691502 is an ATP-competitive PI3K(¿/ß/¿/¿)/mTOR dual inhibitor with Ki of 1.8 nM/2.1 nM/1.6 nM/1.9 nM and 16 nM, little activity against either Vps34, AKT, PDK1, p70S6K, MEK, ERK, p38, or JNK. Phase 2.	False	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1
391925	391925:02:09_00.20	True	0.2	77	37.7	0.0	0.9	70.8	0.0	69.3	17.5	67.4	62.2	40.0	0.0	91.1	46.3	Tubulin	91.1	TCS JNK 5a	inhibitor of c-Jun N-terminal kinase 2/3 (IC50 = 0.3/0.2 µM), Inhibitor of binding or entry into cells for Lassa Virus (IC50 = 0.2 µM); N-(3-Cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)amides as potent, selective, inhibitors of JNK2 and JNK3.  Bioorg Med Chem Lett.  (2007),  17(5),  1296-1301.	False	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2
392651	392651:01:09_00.20	True	0.2	67	64.4	0.0	0.0	88.7	0.0	96.5	26.3	75.3	68.3	67.8	0.0	81.4	72.3	HDAC	96.5	Fimepinostat	Fimepinostat (CUDC-907) potently inhibits class I PI3Ks as well as classes I and II HDAC enzymes with an IC50 of  19/54/39 nM and 1.7/5.0/1.8/2.8 nM for PI3K.a./PI3K.b./PI3K.d. and HDAC1/HDAC2/HDAC3/HDAC10 , respectively.	False	COc1ccc(-c2nc(N3CCOCC3)c3sc(CN(C)c4ncc(C(=O)NO)cn4)cc3n2)cn1
392710	392710:01:09_02.00	True	2.0	87	22.5	0.0	1.3	55.0	0.0	54.5	22.4	66.8	25.9	32.6	0.0	57.7	27.2	LCH	66.8	PRT062607 (P505-15, BIIB057) HCl	PRT062607 (P505-15) HCl is a novel, highly selective Syk inhibitor with IC50 of 1 nM, >80-fold selective for Syk than Fgr, Lyn, FAK, Pyk2 and Zap70.	False	NC(=O)c1cnc(N[C@@H]2CCCC[C@@H]2N)nc1Nc1cccc(-n2nccn2)c1
392649	392649:01:09_02.00	True	2.0	86	6.4	30.1	63.5	0.0	48.0	0.0	43.7	0.0	0.0	0.0	44.1	0.0	0.0	Aurora	63.5	BX-912	BX912 is a potent and specific PDK1 inhibitor with IC50 of 12 nM, 9- and 105- fold greater selectivity for PDK1 than PKA and PKC, respectively. In comparison to GSK3ß, selectivity for PDK1 is 600-fold.	False	O=C(Nc1cccc(Nc2ncc(Br)c(NCCc3c[nH]cn3)n2)c1)N1CCCC1
392079	392079:01:02_02.00	True	2.0	99	9.3	52.0	0.0	0.0	63.0	0.0	34.6	22.5	0.0	2.0	38.1	1.0	6.0	DNA_Synth	63.0		inhibitor of MAP kinase p38 alpha (IC50 = 0.095 µM); Phenoxypyrimidine inhibitors of p38.alpha. kinase synthesis and statistical evaluation of the p38 inhibitory potencies of a series of 1-(piperidin-4-yl)-4-(4-fluorophenyl)-5-(2-phenoxypyrimidin-4-yl) imidazoles.  Bioorg Med Chem Lett.  (2001),  11(9),  1123-1126.	False	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1
392670	392670:01:10_02.00	True	2.0	101	7.3	0.0	0.0	72.6	0.0	77.7	45.7	75.9	35.4	52.0	0.0	66.7	60.1	HDAC	77.7	Varlitinib	ARRY334543 is a selective and potent ErbB1(EGFR) and ErbB2(HER2) inhibitor with IC50 of 7 nM and 2 nM, respectively. Phase 2.	False	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1
392056	392056:01:02_02.00	True	2.0	93	73.4	0.0	0.0	84.0	0.0	79.2	25.1	91.4	45.0	62.0	0.0	80.8	59.4	LCH	91.4		inhibitor of GSK3-beta (IC50 = 0.016 µM); Novel pyrazolopyrimidine derivatives as GSK-3 inhibitors.  Bioorg Med Chem Lett.  (2004),  14(9),  2121-2125.	False	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1
392742	392742:01:09_02.00	True	2.0	119	58.9	0.0	0.0	84.3	0.0	83.8	21.6	89.8	47.4	53.6	0.0	74.5	66.4	LCH	89.8	VE-822	VE-822 is an ATR inhibitor with IC50 of 19 nM.	False	CNCc1ccc(-c2cc(-c3nc(-c4ccc(S(=O)(=O)C(C)C)cc4)cnc3N)on2)cc1
392492	392492:01:09_02.00	True	2.0	92	29.2	91.5	0.0	0.0	38.5	0.0	37.7	21.6	0.0	0.1	34.5	0.0	49.1	AKT_PI3K_MTOR	91.5	Pictilisib	Pictilisib (GDC-0941) is a potent inhibitor of PI3K.a./.d. with an IC50 of 3 nM, with modest selectivity against p110.b. (11-fold) and p110.g. (25-fold).	False	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1
392291	392291:01:02_02.00	True	2.0	101	7.6	22.8	0.0	48.7	0.0	50.5	14.6	75.1	0.6	8.9	0.0	40.8	40.1	LCH	75.1		inhibitor of PI3Kalpha/beta/gamma/delta (IC50 = 1.6/0.0016/0.5/0.031 µM); Synthesis and structure-activity relationships of 1,2,4-triazolo[1,5-a]pyrimidin-7(3H)-ones as novel series of potent ß isoform selective phosphatidylinositol 3-kinase inhibitors. Bioorg Med Chem Lett. 2012 May 1;22(9):3198-202.	False	CSc1nn2c(=O)cc(N3CCOCC3)nc2n1Cc1cccc(Cl)c1Cl
392757	392757:01:09_02.00	True	2.0	78	43.4	39.3	0.0	0.0	69.3	0.0	0.0	18.8	0.0	0.0	39.3	9.0	0.0	DNA_Synth	69.3	PF-3758309	PF-03758309 is a potent, ATP-competitive, pyrrolopyrazole inhibitor of PAK4  with IC50 of 1.3 nM.	False	Cc1nc(Nc2n[nH]c3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1
392746	392746:01:09_02.00	True	2.0	96	9.3	0.0	0.0	66.2	0.0	65.7	25.5	88.1	23.6	39.5	0.0	69.0	50.8	LCH	88.1	KN-93 Phosphate	KN-93 Phosphate is a potent and specific inhibitor of Ca2+/calmodulin-dependent protein kinase II (CaMKII) with Ki of 0.37 ¿M, no remarkable inhibitory effects on APK, PKC, MLCK or Ca2+-PDE activities.	False	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1
392736	392736:01:09_02.00	True	2.0	94	20.7	65.7	0.0	0.0	66.4	0.0	45.9	0.0	0.0	0.0	80.9	0.0	0.0	Pyrimidine_Synth	80.9	TAK-632	TAK-632 is a potent pan-RAF inhibitor with IC50 of 1.4, 2.4 and 8.3 nM for CRAF, BRAFV600E, BRAFWT, respectively.	False	N#Cc1c(Oc2ccc(F)c(NC(=O)Cc3cccc(C(F)(F)F)c3)c2)ccc2nc(NC(=O)C3CC3)sc12
392525	392525:01:09_02.00	True	2.0	72	12.8	0.0	73.5	0.0	11.0	1.9	61.1	0.2	0.0	10.8	12.7	4.5	0.0	Aurora	73.5	WZ-3146	WZ3146 is a mutant selective EGFR inhibitor with IC50s of 2, 2, 5, 14 and 66 nM for EGFRL858R, EGFRL858R/T790M, EGFRE746_A750, EGFRE746_A750/T790M and EGFR, respectively.	False	C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3)ncc2Cl)c1
392656	392656:01:09_02.00	True	2.0	90	48.9	94.1	0.0	0.0	41.1	0.0	27.8	0.0	0.0	0.0	51.9	0.0	32.1	AKT_PI3K_MTOR	94.1	AZD2014	AZD2014 is a novel mTOR inhibitor with IC50 of 2.8 nM; highly selective against multiple PI3K isoforms (¿/ß/¿/¿). Phase 2.	False	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1
392522	392522:01:09_02.00	True	2.0	65	29.9	0.0	92.0	0.0	32.8	0.0	13.9	0.0	0.0	0.0	28.5	0.0	0.0	Aurora	92.0	SNS-314	SNS-314 is a potent and selective aurora kinase inhibitor with IC50s of 9, 31, and 6 nM for aurora A, B and C, respectively.	False	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCNc2ncnc3ccsc23)s1
392481	392481:01:09_02.00	True	2.0	100	20.2	8.4	0.0	63.0	0.0	57.5	14.4	73.2	27.7	51.2	0.0	69.4	67.0	LCH	73.2	Nilotinib	Nilotinib (AMN-107) is a Bcr-Abl inhibitor with IC50 less than 30 nM.	False	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1
392540	392540:01:09_02.00	True	2.0	104	18.8	83.9	0.0	0.0	52.0	0.0	38.5	12.5	0.0	0.0	44.9	0.0	29.2	AKT_PI3K_MTOR	83.9	GSK1059615	GSK1059615 is a dual inhibitor of PI3K.a./.b./.d./.g. (reversible) and mTOR with IC50 of 0.4 nM/0.6 nM/2 nM/5 nM and 12 nM, respectively.	False	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1
392794	392794:01:09_02.00	True	2.0	94	40.8	0.0	0.0	69.9	0.0	71.7	23.6	92.9	27.8	40.3	0.0	65.2	40.2	LCH	92.9	KN-62	KN-62 is a potent and specific inhibitor of Ca2+/calmodulin-dependent protein kinase II (CaMKII) with Ki of 0.9 ¿M.	False	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12
392766	392766:01:09_02.00	True	2.0	52	50.3	0.0	71.7	19.1	0.0	34.7	12.4	14.0	32.1	29.1	0.0	33.3	0.0	Aurora	71.7	NMS-1286937	NMS-P937 (NMS1286937) is an orally available, selective Polo-like Kinase 1 (PLK1) inhibitor with IC50 of 2 nM, 5000-fold selectivity over PLK2/PLK3. Phase 1.	False	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3CCO)CC4)c2)CC1
392643	392643:01:09_02.00	True	2.0	67	16.6	0.0	90.1	0.0	34.7	0.0	23.4	0.0	0.0	0.0	31.8	0.0	0.0	Aurora	90.1	CCT 137690	CCT 137690 is a potent and orally available aurora kinase inhibitor with IC50s of 15, 25, and 19 nM for aurora A, B and C, respectively.	False	Cc1cc(CN2CCN(c3c(Br)cnc4[nH]c(-c5ccc(N6CCN(C)CC6)cc5)nc34)CC2)no1
392523	392523:01:09_02.00	True	2.0	99	19.7	0.0	0.0	25.3	0.0	29.2	48.8	39.0	0.0	24.4	0.0	37.3	10.9	HSP90	48.8	CP-724714	CP-724714 is a potent, selective and orally active ErbB2 (HER2) tyrosine kinase inhibitor, with an IC50 of 10 nM. CP-724714 displays a marked selectivity against EGFR kinase (IC50=6400 nM). CP-724714 potently inhibits ErbB2 receptor autophosphorylation in intact cells. Antitumor activities.	False	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1
391929	391929:01:03_02.00	True	2.0	59	58.4	27.8	0.0	32.6	0.0	34.3	18.8	54.3	28.8	0.0	0.0	33.4	38.4	LCH	54.3		inhibitor of CDK2/4 (IC50 = 0.004/0.006 µM), GSK-3 beta inhibitor (IC50 = 0.016 µM); Synthesis and evaluation of pyrazolo[1,5-b]pyridazines as selective cyclin dependent kinase inhibitors.  Bioorg Med Chem Lett.  (2008),  18(21),  5758-5762.	False	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1
392477	392477:01:09_02.00	True	2.0	94	41.5	96.4	0.0	0.0	68.5	0.0	24.5	0.0	0.0	0.0	75.1	0.0	6.0	AKT_PI3K_MTOR	96.4	Ridaforolimus (Deforolimus, MK-8669)	Ridaforolimus (Deforolimus) is a selective mTOR inhibitor with IC50 of 0.2 nM; while not classified as a prodrug, mTOR inhibition and FKBP12 binding is similar to rapamycin.	False	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C
392585	392585:01:09_02.00	True	2.0	101	9.3	67.8	0.0	0.0	83.6	0.0	26.8	0.0	0.0	0.0	78.0	0.0	0.0	DNA_Synth	83.6	OSI-420	OSI-420 is the active metabolite of Erlotinib (EGFR inhibitor with IC50 of 2 nM).	False	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCO)cc23)c1
392774	392774:01:09_02.00	True	2.0	99	18.1	62.4	3.7	0.0	86.5	0.0	3.3	0.0	0.0	0.0	85.8	0.0	0.0	DNA_Synth	86.5	PD0325901	PD0325901 (PD325901) is selective and non ATP-competitive MEK inhibitor with IC50 of 0.33 nM, roughly 500-fold more potent than CI-1040 on phosphorylation of ERK1 and ERK2. Phase 1/2.	False	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F
392731	392731:01:09_02.00	True	2.0	101	61.5	0.0	0.0	72.3	0.0	72.2	14.9	95.9	32.5	33.7	0.0	66.4	39.3	LCH	95.9	EHop-016	EHop-016 is a potent and selective Rac GTPase Rac1 and Rac3 inhibitor. EHop-016 inhibits Rac1 activity with an IC50 of 1.1 uM in MDA-MB-435 cells. EHop-016 inhibits Vav2 interaction with Rac, Rac-activated PAK1, lamellipodia formation, and cell migration.	False	CCn1c2ccccc2c2cc(Nc3ccnc(NCCCN4CCOCC4)n3)ccc21
392708	392708:01:09_02.00	True	2.0	90	45.3	95.9	0.0	0.0	57.5	0.0	32.4	0.0	0.0	0.0	60.4	0.0	24.7	AKT_PI3K_MTOR	95.9	GDC-0349	GDC-0349 is a potent and selective ATP-competitive inhibitor of mTOR with Ki of 3.8 nM, 790-fold inhibitory effect against PI3K¿ and other 266 kinases. Phase 1.	False	CCNC(=O)Nc1ccc(-c2nc3c(c(N4CCOC[C@@H]4C)n2)CCN(C2COC2)C3)cc1
392600	392600:01:09_02.00	True	2.0	57	82.9	0.0	4.2	81.8	0.0	87.9	8.4	77.4	60.9	57.7	0.0	78.1	36.4	HDAC	87.9	Volasertib (BI 6727)	BI6727 (Volasertib) is a highly potent Plk1 inhibitor with IC50 of 0.87 nM. It shows 6- and 65-fold greater selectivity against Plk2 and Plk3. Phase 2.	False	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C
392761	392761:01:09_02.00	True	2.0	95	39.9	96.3	0.0	0.0	70.4	0.0	24.9	0.0	0.0	0.0	74.2	0.0	6.8	AKT_PI3K_MTOR	96.3	Zotarolimus(ABT-578)	Zotarolimus (ABT-578) is an analogue of rapamycin, and inhibits FKBP-12 binding with IC50 of 2.8 nM.	False	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@H](n3cnnn3)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C
392764	392764:01:09_02.00	True	2.0	94	35.1	96.5	0.0	0.0	64.1	0.0	35.3	0.0	0.0	0.0	65.2	0.0	21.7	AKT_PI3K_MTOR	96.5	Temsirolimus (CCI-779, NSC 683864)	Temsirolimus (CCI-779) is a specific mTOR inhibitor with IC50 of 1.76 ¿M.	False	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C
381944	381944:02:09_02.00	True	2.0	100	20.0	89.5	0.0	0.0	64.5	0.0	25.1	7.6	0.0	0.0	51.3	0.0	35.6	AKT_PI3K_MTOR	89.5	PI-103	PI-103 is a potent PI3K and mTOR inhibitor with IC50s of 8 nM, 88 nM, 48 nM, 150 nM, 20 nM, and 83 nM for p110.a., p110.b., p110.d., p110.g., mTORC1, and mTORC2. PI-103 also inhibits DNA-PK with an IC50 of 2 nM. PI-103 induces autophagy.	False	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1
392447	392447:01:02_02.00	True	2.0	74	69.6	0.0	0.0	83.8	0.0	82.9	33.0	76.3	56.1	64.5	0.0	95.0	51.5	Tubulin	95.0		inhibitor of Vascular endothelial growth factor receptor 2 (IC50 = 0.0054 µM), inhibitor of Tyrosine-protein kinase TIE-2 (IC50 = 0.058 µM); Discovery of Novel Benzimidazoles as Potent Inhibitors of TIE-2 and VEGFR-2 Tyrosine Kinase Receptors.    J Med Chem (2007),  50(18),  4453-4470.	False	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(SC)c4)cc3)ccc2[nH]1
392490	392490:01:09_02.00	True	2.0	99	5.0	24.4	0.0	41.3	12.2	39.2	37.7	70.0	0.0	28.6	0.0	51.7	47.6	LCH	70.0	AC480 (BMS-599626)	AC480 (BMS-599626) is a selective and efficacious inhibitor of HER1 and HER2 with IC50 of 20 nM and 30 nM, ~8-fold less potent to HER4, >100-fold to VEGFR2, c-Kit, Lck, MET etc. Phase 1.	False	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12
392616	392616:01:09_02.00	True	2.0	86	54.1	88.3	0.0	0.0	22.5	0.0	29.3	0.0	0.0	0.0	44.9	0.0	33.2	AKT_PI3K_MTOR	88.3	WYE-132	WYE-132 (WYE-125132) is a highly potent, ATP-competitive, and specific mTOR kinase inhibitor (IC50: 0.19±0.07 nM; >5,000-fold selective versus PI3Ks). WYE-132 (WYE-125132) inhibits mTORC1 and mTORC2.	False	CNC(=O)Nc1ccc(-c2nc(N3CC4CCC(C3)O4)c3cnn(C4CCC5(CC4)OCCO5)c3n2)cc1
392249	392249:01:02_02.00	True	2.0	96	25.0	0.0	0.0	83.1	0.0	75.2	2.6	83.6	40.8	61.0	0.0	80.6	63.5	LCH	83.6		Potent, ATP-competitive Raf kinase inhibitor (IC50 = 10 nM) that displays > 7, > 30 and > 70-fold selectivity over p38¿, GSK3ß and Lck respectively.; Thousands of chemical starting points for antimalarial lead identification. Nature. 2010 May 20;465(7296):305-10.	False	Oc1cc(-c2[nH]c(-c3ccccc3)nc2-c2ccncc2)ccc1Cl
392624	392624:01:09_02.00	True	2.0	100	42.8	0.0	0.0	59.8	0.0	56.9	7.1	93.7	14.1	22.5	0.0	54.9	32.5	LCH	93.7	PHA-665752	PHA-665752 is a potent, selective and ATP-competitive c-Met inhibitor with IC50 of 9 nM,  >50-fold selectivity for c-Met than RTKs or STKs.	False	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1
392582	392582:01:09_02.00	True	2.0	96	42.7	4.1	0.0	63.1	0.0	57.2	16.8	93.3	17.6	36.2	0.0	57.6	43.7	LCH	93.3	SGI-1776	SGI-1776 is an inhibitor of Pim kinases, with IC50s of 7 nM, 363 nM, and 69 nM for Pim-1, -2 and -3, respectively.	False	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1
246673	246673:02:09_02.00	True	2.0	103	32.1	0.0	0.0	57.4	0.0	58.7	33.8	87.0	12.8	29.2	0.0	58.3	36.9	LCH	87.0	Lapatinib (ditosylate)	Lapatinib ditosylate (GW572016 ditosylate) is a potent inhibitor of the ErbB-2 and EGFR tyrosine kinase domains with IC50 values against purified EGFR and ErbB-2 of 10.2 and 9.8 nM, respectively.	False	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1
392733	392733:01:09_02.00	True	2.0	90	15.9	40.5	35.1	0.0	89.2	0.0	17.4	0.0	0.0	0.0	83.7	0.0	0.0	DNA_Synth	89.2	BMS-345541	BMS-345541 is a selective inhibitor of the catalytic subunits of IKK (IKK-2 IC50=0.3 uM, IKK-1 IC50=4 uM). BMS-345541 binds at an allosteric site of IKK.	False	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1
392587	392587:01:09_02.00	True	2.0	63	49.6	0.0	66.6	36.1	0.0	48.4	38.4	37.9	27.4	34.9	0.0	59.7	0.0	Aurora	66.6	AZ960	AZ960 is a potent and specific inhibitor of the JAK2 kinase with a Ki of 0.45 nM.	False	Cc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cc3)c(C#N)cc2F)n[nH]1
392789	392789:01:10_02.00	True	2.0	61	54.1	0.0	0.0	82.6	0.0	85.7	22.6	60.7	76.6	60.0	0.0	81.0	70.7	HDAC	85.7	Bardoxolone Methyl	Bardoxolone Methyl is an IKK inhibitor, showing potent proapoptotic and anti-inflammatory activities. Phase 3.	False	COC(=O)[C@]12CCC(C)(C)C[C@H]1[C@H]1C(=O)C=C3[C@@](C)(CC[C@H]4C(C)(C)C(=O)C(C#N)=C[C@]34C)[C@]1(C)CC2
392608	392608:01:10_02.00	True	2.0	104	12.8	44.3	8.7	0.0	79.9	0.0	27.0	0.0	0.0	0.0	78.9	0.0	0.0	DNA_Synth	79.9	TAK-733	TAK-733 is a potent and selective MEK allosteric site inhibitor for MEK1 with IC50 of 3.2 nM, inactive to Abl1, AKT3, c-RAF, CamK1, CDK2, c-Met, etc. Phase 1.	False	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21
392615	392615:01:09_02.00	True	2.0	98	44.9	26.4	0.0	64.9	0.0	64.7	29.4	85.9	26.9	37.7	0.0	60.9	68.7	LCH	85.9	WAY-600	WAY-600 is a potent, ATP-competitive, and selective mTOR inhibitor with an IC50 of 9 nM for recombinant mTOR enzyme. WAY-600 blocks mTOR complex 1/2 (mTORC1/2) assemble and activation.	False	c1cncc(CN2CCC(n3ncc4c(N5CCOCC5)nc(-c5ccc6[nH]ccc6c5)nc43)CC2)c1
392771	392771:01:10_02.00	True	2.0	100	18.1	18.7	0.0	22.8	24.7	10.4	17.7	57.5	0.0	2.7	0.0	39.8	11.4	LCH	57.5	Bisindolylmaleimide I	Bisindolylmaleimide I (GF109203X) is a highly selective, cell-permeable, and reversible protein kinase C (PKC) inhibitor with a Ki of 14 nM.	False	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21
392313	392313:01:02_02.00	True	2.0	100	17.3	5.5	0.0	49.7	0.0	50.2	19.6	85.6	9.4	30.7	0.0	46.9	34.7	LCH	85.6		inhibitor of Akt1 (IC50 = 0.025 µM); Discovery of 5-pyrrolopyridinyl-2-thiophenecarboxamides as potent AKT kinase inhibitors. Bioorg Med Chem Lett. 2009 Apr 15;19(8):2244-8.	False	NCC(C(=O)Nc1cc(Br)c(-c2ccnc3[nH]ccc23)s1)c1ccccc1
392075	392075:01:02_02.00	True	2.0	82	24.7	0.0	3.5	69.9	0.0	68.8	19.8	61.8	53.5	49.8	0.0	91.9	50.2	Tubulin	91.9		inhibitor of c-Jun N-terminal kinase 2/3 (IC50 = 0.3/0.25 µM), Inhibitor of binding or entry into cells for Lassa Virus (IC50 = 5 µM); N-(3-Cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)amides as potent, selective, inhibitors of JNK2 and JNK3.  Bioorg Med Chem Lett.  (2007),  17(5),  1296-1301.	False	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1
392715	392715:01:09_02.00	True	2.0	87	51.5	37.3	0.0	35.1	37.5	27.4	19.6	68.9	0.9	11.0	0.0	57.5	50.3	LCH	68.9	LY2835219	LY2835219 is a potent and selective inhibitor of CDK4 and CDK6 with IC50 of 2 nM and 10 nM, respectively.	False	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1
392790	392790:01:09_02.00	True	2.0	103	9.2	81.5	0.0	0.0	38.0	0.0	39.3	0.0	0.0	0.0	56.4	0.0	10.2	AKT_PI3K_MTOR	81.5	Rociletinib	Rociletinib (CO-1686) is an orally delivered kinase inhibitor that specifically targets the mutant forms of EGFR including T790M, and the Ki values for EGFRL858R/T790M and EGFRWT are 21.5 nM and 303.3 nM, respectively.	False	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1
391761	391761:01:02_02.00	True	2.0	98	10.4	59.9	0.0	0.0	78.5	0.0	0.0	0.0	0.0	0.0	80.6	0.0	0.0	Pyrimidine_Synth	80.6		inhibitor of Glycogen synthase kinase-3 beta (IC50 = 0.22 µM); not active von GSK3-alpha, inhibitor of Yes1 kinase (IC50 = 1.2 µM); 3-Anilino-4-arylmaleimides: potent and selective inhibitors of glycogen synthase kinase-3 (GSK-3).  Bioorg Med Chem Lett.  (2001),  11(5),  635-639.	False	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O
392015	392015:01:02_02.00	True	2.0	71	45.1	51.2	22.6	0.0	82.6	0.0	16.0	0.0	0.0	0.0	86.7	0.0	0.0	Pyrimidine_Synth	86.7		inhibitor of Cyclin-dependent kinase 1/2 (IC50 = 0.029/0.0028 µM); Oxindole-Based Inhibitors of Cyclin-Dependent Kinase 2 (CDK2): Design, Synthesis, Enzymatic Activities, and X-ray Crystallographic Analysis.    J Med Chem (2001),  44(25),  4339-4358.	False	NS(=O)(=O)c1ccc(/N=C\c2c(O)[nH]c3ccc4ncsc4c23)cc1
392102	392102:01:02_02.00	True	2.0	101	9.8	0.0	0.0	52.2	0.0	51.1	20.2	82.3	19.6	4.0	0.0	56.3	27.2	LCH	82.3		dual EGFR/ErbB-2 inhibitor (IC50 = 0.005/0.25 µM); Thienopyrimidine-based dual EGFR/ErbB-2 inhibitors.  Bioorg Med Chem Lett.  (2009),  19(3),  817-820.  CODEN: BMCLE8  ISSN:0960-894X.  AN 2009:119140    CAPLUS.	False	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1
392234	392234:01:02_02.00	True	2.0	94	12.4	18.2	0.0	7.9	48.3	0.0	15.4	46.2	0.0	0.0	15.2	21.1	0.0	DNA_Synth	48.3		inhibitor of MAP kinase p38 alpha (IC50 = 0.0096 µM); Pyrimidinylimidazole inhibitors of p38: cyclic N-1 imidazole substituents enhance p38 kinase inhibition and oral activity. Bioorg Med Chem Lett. 2001 Nov 5;11(21):2867-70.	False	CCNc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCN(C)CC2)n1
392188	392188:01:02_02.00	True	2.0	101	9.7	58.5	12.6	0.0	92.8	0.0	0.0	0.0	0.0	0.0	80.3	0.0	0.0	DNA_Synth	92.8		inhibitor of MAP kinase p38 alpha (IC50 = 0.042 µM); Pyrimidinylimidazole inhibitors of p38: cyclic N-1 imidazole substituents enhance p38 kinase inhibition and oral activity. Bioorg Med Chem Lett. 2001 Nov 5;11(21):2867-70.	False	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCN(CC(F)(F)F)CC2)n1
392793	392793:01:09_02.00	True	2.0	95	32.6	24.9	0.0	42.6	4.4	49.3	43.4	81.5	5.6	11.5	0.0	46.2	42.5	LCH	81.5	Osimertinib	Osimertinib (AZD-9291) is an irreversible and mutant selective EGFR inhibitor with IC50s of 12 and 1 nM against EGFRL858R and EGFRL858R/T790M, respectively.	False	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C
392638	392638:01:09_02.00	True	2.0	88	51.5	94.9	0.0	0.0	52.6	0.0	30.8	0.0	0.0	0.0	58.0	0.0	26.3	AKT_PI3K_MTOR	94.9	PF-04691502	PF-04691502 is an ATP-competitive PI3K(¿/ß/¿/¿)/mTOR dual inhibitor with Ki of 1.8 nM/2.1 nM/1.6 nM/1.9 nM and 16 nM, little activity against either Vps34, AKT, PDK1, p70S6K, MEK, ERK, p38, or JNK. Phase 2.	False	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1
392050	392050:01:02_02.00	True	2.0	96	5.7	48.7	19.8	0.0	88.0	0.0	0.0	0.0	0.0	0.0	66.7	0.0	0.0	DNA_Synth	88.0		inhibitor of PLK1 kinase (IC50 = 0.011 µM); Discovery of thiophene inhibitors of polo-like kinase.  Bioorg Med Chem Lett.  (2009),  19(3),  1018-1021.	False	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC
392528	392528:01:09_02.00	True	2.0	93	16.8	0.0	0.0	75.7	0.0	67.2	14.7	85.2	30.9	50.6	0.0	75.1	59.0	LCH	85.2	Regorafenib	Regorafenib (BAY 73-4506) is a multi-targeted receptor tyrosine kinase inhibitor with IC50s of 13/4.2/46, 22, 7, 1.5 and 2.5 nM for VEGFR1/2/3, PDGFR.b., Kit, RET and Raf-1, respectively.	False	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1
392015	392015:02:02_02.00	True	2.0	90	7.4	24.0	36.4	0.0	84.7	0.0	0.0	0.0	0.0	0.0	55.0	0.0	0.0	DNA_Synth	84.7		inhibitor of Cyclin-dependent kinase 1/2 (IC50 = 0.029/0.0028 µM); Oxindole-Based Inhibitors of Cyclin-Dependent Kinase 2 (CDK2): Design, Synthesis, Enzymatic Activities, and X-ray Crystallographic Analysis.    J Med Chem (2001),  44(25),  4339-4358.	False	NS(=O)(=O)c1ccc(/N=C\c2c(O)[nH]c3ccc4ncsc4c23)cc1
382128	382128:02:09_02.00	True	2.0	92	24.2	0.0	0.0	61.4	0.0	63.6	12.6	89.7	29.5	23.2	0.0	53.7	25.2	LCH	89.7	PD173074	PD173074 is a potent FGFR1 inhibitor with an IC50 of 25 nM and also inhibits VEGFR2 with an IC50 of 100-200 nM, showing 1000-fold selectivity for FGFR1 over PDGFR and c-Src.	False	CCN(CC)CCCCNc1ncc2cc(-c3cc(OC)cc(OC)c3)c(NC(=O)NC(C)(C)C)nc2n1
392062	392062:01:02_02.00	True	2.0	78	41.3	16.0	0.0	51.2	17.2	39.8	4.9	73.1	24.1	16.1	0.0	64.6	50.2	LCH	73.1		GSK-3 beta inhibitor (Ki = 0.03 µM), inhibitor of CDK2 (Ki = 0.01 µM); Synthesis and evaluation of pyrazolo[1,5-b]pyridazines as selective cyclin dependent kinase inhibitors.  Bioorg Med Chem Lett.  (2008),  18(21),  5758-5762.	False	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1
391925	391925:02:09_02.00	True	2.0	50	76.5	0.0	8.4	74.1	0.0	81.6	34.8	69.4	58.4	62.2	0.0	83.4	50.3	Tubulin	83.4	TCS JNK 5a	inhibitor of c-Jun N-terminal kinase 2/3 (IC50 = 0.3/0.2 µM), Inhibitor of binding or entry into cells for Lassa Virus (IC50 = 0.2 µM); N-(3-Cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)amides as potent, selective, inhibitors of JNK2 and JNK3.  Bioorg Med Chem Lett.  (2007),  17(5),  1296-1301.	False	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2
392651	392651:01:09_02.00	True	2.0	61	74.3	0.0	0.0	90.7	0.0	95.5	22.2	80.0	64.2	69.0	0.0	81.4	72.8	HDAC	95.5	Fimepinostat	Fimepinostat (CUDC-907) potently inhibits class I PI3Ks as well as classes I and II HDAC enzymes with an IC50 of  19/54/39 nM and 1.7/5.0/1.8/2.8 nM for PI3K.a./PI3K.b./PI3K.d. and HDAC1/HDAC2/HDAC3/HDAC10 , respectively.	False	COc1ccc(-c2nc(N3CCOCC3)c3sc(CN(C)c4ncc(C(=O)NO)cn4)cc3n2)cn1
392321	392321:01:02_02.00	True	2.0	82	17.4	0.0	92.1	0.0	18.9	0.0	19.8	0.0	0.0	0.0	15.1	1.4	0.0	Aurora	92.1	ZM-447439	ZM-447439 is an aurora kinase inhibitor with IC50s of 110 and 130 nM for aurora A and B, respectively.; Thousands of chemical starting points for antimalarial lead identification. Nature. 2010 May 20;465(7296):305-10.	False	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1
392443	392443:01:02_02.00	True	2.0	96	14.5	0.0	0.0	80.1	0.0	76.7	0.0	64.9	53.8	64.9	0.0	79.3	48.1	BET	80.1		inhibitor of Glycogen synthase kinase-3 beta (IC50 = 0.016 µM) and GSK3-alpha (IC50 = 0.016 µM); 6-heteroaryl-pyrazolo[3,4-b]pyridines: potent and selective inhibitors of glycogen synthase kinase-3 (GSK-3). Bioorg Med Chem Lett. 2003 Sep 15;13(18):3059-62.	False	O=C(Nc1[nH]nc2nc(-c3nccs3)c(Br)cc12)C1CCCC1
392689	392689:01:09_02.00	True	2.0	112	21.6	0.0	0.0	80.4	0.0	74.6	31.5	64.6	41.6	57.5	0.0	72.4	65.7	BET	80.4	VE-821	VE-821 is a potent ATP-competitive inhibitor of ATR with Ki/IC50 of 13 nM/26 nM.	False	CS(=O)(=O)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1
392491	392491:01:09_02.00	True	2.0	92	13.1	0.0	0.0	49.1	3.4	46.9	30.1	82.9	0.9	17.8	0.0	59.6	31.5	LCH	82.9	Masitinib	Masitinib (AB1010) is a potent, orally bioavailable, and selective inhibitor of c-Kit (IC50=200 nM for human recombinant c-Kit). It also inhibits PDGFR.a./.b. (IC50s=540/800 nM), Lyn (IC50= 510 nM for LynB), Lck, and, to a lesser extent, FGFR3 and FAK. Masitinib (AB1010) has anti-proliferative, pro-apoptotic activity and low toxicity.	False	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1
392648	392648:01:09_02.00	True	2.0	100	12.8	85.2	0.0	0.0	46.4	0.0	44.8	0.0	0.0	0.0	44.1	0.0	29.5	AKT_PI3K_MTOR	85.2	BX795	BX795 is a potent and selective inhibitor of PDK1, with an IC50 of 6 nM. BX795 is also a potent and relatively specific inhibitor of TBK1 and IKK, with an IC50 of 6 and 41 nM, respectively. BX795 blocks phosphorylation of S6K1, Akt, PKC.d., and GSK3.b., and has lower selectivity over PKA, PKC, c-Kit, GSK3.b. etc. BX795 modulates autophagy.	False	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1
392551	392551:01:09_00.20	True	0.2	91	5.0	55.9	1.5	0.0	89.0	0.0	0.0	0.0	0.0	0.0	72.3	0.0	0.0	DNA_Synth	89.0	PHA-793887	PHA-793887 is a pyrrolo[3,4-c]pyrazole that inhibits cyclin-dependent kinases Cdk2/cyclin A, Cdk2/cyclin E, Cdk5/p25, and Cdk7/cyclin H with IC50 values of 8, 8, 5, and 10 nM, respectively. It is more than 6-fold selective for these kinases over Cdk1/cyclin B, Cdk4/cyclin D1, Cdk9/cyclin T, and GSK3ß (IC50s = 60, 62, 138, and 79 nM, respectively). PHA-793887 is cytotoxic to human ovarian A2780, colon HCT116, pancreatic BX-PC3, and leukemic K562, KU812, KCL22, and TOM1 cells both in vitro and in xenograft models. This compound has been examined in patients with solid tumors in phase 1 clinical trials.	False	CC(C)CC(=O)Nc1[nH]nc2c1CN(C(=O)C1CCN(C)CC1)C2(C)C
391840	391840:01:02_00.20	True	0.2	101	8.3	0.0	0.0	54.7	0.0	52.9	29.5	32.4	53.7	43.2	0.0	56.5	29.1	Tubulin	56.5		inhibitor of TGF-beta receptor type I (Alk5) (IC50 = 0.022 µM); Design of novel quinazoline derivatives and related analogues as potent and selective ALK5 inhibitors. Bioorg Med Chem Lett. 2009 Apr 15;19(8):2277-81.	False	Cc1cccc(-c2nc(Nc3ccncc3)c3sccc3n2)n1
392727	392727:01:10_00.20	True	0.2	103	7.4	0.0	0.0	69.5	0.0	60.9	3.2	46.2	53.2	40.6	0.0	70.0	44.4	Tubulin	70.0	AZD2858	AZD2858 is a potent, orally active GSK-3 inhibitor, with IC50s of 0.9 and 5 nM for GSK-3.a. and GSK-3.b., respectively, used in the research of fracture healing.	False	CN1CCN(S(=O)(=O)c2ccc(-c3cnc(N)c(C(=O)Nc4cccnc4)n3)cc2)CC1
391878	391878:01:02_00.20	True	0.2	88	21.2	0.0	0.0	73.3	0.0	72.7	24.7	83.4	34.8	42.6	0.0	71.9	45.2	LCH	83.4		binder of B-Raf kinase (Kd = 0.0005 µM); The identification of potent, selective and CNS penetrant furan-based inhibitors of B-Raf kinase.  Bioorg Med Chem Lett.  (2008),  18(15),  4373-4376.	False	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CC/C4=N\O)c(-c3ccncc3)o2)cc1
391832	391832:01:02_00.20	True	0.2	96	13.0	51.8	22.3	0.0	91.7	0.0	0.0	0.0	0.0	0.0	75.6	0.0	0.0	DNA_Synth	91.7		inhibitor of MAP kinase p38 alpha (IC50 = 0.0085 µM); Pyrimidinylimidazole inhibitors of p38: cyclic N-1 imidazole substituents enhance p38 kinase inhibition and oral activity. Bioorg Med Chem Lett. 2001 Nov 5;11(21):2867-70.	False	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCN(Cc3ccccc3)CC2)n1
392545	392545:01:10_00.20	True	0.2	99	9.2	6.6	21.2	0.0	68.3	0.0	27.3	12.2	0.0	0.0	42.0	11.5	0.0	DNA_Synth	68.3	TCS7010	TCS7010 is a potent and highly selective Aurora A inhibitor with with an IC50 of 3.4 nM.	False	CCN1CCN(C(=O)Cc2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC1
391876	391876:01:02_00.20	True	0.2	86	16.9	0.0	25.3	31.7	0.0	37.1	34.8	38.1	28.6	18.2	0.0	55.3	0.0	Tubulin	55.3		inhibitor of Yes1 kinase (IC50 = 1.5 µM); Inhibitor of binding or entry into cells for Marburg Virus (IC50 = 1.5 µM); Design of potent thiophene inhibitors of polo-like kinase 1 with improved solubility and reduced protein binding.  Bioorg Med Chem Lett.  (2009),  19(6),  1694-1697.	True	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F
392786	392786:01:10_00.20	True	0.2	92	33.7	67.9	0.0	26.7	0.0	20.8	18.2	38.0	9.7	17.7	0.6	20.5	63.4	AKT_PI3K_MTOR	67.9	Torin 2	Torin 2 is an mTOR inhibitor with EC50 of 0.25 nM for inhibiting cellular mTOR activity, and exhibits 800-fold selectivity over PI3K (EC50: 200 nM). Torin 2 also inhibits DNA-PK with an IC50 of 0.5 nM in the cell free assay. Torin 2 can suppress both mTORC1 and mTORC2.	False	Nc1ccc(-c2ccc3ncc4ccc(=O)n(-c5cccc(C(F)(F)F)c5)c4c3c2)cn1
392517	392517:01:09_00.20	True	0.2	73	28.2	0.0	91.1	0.0	7.9	0.0	12.9	0.0	0.7	0.0	13.5	0.0	0.0	Aurora	91.1	AT9283	AT9283 is a multi-targeted kinase inhibitor with potent activity against Aurora A/B, JAK2/3, Abl (T315I) and Flt3 (IC50s ranging from 1 to 30 nM). AT9283 inhibits growth and survival of multiple solid tumors in vitro and in vivo.	False	O=C(Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1)NC1CC1
391923	391923:01:02_00.20	True	0.2	98	12.1	33.6	28.2	0.0	92.4	0.0	0.0	0.0	0.0	0.0	74.1	0.0	0.0	DNA_Synth	92.4		inhibitor of Cyclin-dependent kinase 1/2 (IC50 = 0.019/0.003 µM); Oxindole-Based Inhibitors of Cyclin-Dependent Kinase 2 (CDK2): Design, Synthesis, Enzymatic Activities, and X-ray Crystallographic Analysis.    J Med Chem (2001),  44(25),  4339-4358.	False	CC(C)COC(=O)c1ccc2[nH]c(O)c(/C=N\c3ccc(S(N)(=O)=O)cc3)c2c1
392475	392475:01:09_00.20	True	0.2	100	5.0	47.3	10.9	0.0	34.1	0.0	0.0	0.0	0.0	0.0	46.5	0.0	0.0	AKT_PI3K_MTOR	47.3	Bosutinib	Bosutinib is a dual Src/Abl inhibitor with IC50s of 1.2 nM and 1 nM, respectively.	False	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl
392507	392507:01:09_00.20	True	0.2	53	56.8	0.0	37.4	53.1	0.0	68.3	21.6	48.4	51.7	47.2	0.0	61.7	11.1	HDAC	68.3	BI 2536	BI 2536 is a dual PLK1 and BRD4 inhibitor with IC50s of 0.83 and 25 nM, respectively. BI-2536 suppresses IFNB (encoding IFN-.b.) gene transcription.	False	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1
391898	391898:01:02_00.20	True	0.2	106	5.2	0.0	17.3	23.9	0.0	7.3	6.1	12.6	19.2	0.0	0.0	49.6	0.0	Tubulin	49.6		inhibitor of Glycogen synthase kinase-3 beta (IC50 = 0.001 µM) and GSK3-alpha (IC50 = 0.001 µM); 6-Aryl-pyrazolo[3,4-b]pyridines: potent inhibitors of glycogen synthase kinase-3 (GSK-3).  Bioorg Med Chem Lett.  (2003),  13(18),  3055-3057.	False	CN1CCC(C(=O)Nc2[nH]nc3nc(-c4ccc(O)cc4)c(Br)cc23)CC1
410607	392513:01:09_00.20	True	0.2	98	22.5	91.6	0.0	0.0	74.4	0.0	12.1	0.0	0.0	0.0	71.5	0.0	5.8	AKT_PI3K_MTOR	91.6	Everolimus (RAD001)	Everolimus (RAD001) is an mTOR inhibitor of FKBP12 with IC50 of 1.6-2.4 nM in a cell-free assay.	True	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C
392515	392515:01:09_00.20	True	0.2	97	9.3	11.9	0.0	29.3	19.3	15.4	7.4	36.2	16.1	1.5	0.0	68.0	40.0	Tubulin	68.0	Alisertib	Alisertib (MLN 8237) is an orally active and selective Aurora A kinase inhibitor (IC50=1.2 nM), which binds to Aurora A kinase resulting in mitotic spindle abnormalities, mitotic accumulation. Alisertib (MLN 8237) induces apoptosis and autophagy through targeting the AKT/mTOR/AMPK/p38 pathway in leukemic cells. Antitumor activity.	False	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O
392298	392298:01:02_00.20	True	0.2	96	9.8	67.7	8.0	0.0	76.9	0.0	12.6	0.0	0.0	0.0	67.4	0.0	0.0	DNA_Synth	76.9		inhibitor of MAP kinase p38 alpha (IC50 = 0.0014 µM); Pyrimidinylimidazole inhibitors of p38: cyclic N-1 imidazole substituents enhance p38 kinase inhibition and oral activity. Bioorg Med Chem Lett. 2001 Nov 5;11(21):2867-70.	False	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Nc3ccccc3)n2)cc1
392046	392046:01:02_00.20	True	0.2	107	22.8	0.0	3.9	59.2	0.0	52.7	11.7	50.4	40.3	38.4	0.0	71.6	30.2	Tubulin	71.6		inhibitor of Glycogen synthase kinase-3 (IC50 = 0.00008 µM); also active on CDK2; 5-Aryl-pyrazolo[3,4-b]pyridazines: potent inhibitors of glycogen synthase kinase-3 (GSK-3).  Bioorg Med Chem Lett.  (2003),  13(9),  1581-1584.	False	O=C(Nc1[nH]nc2nnc(-c3cccnc3)cc12)C1CC1
391866	391866:01:02_00.20	True	0.2	85	14.3	38.8	29.6	0.0	92.7	0.0	2.3	0.0	0.0	0.0	74.2	0.0	0.0	DNA_Synth	92.7		inhibitor of Cyclin-dependent kinase 1/2 (IC50 = 0.012/0.0016 µM); Oxindole-Based Inhibitors of Cyclin-Dependent Kinase 2 (CDK2): Design, Synthesis, Enzymatic Activities, and X-ray Crystallographic Analysis.    J Med Chem (2001),  44(25),  4339-4358.	False	NS(=O)(=O)c1ccc(/N=N\c2c(O)[nH]c3ccc4ncccc4c23)cc1
392520	392520:01:10_00.20	True	0.2	83	14.7	0.0	89.7	0.0	16.0	0.0	12.8	0.0	0.0	0.0	16.6	0.0	0.0	Aurora	89.7	Barasertib-HQPA	Barasertib-HQPA (AZD2811) is a highly selective?Aurora B?inhibitor with?an IC50?of 0.37 nM in a cell-free assay, and shows 3700-fold selectivity for Aurora B over Aurora A.	False	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1
392548	392548:01:09_00.20	True	0.2	85	10.0	60.4	9.2	0.0	88.4	0.0	7.1	0.0	0.0	0.0	78.6	0.0	0.0	DNA_Synth	88.4	Pimasertib (AS-703026)	AS-703026 is a highly selective, potent, ATP non-competitive allosteric inhibitor of MEK1/2 with IC50 of 5 nM-2 ¿M in MM cell lines. Phase 1/2.	False	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F
391808	391808:01:02_00.20	True	0.2	94	19.2	0.3	0.3	10.6	0.0	7.0	30.0	26.2	9.9	16.8	0.0	24.6	0.0	HSP90	30.0		inhibitor of TGF-beta receptor type I (Alk5) (IC50 = 0.59 µM); Design of novel quinazoline derivatives and related analogues as potent and selective ALK5 inhibitors. Bioorg Med Chem Lett. 2009 Apr 15;19(8):2277-81.	False	Cc1cccc(-c2nc(Nc3ccc4c(cnn4C)c3)c3ccccc3n2)n1
392087	392087:01:02_00.20	True	0.2	107	6.2	55.4	5.5	0.0	60.8	0.0	41.8	0.0	0.0	0.0	68.4	0.0	0.0	Pyrimidine_Synth	68.4		inhibitor of PDGFR (IC50 = 0.015 µM); Uings I J; Spacey G D; Bonser R W  Effects of the indolocarbazole 3744W on the tyrosine kinase activity of the cytoplasmic domain of the platelet-derived growth factor beta-receptor.    Cellular signalling  (1999),  11(2),  95-100.	False	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O
392730	392730:01:09_00.20	True	0.2	107	7.6	45.8	0.0	0.0	32.7	0.0	32.6	16.9	0.0	7.8	35.7	4.6	0.0	AKT_PI3K_MTOR	45.8	ETP-46464	ETP-46464 is an effective mTOR and ATR inhibitor with IC50s of 0.6 and 14 nM, respectively.	False	CC(C)(C#N)c1ccc(N2C(=O)OCc3cnc4ccc(-c5cnc6ccccc6c5)cc4c32)cc1
391917	391917:01:02_00.20	True	0.2	82	11.7	50.2	0.0	0.0	66.0	0.0	10.3	32.8	0.0	0.0	34.1	19.5	6.7	DNA_Synth	66.0		inhibitor of GSK3-beta (IC50 = 0.01 µM), inhibitor of Cyclin-dependent kinase 2/4 (IC50 = 0.002/0.06 µM); N-Phenyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amines as Potent and Selective Inhibitors of Glycogen Synthase Kinase 3 with Good Cellular Efficacy.    J Med Chem (2004),  47(19),  4716-4730.	False	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1
392563	392563:01:10_00.20	True	0.2	87	31.6	90.2	0.0	0.0	50.7	0.0	16.5	5.8	0.0	0.0	46.8	0.0	39.0	AKT_PI3K_MTOR	90.2	AZD8055	AZD8055 is a novel ATP-competitive mTOR inhibitor with IC50 of 0.8 nM with excellent selectivity (~1000-fold) against PI3K isoforms and ATM/DNA-PK. Phase 1.	False	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO
392013	392013:01:02_00.20	True	0.2	96	10.2	35.2	0.0	13.8	29.6	21.1	13.0	38.1	8.7	10.9	5.8	19.8	37.3	LCH	38.1		inhibitor of Rho-associated protein kinase 1 (IC50 = 0.002 µM), also inhibits firefly luciferase (IC50 = 1 µM); Discovery of Aminofurazan-azabenzimidazoles as Inhibitors of Rho-Kinase with High Kinase Selectivity and Antihypertensive Activity.    J Med Chem (2007),  50(1),  2-5.	False	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21
392527	392527:01:10_00.20	True	0.2	101	6.7	0.0	5.8	45.8	0.0	50.2	33.8	31.4	29.6	37.1	0.0	42.4	12.7	HDAC	50.2	WZ4002	WZ4002 is a mutant selective EGFR inhibitor with IC50s of 2, 8, 3 and 2 nM for EGFRL858R, EGFRL858R/T790M, EGFRE746_A750 and EGFRE746_A750/T790M, respectively.	False	C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)ncc2Cl)c1
391996	391996:01:02_00.20	True	0.2	104	6.7	0.0	0.0	55.7	0.0	48.2	7.9	38.8	46.9	37.2	0.0	65.1	27.4	Tubulin	65.1		inhibitor of Glycogen synthase kinase-3 (IC50 = 0.00095 µM); also active on CDK2; 5-Aryl-pyrazolo[3,4-b]pyridazines: potent inhibitors of glycogen synthase kinase-3 (GSK-3).  Bioorg Med Chem Lett.  (2003),  13(9),  1581-1584.	False	CCN1CCC(C(=O)Nc2[nH]nc3nnc(-c4cccc(F)c4F)cc23)CC1
392358	392358:01:02_00.20	True	0.2	86	6.0	33.5	0.0	8.1	29.1	11.7	23.9	31.5	0.0	9.9	9.2	17.6	31.5	AKT_PI3K_MTOR	33.5		inhibitor of Akt1 (IC50 = 0.008 µM); Discovery of 5-pyrrolopyridinyl-2-thiophenecarboxamides as potent AKT kinase inhibitors. Bioorg Med Chem Lett. 2009 Apr 15;19(8):2244-8.	False	NCCC(NC(=O)c1cc(Br)c(-c2ccnc3[nH]ccc23)s1)c1ccccc1
392203	392203:01:02_00.20	True	0.2	87	16.9	27.3	0.0	49.1	7.5	39.3	19.7	59.2	26.1	22.0	0.0	66.4	73.3	Uncoupler	73.3		Inhibitor of B-Raf V600E mutant (IC50 = 0.0005 µM); Development of potent B-RafV600E inhibitors containing an arylsulfonamide headgroup. Bioorg Med Chem Lett. 2011 Aug 1;21(15):4436-40.	False	CC(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(Nc3ccc(N4CCOCC4)nc3)n2)s1
391941	391941:01:02_00.20	True	0.2	85	10.2	33.9	0.0	0.9	63.4	0.0	5.7	37.9	0.0	0.0	20.7	20.9	0.0	DNA_Synth	63.4		inhibitor of GSK3-beta (IC50 = 0.01 µM), inhibitor of Cyclin-dependent kinase 2/4 (IC50 = 0.006/0.01 µM); N-Phenyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amines as Potent and Selective Inhibitors of Glycogen Synthase Kinase 3 with Good Cellular Efficacy.    J Med Chem (2004),  47(19),  4716-4730.	False	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1
392772	392772:01:09_00.20	True	0.2	55	53.5	0.0	30.1	60.6	0.0	73.9	20.3	49.5	58.5	50.7	0.0	70.6	21.6	HDAC	73.9	Ro3280	Ro3280 is a potent, highly selective inhibitor of PLK1 with an IC50 and a Kd of 3 nM and 0.09 nM, respectively, and nearly has no effect on PLK2 and PLK3.	False	COc1cc(C(=O)NC2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C1CCCC1)CC(F)(F)C(=O)N2C
392778	392778:01:10_00.20	True	0.2	100	13.5	69.5	1.1	0.0	85.8	0.0	9.1	0.0	0.0	0.0	78.4	0.0	0.0	DNA_Synth	85.8	AZD8330	AZD8330 (ARRY-424704) is a potent, uncompetitive MEK1/MEK2 inhibitor, with an IC50 of 7 nM.	False	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O
392511	392511:01:09_00.20	True	0.2	91	15.7	56.1	0.0	0.0	89.7	0.0	8.6	0.0	0.0	0.0	69.4	0.0	0.0	DNA_Synth	89.7	Palbociclib (hydrochloride)	Palbociclib hydrochloride is a highly selective CDK4/6 inhibitor with IC50s of 11 nM and 16 nM, respectively. Palbociclib hydrochloride has the potential for ER-positive and HER2-negative breast cancer research.	False	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O
392551	392551:01:09_02.00	True	2.0	76	29.4	41.1	6.8	0.0	86.9	0.0	0.0	0.0	0.0	0.0	70.9	0.0	0.0	DNA_Synth	86.9	PHA-793887	PHA-793887 is a pyrrolo[3,4-c]pyrazole that inhibits cyclin-dependent kinases Cdk2/cyclin A, Cdk2/cyclin E, Cdk5/p25, and Cdk7/cyclin H with IC50 values of 8, 8, 5, and 10 nM, respectively. It is more than 6-fold selective for these kinases over Cdk1/cyclin B, Cdk4/cyclin D1, Cdk9/cyclin T, and GSK3ß (IC50s = 60, 62, 138, and 79 nM, respectively). PHA-793887 is cytotoxic to human ovarian A2780, colon HCT116, pancreatic BX-PC3, and leukemic K562, KU812, KCL22, and TOM1 cells both in vitro and in xenograft models. This compound has been examined in patients with solid tumors in phase 1 clinical trials.	False	CC(C)CC(=O)Nc1[nH]nc2c1CN(C(=O)C1CCN(C)CC1)C2(C)C
392309	392309:01:02_02.00	True	2.0	55	74.3	0.0	0.0	69.7	0.0	74.9	36.5	80.7	45.0	58.1	0.0	70.2	61.5	LCH	80.7		inhibitor of Akt1 (IC50 = 0.04 µM); Discovery of 5-pyrrolopyridinyl-2-thiophenecarboxamides as potent AKT kinase inhibitors. Bioorg Med Chem Lett. 2009 Apr 15;19(8):2244-8.	False	NC(CNC(=O)c1cc(Br)c(-c2ccnc3[nH]ccc23)s1)c1ccccc1
391840	391840:01:02_02.00	True	2.0	102	10.9	0.0	0.0	68.3	0.0	69.7	0.0	41.6	66.0	49.8	0.0	62.4	35.6	HDAC	69.7		inhibitor of TGF-beta receptor type I (Alk5) (IC50 = 0.022 µM); Design of novel quinazoline derivatives and related analogues as potent and selective ALK5 inhibitors. Bioorg Med Chem Lett. 2009 Apr 15;19(8):2277-81.	False	Cc1cccc(-c2nc(Nc3ccncc3)c3sccc3n2)n1
392088	392088:01:02_02.00	True	2.0	102	5.2	0.0	0.0	64.3	0.0	65.7	0.0	40.7	60.8	40.1	0.0	60.8	26.1	HDAC	65.7		inhibitor of TGF-beta receptor type I (IC50 = 0.26 µM); Identification of Novel Inhibitors of the Transforming Growth Factor .beta.1 (TGF-.beta.1) Type 1 Receptor (ALK5).    J Med Chem (2002),  45(5),  999-1001.	False	OCc1ccc(-c2nc(-c3ccc4c(c3)OCO4)c(-c3ccccn3)[nH]2)cc1
392097	392097:01:02_02.00	True	2.0	100	15.4	0.5	3.6	1.5	0.0	3.1	40.1	30.2	0.0	0.0	14.2	4.7	0.0	HSP90	40.1		inhibitor of Epidermal growth factor receptor erbB1 (IC50 = 0.025 µM), inhibitor of Receptor protein-tyrosine kinase erbB-2 (IC50 = 0.028 µM); Optimization and SAR for dual ErbB-1/ErbB-2 tyrosine kinase inhibition in the 6-furanylquinazoline series.  Bioorg Med Chem Lett.  (2006),  16(17),  4686-4691.	False	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1
392727	392727:01:10_02.00	True	2.0	108	67.2	0.0	0.0	84.1	0.0	79.2	8.9	65.3	62.0	63.0	0.0	84.8	57.2	Tubulin	84.8	AZD2858	AZD2858 is a potent, orally active GSK-3 inhibitor, with IC50s of 0.9 and 5 nM for GSK-3.a. and GSK-3.b., respectively, used in the research of fracture healing.	False	CN1CCN(S(=O)(=O)c2ccc(-c3cnc(N)c(C(=O)Nc4cccnc4)n3)cc2)CC1
392589	392589:01:10_02.00	True	2.0	100	45.9	91.2	0.0	0.0	27.9	0.0	31.2	0.0	0.0	6.2	38.8	0.0	41.8	AKT_PI3K_MTOR	91.2	Torkinib	PP242 is a selective mTOR inhibitor with IC50 of 8 nM; targets both mTOR complexes with >10- and 100-fold selectivity for mTOR than PI3K¿ or PI3K¿/ß/¿, respectively.	False	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21
392328	392328:01:02_02.00	True	2.0	86	5.5	2.6	0.0	35.2	0.0	39.3	0.0	48.1	32.9	0.0	0.0	23.4	18.6	LCH	48.1		inhibitor of MAP kinase p38 alpha (IC50 = 0.61 µM); Pyrimidinylimidazole inhibitors of p38: cyclic N-1 imidazole substituents enhance p38 kinase inhibition and oral activity. Bioorg Med Chem Lett. 2001 Nov 5;11(21):2867-70.	False	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NC3CCNCC3)n2)CC1
392361	392361:01:02_02.00	True	2.0	97	11.6	73.4	0.0	0.0	85.1	0.0	10.6	0.0	0.0	0.0	82.4	0.0	0.0	DNA_Synth	85.1		inhibitor of MAP kinase p38 alpha (IC50 = 0.08 µM); Pyrimidinylimidazole inhibitors of p38: cyclic N-1 imidazole substituents enhance p38 kinase inhibition and oral activity. Bioorg Med Chem Lett. 2001 Nov 5;11(21):2867-70.	False	CCOc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1
392495	392495:01:10_02.00	True	2.0	100	34.4	59.4	0.0	0.0	81.3	0.0	18.5	31.6	0.0	0.0	45.5	0.0	0.0	DNA_Synth	81.3	SU11274	SU11274 is a selective Met inhibitor with IC50 of 10 nM, no effects on PGDFRß, EGFR or Tie2.	False	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)c(C)c1C(=O)N1CCN(C)CC1
392549	392549:01:09_02.00	True	2.0	57	52.7	0.0	35.3	59.8	0.0	72.5	32.9	50.6	56.9	44.8	0.0	79.8	25.7	Tubulin	79.8	HMN-214	HMN-214, an orally bioavailable prodrug of HMN-176, is an inhibitor of polo-like kinase-1 (plk1), with antitumor activity.	False	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1
392169	392169:01:02_02.00	True	2.0	90	27.1	0.0	52.7	14.7	41.5	9.9	8.0	27.9	0.0	3.5	0.0	53.5	0.0	Tubulin	53.5		inhibitor of Glycogen synthase kinase-3 beta (IC50 = 0.008 µM) and GSK3-alpha (IC50 = 0.008 µM) and CDK2 (IC50 = 0.013 µM); 6-aryl-pyrazolo[3,4-b]pyridines: potent inhibitors of glycogen synthase kinase-3 (GSK-3). Bioorg Med Chem Lett. 2003 Sep 15;13(18):3055-7.	False	O=C(Nc1[nH]nc2nc(-c3ccc(O)cc3)ccc12)C1CC1
391878	391878:01:02_02.00	True	2.0	93	78.4	0.0	0.0	81.3	0.0	80.2	18.1	95.9	42.9	53.5	0.0	76.8	49.6	LCH	95.9		binder of B-Raf kinase (Kd = 0.0005 µM); The identification of potent, selective and CNS penetrant furan-based inhibitors of B-Raf kinase.  Bioorg Med Chem Lett.  (2008),  18(15),  4373-4376.	False	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CC/C4=N\O)c(-c3ccncc3)o2)cc1
391832	391832:01:02_02.00	True	2.0	92	17.8	58.9	18.6	0.0	95.3	0.0	3.9	0.0	0.0	0.0	82.7	0.0	0.0	DNA_Synth	95.3		inhibitor of MAP kinase p38 alpha (IC50 = 0.0085 µM); Pyrimidinylimidazole inhibitors of p38: cyclic N-1 imidazole substituents enhance p38 kinase inhibition and oral activity. Bioorg Med Chem Lett. 2001 Nov 5;11(21):2867-70.	False	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCN(Cc3ccccc3)CC2)n1
392621	392621:01:09_02.00	True	2.0	102	11.4	63.9	0.0	0.0	84.0	0.0	43.4	0.0	0.0	0.0	69.8	0.0	0.0	DNA_Synth	84.0			False	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21
392721	392721:01:09_02.00	True	2.0	98	5.9	60.2	0.0	0.0	71.8	0.0	0.0	0.0	0.0	0.0	60.9	0.0	0.0	DNA_Synth	71.8	Neflamapimod	Neflamapimod (VX-745) is a potent, blood-brain barrier penetrant, highly selective inhibitor of p38.a. inhibitor with an IC50 for p38.a. of 10 nM and for p38.b. of 220 nM. Neflamapimod (VX-745) possesses anti-inflammatory activity.	False	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl
392545	392545:01:10_02.00	True	2.0	90	21.9	5.8	0.0	58.0	0.0	57.0	21.6	89.5	16.7	28.2	0.0	58.9	42.3	LCH	89.5	TCS7010	TCS7010 is a potent and highly selective Aurora A inhibitor with with an IC50 of 3.4 nM.	False	CCN1CCN(C(=O)Cc2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC1
286065	286065:02:09_02.00	True	2.0	93	7.1	58.7	13.2	0.0	80.5	0.0	0.0	0.0	0.0	0.0	80.4	0.0	0.0	DNA_Synth	80.5	CI-1040	CI-1040 (PD 184352) is an orally active, highly specific, small-molecule inhibitor of MEK with an IC50 of 17 nM for MEK1.	False	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl
391834	391834:01:02_02.00	True	2.0	97	10.9	54.6	20.8	0.0	88.3	0.0	16.9	0.0	0.0	0.0	79.5	0.0	0.0	DNA_Synth	88.3		inhibitor of MAP kinase p38 alpha (IC50 = 0.033 µM); Pyrimidinylimidazole inhibitors of p38: cyclic N-1 imidazole substituents enhance p38 kinase inhibition and oral activity. Bioorg Med Chem Lett. 2001 Nov 5;11(21):2867-70.	False	CCOC(=O)N1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1
391876	391876:01:02_02.00	True	2.0	58	61.3	0.0	32.0	59.8	0.0	71.7	27.7	79.3	42.2	40.3	0.0	64.0	20.1	LCH	79.3		inhibitor of Yes1 kinase (IC50 = 1.5 µM); Inhibitor of binding or entry into cells for Marburg Virus (IC50 = 1.5 µM); Design of potent thiophene inhibitors of polo-like kinase 1 with improved solubility and reduced protein binding.  Bioorg Med Chem Lett.  (2009),  19(6),  1694-1697.	True	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F
392697	392697:01:09_02.00	True	2.0	88	22.6	88.4	0.0	0.0	67.9	0.0	24.6	0.0	0.0	0.0	52.7	0.0	27.7	AKT_PI3K_MTOR	88.4	Capivasertib, AZD5363	it potently inhibits all isoforms of Akt(Akt1/Akt2/Akt3) with IC50 of 3 nM/8 nM/8 nM, similar to P70S6K/PKA and lower activity towards ROCK1/2. Phase 1/2.	False	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1
392016	392016:01:02_02.00	True	2.0	95	27.1	0.0	1.8	77.7	0.0	75.1	0.0	67.7	61.5	55.1	0.0	81.7	41.0	Tubulin	81.7		inhibitor of Glycogen synthase kinase-3 beta (IC50 = 0.018 µM) and GSK3-alpha (IC50 = 0.018 µM); 6-Heteroaryl-pyrazolo[3,4-b]pyridines: potent and selective inhibitors of glycogen synthase kinase-3 (GSK-3).  Bioorg Med Chem Lett.  (2003),  13(18),  3059-3062.	True	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1
392205	392205:01:02_02.00	True	2.0	99	8.3	44.0	17.7	0.0	59.6	0.0	44.3	0.0	0.0	0.0	77.0	0.0	0.0	Pyrimidine_Synth	77.0	GSK2593074A	GSK2593074A (GSK074) is a necroptosis inhibitor with dual targeting ability to both RIP1 and RIP3.; Discovery of 7-Methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a Potent and Selective First-in-Class Inhibitor of Protein Kinase R (PKR)-like Endoplasmic Reticulum Kinase (PERK) J. Med. Chem. 2012	False	Cn1cc(-c2cnc(N)c3c(-c4ccc5c(c4)CCN5C(=O)Cc4ccccc4)csc23)cn1
391767	391767:01:03_02.00	True	2.0	98	11.9	50.1	0.0	0.2	22.0	3.5	50.1	29.3	0.0	22.4	1.4	19.2	25.2	AKT_PI3K_MTOR	50.1		inhibitor of Vascular endothelial growth factor receptor 2 (IC50 = 0.005 µM), inhibitor of Tyrosine-protein kinase TIE-2 (IC50 = 0.005 µM); Discovery of Novel Benzimidazoles as Potent Inhibitors of TIE-2 and VEGFR-2 Tyrosine Kinase Receptors.    J Med Chem (2007),  50(18),  4453-4470.	False	O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F
392077	392077:01:02_02.00	True	2.0	90	18.3	37.1	0.0	20.2	0.0	14.8	65.0	33.3	0.0	37.7	0.0	40.2	47.9	HSP90	65.0		inhibitor of PLK1/3 kinase (IC50 = 0.03/0.03 µM), inhibitor of Yes1 kinase (IC50 = 0.58 µM); Imidazo[5,1-f][1,2,4]triazin-2-amines as novel inhibitors of polo-like kinase 1.  Bioorg Med Chem Lett.  (2008),  18(23),  6214-6217.	False	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC
392476	392476:01:09_02.00	True	2.0	92	24.7	22.9	0.0	40.4	0.0	36.9	27.4	79.4	0.0	9.4	0.0	41.2	25.9	LCH	79.4	Cediranib	Cediranib (AZD2171) is a highly potent, orally available VEGFR tyrosine kinase inhibitor with IC50s of <1, <3, 5, 5, 36, 2 nM for Flt1, KDR, Flt4, PDGFR.a., PDGFR.b., c-Kit, respectively.	False	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1
392450	392450:01:02_02.00	True	2.0	92	5.4	80.8	0.0	0.0	71.6	0.0	13.4	0.0	0.0	0.0	49.9	0.0	18.6	AKT_PI3K_MTOR	80.8		inhibitor of PI3Kalpha/beta/gamma/delta (IC50 = 0.4/0.0013/0.16/0.01 µM); Synthesis and structure-activity relationships of 1,2,4-triazolo[1,5-a]pyrimidin-7(3H)-ones as novel series of potent ß isoform selective phosphatidylinositol 3-kinase inhibitors. Bioorg Med Chem Lett. 2012 May 1;22(9):3198-202.	False	Cc1c(Cn2c(C)nn3c(=O)cc(N4CCO[C@H](C)C4)nc23)cccc1C(F)(F)F
392136	392136:01:02_02.00	True	2.0	103	6.7	25.9	0.0	15.3	17.8	9.6	42.2	41.1	0.0	16.6	4.0	29.8	18.2	HSP90	42.2		inhibitor of Epidermal growth factor receptor erbB1 (IC50 = 0.016 µM), inhibitor of Receptor protein-tyrosine kinase erbB-2 (IC50 = 0.035 µM); Optimization and SAR for dual ErbB-1/ErbB-2 tyrosine kinase inhibition in the 6-furanylquinazoline series.  Bioorg Med Chem Lett.  (2006),  16(17),  4686-4691.	False	O=S1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1
392106	392106:01:02_02.00	True	2.0	96	7.3	51.9	3.9	0.0	71.2	0.0	41.0	4.7	0.0	0.0	55.7	0.0	0.0	DNA_Synth	71.2		inhibitor of MAP kinase p38 alpha (IC50 = 0.019 µM); Phenoxypyrimidine inhibitors of p38.alpha. kinase synthesis and statistical evaluation of the p38 inhibitory potencies of a series of 1-(piperidin-4-yl)-4-(4-fluorophenyl)-5-(2-phenoxypyrimidin-4-yl) imidazoles.  Bioorg Med Chem Lett.  (2001),  11(9),  1123-1126.	False	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1
391991	391991:01:02_02.00	True	2.0	99	14.3	47.5	0.0	0.0	51.1	0.0	0.0	0.0	0.0	0.0	53.9	0.0	0.0	Pyrimidine_Synth	53.9		inhibitor of MAP kinase p38 alpha (IC50 = 0.025 µM); Phenoxypyrimidine inhibitors of p38.alpha. kinase synthesis and statistical evaluation of the p38 inhibitory potencies of a series of 1-(piperidin-4-yl)-4-(4-fluorophenyl)-5-(2-phenoxypyrimidin-4-yl) imidazoles.  Bioorg Med Chem Lett.  (2001),  11(9),  1123-1126.	False	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1
392786	392786:01:10_02.00	True	2.0	84	57.7	38.4	0.0	61.9	0.0	60.8	24.8	71.6	30.7	42.6	0.0	53.1	67.4	LCH	71.6	Torin 2	Torin 2 is an mTOR inhibitor with EC50 of 0.25 nM for inhibiting cellular mTOR activity, and exhibits 800-fold selectivity over PI3K (EC50: 200 nM). Torin 2 also inhibits DNA-PK with an IC50 of 0.5 nM in the cell free assay. Torin 2 can suppress both mTORC1 and mTORC2.	False	Nc1ccc(-c2ccc3ncc4ccc(=O)n(-c5cccc(C(F)(F)F)c5)c4c3c2)cn1
391999	391999:01:02_02.00	True	2.0	72	45.3	0.0	18.7	71.8	0.0	74.3	7.5	70.2	65.6	54.7	0.0	81.3	41.6	Tubulin	81.3		inhibitor of PLK1/3 (IC50 = 0.0008/0.006 µM); Design of potent thiophene inhibitors of polo-like kinase 1 with improved solubility and reduced protein binding.  Bioorg Med Chem Lett.  (2009),  19(6),  1694-1697.	True	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC
392517	392517:01:09_02.00	True	2.0	70	25.0	0.0	87.2	0.0	0.0	0.0	23.7	0.0	3.9	4.4	0.0	0.0	0.0	Aurora	87.2	AT9283	AT9283 is a multi-targeted kinase inhibitor with potent activity against Aurora A/B, JAK2/3, Abl (T315I) and Flt3 (IC50s ranging from 1 to 30 nM). AT9283 inhibits growth and survival of multiple solid tumors in vitro and in vivo.	False	O=C(Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1)NC1CC1
392622	392622:01:09_02.00	True	2.0	92	7.4	0.0	0.0	61.4	0.0	67.8	24.8	48.1	56.4	56.9	0.0	50.1	62.5	HDAC	67.8	LY2603618	LY2603618 is a selective Chk1 inhibitor with potential anti-tumor activity.	False	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1
391923	391923:01:02_02.00	True	2.0	78	40.1	42.9	37.5	0.0	93.3	0.0	1.1	0.0	0.0	0.0	84.8	0.0	0.0	DNA_Synth	93.3		inhibitor of Cyclin-dependent kinase 1/2 (IC50 = 0.019/0.003 µM); Oxindole-Based Inhibitors of Cyclin-Dependent Kinase 2 (CDK2): Design, Synthesis, Enzymatic Activities, and X-ray Crystallographic Analysis.    J Med Chem (2001),  44(25),  4339-4358.	False	CC(C)COC(=O)c1ccc2[nH]c(O)c(/C=N\c3ccc(S(N)(=O)=O)cc3)c2c1
392116	392116:01:02_02.00	True	2.0	60	62.3	0.0	44.6	46.1	0.0	61.3	32.9	67.4	29.9	31.4	0.0	54.9	5.3	LCH	67.4		inhibitor of Yes1 kinase (IC50 = 5.8 µM); Inhibitor of binding or entry into cells for Lassa Virus (IC50 = 0.2 µM); Design of potent thiophene inhibitors of polo-like kinase 1 with improved solubility and reduced protein binding.  Bioorg Med Chem Lett.  (2009),  19(6),  1694-1697.	True	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl
392105	392105:01:02_02.00	True	2.0	96	9.8	55.2	0.4	0.0	78.6	0.0	0.0	0.0	0.0	0.0	66.4	0.0	0.0	DNA_Synth	78.6		inhibitor of MAP kinase p38 alpha (IC50 = 0.03 µM); Pyrazolo[1,5-a]pyridines as p38 Kinase Inhibitors.    Organic Letters  (2005),  7(21),  4753-4756.	False	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1
392302	392302:01:02_02.00	True	2.0	98	7.9	45.1	0.0	0.0	57.9	0.0	28.4	9.8	0.0	0.0	59.4	0.0	0.0	Pyrimidine_Synth	59.4		inhibitor of MAP kinase p38 alpha (IC50 = 0.01 µM); Phenoxypyrimidine inhibitors of p38.alpha. kinase synthesis and statistical evaluation of the p38 inhibitory potencies of a series of 1-(piperidin-4-yl)-4-(4-fluorophenyl)-5-(2-phenoxypyrimidin-4-yl) imidazoles.  Bioorg Med Chem Lett.  (2001),  11(9),  1123-1126.	False	Cc1ccc(C)c(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1
392544	392544:01:09_02.00	True	2.0	96	29.7	60.5	0.0	1.1	8.2	0.0	45.4	18.0	0.0	16.4	2.3	18.8	36.4	AKT_PI3K_MTOR	60.5	Pelitinib	Pelitinib (EKB-569;WAY-EKB 569) is an irreversible inhibitor of EGFR with an IC50 of 38.5 nM; also slightly inhibits Src, MEK/ERK and ErbB2 with IC50s of 282, 800, and 1255 nM, respectively. 	False	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C
392210	392210:01:02_02.00	True	2.0	104	15.5	19.8	0.0	50.9	0.0	58.4	0.0	71.3	28.1	21.0	0.0	39.7	50.4	LCH	71.3		inhibitor of PI3Kalpha/beta/gamma/delta (IC50 = 2.5/0.0025/2.5/0.13 µM); Synthesis and structure-activity relationships of 1,2,4-triazolo[1,5-a]pyrimidin-7(3H)-ones as novel series of potent ß isoform selective phosphatidylinositol 3-kinase inhibitors. Bioorg Med Chem Lett. 2012 May 1;22(9):3198-202.	False	O=c1cc(N2CCOCC2)nc2n(Cc3cccc(Cl)c3Cl)c(C3CC3)nn12
392009	392009:01:02_02.00	True	2.0	100	47.0	0.0	0.0	75.5	0.0	70.6	0.0	61.8	58.8	55.1	0.0	79.4	46.9	Tubulin	79.4		inhibitor of Glycogen synthase kinase-3 (IC50 = 0.00019 µM); also active on CDK2; 5-Aryl-pyrazolo[3,4-b]pyridazines: potent inhibitors of glycogen synthase kinase-3 (GSK-3).  Bioorg Med Chem Lett.  (2003),  13(9),  1581-1584.	False	CCN1CCC(CC(=O)Nc2[nH]nc3nnc(-c4cccc(F)c4F)cc23)CC1
391896	391896:01:02_02.00	True	2.0	95	9.2	16.9	0.0	16.4	0.0	19.3	48.6	43.6	0.0	17.8	0.0	21.4	1.5	HSP90	48.6		inhibitor of Epidermal growth factor receptor erbB1 (IC50 = 0.085 µM), inhibitor of Receptor protein-tyrosine kinase erbB-2 (IC50 = 0.02 µM); Optimization and SAR for dual ErbB-1/ErbB-2 tyrosine kinase inhibition in the 6-furanylquinazoline series.  Bioorg Med Chem Lett.  (2006),  16(17),  4686-4691.	False	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1
382166	382166:02:10_02.00	True	2.0	98	15.5	66.1	0.0	0.0	55.9	0.0	26.1	2.6	0.0	8.2	38.6	0.0	27.6	AKT_PI3K_MTOR	66.1	Thiazovivin	Thiazovivin is a potent ROCK inhibitor, which can protect human embryonic stem cells. Thiazovivin improves the efficiency of iPSC generation.	False	O=C(NCc1ccccc1)c1csc(Nc2ccncn2)n1
392000	392000:01:02_02.00	True	2.0	100	6.0	6.3	0.0	52.4	0.0	49.6	17.6	75.8	29.3	12.4	0.0	58.3	43.0	LCH	75.8		inhibitor of MAP kinase p38 alpha (IC50 = 0.63 µM); Pyrazolo[1,5-a]pyridines as p38 Kinase Inhibitors.    Organic Letters  (2005),  7(21),  4753-4756.	False	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1
392546	392546:01:09_02.00	True	2.0	84	9.7	0.0	71.0	24.9	0.0	36.9	26.1	15.1	33.2	31.6	0.0	47.9	0.0	Aurora	71.0	PHA-680632	PHA-680632 is an aurora kinase inhibitor with IC50s of 27, 135 and 120 nM for aurora A, B and C, respectively.	False	CCc1cccc(CC)c1NC(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1
392617	392617:01:09_02.00	True	2.0	73	17.8	0.0	93.3	0.0	17.6	0.0	25.2	0.0	0.0	0.0	11.4	0.0	0.0	Aurora	93.3	BMS-754807	BMS-754807 is a potent and reversible inhibitor of IGF-1R/InsR with IC50 of 1.8 nM/1.7 nM, less potent to Met, Aurora A/B, TrkA/B and Ron, and shows little activity to Flt3, Lck, MK2, PKA, PKC etc. Phase 1/2.	False	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)[nH]n2)c2cccn2n1
392475	392475:01:09_02.00	True	2.0	90	36.4	17.5	4.5	23.7	0.0	32.1	45.2	36.4	7.5	26.0	0.0	38.9	29.4	HSP90	45.2	Bosutinib	Bosutinib is a dual Src/Abl inhibitor with IC50s of 1.2 nM and 1 nM, respectively.	False	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl
392781	392781:01:09_02.00	True	2.0	101	19.9	31.4	0.0	31.6	0.0	38.7	22.8	26.0	25.6	24.2	0.0	9.9	39.3	Uncoupler	39.3	Fostamatinib	Fostamatinib (R788) is the oral prodrug of the active compound R406. R406 is an orally available and competitive Syk/FLT3 inhibitor with a Ki of 30 nM and an IC50 of 41 nM. R406 also inhibits Lyn (IC50=63 nM) and Lck (IC50=37 nM).	False	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC
392478	392478:01:09_02.00	True	2.0	77	21.6	61.9	0.0	0.0	24.6	0.0	65.1	14.9	0.0	17.9	16.4	2.7	26.1	HSP90	65.1	Dovitinib	Dovitinib (TKI258, CHIR258) is a multitargeted RTK inhibitor, mostly for class III (FLT3/c-Kit) with IC50 of 1 nM/2 nM, also potent to class IV (FGFR1/3) and class V (VEGFR1-4) RTKs with IC50 of 8-13 nM, less potent to InsR, EGFR, c-Met, EphA2, Tie2, IGF-1R and HER2. Phase 4.	False	CN1CCN(c2ccc3[nH]c(-c4c(O)nc5cccc(F)c5c4N)nc3c2)CC1
392507	392507:01:09_02.00	True	2.0	59	83.4	0.0	4.9	79.7	0.0	86.6	12.9	76.7	58.7	60.3	0.0	77.0	35.8	HDAC	86.6	BI 2536	BI 2536 is a dual PLK1 and BRD4 inhibitor with IC50s of 0.83 and 25 nM, respectively. BI-2536 suppresses IFNB (encoding IFN-.b.) gene transcription.	False	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1
391933	391933:01:02_02.00	True	2.0	102	12.8	65.9	0.0	0.0	73.9	0.0	15.0	13.1	0.0	0.0	53.5	0.0	0.0	DNA_Synth	73.9		inhibitor of MAP kinase p38 alpha (IC50 = 0.0074 µM); Phenoxypyrimidine inhibitors of p38.alpha. kinase synthesis and statistical evaluation of the p38 inhibitory potencies of a series of 1-(piperidin-4-yl)-4-(4-fluorophenyl)-5-(2-phenoxypyrimidin-4-yl) imidazoles.  Bioorg Med Chem Lett.  (2001),  11(9),  1123-1126.	False	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1
392070	392070:01:02_02.00	True	2.0	98	7.3	0.0	0.0	68.4	0.0	67.5	37.6	62.7	32.8	58.5	0.0	67.7	57.7	BET	68.4		inhibitor of Yes1 kinase (IC50 = 0.052 µM); Discovery of 5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide (Pazopanib), a Novel and Potent Vascular Endothelial Growth Factor Receptor Inhibitor.    J Med Chem (2008),  51(15),  4632-4640.	False	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)[nH]nc4c3)n2)c1
392038	392038:01:02_02.00	True	2.0	89	16.2	46.2	0.0	0.0	35.0	0.0	14.6	0.0	0.6	0.0	32.9	0.0	17.4	AKT_PI3K_MTOR	46.2		inhibitor of Ribosomal protein S6 kinase alpha 5 (IC50 = 0.003 µM), inhibitor of Rho-associated protein kinase 1 (IC50 = 0.005 µM), also inhibits Akt 1/2/3 (IC50 = 0.33/2.3/1.3 µM); Novel Rho kinase inhibitors with anti-inflammatory and vasodilatory activities.    Journal of Pharmacology and Experimental Therapeutics  (2007),  320(1),  89-98.	True	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21
391898	391898:01:02_02.00	True	2.0	86	46.8	8.0	0.0	22.3	30.2	7.9	14.0	27.4	22.0	0.0	0.0	59.4	25.9	Tubulin	59.4		inhibitor of Glycogen synthase kinase-3 beta (IC50 = 0.001 µM) and GSK3-alpha (IC50 = 0.001 µM); 6-Aryl-pyrazolo[3,4-b]pyridines: potent inhibitors of glycogen synthase kinase-3 (GSK-3).  Bioorg Med Chem Lett.  (2003),  13(18),  3055-3057.	False	CN1CCC(C(=O)Nc2[nH]nc3nc(-c4ccc(O)cc4)c(Br)cc23)CC1
410607	392513:01:09_02.00	True	2.0	96	40.2	97.5	0.0	0.0	66.0	0.0	25.9	0.0	0.0	0.0	65.3	0.0	17.7	AKT_PI3K_MTOR	97.5	Everolimus (RAD001)	Everolimus (RAD001) is an mTOR inhibitor of FKBP12 with IC50 of 1.6-2.4 nM in a cell-free assay.	True	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C
392538	392538:01:10_02.00	True	2.0	90	40.9	98.3	0.0	0.0	69.5	0.0	25.6	0.0	0.0	0.0	66.6	0.0	21.9	AKT_PI3K_MTOR	98.3	WYE-354	WYE-354 is an ATP-competitive mTOR inhibitor with an IC50 of 5 nM. WYE-354 also inhibits PI3K.a. and PI3K.g. with IC50s of 1.89 uM  and 7.37 uM, respectively. WYE-354 inhibits both mTORC1 and mTORC2. WYE-354  induces autophagy activation in vitro.	False	COC(=O)Nc1ccc(-c2nc(N3CCOCC3)c3cnn(C4CCN(C(=O)OC)CC4)c3n2)cc1
391894	391894:01:02_02.00	True	2.0	57	55.4	0.0	61.9	40.7	0.0	56.1	19.0	33.4	44.3	37.4	0.0	59.6	0.1	Aurora	61.9		inhibitor of PLK1/3 (IC50 = 0.001/0.06 µM); Design of potent thiophene inhibitors of polo-like kinase 1 with improved solubility and reduced protein binding.  Bioorg Med Chem Lett.  (2009),  19(6),  1694-1697.	True	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl
392337	392337:01:02_02.00	True	2.0	94	6.7	53.3	18.2	0.0	85.7	0.0	14.8	0.0	0.0	0.0	87.7	0.0	0.0	Pyrimidine_Synth	87.7		inhibitor of PERK cytoplasmic domain mediated EIF2alpha phosphorylation (IC50 = 0.0012 µM); Discovery of 7-Methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a Potent and Selective First-in-Class Inhibitor of Protein Kinase R (PKR)-like Endoplasmic Reticulum Kinase (PERK) J. Med. Chem. 2012	False	Nc1ncc(-c2ccncc2)c2scc(-c3ccc4c(c3)CCN4C(=O)Cc3ccccc3)c12
391769	391769:01:02_02.00	True	2.0	100	11.1	26.4	0.0	20.8	16.8	18.8	20.8	57.3	0.0	0.0	5.7	24.6	9.0	LCH	57.3		inhibitor of MAP kinase p38 alpha (IC50 = 0.041 µM); Phenoxypyrimidine inhibitors of p38.alpha. kinase synthesis and statistical evaluation of the p38 inhibitory potencies of a series of 1-(piperidin-4-yl)-4-(4-fluorophenyl)-5-(2-phenoxypyrimidin-4-yl) imidazoles.  Bioorg Med Chem Lett.  (2001),  11(9),  1123-1126.	False	Cc1cc(C)cc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1
392428	392428:01:02_02.00	True	2.0	105	9.0	1.7	0.0	25.7	14.6	19.5	34.7	53.3	0.0	8.9	0.0	43.8	7.3	LCH	53.3		inhibitor of MAP kinase p38 alpha (IC50 = 0.06 µM); Phenoxypyrimidine inhibitors of p38.alpha. kinase synthesis and statistical evaluation of the p38 inhibitory potencies of a series of 1-(piperidin-4-yl)-4-(4-fluorophenyl)-5-(2-phenoxypyrimidin-4-yl) imidazoles.  Bioorg Med Chem Lett.  (2001),  11(9),  1123-1126.	False	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(-c4ccccc4)cc3)n2)cc1
392515	392515:01:09_02.00	True	2.0	66	36.6	0.0	90.7	0.0	1.4	8.7	6.2	0.0	14.2	2.5	0.0	15.4	0.0	Aurora	90.7	Alisertib	Alisertib (MLN 8237) is an orally active and selective Aurora A kinase inhibitor (IC50=1.2 nM), which binds to Aurora A kinase resulting in mitotic spindle abnormalities, mitotic accumulation. Alisertib (MLN 8237) induces apoptosis and autophagy through targeting the AKT/mTOR/AMPK/p38 pathway in leukemic cells. Antitumor activity.	False	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O
392298	392298:01:02_02.00	True	2.0	88	28.3	54.7	0.0	0.0	46.8	0.0	52.0	0.0	0.0	0.0	57.1	0.0	0.0	Pyrimidine_Synth	57.1		inhibitor of MAP kinase p38 alpha (IC50 = 0.0014 µM); Pyrimidinylimidazole inhibitors of p38: cyclic N-1 imidazole substituents enhance p38 kinase inhibition and oral activity. Bioorg Med Chem Lett. 2001 Nov 5;11(21):2867-70.	False	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Nc3ccccc3)n2)cc1
392046	392046:01:02_02.00	True	2.0	83	77.5	0.0	2.0	74.3	0.0	71.7	12.8	67.0	51.2	68.1	0.0	81.4	48.3	Tubulin	81.4		inhibitor of Glycogen synthase kinase-3 (IC50 = 0.00008 µM); also active on CDK2; 5-Aryl-pyrazolo[3,4-b]pyridazines: potent inhibitors of glycogen synthase kinase-3 (GSK-3).  Bioorg Med Chem Lett.  (2003),  13(9),  1581-1584.	False	O=C(Nc1[nH]nc2nnc(-c3cccnc3)cc12)C1CC1
392095	392095:01:02_02.00	True	2.0	106	5.7	0.0	0.0	80.0	0.0	73.1	0.1	69.8	39.0	51.2	0.0	73.9	51.3	BET	80.0		inhibitor of Vascular endothelial growth factor receptor 2 (IC50 = 0.091 µM), inhibitor of Yes kinase (IC50 = 0.3 µM); Discovery and Evaluation of 2-Anilino-5-aryloxazoles as a Novel Class of VEGFR2 Kinase Inhibitors.    J Med Chem (2005),  48(5),  1610-1619.	False	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1
392799	392799:01:10_02.00	True	2.0	104	5.5	75.2	0.0	0.0	72.3	0.0	12.4	0.0	0.0	0.0	78.4	0.0	0.0	Pyrimidine_Synth	78.4	Ruxolitinib (INCB018424)	Ruxolitinib is a potent and selective JAK1/2 inhibitor with IC50s of 3.3 nM and 2.8 nM in cell-free assays, and has 130-fold selectivity for JAK1/2 over JAK3.	False	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1
392133	392133:01:02_02.00	True	2.0	92	8.3	64.4	0.0	0.0	76.2	0.0	1.9	0.0	0.0	0.0	54.8	0.0	0.0	DNA_Synth	76.2		inhibitor of MAP kinase p38 alpha (IC50 = 0.3 µM); Phenoxypyrimidine inhibitors of p38.alpha. kinase synthesis and statistical evaluation of the p38 inhibitory potencies of a series of 1-(piperidin-4-yl)-4-(4-fluorophenyl)-5-(2-phenoxypyrimidin-4-yl) imidazoles.  Bioorg Med Chem Lett.  (2001),  11(9),  1123-1126.	False	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1
392012	392012:01:02_02.00	True	2.0	94	6.7	0.0	15.2	48.5	0.0	54.5	15.3	20.3	49.9	43.3	0.0	49.1	28.2	HDAC	54.5		inhibitor of TGF-beta receptor type I  (IC50 = 0.013 µM), inhibitor of Yes1 kinase (IC50 = 1.16 µM); Identification of 1,5-Naphthyridine Derivatives as a Novel Series of Potent and Selective TGF-.beta. Type I Receptor Inhibitors.    J Med Chem (2004),  47(18),  4494-4506.	False	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1
392653	392653:01:10_02.00	True	2.0	98	9.3	25.7	0.0	38.8	0.0	48.6	53.3	51.2	10.0	38.7	0.0	33.4	46.2	HSP90	53.3	Allitinib tosylate	Allitinib tosylate (AST-1306 (TsOH)) is an orally active and irreversible EGFR and ErbB2 inhibitor with IC50s of 0.5 and 3 nM, respectively. Allitinib tosylate also inhibits ErbB4 with an IC50 of 0.8 nM. Allitinib tosylate is an anilino-quinazoline compound and has anti-cancer activity	False	C=CC(=O)Nc1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1
391866	391866:01:02_02.00	True	2.0	60	42.7	49.0	9.1	0.0	69.4	0.0	14.1	0.0	0.0	0.0	55.5	0.0	0.0	DNA_Synth	69.4		inhibitor of Cyclin-dependent kinase 1/2 (IC50 = 0.012/0.0016 µM); Oxindole-Based Inhibitors of Cyclin-Dependent Kinase 2 (CDK2): Design, Synthesis, Enzymatic Activities, and X-ray Crystallographic Analysis.    J Med Chem (2001),  44(25),  4339-4358.	False	NS(=O)(=O)c1ccc(/N=N\c2c(O)[nH]c3ccc4ncccc4c23)cc1
392520	392520:01:10_02.00	True	2.0	71	32.8	0.0	95.0	0.0	24.5	0.0	5.5	0.0	0.0	0.0	17.7	0.0	0.0	Aurora	95.0	Barasertib-HQPA	Barasertib-HQPA (AZD2811) is a highly selective?Aurora B?inhibitor with?an IC50?of 0.37 nM in a cell-free assay, and shows 3700-fold selectivity for Aurora B over Aurora A.	False	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1
391925	391925:01:02_02.00	True	2.0	55	61.5	0.0	36.5	65.8	0.0	76.4	21.1	54.7	62.2	46.4	0.0	82.8	25.0	Tubulin	82.8	TCS JNK 5a	inhibitor of c-Jun N-terminal kinase 2/3 (IC50 = 0.3/0.2 µM), Inhibitor of binding or entry into cells for Lassa Virus (IC50 = 0.2 µM); N-(3-Cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)amides as potent, selective, inhibitors of JNK2 and JNK3.  Bioorg Med Chem Lett.  (2007),  17(5),  1296-1301.	False	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2
391880	391880:01:02_02.00	True	2.0	71	25.2	0.0	44.1	46.2	0.0	55.0	11.2	47.4	55.1	26.6	0.0	67.6	15.0	Tubulin	67.6		inhibitor of PLK1/3 (IC50 = 0.002/0.009 µM), Inhibitor of binding or entry into cells for Marburg Virus (IC50 = 0.6 µM); Design of potent thiophene inhibitors of polo-like kinase 1 with improved solubility and reduced protein binding.  Bioorg Med Chem Lett.  (2009),  19(6),  1694-1697.	False	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC
392076	392076:01:02_02.00	True	2.0	101	10.7	15.5	0.0	29.2	0.0	29.0	28.4	61.5	0.0	4.2	0.0	30.2	12.3	LCH	61.5		inhibitor of Vascular endothelial growth factor receptor 2 (IC50 = 0.042 µM), inhibitor of Tyrosine-protein kinase TIE-2 (IC50 = 0.013 µM); Discovery of Novel Benzimidazoles as Potent Inhibitors of TIE-2 and VEGFR-2 Tyrosine Kinase Receptors.    J Med Chem (2007),  50(18),  4453-4470.	False	O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F
392175	392175:01:02_02.00	True	2.0	92	41.3	80.3	7.1	0.0	74.8	0.0	30.6	0.0	0.0	0.0	67.3	0.0	0.0	AKT_PI3K_MTOR	80.3		inhibitor of Serine/threonine-protein kinase AKT1 (IC50 = 0.01 µM); 2,3,5-Trisubstituted pyridines as selective AKT inhibitors-Part I: Substitution at 2-position of the core pyridine for ROCK1 selectivity. Bioorg Med Chem Lett. 2010 Jan 15;20(2):673-8.	True	Cc1n[nH]c2ccc(-c3cc(OC[C@@H](N)Cc4ccccc4)cnc3-c3ccoc3)cc12
391935	391935:01:02_02.00	True	2.0	95	20.9	0.0	0.0	85.7	0.0	85.9	18.0	70.9	57.8	64.7	0.0	79.2	57.8	HDAC	85.9		inhibitor of GSK3-beta (IC50 = 0.1 µM); Novel pyrazolopyrimidine derivatives as GSK-3 inhibitors.  Bioorg Med Chem Lett.  (2004),  14(9),  2121-2125.	False	COc1cc(/C=N/Nc2ncnc3c2cnn3-c2ccccc2)ccc1O
382147	382147:03:09_02.00	True	2.0	97	16.8	59.5	0.0	0.0	52.3	0.0	23.1	3.7	0.0	0.0	44.0	0.0	15.5	AKT_PI3K_MTOR	59.5	GSK429286A	GSK429286A is a selective inhibitor of ROCK1 and ROCK2 with IC50 of 14 nM and 63 nM, respectively.; Development of dihydropyridone indazole amides as selective Rho-kinase inhibitors. J Med Chem. 2007 Jan 11;50(1):6-9.	False	CC1=C(C(=O)Nc2cc3cn[nH]c3cc2F)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1
392548	392548:01:09_02.00	True	2.0	103	18.0	53.9	8.7	0.0	80.0	0.0	1.9	0.0	0.0	0.0	88.9	0.0	0.0	Pyrimidine_Synth	88.9	Pimasertib (AS-703026)	AS-703026 is a highly selective, potent, ATP non-competitive allosteric inhibitor of MEK1/2 with IC50 of 5 nM-2 ¿M in MM cell lines. Phase 1/2.	False	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F
391908	391908:01:02_02.00	True	2.0	70	42.5	41.2	0.0	12.4	31.7	6.4	18.2	34.0	2.9	0.0	5.6	27.7	34.7	AKT_PI3K_MTOR	41.2		inhibitor of GSK3-beta (IC50 = 0.01 µM), inhibitor of Cyclin-dependent kinase 2/4 (IC50 = 0.01/0.01 µM); N-Phenyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amines as Potent and Selective Inhibitors of Glycogen Synthase Kinase 3 with Good Cellular Efficacy.    J Med Chem (2004),  47(19),  4716-4730.	False	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1
391868	391868:01:02_02.00	True	2.0	73	55.3	0.0	0.0	79.6	0.0	77.2	29.4	82.5	52.6	59.6	0.0	91.3	51.5	Tubulin	91.3		inhibitor of Vascular endothelial growth factor receptor 2 (IC50 = 0.0063 µM), inhibitor of Tyrosine-protein kinase TIE-2 (IC50 = 0.04 µM); Discovery of Novel Benzimidazoles as Potent Inhibitors of TIE-2 and VEGFR-2 Tyrosine Kinase Receptors.    J Med Chem (2007),  50(18),  4453-4470.	False	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)ccc2[nH]1
392390	392390:01:02_02.00	True	2.0	68	10.9	0.0	45.3	2.2	47.8	1.7	27.6	12.5	6.3	15.8	0.5	47.6	5.3	DNA_Synth	47.8		inhibitor of PLK1 kinase (IC50 = 0.002 µM); Discovery of thiophene inhibitors of polo-like kinase. Bioorg Med Chem Lett. 2009 Feb 1;19(3):1018-21.	False	COc1cc2ncn(-c3cc(OCc4sccc4Cl)c(C(N)=O)s3)c2cc1OC
391977	391977:01:02_02.00	True	2.0	94	7.8	48.1	0.0	0.0	65.5	0.0	0.0	0.0	0.0	0.0	30.5	0.0	2.6	DNA_Synth	65.5		inhibitor of MAPK p38 alpha (IC50 = 0.004 µM), inhibits  p38alpha phosphorylation in IL-1-alpha-stimulated HLF cells (IC50 = 0.006 µM); Biphenyl amide p38 kinase inhibitors 4: DFG-in and DFG-out binding modes.  Bioorg Med Chem Lett.  (2008),  18(15),  4433-4437.	False	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1
392238	392238:01:02_02.00	True	2.0	101	23.8	0.0	20.1	49.0	0.0	43.8	0.0	45.7	44.0	26.6	0.0	68.9	14.1	Tubulin	68.9		inhibitor of Glycogen synthase kinase-3 beta (IC50 = 0.004 µM) and GSK3-alpha (IC50 = 0.004 µM) and CDK2 (IC50 = 0.060 µM); 6-aryl-pyrazolo[3,4-b]pyridines: potent inhibitors of glycogen synthase kinase-3 (GSK-3). Bioorg Med Chem Lett. 2003 Sep 15;13(18):3055-7.	False	CCN1CCN(CCCC(=O)Nc2[nH]nc3nc(-c4ccc(O)cc4)c(Br)cc23)CC1
392514	392514:01:10_02.00	True	2.0	97	17.4	78.2	0.0	0.0	91.4	0.0	7.0	0.0	0.0	0.0	77.4	0.0	0.0	DNA_Synth	91.4	Erlotinib (Hydrochloride)	Erlotinib Hydrochloride (CP-358774 Hydrochloride) inhibits purified EGFR kinase with an IC50 of 2 nM.	False	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1
392041	392041:01:02_02.00	True	2.0	98	19.0	0.0	0.0	84.0	0.0	79.3	0.0	81.8	56.4	61.3	0.0	73.6	66.2	BET	84.0		inhibitor of cRaf1 kinase (IC50 = 0.011 µM),  inhibitor of Yes1 kinase (IC50 = 0.41 µM); The discovery of potent cRaf1 kinase inhibitors.  Bioorg Med Chem Lett.  (2000),  10(3),  223-226.	False	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C/c1cc(Br)c(O)c(Br)c1
391808	391808:01:02_02.00	True	2.0	92	30.4	3.3	0.5	8.8	12.1	4.1	27.9	29.0	6.1	12.9	0.0	24.1	0.0	LCH	29.0		inhibitor of TGF-beta receptor type I (Alk5) (IC50 = 0.59 µM); Design of novel quinazoline derivatives and related analogues as potent and selective ALK5 inhibitors. Bioorg Med Chem Lett. 2009 Apr 15;19(8):2277-81.	False	Cc1cccc(-c2nc(Nc3ccc4c(cnn4C)c3)c3ccccc3n2)n1
392273	392273:01:02_02.00	True	2.0	96	12.4	0.0	0.0	62.2	0.0	62.3	2.1	39.3	62.6	42.1	0.0	61.4	33.5	Na_K-ATPase	62.6		inhibitor of TGF-beta receptor type I (Alk5) (IC50 = 0.022 µM); Design of novel quinazoline derivatives and related analogues as potent and selective ALK5 inhibitors. Bioorg Med Chem Lett. 2009 Apr 15;19(8):2277-81.	False	Cc1cccc(-c2cc(Nc3ccncc3)c3ccccc3n2)n1
392722	392722:01:09_02.00	True	2.0	94	23.3	23.5	0.0	0.0	71.1	0.0	2.0	16.9	0.0	0.0	23.2	38.9	22.9	DNA_Synth	71.1	Triciribine	Triciribine is a DNA synthesis inhibitor, also inhibits Akt and HIV-1 with IC50 of 130 nM and 20 nM, respectively; does not inhibit PI3K/PDK1; 5000-fold less active in cells lacking adenosine kinase. Phase 1/2.	False	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23
391779	391779:01:02_02.00	True	2.0	91	7.1	43.0	1.0	0.0	60.7	0.0	0.0	0.0	0.0	0.0	64.8	0.0	0.0	Pyrimidine_Synth	64.8		inhibitor of Ribosomal protein S6 kinase alpha 5 (S6K-alpha-5 = MSK1) with an IC50 ~0.009 µM; (1H-imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: further optimisation as highly potent and selective MSK-1-inhibitors. Bioorg Med Chem Lett. 2005 Jul 15;15(14):3407-11.	False	CCn1c(-c2nonc2N)nc2cncc(Br)c21
392506	392506:01:09_02.00	True	2.0	72	17.3	0.0	89.4	0.0	16.4	0.0	17.8	0.0	0.0	0.0	14.0	0.0	0.0	Aurora	89.4	Danusertib	Danusertib is a pyrrolo-pyrazole and aurora kinase inhibitor with IC50 of 13, 79, and 61 nM for Aurora A, B, and C, respectively.	False	CO[C@@H](C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1
391870	391870:01:02_02.00	True	2.0	94	13.8	57.8	18.9	0.0	85.9	0.0	0.0	0.0	0.0	0.0	83.7	0.0	0.0	DNA_Synth	85.9		inhibitor of Cyclin-dependent kinase 1/2 (IC50 = 0.33/0.046 µM); Oxindole-Based Inhibitors of Cyclin-Dependent Kinase 2 (CDK2): Design, Synthesis, Enzymatic Activities, and X-ray Crystallographic Analysis.    J Med Chem (2001),  44(25),  4339-4358.	False	Cc1ccc2[nH]c(O)c(/N=N/c3ccc(S(N)(=O)=O)cc3)c2c1
392112	392112:01:02_02.00	True	2.0	104	24.9	0.0	0.0	89.1	0.0	85.1	0.0	80.8	49.0	64.0	0.0	77.6	56.6	BET	89.1		inhibitor of PIP4K2A (IC50 = 0.8 µM), inhibitor of Yes1 kinase (IC50 = 0.73 µM); The discovery of potent cRaf1 kinase inhibitors.  Bioorg Med Chem Lett.  (2000),  10(3),  223-226.	False	COC(=O)c1ccc2c(c1)/C(=C/c1cc(Br)c(O)c(Br)c1)C(=O)N2
392631	392631:01:10_02.00	True	2.0	99	20.2	83.2	0.0	0.0	68.4	0.0	21.0	0.0	0.0	0.0	70.6	0.0	0.0	AKT_PI3K_MTOR	83.2	MK-8776 (SCH 900776)	SCH 900776 is a selective Chk1 inhibitor with IC50 of 3 nM. It shows 500-fold selectivity against Chk2. Phase 2.	False	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1
392087	392087:01:02_02.00	True	2.0	106	37.1	80.1	0.0	0.0	28.1	0.0	43.3	10.5	0.0	0.0	37.8	0.0	17.2	AKT_PI3K_MTOR	80.1		inhibitor of PDGFR (IC50 = 0.015 µM); Uings I J; Spacey G D; Bonser R W  Effects of the indolocarbazole 3744W on the tyrosine kinase activity of the cytoplasmic domain of the platelet-derived growth factor beta-receptor.    Cellular signalling  (1999),  11(2),  95-100.	False	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O
392748	392748:01:10_02.00	True	2.0	83	20.9	0.0	12.6	58.2	0.0	58.2	6.6	57.8	63.6	23.2	0.0	80.8	25.7	Tubulin	80.8	HS-173	HS-173 is a novel PI3K inhibitor, that is used for cancer treatment.	False	CCOC(=O)c1cnc2ccc(-c3cncc(NS(=O)(=O)c4ccccc4)c3)cn12
392023	392023:01:02_02.00	True	2.0	95	15.2	5.3	0.0	57.4	0.0	57.9	7.6	86.3	25.9	22.6	0.0	44.9	34.7	LCH	86.3		inhibitor of Insulin-like growth factor I receptor (IC50 = 0.25 µM); Optimization of a series of 4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidine inhibitors of IGF-1R: elimination of an acid-mediated decomposition pathway.  Bioorg Med Chem Lett.  (2009),  19(2),  373-7.	False	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1
391988	391988:01:02_02.00	True	2.0	94	12.4	58.0	19.0	0.0	93.0	0.0	0.0	0.0	0.0	0.0	73.8	0.0	0.0	DNA_Synth	93.0		inhibitor of MAP kinase p38 alpha (IC50 = 0.06 µM); Pyrimidinylimidazole inhibitors of p38: cyclic N-1 imidazole substituents enhance p38 kinase inhibition and oral activity.  Bioorg Med Chem Lett.  (2001),  11(21),  2867-2870.	False	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1
392730	392730:01:09_02.00	True	2.0	86	42.3	80.7	0.0	13.0	13.3	13.4	35.2	41.7	0.2	13.4	15.2	12.1	51.5	AKT_PI3K_MTOR	80.7	ETP-46464	ETP-46464 is an effective mTOR and ATR inhibitor with IC50s of 0.6 and 14 nM, respectively.	False	CC(C)(C#N)c1ccc(N2C(=O)OCc3cnc4ccc(-c5cnc6ccccc6c5)cc4c32)cc1
392677	392677:01:10_02.00	True	2.0	100	5.2	0.0	0.0	68.3	0.0	68.3	31.6	60.6	44.2	45.2	0.0	66.6	54.5	BET	68.3	BI-D1870	BI-D1870 is an ATP-competitive, cell permeable and brain penetrated inhibitor of RSK isoforms, with IC50s of 31 nM/24 nM/18 nM/15 nM for RSK1/RSK2/RSK3/RSK4, respectively.	False	CC(C)CCN1c2nc(Nc3cc(F)c(O)c(F)c3)ncc2N(C)C(=O)C1C
391917	391917:01:02_02.00	True	2.0	61	41.8	18.8	0.0	22.1	17.5	15.9	13.2	36.2	17.6	0.4	0.0	36.5	31.0	Tubulin	36.5		inhibitor of GSK3-beta (IC50 = 0.01 µM), inhibitor of Cyclin-dependent kinase 2/4 (IC50 = 0.002/0.06 µM); N-Phenyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amines as Potent and Selective Inhibitors of Glycogen Synthase Kinase 3 with Good Cellular Efficacy.    J Med Chem (2004),  47(19),  4716-4730.	False	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1
391775	391775:01:02_02.00	True	2.0	86	15.5	0.0	21.9	59.3	0.0	62.0	34.9	68.2	51.0	33.5	0.0	84.7	32.5	Tubulin	84.7		inhibitor of Vascular endothelial growth factor receptor 2 (IC50 = 0.0033 µM), inhibitor of Tyrosine-protein kinase TIE-2 (IC50 = 0.0063 µM); Discovery of Novel Benzimidazoles as Potent Inhibitors of TIE-2 and VEGFR-2 Tyrosine Kinase Receptors.    J Med Chem (2007),  50(18),  4453-4470.	False	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4Cl)cc3)ccc2[nH]1
391997	391997:01:02_02.00	True	2.0	92	29.0	53.8	0.0	0.0	38.6	7.0	0.0	1.2	5.7	0.3	25.3	0.0	27.1	AKT_PI3K_MTOR	53.8		inhibitor of Rho-associated protein kinase 1 (IC50 = 0.009 µM), inhibitor of Yes1 kinase (IC50 = 0.58 µM), inhibitor of RPS6KA1/B1 (IC50 = 1.1/1.6 µM); Development of Dihydropyridone Indazole Amides as Selective Rho-Kinase Inhibitors.    J Med Chem (2007),  50(1),  6-9.	False	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1
392581	392581:01:10_02.00	True	2.0	100	11.6	54.1	0.0	22.0	0.0	22.3	37.7	37.5	0.0	22.8	0.0	10.4	41.6	AKT_PI3K_MTOR	54.1	R406	R406 is an orally available and competitive Syk/FLT3 inhibitor for ATP binding with a Ki of 30 nM, potently inhibits Syk kinase activity in vitro with an IC50 of 41 nM, measured at an ATP concentration corresponding to its Km value. R406 reduces immune complex-mediated inflammation. R406 also inhibits Lyn (IC50=63 nM) and Lck (IC50=37 nM).	False	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC
392535	392535:01:10_02.00	True	2.0	96	39.6	98.0	0.0	0.0	70.1	0.0	29.3	0.0	0.0	0.0	65.1	0.0	21.1	AKT_PI3K_MTOR	98.0	KU-0063794	KU-0063794 is a potent and highly specific dual-mTOR inhibitor of mTORC1 and mTORC2 with IC50 of ~10 nM; no effect on PI3Ks.	False	COc1ccc(-c2ccc3c(N4CCOCC4)nc(N4C[C@H](C)O[C@H](C)C4)nc3n2)cc1CO
392563	392563:01:10_02.00	True	2.0	90	49.2	94.8	0.0	0.0	40.8	0.0	26.4	0.0	0.0	0.0	47.2	0.0	39.1	AKT_PI3K_MTOR	94.8	AZD8055	AZD8055 is a novel ATP-competitive mTOR inhibitor with IC50 of 0.8 nM with excellent selectivity (~1000-fold) against PI3K isoforms and ATM/DNA-PK. Phase 1.	False	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO
392550	392550:01:09_02.00	True	2.0	99	37.5	18.6	0.0	52.5	0.0	51.6	36.2	71.0	13.4	35.4	0.0	52.7	44.7	LCH	71.0	AEE788 (NVP-AEE788)	AEE788 is a potent inhibitor of EGFR and HER2/ErbB2 with IC50 of 2 nM and 6 nM, less potent to VEGFR2/KDR, c-Abl, c-Src, and Flt-1, does not inhibit Ins-R, IGF-1R, PKC¿ and CDK1. Phase 1/2.	False	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1
392711	392711:01:09_02.00	True	2.0	61	45.3	10.7	0.0	46.8	0.0	43.1	17.9	57.7	33.0	16.0	0.0	53.5	46.0	LCH	57.7	P276-00	p276-00 is a novel CDK1, CDK4 and CDK9 inhibitor with IC50 of 79 nM, 63 nM and 20 nM, respectively.	False	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO
392541	392541:01:09_02.00	True	2.0	95	13.0	62.2	18.7	0.0	83.8	0.0	29.9	0.0	0.0	0.0	75.0	0.0	0.0	DNA_Synth	83.8	MGCD-265 analog	MGCD-265 analog is a potent and oral bioavailable inhibitor of c-Met and VEGFR2 tyrosine kinases, with IC50 s of 29 nM and 10 nM, respectively. MGCD-265 analog has significant antitumor activity.	False	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1
392003	392003:01:02_02.00	True	2.0	94	6.9	0.0	0.0	62.8	0.0	62.3	36.4	60.4	26.9	63.8	0.0	70.6	51.7	Tubulin	70.6		inhibitor of Vascular endothelial growth factor receptor 2 (IC50 = 0.01 µM), inhibitor of Tyrosine-protein kinase TIE-2 (IC50 = 0.01 µM); Discovery of Novel Benzimidazoles as Potent Inhibitors of TIE-2 and VEGFR-2 Tyrosine Kinase Receptors.    J Med Chem (2007),  50(18),  4453-4470.	False	COC(=O)Nc1nc2cc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)ccc2[nH]1
392007	392007:01:02_02.00	True	2.0	93	39.6	80.2	0.0	0.0	60.6	0.0	42.7	0.0	0.0	0.0	59.1	0.0	0.0	AKT_PI3K_MTOR	80.2		inhibitor of Insulin-like growth factor I receptor (IC50 = 0.005 µM), inhibitor of JNK1, ALK, INSR (IC50 = 0.012/0.001/0.0063 µM); Discovery of 4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidines: Potent inhibitors of the IGF-1R receptor tyrosine kinase.  Bioorg Med Chem Lett.  (2009),  19(2),  469-473.	False	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1
392013	392013:01:02_02.00	True	2.0	90	52.8	0.0	0.0	66.4	0.0	76.4	10.3	61.8	57.1	44.1	0.0	57.6	52.4	HDAC	76.4		inhibitor of Rho-associated protein kinase 1 (IC50 = 0.002 µM), also inhibits firefly luciferase (IC50 = 1 µM); Discovery of Aminofurazan-azabenzimidazoles as Inhibitors of Rho-Kinase with High Kinase Selectivity and Antihypertensive Activity.    J Med Chem (2007),  50(1),  2-5.	False	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21
392527	392527:01:10_02.00	True	2.0	94	9.7	34.6	0.0	35.6	0.0	34.3	36.8	64.0	9.7	20.5	0.0	36.5	37.8	LCH	64.0	WZ4002	WZ4002 is a mutant selective EGFR inhibitor with IC50s of 2, 8, 3 and 2 nM for EGFRL858R, EGFRL858R/T790M, EGFRE746_A750 and EGFRE746_A750/T790M, respectively.	False	C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)ncc2Cl)c1
391996	391996:01:02_02.00	True	2.0	101	55.1	0.0	2.7	67.2	0.0	61.7	12.0	59.0	50.7	56.4	0.0	77.5	41.2	Tubulin	77.5		inhibitor of Glycogen synthase kinase-3 (IC50 = 0.00095 µM); also active on CDK2; 5-Aryl-pyrazolo[3,4-b]pyridazines: potent inhibitors of glycogen synthase kinase-3 (GSK-3).  Bioorg Med Chem Lett.  (2003),  13(9),  1581-1584.	False	CCN1CCC(C(=O)Nc2[nH]nc3nnc(-c4cccc(F)c4F)cc23)CC1
392358	392358:01:02_02.00	True	2.0	81	58.5	0.0	0.0	50.5	0.0	61.0	12.2	50.1	46.4	37.1	0.0	48.2	37.4	HDAC	61.0		inhibitor of Akt1 (IC50 = 0.008 µM); Discovery of 5-pyrrolopyridinyl-2-thiophenecarboxamides as potent AKT kinase inhibitors. Bioorg Med Chem Lett. 2009 Apr 15;19(8):2244-8.	False	NCCC(NC(=O)c1cc(Br)c(-c2ccnc3[nH]ccc23)s1)c1ccccc1
392303	392303:01:02_02.00	True	2.0	98	15.0	72.9	1.4	0.0	91.8	0.0	0.0	0.0	0.0	0.0	76.5	0.0	0.0	DNA_Synth	91.8		inhibitor of Glycogen synthase kinase-3 beta (IC50 = 0.14 µM); not active von GSK3-alpha; 3-Anilino-4-arylmaleimides: potent and selective inhibitors of glycogen synthase kinase-3 (GSK-3).  Bioorg Med Chem Lett.  (2001),  11(5),  635-639.	False	COc1ccccc1C1=C(Nc2ccc(O)c(Cl)c2)C(=O)NC1=O
392203	392203:01:02_02.00	True	2.0	83	75.3	0.0	0.0	87.2	0.0	85.4	16.3	80.3	62.8	60.9	0.0	87.9	51.4	Tubulin	87.9		Inhibitor of B-Raf V600E mutant (IC50 = 0.0005 µM); Development of potent B-RafV600E inhibitors containing an arylsulfonamide headgroup. Bioorg Med Chem Lett. 2011 Aug 1;21(15):4436-40.	False	CC(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(Nc3ccc(N4CCOCC4)nc3)n2)s1
392053	392053:01:02_02.00	True	2.0	91	77.5	0.0	0.0	83.7	0.0	84.3	29.1	74.6	52.4	58.9	0.0	82.9	52.3	HDAC	84.3		inhibitor of Yes1 kinase (IC50 = 0.002 µM), inhibitor of RET kinase (IC50 = 0.003 µM), inhibitor of RIPK2 (IC50 = 0.003 µM), inhibitor of VEGFR2 (IC50 = 0.186 µM), inhibitor of p38alpha (IC50 = 0.5 µM); The discovery of substituted 4-(3-hydroxyanilino)-quinolines as potent RET kinase inhibitors.  Bioorg Med Chem Lett.  (2007),  17(21),  5886-5893.	False	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12
391941	391941:01:02_02.00	True	2.0	66	45.8	28.1	0.0	22.5	15.5	15.7	11.9	35.7	15.8	0.0	0.0	35.7	38.2	Uncoupler	38.2		inhibitor of GSK3-beta (IC50 = 0.01 µM), inhibitor of Cyclin-dependent kinase 2/4 (IC50 = 0.006/0.01 µM); N-Phenyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amines as Potent and Selective Inhibitors of Glycogen Synthase Kinase 3 with Good Cellular Efficacy.    J Med Chem (2004),  47(19),  4716-4730.	False	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1
392620	392620:01:09_02.00	True	2.0	97	15.4	26.3	0.0	47.5	0.0	53.9	49.7	60.3	16.3	31.9	0.0	40.7	49.5	LCH	60.3	BMS-536924	BMS-536924 is an ATP-competitive IGF-1R/IR inhibitor with IC50 of 100 nM/73 nM, modest activity for Mek, Fak, and Lck with very little activity for Akt1, MAPK1/2.	False	Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NC[C@@H](O)c4cccc(Cl)c4)cc[nH]c3=O)nc12
392772	392772:01:09_02.00	True	2.0	59	83.2	0.0	4.6	81.2	0.0	87.7	14.2	75.4	60.6	62.0	0.0	79.5	39.2	HDAC	87.7	Ro3280	Ro3280 is a potent, highly selective inhibitor of PLK1 with an IC50 and a Kd of 3 nM and 0.09 nM, respectively, and nearly has no effect on PLK2 and PLK3.	False	COc1cc(C(=O)NC2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C1CCCC1)CC(F)(F)C(=O)N2C
392778	392778:01:10_02.00	True	2.0	98	18.8	50.6	9.5	0.0	80.2	0.0	10.8	0.0	0.0	0.0	84.2	0.0	0.0	Pyrimidine_Synth	84.2	AZD8330	AZD8330 (ARRY-424704) is a potent, uncompetitive MEK1/MEK2 inhibitor, with an IC50 of 7 nM.	False	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O
391904	391904:01:02_02.00	True	2.0	76	27.8	12.2	78.8	0.0	63.2	0.0	14.0	0.0	0.0	0.0	61.8	0.0	0.0	Aurora	78.8		inhibitor of Vascular endothelial growth factor receptor 2 (IC50 = 0.065 µM), inhibitor of Yes1 kinase (IC50 = 1.4 µM), also inhibits firefly luciferase (IC50 = 0.56 µM); Discovery of a novel and potent series of dianilinopyrimidineurea and urea isostere inhibitors of VEGFR2 tyrosine kinase.  Bioorg Med Chem Lett.  (2005),  15(15),  3519-3523.	False	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1
392725	392725:01:10_02.00	True	2.0	86	18.0	83.5	0.0	0.0	74.8	0.0	27.0	13.6	0.0	0.0	56.5	0.0	7.1	AKT_PI3K_MTOR	83.5	GSK2334470	GSK2334470 is a novel PDK1 inhibitor with IC50 of ~10 nM, with no activity at other close related AGC-kinases.	False	CNc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2C[C@@H](C(=O)NC3CCCCC3)CC[C@H]2C)n1
392479	392479:01:09_02.00	True	2.0	99	9.5	21.7	0.0	37.8	19.8	36.3	27.9	71.1	2.5	10.1	0.0	50.1	34.6	LCH	71.1	Imatinib (Mesylate)	Imatinib Mesylate (STI571 Mesylate) is a tyrosine kinases inhibitor that inhibits c-Kit, Bcr-Abl, and PDGFR (IC50=100 nM) tyrosine kinases.	False	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1
392398	392398:01:02_02.00	True	2.0	91	5.4	0.0	0.0	69.1	0.0	71.8	0.0	44.2	64.4	47.6	0.0	68.0	41.1	HDAC	71.8		inhibitor of TGF-beta receptor type I (Alk5) (IC50 = 0.09 µM); Design of novel quinazoline derivatives and related analogues as potent and selective ALK5 inhibitors. Bioorg Med Chem Lett. 2009 Apr 15;19(8):2277-81.	False	Cc1cccc(-c2nc(C)cc(Nc3ccncc3)n2)n1
392339	392339:01:02_02.00	True	2.0	98	8.1	19.8	0.0	3.5	10.8	8.9	55.4	36.2	0.0	3.0	18.3	17.0	0.0	HSP90	55.4		inhibitor of Epidermal growth factor receptor erbB1 (IC50 = 0.01 µM), inhibitor of  Epidermal growth factor receptor erbB2/Her2 (IC50 = 0.01 µM); Discovery and Biological Evaluation of Potent Dual ErbB-2/EGFR Tyrosine Kinase Inhibitors: 6-Thiazolylquinazolines.  Bioorg Med Chem Lett.  (2003),  13(4),  637-640.	False	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)cs1
392511	392511:01:09_02.00	True	2.0	90	22.3	55.4	0.0	0.0	90.1	0.0	0.0	0.0	0.0	0.0	65.6	0.0	0.0	DNA_Synth	90.1	Palbociclib (hydrochloride)	Palbociclib hydrochloride is a highly selective CDK4/6 inhibitor with IC50s of 11 nM and 16 nM, respectively. Palbociclib hydrochloride has the potential for ER-positive and HER2-negative breast cancer research.	False	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O
391844	391844:01:02_00.20	True	0.2	85	26.6	52.9	0.0	5.5	52.2	10.9	23.5	35.4	0.6	9.5	22.8	17.1	34.2	AKT_PI3K_MTOR	52.9		inhibitor of Akt1 (IC50 = 0.004 µM); Discovery of 5-pyrrolopyridinyl-2-thiophenecarboxamides as potent AKT kinase inhibitors. Bioorg Med Chem Lett. 2009 Apr 15;19(8):2244-8.	False	CCNCC(Cc1ccccc1)NC(=O)c1cc(Br)c(-c2ccnc3[nH]ccc23)s1
391861	391861:01:02_00.20	True	0.2	73	22.5	0.0	41.5	10.8	43.6	8.0	13.4	25.1	21.7	3.5	0.0	50.4	0.0	Tubulin	50.4		inhibitor of PLK1/3 (IC50 = 0.006/1.1 µM); Design of potent thiophene inhibitors of polo-like kinase 1 with improved solubility and reduced protein binding.  Bioorg Med Chem Lett.  (2009),  19(6),  1694-1697.	True	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl
280136	280136:01:05_00.20	True	0.2	104	6.0	0.0	0.1	51.1	0.0	54.4	0.0	15.1	65.1	27.7	0.0	45.8	16.1	Na_K-ATPase	65.1	SB 525334	SB 525334 is a potent and selective transforming growth factor .b.1 receptor (ALK5) inhibitor with an IC50 of 14.3 nM.	False	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3nccnc3c2)n1
392595	392595:01:09_00.20	True	0.2	67	30.6	0.0	94.2	0.0	18.5	0.0	0.0	0.0	3.1	0.0	8.2	0.0	0.0	Aurora	94.2	AMG 900	AMG 900 is a potent and highly selective pan-Aurora kinases inhibitor with IC50 of 5 nM, 4 nM and 1 nM for Aurora A, B and C, respectively.	False	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1
392283	392283:01:02_00.20	True	0.2	92	9.2	66.0	0.0	0.0	69.0	0.0	44.2	0.0	0.0	0.0	48.7	0.0	7.0	DNA_Synth	69.0		inhibitor of Vascular endothelial growth factor receptor 2 (IC50 = 0.001 µM); Discovery of a novel and potent series of dianilinopyrimidineurea and urea isostere inhibitors of VEGFR2 tyrosine kinase.  Bioorg Med Chem Lett.  (2005),  15(15),  3519-3523.	False	CN(c1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2F)cc1)c1ccnc(Nc2ccc(S(N)(=O)=O)cc2)n1
392596	392596:01:09_00.20	True	0.2	89	36.3	92.9	0.0	0.0	64.3	0.0	30.2	2.2	0.0	0.0	53.3	0.0	30.3	AKT_PI3K_MTOR	92.9	Omipalisib	Omipalisib (GSK2126458) is an orally active and highly selective inhibitor of PI3K with Kis of 0.019 nM/0.13 nM/0.024 nM/0.06 nM and 0.18 nM/0.3 nM for p110.a./.b./.d./.g., mTORC1/2, respectively. Omipalisib has anti-cancer activity.	False	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F
391926	391926:01:02_00.20	True	0.2	94	5.4	45.5	0.0	0.0	65.0	0.0	0.0	1.2	0.0	0.0	37.9	0.0	23.2	DNA_Synth	65.0		inhibitor of MAP kinase p38 alpha (IC50 = 0.023 µM); Phenoxypyrimidine inhibitors of p38.alpha. kinase synthesis and statistical evaluation of the p38 inhibitory potencies of a series of 1-(piperidin-4-yl)-4-(4-fluorophenyl)-5-(2-phenoxypyrimidin-4-yl) imidazoles.  Bioorg Med Chem Lett.  (2001),  11(9),  1123-1126.	False	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1
391924	391924:01:02_00.20	True	0.2	98	7.6	52.4	0.0	17.5	10.0	30.2	46.9	32.6	11.1	34.5	7.4	16.9	49.9	AKT_PI3K_MTOR	52.4		inhibitor of Insulin-like growth factor I receptor (IC50 = 0.0009 µM); Discovery of 4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidines: Potent inhibitors of the IGF-1R receptor tyrosine kinase.  Bioorg Med Chem Lett.  (2009),  19(2),  469-473.	False	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1
392603	392603:01:09_00.20	True	0.2	85	10.0	0.0	23.3	8.2	54.9	0.0	0.0	29.5	0.0	0.0	0.0	39.3	0.0	DNA_Synth	54.9	AZD-5438	AZD-5438 is a potent CDK1, CDK2, and CDK9 inhibitor, with IC50s of 16 nM, 6 nM, and 20 nM in cell-free assays, respectively. AZD-5438 shows less inhibition activity against GSK3.b., CDK5 and CDK6.	False	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C
392433	392433:01:02_00.20	True	0.2	56	31.8	0.0	60.0	31.7	0.2	40.5	5.5	34.7	35.6	16.1	0.0	54.5	1.3	Aurora	60.0		inhibitor of PLK1/3 kinase (IC50 = 0.001/0.006 µM); Heteroaryl-linked 5-(1H-benzimidazol-1-yl)-2-thiophenecarboxamides: potent inhibitors of polo-like kinase 1 (PLK1) with improved drug-like properties. Bioorg Med Chem Lett. 2010 Aug 1;20(15):4587-92.	True	C[C@@H](Oc1cc(-n2cnc3cc(-c4cnn(C)c4)ccc32)sc1C(N)=O)c1ccccc1Cl
392191	392191:01:02_00.20	True	0.2	67	25.6	0.0	42.4	42.2	1.2	43.8	3.9	53.5	37.5	25.9	0.0	67.2	11.5	Tubulin	67.2		inhibitor of PLK1/3 kinase (IC50 = 0.001/0.01 µM); Heteroaryl-linked 5-(1H-benzimidazol-1-yl)-2-thiophenecarboxamides: potent inhibitors of polo-like kinase 1 (PLK1) with improved drug-like properties. Bioorg Med Chem Lett. 2010 Aug 1;20(15):4587-92.	True	C[C@@H](Oc1cc(-n2cnc3cc(-c4ccncc4)ccc32)sc1C(N)=O)c1ccccc1Cl
392354	392354:01:02_00.20	True	0.2	94	17.1	78.7	0.0	0.0	74.3	0.0	24.6	0.0	0.0	0.0	66.6	0.0	2.0	AKT_PI3K_MTOR	78.7		inhibitor of Akt1/2/3 (IC50 = 0.002/0.079/0.003 µM); Discovery of 5-pyrrolopyridinyl-2-thiophenecarboxamides as potent AKT kinase inhibitors. Bioorg Med Chem Lett. 2009 Apr 15;19(8):2244-8.	True	NC[C@H](Cc1ccc(C(F)(F)F)cc1)NC(=O)c1cc(Br)c(-c2ccnc3[nH]ccc23)s1
392623	392623:01:09_00.20	True	0.2	101	16.8	72.7	0.0	0.0	89.1	0.0	28.8	0.0	0.0	0.0	77.7	0.0	0.0	DNA_Synth	89.1	Trametinib	Trametinib (GSK1120212; JTP-74057) is an orally active MEK inhibitor that inhibits MEK1 and MEK2 with IC50s of about 2 nM. Trametinib activates autophagy and induces apoptosis.	False	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1
392289	392289:01:02_00.20	True	0.2	90	15.5	0.0	0.0	80.3	0.0	76.2	10.3	80.0	52.0	57.0	0.0	79.5	63.1	BET	80.3		Inhibitor of B-Raf V600E mutant (IC50 = 0.0012 µM); Development of potent B-RafV600E inhibitors containing an arylsulfonamide headgroup. Bioorg Med Chem Lett. 2011 Aug 1;21(15):4436-40.	False	CC(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2)c(-c2ccnc(Nc3ccc(N4CCOCC4)nc3)n2)s1
391816	391816:01:02_00.20	True	0.2	98	7.4	34.5	3.8	0.0	85.0	0.0	0.0	5.9	0.0	0.0	49.2	0.0	0.0	DNA_Synth	85.0		inhibitor of CDK2/4 (IC50 = 0.45/0.038 µM), GSK-3 beta inhibitor (IC50 = 0.69 µM); Synthesis and evaluation of pyrazolo[1,5-b]pyridazines as selective cyclin dependent kinase inhibitors.  Bioorg Med Chem Lett.  (2008),  18(21),  5758-5762.	False	CN(C)CC(O)COc1ccc(Nc2nccc(-c3cnn4nc(N5CCOCC5)ccc34)n2)cc1
392040	392040:01:02_00.20	True	0.2	100	12.6	63.0	0.0	0.0	31.7	0.0	13.5	0.0	0.0	0.0	50.9	0.0	0.0	AKT_PI3K_MTOR	63.0		inhibitor of Insulin-like growth factor I receptor (IC50 = 0.0004 µM); Discovery of 4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidines: Potent inhibitors of the IGF-1R receptor tyrosine kinase.  Bioorg Med Chem Lett.  (2009),  19(2),  469-473.	False	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1
392071	392071:01:02_00.20	True	0.2	92	5.0	0.0	0.0	58.5	0.0	55.5	0.0	68.0	40.0	21.0	0.0	61.7	36.2	LCH	68.0		SB590885 is a potent B-Raf inhibitor with Ki of 0.16 nM in a cell-free assay, 11-fold greater selectivity for B-Raf over c-Raf, no inhibition to other human kinases.; The identification of potent, selective and CNS penetrant furan-based inhibitors of B-Raf kinase.  Bioorg Med Chem Lett.  (2008),  18(15),  4373-4376.	False	CN(C)CCOc1ccc(-c2nc(-c3ccc4c(c3)CC/C4=N\O)c(-c3ccncc3)[nH]2)cc1
392161	392161:01:02_00.20	True	0.2	97	11.2	0.0	15.8	31.7	0.0	41.3	0.0	34.5	39.8	0.0	0.0	19.0	0.0	HDAC	41.3		inhibitor of MAP kinase p38 alpha (IC50 = 0.01 µM); Pyrazolo[1,5-a]pyridines as p38 Kinase Inhibitors.    Organic Letters  (2005),  7(21),  4753-4756.	False	COc1cccc2c(-c3ccncc3)c(-c3ccc(F)cc3)nn12
392633	392633:01:09_00.20	True	0.2	110	8.1	74.3	0.0	0.0	74.7	0.0	21.1	5.0	0.0	0.0	56.7	0.0	0.0	DNA_Synth	74.7	Dacomitinib	PF-299804 is a potent, irreversible pan-ErbB inhibitor, mostly to EGFR with IC50 of 6 nM, effective against NSCLCs with EGFR or ERBB2 mutations (resistant to gefitinib) as well as those harboring the EGFR T790M mutation. Phase 2.	False	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1
392630	392630:01:09_00.20	True	0.2	97	21.4	90.0	0.0	0.0	76.1	0.0	36.2	0.0	0.0	0.0	65.6	0.0	14.6	AKT_PI3K_MTOR	90.0	GDC-0980 (RG7422)	GDC-0980 (RG7422) is a potent, class I PI3K inhibitor for PI3K¿/ß/¿/¿ with IC50 of 5 nM/27 nM/7 nM/14 nM, respectively. Also a mTOR inhibitor with Ki of 17 nM, and highly selective versus others PIKK family kinases. Phase 2.	False	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12
392255	392255:01:02_00.20	True	0.2	97	7.9	59.5	0.0	0.0	56.6	0.0	26.7	0.0	0.0	0.0	50.8	0.0	3.0	AKT_PI3K_MTOR	59.5		inhibitor of Akt1 (IC50 = 0.063 µM); Discovery of 5-pyrrolopyridinyl-2-thiophenecarboxamides as potent AKT kinase inhibitors. Bioorg Med Chem Lett. 2009 Apr 15;19(8):2244-8.	False	NCC(NC(=O)c1cc(-c2cn[nH]c2)c(-c2ccnc3[nH]ccc23)s1)c1ccccc1
392412	392412:01:02_00.20	True	0.2	102	14.5	0.0	0.0	76.5	0.0	73.7	21.9	80.6	38.1	51.5	0.0	65.7	51.1	LCH	80.6		inhibitor of PLK1 kinase (IC50 = 0.061 µM); Discovery of thiophene inhibitors of polo-like kinase. Bioorg Med Chem Lett. 2009 Feb 1;19(3):1018-21.	False	COc1cc2ncn(-c3cc(OCCCc4ccccc4)c(C(N)=O)s3)c2cc1OC
392159	392159:01:02_00.20	True	0.2	106	14.5	0.0	0.0	63.2	0.0	65.3	0.0	47.7	65.5	25.2	0.0	58.2	20.4	Na_K-ATPase	65.5		inhibitor of TGF-beta receptor type I (Alk5) (IC50 = 0.025 µM); Design of novel quinazoline derivatives and related analogues as potent and selective ALK5 inhibitors. Bioorg Med Chem Lett. 2009 Apr 15;19(8):2277-81.	False	Cc1cccc(-c2nc(Nc3ccncc3)c3ccccc3n2)n1
280852	280852:01:06_00.20	True	0.2	85	36.3	21.7	0.0	62.4	0.0	58.3	9.4	77.8	36.2	33.6	0.0	64.2	69.8	LCH	77.8	Phorbol 12-myristate 13-acetate, PMA	activates protein kinase C in vivo and in vitro, strong NO promoter, promotes expression of iNOS in cultured hepatocytes, T lymphocyte activator.	False	CCCCCCCCCCCCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@@]3(O)C(=O)C(C)=C[C@H]32)[C@@H]2C(C)(C)[C@]12OC(C)=O
392605	392605:01:09_00.20	True	0.2	100	7.4	0.0	0.0	75.4	0.0	67.5	23.5	53.3	53.3	54.6	0.0	69.4	48.3	BET	75.4	PP121	PP121 is a multi-targeted kinase inhibitor with IC50s of 10, 60, 12, 14, 2 nM for mTOR, DNK-PK, VEGFR2, Src, PDGFR, respectively. 	False	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1
391956	391956:01:02_00.20	True	0.2	95	7.3	23.0	30.3	0.0	88.5	0.0	0.0	0.0	0.0	0.0	62.2	0.0	0.0	DNA_Synth	88.5		inhibitor of Cyclin-dependent kinase 1/2 (IC50 = 0.01/0.0023 µM); Oxindole-Based Inhibitors of Cyclin-Dependent Kinase 2 (CDK2): Design, Synthesis, Enzymatic Activities, and X-ray Crystallographic Analysis.    J Med Chem (2001),  44(25),  4339-4358.	False	NS(=O)(=O)c1ccc(/N=N/c2c(O)[nH]c3ccc(-c4cnco4)cc23)cc1
392045	392045:01:02_00.20	True	0.2	102	7.3	0.0	0.0	0.0	4.6	0.0	0.0	4.4	0.0	0.0	26.4	0.0	0.0	Pyrimidine_Synth	26.4	GSK180736A	GSK180736A is potent Rho-associated coiled-coil kinase 1 (ROCK1) inhibitor with an IC50 of 100 nM. GSK180736A is also a selective and ATP-competitive G protein-coupled receptor kinase 2 (GRK2) inhibitor with an IC50 of 0.77 uM.; Development of Dihydropyridone Indazole Amides as Selective Rho-Kinase Inhibitors.    J Med Chem (2007),  50(1),  6-9.	False	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1
392048	392048:01:02_00.20	True	0.2	92	8.3	0.1	0.0	0.0	3.0	0.0	0.0	6.6	4.0	0.0	18.1	0.0	0.0	Pyrimidine_Synth	18.1		inhibitor of Epidermal growth factor receptor erbB1 (IC50 = 0.08 µM), inhibitor of Receptor protein-tyrosine kinase erbB-2 (IC50 = 0.22 µM); Optimization and SAR for dual ErbB-1/ErbB-2 tyrosine kinase inhibition in the 6-furanylquinazoline series.  Bioorg Med Chem Lett.  (2006),  16(17),  4686-4691.	False	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1
280863	280863:01:09_00.20	True	0.2	92	6.0	38.0	0.0	0.0	74.2	0.0	0.0	0.0	0.0	0.0	49.8	0.0	0.0	DNA_Synth	74.2	PD 169316	PD 169316 is a potent, cell-permeable and selective p38 MAP kinase inhibitor, with IC50 of 89 nM. PD169316 selectively inhibits the kinase activity of the phosphorylated p38 without hindering upstream kinases to phosphorylate p38. PD169316 shows antiviral activity against Enterovirus71. PD169316 shows antiviral activity against Enterovirus71.	False	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1
392098	392098:01:02_02.00	True	2.0	98	14.9	3.9	0.0	49.5	0.0	49.8	1.2	85.0	16.4	5.1	0.0	43.8	28.6	LCH	85.0		inhibitor of Epidermal growth factor receptor erbB1 (IC50 = 0.027 µM), inhibitor of Receptor protein-tyrosine kinase erbB-2 (IC50 = 0.026 µM); Optimization and SAR for dual ErbB-1/ErbB-2 tyrosine kinase inhibition in the 6-furanylquinazoline series.  Bioorg Med Chem Lett.  (2006),  16(17),  4686-4691.	False	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1
245488	245488:05:06_02.00	True	2.0	96	7.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	19.3	0.0	20.8	0.0	0.0	Pyrimidine_Synth	20.8	Emodin	p56lck Tyrosine kinase inhibitor.	False	Cc1cc(O)c2c(c1)C(=O)c1cc(O)cc(O)c1C2=O
391835	391835:01:02_02.00	True	2.0	108	20.0	60.2	0.0	0.0	51.3	0.0	0.0	0.0	0.0	0.0	67.4	0.0	0.0	Pyrimidine_Synth	67.4		inhibitor of IKK1/2 (IC50 = 0.8/0.2 µM); 4-Phenyl-7-azaindoles as potent and selective IKK2 inhibitors. Bioorg Med Chem Lett. 2009 May 1;19(9):2504-8.	False	CN(C)CCNS(=O)(=O)c1ccc(-c2ccnc3[nH]ccc23)cc1
391844	391844:01:02_02.00	True	2.0	64	71.5	0.0	34.5	51.6	0.0	66.4	10.1	54.7	50.6	42.4	0.0	52.3	13.5	HDAC	66.4		inhibitor of Akt1 (IC50 = 0.004 µM); Discovery of 5-pyrrolopyridinyl-2-thiophenecarboxamides as potent AKT kinase inhibitors. Bioorg Med Chem Lett. 2009 Apr 15;19(8):2244-8.	False	CCNCC(Cc1ccccc1)NC(=O)c1cc(Br)c(-c2ccnc3[nH]ccc23)s1
280136	280136:01:05_02.00	True	2.0	94	20.6	0.0	5.3	73.1	0.0	74.1	0.0	46.0	63.7	52.4	0.0	67.6	28.2	HDAC	74.1	SB 525334	SB 525334 is a potent and selective transforming growth factor .b.1 receptor (ALK5) inhibitor with an IC50 of 14.3 nM.	False	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3nccnc3c2)n1
391907	391907:01:02_02.00	True	2.0	104	10.0	59.4	0.0	0.0	71.1	0.0	6.8	2.8	0.0	0.0	53.7	0.0	0.0	DNA_Synth	71.1		inhibitor of MAP kinase p38 alpha (IC50 = 0.053 µM); Pyrimidinylimidazole inhibitors of p38: cyclic N-1 imidazole substituents enhance p38 kinase inhibition and oral activity.  Bioorg Med Chem Lett.  (2001),  11(21),  2867-2870.	False	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1
391764	391764:01:02_02.00	True	2.0	100	7.3	0.0	0.0	14.3	29.3	8.1	21.1	44.0	0.0	0.0	3.2	31.7	0.0	LCH	44.0		inhibitor of MAP kinase p38 alpha (IC50 = 0.18 µM); Phenoxypyrimidine inhibitors of p38.alpha. kinase synthesis and statistical evaluation of the p38 inhibitory potencies of a series of 1-(piperidin-4-yl)-4-(4-fluorophenyl)-5-(2-phenoxypyrimidin-4-yl) imidazoles.  Bioorg Med Chem Lett.  (2001),  11(9),  1123-1126.	False	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1
392416	392416:01:02_02.00	True	2.0	102	21.2	70.9	0.0	0.0	63.6	0.0	14.9	0.0	0.0	0.0	62.3	0.0	0.0	AKT_PI3K_MTOR	70.9		Potent, ATP-competitive mitogen- and stress-activated kinase 1 (MSK1 = S6K-alpha-5 = ribosomal protein S6 kinase alpha 5) inhibitor (IC50 = 11 nM in an in vitro kinase assay); targets the N-terminal kinase domain. Inhibits MSK1, MSK2, PKA, PKB, RSK and p70S6K activity in cells. Blocks IL-10 production in macrophages.; Identification of 4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a Novel Inhibitor of AKT Kinase.   J Med Chem. 2008,  51(18),  5663-5679.	False	CCn1c(-c2nonc2N)nc2cncc(CNC3CCNCC3)c21
392253	392253:01:02_02.00	True	2.0	90	7.6	11.0	19.4	0.0	62.9	0.0	0.0	25.3	0.0	0.0	14.6	18.7	0.0	DNA_Synth	62.9		binds to CDC like kinase 2 (IC50 = 0.01 µM), binds to casein kinase 1 alpha/delta/gamma (IC50 = 0.22/0.06/0.06 µM); Assessment of chemical coverage of kinome space and its implications for kinase drug discovery. J Med Chem. 2008 Dec 25;51(24):7898-914.	False	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C
392073	392073:01:02_02.00	True	2.0	100	12.1	71.8	0.0	0.0	62.2	0.0	11.0	0.0	0.0	0.0	53.5	0.0	7.8	AKT_PI3K_MTOR	71.8		inhibitor of Rho-associated protein kinase 1 (IC50 = 0.008 µM), inhibitor of Yes1 kinase (IC50 = 3 µM), inhibitor of RPS6KA1/B1 (IC50 = 0.62/0.56 µM); Development of Dihydropyridone Indazole Amides as Selective Rho-Kinase Inhibitors.    J Med Chem (2007),  50(1),  6-9.	False	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1
382147	382147:02:02_02.00	True	2.0	102	15.4	71.1	0.0	0.0	66.3	0.0	13.2	0.0	0.0	0.0	60.5	0.0	10.5	AKT_PI3K_MTOR	71.1	GSK429286A	GSK429286A is a selective inhibitor of ROCK1 and ROCK2 with IC50 of 14 nM and 63 nM, respectively.; Development of dihydropyridone indazole amides as selective Rho-kinase inhibitors. J Med Chem. 2007 Jan 11;50(1):6-9.	False	CC1=C(C(=O)Nc2cc3cn[nH]c3cc2F)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1
392595	392595:01:09_02.00	True	2.0	67	39.9	0.0	88.1	0.0	0.0	8.1	6.3	0.0	14.3	4.6	0.0	18.6	0.0	Aurora	88.1	AMG 900	AMG 900 is a potent and highly selective pan-Aurora kinases inhibitor with IC50 of 5 nM, 4 nM and 1 nM for Aurora A, B and C, respectively.	False	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1
392350	392350:01:02_02.00	True	2.0	99	9.5	13.3	13.3	0.0	60.1	0.0	0.0	13.0	0.0	0.0	32.3	0.5	0.0	DNA_Synth	60.1		inhibitor of Glycogen synthase kinase-3 beta (IC50 = 0.013 µM), inhibitor of Cyclin-dependant kinase 2 (IC50 = 0.25 µM); Identification of 2-(4-pyridyl)thienopyridinones as GSK-3ß inhibitors. Bioorg Med Chem Lett. 2011 Aug 15;21(16):4823-7.	False	Oc1ncc(-c2ccc(N3CCOCC3)cc2)c2sc(-c3cn[nH]c3)cc12
392074	392074:01:02_02.00	True	2.0	100	16.2	12.5	0.0	60.4	0.0	62.2	33.3	83.8	16.2	43.5	0.0	51.4	50.4	LCH	83.8		inhibitor of Insulin-like growth factor I receptor (IC50 = 0.032 µM); Optimization of 4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidine IGF-1R tyrosine kinase inhibitors towards JNK selectivity.  Bioorg Med Chem Lett.  (2009),  19(2),  360-364.	False	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2
392783	392783:01:09_02.00	True	2.0	94	25.6	0.0	0.0	80.2	0.0	75.2	8.0	88.1	34.2	52.5	0.0	72.1	64.2	LCH	88.1	KU-57788	KU-57788 (NU7441) is a highly potent and selective DNA-PK inhibitor with an IC50 of 14 nM. KU-57788 is an NHEJ pathway inhibitor. KU-57788 also inhibits PI3K and mTOR with IC50s of 5.0 and 1.7 uM, respectively.	False	O=c1cc(N2CCOCC2)oc2c(-c3cccc4c3sc3ccccc34)cccc12
391962	391962:01:02_02.00	True	2.0	101	6.6	0.0	5.4	70.9	0.0	68.2	8.1	44.5	53.2	65.7	0.0	70.4	34.2	BET	70.9		inhibitor of TGF-beta receptor type I (IC50 = 0.066 µM); Identification of Novel Inhibitors of the Transforming Growth Factor .beta.1 (TGF-.beta.1) Type 1 Receptor (ALK5).    J Med Chem (2002),  45(5),  999-1001.	False	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCO4)c(-c3ccccn3)[nH]2)cc1
392283	392283:01:02_02.00	True	2.0	67	45.6	64.1	0.0	0.0	51.2	0.0	17.1	8.6	0.0	0.0	36.8	0.0	8.1	AKT_PI3K_MTOR	64.1		inhibitor of Vascular endothelial growth factor receptor 2 (IC50 = 0.001 µM); Discovery of a novel and potent series of dianilinopyrimidineurea and urea isostere inhibitors of VEGFR2 tyrosine kinase.  Bioorg Med Chem Lett.  (2005),  15(15),  3519-3523.	False	CN(c1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2F)cc1)c1ccnc(Nc2ccc(S(N)(=O)=O)cc2)n1
392596	392596:01:09_02.00	True	2.0	84	44.4	82.2	0.0	5.7	28.4	8.5	25.9	36.4	0.0	5.0	22.4	1.0	47.2	AKT_PI3K_MTOR	82.2	Omipalisib	Omipalisib (GSK2126458) is an orally active and highly selective inhibitor of PI3K with Kis of 0.019 nM/0.13 nM/0.024 nM/0.06 nM and 0.18 nM/0.3 nM for p110.a./.b./.d./.g., mTORC1/2, respectively. Omipalisib has anti-cancer activity.	False	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F
392592	392592:01:09_02.00	True	2.0	101	24.4	0.0	0.0	82.0	0.0	79.2	24.5	68.7	50.3	54.5	0.0	79.1	54.6	BET	82.0	Ibrutinib (Racemate)	it is a potent and highly selective Btk inhibitor with IC50 of 0.5 nM, modestly potent to Bmx, CSK, FGR, BRK, HCK, less potent to EGFR, Yes, ErbB2, JAK3, etc.	False	C=CC(=O)N1CCCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1
391926	391926:01:02_02.00	True	2.0	95	16.4	72.8	0.0	0.0	84.8	0.0	10.6	0.0	0.0	0.0	69.1	0.0	0.0	DNA_Synth	84.8		inhibitor of MAP kinase p38 alpha (IC50 = 0.023 µM); Phenoxypyrimidine inhibitors of p38.alpha. kinase synthesis and statistical evaluation of the p38 inhibitory potencies of a series of 1-(piperidin-4-yl)-4-(4-fluorophenyl)-5-(2-phenoxypyrimidin-4-yl) imidazoles.  Bioorg Med Chem Lett.  (2001),  11(9),  1123-1126.	False	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1
392609	392609:01:09_02.00	True	2.0	103	23.5	83.6	0.0	0.0	78.7	0.0	10.5	0.0	0.0	0.0	79.3	0.0	0.0	AKT_PI3K_MTOR	83.6	CCT128930	CCT128930 is a potent and selective inhibitor of Akt2 (IC50 6 nM) with 28-fold selectivity over the closely related PKA kinase (IC50 168 nM), as well as 20-fold selectivity over p70S6K (IC50 120 nM).	False	NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1
391924	391924:01:02_02.00	True	2.0	96	32.0	75.5	0.0	1.5	28.8	11.0	34.5	35.6	0.0	6.3	22.7	0.0	39.7	AKT_PI3K_MTOR	75.5		inhibitor of Insulin-like growth factor I receptor (IC50 = 0.0009 µM); Discovery of 4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidines: Potent inhibitors of the IGF-1R receptor tyrosine kinase.  Bioorg Med Chem Lett.  (2009),  19(2),  469-473.	False	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1
392131	392131:01:02_02.00	True	2.0	88	19.7	33.0	0.0	0.0	31.5	8.2	22.9	26.3	0.0	0.0	28.5	0.0	9.4	AKT_PI3K_MTOR	33.0		inhibitor of Ribosomal protein S6 kinase alpha 5 (S6K-alpha-5 = MSK1) with an IC50 ~0.004 µM; (1H-Imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: Further optimisation as highly potent and selective MSK-1-inhibitors.  Bioorg Med Chem Lett.  (2005),  15(14),  3407-3411.	False	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1
392603	392603:01:09_02.00	True	2.0	71	26.6	50.7	9.4	0.0	90.7	0.0	27.8	3.9	0.0	0.0	61.0	0.0	0.0	DNA_Synth	90.7	AZD-5438	AZD-5438 is a potent CDK1, CDK2, and CDK9 inhibitor, with IC50s of 16 nM, 6 nM, and 20 nM in cell-free assays, respectively. AZD-5438 shows less inhibition activity against GSK3.b., CDK5 and CDK6.	False	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C
391905	391905:01:02_02.00	True	2.0	93	24.7	0.0	0.0	78.8	0.0	74.6	23.0	73.9	44.7	60.3	0.0	84.0	48.3	Tubulin	84.0		inhibitor of Vascular endothelial growth factor receptor 2 (IC50 = 0.0011 µM), inhibitor of Tyrosine-protein kinase TIE-2 (IC50 = 0.013 µM); Discovery of Novel Benzimidazoles as Potent Inhibitors of TIE-2 and VEGFR-2 Tyrosine Kinase Receptors.    J Med Chem (2007),  50(18),  4453-4470.	False	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1
392433	392433:01:02_02.00	True	2.0	59	27.8	28.3	62.0	0.0	65.2	0.0	34.8	0.0	0.0	0.0	62.3	0.0	0.0	DNA_Synth	65.2		inhibitor of PLK1/3 kinase (IC50 = 0.001/0.006 µM); Heteroaryl-linked 5-(1H-benzimidazol-1-yl)-2-thiophenecarboxamides: potent inhibitors of polo-like kinase 1 (PLK1) with improved drug-like properties. Bioorg Med Chem Lett. 2010 Aug 1;20(15):4587-92.	True	C[C@@H](Oc1cc(-n2cnc3cc(-c4cnn(C)c4)ccc32)sc1C(N)=O)c1ccccc1Cl
392191	392191:01:02_02.00	True	2.0	56	24.2	10.3	66.8	0.0	67.1	0.0	35.1	0.0	0.0	0.0	44.0	0.0	0.0	DNA_Synth	67.1		inhibitor of PLK1/3 kinase (IC50 = 0.001/0.01 µM); Heteroaryl-linked 5-(1H-benzimidazol-1-yl)-2-thiophenecarboxamides: potent inhibitors of polo-like kinase 1 (PLK1) with improved drug-like properties. Bioorg Med Chem Lett. 2010 Aug 1;20(15):4587-92.	True	C[C@@H](Oc1cc(-n2cnc3cc(-c4ccncc4)ccc32)sc1C(N)=O)c1ccccc1Cl
392354	392354:01:02_02.00	True	2.0	84	67.0	0.0	0.0	58.8	0.0	66.6	17.7	67.0	47.4	39.7	0.0	53.6	49.6	LCH	67.0		inhibitor of Akt1/2/3 (IC50 = 0.002/0.079/0.003 µM); Discovery of 5-pyrrolopyridinyl-2-thiophenecarboxamides as potent AKT kinase inhibitors. Bioorg Med Chem Lett. 2009 Apr 15;19(8):2244-8.	True	NC[C@H](Cc1ccc(C(F)(F)F)cc1)NC(=O)c1cc(Br)c(-c2ccnc3[nH]ccc23)s1
392623	392623:01:09_02.00	True	2.0	108	19.3	53.4	2.6	0.0	85.7	0.0	13.2	0.0	0.0	0.0	77.6	0.0	0.0	DNA_Synth	85.7	Trametinib	Trametinib (GSK1120212; JTP-74057) is an orally active MEK inhibitor that inhibits MEK1 and MEK2 with IC50s of about 2 nM. Trametinib activates autophagy and induces apoptosis.	False	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1
280967	280967:01:09_02.00	True	2.0	101	9.5	36.3	25.0	0.0	53.4	0.0	15.1	0.0	0.0	0.0	59.0	0.0	0.0	Pyrimidine_Synth	59.0	SU6656	SU6656 is a Src family kinases inhibitor with IC50s of 280, 20, 130, 170 nM for Src, Yes, Lyn, and Fyn, respectively. SU6656 inhibits FAK phosphorylation at Y576/577, Y925, Y861 sites. SU6656 also inhibits p-AKT.	False	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2
391960	391960:01:02_02.00	True	2.0	108	5.7	47.3	0.0	0.0	73.6	0.0	22.9	5.5	0.0	0.0	61.9	0.0	0.0	DNA_Synth	73.6		inhibitor of MAP kinase p38 alpha (IC50 = 0.2 µM); Phenoxypyrimidine inhibitors of p38.alpha. kinase synthesis and statistical evaluation of the p38 inhibitory potencies of a series of 1-(piperidin-4-yl)-4-(4-fluorophenyl)-5-(2-phenoxypyrimidin-4-yl) imidazoles.  Bioorg Med Chem Lett.  (2001),  11(9),  1123-1126.	False	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1
391780	391780:01:02_02.00	True	2.0	100	6.7	0.0	5.1	63.5	0.0	60.1	4.2	37.9	53.0	53.2	0.0	70.0	35.7	Tubulin	70.0		inhibitor of TGF-beta receptor type I (ALK5) (IC50 = 0.015 µM); Discovery of 4-{4-[3-(pyridin-2-yl)-1H-pyrazol-4-yl]pyridin-2-yl}-N-(tetrahydro-2H- pyran-4-yl)benzamide (GW788388): a potent, selective, and orally active transforming growth factor-beta type I receptor inhibitor.    J Med Chem 2006,  49(7),  2210-21.	False	CN(C)CCOc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1
392289	392289:01:02_02.00	True	2.0	93	69.4	0.0	0.0	90.1	0.0	85.1	19.7	75.3	59.8	72.7	0.0	88.8	63.2	BET	90.1		Inhibitor of B-Raf V600E mutant (IC50 = 0.0012 µM); Development of potent B-RafV600E inhibitors containing an arylsulfonamide headgroup. Bioorg Med Chem Lett. 2011 Aug 1;21(15):4436-40.	False	CC(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2)c(-c2ccnc(Nc3ccc(N4CCOCC4)nc3)n2)s1
391816	391816:01:02_02.00	True	2.0	73	54.7	48.2	0.0	0.0	61.3	0.0	0.0	31.5	0.0	0.0	26.7	0.0	13.5	DNA_Synth	61.3		inhibitor of CDK2/4 (IC50 = 0.45/0.038 µM), GSK-3 beta inhibitor (IC50 = 0.69 µM); Synthesis and evaluation of pyrazolo[1,5-b]pyridazines as selective cyclin dependent kinase inhibitors.  Bioorg Med Chem Lett.  (2008),  18(21),  5758-5762.	False	CN(C)CC(O)COc1ccc(Nc2nccc(-c3cnn4nc(N5CCOCC5)ccc34)n2)cc1
392040	392040:01:02_02.00	True	2.0	96	33.2	36.2	0.0	37.3	0.0	50.6	19.6	73.4	7.9	12.9	0.0	25.3	39.3	LCH	73.4		inhibitor of Insulin-like growth factor I receptor (IC50 = 0.0004 µM); Discovery of 4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidines: Potent inhibitors of the IGF-1R receptor tyrosine kinase.  Bioorg Med Chem Lett.  (2009),  19(2),  469-473.	False	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1
392071	392071:01:02_02.00	True	2.0	98	40.4	0.0	0.0	75.3	0.0	75.2	0.0	89.2	42.6	47.4	0.0	69.2	48.9	LCH	89.2		SB590885 is a potent B-Raf inhibitor with Ki of 0.16 nM in a cell-free assay, 11-fold greater selectivity for B-Raf over c-Raf, no inhibition to other human kinases.; The identification of potent, selective and CNS penetrant furan-based inhibitors of B-Raf kinase.  Bioorg Med Chem Lett.  (2008),  18(15),  4373-4376.	False	CN(C)CCOc1ccc(-c2nc(-c3ccc4c(c3)CC/C4=N\O)c(-c3ccncc3)[nH]2)cc1
392668	392668:01:09_02.00	True	2.0	84	17.1	50.5	0.0	0.0	89.2	0.0	3.0	0.0	0.0	0.0	60.3	0.0	0.0	DNA_Synth	89.2	PHA-767491	PHA-767491 is a potent ATP-competitive dual Cdc7/CDK9 inhibitor with IC50 of 10 nM and 34 nM, respectively.It displays ~20-fold selectivity against CDK1/2 and GSK3-ß, 50-fold selectivity against MK2 and CDK5, 100-fold selectivity against PLK1 and CHK2.	False	O=C1NCCc2[nH]c(-c3ccncc3)cc21
280921	280921:01:08_02.00	True	2.0	90	28.8	31.1	40.2	0.0	87.1	0.0	0.8	0.0	0.0	0.0	81.3	0.0	0.0	DNA_Synth	87.1	SU 9516	cylcin-dependent kinase-2 (Cdk-2) inhibitor, induces apoptosis in colon cancer cells.	False	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2
246899	246899:02:05_02.00	True	2.0	100	5.9	0.0	0.0	70.0	0.0	77.8	0.0	68.0	63.0	43.0	0.0	59.9	41.8	HDAC	77.8	Tamoxifen (Citrate)	Tamoxifen Citrate (ICI 46474) is an orally active, selective estrogen receptor modulator (SERM) which blocks estrogen action in breast cells and can activate estrogen activity in other cells, such as bone, liver, and uterine cells.Tamoxifen Citrate is a potent Hsp90 activator and enhances the Hsp90 molecular chaperone ATPase activity. Tamoxifen Citrate also potent inhibits infectious EBOV Zaire and Marburg (MARV) with IC50 of 0.1 uM and 1.8 uM, respectively. Tamoxifen Citrate activates autophagy and induces apoptosis.	False	CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1
392068	392068:01:02_02.00	True	2.0	100	6.0	9.5	0.0	40.6	0.0	45.6	0.0	64.5	22.5	3.4	0.0	26.9	23.5	LCH	64.5		inhibitor of Epidermal growth factor receptor erbB1 (IC50 = 0.025 µM), inhibitor of Receptor protein-tyrosine kinase erbB-2 (IC50 = 0.025 µM); Optimization and SAR for dual ErbB-1/ErbB-2 tyrosine kinase inhibition in the 6-furanylquinazoline series.  Bioorg Med Chem Lett.  (2006),  16(17),  4686-4691.	False	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1
391774	391774:01:02_02.00	True	2.0	90	39.2	0.9	0.0	74.6	0.0	66.6	31.8	74.8	41.3	66.1	0.0	81.7	76.3	Tubulin	81.7		Inhibitor of B-Raf V600E mutant (IC50 = 0.034 µM); Development of potent B-RafV600E inhibitors containing an arylsulfonamide headgroup. Bioorg Med Chem Lett. 2011 Aug 1;21(15):4436-40.	False	CC(=O)N1CCN(c2ccc(Nc3nccc(-c4sc(C(C)C)nc4-c4cccc(NS(=O)(=O)c5cccc(Cl)c5)c4)n3)cn2)CC1
247192	247192:01:08_02.00	True	2.0	96	12.4	0.0	2.0	31.2	0.0	37.2	0.0	16.2	32.5	0.0	0.0	5.2	0.0	HDAC	37.2	Parthenolide	Parthenolide is a sesquiterpene lactone found in the medicinal herb Feverfew. Parthenolide exhibits anti-inflammatory activity by inhibiting NF-.k.B activation; also inhibits HDAC1 protein without affecting other class I/II HDACs.	True	C=C1C(=O)O[C@H]2[C@H]1CC/C(C)=C/CC[C@@]1(C)O[C@H]21
392630	392630:01:09_02.00	True	2.0	90	44.0	97.6	0.0	0.0	62.4	0.0	28.0	0.0	0.0	0.0	58.3	0.0	31.3	AKT_PI3K_MTOR	97.6	GDC-0980 (RG7422)	GDC-0980 (RG7422) is a potent, class I PI3K inhibitor for PI3K¿/ß/¿/¿ with IC50 of 5 nM/27 nM/7 nM/14 nM, respectively. Also a mTOR inhibitor with Ki of 17 nM, and highly selective versus others PIKK family kinases. Phase 2.	False	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12
392529	392529:01:10_02.00	True	2.0	102	15.2	86.5	0.0	0.0	67.5	0.0	33.2	3.6	0.0	0.0	59.0	0.0	12.4	AKT_PI3K_MTOR	86.5	WZ8040	WZ8040 is a novel mutant-selective irreversible EGFRT790M inhibitor, does not inhibit ERBB2 phosphorylation (T798I).	False	C=CC(=O)Nc1cccc(Sc2nc(Nc3ccc(N4CCN(C)CC4)cc3)ncc2Cl)c1
391759	391759:01:03_02.00	True	2.0	90	9.5	0.0	0.0	47.8	0.0	56.0	38.4	69.5	12.6	33.7	0.0	55.5	29.7	LCH	69.5		inhibitor of Epidermal growth factor receptor erbB1 (IC50 = 0.018 µM), inhibitor of Receptor protein-tyrosine kinase erbB-2 (IC50 = 0.022 µM); Optimization and SAR for dual ErbB-1/ErbB-2 tyrosine kinase inhibition in the 6-furanylquinazoline series.  Bioorg Med Chem Lett.  (2006),  16(17),  4686-4691.	False	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1
390583	390583:01:06_02.00	True	2.0	97	34.7	0.0	0.0	90.0	0.0	84.9	0.0	82.3	55.0	69.7	0.0	81.8	62.4	BET	90.0	T-00127-HEV1	novel inhibitor of phophatidylinositol 4-kinase beta (PI4Kß), antienterovirus.	False	COc1ccc(-c2c(C)nn3c(NCCN4CCOCC4)cc(C)nc23)cc1OC
392069	392069:01:02_02.00	True	2.0	87	39.2	0.0	0.0	71.3	0.0	66.9	10.4	83.6	36.7	51.3	0.0	74.1	45.7	LCH	83.6		GSK-3 inhibitor (IC50 = 0.005 µM); Synthesis and evaluation of novel heterocyclic inhibitors of GSK-3.  Bioorg Med Chem Lett.  (2006),  16(8),  2091-2094.	False	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1
391895	391895:01:02_02.00	True	2.0	78	38.0	0.0	3.9	79.6	0.0	80.8	10.9	65.6	69.8	53.0	0.0	87.6	45.6	Tubulin	87.6		inhibitor of c-Jun N-terminal kinase 3 (IC50 = 1 µM), Inhibitor of binding or entry into cells for Lassa Virus (IC50 = 0.8 µM); N-(3-Cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)amides as potent, selective, inhibitors of JNK2 and JNK3.  Bioorg Med Chem Lett.  (2007),  17(5),  1296-1301.	False	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2
246297	246297:01:08_02.00	True	2.0	96	15.4	77.2	0.0	0.0	75.9	0.0	10.5	0.0	0.0	0.0	66.5	0.0	0.0	AKT_PI3K_MTOR	77.2	Erlotinib	Erlotinib (CP-358774) is a directly acting EGFR tyrosine kinase inhibitor, with an IC50 of 2 nM for human EGFR. Erlotinib reduces EGFR autophosphorylation in intact tumor cells with an IC50 of 20 nM. Erlotinib is used for the treatment of non-small cell lung cancer.	False	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1
392255	392255:01:02_02.00	True	2.0	77	30.1	42.4	0.0	0.0	64.6	0.0	25.3	0.0	0.0	0.0	41.2	2.1	9.3	DNA_Synth	64.6		inhibitor of Akt1 (IC50 = 0.063 µM); Discovery of 5-pyrrolopyridinyl-2-thiophenecarboxamides as potent AKT kinase inhibitors. Bioorg Med Chem Lett. 2009 Apr 15;19(8):2244-8.	False	NCC(NC(=O)c1cc(-c2cn[nH]c2)c(-c2ccnc3[nH]ccc23)s1)c1ccccc1
391871	391871:01:02_02.00	True	2.0	99	26.6	15.3	0.0	61.8	0.0	64.3	42.7	57.1	31.0	57.4	0.0	54.9	62.6	HDAC	64.3		inhibitor of Vascular endothelial growth factor receptor 2 (IC50 = 0.0063 µM), Inhibition of VEGF-induced HUVEC proliferation (IC50 = 0.18 µM), inhibitor of Yes1 kinase (IC50 = 0.09 µM); Discovery of 5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide (Pazopanib), a Novel and Potent Vascular Endothelial Growth Factor Receptor Inhibitor.    J Med Chem (2008),  51(15),  4632-4640.	False	COc1cc(Nc2nccc(Nc3ccc4c(C)[nH]nc4c3)n2)cc(OC)c1OC
392412	392412:01:02_02.00	True	2.0	101	60.8	0.0	0.0	86.3	0.0	83.4	22.3	83.7	47.5	60.8	0.0	81.5	54.6	BET	86.3		inhibitor of PLK1 kinase (IC50 = 0.061 µM); Discovery of thiophene inhibitors of polo-like kinase. Bioorg Med Chem Lett. 2009 Feb 1;19(3):1018-21.	False	COc1cc2ncn(-c3cc(OCCCc4ccccc4)c(C(N)=O)s3)c2cc1OC
392163	392163:01:02_02.00	True	2.0	95	15.0	75.1	0.0	0.0	47.3	0.0	2.8	2.7	0.0	0.0	40.5	0.0	18.9	AKT_PI3K_MTOR	75.1		inhibitor of 3-phosphoinositide dependent protein kinase-1 (IC50 = 0.0016 µM); Structure-based design of potent and selective 3-phosphoinositide-dependent kinase-1 (PDK1) inhibitors. J Med Chem. 2011 Mar 24;54(6):1871-95.	True	CNc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2C[C@@H](C(=O)Nc3ccccc3)CC[C@H]2C)n1
392159	392159:01:02_02.00	True	2.0	104	16.4	0.0	0.0	63.7	0.0	68.6	0.0	33.8	67.1	35.5	0.0	48.5	27.7	HDAC	68.6		inhibitor of TGF-beta receptor type I (Alk5) (IC50 = 0.025 µM); Design of novel quinazoline derivatives and related analogues as potent and selective ALK5 inhibitors. Bioorg Med Chem Lett. 2009 Apr 15;19(8):2277-81.	False	Cc1cccc(-c2nc(Nc3ccncc3)c3ccccc3n2)n1
280852	280852:01:06_02.00	True	2.0	92	31.4	36.4	0.0	62.2	0.0	60.9	16.1	73.0	36.1	42.3	0.0	63.8	76.9	Uncoupler	76.9	Phorbol 12-myristate 13-acetate, PMA	activates protein kinase C in vivo and in vitro, strong NO promoter, promotes expression of iNOS in cultured hepatocytes, T lymphocyte activator.	False	CCCCCCCCCCCCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@@]3(O)C(=O)C(C)=C[C@H]32)[C@@H]2C(C)(C)[C@]12OC(C)=O
392024	392024:01:02_02.00	True	2.0	94	20.7	40.6	0.0	2.3	27.2	21.0	15.4	19.9	6.6	16.5	10.0	0.0	30.9	AKT_PI3K_MTOR	40.6		inhibitor of Akt1/2/3 (IC50 = 0.126/4/ 1.4 µM), inhibitor of Rho-associated protein kinase 1 (IC50 = 0.005 µM), inhibitor of Ribosomal protein S6 kinase alpha 5 (IC50 = 0.015 µM); Identification of 4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a Novel Inhibitor of AKT Kinase.    J Med Chem (2008),  51(18),  5663-5679.	False	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21
392226	392226:01:02_02.00	True	2.0	95	83.9	0.0	0.0	91.9	0.0	90.7	12.7	81.9	59.8	68.8	0.0	84.7	64.3	BET	91.9		Inhibitor of B-Raf V600E mutant (IC50 = 0.012 µM); Development of potent B-RafV600E inhibitors containing an arylsulfonamide headgroup. Bioorg Med Chem Lett. 2011 Aug 1;21(15):4436-40.	False	CC(C)c1nc(-c2cccc(NS(=O)(=O)c3ccccc3)c2)c(-c2ccnc(Nc3ccc4c(c3)CN(C)CC4)n2)s1
392064	392064:01:02_02.00	True	2.0	92	22.6	67.0	0.0	0.0	56.3	0.0	4.8	6.0	0.0	0.0	41.3	0.0	13.3	AKT_PI3K_MTOR	67.0		inhibitor of Rho-associated protein kinase 1 (IC50 = 0.009 µM); Development of Dihydropyridone Indazole Amides as Selective Rho-Kinase Inhibitors.    J Med Chem (2007),  50(1),  6-9.	False	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1
392604	392604:01:09_02.00	True	2.0	96	41.6	97.1	0.0	0.0	60.1	0.0	24.0	0.0	0.0	0.0	60.3	0.0	27.5	AKT_PI3K_MTOR	97.1	OSI-027	OSI-027 (ASP7486) is a potent, selective, orally active and ATP-competitive mTOR kinase activity inhibitor with an IC50 of 4 nM. OSI-027 targets both mTORC1 and mTORC2 with IC50s of 22 nM and 65 nM, respectively.	False	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12
392605	392605:01:09_02.00	True	2.0	86	44.0	28.8	0.0	54.4	0.0	49.5	37.1	57.9	29.7	49.5	0.0	63.7	64.4	Uncoupler	64.4	PP121	PP121 is a multi-targeted kinase inhibitor with IC50s of 10, 60, 12, 14, 2 nM for mTOR, DNK-PK, VEGFR2, Src, PDGFR, respectively. 	False	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1
391956	391956:01:02_02.00	True	2.0	76	23.8	45.3	34.0	0.0	95.7	0.0	7.0	0.0	0.0	0.0	75.5	0.0	0.0	DNA_Synth	95.7		inhibitor of Cyclin-dependent kinase 1/2 (IC50 = 0.01/0.0023 µM); Oxindole-Based Inhibitors of Cyclin-Dependent Kinase 2 (CDK2): Design, Synthesis, Enzymatic Activities, and X-ray Crystallographic Analysis.    J Med Chem (2001),  44(25),  4339-4358.	False	NS(=O)(=O)c1ccc(/N=N/c2c(O)[nH]c3ccc(-c4cnco4)cc23)cc1
392128	392128:01:02_02.00	True	2.0	101	11.2	0.0	0.0	64.6	0.0	66.5	3.8	50.4	38.9	34.1	0.0	47.8	28.2	HDAC	66.5		inhibits the cRAF1/MEK1/ERK2 signalling pathway (IC50 = 0.6 µM); Aza-stilbenes as potent and selective c-RAF inhibitors.  Bioorg Med Chem Lett.  (2006),  16(20),  5378-5383.	False	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1
391811	391811:01:02_02.00	True	2.0	95	6.4	0.0	27.2	14.0	38.1	0.0	0.0	17.0	0.0	3.7	0.0	42.5	0.0	Tubulin	42.5		inhibitor of Glycogen synthase kinase-3 beta (IC50 = 0.035 µM) and GSK3-alpha (IC50 = 0.035 µM); 6-heteroaryl-pyrazolo[3,4-b]pyridines: potent and selective inhibitors of glycogen synthase kinase-3 (GSK-3). Bioorg Med Chem Lett. 2003 Sep 15;13(18):3059-62.	False	O=C(Nc1[nH]nc2cc(-c3ccoc3)ccc12)C1CC1
280863	280863:01:09_02.00	True	2.0	96	5.7	34.6	0.0	0.0	58.2	0.0	0.0	8.8	0.0	0.0	42.7	0.0	0.0	DNA_Synth	58.2	PD 169316	PD 169316 is a potent, cell-permeable and selective p38 MAP kinase inhibitor, with IC50 of 89 nM. PD169316 selectively inhibits the kinase activity of the phosphorylated p38 without hindering upstream kinases to phosphorylate p38. PD169316 shows antiviral activity against Enterovirus71. PD169316 shows antiviral activity against Enterovirus71.	False	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1
392292	392292:01:02_02.00	True	2.0	101	6.2	76.2	0.0	0.0	68.9	0.0	0.0	0.0	0.0	0.0	58.7	0.0	9.6	AKT_PI3K_MTOR	76.2		inhibitor of IKK1/2 (IC50 = 0.25/0.04 µM), inhibitor of ROCK1 (IC50 = 0.02 µM); 4-Phenyl-7-azaindoles as potent and selective IKK2 inhibitors. Bioorg Med Chem Lett. 2009 May 1;19(9):2504-8.	False	NCCNS(=O)(=O)c1ccc(-c2ccnc3[nH]ccc23)cc1
344315	344315:01:04_10.00	False	10.0	83	34.9	0.0	0.0	60.6	0.0	56.9	26.1	35.2	34.4	87.0	0.0	57.3	64.3	Protein_Synth	87.0			False	O=C1NCc2ccccc2CN[C@@H](CO)C/C=C/COc2ccccc2CO1
344003	344003:01:03_10.00	True	10.0	82	40.6	53.0	25.8	0.0	89.6	0.0	9.5	0.0	0.0	0.0	94.0	0.0	0.0	Pyrimidine_Synth	94.0		Dihydroorotate dehydrogenase (DHODH; activity internally confirmed)	False	O=C(Nc1cccnc1)N1Cc2cccc(c2)CN(S(=O)(=O)C(F)(F)F)CC/C=C/C[C@@H]1CO
381768	381768:01:07_10.00	True	10.0	66	56.6	0.0	42.1	25.9	30.5	25.3	18.0	41.6	0.0	41.6	0.0	52.3	12.5	Tubulin	52.3	Autophinib	Autophinib is a potent, selective autophagy inhibitor with IC50s of 90 nM and 40 nM for starvation- and Rapamycin-induced autophagy, respectively. Autophinib is also an ATP competitive Vacuolar Protein Sorting 34 (VPS34) inhibitor with an IC50 of 19 nM. Autophinib inhibits autophagy induced by starvation or Rapamycin by targeting VPS34.; Angew. Chem. Int. Ed. 2017, 56, 8153	False	Cc1cc(Nc2cc(Cl)nc(Oc3ccc([N+](=O)[O-])cc3)n2)[nH]n1
287906	287906:02:09_10.00	True	10.0	98	38.3	0.0	0.0	59.1	0.0	64.6	28.2	79.9	21.7	28.8	0.0	62.0	34.9	LCH	79.9	Pipinib	Hedgehog pathway Inhibitor; targets PI4KIIIß.	False	COC(=O)c1ccc(Nc2nc(NC(C)C)nc3ccsc23)cc1
317004	317004:02:10_10.00	True	10.0	90	34.5	0.0	0.0	51.1	0.0	57.2	35.8	67.7	13.5	20.7	0.0	53.6	19.5	LCH	67.7	Smoothib	antagonist of the protein smoothened (SMO).; Angew. Chem. Int. Ed. 2017, 56, 13021	False	Cc1ccc(Cn2[nH]cc3nc(-c4ccc(N5CCN(C(=O)CCc6c[nH]c7ccccc67)CC5)cc4)nc2-3)cc1
391483	391483:01:09_10.00	True	10.0	85	9.0	30.4	0.0	0.0	41.0	0.0	49.7	4.9	0.0	0.0	45.2	9.1	0.0	HSP90	49.7	Chromopynone-1	glucose uptake inhibitor targeting glucose transporters GLUT-1 and -3.; Nat. Chemistry 2018, 10 and 1103	True	CCOc1cccc2c1O[C@]1(C)C[C@H]2NC(=O)N1c1cccc(C(=O)NCCc2ccc(C)cc2)c1
283242	283242:02:05_10.00	True	10.0	100	24.0	2.3	0.0	7.0	0.0	0.0	38.3	27.0	0.0	9.3	0.9	19.1	0.0	HSP90	38.3	Englerin A	highly efficient, fast-acting, potent, selective, and direct stimulator of transient receptor potential canonical (TRPC) calcium channels TRPC4 and TRPC5.; Angew. Chem. Int. Ed. 2015, 54, 3787	False	CC(C)[C@@]12C[C@@H](OC(=O)CO)[C@@](C)(O1)[C@@H]1CC[C@@H](C)[C@H]1[C@@H]2OC(=O)/C=C/c1ccccc1
392891	392891:01:08_10.00	True	10.0	84	66.3	0.0	0.0	80.2	0.0	78.9	19.7	92.2	34.6	46.7	0.0	70.0	53.0	LCH	92.2	Aumitin	inhibits mitochondrial respiration by targeting complex I.; Chem. Sci. 2018, 9, 3014	False	Cc1cc(Nc2ccccc2)nc(Nc2ccc(NC(=O)c3ccccc3Cl)cc2)n1
394120	394120:01:07_10.00	True	10.0	105	78.9	0.0	0.0	83.8	0.0	80.4	17.4	92.9	38.3	57.8	0.0	74.6	65.6	LCH	92.9	Autoquin	Autoquin is an autophagy inhibitor (IC50 = 0.56 µM). It accumulates in lysosomes and inhibits their fusion with autophagosomes. In addition, autoquin sequesters Fe2+ in lysosomes, resulting in an increase of lysosomal reactive oxygen species and ultimately cell death.; Angew. Chem. Int. Ed. Engl. 2020, 59 (14), 5721-5729. https://doi.org/10.1002/anie.201913712	True	C=CC1CN2CCC1CC2[C@@H](O)c1cc(-c2ccc(F)cc2)nc2ccc(OC)cc12
392584	392584:02:06_10.00	True	10.0	95	9.0	40.2	0.0	16.8	54.8	17.7	16.7	45.9	0.0	0.0	7.3	28.9	35.6	DNA_Synth	54.8	NVP-BHG712	NVP-BHG712 is an oral active EphB4 kinase autophosphorylation inhibitor, with IC50 values of 3.3 nM and 3.0 nM for EphA2 and EphB4, respectively.	False	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1Nc1nc(-c2cccnc2)nc2c1cnn2C
382185	382185:03:06_10.00	True	10.0	98	25.7	0.0	0.0	57.9	0.0	57.3	23.5	86.6	16.7	12.0	0.0	56.9	36.8	LCH	86.6	Aumitin	inhibits mitochondrial respiration by targeting complex I.; Chem. Sci. 2018, 9, 3014	False	Cc1cc(Nc2ccccc2)nc(Nc2ccc(NC(=O)c3ccccc3Cl)cc2)n1
408038	408038:01:06_10.00	True	10.0	94	26.1	7.0	0.0	74.5	0.0	71.9	35.5	85.0	33.5	57.9	0.0	69.6	69.0	LCH	85.0		MGH-CP1 is a potent and selective inhibitor of transcriptional enhanced associate domain (TEAD) palmitoylation. MGH-CP1 exhibits dose-dependent and potent inhibition of TEAD2/4 auto-palmitoylation in vitro with IC50 of 710 nM and 672 nM, respectively.	False	O=C(CSc1nc[nH]n1)Nc1ccc(C23CC4CC(CC(C4)C2)C3)cc1
408385	408385:01:05_10.00	True	10.0	88	45.1	70.5	2.3	0.0	90.8	0.0	4.8	0.0	0.0	0.0	94.9	0.0	0.0	Pyrimidine_Synth	94.9		Dihydroorotate dehydrogenase (DHODH; activity internally confirmed)	False	Brc1ccc2[nH]c3c(c2c1)CCOC31CCCCC1
408552	408552:01:05_10.00	True	10.0	79	79.1	0.0	0.0	88.5	0.0	84.4	18.4	81.3	57.0	69.4	0.0	91.9	62.4	Tubulin	91.9	Azaquindole-1	Azaquindole-1 inhibits starvation- and rapamycin-induced autophagy (IC50 = 0.04 and 0.1 µM, respectively) by targeting the lipid kinase VPS34 (IC50 = 0.35 µM).; Angew. Chem. Int. Ed. Engl. 2020. https://doi.org/10.1002/anie.202000364	True	COc1ccc2nccc([C@@H](O)[C@@H]3C[C@@H]4CCN3c3c4[nH]c4nc(C)c(Br)cc34)c2c1
